"p": 61 "95 ci": 54 "age": 52 "sex": 42 "gender": 36 "hr 95 ci": 34 "p value": 26 "1": 24 "n": 24 "hr": 23 "age years": 21 "p -value": 20 "p-value": 19 "variable": 16 "baseline": 16 " r": 15 "rep": 15 "cases": 15 "parameter": 14 "overall survival": 13 "patient": 13 "location": 13 "status": 12 "controls": 12 "diagnosis": 11 "or": 11 "group": 10 "histology": 10 "?": 9 " ": 9 "or 95 ci": 9 "variables": 9 "no.": 9 "sample": 9 "hazard ratio 95 ci": 9 "stage": 8 "reference": 8 "ref.": 8 "case": 8 "hazard ratio": 8 "site": 8 "id": 7 "cell line": 7 "genotype": 7 "patients": 7 "2": 6 "3": 6 "6": 6 "univariate hr 95 ci": 6 "karyotype": 6 "female": 6 "start/end": 6 "grade": 6 "se": 6 "copd": 6 "smoking status": 5 " 95 ci": 5 "gene": 5 "body weight g": 5 "univariate analysis": 5 "os": 5 "phase": 5 "drug": 5 "#": 4 "induced frequency": 4 "mouse strain": 4 "recurrence": 4 "latency": 4 "disease": 4 "fc ± se": 4 "metastasis": 4 "malignancy": 4 "adjusted or 95 ci": 4 "egfr": 4 "multivariate analysis": 4 "ave": 4 "factor": 4 "survival": 4 "pathology": 4 "diet": 4 "tumor type": 4 "n ": 4 "snp": 4 "pik3ca": 4 "mode of induction": 4 "dosage": 4 "multivariate stage-matched hr 95 ci": 4 "spontaneous frequency": 4 "7": 3 "8": 3 "current smoker": 3 "?dp/dt mmhg s?1": 3 "gene sequence": 3 "plasma": 3 "?2": 3 "?1": 3 "case/ctrl": 3 "tnm": 3 "condition": 3 "cancer weight g": 3 "comments": 3 "groups studied": 3 "wald": 3 "animal number": 3 "gene symbol": 3 "clinical features": 3 "treatment": 3 "ethnicity": 3 "characteristic": 3 "confidence limits": 3 "chi-square": 3 "company": 3 " mg?kg ?1 per day": 3 "relative risk": 3 "pr > chisq": 3 "colorectal cancer-specific mortality": 3 "differentiation": 3 "compound": 3 "age year": 3 "11": 3 "16": 3 "male": 3 "27": 3 "ic50 nm": 3 "characteristics": 3 "overall mortality": 3 "coronary flow ml min?1": 3 "ras status": 3 "histological grade": 3 "biomarker": 3 "references": 3 "disease-specific survival": 3 "lvedp mmhg": 3 "p a": 3 "rfs": 3 "animal body weight g": 3 "amino acid change": 3 "odds ratio": 3 "pten": 3 "ic50 95 ci": 3 "age at diagnosis": 3 "k-ras": 3 "ig × 10qd": 3 "survival months": 3 "p53": 3 "administration method": 3 "study": 3 "+dp/dt mmhg s?1": 3 "df": 3 "wald 95": 3 "origin": 3 "x±s.d.": 3 "breed": 3 "lower": 3 "lung": 3 "intercept": 3 "95.0 ci": 3 "p int *": 3 "upper": 3 "patient number": 3 "pmax mmhg": 3 "wt": 3 "inhibition": 3 "number of patients": 3 "efficiency": 3 "samples": 3 "range": 3 "her2": 3 "category": 3 "": 2 "8093": 2 "95 confidence interval": 2 "water consuption ml/animal/day": 2 "5": 2 "9": 2 "association rules": 2 "3 0-10": 2 "viral load copies/ml": 2 "multivariate stage-stratified hr 95 ci": 2 "after": 2 "tgt": 2 "h": 2 "t": 2 "egfr fish": 2 "?4": 2 "?3": 2 "chd": 2 "p inter b": 2 "death rate": 2 "citation": 2 "0.5 mg": 2 "crude analysis": 2 "primary end-point": 2 "mutation": 2 "pfs": 2 "p?": 2 "?2": 2 "?1": 2 "syndrome": 2 "anca": 2 "function": 2 "comparison": 2 "flt3": 2 "final body weight g": 2 "metabolite": 2 "no of deaths/cases": 2 "grading": 2 "clinicopathological parameters": 2 "or 95 ci c": 2 "cell lines": 2 "gender m/f": 2 "hsct": 2 " weight increase": 2 "weight": 2 "?high": 2 "scd samples": 2 "yes": 2 "rate ± se": 2 "wilcoxon signed-rank": 2 "lna": 2 "identifier": 2 "? †": 2 "heterogeneity": 2 "est 95 ci": 2 "before": 2 "n events": 2 "spec .": 2 "specimen": 2 "sens .": 2 "braf qpcr": 2 "?low": 2 "average": 2 "p trend a": 2 "braf": 2 "dha": 2 "0.01": 2 "?median range": 2 "hcmv seropositivity ": 2 "study design": 2 "training set": 2 "?female": 2 "14.40": 2 "after treatment": 2 "delivery route": 2 "max": 2 "size cm": 2 "cirrhosis": 2 "current status": 2 "kras status": 2 "10": 2 "12": 2 "13": 2 "18": 2 "22": 2 "seizure": 2 "risk group": 2 "min": 2 "birth weight sds": 2 "35": 2 "39": 2 "initial body weight g": 2 "fish": 2 "hr ci": 2 "t-test": 2 "sample number": 2 "98": 2 "perk ihc": 2 "p -value a": 2 "msi": 2 "flt3-wt aml": 2 " mrna": 2 "score": 2 "study reference patients": 2 "aae": 2 "test set": 2 "p ‡": 2 "p †": 2 "p 1": 2 "tumor incidence": 2 "rassf1a": 2 "ref": 2 "median age": 2 "p b": 2 "primary site": 2 "healthy bmmb": 2 "deaths/ person-years": 2 "birth length sds": 2 "aga": 2 "relative risk 95 ci": 2 "epa": 2 "other": 2 "placental weight g": 2 "outcome": 2 "snp array": 2 "who classification": 2 "cancer type": 2 "progression": 2 "patient no.": 2 "no patients": 2 "risk factor": 2 "ercc2-": 2 "protein": 2 "tumor weight g": 2 "patient #": 2 "sl no.": 2 "gag p19+": 2 "body weight gain g": 2 "ldl cholesterol mg/dl and hs-crp mg/l values": 2 "sample name": 2 "fab": 2 "tissue": 2 "amplification of 7q34": 2 "total cases": 2 "gag p19?": 2 "clinical group": 2 "nup": 2 "baseline included": 2 "effect": 2 "age years mean": 2 "kras": 2 "age/sex": 2 "u937": 2 "b2": 2 "adj hr": 2 "patient#": 2 "metaprog/n": 2 "deaths": 2 "aa": 2 "? increase bmd": 2 "no of events": 2 "hr 95 ci *": 2 "ostium": 2 "<0.0001": 2 "patient/": 2 "fn": 2 "avg age": 2 "cancer-specific survival": 2 "hf": 2 " n?=?100": 2 "tumor location": 2 "model": 2 "gefitinib": 2 "line-1 methylation tertiles": 2 "la": 2 "lf": 2 "22 23.4": 2 "ls": 2 "mutations": 2 "event rate": 2 "95 ci p value": 2 "aah samples": 2 "ercc1": 2 "no": 2 "oa": 2 "total": 2 "subtype": 2 "src": 2 "control": 2 "104": 2 "cytogenetics": 2 "2 0-8": 2 "activity": 2 "before treatment": 2 "?wild type": 2 "bcss": 2 "?mutation": 2 "mean age years": 2 "country": 2 "cell type": 2 "mean survival 95 ci months": 2 "variant": 2 "fully adjusted model": 2 "number n": 2 "exp b": 2 "normal": 2 "type": 2 "idh2": 2 "baseline not included": 2 "treatments n?=?6/group": 2 "?unavailable": 2 "carboplatin+paclitaxel": 2 "inhibitor": 2 "tissue type": 2 "disease-free survival": 2 "15 mg": 2 "?male": 2 "groups": 2 "p trend": 1 "proteome profiler array": 1 "geo accession": 1 "median ± se": 1 "r 2": 1 "nrp1*": 1 "hra 95 ci": 1 "0.660": 1 "d7s486 fish": 1 "23 16 ": 1 "0.662": 1 "87 32": 1 "event rate/100-person years rosuvastatin 20 mg group": 1 "212 51": 1 "operated position": 1 "simple or 95 ci": 1 "perinatal": 1 "cda": 1 "86.10": 1 "338 49": 1 "department hepatology": 1 "n = 40": 1 "cdi": 1 "dfs at 10 years": 1 "+": 1 "small rna": 1 "mtoc orientation": 1 "0": 1 "aeff °": 1 "size": 1 "4": 1 "clinical outcome": 1 "birc3*": 1 "10.7": 1 "p53 staining c": 1 "86.40": 1 "primary enzymes involved in metabolism": 1 "p16 methylation in nonsmoker": 1 "mthfr a1298c": 1 "publication treatment": 1 "50.90": 1 "3 0-13": 1 "result": 1 "tgc": 1 "49.50": 1 "ptpn2 exp": 1 "patients ": 1 "aneuploidy": 1 "spontaneous growth assay": 1 "20 21.2": 1 "accuracy patterns ": 1 "antiepileptic drugs": 1 "treatment intensity": 1 "clinical staging": 1 "i": 1 "?1": 1 "m": 1 "?0": 1 "b_pbmc": 1 "cfs": 1 "?3": 1 "melanoma family history": 1 "?2": 1 "v1 §": 1 "w": 1 "6.3": 1 "pe/co gest age weeks": 1 "no biopsies": 1 "target neurons": 1 "cord blood": 1 "years of follow up": 1 "20.802": 1 "protein content of infant diet g/100?ml": 1 "nsclc histology subtype": 1 "154 51": 1 "?0": 1 "r140": 1 "histotype": 1 "others": 1 "hypoxia": 1 "cardiovascular system": 1 "ddpcr copy numbers": 1 "5-year ": 1 "13.90": 1 "r132": 1 "cht": 1 "mirna": 1 "5.983": 1 "xrt": 1 "median survival months 95 ci": 1 "target kinase s": 1 "?f": 1 "4.38 1.15–53.2": 1 "young": 1 "?m": 1 "13.60": 1 "28 4": 1 "esr mm/1 hour": 1 "tki": 1 "combined study": 1 "? nras": 1 "ci ed50": 1 "49.10": 1 "survival period month": 1 "tissue no.": 1 "122 29": 1 "ratio wis/ws": 1 "9.193": 1 "?nf-1 phenotype": 1 "monocytes 109/l median range": 1 "?baseline": 1 "12 months": 1 "cancer": 1 "psa at surgery": 1 "?larynx": 1 "plasma mg/100 ml": 1 "subject age range mean": 1 " e0–e12": 1 "age mean": 1 "co samples": 1 "adjustment for control weight ±s.d.": 1 "17.90": 1 "hr cont §": 1 "23.250": 1 "gender a": 1 "1.074": 1 "suggested threshold for response or concentration attained in therapy mg/l": 1 "cll 172": 1 "recurrence rr 95 ci": 1 "tnm stage": 1 "15 2": 1 "anticancer drug": 1 "risk of progressive disease* ": 1 "1 h/24 h": 1 "102 16": 1 "r172": 1 "pdgfrb/csf1r": 1 "treatment line": 1 "12 years 10–18 months": 1 "90 ci": 1 "toxins": 1 "cancers": 1 "ltbp1*#": 1 "gage7*": 1 "extremity sensory loss": 1 "sensitivity 95 ci": 1 "number of prior therapies": 1 "?0": 1 " n?=?200": 1 "smo status": 1 "urinary levels": 1 "?4": 1 "ee2 conc ng/l a": 1 "?3": 1 "breast pancreas and prostrate 106 .": 1 "nutritional state": 1 "subject 1": 1 "subject 2": 1 "treatment days": 1 " mg/kg se": 1 "29.40": 1 "uremic toxins": 1 "graf level": 1 "1.061": 1 "low hdl cholesterol <1·0 mmol/l male <1·3 mmol/l female": 1 "disease association": 1 "rf +/?": 1 "fuhrman grade": 1 "1.065": 1 "best response": 1 "pesf °": 1 "specimentime torelapse years": 1 "incidence of cataracts ": 1 "rna integrity number": 1 "ultrasonography": 1 "7 11.7": 1 "nhlbi exomes maf ": 1 "3 or more of the following": 1 " e12–e17": 1 "0.22*": 1 "4 14": 1 "ampk status": 1 "gender male": 1 "snps major/minor": 1 "0.694": 1 "ppv 95 ci": 1 "smoking characteristic n ": 1 "snps": 1 "mycn on": 1 "weight 48 hours prior to harvest average ± st dev n": 1 "arsenic as": 1 "plasma protein binding ": 1 "?positive": 1 "k-ras status": 1 "cqu": 1 "?both ?7 and +8": 1 "lung cancer presence": 1 "vascular invasion": 1 "?>618 u/l": 1 "215": 1 "muscle": 1 "years of follow-up": 1 "218": 1 "histopathological diagnosis": 1 "lvdd mm": 1 "12 weeks post-ovx": 1 "patient survival months median range": 1 "department": 1 "tgf ? probability of high tgf? tgf? > 0 pg/ml": 1 "0.238": 1 "p-egfr": 1 "role/function": 1 "tissue sample": 1 "plasma testosterone level ng/ml": 1 " a prognostic indices/univariate model": 1 " vascular relaxation compared to baseline": 1 "74.20": 1 "ldh": 1 "222": 1 "huvecs": 1 "stage iv patients": 1 "ldl": 1 "detection method": 1 "tma population": 1 "cmet ihc": 1 "3–8": 1 "first author": 1 "rps3a expression": 1 "230": 1 "?": 1 "235": 1 "p-450 inhibited": 1 "? 2": 1 "medications": 1 "rad21 positive": 1 "11 4": 1 "adenocarcinomas": 1 "241": 1 "a/a": 1 "lung weight g mean±s.d.": 1 "gene title target description/symbol": 1 "245": 1 "hypogonadism polycystic ovarian syndrome pcos and erectile dysfunction 104 .": 1 "relapse free survival": 1 "b-raf status": 1 "3.60": 1 "exon 9": 1 "dispersed": 1 "experimental groups number of patients": 1 "facial nerve involvement": 1 "treatmentprior to surgery": 1 "multivariable analysis *": 1 "259": 1 "rs391957 gg": 1 "cadmium cd": 1 "time min": 1 "acth treatment": 1 "?unknown": 1 "ig-type": 1 "262": 1 "odds ratio 95 ci and genotype": 1 "265": 1 "hbf median range": 1 "162 49": 1 "disease duration years": 1 "tumor id": 1 "number of ara-criteria ra": 1 "p-erm *": 1 "age yr": 1 "source": 1 "?<3.5 g/dl": 1 "mean survival time months": 1 "274": 1 "uninfected control subject": 1 "npm1": 1 "?poorly": 1 "neurofibromas": 1 "study group from": 1 "pt#": 1 "3.825": 1 "m stage": 1 "?supratentorial": 1 "ldh u/l": 1 "ggt culture": 1 "median": 1 "overall": 1 "hbv": 1 "82.10": 1 "psd": 1 "agbl5": 1 "f4 cirrhosis": 1 "hcc": 1 "291": 1 "nirf phenotype": 1 "house": 1 "total no.": 1 "metastases": 1 "progressors": 1 ".15": 1 "l4-l6 vertebrae mean bmd g/cm 2 ": 1 ".16": 1 "recurrent tumor": 1 "527 81": 1 "iii and iv": 1 "microarrays plataform": 1 "hcv": 1 "tissue source": 1 "ptc": 1 "total n": 1 "estradiol pg/ml": 1 "pathological type": 1 "plasma membrane": 1 "center": 1 "lens weight mg": 1 "hcv and/or hbv": 1 "0.199": 1 "tnm *": 1 "unmethylated": 1 "pigmentation": 1 "best marrow post–tx blasts": 1 "70.60": 1 "mc / cc": 1 "0.192": 1 "albumin": 1 "clinic stage": 1 "sex m/f": 1 "clinical diagnosis": 1 "rs391957 ag": 1 "n/a": 1 "beta 2": 1 "consistency": 1 ".35": 1 "5-yr dfs ": 1 "wald-chisquarestatistics": 1 "measures": 1 "subgroups": 1 "tumor parameters": 1 "ird ": 1 " ihc": 1 "line1 cpg site": 1 "95 ci months": 1 "rs391957 aa": 1 "control zinc diet ": 1 "hypertriglyceridaemia triglycerides ?1·7 mmol/l": 1 "lisch nodule": 1 "blood vs marrow": 1 "alta iu/l": 1 "sample size n": 1 "lns": 1 "positivity ": 1 "dbsnp id": 1 "pdgfra exon 18 mutation": 1 "calculated risk": 1 "primary": 1 "5-year survival ": 1 "loc": 1 "cerebellar ataxia": 1 "cetux inhib.": 1 "low zinc diet ": 1 "p16 methylation in smoker": 1 ".55": 1 "drugs c": 1 ".59": 1 ".005": 1 "154 35": 1 "13 2–109": 1 "trial description": 1 "tumor size cm median range": 1 "mmp9": 1 "fine needle biopsy": 1 "metastatic disease ": 1 "dementia onset yrs": 1 "5 8.3": 1 "59.2": 1 "geneid": 1 "59.8": 1 "pten ihc": 1 "toxins eg alcohol tobacco aflatoxins": 1 "egfr status": 1 "time point 3": 1 "13.00": 1 "time point 4": 1 "controls**": 1 "gender male/female": 1 "uca": 1 "1.833": 1 "hiv": 1 "patient status": 1 "time point 1": 1 "time point 2": 1 "uci": 1 "56.7±12.5 yrs": 1 "ic50 95 ci * ": 1 "26 10": 1 "liver weight": 1 "urine samples": 1 "serum salicylates mg/l †": 1 "ggt -infected wheat roots": 1 "?mixed": 1 "human offspring": 1 "33.70": 1 "lonafarnib": 1 "jejunum/ileum": 1 "nuclear morphology": 1 "23 24.5": 1 "altitude m": 1 "p53 mutations b": 1 "tumor size/cm": 1 "reference factor": 1 "cd8 counts cells/?l": 1 "70.3 29.2–91.2": 1 "followup": 1 "pik3ca status": 1 "mean": 1 "median pfs 95 ci months": 1 "additional therapy": 1 "lvef ": 1 "ihq mmr loss": 1 "290 65": 1 "status at the time of blood sample": 1 "areg probability of high areg areg ? 23.8 pg/ml": 1 "relative risk * with 95 ci": 1 "0.788": 1 "heavy metals": 1 "event of mapping": 1 "0.785": 1 "0.302": 1 "rare se": 1 "percent of lymphoid cells absolute numbers/mm3": 1 "heterogeneity sources": 1 "tumor volume at presentation": 1 "virus stain": 1 "peripheral blood blast day 1": 1 "tumor reference": 1 "neutrophils 103/?l": 1 "histology code": 1 "transmittance": 1 "51.50": 1 "hspa8*": 1 "population": 1 "dfs": 1 "dose": 1 "relapse c months": 1 "medication history": 1 "ischemic time": 1 "age mean±s.d.": 1 "txnl2*": 1 "relative": 1 "organ": 1 "0.325": 1 "afp serum level": 1 "ci mean ± sd at ed50": 1 "1?g/ml hg slr change/fold change": 1 "nilotinib": 1 "tumor pigmentation**": 1 "hip2k qpcr": 1 "108 40": 1 "patients age years median range": 1 "animal model offspring": 1 "87.00": 1 "enos": 1 "age at resection": 1 "variables *": 1 "hpv": 1 "55.891": 1 "sim µm": 1 "disease activity index": 1 "serum": 1 "dia": 1 "fabsubtype": 1 "echocardiographic measurements": 1 "differe-ntiation": 1 "cardiac catheterization data": 1 "risk of relapse a": 1 "relation to survival": 1 "12–20": 1 "trail": 1 "habit": 1 "0.02": 1 "stress tac": 1 "0.03": 1 "pik3ca amplifivation": 1 "test": 1 "fistulotomy n=8": 1 "ascorbic acid post mm": 1 "s100": 1 "analysis assay": 1 "ch10 map position": 1 "minor allele frequency 1": 1 "87.50": 1 "follow-up mo": 1 "0.763": 1 "nodal metastasis": 1 "absolute hbf": 1 "title": 1 "normoglycemic mother n?=?6": 1 "size & age": 1 "duration": 1 "brain region": 1 "prostate 3 ha": 1 "pleural invasion": 1 "gestational age weeks": 1 "methylated": 1 "n stage": 1 "er+/pr+ cancer versus healthy": 1 "biological replicate": 1 "87.40": 1 "hypertension blood pressure ?130/85 mm hg or medication": 1 "meta-analysis": 1 "0.43": 1 "lethal activity 1": 1 "vitamin c supplementation/day": 1 "klk2*": 1 "rra 95 ci": 1 "ns d": 1 "obstructive sleep apnea osa 103 .": 1 "ex20/ex9 prevalence ratio 95 ci": 1 "or 1": 1 "95 ci of median": 1 "9 16 ": 1 "1.194": 1 "sample id": 1 "0.55": 1 "450 69": 1 "selenium form": 1 "crp a mg/l": 1 "or $": 1 "mib index ": 1 " blasts pb/bm": 1 "0.380": 1 "stadium": 1 "specimen#": 1 "cfs × gender": 1 "1634.6": 1 "tki duration": 1 "csf concentration": 1 "upf": 1 "alive/dead": 1 "t stage": 1 "tx status": 1 "3?g/ml hg slr change/fold change": 1 "0.62": 1 "age weeks": 1 "disease latency a": 1 "year *": 1 "upn": 1 "?hypopharynx": 1 "adverse effects": 1 "83.50": 1 "death yrs": 1 "tk mut": 1 "skin": 1 "trial #": 1 "0.75": 1 "#aberrations": 1 "total weight loss kg": 1 "targets": 1 "geometric ls mean": 1 "?no adjuvant": 1 "rtvc mean ": 1 "or2 b": 1 "number taking drug percentage": 1 "205 32": 1 "0.89": 1 "neonate": 1 "0.86": 1 "positive": 1 "histology type": 1 "g1-g2": 1 "agents": 1 "0.83": 1 "?infratentorial": 1 "tu location": 1 "0.91": 1 "cells injected": 1 "inheritance": 1 "polymorphism": 1 "median follow-up years": 1 "?-1-antitrypsin deficiency": 1 "hr 95 ci 2 vs 0/1": 1 "3 5.0": 1 "plasma lipid/stenosis/icr": 1 "1.152": 1 "ref #": 1 "induction of diabetes": 1 "co-treatment": 1 "79.5±14.9": 1 "smoking history": 1 "position": 1 "?range": 1 "em fibrils": 1 "rmh score": 1 "47 7": 1 "cafe-au-lait spots": 1 "dss": 1 "rs number": 1 "mec": 1 "peripheral blood": 1 "rbc 106/?l": 1 "mitotic count/50 hpf": 1 "duration >": 1 "men": 1 "64 15": 1 "relative risk/odds ratio": 1 "sl ?m": 1 "12 4": 1 "4.00": 1 "pazopanib targets ?": 1 "storage time days": 1 "study group": 1 "chronic hepatitis b c and d": 1 "0.357": 1 "immuno": 1 "h3k9me2 label": 1 "rad001": 1 "prostate cancer": 1 "human ckd non-diabetic": 1 "last fo low-up": 1 "diabetic nephropathy": 1 "cases n?=?442": 1 "sponsor/pi": 1 "prior therapies": 1 "histological subtype mucin producing": 1 "b/t": 1 "hsp27 staining score": 1 "23 aug 2009": 1 "22.30": 1 "mthfr c677t": 1 "carcinomas": 1 "mutational status": 1 "59 13": 1 "phagosome age": 1 "lc50 values 95 confidence interval": 1 "pt stage": 1 "all pts 217": 1 "14": 1 "zan": 1 "230 33": 1 "19": 1 "rap a/v/m": 1 "47 11": 1 "58.00": 1 "symptom": 1 "full cohort": 1 "pathological grade": 1 "geno x diet": 1 "total months on haart": 1 "20": 1 "21": 1 "tumor weight g median range": 1 "b1r": 1 "25": 1 "26": 1 "28": 1 "60 14": 1 "29": 1 "experiments": 1 "asbestos exposure": 1 "later life": 1 "tet21 n": 1 "sample type": 1 "30": 1 "authors year": 1 "31": 1 "32": 1 "33": 1 "34": 1 "56 9": 1 "expression": 1 "b2r": 1 "childhood": 1 "antigen expression": 1 "38": 1 "216.83": 1 "moderate chronic asthma": 1 "central obesity waist circumference >102 cm male >88 cm female": 1 "indication for discontinuation": 1 "0.0001": 1 "platelets 106/?l": 1 "operation": 1 "group a": 1 "42": 1 "43": 1 "44": 1 "48": 1 "ci at fa 0.5": 1 "ci at fa 0.9": 1 "ajcc staging colorectal cancer": 1 "?normal": 1 "dacom.ic50 g": 1 "rs2124344 cc pemt intron": 1 "healthy kidney": 1 "40–56": 1 "64 1-165": 1 "diameter": 1 "reported effects from literature": 1 "50": 1 "52": 1 "128 31": 1 "retinal sorbitol nmol/mg protein *": 1 "55": 1 "56": 1 "57": 1 "prognostic ?": 1 "hyperglycemic mother n?=?6": 1 "58": 1 "59": 1 "hf diet rats hfd": 1 "mln": 1 "286 68": 1 "coefficient": 1 "108.630": 1 "hr ‡": 1 "biopsy no.": 1 "60": 1 "62": 1 "66": 1 "vitamin c level": 1 "proteinuria mg/24h": 1 "s_pmn": 1 "proteinuria": 1 "father": 1 "66.5?±?10.2": 1 "leukemia/mice": 1 "systolic blood pressure mm hg": 1 "autoimmune hepatitis": 1 "71": 1 "73": 1 "coronary heart disease chd myocardial infarction mi and stroke 105 .": 1 "78": 1 "cohort 2 multilinear analysis glm individual samples": 1 "baseline*": 1 "sflt1": 1 "healthy": 1 "80": 1 "comment": 1 "n =50": 1 "controls n?=?543": 1 "homozygous family members bmi": 1 "sample code": 1 "89": 1 "p=0.2772": 1 "0.703": 1 "1.508": 1 "??618 u/l": 1 "relation": 1 "half-life h": 1 "1.512": 1 "patients total number": 1 "time since diagnosis months": 1 "210 30": 1 "90": 1 "pten mutated exons": 1 "bez235": 1 " blasts 1": 1 "99": 1 "14.20": 1 "discovery study": 1 "donor’s id": 1 "ihc": 1 "var": 1 "pap s/d/m": 1 "?women": 1 "mean concentration pg/ml": 1 "43.9±34.9 cm3": 1 "20 may 2009": 1 "reported effect on anril expression": 1 "patient's age": 1 "rectum": 1 "70.4 17.1–94.6": 1 "relative telomere length": 1 "2.770": 1 "0.722": 1 "4 1": 1 "co-expression of phosphorylated targets": 1 "+/+": 1 "iii": 1 "gender no ": 1 "median age range – years": 1 "diet and treatment": 1 "pazopanib ic50 µm †": 1 "66.30": 1 "other information": 1 "3.102": 1 "66.1?±?12": 1 "replication": 1 "hypo methylation": 1 "mri": 1 "nucleus": 1 "kit exon 9 mutation": 1 "1.986": 1 "fasting plasma glucose ?6·1 mmol/l": 1 "who classification*": 1 "lymph node metastasis n": 1 "braf mutation association": 1 "rs2124344 ct-tt pemt intron": 1 "mrna population": 1 "pdgfrb": 1 "?astrocytoma grade iii": 1 "340 52": 1 "18.558": 1 "transactivation class * ": 1 "growth phase": 1 "46.40": 1 "increased serum transaminase nonalcoholic steatohepatitis nash nonalcoholic fatty liver disease nafld hepatic fibrosis and cirrhosis 100 .": 1 "1.950": 1 "ensat 2008 stage": 1 "gr nescre": 1 "ci at ed 50 ±s.d.": 1 "treatment group a": 1 "607 87": 1 "pairwise comparision": 1 "stage group at diagnosis- ajcc 6th ed .": 1 "total n=1214": 1 "lymphedema diagnosis": 1 "overall risk profile": 1 "sequence": 1 "rupp": 1 "reperfusion time": 1 "intervention": 1 "1.960": 1 "sensitivity ": 1 "relation to clinicopathological factors": 1 "death": 1 "?female": 1 "common se": 1 "non-progressors": 1 "ocular": 1 "age at diagnosis y": 1 "non-producer": 1 "saline n?=?10": 1 "serum leucine levels ? mol/l": 1 "pik3ca mutation association": 1 "sec61?*": 1 "equivalent human age": 1 "msi status": 1 "gene deleted": 1 "wbc 103/?l": 1 "inf": 1 "tumorgrade": 1 "16.5 0.6–69": 1 "multivariable": 1 "8.40": 1 "proband": 1 "? kras": 1 "?well": 1 "patient sex": 1 "locus": 1 "age of animal": 1 "lad mm": 1 "pmi hrs": 1 "year": 1 "?iv": 1 "accuracy": 1 "chr a": 1 "spouse": 1 "transplanted organ": 1 "p493-6": 1 "b+pmn": 1 "cells showing receptor ": 1 "ir ": 1 "peff °": 1 "cd3eap q504k#": 1 "mean age ±sd": 1 "body fat loss kg": 1 "?ii": 1 "proliferation profiles": 1 "0.898": 1 "neurotrophic factor": 1 "0.417": 1 "fracture rrr": 1 "mlh1 methylation": 1 "wt kras responders ": 1 "373 57": 1 "adolescence": 1 "?astrocytomas grade iv": 1 "adenomas": 1 "0 0": 1 "pde4a*": 1 "hyper/hypo": 1 "202 31": 1 "mt kras ": 1 "aah": 1 "?major salivary glands": 1 "association with prognosis": 1 "16.000": 1 "52.30": 1 "sleep": 1 "? -fetoproteina ng/ml": 1 "cell/tumor": 1 "1 h/6 h": 1 "average ci": 1 "elevated": 1 "1.211": 1 "false discovery rate": 1 "arms-qpcr": 1 "wild-type family members bmi": 1 "cohort size": 1 "metastatic progression": 1 "10.393": 1 "onset": 1 "a prevention rate ": 1 "duodenum": 1 "predictions": 1 "pharmacological therapy": 1 "histiocytes": 1 "pi3k inhibitor": 1 "uv blockage ": 1 "?nd": 1 "nyha class": 1 "possible ptc-subtype": 1 "hras status": 1 "risk groups": 1 "30?/0?": 1 "27.00": 1 "age and hematological features at diagnosis": 1 "385 87": 1 "cimp": 1 "rr or hazard ratio hr 95 ci": 1 "nefh*": 1 "cdna flj45990": 1 "?no mutations": 1 "??diabetes mellitus": 1 "wbc 109/l median range": 1 "cell lines d": 1 "cd4 counts cells/?l": 1 "0.889": 1 "15.00": 1 "reproductive system": 1 "status d months": 1 "47.70": 1 "mlh1 expression": 1 "end": 1 "prognostic weight 0–100": 1 "3.267": 1 "differentiation grade": 1 "? ptpn11": 1 "proteomics": 1 "100 15": 1 "significance": 1 "33 july 2010": 1 "prognostic association": 1 " weight loss as ffm": 1 "localization": 1 "mean survival years": 1 "lbw mean±sd": 1 "os m": 1 "85 13": 1 "years": 1 "treatment duration": 1 "number": 1 "histological diagnosis no animals": 1 "risk level": 1 "who grade *": 1 "imaging test every 3 years": 1 "84.00": 1 "microalbuminuria hypofiltration hyperfiltration glomerulomegaly focal segmental glomerulosclerosis and chronic kidney disease 99 .": 1 "ahr": 1 "0.016": 1 "+/?": 1 "0.014": 1 "karnofsky score": 1 "or1 a": 1 "authors": 1 "312 48": 1 "leucine content of infant diet mg/100?ml": 1 "major metabolites": 1 "mean ci": 1 "survival *": 1 "ratio of fed/fasted": 1 "cell": 1 "fabric status": 1 "# events/# patients*": 1 "0.047": 1 "sphincterotomy n=8": 1 "38 63.3": 1 "p value significance": 1 "age sex": 1 "number of lung cancer cases": 1 "43.048": 1 "lgr6*": 1 "0.032": 1 "40 42.6": 1 "treatment group": 1 "species": 1 "i 2 ": 1 "12 12.8": 1 "pathological t stage pt no ": 1 "gage7*#": 1 "methylation alterations b": 1 "?? 3.5 g/dl": 1 "tumor depth pt": 1 "type of infant diet": 1 "diet-induced obese rats dio": 1 "trial": 1 "bmi1*": 1 "238 87": 1 "copy number alterations": 1 "dukes": 1 "11 18.3": 1 "stress mi": 1 "patient bmi sds": 1 "no of animals n": 1 "egfr gene status": 1 "genotype nf1 gene mutation": 1 "odds ratio 95 ci": 1 "mol weight": 1 "dx/rel": 1 " senescent cells **": 1 "number of patients/recurrence/death": 1 "458": 1 "yes/no": 1 "4/22": 1 "auc h × ng ? ml ?1": 1 "18/22": 1 "localisation": 1 "8.547": 1 "bioavailability oral ": 1 "up-regulated": 1 "any": 1 "cd14?": 1 "?not determined": 1 "sex status": 1 "0.1": 1 "age mo date": 1 "kdelr1": 1 "death/retrieval time hours": 1 "maximum diameter cm": 1 "lifetime crc risk": 1 "anatomic site": 1 "rectal prolapse n=6": 1 "node positive ": 1 "9 2": 1 "retinal fructose nmol/mg protein *": 1 "cytogenetic risk group": 1 "hepatic": 1 "caco-2": 1 "or ci effect size": 1 "physical/chemical/clinical properties": 1 "validation n ?=?336": 1 "inppl1 p.t180a": 1 "aphasia": 1 "hazard ratioa": 1 "p value vs benign meningioma": 1 "tnm stage age and sex b": 1 "fa-treated n?=?10": 1 "nr series": 1 "histological findings": 1 "172 63": 1 "vgf gene qmsp negative": 1 "amplification": 1 "maximal tumor diameter": 1 "?male": 1 "optic glioma": 1 "methylation status of tumor biopsies": 1 "5.00": 1 "days at altitude": 1 "11.00": 1 "risk score": 1 "asta iu/l": 1 "relative risk or odds ratio": 1 "ws proteins mass mg": 1 "mel 60/30 or nevus 60/30": 1 "all patients": 1 "36–82": 1 "2.804": 1 "patient age": 1 "backbone": 1 "patient neuro-behavioural phenotype": 1 "blood parameter": 1 "total sample": 1 "diet intake": 1 "?-coefficient": 1 "no of deaths": 1 "c-myc on": 1 "association with hcc risk": 1 "viral load copies/ ml": 1 "tumor": 1 "ash": 1 "methylationb": 1 "cut-off value": 1 "regional lymph nodes": 1 "retroauricular skin b": 1 "fibrosis stage": 1 "wis proteins mass mg": 1 "mother": 1 "mouse": 1 "mitotic index": 1 "performance status": 1 "animal group": 1 "tobacco use": 1 "ci at ed 90 ±s.d.": 1 "exon 20": 1 "body mass index": 1 "acanthosis nigricans lichen planus systemic lupus erythematosus burn-induced insulin resistance psoriasis androgenetic alopecia skin tags skin cancer and acne inversa 101 .": 1 "auc a": 1 "parameters": 1 "expressiona": 1 "gastric": 1 "fuhrman nuclear grade no ": 1 "peripheral blood blast day 15": 1 "negative": 1 "training n ?=?976": 1 "18.80": 1 "43.30": 1 "61 27-82": 1 "resected tissue": 1 "prv µm": 1 "gene title": 1 "patient's sex": 1 "dmel": 1 "hypo": 1 "delivery": 1 "race": 1 "htlv-1-infected subjects": 1 "# significantly different proteins": 1 "genotypes": 1 "?iii": 1 "probe set id affymetrix": 1 "ln metastasis": 1 "target": 1 "gist": 1 "hr/or/rr 95 ci highest vs lowest": 1 "specificity 95 ci": 1 "tnm_n": 1 "breslow depth": 1 "family history": 1 "tnm_m": 1 "wbc": 1 "73 12": 1 "73 10": 1 "tnm_t": 1 "550 84": 1 "level of": 1 "5 1": 1 "experimental": 1 "cart": 1 "17 16 ": 1 "liver weight/100 g": 1 "?median": 1 "patient characteristics": 1 "t max h": 1 "cohort 2 cfs proteome": 1 "colonoscopy findings": 1 "primary/secondary?": 1 "lymphatic invasion": 1 "function/ relation to malignancy": 1 "genbank accession n o": 1 "5-yr os ": 1 "age years/sex": 1 "relative risk rr 95 confidence interval ci": 1 "geno": 1 "tumor sample": 1 "signficance 3": 1 "univariable analysis *": 1 "non-diet controls ndc": 1 "0.809": 1 "0.806": 1 "ascorbic acid minimum pre mm": 1 "msh2 expression": 1 "bone marrow µg/108 cells": 1 "59 62.8": 1 "cause of death": 1 "egfr *": 1 "post-exposure sample": 1 "onset of symptoms": 1 "older": 1 "categories": 1 "pathology grade": 1 "f1-2": 1 "h&e": 1 "?moderate": 1 "socs3 ko": 1 "cd4 cells/ ?l": 1 "main presenting symptom": 1 "6.001": 1 "a ptch1 and smo mutation status": 1 "severe chronic asthma": 1 "?mucinous": 1 "0.829": 1 "0.1219": 1 "engraftment": 1 "ki-67": 1 "mild chronic asthma": 1 "pathologic diagnosis": 1 "met fish": 1 "bmi1*#": 1 "risk allele": 1 "first symptom s": 1 "body weight": 1 "protocol": 1 "cebpa": 1 "wbc ×109/l": 1 "37 61.7": 1 "total mortality rr 95 ci": 1 "follow-up months****": 1 "15 25.0": 1 "hyper": 1 "random-effects model": 1 "strain": 1 "gene s": 1 "35.20": 1 "2.400": 1 "age at surgery years": 1 "tu size": 1 "effects": 1 "altered mental status": 1 "activated node": 1 "metastasis-free survival": 1 "producer": 1 "sponsor": 1 "last status***": 1 "11.40": 1 "marrow pre-tx blasts": 1 "kit exon 11mutation": 1 "lead pb": 1 "624.6": 1 "egfr hirsch": 1 "??7": 1 "rt-pcr": 1 "association between pik3ca mutation and prognosis ": 1 "adpgk": 1 "matts’ score a": 1 "67.40": 1 "chromosome location": 1 "lymphoma types": 1 "# of clusters": 1 "399#": 1 "plasma half-life h": 1 "age yr first examined": 1 "primary b": 1 "study and year": 1 "headache": 1 "80.10": 1 "rentgmk+/?": 1 "5.803": 1 "p interaction a": 1 "age b": 1 "haematuria": 1 "ncep atp iii2001": 1 "ajcc stage": 1 "16.30": 1 "35 37.2": 1 "ptch1 status": 1 "scc": 1 "p -value t -test*/ ? 2 -test": 1 "scd": 1 "laboratory number": 1 "body composition method": 1 "dicer": 1 "1.352": 1 "tumor site": 1 "pathology/lesion type": 1 "6.3 1.8-17.5": 1 "age y": 1 "thompson grade": 1 "a1c ": 1 "n=23": 1 "scr": 1 "upper 95 ci": 1 "ki-67 a": 1 "duration mo": 1 "egfr ihc": 1 "event rate/100-person years placebo group": 1 "average time to progression days*": 1 "age at study": 1 "number of metastatic sites": 1 "therapeutic effects": 1 "49 52.1": 1 "age at diagnosis months median range": 1 "hipk2 qpcr": 1 "bl": 1 "birth weight g": 1 "1 focus": 1 "bw": 1 "pcwp a/v/m": 1 "tk acgh": 1 "positive expression definition": 1 "ppv ": 1 "npv 95 ci": 1 "pathological and prognostic association refs": 1 "hereditary metabolic liver diseases eg hereditary hemochromatosis": 1 "study 1": 1 "sev": 1 "ch": 1 "study 2": 1 "ci": 1 "number of animals": 1 "palindromia month": 1 "renal": 1 "follow-up years *": 1 "disease status": 1 "tumor location/size*": 1 "?adjuvant": 1 "hr 95 ci 2": 1 "20 33.3": 1 "hr 95 ci 3": 1 "?men": 1 "major feed components": 1 "123 29": 1 "selumetinib pk parameters": 1 "cpg site": 1 "baseline sample": 1 "analysis overall survival": 1 "dm": 1 "p-pdgfrb": 1 "construction dataset n=891": 1 "f3": 1 "0.982": 1 "pfs months": 1 "dx": 1 "362 85": 1 "2?g/ml hg slr change/fold change": 1 "0.976": 1 "0.977": 1 "validation dataset n=323": 1 "number of pzarticipants": 1 "123 19": 1 "y757f": 1 "85.80": 1 "rarb": 1 "g3-g4": 1 "allograft": 1 "19 31.7": 1 "23 38.3": 1 "no ?m": 1 "weight at harvest average ± st dev n": 1 "48.50": 1 "fzd6tfip11": 1 "western": 1 "cd8 cells/ ?l": 1 "age at presentation": 1 "brafv600e": 1 "sib1": 1 "sib2": 1 "corrected p interaction b": 1 "3-year ": 1 "496 79": 1 "0.510": 1 "111 16": 1 "gleason grade sum": 1 "management": 1 "repeats of amino acid": 1 "node | metric": 1 "hr 95 ci <=8 vs >8": 1 "subset": 1 "lvfs ": 1 "flt3-itd status": 1 "vert": 1 "frequency refs": 1 "hbv infection": 1 "0.142": 1 "4.602": 1 "lvp s/d/e": 1 "?paranasal sinuses": 1 "crude hr": 1 "p-erk1/2 *": 1 "312#": 1 "dnmt3a": 1 "if": 1 "weight lbs": 1 "1 h/1 h": 1 "ii": 1 "concomitant food intake fda recommendation": 1 "io": 1 "pstage": 1 "is": 1 "gender female": 1 "?non-mucinous": 1 "covariate 1": 1 "autoimmune disease association": 1 "begin": 1 "association with cancer": 1 "rank #": 1 "313 48": 1 "hr positive ": 1 "subject id": 1 "nbw mean±sd": 1 "age to begin yr": 1 "0.163": 1 "0.168": 1 "0.161": 1 "tvb mm3 mean ± sd": 1 "biochemical test annually": 1 "0.155": 1 "751#": 1 "subject number": 1 "rvp s/d/e": 1 "mutation status": 1 "0.150": 1 "tert promoter": 1 "discovery": 1 "bmi": 1 "before ovx": 1 "lm": 1 "time of tumor growth days median range": 1 "scd/cis samples": 1 "whole blood": 1 "begin/end": 1 "c-myc off": 1 "aah/bac samples": 1 "publication": 1 "liver metastases": 1 "dose mg": 1 "mr": 1 "pten loss of expression association": 1 "patient no .": 1 "prevalence of variant in publically available databases": 1 "concomitant medication n ": 1 "p*": 1 "down-regulated": 1 "ak d": 1 "9 june 2008": 1 "nv": 1 "16.50": 1 "freckling": 1 "case-control cohort": 1 "toxin": 1 "?/?": 1 "visual impairment": 1 "concentration max ng ? ml ?1": 1 "mutated": 1 "progression-free survival": 1 "verified status": 1 "breast cancer mortality rr 95 ci": 1 "control samples": 1 "diastolic bp mmhg": 1 "42 16": 1 "??overweight in males": 1 "myhc gel": 1 "108": 1 "clinicopathological characteristics": 1 "states of insulin resistance": 1 "ercc1 c8092a/": 1 "pn": 1 "pde4 inhibitor": 1 "ps": 1 "pt": 1 "feeding regimen": 1 "111": 1 "115": 1 "msh6 expression": 1 "estimate": 1 "flt3 mutational status": 1 "2 0-7": 1 "tissues": 1 "12.00": 1 "relapse": 1 "p value a": 1 "mycn off": 1 "151 23": 1 "2.87": 1 "relative risk of pdac": 1 "0.091": 1 "tnm a7": 1 "0.096": 1 "0.094": 1 "placenta": 1 "i 2": 1 "126 46": 1 "bcss at 10 years": 1 "intranasal dose": 1 "conditions": 1 "vgf gene qmsp positive": 1 "rad21 negative": 1 "side of brain": 1 "sub": 1 "rt": 1 "56.70": 1 "ast/alt ratioa": 1 " a prognostic indices/model including vascular invasion {enter function} n ": 1 "pdgfra exon 10 mutation": 1 "hes1*": 1 "32.60": 1 "19.90": 1 "132": 1 "transgelin": 1 "sf": 1 "high zinc diet ": 1 "sg": 1 "138": 1 "specificity": 1 "stage iii-iv disease": 1 "mbl 45": 1 "lower 95 ci": 1 "ascorbic acid pre mm": 1 "range pg/ml": 1 "lymphocytes 103/?l": 1 "heterozygous family members bmi": 1 "reported association": 1 "study population": 1 "140": 1 "141": 1 "148": 1 "v3": 1 "prognostic indices/covariate model n ": 1 "81.20": 1 "urine": 1 "plasma corticosterone ?g per 100?ml": 1 "ua": 1 "polymorphisms id": 1 "mercury hg": 1 "159": 1 "prdx4*": 1 "total n ": 1 "loh status": 1 " n?=?42": 1 "spleen weight": 1 " hbf": 1 "population cohort": 1 "6.00": 1 "ope": 1 "?oropharynx": 1 "pe samples": 1 "165": 1 "gastrointestinal": 1 "sv40 presence": 1 " n?=?39": 1 "ltbp1*": 1 "distal limb weakness": 1 "extent methylation †": 1 "fit positive n=59": 1 "univariable": 1 "6 2": 1 "changes": 1 "0.087": 1 "litter size": 1 "plasma concentration": 1 "174": 1 "metabolism by": 1 "?oral cavity": 1 "0.085": 1 "kit": 1 "patient sample": 1 "length of dietary": 1 "v l/kg 70-kg subject assumed": 1 "age1/": 1 "co-morbidities": 1 "chr 7 status": 1 "confidence ": 1 "gbm model": 1 "180": 1 "181": 1 "diet assessment method": 1 "182": 1 "4.976": 1 "dna methylation": 1 "hormonal profile": 1 "gbm": 1 "0.074": 1 "?na": 1 "6.37": 1 "young adult": 1 "193": 1 "oscc-specific death": 1 "m-p": 1 "idh1": 1 "dapk": 1 "positivity": 1 "fixed-effects model": 1 "overall death": 1 "nondiabetic retinopathy age related cataract-nuclear cortical posterior subcapsular central retinal artery occlusion primary open angle glaucoma oculomotor nerve palsy and lower lid entropion 102 .": 1 "ethnic": 1 "method": 1 "orr ": 1 "pik3ca mutation ": 1 "dose mmol/kg": 1 "ffm * loss kg": 1 "significantly differentially expressed transporters 1": 1 "patients with npc vs healthy controls": 1 "24 weeks post-ovx": 1 "369 88": 1 "90 33": 1 "healthy subjects n=10": 1 "64.80": 1 "sensitivity": 1 "systolic bp mmhg": 1 "12.50": 1 "name of disease": 1 "platelets ×109/l": 1 "fit negative n=513": 1 "m/f": 1 "spleen size a": 1 "xrcc1-": 1 "hgf probability of high hgf hgf ? 1510 pg/ml": 1 "extent of cad": 1 "case#": 1 "feature": 1 "cytogenetic classification": 1 "cell vitality": 1 " n?=?61": 1 "mets c": 1 "biological and clinical": 1 "??non-alcoholic steatohepatitis nash or non-alcoholic fatty liver disease nafld": 1 "squamous cell carcinomas": 1 "36.10": 1 "12.60": 1 "ht29-mtx": 1 " n?=?58": 1 "?accumulation": 1 "symptom onset yrs": 1 "tumor status": 1 "affected gene s": 1 "disease duration": 1 "risk stratification of primary gist by mitotic index size and site*": 1 "382 86": 1 "prostate 12 hb": 1 "braf mutations": 1 "age atdiagnosis years": 1 "braf v600e": 1 "skeletal dysplasia": 1 "dena administration": 1 "false positive rate ": 1 "69 17": 1 "age range": 1 "mcl-1 *": 1 "replicative study": 1 "i–ii": 1 "cd14+": 1 "risk ofrelapse *": 1 "concomitant food intake effect on bioavailability": 1 "regression coefficient se": 1 "tch": 1 "patient pt/profile pr": 1 "healthy controls": 1 "pathological types": 1 "er-/pr- cancer versus healthy": 1 "31.3 5.4–226.6": 1 "multi or 95 ci": 1 "c-kit": 1 "confidence": 1 "56.40": 1 "efficacy": 1 "cholesteatoma a": 1 "24.00": 1 "response": 1 "rs10118570": 1 "total all ages combined": 1 
"p": 51 "=": 48 "s": 30 "?": 28 "m": 22 "+": 21 "r": 19 "t": 15 "i": 14 "n": 12 "d": 10 "c": 9 "rev": 9 "protein": 9 "for": 9 "za": 9 "": 8 "a": 8 "e": 8 "x": 8 "?": 8 "md": 8 "substrate": 8 "treatment": 7 "2 d": 7 "f": 6 "l": 6 "u": 6 "p value": 6 "study": 6 "k m ?m": 6 "p -value": 6 "m+i": 6 " ": 5 "g": 5 "ic503 ? m": 5 "k cat min?1": 5 "r egf x 1": 5 "k d ?m": 5 "t/n4": 5 "enzyme": 5 "m +": 5 "sd": 5 "+ 2 r egf p r egf p ": 5 "–": 4 "n = 22": 4 "group": 4 "max": 4 "r 0 x 1": 4 "k cat s?1": 4 "aar": 4 "p-value": 4 "rtg3?": 4 "rtg1?": 4 "r ?? p value": 4 "bb": 4 "u/d": 4 "mc": 4 "control": 4 "10 d": 4 "b": 3 "k": 3 "a p": 3 "c elegans": 3 "rr 95 ci": 3 "women": 3 "bdnf": 3 "mw kda": 3 "k 3 k -3": 3 "7 d": 3 "k cat/ k m mm?1min?1": 3 "lpa": 3 "mean": 3 "chun et al 2010": 3 "rh nm": 3 "men": 3 "p -value**": 3 "4 d": 3 "reference": 3 "k 5 k -5": 3 "references": 3 "k m ? m ": 3 "egf": 3 "e 1 *": 3 "p e": 3 "1 i l": 3 "k 6 k -6": 3 "k 4 k -4": 3 "sprouty2": 3 "rr ": 3 "name": 3 "gene": 3 "5 d": 3 "strain": 3 "k 1 k -1": 3 "time h": 3 "cc": 3 "dm": 3 "14 d": 3 "r 0 *": 3 "sc": 3 "1 j r": 3 "drug": 3 "r 2": 2 "r * p ": 2 "v 2 o 5": 2 "spearman r": 2 "c v i j pc": 2 "e 1 0 0": 2 "v": 2 "mirna": 2 "pbs": 2 "e 3 *": 2 "alk_f1245c_t3734g": 2 "f +/ f ?": 2 "e2t": 2 "ma m65287 actr": 2 "?": 2 "source": 2 "joshi and banerjee 2008 ": 2 "k 7 k -7": 2 "benesch et al 2008 ": 2 "couec et al 2012 ": 2 "mx b": 2 "clinical features": 2 "n?=?2": 2 "? h kcal/mol": 2 "k cat/ k m": 2 "col2?1": 2 " r * *": 2 "e 2 *": 2 "rb 34": 2 "rm 24": 2 "dhfr-h10": 2 "c v i j gsh": 2 "cm only": 2 "human": 2 "?phase a": 2 "parekh et al 2011 ": 2 " r egf p r egf p ": 2 "k 2": 2 "k 1": 2 "k 4": 2 "k 3": 2 "yan et al 74 ": 2 "n?=?11": 2 " r l e 1 *": 2 "e2t only": 2 "l643p": 2 "116113": 2 "116114": 2 "t 1/2": 2 "group w": 2 "group s": 2 " ml.min ?1 .100g ?1 ": 2 "benvenuti s et al 20 ": 2 "r 0 x 2": 2 "k 2 k -2": 2 "t-test": 2 "av a": 2 "r egf * r 0 *": 2 " e 1 e 2 *": 2 "sequence": 2 "death": 2 "parameter": 2 "int": 2 "f<50 d ": 2 "rat sequence 5'-3'": 2 "ma l29454 fibrillin": 2 "pathway": 2 "mx/av c": 2 "p b": 2 "p d": 2 "clone": 2 "c v i pc": 2 "age": 2 "ain": 2 "gururangan et al 2010 ": 2 " e 2 *": 2 "fgfri": 2 "pik3ca_h1047rl_a3140 gt": 2 "hartman et al 77 ": 2 "ic 50 ? m": 2 " r * e 2 *": 2 "pactii- iqg1 miller units": 2 "protein domain": 2 "r * e 1": 2 "r l 0": 2 "r l *": 2 "?mod b": 2 "ave": 2 "s cerevisiae": 2 "ma x56123 talin": 2 " r l e 2 *": 2 "wky": 2 "1 d": 2 "1 n": 2 "bf": 2 "bl": 2 "uspc-2": 2 " r l *": 2 "uspc-1": 2 "ce": 2 "cm": 2 "h10": 2 "v max ?mol·min?1·mg?1": 2 "fc": 2 "gk": 2 "e 1 * e 2": 2 "pham et al 15 ": 2 "c v i gsh": 2 "r * p r * 0": 2 "d melanogaster": 2 "free fatty acids": 2 "ligand": 2 "fup": 2 "mf": 2 " e 1 *": 2 " r * e 1 *": 2 "115113": 2 "115114": 2 "r 0 0": 2 "total": 2 "pa": 2 "ps": 2 "pactii miller units": 2 "rf": 2 "sf": 2 "cell line": 2 "testis": 2 "k cat/ k m mm?1?min?1": 2 "wt": 2 "constitutive activity": 2 "m - dm": 2 "e 4": 2 "ifl + bv": 2 "12-s-hete": 1 "1990–2008": 1 "r 1": 1 "r 3": 1 "sfrp1": 1 "r 5": 1 "hwang et al 2013 ": 1 "r 4": 1 "0.661": 1 "target s": 1 "hm1imss colon/culture": 1 "—": 1 "variable 1": 1 "dd u75916 zo-2": 1 "ma m15525 laminin b1": 1 "#": 1 "ctnnb1_d32agt_a95cgv": 1 " e 1 p *": 1 "phase iii wells et al placebo": 1 "r a": 1 "d + dn-rac1": 1 "size": 1 "gly": 1 "k d nm a wt?c1b": 1 "v max": 1 "ngdp": 1 "c/p ratio": 1 "k562/a02": 1 "n = 55": 1 "relative colony formation 1": 1 "n = 51": 1 "male breast cancer": 1 "gnaq_q209h_a627t": 1 "cut-off": 1 "n = 59": 1 "cd44p": 1 "r * e 1 p ": 1 "ms b": 1 "r * p r * p ": 1 " ap c §": 1 "d raf*/dt=-k13y 13": 1 "az peptide": 1 "n = 66": 1 "underlying mechanism s": 1 "n = 61": 1 "ctcf p": 1 "caagctggtgttcctgggag": 1 "h": 1 "ch3": 1 "q": 1 "inoue et al 2012": 1 "n =1054": 1 "chondrocyte": 1 "d raf*=-k14y 14y 15+k15y 16+k16y 16": 1 "fgfr3_r248c_c742t": 1 "edg1 edg5 edg3 edg6 edg8": 1 "jak2_v617f_g1849t": 1 "age months": 1 " e 1 e 3 + e 1 e 4 + e 2 e 3 + e 2 e 4 + e 3 0 + e 3 e 4 + r 0 e 3 + r 0 e 4 + r l e 3 + r l e 4": 1 "mcf-7/adr": 1 " r * e 1 p *": 1 "property 1 pr ? 0.9 f t g 900 p 53 < 3.3 × 10 4 ": 1 "pik3ca_s405f_c1214t": 1 " r egf p r 0 0 + r egf p r egf 0 + r egf p r 0 p ": 1 "p??? ???? ? p min": 1 "0.619": 1 "tnk2_e346k_g1036a": 1 "chf": 1 "dsc3 m": 1 "c n?=?15": 1 "chr": 1 "r l p ": 1 "mautner et al 2010 ": 1 "pathway p": 1 "dsc3 u": 1 "r ggcgacatgtaggatctcgt": 1 "bleo ? g?ml ?1": 1 "fbwx7_r465c_c1393t": 1 "l vs m": 1 "l vs h": 1 "n = 1316": 1 " nacl m": 1 "edg2 edg4 edg7": 1 "kras_a146pt_g436ca": 1 " e 1 e 2 + r 0 e 2 + r l e 2": 1 "c elegans *": 1 "n = 15": 1 "f aagtttgtcattcggaacatt": 1 "n = 16": 1 "cells a": 1 "oxo ete": 1 " e 1 e 3 + e 1 e 4 + e 2 e 3 + e 2 e 4 + r 0 e 3 + r 0 e 4 + r l e 3 + r l e 4": 1 " e 4 *": 1 " r egf p r egf *": 1 "n = 21": 1 "idh2_r172gw_a514 gt": 1 "frap_s2215y_c6644t": 1 "braf_g469eva_g1406atc": 1 "k 1 ?m ? 1 s ? 1 ": 1 "n = 20": 1 "v dj/dj": 1 "ishikiwa": 1 "adjusted r 2": 1 "nras_q61rpl_a182gct": 1 "by eim": 1 "ccagatgattgctaacaaggtcag": 1 "cka": 1 "tca a": 1 "s692g": 1 "b4galt1": 1 "kit_l576p_t1727c": 1 "catggctaccgttctcctgc": 1 "pik3ca_n345k_t1035a": 1 "us-trial krug et al 2009 ": 1 "ggccgcttttctggattcat": 1 "dm + s": 1 "experiment": 1 "mcf-7": 1 "glivec": 1 "hecht et al 38": 1 "therapeutic indication": 1 "fgfr3_k650mt_a1949 tc": 1 "pik3ca_y1021c_a3062g": 1 "+ 2 r egf p r 0 0 + 2 r egf 0 r 0 p + 2 r 0 p r 0 p ": 1 "r ggtatggatccaacccactg": 1 "ngmp": 1 "mutation": 1 "n d": 1 " r l e 2 + r l e 3 + r l e 4": 1 "11 dpa": 1 "cddp ? m ": 1 "gcctggatggctacgtacatg": 1 "2 tp": 1 "cgctccagttgtgtcctgaag": 1 "n s": 1 "r atggctgcttccctctatagt": 1 "egfr-yfp": 1 "1 i l 1 i l +1": 1 "d erk/dt=k28y 26": 1 "ddu89417 ribosomal protein l3 x3": 1 "promoter driving cre": 1 "k 2 s ? 1 ": 1 "k562": 1 "tctactgctgctttgctcacg": 1 "dmp-1": 1 "-0.447": 1 "median pfs": 1 "k cat s ?1 ": 1 "r tgtgcagagctctcttcagac": 1 "ma m37761 calcyclin": 1 "ctnnb1_s45cfy_c134gta": 1 "time months": 1 "k catgmp/ k mgmp µm?1 min?1": 1 "? h kcal mol?1": 1 "con": 1 "neor1 f": 1 "alkaloid": 1 "dd x040170 sparc": 1 " r * p *": 1 "cpa": 1 "function": 1 "k-rasb-farn": 1 "ma l02914 aquaporin": 1 "ctnnb1_t41aps_a121gcs": 1 "k-rasb": 1 "ca2+ flux #": 1 "ma aa237529ubiquinol-cytochrome c reductase 7.2": 1 "ma x62940 tsc-22": 1 " r 0 0 + r 0 p + r 0 e 1 + r 0 e 1 p + r 0 e 2 + r l 0 + r l p + r l e 1 + r l e 1 p + r l e 2": 1 "rasd2 f": 1 "fold_change": 1 "rhamm": 1 "neor1 r": 1 "k 11": 1 "k 10": 1 "n7r/l20r": 1 "pik3ca_f909l_c2727g": 1 "rasd2 r": 1 "d mek/dt=-k17y 14y 17+k18y 18": 1 "f gagatgtactactgctccaagtg": 1 "ma z31553 cctz chaperonin containing tcp-1 ? z": 1 "met_h1112y_c3334t": 1 " r egf * r egf *": 1 "z 3 = r 0 0 1 + r 1 0 1 + r 0 1 1 + r 1 1 1     52d": 1 "lps ?": 1 "5?yrs – lpfs*": 1 "ggctctcctatcccttctccc": 1 "c albicans": 1 "cdk4_r24h_g71a": 1 "idh2_r140lq_g419 ta": 1 "rhoa–akap-lbc dh–ph": 1 "d n?=?5": 1 "cluster": 1 "d erk*.mkp/dt=k26y 24y 25-k27y 22-k28y 22": 1 "css": 1 "ray et al54": 1 "?1.29": 1 "rab6 f": 1 " r 0 e 3 + r 0 e 4 + r l e 3 + r l e 4": 1 "brown et al 79": 1 "2 k 4 k -4": 1 "cacttgggaggccaggaatc": 1 "e + v": 1 "tccttcattctcaaactcactcatgt": 1 "rab6 r": 1 "lpa ?": 1 "k cat /k m s?1 m?1": 1 "r 0 e 1 *": 1 "kras_q61lpr_a182tcg": 1 "genes": 1 "r ccttccccaagatgtcttca": 1 "ryan et al 86": 1 "ryan et al 89": 1 "r atcaaaccaaaacccttagggg": 1 "idh1_r132hl_g395at": 1 " r 0 e 4 + r l e 4": 1 "r actcagtgagtcacaggagga": 1 "type-a": 1 "+ r egf p r 0 0 + r egf 0 r 0 p + r 0 p r 0 p ": 1 " n?=?98": 1 "s&ig": 1 "ma u48737 prp4m": 1 "phenotype": 1 "r ttttggttggtttgcctaaaa": 1 "oka et al 2010": 1 "?6integrin cases": 1 "oka et al 2009": 1 "capeox + bv": 1 " r l 0 + r l p + r l e 1 + r l e 1 p + r l e 2": 1 " r 0 e 2 + r l e 2": 1 "sharp study llovet et al 2008 ": 1 "asia-pacific study cheng et al 2008 ": 1 "oxysterols": 1 "horizon-rft 69": 1 "? actin f": 1 "braf_v600lm_g1798 ta": 1 "cggatacagggacattccttatca": 1 "0.186": 1 "ma u10090 c57bl/6 ly-49d-ge antigen": 1 "?0.006": 1 "? actin r": 1 "ma x62742 ma": 1 "pik3ca_e418k_g1252a": 1 "pdgfra_n659k_c1977a": 1 "ma aa408104 translational initiation factor eif-2 ?": 1 "z 7 = r 1 1 1     52h": 1 "spry 4 f": 1 "q115r": 1 "fatty acid derivatives": 1 "rahman colon/culture": 1 "r ccccagcaaagtgagagaag": 1 "pik3ca_g1049r_g3145c": 1 "sfrp1+osmr d": 1 "measure": 1 "v711m": 1 "mbp-h10": 1 "tmean ? ns": 1 "erk2": 1 "erk1": 1 "osmr": 1 "kb/vcr": 1 "kit_v560d_t1679a": 1 "mek*+erk<->mek*.erk->erk*": 1 "gpba": 1 "ma u20282 spbp": 1 "aaagccgcgatcacgga": 1 "k daz-odc µm": 1 "dd x15013.1 ribosomal protein l7a x3": 1 "urea-induced unfolding": 1 "spry 4 r": 1 "van 't veer et al 29 ": 1 "?": 1 "kawamata et al 2003": 1 "ctnnb1_s37cfy_c110gta": 1 "dd ma u42383 fin 13": 1 "p16 ink4a": 1 " mol": 1 "fullname": 1 "time": 1 " r 0 0 r 0 0 + r egf 0 r 0 0 + r 0 p r 0 0 + r egf 0 r egf 0": 1 "? 2 c": 1 "dc6 library": 1 "chang et al 18": 1 "tpbg/5t4 f": 1 "igf-1 govoni et al 2007a ": 1 "ma d90362 cap102/alpha catenin": 1 "tpbg/5t4 r": 1 "dd af170920 hspc030": 1 "gene symbol": 1 "igf-1 govoni et al 2007b ": 1 " r l e 1 + r l e 1 p + r l e 2": 1 "?ct": 1 "egfr_l858r_t2573g": 1 "up-regulated in our study": 1 "vp-16 ? m ": 1 "f p": 1 "kras_g10r_g28a": 1 "histone": 1 "p c&ig": 1 "ma aa408185 sfrs7": 1 "kohno et al 2006": 1 "akt1_k179m_a536t": 1 "agcaccagatgtgtccgtccatccaccaac": 1 "? g d kcal.mol?1 at 37°c": 1 "ht-29": 1 " e 1 e 4 + e 2 e 4 + r 0 e 4 + r l e 4": 1 "property 3 pr ? 0.9 f 20 pi 3 k a/pi 3 k tot > 0.5": 1 "? g kcal mol?1": 1 "ecm/adhesion": 1 "pdgfra_v561d_t1682a": 1 " r 0 0 + r 0 e 1 + r 0 e 2 + r 0 e 3 + r 0 e 4 + r l 0 + r l e 1 + r l e 2 + r l e 3 + r l e 4": 1 "kolkman et al 14 ": 1 "2 i l": 1 "r * 0": 1 "reismüller et al 2010 ": 1 "d mek*/dt=-k20y 19y 20+k21y 21+k22y 21": 1 "+ r egf p r 0 p + 2 r egf p r egf p ": 1 "lpi": 1 "maxilla": 1 "gper": 1 "nucleotide": 1 "e 1 e 2 *": 1 " r egf *.*": 1 "lps": 1 "ch7 60 cm": 1 "?variable 2": 1 "? c": 1 "p value l interrogans": 1 " e 2 e 3 *": 1 "pik3ca_e110k_g328a": 1 "superfamilyc": 1 "kit f": 1 "conditioned media": 1 "ma l02918 procollagen type v alpha 2": 1 " r * p r * p ": 1 "dd u93231.1 aldose": 1 "tgggagctcttctccttaggaa": 1 "cgggtgtgtgcccaggtt": 1 "park et al 2007": 1 "nrp1 f": 1 " r l e 4 *": 1 "a l t ? t": 1 "stage iv n?=?4": 1 "dd af064236.1 smoothelin large isoform l2": 1 "water": 1 "ki6783": 1 "gna11_q209lp_a626 tc": 1 "n?=?4": 1 "?": 1 "? 0 t ? t": 1 "n?=?8": 1 "braf_g464eva_g1391atc": 1 "?": 1 "nrp1 r": 1 "3 h": 1 "kit r": 1 "?": 1 "?": 1 "s 2": 1 "s 1": 1 "s 4": 1 "hannedouche et al 2011 liu et al 2011": 1 " kcal.mol-1": 1 "s 3": 1 "s 6": 1 "s 5": 1 "s 8": 1 "s 7": 1 "z 0 = r 0 0 0 + r 1 0 0 + r 0 1 0 + r 0 0 1 + r 1 1 0 + r 1 0 1 + r 0 1 1 + r 1 1 1     52a": 1 "s 9": 1 "avg ± std dev.": 1 " e 1 e 2 + e 1 e 3 + e 1 e 4 + e 2 0 + e 2 e 3 + e 2 e 4 + r 0 e 2 + r 0 e 3 + r 0 e 4 + r l e 2 + r l e 3 + r l e 4": 1 "reference s": 1 "2.5x ? -ecs + pcs": 1 "ma aa184551 cadherin-11": 1 "f tcttgtatgaggactccgtgc": 1 "xelox + bv?xelox + bv/bv alone": 1 "pik3ca_y1021hn_t3061ca": 1 "dd m34561 hsp70": 1 "bcnu ? m ": 1 "v dj/v dj": 1 "ma x80232 sig41": 1 "1 n 1 j 1": 1 "ccgaactctccttttcctttga": 1 "tttctgtggatcatagctccca": 1 "grant et al 2009": 1 "plotkin et al 2009 ": 1 "shiraishi et al 20": 1 "phase ii wells et al 300 mg": 1 "ttcttgtcaccttccccttctc": 1 "constitutive activity cysltd4 udp-glucose": 1 "met_m1268t_t3803c": 1 "n7r": 1 "osteoblast": 1 " r * p .*": 1 "heat-induced unfolding": 1 "egfr_s720p_t2158c": 1 "k a ×105 m?1": 1 "mt b": 1 "ma m62867 msy-1": 1 "r 0 x 1 r 0 x 2": 1 "raf 1": 1 "r 0 x 1 r 0 x 1": 1 "pik3ca_e545agv_a1634cgt": 1 "e p value": 1 "r egf x 2": 1 "d mkp/dt=-k26y 24y 25+k27y 26": 1 "ma d49382 nedd5 septin": 1 "cdk4_r24c_c70t": 1 "node1": 1 "ma j04695 ?-2 type iv collagen": 1 "node2": 1 "b p": 1 "d erk*/dt=-k25y 23": 1 "niketeghad et al 19": 1 "kit_k642e_a1924g": 1 "d + dn-rhoa": 1 "r tgtcactaagttccaacttccg": 1 "k m mm": 1 " d": 1 " e": 1 "ma x59728 gas5": 1 "ggtggagatcctggagtacaactt": 1 "d rerio": 1 "h sapiens": 1 "v5-h6": 1 " k": 1 "characteristic": 1 "a thaliana": 1 "stress response": 1 "d15mit229": 1 "cdbound d": 1 "dha": 1 "dd.ma u53584 mt dna polymerase ?": 1 "e 1 0 p ": 1 "r ccgtttagcggaatgctttcttag": 1 "gpr23 gpr92 p2y5": 1 "miller et al 27 ": 1 " r egf p r egf 0 + 2 r egf p r egf p ": 1 "tissue samples": 1 "ma u19854 ubiquitinating enzyme e2-20k": 1 "tgtcatatctctccattttagaaatcca": 1 "kit_r634w_c1900t": 1 "? h m": 1 "trx-h10": 1 " a model 1": 1 "gpr84": 1 "sakk-trial weder et al 2007 ": 1 "gpr87": 1 "tgctccgggctgaccat": 1 "francesca et al 10 ": 1 "mek2": 1 "mek1": 1 "0.09": 1 "h10-trx": 1 " r 0 0 + r egf 0 + r 0 p + r egf p + 2 r 0 0 r 0 0": 1 "r agggttgctgcactgttacta": 1 "trait": 1 "kit_v559adg_t1676cag": 1 "lpa1 lpa2 lpa3": 1 "auroc": 1 "lzr": 1 "t?+?s n?=?3": 1 "r l e 1 *": 1 "r cgaagttctgcctggtaaacg": 1 "traf4-ko g": 1 "interaction protein": 1 "z 1 = r 1 0 0 + r 1 1 0 + r 1 0 1 + r 1 1 1     52b": 1 "n?=?60": 1 "pd166866": 1 "alk_f1245vi_t3733ga": 1 "temperature °c": 1 "fgfr3_s371c_a1111t": 1 "95 ci": 1 "z 2 = r 0 1 0 + r 1 1 0 + r 0 1 1 + r 1 1 1     52c": 1 "k 8 k -8": 1 "s10r": 1 "f tccttttggatctggtcctg": 1 "met_h1112_a3335gt": 1 "-0.13": 1 "ligandf": 1 "letrozole": 1 "gpr55": 1 "0.43": 1 "t m o c": 1 "mirnas": 1 "allele": 1 "n?-actin": 1 "l-dox n m ": 1 "cctgcttcaccaccttcttga": 1 "igf-1 sheng et al 2013 ": 1 "ma w08453 destrin": 1 "sorafenib": 1 "ma x83934 ryanodine receptor type 3": 1 "2 k 3 k -3": 1 "atcc39462": 1 "mca-treated": 1 " r l e 1 p + r l e 2": 1 " e 3 *": 1 "h10-gst": 1 "spry2 f": 1 "ma m86736 acrogranin": 1 "k 2 2 k -2": 1 "ma aa198790ubiquinol-cytochrome c reductase 6.4": 1 "gccgtcggcaccagggtcagctccc": 1 "gpr30": 1 "pu m": 1 "gpr31": 1 " s+c&ig": 1 "buttitta f et al 14 ": 1 "spry2 r": 1 " min?1 ?m?1": 1 "gpr34": 1 "? s e.u.": 1 "gpr35": 1 "kinase": 1 "pu h": 1 "f acccactaagcctccattgg": 1 "s pombe": 1 "rf b": 1 "wang et al 28 ": 1 "bai1": 1 "nras_q61ekx_c181gat": 1 "c n?=?3": 1 "k on m -1 min -1": 1 "rna processing": 1 "r ctggtagccttggggatgta": 1 " r l e 1 + r l e 2 + r l e 3 + r l e 4": 1 "lpa4 lpa5 lpa6": 1 "ma u63323 translation initiation factor eif4g2": 1 "ttatcctggactctgcatcgtct": 1 "0.88": 1 "gccacgggagctgaccctggtgccgacggc": 1 "0.84": 1 "tgccaattgttgcctgataggt": 1 "gpr17": 1 "gpr18": 1 "r ctcagcagactgcccgaggaa": 1 " e 1 e 2 + e 2 0 + r 0 e 2 + r l e 2": 1 "k i nm a": 1 "smith et al 87": 1 "m w × 10?4": 1 "prkag2_n488i_a1463t": 1 "msdtmax å2": 1 "bolland et al 75": 1 "activity a": 1 "0.98": 1 "0.344": 1 "ma u65636 beta proteasome subunit lmp3": 1 "specificitya": 1 "t m °c": 1 " e 1 e 2 + e 1 e 3 + e 1 e 4 + r 0 e 2 + r 0 e 3 + r 0 e 4 + r l e 2 + r l e 3 + r l e 4": 1 "tcacagggacgctgctctg": 1 "normal epithelium": 1 "escc": 1 "prkcq /pkc? r": 1 " lp": 1 "m  sin ? c": 1 "dd ab017020 hnrnp d-like/jktbp x2": 1 "r tgatcctgcccaggccaaaga": 1 "akt2_e17k_g49a": 1 "k d m -1": 1 " r l p + r l e 1 + r l e 1 p + r l e 2": 1 "braf_g469r_g1405ca": 1 "ctnnb1_s37apt_t109gca": 1 "k 6": 1 "k 5": 1 "k 8": 1 "k 7": 1 "k 9": 1 "l longbeachae": 1 " r egf p r 0 p + 2 r egf p r egf p ": 1 "n?=?14": 1 "gpr 133 r": 1 "cdfree d": 1 "ctnnb1_d32hny_g94cat": 1 "n?=?19": 1 "gpr 133 f": 1 "cirrhosis": 1 " nm": 1 "m w / m n": 1 "kras_g12src_g34act": 1 "compound": 1 "masi et al 36": 1 "k d": 1 "kitamura et al 2012 sugo et al 2006": 1 "s26": 1 "pretreatment": 1 "5?yrs – css*": 1 "k m": 1 "19 21": 1 "akr1c2": 1 "akr1c3": 1 "akr1c1": 1 "receptor fold d": 1 "v e *": 1 "tumor classification": 1 "s1p": 1 "has 3v1": 1 "d raf/dt=k16y 16": 1 "hopx f": 1 "e 3 e 4": 1 "met_r988c_c2962t": 1 "nras_g13dav_g38act": 1 "z 4 = r 1 1 0 + r 1 1 1     52e": 1 "hopx r": 1 "d2mit490": 1 "col1?2": 1 " r l p *": 1 "affinity of domain": 1 "gpc6 r": 1 "gpc6 f": 1 "d raf=-k11y 11y 12+k12y 13": 1 "? g kcal/mol": 1 "12 h": 1 " r 0 p + r 0 e 1 + r 0 e 1 p + r 0 e 2 + r l p + r l e 1 + r l e 1 p + r l e 2": 1 "r * e 1 e 2 *": 1 "cgctgcttaaaccatttctgc": 1 "26": 1 "global": 1 " r egf 0 r 0 0 + 2 r egf 0 r egf 0 + r egf p r 0 0": 1 "pik3ca_h1047rl_a3140 gt..1.": 1 "d pp2a=-k20y 19y 20+k21y 21": 1 "1d": 1 "aattcctcaaggcaacaagtatctg": 1 "akap-lbc dh": 1 "saline-treated": 1 " r * e 4 *": 1 "2g": 1 "p model *": 1 "5-ox-ete": 1 "gtgaatgaaacaaccatgacctacat": 1 "kcat/ k m mm?1?min?1": 1 "murakami et al 2008 inoue et al 2012": 1 "antigen presentation": 1 "d erk*/dt=-k26y 24y 25+k27y 26+k28y 26": 1 "cytotoxicity ic 50 a": 1 "x 1": 1 "x 3": 1 "x 2": 1 "x 5": 1 "f ttgtttccccagatcctgtc": 1 "x 4": 1 "x 7": 1 "x 6": 1 "x 9": 1 "x 8": 1 "compd": 1 "mkp": 1 "cccaggaacatccaggcttt": 1 "pik3ca_e542kq_g1624ac": 1 "g 0/g 1": 1 "tgactctgcagctcctcaaaga": 1 "r gtggtttatgctggcaaagag": 1 "glyc": 1 "59": 1 "hurwitz et al 34": 1 "k d µm": 1 "e-ratio": 1 "fm 4-64 localization": 1 "4f": 1 "k cat / k m s ?1 ? mm ?1 ": 1 "tggagatatgttggaaatgattctg": 1 "aom-treated": 1 "catgtcctgggcctgcac": 1 "59 65": 1 "65": 1 "66": 1 "l = 1 .. k 1 - 1": 1 "tg1019": 1 "braf_g466r_g1396ca": 1 " e 1 e 4 + e 2 e 4 + e 3 e 4 + r 0 e 4 + r l e 4": 1 "dtss": 1 "r gatcgattcctgacaaccttg": 1 "akr1b1": 1 "stage iii n?=?15": 1 " r egf 0 + r egf p + r egf 0 r 0 0 + 2 r egf 0 r egf 0": 1 "gpr119": 1 "6h": 1 "h10-gfp": 1 "phase i holden et al 50–600 mg": 1 "g 2/ m": 1 "ma af017153 mdeah9": 1 "? e": 1 "serum fgf19": 1 "k obs min?1b": 1 "serum fgf21": 1 "l/b ratio p": 1 "egfr_l861_t2582ag": 1 "braf_v600eag_t1799acg_f": 1 "gapdh f": 1 "prkar 2b f": 1 "k cat/ k m 103 × m?1 s?1": 1 "braf_v600eag_t1799acg_r": 1 "ma u60087 tap2-d": 1 "met_t1010i_c3029t": 1 "gapdh r": 1 "g 2/m": 1 "tgttgctgcttgcgcgaggtcaccaccttc": 1 "talon": 1 "mammals": 1 "? g d kcal.mol-1": 1 "dd nm010239 ferritin heavy chain": 1 "pd173074": 1 "corn oil control": 1 "retrovirus": 1 "cctcgctcataacattttcgg": 1 "diets": 1 "p-value c vs d": 1 "9h": 1 "m  cos ? c": 1 "choline": 1 "pathological characteristics": 1 " r 0 e 1 + r 0 e 1 p + r 0 e 2 + r l e 1 + r l e 1 p + r l e 2": 1 "p-value c vs r": 1 "gdnf": 1 "ch2 65 cm": 1 "6-atr-parm": 1 "ciana et al 2006 maekawa et al 2009 qi et al 2013": 1 "ctnnb1_s33apt_t97gca": 1 " n t §": 1 "1 j r 1 j r +1": 1 "gpr183": 1 "ests": 1 "a66 s": 1 "r egf * r egf *": 1 "d discoideum": 1 "n = 1057": 1 "e 2 0 0": 1 "energy production": 1 "2 j r": 1 "idh1_r132cgs_c394tga": 1 "n7r/p11r": 1 "ma geni": 1 "gpr174": 1 "kit_n566d_a1696 g": 1 "met_y1253d_t3757 g": 1 "k off min -1": 1 "s n?=?3": 1 "tttttattcttcaggcaggacttga": 1 "f tgaatttggctcaggagctgc": 1 "1x ? -ecs + pcs": 1 "t m": 1 "r n?=?15": 1 "mut": 1 "d erk/dt=-k23y 19y 22+k24y 23": 1 "prkar 2b r": 1 "p11r": 1 "p value l biflexa 2": 1 "usaite et al 12 ": 1 "ttaggg/1": 1 "+lata": 1 "f tcccctgaacctgaatgcctgg": 1 "t n?=?3": 1 "c p": 1 "ccatgtctgggcacctctct": 1 "idh2 mutation ": 1 "variable": 1 "díaz-rubio et al 35": 1 "ma aa254996 alanyl-trna synthetase": 1 "v max/ k m": 1 "r * e 1 *": 1 "gapdh": 1 "optimal": 1 " r 0 e 2 + r 0 e 3 + r 0 e 4 + r l e 2 + r l e 3 + r l e 4": 1 "r = 1 .. k 2 - 1": 1 "protein of f k": 1 "time-resolved fret atp k m": 1 "fractionbound c": 1 ">0.977": 1 "références": 1 "akt2_g175r_g523c": 1 "d mek*/dt=-k19y 18": 1 "porphyrin": 1 "rat": 1 "bile acid": 1 " r l e 3 + r l e 4": 1 "akt3_g171r_g511a": 1 "f ggcagagggcgctttaatttc": 1 "cape + bv ± mitc": 1 "pik3ca_r088q_g263a": 1 "tnk2_r99q_g296a": 1 " r 0 p r 0 p + r egf p r 0 p + r egf p r egf p ": 1 " r egf p .*": 1 "e 1 * e 3 *": 1 "kit_v825a_t2474c": 1 "ma u70315 u1 snrnp- c": 1 "ic50-based pi3k? fold selectivity": 1 "tmz ? m ": 1 "m vs h": 1 "igf-1r wang et al 2011 ": 1 "frub": 1 "fold change p": 1 "-0.289": 1 "df a": 1 "pik3ca_e542vg_a1625tg": 1 "alignmentd": 1 "ark1c4": 1 "mckinsey et al": 1 "equilibrium k d m -1": 1 "gccacgggagctgaccctggtgccg": 1 "ark1c1": 1 "0 h": 1 "ark1c3": 1 " ne c §": 1 "ark1c2": 1 "akr7a2": 1 "akr7a3": 1 "k d s -1": 1 "r egf x 1 r 0 x 2": 1 "r egf x 1 r 0 x 1": 1 " r egf p r * p ": 1 "residue sb": 1 "gggcacctcggaggagc": 1 "idh2_r172mk_g515 ta": 1 "kras_q61ekx_c181gat": 1 " r 1 = r 2 =0": 1 "igf-1r zhang et al 2002 ": 1 "k m atp": 1 "ccgccaagctcttcagca": 1 "tmax ns": 1 "ark1b1": 1 "ecp 80 mmhg n?=?8": 1 "erk*+mkp<->erk*.mkp->erk": 1 "+ r egf p r 0 0 + r egf 0 r 0 p + 2 r egf p r egf 0": 1 "p a": 1 "98072": 1 "p c": 1 "r p value": 1 "dd af081140 homologue to eif6/integrin b4 int prot.": 1 "p f": 1 "12 dpa": 1 "s1p1 s1p2 s1p3 s1p4 s1p5": 1 "ark1a1": 1 "nt c": 1 "egfr_y813c_a2438g": 1 "taqmeth v": 1 "s275p": 1 "hydroxy fatty acids": 1 "k i b": 1 "stfa1 r": 1 "d ras.gtp/dt=- k11y 11y 12+k12y 13+k13y 13": 1 "h10-mbp": 1 "growth control": 1 "tabata et al 2007": 1 " e 1 0 + e 1 p + e 1 e 2 + r 0 e 1 + r 0 e 1 p + r 0 e 2 + r l e 1 + r l e 1 p + r l e 2": 1 "k m 10?3 mm": 1 "fbwx7_r479ql_g1436at": 1 "peptide sequence a": 1 "t °c": 1 "residue": 1 "stfa1 f": 1 "family": 1 "total n?=?60": 1 "0.028": 1 "+ 2 r egf 0 r 0 0 + 2 r 0 p r 0 0 + 2 r egf 0 r egf 0": 1 "ligand fold d": 1 "os m": 1 "dd af100726 nadh dehydrogenase s4": 1 "r ggtcctggaatgaagccatg": 1 "f atggagatgaagaagaagattaac": 1 "p2y10": 1 "hydroxy ete": 1 "pik3ca_a1046v_c3137t": 1 "g2a": 1 "asat u/l": 1 "0.019": 1 "eortc trial van schil et al 2010 ": 1 "grb2 k d nm": 1 "0.012": 1 "yeast": 1 "0.014": 1 "ma bafi": 1 "n7r/s10r/p11r": 1 "aggatcggatgagcgacct": 1 "p s&ig": 1 "ma z30970 timp-3": 1 "authors": 1 "p -value* gene": 1 "braf_v600_g1800": 1 "balsara et al 21": 1 "pdpk1_d527e_c1581g": 1 " r 2 = r 3 =0": 1 "idh2_r172s_g516t": 1 "ma l11613 proteasome lmp2": 1 "stage i n?=?21": 1 "peptide name": 1 "0.046": 1 "igf-1 sjogren et al 1999 sjogren et al 2002 ": 1 "tgggcggacagaaatatggt": 1 "akt1_e17k_g49a": 1 "n.a.": 1 "pik3ca_q060k_c178a": 1 "k catgdp/ k mgdp µm?1 min?1": 1 "lpfs": 1 "cytoskeleton organization": 1 "tgtctggccgcgtgatg": 1 "f actgtccggatctgtgctct": 1 "f p value": 1 "genes l biflexa": 1 "pik3ca_h1047y_c3139t": 1 "sham": 1 "nsw 150": 1 "kit_n822yhd_a2464tcg": 1 "chemoradiation sonis et al.": 1 "amplicon size bp": 1 " ×10?3": 1 "ttcatagactattgtgctccggg": 1 "vegfr2i1": 1 "pik3ca_t1025sa_a3073tg": 1 "akr1b10": 1 "h2?h2??": 1 "zeller et al": 1 "trial": 1 "uniprotkb/swiss-prot accession number": 1 "r ccttccacaatgccaaagtt": 1 "ala": 1 "v dj+/v dj+": 1 "gaaggtggtgacctcgcgcaagcagcaaca": 1 "26 h": 1 "braf_l597r_t1790g": 1 "ma si prr": 1 "ic50 at 2 × k m atp": 1 "aaccgtgaaaagatgacccagat": 1 "pik3ca_m1043i_g3129atc": 1 "ma d85561 proteasome subunit mecl1": 1 "? c p": 1 "gene_id": 1 "ddma af110520 mhc class ii": 1 "pa m": 1 "pa h": 1 "prkcq/pkc? f": 1 "f gggtgtgaaccacgagaaat": 1 "ma x67083 chop-10": 1 "f caagagggccatctgtacca": 1 "ccagcggcgccaggaa": 1 "slaby et al 2010": 1 "gene/exon": 1 "5-atr-parm": 1 "urea mmol/l": 1 "irinotecan bowen et al.": 1 "fgfr2_s252w_c755g": 1 "pdgfra_d842v_a2525t": 1 "? d": 1 "gof/lof": 1 "gttggtggatggacggacacatctggtgct": 1 "kusano et al 14": 1 "dd m22756 nadh dehydrogenase s2": 1 "d mek*.pp2a/dt=k20y 19y 20-k21y 17-k22y 17": 1 "alk_r1275ql_g3824at": 1 "s1p spc ?": 1 "nras_g13src_g37act": 1 " r egf 0 r 0 p + r egf p r egf 0 + r egf p r 0 p ": 1 "braf_e586k_g1756a": 1 " r l 0 + r l e 1 + r l e 2 + r l e 3 + r l e 4": 1 "hepatic": 1 " r * * r * *": 1 "exp": 1 "tamoxifen": 1 "g 0/ g 1": 1 "d pp2a/dt=-k14y 14y 14+k15y 16": 1 " r * e 3 *": 1 "l20r": 1 "k-ras": 1 "ma d14340 zo-1": 1 "d raf*.pp2a/dt=k14y 14y 15-k15y 12-k16y 12": 1 "9 h": 1 "ark1b10": 1 "tgtgcaaaaccaacagacctagat": 1 "bipolar disorder": 1 "ecc-1": 1 "tgr5/bg37": 1 "tumor": 1 "r * 0 r * 0": 1 "kras_g13dav_g38act": 1 "ffa1 ffa2 ffa3 ffa4": 1 "ciafre et al 2005": 1 " r 0 p + r egf p + r 0 p r 0 0 + r egf p r 0 0 + r egf 0 r 0 p ": 1 "7?25-dihydrocholesterol constitutive activity": 1 "ma u93862 ribosomal protein l41": 1 "poole et al 72": 1 "narayana et al 2010 ": 1 "cyslt ? nucleotides ?": 1 "nras_q61hhq_a183tcg": 1 "pdgfi": 1 "alat u/l": 1 "pde3a f": 1 "ma d31966 rna polymerase i 40 kda subunit": 1 "tol et al 37": 1 "description": 1 "ct iriox + bv": 1 "ma x61800 c/ebp ?": 1 "ma u81829 calumenin": 1 "target cell": 1 "pde3a r": 1 "property 7 pr ? 0.9 f 100 p 53/10000 ? a ? f 100 p 53/10000 ? 0.4": 1 "3-4 tp": 1 "factor": 1 "lps lpc h+ 9-hode": 1 "gene title": 1 "p node1 †": 1 "ma l08235 clusterin": 1 "r 0 p ": 1 "x 10": 1 "pn h": 1 "von bubnoff et al53": 1 "gpr3 gpr6 gpr12": 1 "x 11": 1 "pn m": 1 "gttcaacgctccagttataaaccg": 1 "r egf *": 1 "type of rearrangement": 1 "r ? p value": 1 "tissue": 1 "0.819": 1 "ignatov et al 2003 uhlenbrock et al 2002": 1 "k a ×105?m?1": 1 "case": 1 "item": 1 "ince et al 33": 1 " e 1 e 3 *": 1 "phase i tamura et al 100–400 mg": 1 "fgfr3_y373c_a1118g": 1 "dmfs": 1 "5 h": 1 "f gactcagagatgtaagatccc": 1 "folfoxiri + bv": 1 "protein degardation": 1 "n7r/s10r/l20r": 1 " r egf p r * *": 1 "r 0 * r 0 *": 1 "k cat": 1 "ptso": 1 " e 1 e 3 + e 1 e 4 + r 0 e 3 + r 0 e 4 + r l e 3 + r l e 4": 1 "ptsp": 1 "dd af058955 succinyl-coa synthetase ?": 1 "slamon et al 43": 1 "5?yrs – dmfs*": 1 "epha3_k761n_g2283": 1 "alk_i1171n_t3512a": 1 "gc effects": 1 "pik3ca_m1043v_a3127g": 1 "kit_n822knk_t2466gca": 1 "bradeen et al52": 1 "d 0": 1 "time days": 1 "substrate inhibition": 1 "idh2_r140w_c418t": 1 "schizophrenia": 1 "e coli": 1 "f atcaattatgaaagtttactgcc": 1 "genes l interrogans": 1 "creatinine µmol/ml": 1 "age/nb": 1 "idh2_r140w_c419t": 1 "k m choline": 1 "k _1 s ? 1 ": 1 " pmol/min/mg protein": 1 "v dj+/v dj?": 1 "effects": 1 "d p": 1 "biological process": 1 "dox n m ": 1 "saal h et al 16 ": 1 "d7mit101": 1 "acp1 f": 1 "fbwx7_r465hl_g1394at": 1 "substratea": 1 "davenport et al 2013": 1 "sc ": 1 "nras_g12dav_g35act": 1 "2 k 7 k -7": 1 "suv *": 1 "patient": 1 "z 5 = r 1 0 1 + r 1 1 1     52f": 1 "acp1 r": 1 "frap_r2505p_g7514c": 1 "gccatgatgaaaaactcagtcg": 1 "fgfr3_g697c_g2089t": 1 "a2": 1 "h3k27me 3 p": 1 "a7": 1 "?lata": 1 "pik3ca_c420r_t1258c": 1 "alk_f1174liv_t3520cag": 1 " r egf p + r egf p r 0 0 + r egf p r egf 0 + r egf p r 0 p ": 1 "0.546": 1 "+ 2 r egf p r egf 0 + 2 r egf p r 0 p + 2 r egf p r egf p ": 1 "egr-1": 1 "cggacacagcaaagccagat": 1 "b2": 1 "pfs m": 1 "kit_d816hny_g2446cat": 1 "b6": 1 "pik3ca_e453k_g1357a": 1 "rank": 1 "d1mit181": 1 "pdgfra_d842_g2524ta": 1 "pm + e": 1 "r ggtacaagagccagcagcata": 1 "catcctcacaggagatgtcttcat": 1 "pik3ca_k111n_g333c": 1 "gcctctggctgcctgcaagtccctgc": 1 "ggtgaggacgggaggggagaagagtagtcg": 1 "pik3ca_h701p_a2102c": 1 "pah trans -dihydrodiols": 1 "c2": 1 "c7": 1 "f cctacatcgtgggcttcta": 1 "+ r egf 0 r 0 p + 2 r egf p r egf 0 + r egf p r 0 p ": 1 "1 h": 1 "2???ct": 1 "2 k 2 k -2": 1 "pik3ca_q546lpr_a1637tcg": 1 "raf +ras gtp<->raf.ras gtp->raf*": 1 "quinone": 1 "erk phosphorylation $": 1 "marchio et al 13": 1 "michaelson et al 88": 1 "r cagcgccttctcgttattcag": 1 "d1": 1 "d2": 1 "br": 1 "histones": 1 "sn34452": 1 "ca": 1 "ccgtcccgcgttcgct": 1 "kiti": 1 "set": 1 "cg": 1 "gpr40 gpr43 gpr41 gpr120": 1 "k 7 2 k -7": 1 "tgtgtccgtcgtggatctga": 1 "egfr_t790m_c2369t": 1 "igf-1 baker et al 1993 liu et al 1993* bikle et al 2001 wang et al 2006b ^": 1 "cl": 1 "e2": 1 "f ggcgcctgcgattagtgctaca": 1 "sample": 1 "k cat/ k m m ?1·s?1 × 10?3": 1 "ma l03279 cbf": 1 "dd x04017 sparc": 1 "g gallus": 1 " r * p r *.*": 1 "0.503": 1 "female breast cancer": 1 " specificity": 1 "k daz-azi µm": 1 " r egf * r * *": 1 "h1?": 1 "dp": 1 "f2": 1 "kegg pathway 1": 1 "f5": 1 "mek*+pp2a<->mek*.pp2a->mek": 1 "pw m": 1 "0.977": 1 "ma k01700 p53": 1 "calcium binding": 1 "de groot et al 11 ": 1 "protein nameb": 1 "c&ig": 1 "g4": 1 "g7": 1 " debris": 1 "glade bender et al 2008 phase i trial": 1 "attactttaactgggagaggaaccc": 1 " r 0 e 1 p + r 0 e 2 + r l e 1 p + r l e 2": 1 "upar cases": 1 "pw h": 1 "alk_f1174l_c3522ag": 1 "r norvegicus": 1 "h3?": 1 "? t ? s kcal/mol": 1 "cgactactcttctcccctcccgtcctcacc": 1 "ft": 1 "h6": 1 "ic 50 a ? m": 1 "1960–1989": 1 "kinetic parameter": 1 "ciaccio et al 2010": 1 "gfp-h10": 1 "1 tp": 1 "ctnnb1_s45apt_t133gca": 1 "pik3ca_p539r_c1616g": 1 "d rasgtp.raf/dt=k11y 11y 12-k12y 14-k13y 14": 1 "h4?": 1 "i1": 1 " r egf 0 r egf 0 + r egf p r egf 0 + r egf p r egf p ": 1 "i2": 1 "protein synthesis": 1 " r l e 1 p *": 1 "motif br": 1 "met_n375s_a1124g": 1 "transcription": 1 "l233s": 1 "nras_g12src_g34act": 1 "pdba": 1 "hp": 1 "k m µm": 1 "hs": 1 "e 2 * e 4": 1 "e 2 * e 3": 1 "gst-h10": 1 "5dpa": 1 "model": 1 "ocn": 1 "f gttatgggatgtcgtggctgtc": 1 "10 0c": 1 "fgfr2_n549kk_t1647ga": 1 "ig": 1 "pik3ca_q546ek_c1636 ga": 1 " r egf * r * p ": 1 "reations": 1 "tgtatggatgaaagcaatctgagag": 1 "cdh13": 1 "r accaccctggtcatagatcg": 1 "ma d86214 ca2+ dep activated prot for secretion": 1 "gene id": 1 "odn": 1 "fbwx7_r505hlp_g1514atc": 1 "k 9 k -9": 1 "price et al 39": 1 "f aggaaggaagagcctcgtcgt": 1 "k a m -1s -1": 1 "ma x66091 asf": 1 "c-sh2 k d ?m": 1 "ka": 1 "kb": 1 "foxl2_c134w_c402g": 1 "? t mb?? °c": 1 "braf_k601e_a1801g": 1 "p_value": 1 "gene_name": 1 "? r t ? t": 1 "d raf*/dt=-k17y 14y 17+k18y 18+k19y 18": 1 "uc6 library": 1 "ma u11274 auf1": 1 "2.18": 1 "la": 1 "lc": 1 "dog1 r": 1 "s1p lpa ? lps ?": 1 "1960–2008": 1 "m s": 1 "estrogen": 1 "ls": 1 "egfr_g719_g2155ta": 1 "dog1 f": 1 "ma l20509 matricin": 1 "gci 89": 1 "pik3r1_n564k_c1693ag": 1 "guan et al 17": 1 "h3k4me 3 p": 1 "p -value* protein": 1 "overton et al 2006 soga et al 2005": 1 "o1": 1 "o2": 1 "wong et al 16": 1 "mr": 1 "?0.05": 1 "+ r egf p r egf 0 + 2 r egf p r 0 p + 2 r egf p r egf p ": 1 " sensitivity": 1 "mx": 1 "costenoble et al 13 ": 1 "conde et al 2011 ": 1 "nd": 1 "nh": 1 "c-terminal fusion": 1 "nn": 1 "no": 1 "has 2": 1 "has 1": 1 "l239p": 1 "localization staging": 1 "cimp subgroup n ": 1 " r 4 = r 5 =0": 1 " e 1 e 4 + e 2 e 4 + e 3 e 4 + e 4 0 + r 0 e 4 + r l e 4": 1 "d raf*.mek/dt=k17y 14y 17-k18y 19-k19y 19": 1 "phyllanthus": 1 "packer et al 2009 ": 1 "fgfr3_g370c_g1108t": 1 "f atgcctccatgtgtagtgcgg": 1 "dm ng?ml ?1": 1 "pm": 1 "pn": 1 "dd nm007241 eap330 of ell": 1 "e 1 * p ": 1 "pt": 1 "nag ?": 1 "ecp 300 mmhg n?=?7": 1 "f cagagtctcctttgcctgag": 1 "m musculus": 1 "composite": 1 "mandible": 1 "sig status": 1 "ma aa048927 aminoacyl-trna synthetase": 1 "raf*+pp2a<->raf*.pp2a->raf": 1 "braf_d594gv_a1781 gt": 1 "10a": 1 "d mek*/dt=-k23y 19y 22+k24y 23+k25y 23": 1 "pik3ca_e545d_g1635ct": 1 "gja1/cx43 f": 1 "ma d43643 yl-1": 1 "13 14": 1 "mutant": 1 "f tctcccgaccaaaaataagg": 1 "rr": 1 " e 1 e 4 + r 0 e 4 + r l e 4": 1 "suz12 p a": 1 "ubiad1": 1 "se": 1 " e 1 0 + e 1 e 2 + e 1 e 3 + e 1 e 4 + r 0 e 1 + r 0 e 2 + r 0 e 3 + r 0 e 4 + r l e 1 + r l e 2 + r l e 3 + r l e 4": 1 " n?=?108": 1 "p s+c&ig": 1 "sr": 1 "gilz effects": 1 "function s": 1 "r tgactccgggcttgtgcgtaa": 1 " r 0 e 1 + r 0 e 2 + r 0 e 3 + r 0 e 4 + r l e 1 + r l e 2 + r l e 3 + r l e 4": 1 "symbol": 1 " r * *.*": 1 "n-terminal fusion": 1 "2-acyl lps": 1 " liii": 1 "h2/h8/h6": 1 "ma u35323 h2-m ? h2-m ?2 h2-m ?1 lmp2": 1 "oea lpc": 1 "ma j04694 ?-1 type iv collagen": 1 "gnas_r201h_g602a": 1 "type-b3": 1 "type-b1": 1 "type-b2": 1 "demichele et al 42": 1 "0.054": 1 "161": 1 "genotype": 1 "type-ab": 1 "c-4e7": 1 "kras_g13src_g37act": 1 "m n × 10?4": 1 "detected by comparative genomic hybridization cgh": 1 "current study": 1 "sakakura et al 15": 1 "175": 1 "p node2 †": 1 "dd af159396.1 mt cytochrome b": 1 "gja1/cx43 r": 1 "target dna": 1 "osteocyte": 1 "metabolites": 1 "l624p": 1 "p??? ????? ? w min": 1 "? 0 t ? t": 1 "wolf-yadlin et al 2007": 1 "location": 1 "effect s": 1 "7 dpa": 1 "6 h": 1 "d mek*.erk/dt=k23y 19y 22-k24y 24-k25y 24": 1 "v 1": 1 "nras_a146t_g436a": 1 "v 2": 1 "none": 1 "+ 2 r 0 p r 0 p + r egf p r egf 0 + 2 r egf p r 0 p ": 1 "e 3 0 0": 1 "f ttccagcttgaaagcccagcc": 1 "r ttcaggcacggatgcagatg": 1 "finn et al 46": 1 "ma u09138 ppar ?2": 1 "gnas_r201sc_c601at": 1 "phase": 1 "n = 1247": 1 "1 n 1 i 1": 1 "idh1 mutation ": 1 "pacrg f": 1 "f ctcaatgccggcttcaaagag": 1 "raf*+mek<->raf*.mek->mek*": 1 "egfr_t854i_c2561t": 1 "exp 2": 1 "exp 1": 1 "r agtgtcaagttctgctccctg": 1 "ma l15447 rnu1a-1": 1 "pacrg r": 1 "ma x97042 ubcm4": 1 "+ r egf p r egf 0 + r egf p r 0 p + r egf p r egf p ": 1 "exp 6": 1 "exp 5": 1 "e 2": 1 "exp 4": 1 "exp 3": 1 "v c": 1 "ccagaggctgttgctgcttgcgcaagg": 1 "2 k 5 k -5": 1 " e 2 e 4 *": 1 "pik3r1_d560y_g1678t": 1 "dd x04653 t-cells activating protein tap": 1 " kcal.mol-1.k-1": 1 "v p": 1 "z 6 = r 0 1 1 + r 1 1 1     52g": 1 "mau22031 20s proteasome subunit lmp7": 1 "e 2 e 3 *": 1 "frasch et al 2013 obinata et al 2005 parks et al 2005": 1 "fatty acid derivatives ?": 1 "cellularity": 1 "f gggagccgagcgaacaa": 1 "? c p cal/mol/k": 1 "ch1 43 cm": 1 "stage ii n?=?20": 1 "pap r": 1 "e f": 1 "campbell ig et al 3 ": 1 "pdgfra_n659y_a1975t": 1 "f cagcagtgaccaccaactgtc": 1 "gfp": 1 "ma plzf h ?ma plzf k": 1 "kras_q61hhe_a183ctg": 1 "bw a": 1 "m1a": 1 " r l e 2": 1 "pap f": 1 " r l e 4": 1 "76 h": 1 "prossnitz and barton 2009": 1 "r gcttttcttggattcatttgtc": 1 "f gtgaactcacgtggggagat": 1 "2-arachidonyl lpa": 1 "37 0c": 1 "2-arachidonyl lpi": 1 "gccgtcggcaccagggtcagctcccgtggc": 1 " e 3 e 4 *": 1 "relative brightness e": 1 "f ctgtgggcttacagagccaaa": 1 "kras_g12dav_g35act": 1 "tag": 1 "m2b": 1 "oxe": 1 "ma u28789 pact": 1 "tissue type": 1 "vanmeter et al 2009": 1 "patients": 1 "pik3ca_e545kq_g1633ac": 1 " e 1 p + e 1 e 2 + r 0 e 1 p + r 0 e 2 + r l e 1 p + r l e 2": 1 "prkcn/prkd3 r": 1 "ma x01756 cytochrome c mc1": 1 "ret_m918t_t2753c": 1 "prkcn/prkd3 f": 1 "guo et al 2011": 1 "ma x54149 myd118": 1 "midorikara et al 22": 1 "oberthuer et al 27 a": 1 "dd m35244 mhc-1b h2-tl-t10-129": 1 "hc-3": 1 "kit_y553n_t1657a": 1 "wt g": 1 "dd aa240130 est~gmp reductase reductase": 1 "ctnnb1_g34eva_g101atc": 1 "ggctgcgacccgttgc": 1 "met_y1248hd_t3742cg": 1 "ch15 22 cm": 1 "ma u03283 c3h cytochrome p450 cyp1b1": 1 "regimen": 1 "sig phenotype *": 1 "suzuki et al 2013 wang et al 2006b": 1 "narayana et al 2012a ": 1 "braf_g466eva_g1397atc": 1 "ozr": 1 "akt1_g173r_g517c": 1 " e 1 e 4 *": 1 " r l e 3 *": 1 "adaptor": 1 "prkag1_r70q_g209a": 1 "phase iii wells et al 300 mg": 1 "r.agaagtcagaggcaggtgga": 1 "kolkman et al 9 ": 1 "r egf x 1 r egf x 2": 1 " r 0 p r 0 0 + r egf p r 0 0 + r egf 0 r 0 p + 2 r 0 p r 0 p ": 1 "r egf x 1 r egf x 1": 1 "asgharzadeh et al 28 b": 1 "d mek/dt=k22y 21": 1 "wild": 1 "f226": 1 
"ni": 74 "x": 57 " ? ? ?": 43 "1": 36 "?": 29 "+": 25 "?": 24 "p-value": 23 "gene": 16 "name": 14 "24 h": 12 "treatment": 12 "0.02": 12 "references": 12 "target": 12 "12 h": 11 "ni/rsp5": 11 "source": 10 "0.085": 10 "": 9 "ontology term": 9 "v8": 9 "institution": 9 "group": 9 "reference": 9 "2.0": 8 "<.0001": 8 "3 h": 8 "0.016": 8 "up": 8 "6 h": 8 "0.0004": 8 "1.0": 8 "n": 7 "down": 7 "nucleus": 7 "0.0099": 7 "mirna": 7 "day 7": 7 "0.0071": 7 "0.0003": 7 "mouse": 7 "1/200": 7 "rabbit": 6 "dub": 6 "10": 6 "oxys": 6 "species": 6 "immune response": 6 "wistar": 6 "dilution": 6 "organism": 6 "small gtpases": 6 "ihc": 6 "e2/e3": 6 "age": 6 "antibody": 6 "0.0261": 6 "2": 5 "rabbit polyclonal": 5 "fc pat 11": 5 "fc pat 12": 5 "fc pat 3": 5 "fc pat 2": 5 "fc pat 6": 5 "fc pat 5": 5 "fc pat 4": 5 "fc pat 9": 5 "fc pat 10": 5 "company": 5 "human": 5 "mammals": 5 "average fc": 5 "strain": 5 "gaps": 5 "p9": 5 "cytoplasm": 5 "3 days": 5 "phenotype": 5 "0.0128": 5 "ni/ni": 5 " +? ?": 5 "0.0051": 5 "0.0078": 5 "0.0007": 5 "0.0032": 5 "egfr": 5 "yeast": 5 "protein": 5 "tissue": 5 "cell adhesion": 5 "p-value from tdsit": 5 "18 h": 5 "donkey": 5 "—": 4 "5": 4 "defense response": 4 "jackson immunoresearch laboratories inc.": 4 "metabolism": 4 "drosophila": 4 "sanger sequencing": 4 "start": 4 " ihc": 4 "0.21": 4 "0.16": 4 "0.27": 4 "3.1": 4 "mcc": 4 "met": 4 "candida albicans": 4 "colony formation ratio/ct": 4 "end": 4 "0.006": 4 "transcription": 4 "m1": 4 "m2": 4 "m3": 4 "z -score": 4 "tumour mass mg": 4 "24 hrs": 4 "wt": 4 "method": 4 "maxic": 4 "rhodopsin-like receptors": 4 "groups": 4 "0.0097": 4 "+dox": 4 "0.0121": 4 "0.0169": 4 "cell cycle": 4 "0.0157": 4 "count": 4 "day 1": 4 "7 days": 4 "secretin receptor family": 4 "apoptosis": 4 "par 1": 4 "simic": 4 "0.0048": 4 "0.0059": 4 "0.0008": 4 "0.0005": 4 "0.0002": 4 "0.0016": 4 "0.0015": 4 "0.0028": 4 "0.0031": 4 "inc": 4 "0.0044": 4 "intracellular": 4 "1?h": 4 "signal transduction": 4 "0.2": 4 "gefs": 4 "ub receptor": 4 "0.1627": 4 "description": 4 "iccs": 4 "etk/bmx": 4 "sn ": 4 "class a": 4 "class b": 4 "sp ": 4 "cell communication": 4 "simj": 4 "mitochondrion": 4 "x ????": 4 "24?h": 4 "q-value": 3 "0": 3 "?vasodilation": 3 "m": 3 "72 h": 3 "angiogenesis": 3 "metabotropic glutamate receptor": 3 "alternations": 3 "function": 3 "cxcl1": 3 "n-v n=6": 3 "genes": 3 "cell lines": 3 "5? probe": 3 "plasma membrane": 3 "lps": 3 "prrb": 3 "colony area mm 2 ": 3 "0.19": 3 "0.14": 3 "0.44": 3 "0.36": 3 "0.56": 3 "0 mg/kg": 3 "25": 3 "0.0464": 3 "mk1": 3 "mk3": 3 "mk2": 3 "agent": 3 "neurogenesis": 3 "4 h": 3 " fish": 3 "human fungal pathogens": 3 "sicont": 3 "1/500": 3 "ashbya gossypii": 3 "siher2": 3 "0.001": 3 "0.004": 3 "0.005": 3 "0.002": 3 "tokens": 3 "fusarium oxysporum": 3 "d-score": 3 "?antifibrotic": 3 "fdr": 3 "frizzled": 3 "marker": 3 "effect": 3 "30 mg/kg": 3 "0.1251": 3 "b1": 3 "ustilago maydis": 3 "b2": 3 "b3": 3 "fold": 3 "magnaporthe oryzae": 3 "e1": 3 "e2": 3 "e3": 3 "regulation of transcription": 3 "fc": 3 " 100 nm": 3 "ph": 3 "extracellular space": 3 "t1": 3 "t2": 3 "t3": 3 "small gtpase mediated signal transduction": 3 "genotype": 3 "phase": 3 "drug": 3 "development": 3 "cancer examples": 3 "standard": 3 "0.0096": 3 "i3a": 3 "thxid™ -braf test": 3 "mcd-ali n=7": 3 "extracellular": 3 "0.0103": 3 "0.0113": 3 "probeset": 3 "10 mg/kg": 3 "zebrafish": 3 "hla allele group": 3 "gene symbol": 3 "0.0125": 3 "nucleobase nucleoside nucleotide and nucleic acid metabolism": 3 "0.0159": 3 "proteominer": 3 "plant fungal pathogens": 3 "hrm": 3 "c10 fcs": 3 " g/l": 3 "brca1": 3 "phosphorus metabolism": 3 "day 0": 3 "kinase": 3 "amino acid": 3 "il-2": 3 "il-6": 3 "0.0001": 3 "8 h": 3 "mcd-v n=7": 3 "2.5 fcs?+?egf": 3 "effect size": 3 "igg": 3 "0.0056": 3 "protein amino acid phosphorylation": 3 "type/token": 3 "0.0065": 3 "nucleic acid binding activity": 3 "0.0073": 3 "0.0079": 3 "0.0011": 3 "0.0014": 3 "0.0013": 3 "0.0029": 3 "0.0037": 3 "0.0042": 3 "phosphorylation": 3 "attested/possible": 3 "0 h": 3 "48 h": 3 "?antihypertrophic": 3 "histology": 3 "apc": 3 "0.0351": 3 "zymoseptoria tritici": 3 "vehicle": 3 "phosphate metabolism": 3 "0.0384": 3 "increase": 3 "sample": 3 "dmso": 3 "c2.5 fcs": 3 " 63 ": 3 "# peps": 3 "ethanol": 3 "class c": 3 "class f": 3 "response to biotic stimulus": 3 "enhancement factor": 3 "receptor": 3 "aspergillus fumigatus": 3 "?antithrombotic": 3 "cell line": 3 "symbol": 3 "150": 3 "heat shock": 3 "cdi": 2 "senescent cells ": 2 "3": 2 "4": 2 "10.0": 2 "6": 2 "7": 2 "8": 2 "9": 2 "amplicon": 2 "tgf-?1+ tnf-?": 2 "7/86–6/87": 2 "chr": 2 "fellow vascular surgery mount sinai hospital new york n.y.": 2 "radionuclide": 2 "1989–": 2 "average ?ct": 2 "cancer": 2 "subcutaneous": 2 "cytoskeleton": 2 "h3k9me3": 2 "con": 2 "2002–": 2 "cell cycle control": 2 "muscle": 2 "ldh": 2 "n-ali n=7": 2 "dose gy": 2 "ifn-?": 2 "concentration m": 2 "ga +": 2 "ga -": 2 "cell signaling technology": 2 "1 day post-injury": 2 "ion transport": 2 "santa cruz technology": 2 "primary": 2 "h-rasv12": 2 "water": 2 "3rdstage normal helper phage": 2 "facs s/na": 2 "fda approved": 2 "rowspanempty": 2 "head of section pathology division national cancer center research institute": 2 "primary antibodies": 2 "?antiproliferative": 2 "0.11": 2 "pmp-072": 2 "0.22": 2 "0.18": 2 "0.13": 2 "cellular_component unknown": 2 "0.34": 2 "0.29": 2 "0.25": 2 "0.43": 2 "0.40": 2 "0.41": 2 "0.54": 2 "hydrolase activity": 2 "biosynthesis": 2 "supplier": 2 "0.67": 2 "0.65": 2 "immunogen": 2 "10 n?=?3": 2 "synergy score": 2 "professor department of pathology keio university school of medicine": 2 "acetonitrile": 2 "cellular process": 2 "acidic vacuoles": 2 "mitotic cell cycle": 2 "band": 2 "11": 2 "12": 2 "13": 2 "14": 2 "?vasoconstriction": 2 "epitope no.": 2 "?oxidative stress": 2 "z-score": 2 "2ndstage mutant helper phage": 2 "average range": 2 "50": 2 "fs188": 2 "79": 2 "81": 2 "2009–": 2 "1999–": 2 "fs164": 2 "sham+val n=10": 2 "62 weeks": 2 "nm_030873": 2 "fs120": 2 "?endothelial disruption": 2 "1996–": 2 "mtt": 2 "mts": 2 "sequence": 2 "12.5": 2 "chf-s": 2 "3 weeks": 2 "?? o2?": 2 "1996–1997": 2 "gtpase h-ras": 2 "12 weeks": 2 "tnf?": 2 "structural constituent of cytoskeleton": 2 "?vasopressin release": 2 "temsirolimus survival": 2 "measurement": 2 "lvedp mmhg": 2 "lvh+val n=10": 2 "vegfa": 2 "4.9": 2 "0.011": 2 "uracil permease fur4": 2 "3rdstage mutant helper phage": 2 "0.014": 2 "manufacturer": 2 "facs astrocytes": 2 " 62.5 mg/kg": 2 "pten": 2 "cytokine/chemokine concentration pg ml ?1": 2 "cytokine": 2 "igm day 4": 2 "0.007": 2 "tnf-?": 2 "dna repair": 2 "bibr10?m": 2 "gpx activity nmol nadph ox/min/mg prot": 2 "?aldosterone release": 2 " 14 ": 2 "lower chamber": 2 " 15 ": 2 "gab1": 2 " 16 ": 2 "p16": 2 "h-rasv12g37": 2 "se dose rate mg/kg": 2 "fold expression": 2 "ifn?": 2 "delivery": 2 "ascl1": 2 "0.1256": 2 "fas": 2 "cytokines": 2 "nru": 2 "db/m": 2 "il-1?": 2 "chf-ex": 2 "?? il-10": 2 "poly adp-ribose polymerase acc# m18112": 2 "g217b": 2 "rt-pcr": 2 "elisa signal": 2 "bibr5?m": 2 "genebank accession": 2 "wky": 2 "cos10?m": 2 "cytosol": 2 "28 days post-injury": 2 "antibodies": 2 "s phase of mitotic cell cycle": 2 "ga": 2 "gt": 2 "0.1096": 2 "2 ^ -? ct": 2 "+dox/? dox": 2 "2.09": 2 "cat.n°": 2 "tunel assay": 2 " cov": 2 "me12": 2 "me08": 2 "2.29": 2 "author": 2 "me02": 2 "me01": 2 "me05": 2 "me04": 2 "2.57": 2 "2.56": 2 "2.55": 2 "response to external stimulus": 2 "visiting research fellow the burnham institute dr erkki ruoslahti": 2 "g-protein coupled receptor protein signaling pathway": 2 "non-acidic vacuoles": 2 "pmp-311": 2 "7/76–6/77": 2 "mutant": 2 "g-csf": 2 "si": 2 "direktor 1st medical department": 2 "48hrs/0hr": 2 "ic 50 mg/ml after 24 h": 2 "none": 2 "14.4": 2 "oncogenesis": 2 "trade/code name": 2 "vein graft failure": 2 "ga ++": 2 "muc2": 2 "set2": 2 "set1": 2 "cerebellum": 2 "egf receptor": 2 "6.3": 2 "0.0098": 2 "0.0095": 2 "0.0093": 2 "newly dx vs progression": 2 "vemurafenib survival": 2 "?? histamine release": 2 "resident general surgery mount sinai hospitalm new york n.y.": 2 "?proliferation": 2 "0 n?=?3": 2 "migration number of cells": 2 "vol.": 2 "mouse monoclonal": 2 "g186a": 2 "db/db": 2 "ptgs2": 2 "lvh n=12": 2 "0.0106": 2 "0.1435": 2 "14 days post-injury": 2 "0.0111": 2 "# pep": 2 "0.0112": 2 "alternation": 2 "aver-ageper day": 2 "sham-ex": 2 "day1 *": 2 "time": 2 "0.0176": 2 "7.17": 2 "0.0178": 2 "2-methoxyestradiol": 2 "0.0198": 2 "0.0197": 2 "incidence": 2 "0.0123": 2 "at2 receptor subtype": 2 "0.0139": 2 "hpv-negative": 2 "7/81–6/85": 2 "0.0147": 2 "0.0151": 2 "downregulated genes": 2 "humoral immune response": 2 "7.8": 2 "ni/rabex-5": 2 "protein modification": 2 " ++? ?": 2 " n?=?6": 2 "ejaculate": 2 "hla supertype": 2 "integral to membrane": 2 "brca2": 2 "c-met": 2 "hypertension": 2 "day 3": 2 "?? chemotaxis": 2 "day 14": 2 "day 4": 2 "antigen": 2 "at1 receptor subtype": 2 "chief pathology division national cancer center research institute": 2 "protein kinase activity": 2 "gm-csf": 2 "agents": 2 "0.0806": 2 "host": 2 "position": 2 "arsenical": 2 "b6 hp": 2 "compound": 2 "sam results": 2 "12 n?=?3": 2 "sham n=10": 2 "mthfr": 2 "96hrs/0hr": 2 "il-4": 2 "fish": 2 "0.0888": 2 "day2 *": 2 "ub receptor/adaptor": 2 "regulation of transcription dna-dependent": 2 "ferrioxamine b transporter sit1": 2 "0.0047": 2 "0.0055": 2 "0.0054": 2 "0.0053": 2 "0.0063": 2 "0.0061": 2 "nuclei": 2 "0.0069": 2 "causes": 2 "il6": 2 "total cells counted": 2 "0.0088": 2 "0.0084": 2 "0.0083": 2 "cos5?m": 2 "0.0012": 2 "h-rasv12s35": 2 "0.0023": 2 "0.0022": 2 "0.0020": 2 "24hrs/0hr": 2 "0.0026": 2 "0.0025": 2 "0.0024": 2 "0.0034": 2 "0.0033": 2 "0.0039": 2 "0.0045": 2 "morphogenesis": 2 "rat": 2 "igg day 12": 2 "pool": 2 "gene name": 2 "university medical center mainz": 2 "aa no.": 2 "percent dead cells *": 2 "tumor incidence": 2 "sham-s": 2 "gene description": 2 "mol mass g/mol": 2 "clone": 2 "lactate transporter jen1": 2 "accession": 2 "1.84": 2 "setdb1": 2 "1.95": 2 "-dox": 2 "day3 *": 2 "at2": 2 "at1": 2 "refs": 2 "16 hrs": 2 "atm": 2 "atp": 2 "recurrent": 2 "combined survival": 2 "7/85–6/86": 2 "ax2": 2 "genotypes": 2 "?cardiac hypertrophy": 2 "run #1": 2 "run #2": 2 "2ndstage normal helper phage": 2 "chemotaxis inflammatory response": 2 "h-rasv12c40": 2 "sponsor": 2 "rna binding activity": 2 "hexane": 2 "1 h": 2 "fswt": 2 "chief resident general surgery mount sinai hospital new york n.y.": 2 "ni ni": 2 "9.62": 2 "shr": 2 "inf/mock 1": 2 "research member pathology division national cancer center research institute": 2 "vice-dean keio university school of medicine": 2 "peter robert galle md phd": 2 "?inflammation": 2 "before injury": 2 "tgf-?1": 2 "?platelet aggregation": 2 "100": 2 "b6 h poly": 2 "tlr4": 2 "0.0239": 2 "0.0234": 2 "?dox": 2 "endostatin": 2 "refseq": 2 "0.1507": 2 "pcdna6": 2 "hpv-positive": 2 "kit": 2 "microarray": 2 "trypsin activity": 2 "goat": 2 "cell surface receptor linked signal transduction": 2 "ic50 nm/l *": 2 "?fibrosis": 2 "inhibitor": 2 "rotating internship mercy catholic medical center darby pa": 2 "0.0266": 2 "cd4": 2 "cd3": 2 "response": 2 "cd8": 2 "extracellular matrix structural constituent conferring tensile strength activity": 1 "nls-bearing substrate-nucleus import": 1 "14th week": 1 "crc cells": 1 "kringle 5": 1 "response to wounding": 1 "uxsl": 1 "massachusetts general hospital cancer center harvard medical school": 1 "laminin receptor 1 67kd ribosomal protein sa": 1 "n-linked glycosylation": 1 "ctla-4 blockade": 1 "bmpr2 gas7 lppr4 pld1 rasgrf1": 1 "c225?+ ? 125 i-cldr": 1 "target molecule": 1 "mean vacuole size +/- sem µm": 1 "regulation of cell volume": 1 "cv confusion matrix threshold?=?2.66891": 1 "lmwp": 1 "sensory organ development": 1 "vasoactivity": 1 "-": 1 "titratable acidity": 1 "non-tumor bearing mice": 1 "cds": 1 "extracts": 1 "reduced flash index": 1 "collagen type i": 1 "role": 1 "pigment biosynthesis": 1 "gtpcyclohydrolase i": 1 "cell surface receptor linked signal transduction jak-stat cascade": 1 " 70 ": 1 "microtubules": 1 "ywhae": 1 "mesenchymal-like": 1 "used in meta-analysis?": 1 "green 17": 1 "dld-1 *": 1 "uptake parameter": 1 "diabetes mellitus/glucose intolerance cushingoid facies hyperlipidemia growth retardation menstrual irregularities suppression of pituitary-adrenal axis": 1 "glucose": 1 "salt": 1 "chek2": 1 "cfi": 1 "cxcl5 ena- 78": 1 " 71 ": 1 "company and location": 1 "acute-phase response": 1 "prim-mef": 1 "14-3-3?": 1 "rab5a": 1 "blood": 1 "ship?/?rag?/?": 1 "1422115_a_at": 1 "viscosity": 1 "dopamine transporter": 1 "rab4a": 1 "v1 ¥": 1 "tubulin beta 5": 1 "t 1416": 1 "tubulin beta 3": 1 "heme metabolism": 1 "dp/dt mmhg/s": 1 "manganese ion transport": 1 " 72 ": 1 "histidineprototrophy": 1 "gp130flox": 1 "mrna target": 1 "tumor multiplicity": 1 "dffb": 1 "gene ontology": 1 "dba/2j stress-4 h": 1 "top2a-n": 1 "1418724_at": 1 "dg cu": 1 "chf": 1 "myot": 1 "vegf-c/vegfr3": 1 "aldoc": 1 "transferase activity transferring phosphorus-containing groups": 1 "top2a-c": 1 "vegf-c/vegfr2": 1 "fabp7 cyto": 1 "nm_017138": 1 "cross 22": 1 "camk2d cpne2 cpne8 gpr98 hpcal1 kcnip1": 1 "clone or source": 1 "b12 hdac6": 1 "epithelial cells 39": 1 "neural": 1 "4hbm_consensus": 1 "gene_symbol": 1 "losartan plus prrb": 1 "cell membrane": 1 "primary population s": 1 "ck2": 1 "igh split": 1 "6th 2002": 1 "week 10": 1 "578–597": 1 "spain 157 ": 1 "mouse strain": 1 "potassium channel subfamily v member 1": 1 "tet2 idh1/idh2 asxl1/asxl2 ezh2 dnmt3a eed suz12": 1 "rab9b": 1 "research phase": 1 "pcna * rfc2 * caf1 * dnapol-? dnapol- ? small subunit rfc1 #": 1 " 75 ": 1 "363–370": 1 "ran protein binding activity": 1 "phenotype false discovery rate*": 1 "sequence status": 1 "adenylate cyclase": 1 "translation": 1 "1449305_at": 1 "pfti2": 1 "antimicrobial humoral response sensu invertebrata": 1 "?bax 96 parp-1 and parp-2 97 pip3 98 gage 99 ": 1 "human ?2 ivnc1": 1 "lepr": 1 " 76 ": 1 "investigators": 1 "experiment": 1 "1995–1998": 1 "mirna class": 1 "·?-catenin degradation": 1 "order": 1 "m-rna for nb thymosin beta acc# d82345": 1 "s.no": 1 "cls": 1 "tnf": 1 " 77 ": 1 " 78 ": 1 "rescreening results a": 1 "8 weeks old": 1 "cma": 1 "bnip3l": 1 "nm_017188": 1 "suv39h1 nuclear": 1 "cd44/cd24/esa": 1 " id/g 24 h post-injection": 1 "liver extract": 1 "sodium and fluid retention hypertension": 1 "522–537": 1 "ni/p62": 1 "granulocyte-colony stimulating factor g - csf ": 1 "72 hrs": 1 "skgyafiefasfedak": 1 "synchrotron": 1 "dpp6 dpp10 kcna1 atp1b4": 1 "growth in soft agar*": 1 "eprs * qrs * rrs * p38 #": 1 "dasatanib": 1 "bmpr2 chst11 fam5c prkcd rspo3 znf423": 1 "product": 1 "exos/exot/yope_consensus": 1 "cnt": 1 "asic2": 1 "# differentiating genes": 1 "hcdc37 homolog acc# u43077": 1 "insulin-like growth factors 1 and 2 igf -1 and -2": 1 "thymosin beta-10 acc# s54005": 1 "mas receptor": 1 "porphyrin biosynthesis": 1 "camp-dependent protein kinase activity": 1 "depl /ics": 1 "tumor 32 38 64 68 ": 1 "nm_031455": 1 "capan-2": 1 "transfected dna source": 1 "leto": 1 "positive cellsmean ± sd": 1 "ccl5": 1 "crl5872": 1 "ccl2": 1 "capillary sprouting": 1 "nm.012960": 1 "ccl3": 1 "epsin 1 eps15": 1 "neuropeptide signaling pathway": 1 "pipo": 1 "relative fold change": 1 "phagosome escape": 1 "tccc5": 1 "nm_207361": 1 "lat": 1 "crl5869": 1 "mouse model": 1 "milnesium tardigradum": 1 "p18 protein acc# j04991": 1 "cycle phase": 1 "bacterial strain": 1 "internalization after 90- min suspension": 1 "half-life": 1 "gaussia gaussia princeps": 1 "harc tat": 1 "cultured astrocytes": 1 "pcr card": 1 "flot2": 1 "transfectant": 1 "regulation of progression through cell cycle angiogenesis": 1 "isotype": 1 "chicken": 1 "hspel": 1 "tumor tissue": 1 "cancer load number/rat mean ± sem": 1 "hist1h4c": 1 "kchb10": 1 "rsp5 adapter ear1": 1 "3.19": 1 "0.33 ***": 1 "in-gel 2": 1 "solutesodium symporter activity": 1 "in-gel 1": 1 "adp-sugar diphosphatase activity": 1 "klrb1b": 1 " centistrokes/min": 1 "amyloid precursor protein app": 1 "?memory facilitation": 1 "v8*": 1 "totals": 1 "tmsbl0": 1 "3.34": 1 "dna repair/replication": 1 "ck5 krt5": 1 "tbx2-mef": 1 "3.30": 1 "probe": 1 "megf6 nrxn3": 1 "cxcl8": 1 "ni/mdm2": 1 "cxcl6": 1 "angiotensinogen at1 receptor ace": 1 "other agents": 1 "centromere protein f": 1 "19.2": 1 "cxcl5": 1 "cxcl3": 1 "hr beats/min": 1 "imamura 2012 41": 1 "cxcl2": 1 "54 hpf": 1 "ccr 1": 1 "cytoband": 1 "?? eosinophil peroxidase release": 1 "increased ve/vco2 at at": 1 "1ststage normal helper phage": 1 "3.39": 1 "glucose-limited medium": 1 "voltage-gated ion channel activity": 1 "mic ?g/ml": 1 "ras-related small gtp binding protein rab5 rab5 acc# u18420": 1 "hmgbl": 1 "1420603_s_at": 1 " i.b.": 1 "purine ribonucleoside catabolism": 1 "0.0575": 1 "mitochondrial membrane": 1 " a radioactive tlc lipid kinase assay using 100 ?m atp": 1 "colocalization": 1 "akap13": 1 "andreyev 1998 11": 1 "3.54": 1 "reduced mxc index": 1 "ni/ni ni/ni ubc13/rnf126 rabring 7 ni/triad": 1 "new nonmonoamirte-based antidepressants.": 1 "execution time": 1 "potassium channel activity": 1 "inner membrane": 1 "norm_0 h": 1 "stimulator cytokine produced": 1 "gpc3 gpi rgs12 st8sia4 tbr1 tnr": 1 "ni/triad": 1 "dg zn": 1 "igf-1r": 1 "1bbp": 1 "ecdysone treatment": 1 "gds144 5 wk exercise": 1 "sglt1": 1 "alg12 ap3m1 apba3 arcn1 arf4 arfip2 asb3 bet1 bet1l cd68 cdk2ap2 cdk5rap3 cdk7 copa copb2 copg creb3l2 creld2 dad1 ddit3 derl1 dhdds dnajb9 dnajb11 dnpep edem1 edem2 eif2ak3 elovl2 entpd7 eny2 ero1lb fam18b fkbp2 gabarap gdap2 ggcx gla gle1?l golga1 golga3 gys1 h13 h47 hbp1 hdldp herpud1 hist1h2ad hmbox1 ift20 impdh1 isg20 kbtbd3 lman2 lrrc59 mbnl2 mdh1 mef2c napa nbr1 ncstn nfxl1 oat p4hb pde4dip pdia3 pdia6 pecr pgm3 pla2g6 polr3k ppib ppp1r10 prdx6 preb rpn1 sar1a sec13l1 sec23b sec24d sec63 selm slc2a6 slc30a5 slc30a7 spcs2 srp19 srp54b srpr srprb ssr2 ssr3 stch stt3a stx5a stx18 tbc1d15 tipf5 tme3 tmem39a tmem167b tnfaip1 txndc4 txndc11 ube1dc1 ufd1l ufm1 yipf2 zfand2a": 1 "sglt2": 1 "egi-1": 1 "target molecules examples": 1 "general amino acid permease gap1": 1 "cytosolic large ribosomal subunit sensu eukarya": 1 "bmms b": 1 "nm_000204": 1 "320–450": 1 "24h": 1 "?dp/dt mmhg/sec": 1 "negative regulation of natural killer cell mediated cytotoxicity": 1 "65kd subunit a * catalytic subunit microtubule star * regulatory subunit twins #": 1 "apoptosis induction of apoptosis": 1 "polydispersity index": 1 "gipi3k2": 1 "gds1302 3 ug/kg tcdd": 1 "gipi3k1": 1 "protein amino acid dephosphorylation": 1 "profilin 2": 1 "rras2": 1 "dopamine": 1 "?? il-8 rantes eotaxin ip-10": 1 "tgisdvfak": 1 "map1b": 1 "cationic amino acid transporter cat-1": 1 "3.81": 1 "3.86": 1 "3.85": 1 "gds488 1 hr mi": 1 "separation": 1 "transcription factor etr101 acc# m62831": 1 "zucp5": 1 "zucp4": 1 "3.92": 1 "phosphate transport": 1 "targeted disease": 1 "zucp1": 1 "zucp2": 1 "?? il-5 tnf-? gm-csf mip-1?": 1 "testis zn": 1 "ctsd": 1 "leukaemic samples *": 1 "3.97": 1 "nk cell-specific mechanism": 1 "430–437": 1 "gds2258 female tac": 1 "epiregulin": 1 "transmembrane receptor protein phosphatase activity": 1 "ube2d/idol": 1 "calcium channel subunit beta 3": 1 "lkb": 1 "ship?/?": 1 "heme-copper terminal oxidase activity": 1 "12 mo": 1 "total b": 1 "progesterone receptor": 1 "mice": 1 "transferase activity transferring sulfur-containing groups": 1 "all cancers ": 1 "ube20/mage-l2-trim27": 1 "crl5928": 1 "coronary perfusionpressure mmhg": 1 "certhrax": 1 "pederin": 1 "ced-5 n1812": 1 "pak2": 1 "hroc113p": 1 "chang 2009 43": 1 "albumin": 1 "fung": 1 "vdac conductance": 1 "rar-?": 1 "cideb †": 1 "small ribosomal subunit": 1 "sex determination": 1 "rab12": 1 "90.0": 1 "nm_004673": 1 "stability and splicing of mrna": 1 "dose/day": 1 "measures": 1 "hepg2": 1 "lbh589/obatoclax": 1 "panc-1": 1 "alcohol dehydrogenase activity iron-dependent": 1 "rna-nucleus export": 1 "cytarabine cyto star": 1 "unc-119 homolog c elegans": 1 "sugar binding activity": 1 "hcdc10 cdc10 homolog acc# s72008": 1 "n33": 1 "1996": 1 "pros": 1 "· spermidine/spermine acyltransferase ssat induction": 1 "ae788": 1 "pac1 isoforms": 1 "progesterone receptor membrane component 1": 1 "rassf6**": 1 "stem cell maintenance": 1 "apoptosis and/or p53 related.": 1 "heavy metal binding": 1 "cxc chemokine": 1 "quercetin-3-glucoside-7-rhamnoside": 1 "tumor bearing mice": 1 "br-bw": 1 "nondiabetic at1-r knockout mice": 1 "nptx2": 1 "arhgef2": 1 "socs3": 1 "ribosomal protein l5": 1 "passage 36": 1 "arl5b dock4 rab36 rasd2 rasgrf1 rasl11a rasl12 rgs12 rgs16": 1 "arf – rho": 1 "ecm focal adhesion": 1 "gds648 igf1r+ capi3k": 1 "glutathione conjugation reaction": 1 "transfection": 1 "negative regulation of cell differentiation": 1 "chelt": 1 "rac3 rac3 acc# af008591": 1 "kded10": 1 "apoptosis regulator activity": 1 "adenosine metabolism": 1 "kded19": 1 "lt1": 1 "lt3": 1 "lt2": 1 "evaluation time": 1 "anti biotin dl549": 1 "kded20": 1 "methylation": 1 "rosty 2013 23": 1 "gh receptor ghr": 1 "parathymosin acc# m24398": 1 "coreceptor activity": 1 "killer cell lectin-like receptor subfamily b member 1b": 1 "antagonists": 1 "cona-cy3": 1 "hydrolase activity acting on acid anhydrides catalyzing transmembrane movement of substances": 1 "pglyrp1": 1 "rab1b": 1 "mglu4a mqlu4b mglu4c mglu4d": 1 "pre-incubation time/sample": 1 "contnet µg/mg": 1 "ni/ rglg1 rglg2": 1 "sh-sy5y": 1 "reference s": 1 "rab1a": 1 "cona-cy5": 1 "lta": 1 "gene targeted": 1 "retina 84 ": 1 "10.5 hpf": 1 "cluster thirteen 1208": 1 "basic function": 1 "brcc36 brisc-shmt2 complex": 1 "chromosome": 1 "rapgef6": 1 "anti-pdia3 abe1032": 1 " nmol/mg": 1 "absorbance maximum ?max nm": 1 "re14.5": 1 "cytopathogenicity": 1 "ch60 dnak hldd kprs odp1 rpe rs2 syp": 1 "epha3": 1 "substrates????": 1 "scored positive with histone misprocessing reporter": 1 "· cpla2 decrease": 1 "shared tumor-specific antigens cancer - testis antigens": 1 "rad51c rad51c acc# af029669": 1 "up-regulated **": 1 "giayiefk": 1 "losartan": 1 "oxidoreductase activity acting on the ch-nh2 group of donors": 1 "tbc1d20": 1 "manual annotation*": 1 "1421424_a_at": 1 "solute carrier slc3a2": 1 " 81 ": 1 "gtpase": 1 "kininogen 1": 1 "dose": 1 "rpl5": 1 "periconia species": 1 "antibody clone": 1 "v2 ¥": 1 "1100": 1 "vl failure": 1 "china 153 156 ": 1 "sirna*": 1 "nr2a-nmdar 35": 1 "subgroup": 1 " 82 ": 1 "no ecdysone treatment": 1 "pld1 pter": 1 "maspin": 1 "gastroenterological": 1 "mast cells 2 38 39": 1 " 83 ": 1 "rna polymerase ii elongation factor-like protein acc# z47087": 1 "mrna for transcriptional activator hsnf2b acc# d26156": 1 "secretion apparatus": 1 " i.p.": 1 "stage": 1 "sim µm": 1 "transporter": 1 "coding events": 1 "rpn 1": 1 "reversal fold": 1 "us and australia phase 1 29": 1 "invalid result": 1 "large ribosomal subunit": 1 "prostatic secretions": 1 "vegfr/pdgfr/c-kit": 1 "0.12": 1 " 84 ": 1 "asp awd * cup * young arrest hsp83 * polo * † pumillio topoisomerase 2 * valois pp1-87b * cdc2c * pp2a catalytic subunit microtubule star * † ?tub67c * 14-3-3 ? * pcna * † rfc2 * † twinstar * pitslre rpn2 * klp10a * brat rfc1 #": 1 "mhc class i mfi clone w6/32": 1 "adrenergic stimulation": 1 "syk orzap-70": 1 "0.07": 1 "sst4": 1 "sst5": 1 "potential therapeutic": 1 "?2.09 *": 1 "casein kinase activity": 1 "sst2": 1 "sst3": 1 "0.23": 1 "agonist": 1 "sst1": 1 "611–624": 1 "epb41l2 prkcd": 1 "ras – rho": 1 "0.17": 1 "new monoamine-based antidepressants": 1 "0.15": 1 "basal cell carcinoma": 1 "glycine max": 1 "p53ts 32° growth arrest": 1 "proteolysis and peptidolysis": 1 "log 2 tr7h/trc": 1 "n treatment groups": 1 "ectodermal-neural cortex 1": 1 "cdh1": 1 "group i grm1 grm5 group ii grm4 grm7 grm8 group iii grm2 grm3": 1 "acadm": 1 "haloperidol": 1 "0.28": 1 "skgiayiefk": 1 "latency range days": 1 "0.26": 1 "0.24": 1 "nuclear": 1 "mouse icam 1 c-myc": 1 "sirna hiv könig": 1 "regulation of mitotic cell cycle": 1 "translocation": 1 "decoys": 1 "length": 1 "0.45": 1 "md=67": 1 "trail-r1 trail-r2": 1 "a1 ccrl2 gpr137b a2 ccr10 cxcr4 a4 oprl1 ssr1 ssr2 ssr3 ssr4 a5 galt ltb4r a6 gpr176 a7 ednra ednrb gpr37 gpr39 a10 lgr4 a11 p2ry2 a13 lpar1 lpar2 s1pr1 s1pr2 mc1r gpr3 a14 ptger4 a15 lpar5 f2rl1 f2rl2 f2rl3 gpr68 gpr35 f2r a16 opn3 a17 adrb2 a18 hrh1 adora1 adora2b gpr64 gpr161 gpr173 a19 htr7": 1 "osteopontin cleavage product": 1 "gds144 10 min exercise": 1 "0.39": 1 "?adenovirus basic core protein 95 ": 1 "0.35": 1 "s.no.": 1 "aim1 gbas lmo2 lmo3 mcf2 map4 neto1 qsox1 rp6-213h19.1 syf2 ube2e1": 1 "wwox": 1 "ni/chip": 1 "upregulated genes": 1 "mrna for transcription factor areb6 acc# d15050": 1 "sorafenib": 1 "0.55": 1 "migration differentiation and survival": 1 "accession number": 1 "sirna": 1 "0.52": 1 "0.50": 1 "baff": 1 "ka1 ka2": 1 "pancreas": 1 "mrna for proliferation-associated gene pag acc# x67951": 1 "click beetle red pyrophorus plagiophtalamus": 1 "anti-hh antibodies": 1 "induces cell migration b": 1 "ca2+ into mitochondria": 1 "protein phosphatase activity": 1 "0.66": 1 "nm_054008": 1 "c-met agonist a": 1 "sham-pbs n=10": 1 "0.60": 1 "0.61": 1 "tgfb2": 1 "g-coupled receptors": 1 "0.59": 1 "mean arterial pressure mmhg ": 1 "rna polymerase ii elongation factor siii acc# l34587": 1 "0.58": 1 "dna dependent dna replication": 1 "mage": 1 " 58 59 ": 1 "skin": 1 "0.77": 1 "vesicle": 1 "0.78": 1 "0.75": 1 "0.76": 1 "0.74": 1 "0.71": 1 "?fb cultures": 1 "86.8": 1 "0.69": 1 "mas": 1 "theopederins": 1 "t 614": 1 "hcr2hi": 1 "vegf-d/vegfr3": 1 "rheb": 1 "+1": 1 "isorhamentin pure": 1 "vegf-d/vegfr2": 1 "+2": 1 "+3": 1 "ras? cdc42? transformation ras? cdc42? pak4? transformation rasgrf –i cdc42 ras rac1? plc?1? rasgrp1? ras": 1 "neurologic": 1 "0.85": 1 "human ?3 ivnc1": 1 "med os mos": 1 "gds488 24 hr mi": 1 "18.16": 1 "chloride transport": 1 "gyl1": 1 "ethanol oxidation": 1 "purine nucleotide binding activity": 1 "psca": 1 "galactose binding lectin": 1 "polr2g": 1 "cell/mmp": 1 "arhgef37": 1 "2k1c+gw": 1 "ni/nedd4-1 nedd4-2": 1 "diet form": 1 "zinc-independent": 1 "muscle fiber": 1 "psd4": 1 "cd3eap q504k": 1 "group iii": 1 "santa cruz technology santa cruz ca usa": 1 "anti goat alexa 594": 1 "e3 ligase nedd4-l": 1 "arhgef26": 1 "sc-18607": 1 "1419431_at": 1 "smoothened": 1 "solanum lycopersicum": 1 "rpll0": 1 "bind int hiv 23": 1 "tgbc1-tkb": 1 "b1 glp1r b2 gpr56 gpr64 gpr97 gpr110 gpr115 gpr126 gpr125 gpr128 gpr133 cd97 bai2 cslsr1 lphn2 lphn1 celsr3 celsr2 bai1 gpr116": 1 "cck marcks tac1": 1 "motility speed": 1 "aasdhppt brca1 cdca8 eif1a h2afx hnrpa3 hs2st1 khsrp kif18a marcks mastl ncapd2 osgep rapsn ric8b rrm2b sdccag8 txnl1 zfp473": 1 "apr 1997–present": 1 "rgc32": 1 "spindle": 1 " 60 61 ": 1 "apt121p19arf?/?": 1 "physiological medium": 1 "reference ranges": 1 "arf family": 1 "di- tri-valent inorganic cation homeostasis": 1 "structure": 1 "tbc1d12": 1 "delivered vt ml/kg": 1 "?? erk 1/2": 1 "pretreatment": 1 "chromatin remodeling complex": 1 "circulation": 1 "jackson immunoresearch laboratories inc west grove pa usa": 1 "transmembrane receptor protein tyrosine phosphatase activity": 1 "interleukin-10 il-10": 1 "gyp1": 1 "cbl dose": 1 "oryza sativa": 1 "gyp2": 1 "lymphocyte differentiation": 1 "dye exclusion": 1 "cell growth": 1 "gyp6": 1 "s100a2": 1 "gyp7": 1 "kcha10": 1 "gyp8": 1 "ni/nedd4 itch": 1 "nuclear architecture": 1 "?hnrnpu 100 hnrnpa1 100 nsp 5a3a 101 ": 1 "rhobtb2": 1 "nus1": 1 "?-galpositivity": 1 "bevacizumab": 1 "seoul national university hospital": 1 "0.0450": 1 "ratio c3/c5": 1 "cohesin complex and related proteins": 1 "disease type": 1 "eml-alk translocation nomenclature": 1 "0.0457": 1 "raw_24 h": 1 "15": 1 "16": 1 "17": 1 "18": 1 "thyroid hormone generation": 1 "0.0453": 1 "19": 1 "705-585-147": 1 "mrna": 1 "tp53": 1 "a4 gpr22 gpr1 a5 gpr100 gpr106 gpr142 a6 gpr103 a7 gpr39 a8 gpr44 gpr77 a9 gpr50 gpr73 gpr75 gpr19 a10 gpr49 gpr48 a11 gpr82 gpr40 gpr43 grp109b gpr81 a12 gpr87 gpr34 gpr171 a13 gpr3 gpr12 gpr6 a15 gpr4 gpr68 gpr119 gpr35 gpr132 gpr18 gpr65 gpr20 a18 gpr61 gpr84 gpr85 gpr45 gpr63 gpr88 gpr173 gpr27 gpr21 orphan gpr141 gpr23 gpr26 gpr33 gpr35 gpr37 gpr54 gpr135 gpr149 gpr150 gpr151 gpr152 gpr153 gpr160": 1 "platelets": 1 "carbohydrate kinase activity": 1 "anti-pdia3 nbp1-84797": 1 "angiogenesis proteolysis": 1 "hepg2/c3acells": 1 "20": 1 "21": 1 "interferons- ? ? and ?": 1 "22": 1 "23": 1 "24": 1 "26": 1 "27": 1 "celecoxib": 1 "0.0465": 1 "myeloid cell lines": 1 "29": 1 "re-engagement": 1 "carboxypeptidase s cps1": 1 "mitotic spindle cytoskeleton and centromeres": 1 "sim µm + mevalonate µm": 1 "tff1": 1 "clone name": 1 "mif": 1 "nmda": 1 "prevention of thrombus formation": 1 "gxcdd-": 1 "hspas": 1 "cdse": 1 "ngf receptor trka": 1 "ca2+ mobilization from intracellular and extracellular stores": 1 "?? ifn-? gm-csf tnf-?": 1 "steroid hormone receptor activity": 1 "0.0478": 1 "cases n?=?36": 1 "38": 1 "0.0476": 1 "cardiovascular": 1 "scramble peptide": 1 "klk1": 1 "group i": 1 "translocation partner": 1 "7q21.1": 1 "0.0485": 1 "0.0484": 1 "0.0483": 1 "tgf-beta superfamily": 1 "taro yamashita md phd": 1 "sumo 04493": 1 "c9 somite": 1 "?? ltc4 ltd4 and pgd2": 1 "0.0402": 1 "cluster twelve 619": 1 "c57bl/6 stress-8 h": 1 "proliferin thrombospondin-1 tsp -1": 1 "ras-tum": 1 "ic 50": 1 "eml5 map7 phldb2 tubgcp5": 1 "mrna for rna polymerase ii 140 kda subunit acc# x63563": 1 "10.17": 1 "sacrificed moribund": 1 "rassf7**": 1 "somatic reprogramming to ipscs": 1 "uk aatd national registry": 1 "0.0410": 1 "rhov": 1 "rhou": 1 "438–449": 1 "cancer incidence ": 1 "aldh1a3": 1 "chemokine receptor": 1 "harc rev": 1 "0.0417": 1 "3a1-2": 1 "550–650": 1 "3a1-1": 1 "rhob": 1 "0.0426": 1 "0.0424": 1 "crl5810": 1 "percentage inhibition": 1 "0.0423": 1 "e3 ligase c-cbl": 1 "rasl10b": 1 "160 6": 1 "14-3-3 epsilon acc# u54778": 1 "plce1": 1 "ni amsh ni": 1 "mmr": 1 "ubc13/ni": 1 "angiopoietin apn ": 1 "nuclear undecaprenyl pyrophosphate synthase 1 homolog": 1 "71": 1 "crl5807": 1 "g-protein related": 1 "crl5800": 1 "prothymosin alpha acc# m14630": 1 "0.0431": 1 "metastatin": 1 "8.5±0.4 *": 1 "mouse embryonal carcinoma": 1 "esr1": 1 "clinical phase": 1 "interleukin-4 il-4": 1 "pf-0449913 pfizer": 1 "9101": 1 "g-protein coupled photoreceptor activity": 1 "480–650": 1 "srgap2b": 1 "vl success": 1 "rna metabolism": 1 "neurotransmitters": 1 "conc µm": 1 "mmtv- c- myc": 1 "gds794 21 day tac": 1 "tumour formation in nude mouse*": 1 "60 hpf": 1 "thyroid hormone metabolism": 1 "culture astrocytes": 1 "cattle": 1 "mdr1 b": 1 "tfk1": 1 "karapetis 2008 44": 1 "antithrombin iii fragment": 1 "36 hpf": 1 "single-step": 1 "lupus p70 ku autoantigen protein acc# j04611": 1 "nm_000198": 1 "tfiib related factor hbrf hbrf acc# u75276": 1 "spliceosomal proteins": 1 "stk11": 1 "protein-ligand dependent protein catabolism": 1 "gender": 1 " aag/cag": 1 "vascular remodeling": 1 "retinoic acid receptor beta": 1 "cell adhesion molecule activity": 1 "embryonic vasculopathy anomalous vasculogenesis and angiogenesis": 1 "hmec-1 ic50 ?m *": 1 "sbp decrease mmhg": 1 "frequency breaths/min": 1 "8.04": 1 "349–362": 1 "low-dose stz c57bl/6j": 1 "1419610_at": 1 "ctla-4 blockade?+?il-2": 1 "mvd a": 1 "1449184_at": 1 "defective angiogenesis": 1 "ebr": 1 "censor": 1 "dpp8": 1 "er ? /pi3k": 1 "4c1-4": 1 "cd49f itga6": 1 "mir_name": 1 "ecp": 1 "pyruvate kinase muscle.": 1 "0.0493": 1 "kras status ": 1 "iota toxin comparison wt?=?100 a": 1 "0.0491": 1 "cortex": 1 "angiogenin ag and angiotropin at ": 1 "95 confidence intervals": 1 "direct penetration": 1 " 47 48 49 ": 1 "mal unselective": 1 "human ?-opioid receptor": 1 "1-hr room temperature blocking conditions": 1 "edl": 1 "cell cycle mitosis": 1 "cluster ten 815": 1 "clinicaltrials.gov identifier": 1 "tsp-4 mrna": 1 "1421227_at": 1 "exportin-1 * importin-? re-exporter * importin ? * importin-? *": 1 "12.9": 1 "jiang 2008 58 ": 1 "reduced vegf fgf epc circulation cytokines ecm/bm degradation increased ages and mmp": 1 "regulation of actin polymerization and/or depolymerization": 1 "week 9": 1 "diabetic at1-r knockout mice": 1 "week 8": 1 "week 7": 1 "week 6": 1 "wtcrk docki": 1 "pstat5a/b tyr694": 1 "untreated ht1376 cells": 1 "hsd3b2": 1 "diabetic rats": 1 "hsd3b1": 1 "il1rn": 1 "hcmv": 1 "pentose metabolism": 1 "69.7": 1 "parameter": 1 "heart rate": 1 "clp1 cka2 ckb1-2 yef3 fks1 vid24 gcd11 nap1 pap1 pcf11 pti1 ref2 mrp4 mrp7 rna14 rsm19m rsmm22 rsm23m mrp51 mrps9 mrps18 swd2 ysh1": 1 "8 hrs": 1 "laminin5": 1 "transforming growth factor- ? tgf- ? activated form": 1 "tbc1d4": 1 "ni/trim13": 1 "european birth date": 1 "mvs": 1 "oxidoreductase activity acting on the ch-nh2 group of donors oxygen as acceptor": 1 "pbse": 1 "1424814_a_at": 1 "bmpr1a": 1 "cell cycle process": 1 "v3 ¥": 1 "ventral": 1 "dgcr8": 1 "cell-matrix adhesion": 1 "variable": 1 "vhl": 1 "coronary flow ml/min/g": 1 "optimal": 1 "msb3": 1 "year": 1 "msb4": 1 "institut paoli-calmettes marseille france": 1 "striated muscle thin filament": 1 "ank1 inf2 itgax wasl": 1 "cell culture medium": 1 "pctaire-2 for serine/threonine protein kinase acc# x66360": 1 "atherosclerosis": 1 "hpde4b": 1 "hpde4a": 1 "hpde4d": 1 "hpde4c": 1 "alf clone number": 1 "serunvglucocorticoid regulated kinase": 1 "importin beta-subunit": 1 "milligrams/deciliter": 1 "kkay-candesartan": 1 "nm_0s0888": 1 "kallikrein anp enos endothelin": 1 "kruppel related zinc finger protein htf10 acc# l11672": 1 "stag2 smc1a smc3 rad21 ctcf1": 1 "1419728_at": 1 "ck19 krt19": 1 "nm_138900": 1 "endocrine": 1 "neurotransmission": 1 "intraperitoneal": 1 "er stress": 1 "nm_031683": 1 "8.82": 1 "g-protein coupled receptor activity": 1 "inflammatory response blood coagulation": 1 "8.88": 1 "no hits": 1 "caveolin homolog cav1": 1 "mmtv- neu": 1 "non-injured hemisphere": 1 "411–420": 1 "flow cytometry positive": 1 "specie": 1 "rasgrp1": 1 "human breast cancer susceptibility virus": 1 "reduced vegf and growth factors sorbitol-inositol imbalance increased ace ang-ii and tissue factor mrna": 1 "taxis": 1 "cell-cell signaling": 1 "hctr": 1 "holoprosencephaly": 1 "indication s": 1 "molecular_function": 1 "proteominer 2": 1 "tr-bw": 1 "?? eosinophil-derived neurotoxin": 1 "1p36.11": 1 "h2373": 1 "pkm2": 1 "angiogenesis multicellular organismal development": 1 "gds488 7 day mi": 1 "hybsibius dujardini": 1 "hf/angii/adgfp n?=?16": 1 "pt-aga 22": 1 "extracellular matrix structural constituent": 1 "human ?1 ivnc1": 1 "decreased sao2": 1 "species ortholog": 1 "mi362-5p": 1 "cxcl9 † mig": 1 "0.1198": 1 "rassf4*": 1 "primary site": 1 "1418976_s_at": 1 "370–500": 1 "peep cm h2o": 1 "soleus": 1 "opthalmic": 1 "msh2": 1 "nm.053611": 1 "?-synuclein mutant isoforms pphosphorylated ?-synuclein": 1 "msh6": 1 "p300 protein acc# u01877": 1 "metabolic process": 1 "5 cgy": 1 "kinases phosphatases": 1 "mitofusin mfn2": 1 "microrna": 1 "group n=3": 1 "ionic insulation of neurons by glial cells": 1 "ptbc1d4": 1 "food consumption b": 1 "electrical response": 1 "basic fibroblast growth factor b fgf ": 1 "erlotinib": 1 "?? il-8": 1 "significance": 1 "mi362-3p": 1 "30.5": 1 "organic acid transporter activity": 1 "wtcrk gfpi": 1 "nr2b-nmdar 35": 1 "4.0": 1 "4.1": 1 "g1e": 1 "tyrosine kinase inhibitor inn": 1 "hlfo": 1 "glioblastoma culture": 1 "0.022": 1 "assays": 1 "0.021": 1 "glycine": 1 "connective tissue growth factor ctgf": 1 "reduced angiogenesis and collateral formation": 1 "ossification anti-apoptosis": 1 "rad51d": 1 "rad51c": 1 "?? ltb4": 1 "suicide genes": 1 "pma/ionomycin stimulation": 1 "epo": 1 "transient phase block": 1 "response rate": 1 "tom1": 1 "0.012": 1 "5-ht7 antagonists": 1 "potential function of variants": 1 "plasma glycoprotein": 1 "glur1 glur2 glur3 glur4": 1 "0.015": 1 "0.013": 1 "mitochondrial rna extract": 1 "viral budding": 1 "coenzymes and prosthetic group biosynthesis": 1 "adcy1 adcy10 adcy2 adcy3 adcy4 adcy5 adcy6 adcy7 adcy8 adcy9 aqp1 aqp2 aqp3 aqp4 aqp5 aqp6 aqp7 aqp8 aqp9 aqp10 aqp11 aqp12a aqp12b bax calm1 calm2 calm3 camk1 camk1d camk1g camk2a camk2b camk2d camk2g camk4 cask cav1 cav2 cav3 ccne1 cdc2 cdh1 cdh10 cdh11 cdh12 cdh13 cdh14 cdh15 cdh16 cdh17 cdh18 cdh19 cdh2 cdh20 cdh3 cdh4 cdh5 cdh6 cdh7 cdh8 cdh9 cip85 csnk1a1 csnk1a1l csnk1d csnk1g1 csnk1g2 csnk1g3 csnk2a1 csnk2a2 csnk2b ctnna1 ctnna2 ctnna3 ctnnal1 ctnnb1 ctnnbl1 ctnnd1 ctnnd2 dbn1 egfr gja1 gja10 gja3 gja4 gja5 gja8 gja9 gjb1 gjb2 gjb3 gjb4 gjb5 gjb6 gjb7 gjc1 gjc2 gjc3 gjd2 gjd3 gjd4 gje1 gna11 gna12 gna13 gna14 gna15 gnai1 gnai2 gnai3 gnal gnao1 gnaq gnas gnat1 gnat2 gnat3 gnaz gnb1 gnb1l gnb2 gnb2l1 gnb3 gnb4 gnb5 gng10 gng11 gng12 gng13 gng2 gng3 gng4 gng5 gng7 gng8 gngt1 gngt2 grb2 gucy1a2 gucy1a3 gucy1b2 gucy1b3 gucy2a gucy2b gucy2c gucy2e hras hsp70-1a hsp70ry hsp70-4 hsp70-1b hsp70t hsp70-3 kras map2k1 map2k2 map2k3 map2k4 map2k5 map2k6 map2k7 map3k1 map3k10 map3k11 map3k12 map3k13 map3k14 map3k15 map3k2 map3k3 map3k4 map3k5 map3k6 map3k7 map3k8 map3k9 map4k1 map4k2 map4k3 map4k4 map4k5 mapk1 mapk10 mapk11 mapk12 mapk13 mapk14 mapk15 mapk3 mapk4 mapk6 mapk7 mapk8 mapk9 mllt4 mpdz nras ocln p2-receptor p2rx7 p2ry1 panx1 panx2 panx3 pdgfra pdgfrb pdgfrl pkp1 pkp2 pkp3 pkp4 plcb1 plcb2 plcb3 plcb4 plcd1 plcd3 plcd4 plce1 plcg1 plcg2 plch1 plch2 plcl1 plcl2 plcz1 prkaa1 prkaa2 prkab1 prkab2 prkaca prkacb prkacg prkag1 prkag2 prkag3 prkar1a prkar1b prkar2a prkar2b prkca prkcb prkcd prkcdbp prkce prkcg prkch prkci prkcq prkcz prkg1 prkg2 ptprm raf1 sos1 sos2 src tjap1 tjp1 tjp2 tjp3 tsg101 tuba1a tuba1b tuba1c tuba3c tuba3d tuba3e tuba4a tuba8 tubal3 tubb1 tubb2a tubb2c tubb3 tubb4 tubb6 tubd1 tube1 tubg1 tubg2 vcl": 1 "left intraventricular developedpressure mmhg": 1 "?? ltc4": 1 "1418652_at": 1 "ecteinascidin 743 et743": 1 "lvdp mmhg": 1 "zap-70": 1 "secondary antibodies": 1 "b1 crhr1 crhr2 gcgr ghrhr gipr glp1r glp2r sctr b2 bai2 bai3 cd97 celsr1 eltd1 emr1 emr2 emr3 gpr110 gpr111 gpr113 gpr114 gpr115 gpr123 gpr125 gpr126 gpr128 gpr144 gpr56 gpr64": 1 "cell": 1 "1998–2002": 1 "macromolecular crowders": 1 "mir_seq": 1 "bw-br": 1 "promote infection": 1 "ship+/+": 1 "non-nucleoside analogs --epigallocatechin-3-gallate procaine procainamide hydralazine": 1 "angiopoietin-2 in the absence of vegf": 1 "multi-step": 1 "trna multi-synthetase complex msc": 1 "anti-cd3? 10 ?g/ml": 1 "basophils 2": 1 "cytoskeleton organization": 1 "decoy receptor for vegf": 1 "kded2": 1 "embryogenesis and morphogenesis": 1 "kded7": 1 "zeaxanthin": 1 "kded5": 1 "eamedgeidgnk": 1 "cd4/cd8": 1 "retinal capillary occlusion": 1 "intramolecular isomerase activity interconverting aldoses and ketoses": 1 "homophilic cell adhesion": 1 "biological function": 1 "target tyrosine kinases": 1 "heat shock protein 8": 1 "total phenolics": 1 "downregulated": 1 "secreted phosphoprotein 1": 1 "neo8": 1 "ner": 1 "neurite outgrowth and extension": 1 "spheroid formation*": 1 "beta3-adrenergic receptor activity": 1 "350–470": 1 "30 hpf": 1 "biotin metabolism": 1 "class route": 1 "neo1": 1 "neo7": 1 "neo4": 1 "cell motility": 1 "malate": 1 "response to pest/pathogen/parasite": 1 "1989–1993": 1 "no similarity": 1 " ±s.e.m.": 1 "0.009": 1 "# mtoc polarized": 1 "?protection against seizures": 1 "mage bage gage gntv ny-eso-1 rage trp2-int2": 1 "unimodal analysis": 1 "oncogenic rtk examples": 1 "ferritin light chain i": 1 "0.003": 1 "dld-1 akt 1/2 ko *": 1 "upregulated": 1 "?? icam-1 vcam-1": 1 "raet1a": 1 "hippocampus": 1 "cell death": 1 "c xcl1": 1 "6a1-3": 1 "vascular occlusion inflammation": 1 "des-acyl ghrelin": 1 "orphan designation": 1 "epitope elispot activity": 1 "frequency sirna": 1 "qtrap® 5500": 1 "monolayer clearance ": 1 "?hepatitis b virus core protein 91 ": 1 "gzme": 1 "net1": 1 "pparg": 1 "jak/stat/socs": 1 "phenol metabolism": 1 "igf1": 1 "cnf1": 1 "nis": 1 "nm_032070": 1 "inactivation of mapk": 1 "chemokine c-c motif receptor 1": 1 "models": 1 "peptide": 1 "plxna1 sema3a sema6a unc5c": 1 "inflammatory response immune response": 1 "ndlavvdvr": 1 "dnaja 1": 1 "neurofilaments": 1 "g2 and m phase of mitotic cell cycle": 1 "hgnc id": 1 "hltf": 1 "gds144 4 wk exercise": 1 "rras": 1 "mdm2+/+": 1 "inflammatory response": 1 "ils #": 1 "activator protein 1 ap -1": 1 "human protein": 1 "htb182": 1 "procoagulant effect": 1 "ic50 value nm": 1 "flt3l": 1 "oletf+4-pba": 1 "new category*": 1 "chemoattractant *": 1 "tgfb": 1 "gab2": 1 "1427161_at": 1 "twi †": 1 "?? gm-csf vegf": 1 "igf-i receptor igf-ir": 1 "5.12": 1 "100 kda coactivator acc# u22055": 1 "#snps": 1 "translutein": 1 "48h": 1 "general amino acid transporter gap1": 1 "5.16": 1 "apoe": 1 "saha/obatoclax": 1 "mrna for tbp associated factor tafii68 acc# x98893": 1 "classic": 1 "p53 mean area fraction ": 1 "8.9±0.2": 1 "nucleotide binding activity": 1 "biological effect": 1 "igg2": 1 "igg1": 1 "5.09": 1 "clcf1": 1 "5.25": 1 "rassf2a*": 1 "5.28": 1 "epcam": 1 "cellular respiration": 1 "nm_012497": 1 "18.92": 1 "no.": 1 "normal wild-type mice": 1 "overexpressed": 1 "vascular endothelial growth factor vegf ": 1 "camk1d mapk11 mgc42105 ppp4r2 rp6-213h19.1 stk11ip": 1 "p15": 1 "478–486": 1 "core composition": 1 "proteolysis": 1 "histological subtype": 1 "microtubule-based process": 1 "gaba": 1 "?? bacterial permeability-increasing protein": 1 "cytoskeleton organization and biogenesis": 1 "np1": 1 "pleiotrophin ptn ": 1 "np2": 1 "gpr124 gpr126": 1 "nih-met5 day 4": 1 "bdl-pbs n=10": 1 "9205": 1 "nih-met5 day 7": 1 "nih-met5 day 1": 1 "canstatin": 1 "disease-free survivaltime mo **": 1 "pcna": 1 "thrombosis": 1 "cd8+ depl sfc/m *": 1 "thermo potent virus gene": 1 "gene title": 1 "prv µm": 1 "v600 mutation": 1 "nr1": 1 "pyruvate": 1 "rabl3": 1 "rabl4": 1 "pgrmc 1": 1 "3a2-7": 1 "samd9": 1 "1ststage mutant helper phage": 1 "phase iii zeta study 22": 1 "elisa positive": 1 "map1b map4 s100b stmn3": 1 "tol proteins": 1 "transferase activity transferring pentosyl groups": 1 "substance p neuropeptide k and neurokinin": 1 "immune response antigen processing and presentation": 1 "mglu7a mglu7b mglu7c mglu7d": 1 "2 glucose": 1 "probe set": 1 "fat": 1 "ach µm": 1 "nrc": 1 "5.76": 1 "checkpoint suppressor 1 acc# u68723": 1 "rab family": 1 "liver": 1 "primary antibody name": 1 "?a4": 1 "tac+imd": 1 "cd146 mcam": 1 "tnf ?": 1 "t-cells 2 38 39": 1 "cyp2a3a": 1 "?hepatitis c virus core 93 ": 1 "mia paca-2": 1 "tefferi 24": 1 "neuroblastoma 2a cells": 1 "human protooncogene tyrosine kinase": 1 "zlog 2 chip ser5p/tr": 1 "ubch5/mitol": 1 "ni/nedd4-2s": 1 "p73": 1 "trabectedin yondelis": 1 "?b2": 1 "wt n ": 1 "?dp/dt mmhg/s": 1 "dial": 1 "hinokitiol": 1 "calcium-binding and signaling": 1 "systematic name": 1 "protein kinase ck2 activity": 1 "sirna flu fly 98": 1 "plce": 1 "complement component l.s subcomponent": 1 "paco2 mmhg": 1 "0.73 ***": 1 "nm_031603": 1 "bw-tr": 1 "astrazeneca": 1 "ncbi interactions 1434": 1 "apt121 mdm2c305f/c305f": 1 "?promotes endothelial function": 1 "chemotax motility": 1 "bms-833923 xl139 bms/exelexis": 1 "0.1299": 1 "#peps": 1 "p9*": 1 "pmns ×10 3 ": 1 "cct196969 ?m ": 1 "0.1215": 1 "secretin-like receptor activity": 1 "cycles": 1 "grm1 grm5 gpr173 gpr177 gpr98 hrh3 rgs12 rgs16": 1 "aat genetic modifiers study": 1 "wd=17": 1 "nm_017312": 1 "?p53 74 arf 75 mdm2 76 prb 77 p21 78 gadd45a 79 ": 1 "sepina1a": 1 "0.1221": 1 "intracellular calcium": 1 "?-synuclein wild-type": 1 "teadaektfeek": 1 "· vhl increase": 1 "gdc-0449 vismodegib genentech": 1 "staff physician gastroenterology tokyo university school of medicine": 1 "treatments *": 1 "humoral defense mechanism sensu vertebrata": 1 "effects": 1 "restin": 1 "cyclooxygenase cox and lipoxygenase lox ": 1 "deaminase activity": 1 "parp inhibitor": 1 "samd9l": 1 "pathology": 1 "gds2335 diabetic endu": 1 "p5 replicative": 1 "ras family": 1 "· rac1 induction": 1 "dna replication transcription and repair": 1 "nm_03i099": 1 "procollagen type xviii alpha 1": 1 "nm_006622": 1 "chromosome location": 1 "similarity ": 1 "excessive angiogenesis": 1 "gli repressors": 1 "vegf fgf enos antithrombotic agents sod heme oxygenase": 1 "bdl-egcg n=10": 1 "?facilitates wound healing": 1 "?japanese encephalitis virus core protein 94 ": 1 "vegfr/pdgfr/c-kit/raf": 1 "angptl1": 1 "fold-induction": 1 "gds488 8 wk mi": 1 "chip rnapolii/tr ?tpk2/wt": 1 "epsin 1 esp15 eps15r": 1 "psychosis altered mood states headaches pseudotumor": 1 "dact1 dock4 lin7a pvrl1 ppfibp1": 1 "plk2": 1 "inhibition rate ": 1 "dicer": 1 "pt-sga 20": 1 "secretory granule neuroendocrine protein 1 7b2 protein": 1 "hmcl": 1 "akita c57bl/6j × 129s6/svev f1": 1 "?-subunit of kv11.1 channel herg-k": 1 "bicoid caudal dorsal hunchback hsp83 * osa pumillio retained": 1 "national cholesterol education program": 1 "resistance index": 1 "p-p44/42 mapk": 1 "af": 1 "gja4": 1 "wb 1": 1 "egfr ihc": 1 "42 hpf": 1 "ar": 1 "plstire for serine/threonine protein kinase acc# x66365": 1 "a1 ccr2 ccr3 ccr4 cr8 ccrl2 cx3cr1 gpr137b a2 ccr6 ccr7 ccr9 ccrl1 cxcr1 cxcr2 cxcr3 cxcr4 cxcr5 cxcr6 cxcr7 per gpr182 a3 gpr15 gpr25 a4 gpr1 sstr1 sstr2 sstr3 sstr4 sstr5 a5 cysltr1 cysltr2 galr1 galr2 galr3 rxfp1 rxfp2 rxfp4 a6 avpr1b cckar cckbr gnrhr gpr176 gpr22 hcrtr2 qrfpr a7 brs3 ednrb ghsr gpr37 gpr39 gprp trhr a8 c3ar1 cmklr1 fpr1 gpr1 gpr32 gpr77 a9 gpr19 gpr50 ppyr1 prlhr prokr1 prokr2 tacr1 tacr2 tacr3 a10 tshr a11 ffar1 ffar2 ffar3 gpr31 gpr82 hcar1 hcar2 hcar3 oxgr1 p2ry1 p2ry11 p2ry2 p2ry4 p2ry6 pwry8 a12 gpr171 gpr87 p2ry13 p2ry14 ptafr a13 cnr1 cnr2 gpr12 gpr3 gpr6 s1pr1 s1pr2 s1pr4 s1pr5 a14 ptgdr ptger1 ptger2 ptger3 ptger4 ptger ptgir tbxa2r a15 f2r f2rl1 f2rl2 f2rl3 gpr132 gpr17 gpr183 gpr35 gpr65 p2ry10 a16 rgr rho rrh a17 drd1 drd2 drd4 hrh2 htr2a htr2b htr2c htr6 taar1 taar2 taar3 taar5 taar6 a18 chrm1 chrm2 chrm4 gpr161 gpr173 gpr21 gpr27 gpr45 gpr52 gpr61 gpr63 gpr78 gpr85 gpr88 hrh1 hrh3 hrh4 a19 htr1d htr1f htr4 htr7": 1 "post golgi transport": 1 "no mediated signal transduction": 1 "nucleocytoplasmic transport": 1 "296–318": 1 "hpv-16": 1 "nm_o225o0": 1 "sgnel": 1 "japan phase 1 12": 1 "d1": 1 "d2": 1 "d3": 1 "oogenesis": 1 "actin cytoskeleton": 1 "pakt ser473 xp": 1 "antagonist of hgf/sf- induced cell migration b": 1 "pde3a 58 ": 1 "rat glia-derived nexin": 1 "kiser": 1 "leukaemic samples**": 1 "level of acetylated h4": 1 "gefq ?": 1 "elevated intraocular pressure": 1 "tokyo women's medical university": 1 "neutralizing antibody": 1 "fabp7 nu": 1 "disease status": 1 "day 8 notch off": 1 "sparc cleavage product": 1 "total=114": 1 "zeaxanthin stereoisomer": 1 "acyl-coenzyme a dehydrogenase c-4 to c-12 straight-chain": 1 "cyto c release": 1 "naive": 1 "branded name": 1 "ereg †": 1 "australia 155 ": 1 "mass culture": 1 "lelqgpr": 1 "vimentin": 1 "h19": 1 "posterior subcapsular cataracts increased intraocular pressure glaucoma exopthalmos": 1 "pfs months": 1 "increased vascular permeability": 1 "her2 mfi": 1 "underexpressed": 1 "16 weeks old": 1 "imatinib": 1 "rarb": 1 " 42 43 ": 1 "cediranib": 1 "drug pair": 1 "complement activation": 1 "crf1 antagonists": 1 "signal transducer activity": 1 "ac activation gs camp production": 1 "0.1073": 1 "ni/c-cbl": 1 "interaction demonstrated by": 1 "h1": 1 "h1x": 1 "total cells ×10 3 ": 1 "skin sensation": 1 "immuno-fluorescence": 1 "428–437": 1 "mglu1a mglu1b mglu1c mglu1d": 1 "diabetes/renal": 1 "unmethylated ": 1 "h2o": 1 "ramucirumab": 1 "transmission of nerve impulse": 1 " v/v": 1 "golgi-endosomes-mvbs": 1 "hydroxamic acids saha trichostatin a sbha": 1 "be 2-c": 1 "form": 1 "wt1": 1 "4r79.2": 1 "dna binding": 1 "method administered/timing": 1 "ricinus communis": 1 "sirna hiv zhou 303": 1 "fgd4": 1 "fgd3": 1 "hr": 1 "tfpi tpa": 1 "ht": 1 "nm.031327": 1 "coffea arabica": 1 "cell type overexpression": 1 "degs1": 1 "rodent": 1 "encapsulation effciency b": 1 "dnmt3a": 1 "effective dose µm": 1 "inflammatory response and chemotaxis": 1 "ip": 1 "injured hemisphere": 1 "2.02": 1 "ir": 1 "2.01": 1 "frizzled receptor signaling pathway": 1 "2.00": 1 "p- tyrosine": 1 "30–50": 1 "hh-ag*": 1 "inflammatory response signal transduction": 1 "nm.017023": 1 "gene id": 1 "78 83 84 88": 1 "p38 gamma map kinase acc# u66243": 1 "vtqdelkevfedaaeir": 1 "ercc2-312 asn/asp": 1 "1437270_a_at": 1 "rat glucose-regulated protein": 1 "pdgf-related": 1 "neurotransmitter transporter activity": 1 "1416676_at": 1 "ldl receptor": 1 "2.14": 1 "affymetrix probe id": 1 "2.13": 1 "e3 ligase parkin": 1 "2.12": 1 "norm_24 h": 1 "pde8": 1 "2.06": 1 "2.04": 1 "cysteine rich protein 61": 1 "high mobility group box 1": 1 "su 2009 64 ": 1 "anti-pdia3 hpa003230": 1 "rasa2": 1 "hf-veh": 1 "cyclin protein gene acc# m15796": 1 "rasa3": 1 "rasa4": 1 "p70s6": 1 "loading capacity ?g/mg": 1 "2.23": 1 "2.22": 1 "2.21": 1 "?-tubulin": 1 "pp2a 65kd subunit a * pp2a catalytic subunit microtubule star * † 14-3-3 ? * 14-3-3 ? * † hsp83 * pp2a regulatory subunit twins ras1 † erk-a phyllopod #": 1 "hmgic": 1 "huh28": 1 "run # 1 hl": 1 "deficient mice": 1 "7.39±0.07": 1 "epigenetic factors": 1 "moderate-penetrance": 1 "kng1": 1 "?? elastase release": 1 "heparanase": 1 "2.34": 1 "2.32": 1 "andrew x zhu md phd": 1 "thymosin beta 10": 1 "2.28": 1 "vein graft failure ischaemia thrombosis": 1 "2.26": 1 "1/2000": 1 "administered product": 1 "migration rate ± sd": 1 "aspartate": 1 "mi": 1 "selective target": 1 "er ? /mer ?": 1 "soluble fms-like tyrosine kinase-1 s-flt-1": 1 "helicase activity": 1 "diagnosis": 1 "ubqln1": 1 "6a2-4": 1 "2.44": 1 "2.43": 1 "table name size": 1 "2.39": 1 "nd": 1 "rash gr3–4 ": 1 "bcma": 1 "14 h": 1 "complement activation alternative pathway": 1 "24 hpf": 1 "heat": 1 "dorsal": 1 "nucleoplasm": 1 "chemokine c-c motif ligand 5": 1 "rap family": 1 "2.58": 1 "atm hz/ brca1 wt": 1 "ni/scf?-trcp": 1 "2.53": 1 "isorhamnetin-7-rhamoside": 1 "hemoglobin": 1 "c fructose-biphosphale": 1 "44.3±6.4": 1 "toxin": 1 "cosmic database": 1 "bind int hiv": 1 "ad1108": 1 "2.48": 1 "aqp5": 1 "ad1104": 1 "?n-chok?1·adp·hc-3": 1 "ad1102": 1 "dnajb13": 1 "0.119": 1 " 13 31 ": 1 "samowitz 2000 21": 1 "pdgf": 1 "gp130–": 1 "2.62": 1 "1 day": 1 "therapeutic approach": 1 "radiation": 1 "cisplatin mg?m ?2 day 1": 1 "pg": 1 "interleukin-8 il-8": 1 "dim.1": 1 "mtor": 1 "mirna levels in ago2 ip following ltp induction": 1 "dim.4": 1 "silac": 1 "asap2": 1 "dim.5": 1 "dim.2": 1 "group ii grm2 group vi gprc6a orphan gprc5b gprc5c gprc5d gpr156 gpr158": 1 "dim.3": 1 "2.72": 1 " 32 33 ": 1 "nuclear factor nf45 acc# u10323": 1 "2.75": 1 "1418237_s_at": 1 "cftr": 1 "2.73": 1 "calu6 sk-mes-1": 1 "?? cr3": 1 "1vgc": 1 "vainchenker 14": 1 "side effect": 1 "2a1-2": 1 "2.86": 1 "transmembrane receptor protein serine/threonine kinase signaling pathway": 1 "2.85": 1 "ankyrin spectrin actin and formin": 1 "ced-10 n1993": 1 "dcm cepin": 1 "phosphatidylinositol 3-kinase activity": 1 "0.094": 1 "ras homolog enriched in brain": 1 "ribosome biogenesis": 1 "histogenesis and organogenesis": 1 "qkvegtepttafnlfvgnlnfnk": 1 "colony area ?m 2 ": 1 "activity": 1 "tumstatin": 1 "cell activation": 1 "3+o2g ": 1 "edn1": 1 "erk3 protein kinase acc# l77964": 1 "tyrosine kinase inhibitors": 1 "epcam tacstd1": 1 " s.c.": 1 "plus lps": 1 "replication fork": 1 "vector": 1 "helix-loop-helix protein id-2 acc# m97796": 1 "metalloprotease": 1 " mg/l gallic acid equivalents": 1 "nm_ 139060": 1 "proton medical research center university of tsukuba": 1 "anthrax 16 21 24 97 ": 1 "eamedgeidgnkvtldwakpk": 1 "alpha-type channel activity": 1 "ppar? agonist": 1 "nm_021261": 1 "complement activity": 1 "tk": 1 "v1": 1 "v2": 1 "v3": 1 "oxidative stress": 1 "country": 1 "asp-like microcephaly associated": 1 "mouse mammary tumor virus": 1 "ca2+ atpase": 1 "??ct*": 1 "glut10": 1 "glut14": 1 "contractility/relaxation": 1 "glut12": 1 "dompé": 1 "glut11": 1 "dako": 1 "mdm-2 mean area fraction ": 1 "il-2r": 1 "?nucleostemin 85 pes1 86 ttf1 87 frgy2a/yb1 88 nsun2 89 ": 1 "functional assay": 1 "nm_024356": 1 "mlh1": 1 "substrate": 1 "125 i-cldr": 1 "nm_024351": 1 "negative regulation of wnt receptor signaling pathway": 1 "failure": 1 "residual sugar": 1 "histonehl-0": 1 "suboptimal": 1 "region": 1 "pd=30": 1 "od value": 1 "current study": 1 "anti-mir*": 1 " years": 1 "cold": 1 "gag": 1 "proteolysis immune response": 1 "pol iii": 1 "il-24": 1 "gain-of-function": 1 "gads orgrb2": 1 "increased free fatty acids polyol pathway cytokines icam vcam": 1 "ec50 µm": 1 "tyms": 1 "cenpf": 1 "cyclin-dependent kinase inhibitor 2a": 1 "intermediate filament cytoskeleton": 1 "0.0673": 1 "day 8 notch on": 1 "class error rate": 1 "plekhg6": 1 "9 mo": 1 "nefh nefm nefl": 1 "protection* ": 1 "tumor uptake": 1 "qpcr": 1 "mfrm 1860-1": 1 "mfrm 1860-2": 1 "mfrm 1860-3": 1 "microrna expression qrt-pcr": 1 "mfrm 1860-4": 1 "0.1136": 1 "reduced vegf il-1 tgf- ?": 1 "gch": 1 "april": 1 "maximum effect": 1 "rsk1": 1 "dapk": 1 "pumilio cup * brat smaug bicoid tsunagi mago nashi * hrb27c * nac? hel25e * valois me31b * vasa eif4e † squid † #": 1 "market authorization holder mah": 1 "cont": 1 "rsk3": 1 "rassf5**": 1 "rsk2": 1 "cons": 1 "rsk4": 1 "orr ": 1 "gametogenesis": 1 "proneural": 1 "sf3b1 srsf2 u2af1 zrsrs2 sf3a1 u2af65 sf1": 1 "samples": 1 "comb": 1 "examples": 1 "radioactive tlc assay": 1 "mt1g d": 1 "comt": 1 "regulation of osteoclast differentiation": 1 "copd": 1 "cluster four 271": 1 "coq3": 1 "dnaj-like protein": 1 "zlog 2 chip 8wg16/tr": 1 "i?b??/??": 1 "harc rev 56": 1 "h3k4me3": 1 "brain": 1 "regulation of progression through cell cycle regulation of transcription dna-dependent": 1 "transcription factor sl1 acc# l39059": 1 "mean tumor volume mm3": 1 "ggh": 1 "time weeks": 1 "actin polymerization regulator wash": 1 "nos2": 1 "consequences": 1 "aatagaattcgatatgcttatagaaatagttgtg": 1 "synaptic transmission": 1 "0.1105": 1 "sirna knock-down": 1 "cacna1g cacng4": 1 "ghs": 1 "ppeak cm h2o": 1 "3t3 embryonic fibroblast": 1 "percent agreement": 1 "0.1111": 1 "scf?-trcp": 1 "transcription factor il-4 stat acc# u16031": 1 "major go category ies": 1 "mav toxin": 1 "rap1gap2": 1 "lamrl": 1 "lung lesions": 1 "?4.2±2.3": 1 "other related": 1 "cyr61": 1 "h2o2": 1 "625–645": 1 " 79 80 ": 1 "her2 ec": 1 "4g2": 1 "?dendritic arborization": 1 "syt10": 1 "testis cu": 1 "xenical": 1 "cost": 1 "muc1": 1 "calycosin concentration mmol/l": 1 "rho family": 1 "alageavslklvsvglltasni": 1 "rassf1? a": 1 "cd133": 1 "atm hz/ brca1 hz": 1 "principal scientist center for liver cancer national cancer center korea": 1 "llo56": 1 "assay": 1 "348–362": 1 "locations": 1 "625–636": 1 "animal models": 1 "nimotuzumab": 1 "soce component": 1 "at 25°c": 1 "c11 somites": 1 "kainate": 1 "vent rate breaths/min": 1 "vascular permeability factor vpf ": 1 "nm_022934": 1 "experimental protocols": 1 "wt ¥": 1 "0hr/0hr": 1 "45.2": 1 "glutamate": 1 "2k1c+gw+snmp": 1 "set7": 1 "diffusable/secreted gene products": 1 "set6": 1 "set3": 1 "no/tnf alpha/il-6": 1 "metabotropic receptors": 1 "set5": 1 "set4": 1 "blt1": 1 "decrease in lesion size ": 1 "run # 2 lh": 1 "cd44 c": 1 "day8": 1 "placental growth factor pgf ": 1 " 63 64 65 66 ": 1 "epitope": 1 "wine": 1 "mtt ?": 1 "xrcc1": 1 "sea pansy renilla reniformis": 1 "i/r": 1 "tunel &": 1 "pmnl": 1 "pc5-t": 1 " eggshell phenotype *": 1 "cxcl11 † itac": 1 "persistency": 1 "pdgfr alpha": 1 "ni/parkin ni/parkin": 1 "complement factor i": 1 "prinomastat": 1 "uncll9": 1 " 44 45 46 ": 1 "global dna methylation": 1 "control peptide": 1 "annotation *": 1 "days": 1 "huc/d": 1 "c elegans": 1 "rad51d acc# af034956": 1 "lcat apoai apoe mrna": 1 "diaphorase nadh cytochrome b-5 reductase": 1 "rap–gdp·bef3?-rap1gap q204a": 1 "sodium dismutase sod1 mutant isoform g93a": 1 "6.3±0.5": 1 "0.0092": 1 " mean?±?sem n?=?3": 1 "0.0091": 1 "passage 3": 1 "igfbp1": 1 "time of cbl treatment": 1 "8.4±0.2 *": 1 "amino acid transport": 1 "sunitinib": 1 "hypoxia": 1 "polo-like kinase 2": 1 "transformation efficiency**": 1 "rb loss": 1 "negative regulation of osteoclast differentiation": 1 "animal species": 1 "arf6": 1 "tnf receptor 1 tnf-r1": 1 "compound name": 1 "pd0325901": 1 "levels of confidence": 1 "invitrogen": 1 "ataxin-3": 1 "replication population": 1 "topoisomerase i acc# j03250": 1 "emission maximum ?em nm": 1 "fzd1 fzd2 fzd4 fzd5 fzd6 fzd7 fzd8": 1 "· enhanced degradation of transcription factors sp1 and sp4": 1 "down-regulated **": 1 "hp-f": 1 "mglu8a mglu8b mglu8c mglu8d": 1 "tight junctions": 1 "ic 50 nm": 1 "activation of nf-kappab-inducing kinase": 1 "igfbp7 transcript expression": 1 "nf-l–cre stat3flox/ko": 1 "cytochrome p450 subfamily iia phenobarbital-inducble": 1 "b1 crhr1 gipr vipr1": 1 " dna": 1 "immunoblot": 1 "imc-3g3": 1 "ifngr1": 1 "pms2": 1 "spata13": 1 "bcirg 006": 1 "p-akt": 1 "sumo k01211": 1 "pigment epithelium-derived factor pedf": 1 "ni/nedd4 cul5": 1 "mi532-3p": 1 "p value* spine": 1 "gyafiefasfedak": 1 "bacterial strains": 1 "0.0966": 1 "nm_031014": 1 "pol i": 1 "approach": 1 "post-induction": 1 "5-ht4 and 5-ht6 agonists": 1 "genomically stabile ": 1 "arl1": 1 "sample size": 1 "pex": 1 "catecholamine metabolism": 1 "raw_0 h": 1 "v-myc myelocytomatosis viral related oncogene neuroblastoma derived": 1 "ligand-regulated transcription factor activity": 1 "gene transcript targeted by rnai": 1 "dual specificity phosphatase 6": 1 "recurrence": 1 "cultured with il6": 1 "pcna acc# m15796": 1 "1/1000": 1 "flotillin 2": 1 "day 4–10": 1 "15mer elispot activity": 1 "fhit": 1 "r2hbjj µm": 1 "gtp-rhoa": 1 "ank3 kcnip1 kcnc2 kcnd2 kcnf1 kcnk5 kcnk10 scn3b shc3": 1 "cell signaling technology danvers ma usa": 1 " 30 ": 1 "er ? /src": 1 "vessel area b": 1 "peg3": 1 "mushroom/plant": 1 "nop5/nop58 pdgfra prr5 rgs12": 1 "rassf10*": 1 "pgr": 1 "frequency of methylation ": 1 "nm_053297": 1 "vascular endothelial growth inhibitor vegi": 1 " cag/cgg": 1 "nf-l–cre stat3flox/wt": 1 "melatonergic mt1/2 agonist / 5-ht2c antagonist agomelatine new monoamine-based antidepressants": 1 "names": 1 "6a3-5": 1 "in-house": 1 "sample taken": 1 "1419697_at": 1 "nm_012779": 1 "bacteria": 1 "chromatin remodeling": 1 "regulation of metabolism": 1 "actin polymerization and/or depolymerization": 1 "gilliland 16": 1 "study description": 1 "mrna for putative serine/threonine protein kinase acc# y10032": 1 "kidney": 1 "cox-2": 1 "sstr1": 1 "sstr4": 1 "sstr5": 1 "sstr2": 1 "sstr3": 1 "p100?/?": 1 "dba/2j stress-8 h": 1 "obatoclax /rtx": 1 "thp-1": 1 "10.9±1.1": 1 "cyclohydrolase activity": 1 "golgi apparatus": 1 "anti-apoptotic": 1 "?hepatitis delta virus antigens 90 ": 1 "nrp1 pdzrn3 plxna4": 1 "mglu6": 1 "transforming growth factor beta tgf ?": 1 "pka": 1 "neuropeptides": 1 "calcr chgb crhbp npy2r nts uts2b": 1 "pkc": 1 "aplysia": 1 "epitope number": 1 "pigment metabolism": 1 "thrombospondin-1 and -2": 1 "6 mo": 1 "c57bl6j-vehicle": 1 "gse 6593": 1 "at2r": 1 "1979–1985": 1 "role/function": 1 "711-585-152": 1 "mdr3": 1 "ypda": 1 "peptide receptor activity": 1 "orthomcl family id": 1 "at1r": 1 "lrp2": 1 "udp-glucuronate decarboxylase 1": 1 "900–4000": 1 "nm_021697": 1 "cluster nine 724": 1 "pattern specification": 1 "h pylori seropositive": 1 "high-penetrance": 1 "kinase assay": 1 "muts": 1 "mitochondrial inner membrane": 1 "sarcomere alignment": 1 "animal model": 1 ">1000": 1 "mouse 3? nerve growth factor": 1 "phosphorylation related": 1 "tfiid subunit tafii55 tafii55 acc# u18062": 1 "genotype igfbp7 locus": 1 "pip cmh2o": 1 "kinase activity": 1 "atp-binding cassette abc transporter activity": 1 "mutant n ": 1 "0.0101": 1 "xenobiotic metabolism": 1 "major molecular targets": 1 "0.0109": 1 "sphere formation of cscs": 1 "ll?+?qgnk?+?fidstkr?+?lg?+?l?+?td?+?pskal?+?avre?+?f?+?qtqsqpde – qhvlqleqa?+?ahwqqhdpkefaqrs?+?lvk?+?lrfemg": 1 " 39 ": 1 "particle size nm a": 1 "digestion": 1 "tumor formation": 1 "harc tat 69": 1 "0.0119": 1 "hroc87x": 1 "tubulin alpha 1": 1 "time min": 1 "2a2-1": 1 "reduced wound healing transplant failure": 1 "hydrodynamic radius å": 1 "organelle organization and biogenesis": 1 "anti sheep alexa 488": 1 "87.4±11.2": 1 "mir-31/mir-155/mir-564": 1 "qstar® elite": 1 "28.9": 1 "?? il-4 il-13": 1 "ubch5 ubc13/k3 k5": 1 "antagonist": 1 "anxa1": 1 "2k1c": 1 "ypka": 1 "increased vegf": 1 "ic50 µmol/l against": 1 "epoxyketones trapoxin b 2-amino-8-oxo-910-epoxydecanoic acid": 1 "t-sga 26": 1 "ck8-18": 1 "pt1": 1 "pt3": 1 "pt2": 1 "· mrp4 inhibition": 1 "b6 memory": 1 "osteoporosis vertebral and femoral fractures aseptic necrosis of femoral head myopathy muscle weakness": 1 "pao2 mmhg": 1 "11p13": 1 "enc1": 1 "smell i": 1 "cluster fifteen 725": 1 "52 53 54 58": 1 "ced-1 e1735": 1 "author year": 1 "protooncogene tyrosine kinase c-myc": 1 "aifm1 rp6-213h19.1 stc2": 1 "dss2": 1 "dss1": 1 "cct241161 ?m": 1 "histopathology": 1 "increased skeletal muscle fatigue": 1 "hepatocyte growth factor hgf ": 1 "ni/parkin": 1 "?a": 1 "?b": 1 "ecad18": 1 "b61 hdac1": 1 "psme4": 1 "perk": 1 "proliferation and cell cycle progression": 1 "blnk or slp-76": 1 "sirna hiv könig 293": 1 "disease": 1 "btea-like lrt_consensus": 1 "apaf-1": 1 "decreased breathing reserve": 1 "western blotting": 1 "hdi": 1 "pts": 1 "pentose catabolism": 1 "chrom": 1 "othersa": 1 "organellar ribosome": 1 "integrins ? v ? 3 and ? v ? 5": 1 "immunophenotype": 1 "melanocytic protein mart1": 1 "psmd6": 1 "protein kinase c": 1 "platelet factor 4 chemokine c-x-c motif ligand 4": 1 "macro- pinocytosis": 1 "7.30±0.05": 1 "culture time": 1 "mglu2 mglu3": 1 "hcdc2 acc# x05360": 1 "lat py226": 1 "gfgfvdfnseedak": 1 "gds1302 1.5 ug/kg tcdd": 1 "anti-nox2 54.1": 1 "sample distribution": 1 " dc ?m": 1 "0.0172": 1 "stard13": 1 "before transfer": 1 "5c1": 1 "nordic countries 162 ": 1 "nm_139254": 1 "neuropeptides and receptors": 1 "325–333": 1 "0.0179": 1 "hfd": 1 "experiment 1": 1 "experiment 2": 1 "actin filament-based process": 1 "0.0187": 1 "0.0186": 1 "pdgfr/bcr-abl/c-kit": 1 "1-phosphatidylinositol 3-kinase complex": 1 "nm_031830": 1 "src kinases": 1 "ras-hp": 1 "ship+/?rag?/?": 1 "liver uptake": 1 "genotype *": 1 "intramolecular isomerase activity": 1 "sequence alterations": 1 "0.0196": 1 "0.0193": 1 "0.0192": 1 "small molecular weight carboxilates sodium butyrate valproic acid sodium phenylbutyrate and pivaloyloxymethyl butyrate": 1 "g protein coupled receptor": 1 "map kinase-activating death domain protein madd acc# u77352": 1 "timma prediction": 1 "blood vessel development": 1 "complement component factor i": 1 "mmtv- pymt": 1 "bcl-2-related ovarian killer protein": 1 "chromosome instability ": 1 "7.46": 1 "1419915_at": 1 "gds488 4 hr mi": 1 "hif": 1 "0.1457": 1 "0.0124": 1 "0.1454": 1 "peptidoglycan recognition protein 1": 1 "hiv": 1 "mrna for traf5 acc# ab000509": 1 "sod2": 1 "egfr/vegfr": 1 "0.0138": 1 "0.0137": 1 "reduced mpm-2 index": 1 "fluid secretion": 1 "# fish injected": 1 "average tumor volume mm3": 1 "wap- t antigen": 1 "zucp2l": 1 "aleltglk": 1 "?hiv rev and tat proteins 47 ": 1 "0.0141": 1 "sirna hiv fellay 63": 1 "restenosis": 1 "0.0149": 1 "arl4c": 1 "arl4d": 1 "amado 2008 7": 1 "dna replication": 1 "mitochondrial ribosome": 1 "sirna hiv zhou": 1 "fgyvdfesaedlek": 1 "be mmol/l": 1 "rps4 * rpl8 * rps10b rpl27a * rps7 * rps3a * rps16 * rps19 * rpl13 * rpl9 * rps3 * rpl10ab * rps26 rps6 rps10a rpl28 rps13 rpl13a rps14a rps20 rpl15 rpl31 rps15aa rpl7a rps9 rpl23 rps17 rpl7 rpl4 rpl14 rpl18a rps25 rpl22 rplp0 rpl36 rpl11 rps8 rpl32 rps23 rps18 rps5a #": 1 "cdc42 ?m": 1 "nm_013175": 1 "ras-lp": 1 "synphilin-1": 1 "thymosin beta-4 acc# m17733": 1 "arl5b": 1 "maternal mrna regulation": 1 "cation channel activity": 1 "0.0156": 1 "nhej": 1 "prolactin 16-kda fragment": 1 "particle associated hiv": 1 "insulin-like growth factor binding protein 2 igfbp2 acc# m35410": 1 "a2780 proliferation": 1 "lrrk2": 1 "protein serine/threonine kinase activity": 1 "0.0162": 1 "0.0161": 1 "0.1491": 1 "protein metabolism": 1 "junb": 1 "methylated ": 1 "calm1": 1 "lat y136f": 1 "neurotransmittersodium symporter activity": 1 "chip rnapolii/tr 2h ypgal/ypd": 1 "protein modification synthesis and degradation": 1 "fusion protein characteristics cell growth inhibition studies were done in ba/f3 cells expressing each eml4-alk variant": 1 "spermatid development": 1 "vent time min": 1 "tnm edition": 1 "nachr": 1 "argininosuccinate synthase 1": 1 "quercetin pure": 1 "population": 1 "control depl sfc/m": 1 "7.1": 1 "cyld": 1 "dna mismatch repair protein homolog hmlh1 acc# u07343": 1 "gtp-cdc42": 1 "?changes in blood flow": 1 "adhesive factor": 1 "calcium channels": 1 "lectin": 1 "555–561": 1 "group ii": 1 "activating transcription factor 3 atf3 acc# l19871": 1 "dna-pkcs acc# u34994": 1 "pd cultures": 1 " n?=?5": 1 "nm_013097": 1 "mib-1": 1 "711-545-125": 1 "?mouse mammary tumor virus p14 env-related protein 92 ": 1 "neurites dendrites and axons": 1 "differentially expressed genes": 1 "normal rats": 1 "advantages": 1 "group vs.": 1 "neurofilament": 1 "rattus norvegjeus deoxyribonuclca.se 1": 1 "biogenic amine metabolism": 1 "reference panel mirna": 1 "maturation stage": 1 "skoda 15": 1 "ribosomal protein l10": 1 "dna methylation inhibitors": 1 "ribosome complexes": 1 "cyclic-nucleotide dependent protein kinase activity": 1 "specific ova ig o.d *": 1 "dna repair protein xrcc9 xrcc9 acc# u70310": 1 "cbl calreticulin calr setbp1 gnas rhoa": 1 "rescue rates ": 1 "zinc-dependent": 1 "20.0": 1 "cur61414": 1 "gds1247 dysf –/–": 1 "age/ sex": 1 "genes transferred": 1 "ribosomal protein l21": 1 "pathways": 1 "ki67": 1 "intracellular signaling cascade": 1 "swi/snf complex 170 kda subunit baf170 acc# u66616": 1 " aac/gac": 1 "protein ?g/ml": 1 "3 mo": 1 "ribosomal protein l32": 1 "fms-like tyrosine kinase 3 ligand": 1 "ras1 signaling pathway": 1 "vavatpak": 1 "7.2±0.5 *": 1 "2006": 1 "oletf": 1 "sislyytgek": 1 "troponin complex": 1 "free vegf-a": 1 "histone deacetylase inhibitors": 1 "450–640": 1 "lat py171": 1 "nuclear localization sequence binding activity": 1 "arf ?copi cdc42 arf1? rac1? tgn carrier formation arap1 –i arf1 cdc42 arf1? arhgap21 –i cdc42": 1 "solutecation symporter activity": 1 "72h": 1 "increased risk of infections including fungal": 1 "nm_007207": 1 "standard 1": 1 "annamides": 1 "ic50": 1 " 40 ": 1 "calca": 1 "vegf-trap": 1 "chr.": 1 "day 10": 1 "rhodopsin": 1 "0 day": 1 "p53 ihc": 1 "day 6": 1 "day 5": 1 "mda-mb-231": 1 "dok4 mcf2 ndrg4 s100b stmn3 tnr": 1 "3p21.3": 1 " 41 ": 1 "0.0858": 1 "dcn fst nbl1 pdzrn3 sap30l thbs4 zeb2": 1 "osk mrnp": 1 "increase vs pten": 1 "1 ?g/ml": 1 "med pfs mos": 1 "a1 gpr137b ccr4 a2 cxcr7 gpr182 a4 gpr1 gpr22 a5 gpr100 gpr106 gpr142 cysltr2 galr3 a6 gpr103 a7 gpr39 a8 gpr44 gpr77 cmklr1 a9 gpr19gpr50 gpr73 gpr75 gpr83 a10 gpr48 gpr49 lgr4 a11 gpr40 gpr43 gpr81 gpr82 gpr109b a12 gpr34 gpr87 gpr171 a13 gpr3 gpr6 gpr12 mc5r s1pr2 lpar1 lpar2 a14 ptger1 a15 lpar4 f2rl1 lpar5 f2r gpr4 lpar6 gpr18 gpr20 gpr35 gpr65 gpr68 gpr119 gpr132 a17 adrb1 adrb2 adrb3 a18 gpr21 gpr27 gpr45 gpr61 gpr63 gpr84 gpr85 gpr88 gpr173 adora2b orphan gpr23 gpr26 gpr33 gpr35 gpr37 gpr54 gpr83 gpr135 gpr146 gpr149 gpr150 gpr151 gpr152 gpr153 gpr160": 1 "nm_i73102": 1 "ercc2-751 lys/gln": 1 "rna processing": 1 "sos1": 1 "smad4": 1 "staff physician internal medicine ii tokyo university school of medicine tokyo japan": 1 "day 30": 1 "positive regulation of immune response to tumor cell": 1 "nm_019232": 1 "cd4+ **": 1 "nih/3t3": 1 "bepa": 1 "clinicopathological descriptions": 1 "neuronal stability": 1 "hct 116 + ch 3 h- ras codon 12 middle gc": 1 "fras1 related extracellular matrix protein 2": 1 "growth rate mm3/day": 1 "0.0874": 1 "ni/traf6-sarm1": 1 "gludl": 1 "c 3 t- antigen": 1 "96 hrs": 1 "nm_001946": 1 "q-pcr met": 1 "t-cell differentiation": 1 "· nag-1 induction": 1 "aspm": 1 "adam23 scube1 scube1/2": 1 "crmp2": 1 "crmp3": 1 "anti rabbit alexa 488": 1 "crmp4": 1 "colied-coil domain containing 3": 1 "polymorphism": 1 "somatic reprogramming to cscs": 1 "crmp5": 1 "interleukin-12 il-12": 1 "gds496 3 wk tnfa+": 1 "associate professor department of radiation oncology samsung medical center sungkyunkwan university school of medicine": 1 "5-aminoimidazole-4-carboxamide ribonucleotide formyltransferasc": 1 "atm wt/ brca1 hz": 1 "c57bl/6 stress-4 h": 1 "3? probe": 1 "baits": 1 "neutrophils": 1 "?? ca2+ clearance from cytosol": 1 "granzyme e": 1 "t- c days §": 1 "hct 116 h- ras codon 12 middle gc": 1 "camp metabolism": 1 "fill": 1 "heart": 1 "day 45": 1 "crmp1": 1 "rat assembly protein": 1 "fibronectin 20-kda fragment": 1 "nm_138877": 1 "neutrophils 2 38 39": 1 "zhao 25": 1 "pe volume ml": 1 "apr 1991-mar 1997": 1 "spry2": 1 "arresten": 1 "inf / mock": 1 "47 1": 1 "pfn2": 1 "dose level": 1 "a2780cp *": 1 "spry4": 1 "tipifarnib": 1 "chondromodulin i": 1 "mdm2c305f/c305f": 1 "gds446 dnpi3k": 1 "study group": 1 "excision repair protein ercc1 acc# m13194": 1 "aquaporin-2 water channel": 1 "mutyh": 1 "protein phosphatase 2a pp2a": 1 "regulation": 1 "oestrogen receptor ?": 1 "regulation of cell differentiation": 1 "ass1": 1 "glur5 glur6 glur7": 1 "16th week": 1 "?? adherence to fibronectin-coated plates": 1 "72–80": 1 "4.15": 1 "26s proteasome": 1 "kkay-vehicle": 1 "jelinek 23": 1 "biomol id#": 1 "nm_012578": 1 "?mnda 69 gcn5 70 histones 37 c/ebp ? 71 tpt1 72 dot1l 73 ": 1 "lc50 values 95 confidence interval": 1 "found dead": 1 "lymphocytes ×10 3 ": 1 "4.26": 1 "?? il-2 il-6 il-8 il-12 il-18": 1 "0.1309": 1 "ras oncogenic stress": 1 "paired box gene pax6 homologue acc# m93650": 1 "nm_012570": 1 "transcription cofactor activity": 1 "macromolecule catabolism": 1 "swi/snf complex 60 kda subunit baf60c acc# u66619": 1 "enzyme substrate": 1 "il-8": 1 "hsv-1": 1 "infectious": 1 "0.1314": 1 "reduction in blood pressure": 1 "4.38": 1 "nr2a nr2b nr2c nr2d": 1 "gab activator": 1 "glutamate dehydrogenase i": 1 "p110?": 1 "objects/networks": 1 "p110?": 1 "p110?": 1 "p110?": 1 "plants": 1 "temperature": 1 "alk fusion variant": 1 "cytokines added": 1 "2o2g ": 1 "reaction": 1 "internalization receptor activity": 1 "hgid": 1 "adhesion": 1 "cla4ecori-rv": 1 "rasgef1a": 1 " 25 29 ": 1 "phagocytosis engulfment": 1 "drosha": 1 "nm_019187": 1 "2c9 gene": 1 "4.39": 1 "gds2258 male tac": 1 "6 hpf": 1 "fumarate": 1 "plc stimulation gq ip3 turnover": 1 "ratio": 1 "334–342": 1 "il1b": 1 "sc-101806": 1 "nm_03i119": 1 "hdac1-ip ac-h4": 1 "descriptions": 1 "presentation": 1 " eggshell phenotype": 1 "arhgdib bai3 fam152a prkcd rprml scn3b shc1 shc3 snrk tnfaip8l3 trp53i11 ube2d3": 1 "compd": 1 "at4 receptor subtype": 1 "g-protein signaling adenylate cyclase activating pathway": 1 "nqo1": 1 "ladeiro 2008 63 ": 1 "ns/s": 1 "hsd3b2 hsd3b1 cyp21a2": 1 "umegaki award jastro": 1 "2a3-5": 1 "nm_139336": 1 "2a3-2": 1 "pod6": 1 "vegf-a/vegfr1": 1 "16.9": 1 "vegf-a/vegfr2": 1 "s6k": 1 "oncogenes expressed": 1 "nucleic acid-based mg98 antisense oligonucleotide": 1 "1419297_at": 1 "16.0": 1 "il10": 1 "hif1 ?": 1 "6 hrs": 1 "enzastaurin": 1 "spin3": 1 "glutamatergic agents nmda blockers ampakines mglu modulators riluzole lamotrigine": 1 "pod4": 1 "dj-1 mutant isoform l166p": 1 "pol ii": 1 "del17": 1 "sample input": 1 "proton-transporting atp synthase complex": 1 "cxcl4 † pf4": 1 "heat shock protein 1 chaperonin": 1 "pur pur-alpha acc# m96684": 1 "prv µm + mevalonate µm": 1 "demethylation": 1 "succinate": 1 "epidemiology": 1 "adherens junction": 1 "1448995_at": 1 "ic50 nm": 1 "rasal1": 1 "bcl2adenovirus e ib 19 kda-interacting protein 3-like": 1 "cell migration": 1 "del13": 1 "angiogenesis inhibitor name": 1 "nm_003633": 1 "t-aga 25": 1 "phospho-her2 py1248": 1 "osaka medical school osaka japan": 1 "ccl20": 1 "72–79": 1 "grb7 sh2": 1 "4.83": 1 "pmean cm h2o": 1 "wtcrk c3gi": 1 "anxa6 cabp1 cadps2 camk1d pvalb rcan2 rgs12 s100b slc8a1 stc2thbs4": 1 "channel/pore class transporter activity": 1 "0.0049": 1 "ige": 1 "0.0046": 1 "1420421_s_at": 1 "phosphotransferase activity alcohol group as acceptor": 1 "4.93": 1 "mrna for dna binding protein taxreb67 acc# d90209": 1 "igm": 1 "vasostatin": 1 "il4r": 1 "day12": 1 "prairie vole": 1 "disadvantages": 1 "department of gastroenterology kanazawa university hospital": 1 "cellular machines": 1 "p-value **": 1 "igfbp7 methylation": 1 "cd8+ **": 1 "catalog #": 1 "0.0052": 1 "ngf/tnf 6 c-domain receptor activity": 1 "ligand-dependent nuclear receptor activity": 1 "hypermethyaltion": 1 "0.0058": 1 "lycopene content mg/100 g wet basis": 1 "decreased work rate": 1 "vegfr/pdgfr": 1 "secreted": 1 "s721a": 1 "anti-nox2 nl7": 1 "antiatherogenic": 1 "0.0067": 1 "cfi †‡": 1 "0.0064": 1 "transcription dna-dependent": 1 "6mo srf tg vs ntg": 1 "gds648 igf1r+ dnpi3k": 1 "0.0060": 1 "amygdala": 1 "cbm-msc": 1 "tmre #": 1 "huh-7/neo": 1 "tubb3": 1 "tubb5": 1 "imm-mef": 1 "faslg": 1 "0.0077": 1 "0.0074": 1 "purine ribonucleoside metabolism": 1 "alcohol dehydrogenase activity metal ion-independent": 1 "nm_016986": 1 "il6r": 1 "coffea canephora": 1 "brink 2003 31": 1 "????ce": 1 "histological grade": 1 "0.0081": 1 "huang 2009 66 ": 1 "h4k20me3": 1 "meth-2": 1 "il8": 1 "meth-1": 1 "tubal": 1 "neuronal pentraxin ii": 1 "????cm": 1 "abc-transporter": 1 "0.0087": 1 "target neuronal cell": 1 "embryos containing migrating cells/total embryos": 1 "ubch7/traf6": 1 "0.0009": 1 "inhibit infection": 1 "transcription from pol ii promoter": 1 "ionotropic receptors": 1 "mld ? g/kg 1": 1 "pole": 1 "db/db c57blks/j": 1 "frog": 1 "rna polymerase transcriptional mediator h-med6 acc# u78082": 1 "kyoto university graduate school of medicine kyoto japan": 1 "harc nef": 1 "synaptic vesicle-related": 1 "as odn": 1 "0.0018": 1 "0.0017": 1 "arhgdib astn1 reln rftn1": 1 "gamma-glutamyl hydrolase": 1 "suv39h1": 1 "glut8": 1 "glut9": 1 "glut6": 1 "mhc class i mfi clone g42–2.6": 1 "glut7": 1 "decreased vo2 maximum": 1 "glut4": 1 "cla4xmai-fw": 1 "glut5": 1 "glut2": 1 "glut3": 1 "glut1": 1 "chemokine c-x-c motif ligand 5": 1 "gdp-rhoa": 1 "cytidine deaminase analogs zebularine": 1 "nm_013067": 1 "membrane attack complex": 1 "chemokine c-x-c motif ligand 9": 1 "0.0021": 1 "structural maintenance of chromosomes 1 like i": 1 "ph intracellular": 1 "?n-chok?·adp·pho-hc-3": 1 "transporters": 1 "0.0027": 1 "fold change": 1 "spp1 †": 1 "jean-luc raoul": 1 "nm_053948": 1 " mrna": 1 "traf6": 1 "0.0038": 1 "gemcitabine mg?m ?2 days 1 and 8": 1 "0.0036": 1 "inp": 1 "birc5": 1 "ip3": 1 "us 149 152 ": 1 "8.1": 1 "0.0041": 1 "need for reapplication": 1 "fructose????": 1 "rb1": 1 "mi500a-3p": 1 "log2 24 h/0 h": 1 "pard3 ptprf rhob wasl": 1 "p-p-bond-hydrolysis-driven transporter activity": 1 "nischarin": 1 "pc10-l": 1 "increased laminin fibronectin collagen iv ecm components lipidosis": 1 "chemotaxis immune response": 1 "ser/thr kinase pink1": 1 "apoptosis immune response": 1 "approved selective tki for treatment": 1 "ace1": 1 "byung ihn choi md phd": 1 "ras": 1 "slide 5": 1 "slide 6": 1 "slide 3": 1 "copy number value mean": 1 "slide 4": 1 "slide 1": 1 "slide 2": 1 "??proliferation in response to anti-cd3 ab": 1 "melmskdelkkaasvfgkpigesyqaildaleeyhnlsgntadyeleqveklfelnkqidgyllehpd sgrnpaltqlkeqlntrl": 1 "oxidative stress genes": 1 "arhgag40": 1 "?? ltb4 pge2 tbx b2": 1 "axon guidance": 1 "transcription factor tfiiib htfiiib90 acc# u28838": 1 "chemotax index": 1 "96 h": 1 "evfedaaeir": 1 "de roock 2010 42": 1 "enp probe": 1 "12 hrs": 1 "srgap3": 1 "ubc sumo3 ubc9 ntrk1 tba1a hsp74": 1 "xrcc1-399 gln/arg": 1 "srgap1": 1 "srgap2": 1 "apt121p19arf+/+": 1 " 37 38 ": 1 " 58 62 ": 1 "nuclear proten 1": 1 "aaatcccgggaatatgtctctttcagctgcagcga": 1 "chemistry": 1 "gene model *": 1 "citrate": 1 "h2-oa": 1 "ck14 krt14": 1 "· ppar? induction": 1 "atf family member atf6 atf6 acc# af005887": 1 "organogenesis": 1 "anti rabbit alexa 594": 1 "gllsrlgaal-rpfvaii-wl": 1 "macrophages ×10 3 ": 1 "escrt 2": 1 "interventions": 1 "abs": 1 "ad5": 1 "chip rnapolii/tr ?tpk1/wt": 1 "exp in cd4": 1 "particle associated hiv 248": 1 "thymosin beta-10 acc# m20259": 1 "leukaemic samples*": 1 "78.4": 1 "apoptosis and cell death": 1 "adamts8 cpne2 cpne8 pdgfra reln": 1 "iso": 1 "protein tyrosine kinase activity": 1 "0.79 ***": 1 "obatoclax": 1 "ref": 1 "tp53 mutation status*": 1 "5 cgy + 2 gy": 1 "dephosphorylation": 1 " cag/aag": 1 "nik-i-kappab/nf-kappab cascade": 1 "20 21 61 29 27": 1 "ontology": 1 "fzd2 fzd3 fzd4 fzd5 fzd6 fzd7 fzd8 fzd9 fzd10": 1 "laty136f": 1 "200-502-211": 1 "gstt1": 1 "normal-veh": 1 "wtcrk triplei": 1 "gds794 2 day tac": 1 "3 beta-hydroxysteroid dehydrogenase type 1": 1 "3 beta-hydroxysteroid dehydrogenase type 2": 1 "pro-apoptotic": 1 "2 ?×? 4 h tgf-?1 pulses": 1 "4a1-4": 1 "16q13": 1 "saha vorinostat": 1 "t80 cell line": 1 "production": 1 "chip rnapolii/tr 2h ypgal/14.5h ypgal": 1 "clonal culture": 1 "4a1-7": 1 "heart rate beats/min": 1 "total ige ng/ml": 1 " 50 ": 1 "pi**": 1 "+dp/dt mmhg/s": 1 "frequency ": 1 "ladtperlawlaaelnhadnvdhqqlldamrgqtvqspvlaaalaeaqrrkvaviaenirkevifpslyrpgqpd snvallrraeeqlrhatspaeinqalndivdnysargflrfgkplssttvemakawrnkeft": 1 "description *": 1 " 51 ": 1 "spp1": 1 "aldo-keto reductase activity": 1 "tumor/muscle ratio": 1 "0.30–0.60": 1 "carbohydrate binding activity": 1 "hee chul park md phd": 1 "intracellular growth": 1 "emax reduction": 1 "ank3 cap2 clmn epb41l2 fnbp1 klhl2 marcks mtpn myo1b": 1 "tissue inhibitors of matrix metalloproteinases timps": 1 "iranian": 1 "rac1 ?m": 1 "water resistant": 1 "rab33b": 1 "pold1": 1 "transforming growth factor beta 2": 1 " 52 ": 1 "?human t-cell lymphotropic virus rex 48 ": 1 "col18a1 †": 1 "heavy metal ion transport": 1 "auxin carrier pin2": 1 "pma/ionomycin": 1 "1.15": 1 "individual efficacies": 1 "true\predicted": 1 "p-53": 1 "gstp1": 1 "chip rnapolii/tr rap1?sil/rap1": 1 "1.33": 1 "7.29±0.05": 1 " 53 ": 1 "gds591 doxy - tta+": 1 "clonogenic assay ic50 nm": 1 "nm_012963": 1 "high-dose stz c57bl/6j": 1 "sirna hiv brass 283": 1 "muscle development": 1 "ptsc2": 1 "ova 40 ?g/ml": 1 "angiostatin": 1 "cell differentiation": 1 "cardiotrophin-like cytokine factor 1": 1 "1.46": 1 "1.43": 1 "1.44": 1 "1.42": 1 "dusp6 dusp10": 1 "07–524": 1 "nm_000965": 1 "p110? e545k": 1 "kcnvl": 1 "efv toxin": 1 "rapamycin/temsirolimus": 1 " actin polymerized": 1 "1.52": 1 "cacnb3": 1 "1.49": 1 "sham": 1 "accrual # tumor assessed": 1 "20th week": 1 "col21a1 col4a2 dcn fntm2 itgax thbs4 tnr": 1 "transforming growth factor alpha tgf ?": 1 "negative regulation of transcription": 1 "pathway category": 1 "458–467": 1 "osa pho su var3-7 * mod mdg4 h2av * nlp * caf1 * ctbp * h2b rpd3 groucho mi-2 hp1 #": 1 "1.67": 1 "arhgap23": 1 "arhgap26": 1 "1.65": 1 "nk-1 receptor antagonists": 1 "1.63": 1 "gstm1": 1 " 57 ": 1 "sbm-msc": 1 "orthotopic": 1 "caga": 1 "arhgap32": 1 "1.59": 1 "39.4±4.5": 1 "q-pcr gpx3": 1 "non-normal": 1 "gd s2335 healthy endu": 1 "alk": 1 "rna": 1 "1.78": 1 "focal adhesion protein paxillin": 1 "arhgap17": 1 "?pkr 102 brca1-bard1 103 akt 104 fbw7 ? 105 hlj1 106 ": 1 "unit": 1 "lipid raft": 1 "mi502-3p": 1 "?? gm-csf tnf-? il-1?": 1 "96.1": 1 "amk": 1 "k4-cre apccko/+": 1 "1.82": 1 "mtt assay ic50 nm": 1 "aldh": 1 "1.80": 1 "# actin polymerized": 1 "1.89": 1 "epstein–barr virus positive ": 1 "1.87": 1 "benzamides ci-994 ms-275": 1 "molecular mass kda": 1 "sarcomere": 1 "ref.": 1 "mmtv- ha-ras": 1 "?? membrane-stabilizing effects": 1 "ribophorin i": 1 "sirna wnv": 1 "itsn1": 1 "translocated gene": 1 "nstwsgesk": 1 " bacteria-occupied vacuoles which are perinuclear mean +/- sem": 1 "1/100": 1 "follow-up**": 1 "1.93": 1 "fatty acid metabolism": 1 "sin3 associated polypeptide p18 sap18 acc# u96915": 1 "up-regulated": 1 "n?=?54": 1 "families involved in the interaction": 1 "arhgap42": 1 "application": 1 "deoxycytidine analogs 5-azacytidine 5-aza-2-deoxycytidine 1-?-d-arabinofuranosil 5-azacytosine dihydro- 5-azacytidine": 1 "0.3": 1 "gds591 doxy + tta+": 1 "0.4": 1 "exou": 1 "rna polymerase ii acc# l37127": 1 "duration weeks": 1 "disease model": 1 "0.0327": 1 "0.0326": 1 "homo sapiens 3? est": 1 "12th week": 1 "0.1–0.25": 1 "0.12–0.81": 1 "antibody & egfr correlation p-value": 1 "glsedtteetlkesfdgsvr": 1 "egr1": 1 "chrna5 chrna7 dip2a gabre htr1f pdzrn3 prkcd rgs4 slc38a10": 1 "prolactin receptor": 1 "atp dependent helicase activity": 1 "lps stimulation": 1 "platelet factor-4": 1 "brain development": 1 "caix": 1 "cd19+/+": 1 "bxpc-3": 1 "cmc-smb": 1 "casein kinase i.delta": 1 "ctnna1": 1 "optimum concentration": 1 "h pylori seronegative": 1 "· ikk inhibition": 1 "pearson cc ± s.d.": 1 "cytoprotection *": 1 "chromatin assembly factor-i p150 subunit acc# u20979": 1 "monocytes/macrophages 2 38 39": 1 "7.5±0.6 *": 1 "nr2a/nr2b-nmdar 36": 1 "grade": 1 "0.0340": 1 "map kinase kinase kinase mtk1 acc# af002715": 1 "acetyl-histone h3": 1 "0.0348": 1 "70.0": 1 "doses": 1 "gramantieri 2007 65 ": 1 "periplasm": 1 "0.0344": 1 "ctnnb1": 1 "abe award jastro": 1 "0.75 ***": 1 "ni/??": 1 "fzd3 fzd4 fzd5 fzd6 fzd7 fzd9": 1 "mesenchymal": 1 "0.0353": 1 "0.0352": 1 "at4": 1 "0.0356": 1 "collagen": 1 "nr3a nr3b": 1 "arpp21 camk2d lppr4 prkar2b prkcd ptprz1 snrk": 1 "ubc13/parkin": 1 "cluster sixteen 1266": 1 "tnf-r1": 1 "nm_022229": 1 "aged b6": 1 "dusp": 1 "?? eosinophil cationic protein": 1 "survivin-c": 1 "antibody therapies": 1 "alkalosis": 1 "epigenetic regulation": 1 "mycelia": 1 "lvsp mmhg": 1 "039": 1 "cytoplasmic": 1 "nm_022298": 1 "survivin-n": 1 "decorin": 1 "ecad9": 1 "acne increased bruising impaired wound healing": 1 "ecad7": 1 "embryonic pattern formation": 1 "lutein": 1 "glycerol": 1 "thymosin": 1 "ecad3": 1 "prothymosin alpha mrna prot-alpha acc# m26708": 1 "rgc32 protein.": 1 "neurotransmitters and receptors": 1 "gds1302 6 ug/kg tcdd": 1 "vavatpakk": 1 "nrp1": 1 "alix": 1 "rpl32": 1 "predicted epitope": 1 "0.0306": 1 "prothrombin kringle 2": 1 "comodule 1680": 1 "rtk name": 1 "minus lps": 1 "0.0309": 1 "lde225 novartis": 1 "target cell": 1 "negative": 1 "inhibitors of smooth muscle cell migration/proliferation": 1 "exosomes": 1 "rpl21": 1 "ubc13/rnf5": 1 "kit m14": 1 "ubc13/rnf8": 1 "13.1±1.3 *": 1 "5th 1997": 1 "african americans": 1 "forskolin": 1 "0.0315": 1 "dna replication factor c complex": 1 "shp1": 1 "+dp/dt mmhg/sec": 1 "adherens": 1 "0.0311": 1 "0.0310": 1 "structural molecule activity": 1 "proteolysis cytolysis": 1 "sodium and potassium channels": 1 "requirement for": 1 "0.0320": 1 "12.7±1.1 *": 1 "dnasel": 1 "reduced mute index": 1 "elkktlipketlvpltkleiaemvaedafvhtcrdqicslskivygsqgvlnkniieiiknpskgqqlatqiertpysvh slagfdlicfktgarvraekhvallscavanfthavkharqeitkehqaeqnrlrqevpmps": 1 "bcl2-like 14": 1 "p53 mutations": 1 "hroc24p": 1 "sirna flu fly": 1 "csnkld": 1 "drug concentration or gene manipulation": 1 "survival wk": 1 "cd4+ depl sfc/m *": 1 "ni 1/rsp5": 1 "1htg": 1 "knockout mouse": 1 "· erk 1/2 inhibition": 1 "chemotaxis": 1 "pk group": 1 "potassium inwardly-rectifying channel subfamily j member 1": 1 "chromosomal localization": 1 "mapkkk cascade": 1 "sustained phase block": 1 "actin monomer binding activity": 1 "rna#": 1 "?? inos": 1 "pre-induction": 1 "sc-1494": 1 "chelator": 1 "80–100": 1 "nm_000050": 1 "phosphate-limited medium": 1 "mmps 2913 and 14": 1 "loss-of-function": 1 "subcellular localization": 1 "?myc 59 ape1/ref-1 60 nfkb1 61 ar 62 miz1 63 ap2 ? 64 hexim1 65 yy1 66 cbf-a 67 irf1 68 ": 1 "pancreatitis with high dose steroids peptic ulcer": 1 "france 158 ": 1 "rab/gap": 1 "tokyo women's medical college tokyo japan": 1 "non-histone chromosomal architectural protein hmgi-c": 1 "protein catabolism": 1 "stress": 1 "signaling consequences": 1 "gds1001 atp1a1+/–": 1 "regulatory subunits dox-a2 * rpn2 * rpn7 * rpn11 #": 1 "steroid biosynthetic process": 1 "international diabetes federation": 1 "bombyx nuclear polyhedrosis virus": 1 "mrna/protein": 1 "disorder": 1 "0.30 ***": 1 "ass1 cfi dusp10 dusp6 enc1 plk2 rarb hsd3b2 hsd3b1": 1 "mrc-ppu reagents dundee university nethergate dundee united kingdom": 1 "1449254_at": 1 "membrane": 1 "0.0368": 1 "404–410": 1 "vegf c": 1 "excitation wavelength nm": 1 "p53 timps rb p21": 1 "predicted efficacy": 1 "cell cycle response": 1 "dna replication licensing factor humcm2 acc# d83987": 1 "mhc class i molecule": 1 "e coli": 1 "mice numbers": 1 "therapeutic priority": 1 "rerg": 1 "ethanol metabolism": 1 "t 1114": 1 "0.0378": 1 "binding properties": 1 "404–420": 1 "ncbi interactions": 1 "ghrelin": 1 "0.0386": 1 "interferon-inducible protein-10 ip-10": 1 "rnd1": 1 "arv clone number": 1 "0.0389": 1 "pttg1-n": 1 "bacteroides thetaiotaomicron vpi-5482 bacteroidetes/chlorobi": 1 "mads/mef2-family transcription factor mef2c acc# l08895": 1 "mast cell model organism used": 1 "china phase 1 13": 1 "disengagement": 1 "kcnjl": 1 "cdk1-n": 1 "vtqdelk": 1 "pttg1-c": 1 "nap nucleosome assembly protein acc# m86667": 1 "frequency in nsclc": 1 "non-human primate": 1 "hepatocyte growth factor": 1 "factor 1": 1 "pdcd7": 1 "factor 2": 1 "0.0393": 1 "0.0391": 1 "sheep": 1 "increased anti-anxa2 antibody response elisa": 1 "biogenic amine biosynthesis": 1 "amount": 1 "525–537": 1 "caspase-8": 1 "angiopoietin-like 1": 1 "vegf-b/vegfr1": 1 "profilin ii": 1 " 54 55 56 ": 1 "protein amino acid methylation": 1 "bcl2l14": 1 "plccells": 1 "progenies #": 1 "cdk1-c": 1 "ptp opening": 1 "parameters considered": 1 "dusp10": 1 "tumor type": 1 "tumor suppressor": 1 "cerebral blood flow of the baseline ": 1 "pik3cg": 1 "t-all no.": 1 "bc-819": 1 "scf": 1 "galactosyltransferase activity": 1 "bax": 1 "mr deaths/100000/year *": 1 "amg-102": 1 "autophagy": 1 "rap2a": 1 "rap2b": 1 "rap2c": 1 "bc-821": 1 "tumour necrosis factor alpha tnf ?": 1 "chick embryos": 1 "chemokine c-x-c motif ligand 11": 1 "anti-nox2 c-15": 1 "hdac6": 1 "symptoms": 1 "hdac8": 1 "special in hcc 61 ": 1 "study treatment": 1 "f 10": 1 "plk2 dusp6 dusp10 frem2 angptl1": 1 " 73 74 ": 1 "ldhb": 1 "?crm1 44 rpgr and rpgrip1 107 eg5 108 plk2 109 ctcf 110 ": 1 "anpep": 1 "bcr": 1 "emission wavelength nm": 1 "isolate": 1 "htr1b": 1 "calcium-related": 1 "cadps2 sv2b synj1": 1 "nm_053330": 1 "tiam1": 1 "i.p injection 2": 1 "i.p injection 1": 1 "phosphagen metabolism": 1 "a21272": 1 "qgteidgr": 1 "sopb/ipgd": 1 "parp1": 1 "lactate": 1 "vaca": 1 "signal pathway inhibitors": 1 "authors or protocol id": 1 "inhibition percentage": 1 "pco2 mmhg": 1 "erk1 mrna for protein serine/threonine kinase acc# x60188": 1 "ber": 1 "nm_021766": 1 "antigen retrieval": 1 "9.60": 1 "cd19?/?": 1 "sgk": 1 "spine lmd†": 1 "world health organization": 1 "huh-7/bcl-2": 1 "transcripts": 1 "liver-tumor dysregulation": 1 "tetrahydrocortisol-s": 1 "japan 151 ": 1 "shh": 1 "response to stress": 1 "c8 somite": 1 "gtp-rac1": 1 "35.8±6.2": 1 "plasminogen activator inhibitor pai": 1 "5 hrs": 1 "harc nef 6": 1 "goat polyclonal": 1 "tfiiic box b-binding subunit acc# u02619": 1 "songbird": 1 "vis toxin": 1 "signaling proteins": 1 "interferon receptor ifnar1": 1 "diabetic wild-type mice": 1 "growth inhibition ": 1 "coagulation factor x": 1 "sipa1": 1 "log ec50 m": 1 "myofibril": 1 "receptor-mediated endocytosis": 1 "protein phosphatase type 2c activity": 1 "bile acid biosynthesis": 1 "caspace™ #": 1 "platelet-derived endothelial cell growth factor pd - ecgf ": 1 "calpain7": 1 "cyp2e1": 1 "snp hiv fellay": 1 "quantum yield": 1 "stroke": 1 "mgmt": 1 "cdkn2a †": 1 "ribose catabolism": 1 "p110? h1047r": 1 "mlck2": 1 "frizzled receptor activity": 1 "monovalent inorganic cation transporter activity": 1 "phosphatidylinositol transporter activity": 1 "anti-pdia1 h-160": 1 "prevalence ": 1 "worms": 1 "degs": 1 "proliferin-related protein": 1 "nm_031131": 1 "apt121mdm2+/+": 1 "alanyl aminopeptidase": 1 "anti-pdia3 h-220": 1 "?a3/a1": 1 "joong-won park": 1 "po2 mmhg": 1 "0.29 ***": 1 "click beetle green cratomorphus distinctus": 1 "concentration ng/ml*": 1 "ptpn11": 1 "model": 1 "rhabdomyosarcoma": 1 "tumor-bearing mice": 1 "ipi-926 infinity": 1 "nm_000862": 1 "hmecsu ic50 ?m *": 1 "40.0": 1 "cdh13": 1 "4 h tgf-?1 pulse": 1 "1/50": 1 "arf – rab rho – rab": 1 "chip rnapolii/tr 14.5hypgal/ypd": 1 "cluster six 474": 1 "kkay-azilsartan": 1 "ced-12 n3261": 1 "hrasv12": 1 "schering-plough": 1 "hybrid molecules chap 31 chap50": 1 "coenzyme q ubiquinone": 1 "flowering": 1 "a4502": 1 "c10 somites": 1 " 66 ": 1 "case #": 1 " 67 ": 1 "smo": 1 "450–457": 1 "invalid rate ": 1 "col1a2": 1 "prkaa1": 1 "chromosomal location": 1 "gds446 capi3k": 1 "nm_012828": 1 "tgfr1 ef1g atn1 mdfi pls1 trip6 caco2 kr412 ap2m1 mcm7 pabp1 ari2 fhl3": 1 "upstate chicago il usa": 1 "dosing": 1 "atp6ap2": 1 "pod12": 1 "tyrosine 3-monooxygenase'tryptophan 5-monooxygenase": 1 "firefly photinus pyralis": 1 "83±8.4": 1 "mcf2 rab39 rasgrp1 rgs4 rhob stard13": 1 " 69 ": 1 "nucleic acid synthesis": 1 "foci/?g dna*": 1 "hf-zj001": 1 "nm_053356": 1 "medulloblastoma": 1 "nm_031100": 1 "herisqhwqnpvgelniggkryriidnqvlrlnphsgfslfregvgkifsgkmfnfsiarnltdtlhaaqk": 1 "cyth1": 1 "fractional vol occupancy ? b": 1 "jtp-74057": 1 "cam kinase i acc# l41816": 1 "calcr htr1f npy2r ptger4 rgs4": 1 "cilengitide": 1 "1.3": 1 "kc2d3": 1 "1.7": 1 "effective concentration a": 1 "down-regulated": 1 "bok": 1 "kc2d8": 1 "hf/angii/adapn n?=?16": 1 "ercc1": 1 "inorganic anion transport": 1 "nuprl": 1 "sjogren syndrome antigen b": 1 "ercc5": 1 "nm_031116": 1 "470–660": 1 "total": 1 "subtype": 1 "t 414": 1 "cell death-inducing dna fragmentation factor alpha subunit-like effector b": 1 "· 15-lox-1 induction": 1 "rsp5 adapter sna3": 1 "in-solution 2": 1 "in-solution 1": 1 "frem2": 1 "ppras40": 1 "histone deacetylase": 1 "virulence": 1 "similarity with": 1 "retinoic acid early transcript 1 alpha": 1 "arabidopsis thaliana": 1 "ercc1 c8092a/": 1 "specimen characteristics": 1 "0.0207": 1 "ssb": 1 "0.0202": 1 "0.0200": 1 "agtr1": 1 "?5.2±2.1": 1 "0.0209": 1 "0.0208": 1 "inhibition ": 1 "nm_002523": 1 "0.0218": 1 "phagocytosis": 1 "cell-cell adhesion": 1 "tissues": 1 "18.7": 1 "0.0211": 1 "asthma": 1 "direction and quality of interaction": 1 "4060": 1 "rab1b? gbf1? arf1 rab11? rab8? tgn to cilia transport arf4 rho? mdia? rab6? retrograde transport": 1 "128": 1 "sam results *": 1 "selection criteria": 1 "aptamers": 1 "mir21-5p": 1 "ni/nedd4-1": 1 "0.0229": 1 "tlr1": 1 "active peptide": 1 "0.0225": 1 "0.0222": 1 "tlr9": 1 "sum": 1 "?-actin": 1 "primary antibody incubation": 1 "enox1 fam84a gas7 klhl2 rasl11a rftn1 tmem158 trib2": 1 "620–1100": 1 "tlr2": 1 "translation regulator activity": 1 "?ebp1 80 senp3 and senp5 81 rpl5 43 rps9 82 rpl23 63 nucleolin 83 p120 50 npm3 25 usp36 84 ": 1 "final conc.": 1 "specificity": 1 "0.0230": 1 " mtoc polarized": 1 "hgf/sf antagonist a": 1 "2.1 s": 1 "vav3": 1 "positive control": 1 "development phase": 1 "73.5±11.7": 1 "genesymbol *": 1 "0.0236": 1 "0.0233": 1 "cd19": 1 "chymotrypsin activity": 1 "cd14": 1 "fmlp stimulation": 1 "cd10": 1 "il1 ?": 1 "eosinophils 2 36 37": 1 "motility": 1 "phosphodiesterase": 1 "tipifarnib mg twice daily days 1–7": 1 "delay in tumor growth days": 1 "muscle contraction": 1 "?? adhesion to bronchial epithelial cells": 1 "ampar 40": 1 "suppliers": 1 "non-histone chromosomal protein hmg-17 acc# m12623": 1 " 34 35 36 ": 1 "4g3-2": 1 "cell type": 1 "testis": 1 "cd45": 1 "nm_013226": 1 "gds794 10 day tac": 1 "p27kip1": 1 "hf/pbs n?=?12": 1 "ccdc3": 1 "igf1r": 1 "aquaporin5": 1 "713-545-147": 1 "50–80": 1 "cd34": 1 "mrna for nucleosome assembly protein acc# d50370": 1 "tls3": 1 "nm_013216": 1 "cd33": 1 "endorepellin": 1 "iqsec1": 1 "excitability": 1 "dopamine transporter dat": 1 "wtcrk abli": 1 "1422814_at": 1 "llo118": 1 "patient id *": 1 "epsin 1 ankrd 13": 1 "nm.012542": 1 "1450140_a_at": 1 "?3.9±1.6": 1 "t47d mda-mb-231": 1 "srbc": 1 "histocompatibility 2 o region alpha locus": 1 "nuclear factor kappa b nf -?b": 1 "photoreceptor activity": 1 "thalamus": 1 "normal": 1 "e-ce": 1 "dual specificity phosphatase 10": 1 "vitis vinifera": 1 "cyclic peptides apicidin depsipeptide": 1 "pard3": 1 "mago nashi * tsunagi cup * me31b * hrb27c * nac? smaug hel25e * valois eif4e squid vasa #": 1 "ad12s": 1 "48 hrs": 1 "cd56": 1 "g-protein chemoattractant receptor activity": 1 "invalid test": 1 "dusp6": 1 "drought": 1 "protein synthesis and turnover": 1 "acetylcholine": 1 "mir21-3p": 1 "hmlh1": 1 "heme biosynthesis": 1 "6.33": 1 "il17a": 1 "pc5-t +hyase ?": 1 "meiosis": 1 "wtcrk sosi": 1 "candida glabrata": 1 "cluster one 1187": 1 "mgmt promoter": 1 "low-penetrance": 1 "sirna hiv brass": 1 "disease studied": 1 "meta-analysis with 300 mg dose 14 15": 1 "0.0292": 1 "48 hpf": 1 "6.46": 1 "igfbp7 mutation": 1 "mycn": 1 "murakami 2006 57 ": 1 "6.42": 1 "15mer peptide": 1 "viral replication": 1 "ampa": 1 "intermediate filament": 1 "antisense oligonucleotides": 1 "nm_004316": 1 "musculoskeletal": 1 "chromatin structure": 1 "troponin-1": 1 "druggable?": 1 "intestine": 1 "polymerase rna 11 dna directedpolypeptide g": 1 "hotspot": 1 "median range": 1 "binding affinity kd": 1 "procollagen type i alpha 2": 1 "b2 gpr56 gpr64 gpr97 gpr110 gpr115 gpr126 gpr128 gpr133 gpr116": 1 "10 ?g/ml": 1 "place": 1 "vegfr-2": 1 "microsatellite instability ": 1 "m2*": 1 "cell proliferation": 1 "kegyvdfesaedlek": 1 "igfbp7 protein detection in total cell lysate": 1 "specificity against": 1 "pmp22 t 1/2 h": 1 "amino acid synthesis": 1 "m3#": 1 "integral to plasma membrane": 1 "0.0248": 1 "0.0246": 1 "0.0245": 1 "nitrogen-limited medium": 1 "incubator time hours": 1 "inflammatory stimulus": 1 "epithelial-like": 1 "cd44 variant isoform": 1 "emax kev": 1 "soluble vcam e2f": 1 "tac": 1 "glaxosmith kline": 1 " +++? +++": 1 "huang 2008 61 ": 1 "increased vegf fgf pdgf cytokines tgf- ? integrins": 1 "aplidine": 1 "loss of lipid rafts association after 0- to 5-min suspension": 1 "0.0255": 1 "cyclopamine": 1 "actin modulating activity": 1 "tibialis": 1 "toshiyuki okumura": 1 "2 gy": 1 "titers of neutralizing activities ? log 2 *": 1 "group vi gprc6a orphan gprc5b gprc5c gpr156 gprc5d gpr158": 1 "0.0269": 1 "cpg site probed": 1 "0.0268": 1 "0.0267": 1 "a2780 *": 1 "1o2g ": 1 "cam": 1 "alcohol catabolism": 1 "log 2 tr5h/trc": 1 "effect on rs3-pa uptake*": 1 "studies": 1 "7th 2009": 1 "predictor": 1 "0.0274": 1 "thalidomide/lenalidomide": 1 " 67 68 ": 1 "gene identifier": 1 "0.0270": 1 "cell cycle and cell growth": 1 "tcp": 1 "dna replication and chromosome cycle": 1 "glra2 gria4 grik2 grm1 grm5 hrh3 pld1 slc8a1 slc32a1": 1 "?? il-2 il-3 il-4 il-5 il-13": 1 "mitochondria": 1 "achaete-scute complex homolog 1": 1 "n-ali n-7": 1 "ube2d ube2l3/nedd4-2": 1 "ferrichrome c transporter arn1": 1 "cd2": 1 "cd1": 1 "regulation of cyclin-dependent protein kinase activity cell cycle": 1 "cd5": 1 "cd7": 1 "0.0287": 1 "2 h": 1 "15mer": 1 "category": 1 "0.0282": 1 "0.0280": 1 
"12 hr": 13 "dilution": 12 "david gene name": 10 "4 hr": 10 "acc no": 10 "1 hr": 10 "hr": 8 "source": 8 "30 min": 7 "24 hr": 6 "control": 6 "st dev.": 6 "kurt.": 6 "mean": 6 "igf-1 and l.obtusiloba extract": 5 "p": 5 "60 min": 5 "p-value": 5 "igf-1": 5 "l.obtusiloba extract": 5 "gene name": 4 "clone": 4 "240 min": 4 "20 min": 4 "antibody": 4 "72 hr": 4 "2 hr": 4 "colony diameter mm": 3 "0": 3 "95ci": 3 "ese-16": 3 "amount ml": 3 "6 hr": 3 "mm": 3 "1.5": 3 "ki nm": 3 "40 min": 3 "compound": 3 "10": 3 "cell line": 3 "reagents": 3 "10 min": 3 " ml/min": 3 "200 nm": 3 " growth": 3 "gene": 3 "group": 3 "accession #": 2 "hr 95ci": 2 "egf=10 nm hrg=10 nm": 2 "+acc": 2 "covariate": 2 "egf=10 nm hrg=0 nm": 2 "fold changes": 2 "95 ci nm": 2 "95 ci": 2 "company": 2 "functional groups": 2 "lines": 2 "n=97": 2 "hi mm": 2 "fresh 0 hr": 2 "li mm": 2 "egf=0 nm hrg=0.5 nm": 2 "5 min": 2 "antigen": 2 "3.0": 2 "3.8": 2 "manufacturer": 2 "2.0": 2 "species": 2 "2.5": 2 "spot number": 2 "glucose 2 hr": 2 "10 nm": 2 "1.0": 2 "1.2": 2 "1.4": 2 "8 hr": 2 "0.2": 2 "0.5": 2 "entrez gene no .": 2 "hr beats/min": 2 "protein": 2 "95 ci of hr": 2 "?acc": 2 "egf=0 nm hrg=10 nm": 2 "egf=0.5 nm hrg=0 nm": 2 "*relative growth ": 2 "ec50/ic50 nm": 2 "description": 2 "48 hr": 2 "ic50 nm": 2 "egf=0.5 nm hrg=0.5 nm": 2 "10 ?m": 2 "10 mm glucose": 2 "gene symbol": 2 "1 min": 2 " mmhg": 2 "protein name": 2 "144 hr": 2 "10 mm glucose+75 µm fructose": 2 "ivss mm": 1 "nm 021835.2": 1 "nm 013069.1": 1 "1 6": 1 "mcf-12a": 1 "p * initial po2 mm hg": 1 "*cebpd ccaat/enhancer binding protein c ebp delta": 1 "nm 012551.1": 1 "retrieval": 1 "secondary antibody": 1 "-dp/dt mm hg/s": 1 "qrt-pcr": 1 "antibody source": 1 "antibody source 1°/2°‡": 1 "ao": 1 "dfs": 1 "1": 1 "2": 1 "4": 1 "5": 1 "inos expression": 1 "7.3": 1 "? 4 mol/ l cm": 1 "treatment": 1 "1 mm ppa": 1 "7.9": 1 "revelation substrate": 1 "0 8": 1 "cis-eqtl": 1 "m65i49": 1 "10–20": 1 "nm 013166.1": 1 "pmol adducts/ ? mol guanine": 1 "cvfi": 1 "primary antibody dilution†": 1 "*cntf ciliary neurotropic factor": 1 "correlation coefficient": 1 "cf": 1 "kd nm bms-754807": 1 "ck": 1 "0.01": 1 "$positive cases ": 1 "co": 1 "abbreviation": 1 "n": 1 "* 1x vitamins prepared as 1000x stock": 1 "percent control 10 ?m": 1 "s": 1 "32.1": 1 "product number": 1 "?2 { ml o2 105 cells/ ng mkt-0772}": 1 "emmax 2 nm": 1 "mean zeta-potential ph": 1 "l23148": 1 "*cp ceruloplasmin": 1 "aa892559": 1 "calcium signal percentage/quality/onset": 1 "24.96": 1 "antigen retrieval": 1 "0.04": 1 "0.05": 1 "0.02": 1 "0.03": 1 "ginger mg/ml": 1 "antibodies": 1 "vegf vascular endothelial growth factor form 3": 1 "66.4": 1 "nm 012937.1": 1 "*fcgr3 fc receptor igg low affinity iii": 1 "10 hour": 1 "24.96 hr cv": 1 "0.24 hr cv": 1 "31.6": 1 "nm 012588.1": 1 "0.15": 1 "nm 013154.1": 1 "5.0": 1 "bms7531 ?m": 1 "secondary antibody dilution": 1 "solvent": 1 "d88250": 1 "percent control 50 nm": 1 "ga in weeks at screening": 1 "pbs": 1 "5.9": 1 "trabectedin nm": 1 "antibodies/probes": 1 "0.96 hr cv": 1 "ratio 96hrs/0hr": 1 "menadione mm": 1 "zalypsis nm": 1 "gene_ihs": 1 "0 min": 1 "0.25": 1 "n=93": 1 "0.24 hr": 1 "0.45": 1 "microarrays": 1 "gene bank": 1 "fs ": 1 "nm 031832.1": 1 "0.35": 1 "allele": 1 "120 min": 1 "4.3": 1 "working dilution": 1 "tg mm": 1 "4.7": 1 "4.8": 1 "4 hour": 1 "nm 138900.1": 1 "4.9": 1 "d90404": 1 "m3i837": 1 "hep3b": 1 "ctsc cathepsin c": 1 "m96601": 1 "mcf-7": 1 "rkis1": 1 "supplier": 1 "fbg mm": 1 "auc0?24 h id.h": 1 "id": 1 "mda-mb-231": 1 "nm 019289.2": 1 "lvedd mm": 1 "melan-a vs b16": 1 "cox-2 expression": 1 "unadjusted hr": 1 "nm 012637.1": 1 "is": 1 "10 mm ppa": 1 "clblood b ml/min/kg": 1 "gene id": 1 "supplement": 1 "rol1 ?m": 1 "3.1": 1 "3.3": 1 "3.4": 1 "3.5": 1 "pfs": 1 "cervical length mm": 1 "ec50 nm": 1 "immunogen": 1 "crybb2 crystallin beta b2": 1 "rms error mm hg": 1 "adjusted hr": 1 "antibody target": 1 "*cd74 antigen": 1 "ldl-c mm": 1 "antibody#": 1 "kd nm hela": 1 "bms753 100 nm + sr11237 100 nm": 1 "second antibody": 1 "dilution overnight in incubation": 1 "all 13289": 1 "loci_based p": 1 "atx substrate": 1 "no gcsf": 1 "proliferation": 1 "mushrooms": 1 "snp": 1 "aa946503": 1 "2.6": 1 "2.7": 1 "sk-hep1": 1 "fungal strain": 1 "clone #": 1 "j05i22": 1 "0.9 salt": 1 "0.96": 1 "final concentration": 1 "c-jun": 1 "aa945867": 1 "host": 1 "10 mm fructose": 1 "mv nm": 1 "-2": 1 "-7": 1 "yield w/w": 1 "lvsp mm hg": 1 "1.1": 1 "1.3": 1 "ti mm": 1 "** 1x metals prepared as 1000x stock": 1 "1.8": 1 "1.9": 1 "isotype": 1 "nm 053843.2": 1 "biocarta pathway": 1 "apoptosis": 1 "*arpclb actin related protein 2/3 complex": 1 "percent control 200 nm": 1 "ros": 1 "lvdd mm": 1 "l209i3": 1 "*mgp matrix c51a protein": 1 "0.2 salt": 1 "half-life min": 1 "os": 1 "gene_based p": 1 "19.6": 1 "culture vessel": 1 "survival n=136": 1 "number of hearts producing ao during reperfusion": 1 "0.1": 1 "gene/fold change": 1 "0.3": 1 "0.4": 1 "pf-8380": 1 "25 ?m": 1 "pi": 1 "0.7": 1 "pl": 1 "r2": 1 "gcsf 24 hr a": 1 "percentiles mm": 1 "s32826": 1 "swelling ": 1 "lps+napb 0.2 mm": 1 "particles": 1 "24 h": 1 "camp response/cho-k1": 1 "peptide": 1 "incubation time": 1 "15": 1 "nm 016994.1": 1 "90 min": 1 "ca2+ response/cho-k1": 1 "aa817854": 1 "blocking/antibody dilution buffer*": 1 "5 ng/ml tgf-?1 20 nm sb431542": 1 "-2.1": 1 "20": 1 "late changes 35 days": 1 "no treatment": 1 "25": 1 "q1 ml o2/ 105 cells * min": 1 "48 hour": 1 "cytokine ng/mgprotein/24 h": 1 "mr/d": 1 "kd nm elisa": 1 "combination index ci": 1 "frozen-thawed 24 h": 1 "? 3": 1 "specificity": 1 "30": 1 "tc mm": 1 "cenp-m incubation with": 1 "variables": 1 "25 nm": 1 "ic 25 a mm": 1 "growth inhibition": 1 "gcsf 48 hr b": 1 " beats/min": 1 "buffer volume ml": 1 "ai0i2030": 1 "?r { ml o2 105 cells0.5/ ng mkt-0770.5}": 1 "lvsd mm": 1 "x02601": 1 "nm 130741.1": 1 "igfbp3 insulin-like growth factor binding protein 3": 1 "8 h": 1 "cd47 integrin-associated protein": 1 "tw": 1 "cell lines": 1 "protein identified": 1 "ivsd mm": 1 "*c 1 s complement component i s subcomponent": 1 "5 ng/ml tgf-?1": 1 "nm 012515.1": 1 "anti vcam-1 cross-linking": 1 "24 hour": 1 "95 confidence interval of hr": 1 "loci_ihs": 1 "detection system": 1 "xi3044": 1 "mn nm": 1 "basal": 1 "genotype": 1 "surface area cm2": 1 "ad-nbs1": 1 "extract": 1 "ad5-caalk5": 1 "name": 1 "lps+napb 0.1 mm": 1 "hypocotyl length mm": 1 "retinoic acid treatment": 1 "activity ": 1 "nm 017097.1": 1 "psp": 1 "1 mm ba": 1 "idl inhibitor of dna binding 1": 1 "napb 0.5 mm only": 1 "magnitutde of expression change": 1 "extended 24 h": 1 "t min": 1 "j02962": 1 "lvedp mm hg": 1 "brp-lpa": 1 "lpa mm2": 1 "tra1 ?m": 1 "0 hr": 1 "af083269": 1 "target": 1 "protein score": 1 "concentration mm": 1 "ascites volume ml": 1 "conidial volume ?m3": 1 "hazard ratio hr": 1 "percent control 1000 nm": 1 "dp/dt mm hg/s": 1 "funnel": 1 "conidial diameter ?m": 1 "m32062": 1 "6 mm ba": 1 "?15": 1 "binding": 1 "nm 019195.2": 1 "egrl early growth response 1": 1 "refseq rna": 1 "anti-psma cross-linking": 1 "nm 133523.1": 1 "nm 012532.1": 1 "calculated estimate of ic50 nm": 1 "*bzrp benzodiazepin receptor": 1 "x52477": 1 "ic 50 gelam honey mg/ml": 1 "ic 50 a mm": 1 "product size kda": 1 "xi6072": 1 "slc6a6 solute carrier family 6 member 6": 1 "?20": 1 "reporter gene response/cho-k1": 1 "method": 1 "?25": 1 "calculated q2 ml o2/ 105 cells * min": 1 "*lgals3 ige binding prolein": 1 "lps+napb 0.5 mm": 1 "exmax 1 nm": 1 "nm 017206.1": 1 "frozen-thawed 3 h": 1 "ppar? expression": 1 "root length mm": 1 "?30": 1 "7e11c cross-linking": 1 "afo17437": 1 "af023087": 1 "feature": 1 "mean/median cl mm": 1 "genes down-regulated by atf3 knockdown": 1 "25.9": 1 "incubation time and temperature": 1 "acid release": 1 "hdl-c mm": 1 "*mmp3 matrix metalloproteinase 3": 1 "lps": 1 "18 hr": 1 " mkt-077 µg/ml": 1 "*c3 complement component 3": 1 "4 h": 1 "nm 012797.1": 1 "incidence": 1 "extended 3 h": 1 "log m diff expressed": 1 "transfection": 1 "cvfiii": 1 "tumor origin": 1 "inhibitor": 1 "lvef": 1 "antibody subcellular localization": 1 "ef ": 1 "lvw/bw mg/g": 1 "average ml": 1 "antibody/clone": 1 "nm 012862.1": 1 "h2o2 mm": 1 "wald-p": 1 "* protein-tyrosine phosphatase ptpnl": 1 "9.6": 1 "2 0": 1 "week": 1 "km µm": 1 "antibody name": 1 "kd mm": 1 "nm 031836.1": 1 "fgf2-ad-nbs1": 1 "cmax id": 1 "? pkaa": 1 "*lcn2 lipocalin 2": 1 "variable": 1 "t test a": 1 "doxo nm": 1 "2 h": 1 "8.1": 1 "published biochemical ic50 nm": 1 
"references": 29 "gene": 23 "reference": 22 "ligand": 21 "location": 19 "ref.": 18 "function": 13 "receptor": 13 "selectivity": 12 "effects": 12 "position": 11 "gdp dissociation rate constants 10–3 s–1": 10 "span fraction": 10 "cells": 10 "potency": 10 "name": 10 "origin": 10 "sequence": 9 "score": 9 "substrate": 9 "1": 8 "molecule": 8 "protein": 8 "domain": 7 "species": 7 "description": 7 "primers": 6 "0.01": 6 "structure": 6 "chromosomal location": 6 "3": 5 "source": 5 "chromosome": 5 "treatment": 5 "brain region": 5 "67": 5 "caveolin associated molecule": 5 "gene name": 5 "strand": 5 "product size bp": 5 "2": 4 "pdb id": 4 "2.2": 4 "median": 4 "nucleotide": 4 "ligands": 4 "amino acid": 4 "start site": 4 "# amino acids": 4 "modification": 4 "68": 4 "89": 4 "91": 4 "92": 4 "matrix": 4 "ref": 4 "d-domain motif": 4 "residue": 4 "fxfp motif": 4 "genbank accession #": 4 "p-value": 4 "isozyme": 4 "interaction partner": 4 "mechanism": 4 "refs": 4 "effect": 4 "site s with the consensus px s/tp sequence": 4 "model": 4 "distance å": 4 "cell type": 4 "region": 4 "?r/rf": 4 "range": 4 "site": 4 "model species": 3 "0": 3 "4": 3 "6": 3 "?1": 3 "?2": 3 "?3": 3 "?4": 3 "2.1": 3 "2.5": 3 "2.7": 3 "gene symbol": 3 "nhs-edc reaction": 3 "p value": 3 "distance restraints": 3 "0.05": 3 "free energy": 3 "gcn5 ko": 3 "kinase": 3 "3.6": 3 "ttp wks": 3 "reaction": 3 "43": 3 "# s/tp sites": 3 "85": 3 "87": 3 "88": 3 "dose concentration affinity": 3 "binding partner": 3 "locus": 3 "protein position": 3 "active gsk-3? positive ": 3 "docking score": 3 "family": 3 "system": 3 "mirna name": 3 "target": 3 "annealing temperature °c": 3 "transcription factor": 3 "active gsk-3? negative ": 3 "strain penalty": 3 "partner": 3 "rec site": 3 "504": 3 "snr": 3 "control": 3 "pi": 3 "n- myc ko": 3 "symbol": 3 "method": 3 "interacting proteins": 3 "category": 3 "mirna id": 2 "?": 2 "target molecule": 2 "accession #": 2 "2796": 2 "n": 2 "6.2": 2 "molecular weight da": 2 "starter binding temperature": 2 "? free": 2 "cooperation": 2 "inhibition constant nm": 2 "phosphorylation site": 2 "ec50 nm": 2 "native": 2 "redundancy": 2 "biotin-2": 2 "biotin-1": 2 "2.3": 2 "arno": 2 "cycle phase": 2 "catalytic": 2 "comments": 2 "bmax": 2 "mode of action": 2 "a ??g kcal/mol": 2 "state": 2 "binding site": 2 "genes": 2 "251": 2 "phenotype": 2 "free energy kcal/mol": 2 "cnv ln vs gfp": 2 "shared genes": 2 "the best docking energy kcal/mol": 2 "+e2/?e2": 2 "adjusted p-value bh": 2 "b solvent accessibility ": 2 " hypomethyl.": 2 "3.16e-05": 2 "2413": 2 "dose": 2 "amino acids": 2 "electrostatic energy kcal/mol": 2 "1.102": 2 "enrichment/ depletion": 2 "title": 2 "genomic position": 2 "codon": 2 "chr.": 2 "3.4": 2 "3.7": 2 "logp": 2 "sequence 5?-3?": 2 "compound": 2 "358": 2 "tm °c": 2 "il-6": 2 "-2.4": 2 "expression": 2 "384": 2 "387": 2 "hormone trt": 2 "52": 2 "6042": 2 "57": 2 "modified amino-acid residue": 2 "plasmid": 2 "72": 2 "molecule name": 2 "region size bases": 2 "primer sequence 5??3?": 2 "93": 2 "95": 2 "99": 2 "effect on stability": 2 "mamps": 2 "tf binding motif pwm": 2 "secondary structure": 2 "12.4": 2 "phosphopeptide sequence": 2 "cycle study brain region": 2 "1.05e-06": 2 "molecules": 2 "linker": 2 "snp name": 2 "h-bond forming residues": 2 "840": 2 "localization": 2 "functional role": 2 "gp130": 2 " hypermethyl.": 2 "residue and rsa ": 2 "identification number": 2 "inner domain": 2 "residual dipolar couplings": 2 "mode": 2 "domains": 2 "accession": 2 "application": 2 "exon": 2 "histology": 2 "peptide": 2 "pop s&w": 2 "amino acid substitution": 2 "tumor": 2 "total internal energy kcal/mol": 2 "gene set": 2 "evalue": 2 " inter methyl.": 2 "3'utr position": 2 "start position": 2 "biological process": 2 "substrates": 2 "autodock binding energy": 2 "2680": 2 "fold": 2 "bch": 2 "2693": 2 "proteins": 2 "cd": 2 "sample": 2 "interacting atom from the c-domain sace and the zinc ion": 2 "nucleosome location": 2 "cell types": 2 "transcripts": 2 "s no": 2 "pdb structure": 2 "interacting protein": 2 "class": 2 "id": 2 "dependency": 2 "alteration": 2 "crystal": 2 "other names": 2 "rmsd å ´ ": 2 "kd": 2 "gp80": 2 "aptamer": 2 "box vol å3": 2 "cys–his boxes": 2 "cral_trio": 2 "rapamycin phenotype": 2 "4056": 2 "enzyme class": 2 "6251": 2 "electrostatic interaction": 2 "mgd symbol": 2 "172": 2 "outer domain": 2 "official gene name": 2 " vdw + hbond + desolv energy kcal/mol": 2 "competition": 2 "phase": 2 "antibody": 2 "gdp": 2 "transcript": 2 "drug": 2 "kinase s": 2 "0.666": 1 "clinical implication": 1 "functions": 1 "seemet antibody": 1 "2791": 1 "gene annotation": 1 "remote": 1 "x-ray or nmr": 1 "plexin-b1?1 – rac1* complex": 1 "1455": 1 "#": 1 "domain instances per gene": 1 "netgrep": 1 "??????overall": 1 "nm_005527.3": 1 "target site": 1 "proposed substrate": 1 "catalytic core": 1 "5": 1 "principal effector-cell expression profile a": 1 "9": 1 "chr location 1": 1 "role": 1 "5 mimicking interface": 1 "fscor": 1 "rmsd from representative crystal structure †": 1 " a residues conserved within cral_trio domains": 1 "impropers °": 1 "arf1": 1 "0.000961245": 1 "igg subclass": 1 "1c "expressed" probe sets 824": 1 "5834": 1 "b": 1 "?5": 1 "viral ligands": 1 "tro gpr68": 1 "hiv-1 interacting": 1 "1st line": 1 "parent molecule": 1 "7.56e-05": 1 "component": 1 "candidate gene": 1 "exosgap": 1 "site of": 1 "information": 1 "agilent": 1 "6.9": 1 "em_htgak033272 mus musculus 15 days embryo": 1 "pam 250": 1 "log phase": 1 "?h-nh": 1 "siscr": 1 "8.51e-05": 1 "lamb1 tro": 1 "targeting motif": 1 "import probability 21 ": 1 "oncolytic virus": 1 "a_rotation res.4 11": 1 "4 finding putative small-molecule pockets": 1 "blastocyst/ oocytes day 9 ": 1 "drug molecule": 1 "ec50 erbb3 nm": 1 "bh domains present": 1 "kog0735 oaaa+-type atpase 1/8": 1 "2.55e-05": 1 "chr": 1 "0.000948698": 1 "treatment after anti-egfr agent": 1 "catalytic subunit": 1 "86.6 ": 1 "aff_rescale": 1 "mirna": 1 "cluster no.": 1 "compounds": 1 "small molecule inhibitor": 1 "ligand + actd": 1 "stimulatory": 1 "poly-adenelation features **": 1 "em_est human fetal lung 5? cdna est clone w16714": 1 "sequential |i?j|?=?1": 1 "hi loop": 1 "lens": 1 "m ?": 1 "igfbps": 1 "gtpase effector protein/effector domain crystal structures": 1 "probe sequence": 1 "hrt study 20 most stably expressed": 1 "acceptor": 1 "0.00864687": 1 "arf subfamily": 1 "peak": 1 "# lig tors": 1 "wt rac1": 1 "length ?m ": 1 "glycan structure & reactive lectins": 1 "?gnon-polar": 1 "cancer": 1 "tlr": 1 "4557": 1 "bcl2l1 ddx43 exosc9 tro eprs": 1 "dock score a": 1 "stimulatory effect": 1 "affinity for igg": 1 "mean division rate 10?2 h?1": 1 "hes/hey protein": 1 "koff": 1 "cle": 1 "kog0935 uclathrin adaptor complex small subunit 1/6": 1 "targeting technique": 1 "physical interaction partners": 1 "ligand only": 1 "gtp": 1 "sequence change": 1 "# genes 2": 1 "n a": 1 "nm_004083.4": 1 "mutation": 1 "reservoir solution": 1 "homo sapiens": 1 "b subtilis obg as template": 1 "type molecules": 1 "expression levels": 1 "approach **": 1 "zebrafish prey genes genbank accession number": 1 "p fisher test": 1 "intra-residue": 1 "tissue/tumour type": 1 "splicing 2": 1 "nutritional state": 1 "pgf": 1 "mass difference": 1 "noe violations": 1 "2a all probe sets 1433": 1 "mat isoform": 1 "implications": 1 "gdp dissociation constant k?1 × 1000 min?1": 1 "delivered molecule": 1 "zif domain": 1 "cnv": 1 "map kinase pathway": 1 "homo sapiens heat shock 70kda protein 6 hsp70b' hspa6 mrna.": 1 "?most favored regions": 1 "0.000126234": 1 "anatomical site of origin": 1 "2.4": 1 "2.6": 1 "predicted affinity": 1 "blastocysts/ cleavage day 9 ": 1 "inhibitory": 1 "p-mapk a": 1 "merlin construct": 1 "nrsf site": 1 "facs binding": 1 "cox-2": 1 "cox-1": 1 "location *": 1 "?hydrogen bond pairs hn-o n-o": 1 "physiological/pathophysiological impact": 1 "kog0336 aatp-dependent rna helicase 2/6": 1 "motif": 1 "erbb receptor": 1 "mitochondrial localization": 1 "core sequence": 1 "glab/gst-gli1zf k340a": 1 "binding sites *": 1 "kog0924 amrna splicing factor atp-dependent rna helicase 1/2": 1 "? bound htel": 1 "0.691": 1 "activatory": 1 "location of curcumin": 1 "lamb1": 1 "metabolism": 1 "rump width1": 1 "arg209 bonding": 1 " mfi": 1 "theoretical mass": 1 "5482": 1 "subfamily": 1 "amplicon position pb": 1 "pc-3 npa hela cells": 1 "homo sapiens aldehyde dehydrogenase 1 family member b1 aldh1b1 nuclear gene": 1 "wt ras-sno": 1 "interaction in y2h": 1 "0.002218": 1 "nm_001165.3": 1 "lyrm a": 1 "kog0736 operoxisome assembly factor 2 containing the aaa+-type atpase domain 1/4": 1 "map kinase": 1 "at1b": 1 "targeted region": 1 "at1a": 1 "drosophila": 1 "227": 1 "corby": 1 "19.0": 1 "cluster": 1 "kog0983 tmitogen-activated protein kinase mapk kinase mkk7/jnkk2 1/2": 1 "identity ": 1 "iiib": 1 "iiic": 1 "233": 1 "deviations from standard geometry xplor-nih": 1 "0.00390±0.00023": 1 "?angles": 1 "6361": 1 "ptgs2": 1 "7696": 1 "?bonds": 1 "??????without the asymmetric internal loop and the adenine bulge": 1 "melanoma": 1 "?disallowed regions": 1 "kinase activity": 1 "function/response": 1 "interacting disc1 constructs": 1 "bond lengths å": 1 "annealing temp °c": 1 "em_est ai673781 nci_cgap gas4 homo to73a09.x1": 1 "c6 glioma cells": 1 "glide emodel": 1 "kd ?m": 1 "lgg": 1 "sanger-confirmed tumors": 1 "aza µm": 1 "bmi1": 1 "data collection and refinement": 1 "gtp?s": 1 "uniprot id": 1 "residues involved in ?-? stacking": 1 "crystal age": 1 "268": 1 "effects on interacting proteins": 1 "lhr": 1 "itreg": 1 "?gbind": 1 "organism s": 1 "1.47 ± 0.16 å": 1 "ligand dataset": 1 "ddx43 eprs": 1 "tumor state": 1 "distance bins": 1 "pyropheophorbide a": 1 "control element name": 1 "soce machinery": 1 "total noe": 1 "sd ±": 1 "em_htgbx284653 human dna sequence": 1 "on/off": 1 "lysine": 1 "ssh redundancy": 1 "0.171": 1 "em_humaf231056 homo sapiens brg1-a": 1 "family pdb chain": 1 "single nucleotide polymorphism id": 1 "cl?": 1 "hcc": 1 "crystal structures": 1 "polymorphism 1": 1 "ship-1 and ship-2 interacting proteins": 1 "interdivision time h": 1 "disease": 1 "homo sapiens prostaglandin-endoperoxide synthase 2 prostaglandin g/h synthase a": 1 "plasma membrane": 1 "homo sapiens aha1 activator of heat shock 90kda protein atpase homolog 1 yeast": 1 "surface analysis hydrophobicity profiles 3-d cluster analysis residue conservation": 1 "nr_024151.1": 1 "em_newak030698 mus musculus 10 day": 1 "core survival pathway s inhibited…": 1 "cellular localization": 1 "gene chromosomal location": 1 "outcome of interaction": 1 "?intraresidue": 1 "residues": 1 "c-s-zn 107°": 1 "human/mice": 1 "tumor selectivity": 1 "1.59e-05 0.00562257": 1 "?-? stacking": 1 "obs.": 1 "jtt-705": 1 "common *": 1 "3.18e-06": 1 "seeding technique": 1 "major signaling molecules": 1 "rmsd å": 1 "experimental model": 1 "t ? s kcal/mol": 1 "1983": 1 "recognition sequence": 1 "ca2+": 1 "repression ***": 1 "histologic type": 1 "cytokines produced": 1 "itk qd 525/655 nh2-peg": 1 "annealing temp 0°c": 1 "1.35±0.11": 1 "fda approval": 1 "surface modification": 1 "hgg": 1 "priming residue kinase": 1 "unknown": 1 "2843": 1 "dendrotoxin-1 dtx-1": 1 "1994": 1 "0.0461742": 1 "gabaa receptor subunit": 1 "chain": 1 "tgfbr2": 1 "loss of detectable alk rearrangement": 1 "nm_000692.3": 1 "early gestation": 1 "molecular function": 1 "drop size": 1 "c-n-zn 125°": 1 "nutrient": 1 "homo sapiens dna-damage-inducible transcript 3 ddit3 mrna.": 1 "molecules co-involved in cancer cell invasion": 1 "hspa1a": 1 "hspa1b": 1 "regulatory subunit": 1 "ras fig 5 121pa": 1 "major functions": 1 "abtb2 rnf126": 1 "hspa1l": 1 "uch": 1 "1539": 1 "combination": 1 "prostate cancer cells": 1 "cys–gln–his–asp": 1 "genome position": 1 "pore forming subunit": 1 "7.20e-06": 1 "gene designation": 1 "homo sapiens claudin 12 cldn12 mrna.": 1 "caco-2 apical to basolateral efflux ratio": 1 "compund id": 1 "primer name": 1 "elisa": 1 "ddx43 exosc9 eprs": 1 "pany material": 1 "1.21?±?0.19": 1 "1542": 1 "kcat/km s?1m?1": 1 "best result": 1 "trf1": 1 "?": 1 "em_humak000921 homo sapiens cdna for flj10059": 1 "?": 1 "cancer cells / mouse modells": 1 "therapeutic application": 1 "0.00044493": 1 "ensembl": 1 "significantly mutated domain instance": 1 "nm_002155.3": 1 "cks1 binding domain mutations": 1 "activated/memory": 1 "reference s": 1 "4 allosteric cooperativity": 1 "histone h3 residue": 1 "binding affinity and use": 1 "process": 1 "end position": 1 "2.21e-06": 1 "ion charge": 1 "1-hexadecene": 1 "reservoir volume": 1 "number of s/tp sites": 1 "nm_181702.1": 1 "n input genes": 1 "prrs": 1 "interaction": 1 "hco3?": 1 "glab/gst-gli1zf k340a/k350a": 1 "receptor protein": 1 "complementation group": 1 "race p-value": 1 "noninteracting disc1 constructs": 1 "annealing temperature": 1 "ambiguous": 1 "?? ? bound– ? free": 1 "0.786": 1 "expression in t-cell subsets": 1 "?snp": 1 "unique id": 1 "normalized docking score": 1 "tj proteins": 1 "mirna sequence": 1 "nanoparticle": 1 "em_musak129314 mus musculus mrna": 1 "aliases commonly used aliases in bold": 1 "route": 1 "196 947": 1 "7.0": 1 "7.3": 1 "relative": 1 "7.6": 1 "pdb code": 1 "7.7": 1 " b": 1 "cellular functions": 1 "em_est human hela cell 5? cdna est clone aa180335": 1 "e-value": 1 "region of tau involved": 1 "ankrd26 interacting region aa residues": 1 "lectin": 1 "associated protein": 1 "1b all probe sets 1444": 1 "em_humaf521671 homo sapiens swi/snf": 1 "ensembl gene id": 1 "mll interaction site": 1 "interacting partners": 1 "structural location": 1 "stress response": 1 "d distance violations >0.5 å": 1 "philadelphia": 1 "erbb2 homodimer": 1 "unique subfamily features": 1 "abtb2 pbrm1": 1 "kog2733 suncharacterized membrane protein 1/2": 1 "rump angle1": 1 "hb-hdacis": 1 "0.000437924": 1 "ang ii peptide": 1 "binding curve fit": 1 "length of product bp": 1 "ergic3": 1 "cds position": 1 "core set": 1 "55.7": 1 "homo sapiens cytochrome p450 family 24 subfamily a polypeptide 1 cyp24a1 n": 1 "primers 5'- 3'": 1 "ct comparison": 1 "slimpred score": 1 "cycle study 20 most stably expressed": 1 "0.0 ": 1 "701": 1 "lym": 1 "nohnh": 1 "?-cd-l-arg": 1 "parameter value": 1 "allelic": 1 "0.0 ± 0.0": 1 "foxd1": 1 "down": 1 "edc reaction": 1 "product length": 1 "sst4": 1 "sst5": 1 "hp1?": 1 "kog0658 gglycogen synthase kinase-3 1/8": 1 "?gds": 1 "? h obs kcal/mol": 1 "homo sapiens heat shock 70kda protein 7 hsp70b hspa7 non-coding rna.": 1 "nucleotide alteration": 1 "sst2": 1 "sst3": 1 "pathways": 1 "position 2": 1 "sst1": 1 "target genes": 1 " absorbance": 1 "cys–his–asp": 1 "em_humak074940 homo sapiens cdna": 1 "729": 1 "em_est mouse mammary gland 5?cdna est aa709949": 1 "cdocker interaction energy cie kcal/mol": 1 "putative functions": 1 "dcaf": 1 "papp × 10?6 cm s?1": 1 "region number": 1 "glucose transport isoforms": 1 "company": 1 "3' utr": 1 "region in brca1 aa": 1 "kog0739 oaaa+-type atpase 1/4": 1 "length": 1 "function/identity of binding partner": 1 "hk family member": 1 "material": 1 "742": 1 "allele": 1 "similarity over bp": 1 "kog0734 oaaa+-type atpase containing the peptidase m41 domain 1/8": 1 "nm_004354.1 nm_031966.2": 1 "initial contacts": 1 "band size": 1 "??": 1 "bag3": 1 "sirna": 1 "variants": 1 "non viral ligands": 1 "target protein": 1 "scatchard analysis": 1 "1 establish protein–protein interaction": 1 "residues involved in charge interactions": 1 "somatic gene mutation": 1 "light chain": 1 "homo sapiens protein phosphatase 1 regulatory inhibitor subunit 15a ppp1r15a": 1 "757": 1 "sense strand 5?->3?": 1 "exons": 1 "topology": 1 "catalog no .": 1 "rho q63l": 1 "genome and structure": 1 "classification": 1 "chol": 1 "oligonucleotide": 1 "heavy": 1 "6 functional oligomer status in action": 1 "annealing temp.": 1 "3.1": 1 "em_estau117440 homo sapiens cdna clone": 1 "p-value*": 1 "2b representative probe sets 544": 1 "3.9": 1 "em_humaf259792 homo sapiens p250r": 1 "status": 1 "0.00378565": 1 "deubiquitinating enzymes dubs": 1 "??????without the gaaa tetraloop": 1 "c51s/c118s": 1 "tight junction": 1 "mg2+": 1 "product bp": 1 "binding constant": 1 " occupied": 1 "binding affinity ic50 nm": 1 "scaffold": 1 "key domains motifs": 1 "kog0751 cmitochondrial aspartate/glutamate carrier protein aralar/citrin contains ef-hand ca2+-binding domains 1/1": 1 "position a": 1 "kinetic": 1 "6418": 1 "homo sapiens heat shock 70kda protein 1a hspa1a mrna.": 1 "inheritance": 1 "kog3098 suncharacterized conserved protein 1/2": 1 "s-zn 2.3 å a": 1 "flanking sequence": 1 "cellular adhesion": 1 "function of the molecule": 1 "gccontent ": 1 "logd": 1 "usp": 1 "ref .": 1 "arg146 bonding": 1 "host": 1 "baits": 1 "7757": 1 "nm_002632.4": 1 "calculated": 1 "nm_012129.2": 1 "km for methionine": 1 "nm_000927.3": 1 "????bonds å": 1 "?medium range 2 ? |i-j| ? 4": 1 "average coverage": 1 "size bp": 1 "homo sapiens placental growth factor pgf mrna.": 1 "em_inv af053091 drosophila melanogaster eyelid gene": 1 "73.3": 1 "b_rotation res 4 11": 1 "deaf1 c": 1 "0.000380118": 1 "log fold change": 1 "5120": 1 "pdb complex with ras protein": 1 "interacting genes/toxins": 1 "yb-1 domain": 1 "5123": 1 "source/catalogue#": 1 "abundance": 1 "effective against": 1 "interaction partner or substrate": 1 "apoptosis": 1 "clinical association references": 1 "?additional allowed regions": 1 "kog0727 o26s proteasome regulatory complex atpase rpt3 2/10": 1 "?gexp b": 1 "stable to reducing agents": 1 "orf binding b": 1 "proteins activated/up-regulated": 1 "arsenical": 1 "k d": 1 "mrna decay half-life h": 1 "clinical feature": 1 "minimum number of binding sites per gene": 1 "dub": 1 "homo sapiens solute carrier family 31 copper transporters member 2 slc31a2": 1 "leukemia cells": 1 "em_humaf265208 homo sapiens swi snf complex": 1 "accession no": 1 "total length bp": 1 "rna binding": 1 "dgtp": 1 "nomenclature": 1 "target sites": 1 "flexible ligand docking grid or explicit receptor representations mc minimization": 1 "band": 1 "amhara high pbs tail cut-off": 1 "proton": 1 "genomic location": 1 "initial ranking": 1 "tfa2a binding site score threshold": 1 "mhc": 1 "candidate tf": 1 "gds sensitivity": 1 "mrna": 1 "position of interrogated cpgs*": 1 "free energy sum": 1 "2nd line": 1 "estimated stoichiometry ": 1 "-2.0": 1 "?1 domain": 1 "number of cases": 1 "-2.6": 1 "processing": 1 "-2.7": 1 "homo sapiens baculoviral iap repeat-containing 3 birc3 transcript variant 1": 1 "-2.1": 1 "? g kcal/mol": 1 "nm_000963.1": 1 "-2.3": 1 "dna binding activity fold-change from control": 1 "23": 1 "mass kda": 1 "components": 1 "24": 1 "pdb codes *": 1 "facs": 1 "base change": 1 "experimental mass": 1 "reference accession number 3": 1 "377": 1 "long-range |i?j|?5": 1 "narada": 1 "32": 1 "mjd": 1 "adhesion": 1 "sec of monomer": 1 "location pdb": 1 "prognosis": 1 "a59g": 1 "em_humal591545 human dna sequence": 1 "#lig tors": 1 "0.009?±?0.000": 1 "hspb8": 1 "dfc clustering": 1 "abcb1": 1 "effector t cell": 1 "pitative regulatory protein": 1 "dna in tail±se": 1 "memory t-cell": 1 "direct effect on t cells": 1 "heptamer seed": 1 "generously allowed ": 1 "42": 1 "junction": 1 "45": 1 "binding factor": 1 "kog4431 runcharacterized protein induced by hypoxia 1/2": 1 "data source": 1 "49": 1 "aldh1b1": 1 "processing form": 1 "substrate/mmp-9 source": 1 "hspa7": 1 "hspa6": 1 "hydrophobic": 1 "50": 1 "51": 1 "copy number variations": 1 "53": 1 "em_estcd630360 flp homo sapiens": 1 "54": 1 "55": 1 "59": 1 "cbm sequences and location aromatic positions emboldened": 1 "cyp24a1": 1 "phosphorylated": 1 "medium-range |i?j|<5": 1 "mlr": 1 "most favoured ": 1 "regulator": 1 "c-o-zn 125°": 1 "69": 1 "ion score": 1 "amhara pbs tail cut-off": 1 "pubmed ids *": 1 "mrna levels": 1 "adherens junction": 1 "520 331": 1 "m-apo": 1 "definition": 1 "76": 1 "1.09e-05": 1 "template structure used for modeling": 1 "surface complex #/cell": 1 "pike isoform": 1 "alternative names": 1 "structure mechanism of interaction": 1 "probe sequences": 1 "lmo4lim2•deaf1404–418 c": 1 "formula": 1 "y32c": 1 "codon change": 1 "s-zn-n 107°": 1 "cldn12": 1 "n-succinimidyl iodoacetate and 2-iminothiolane reaction": 1 "putative target gene s": 1 "ic50 ?mol/l p110? p110? p110? p110?": 1 "loss": 1 "human orthologue": 1 "dctp": 1 "rad ?c": 1 "atomic rmsd å": 1 "structural signalling": 1 "94": 1 "0.00859784": 1 "wt rhoc": 1 "dttp": 1 "0.00116056": 1 "region coordinates": 1 "peptide rank": 1 "anatomical site": 1 "adj p -value": 1 "homo sapiens bcl2-associated athanogene 3 bag3 mrna.": 1 "blocking capacity ": 1 "activator": 1 "homo sapiens heat shock 70kda protein 1-like hspa1l mrna.": 1 "?generously allowed regions": 1 "type of qd": 1 "dppc": 1 "3814": 1 "correlated mrna expression profiles correlated elution domain fusion patterns automated literature mining": 1 "identity": 1 "frequency †": 1 "1637": 1 "size mm": 1 "?> 0.5 å": 1 "bovine thigh muscle gene af045073": 1 "foxo4": 1 "cell line/band": 1 "nucleus": 1 "expression level and site": 1 "hexamer seed": 1 "subunit": 1 "0.0388166": 1 "cog0149 gtriosephosphate isomerase 3/2": 1 "0.0158406": 1 "18.0 ± 3.2": 1 "genes of interest": 1 "fertility": 1 "0.000758471": 1 "growth/proliferation both positively or negatively": 1 "atp binding": 1 "0.00210428": 1 "bond angles °": 1 "ligands binding": 1 "pairwise all heavy atom rmsd from average structure å": 1 "differences human - > mouse": 1 "mascot score": 1 "2992": 1 "hydrogen bond acceptors": 1 "dock subfamily": 1 "nucleotide substitution": 1 "associated genes": 1 "percentile 1": 1 "initial tm dimer structure": 1 "lxr sites": 1 "pcr cycles": 1 "applied agent": 1 "posttranslational": 1 "fold-change st362 vs control": 1 "3.66e-06": 1 "em_humak025945 homo sapiens cdna flj22292": 1 "constant*": 1 "in structure": 1 "protein size amino acids": 1 "expression/reference": 1 "nm_001013251.1": 1 "interaction type": 1 "hydrogen bond donors": 1 "target identification": 1 "0.0044504": 1 "0.000113939": 1 "molecular weight g/mol": 1 "birc3": 1 "rasgrp1 c1 domain": 1 "growth suppression": 1 "6 ligand docking": 1 "8.1": 1 "netmatch": 1 "kb × 105 m?1": 1 "kog0003 jubiquitin/60 s ribosomal protein l40 fusion 31/16": 1 "?gele a": 1 "sequence 5' ? 3'": 1 "?einternal": 1 "targeted mechanism": 1 "1 perturbation event at the allosteric site": 1 "affymetrix": 1 "rf s?1": 1 "bound energy": 1 "procheck–ramachandran statistics all": 1 "substrate functions": 1 "homo sapiens solute carrier family 7 cationic amino acid transporter y+ syste": 1 "0.891": 1 "atf3": 1 "?backbone": 1 "scna": 1 "yeast protein": 1 "disallowed ": 1 "cryo solution": 1 "promoter binding region": 1 "extracellular region": 1 "n-zn 2.0 å a": 1 "hyaluronic acid": 1 "bond distance": 1 "0.0125 ± 0.0004": 1 "0.000579055": 1 "hdac family": 1 "data set": 1 "soluble form pg/ml": 1 "western blot": 1 "ztf": 1 "mutation/ polymorphism": 1 "trials": 1 "dihedral angle restraints b": 1 "im-treated k562 cells 38 ": 1 "accessory domains in noncatalytic form": 1 "genetic modification": 1 "primer sequence": 1 "rasgrp3": 1 "controls": 1 "glab/gst": 1 "microarray fold-change umi/uvm": 1 "intramolecular association": 1 "motif rank": 1 "site number": 1 "833": 1 "834": 1 "rab 2fola": 1 "human homolog": 1 "histone h4 residue": 1 "virtual signature class": 1 "dna binding site": 1 "0.64 ± 0.11 å": 1 "0.493±0.018": 1 "5 location of functional site": 1 "0.0361717": 1 "direct regulators": 1 "protein alteration": 1 "cleavage ": 1 "volume": 1 "primary site": 1 "affinity peptide-mhc": 1 "fold-changes": 1 "egfr": 1 "healthy liver": 1 "this study": 1 "0.00883196": 1 "binding site on rock": 1 "6.92e-07": 1 "suppression by flo8": 1 "t1/2": 1 "oligonucleotide sequence 5?–3?": 1 "amino acid replacement": 1 "na+": 1 "aff": 1 "copy number increase": 1 "inflection point": 1 "1.8?±?1.0": 1 "assay type": 1 "polar surface area å2": 1 "detection level": 1 "em_est human fetal liver 5? cdna est clone n73163": 1 "amino acid change": 1 "significance": 1 "diameter ?m ": 1 "er/golgi": 1 "ligand atom e": 1 "4.0": 1 "ligand atom f": 1 "detected": 1 "pathway/process": 1 "4.6": 1 "total number of restraints": 1 "age": 1 "4.9": 1 "shaft": 1 "deviations from idealized covalent geometry": 1 "assays": 1 "typical ligand": 1 "carbohydrate": 1 "number": 1 "additionally allowed ": 1 "c80s": 1 "property": 1 "kaikobase id": 1 "structural data supporting interaction": 1 "jamm": 1 "kog0329 aatp-dependent rna helicase 3/8": 1 "crossing": 1 "conserved in mouse": 1 "kog0332 aatp-dependent rna helicase 2/6": 1 "aggregates": 1 "0.00318131": 1 "mitochondrial derived-damp molecule": 1 "oocytes n": 1 "kog0936 uclathrin adaptor complex small subunit 1/6": 1 "lyrm domain amino acid residue start–end": 1 "top1": 1 "top2": 1 "shcd/egfr": 1 "894": 1 "identifiera": 1 "kog0731 oaaa+-type atpase containing the peptidase m41 domain 1/9": 1 "co-located variation": 1 "?gpolar": 1 "1.4 ": 1 "homo sapiens heat shock 70kda protein 1b hspa1b mrna.": 1 "heat map": 1 "interactions receptor residue ?interacting protein residue": 1 "analogue": 1 "hugo id": 1 "cacg": 1 "lncap *": 1 "protein binding": 1 "cell-ecm interaction": 1 "1056 ?31/nt": 1 "upstream pathway s": 1 "binding site volume å3": 1 "ras cluster": 1 "t09": 1 "1.18?±?0.19": 1 "expression region": 1 "??????without the adenine bulge": 1 "1.4838 ± 0.0399": 1 "product size": 1 "nm_004281.3": 1 "predicted binding site for": 1 "human cfs": 1 "target characterization": 1 "0.99?±?0.24": 1 "steady state ss": 1 "em_humaf521670 homo sapiens swi/snf": 1 "ncbi name": 1 "100.5": 1 "blosum 62": 1 "integrin subunit": 1 "ligand specificity": 1 "nucleotide changes": 1 "muc-1 as1411 tta1": 1 "expression domain embryo": 1 "end nt": 1 "homo sapiens cyclin g2 ccng2 mrna homo sapiens cyclin b1 ccnb1 mrna": 1 "c/s": 1 "approximate frequency ": 1 "pfam domains": 1 "enriched seed": 1 "0.00147967": 1 "450": 1 "hla-a2 subtype": 1 "itsn2": 1 "itsn1": 1 "dock protein": 1 "surface ?m 2": 1 "identified phosphatase": 1 "target class": 1 "effector rbd": 1 "histological analyses of chicken liver samples": 1 "nm_005938.2": 1 "467": 1 "nhp": 1 "469": 1 "number of snvs": 1 "ccng2 ccnb1": 1 "-3.6": 1 "-3.1": 1 "-3.2": 1 "ring": 1 "copy number decrease": 1 "qds 605655705 -cooh": 1 "pml domain": 1 "0.39?±?0.08": 1 "l pneumophila lgts": 1 "primer pair": 1 "homo sapiens solute carrier family 44 member 2 slc44a2 mrna.": 1 "genbank accession#": 1 "destabilizing conditions": 1 "apo": 1 "position peptide": 1 "chemical name": 1 "binding of e 3": 1 "binding of e 1": 1 "binding of e 2": 1 "483": 1 "p-tyr site": 1 "general cytosol nm": 1 "distribution tissue/cell": 1 "hydrogen bond restraints": 1 "energy minimization graphic modelling": 1 "interaction site in mutyh": 1 "peptides": 1 "homo sapiens activating transcription factor 3 atf3 transcript variant 4 mrn": 1 "490": 1 "conjugation/modification method": 1 "morphine": 1 "a shp-1 sirna target sequences": 1 "human protein": 1 "endpoint": 1 "domains of docks for interaction": 1 "homo sapiens gtp binding protein overexpressed in skeletal muscle gem transcript.": 1 "interaction in pulldown": 1 "gab1": 1 "backbone": 1 "gab2": 1 "gab3": 1 "em_est ai439094 nci_cgap kid11 homo ti87a06.x1": 1 "at2": 1 "his–asp–zn 2+": 1 "no filter": 1 "regulated genes": 1 "?sequential |i-j| = 1": 1 "biological effect": 1 "ion precursor": 1 "3 modeling protein–protein interaction": 1 "cog0451 mgnucleoside-diphosphate-sugar epimerases 3/4": 1 "hdac enzyme": 1 "hugo": 1 "stature1": 1 "mrna stability": 1 "em_est human testis i 5? cdna est clone aa383798": 1 "binding region": 1 "protein domain": 1 "n target genes": 1 "blast homology region": 1 "segment": 1 "overall survival": 1 "em_humaf268913 homo sapiens osa1": 1 "strain energy": 1 "reported mrna targets": 1 "nanomaterials": 1 "g1/s transition module": 1 "dgc member": 1 "cpg sites": 1 "parameters": 1 "bcl2l1 exosc9 lamb1 smcr7l pbrm1 eprs rnf126": 1 "3 dominant thermodynamic factor": 1 "level-2 atc description": 1 "ta °c": 1 "em_musac084826 genomic sequence": 1 "non": 1 "preferential activation": 1 "full-length wt ras": 1 "o-zn 2.03 å a": 1 "gdf15": 1 "1.85?±?0.12": 1 "pkc?": 1 "foci": 1 "allele substitution": 1 "hypo": 1 "race": 1 "cohort and lineage": 1 "physicochemical property": 1 "ec50 egfr nm": 1 "0.0136702": 1 "homolog common name a": 1 "em_new af219114 homo sapiens chromatin remodeling": 1 "related neurological diseases": 1 "morphine +tat": 1 "source of purification": 1 "blastocysts day 7 ": 1 "p3b": 1 "p3a": 1 "cdte/cds -cooh": 1 "tissue": 1 "t thermophilus obg as template": 1 "????maximum noe violations å": 1 "experimental": 1 "nm_001040619.1": 1 "base pair planarity restraints": 1 "diffusion coefficient d 10 -4 ?m 2 /s": 1 "state cycle sc": 1 "target renal loci": 1 "dlipc": 1 "hexadecanoic acid": 1 "nm_012111.1": 1 " b residues conserved within bch domains": 1 "+gds": 1 "study": 1 "subcellular localization": 1 "peptide sequences": 1 "pheophorbide a?": 1 "rigid-body docking energy minimization side-chain refinement flexible docking": 1 "human chromosome position": 1 "gain": 1 "vehicle": 1 "fgfr isoform": 1 "residues involved in h-bond formation": 1 "em_est rs6253 rat pc-12 ngf-treated cdna h34625": 1 "nm_014365.2": 1 "ref amino acid": 1 "ions csf/plasma": 1 "hct-116 *": 1 "nm_020428.2": 1 "?2 domain": 1 "kog0001 orubiquitin and ubiquitin-like proteins 31/16": 1 "homo sapiens growth differentiation factor 15 gdf15 mrna.": 1 "organization": 1 "egf-stimulated mcf-10a cells 19 ": 1 "nm_014330.2": 1 "silgf-ir": 1 "ligand atom": 1 "caax motif": 1 "section": 1 "slc7a11": 1 "hdms": 1 "solvation \documentclass 10pt{article} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{pmc} \usepackage euler{upgreek} \pagestyle{empty} \oddsidemargin -1.0in \begin{document} \begin{equation*} {\delta}g_{{\mathrm{pb}}}+{\delta}g_{{\mathrm{sa}}}\end{equation*}\end{document}": 1 " refs": 1 "conserved in gab1": 1 "refs.": 1 "number of matches": 1 "hyper": 1 "em_humab033061 homo sapiens mrna for kiaa123": 1 "strain": 1 "homo sapiens forkhead box d1 foxd1 mrna.": 1 " il-15 ng/ml": 1 "survival": 1 "lead discovery and optimization": 1 "gene s": 1 "0.00430455": 1 "fold-change meb55 vs control": 1 "8.86e-05": 1 "slc31a2": 1 "9.2": 1 "suppression by cks1 overexpression": 1 "sptpgap": 1 "em_htgac094993 rattus norvegicus clone": 1 "remark": 1 "finish position bp": 1 "donor": 1 "effects in dn": 1 "amhara high mr tail cut-off": 1 "slc44a2": 1 "elisa binding": 1 "pfam domain remarks": 1 "gpi/crgd": 1 "enzyme": 1 "glab/gst-gli1zf": 1 "?long range 4 < |i-j|": 1 "kog0934 uclathrin adaptor complex small subunit 1/6": 1 "genome-wide": 1 "comments references": 1 "adapter molecules": 1 "kd nm": 1 "proposed name": 1 "3.87e-05": 1 "target gene": 1 "cog5272 oubiquitin 31/16": 1 "interaction partners": 1 "bppb peptide": 1 "cdc24p ste4p interaction": 1 "pdb single domain": 1 "complex": 1 "rank": 1 "nm_000782.3": 1 "structural element": 1 "aa": 1 "2681": 1 "product com": 1 "2679": 1 "79.8": 1 "plant": 1 "hela intracellular": 1 "method enzymatic": 1 "number of ‘attta’ motif": 1 "selectivity over mtor": 1 "renal phenotype": 1 "viability": 1 "0.0184042": 1 "0.0001284": 1 "resolution å": 1 "2684": 1 "relevant information": 1 "domains participating in swap events d1 <--> d2": 1 "ca": 1 "charge": 1 "pairwise rmsd secondary structure c ": 1 "cytosol": 1 "sift prediction score": 1 "cdse -cooh": 1 "2220": 1 "interacting hes/hey domain": 1 "consensus binding motif": 1 "?all heavy atoms": 1 "receptor activated": 1 "cytokines/ signaling": 1 "promoter binding a": 1 "naive": 1 "dc": 1 "potential pocket": 1 "0.506": 1 "nonwater entropy \documentclass 10pt{article} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{pmc} \usepackage euler{upgreek} \pagestyle{empty} \oddsidemargin -1.0in \begin{document} \begin{equation*} -t{\delta}s\end{equation*}\end{document}": 1 "mean deviations from the ideal geometry": 1 "1.53e-05": 1 "zinc ii angle restraints b": 1 "mus musculus": 1 "antibodies": 1 "fused domain": 1 "957": 1 "growth factors": 1 "amino acid sequence at a specific position": 1 "2243": 1 "species 1": 1 "ev": 1 "s-zn-o 102°": 1 "1387": 1 "2234": 1 "putative functional murine": 1 "ship-2 interacting proteins": 1 "phosphorylation site motif": 1 "description of domain d2": 1 "41211": 1 "description of domain d1": 1 "????angles °": 1 "interacting atom from the c-domain of sace": 1 "spot no.": 1 "rate": 1 "activation domain hybrid": 1 "3.6 -2.1": 1 "nm_004472.2": 1 "long non-coding rna": 1 "attractors": 1 "cdse/znse -cooh": 1 "mad of semet derivative": 1 "ecv304 cells": 1 "dna binding domain hybrid": 1 "h-ras": 1 "experimental localization *": 1 "form": 1 "500": 1 "1.43e-05": 1 "dna binding": 1 "binding affinity kcal/mol": 1 "native isopeptide bond 1": 1 "laminin a3 lg45 heparin binding sites": 1 "microarray fold-change umii/uvm": 1 "cdna library": 1 "kog0923 amrna splicing factor atp-dependent rna helicase 1/2": 1 "nitrated peptide": 1 "transcription": 1 "blood element": 1 "abtb2 bcl2l1 exosc9 lamb1 pbrm1 tro": 1 "ppp1r15a": 1 "wsn": 1 "178 015": 1 "tumor + cox-2 sirna state": 1 "animals": 1 "517": 1 "kog0004 jubiquitin/40s ribosomal protein s27a fusion 31/16": 1 "k+": 1 "kog0266 rwd40 repeat-containing protein 3/5": 1 "?gsol": 1 "endothelial cell surface receptors/activator": 1 "0.000245971": 1 "metal": 1 "ugua n aua *": 1 "gene id": 1 "em_humak074940 homo sapiens cdna flj90459": 1 "vhl gene region": 1 "em_humaf219114 homo sapiens chromatin remodeling": 1 "affinity filter": 1 "percentage astrocytic expression": 1 "kog0005 doubiquitin-like protein 31/16": 1 "sensitisation": 1 "large clostridial toxins": 1 "entropy": 1 "532": 1 "533": 1 "description backbone": 1 "535": 1 "em_humaf265208 homo sapiens swi-snf": 1 "method non-enzymatic": 1 "0.0212245": 1 "protein docking site or other known function": 1 "????internucleotide noes n n ?+?1": 1 "correlated transcripts": 1 "iapv nc_009025": 1 "0.00419823": 1 "10 601": 1 "kog0925 amrna splicing factor atp-dependent rna helicase 1/2": 1 "off": 1 "target residue s": 1 "3rd line": 1 "em_humak027655 homo sapiens cdna flj14749": 1 "associated pathogenesis": 1 "molecule type": 1 "nm_005345.4": 1 "551": 1 "binding domain": 1 "amino acid mutation": 1 "method used for identification": 1 "158.7": 1 "helix": 1 "charge interactions": 1 "mr": 1 "gene ms": 1 "biomarkers": 1 "restrictions": 1 "mw": 1 "????intranucleotide noes": 1 "nucleotide sequence 5??3? sense/anti-sense": 1 "entry": 1 "mode of re-stimulation": 1 "????long range noes n n ?+? m m ?>?1": 1 "dilution": 1 "silkdb id": 1 "1.4": 1 "km ?m": 1 "enzymatic antioxidant": 1 "0.000290977": 1 "z score": 1 "nk": 1 "loss/gain of function": 1 "p1": 1 "methy": 1 "p2": 1 "cbm location": 1 "cellular location": 1 "analysis of “hot-spots” surface cavities": 1 "alt amino acid": 1 "pheophorbide a": 1 "total": 1 "amino acid number": 1 "subtype": 1 "p -value": 1 "0.94?±?0.26": 1 "s-zn-s 112°": 1 "gene interaction": 1 "fiber modification": 1 "?eelectrostatic": 1 "kog0881 ocyclophilin type peptidyl-prolyl cis-trans isomerase 6/12": 1 "kcat s?1": 1 "on": 1 "nm_001024847.1": 1 "wt ras": 1 "colony color": 1 "m kda": 1 "consensus sites ttn 4–6aa": 1 "tail length±se": 1 "persistent presence of alk rearrangement": 1 "function/biological effect": 1 "0.0294943": 1 "similarity with": 1 "factor p-value": 1 "a start nt": 1 "titer mg/l": 1 "rna segment protein": 1 "pt": 1 "kog0730 oaaa+-type atpase 3/10": 1 "grantham": 1 "12.0 ": 1 "isoform specificity": 1 "bcl2l1 smcr7l": 1 "em_est aa709949 mouse mammary gland t92d01.r1": 1 "ramachandran statistics d": 1 "length bp": 1 "sequence of binding region / mab epitope mapping": 1 "h-bond number": 1 "nm_004864.1": 1 "c51s": 1 "cdse/cds/zns n- 2-aminoethyl-6 8-dimercaptooctanamide amine-dhla": 1 "nm_001860.2": 1 "mutant": 1 "amino-acid substitution": 1 "location at diagnosis": 1 "enhancer": 1 "4077": 1 "activity": 1 "specific antagonists": 1 "gtpase superfamily subdivisions": 1 "3?-utr position": 1 "nm_005346.3": 1 "??????without the asymmetric internal loop": 1 "sd": 1 "current": 1 "138": 1 "specificity": 1 "ddit3": 1 "vector": 1 "conservation status": 1 "t-cell phenotype": 1 "semet sad": 1 "regulatory roles": 1 "svm": 1 "aa change": 1 "hmts": 1 "running time s": 1 "149": 1 "gef domain 3": 1 "location relative to atg": 1 "t or b cell distribution": 1 "total dihedral angle restraints talos a": 1 "kv structure": 1 "0.00147308": 1 "bcl2l1 exosc9 gpr68": 1 "152": 1 "frequency": 1 "erk kinase module": 1 "7.45e-05": 1 "156": 1 "kinases": 1 "methylation status": 1 "angioinhibitor": 1 "?ggas": 1 "details": 1 "up": 1 "em_est human neuronal 5?cdna est clone aa243104": 1 "homo sapiens heat shock 22kda protein 8 hspb8 mrna.": 1 "query": 1 "activation 3": 1 "no of patients": 1 "mitochondrion": 1 "regulated gene names": 1 "body depth1": 1 "aa position": 1 "growth on leu? medium": 1 "tumor types": 1 "embryonic nuclei n": 1 "membranous form positive cells": 1 "biochemical presentation": 1 "kog0543 ofkbp-type peptidyl-prolyl cis-trans isomerase 3/1": 1 "potential energy \documentclass 10pt{article} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{pmc} \usepackage euler{upgreek} \pagestyle{empty} \oddsidemargin -1.0in \begin{document} \begin{equation*} {\delta}e_{{\mathrm{mm}}}\end{equation*}\end{document}": 1 "evidence for a direct interaction with mll": 1 "anacetrapib": 1 "torsion angle restraints": 1 "prey groups": 1 "interaction type reference": 1 "pbs *": 1 "em_humaf468300 homo sapiens brg1-b": 1 "arf 1hurab": 1 "wt": 1 "c protein mg/ml": 1 "cases": 1 "expression domain": 1 "?evdw": 1 "interaction effect": 1 "0.00238603": 1 "drosophila model": 1 "targeted by hdaci?": 1 "ran 1l2ma": 1 "jin-3": 1 "binding **": 1 "jin-2": 1 "jin-1": 1 "rho 1a2ba": 1 "cell cycle regulation": 1 "ligand + u0126": 1 "ddr pathway": 1 "+ste18p": 1 "kog4604 suncharacterized conserved protein 1/2": 1 "2701": 1 "phospho-siteplus": 1 "morphogenic effect": 1 "experimental mutation of cbm": 1 "chromo-some": 1 "effect of phosphate": 1 "receptor 2": 1 "receptor 1": 1 "relative binding affinity for igfs": 1 "bcl2l1 ddx43 exosc9 ctdspl pbrm1 tro": 1 "microarray fold change": 1 "preys binding region frequency": 1 "amino acid residues aa": 1 "comb": 1 "confirmed ‡": 1 "14.1": 1 "otu": 1 "gene category": 1 "molecular mass": 1 "1.9898 ± 0.2513": 1 "blocker": 1 "metal ion binding": 1 "start position bp": 1 "1.49e-05": 1 "chr position": 1 "gem": 1 "conservation a": 1 "protein name": 1 "homo s apiens forkhead box o4 foxo4 mrna.": 1 "rangtp rmsdchain å": 1 "em_humaf253515 homo sapiens baf250": 1 "?impropers": 1 "m/z": 1 "c181s/c184s": 1 "cnloh": 1 "homo sapiens solute carrier family 3 activators of dibasic and neutral amino ac": 1 "average odds of regulation": 1 "0.0371505": 1 "interaction location": 1 "plexinb1cyto – rac1* complex": 1 "section of sequence alignment a numbers indicate amino acid residues 22 ": 1 "homo sapiens transforming growth factor beta receptor ii 70/80kda tgfbr2 t": 1 "elements": 1 "torcetrapib": 1 "kinetic rate law": 1 "kog0737 oaaa+-type atpase 1/6": 1 "function in cancer": 1 "mib/mib2": 1 "ensembl display": 1 "time weeks": 1 "accessory domains removed": 1 "kon": 1 "kog0549 ofkbp-type peptidyl-prolyl cis-trans isomerase 3/2": 1 "noe violations >0.3?å": 1 "ship-1 interacting proteins": 1 "other binding proteins": 1 "inhibitor": 1 "egfr peptide sequencea": 1 "datp": 1 "adenovirus": 1 "ahsa1": 1 "1.20?±?0.23": 1 "gene/bta": 1 "tap": 1 "effector binding proteins": 1 "sirna sequence": 1 "receptors": 1 "interaction p-value": 1 "tat": 1 "slc3a2": 1 "??/? angles for each amino acid": 1 "braf mutations": 1 "hela cells": 1 "gem core": 1 "homo sapiens chemokine c-c motif ligand 3-like 3 ccl3l3 mrna.": 1 "immune/inflammation response": 1 "2 locate interface": 1 "nm_014331.3": 1 "ccl3l3": 1 "0.00297397": 1 "nm_001001437.3": 1 "corrected p": 1 "het.": 1 "homo sapiens atp-binding cassette sub-family b mdr/tap member 1 abcb1 mrn": 1 "protein - nucleotides interactions": 1 "domain d1": 1 "tfap2a-regulated genes": 1 "domain d2": 1 "23.3": 1 "23.1": 1 "paris": 1 "c118s ras": 1 "ctdspl rnf126": 1 "lmo4 c": 1 "confirmation of structural integrity of mutant": 1 "mrna orientation": 1 "bcl2 family members": 1 "?> 0.3 å": 1 "molecule commercial name": 1 "role of phosphorylation": 1 "h-bonding": 1 "2 b": 1 "assay": 1 "2 extent of conformational change at the substrate site": 1 "position in the protein sequence": 1 "cdse/zncds cysteine": 1 "product company": 1 
"reference": 104 "gene": 73 "p-value": 59 "p value": 52 "1": 51 "?": 46 "n": 44 "up": 42 "down": 42 "negative": 41 "positive": 37 "name": 36 "p -value": 35 "fold change": 33 "p": 32 "references": 31 "number": 28 "?": 27 "genotype": 27 "total": 25 "gene name": 25 "no": 23 "description": 23 "high": 23 "treatment": 22 "low": 22 "2": 21 "institution": 20 "+": 19 "accession number": 19 "recipients": 19 "f": 18 "cell type": 18 "tumor type": 17 "gene symbol": 17 "3": 16 "variable": 16 "all": 16 "cell line": 16 "0": 15 "p -value *": 15 "method": 15 "symbol": 15 "characteristics": 14 "group": 14 "population": 14 "no of cases": 13 "iv": 13 "characteristic": 13 "ref.": 13 "mirna": 13 "m": 12 "csa": 12 "yes": 12 "antibody": 12 "wald ?2": 12 "hr 95ci": 12 "frequency": 12 "": 11 "variables": 11 "pi": 11 "kinase": 11 "source": 11 "no.": 11 "# correctly classified samples": 11 "amino acid change": 11 "accuracy ": 11 "species": 10 "type": 10 "function": 10 "no ": 10 "age": 10 "sample": 10 "protein name": 10 "stage": 9 "cancer type": 9 "minimal to mild": 9 "oletf": 9 "wild type": 9 "type of study": 9 "specificity": 9 "mutation": 9 "0800-0845": 9 "groups": 9 "case": 9 "4": 8 "expression": 8 "58": 8 "fold": 8 "n ": 8 "na": 8 "disease": 8 "overall survival": 8 "p21": 8 "liver": 8 "gene id": 8 "ref": 8 "exon": 8 "protein": 8 "tissue type": 8 "6": 7 "8": 7 "result": 7 "a": 7 "risk genotype/allele": 7 "microrna": 7 "study": 7 "ii": 7 "mean": 7 "polymorphism rs": 7 "compound": 7 "or p value1": 7 "control": 7 "p a": 7 "subjects with type 2 diabetes n ": 7 "egfr": 7 "strong": 7 "snp": 7 "nucleotide change": 7 "sensitivity": 7 "tac": 7 "5": 6 " survival": 6 "caucasian": 6 "chromosome": 6 "12 h": 6 "p -value a": 6 "parameter": 6 "absent": 6 "0.000": 6 "strain": 6 "author": 6 "study population": 6 "german": 6 "sample size": 6 "animal model": 6 "expression a": 6 "present": 6 "ratio": 6 "cytoplasmic": 6 "parameters": 6 "tissue": 6 "5 y ": 6 "—": 6 "severely decreased": 6 "lof": 6 "ouabain": 6 "nuclear": 6 "pathway": 6 "p22": 6 "classification results in the test set": 6 "cases": 6 "location": 6 "drug": 6 "exposure": 6 "hr 95 ci": 6 "accession no.": 6 "number of cases": 6 "outcome": 6 "type of cancer": 6 "48 h": 6 "results": 6 "target": 6 "rnai": 6 "k+-free medium": 6 "sem": 6 "model": 6 "-": 5 "k": 5 "comments": 5 " rr": 5 "41": 5 "study type": 5 "a blazei": 5 "0.016": 5 "0.033": 5 "0.006": 5 "main limitations": 5 "transcription factor": 5 "patients n ?=?94": 5 "or": 5 "wt": 5 "classification results in loocv": 5 "pedigree": 5 "or 95  ci": 5 " n?=?13": 5 " 33 ": 5 "controls n ?=?114": 5 "? grade 3": 5 "ethnicity": 5 "95 ci": 5 "genotype or allele": 5 "g frondosa": 5 "iii": 5 "gene symbol title": 5 "histology": 5 "kras": 5 "positive rate ": 5 "weak": 5 "negative ": 5 "individual": 5 "abbreviation": 5 "reference s": 5 "mod": 5 "p11": 5 "main strengths": 5 "npv": 5 "0800-0900": 5 "phenotype": 5 "ppv": 5 "— <<0.1": 5 "tumor": 5 "both": 5 "patient": 5 "sex": 5 "high expression": 5 "mutation type": 5 "response": 5 "7": 4 "?": 4 "i": 4 "r": 4 "chr": 4 "genes": 4 "cell lines": 4 "rpmm": 4 "entrez gene name": 4 "author published year reference no.": 4 "12": 4 "14": 4 "16": 4 "17": 4 "19": 4 "male": 4 "22": 4 "34": 4 "agent": 4 "51": 4 "63": 4 "no of cases /controls": 4 "correlations with clinicopathological features": 4 "0.014": 4 "0.001": 4 "fdr": 4 "mw": 4 "mapk1": 4 "dilution": 4 "methylation status": 4 "report number of cases and grades": 4 "os months": 4 "affymetrix id": 4 " 36 ": 4 "time": 4 "parametric p-value": 4 "survival analysis": 4 "nutritional status": 4 "clone": 4 "probe id": 4 "positive negative ": 4 "antibody used": 4 "< 0.001": 4 "histological type": 4 "g lucidum": 4 "log phase": 4 "citation": 4 "diploid tumors": 4 "condition": 4 "diabetic": 4 "dose": 4 "human": 4 "delivery route": 4 "type of regulation": 4 "source of controls": 4 "female": 4 "ttp months": 4 "side effects": 4 "mechanism": 4 "immunostaining percentage": 4 "refs.": 4 "origin": 4 "mutant": 4 "country": 4 "no of patients": 4 "v1/2 mv": 4 "p -value fisher's exact test": 4 "120 h": 4 "rpd3 s": 4 "rpd3 l": 4 "common name": 4 "ngf type and dosage": 4 "other correlations": 4 "standard error": 4 "or 95 ci**": 4 "diabetic+ins": 4 "2006": 4 "sample id": 4 "?2": 4 "polymorphism": 4 "other": 4 "spot number": 4 "redox stress reduction": 4 "quality control of genotyping": 4 "number of contigs": 4 "100": 4 "category": 4 " ": 3 "*": 3 "9": 3 "c": 3 "s": 3 "tokyo women's medical university institute of gastroenterology assistant": 3 "mutation frequency per 100 bp": 3 "shared edges": 3 "cancer": 3 "fold of activation/inhibition": 3 "findings": 3 "pqq?": 3 "cytoband": 3 "+4-pba": 3 "24 h": 3 "type of chemo": 3 "d5w 0.9 saline": 3 "tzd": 3 "tissue microscopic lesion": 3 "unknown": 3 "3 9": 3 "day": 3 "?": 3 "3 h": 3 "relative risk or odds ratio 95 confidence interval": 3 "braf": 3 "forked": 3 "company": 3 "0.35": 3 "0.54": 3 "construct": 3 "patient id": 3 "status": 3 "0.72": 3 "sin3 kd i a": 3 "fold-change": 3 "topotecan oxaliplatin": 3 "intensity": 3 "10": 3 "15": 3 "36": 3 "39": 3 "45": 3 "49": 3 "52": 3 "11 42": 3 "60": 3 "64": 3 "68": 3 "72": 3 "number of matched peptides": 3 "registration": 3 "mascot score": 3 "sin3 kd ii a": 3 "bac number": 3 "prostate adenocarcinoma": 3 "fold change 2": 3 "?grade 3": 3 "chr location": 3 "localization": 3 "0.028": 3 "pqq+/?": 3 "0.019": 3 "0.011": 3 "0.012": 3 "0.010": 3 "0.013": 3 "0.041": 3 "singed": 3 "0.031": 3 "400?µm": 3 " no of events = 25": 3 "0.009": 3 "0.005": 3 "chip expression": 3 "type of mutation": 3 "probe set": 3 "effect": 3 "virus": 3 "spot no.": 3 "no observed": 3 "ns": 3 "os": 3 "ihcs": 3 "sd": 3 "o.ooi": 3 "number of patients": 3 "tumour type": 3 "0.9saline d5w": 3 "associated functions": 3 "expression value a": 3 "in vitro": 3 " 37 ": 3 "gis1rph1-wt": 3 "total no.": 3 "low expression": 3 "oxaliplatin topotecan": 3 "7.8": 3 "gene rank top ": 3 "moderate/ strong ": 3 "smad4": 3 "gene copy no.": 3 "loss of heterozygosity": 3 "no of peptides matched": 3 "5 19": 3 "800?µm": 3 "preparation": 3 "value": 3 "8.9": 3 "controls": 3 "tumor incidence": 3 "frequency ": 3 "number ofcell lines": 3 "1st - 2nd probe id": 3 "refs": 3 "mass da": 3 "subcellular localization": 3 "fold of activation or inhibition - by k+-free medium/p value": 3 "600?µm": 3 "homozygous tt genotype in recipients associated with enhanced incidence of acute rejection.": 3 "case #": 3 "?renal fibrosis": 3 "progression-free survival": 3 "all grade": 3 "mitogen-activated protein kinase kinase 1": 3 "microarray": 3 "adjusted or a 95ci": 3 "mouse strain": 3 "n a": 3 "fold of activation by": 3 "oxaliplatin 0.9 saline": 3 "product": 3 "leto": 3 "4 12": 3 "rph1-wt": 3 "various cancers": 3 "study reference": 3 "mild to moderate": 3 "0.9 saline oxaliplatin": 3 "no 2": 3 "no 1": 3 "no 6": 3 "no 5": 3 "no 4": 3 "no 3": 3 "differentiation": 3 "average degree difference": 3 "breast": 3 "genomic location": 3 "negative/weak ": 3 "mir": 3 "sponsor exhibition": 3 " cv support": 3 "sequence": 3 "mws": 3 "culture condition": 3 "pqq?/+": 3 "mitogen-activated protein kinase 1": 3 "pten": 3 "positive rate": 3 "map2k1": 3 "promoter": 3 "fold of activation or inhibition - by ouabain/p value": 3 "positive samples": 3 "vector": 3 "adjusted or": 3 "region": 3 "25 39": 3 "+cyclosporine a": 3 " seq cover": 3 "no of mice": 3 "all cases": 3 "or 95 ci a": 3 "bone marrow hypocellularity": 3 "percent": 3 "uniprot accession number": 3 "pqq treatment group fold change relative to pqq+": 3 "2013": 3 "t-value": 3 "abcb1": 3 "sequence coverage ": 3 "event": 3 "subnetwork and overlap": 3 "mrna fold change": 3 "rbp": 3 "data set": 3 " 95 ci a": 3 "mss 2": 3 "percentage": 3 "t -test p": 3 "msi-h 2": 3 "number and cases": 3 "134": 3 "normal": 3 "range": 3 "gis1-wt": 3 "cg number": 3 "identified protein gene": 2 "updated-state": 2 "b": 2 "g": 2 "t": 2 "positive ": 2 "in silica": 2 "2 fasl": 2 "0-10": 2 "uniprot kb/swiss-prot acc number": 2 "positive n?=?210 ": 2 "colorectal cancer": 2 "s.no": 2 "101–200 weak": 2 "cdna sequence": 2 "flt3": 2 "fluo": 2 "219": 2 "a thaliana orthologue": 2 "treatment type": 2 "cdc42 expression": 2 "10-20": 2 "duration of chase": 2 "fap fold change from progenesis control=1": 2 "targeted disease": 2 "start": 2 "short": 2 "s no.": 2 "shr #": 2 "low grade": 2 "pma b": 2 "n-fold change control transfected": 2 " no of patients = 155": 2 "breslow generalized wilcoxon": 2 " no of patients = 164": 2 "potentially relevant therapies": 2 "concentration": 2 "wild type ": 2 " +": 2 "log odds": 2 "number negative percentage": 2 "10 asa classes": 2 "immune effects": 2 " n": 2 "rate constant 1 ?/h": 2 "journal": 2 "ph range specific unique no.": 2 "percentage of tunel": 2 "maximum": 2 "under": 2 "follow-up range in months": 2 "age years": 2 "0.23": 2 "0.34": 2 "col-cre egfr wa5/f": 2 "a gene encoding a member of the map kinase family known as extracellular signal-regulated kinases erks which act as an integration point for multiple biochemical signals and are involved in a wide variety of cellular processes such as proliferation differentiation transcription regulation and development": 2 "0.45": 2 "0.40": 2 "0.41": 2 "0.38": 2 "0.36": 2 "0.56": 2 "directionality": 2 "0.52": 2 "0.50": 2 "alleles": 2 "average contig length bp": 2 "0.63": 2 "0.60": 2 "0.61": 2 "0.71": 2 "interferon regimen duration in weeks": 2 "308": 2 "that have a direct myc binding site": 2 "40-50": 2 "?-catenin": 2 "vaginal cancer": 2 "1+": 2 "11": 2 "regulator of pars": 2 "13": 2 " n°": 2 "lymphocytes": 2 "mrna": 2 "2+": 2 "21": 2 "23": 2 "minor allele in nci60 panel number of alleles * ": 2 "11 46": 2 "3+": 2 "32": 2 "38": 2 "z-score": 2 "43": 2 "47": 2 "toptecan followed by oxaliplatin": 2 "huvec": 2 "adjusted a or 95 ci": 2 "53": 2 "56": 2 "rate of hcc n/n": 2 "61": 2 "62": 2 "66": 2 "67": 2 "common": 2 "71": 2 "74": 2 "78": 2 "11 20": 2 "2009–": 2 "87": 2 "gene set name n1": 2 "97": 2 "mutated by sseq ": 2 "ratio b": 2 "functional categories": 2 "low ": 2 "censored survivors": 2 "p linteus": 2 "nr of assigned spectra": 2 "pathogen": 2 "infiltration or metastasis": 2 "accession numbers": 2 "empiric": 2 "year": 2 "egl": 2 "aslna ": 2 "d5w topotecan": 2 "cd44 negative": 2 "stage at diagnosis": 2 "specif": 2 "msh2": 2 "this study": 2 "msh6": 2 "mss tumors": 2 "end": 2 "vpc": 2 "0.029": 2 "0.022": 2 "accession no or reference": 2 "omim no.": 2 "0.020": 2 "age of schizophrenia diagnosis": 2 "weak ": 2 "0.017": 2 "0.015": 2 "+/?": 2 "0.044": 2 "egfr status metastases": 2 "0.042": 2 "0.048": 2 "0.049": 2 "0.046": 2 "0.047": 2 "theoretical mw": 2 "mating of wild type": 2 "0.037": 2 "type of study focal or global ischemia": 2 "# of up's *": 2 "vul": 2 " no of events = 35": 2 " no of events = 32": 2 "on day 118": 2 "0.002": 2 "453": 2 "chromosomal aberrations": 2 "nonsynonymous+nonsense+frameshift": 2 "in vitro cell type": 2 "non methylation": 2 "493": 2 "antisense to mrna": 2 "emt correlation t -statistic": 2 "theoretical pi": 2 "latency time for tumor development days *": 2 "cystic fibrosis": 2 "5 9": 2 "opc *** ": 2 "annealing temperature °c": 2 " all diff reg .": 2 "membranous": 2 "statistics": 2 "total insertions": 2 "berberine": 2 "chromosome location": 2 "stable disease": 2 "intermediate": 2 "1354": 2 "gene and exon": 2 "protein description": 2 "cs": 2 "agonist for tlr 9": 2 "df": 2 "log rank mantel-cox": 2 "nuclear membrane": 2 "12677g>t/a": 2 "fc": 2 "fe": 2 "cpc ** ": 2 "rescued ability ": 2 "official symbol a": 2 "10 29": 2 "topotecan d5w": 2 "70-80": 2 "percentage of ki67 positive cells": 2 "averaged tumour size mm": 2 "gene accession no.": 2 "nd": 2 "syndecan-4 positive tumour cells": 2 "control nacl": 2 "pl": 2 "n°": 2 "pt": 2 "p value a": 2 "100+3d": 2 "percentile ": 2 "donors": 2 "d5w followed by topotecan": 2 "tf": 2 "48hrs/0hr": 2 "ti": 2 "rin1 ?/? ": 2 "overall rank": 2 "va": 2 "minor allele frequency in sensitive cell lines number of alleles * ": 2 "vv": 2 "hela": 2 "phase": 2 "source or reference": 2 "ges": 2 "normal eggs laid a": 2 "colony stimulating factor 1 receptor": 2 "sens": 2 "2d gel ph range": 2 "mitotane with a blood level 14–20?mg/l": 2 "mutated by aslna ": 2 "spearman rs": 2 "factors": 2 "ser ": 2 "no of tissue sample cancer/normal": 2 "probability of yy ": 2 "egfr positive ": 2 "?f ms": 2 "accurancy": 2 "gps": 2 "number of enriched genes": 2 "614": 2 "no pos ": 2 "approach": 2 "cell strain": 2 "no fasl": 2 "641": 2 "clinical and pathological associations in gi cancers": 2 " n?=?14": 2 " n?=?17": 2 "human homologue": 2 "bone metastases in mice": 2 "names": 2 "delta viability": 2 "or 95 ci": 2 "cox-2": 2 "age of cancer diagnosis": 2 " 35 ": 2 "full name": 2 "iiia": 2 "upregulation": 2 "function s of protein": 2 "# analyzed": 2 "complete name": 2 "geom mean of intensities in chordoma": 2 "cervical cancer": 2 "hd1": 2 "hd3": 2 "hd2": 2 "7 h": 2 "10 33": 2 "whole series": 2 "15.0": 2 "resolution limits å": 2 "ce-sox": 2 "rel fold change ": 2 "high ": 2 "difference in alteration frequency": 2 "resolution range å": 2 "dssp asa values": 2 "first quartile low lmo4 expression # tumors ": 2 "log-rank p -value": 2 "strong ": 2 "mirna family": 2 "current-state": 2 "ptp type": 2 "probability of xx ": 2 "kin17 expression": 2 "aliases commonly used aliases in bold": 2 "cluster 0 probability": 2 "par-4": 2 "active component": 2 "recipients/donors": 2 "par-1": 2 "par-2": 2 "par-3": 2 "lbfc": 2 "percent methylated": 2 "codon": 2 "geom mean of intensities in blood": 2 "day 0": 2 "chr.": 2 "753": 2 "number of singletons": 2 "# of paths": 2 "colony number sd": 2 "codon 12": 2 "gene name in array hg-u133 plus 2.0": 2 "1–100 trace": 2 "average coverage": 2 "number of mutations": 2 "virus type": 2 "nacl followed by oxaliplatin": 2 "96hrs/0hr": 2 "2006–present": 2 "voltage dependence of activation": 2 "6 hpf": 2 "encodes a member of the claudin family which includes integral membrane proteins and components of tight junction strands that serve as a physical barrier to prevent solutes and water from passing freely through the paracellular space between epithelial or endothelial cell sheets and also play critical roles in maintaining cell polarity and signal transductions": 2 "16.2": 2 "comment": 2 "unadjusted p value": 2 "kras mut b ": 2 "iia": 2 "percentage of reduction versus no cr addition": 2 "15 21": 2 "24hrs/0hr": 2 "have drug": 2 "validated by": 2 "egfr status primary tumors": 2 "sseq ": 2 "pool": 2 "claudin 7": 2 "16.000": 2 "endo-cardium": 2 "itd": 2 "# of proteins": 2 "rascal ii 21 ": 2 "stage of cancer during sampling": 2 "odds ratio": 2 "er +": 2 "3 asa classes": 2 "application": 2 "chemical name": 2 "percentage of autophagy": 2 "codon_k13": 2 "c-huh7": 2 "clinicopathological features": 2 "time of administration": 2 "20-30": 2 "fourth quartile high lmo4 expression # tumors ": 2 "rate constant 2 ?/h": 2 "human chromosome position": 2 "a stage_tnm_simpl = ii": 2 "clone name mrna": 2 "pmoles": 2 "gene s": 2 "9.3": 2 "jpa": 2 "lin28 expression low": 2 "q value": 2 "sub-type": 2 "spot id": 2 "all n": 2 "50-60": 2 "time h": 2 "wky #": 2 "downregulation": 2 "compounds type": 2 "961": 2 "day 5–8": 2 "t-huh7": 2 "2005–present": 2 "false": 2 "flt3-itd status": 2 "type‡ host gene host strand": 2 " 64 ": 2 " 65 ": 2 "lung": 2 "biological process b": 2 " 66 ": 2 "masatoshi kudo md phd": 2 "e15.5": 2 "gfap": 2 "matrigel™ invasion": 2 "1992–1996": 2 "sample specific p -value": 2 "receptor": 2 "minor allele": 2 "patient group": 2 "complete response ": 2 "late stage of diabetes": 2 "p-value *": 2 "variant": 2 "sig p_value": 2 "p-value 2": 2 "pg101": 2 "arbitrary relative intensity a": 2 "rec 1": 2 "rec 2": 2 "controls n=200 ": 2 "48 hpf": 2 "p-value c": 2 "p-value b": 2 "24?h": 2 "mnv ±sd": 2 "professor of research icrea bclc group liver unit hospital clínic barcelona professor of medicine director division of liver diseases mount sinai school of medicine new york": 2 "site": 2 "protein source": 2 "liver and other cancers": 2 "aa/ab/bb a": 2 "papillomas ": 2 "q-value": 2 "5.926": 2 "epi-cardium": 2 "no of leukemogens": 2 "number of samples": 2 "cytology a": 2 "1997–2004": 2 "control d5w": 2 "completeness ": 2 "301–400 strong": 2 " 74 ": 2 "pmpmease staining intensity n ": 2 " 75 ": 2 " 77 ": 2 " 78 ": 2 "72 hpf": 2 "pds phase": 2 "michiie sakamoto": 2 "imip": 2 "comparison": 2 "half-life": 2 "e18.5": 2 "technique": 2 "? no": 2 "protein sequence": 2 "type of tissue": 2 "dataset": 2 "overall": 2 "total n": 2 "pakt": 2 "1987": 2 "experimental model": 2 "loh": 2 "1996": 2 "1994": 2 "1999": 2 "lr+": 2 "lr-": 2 "# of gliomas": 2 "combination": 2 "100?mg/m2": 2 "oxaliplatin followed by nacl": 2 "at 2r": 2 "mild": 2 "fold change array": 2 "number of reads": 2 "partial methylation": 2 "topotecan followed by d5w": 2 " 85 ": 2 "relevant histological subtypes": 2 "chi-square": 2 "egfr negative ": 2 "at 1r": 2 "cell/organism tested in": 2 " 87 ": 2 "chemotherapy": 2 " 88 ": 2 "20 67": 2 "20 36": 2 "test of equality of survival distributions for the different levels of codon_k13.": 2 "number of annotated genes": 2 "no 8": 2 "no 7": 2 " ?": 2 "strength of evidence for clinical use*": 2 "reference no .": 2 "deceased": 2 "module": 2 "isoform": 2 "experts": 2 "start site": 2 "median fold change": 2 "lpaat- ? -positive": 2 "fdr q-val": 2 "±sd": 2 "space group": 2 "genistein": 2 "cells": 2 "codon change": 2 "crkl up-regulated": 2 "size mb": 2 "csf1r": 2 "small eggs laid a b": 2 "biomarker": 2 "catalog number": 2 "muv": 2 "crkl down-regulated": 2 " 91 ": 2 "copa value": 2 " 92 ": 2 "none reported": 2 "gene product": 2 "upper confidence interval 95": 2 "early phase only up-regulated mechanistic genes": 2 "itgb1": 2 "401–500 very strong": 2 "decreased": 2 " 95 ": 2 "overlap with mrna": 2 "p *": 2 "10 hpf": 2 "dbsnp id rs number": 2 "significance": 2 "mct02 ihc result": 2 "ltr positive": 2 "fms-related tyrosine kinase 3 ligand": 2 "amplicon size bp": 2 "nes": 2 "ncbi name": 2 "site of cancer": 2 "x-fold change": 2 "negative staining": 2 "ptk2": 2 "p19": 2 "kras wt a ": 2 "voltage dependence of inactivation": 2 "sample name": 2 "cnis": 2 "gnai3": 2 "lentivirus": 2 "total cases": 2 "median survival time months": 2 "fraction of samples methylated": 2 "duration days": 2 "in vivo animal mode": 2 "cycles": 2 "marker": 2 "moderate ": 2 "b-gal fold change": 2 "focal adhesion kinase expression": 2 "t-bhp * nmol": 2 "burden": 2 "fold change compared to control": 2 "logistic regression for prediction of neck nodal metastasis #": 2 "class": 2 "0.999": 2 "30-40": 2 "peaks": 2 "3 12": 2 "ligand": 2 "library": 2 "mean scores": 2 "oocytes laid a c": 2 "2.31": 2 "in coding region": 2 "diagnosis": 2 "24 hpf": 2 "code": 2 "2.72": 2 "fraction ": 2 "egfr dsk5/+": 2 "number positive percentage": 2 "onc": 2 "positive staining": 2 "no of genes": 2 "type of tumour": 2 "possible proteins": 2 "mlh1": 2 "total clones": 2 " n?=?34": 2 "recovery from inactivation": 2 "md-fraction": 2 "clonogeniccapability": 2 ">30": 2 "samples": 2 "# of other phenotypes": 2 "exposure mode": 2 "d-fraction": 2 "13 54": 2 "adenovirus": 2 "line": 2 "author reference": 2 "log2 fold change": 2 "wild": 2 "sample size treatment group/control group": 2 "cd44 positive": 2 "test type": 2 "no amplifiable dna": 2 "event free survival": 2 "n-fold change anti-mir transfected": 2 "average read length bp": 2 " 106 ": 2 "number of mice analyzed": 2 " 103 ": 2 "stage b": 2 "indication": 2 " 102 ": 2 "ove442": 2 "latency": 2 "number of cell division": 2 "invasive ssc or spindle cell carcinoma ": 2 "observed effects": 2 "pmn": 2 "line of treatment": 2 "catenin beta 1": 2 "validation by pcr": 2 "minimal": 2 "in vivo tumour growth analysis": 2 "2011–present": 2 "fdr_bh": 2 "snp id affy.": 2 "p450": 2 "mrna target and effect": 2 "chisq": 2 "crude or 95 ci": 2 "cell number": 2 "major allele": 2 "protein tyrosine kinase 2": 2 "mmse": 2 "rac1 expression": 2 "end site": 2 "josep m llovet md": 2 "chinese": 2 "2012": 2 "?hypoxia resistance of rcc cells": 2 "2011": 2 "2009": 2 "2008": 2 "2007": 2 "c-met": 2 "rascal i 18 ": 2 "no reported": 2 "lin28 expression high": 2 "area under mlc activation curve with respect to different time range time unitmin": 2 "partial response ": 2 "true": 2 "60-70": 2 "partial response": 2 "flt3lg": 2 "tunel positive": 2 "cldn7": 2 "randomized placebo-controlled": 2 "prognosis": 2 "minor allele frequency in resistant cell lines number of alleles * ": 2 "time point": 2 "201–300 intermediate": 2 "fabp7": 2 "geom mean of intensities in class 1": 2 "geom mean of intensities in class 2": 2 "31 91": 2 "early stage of diabetes": 2 "retrovirus": 2 "integrin": 2 "sequence coverage": 2 "cases n=125 ": 2 "e coli o157h7": 2 "score": 2 "total no of cases ": 2 "n-fold change": 2 "8hrs/0hr": 2 "0 0": 2 "2012–present": 2 "fold change log 2 mean": 2 "professor and chairman department of hepatology and gastroenterology kinki university school of medicine president kinki university medical center": 2 "p value*": 2 "a stage_tnm_simpl = i": 2 "no drug": 2 "gene description": 2 "p values": 2 "mlc activation curve": 2 "reference or source": 2 "spot": 2 "n evaluable": 2 "1.79": 2 "vocal cord dysfunction": 2 "extensive methylation": 2 "whole series 1": 2 "whole series 2": 2 "accession": 2 "amino acid coverage ": 2 "1000-1800": 2 "0.7": 2 "0.8": 2 "disease model": 2 "cyclin d1": 2 "grade": 2 "ctnnb1": 2 "12 19": 2 "department of pathology keio university school of medicine": 2 "array id": 2 "auc": 2 "chromosomal localization": 2 "component of mirnps repression of translation": 2 "gnaq": 2 "oxaliplatin followed by topotecan": 2 "er ?": 2 "?s ms": 2 "lpaat- ? -negative": 2 " of total": 2 "database": 2 "mir name": 2 "break point": 2 "age/sex": 2 "pattern number": 2 "high grade": 2 "number of animals": 2 "phen": 2 "urothelial cell carcinoma": 2 "swiss-prot accession no.": 2 "streptozotocin": 2 "over": 2 "crystalline structure": 2 "97.3": 2 "sox": 2 "simvastatin 20 mg/day": 2 "1.9": 2 "cancer/metastatic tumor": 2 "8 cell": 2 "angii": 2 "counts": 2 "total megabases": 2 "tissues": 2 "133": 2 "135": 2 "136": 2 "number of unique reflections": 2 "cd47": 2 "159": 2 "papillomas with early local invasion ": 2 "7 10": 2 "mo/m?": 2 "ucrna": 2 "lower confidence interval 95": 2 "affymetrix probe set id": 2 "in vivo": 2 "n of events": 2 "expression of pars": 2 "subcutaneous tumor growth in mice": 2 "2 h": 2 "study cohort": 1 "prospective studies with incident cases for diabetes especially at lower exposure ranges": 1 "germline mutations": 1 "interior staining": 1 "pedigree id": 1 "activated at 3 d by gis1 c": 1 "nm_020750": 1 "30 100": 1 "effect of knockdown on ack anti-apoptotic activity": 1 "numberof births": 1 "association in cancer": 1 "doxorubicin": 1 "atp2b4": 1 "variable *": 1 "lifespan data from figure 2": 1 "#": 1 "chronic antidepressants change neuroplasticity cellular resilience and synaptic plasticity": 1 "displasia foldchange": 1 " response": 1 "psychosocial and emotional factors": 1 "associate professor of medicine medical university of vienna vienna austria": 1 "accession #": 1 "director sasaki foundation": 1 "alk no mutation at 2p23 increased number suggesting polysomy chromosome 2": 1 "hr range b/min": 1 "gene name description": 1 "1419736_a_at": 1 "latency days": 1 "t lymphocytes are found in follicular lymphoid aggregates": 1 "10.3": 1 "cds": 1 "sensitivity in breast cancer": 1 "amplicon": 1 "?2 increase in cell size – introduction of g1 phase in the cell cycle? 143.": 1 "secondary mutations of imatinib resistance 90 93 – 97": 1 "14.15 – 15.30": 1 " of mice with tumor necrosis": 1 "5854.7": 1 "38±7*": 1 "hin-1 / rassf1a panel": 1 "in cosmic†": 1 "?fgfr3": 1 "d": 1 "e": 1 "preferential inclusion of splice variants 4": 1 "h": 1 "cfn": 1 "bq205672": 1 "above lp": 1 "l": 1 "effect of fulvestrant 200 nm on growth ¶": 1 "han a": 1 "q": 1 "orhet 95ci b": 1 "investigator award of the japan society of hepatology": 1 "?rb protein": 1 "100 everolimus 10 mg by mouth daily taken consistently at same time and with or without food": 1 "32.3?±?0.9*": 1 "u": 1 "v": 1 "ecdysone dependency": 1 "tumors fusion is present in": 1 "extensive methylation ?10": 1 " malformed nc": 1 "inhaled foreign bodies": 1 "cgn": 1 "b a p-78-dione-dade": 1 "functions/effects": 1 "rs11599672 cases/controls": 1 "1 chain a": 1 "cha": 1 "type of study ref": 1 "p53 mutation": 1 "c-huh7f": 1 "number of individuals / bacteriomes sampled and pooled quantity of rna used from samples ": 1 "ep receptor": 1 "658/2750 = 23.92": 1 "location of amplicon proviral locus 2": 1 "suppresses cell viability via ampk-induced hsp70 and egfr downregulation": 1 "methylated at u1and d1": 1 "no of ns mutations": 1 "chromosomal locus": 1 "scf if": 1 "tgf-?1 pg/ml": 1 "neural": 1 "oncogene s expressed": 1 "type of cell death": 1 "# of mice with tumors ": 1 "sara": 1 "estimated new cases in the united states in 2012": 1 "functional category": 1 "cis": 1 "csa/tac": 1 "locus link": 1 "provider": 1 "upregulation of igfbp-1 expression reduction in circulating free igf-1": 1 "genomic signature/dlda": 1 "may 2000": 1 "multiple": 1 "lfire-1": 1 "s.n.": 1 "cgggcgggcgc t agggaggg t": 1 "number of clones mutated+nonmutated": 1 "disease characteristic": 1 "healthy adults n": 1 "ncoa1": 1 "asd gene count": 1 "ccbl ? zap70 ? ccbl": 1 "total count": 1 "tmd": 1 "adc a n=20": 1 "lecturer/assistant professor kyoto university school of medicine dept of gastroenterology and hepatology": 1 "r -factor ": 1 "fms-related tyrosine kinase 3 1": 1 "mir-155": 1 "total ": 1 "induces apoptosis in ht-29 colon cancer cells via the ampk/cox-2 pathway": 1 " codon mutation a amino acid change": 1 "555.6": 1 "reducing iron overload and subsequent oxidative stress induced via elevated ferritin.": 1 "ser/thr kinases b": 1 "angiogenesis": 1 "adenylate cyclase 8": 1 "arterial and venous thromboembolic phenomenon": 1 "sequence name 1": 1 "0.9795": 1 "aris101": 1 "associated with hyperplasic polyposis with increased incidence in serrated adenomas like kras germ-line mutation in the cardiofaciocutaneous syndrome": 1 "women": 1 "15 53.6": 1 "ashm frequency": 1 "2004–": 1 "non—small cell lung carcinoma": 1 "presence or absence in viruses of the whole domain fusion events": 1 "stage of methylation": 1 "redundancy": 1 "2-6": 1 "percentage of cases found": 1 "types of mutations found in codon 12 a": 1 "cgggcgggcgcgagggaggg t": 1 "usually good prognosis": 1 "genbank acc no.": 1 "hm1imss colon/hm1imss culture": 1 "asian": 1 "number int sites": 1 " of expressed": 1 "genbankaccession no.": 1 "gastro-oesophageal reflux": 1 "phase 1": 1 "coc": 1 "2.5": 1 "2.6": 1 "sequence conservation and location on structure": 1 "ki-67 index or tnm stage": 1 "b or t cell": 1 "mir-181": 1 "markers": 1 "pinch1 fl/fl": 1 "against total promoser database": 1 "molecular weight kda": 1 "agggagggcgctgggaggaggg": 1 "number of hres upstream of start site": 1 "no of snps in pathway": 1 "molar ratio": 1 "#bkz hdfs with function": 1 " p5.pxx and/or p7.pxx": 1 "total snps after algorithm filtering": 1 "genotype or description": 1 "logarithm of the odds lod score": 1 "negative n?=?452 ": 1 "enrichment p -value": 1 "tra": 1 "dead/dosed": 1 "location of metastasis": 1 "induces proliferation and survival capacity when overexpressed in bone marrow progenitor cells 78 ": 1 "flt1": 1 "entrez id": 1 "relative attenuation of tgf-?-dependent smad3/4-specific transcriptional response": 1 "high foxo3": 1 "paxtools software": 1 "infusion site": 1 "tsa": 1 "identify animal models appropriate for arsenic-induced diabetes": 1 "72.1": 1 "type of physician": 1 "stress type": 1 "differential expression/functional significance of glycolipids": 1 "213": 1 "acute myeloid leukemia": 1 "tss": 1 "pfam domain": 1 "2126.0": 1 "t22b3.2": 1 "neurotrophins": 1 "direction": 1 "bdnf mrna": 1 "genetic susceptibility related to both response to arsenic and diabetes": 1 "ngf-induced neurites b": 1 "borda rank": 1 "csf": 1 "effect on nash/fibrosis/inflammation": 1 "haplotype 2677g-3435c in donor kidney associated with lowered incidence of nephrotoxicity.": 1 "p-value bonferroni corrected": 1 "mode of action": 1 "japan": 1 "number of cetuximab cycles": 1 "234": 1 "b1286045": 1 " 155 ": 1 "?-catenin of control": 1 "dna-dna and dna-protein crosslinks": 1 "hepatic steatosis hepatitis": 1 "ic50 ?m ? or inhibition ": 1 "tnm a": 1 "activating mutation in the braf serine–threonine kinase a downstream mediator of signaling through the raf–mek–erk1/2 pathway which mimics the biologic consequences of kras mutation": 1 "type of change": 1 "microrna-206 expression": 1 "negative n ?=? 499 ": 1 "leukocyte migration": 1 "independent prognostic factor": 1 "transitions over transversions": 1 "csnk2b": 1 "ratio of area": 1 "2246.2": 1 "242": 1 "encodes a member of the peptidyl-prolylcis-trans isomerase ppiase family ppiases catalyze the cis-trans isomerization of proline imidic peptide bonds in oligopeptides and accelerate the folding of proteins.": 1 "transduction efficiency luciferase activity of ad.luc.rgd over ad.luc": 1 " 156 ": 1 "symbol/description": 1 "genea": 1 "small intestine": 1 "ap-1": 1 "high staining": 1 "human disease": 1 " 153 ": 1 "254": 1 "invasion front": 1 "erbb2 ": 1 "down val": 1 "specimens no ": 1 "counteracts monocytopoiesis 54 ": 1 " iv novel drug design and texting in cellular and experimental hypertensive models": 1 "transfected cdna": 1 "nuclear hif-1? expression": 1 " 154 ": 1 "control animals—normal healthy controls received olive oil 0.5?ml orally by gastric intubation for 21 days daily": 1 "fusions of chromosomes": 1 "nutlin response": 1 "encodes the receptor for the tachykinin neuropeptide substance k also referred to as neurokinin a nk this neurokinin 2 nk2 receptor is a member of the tachykinin family of g-protein-coupled receptors the nk2 receptor is predominantly expressed in the periphery gastrointestinal smooth muscle nk2 receptors are thought to mediate gastrointestinal contraction and airway and lung function.": 1 "golgi proteins tested": 1 "cuticle score in apc2 single mutant": 1 "263": 1 "nakayama cancer research institute scholarship": 1 "1424638_at": 1 "lunch provided and poster viewing.": 1 "?1 resumption of symmetric mitotic division.": 1 "polymorphism a": 1 "ra a": 1 "age at onset range within family": 1 "levels of uncomplexed ?-catenin": 1 "similar to mouse similar to signal peptidase": 1 "molecular mechanism s of pten alteration": 1 "average ic50 ?m across all cell-lines": 1 "270": 1 "processing of pri-mirna into pre-mirna": 1 "276": 1 "lon protein expression": 1 "carbon source": 1 "ptrend": 1 "other mutations": 1 "281": 1 "284": 1 "?5 resistance to genotoxins – expression of multidrug resistance genes? 192 193.": 1 "staining scorea": 1 "differential rab7 expression levels reported in the oncomine database prostate cancer": 1 "ca2+ overload": 1 "variales": 1 " p5.px and p6.px": 1 "7 negative": 1 "3.4 mds/mpn unclassifiable": 1 "pprom vs ptb": 1 "transplantation-related mortality ": 1 " v investigation of exercise and other alternative strategies in hypertension attenuation.": 1 "293": 1 "2.1.3 essential thrombocythemia et": 1 "encodes a member of the epidermal growth factor egf receptor family of receptor tyrosine kinases": 1 "c-myc of control": 1 "sample µg": 1 "encodes a cytoskeletal protein that anchors actin to a variety of intracellular structures": 1 "marker or gene": 1 "guanine nucleotide binding protein g protein q polypeptide": 1 "sample #": 1 "unmethylated": 1 "wine reception / presentation of prizes / meeting close.": 1 "downregulated mirna": 1 "fold change in frequency": 1 "f 1": 1 "axin2 of control": 1 "a hdacs histone deacetylases": 1 "second gene refseq accession number": 1 "encodes the alpha chain of the interleukin-4 receptor a type i transmembrane protein that can bind interleukin 4 and interleukin 13 to regulate ige production the encoded protein also can bind interleukin 4 to promote differentiation of th2 cells receptor for both interleukin 4 and interleukin 13 couples to the jak1/2/3-stat6 pathway the il4 response is involved in promoting th2 differentiation the il4/il13 responses are involved in regulating ige production and chemokine and mucus production at sites of allergic inflammmation.": 1 "dna damage genomic instability": 1 " ifncpe50 10–5000 u/ml": 1 "nonsynonymous snps in all strains": 1 "pma a": 1 "experimental liver i-r model": 1 "map kinases regulated by lplunc1": 1 "tumor stage *": 1 "cell line innoculated": 1 "mirna b": 1 "mirna a": 1 "random aneuploidy": 1 "cancer types": 1 "nsc id b": 1 "poorly differentiated": 1 "dna sequence change b": 1 "type of carcinoma": 1 "tumor formation at 2m mean of maximum diameter of tumors mm": 1 "gene length": 1 "1425472_a_at": 1 "percentage of annotated contigs by refseq": 1 "networking/farewell lunch": 1 "redistributed to er under src microinjection either mouse syf or human wi38 fibroblasts": 1 "positive a ": 1 "hi activates the sympathetic nervous system.": 1 "?2 test": 1 "tive-ltc cells": 1 "specific activity min?1": 1 "class comparison": 1 "fold change at 144 hrs 144 hrs at 31°c vs 144 hrs at 37°c": 1 "effect of tat-rasgap 317-326 on ic 50": 1 "n° of positive cases/number of cases analysed by immunohistochemistry": 1 " adenocarcinoma 1 ": 1 "nucleotide": 1 "mapped location on the rat genome rat chromosome number from base pairs to base pairs": 1 "socs3": 1 "common doses and dosage form": 1 "h_kit1": 1 "h_kit2": 1 "reference number clone number": 1 "molecular function": 1 "7966.5": 1 "atp loss": 1 "experimental effects where known and potential binding region overlap": 1 "nrde-3": 1 "source of mir isolation": 1 "germ-line mutation in hereditary nonpolyposis colorectal cancer epigenetic silencing causes loss of tumor mlh1 protein expression mmr gene mutations cause microsatellite instability.": 1 " no of patients = 136": 1 "1 copy": 1 " no of patients = 132": 1 "luteolin": 1 "kras mutation status": 1 "effect on steatosis": 1 "upregulation fold/normal": 1 "cg number b": 1 "total females observed": 1 "as part of the asthmatic diathesis": 1 "non-infectious pneumonitis by exclusion – no clinical or other evidence of infection": 1 "ubiquitinated in s cerevisiae ?": 1 "the encoded protein an alpha subunit in the gq class couples a seven-transmembrane domain receptor to activation of phospolipase c-beta mutations at this locus have been associated with problems in platelet activation and aggregation.": 1 " no of patients = 140": 1 "total n=180": 1 "start kb": 1 "integrin beta 1 fibronectin receptor beta polypeptide antigen cd29": 1 "eif4e": 1 "?": 1 "methylation": 1 "dbt": 1 "total number ": 1 "predicted activation state 1": 1 "mutated gene": 1 "modulation of gsk3-tsc2-mtorc1 signalling": 1 "lux-lung 6 25 afatinib 40 mg": 1 "in vitro kinase inhibition ic 50 nm": 1 "? tnf- ? in irradiated mice": 1 "eif1a": 1 "208.4": 1 "induces apoptosis in ht-29 colon cancer cells which correlated with ampk activation in capsaicin-treated colon cancer cells": 1 "bc085931": 1 " n=24 a": 1 "suppressed no and pge2 production and ameliorated the symptoms of lps-induced hepatitis and etoh/hcl-induced gastritis in mice": 1 "therapy": 1 "of complement": 1 " no of patients = 125": 1 "mice/rat strain": 1 "n29s": 1 "positive n?=?339 ": 1 "2006–2007": 1 "third": 1 "tcrbind ? fyn ? pagcsk ? lck ? zap70 ? ccbl ? tcrbind": 1 "? multiple gene amplifications and deletions—notably egfr vegfa and other receptor tyrosine kinase gene amplification or cell cycle regulatory gene amplification ccnd1 ccne1 cdk6 ": 1 "2010–": 1 "type of nis": 1 "doubling time hrs": 1 "seq positive": 1 "subunits": 1 "ankrd12 low": 1 "number of ppis detected": 1 "activates ampk via sirt1 in both er-positive and er-negative breast cancer cells leading to inhibition of 4e-bp1 signaling and mrna translation via mtor": 1 "protein targeting": 1 "pr status": 1 "aeg-1 protein expression in the cytoplasm": 1 "intracellular localization": 1 "b aceview gbm": 1 "meanvalue sd": 1 "dfs": 1 "immunotherapy group": 1 "multiple mutations‡": 1 "id number a": 1 "# of sarcomas at injection site median latency": 1 "e coli salmonella": 1 "1 myeloid lymphoid and hematopoietic stem cell neoplasm with hypereosinophilia and a recurrent somatic gene defect": 1 "first author reference": 1 "18 nucleotides small rna conserved from insects to mammals involved involved in transcription regulation 25 - 26 ": 1 "aug 2009–present": 1 "methylation in cancer": 1 "protein import into nucleus translocation follicular dendritic cell differentiation": 1 "2452": 1 "induces ampk and autophagy inhibiting mtor and further inducing autophagy in both hacat cell line and primary normal human epidermal keratinocytes this effect was independent of akt and lkb1 but dependent on cammk?": 1 "? cfu-gm bfu-e il-1 ? il-6 gm-csf": 1 "term": 1 "ctr 1": 1 "against total of all clusters": 1 "mlh1 msh2 msh6 pms2": 1 "1.5 mds unclassifiable": 1 "evidence for pcsc activity in vivo": 1 "nm_031327": 1 "number of contigs with >2 reads": 1 "encodes the receptor for colony stimulating factor 1 a cytokine which controls the production differentiation and function of macrophages this receptor mediates most if not all of the biological effects of this cytokine ligand binding activates the receptor kinase through a process of oligomerization and transphosphorylation the encoded protein is a tyrosine kinase transmembrane receptor and member of the csf1/pdgf receptor family of tyrosine-protein kinases.": 1 "mtus1": 1 "start site b": 1 "ic 50 without peptide": 1 "cost-effective strategies for analysis and markers of seafood arsenic": 1 "mpzl1": 1 "relation to survival": 1 "levels of no produced": 1 "div": 1 "predicted sensitivity to egfr tki": 1 "cuticle score in apc2 apc1 double mutant": 1 "copy number of pik3ca not amplified n = 78": 1 "number n = 90 ": 1 "antiangiogenic peptides": 1 "m / z": 1 "pathological diagnosis": 1 "ayis4": 1 "upregulated in t 211 aml 79 ": 1 "test": 1 "410.0": 1 "cluster analysis of different stress conditions n0 to n19": 1 "triglyceride toxicity obesity toxicity triad": 1 " iii proteomic and genomic large-scale studies in hypertension development and treatment": 1 "0.20": 1 "0.21": 1 "fitness score of sensitivity avg 4": 1 "transcripts affected": 1 "outcome prediction": 1 "tnbs/con mean?±?sd": 1 "relative risk or odds ratio 95 confidence intervala": 1 "0.16": 1 "ayis4 ndf59": 1 "nm_017023": 1 "up in rpd3 ? 110": 1 "nude": 1 "standard deviation": 1 "1166.7": 1 "previous primary months before": 1 "1450986_at": 1 "stage of ovarian cancer": 1 "1162": 1 "nm_017009": 1 "duration": 1 "brain region": 1 "0.28": 1 "0.26": 1 "total no of pq resistant clones": 1 "allele frequency c": 1 "number of differentially regulated genes a vs b": 1 "app and aplp2 pathway relationship": 1 "umu": 1 "translocation": 1 "total number of associations": 1 "0.44": 1 "length": 1 "ic50 µm with azi": 1 "encodes an actin protein involved in cell motility structure and integrity and is a major constituent of the contractile apparatus": 1 "0.39": 1 "99.7": 1 "epo expression as pf method": 1 "specificity in healthy and benign breast disease controls": 1 "retrovirus-derived pseudotyping with heterologous coat proteins improves biosafety": 1 "upstream regulator": 1 "estimated deaths in the united states in 2012": 1 "abcb13435c>t abcb1c1236t abcb12677g>t/a": 1 "1184": 1 "study details": 1 "0.48": 1 "0.49": 1 "dna": 1 "staining pattern 1": 1 "protein with putative py event": 1 "fold up or down regulation snb19 u251 5310 4910": 1 "mean amino acid change score per single nt deleterious mutation ±sd": 1 "regulation of leukocyte activation": 1 "snp type": 1 "0.64": 1 "inflammatory and immune response": 1 "0.65": 1 "kinase family": 1 "mathematical description of sixteen genes in feedback loops of p53": 1 "source of pcscs": 1 "number ": 1 "3.0": 1 "fmr1": 1 "nm_017066": 1 "gucy2c": 1 "aeg-1 mrna expression": 1 "352.8": 1 "dog": 1 "dok": 1 "acquisition of spindle shapeb": 1 "microarray data": 1 "positive + no.": 1 "scaffolds only 254 node pairs": 1 "0.77": 1 "0.78": 1 "232.0": 1 "0.76": 1 "0.73": 1 "number of clusters": 1 "specificity ": 1 "relative movement rm": 1 "cox-independent": 1 "primer sequence 5?–3?": 1 "0.68": 1 "no of non-leukemogens": 1 "forward": 1 "both k-ras/braf mutation and rassf2 methylation": 1 "5 negative": 1 "antibody*": 1 "30-": 1 "activation of 4e-bp-1 expression inhibiting mrna translation": 1 "initial dose and dose modifications": 1 "fmrp": 1 "nnos or type i": 1 "copy #": 1 "t47d": 1 "p across four mutants": 1 "c higher transporter activity less drug absorption t lower transporter activity more drug absorption.": 1 "number of pairs": 1 "endometriosis samples": 1 "all edges 450 node pairs": 1 "chugai award": 1 "bait": 1 "assistant professor laboratory of molecular medicine the university of tokyo": 1 "angii inhibition or receptor blockade acei-prils arbs-sartans both inhibiting the effect of angiotensin-ii locally as well as systemically affecting hemodynamic stress through their antihypertensive effect as well as the deleterious effects of angiotensin ii on cells at the local level – injurious stimuli -decreasing the stimulus for o2• production decreasing the a-flight toxicities the positive effects on microalbuminuia and delaying the progression to end stage renal disease plus the direct-indirect antioxidant effect within the arterial vessel wall and capillary antioxidant effects aspirin antiplatelet anti-inflammatory effect on the diabetic hyperactive platelet adrenergic non-selective blockade in addition to its blockade of prorenin ? renin conversion amlodipine – felodipine with calcium channel blocking antihypertensive effect in addition to their direct antioxidant effects.": 1 "cytogenetic finding": 1 "5–10": 1 "suppression of cytokine production": 1 "? il-1 il-6 tnf- ?": 1 "311": 1 "topotecan/ d5w": 1 "ab administration route": 1 "drg": 1 "september 2000": 1 "? a peptides": 1 "post-translational modifications": 1 "?a no gene defect and no chromosome defect detectable": 1 "365.0": 1 "previous reports in cancer pubmed id": 1 "method for prediction and ranking": 1 "a tf peak #": 1 "4.2 pdgfrb": 1 "+n": 1 "3-day assay": 1 "egfr mutation screening method": 1 "caix in tumor": 1 "secretion system": 1 "immunogenic": 1 "immunoglobulin deficiencies": 1 "methylation frequency in primary mm samples": 1 "323": 1 "gene name of the ligand": 1 "predicted extent of loh": 1 "international symposium on cancer research and treatment": 1 "number of impulses in 24 hrs.": 1 "negative n?=?598 ": 1 "1419431_at": 1 "2012–": 1 "?-block viral drivers of growth survival and immune evasion": 1 "macrophages and lymphocytes in lps-treated mice": 1 " genetic contrast and growth phase": 1 "stain": 1 " embryonic lethality at 25°c a": 1 "smoking": 1 "338": 1 "dosage modification": 1 "negative n?=?595 ": 1 " redundancy": 1 "young investigator travel award in american association for the study of liver diseases aasld": 1 "60.2": 1 "rab31 batch": 1 "overexpressed in aml with mll rearrangements 75 ": 1 "345": 1 " 158 ": 1 "adaptations": 1 "percentage tumor or nevus": 1 "gene type": 1 "v-src sarcoma viral oncogene": 1 "cdna": 1 "378.0": 1 "gain b/min/mmhg": 1 "total number of eyes": 1 "effect on disease": 1 "11070.1": 1 "11180": 1 "resident in internal medicine tokyo university school of medicine tokyo japan": 1 "dur": 1 "tm melting temp in °c": 1 "strong positive": 1 "reason selected": 1 "98.1 98.0": 1 "induces apoptosis in chemoresistant ht-29 colon cancer cells via modulation of ampk signaling pathway": 1 "number of protein chains": 1 "g0/g1": 1 "downregulated in t 1517 aml apl 40 44 ": 1 "356": 1 "first model absent": 1 "358": 1 "band": 1 "23 48": 1 "60.9": 1 "1.": 1 "assistant professor department of medicine ii university of tokyo": 1 "mode of action tested * ** ": 1 "974.6": 1 "weeks to confluence": 1 "18": 1 "individual study analysis ? b": 1 "functional effects of acetylcholine": 1 "3.2 juvenile myelomonocytic leukaemia jmml": 1 "action target on atf-2": 1 "serrated adenocarcinomas n ": 1 "brain regions examined": 1 "367": 1 "368": 1 "number of clusters with >1 contig": 1 "gl-ps": 1 "2-": 1 "2.": 1 "24": 1 "mass kda": 1 "shift down": 1 "28": 1 "1449233_at": 1 "renal impairment no modification required": 1 "11 44": 1 "mutated at codon 12 or 13": 1 "370": 1 "fragmentation": 1 "gln/gln": 1 "number of intestinal nuclei ± s.d n": 1 "1h": 1 "2ros 9958 gene set linked": 1 "sample type": 1 "3.": 1 "30": 1 "final score": 1 "33": 1 "1r": 1 "35": 1 "23 41": 1 "37": 1 "group v": 1 "10.8 4.2": 1 "382": 1 "total # of significant mirs array a+b analysis ia": 1 "structural abnormalities": 1 "no of deaths nn?=?406": 1 "months to passage 10": 1 "survival time": 1 "sparassis crispa": 1 "tfbs": 1 "group i": 1 "2g": 1 "cortical": 1 "1045-1145": 1 "4.": 1 "observed or experimental change": 1 "cgrp dose": 1 "40": 1 "days of treatment": 1 "42": 1 "44": 1 "lin-29 fold change": 1 "? bone marrow flow cytometry loss of primitive mlp lmpp population and reduction of gmp cd56+ plasma cells present all morphological tests may be normal": 1 "48": 1 "tacr2": 1 "cytogenetic response": 1 "overall survival ": 1 "3b": 1 "5.": 1 "50": 1 "tumor/recipients": 1 "54": 1 "mir-222 expression": 1 "471.4": 1 "longest length of unique sequences bp": 1 "57": 1 "59": 1 "disease-specific genotype/phenotype in ipscs and/or generated neural cells": 1 "raphe": 1 "p -values": 1 "1.2 rc with multi-lineage dysplasia rcmd": 1 "number of methylated cpg sites": 1 "4f": 1 "1522.5": 1 "• decreases adhesiveness of the endothelial layer to monocytic wbcs the "teflon effect".": 1 "6.": 1 " up": 1 "65": 1 "hsf positive/negative regulators of interest in cancer": 1 "limited cloning capacity nonpathogenic integrate randomly in the absence of the rep gene": 1 "hypothesis of neuroplasticity 200s": 1 "effects of w-cin": 1 "69": 1 "1wk": 1 "60 58": 1 "routine tests": 1 "plasmid": 1 "speed": 1 "n-ffold ±semb": 1 "increase proteolytic activity of ec interaction with integrins hspg lrp disassembly of focal adhesion and ec migration": 1 "7.": 1 "70": 1 "exon intron": 1 "75": 1 "76": 1 "snv calls from roibc": 1 "nucleoporin 62": 1 "endometrioid well-differentiated morphology": 1 "chronic antidepressants induce adaptive changes in postreceptor signaling cascades and in gene expression": 1 "11 17": 1 "liver breast": 1 "6h": 1 "38.4": 1 "genes found": 1 "82": 1 "84": 1 "85": 1 "86": 1 "igfr1": 1 "frequency of a allele p*": 1 "tumour growth inhibition in vivo by r115777": 1 "increased expression of cyp4a or cyp4f enzymes in cancer tissues": 1 "dominant mode of inheritance": 1 "small nuceolar rnas snorna": 1 "no influence of cyp3a4*1b on csa/tac pharmacokinetics was found cyp3a5 expressers were associated with significantly lower dose-adjusted csa/tac concentrations and higher allograft rejection episodes in patients on tac therapy.": 1 "level of expression *": 1 "3 e-value": 1 "poor prognosis": 1 "loss": 1 "tracheobronchomalacia": 1 "9.": 1 "90": 1 "91": 1 "92": 1 "pah inhibition of medical thickening of pulmonary arteries leading to the improvement in right ventricular pressure cardiac output and arterial pressure of oxygen schermyuly et al 2005 in vivo ": 1 "vaf": 1 "high-grade and muscle-invasive urothelial tumors harbor inactivating mutations of rb gene": 1 "m esculenta": 1 "fold change at hypoxia": 1 "4interproscan predicted domain": 1 "protection from apoptosis induced via oxidative stress*.": 1 "phase of the cell cycle": 1 "carcinogen action": 1 "p -value 1": 1 "cases/controls": 1 "fibrosis": 1 "phd in medicine tokyo medical and dental university": 1 "scenario name": 1 "43–11208": 1 "proliferation needed": 1 "gender": 1 "n?=?54 55.1": 1 "p-site": 1 "access number": 1 "bioeffect and physical response": 1 "wnt pathway activated by": 1 "3rd instar larvae": 1 "9h": 1 "example files": 1 "11956.1": 1 "?insulin resistance": 1 "europe": 1 "long-term gene expression": 1 "replication": 1 "invited professor kyoto prefectural medical university": 1 "namiki izumi md phd": 1 "upregulated in aml with cebpa mutations 71 ": 1 "? sirt6 ? pancreatic cancer cells": 1 "rb expression": 1 "relative change in mitf mrna upon atf2 kd *": 1 "no bacteria": 1 "tumour core i/actin a": 1 "sperm": 1 "homozygous tt genotype in donor kidney associated with enhanced incidence of nephrotoxicity.": 1 "water extracts mycelia and fruit bodies": 1 "30 gy": 1 "nm_012154": 1 "<3": 1 "median expression": 1 "observed mh+": 1 "total numberof cells": 1 "proximity to genes <100 kb distance": 1 "lymph node metastasis": 1 "23 92": 1 "acute cholecystitis": 1 "eye score": 1 "timp-1/marker": 1 "professor and chairman department of genome biology kinki university faculty of medicine": 1 "pneumonitis": 1 "m.w.": 1 "ret mutation": 1 "lon staining iod ×104 a": 1 "rt min": 1 "type of therapeutic agent": 1 "interleukin 6": 1 "potential rhogef": 1 "reaction system": 1 "missense mutations": 1 "n spns - pts": 1 "am?/?": 1 "median os months": 1 "gfap-sb a": 1 "cancer type/significance/specific type of drug resistance": 1 "?d other defects jak2 fusion gene flt3 fusion gene": 1 "methylation status in cma": 1 "model group": 1 "integrin ?v?6": 1 "15–25": 1 "observed colon cancer cases": 1 "mechanism of carcinogenesis": 1 "1991–1992": 1 "12.5": 1 "angiogenesis peptidoglycan metabolic process": 1 "1 h post-dose severity of test article-related microscopic lesions": 1 "upregulated with 5-aza fold change": 1 "8795.5": 1 "t2lc a": 1 " 1 *": 1 "wst-1 assay dsrna only": 1 "total # of significant mirs array a+b analysis iib": 1 "r.m.s.d bond angles °": 1 "aneuploidies of metaphases c": 1 "negative edges only 126 node pairs": 1 "p12-11.1": 1 "nlgn1": 1 "total number of alignments to controls": 1 "nlgn3": 1 "sequence 5??3?forward and reverse": 1 "1204": 1 "dgcr8": 1 "scaffolds only 219 node pairs": 1 "foxm1 positive": 1 "no of total reads": 1 "1996–1997": 1 "knock out": 1 "base pair sequence": 1 "precancerous lesion": 1 "strength of ventralization": 1 "ischaemic and/or hemorrhagic stroke separated into prior and not prior cerebrovascular disease": 1 "cell culture medium": 1 " 3 passive cell-mediated administration": 1 "evidence in ad patients": 1 "promune": 1 "functional domains": 1 "mirs common in analysis i and ii": 1 "qrt-pcr": 1 "p16 expression": 1 "number of hres after start site": 1 "n major": 1 "? tnf- ? nitrite ions": 1 "3' end": 1 "simi lar to hypothetical protein flj12484": 1 "suppression of ghr expression with downregulation of hepatic igf-1 synthesis": 1 "cht-response": 1 " no of events = 20": 1 " no of events = 21": 1 "tumours in or impinging on central airways": 1 "5? truncated?e": 1 "28 46": 1 "polyploidy": 1 "fold change 1": 1 " no of events = 19": 1 " no of events = 17": 1 "steatosis": 1 "combined p -value": 1 "spia noteworthy": 1 "annotation": 1 "drug treatment to rescue phenotypes": 1 "density": 1 "highly enriched functions": 1 "no of pmg": 1 "myc induced nuclear antigen": 1 "logistic regression model for hnscc susceptibility dominant model #": 1 "28 50": 1 "on-target readsa of mapped reads": 1 "p †": 1 "best response to igf1r+mtor inhibitor": 1 "leucine content of milk mg/100?ml": 1 "? marked dna hypermethylation including in cdkn2a p16 but not mlh1 promoters": 1 "tag snp": 1 "cha a": 1 "car receptors": 1 "mir -106 b": 1 "nucleotide genomic": 1 "thick lp": 1 "46.196–2.100": 1 "patients' number": 1 "invaginations and exaggerated membranes c ": 1 " acml": 1 "mice with tumor necrosis": 1 "16 47": 1 "1010.0": 1 "nuclear foxo1 export": 1 "human homolog": 1 "total number of mutations found": 1 "activation of oh-1 expression inhibition of mitochondrial function and reactive oxygen species formation inhibition of nf?b inhibition of inflammation": 1 "immunophenotype by flow cytometry a": 1 "no of vsv-specific gcs *": 1 "? a il-4": 1 "response to tissue damage inflammation tissue remodeling": 1 "139.9": 1 "inhibits akt/mtor signaling via ampk and potentiates the effects of gefitinib in breast cancer": 1 "g1 ": 1 "paa µg/ml 1": 1 "g/a": 1 "better characterization of other biomarkers of exposure i.e toe- and fingernails noninvasive and reflect long-term exposure saliva buccal cells target tissues": 1 "g/g": 1 "average length of singletons bp": 1 "53 83": 1 "patient demographics": 1 "9 100 ": 1 "observed rate min?1": 1 "?angiogenesis": 1 "rab31 low": 1 "tachykinin receptor 2": 1 "g2 ": 1 " ?g/g": 1 "hypomethylated": 1 "expression of tipe2": 1 "? lymphocyte subsets b cell and nk cell deficiency cd4cd8 inversion <1·0 absence of cd1c+ cd141+ and plasmacytoid blood dcs": 1 "target sample size": 1 "relation to cgi": 1 "lines": 1 "nfatc4": 1 "genome integration": 1 "assistant professor kyoto university school of medicine dept of medicine and clinical science": 1 "proband no ": 1 "number of differentially expressed genes": 1 "promoter regions": 1 "germ-line mutation in familial adenomatous polyposis somatic inactivation found in 85 of sporadic colorectal cancers apc mutations cause chromosomal instability.": 1 "16 29": 1 "number of litters": 1 "gene symbol affected": 1 "16 30": 1 "tumor model": 1 "expected probability ": 1 "4.4": 1 "vegfb": 1 "vegfc": 1 "simulation starting point": 1 "claudin gene": 1 "4.9": 1 "0.023": 1 "estimated unique transcript": 1 "0.027": 1 "0.024": 1 "treatment duration": 1 " sequence coverage": 1 "no of samples cancer/normal": 1 "littermates": 1 "87.5": 1 "87.4": 1 "epitope sfc/m": 1 " of cells with ruffles": 1 "sequences source in ncbi": 1 "response rate": 1 "prognostic significance": 1 "tsn-1": 1 "oral presentations plenary i clinical research.": 1 "? b tumor lysates": 1 "kegg id": 1 "473.7": 1 "germ-line mutation in cowden’s syndrome which carries a high risk of breast cancer with 10 increased risk of colorectal cancer possible role in maintenance of chromosomal stability": 1 "406": 1 "408": 1 "authors": 1 "proposed mechanism": 1 "0.045": 1 "cytoplasmatic hif-1? expression": 1 "aberration type": 1 "0.043": 1 "rrna processing ribosome biogenesis and assembly": 1 "ryosuke tateishi": 1 "0.040": 1 "era": 1 "gfp + leukocytes b": 1 "ihc score no cases": 1 "day 105": 1 "0.039": 1 "220.9": 1 "translational response": 1 "cdk4 genotyping results": 1 "additional samples used only forqrt-pcr unpaired": 1 "hugo id": 1 "0.032": 1 "7883.7": 1 "8 h maa": 1 "documented prognostic impact": 1 "gene orthologous grouping": 1 "0.030": 1 "74.4": 1 "esi": 1 "cx10": 1 "353.7": 1 "sb203580": 1 "233.8": 1 "iri sensitivity": 1 "univariate analysis or 95 ci": 1 "486.4": 1 "genomically stable 20 of gastric cancers": 1 "direction of change": 1 "source of lung cancer specimen": 1 "percentage of cells cd8+ and mart1/hla-a2+": 1 "d_kit2_a16": 1 "1427299_at": 1 "2662.4": 1 "regulation of cell growth regulation of protein amino acid phosphorylation": 1 "during the diagnosis 3 mo 6 mo and every 6 mo until ccyr then every 12 mo if molecular test is not available at failure or unexpected myelosuppression": 1 "p-value for grade 3 pnst enrichment": 1 "moderate expression": 1 "tics-m": 1 "guanine nucleotide binding protein g protein": 1 "this receptor binds insulin-like growth factor with a high affinity it has tyrosine kinase activity the insulin-like growth factor i receptor plays a critical role in transformation events igfrs mediate their intracellular actions through the pi 3-k and ras/raf/mapk signaling pathways and downstream effectors include mtor p70 s6 kinase erk and jnk many tumors have altered expression of igf1r and its ligands and this constitutes an early possible initiating event in tumorigenesis.": 1 "100.0": 1 "?n692/ev ratio": 1 " no of events = 24": 1 "0.008": 1 "hst-1": 1 "true leaves before first inflorescence": 1 "0.007": 1 "inhibition of infection of cells with the new world arenavirus pichindé picv": 1 "3010.9": 1 "apoptotic cytotoxic effects by sstr2 and sstr3 signalling": 1 "networking coffee": 1 "n?=?17 20.2": 1 "0.003": 1 "patient no.": 1 "12p24.2": 1 "lnz308": 1 "41 57": 1 "chromosomal location*": 1 "enrichment in all gexp?? tp53's hypergeom p ": 1 "clinicopathological parameter": 1 "associate professor department of gastroenterology university of tokyo": 1 "main characterization compared to prp expressing cells": 1 "transport": 1 "modulation of autophagy by inhibitors": 1 "no differences between treatment and controlled group": 1 "tn1 ×106": 1 "lana peak #": 1 "b immuno-histochemistry": 1 "inhibition of vegf165": 1 "organism and genetic line": 1 "aroclor 1254 regulated genes 857 observed number of genes": 1 "chemical group": 1 "b-raf v600e mutation": 1 "prevalence 70 of low-grade non-muscle-invasive tumors 20 of muscle invasive tumors": 1 "time course of degeneration": 1 "every 21 days": 1 "wa-c": 1 "a upregulated degs": 1 "best subject award of the 21th annual meeting of japan society for surgical infection": 1 "196±11": 1 "number of predicted coiled coils": 1 "phase 2 for several different cancer indications": 1 "absolute t-value p-value": 1 "cyp3a4*1/*1+cyp3a5*1/*3 and cyp3a4*1/*1b+cyp3a5*1/3 genotypes in recipients are associated with a higher incidence of nephrotoxicity.": 1 "genotype & strain of sperm incubated with wt icr eggs a": 1 "nuclear only or nuclear/cytoplasmic positive": 1 "history of cutaneous melanoma": 1 "2.2.3 mastocytosis": 1 "n+/?": 1 "486": 1 "overall frequency of? hras mutations": 1 "in vitro data": 1 "catalog number for lst shrna": 1 "number of transformed clones": 1 "oncostatin m receptor": 1 "dataset 2 ref 30": 1 "6 18": 1 "? tnf- ? il-1 ? il-10 il-12 gm-csf il-18": 1 "computational methods for array data analysis": 1 "np_065801": 1 "promoted both the phenotypic and functional maturation of dc derived from": 1 "ingredients": 1 "effect of combination observed": 1 "?b jak2 v617f myeloproliferative neoplasms mpn-eo": 1 "? a soluble factors pge vegf tgf- ? ido-1 arginase": 1 "msra": 1 "expression in cancer": 1 "6 23": 1 "performance of the compound covariate predictor classifier": 1 "5.09": 1 "number of unique sequences": 1 "no dp t3.70high thymocytes": 1 "sorafenib ": 1 "documentation in vitro/in vivo effect": 1 "e2f site position": 1 "unit cell å °": 1 " a chromosome number": 1 "2wk": 1 "positive controls": 1 "administration": 1 "total number of colonies after interaction with cdna library": 1 "psa after": 1 "csr-1": 1 "nuclear accumulation found to be an independent predictor of tumor recurrence and survival when combined with tumor grade stage lymph node stage and p53 status": 1 "relapse-free survival": 1 "p1/p2": 1 "no 10": 1 "?a pdgfra -rearranged neoplasms": 1 "group of rat treated with": 1 "ovulation transport": 1 "pdgfc": 1 "bacterial vvectors eg salmonella": 1 "cytoskeleton organization and biogenesis": 1 "dept of cellular & molecular medicine in university of california san diego howard hughes medical institute hhmi": 1 "tunel positive response ": 1 "fusion protein": 1 "pathological review based on h&e subtype after biomarker staining": 1 "nmd3 homolog": 1 "cardiovascular disease category": 1 "# of genes": 1 "hrm positive": 1 "inhibits mtor independent of ampk": 1 "4831.9": 1 "hi induces ang ii which is the most potent stimulus for production of nad ph oxidase with reactive oxygen species generation superoxide production and resultant vascular oxidative stress.": 1 "rna binding motif protein": 1 "encodes one of the three catalytic subunits of protein phosphatase 1 pp1 pp1 is a serine/threonine specific protein phosphatase known to be involved in the regulation of a variety of cellular processes such as cell division glycogen metabolism muscle contractility protein synthesis and hiv-1 viral transcription increased pp1 activity has been observed in the end stage of heart failure studies in both human and mice suggest that pp1 is an important regulator of cardiac function.": 1 "h_kit2_2tet": 1 "345 line 20 wk after promotion": 1 "conclusion": 1 "in vivo data": 1 "a gene transcript alterations in microarray analyses of pooled crc tumors from patients randomized to preoperative nsaid treatment versus sham treatment.": 1 "psat1 in tumor": 1 "transcribed": 1 "quercetin": 1 "49847": 1 "p interactiona": 1 "variable n?=?71": 1 "prediction on gene function": 1 "vice dean for graduate affairs and avison distinguished professor department of pathology yonsei university college of medicine": 1 "injury model": 1 "? b til/draining lymph nodes t cells": 1 "jca-mauvernay award japanese cancer association": 1 "wild-type": 1 "mascot score a": 1 "reduction of proinflammatory cytokines il-1 ? il-6 tnf- ? gm-csf and mmps": 1 "sequencing primer": 1 "mrna expression": 1 "unadjusted for covariates": 1 "5.68": 1 " months": 1 "gaps in med.": 1 "best subject award of the 45th annual meeting of the japanese society of hepatology": 1 "embryonic lethality in apc2 single mutant": 1 "similar to atp synthase subunit b-like": 1 "other effect": 1 "2351.9": 1 "large scale deletions kss pearson’s syndrom peo": 1 "level of the risk of progression": 1 "the *3/*3 genotype in recipients is associated with a lowered incidence of acute rejection episodes and hypertension.": 1 "no of patients cancer type": 1 "tumor frequency a": 1 "5.79": 1 "sa 7182": 1 "microtubule-based process and movement": 1 "phenotype measured": 1 "predicted ubiquitination site s": 1 "2.5 ?m b": 1 "for advanced solid malignancies": 1 "primer sequence 5?-3?": 1 "phase 2 for advanced solid malignancies": 1 "phospho-erk1/2": 1 "suppression of rxr/lxr?-mediated activation of srebp-1": 1 "down glu": 1 "424.0": 1 "gain": 1 "down gln": 1 "change in expression in mpnsts": 1 "percent fusion observed": 1 "distant metastasis": 1 "meta-analysis z-score c": 1 "5.99": 1 "of action c": 1 "sanger sequencing *": 1 "rkip n ": 1 "go id and term": 1 "5.94": 1 "mir-17-92": 1 "trait and snp": 1 "direct oxidation of polyunsaturated fatty acids present in lipids": 1 "total prediced colon cancer": 1 "lipotoxicity – hyperlipidemia – obesity toxicity triad": 1 "100 &": 1 "selected phosphomotifs showing strong interaction with grb2 on peptide microarray": 1 "13.4": 1 "xx-yyb": 1 "type i tumors": 1 "mutant a": 1 "selected by egfr": 1 "9373.4": 1 "hmga1 †": 1 "protocol": 1 "exposure data on other arsenicals i.e thioarsenicals roxarsone": 1 "freshwater": 1 "phase 2 launched in 2005": 1 "impact of arsenic metabolism": 1 "aml1 55 bim 93 pten 91 p21 94 ": 1 "gene of interest": 1 "timp1 †": 1 "afp †": 1 "lf of sap mmhg2": 1 "392a>g": 1 "cases n": 1 "caucasian asian black": 1 "statistical significance in real-time rt-pcr validation p -value": 1 "pathology": 1 "sigset": 1 "recipient strain": 1 "number of contigs >99 pb": 1 "v2 * ": 1 " iv daily": 1 "rt-pcr": 1 "with rice ids c": 1 "number of acfs/cm2? mean ± sem": 1 "842.2": 1 " of annotated": 1 "injected mrna": 1 "extra seq bph": 1 "1330": 1 "bta1": 1 "tumor formation at 3 weeks mean of maximum diameter of tumors mm": 1 "against infectious disease and cancers": 1 "no changes in csf levels of a?1?42 ?sapp totapp total tau plasma levels of a?1?42 adas cog and mmse ?sapp increased": 1 "? pathways redox homeostasis cell survival": 1 "intermittent exposure to sun n ": 1 "variance": 1 "various": 1 "exon variant": 1 "impact on mtor network": 1 "no cd8 sp t3.70high thymocytes": 1 "low or none n ": 1 "– grade 3 hold therapy until improved consider corticosteroid eg prednisone 25–50 mg with rapid taper before resuming everolimus at lower dose": 1 "less than 200 nt trascripts that may regulate gene expression through the interaction with genes promoter sites 19 ": 1 "cdv µm 1": 1 "best cutoff": 1 "other names/inci *": 1 "expert member pharmaceuticals and medical devices agency": 1 "er-? knockdown": 1 "mean path length": 1 "s aspratus": 1 "1.3 ra with excess blasts raeb": 1 "367.4": 1 "#proteins": 1 "immunological functions": 1 "rank": 1 "effect on period as parameter is increased decreased": 1 "hmga2 n?=?60": 1 "aa": 1 "early phase only down-regulated mechanistic genes": 1 "? phenotypes of sirt2 ko mice liver cancer mammary gland tumor": 1 "ai": 1 "ao": 1 "involvement in transport": 1 "probe set id": 1 "reverse pds atccct": 1 "pancreatitis": 1 "mathematical description of sixteen genes under stresses": 1 "tumour type s screened": 1 "dna packaging transcription": 1 "0.00075 µg/ml mnu": 1 "bp": 1 "scca tumor xenograft": 1 "e-cadherin expression": 1 "number of colonies in soft agar": 1 "charge": 1 "study 1": 1 "'grouped on mature' sequences": 1 "study 2": 1 "1374": 1 "atpase of c": 1 "cm": 1 "refnet": 1 "residues forming hydrogen bonds with ar-c155858 in last 40 ns": 1 "induced myc signature genes": 1 "e6": 1 "e7": 1 "pakt a": 1 "1368": 1 "day 8 notch off": 1 "?-induce lytic viral gene expression": 1 "longest sequence after trimming bp": 1 "mutation status of kras / braf": 1 "gna11 exon 5 genotyping results": 1 "source gene": 1 "up-regulated mechanistic genes in all three immune response phases": 1 "ereg †‡": 1 "mcf7": 1 "1375": 1 " n in training": 1 ">1.5-fold down": 1 "type iii sum of squares": 1 "1000-tba": 1 "chrom localization": 1 "2008–present": 1 "gars": 1 "gart": 1 "er": 1 "mitogen-activated protein kinase 11": 1 "number of associations in subset": 1 "amplified b": 1 "#upets": 1 "5.1": 1 "5.3": 1 "other insertions in tumor": 1 "in combination with lsm": 1 "5.7": 1 "stomatitis rash diarrhea – symptomatic management": 1 "fl": 1 "experiment type": 1 "no of pna+ gcs *": 1 "?tp53 mutation": 1 "oc‡": 1 "fov": 1 "rho no.": 1 "ontology specification": 1 "rate": 1 "immune response": 1 "gene fusion": 1 "nfil3 ?/?": 1 "gb": 1 "small interfering rnas sirna": 1 "redistributed to er under egf stimulation hela cells": 1 "anvisa *": 1 "second gene binding sites of other tfs": 1 "a gg ag gggcgcg g gggagggg": 1 "additional plasmid": 1 "probable mechanism": 1 "501": 1 "bf228368.i": 1 "medical research award japan medical association": 1 "pten mutations in exons 7 and 8": 1 "461.1": 1 "assistance of dicer function in pre-mirna processing complex": 1 "piperine": 1 "microsatellite instability 22 of gastric cancers": 1 "10 14": 1 "p- value": 1 "10 16": 1 "h3k4me3 present at p53re": 1 "ms mass": 1 "id": 1 "519": 1 "inflammation response": 1 "associate professor department of gastroenterology and hepatology kinki university school of medicine": 1 "management of specific problems": 1 "1908.4": 1 "p value**": 1 "igf pathway member": 1 "fine particles of fruiting body abp-f": 1 "agilent systematicname": 1 "alteration": 1 "3.1 chronic myelomonocytic leukaemia cmml": 1 "4.3 fgfr1 8p11 myeloproliferative syndrome a k a stem cell leukaemia/lymphoma": 1 "council meeting": 1 "literature": 1 "~51760": 1 "0.162": 1 "fucoidan source": 1 "341.8": 1 "oligonucleotide primers": 1 "lamin a": 1 "haeme oxygenase-1 oh-1": 1 "renin": 1 " of total b": 1 "insertions in paneth tumors": 1 "cell doubling time h": 1 "li": 1 "gab2 expression of lung squamous cell carcinomas": 1 "role of ppar ? expression": 1 "molecule type": 1 "cells without variant s": 1 "second": 1 "iron-mediated decomposition of lipid hydroperoxides can yield a plethora of follow-up products such as conjugated dienes hydrocarbon gases e.g ethane ethene and carbonyl compounds such as malondialdehyde mda alkenals alkadienals and ??-unsaturated aldehydes e.g crotonaldehyde acrolein new studies on autoxidation of arachidonic acid revealed that intermediate formation of monocyclic peroxides bicyclic endoperoxides and dioxolane-isoprostane peroxides may also occur.": 1 "aptamer": 1 "fluorescence": 1 "expressed in cancer": 1 "eurtac 8 erlotinib 150 mg": 1 "total numbers of gexp?? tp53": 1 "no of genes +/? 500kb": 1 "no of germinal centers *": 1 "no of cases with respective entpd5 staining scores": 1 "inoculated cells": 1 "mr": 1 "ms": 1 "hs83-d-cbl gene": 1 "enhance immune response to infected cells": 1 " 41 82 83 84 ": 1 "mcm7": 1 "p*": 1 "at ? ta": 1 "prostate carcinoma": 1 "activation of lacz b": 1 "?resistance of rcc cells to direct anti-proliferative everolimus effects": 1 "p6": 1 "alg-2": 1 "alg-1": 1 "alg-4": 1 "increasing the levels of enzymes that detoxify oxidants and electrophils i.e catalase sod gpx gstr nadph-quinone oxidoreductase nqo1 ho-1 hsp70 etc.": 1 "response to therapy b": 1 "type of malignancy": 1 "?/?": 1 "gatekeeper in cell cycle control prevalence >50 of high-grade muscle-invasive tumors cyclin-dependent kinase inhibitor prevalence 64 of radical cystectomy specimens": 1 "all scores": 1 "high mir-216b expression n =60": 1 "ov": 1 "most frequent tissues affected": 1 "approved by fda for treatment of age-related": 1 "app and aplp2 role": 1 "cause of over and underexpression": 1 "rm genes fdr < 0.05": 1 "cloning frequency in non-malignant tissue ": 1 "101.3": 1 "po": 1 "division of internal medicine alma mater studiorum university of bologna": 1 "10090": 1 "indications": 1 "ps": 1 "hgnc ortholog name": 1 "czech & caucasian": 1 "10/2000": 1 "s ": 1 "cdh13 methylation": 1 "m musculus": 1 "positive edges only 251 node pairs": 1 "increased at/af telemetric ecg": 1 "target/class": 1 "downregulated by il-1?": 1 "ca-125": 1 "patients with *1*1*1*1 cyp3a5- and cyp3ap1-linked genotypes need higher doses of csa as compared to the patients with *1*3*1*3 and *3*3*3*3 linked genotypes.": 1 "cd99 molecule": 1 "predictor of time to recurrence and overall survival": 1 "phd graduate school of medicine university of tokyo": 1 "genes in cluster": 1 "alpha fetoprotein": 1 "6 negative": 1 "ra": 1 "cluster1 probability": 1 "17.15 – 18.00": 1 "curcumin diferuloylmethane from turmeric curcuma longa l.": 1 "178/1120 = 15.89": 1 "t2": 1 "inhibits pi3k/akt and mtor and activates ampk in non-small cell lung cancer": 1 "graduate of wakayama medical university md degree": 1 "loss of junctional e-cadherinc": 1 "laryngeal carcinoma": 1 "up in dep1 ? 141": 1 "total n = 71": 1 "grifola frondosa": 1 "occurrence in other proteomic analyses": 1 " 27 ": 1 "negative -": 1 "igfbp3 mrna expression level": 1 "end bp .": 1 "• cardiac myocyte-targeted stat3 knockout mice show greater sensitivity to inflammation cardiac fibrosis and heart failure with advanced age 6": 1 "so": 1 "sp": 1 "megalencephaly patients": 1 "n?=?67 79.8": 1 "lf ms2": 1 "558.9": 1 "950.8": 1 "sw": 1 "elston grade 1": 1 "lif †": 1 "o.oo8": 1 "interpro no *": 1 "single": 1 "residue mutation": 1 "regulation of expression": 1 "elston grade 3": 1 "mma v 1500 ppm": 1 "tt": 1 "type of tumor and normal cell": 1 "drug or treatment": 1 "antitumor activity and/or mechanism": 1 "kras c12/13 and c59/61 sequence change": 1 "strategy and study first author year reference no a": 1 "ua": 1 "notable genes": 1 "antiproliferative effect of het0016": 1 "n?/?": 1 "increasing the levels of direct antioxidants such as gsh co and bilirubin.": 1 "uk": 1 "increased at/af in sedated mice": 1 "16.0 – 16.15": 1 "phosphorylated substrates of pka": 1 "?3 is it possible to expand raju cell population without differentiation under proper culture conditions such as egf or fgf2 43 144-148.": 1 "hdac6 binds ubiquitinated protein aggregates and this leads to the dissociation of the basal complex and eventual activation of the aggresome pathway 28 33 36 .": 1 "o.oos": 1 "increasing dna repair activity*.": 1 "total differentially expressed tdfs": 1 "cell motility or metastasis": 1 "0.050": 1 "188.3": 1 "incidence of oral papilloma": 1 "460.3": 1 "1423643_at": 1 "pathway definition": 1 "wb": 1 "tumor formation at 2 weeks mean of maximum diameter of tumors mm": 1 "6 8": 1 "6 9": 1 "macrophages": 1 "k472e": 1 "nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor beta": 1 "combined p-value": 1 "cdna/ a thaliana orthologue": 1 "mean b-factor": 1 "this snp has no influence on csa levels or rejection episodes.": 1 "examples of mirnas regulated by dna methylation": 1 "functional classification": 1 "6 h": 1 "bhlhb8": 1 "?7 are they transiently expressing stem cell specific growth genes? e.g nanog oct-4 wnt bmi1 etc 188-191": 1 "upregulating il-1?": 1 "jun 2006–sep 2006": 1 "fold change by microarray": 1 "growth of cells expressing app sirna or aplp2 sirna": 1 "complex i ndufs1 ndufs2 ndusfs4 ndufs8 ndufv1": 1 "phase-iii 5 ipi monotherapy 3 mg/kg 131": 1 "gsk3": 1 "n?=?44 44.9": 1 "m albus": 1 "mutations in nuclear genes encoding the respiratory chain proteins": 1 "mtzr": 1 "e113d": 1 "14.1": 1 "14.0": 1 "number of mutations identified in tcga": 1 "chemical or genetic perturbations": 1 "2 orders more sensitive than other dyes": 1 "hyperglycemia – home glucometer diet modification/oral agents or insulin as required maintain dose": 1 "regulation of cell proliferation": 1 "pool sfc/m": 1 "14.7": 1 "p212121": 1 "repressed myc signature genes": 1 "augmentation of nuclear foxo1 signalling": 1 "at ? cg": 1 "shift second carbon source": 1 "#total pets": 1 "ild inhibition of the differentiation of fibroblast into myofibroblast proliferation and ecm production leading to histologic efficacy daniels et al 2004 aono et al 2005 in vitro and in vivo abdollahi et al 2005 chaudhary et al 2006 in vivo ": 1 "18340 17402 working set 938 test set": 1 "keynote address “clinical genomics merging human genetics and genomics” prof james r lupski neurogenetics baylor college of medicine usa": 1 "rosa-sb11": 1 "210±10*": 1 "2.1.2 polycythemia vera pv": 1 "sell": 1 " of tumors with gcis": 1 "epigenetic marker": 1 "1440.0": 1 "plantgdb est": 1 "or a meta": 1 "a gg ag gggcgcg g gg a agggg": 1 "rna molecules involved in modification and processing of other rnas especially rrnas trnas and snrnas mainly by site-specific methylation and pseudouridylation 15 - 17 ": 1 "samples number": 1 "hm1imss culture/rahman culture": 1 "amino acid oxidation": 1 "total number examined": 1 "sequences after filtering": 1 "?b with a nonspecific chromosome/gene abnormality": 1 "19 33.9 ": 1 "consider utilizing existing cohorts nested case–control design and follow-up of cross-sectional populations": 1 "her2": 1 "25 44.6 ": 1 "metastasis characteristics": 1 "average number of ests in contigs": 1 "at a": 1 "class of small non-coding rnas that targets protein-coding mrnas at the post-transcriptional level 18-22 nt 10 - 11 .": 1 "number of leukocytes a": 1 "ukts": 1 "139.4?±?6.4": 1 "p value fisher's exact test": 1 "metastatic status": 1 "reverse virus-mediated cell maintenance": 1 "atpase ca++ transporting plasma membrane 4": 1 "0.025 µg/ml mnu": 1 "disease-free survival": 1 "? inos": 1 "no nr sequences": 1 "at ? gc": 1 "? capacity of dc to promote the proliferation of naïve allogenic t cells and": 1 "0.2448": 1 "ballroom f-h meet the experts iii evs in cardiovascular disease chair chantal boulanger speakers eduardo marban and dominique de kleijn": 1 "aa2–56": 1 "lymphopenic infections – consider possible opportunistic infections such as candida or aspergillus": 1 "right colon": 1 "switching to another statin preferably with different metabolism an alternate-day or weekly dosage of statins with longer half-life combination therapy with ezetimibe with infrequent statin dosing nonstatin lipid lowering drugs bsa ezetimibe fibrate nicotinic acid dietary manipulation and nutraceuticals": 1 "exact mature/*sequences": 1 "smr relative risk or odds ratio 95 confidence interval": 1 "tumor suppressor activity": 1 "severe cortical a": 1 "xx-yy": 1 "prosc": 1 "haplotype 1236c-2677g-3435t is prone to an enhanced risk of acute rejection.": 1 "edges": 1 "negative regulators of telomere length through inhibition of telomerase and involved in telomere associated diseases including many cancers 27 ": 1 "rbmx": 1 "• anti-inflammatory effect.": 1 "validate spot urine findings with 24-hr urine samples for a sample of the study population": 1 "n major event a": 1 " n=110 a": 1 "impact of rapamycin on behavior": 1 "moderate ++": 1 "concentration ?m": 1 "? apoptosis of a portion of the activated": 1 "murine model": 1 "• mice with cardiac myocyte-targeted stat3 overexpression develop cardiac hypertrophy but are resistant to doxorubicin-induced cardiomyopathy 9": 1 "number of gfphi leukocytes d": 1 "no n=132": 1 "0hr/0hr": 1 "5120.5": 1 "pathway p ds <0.05": 1 "• promotes vasodilatation of vascular smooth muscle.": 1 "dma v 1000 ppm": 1 "condition s with highest expression": 1 " by weight": 1 "gldc in stroma": 1 "number of mice with tumors": 1 "180-genes": 1 "angiotensin ii": 1 "cellular": 1 "carriers of combined genotype of cyp3a4*1/*1-cyp3a5* 3/*3 seem to require lower tac doses to get the target concentration levels.": 1 "epitope": 1 "accession number    ": 1 "-t2 rrna 28s": 1 "virus delivered": 1 "frequency in t 821 aml": 1 "r10g": 1 "275375/320113/151718": 1 "snps within cgis": 1 "non-functional sequences of dna originally derived from functional genes but with mutations or premature stop codons that avoid their expression involved in regulation of gene expression and recombination 24 ": 1 "line-1 methylation levelmean ": 1 "weak positive 34 32": 1 "peroxisome count b": 1 "r merge": 1 "r407k": 1 "bdes": 1 "az peptide": 1 "phf14 seq": 1 "number of gexp?? tp53 correlations which are possible p53 transcriptional targets": 1 "caix in stroma": 1 "phenotype and latency non-infected versus infected with m-mulv": 1 "selected clonal aneuploidy": 1 "1492": 1 "europid men": 1 "6 h post-dose severity of test article-related microscopic lesions": 1 " 67 68 69 ": 1 "qpcr *": 1 "protein domain s": 1 "unigene length pb ": 1 "6.0": 1 "6.3": 1 "predicted/known function": 1 "novel": 1 "#pathway-asso pet1 over pet1 over known gene-asso pet1": 1 "hi promotes na+ and h2o retention which increases blood volume and pressure in turn this activates the reabsorption of uric acid resulting in elevation of sua in turn increased sua has been shown to increase tubular reabsorption of na+.": 1 "smoking pack/year": 1 "? = ? = 90 ? = 120": 1 "frequency of hras in pcc ?with unknown mutations": 1 "statins improving plaque stability pleiotropic effects independent of cholesterol lowering improving endothelial cell dysfunction moreover the direct/indirect antioxidant anti-inflammatory effects within the islet and the arterial vessel wall promoting stabilization of the unstable vulnerable islet and the arterial vessel wall style lifestyle modification weight loss exercise and change eating habits stop smoking.": 1 "percentage of determined nodes": 1 " malf n c": 1 "extraction method": 1 "gpi": 1 "fold of modulation by ouabain/k+-free medium in huvec or hela": 1 "nuclear receptor coactivator 1": 1 "validation of mirna binding site": 1 "epstein–barr virus positive 9 of gastric cancers": 1 "mating and sporulation frequency b": 1 "receptor responsible for signaling pathways mediating growth arrest and apoptosis inactivated by frame shift mutation in polya repeat within tgfbr2 coding sequence in patients with mismatch-repair defects or by inactivating mutation of kinase domain.": 1 "reference samples": 1 "tts mapping b": 1 "parasite exposure c": 1 "phase-ii 49 ipi monotherapy different doses 217 71 each at 3 mg/kg and 10 mg/kg": 1 "609": 1 "no devoloping leukemia": 1 "positive n?=?257 ": 1 "hbegf †": 1 " of mir-124a-3p counts": 1 "depression is caused by abnormalites in monoamine receptors.": 1 "below median": 1 "lipid": 1 "frequency diff_gene": 1 "retroarray samples paired": 1 "igfbps": 1 "sperm and oocytes ": 1 "440/3686 = 11.93": 1 "3 days": 1 "ic 50 nm": 1 "mouse gasgenes a": 1 "2redundancy in ao": 1 "grn": 1 "time to maximum": 1 "accesion no.": 1 "excellent poster award of japan digestive disease week 2008": 1 "582.4": 1 "gb number": 1 "enhances 5-fluorouracil-induced cell growth inhibition of hepatocellular carcinoma cells associated with ampk hyperactivation and cox-2 inhibition": 1 "facs or otherwise identified cerebral neurons*+": 1 "peripheral wbc/µl ×103": 1 "peaks in promoter": 1 "uncontrolled open": 1 "marker for early detection?": 1 "transcript 1": 1 "pcsc marker profile": 1 "localised": 1 "channel": 1 "inadequate treatment": 1 "encodes a pdgf that has a role in endothelial cell growth stimulating their proliferation and migration and also has effects on the permeability of blood vessels.": 1 "possible source of exposure": 1 "protein phosphatase 1 catalytic subunit beta isozyme1": 1 "630": 1 "methylenetetrahydrofolate dehydrogenase nadp+ dependent 1 methenyltetrahydrofolate cyclohydrolase formyltetrahydrofolate synthetase1": 1 "n50 contig length": 1 "1460227_at": 1 "632": 1 "633": 1 "tcrbind ? pagcsk ? lck ? fyn ? tcrphos ? zap70 ? ccbl ? tcrbind": 1 "?v integrin": 1 "gtp": 1 "tgf-?1-induced responsea": 1 "patient * #": 1 "mcf10a": 1 "3.4.1 provisional entity rars and thrombocytosis rars-t": 1 "643": 1 "10-genes": 1 "? nk activity of spleen cells in naïve balb/c mice": 1 "brca status": 1 " n?=?15": 1 "total in population": 1 " n?=?12": 1 "research associate baylar university medical center division of gastroenterology": 1 " 30 ": 1 "specimen no.": 1 "various peptides from the second and third type i repeats": 1 "no of patients n n?=?884": 1 "ala gct": 1 " n?=?25": 1 "par-3 partitioning defective 3 homolog": 1 " n?=?22": 1 "principle of ctc enrichment and detection": 1 " 31 ": 1 "folfox": 1 "aa252–330": 1 "history ofinfertility": 1 "32/350 = 9.14": 1 "hbsag": 1 "detection of dna lesionsc reference no.": 1 "13108.3": 1 "chordata 2173 gene set linked": 1 "50.0": 1 "?increased intraglomerular pressure": 1 "vol.": 1 " 32 ": 1 "670": 1 "hdac6 inhibition leads to hyperacetylated cortactin and impaired cell motility 15 17 .": 1 "isoelectric point *": 1 "?mesangial hypertrophy": 1 "677": 1 "relative expression": 1 " of stained tumor cells": 1 "s484p  ": 1 "134169": 1 "leads to cell growth inhibition and apoptosis in lung cancer cells via activation of ampk and inhibition of akt/mtor": 1 " 34 ": 1 "1427908_at": 1 "cg ? gc": 1 "treatment ?": 1 "1711.5": 1 "50.4": 1 "# mice treated": 1 "claudins": 1 "no sequences obtained": 1 "md graduated from the university of tokyo": 1 "distal to fra10f": 1 "units": 1 "2001–present": 1 "0.244": 1 "oocytes only ": 1 "nr of mirnas with seeds and negative correlation": 1 "692": 1 " iii identification of novel pharmacologic targets and nonpharmacologic strategies in hypertension attenuation": 1 "percentage of contigs annotated": 1 "total snps in 5'-utr": 1 "total length of sequences mbp": 1 "? binding partners elk4 etc.": 1 "normalized grb2 binding intensity": 1 "degree of medical science phd tokyo women's medical univ.": 1 "erbb2": 1 "overall signaling effect": 1 "0.135 0.621": 1 "mean composite score ± sem": 1 "median age of diagnosis?±?1 sd": 1 "ischemia-reperfusion": 1 "no of participating patients with egfr mutations": 1 "first gene binding sites of other tfs": 1 "her- 3 expression membranous or cytoplasmic": 1 "genes responsible for x-linked deafness ataxia and sideroblastic anaemia": 1 "detection method": 1 "mean duration of ben ±1sd": 1 " change b": 1 "up val": 1 "poor access to medical facilities": 1 "cancer vaccine": 1 "oral cavity cases": 1 "iiib": 1 "major findings": 1 "history of previousectopic pregnancy": 1 "frequency at diagnosis 5 6": 1 "gene and accession number of detected transcripts": 1 "?nonenzymatic enhancement of angiotensin ii synthesis": 1 "impact of diet bmi and physical activity": 1 "expressed by": 1 "special situations": 1 "mw kda": 1 "or 95 ci †": 1 "n?=?44 4119": 1 " 38 ": 1 "definition of positivity": 1 "molecule": 1 "transmembrane glycoprotein involved in calcium-dependent intercellular adhesion": 1 "jsgs award science of the year 2013": 1 "host-cell target": 1 "associate professor of medicine division of hematology/oncology ucla david geffen school of medicine university of california los angeles": 1 "gcis q- value library #": 1 " n?=?94": 1 "csa tac": 1 "mir-146a knock-out mice present myeloid malignancies 59 60 ": 1 "eukaryotic initiation factor 4 binding protein-1 4e-bp-1": 1 " 39 ": 1 "mutation present in >90 of tumors with microsatellite instability and 15 of microsatellite stable colon cancers": 1 "shift up": 1 "pna+": 1 "dilution and incubation time": 1 "downregulates cox-2 and pakt in an ampk-dependent manner leading to apoptosis of h29 colon cancer cells": 1 "complex ii sdha sdhb sdhc sdhd": 1 "6986a>g": 1 "phosphosite 2": 1 " unique and non-ribo": 1 "literature a": 1 "literature b": 1 "melting point °c": 1 "tumor id": 1 "iud user or progestagencontraception": 1 "pstaire box sequence b no of substitutions": 1 " properly classified": 1 "clusters of ? two peroxisomes with adherent membranes c ": 1 "28.8": 1 "22 42": 1 "22 41": 1 "evidence found in pah": 1 "deoxyri bo nuclease 1 dnasel": 1 "antagonist": 1 "1990–1992": 1 "smads": 1 "han": 1 "colony formation assay": 1 "22 34": 1 "substitution type": 1 "keyword": 1 "t mongolicum": 1 "angiotensin ii also induces pkc-? isoform amylin hyperamylinemia / amyloid toxicity ages/afes advanced glycosylation/fructosylation endproducts apolipoprotein b antioxidant reserve compromised absence of antioxidant network aging adma asymmetrical dimethyl arginine": 1 "function of phosphosite": 1 "incidence ": 1 "22 46": 1 "tcrbind ? tcrphos ? zap70 ? ccbl ? tcrbind": 1 "st6gal1 mrna level b": 1 "1986–1992": 1 " n?=?59": 1 "1 negative": 1 "related gene counts": 1 "histopathology": 1 "total of ests": 1 " n?=?52": 1 "frequency of missense mutations in breast cancer # most frequent in breast cancer in other tumors # most frequent": 1 "moderately resistant": 1 "fold change rt-pcr a": 1 "syndecan-4 stromal staining": 1 "a candidate or bonafide tumor suppressor genes on chromosome 8p": 1 "angiogenesis blastocyst growth": 1 "mrna-mirna pair": 1 "mrna processing rna splicing": 1 "squamous cell lung carcinoma": 1 "viral vectors": 1 "tn4 ×106": 1 "type iii": 1 "ballroom d meet the experts vii evs in the tumor microenvironment chair aled clayton speakers david lyden and mattias belting": 1 "#hiv interactors": 1 "major function": 1 "experimental versus control condition": 1 "positive n?=?114 ": 1 "metachronous": 1 "nr of mirnas with ?7mer seeds and negative correlation": 1 "catechin": 1 "min degree": 1 "subfamily of fgf": 1 " n=33 a": 1 "caucasians": 1 "brca1 mutation": 1 "29679": 1 "invited researcher genetics division national cancer center research institute": 1 "gene id ensrnog": 1 "doublet": 1 "?3 progressive but aberrant differentiation.": 1 "persistent or unacceptable grade 2 toxicities at 10 mg dose 10 mg alternating with 5 mg": 1 "frequency of lys allele p*": 1 "cases*": 1 "stat-3-specific transcriptional activity of control": 1 "cases ": 1 "frequency in primary tumor*": 1 "adas cog cgi and npi scales": 1 "department of gastroenterology and hepatology kinki university": 1 "alternative splices": 1 "number of intense bands": 1 "sirt3 protein": 1 "impact on ras activity of control c": 1 "clinical characteristics": 1 "sirtuin": 1 "gene/mutation*": 1 "model system": 1 "integrin–binding sequence of the n-ter domain": 1 "numerical abnormalities": 1 "protein-level dosage compensation": 1 "as iii 150 ppm": 1 "start bp .": 1 "adverse events": 1 "who grade": 1 "blast result": 1 "length to sc bpc": 1 "bm387283": 1 "high n?=?19": 1 "genes identified based on b statistic": 1 "methylation markers": 1 "raised in": 1 "kallikrein 1 integral optical density value": 1 "proximal": 1 "adjusted for covariates": 1 "mutation or activity/expression": 1 "fs/d": 1 "bcl3 †": 1 "papulation 0–3": 1 "found in tissuereference": 1 "abnormality in resistance": 1 "ic50 µm without azi": 1 "? pathways dna repair inflammation gene transcription in glycolysis myc signaling ribosomal biogenesis": 1 "shi-ming lin": 1 "ain-1 a": 1 "genes responsible for deficiency of coenzyme q and cardiolipin": 1 "after removal of vector poly-a contaminating microbial sequences and very short sequences >100 bp gigr706801–gr716890": 1 "number of genes": 1 "3190.2": 1 "breast tumor data": 1 "the cell cycle regulator": 1 "1547": 1 "bcl-2/bax": 1 "kinetics of translocation of gfp-pkc? plasma membrane": 1 "irf-7 *": 1 "final total daily dose d mg": 1 "a days": 1 "46 75": 1 "1554": 1 "1999–2003": 1 "effect of schwann cell specificdicer depletion in p4 pvalue": 1 "n° of positive cases/number of cases analysed by rt-pcr": 1 "neutropenic infections – as for chemotherapy-related febrile neutropenia": 1 "cytoplasmic nuclear": 1 "encodes the integrin beta 1 protein which is a membrane receptor involved in cell adhesion and recognition in a variety of processes including embryogenesis hemostasis tissue repair immune response and metastatic diffusion of tumor cells.": 1 "nfkbib": 1 "831.6": 1 "leukemia inhibitory factor": 1 "genomic position and allelesa": 1 "taqman fold change": 1 "52 54": 1 "sbp mmhg": 1 "somatic cell properties of mitotic derivatives of raju cells": 1 "guanylate cyclase 2c heat stable enterotoxin receptor": 1 "# tumor-free mice at the end of the treatment b": 1 "interior positions in globule p *": 1 "1.1.3 refractory neutropenia": 1 "2008–2011": 1 "polyadenylated rnas greater than 200 nucleotides in length that regulate gene expression through epigenetic regulation splicing imprinting transcriptional regulation and intracellular transport >200 nt 21 ": 1 "calm2": 1 "additional genes in cis": 1 "positivity in primary nlphl cases a": 1 "protein function gene ontology": 1 "inhibition of the inflammatory cytokines il-1 ? and tnf- ?": 1 "rassf2 methylation status": 1 "raf case": 1 "ttp mos.": 1 "histopathologic description": 1 "percentage of tumorsamples show more signalthan pneumocytes": 1 "7-9": 1 "h_kit2_t12/21": 1 "g2/m": 1 "non-related tk a": 1 "cyp3a4 cyp3a4": 1 "non- hodgkin's lymphoma cutaneous t-cell": 1 "number of ligands": 1 "primary reference": 1 "?water and solute retention": 1 "androgen receptor ar": 1 "mosaic mutations of mosaic": 1 "7.6": 1 "group iv": 1 "gs?": 1 "support agilent array": 1 "sr11237": 1 "real-time rt-pcr": 1 "h sapiens": 1 "group ii": 1 "library name": 1 "tsai-chen’s": 1 " n?=?3": 1 "104 bacteria/ml": 1 "assembly": 1 "39 61": 1 "strong expression": 1 "? phenotypes of sirt4 ko mice lung cancer": 1 "subjects": 1 "ballroom d-e plenary session chairs marca wauben and andrew hill": 1 "differentially expressed genes": 1 "ergo-1": 1 "rat cdna clone partial cds": 1 "geographic origin": 1 "103.6": 1 "encodes an integrin membrane receptor involved in cell adhesion and a number of processes including immune response": 1 "706": 1 "no of icm picked": 1 "her2 status primary tumors": 1 "promoter methylation status": 1 "encodes a member of the dual specificity protein kinase family which acts as a mitogen-activated protein map kinase kinase map kinases also known as extracellular signal-regulated kinases erks act as an integration point for multiple biochemical signals as an essential component of map kinase signal transduction pathway this kinase is involved in many cellular processes such as proliferation differentiation transcription regulation and development.": 1 "areas or origin": 1 "decreased capacity of oxphos due to diminished activities of respiratory chain complexes and matrix enzymes resulting from mutations and inhibitions": 1 "of bdnf/trkb": 1 "total distance µm±sd": 1 "hla supertype": 1 "kinase insert domain receptor a type iii receptor tyrosine kinase": 1 "1421207_at": 1 "prevalence >50 of all urothelial tumors and increased prevalence in low-grade tumors": 1 "nashdx": 1 "a acute eosinophilic leukemia hypereosinophilia and eosinophils ?30 and myeloblasts ?20": 1 "# of gexp??tf links in tcga": 1 "cpg island a": 1 "with ngf": 1 "positive n?=?111 ": 1 "method of synthesis": 1 "hsf": 1 "source of dna": 1 "?vascular resistance to vegfr and pdgfr inhibition by sunitinib": 1 "729": 1 "s100?": 1 "normal n=9": 1 "median survival": 1 "level of evidence": 1 "c14b1.7 a": 1 "hi induces ang ii which promotes the map kinase pathway and remodeling.": 1 "jun 1999–may 2000": 1 "cox of c": 1 "protocol for dc": 1 "7-day assay": 1 "locus tag": 1 "guanine nucleotide-binding proteins g proteins are involved as modulators or transducers in various transmembrane signaling systems.": 1 "15 58": 1 "mycn amplified": 1 "previous medical history": 1 "location on chromosome 10 mb": 1 "27 42": 1 "iia/i": 1 "type of response": 1 "estrogen-dependent": 1 "increase fold in treated larva b": 1 "nodes": 1 "agi code": 1 " 3 immunoresistance genes": 1 "encodes a class iii receptor tyrosine kinase that regulates hematopoiesis the receptor is activated by binding of the fms-related tyrosine kinase 3 ligand to the extracellular domain which induces homodimer formation in the plasma membrane leading to autophosphorylation of the receptor the activated receptor kinase subsequently phosphorylates and activates multiple cytoplasmic effector molecules in pathways involved in apoptosis proliferation and differentiation of hematopoietic cells in bone marrow.": 1 "transcription processing and chromatin structure": 1 "all edges 67 node pairs": 1 " 40 ": 1 "750": 1 "2002–present": 1 "64.5": 1 "residues in disallowed region ": 1 "relevant targets": 1 "sensitive": 1 "sum of": 1 " 41 ": 1 "average contig coverage": 1 " down": 1 " percent of optic lobes affected": 1 "single-wavelength": 1 "htert": 1 "adverse effects": 1 "her2 status metastases": 1 "name of study": 1 "snp site": 1 "1.1.4 refractory thrombocytopenia": 1 "association of claudin protein expression based on ihc and patient survival": 1 "1230-1330": 1 "icd and damps in vitro": 1 "relative bundle area": 1 " 42 ": 1 "clinical parameter desmedt et.al 2007 ": 1 "codon 13": 1 "abmk": 1 "773": 1 "inos or type ii": 1 "mammary gland": 1 "ng/ul rna": 1 "sequences and location at 3?utr of human cd44 mrna": 1 "cdkn2a genotyping results": 1 "100 ?l sample/50 times more sensitive": 1 "independent predictor of tumor recurrence": 1 "gene function": 1 "trigger": 1 "significance p value": 1 " 43 ": 1 "before senescent-like phenotype": 1 "transgene localization": 1 "psph in tumor": 1 "total rna yield ug": 1 "c/ebpb 110 ": 1 "completely resistant": 1 "210.4": 1 "resident in medicine & clinical fellow in gastroenterology mitsui memorial hospital tokyo": 1 "0.346": 1 "bac clone": 1 "?tissues biopsy special stains for mycobacteria and fungi neoplastic lesions investigated for hpv and herpes virus nucleic acid or antigens": 1 "direct/indirect carcinogenesis*": 1 "fisher’s exact test p value": 1 "casa noteworthy": 1 "? pathways genome stability by modulation of mitotic integrity": 1 "children ch": 1 "identified protein": 1 "b_rotation res 4 11": 1 "? 3 expression": 1 "frequency of a148t gene cdkn2a polymorphism": 1 "designation": 1 " 1 active vaccination subunit vaccines from tumor lysates": 1 "macugen": 1 "fc 5": 1 "alkali extract": 1 "rs number": 1 "enhance immunogenicity of infected cells": 1 "minimal common region": 1 "riceids with gos d": 1 "?d cbfb -fusion gene-related acute myeloid leukemia aml-eo": 1 "1.2 mm al": 1 "activation of the alternative complement pathway": 1 "number of the matched peptides": 1 "gab2 expression of lung adenocarcinomas": 1 "processing of pre-mirna into mirnamirna *": 1 "total consensus megabases": 1 "average singlet length bp": 1 "2000–2006": 1 "in med.": 1 "3944.2": 1 "clinicopathological factors": 1 "r.m.s.d bond length å": 1 "number of sequences": 1 "regulation": 1 "activates ampk and suppresses lps-induced nf-?b-dependent cox-2 activation in raw 264.7 macrophage cells": 1 "• cardiac myocyte stat3-deficient mice show reduced myocardial capillary density and increased interstitial fibrosis within 4 mo followed by dilated cardiomyopathy with impaired cardiac function and premature death due to heart failure 5": 1 "positive 57 55": 1 "np_002015": 1 "khan and e coll protocol sz/m": 1 "16th week": 1 "number of negative correlations gexp lower | ? tp53 ": 1 "4.15": 1 "stat-3-ser 727 phosphorylation of control": 1 "mouse id with tumor": 1 "total length of ests kbp": 1 "tumor grade bng": 1 "relaxation of vsm*": 1 "methylated 2": 1 "er status": 1 "284.8": 1 "sequence 5??3?a or description restriction sites are underlined": 1 "potentiates arsenic trioxide-induced apoptosis in human leukemia cells by activation of ampk": 1 "hras1 †": 1 "284.1": 1 "iarc classificationa": 1 "od 260/230": 1 "aggressive control of diabetes to hba1c of less than 7 this usually requires combination therapy with the use of insulin secretagogues insulin sensitizers ppar-gamma agonists biguanides alpha-glucosidase inhibitors and ultimately exogenous insulin decreasing modified ldl cholesterol i.e glycated-glycoxidated ldl cholesterol improving endothelial cell dysfunction also decreasing glucotoxicity and the oxidative-redox stress to the intima and pancreatic islet aggressive control of blood pressure which usually requires combination therapy including thiazide diuretics to attain jnc 7 guidelines aggressive control of homocysteine with folic acid with its associated additional positive effect on re-coupling the enos enzyme reaction by restoring the activity of the bh4 cofactor to run the enos reaction via a folate shuttle mechanism and once again produce eno aggressive control of uric acid levels with xanthine oxidase inhibitors allopurinol and oxypurinol should be strongly considered in view of the prevailing literature in order to achieve more complete global risk reduction": 1 "?2.69 ± 0.21": 1 "1994–1999": 1 "4.19": 1 "hgfr": 1 "547.5": 1 "? d counterattack fas ligand and pd-l/b7-h family members": 1 "2redundancy in so": 1 "mir-196b": 1 "29.9": 1 "fold change log2 a": 1 "melanocytes/melanoma cells": 1 "cysteine rich protein 61 cyr61": 1 "lux-lung 3 24 afatinib 40 mg": 1 "total of unigenes": 1 "29.4": 1 "? a bcl-2 survivin": 1 "sequenom's assay name": 1 "29.0": 1 "without signal": 1 "4.44": 1 "reaction": 1 "percentage of inhibition": 1 "low n?=?19": 1 "low n?=?18": 1 "immunocytotoxicity": 1 "country total no of nodes": 1 "mib-1 b ": 1 "charactistics": 1 "pathways and genes correlated with tf loss of function mutations david/biocarta": 1 "protein targeting transport": 1 "anthocyanin": 1 "atrial dilation": 1 "8 h": 1 "number of peptide to spectrum matches / unique peptides": 1 "277.05": 1 "gene module by mcl algorithm": 1 "shrna 19mer identified": 1 "dlc1": 1 "st6gal1 irs b": 1 "cd4 +": 1 "phase iii 6 ipi and dtic ipi at 10 mg/kg 250": 1 "braf mutation": 1 "4.66": 1 "*18b": 1 "shep-tr- mir-17-92": 1 "codon 146": 1 "? a lak cells": 1 "c david glioma": 1 "protein content of milk g/100?ml": 1 "unigene symbol": 1 "acc number": 1 "16.3": 1 "genbank acc no": 1 "higher in her2+": 1 "percentage of annotated contigs by swissprot": 1 "? b cd133": 1 "encodes an integrin alpha chain family protein integral to the membrane and known to be involved in cellular adhesion/aggregation processes": 1 "no differences in the cognitive score between treatment and control groups": 1 "recessive model or 95 ci † ‡": 1 "tumorigenesis": 1 "north india": 1 "4.87": 1 "opening of the pt pore": 1 "fragment size in bp": 1 "aa665–721": 1 "gc subtype": 1 "patient numbers treated/control": 1 "xiap* median": 1 "previous id": 1 "director kyoundo hospital tokyo japan": 1 "reason s for dose modification": 1 "microarray *": 1 "0 gy": 1 "primers 5’ to 3’": 1 "strain a": 1 "inhibited by plzf": 1 "codon 61": 1 "msi vs mss": 1 "p53 stabilization": 1 "galactomannan": 1 "no of cells transplanted": 1 "total sample size": 1 "igg": 1 "4.90": 1 "ballroom e meet the experts v bacterial and parasite evs chair pamela wearsch speakers yong song gho and antonio marcilla": 1 "igm": 1 "48876/3744": 1 "emax mev": 1 "effect of manipulation on behavioral consequences": 1 "biofilm": 1 "upregulated mirna": 1 "978.6": 1 "48?h": 1 "oncogene and transducer of receptor of tyrosine kinase": 1 "antigen class/description": 1 "ihc": 1 "2 ctnnb1": 1 "increased microvessel density independent predictor of disease free and overall survival increased serum vegf independent predictor of poor disease survival on univariate analysis": 1 "generated neural cell type": 1 "prohibitin expression": 1 "profile2 *": 1 "status of p53 a": 1 "15 44": 1 "protein target a": 1 " ii improvement in gene expression quantitation and transcriptome data": 1 "microarray a": 1 "control group a": 1 "3' gene": 1 "stimulating gsh regeneration via glutathione and thioredoxin reductase.": 1 "peptide sequence": 1 "iib": 1 "#known gene-asso pet1 over pet1": 1 "classical": 1 "mss-aneuploid": 1 "methanol": 1 "neurofibromas or plexiform neurofibromas": 1 " 72 73 ": 1 "small 0.1–1?mm": 1 "adas cog and cgic change score": 1 "stable disease ": 1 "1644": 1 "15 25": 1 "2972": 1 "nos2 low": 1 "subclass": 1 "first": 1 "compound/company/route of administration": 1 "changes in proteasome-mediated protein degradation pathway": 1 "culture medium": 1 "1416184_s_at": 1 "type iii collagen ng/ml": 1 "human breast cancer cell lines with endogenous mutation based on handbook of p53 mutations in cell lines v 1.0 http//p53.free.fr/ ": 1 "psk1/ev ratio": 1 "pdgfrl": 1 "relationship to response": 1 "other alterations": 1 "od 260/280": 1 "decrease in total smad3c": 1 "aaa36765": 1 "331.2?±?10.0º": 1 "ril / cdh13 panel": 1 "materials/carriers": 1 "study size": 1 "? d tgf- ? knockdown": 1 "cerebellar": 1 "keywords associated with the domain": 1 "relation to clinicopathological factors": 1 "caveolin-1 and akt negative n =137": 1 "3071.7": 1 "spp1 †": 1 "decreases reactive oxygen species levels and induces antioxidant enzymes manganese superoxide dismutase and catalase in a ampk and pten-dependent manner in prostate cancer cells": 1 "functional annotations by david": 1 " 78 103 129 ": 1 "isoforms present in ctls": 1 "positive n?=?98 ": 1 "only reproduction": 1 "fold of changeb": 1 "decrease in total smad2c": 1 "resistance confirmed": 1 "shank3": 1 "markus peck-radosavljevic": 1 "biomarker staining": 1 "chronic antidepressants alter sensitization state of receptors": 1 "downregulating il-1?": 1 "952.3": 1 "c16c10.3": 1 "1113.8": 1 "postinitiation phase of ? -catenin positive cells": 1 "intermediate and late phase only up-regulated mechanistic genes": 1 "1689": 1 "dna mutations": 1 " restriction with respect to ad-libitum diet": 1 "number of receptors/cell bmax": 1 "profile1 or signature *": 1 "enzymatic activity": 1 "growth": 1 "molec wt da": 1 "2746.3": 1 " of sequence coverage": 1 "her- 4 expression membranous or cytoplasmic": 1 "main types of decay probability b": 1 "cancer target": 1 "synovial t cells exist in an environment favouring cell survival": 1 "resolution": 1 "sesamol ppm": 1 "c = skin lesion score": 1 "ath1": 1 "snail expression": 1 "most frequent codons mutated": 1 "histopathologic classification": 1 "incidence/no of reported cases": 1 "hits in subset": 1 "transient stem cell properties of raju cells": 1 "int-2": 1 "type of patients": 1 "cancer indication": 1 "non-coding rna molecules involved in pre-mrna splicing and regulation of transcription factors 20 ": 1 "mycn nonamplified": 1 "? sirt2 ? gliomas breast cancers hcc head and neck squamous cell carcinoma esophageal adenocarcinoma": 1 " number of blue colonies": 1 "criterion": 1 "primer": 1 "endosome area ?m2": 1 "putative target genes": 1 "taqman": 1 "clinicopathological or molecular feature": 1 "graduated from kyoto university": 1 "similar lbs": 1 "comments on final structure": 1 "both systems": 1 "karyotype of neoplasm": 1 "number of": 1 "kras and braf wild type": 1 "antiviral activity in vitro": 1 "gene/accession no.": 1 "224.2": 1 "aa no.": 1 "357.0": 1 "1690.3": 1 "time for enrichment minute": 1 "platinum-sensitivity": 1 "randomized double-blind placebo-controlled": 1 "patients with a cyp3a4*1/*1 genotype were found to have a higher dose-adjusted concentration compared with those with cyp3a4*18b/*18b.": 1 "stat3 ? ": 1 "source of organisms": 1 "duration in weeks range": 1 "357.6": 1 "early phase down-regulated genes": 1 "chief investigator of study group of data mining analysis for chronic hepatitis c in japanese ministry of health welfare and labor": 1 "no relationship was observed between the recipient cyp3a5 6986a>g genotype and the incidence of acute rejection.": 1 "non-mutated": 1 "transposase vector mpbase ?g": 1 "xenografts with colon breast": 1 "? sirt2 ? acute myeloid leukemia neuroblastoma pancreatic cancer hcc.": 1 "dna single-nucleotide mismatch-repair defect permitting the accumulation of oncogenic mutations and tumor-suppressor loss inactivating mutation impairs ability to repair strand slippage within nucleotide repeats.": 1 "? tnf- ? il-8 no": 1 "function of rhamm in cancer": 1 "most frequent mutations": 1 "laboratory of molecular medicine human genome center institute of medical science the university of tokyo": 1 "productive matings ": 1 "detection limit": 1 "neurosphere number": 1 "tomomi kogiso": 1 "macrophages and dcs in normal mice": 1 "rin-induced neurites a": 1 "? tnf- ? ifn- ? released from spleen cells tnf- ? expressed": 1 "free fatty acid toxicity obesity toxicity triad": 1 "treatment response criteria": 1 "competed out by mtx b": 1 "production": 1 "nm_012915": 1 "bp50 mmhg": 1 "swissprot accession number": 1 "krt19": 1 "tissue localization in the brain": 1 "secondary screen df or specific mutation": 1 "a_rotation res 4 11": 1 "raf ctrls": 1 "smad3 wt or mutant": 1 "prnp ?/? mouse origin": 1 "comments regarding the possible connection of the identified mirna gene with breast cancer and/or estrogenic responses bone fide targets of mirnas are indicated": 1 "mlh1 expression": 1 "859": 1 "elicits a powerful immune response": 1 "up in set2 ? b": 1 "monoaminergic hypothesis 1960s-1970s": 1 "description of the proteins expressed in high abundance in hypertrophied salivary glands": 1 "nuclear in control methanol": 1 "methylenetetrahydrofolate dehydrogenase nadp+ dependent 2 methenyltetrahydrofolate cyclohydrolase": 1 "cox dependence unclear": 1 "abcb1 no.": 1 "cells injected on day 0": 1 "number ofmicroarrays": 1 "titer for is": 1 "179.7": 1 "time of tumor sample": 1 "study in patient samples?": 1 "cells with variant s": 1 "progastrin staining in hp epithelial cells": 1 "drug or stimulus": 1 "intensity of staining": 1 "2.1 classic": 1 "significant adverse effects": 1 "?6 are they transiently expressing tissue stem cell specific surface markers? e.g cd34+ for hematopoietic cells 8 cd133+ for brain cells 12 13 cd44+ cd33- lowlin- for breast cells 9-11 cd20+ for skin cells 40 cd44+? 2? 1hi/cd133+ for prostate cancer cells 41.": 1 "jun 2000–may 2001": 1 "growth hormone receptor ghr": 1 "? blood count monocytopenia may be obscured by progenitor mobilization or atypical lymphocytosis during infection": 1 "a antibodies for pla analysis": 1 "cytogenetic risk": 1 "chemical class": 1 "3 h maa": 1 "21 39": 1 "affected gene": 1 "resident in internal medicine surgery and anesthesiology tama-hokubu medical center tokyo japan": 1 " 5 dendritic cell vaccination": 1 "endometrial sarcoma": 1 "889": 1 "slow proliferation": 1 "52.8": 1 "bmes trend": 1 "average tumor weight g": 1 "role of ppar ?": 1 "function of cd44 in cancer": 1 "case control": 1 " p 567.pxx": 1 "other cancers in patient": 1 "7859": 1 "percentage of mitochondria with altered cristae": 1 "study phase": 1 " n?=?171": 1 "position bp": 1 "interpro identification": 1 "1?g": 1 "critical components of transforming growth factor ? pathway signaling along with related proteins smad2 and smad3 smad4 and smad2 are located on chromosome 18q a frequent site of loss of heterozygosity in colorectal cancers inactivated by homozygous deletion or mutation.": 1 "activated in pds by gis1 c": 1 " 56 ": 1 "probe sets": 1 "cgggcgggcgcgagggagggg": 1 "sequences 5'?3'": 1 "encodes one of the two receptors of the vegf and is a main mediator of vegf-induced endothelial proliferation survival migration tubular morphogenesis and sprouting.": 1 "20th week": 1 "average length of unique sequences bp": 1 "etiologic agent/pathologic condition": 1 "mss-diploid": 1 "advantage and limitations": 1 "inhibition of proinflammatory cytokines no and tnf- ?": 1 "usa 7811": 1 "precision": 1 "f58g1.1": 1 "modifier": 1 "reverse stre cccct": 1 "activates ampk to suppress cox-2 and inhibit cell survival in ht-29 colon cancer cells": 1 "blood volume per test ml": 1 "stimulates ampk resulting in downregulation of ppar? in 3t3-l1 adipocytes and in cox-2 in mcf-7 breast cancer cells inhibiting differentiation and growth": 1 "gdnf detection": 1 "?7 they are subject to aging and associated senescence brought about by telomere attrition.": 1 "fold change lplunc/vector": 1 "hybrid intensity of control": 1 "sex/age": 1 "5231": 1 "same as ppp1ca above": 1 "pts with 3 or more spns": 1 "? endocytic activity of dc": 1 "? substrates h3k18": 1 "protein/gene definition": 1 "3 mds/mpn": 1 "weak expression": 1 "trkb mrna": 1 "total number of clones scored": 1 "mw kd": 1 "odds ratio 95 ci": 1 "strong positive rate ": 1 "ndf59 aris101": 1 "human mammary epithelial cell characteristics associated with the presence of mutant p53": 1 "hdac6 forms a complex with sgs and g3bp1 and eventually induces a reversible translational suppression 43 .": 1 "nucleotide state": 1 "support vector machine predict": 1 "days n for doubling birth weight3": 1 "distribution of decreased/increased transcripts in the nhx1 mutant 2": 1 "endothelium": 1 "?glomerular and tubolointerstitial microinflammation": 1 "?-infuse virus-directed cytotoxic t cells": 1 "assistance of drosha function in the microprocessor": 1 "deregulation in mm versus normal control unless specified": 1 "subgroups n ": 1 "planktonic": 1 "depth ?m": 1 "number of non-h atoms†": 1 "repressed in log phase by gis1 a": 1 "cancer site": 1 "treatments investigated": 1 "stromal staining": 1 "negative n?=?693 ": 1 "score2": 1 "score3": 1 "score4": 1 "rm for group*": 1 "similar to riken cdna 3930401k13": 1 "primary location": 1 "moap-1 staining pattern": 1 "distance between the outer and inner mitochondrial membrane nm": 1 "bc088347": 1 "24-hydroxyursolic acid from persimmon": 1 "positive edges only 271 node pairs": 1 "cd36-mediated ec apoptosis inhibition of ec response to agf binding to protein/glycosaminoglycans tgf-?activation integrin antagonist": 1 "high n ": 1 "sorbs3": 1 "3.3 atypical chronic myeloid leukaemia bcr-abl1-negative": 1 "occasional changes of genome favorable for cell survival and proliferation": 1 "t1/2 h ± s.d.": 1 "tumour cells 10 4 *": 1 "npcis fos ?/?": 1 "gene encodes a protein that is a membrane bound gtpase that is linked to 7-tm receptors": 1 "tdcis p -value library #": 1 "wky-7": 1 "species and hormone treatment": 1 "adenylyl cyclase activity pmol of camp/mg/min a": 1 "a1029745": 1 "division of hepatology department of gastroenterology and hepatology chang gung memorial hospital chang gung university": 1 "abcb1 3435c>t abcb12677g>t/a": 1 "brain tumour type": 1 "score1": 1 "actb": 1 "ligand name": 1 "risk/ non-risk allele": 1 "strong +++": 1 "no of genes b": 1 "2003–present": 1 "gfphi leukocytes c": 1 "regulated genea": 1 "detection": 1 "negative n = 6": 1 "arg1 post-nom": 1 "17cen-q12": 1 " bilaterality of tumors*": 1 "protein domainsb": 1 "poor compliance/adherence to therapy": 1 "130/1149 = 11.31": 1 "1–3": 1 "cut-off value": 1 "17.6": 1 "atpase inhibitor rat mitochondrial 1f1": 1 "isoform targeted": 1 "?e-cadherin": 1 "?-upregulate viral antigen presentation": 1 "loss of e2a": 1 "correlation with sequence length": 1 "toxicity": 1 "leading term a": 1 " ii subsequently": 1 "1996–2006": 1 "1 myelodysplastic syndromes mds": 1 "chromatin state at tss": 1 "s/s or s/ +": 1 "dose of topotecan mg/kg": 1 "ncbi accession no.": 1 "?personal history sometimes with family history of warts mycobacterial infection autoimmunity chest disease cytopenias acute myeloid leukaemia": 1 "genes at the locus of amplification": 1 "hmlh1 expression": 1 "? c mhc and/or costimulator molecules": 1 "brain different regions": 1 "p-akt expression": 1 " 6 *": 1 "165.8": 1 "explanation of biopax entities example documentation best practice recommendations use cases and instructions for carrying out frequently used technical tasks.": 1 "kras mutation": 1 "the cell-surface phenotype is suggestive of chronic immune activation e.g expression of cd45ro cd69 and subsets of chemokine receptors": 1 "type of ovarian cancer": 1 "associated scc?": 1 "hypertriglyceridemia – diet modification": 1 "clinicopathological variables a": 1 "award of fukuoka medical society": 1 "mouse strain rcas vectors delivered": 1 "total thymocytes ×107": 1 "snv concordance to validation data set": 1 "animal/cell": 1 "annotated gene": 1 "pik3ca ": 1 "srebp-1": 1 "anomalies": 1 "? il-1 ? tnf- ? il-6": 1 "2003–2004": 1 "times and temperatures": 1 "775.2": 1 "adcy8": 1 "diameter mitochondria ?m": 1 "plasma concentration endogenous": 1 "f55a12.1": 1 "activates ampk to induce cell death in caov3 ovarian cancer cells in a p38 mapk-dependent manner": 1 "evidences of immunogenicity": 1 "recurrence tamoxifen versus no tamoxifen": 1 "genetic defect": 1 "positive n?=?88 ": 1 "sequences in the pro-collagen domain": 1 "24 h maa": 1 "human cd14+ mononuclear cells": 1 " of specific codon mutations": 1 "caveolin-1 isoform": 1 "a gene encoding a protein necessary for the creation and maintenance of epithelial cell layers by regulating cell growth and adhesion between cells and also anchors the actin cytoskeleton": 1 "contractile function": 1 "# of tumors": 1 "invasive": 1 "sr11237 100 nm + bms ligands a": 1 "germ-line mutation in li–fraumeni syndrome inactivation may coincide with malignant transformation of adenomas.": 1 "cyp3a4*22 was not associated with changes in tacrolimus dose requirements.": 1 "ppid": 1 "body fluid": 1 "promotes autophagy-mediated cell death in chronic myelogenous leukemia cells in an ampk-dependent manner": 1 "ssecks inductionb": 1 "dose mg/kg/day": 1 "snp id and other information": 1 "p down": 1 "loss-of-function": 1 "type of microvesicles according to publication authors": 1 "number of people at risk": 1 " m–h? msel a": 1 "hdac6 inhibition leads to apoptosis 37 .": 1 "reference number": 1 "effect of schwann cell specificdicer depletion in p4 log2 ratio": 1 "zk1248.7": 1 "survival weeks phi": 1 "unmethylation and partial methylation <10": 1 "titer for wb": 1 "the anti-hcc effects": 1 "cancer tissue type": 1 "ab167522": 1 "single stranded rna complementary to transcribed mrnas involved in binding and blocking the translation process of the mrna target 22 ": 1 "1449254_at": 1 "less differentiated phenotype": 1 "grade score": 1 "positive n?=?84 ": 1 "concentration in ?m": 1 "126842 18445": 1 "4496.3": 1 "in vivo model": 1 "proportion of aqp5 labeling": 1 "gene a": 1 "bronchomalacia": 1 "heart failure": 1 "carcinogen dose and time of treatment": 1 "x-ray source": 1 "transgenic marker": 1 "rala expression": 1 "2480.0": 1 "induces cell death in hepg2 cells and reduces tumor volume in a tumor xenograft model": 1 "1451042_a_at": 1 "abnormality": 1 "pfam description of the domain": 1 "percentage of protein coverage": 1 "9.7": 1 "9.8": 1 "? gata-2 gene deletion mutation in codons 1–398 or intron 5 enhancer": 1 "pp32 nuclear expression": 1 "32-83": 1 "matched peaks": 1 "a gg ag gggcgc t g gggaggg t": 1 "hi increases the number of at-1 receptors.": 1 "genetic change": 1 "comparison group b": 1 "cav-1 expression is significantly increased in prostate cancer versus normal epithelium cav-1 expression is increased in metastatic versus localized prostate cancer in contrast with psa cav-1 is an oncogene that significantly contributes to the biology of aggressive disease prostate cancer cells secrete cav-1 into the tumor microenvironment like endogenous cav-1 secreted cav-1 promotes malignant progression through antiapoptotic activities stimulation of angiogenesis castrate-resistant growth and metastases formation secreted cav-1 can be reliably and reproducibly measured from peripheral blood using a cav-1-specific elisa serum cav-1 levels are significantly higher in men with clinically localized prostate cancer than in men with bph or healthy controls high pretreatment levels of serum cav-1 predict for a shorter time to biochemical recurrence in patients undergoing radical prostatectomy for localized disease.": 1 "9.19": 1 "complete response": 1 "change in expression over disease progression": 1 "nuclear membrane organization and biogenesis": 1 "this gene encodes a nuclear-encoded mitochondrial bifunctional enzyme with methylenetetrahydrofolate dehydrogenase and methenyltetrahydrofolate cyclohydrolase activities the enzyme functions as a homodimer and is unique in its absolute requirement for magnesium and inorganic phosphate.": 1 "activated in pds by rph1 d": 1 "approximate reported frequency": 1 "13 46.4": 1 "study group 1": 1 "?-reduce immune tolerance": 1 "study group 2": 1 "?-viral protein activates a toxin gancyclovir": 1 "cdc25a protein expression": 1 "number of affected individuals in family total number of tumors": 1 "number of nodules": 1 "s-phase of control ± standard error": 1 "method of production of cell lines": 1 "macrometastasis b": 1 "product size bp": 1 "tgf- ? 1 expression": 1 "915": 1 "number of reads assembled": 1 "9.37": 1 "nb snp": 1 "fat-1 mouse": 1 "blast response ": 1 "professor and chairman department of genome biology kinki": 1 "proteina": 1 "peroxisome proliferator activated receptor gamma": 1 "gastric lesion": 1 "similar to apoptosis related protein apr-3": 1 "promoter associated longrnas pars": 1 "hisako yamakawa award at tokyo women's medical university": 1 "myc †": 1 "50-75": 1 "? sirt7 ? hepatocellular carcinoma hcc": 1 "isoelectric point pi": 1 "p27 54 ": 1 "embryos": 1 "proteins": 1 "transcript support": 1 "genetic contrast": 1 "0.558": 1 "6986a>g a>g/*1 a a>g/*3 g": 1 "positive n?=?399 ": 1 "strain or plasmid": 1 "bms ligands a": 1 "bcr/tcr-based tumor type": 1 "0.502": 1 "target tissue": 1 "director translational research laboratory national cancer center hospital": 1 "protein function": 1 "history of abdominalor pelvic surgery": 1 "number of mirnas": 1 "expression of activating mutant fgfr3 gene correlates with non-muscle invasive clinical course": 1 "rho1e br233": 1 "type of cell": 1 "status of menstruation": 1 "insertions in kinase domain?": 1 "dose µg/ml": 1 "enhances cytotoxicity of anti-cancer agent via atp depletion and reducing autophagy by activation of ampk and inactivation of mtor expression": 1 "mutations in adenomas": 1 "cd44s protein reference": 1 "clinically unfavorable cup": 1 " 61 ": 1 "cd4 and cd8": 1 "change in expression knockdown cells relative to control": 1 "western": 1 "25-50": 1 "ballroom f-h meet the experts vi evs in inflammation and immunity chair esther nolte-'t hoen speakers edit buzás and stefano pluchino": 1 "number of atoms": 1 "involvment in cancer": 1 "age group": 1 "mse within treatment": 1 "9.86": 1 "isoforms": 1 " 62 ": 1 "predicted effect on coding sequence b": 1 "altered mmr gene": 1 "1.1.1 refractory anaemia ra": 1 "mouse genotype": 1 "ewog/ebmt": 1 "constitutive up-regulated by sex hormones and shear stress": 1 "cancer-specific survival": 1 "primary tumor": 1 "44.5 ± 5.2": 1 "decrease in enhancement – by blocking angiogenesis mediated by vegf or pdgf pathways tkis – by apoptosis or hyalinization all mtts": 1 " 63 ": 1 "methylation negative": 1 "microtubule loss": 1 "increased risk in phts": 1 "short-chain rna molecules involved in aminoacids transfer for protein synthesis 7 .": 1 "gene-specific or genome-wide": 1 "locus id": 1 "a similar lbs": 1 "case n": 1 "fluorometry": 1 "630.8": 1 "992": 1 "dataset name": 1 "5 encoding a protein responsible for cell-cycle regulation inactivating missense mutations paired with loss of heterozygosity at 17p inactivating mutation causes loss of regulation of cell-cycle arrest and cell death.": 1 "kras mutations identified in only one codon": 1 "*1b -290a>g": 1 "gene length *": 1 "er to golgi vesicle-mediated transport apoptosis": 1 "n major a": 1 "xm_233944": 1 "assess low-concentration effects in vitro": 1 "2?g": 1 "tumorlocation": 1 "phospholipase d2 pld2 and cancer": 1 "livability": 1 "t465a": 1 "count background": 1 "additional compound": 1 "nok expression": 1 "alive": 1 "clinicopathologic features": 1 "sig.": 1 " 67 ": 1 "fold induction fi of cells cd8+ and mart1/hla-a2+": 1 "binding to nucleolin": 1 "number of mutated genes": 1 "inflammation": 1 "encodes cytoplasmic protein tyrosine kinase which is found concentrated in the focal adhesions": 1 "inhibition of il-6 il-1 ? and tnf- ? production in raw264.7 cells": 1 "40.3": 1 "programme": 1 "harvey rat sarcoma virus oncogene 1": 1 " of mice with tumors": 1 "genbank accession number": 1 "rho1e br246": 1 "6008.9": 1 "sample ref": 1 "arabidopsis gene s expect e value and function if known": 1 "breaks of chromosomes": 1 "total snps in 3'-utr": 1 "negative n?=?310 ": 1 "interleukin 4 receptor": 1 "fungal strain": 1 "bnip1": 1 "72?h": 1 "total number of sequence reads": 1 "p value of vhmecs": 1 "poxvirus": 1 "mutant reads a": 1 "? unique gtpase-activating mutations or fusions rhoa or arhgaps": 1 "databases making data available in biopax format software systems for storing visualizing and analyzing biopax pathways.": 1 "actinin alpha 2": 1 "free and distinct a": 1 "other cancer": 1 "?ct ct lp-1d1b-ct lp-1cl1": 1 "study subject id": 1 "entire group n?=?103": 1 "liver metastases": 1 "alignments to actual concentration r2": 1 "relative risk of ad odd ratio": 1 "orallele 95ci b": 1 "related rtk a": 1 "effects on i-r injury": 1 "total number of brdu-labeled cells": 1 "gene symbol and location": 1 "tumour sample positive": 1 "ras statusa": 1 "leukemia type": 1 "andrographolide": 1 "1992–1993": 1 "8 positive": 1 "myeloproliferative syndrome": 1 "human cancer type": 1 "fluid retention anasarca pleural effusions pulmonary edema": 1 "no of 4c11+ gcs *": 1 "cancer/biological function associations": 1 "in vivo / in vitro": 1 "t2atg": 1 "cyclin group": 1 "fusion partner with ss18": 1 "hi stimulates vsmc proliferation and migration and remodeling.": 1 "misregulation in aml": 1 "os mos.": 1 "chronic obstructive pulmonary disease": 1 "sequence variant in disc1": 1 "data set 1 correlation with me3 p value": 1 "subsequent metastasis months later": 1 "vig-1": 1 "mutation type/s": 1 "ai071183": 1 "unit cell parameters å°": 1 "1418305_s_at": 1 "total mirna": 1 "ilmnid a": 1 "activating mutations": 1 "correlation with gc": 1 "theoretical mh+": 1 "cell diameter ?m": 1 "observed data": 1 "l lepideus": 1 "kdr": 1 "fc microarray": 1 "patient number": 1 "in children": 1 " n?=?102": 1 "y487h": 1 "md in medicine tokyo medical and dental university": 1 "function a": 1 "function b": 1 "ain-2 a": 1 "silent": 1 "board member of japanese society of hepatology": 1 "cell survival": 1 "origin of specimen": 1 "glucotoxicity compounds peripheral insulin resistance reductive stress sorbitol/polyol pathway pseudohypoxia increased nadh/nad ratio": 1 "aa change": 1 " 7 *": 1 "ews-rearrangements": 1 "mgmt expression*": 1 "down in set2 ? a": 1 "average latency weeks": 1 "below lp": 1 "mortality": 1 "? tnf- ? no": 1 "affymetrix u133a chips": 1 "effect on amplitude as parameter is increased decreased": 1 "localization and other information": 1 "33 59": 1 " n?=?121": 1 "shc low": 1 "effects on cbs": 1 "postdoctoral research fellow baylor college of medicine": 1 "p-value $": 1 " n?=?129": 1 "? b loss of apoptosis effector molecules caspases p53 family": 1 "no product visible": 1 "position in 3? utr": 1 "authors and references": 1 "residue a mutated to cys": 1 "other observations": 1 "33 61": 1 "positive expression of rassf1a": 1 "p value of immortal vhmecs": 1 "bcl-2": 1 "bj b": 1 "peak area": 1 "2 myeloproliferative neoplasms mpn": 1 "msi-h": 1 "rel intensity meth at taqa": 1 "cancer mutated at": 1 "brazilian": 1 "33 54": 1 "other coordinated mutation": 1 "neuronal messenger": 1 "progressive disease": 1 "young investigator's bursary for the easl european association for the study of the liver": 1 "target prediction 2": 1 "snv calls reported in dbsnp137cd ": 1 "effect a": 1 "number of colonies/ 105 cells/?g plasmid dna": 1 "kras mutation not detected": 1 "e7/db tetramer positive activated cd8+ t cells in tumors tils": 1 "go biologicalprocess": 1 "no of arrays with p<0.05": 1 "the japanese society of gastroenterological surgery": 1 "763.5": 1 "knockin mouse models with mutant tp53 expressed in mammary epithelium": 1 "up regulated tf": 1 "encodes a receptor with tyrosine-kinase activity that has roles in the regulation of many biological processes including embryonic development angiogenesis cell proliferation and differentiation and contribute to the pathophysiology of some diseases including cancer.": 1 "metabolic regulation of neuropeptide gene expression": 1 "coverage": 1 "ballroom e meet the experts ii stem cells and evs as therapeutics chair steven m jay speakers bernd giebel and sai kiang lim": 1 "pard3": 1 "5' end": 1 "missense/stop": 1 "strains mated": 1 "csf levels of ?sapp ?sapp tau phospho-tau a?1?42 and plasma levels of a?1?42": 1 "predicted to connect to gene s": 1 "b chronic eosinophilic leukemia hypereosinophilia and eosinophils ?30 and myeloblasts <20 and no underlying stem cell myeloid or lymphoid neoplasm found": 1 "protein synthesis and turnover": 1 "rvsmc": 1 "? pathways anchorage independent growth contact inhibition": 1 "study sample size": 1 "psph in stroma": 1 "scaffolds only 39 node pairs": 1 "mp1 positive": 1 "induces autophagy-mediated cell death by suppressing mtor in prostate cancer cells": 1 "carriers of *1 allele have functional enzyme and require higher drug doses to reach target levels carriers of *3 allele have nonfunctional allele the enzyme is not metabolizing the drug so they need lower doses.": 1 "enhances anti-tumor effects of temozolomide in glioblastoma via ros-dependent ampk-tsc-mtor signaling pathway": 1 "head section of drug resistance national cancer center research institute": 1 "activates ampk in the liver and prevents diethylnitrosamine-induced liver tumorigenesis in obese and diabetic mice": 1 "incidence of dcm": 1 "rahman colon/rahman culture": 1 "bq201826": 1 "of sets": 1 " i integration of “omics” tools as a multiple strategy": 1 "suboptimal to ltf or death": 1 "dataset 1 ref 29": 1 "type of sample": 1 "n491i": 1 "single step/short time": 1 "tcrrearrangement": 1 "number of nodes": 1 "intermediate and late phase only down-regulated mechanistic genes": 1 "sister chromatid exchanges": 1 "?30": 1 "integration site": 1 "the number of samples": 1 "coexisting mutations": 1 "shc high": 1 "6–8 h": 1 "suppressor or candidate tumour suppressor": 1 "young nyun park md phd": 1 "ballroom f-h meet the experts ix possibilities and limitations of single ev-based analysis chair jennifer jones speakers marca wauben and alain brisson": 1 "epor expression as pf method": 1 "incorrect terminations": 1 "real-time rt-pcr challenged with v dahliae": 1 "assistant professor in gastroenterology yamanasi university school of medicine": 1 "mean of uvb sites with double nt changes that were deleterious ±sd": 1 "net displacement µm±sd": 1 "13-15": 1 "observation": 1 "hdac6 overexpression leads to increased cell motility 3 21 28 38 .": 1 "decreased e-cadherin expression independent predictor of tumor progression to muscle invasion and decreased disease-specific survival": 1 "fraction": 1 "genes for autosomal dominant optic atrophy": 1 "established direct interactions a question mark indicates a presumed but not fully established interaction": 1 "?2 reactivation of telomerase conferring extended mitotic life span 139-141.": 1 "predictive value for sunitinib b": 1 "methylation positive": 1 "h-ras 12v/h-ras?e 12v": 1 "in vivo or vitro": 1 "no of patient": 1 "staining": 1 "half life t 1/2 ": 1 "associated go terms": 1 "3?utr": 1 "experimental groups": 1 "bilateria 5223 gene set linked": 1 "3 negative": 1 "mitochondrial morphology tem": 1 "sample notes": 1 "department of gastroenterology and hepatology musashino red cross hospital": 1 "-t1 core i protein": 1 "division chief division of gastroenterology and hepatology kyoundo hospital": 1 "spearman's rho": 1 "ic 50 b nm": 1 "calorie restriction": 1 "receptors": 1 "imaging findings indicating tumor recurrence": 1 "cbs46229": 1 "recipients donors or both": 1 "ovary carcinoma": 1 "tcrbind ? fyn ? tcrphos ? zap70 ? ccbl ? tcrbind": 1 "assistant professor in gastroenterology kagawa university school of medicine": 1 "scid- beige": 1 "no of patients examined": 1 "tephrosin plant rotenoid": 1 "sg phenotype difference from wt ": 1 "phd degree wakayama medical university": 1 "myl2": 1 "a2780 *": 1 "• mice with reduced stat3 activity/levels have increased susceptibility to doxorubicin-induced heart failure and greater susceptibility to lps-induced toxicity 8": 1 "subgroups n": 1 "total papillomas": 1 "coronary death nonfatal myocardial infarction fatal and nonfatal stroke": 1 "the sequence were submitted to ncbi at 2006 giee592400–ee593286 eh122780 eh122781": 1 "tumour suppressor or oncogene role": 1 "p - value": 1 "studies": 1 "25–30": 1 "damp/pamp": 1 "balloon": 1 "tumor grade *": 1 "group p-value": 1 "time for s-phase transit t s h": 1 "hemispheric": 1 "function in relation to cancer and mdr": 1 "example cases of mutation disambiguation dictionary records and patterns": 1 "presence of muscarinic receptors chat and/or acetylcholine": 1 "jund levels in macrophages *": 1 "name of the compound": 1 "codon 133 status": 1 "type 2": 1 "mirna id": 1 "sfrp1": 1 "bronchial amyloidosis": 1 "14th week": 1 "highly conserved genomic elements involved in the maintenance of splicing factors expression levels and gene expression regulation 23 ": 1 "effects on autophagy": 1 "no relationship has been reported between recipient cyp3a4–392a>g genotype and the incidence of acute rejection or renal function.": 1 "low foxo3": 1 "term and function": 1 "activates ampk and inhibits uvb-induced tumorigenesis in the skh-1 hairless mouse model": 1 "6798.5": 1 "setting up posters poster sessions viii ix x xi xii xiii": 1 "author/ref.": 1 "ibs-d": 1 "ibs-c": 1 "small rna": 1 "encodes a protein belonging to the family of p-type primary ion transport atpases characterized by the formation of an aspartyl phosphate intermediate during the reaction cycle these enzymes remove bivalent calcium ions from eukaryotic cells against very large concentration gradients and play a critical role in intracellular calcium homeostasis.": 1 "no of sites": 1 "metastatic suppressor gene gtpases play a central role in coordinating signal transduction pathways that affect actin and tubulin a cytoskeleton and cell migration": 1 "10667": 1 "type d": 1 "type a": 1 "expression of rhob ": 1 "size": 1 "indirectly by lipid synthesis inhibition fatty acid desaturation or lipase activation": 1 "activation of wnt signaling due to the inability to degrade the ?-catenin oncoprotein inactivating mutation causes loss of regulation of spindle microtubules during mitosis .": 1 "e-mw": 1 "infectious agent": 1 "? b indirect approaches anti-vegf anti-ctla-4 anti-pd-1/pd-l1 and anti-treg": 1 "pharyngolaryngeal n=40": 1 " 70 ": 1 "hgnc symbol ortholog in human mouse": 1 "fscor": 1 "unigenes with e?0.0001 vs nr/nt database": 1 " i novel studies cross talking proteomic and genomic data": 1 "range contig length": 1 "example": 1 "e-pi": 1 "incidence of tested mice brought solid tumor": 1 "transposon vector pb-upa ?g": 1 "similar to mouse eye! in g2 ccng2 gene.": 1 "utr-snps with p < 0.01": 1 "total counts ngs data": 1 " 71 ": 1 "median progression-free survival months": 1 "utr-snps with p < 0.05": 1 "dosing and duration": 1 "award for cancer research": 1 "mg 100 g?1": 1 "graduated from graduate school of medicine kyoto university": 1 "102983": 1 "0.623": 1 "low n = 59": 1 "up/down": 1 "egfra": 1 "ri a": 1 "?n": 1 "t498a": 1 "copy number": 1 "others": 1 "keynote address “marfan syndrome and related disorders from gene to therapy” prof bart loeys university of ghent belgium.": 1 "or 95ci": 1 "genomic region": 1 "cmt progression": 1 "number of positive correlations gexp higher | ? tp53 ": 1 "ezrin expression": 1 "k502r": 1 "impaired adp/atp transport": 1 "glucose metabolism": 1 "nod- scid": 1 "radionuclide": 1 "no of recurrently mutated rm genes": 1 "mascot protein score": 1 "caucasian black asian &amp korean": 1 "alteration frequency n=40": 1 "cd31 if": 1 "38 53": 1 "ld 50 s for hqba n": 1 "35.1?±?1.5*": 1 "? phenotypes of sirt3 ko mice mammary gland tumors": 1 "tissue b": 1 "p2x7 mrna expression n ": 1 "population sample": 1 "jun 2003–may 2006": 1 "226.6": 1 " all probes": 1 "negative 14 13": 1 "n #": 1 "ratio of na+/nh4+atpase activity to na+/k+atpase activity": 1 "efficiency amplification ": 1 "methylated in cancer": 1 "change in expression 1 in resistant cell lines": 1 "cdna change": 1 "every 2 wks until chr then every 3 mo or as needed": 1 "nucleolar protein 5": 1 "etoposide + 40?mg/m2 cisplatin": 1 " 76 ": 1 "kras mutations at codons 12 and 13 from rascal and rascal ii studies": 1 "obstructive bronchiolitis": 1 "no of fused mitochondria /total scored": 1 "start deletion": 1 "no of squamous tumors/total tumors based on biomarker staining": 1 "41.3": 1 " with": 1 "unique peptide number": 1 "1° fate marker ayis4 egl-17gfp scored at pn.px": 1 "sequence change": 1 "flowe": 1 "agonist for toll-like receptor 9 tlr 9": 1 "increase in phosphorylated smad2b": 1 "0 µg/ml mnu": 1 "there is an imbalance of pro- and anti-inflammatory cytokines with a predominance of macrophage products in inflamed joints": 1 "gene expression profile": 1 "encodes the guanine nucleotide binding protein that couples a seven-transmembrane domain receptor to activation of phospolipase c-beta.": 1 "early stage n=19": 1 "conserved": 1 "target of rnai": 1 "mouse model and phenotype": 1 "reporter name": 1 "n rare+hz a": 1 "tissue/tumour type": 1 "i/? i": 1 "antitumor activity in nude mouse": 1 "? macrophage activity": 1 "egfr ": 1 "localization of k-ras mutated carcinomas": 1 " 79 ": 1 "cellular origin of the whole domain fusion events": 1 "study/year ref": 1 "multivariate analysis or 95 ci": 1 "fold change by qrt-pcr": 1 "detailed leukemia subtypes a": 1 "t499a": 1 "?3?1 integrin antagonists": 1 "mhc class l": 1 "antiproliferative activity in a broad": 1 "immune response tyrosine phosphorylation of stat3 protein": 1 "guanine nucleotide-binding proteins g proteins are involved as modulators or transducers in various transmembrane signaling systems the g o protein function is not clear.": 1 "effect on protein or mrna": 1 " days": 1 "acyl-coenzyme a dehydrogenase c-4 to c-": 1 "peak assignment": 1 "4 15": 1 "rat hippocampus *": 1 "protein length": 1 "braf 2 ": 1 "3.01": 1 "cys tgt": 1 "ss'jr rattus norvegicuscdna mrna": 1 "51 52": 1 "no of analyzed patients": 1 "inhibition of blood vessel adhesion": 1 "number of gfp+ leukocytes d": 1 "3.15": 1 " no expression": 1 "3.12": 1 "3.05": 1 "cultured astrocytes": 1 "transfectant": 1 "regulation of progression through cell cycle angiogenesis": 1 "2.2.1 chronic neutrophilic leukaemia": 1 "antibody lineage": 1 "51 65": 1 "tumor tissue": 1 "arg1 pre-nom": 1 "tubule formation /nuclear grade /mitotic rate": 1 "rab13 member ras oncogene family": 1 "type i": 1 "type of samples": 1 "? 4th": 1 "2588.0": 1 "3.19": 1 "papillomas/mouse": 1 "catalog no.": 1 "number of microsatellite markers used": 1 " 36 38 ": 1 "glut-1 in tumor": 1 "latency time for senescent-like phenotype escape days": 1 "asn/asn": 1 "?f other who-defined myeloid neoplasms with hypereosinophilia": 1 "end site b": 1 "renal function": 1 "generally tm °c": 1 "after senescent-like phenotype": 1 "methylation frequency": 1 "cholera toxin": 1 "low n=69": 1 "access no.": 1 "dose gy": 1 "breast pancreas": 1 "3.42": 1 "population location": 1 "expressed in testis": 1 "652/2445 = 26.66": 1 " 2 passive antibody administration": 1 "clade": 1 "1416605_at": 1 "21.256": 1 "3.61": 1 "igf-1r": 1 "exogenous gene effect": 1 "atm-p53 pathway inactivation": 1 "nf- b": 1 "274.0": 1 "strains": 1 "sequences pulled down using anti-ubx antibodies": 1 "mean age years of proband": 1 "np_803187": 1 "mesh term for profile1/signature": 1 "who/fab classification": 1 "#mappable over upets": 1 "dissociation constant kd pm": 1 "other oxidation-derived products such as 5-hydroxy-dc 5-hydroxy-du and uridine glycol with c-t transitions": 1 "internal membranes": 1 "run-in period": 1 "centrosome clustering": 1 "no of phenotypes": 1 "grade 3 to 4": 1 "site of synthesis": 1 "authors year of publication": 1 "1922": 1 "hairpin identity": 1 "methodology of detection": 1 "recipients or donors": 1 "role in ad pathophysiology": 1 "rat locus prioritized by high-resolution substitution mapping of the s/jr rat": 1 "transformed y187 yeast strain": 1 "rs2274223 cases/controls": 1 "hmga2": 1 "3.95": 1 "low n=31": 1 "distribution in normal drg": 1 "wavelength å": 1 "842957": 1 "low n=36": 1 "shiseikai 2nd hospital": 1 "am+/+ a": 1 "8–12": 1 "methylation in immortal vhmecs": 1 "further investigations": 1 "epiregulin": 1 "98.8 97.5": 1 "#bkz hdfs": 1 "snps within a whole genome": 1 "arg1 absent": 1 "macrophage activation **": 1 "? granulocytes monocytes ? ? t cells and nk1.1 cells in the peripheral cells in": 1 "pathway jpa": 1 "ct in neuronal cell body": 1 "p -hpea-eda phenolic compound of virgin olive oil": 1 "effect of aml1/eto on the molecule": 1 "mice": 1 "nia est id": 1 "? blood lupus anti-coagulant elevated flt3 ligand 10- to 100-fold absent transitional b cells and cd56bright nk cells": 1 "g2019s": 1 "194±13": 1 "similar to translation af289554_1 homo": 1 "plasma membrane": 1 "total fruits produced": 1 "microrna-offset rnas morna": 1 "lineage tracing in the stomach": 1 "animal number": 1 "important references": 1 "inadequate medical facilities": 1 "26 41": 1 "n/a": 1 "14172": 1 "fdr ": 1 "n/c": 1 "polysaccharide": 1 "d_kit2": 1 "constitutive up-regulated by sex hormones nerve and brain injury": 1 "d_kit1": 1 "mir-146a": 1 "identification method": 1 "localization to endosomes": 1 "primary screen df a": 1 "pigments mg/g of fresh biomass of cells": 1 "peak no.": 1 "inhibition of the vegf-induced": 1 "? e age and loss of functional immune system": 1 "26 54": 1 "? phenotypic and functional maturation of dc": 1 "cq_id": 1 "mean i/sigma i": 1 "1986": 1 "passage 16": 1 "imatinib response b": 1 "etoposide": 1 "decrease in size": 1 "hormone receptors": 1 "agene encoding a protein necessary for the creation and maintenance of epithelial cell layers by regulating cell growth and adhesion between cells and also anchors the actin cytoskeleton": 1 "influence of the cyp3a4 392a>g snp on the pharmacokinetics of either csa or tac is limited.": 1 "chronic exposure to sun n ": 1 "low * expression": 1 "fisetin": 1 "associate professor laboratory of genome technology the university of tokyo": 1 "erythrocyte maturation": 1 "mean number of foci/well +/- se": 1 "cox-dependent": 1 "n33": 1 "1998": 1 "perk status": 1 "pros": 1 "1995": 1 "prot": 1 "metastasis": 1 "1993": 1 "genes for x-linked deafness-dystonia syndrome": 1 "relative distribution of gfp-pkc?": 1 "cell adhesion/angiogenesis/cell migration": 1 "? sirt3 ? breast cancer hcc head and neck squamous cell carcinoma": 1 "arg1 external": 1 "total icr eggs set up": 1 "treatment of cho sn ? g?agt?ml ?1 >": 1 "murine": 1 "14 56": 1 "lymphoma subtype": 1 "evidence for genomic deletion? mlpa/cgharraycgh/fish": 1 "tenascin c": 1 "first author year of publication and reference": 1 "high and moderate a n = 31": 1 "repression of cd28 gene transcription": 1 "number of contigs >500 pb": 1 " v identification of novel differential molecular signalling and expression between physiologic and pathologic cardiac hypertrophy": 1 "passage 41": 1 "neuro-peptide": 1 "1015-1045": 1 "hi promotes pi3 kinase akt-map kinase shunt impairing the metabolic pi3 kinase-akt pathway while promoting the mapkinase remodeling pathway.": 1 "ttp on first line with cetuximab": 1 "monoaminergic receptor hypothesis 1980s": 1 "confidence 3": 1 "14 22": 1 "uncoupling of tcr signal transduction pathways": 1 "sub-cellular localization": 1 "ednrb": 1 "base line": 1 "encodes a major sialoglycoproteins of the human erythrocyte membrane which bear the antigenic determinants for the mn and ss blood groups.": 1 "p value for tumor incidence sox2 versus gfp": 1 "uncontrolled open trial": 1 "28782": 1 "published data": 1 "gene defect": 1 "include kras and/or pten mutations": 1 "epigenetic research that includes an emphasis on developmental effects": 1 "percent mutant allele": 1 "psa before": 1 "ballroom d-e plenary closing ceremony prizes & announcement of isev 2016": 1 "graphical representation": 1 "imaging findings which indicate response to mtt": 1 "inhibitor type": 1 "weak positive": 1 "nm_002024": 1 "days after immunization": 1 "product name": 1 "? bone marrow megakaryocyte dysplasia hypocellularity fibrosis cytogenetics monosomy 7 trisomy 8 asxl1 mutation": 1 "? b gm-csf": 1 "18.1±3.9**": 1 "rmsd bond angles °": 1 "1417156_at": 1 "activated at 3 d by rph1 d": 1 "no relationship was shown between recipient cyp3a5 6986a>g genotype and patient renal function.": 1 "hi hyperproinsulinemia and hyperamylinemia synergistically activate ras with subsequent increase in ang ii renin and aldosterone.": 1 "fc up-regulation in l&h cells versus gc b cells": 1 " 80 ": 1 "level of tcf activity": 1 "egcg analogs activate ampk leading in inhibition of cell proliferation up-regulation of the cyclin-dependent kinase inhibitor p21 downregulation of the mtor pathway and suppression of stem cell population in human breast cancer cells": 1 "acgh platform": 1 "relevance to lb disorders": 1 "peptides from the n-ter domain": 1 "1.115": 1 "outcome of increased socs2 expression": 1 "ighrearrangement": 1 "estrogen receptor positive diploid microsatellite unstable": 1 "h-y tcr+ male": 1 "68.0": 1 "milk": 1 "? immunoglobulins normal levels occasional iga or igg deficiency": 1 "12.15 – 13.15": 1 "gdnf levels": 1 "localization of the ligand and other information": 1 "smear": 1 "heart rate or pulse interval": 1 "lectins tml-1 tml-2": 1 "intracristal space nm": 1 " 82 ": 1 "date of approved": 1 "left colon": 1 "frequency of methylation n": 1 "conduction": 1 "percentage of improvement": 1 "actin stress fiber formationc": 1 "adas cog": 1 "survival time months b": 1 "codon 13 a": 1 "position from atg": 1 "immunoregultion and tolerance": 1 "locus rassf1a /cell line": 1 " 83 ": 1 "extra cells ± s.d.": 1 "par involved": 1 "1758.1": 1 "correlation a with phenotypic characteristics of ecs p-value": 1 "b days": 1 "? recovery of cfu-gm response after dox induced hematopoietic suppression": 1 "mina": 1 "product length bp a ": 1 "length bpb": 1 "0.745": 1 "gene names": 1 "size amino acids": 1 "pathway number of genes annotated in the pathway": 1 "numberof patients ": 1 "20 ?m b-responsive tdfs": 1 "negative edges only 94 node pairs": 1 "agro 100": 1 "gene most frequently mutated codons": 1 "clinical parameter": 1 "way of cgrp administration": 1 "1236c>t": 1 "at 8 weeks": 1 "27.9±2.8": 1 "sequencing *": 1 "type ii tumors": 1 "predicted pairing of target and mirna": 1 "size kb": 1 "physicallocus bp": 1 "official gene symbol": 1 "mrna fold change*": 1 "department of orthopaedic surgery university of tokyo": 1 "type of analysis": 1 "gene mutations": 1 "implicated in disease": 1 "al-toxicity-responsive tdfs": 1 "number of protein residues": 1 " i day 1": 1 "e deprivation": 1 "peak within ± 100 kb": 1 "title": 1 " 86 ": 1 "investigate potential increased risk for type 1 diabetes and gestational diabetes": 1 "colostrum": 1 "go terms": 1 "?e myelodysplastic syndromes with hypereosinophilia mds-eo": 1 "vaximmune": 1 "methylated": 1 "oral presentations plenary ii basic research 15.30 - 16.00 tea and coffee / poster viewing.": 1 "uric acid toxicity antioxidant early in physiological range and a conditional prooxidant late when elevated through the paradoxical antioxidant ? prooxidant": 1 "iarc classification": 1 "cyclin families": 1 "chairman award of the 20th meeting of japanese society of hepato-biliary-pancreatic surgery": 1 "disease group": 1 "p-values": 1 "recent aspiration particularly in handicapped children": 1 "akt-phosphorylated cytoplasmic foxo1 dissociates and thereby inhibits the tsc1/tsc2 heterodimer": 1 "triterpenoids": 1 "data set 2 correlation with me3 p value": 1 "polyps adenomas": 1 " 89 ": 1 "gene function or genbank accession no.": 1 "supplier": 1 "non-serrated adenocarcinomas n ": 1 "19 73": 1 "1.196": 1 "immune potentiating platform": 1 "endothelial cell dysfunction with enos uncoupling decreased eno and increased ros.": 1 "2° fate marker nis106 lin-11gfp scored at pn.pxx": 1 "instantaneous frequency hz": 1 "increased energy needs": 1 "whole domain fusion events": 1 "baicalein": 1 "sense": 1 "no of pups": 1 "diagnosis a": 1 "genebank": 1 "downregulated in cn-aml 22 ": 1 "• decreases platelet adhesiveness.": 1 "p-value*": 1 "other category": 1 " npcis fos +/+ and fos +/?": 1 "immunogen": 1 "0 mm al": 1 "t14-y15-t161": 1 "lung cancer and glioma cell lines": 1 "targets": 1 "medium supplements": 1 "inhibition rate at 1??m ": 1 "or a": 1 "51265": 1 "n major event": 1 "prg-2": 1 "integrin alpha 4": 1 "prg-1": 1 "tokyo women's medical university institute of gastroenterology resident": 1 "hm-1": 1 "28 100": 1 "encodes the tyrosine-protein kinase protein that plays a role in cell growth according to the adherens junction bayesian network model the gene relationship src -> rac1 rac1 gene expression was suppressed across all three phases rac1 ras-related c3 botulinum toxin substrate 1 rho family small gtp binding protein rac1 encodes a gtpase protein belonging to the ras superfamily of small gtp-binding proteins that regulate a diverse array of cellular events including the control of cell growth cytoskeletal reorganization and the activation of protein kinases": 1 "plantgdb est no.": 1 "optimal dilution": 1 "family history of nf1": 1 "neurofibroma cis": 1 "wt+gw *": 1 "cited as": 1 "number of uveal melanoma": 1 "co-expression": 1 "ic50 with azi/ic50 without azi": 1 "type of lesion": 1 "selectivity": 1 "? c ?? t cells": 1 "recognition": 1 "t3ss description": 1 "no ?": 1 "ref .": 1 "as v 200 ppm": 1 "no animals per necropsy time point hours": 1 "readout": 1 "antisense rnas": 1 "in vitro growth analysis": 1 "no 9": 1 "sunitinib ": 1 "note dose is not adjusted for body size did not reduce interpatient variation for temsirolimus 67": 1 "group iii": 1 "neuropathic pain": 1 "169.2": 1 "background": 1 "hot-water extract": 1 "50 mg/kg": 1 "mean mutant allele freq a b ×10?4": 1 "rhinosinusitis": 1 "441.2": 1 "vascular endothelial growth factor b vegfb signals via the endothelial receptor vegfr1 mim 165070 and is a regulator of blood vessel physiology with a role in endothelial targeting of lipids to peripheral tissues": 1 "priming & boosting or others strategies for immune potentiating": 1 "mapk pathway gene": 1 "induces granulocytc differentiation in aml cells 26 30 33 mir-223 knock-out mice present altered granulocyte immunological function 35 ": 1 "source and clonality": 1 "model for disease": 1 "mgmt expression": 1 "men": 1 "mer": 1 "tcrbind ? pagcsk ? lck ? zap70 ? ccbl ? tcrbind": 1 "cirrhosis": 1 "protein phosphatase 1 catalytic subunit alpha isozyme1": 1 "abcb1 c>t 3435 c>t": 1 "mir-31 expression": 1 "710 line 29 wk after promotion": 1 "doubling time h 22°c": 1 "confluent condition amount of cells ×106": 1 "structure": 1 "19 26": 1 "frequency of methylationincidence": 1 "approach using ha-binding peptide": 1 "green tea polyphenols": 1 "inos": 1 "vsv specific": 1 "scaling/crusts 0–3": 1 "time to progression": 1 "increase in size": 1 "shrbs3": 1 "loss of tumor suppressor gene function": 1 "hf ms2": 1 "val gtt": 1 "10 32.3": 1 "rhobtb2": 1 "locus of insertion frequency ": 1 "sago-1": 1 "sago-2": 1 "moderate": 1 " 0.015": 1 "phosphoribosylglycinamide formyltransferase phosphoribosylglycinamide synthetase phosphoribosylaminoimidazole synthetase": 1 "sensitivity for hgd": 1 "hmlh1 immunohistochemistry": 1 "tp53": 1 "defective b": 1 "confirmatory test": 1 "gep affy 2.0": 1 "?a ph+ chronic myeloid leukemia cml-eo": 1 "animal": 1 "? substrates foxo3a": 1 "50 5 mg daily for grade 3–4 toxicities on full dose after interruption until grade 2 or better": 1 "epitope no.": 1 "protein amino acid phosphorylation ribosome biogenesis and assembly": 1 "np_073557": 1 "base change": 1 "qrt-pcr total samples": 1 "no of cpgs": 1 " ifncpe50>5000 u/ml": 1 "1416342_at": 1 "gypa": 1 "activates ampk and induces apoptosis in ht-29 colon cancer cells also block egf-induced erks phosphorylation and inhibits ap-1 activity and cell transformation": 1 "benign": 1 "overall cases": 1 "n of total cases analized": 1 "middle": 1 "time of analysis": 1 "plcb3": 1 "maf ctrl": 1 "approved gene name": 1 "breast adenoacrcinoma": 1 "recommendations for graphical representation using systems biology graphical notation sbgn as a guide.": 1 "jip-1": 1 "?hras": 1 "wnt activating lesion": 1 "percentage of colony growth": 1 "nmd3": 1 "human homologs   ": 1 "list of data sources & supporting software": 1 "tumor formation at 4 weeks mean of maximum diameter of tumors mm": 1 "increase in number of smaller vesicles": 1 "method of analysis": 1 "diameter": 1 "algorithm identifer": 1 "type of mutation of mtdna": 1 "saturation density 105 cells/cm2": 1 "best reponse to igf1r inhibitor": 1 "down reg .": 1 "snp variant": 1 "translation and initiation": 1 "418.2": 1 "primary tumor localization": 1 "inotropic effect": 1 "nuclear accumulation of p53 predictor of tumor recurrence progression to muscle invasion and mortality": 1 "paths": 1 "all orfs": 1 "positive no ": 1 "data from li et al gsm385747 **": 1 "rhoa": 1 "enos or type iii": 1 "91.1": 1 "survivin* median": 1 "gene ontology enrichment analysis": 1 "atorvastatin calcium 80 mg/day": 1 "percentage of annotated contigs by uniprotkb/trembl": 1 "chief investigator of study group of clinical study in viral hepatitis and hepatocellular carcinoma including japan red cross hospital association supported by japanese ministry of health welfare and labor": 1 "down in nhx1": 1 "pdgf-bcdkn2a null h3.3k27mic50 ?m": 1 "+++": 1 "salt-sensitivity": 1 "mediator module": 1 "n50 read length bp": 1 "induces apoptosis and ampk in human tumor cells": 1 "metastatic": 1 "or and 95ci": 1 "proximal to fra10f": 1 "post-translational modification": 1 "cd14 molecule": 1 "fold- change gene expression": 1 "risk variant": 1 "cytoplasmic positive only": 1 "? membrane molecules including mhc i ii cd80 and cd86 and il-12p70 in dc": 1 "ctcf present": 1 "100 randomized gene lists 857 mean of the expected number of genes": 1 "induces apoptosis via ampk activation and p53 in ht-29 colon cancer cells": 1 "? tnf- ?": 1 "pazopanib ": 1 "this allele is linked to a reduction in cyp3a4 mrna production and enzyme activity in human livers.": 1 "gravidity": 1 "number of gene s with affected mrna expression": 1 "cyld-mediated hdac6 inhibition leads to delay in the cell cycle and reduced rate of cytokinesis 30 32 .": 1 "type of toxicity": 1 "• no inhibits prooxidant actions of uric acid during copper-mediated ldl oxidation.": 1 "acession number": 1 "moz": 1 "n50 read length": 1 "mpa": 1 "measured masses m+h+": 1 "approaches to interfere the ha-cd44 interaction": 1 "number of clusters with 1 contig": 1 "apr 1997–may 1999": 1 "argonautes": 1 "227.5": 1 "progeny expressing": 1 "sequence 5’ to 3’": 1 "mpn": 1 "injected a": 1 "0.5 gy": 1 "mpu": 1 "169966": 1 "mpw": 1 "dose–response relationship": 1 "ip_number": 1 "in hsc under fibrotic condition reference": 1 "+/+": 1 "improvements in po trends to improving in so": 1 "unfit cells": 1 "ser agt": 1 "bf2s3172": 1 "a cells with extensive junctional communication": 1 "assay code": 1 "cd44s expression in cell lines": 1 "number of mabs *": 1 "pdgf-b p53 lossnestin tv-aplate 1ic50 ?m": 1 "<10": 1 "grade ii": 1 "upregulated in flt3-itd aml 107 108 ": 1 "number of cells with golgi localization of ubiad1": 1 "tissue or cell line origin": 1 "cycle s in which dose was modified": 1 "histological subtype a": 1 "?2.16 ± 0.14": 1 "lzts1": 1 "high n=63": 1 "maintain nk activity of spleen cells in tumor-bearing mice": 1 "let-7 fold change": 1 "construct total number of amino acids aa": 1 "dna analyzed": 1 "<25": 1 "tn2 ×106": 1 "total reads a": 1 "best subject award of the 15th ajinomoto award in the 49th annual meeting of the japanese society of hepatology best paper in the year of jspen": 1 "ten-year mortality rate /1000 in breast cancer patients based on 17": 1 "high n=94": 1 "9 26": 1 "medical staff fourth department of internal medicine wakayama medical university hospital": 1 "mutation analysis": 1 "mab against igf-1 and -2": 1 "transfected construct": 1 "first gene refseq accession number": 1 "biogroup": 1 "methylated sugars": 1 "ballroom e meet the experts viii evs as diagnostics and prognostics chair fred hochberg speakers lorraine o'driscoll and clark chen": 1 "glycophorin a mns blood group": 1 "activates ampk and inhibits downstream mtor which induces apoptosis in glioblastoma multiforme cells by p53 and p21 induction": 1 "clinicaltrials.gov identifier": 1 "cell volume pl": 1 "3coverage": 1 "cell phenotype": 1 "9 35": 1 "high n=89": 1 "decrease in absolute risk at 15 years ": 1 "frequency of asp allele p*": 1 "sensitivity ": 1 "51.535 57.157 104.216 90.000 90.000 90.000": 1 " 90 ": 1 "predictive value for imatinib a": 1 "in patients with failure suboptimal response and before changing therapy with second generation tkis": 1 "guanine nucleotide binding protein g protein alpha activating activity polypeptide o": 1 "p62 and keap1 double-positive lesions": 1 "2.1.1 chronic myelogenous leukaemia bcr-abl1 positive cml": 1 "p53 gene": 1 "grape polyphenols": 1 "activates ampk to induce apoptosis in multiple myeloma cells": 1 "transgenic": 1 "cromossomal localisation": 1 "antitumor immunity in vivo": 1 "primarily associated with non-muscle-invasive clinical course": 1 "locus": 1 "m60801": 1 "mean onset d": 1 "egfr mutation not detected": 1 "t b a °c": 1 "end deletion": 1 "limitations viral titres and safety": 1 "mesh term for profile2": 1 "sensitivity confirmed het deletion strain": 1 "ipass 3 gefitinib 250 mg": 1 "phosphoprotein-grb2 reported": 1 "cancer syndrome": 1 "total number of hits": 1 "c-terminal extension?": 1 "leukocyte activation": 1 "# of significant gos e": 1 "b a p-78-dione-dguo": 1 " 93 ": 1 "n+/+": 1 "56.6": 1 "adeno-associated virus aav": 1 "electrophoresis analysis": 1 "the level of expression/activity during senescence": 1 "other papilloma manifestations": 1 "well differentiated": 1 "adenomas": 1 "tuba1c": 1 "amount in kcal/day": 1 "100 mg/kg": 1 "oligonucleotide sequences 5²-3²": 1 "4 gy": 1 "percent genotype of live embryos": 1 "up in nhx1": 1 " 94 ": 1 "matrix": 1 "v-erb-b2 erythroblastic leukemia viral oncogene homolog 2": 1 "metformin treated—three days after the induction of diabetes metformin 500?mg/kg body weight dissolved in 0.5?ml physiological saline was administered by gastric intubation for 21 days daily.": 1 "transcribed ultraconserved regions t-ucr": 1 "website": 1 "histologically proven sites of involve-ment": 1 "ago2": 1 "mir-10a gene targets predicted by miranda targetscan and pictar": 1 "color change": 1 "ribosomal protein s6 kinase polypeptide 3": 1 "count in cancers": 1 "affected molecular mechanism": 1 "phgdh in tumor": 1 "p53 no.": 1 "itga4": 1 "3 who-defined myeloid neoplasm with hypereosinophilia mpn-eo": 1 "product number": 1 "histological abnormalities": 1 "ttf1 expression": 1 "p 1": 1 "type chromosome location": 1 "p 3": 1 "positive n=7": 1 "p 2": 1 "myelocytomatosis oncogene": 1 "to sir2p": 1 " 96 ": 1 "37093": 1 " i day 1–5": 1 "asian men and women south and east and other similar groups": 1 "koichi matsuda": 1 "accession no tigra harvestb uniref90c": 1 "challenge type": 1 "univariate kaplan–meier analyses for a distant metastases-free survival of patients": 1 " 97 ": 1 "location after start site": 1 "a apd": 1 "platform manufacturer": 1 "product description": 1 "animals tissue cells or sirt1 activator": 1 "nm_022720": 1 "arid1a mutations by sequencing": 1 "richard s finn md": 1 "• anti-fibrotic effect when no is normal or elevated mmps are quiescent conversely if no is low mmps are elevated and active.": 1 "? substrates h3k9 h3k56": 1 "up gln": 1 "up glu": 1 "allergic bronchopulmonary aspergillosis": 1 "fold change rt–pcr": 1 " 98 ": 1 "?mmps are redox sensitive.": 1 "march 1999": 1 "1438917_x_at": 1 "4 group": 1 "primers for rt-pcr": 1 "hdac6 deacetylates hsp90 and prevents the maturation of glucocorticoid and androgen receptors 40 – 42 .": 1 "dead larvae ": 1 "nesg1 ": 1 "lobular": 1 "array type": 1 "orhom 95ci b": 1 "final effect on t 821 cells": 1 "2.2.4 mpn unclassifiable": 1 "go cellular component": 1 " 99 ": 1 "indoor/outdoor pollution": 1 "simulation time ns": 1 "cfreg": 1 "counteracts monocytopoiesis 55 57 ": 1 "phenotype of ship-1 ko": 1 "history and examination": 1 "biochemical data": 1 "tumor was detected": 1 "control group": 1 "small molecule tki": 1 "mouse mutant": 1 "alg-1 clip 4": 1 "1421977_at": 1 "ossification anti-apoptosis": 1 "unresponsiveness ": 1 "number of mice": 1 "nas": 1 "bnt predict": 1 "number of patientswith crp -286 mutation ": 1 "seeding density": 1 "crossing": 1 "insertions in severe tumors 1": 1 "ma bafi": 1 "number of target molecules in dataset": 1 "time of delivery": 1 "no of relatives with gists a": 1 "range of onset d": 1 "gary ruvkun ph.d department of genetics massachusetts general hospital boston ma usa the tiny rna pathways of c elegans": 1 "sequences before filtering": 1 "graft site preparation": 1 "diabetes induced— 50?mg/kg b.wt streptozotocin dissolved in 0.5?ml of 0.1?m citrate buffer ph 4.5.": 1 "forward stre agggg": 1 "manders coefficients m1 m2": 1 "average coverage on roib": 1 "manufacturer": 1 "d5w/ topotecan": 1 "b value": 1 "positive n?=?183 ": 1 "described before?": 1 "?rhogd12": 1 "4360": 1 "nearby expressed coding and non-coding rnas": 1 "4362": 1 "clinicopathological feature": 1 "outcome months": 1 "p-value bonferroni-corrected": 1 "?loss of heterozygosity of chromosome 9": 1 "status of infection": 1 "average est size after trimming bp": 1 "type of tolerogenic response": 1 "t cells are terminally differentiated with significant telomere loss": 1 "figure 4": 1 "r06c7.1": 1 "cd8+ til??tregs ratio": 1 "r work": 1 "semantic role": 1 "insulin toxicity endogenous hyperinsulinemia-hyperproinsulinemia inflammation toxicity": 1 "biological function": 1 "expression in asm": 1 "rassf6": 1 "mean tumor volume at sacrifice mm3*": 1 "cbs44857": 1 "1418349_at": 1 "secreted phosphoprotein 1": 1 "neg": 1 "translation endocytosis": 1 "selected by egfr positive": 1 "assay method": 1 "mrna bp": 1 "uterus carcinoma": 1 "• no has diverse anti-atherosclerotic actions on the arterial vessel wall including antioxidant effects by direct scavenging of ros – rns acting as chain-breaking antioxidants and it also has anti-inflammatory effects.": 1 "endosome number *": 1 "percentage of roib with at least 1×/10×/30× coverage": 1 "primers for chip": 1 "methylated in normal upper aerodigestive tissue": 1 "tool": 1 "no expression": 1 "p53 mutation effect": 1 "percentage of total mutations ": 1 "fabio piscaglia md phd": 1 "nola1": 1 "inhibiting cytokine-mediated inflammation via the induction of leukotriene b4 reductase.": 1 "mice with no tumor necrosis": 1 "# of mice injected": 1 "cyclin-dependent kinase inhibitor prevalence 64 of radical cystectomy specimens": 1 "nola2": 1 "antiproliferative effect of wit002": 1 "university school of medicine": 1 "most common syntactic positions": 1 "fold change at standard culture 72 hrs vs 144 hrs": 1 "resveratrol": 1 "point mutations": 1 "total number of sections examined": 1 "position*": 1 "2871.1": 1 "7 22.6": 1 "inibits myeloid differentiation in aml cells and cd34+ progenitor cells 79 80 induces leukemia when overexpressed in mouse bone marrow 81 82 ": 1 "clusters a": 1 "effect on hsfs": 1 "peaks with similar lbss": 1 "history of blue nevi": 1 "telomere-associated ncrnas terras": 1 "calcium/calmodulin-dependent protein kinase ii alpha": 1 "– grade 1–2 continue everolimus but monitor weekly until stable/improving": 1 "ddx39": 1 "?cdh1 e-cadherin mutation somatic": 1 "250.36": 1 "ppar?": 1 "mutation / transgene": 1 "?9 telomere attrition chromosome breakage-fusion-bridge cycle or genetic stress will result in senescent phase with mn/pg formation mitotic crisis and mitotic catastrophe.": 1 "negative n?=?526 ": 1 "mean number of tokens at 20th time point": 1 "pearson correlation": 1 "in nk cells in tumor-bearing mice": 1 "low mir-216b expression n =90": 1 "loss of junctional zo-1c": 1 "cyclin d1 expression": 1 "mct4 in stroma": 1 "pseudogenes": 1 "hdac isoform": 1 "lymph nodes": 1 "restoration of contact inhibition": 1 "rel intensity meth at hpych4iv": 1 "study and covariate": 1 "inflammatory response": 1 "ranking by #ppis": 1 "pupal age": 1 "bag3 staining score *": 1 "germ-line mutation in the cardiofaciocutaneous syndrome kras mutation occurs as early event in adenoma-carcinoma sequence concordance of primary tumor and metastases.": 1 "downregulated in aml with mll rearrangements and deleted in aml with loss of chromosome 7q 44 84 ": 1 "? nk activity on cancer patients": 1 "vendor": 1 "copy number of pik3ca amplification n = 37": 1 "history of uveal melanoma": 1 "confluent density ×106 *": 1 "cancer a": 1 "?3": 1 "number of experiments 100 cells scored/experiment": 1 "comparison between genotypes": 1 "amino acid consequence": 1 "y49f6a.1": 1 "pdgf-bcdkn2a nullh3.3 wtic50 ?m": 1 " no of patients = 89": 1 "media ml/well": 1 "18.92": 1 " no of patients = 85": 1 "44 72": 1 "2.2 non-classic": 1 "every 28 days": 1 " no of patients = 73": 1 "gnao1": 1 "methylation in vhmecs": 1 " no of patients = 74": 1 "not reduced": 1 "44 61": 1 "p23": 1 "nnp": 1 "serum fibrosis scores alone": 1 "p27": 1 "nnt": 1 "mtdh expression": 1 "expression of mir-493": 1 "nuclear after leptomycin b treatment": 1 "aw528454": 1 "cytogenetic": 1 "effect for pathophysiology of renal injuries": 1 "spouse no ": 1 "spot number in 2d-ppm": 1 "ski protein levels western blotting": 1 "nr of assigned sectra": 1 "gene title": 1 "32 59": 1 "mecp2": 1 "9cra": 1 "etoh": 1 "metaphases analyzed cell lines analyzed": 1 "impact of early-life exposures": 1 "primer plasmid or strain": 1 "mol wt range": 1 "doubling time h": 1 "final with extensions": 1 "on cyp450 3a4 strong inhibitor start at 5 mg daily increase cautiously after 4 weeks if no grade 2 ae": 1 "colon": 1 "positive n?=?180 ": 1 "myelination effect indicer +/? dhh-cre+ log2 ratio": 1 "protein group": 1 "oligo name": 1 ">1.5-fold up": 1 "criteria": 1 "? c loss of classical mhc and/or gain of nonconventional mhc": 1 " 228 234 235 ": 1 "number of cases n": 1 "transcribed locus": 1 "#proteins with function": 1 " larval lethality at 25°c a": 1 "erythema intensity 0–3": 1 "?6 loss of expression of multidrug resistance genes?": 1 "encodes a protein that inhibits nf-kappa-b by complexing with and trapping it in the cytoplasm however the unphosphorylated form resynthesized after cell stimulation is able to bind nf-kappa-b allowing its transport to the nucleus and protecting it to further nfkbia-dependent inactivation.": 1 "affymetrix fold change": 1 "average length of contigs bp": 1 "rde-1": 1 "macular degeneration": 1 "?-catenin & pdgfr?": 1 "berruti and coll protocol edp/m": 1 "rassf10": 1 "longer than 200 nt trascripts that may regulate gene expression through the interaction with genes promoter sites 19 ": 1 "increased 8-ho-dg levels with g-t transversions": 1 "ubiquitin-like peptide": 1 "peptide 4n1 in the c-ter domain": 1 "amplicon size bp and nucleotide number": 1 " vi identification of novel hypertension biomarkers in blood samples.": 1 "marker and parameter": 1 "ntg": 1 "systematic name": 1 "ishg agm.": 1 "cdkn1a †": 1 " ii day 2": 1 "accession number mrna": 1 "repressed in log phase by rph1 b": 1 "arterial pressure": 1 "germ-line mutations in familial juvenile polyposis with a risk of colorectal cancer as high as 60 over three to four decades.": 1 "blockade of neovessel formation by vascular endothelial cells": 1 " time active": 1 "receptor type activated": 1 "skewness of atypical replacement samples to positions in the protein globule": 1 "hr 95  ci": 1 "used": 1 "longest train duration": 1 "activating growth factors": 1 "the rapeutic application": 1 "positive edges only 37 node pairs": 1 "cis-associated gene": 1 "3259.5": 1 "?c fgfr1 -rearranged neoplasms": 1 "ic50 survival mortality or growth inhibition or dose": 1 "first ip": 1 "hdac6 inhibition also leads to its impaired catalytic domain affecting mt dynamism 39 .": 1 "46.20–2.10 2.21–2.10": 1 "effects": 1 "mir-221 expression": 1 "encodes a cell surface glycoprotein involved in leukocyte migration t-cell adhesion ganglioside gm1 and transmembrane protein transport and t-cell death by a caspase-independent pathway": 1 "similar to retinitis pigmentosa gtpase": 1 "hu mm 1": 1 "hypertrophy": 1 "0.805": 1 "molecular classification and recurrent molecular/chromosome defects": 1 "ubiquitin-mediated proteolysis": 1 "chrom no.": 1 "recurrent aspiration": 1 "school of medicine st marianna univ.": 1 "ski protein levels": 1 "df or mutation tested": 1 "negative n?=?529 ": 1 "language documentation": 1 "fluorescence microscopy": 1 "avg degree": 1 " protocol 1 2 +/or 3": 1 "suppressor of cytokine signaling 3": 1 "oligonucleotide or plasmid": 1 "target gene": 1 "gist location": 1 "no samples with loh": 1 "un-erupted spns": 1 "nucleolar protein family a member 1": 1 "nucleolar protein family a member 2": 1 "percentage of hairpins": 1 "growth of cells expressing app sirna and aplp2 sirna": 1 "identified by": 1 "actn2": 1 "capsaicin": 1 "dicer": 1 "co-exposure between arsenic and other chemicals including metals": 1 "974976": 1 "berberine-induced ampk activation inhibits the metastatic potential of tumor cells through a reduction in the activity of the erk signaling pathway and cox-2 protein levels": 1 "antibody source": 1 "8 hours menadione": 1 "10 of cases": 1 "calmodulin 2 phosphorylase kinase delta": 1 "msi-l/mss": 1 "type of linkage": 1 "oncoprotein class": 1 "duration until disease-progression unacceptable toxicity despite dose reduction or patient refusal": 1 "lxr?": 1 "cenp-f localization at the kinetochore": 1 "known properties": 1 "proximal colon n?=?24": 1 "n-terminus–c-terminus": 1 "? sirt6 ? pancreatic cancer colon carcinoma liver cancer": 1 "mtdna copy number median interquartile range": 1 "no mutants": 1 "viral persistence": 1 "44.7": 1 "type of biomarker": 1 "human chemokine activity": 1 "gjic ?": 1 "type of modification": 1 "unknown function": 1 "rnaseq": 1 "total number of mice": 1 "reverse strand matches": 1 "fold-change p-value": 1 "nmoles": 1 "tested alleles": 1 "integrin beta 1 fibronectin receptor": 1 "ukf-nb-4 hi vs ukf-nb-4 rank a / p -value/genes affected b ": 1 "mfn2 expression in tumor tissue": 1 "commonly hypermethylated in resistant cells": 1 "mediates the control of a large number of enzymes and other proteins by ca 2+ and is involved in a genetic pathway that regulates the centrosome cycle and progression through cytokinesis.": 1 "vimentin": 1 "activation of sestrin3 expression activation of ampk-mediated phosphorylation of tsc2 activating the inhibitory function of tsc1/tsc2 thus suppressing mtorc1": 1 "encodes a member of the map kinase family map kinases also known as extracellular signal-regulated kinases erks act as an integration point for multiple biochemical signals and are involved in a wide variety of cellular processes such as proliferation differentiation transcription regulation and development involved in both the initiation and regulation of meiosis mitosis and postmitotic functions in differentiated cells by phosphorylating a number of transcription factors such as elk1 phosphorylates eif4ebp1 required for initiation of translation.": 1 "name of drug": 1 "ng/ul": 1 "catalog number for 2nd shrna": 1 "10979": 1 "nol5a": 1 "antibodies": 1 "president award of the 19th meeting of japanese society of hepato-biliary-pancreatic surgery": 1 "transported to neuronal population": 1 "p value ?2": 1 "20304": 1 "t reesei ?tmk3 colony diameter mm": 1 "t reesei parent strain colony diameter mm": 1 "udp-glucuronate decarboxylase 1 uxsl": 1 "31.1": 1 "real-time rt-pcr b": 1 "eluent a ": 1 "parameters changed": 1 "maximum gene size": 1 "193.0": 1 "shmt1 in tumor": 1 "attenuation of monocyte activity in neoangiogenesis": 1 "bronchiectasis": 1 "gc ? at": 1 "pp71 if": 1 "cellular component": 1 "60±13**": 1 "pinch1 ?/?": 1 "research staff pharmacology division national cancer center research institute": 1 "ndf59 nis106": 1 "micrornas mirna": 1 "unmethylated ": 1 "transforming growth factor beta 2 tgfb2": 1 "position of peptide in the polypeptide chain": 1 "number ofpatients with pc mutation ": 1 "pathology associated with apoptosis": 1 " 227 ": 1 "genes ref number": 1 "mut case": 1 "37 70": 1 "in psk1 only": 1 "obs": 1 "tumor location": 1 "total embryos": 1 "immunohistochimical expression of cd44 protein": 1 "monocyte expression of pstat3": 1 "inhibit il-1 ? tnf- ? no pge2": 1 "international medical center of japan": 1 "?c kit d816v+ systemic mastocytosis sm-eo": 1 "418/2335 = 17.90": 1 "herbal galactogogue": 1 "overall response and disease control rate": 1 "blood pressure": 1 "expression of mirnas/mrna in primary rb tumours": 1 "4461": 1 "experimental sensitivity to egfr tki erlotinib": 1 "results/status": 1 "1.4 mds with isolated del 5q": 1 "web ontology language owl xml file developed using free protégé ontology editor software 65 .": 1 "shmt1 in stroma": 1 "pro-angiogenic peptides": 1 "chn 7830": 1 "mutation status in other npc studies": 1 "activate the immune system through tlr 9 against cancer": 1 "affymetrix probe id": 1 "2.13": 1 "2.11": 1 "total length/coding sequences kbp": 1 "resident in medicine university of tokyo tokyo": 1 "nuclear localization beta-catenin number of cases and percent of total": 1 " iv identification of posttranslational polymorphism and genetic factors": 1 "score core/matrix": 1 "?mesangial cell proliferation and hypertrophy": 1 "2.04": 1 "normalized rat brain transcribed locus": 1 "repair or avoidance of dna damage": 1 "anti-mitotic cytostatic effects by sstr1 sstr2 sstr4 and sstr5 signalling": 1 "modifications": 1 "fgfr": 1 "2007–2011": 1 "mechanism of action": 1 "tissue/organ/whole organism": 1 " b altered in shr": 1 "and mycelium abp-m": 1 "main feature s": 1 "guanine nucleotide binding protein g protein alpha inhibiting activity polypeptide 3": 1 "tumor type1": 1 "2.19": 1 "2.16": 1 "complete": 1 "purity of enriched tumor cells": 1 "comparator strategies": 1 "unmethylated in human es cells ohm et al 2007": 1 "2.34": 1 "supporting reads#": 1 "different statins": 1 "clinically favorable cup": 1 "particular clinical features": 1 "enriched go terms among repressed myc signature genes": 1 "migration rate ± sd": 1 "peak height": 1 "158.0": 1 "mutant melting peak": 1 "tumors estimated penetrance": 1 "? 2 -test": 1 "months": 1 "mapped reads of total reads": 1 "hrm positive only": 1 "e2f1 30 mef2c 35 nfia 26 ": 1 "up in eaf3 ? 41": 1 "braf exon 11 g469r mutated non-v600e mutation": 1 "yong investigator award": 1 "her2a": 1 "prediction by mirna database s": 1 "modulated by 5-aza-cdr": 1 "mammary carcinomas associated with mutant p53 in mouse models": 1 "r462e": 1 "mir-301 expression": 1 "average read length": 1 "flavonoids": 1 "50 91": 1 "imprinting status in cattle": 1 "3accession": 1 "age at dx": 1 "hypothesis of signaling adaptation 1990s": 1 "suppression of the gh/igf-i axis inhibition of gh secretion negative regulation of igf-i production increased release of igfbps": 1 "plating efficiency of stable nih-3t3–derived cell lines": 1 "2.53": 1 "gene encodes a protein that is a member of the dual specificity protein kinase family which acts as a mitogen-activated protein map kinase kinase and is an integration point for multiple biochemical signals": 1 "gb + e": 1 "chi-square test p -value": 1 "number of tumors": 1 "sa treated—three days after the induction of diabetes sa 300?mg/kg body weight dissolved in 0.5?ml olive oil was administered by gastric intubation for 21 days daily.": 1 "nature of defect": 1 "4/1987–3/1993": 1 "mcl1 84 cdk6 84 igfr 84 jak2 84 dnmt3a 84 dnmt3b 84 ": 1 "0.1927": 1 "tumors": 1 "histological diagnosis": 1 "histologically measured by microvessel density biochemically measured by serum vegf": 1 "neurotrophin": 1 "tumor weight gm": 1 "number of contigs with 2 reads": 1 " protocol 3": 1 " protocol 2": 1 "source in which metformin demonstrated antitumor activity": 1 "remarks": 1 " protocol 1": 1 "2.71": 1 "sorafenib total daily dose on c1 d1 c mg": 1 "effects on cell cycle": 1 "cytogenetics": 1 "e/er sensitivity": 1 "? binding partners hif1? c-jun myc nf-kb": 1 "example files for biochemical pathway protein and genetic interaction protein phosphorylation insulin maturation gene regulation generic molecules in owl xml.": 1 "only infects dividing cells": 1 "control n": 1 "molecular mechanisms implicated by mutation": 1 "basal map mmhg": 1 "1418133_at": 1 "antigen retrieval method for ihc": 1 "detection in 2nd generation n = 108": 1 "type of tumors": 1 "1982–1983": 1 "2.88": 1 "guanine nucleotide binding protein g protein q polypeptide1": 1 "pdk1": 1 "often serous papillary histology": 1 "?glomerulosclerosis": 1 "?-the natural end point of lytic viral infection": 1 "13 23": 1 "13 20": 1 "number of cells": 1 "23.3±4.7***": 1 "cell population": 1 "il-4r": 1 "mtdna copy number": 1 "free r -factor ": 1 "cardio-toxin pre-injury": 1 "patients carrying one or two t alleles required significantly lower tac doses compared with patients homozygous for the wild-type c allele.": 1 "aug 2006–aug 2009": 1 "4ebp1": 1 "hr status": 1 "in ?n692 only": 1 "relative risk ci 95": 1 "adhesion molecule receptor": 1 "p value †": 1 "regulation of progression through cell cycle release of cytochrome c from mitochondria": 1 "c04f12.1": 1 "reduced rb expression": 1 "inducible": 1 "depression is caused by e decreased availability of monoaminergic neurotransmitters antidepressants boost monoamine levels": 1 "range of contig length bp": 1 "gene symbol 1": 1 "baseline and tumour characteristics": 1 "natural product or compound type ": 1 "oxidative stress": 1 "number of reads assembled in contigs larvae/pupa/adult": 1 "c other myeloid neoplasm or stem cell neoplasm with hypereosinophilia – who classification criteria and hypereosinophilia but eosinophils <30": 1 "vessel type": 1 "induces apoptosis in colon cancer cells by attenuation of h2o2-stimulated cox-2 expression via ampk": 1 "cell-cycle control": 1 "131.7": 1 "lower plateau b/min": 1 "igf-binding protein-1 igfbp-1": 1 "hypophosphatemia – oral phosphate replacement": 1 "enos mediated ras activation by s-nitrosylation": 1 "80.0": 1 "confers resistance or increases sensitivity?": 1 "741.7": 1 "effect of meki 10–0.3 µm on growth": 1 "gene symbol a": 1 "probe ids": 1 "gene symbols": 1 "? extensive dna hypermethylation with epigenetic silencing of mlh1": 1 "number of ests": 1 "5.22 ± 0.29": 1 "activation of p21 expression cell cycle inhibition growth inhibition": 1 "number of disallowed ?? angles": 1 "percent of pool": 1 "etiology b": 1 "gene number d": 1 "8 hours h2o2": 1 "gain-of-function": 1 "neurosphere size mm": 1 "number of sequenced plasmid clones with founder mutation": 1 "optimal to ltf or death": 1 "hm1imss colon/rahman colon": 1 "interaction with ste11": 1 "orf": 1 "reported percentage of methylation in breast tumors": 1 "amino-acid change": 1 "reductase inhibitors hmg-coa decreasing modified ldl-cholesterol i.e oxidized acetylated ldl-cholesterol decreasing triglycerides and increasing hdl-cholesterol improving endothelial cell dysfunction restoring the abnormal lipoprotein fractions thus decreasing the redox and oxidative stress to the arterial vessel wall and myocardium.": 1 "2289.3": 1 "day 8 notch on": 1 "nntt at 15 years": 1 "preexisting liver disease": 1 "a number of genes": 1 "29.6±2.1": 1 "sampling time hours post-injection": 1 "agggagggcgc c gggaggaggg": 1 "fellowship award of japanese society for parenteral and enteral nutrition jspen 2012": 1 "25 74": 1 "number of singlets": 1 "tumor onset time days": 1 "pep count": 1 "none": 1 "34-dms a methylated resveratrol derivative induced autophagy in endothelial cells through activation of ampk and the downstream inhibition of mtor signaling pathway": 1 "transgenic line": 1 "cons": 1 "biotinylated antibody": 1 "proportion ": 1 "lymph-node metastasis": 1 "proneural": 1 "pts with 2spns": 1 "?-catenin-positive foci": 1 "features of interest": 1 "1137.2": 1 " 4 gene therapy": 1 "alterations in dendrites and dendritic spines": 1 "erupted spns": 1 "mtorc1 signaling": 1 "antisense": 1 "urate redox shuttle": 1 "optimal to sub-optimal care": 1 "most differentially expressed mirs": 1 "baroreflex control of heart rate": 1 "25 52": 1 "interpro term": 1 "il6 †": 1 " hypomethylation": 1 "endothelin receptor type b": 1 "distribution": 1 "copd": 1 "cd59 molecule complement regulatory protein": 1 "decreased cytosolic adenine nucleotide concentrations": 1 "rita golfieri md": 1 "total number": 1 "trigger apoptosis of infected cells": 1 "area of minimal enclosing ellipse ?m 2 ": 1 "actin beta": 1 "inside fra10f": 1 "description from sgd": 1 "lentinus lepideus": 1 "number of changes a": 1 "matrix metallopeptidase 19": 1 "name of protein": 1 "karyotype of stromal cells": 1 "ic50 az peptide/ic50 az_wt": 1 "no of es cells electroporated": 1 "relative binding b": 1 "window sizes analysed kbp": 1 "minimum": 1 "negative n?=?409 ": 1 "1988–1990": 1 "13 50": 1 "assistant professor department of gastroenterology university of tokyo": 1 "aa892839": 1 "the percentage of golgi localization ": 1 "increased levels of oncogenes or k-ras mutation": 1 "t-test mna vs mnsc lower in mna": 1 "mtdna copy number a": 1 ">75": 1 "total utr-snps": 1 "type of sumo interactor": 1 "coenzyme name": 1 "liposomes": 1 "25 45": 1 "changes leading to or associated with apoptosis": 1 "58.3": 1 "of chemotherapeutic agents effects": 1 "58.7": 1 "proposed": 1 "mean tumor latency": 1 "membrane receptors relative mrna expression in relation to gapdh": 1 "?pik3ca mutation": 1 "cy-induced leukopenia": 1 "ssc inhibition of the differentiation of fibroblast into myofibroblast proliferation and ecm production distler et al 2007 in vitro and in vivo ": 1 "major go category ies": 1 "stimulation of brduincorporation by fgf1": 1 "best struct motif": 1 "best motif of sequence": 1 "4 myeloid and/or lymphoid neoplasms with eosinophilia and abnor-malities of": 1 "hypertension toxicity homocysteine toxicity hs-crp": 1 "related to in microarray analysis": 1 "2250.7": 1 "h2o2 treatment": 1 "er? status": 1 "model type": 1 "primary ciliary dyskinesia": 1 "2009–present": 1 "level of matched disease in mesh tree #": 1 "cost": 1 "7q35-36": 1 "16.15 – 17.15": 1 "? hypermutation of many genes including hla class 1 factors affecting antigen presentation": 1 "a cylindracea": 1 "departments of internal medicine and gastroenterology tokyo women's medical university": 1 "assay": 1 "compliance": 1 "? substrate glutamine dehydrogenase": 1 "experimental condition": 1 "5804": 1 "ppw-2": 1 "prey library used": 1 "r 1": 1 "not normally present expression induced by cytokines and endotoxin": 1 "ppw-1": 1 "expression level": 1 "ratio of height": 1 "peak within 100 kb-1 mb": 1 "c versicolor": 1 "functionc": 1 "45.9": 1 "sizes bp": 1 "foxm1 negative": 1 "saitama municipal hospital": 1 "plakophilin 3 predicted": 1 "?4 increase in cell size accompanied by increase in cell cycle duration-introduction of g1 phase in the cell cycle rajaraman unpublished 143.": 1 "analysis": 1 "apoptosis index": 1 "tumor stage": 1 "functional annotation": 1 "lelfd": 1 "a 0": 1 "target site": 1 "gene encodes an adapter protein involved in asymmetrical cell division and cell polarization processes and plays a central role in the formation of epithelial tight junctions": 1 "antisense/sirna": 1 "primers": 1 "primer probe pool": 1 "n-myr": 1 "2004–2006": 1 "percent of total transcripts": 1 "-t3 homo sapiens mrna for kiaa1468 protein": 1 "dendritic cells dcs provide the key link between innate and adaptive immunity by recognizing pathogens and priming pathogen-specific immune responses flt3lg controls the development of dcs and is particularly important for plasmacytoid dcs and cd8 stimulates the proliferation of early hematopoietic cells by activating flt3.": 1 "response duration months": 1 "location of py": 1 "11.0 – 12.15": 1 "ip_name": 1 "a = b = 241.99 c = 76.59": 1 "? substrates h4k16 in promoter of nedd4 k-ras": 1 "assistant professor in gastroenterology tokyo university school of medicine": 1 "dead eggs ": 1 " 109 ": 1 "differentially expressed mirnas": 1 "2004–2012": 1 "permutep": 1 "this gene encodes a protein that possesses three distinct enzymatic activities 510-methylenetetrahydrofolate dehydrogenase 510-methenyltetrahydrofolate cyclohydrolase and 10-formyltetrahydrofolate synthetase.": 1 "effect and efficacy": 1 "a k": 1 "?4 loss of tissue specific stem cell surface markers due to differentiation during extended mitotic proliferation?": 1 "component": 1 "?5 loss of expression of stem cell specific self-renewal genes?": 1 "potential mechanisms of sunitinib resistance": 1 "initiation phase of ? -catenin positive cells": 1 "bmp-6": 1 "best responses": 1 "p up": 1 "a x": 1 "methylation and/or loss of p16mst1 and or p15": 1 "a y": 1 "c elegans": 1 "8946.3": 1 "1205lu clones": 1 "444.7": 1 "conc.": 1 "? substrates foxo1 foxo3a cdh1 cdc20 h3k56 h4k16 etc.": 1 " 107 ": 1 "similar to mouse intronless mdb0109 gene.": 1 "deguelin": 1 "5852": 1 "surface positions in globule p *": 1 "go term": 1 "abcc1 no.": 1 "aptamer activity": 1 "dead asp-glu-ala-asp box polypeptide 39": 1 "to be defined": 1 "induction of nondeletional proliferative hyporesponsiveness": 1 "predicted protein length": 1 "small nuclear rnas": 1 " 108 ": 1 "tumor formation at 4m mean of maximum diameter of tumors mm": 1 "overexpressed in aml with mll rearrangements 74 – 78 ": 1 "go number": 1 "type of abnormal expression": 1 "1450297_at": 1 "response of cell or molecule": 1 "vector type": 1 "mlk3 alterations": 1 "p -value of overlap": 1 " 105 ": 1 "3214": 1 "neurones": 1 "n -hexane": 1 "l83v": 1 "pct": 1 "cancer hallmarks 32": 1 "?b pdgfrb -rearranged neoplasms": 1 "other cases": 1 "fertilized 2-cells embryos after 1 day": 1 "forward primer 5' to 3'": 1 "log-rank p": 1 "number of reflections": 1 "p-akt": 1 "no of genes$": 1 "etiology": 1 "epigallocatechin gallate egcg": 1 "negative n=15": 1 "accession # †": 1 "no relationship was found between donor cyp3a5 6986a>g genotype and the nephrotoxicity.": 1 "main findings": 1 "no of total": 1 "exposure to allergens": 1 "dbc2": 1 "rate of response": 1 "mutants": 1 "lifespan": 1 "attenuation of cox-2 overexpression during acute endotoxemia": 1 "arhi expression": 1 "full gene name": 1 "aeg-1 expression": 1 "nr3c1": 1 "number of foci positive for both n/c": 1 "tnm stage": 1 "gene name symbol": 1 "sdh of c": 1 "mouse hippocampus **": 1 "c elegans orthologs": 1 "abcb1 genotype of the donor is a major risk factor for csa-related nephrotoxicity after renal transplantation.": 1 " iii daily": 1 " 104 ": 1 "embryonic lethality in apc2 apc1 double mutant": 1 "integration": 1 "coverage ": 1 "gnaq exon 5 genotyping results": 1 "every 3 mo until mmr then every 6 mo": 1 "31 58": 1 "subclasses of mmps": 1 "p-msk1": 1 "diabetics high risk of hyperglycemia grade 2+ based on temsirolimus data 68": 1 "large 5–8?mm": 1 "cancer cell/tissue": 1 "effect of neuropeptide treatment on lh release in vivo": 1 "genes identified based on twofold change cut-off": 1 "number of cases studied": 1 "genetic factors": 1 "plasma levels of ldl major coronary events strokes and revascularizations separated into prior and not prior cerebrovascular disease": 1 "hugo approved name": 1 "type ii receptor": 1 " 101 ": 1 "pgr": 1 "viral respiratory tract infections": 1 "258±12*": 1 " females with ectopic veins only": 1 "cgg a cgg a cgcgagg a agg at": 1 "merotelic attachment": 1 "readies them for t-cell-mediated immune responses": 1 "frda1 friedreich’s ataxia gene": 1 " of tumors with tdcis": 1 "20494": 1 "279.7": 1 "gwas p-value meta": 1 "increased expression": 1 "no event": 1 "epigenetic research related to mechanisms": 1 "auc 95 ci": 1 "18 69": 1 "mptp susceptibility": 1 "breast / thyroid cancer": 1 "t-mw": 1 "positive n?=?16 ": 1 "fim-h mannose specific lectin": 1 "presidential prize of the 45th annual meeting of japan society of hepatology": 1 "average contig length": 1 "strain genotype a": 1 "?lungs diminished lung volumes and transfer factor pulmonary infilatrates on ct pulmonary alveolar proteinosis on biopsy without gm-csf antibodies": 1 "snps": 1 "2 negative": 1 "human disorders": 1 "7258.6": 1 "lin28a 83 ": 1 "ihpba 2014 best oral award": 1 " 100 ": 1 "inhibition of proinflammatory cytokine production": 1 "cytologyb": 1 "146.0": 1 "pkc? phosphorylation mol of pi/mol of protein": 1 "over-expression of egfr": 1 "gldc in tumor": 1 "k-ras status": 1 "eurocord/cibmtr": 1 "t-pi": 1 "virus species": 1 "grade 1 to 2": 1 "ballroom d meet the experts i diversity of evs chair clotilde théry speakers jan lötvall and stephen j gould": 1 "vascular invasion": 1 "percent binding relative to the binding by phosphorylated wild-type smad3": 1 "serrated adenomas": 1 "inflammatory pain": 1 "rel intensity meth at bstui": 1 "role/function": 1 "italian": 1 "post-transcriptional gene silencing rna-mechanism that involves the degradation of messenger rna in a highly sequence-specific manner 21-22 nt 12 ": 1 "? proliferation of one-way mlc induced by dc": 1 "line of cetuximab treatment": 1 "peptide from the type iii repeats": 1 "pn1": 1 "solubility in hexane or ether": 1 "hdac6 expression and its mediated hsf1 activation are essential for tumor growth and maintenance of oncogenic phenotype by promoting anchorage-independent proliferation to transformed cells 3 26 – 35 .": 1 "pn0": 1 "pn3": 1 "pn2": 1 "p2df": 1 "negative n?=?499 ": 1 "first author": 1 "13.15 – 14.15": 1 "pma": 1 "receptor for the e.coli heat-stable enterotoxin e.coli enterotoxin markedly stimulates the accumulation of cgmp in mammalian cells expressing gc-c also activated by the endogenous peptide guanylin.": 1 "rna derived from pre-microrna with expression levels unrelated to those of the associated micrornas 20 nt 18 ": 1 "first gene ahr binding sites": 1 "level of evidence gene top three applications linking the gene to": 1 "broad tropism easy to produce high titre stocks widely characterised in vivo": 1 "bmes": 1 "? 2": 1 "8 hours diamide": 1 " lam?2+": 1 "gene expression data": 1 "?8 potential to differentiate although aberrantly.": 1 "frequency of cn loss": 1 "or 95 ci *": 1 "change in expression in asthma human": 1 "expressing the wild type or mutant pkg1?": 1 "tissue of origin": 1 "growth factor": 1 "physicochemical properties": 1 "?-alter viral epigenetic controls methylation acetylation": 1 "no of genes in pathway": 1 "tcrbind ? pagcsk ? lck ? tcrphos ? zap70 ? ccbl ? tcrbind": 1 "rhoa and effectors b": 1 "spot    ": 1 "epitope sequence": 1 " 3htd": 1 "nup62": 1 "prognostic/therapeutic implications of pten loss": 1 "number of unique pttss": 1 "median survival months": 1 "le2ko vs control with hfhsd <0.5": 1 "wu et al 2007 a": 1 "forward strand matches": 1 "normal core i/actin a": 1 "mab against igf-1r": 1 "sr proteins expression affected by rnai of hnrnp a1 fus/tls hnrnp h and p68 rna helicase": 1 "bmi1": 1 "permutation p-value": 1 "high-quality sequences q>20 and at least 100 bp in length": 1 "pr ": 1 "sperm only ": 1 "81.3": 1 "np_036286": 1 "egfl7 n ": 1 "or 95 ci b": 1 "ea group": 1 "total regulated genes": 1 "# of sarcomas at a distant site median latency": 1 "pathology/fusion type": 1 "50 mmol l?1 nh4cl for 6 days": 1 "16?h": 1 "genbank no.": 1 "probe in cytoplasm": 1 "gene classification": 1 "ps6": 1 "cyclin subfamily": 1 "adjuvant": 1 "synonymous snps in all strains": 1 "81.8": 1 "leaks in mitochondrial outer membrane loss of cytochrome c": 1 "karyotype b": 1 "caucasian &amp north indian": 1 "t22h9.3": 1 "positive n = 64": 1 "matching scored": 1 "mouse id": 1 "cb545090": 1 "747206": 1 "cr-containing plates": 1 "phase 1 renal cell carcinoma": 1 "rmsd bond lengths å": 1 "median": 1 "not inhibited by plzf": 1 "hr 95 cu": 1 "disease gene/molecular defect": 1 "? pathways myc signaling": 1 "source of arsenic": 1 "osmr": 1 "point mutations melas merrf narp lhon": 1 "psk": 1 "• cardiac myocyte-specific gp130 knockout mice develop heart failure in response to pressure overload accompanied by increased cardiac myocyte apoptosis 7": 1 "upregulation of activation antigens such as cd69": 1 "ongoing trials in": 1 "best response n ": 1 "targeted genes   ": 1 "scc a n=20": 1 "h-y tcr+ female": 1 "known to interact w/ras": 1 "apparent ka ratio rhtrail-c3 / wt rhtrail by spr": 1 " descendants of p3.p p4.p and p8.p": 1 "itoe okamoto scholarship grant at tokyo women's medical university": 1 "suboptimal to optimal care": 1 "methylation level mean ± sd positive rate*": 1 "often aneuploid with alterations in cdk2a p53 and erbb2": 1 "gc ? ta": 1 "centrosome overduplication": 1 "residues in allowed region ": 1 "ptn": 1 "chrysin": 1 "genomic size of the mapped location": 1 "ag/gg": 1 "litter size b": 1 "professor department of gastroenterology juntendo university": 1 "primers 5? to 3?": 1 "naked dna": 1 "prostate": 1 "zebrafish": 1 "10.1 2.8": 1 "functional group": 1 "aeg-1 protein expression in the nucleus": 1 "genes identified based on rank in fold change without cut-off": 1 "number of waters": 1 "gene and function": 1 "hla allele group": 1 "patients id": 1 "second ip": 1 "tcf7l1": 1 "8 14": 1 " females with blistered wings": 1 "experiment a": 1 "experiment b": 1 "curcumin": 1 "primers used in real-time pcr": 1 "7.17": 1 "regulation of leukocyte migration": 1 "trail-r1": 1 "trail-r2": 1 "upreg .": 1 "relative fecundity": 1 "encodes protein that belongs to the serine/threonine protein kinases family and to the ca 2+/calmodulin-dependent protein kinases camks subfamily camks have numerous cellular functions and they influence processes as diverse as gene transcription cell survival apoptosis and cytoskeletal re-organization.": 1 "8 24": 1 "348/783 = 44.44": 1 "smurf2": 1 "high-quality reads": 1 "antibiotics": 1 "distal colon and rectum n?=?47": 1 "? il-2 ifn- ? and tnf- ? production in splenocytes": 1 "337.0": 1 "suppression of ppar? and ppar?-mediated lipogenesis": 1 "calculated pi value": 1 "source of biomarker": 1 "array of tumor cell types enhancement": 1 "methods": 1 "pwm": 1 "decreased substrate supply o2 fatty acids glutamate pyruvate etc": 1 "challenges in cardiac proteomic and hypertension research": 1 "encodes a cell surface adhesion molecule that belongs to a family of adhesion/homing receptors": 1 "more npc literature": 1 "tumor size": 1 "mouse-human identity": 1 "experimentally verified protein type s": 1 "modulation of autophagy by stimulators": 1 "control intake type or kcal/day": 1 "vascular endothelial growth factor b": 1 "vascular endothelial growth factor c": 1 "8 31": 1 "mthfd2": 1 "mthfd1": 1 "tgfbr2": 1 "i504t": 1 "7.38": 1 "tg/gg": 1 "above median": 1 "size mb c": 1 "aqp5 labeling intensity": 1 "9 positive": 1 "trbp": 1 "adenocarcinoma foldchange": 1 "egfr status": 1 "platelet derived growth factor c": 1 "bcl2/adenovirus e1b interacting protein 1 nip1": 1 "7.42": 1 "asp gat": 1 "genes for hereditary spastic paraplegia": 1 "major": 1 "major functions": 1 "• anti-oxidant effect it scavenges reactive oxygen species locally and acts as a chain-breaking antioxidant to scavenge ros.": 1 "small endogenous non-coding rnas that form the pirna-induced silencing complex pirisc in germline development involved in the regulation of transposons stability and stem-like epigenetic state of cancer cells 26-31 nt 13 - 14 ": 1 "family origin": 1 "transcription factor 7-like t-cell specific hmg-box": 1 "site of origin": 1 "rrm2 b": 1 "encodes a g protein-coupled receptor which activates a phosphatidylinositol-calcium second messenger system.": 1 "cr concentration mg/l": 1 "wider implications": 1 "probe at membrane": 1 "rodent and model": 1 "hypermethylated": 1 "no of non-silent mutations per sample avg": 1 "? b immunosuppressive cells treg and mdsc": 1 "tacc": 1 "promoter methylation of mgmt /h mlh1": 1 "trf1": 1 "substitution": 1 "1983–1986": 1 "homologous human genomic segment human chromosome number from base pairs to base pairs": 1 "pretreatment *": 1 "1 + 2": 1 "p53 status this study": 1 "46.7": 1 "46.1": 1 "inhaled foreign body": 1 "no of stained slides for ihc": 1 "invited professor department of internal medicine kitasato university school of medicine": 1 "activation of the human complement system via the": 1 "decrease relative ad risk 0.29": 1 "instructor department of medicine ii university of tokyo": 1 "synovial t cells are hyporesponsive to tcr ligation": 1 "ic 50 with 10 ? m tat-rasgap 317-326 ": 1 "clinical or epidemiological features": 1 "basal hr b/min": 1 "ribosome biogenesis and assembly": 1 "cyclin-dependent kinase inhibitor 1a p21": 1 "21 67.7": 1 "up- or down-regulation": 1 "no of embryos": 1 "developmental": 1 "cluster 1 probability": 1 "ubiquitination detected in absence of stress?": 1 "frame-shift?f": 1 "7.81": 1 "256.78": 1 "no of mutated samples sample name": 1 "heparin-binding egf-like growth factor": 1 "second gene ahr binding sites": 1 "extent of body lesions 0–100 according to the rule of nines.": 1 "pdgfr?-positive foci": 1 "confirmation rate ": 1 "rmsd to initial å": 1 "4158.9": 1 "mean b value å2": 1 "33.3": 1 "oxidant sensitivity": 1 "route": 1 "phenotype following rnai treatment or in mutant strains": 1 "b y": 1 "1277.9": 1 "b x": 1 "33.9": 1 "ic50 a nmol/l": 1 "tissue and condition": 1 "efficiency of migration net/total µm±sd": 1 "ramachandran plot ‡": 1 "kras expression": 1 "amino acids": 1 "malignancy type": 1 "all genes selected by one or more protocol": 1 "ensembl gene id": 1 "mir-133b level": 1 "putative function": 1 "ly294002": 1 " n in validation": 1 "immunochip p-value meta": 1 "mean amino acid change score per double nt deleterious mutation ±sd": 1 "nm_013097": 1 "approval status year of first approval": 1 "55±5": 1 "1384.4": 1 "1424942_a_at": 1 "?jak2 gene amplification": 1 "h mlh1 methylation": 1 "q501r": 1 "percent of controls present >?=?1": 1 "1024.3": 1 "2 copies": 1 "cytoplasmic skp2 staining": 1 "lung carcinoma": 1 "apigenin": 1 "count n": 1 "molecular mass da/pi": 1 "negative regulation of transcription from rna polymerase ii promoter": 1 "20.7": 1 "29.8 ± 5.8": 1 "selectin l lymphocyte adhesion molecule 1": 1 "previous administration of bevacizumab for metastatic disease": 1 "hp1?": 1 "human gene and function": 1 "h_kit2_t21": 1 "2.1.4 primary myelofibrosis pmf": 1 "ic50 mean ± sem": 1 "percentage of tumor samples show less signal than pneumocytes": 1 "ki67": 1 "decreased resistance against ca2+- and ros-induced stress": 1 "negative edges only 11 node pairs": 1 "drosophila homolog": 1 "b-cell leukemia/lymphoma 3": 1 "insulin-like growth factor 1 receptor1": 1 "average number of macrochaetes *": 1 "no mutated samples": 1 "350865036": 1 "ssecks induction plus v-src activationc": 1 "putative functions": 1 "2010": 1 "presence of metastases": 1 "sponge species": 1 "number of blue nevi": 1 "loss of rassf1a expression": 1 "average methylation ": 1 "2004": 1 "2003": 1 "history of previousspontaneous of inducedabortions": 1 "homo": 1 "rna component of ribosomal subunit involved in protein translation 8 - 9 ": 1 "there is a bias towards the development of t helper th1 cells": 1 "genetic marker": 1 "symbol or cg number of gene targeted": 1 "t23d8.7": 1 "1455899_x_at": 1 "negative n?=?370 ": 1 "rab31 high": 1 "2014": 1 "enrichment score correlation coefficient": 1 "myelin protein zero-like 1": 1 "no/low expression": 1 "phenotypes suppressed 3": 1 "variants": 1 "rps6ka3": 1 "578.6": 1 "1 st filtration": 1 "neurodevelopmental step from figure 1 ": 1 "mda-mb-231": 1 "detection in sporadic non mosaic patients non mosaic": 1 "cer b": 1 "? phenotypes of sirt6 ko mice increased adenoma in sirt6 f/f v-c apc min/+": 1 "internodes cm": 1 "period from initial diagnosis to metastasis yrs": 1 "c?-c? distance from x-ray structures/å": 1 "n?=?21": 1 "nominal mass mr": 1 "total number in myrbase": 1 "no association has been shown between the cyp3a4-392a>g genotype and the rate of acute rejection creatinine clearance 1-year patient survival or graft loss.": 1 "up in pho23 ? 99": 1 "origin of cell bodies": 1 "weak +": 1 "classic herbal composite formula": 1 "matching protein": 1 "day 34": 1 "nearest known gene within 100 kb": 1 "relevant characteristics": 1 "ra inhibition of transformation/proliferation of synovial fibroblasts kameda et al 2006 sandler et al 2006 in vitro delay in joint destruction paniagua et al 2006 ando et al 2006 in vivo ": 1 "activation of p27 cell cycle inhibition growth inhibition": 1 "kazuto nishio md phd": 1 "erythema distribution 0–3": 1 "worse prognosis": 1 "predicted protein changes": 1 "agents": 1 "bcbl-1 cells": 1 "n?=?48": 1 "1-29": 1 "first identification": 1 "n?=?41": 1 "reduction of pro-angiogenic factors": 1 "hog pathway": 1 "array ba": 1 "increased arterial stiffness and pulse wave velocity impaired endothelial function and vasodilatation chronic vascular inflammation intima media thickness and early atherosclerosis hemorheological disturbances of blood flow capillary rarefaction and dysfunctional regulation shorter telomere length/lower telomerase activity impaired glucose and lipid metabolism insulin resistance oxidative stress arterial calcification increased deposition of matrix substances small vessel degeneration in brain and kidney increased left ventricular heart lvh load with hypertrophy": 1 "pleiotrophin": 1 "frequency of cn gain": 1 "reference range": 1 "resident in obstetrics gynecology and pediatrics tokyo metropolitan tama medical center tokyo japan": 1 "24 h post-dose severity of test article-related microscopic lesions": 1 "node name": 1 "20.536": 1 "in vivo mg/kg": 1 "increased protein expression independent prognostic marker of disease relapse following radical cystectomy": 1 "encodes the receptor for colony stimulating factor 1 a cytokine which controls the production differentiation and function of macrophages this receptor mediates most if not all of the biological effects of this cytokine.": 1 "total no of gene-trap clones g418 r": 1 "array aa": 1 "5-azac": 1 "lower in her2+": 1 "3435c>t": 1 "description of transgenic promoter": 1 "number of substrates in signature": 1 "amino acid": 1 "methylation frequency beta-value": 1 "n?=?12": 1 "direct blocking of autocrine/paracrine ‘survival factor’ secretion by cancer cells": 1 "n?=?15": 1 "tumor cell expression of pstat3": 1 "virus family": 1 "a2780cp *": 1 "loss of tumor-suppressors": 1 "expression of receptors in gnrh neurons": 1 "? bmcs growth and differentiation into cfu-gm": 1 "gene/sequence id protein description": 1 "effect in pca": 1 "director department of gastroenterology chigasaki municipal hospital kanagawa": 1 " 110 ": 1 "patients with at least one cyp3a5*1 allele had a greater survival rate than cyp3a5*3 homozygotes cyp3a5*3/*3 genotype is associated with decreased patient survival.": 1 "147.9": 1 "cd44 unmethylated promoter in primary lymphomas": 1 "frequency of t allele p*": 1 "95.5": 1 "refinement statistics": 1 "14.0 – 14.15": 1 "effect of combination expected additive effect§": 1 "parent variety": 1 "26675": 1 "accession no": 1 "n?=?63 58.9": 1 "f514l": 1 "complex iii uqcrb subunit vii": 1 "type i collagen ng/ml": 1 "pravastatin 40 mg/day": 1 "mean of dinucleotides that are uvb sites ±sd": 1 "normal function": 1 "sli-1 mutation does not block cell death in the pharynx": 1 "calculated masses m+h+": 1 "hi creates cross talk between the insulin receptor and at-1 receptor resulting in a more profound ang ii effect.": 1 "82.0": 1 "association with clinical parameters": 1 "at 4 weeks": 1 "atrial thrombi": 1 "supported by data?": 1 "enhances prostate cancer cell response to ionizing radiation by modulation of ampk": 1 "family history of cancer": 1 "c-myc": 1 "lc no pos ": 1 "mutations in nuclear genes controlling the stability of mtdna": 1 "suppression of ar transactivation": 1 "developmental abnormalities of the upper airway": 1 "bioactions in vitro": 1 "intensity relative to that of control": 1 "ant1 twinkle polgi1 tp th2 dguok deoxynucleotide carrier": 1 "pagcsk ? lck ? fyn ? pagcsk": 1 "82.4": 1 "upregulated by il-1?": 1 "2 3.6 ": 1 "n-terminal extension?": 1 "fold of activation by ouabain/k+-free medium in huvec or rvsmc": 1 "27990": 1 "10.0 – 10.55": 1 "endosome marker or cargo": 1 "drosha": 1 "wst-1 assay dsrna+ecdysone": 1 "number of observations": 1 "n rare+hz event a": 1 "genes identified with a strong matrix score": 1 "cytoband a": 1 "predicted values for an additive effect": 1 "basic helix-loop-helix domain containing class b 8": 1 "descriptions": 1 "compd": 1 "mef2a": 1 "dominant model or 95 ci † ‡": 1 "cell adhesion and basement membrane": 1 "nm_139336": 1 "cardiovascular disease modeled with hipsc-cms": 1 "registration / tea and coffee.": 1 "total inflorescences on main stem": 1 "number n of examined studies": 1 "fold change cancer/healthy": 1 "subcategory": 1 "crcs crc": 1 "effect size": 1 "irpc “eminent scientist of the year” gold medal international research promotion council": 1 "efficiency ": 1 "mean surface area µm2": 1 "43 86": 1 "research resident foundation for promotion of cancer research at national cancer center research institute": 1 "asp/asn": 1 "ppar ? ligand": 1 "epidemiology": 1 "geom mean of intensities in class 4": 1 "regulation of transcription dna-dependent": 1 "geom mean of intensities in class 3": 1 "fti sensitivity": 1 "encodes a trifunctional polypeptide it has phosphoribosylglycinamide formyltransferase phosphoribosylglycinamide synthetase phosphoribosylaminoimidazole synthetase activity which is required for de novo purine biosynthesis.": 1 "tsc2": 1 "definition": 1 "7593.1": 1 "alternative criteria choi size and attenuation ct criteria mass criteria": 1 "number of hits": 1 "encodes a protein that is member of the nuclear factors of activated t cells dna-binding transcription complex that plays a role in the inducible expression of cytokine genes in t cells especially in the induction of the il-2 and il-4.": 1 "max degree": 1 "molecular weight kda *": 1 "5-azac?+?tsa": 1 "1437238_x_at": 1 "n?=?17 12.0": 1 "?p53 protein": 1 "mef2d": 1 "forward pds agggat": 1 "pfsa": 1 "multiple linear regression predict": 1 "alternative pathway in human serum": 1 "initial morphology": 1 "on cyp450 3a4 inducer cautious dose escalation if no grade 2 toxicity after 4 weeks at 10 mg": 1 "all adenomas": 1 "35–55": 1 "potential ligands": 1 "205.9": 1 "lymphoma non-small-cell lung cancer": 1 "genes in each subgroup number": 1 "moderate hepatic impairment child–pugh class b 5 mg daily": 1 "consequence of alteration": 1 "preexisting immunity": 1 "count in dbsnp": 1 "55 56": 1 "genetic association to human cardiovascular disease": 1 "gb a accession #": 1 "reduced": 1 "data collection and processing statistics": 1 "fucogalactan": 1 "donors are classified by flt3-itd mutation status": 1 "simvastatin 40 mg/day": 1 "increasing the levels of phase ii enzymes.": 1 "182.9": 1 "rectum": 1 "targets related to ad": 1 "gene function2": 1 "cd47 binding": 1 "astrocytoma": 1 "type of measurement": 1 "phase 2 melanoma": 1 "negative no ": 1 "frequency of hras in pcc/pgl? with unknown mutations": 1 "35–45": 1 "nm_016986": 1 "cases n=31": 1 "number of cancers with snvs": 1 "tumor size mm 2 in balb/c nu/nu": 1 "1.1.2 ra with ring sideroblasts rars": 1 "java programming library supporting import/export conversion validation can be used to add biopax support to software.": 1 "phytochemical": 1 "welcome.": 1 "progestin": 1 "dichloromethane": 1 "?vascular resistance to vegf pathway inhibition": 1 "initial carbon source 7 hr": 1 " iii day 3 4": 1 "in adults": 1 "multifoci 64 4c-alex 384 well optofluidics chip in development": 1 "successfully cloned": 1 "hypercholesterolemia – diet modification prevastatin if necessary other statins are cyp450 substrates 66": 1 "1416646_at": 1 "plating efficiency": 1 "encodes a surface antigen that is preferentially expressed on monocytes/macrophages it cooperates with other proteins to mediate the innate immune response to bacterial lipopolysaccharide cooperates with md-2 and tlr4 to mediate the innate immune response to bacterial lipopolysaccharide lps acts via myd88 tirap and traf6 leading to nf-kappa-b activation cytokine secretion and the inflammatory response.up-regulates cell surface molecules including adhesion molecules.": 1 "47.0": 1 "stimulates the proliferation of early hematopoietic cells by activating flt3 synergizes well with a number of other colony stimulating factors and interleukins": 1 "number of tumor foci": 1 "c pruinosa": 1 "monovalent cations ionic radius in picometers": 1 "celastrol": 1 "2 long non-coding rnas >200 nt.": 1 "first exon": 1 " p6.px only": 1 "d25e": 1 "aw253722": 1 "218.8": 1 "number ofabortions": 1 "# of probesets b": 1 "no association was seen between cyp3a4*1bgenotype and tac dose requirements.": 1 "clinical pathological features": 1 "encodes a protein that is a membrane bound enzyme that catalyses the formation of cyclic amp from atp": 1 "5' gene": 1 "lineage negative ×106": 1 "not evaluated": 1 "incitement award japanese cancer association": 1 "encodes a cytoplasmic protein tyrosine kinase that is found concentrated in the focal adhesions that form between cells growing in the presence of extracellular matrix constituents the encoded protein is a member of the fak subfamily of protein tyrosine kinases.": 1 "pts with 1 spn": 1 "dowmregulated in t 821 aml 33 ": 1 "resources": 1 "assembly statistics": 1 "clinico-pathological parameters": 1 "casein kinase 2": 1 "2010–present": 1 "encodes a member of the phosphoinositide phospholipase c beta enzyme family that catalyze the production of the secondary messengers diacylglycerol and inositol 145-triphosphate from phosphatidylinositol in g-protein-linked receptor-mediated signal transduction phospholipases are ubiquitously expressed and have diverse biological functions including roles in inflammation cell growth signaling and death and maintenance of membrane phospholipids.": 1 "adjuvant chemotherapy": 1 "? nk cells activity inf- ? indirectly through il-12 produced by": 1 "dj-1 expression a": 1 "am+/?": 1 "6850.0": 1 "cancer type effect of expression on treatment": 1 "mutation status in this study": 1 "gain of oncogenes": 1 "littermate": 1 "promotion of the activation of pi3k pathway signaling through the loss of function by inactivating mutation resulting in cell-survival signaling and apoptosis suppression.": 1 "patient number n =": 1 "mean lifespan days": 1 "capillary leak syndrome unilateral pulmonary edema": 1 "normal a": 1 "rat": 1 "18384": 1 "ras": 1 "end kb": 1 "primary tumour": 1 "pathogenicity": 1 "pshift change a": 1 "jsps prize japan society for the promotion of science": 1 "260/230": 1 "66/483 = 13.66": 1 "tumor volume ? +/?sem * at day?=?18": 1 "a erp": 1 "arg cgt": 1 "35.00–2.20 2.32–2.20": 1 "3° fate marker aris101 k09h11.1yfp scored at pn.px-pn.pxx": 1 "frequency background": 1 "gene ‡": 1 "21.5": 1 "bq7 82630": 1 "24 77.4": 1 "aav": 1 "controls ": 1 "only immune": 1 "21.7": 1 "forward orientation?d": 1 "up in sin3 ? 130": 1 "1134.1": 1 "4.1 pdgfra": 1 "risc proteins": 1 "? a multidrug resistance proteins": 1 "transcriptional response": 1 "t23b3.2": 1 "frameshift and nonsense mutations": 1 "tumour id": 1 "ratio of b and a": 1 "common situations": 1 "array platform": 1 "tnc †": 1 "in vitro ?m": 1 "fold change*": 1 "high irs 4–12": 1 "head of the radiology unit and vice director of department of digestive diseases and internal medicine sant'orsola-malpighi hospital university of bologna": 1 "mutations in adenocarcinomas": 1 "4764": 1 "prorenin": 1 "percentage of annotated contigs by nr": 1 "nos2 high": 1 "p value1": 1 "?sapp ?sapp decreased adas-cog slightly increased": 1 "effects on apoptosis pathways extrinsic intrinsic common": 1 "mmp19 †": 1 "no of stem cell colonies": 1 "2117": 1 "mir -93": 1 "suppresses breast cancer mcf-7 cell viability via the amp-activated protein kinase ampk-induced p53-polo like kinase 2 plk-2 pathway": 1 "1p 3p 4 5q 9 11q 13q 17q 18q": 1 "functional groups * gene name": 1 "copa score tumor 90th copa percentile/normal 90th": 1 "ankrd12 high": 1 "glial fibrillary acidic protein": 1 "vulnerable atherosclerotic plaque milieu of being acidic proinflammatory excess metal ions fe cu from vasa vasorum rupture and red blood cell plasma membranes due to intraplaque hemorrhage and plaque thrombus formation.": 1 "need to consider internal dose": 1 "104 cfu/ml": 1 "4.5 #": 1 "potential microrna as prognostic marker": 1 " 129 ": 1 "phospholipase c beta 3 phosphatidylinositol-specific": 1 "molecular": 1 "src ? ": 1 "aff": 1 "a transcription factor activated by beta catenin and known to mediate the wnt signaling pathway": 1 "n rare+hz": 1 "unmethylated in hnscc tumor tissue": 1 "total number of lens epithelial cells": 1 "descriptive name": 1 "assumed fibre type": 1 "p valueb": 1 "distal": 1 "number of healthy controls n": 1 "313.2": 1 "4 negative": 1 "assistant professor in gastroenterology teikyo university school of medicine": 1 "lipids": 1 "peripheral staining": 1 "h2o2 over representation": 1 "s494p  ": 1 "activates ampk leading to a reduction in mtor phosphorylation and inhibition of ht-29 colon cancer cell growth": 1 "no of terminal nodes in group": 1 "averages and standard deviations of normalized log2 intensities on microarrays": 1 "r free": 1 "lys/gln": 1 "rate’s derivative": 1 "molecular mass g/mol": 1 "375.6": 1 "input signal": 1 "crcs": 1 "system": 1 "1.25": 1 "1.26": 1 "1.46": 1 "1.44": 1 "in ng/ml quantity": 1 "4c-alex 96 wells current prototype": 1 "mapp name *": 1 "human common variants": 1 "lupus nephritis inhibition of mesangial proliferation ecm production and crescentic formation leading to decrease in proteinuria and improvement in renal failure gilbert et al 2001 sadanaga et al 2005 zoja et al 2006 in vivo ": 1 "1.39": 1 "ribosomal large subunit export from nucleus": 1 "reported p53 status b": 1 "nrg1": 1 "creb": 1 "no of patients ": 1 "adjacent tissue": 1 "1.52": 1 "prediction based on analysis of mutational status alone exons 18–21": 1 "igf1r-alpha cytoplasm or membrane ihc expression": 1 "enhancing intratumoral nodule": 1 "# of transcripts influenced under each treatment 1": 1 "outputs": 1 "1.60": 1 "sample/status": 1 "t/c": 1 "1.62": 1 "log 2 e2/etoh": 1 "mean of domain ra": 1 "3518.5": 1 "cyp3a4": 1 "1.71": 1 "cyp3a5": 1 "ma si prr": 1 "no of bm recipients": 1 "signal transduction": 1 "1198/8356 = 14.33": 1 "atrial fibrosis": 1 "rnd": 1 "molecular classification": 1 "1.73": 1 "n?=?73 88.0": 1 "high mobility group at-hook 1": 1 "c/c": 1 "total ug": 1 "binding of control": 1 "mutation frequency for rhoh": 1 "1.80": 1 "proteotoxic stress": 1 "piwi-interacting rnas pirna": 1 "1.87": 1 "positive frequency ": 1 "1.88": 1 "line ¶": 1 "1.86": 1 "csf levels of a?1?42 ?sapp ?sapp totapp and total tau plasma levels of a?1?42 adas cog": 1 "rol": 1 "673.9": 1 "oral cavity n=140": 1 "0-1": 1 "ros": 1 "combined effect of risk alleles b cases/controls": 1 "animal/cell line tested": 1 "ratios": 1 "gene amplification": 1 "supposed breakpoint": 1 "83.0": 1 "increase in tumor density": 1 "nf- ? b 60 ": 1 "mir -25": 1 "filter common or commercial name": 1 "0.0": 1 "singlet": 1 "0.3": 1 " 122 ": 1 "0.5": 1 "n.d.": 1 "0.9": 1 "drug control—animals received sa at a dose of 300?mg/kg b wt in olive oil 0.5?ml orally by gastric intubation for 21 days daily.": 1 "long r7/8": 1 "negative n?=?611 ": 1 "type i receptor": 1 "12th week": 1 "? il-1 ?": 1 "synchronous": 1 "pdgf-b p53 lossgfap tv-aic50 ?m": 1 "12 35": 1 "q- value": 1 "eif4g1": 1 "setting up posters poster sessions xiv xv xvi xvii xviii xix xx": 1 "maximum in deer distance distribution/å b": 1 "chemotherapy associated with cetuximab": 1 "np_037367": 1 "apa": 1 "611.3": 1 "apc": 1 "vascular permeability": 1 "additional information": 1 "apn": 1 "pathway type": 1 "reverse primer 5' to 3'": 1 "apu": 1 "12 46": 1 "apw": 1 "fold change at temperature shift 72 hrs vs 144 hrs": 1 "? pathways inflammation angiogenesis resistance against chemotherapeutic agents.": 1 "increased at/af in ep study": 1 "k-ras": 1 "mean age years of spouse": 1 "crm1": 1 "bp change mm?hg b": 1 "gene expression": 1 "hf of sap mmhg2": 1 "ribosomal 5s and 5.8s rna rrna": 1 "sensitivity to egfr tki": 1 "diamond light source beamline i02": 1 "plate format": 1 "12 17": 1 "notes motifs and potential effects on structure and function": 1 "rsv": 1 "mesenchymal": 1 "? pathways glutamine metabolism": 1 "12 21": 1 "cell cycle phase": 1 "microarray relative change log2 fold change": 1 "karyotypic heterogeneity – basis for phenotypic selection": 1 "mir-342": 1 "r379g": 1 "understand limitations of recist": 1 "20 ?m b": 1 "number of impulses per train": 1 "chromosome instability 50 of gastric cancers": 1 "mouse": 1 "non-serrated adenomas": 1 " ifncpe50 a <10 u/ml": 1 "1728/6741 = 25.63": 1 "relevant antigen": 1 "tn3 ×106": 1 "mct4 in tumor": 1 "tnf-? production ‡": 1 "mechanisms of glucose homeostasis in other tissues in vitro": 1 "positive case ": 1 "975190": 1 "mutation rate": 1 "p wild-type vs mutant": 1 "mean age of onset": 1 "single- or double-strand breaks": 1 "avb": 1 "germline mutation": 1 "triple-negative": 1 "fluroimmunoassay": 1 "known as event 2": 1 "encodes the regulatory light chain associated with cardiac myosin beta or slow heavy chain ca+ triggers the phosphorylation of regulatory light chain that in turn triggers contraction myosins are a large family of motor proteins that share the common features of atp hydrolysis actin binding and potential for kinetic energy transduction.": 1 "enhances phagocytic activity downregulation of tnf- ? il-1 ? il-6 ifn- ? il-12 and il-18": 1 "gaps in lp": 1 "number of treatments": 1 "grade a": 1 "grade c": 1 "tubulin alpha 1c": 1 "c06a1.4 a": 1 "expression array systemfold change": 1 "pdk1+gw **": 1 "family history": 1 "*low": 1 "strongly positive rate ": 1 "alp*": 1 "2 eosinophilic leukemia without a recurrent somatic gene defect listed above": 1 "1 small non-coding rnas < 200 nt.": 1 "no ngf": 1 "10.55 – 11.00": 1 "nucleotide change a": 1 "gene set": 1 "rv for group*": 1 "ln18": 1 "methunmeth ratio for msp": 1 "lymphatic invasion": 1 "30.00–2.20 2.26–2.20": 1 "antibody type": 1 "no manually confirmed": 1 "number of mirnas screened": 1 "2057.1": 1 "hyb2055": 1 "eukaryotic translation initiation factor 1a": 1 " 1 antiapoptosis genes": 1 "number of interactions": 1 "gene name a": 1 "tumor occurrence ": 1 "myosin light chain 2 regulatory cardiac slow1": 1 "chromosome loci identified": 1 "ret receptor protein": 1 "serum or plasma positive no ": 1 "10 276": 1 "msh2 expression": 1 "ligand abbrev.": 1 "rho1e3.10": 1 "perinuclear clustering": 1 "ukf-nb-4 higcv vs ukf-nb-4 rank a / p -value/genes affected b ": 1 "location ratio": 1 "cell adhesion": 1 "roundness": 1 "? diffuse histologic subtype": 1 "board member of japanese association for liver cancer": 1 "no animals per group": 1 "some targets": 1 "gnas": 1 "459.4": 1 "67.9 ± 8.5": 1 "disorder": 1 "myelination effect indicer +/? dhh-cre+ pvalue": 1 "bp relative to tss a": 1 "topology in k+ buffer a": 1 "presence of symbiont": 1 "obliterative bronchiolitis": 1 "sestrin3": 1 "dose level mg per day": 1 "biochemical marker": 1 "total sample size intervention/ control": 1 "l508s": 1 "naoshi nishida md phd": 1 "array ratio": 1 "196.8": 1 "p11-12": 1 "a = body involvement": 1 "24 71": 1 "defects leading to w-cin": 1 "10788.3": 1 "nuclear export of pre-mirna": 1 "mir-125b": 1 "?resistance of hif1? target gene expression to repression by everolimus": 1 "35.2": 1 "third ip": 1 "pparg †": 1 "latency/penetranee": 1 "31st blastx result on tribolium castaneum": 1 "biological process": 1 "genes considered": 1 "tcga": 1 "exportin-5": 1 "cgp gene set": 1 "transfer rnas trna": 1 "24 43": 1 "24 45": 1 "jun 2001–may 2003": 1 "interactions": 1 "loh markers": 1 "pimaric acid": 1 "mif expression a": 1 "cloning frequency in malignant tissue ": 1 "activation of both classical and alternative pathways": 1 "metastasize to bone?": 1 "57±3": 1 "authentication": 1 "facs cerebral astrocytes*": 1 "resolvin e1": 1 "encodes a receptor tyrosine- kinase and plays a key role in vascular development and regulation of vascular permeability vascular endothelial growth factor is a signaling protein involved in the regulation of angiogenesis and vasculogenesis vegf binds to and activates a receptor tyrosine kinase vegfr.": 1 "5.6 5.7": 1 "modulus of elasticity e": 1 "sd ": 1 "agene encoding a member of the map kinase family known as extracellular signal-regulated kinases erks which act as an integration point for multiple biochemical signals and are involved in a wide variety of cellular processes such as proliferation differentiation transcription regulation and development": 1 "219.6": 1 "founder line": 1 "encodes a cell surface receptor and is believed to be involved in regulation of integrin-mediated cell motility": 1 "? a direct tumor binding various tumor antigens": 1 "1422407_s_at": 1 "present uroepithelial tumors ": 1 "pic50": 1 "ffpe tissue type": 1 "ref or acc number": 1 "ssecks induction": 1 "extent of lesions in the face 0–100": 1 "max mutant allele freq a c ×10?4": 1 "22.4": 1 "22.3": 1 "number of hairpins out of 300": 1 "• counteracts smooth muscle cell proliferation.": 1 "scg": 1 "bax": 1 "fitness score of resistance avg 3": 1 "hi increases membrane cation-transport increasing intracellular ca++ which increases tone and pressure.": 1 "accession number protein": 1 "17 50": 1 "mean ec50 of compound": 1 "10 17.9 ": 1 "basic concept of method": 1 "significant in hcc": 1 "mirna target": 1 "n rare+hz event": 1 "predicted consequence to transcript b": 1 "associated neoplasm": 1 "symptoms": 1 "17 65": 1 "iv/i": 1 "ruffles per cell +/- s.d.": 1 "medium 2–4?mm": 1 "late stage n=21": 1 "23.1 ± 0.8": 1 "additional species in which gene is imprinted/preferentially-expressed allele3": 1 " p-s6 s235+ and p-s6 s240+": 1 "high n?=?20": 1 "dead": 1 "thyroid cancer": 1 "17 28": 1 "high n?=?21": 1 "9396 protein 1578 water 25 ions": 1 "total number of assembled sequences": 1 "encoding the kras g-protein with constitutive activation resulting in the activation of both the pi3k–pdk1–pkb and raf–mek–erk1/2 signaling pathways thereby promoting cell survival and apoptosis suppression.": 1 "insufficient dna samples": 1 "pretreatment checklist pretreatment suitability see text ‘patient-selection’ medication list for cyp450 3a4 inhibitors or inducers strong inhibitors should not be co-administered 66 afinitor® counseling information eg common adverse events avoid live vaccines and grapefruit juice provide patient with reporting instructions eg fever respiratory symptoms record baseline tumor/symptom evaluation repeat every 8 weeks lab at baseline and every 4 weeks or more often if risk factors such as diabetes are present lab = cbc and differential phosphorus lft creatinine fasting glucose cholesterol triglycerides cxr at baseline and every 8 weeks or if cough/dyspnea develop ct chest if lung disease or lung metastases present at baseline and as needed for re-evaluation": 1 "mode of usage in hnscc": 1 "methods of detection": 1 "name of mirna": 1 "encodes a member of the dual specificity protein kinase family that lies upstream of map kinases and stimulates the enzymatic activity of map kinases upon wide variety of extra- and intracellular signals": 1 "induces granulocyitc differentiation in aml cells 38 ": 1 "subg1": 1 "set": 1 "induces apoptosis and inhibits proliferation of aml cells 44 ": 1 "count diff_gene": 1 " n = 72": 1 "10–30": 1 "differentially transcribed genes": 1 "top three applications": 1 "10–35": 1 "genetic manipulation to model genotypes of acquired resistance": 1 "acf incidence ": 1 "impaired biogenesis of mitochondria": 1 "test samples": 1 "e3 ligase": 1 "sift prediction": 1 "recognizing repairing and removing damaged proteins.": 1 "40?mg/m2": 1 "cell shape and morphogenesis": 1 "mir-29b": 1 "day 8 notch on versus notch off": 1 "11.9 33.8": 1 "effect of jab1/csn5 interaction": 1 "suppression of mmp-9 induction and migration of human aortic smooth muscle cells": 1 "mean decrease gini": 1 "congestive cardiac failure": 1 "growth factors": 1 "transcripts": 1 "site of action": 1 "adverse event": 1 "fluorescence spectroscopy": 1 "fgf-2 binding and sequestration": 1 "antiviral activity in vivo": 1 "3567": 1 "potassium inwardly-rectifying channel": 1 "name description": 1 "xenograft tumor frequency in different mouse strains": 1 "mcc d": 1 "total of hp": 1 "deletions": 1 "family members and characteristic": 1 "nucleotide change amino acid change": 1 "tested rnai lines": 1 "sig": 1 "observed expression pattern in gbms": 1 "in vitro/in vivo selection of resistant models": 1 "icer b c": 1 "ratio +gh/?gh 5a/5b/15 min 3": 1 "tgf-?1-mediated responsea": 1 "nomilin": 1 "msi-diploid": 1 "mean of uvb sites with single nt changes that were deleterious ±sd": 1 "irinotecan": 1 "rab31 medium": 1 "bgt inoculation": 1 "nuclear factor of activated t-cells cytoplasmic calcineurin-dependent 4": 1 "solubility in alcohol or acetone": 1 "tissue inhibitor of metallo-proteinase 1": 1 "1.6 childhood mds": 1 "kcl or nh4cl concentration mmol l?1": 1 "tts length": 1 "percentage of brdu-labeled cells": 1 "europid women": 1 "cdna library": 1 "method development for urinary dmaiii and mmaiii and measurement of arsenic metabolites in blood": 1 "chromatin state at occupied p53re location": 1 "future direction in cardiac proteome and hypertension research": 1 "nm_031131": 1 "fms-related tyrosine kinase 3": 1 "protein/gene": 1 "transcription initiation rnas tirnas": 1 "ski": 1 "inhibits colon cancer migration via ampk activation-mediated downregulation of integrin b1 signaling": 1 "80 of cases": 1 "no of mice with tumors/ total mice": 1 "mode of action tested*": 1 "low n?=?18": 1 "5508.2": 1 "lkb1 recombination by pcr": 1 "50-genes": 1 "replicates in epithelial cells": 1 "genes overexpressed in the tumour": 1 "tumor differentiation": 1 "her-2/neu status": 1 "affected cancer drug/treatment": 1 "localization tag sequence": 1 "96.2 *": 1 "methanol extract": 1 "growth strength": 1 "30 88": 1 "positive ++ to +++ no.": 1 "targets/function/clinical relevance": 1 "sequencea": 1 "2.2.2 chronic eosinophilic leukaemia not otherwise specified cel-nos": 1 "pdgf-bp53 loss nestin tv-a plate 2ic50 ?m": 1 "blm": 1 "?8 therefore they have limited division potential.": 1 "? immune response gene dysregulation with cd274 and pdcd1lg2 pd-l1 and pd-l2 amplification and overexpression": 1 "no of courses": 1 " 2 drug resistance genes": 1 "working dilution for ib if ihc co-ip": 1 "*22 intron 6c>t": 1 "nis106": 1 "97.9": 1 "fractions b-4 and b-5": 1 "fold of modulation by ouabain/k+-free medium in hela or rvsmc": 1 "total number of mutations": 1 "mse within gene": 1 "# pet1": 1 "a1229209": 1 "anova on microarray": 1 "dose of oxaliplatin mg/kg": 1 "817.8": 1 "retrieval method": 1 "loss of arid1a protein expression": 1 "• ischemic pre/post-conditioning lost in tnf? knockout 1 tnf? receptor knockout 2 il-6 knockout 3 or cardiac-myocyte stat3 knockout mice 4 • cardiac myocyte stat3-deficient mice show enhanced sensitivity to ischemia-reperfusion injury 5": 1 "n-cadherin expression": 1 "suppression of atp synthesis": 1 "microarray analyses": 1 "drug dosage": 1 "bowel-related complications ischemic colitis pneumatosis intestinalis": 1 "mutations": 1 "positivity in gc b cells": 1 "effects on nucleolus": 1 "shiseikai scholarship grant": 1 "rbm5 expression": 1 "aml transformation": 1 "official full name": 1 "pulmonary eosinophilic syndromes eg churg-strauss pulmonary eosinophilia": 1 "30 55": 1 "biochanin-a": 1 " m–h? mse2 b": 1 "immunogenicity": 1 "il-23 negative": 1 "number of array": 1 "mutation coordinates hg19": 1 "10–15": 1 "z score": 1 "brainstem and optic": 1 "t-huh7e": 1 "asp gtc": 1 "29 55": 1 "decrease in tumor density": 1 "?10 absence of senescent check points constitutes a built-in mechanism for accumulation of additional mutations via breakage-fusion-bridge cycle setting in motion the next cycle of s/t-neosis 66 67.": 1 "level of sox10 upon atf2 kd **": 1 "cml phase n.": 1 "disease a": 1 "subtype": 1 "b = facial involvement": 1 "this gene encodes a class iii receptor tyrosine kinase that regulates hematopoiesis the receptor consists of an extracellular domain composed of five immunoglobulin-like domains one transmembrane region and a cytoplasmic kinase domain split into two parts by a kinase-insert domain the activated receptor kinase subsequently phosphorylates and activates multiple cytoplasmic effector molecules in pathways involved in apoptosis proliferation and differentiation of hematopoietic cells in bone marrow.": 1 "disease b": 1 "other fusions 3 ": 1 "seed match": 1 "d_kit2_t12/21": 1 "1416128_at": 1 "tatsuo inoue": 1 "technic": 1 "src": 1 "cd44 unmethylated promoter in cell lines": 1 "10.": 1 "# of mice": 1 "encodes a cell surface glycoprotein that regulates complement-mediated cell lysis and it is involved in lymphocyte signal transduction this protein is a potent inhibitor of the complement membrane attack complex whereby it binds complement c8 and/or c9 during the assembly of this complex thereby inhibiting the incorporation of multiple copies of c9 into the complex which is necessary for osmolytic pore formation this protein also plays a role in signal transduction pathways in the activation of t cells involved in signal transduction for t-cell activation complexed to a protein tyrosine kinase": 1 "103": 1 "clinicopathological characteristics": 1 "transformed clones ": 1 " a altered in wky": 1 "down-regulated tf": 1 "effects on ad": 1 "tf a": 1 "accession no b": 1 "classes of enzymes type of reaction which involves the prosthetic group": 1 "cytological diagnosis": 1 " of each histotype": 1 "ballroom d meet the experts iv evs in biotechnology and therapeutics chair raymond schiffelers speakers janusz rak and samir el-andaloussi": 1 "112": 1 "shep tet21- n-myc": 1 "age days when": 1 "lung tumor data": 1 "phenotype observed/recapitulated in vitro": 1 "entire non-coding genome": 1 "?decreased at2r synthesis": 1 "family set": 1 "10a": 1 "fold stimulation over intrinsic": 1 "diff reg probes": 1 "biological effect of target gene": 1 "associate professor kinki university school of medicine dept of gastroenterology and hepatology": 1 "regulation of progression through cell cycle response to dna damage stimulus": 1 "40–5565": 1 "1.1 refractory cytopenia rc with uni-lineage dysplasia rcud": 1 "folfiri": 1 "ssecks induction plus v-src activation": 1 "negative n?=?621 ": 1 "enhancer": 1 "number of cutaneous melanomas": 1 "peptidylprolyl isomerase d": 1 "k- ras ": 1 "12252": 1 "total staining scorea": 1 "term p-value b": 1 "cell subset": 1 "specific antagonists": 1 "130": 1 "pustulation 0–3": 1 "132": 1 "residue no.": 1 "mutations in nuclear genes indirectly involved in repiratory chain": 1 "cd14": 1 "treatment begins on": 1 "mir-223": 1 "keratin 19": 1 "to gts1p": 1 "tcrbind ? fyn ? pagcsk ? lck ? tcrphos ? zap70 ? ccbl ? tcrbind": 1 "hoxb8 114 ": 1 "american association for the study of liver diseases": 1 "low irs 0–3": 1 "cd44": 1 "research question": 1 "157": 1 "takako satake scholarship grant at tokyo women's medical university": 1 "total n ": 1 "ppp1cb": 1 "growth factor supplied": 1 "plasmids a wt/ql": 1 "membrane occupied": 1 "ppp1ca": 1 "promoter-associated short rnas pasrs": 1 "24/102 = 23.52": 1 "160": 1 "il-23 positive": 1 "164": 1 "matching gene": 1 "7 14": 1 "cx10 + e": 1 "number of tissues": 1 "delivery method": 1 "tumor n=56": 1 "mitotic-checkpoint relaxation": 1 "lmna": 1 "? substrates mnsod skp2 etc.": 1 "cohesion defects": 1 "stimuli or tfs that control expression": 1 "177": 1 "hbv hcv hiv": 1 "7 21": 1 "7 27": 1 "cell clone": 1 "missing": 1 "kme3 of probe *": 1 "lp peaked": 1 "type ii": 1 "cd59": 1 "donor cells": 1 "number of mm cells lines with methylation": 1 "gene encodes a beta subunit of casein kinanse ii a serine/threonine protein kinase that is thought to have a regulatory function in cell proliferation cell differentiation and apoptosis and also thought to influence wnt signaling via beta-catenin phosphorylation and the pi 3-k signaling pathway via the phosphorylation of akt": 1 "significantly mutated domain instance counts": 1 "cell cycle regulation": 1 "low staining": 1 "coding event": 1 " 8 ": 1 " of all codon 12/13 mutations": 1 "cytoplasmic er": 1 "rrna processing translation": 1 "glut-1 in stroma": 1 "1145-1230": 1 "long non-coding rnas lncrna": 1 "target for sirt1": 1 "no of correlated snps": 1 "49.0": 1 "reported percentage of methylation in breast cancer cell lines": 1 "maf case": 1 "6.48": 1 "fold change *†": 1 "up in rco1 ? 116": 1 "trans formation": 1 "strain mutant and/or plasmid": 1 "cmax µg/ml ± s.d.": 1 "drug target": 1 "irf-3": 1 "mochida memorial foundation for medical and pharmaceutical research scholarship grant": 1 "6.57": 1 "case age/sex": 1 " of total mirna counts": 1 "oncogenic activity": 1 "involved exons a": 1 "260/280": 1 "fms-related tyrosine kinase 1 vascular endothelial growth factor/vascular permeability factor receptor": 1 "number of sequenced clones": 1 "cd25+cd4+foxp3+ tregs in the tumor": 1 "nm_013235": 1 " ii ms-based proteomics coupled with ngs approach": 1 "type of germline mutation": 1 "625.4": 1 "cd99": 1 "h-ras 12v/gst": 1 "# of peaks called": 1 "calreticulin expression": 1 "1420715_a_at": 1 "????? primer 5 ? -3 ? ": 1 "pshift d0": 1 "potential mechanisms of everolimus resistance": 1 "p < 5×10?5": 1 "positive n?=?300 ": 1 "p < 5×10?4": 1 "6.72": 1 "randomly selected sequences": 1 "results of inhibiting igfbp activity": 1 "625.6": 1 "s.d.": 1 "candidategenes": 1 "camk2a": 1 "hispidulin": 1 "?1 short cell cycle duration of nascent raju cells before they undergo first mitosis – an indication of lack of g1 phase? 5 6.": 1 "327.5": 1 "emission ratio c": 1 "caveolin-1 and akt positive n =23": 1 "imaging findings of drug toxicity": 1 "all edges 452 node pairs": 1 "patients": 1 "total base pairs bp": 1 "molecular target": 1 "animal and in vitro": 1 "msh2 immunohistochemistry": 1 "anticomplement activity": 1 "produces a myeloproliferative disorder when overexpressed in mouse hematopoietic stem cells 109 ": 1 "glucosidase alpha acid pompe disease.": 1 "?-activate t cells e.g pd-l1 inhibitor": 1 "departure": 1 "pshift d7": 1 "acc no.": 1 "clinical parameter ivshina et.al 2006 ": 1 "transgenic model": 1 "neutrophil apoptosis": 1 "2 3": 1 "negative n?=?625 ": 1 "sub-group": 1 "2 8": 1 "car": 1 "mutations of g/c nucleotides": 1 "?p21 protein": 1 "change in 3d spheroids": 1 "type and number of samples": 1 "nm_177438": 1 "department of gastroenterology graduate school of medicine the university of tokyo": 1 "cell cycle and cell growth": 1 "ref seq": 1 "qpcr relative change": 1 "r merge *": 1 "structure of prosthetic group derivative": 1 "germlings with >1 nucleus a": 1 "cbc": 1 "3max identity": 1 "accession number a": 1 "lux-lung 1 30 afatinib 50 mg": 1 "scara5": 1 "efficacy": 1 "cd4": 1 "genotype of mouse": 1 "visiting professor wakayama municipal college of medicine wakayama": 1 "cd8": 1 "glycyl t-rna synthase": 1 "ancillary findings hemorrhage cystic change transient increase in size": 1 
"function": 42 "reference": 33 "target": 27 "references": 19 "pathway": 16 "gene": 15 "p-value": 11 "mirna": 9 "sense": 9 "mechanism of action": 9 "mechanism": 9 "antisense": 9 "drug": 9 "ref.": 8 "description": 8 "biological process": 8 "protein": 7 "effect": 6 "molecular function": 5 "reference s": 5 "role": 4 "e-value": 4 "virus": 4 "id": 4 "signaling molecular": 4 "regulation": 4 "unigene": 4 "": 3 "q-value": 3 "size": 3 "effector": 3 "cellular function": 3 "genes involved": 3 "cellular component": 3 "microrna": 3 "potential function": 3 "dorsal": 3 "compound": 3 "genes": 3 "agent": 3 "cell type": 3 "disease": 3 "motifs/domains": 3 "t?=?720": 3 "signaling": 3 "process": 3 "ventral": 3 "target gene": 2 "?": 2 "target s": 2 "gene product": 2 "signaling upstream": 2 "proteins": 2 "functional annotation clusteringa": 2 "kegg pathway classification": 2 "mrna target": 2 "target genes": 2 "fc": 2 "gsa": 2 "mirnas": 2 "cancer": 2 "approach": 2 "action": 2 "cooperation": 2 "dependency": 2 "10 µm": 2 "system": 2 "redundancy": 2 "7 days": 2 "trafficking": 2 "molecular target s": 2 "microrna s": 2 "signal transduction": 2 "metabolism": 2 "cellular process": 2 "1 day": 2 "receptor": 2 "ras-related phenotypes": 2 "5 µm": 2 "29": 2 "phenotype": 2 "4 days": 2 "mammalian relative s": 2 "signaling downstream": 2 "48": 2 "factor": 2 "functional classification": 2 "competition": 2 "target pathway": 2 "proteins involved": 2 "pathway name – elk3": 2 "model system": 2 "immunosuppressive agent": 2 "cellular target": 2 "pharmacology": 2 "refs.": 2 "receptors": 2 "effects": 2 "pathogen": 2 "associated genes": 2 "p value": 2 "category": 2 "pathway name – hsa-mir-155-5p": 2 "ncrnas": 2 "transcription factor": 1 "experimental system": 1 "target significance": 1 "target gene symbol": 1 "epigenetic ageing marker": 1 "functional importance": 1 "activated pathway description con't": 1 "mechanism *": 1 "target function": 1 "ac": 1 "#": 1 "nonpolar/hydrophobic": 1 "syndecan targeting therapies": 1 "tnf?": 1 "key proteins": 1 "technical approach": 1 "plant": 1 "chaperone system": 1 "polar/electrostatic": 1 "rassf1aa133s": 1 "adomet-dependent methyltransferases": 1 "benjamini *": 1 "ucucuugcagucucuucactt": 1 "aae": 1 "cellular functions": 1 "host-pathogen": 1 "target gene mrna": 1 "associated disease": 1 "not gli1/2 downstream": 1 "antiangiogenic compounds": 1 "mechanism s": 1 "serum marker": 1 "potential genes": 1 "mechanism hijacked": 1 "associated with signaling dysregulation": 1 "d": 1 "downregulation": 1 "gene encoding": 1 "involved pathway s": 1 "predicted target s": 1 "fly": 1 "co-chaperone": 1 "partner": 1 "u": 1 "novel proteins": 1 "role in development": 1 "e3 ligase": 1 "renal cell/compartment": 1 "positively regulated cellular organelles": 1 "evidence": 1 "gene names": 1 "egf/egfr signaling pathway": 1 "second messenger": 1 "5?-ggacuucucagagguggaatt-3?": 1 "ref": 1 "targeting domain/mechanisma": 1 "effector name": 1 "relevant biology": 1 "signal": 1 "bio-functions": 1 "responsible signaling pathway": 1 "regulated expression": 1 "pathway or target": 1 "criteria fulfilled": 1 "sympathetic receptor": 1 "compound name": 1 "secretion": 1 "go molecular function": 1 "mediator": 1 "protein context": 1 "sch9?/wt": 1 "mcf-7/s0.5": 1 "title": 1 "cellular result": 1 "participation ": 1 "epigenetic target": 1 "effector s": 1 "virus/virus protein": 1 "company": 1 "class": 1 "direct effect": 1 "potential target s": 1 "gli1/2 downstream": 1 "target disease": 1 "genego pathway": 1 "signaling pathway": 1 "go cellular component": 1 "significance": 1 "action manner": 1 "aga": 1 "family": 1 "functional role": 1 "specific function": 1 "localization/biological function": 1 "target protein": 1 "accession no.": 1 "developmental stage": 1 "enzymatic function": 1 "components of pathway": 1 "indirect/remote": 1 "main cellular signaling": 1 "model": 1 "pathway system": 1 "biological functlon s": 1 "sirt1 role": 1 "sequences coverage ": 1 "potential diabetogenic mechanism": 1 "readouts": 1 "yeast": 1 "gene name – species": 1 "fdr***": 1 "beneficial role": 1 "5?-acgugacacguucggagaatt-3?": 1 "host targets": 1 "molecular components": 1 "proposed mechanism": 1 "chromatin/epigenetic regulation": 1 "regulated proteins reference": 1 "associated bacteria": 1 "validated target genes": 1 "u/d": 1 "targets": 1 "ligand": 1 "manufacturer": 1 "biological function s": 1 "guucagcguguccggcgagtt": 1 "screening modes": 1 "cell compartment involved": 1 "predicted targeting pathways": 1 "drugs": 1 "change": 1 "medicinal plant component": 1 "viral protein": 1 "snp": 1 "species": 1 "references??": 1 "cellular signaling": 1 "markers": 1 "associated cancers": 1 "remodeling": 1 "functional outcome": 1 "biological function": 1 "tgf?": 1 "mcf-7/182r-6": 1 "via p63 inhibition": 1 "‹?e vdw›": 1 "host": 1 "motif": 1 "downstream consequences": 1 "repair mechanism": 1 "snail’s effect": 1 "author": 1 "epigenetic mark": 1 "epigenetic change": 1 "panther molecular function": 1 "endocrine therapeutic": 1 "diamondback 360° oas csi": 1 "effector domain": 1 "function category": 1 "foxo": 1 "clinical development": 1 "cancer type": 1 "functional relevance": 1 "cqu": 1 "cause": 1 "virulence factor": 1 "general function": 1 "kegg pathway": 1 "targeting antigen": 1 "protein target": 1 "deleterious role": 1 "upregulatedgenes": 1 "‹?g np›": 1 "kegg signaling pathway analysis": 1 "biological process targeted": 1 "involved pathway": 1 "comments": 1 "subfamily related to the function": 1 "mcf-7/tamr-1": 1 "single target": 1 "risk factor": 1 "dub": 1 "putative mechanism": 1 "component of milk": 1 "functional pathway": 1 "p104-c": 1 "p104-b": 1 "p104-a": 1 "methylation frequency": 1 "disease gene": 1 "mode of action": 1 "gene entrez gene id": 1 "vertebrate": 1 "potential implication of mtor signaling": 1 " total": 1 "igf1": 1 "upregulation": 1 "“direct” target genes": 1 "lucena-1": 1 "diseases": 1 "long-ncrna": 1 "pathway component": 1 "hdac isoform": 1 "# genes": 1 "pathogenesis": 1 "il1?": 1 "tissue expression": 1 "molecule": 1 "components": 1 "activity": 1 "p -value**": 1 "associated with leukemic transformation": 1 "biological consequence": 1 "target mrnas": 1 "downstream#": 1 "functional modulation": 1 "inducing genotoxic agens": 1 "genes/pathways": 1 "cells involved": 1 "mir": 1 "possible mechanism s?": 1 "signal transduction pathway": 1 "cellular organelle": 1 "major localization": 1 "expression": 1 "559 sirna": 1 "effector/target": 1 "q.val": 1 "mechanisms of the action": 1 "biology process": 1 "biological effect": 1 "protein identification": 1 "pathogenetic mechanism": 1 "targeting moiety antibody": 1 "cellular/biological process": 1 "host pathway": 1 "ratio": 1 "administration": 1 "functionally important elements": 1 "source": 1 "panther molecular function process": 1 "major genetic alterations": 1 "features": 1 "modulator": 1 "ras2?/wt": 1 "go description biological process": 1 "ptms": 1 "substrate": 1 "mammalian orthologs": 1 "nf-?b pathway involved": 1 "cellular level": 1 "molecular characteristics": 1 "transcription-factor": 1 "predicted target genes": 1 "uggcguaagaggagagagatt": 1 "pathway categories": 1 "cellular clock": 1 "affected genes": 1 "name": 1 "key message": 1 "activated pathway description": 1 "mir-34": 1 "host target": 1 "antioxidants": 1 "potential role": 1 "secondary machinery": 1 "nhps/nps": 1 "target cell": 1 "host defense and survival": 1 "multiple target": 1 "intracellular signaling": 1 "non-specific sirna": 1 "micro-rnas": 1 "target/s": 1 "igf-1 signaling pathway": 1 "substrate-digesting mmps": 1 "targeting tool": 1 "p.val": 1 "hgf/cmet pathway involvement": 1 "inhibiting angiogenic process": 1 "stem cell process": 1 "pathway description": 1 "post-translational modification": 1 "cucgccggacacgcugaactt": 1 "neurological diseases": 1 "related neurological diseases": 1 "ucucucuccucuuacgccatt": 1 "regulatory pathway": 1 "description/type": 1 "biological function/process": 1 "human herpesvirus": 1 "residues": 1 "involved mechanism": 1 "direct target": 1 "tissue level": 1 "sqcc": 1 "target organ s": 1 "rassf1awt": 1 "effect on host cells": 1 "nano-platform": 1 "target tissue/system": 1 "tor1?/wt": 1 "deregulation": 1 "integrin signaling": 1 "gene symbol": 1 "phase": 1 "role in dendrite morphogenesis": 1 "subpathway": 1 "method": 1 "worm": 1 "probability": 1 "cancer types": 1 "‹?e ele›": 1 "identified regulation mechanism": 1 "examples": 1 "name manufacturer*": 1 "kinase target": 1 "target gene/site": 1 "subcellular localization": 1 "direct": 1 "ucuccuucagcuucuucactt": 1 "risks to health": 1 "event": 1 "organ/entity": 1 "cellular processes": 1 "go biological process": 1 "age-related disease": 1 "epigenetic modification": 1 "embryonic pathway": 1 "gfp": 1 "il6": 1 "targeting microrna": 1 "associated with epigenetic dysregulation": 1 "biological process and molecular functions": 1 "dna replication/repair": 1 "predicted target": 1 "suppressed pathway description": 1 "go biological processes": 1 "gugaagaagcugaaggagatt": 1 "references?": 1 "factor/molecule": 1 "direct oncogenic mechanisms": 1 "‹?g solv›": 1 "micrornas involved": 1 "reduced activity?": 1 "gugaagagacugcaagagatt": 1 "target names": 1 "5?-uucuccgaacgugucacgutt-3?": 1 "development": 1 "tissue type": 1 "dbd": 1 "mitosis": 1 "sequence": 1 "molecular mechanism": 1 "plant biological pathway": 1 "count*": 1 "biological activity": 1 "target decrease": 1 "‹?g mmpbsa›": 1 "purpose": 1 "potential effect": 1 "target cells": 1 "5?-uuccaccucugagaagucctt-3?": 1 "physiological function expected phenotypic performance": 1 "function/putative function": 1 "a ? homeostasis": 1 "molecular readout": 1 "enzyme": 1 "therapy": 1 "stimulus": 1 "downregulated genes": 1 "groups": 1 "‹?g pb›": 1 "global pathway": 1 "sclc": 1 "main role and function": 1 "target src pathway": 1 "effector protein/ phospholipid": 1 
"characteristic": 30 "p-value": 28 "": 26 "high": 26 "low": 25 "no.": 22 "p value": 21 "reference": 19 "no of patients": 18 "type": 17 "gene": 16 "?": 15 " ": 15 "number of genes": 15 "p": 14 "references": 13 "total": 13 "n": 11 "number": 11 "3": 10 "no ": 10 "negative": 10 "genes": 9 "no of cases": 9 "characteristics": 9 "p *": 9 "number of patients": 9 "type of cancer": 8 "p -value": 8 "no of genes": 8 "2": 7 "4": 7 "subtypes of dementia": 7 "mutation": 7 "no of samples": 7 "change in amino acid": 7 "or a": 7 "number of cases": 7 "variables": 7 "variable": 7 "genotype": 7 "1": 6 "5": 6 "function": 6 "no of cases ": 6 "group": 6 "positive": 6 "no of patients ": 6 "all": 6 "cancer type": 6 "protein": 6 "tumor type": 6 "cell type": 6 "number of patients ": 6 "+": 5 "uge+sca1-hi 209": 5 "number of samples": 5 "6": 5 "7": 5 "a": 5 "uge-only 1050": 5 "condition": 5 "sca1-hi+sca-lo 112": 5 "moderate": 5 "case no.": 5 "sca1-hi-only 296": 5 "description": 5 "study": 5 "all sections 1667": 5 "fold change over control": 5 "author": 5 "no": 5 "cases": 5 "frequency ×10?2": 5 "gene symbol": 4 "high ": 4 "c-met": 4 "number ": 4 "?2": 4 "++": 4 "12": 4 "low ": 4 "subnetwork and overlap": 4 "outdegree": 4 "year": 4 "gene name": 4 "fold change b": 4 "pathway": 4 "controls": 4 "rassf1a": 4 "p a": 4 "frequency ": 4 "amino acid change": 4 "betweenness": 4 "ref.": 4 "no of cells": 4 "indegree": 4 "overlap": 4 "type of study": 4 "gene name a": 4 "database": 4 "strong": 4 "1.4": 4 "nucleotide change": 4 "gene symbol a": 4 "gene accession no a": 4 "weak": 4 "0": 3 "8": 3 "b": 3 "second tumor": 3 "medium": 3 "agreement of the genotype distributions in the patients with the hardy-weinberg law p-value": 3 "2.7": 3 "motif": 3 "dataset": 3 "source": 3 "yes": 3 "control n ": 3 "mn frequency ×10?2": 3 "agreement of the genotype distributions in the controls with the hardy-weinberg law p-value": 3 "first tumor": 3 "#genes": 3 "number of samples with mutations mutation frequency in 76 samples": 3 "number of samples with mutations in 76 samples mutation frequency": 3 "e2f5/ca125": 3 "supported by a": 3 "moderate/ strong ": 3 "hr-95 ci a": 3 "response to treatment-outcome": 3 "trial no.": 3 "number of sequences": 3 "number of enrolled patients and controls": 3 "10": 3 "18": 3 "type of implication": 3 "21": 3 "no of cells with mns": 3 "sa used for treatment": 3 "type of ra": 3 "type of animal/cells": 3 "fold change": 3 "network": 3 "parameter": 3 "negative/ weak ": 3 "asthma n ": 3 "fc?ri-?": 3 "fc?ri-?": 3 "fc?ri-?": 3 "other": 3 "aml": 3 "increased": 3 "name": 3 "target": 3 "effect": 3 "case number": 3 "ci": 3 "proportion": 3 "change": 3 "publication": 3 "mt": 3 "weight of animal/age": 3 "no of streptomyces isolated": 3 "up": 3 "mn-dm+": 3 "region": 3 "wt": 3 "normal": 3 "data type": 3 "p-value a": 3 "dose of ra": 3 "patients": 3 "type a": 2 "9": 2 "10.7": 2 "example": 2 "mn-dm?": 2 "r": 2 "6.3": 2 "6.8": 2 "go term": 2 "mn-dm+/ mn ": 2 "or 95ci": 2 "mirna": 2 "ykt6": 2 "n a": 2 "treatment type of study type of patients": 2 "top": 2 "see description above": 2 "consequence": 2 "or 95 ci": 2 "negative ?": 2 "cause": 2 "type of test": 2 "19.1": 2 "cytoband": 2 "95?ci": 2 "cancer type and case number": 2 "possible statin-induced mechanisms": 2 "difference": 2 "molecule": 2 "all cases": 2 "no of controls": 2 "margins": 2 "hr 95 ci": 2 "strong 2+": 2 "study name": 2 "complete or partial response": 2 "total no.": 2 "start": 2 "auc 95ci": 2 "low frequency": 2 "#interactions": 2 "identifier": 2 "low protection": 2 "h-ras colony number in ": 2 "incidence": 2 "small": 2 "type b/c": 2 "<1e?30": 2 "crude or 95 ci": 2 "?": 2 "strength of evidence": 2 "no of controls ": 2 "<1e?05": 2 "<1e?15": 2 "previous report": 2 " +": 2 "karyotype": 2 "domain": 2 " a": 2 "first author reference": 2 "term": 2 "chk2": 2 "stage": 2 "number of genes without a homolog in s cerevisiae among total number of genes within cluster": 2 "filter 1": 2 "down": 2 "geo number": 2 "accession number": 2 "classification": 2 "weak +": 2 "or b": 2 "position a": 2 "number of patientswith crp -286mutation ": 2 "number of mutations": 2 "11": 2 "13": 2 "15": 2 "20": 2 "22": 2 "23": 2 "29": 2 "31": 2 "corrected p -value": 2 "1e?30": 2 "adjusted a or 95 ci": 2 "51": 2 "c+466t snp": 2 "sample number": 2 "disadvantages": 2 "p -values for different phenotypes": 2 "p -value b": 2 "1e?15": 2 "number of patients with a reduction": 2 "positive to negative": 2 "1e?05": 2 "encode receptors for inositol 145-trisphosphate a second messenger that mediates the release of intracellular calcium": 2 "biomarker": 2 " of patients with different expression levels": 2 "intermediate and late phase only up-regulated mechanistic genes": 2 "8.9": 2 "score": 2 "high protection": 2 "early phase only up-regulated mechanistic genes": 2 "mir-126-5p": 2 "no of snps in 3?utr": 2 "drug type": 2 "stage/cancer type": 2 "relative size of the acini number of acini examined": 2 "ontology": 2 "end": 2 "array type": 2 "age": 2 "species": 2 "neg": 2 "overall consensus": 2 "data collection": 2 "0.0": 2 "exon": 2 "histology": 2 "chip expression": 2 "total no of cases": 2 "strong +++": 2 "no of tfs": 2 "p-erk1/2": 2 " of empty lumen": 2 "change increased – decreased": 2 "grade 1": 2 "overall survival": 2 "auc": 2 "p53": 2 "number of patients with crp -286 mutation ": 2 "case": 2 "low penetrance": 2 "up to fold change": 2 "il-18rap": 2 "disorder": 2 "lack of or down-regulated expression ": 2 "change in ca2+i nm": 2 " of total": 2 "study and year": 2 "stable disease": 2 "sequence 5? to 3?": 2 "no of events": 2 " of crp change": 2 " of tm change": 2 "genetic polymorphisms": 2 "type of tumor": 2 "number of gene probes that are in common with at least one other profile eschscnsc": 2 "id": 2 "large": 2 "case 5": 2 "case 3": 2 "541": 2 "n*": 2 "gene id or name": 2 "no of mn-dm+": 2 " responding": 2 "1.7": 2 "subclusters": 2 "negative to positive": 2 "number of cells": 2 "il-4r": 2 "study population": 2 "expression of tet2": 2 "symbol": 2 "p-value †": 2 "with homology ": 2 "drug/intervention": 2 "progressive disease": 2 "location": 2 "children": 2 "method": 2 "samples": 2 "sensitivity": 2 "protein name": 2 "observation": 2 "drug": 2 "note": 2 "number ofpatients ": 2 "moderate ++": 2 "category": 2 "opisthorchis viverrini sequences": 1 "results of the study": 1 "fisher exact test unadjusted p-value": 1 "average distance kb": 1 "vwf number of vessels/mm2": 1 "features and description of data": 1 "explanation": 1 "comments not part of the guidelines": 1 "raw p-value": 1 "expected number": 1 "minimal length": 1 "number of cell lines re-tested": 1 "—": 1 "no of bioactive streptomyces ": 1 "percent fraction of events as per the following types with the domain": 1 "ed-1 number of macrophage/mm2": 1 "overall response a": 1 "yes—high plasma ykl-40 reflects poor prognosis and is independent of other routinely used biomarkers.": 1 "target scenario": 1 "2.31 2.15 707": 1 "baseline q1–q3 pg/ml": 1 "encodes a cytokine that regulates t and natural killer cell activation and proliferation.": 1 "analysis": 1 "correlation to clinical information": 1 "number of independent selections": 1 "10.5": 1 "methylated no.": 1 "k d nm a wt?c1b": 1 "10.1": 1 "or 95ci b": 1 "10.0": 1 "pretreatment ereg level": 1 "- "apply abundantly before sun exposure".": 1 "number of hubs": 1 "expression level of dab2": 1 "end of treatment q1–q3 ng/ml": 1 "arrayexpress id": 1 "kras/pik3ca": 1 "7 the minimum spf of a sunscreen should be 6 and the minimum uva protection factor should correspond to 1/3 of the spf.": 1 "1000": 1 "p-erk1/2-positive in ca19-9 false negative ": 1 "result": 1 "nucleotide and effect*": 1 "positive edges only 771 nodes": 1 "number of cells/well": 1 "negative edges only 377 nodes": 1 "target scan/mami in decimals/mitg in italics score human": 1 "fold ? by id1": 1 "0.39 0.42 440": 1 " of mutations in d310": 1 "c": 1 "patterns of mutations": 1 "d": 1 "e": 1 "f": 1 "g": 1 "number of concepts": 1 "other mutation": 1 "interleukin 1 beta": 1 "component": 1 "pgfp-sifawt": 1 "grade 2a papules or pustules 6–20 or 2–5 areas of erythema or edema <1?cm in size": 1 "6.1": 1 "6.2": 1 "• wide variations in local protocols e.g how often surveillance should be conducted if at all the number of biopsies": 1 "ptprc": 1 "encodes a protein structurally related to the cxc subfamily of cytokines this cytokine displays chemotactic activity for monocytes lymphocytes basophils and eosinophils by recruiting leukocytes to sites of inflammation this cytokine may contribute to tumor-associated leukocyte infiltration and to the antiviral state against hiv infection.": 1 "sialophorin cspg2": 1 "assay to pi3k?": 1 "year of publication": 1 "3.40 3.70 216": 1 "no of ests in unique tc": 1 "nsc 2492": 1 "central nucleation a": 1 "no of patients n = 39": 1 "gene ontology": 1 "• with fits no dietary or medication restriction is necessary": 1 "positive edges only 150 nodes": 1 "down-regulated in pii": 1 "blastocyst specific": 1 "5852": 1 "neurexin 3": 1 "positive edges only 120 nodes": 1 "indication for orchidectomy": 1 "chr": 1 "list": 1 "fold change from microarray data": 1 "sustained stabilization of disease in a patient with cervical cancer treated within a phase i trial of the hdac inhibitor ms-275": 1 "no of subjects ": 1 "homo sapiens—reflist 21804": 1 "p53 mutation n=273 ": 1 "hsc 1977": 1 "the percent of tumors with loh": 1 "???—high plasma ykl-40 reflects poor treatment response in some patients more studies are needed.": 1 "type of cell death": 1 "main terms": 1 "?1-aab": 1 "go number": 1 "proportion among 1267 cases": 1 "cv n?=?9": 1 "cases no ": 1 "p -value of overlap": 1 "1.95 1.33 983": 1 " sub-g1": 1 "lps-stimulated event and system studied": 1 "number of putative microclones": 1 "characteristic at initial diagnosis": 1 "sperm and oocytes ": 1 "spouse families": 1 "immunopositive tubular cross-sections ": 1 "citation": 1 "cd4+cd8+": 1 "other ": 1 "type of screen": 1 "clinicopathologic parameters": 1 "dapple p -value": 1 "wortmannin nm": 1 "in vitro": 1 "six or more café-au-lait macules >5mm in greatest diameter in prepubertal individuals and >15mm in postpubertal individuals two or more neurofibromas of any type or one plexiform neurofibroma freckling in the axillary or inguinal regions optic glioma two or more iris hamartoma lisch nodules distinctive bony lesion such as sphenoid dysplasia or thinning of the long bone cortex with or without pseudoarthrosis a first-degree relative parent sibling or offspring with nf1 based on the above criteria": 1 "- "100 protection against uv radiation or antisun effect".": 1 "number of stage 3b samples with mutations mutation frequency in 8 samples": 1 "cancer": 1 "nsc 2458": 1 "main findings": 1 "number experimentally verified + homologs†": 1 "- "designations that imply total protection or solar radiation blocking".": 1 "type of glioma": 1 "no of tc c": 1 "hypermethylation": 1 "number with increase in score": 1 "what is the potentially useful role of the ros?": 1 "application of the study or study design": 1 "mapk status variation": 1 "pitx2 filtered genes": 1 "baseline q1–q3 ng/ml": 1 "mcf-7": 1 "r 2 and d?": 1 "a p value": 1 "dglut": 1 "the veer data": 1 "type of junction": 1 "period": 1 " reference": 1 "fiber": 1 "ast/alt ratio a": 1 "no of analysable snps": 1 "very strong": 1 "microrna data": 1 "early phase up-regulated mechanistic genes": 1 "• surveillance is time consuming and costly": 1 "no studied down-regulated": 1 "a dna copy number": 1 "no of pairs": 1 "pfs days": 1 "• fits have greater sensitivity for advanced adenomas than gfobts": 1 "mir-200b low n?=?78": 1 "encodes an accessory subunit of the heterodimeric receptor for il18 this protein enhances the il18 binding activity of il18r1 il1rrp a ligand binding subunit of il18 receptor required for the high affinity binding of interleukin 18 il-18 to its receptor complex by similarity together with il18r1 mediates il-18-dependent activation of nf-kappa-b and jnk": 1 "does not procure acute or late side effects.": 1 "number of non-metastasis samples with mutations mutation frequency in 16 samples": 1 "encodes a cytoskeletal protein that is concentrated in areas of cell-substratum and cell-cell contacts and plays a significant role in the assembly of actin filaments and in spreading and migration of various cell types including fibroblasts and osteoclasts": 1 "percent fraction of genes that show the following events with the domain.": 1 "activity of protein": 1 "number of identified genes/pathways": 1 "initial condition of systems 2": 1 "number of unknown samples with mutations mutation frequency in 1 sample": 1 "2/29": 1 "4.87 4.06 1000": 1 "end of treatment q1–q3 pg/ml": 1 "- reapply the photoprotector approximately every two hours or according to instructions on the label.": 1 "very high protection": 1 "cases with complete data on adjusting covariates": 1 "redundancy": 1 "number of gene targets re-tested": 1 "compound?": 1 "pser20pak2": 1 "product": 1 " females with ectopic veins only": 1 "5 ? -sage a": 1 "genbank acc no.": 1 "sample-block number": 1 "number of activesb": 1 "total number of sequences examined": 1 "encodes a protein that is a member of the vesicle-associated membrane protein vamp/synaptobrevin family synaptobrevins/vamps syntaxins and the 25-kd synaptosomal-associated protein snap25 are the main components of a protein complex involved in the docking and/or fusion of synaptic vesicles with the presynaptic membrane this gene is thought to participate in neurotransmitter release at a step between docking and fusion.": 1 "encodes a member of the aggrecan/versican proteoglycan family protein involved in cell adhesion proliferation migration and angiogenesis and may play a role in intercellular signaling and in connecting cells with the extracellular matrix": 1 "estimated number of genes c": 1 "frtl5 ret-ptc1 a": 1 "mn-dm+ /mn ": 1 "2.3": 1 "lesion type": 1 "nucant 7 n7": 1 "2.9": 1 "z-value a /p-value b": 1 "ccl8": 1 "met/del": 1 "chordata 2173 gene set linked": 1 "overlapping functions": 1 "il-8rb": 1 "direct tpg": 1 "utrophin a": 1 "no of sections/approximate volume screened": 1 "methylation status and expression levels": 1 "not complex": 1 "platforms": 1 "number with decrease in score": 1 "type 1 ": 1 "truncation gene-": 1 "no of snps in pathway": 1 "number of ac samples with mutations mutation frequency in 52 ac samples": 1 "number of references": 1 "ssp no.": 1 "the soluble form is chemotactic for t-cells and monocytes but not for neutrophils the membrane-bound form promotes adhesion of those leukocytes to endothelial cells may play a role in regulating leukocyte adhesion and migration processes at the endothelium binds to cx3cr1": 1 "comparison": 1 "type d – fingerprint is partial in both the isoforms and possess differing number of constituent motifs": 1 "anp32a the acidic nuclear phosphoprotein 32 family member a in the literature it has also been referred to as lanp mapm pp32 phap i i1pp2a c15orf1 mgc119787 and mgc150373 anp32 is a 30-kda phosphoprotein that is mainly described in the nucleus it is characterized by an n-terminal tandem arrays of a leucine rich repeat and an acidic carboxyl half anp32a is implicated in a number of cellular processes including modulation of cell signaling and transduction of gene expression to regulate the morphology and dynamics of the cytoskeleton cell adhesion and differentiation and caspase-dependent and caspase-independent apoptosis 78 .": 1 "number of annotations": 1 "list of gene symbols": 1 "vascular cell type": 1 "201": 1 "• dysplastic lesions are often flat and indistinguishable endoscopically": 1 "++ a": 1 "203": 1 "most upregulated": 1 "width nm a": 1 "mice no.": 1 "no of relative affected": 1 "irs-2 expression": 1 "number of small error predictions": 1 "n7r/l20r": 1 "technique": 1 "interleukin receptor b": 1 "what types of cells produce the ros?": 1 "gene-expression signature": 1 "response rate of 38.1 with the dna methylation inhibitor 5-aza-2-deoxycytidine plus cisplatin in advanced or recurrent cervical cancer*": 1 "94 18.9": 1 "oocytes only ": 1 "type of samples": 1 "alu orientation *": 1 " n+c in both lepidic and invasive": 1 "pkn": 1 "no of cells 104": 1 "pfam domain": 1 "standard curve equation and efficiency e in the different tissues calculated from one sample each time": 1 "library type": 1 "msp only": 1 "diagnostic method": 1 "19.9": 1 "19.6": 1 "high 8.23 {2457}": 1 "full name": 1 "type of ligand": 1 " in g1": 1 "cxcl9": 1 "ttp": 1 "positive plasma from whole blood treated with lps and negative controls use of inhibitory antibodies are important to confirm that the procoagulant activity measured is due to tf": 1 "type 2 ": 1 "snap23": 1 "19.3": 1 "no of tumors with allele1 homozygous genotype": 1 "low expression no ": 1 "number of ampars": 1 "protection category designation indicated on label pcd": 1 "not i-site": 1 "cluster": 1 "mode of action": 1 "number of transporters in ich percentage of total transporters": 1 "computational data": 1 "number of pathway up-regulated": 1 "• sampling bias dysplasia may be focal patchy or diffuse": 1 "?": 1 "gosr2": 1 "number with tumor": 1 "? 2": 1 "mrna decrease": 1 "opisthorchis viverrini sequences n?=?61417": 1 " females with two blistered wings": 1 "1.55 1.33 789": 1 "cip-1-associated regulator of cyclin b": 1 "controls no ": 1 "type of change": 1 "a complete and draft genomes of l pneumophila obtained by classical or new generation sequencing": 1 "syntaxin 10": 1 "macular or papular rash or erythema but no other associated symptoms": 1 "tissue of origin": 1 "240": 1 "242": 1 "amplification of transcripts by classical pcr": 1 "total number of synaptic nmdars": 1 "no of genes in pathway": 1 "small intestine": 1 "where in the cells are the ros produced?": 1 "hb-19": 1 "phase/used in combination with other agents": 1 "type of tissue": 1 "class and level of evidence": 1 "crmp and cancer type": 1 "ccr8": 1 "ccr4": 1 "networks": 1 "apr 1997": 1 "250": 1 "refined†": 1 "number of specific interactions": 1 "expression of crmp in tumor tissues": 1 "number of unknown samples with mutations mutation frequency in 2 samples": 1 "in offering their data and interpretation on why inhibiting growth factor receptor inhibition has not been effective in prolonging glioblastoma survival…”growth factor receptor/pi3k/akt pathway is complex and nonlinear having many inputs from other pathways cross covering paths compensating for a particular block multiple sites of feedback regulation both positive and negative and a large number of downstream effectors “ 306 our comments in parentheses.": 1 "babies older than 6 months of age": 1 "phenotype": 1 "sperm only ": 1 "number of trinucleotide repeats": 1 "clinicopathological parameters": 1 "common name": 1 "without animal in model": 1 "worst grade any patient": 1 "contactin 1": 1 "type of modulation for antidepressant outcome": 1 "or 95 ci b": 1 "acetylcoa": 1 "268": 1 "ppv": 1 "no change ": 1 "number of stage 1b samples with mutations mutation frequency in 18 samples": 1 " of commondmrs of defined dmrs in respective group": 1 "number of counts": 1 "brain regions": 1 "3.85 3.72 898": 1 "number of occasions mosaic": 1 "pearson's correlation in both primary and recurrent cases": 1 "source scenario": 1 "total no of tumors with loh": 1 "no of differentially expressed operons by glutamine": 1 "origin of microarray probe": 1 "no of pups per litter mean ± sem": 1 "number of animals obtained": 1 "e_value": 1 "flk-1 of positive staining cells": 1 "4.24 4.04 697": 1 "pediatric": 1 "number positive": 1 "bmp6 meth": 1 "late": 1 "mirna-143 expression": 1 "number of non-hubs": 1 "mir-375 low level": 1 "gene models": 1 "no arguments at all": 1 "somatic mutations in the d-loop of mtdna": 1 "given": 1 "total n  = 11": 1 "fold ? by e47er": 1 "3.85 3.72 885": 1 "number with breslow ?>?0.75 mm": 1 "certificated by the japanese society of gastroentero-endoscopy": 1 "expression of p-mapk": 1 "year of study": 1 "number of clones in y1 cells": 1 "set nuclear oncogene in the literature it has also been referred to as 2pp2a igaad taf-i i2pp2a ipp2a2 phap ii and taf-ibeta set is a 39-kda phosphoprotein with a highly acidic carboxyl-terminus it is a multifunctional protein widely expressed in various tissues and localizes predominantly in the nucleus it is involved in apoptosis transcription nucleosome assembly and histone binding 79 .": 1 "strong co-expression both of ?6 integrin and upar": 1 "library specific clusters": 1 "proportion of lesions positive": 1 "vamp2": 1 "phosphoenrichments": 1 "293": 1 "gene ontology category": 1 "five criteria to determine if a cytokine is an intrinsic factor involved in uvb hyperpigmentation": 1 "30 - 50": 1 "gene–environment interactiona": 1 "pi3k change": 1 "1-extended": 1 "a assessment": 1 "early": 1 "cd4+cd8?": 1 "allele frequencies ": 1 "rufy3": 1 "1.48 1.33 996": 1 "center": 1 " a genes that appear to control autophagic degradation 23": 1 "average length bp": 1 "number of different conditions per cell line tested": 1 "no of patients with kras mutation/total no of patients ": 1 "unmethylated": 1 "mean±s.d.": 1 "induced and/or inhibits signalling by": 1 "jia-associated genes with correlated expression data that lie within the minimal essential network men": 1 "case no n?=?110": 1 "mirna targeted for inhibition": 1 "s -glutathionylation occurs at a discrete site and changes the function of the modified protein s -glutathionylation occurs under physiological conditions i.e relatively high gsh/gssg ratio s -glutathionylation occurs within intact cells in response to a physiological stimulus and elicits a physiological response there is a rapid and efficient mechanism for the formation of specific s -glutathionylated proteins there is a rapid and efficient mechanism for reversing the s -glutathionylation reaction.": 1 "ramalho-santos et al.": 1 "catagories of genes with altered response": 1 "outcome by gcn status no of patients ‡": 1 "distinct eqs": 1 "15.2": 1 "aberrant crypt/acf": 1 "encodes a protein that functions in the vertebrate nervous system as cell adhesion molecules": 1 "median somatic mutation frequency per mb": 1 "ras homolog gene family member c": 1 "what is the source of the ros?": 1 "infant": 1 "2.33 2.19 916": 1 "survival analysis a": 1 " of cytoplasmic small aggregates": 1 "number of sc samples with mutations mutation frequency in 20 sc samples": 1 "oocyte specific": 1 "perk change": 1 "intestinal + diffuse": 1 "high sensitivity for cancer?": 1 "weak 1+": 1 "conclusions": 1 "primers for qpcr": 1 "filter applied": 1 "p16ink4a": 1 "std c": 1 "b not i-microarrays": 1 "bioie-p450": 1 "?c": 1 "number of mutations per selection†": 1 "2/13 15": 1 "form of the signal over time": 1 "inositol polyphosphate-4-phosphatase type i": 1 "?h": 1 "with animal in model": 1 "3-phosphoinositide dependent protein kinase-1": 1 "tetrapoda and younger 5495 gene set linked": 1 "cases ": 1 "non-correlated genes": 1 "2.19 2.16 666": 1 "grade 3b papules or pustules >20 or more than 5 areas of erythema or edema <1?cm in size and pain pruritus or effect on emotions or functioning": 1 "cmet change": 1 "- "if the quantity applied is not adequate the level of protection will be reduced".": 1 "encodes a predicted seven transmembrane g protein- coupled receptor and belongs to the cxc chemokine receptor family a blc b-lymphocyte chemoattractant cytokine receptor that binds to b-lymphocyte chemoattractant blc involved in b-cell migration into b-cell follicles of spleen and peyer patches but not into those of mesenteric or peripheral lymph nodes may have a regulatory function in burkitt lymphoma bl lymphomagenesis and/or b-cell differentiation.": 1 "chemokine c-x-c motif receptor 2": 1 "significant tfbs present in all promoters of a given cluster 2": 1 "biological processes affected by over-expression of wild type and truncated hmga2": 1 "significant tfbs present in all promoters of a given cluster 1": 1 "number of sirna targets assayed for protein expression by rppa in screen": 1 "number of gene targets re-validated using different sirna sequences": 1 "average no of discrete dots/cell a": 1 "number of wells plated": 1 "initial and following dose": 1 "fold change at 144 hrs 144 hrs at 31°c vs 144 hrs at 37°c": 1 "1999": 1 "uniprot symbol": 1 "3.40 3.70 203": 1 "encodes a trafficking membrane protein which transports proteins among the medial- and trans-golgicompartments due to its chromosomal location and trafficking function this gene may be involved in familial essential hypertension.": 1 "anti-sense 5? to 3?": 1 "possible reason of mrna decrease": 1 "number of occurrences in alu inserts": 1 "number of gene targeted that increased pakt in screen z-score >1.4": 1 "number of sign.models": 1 "change observed": 1 "both names in dictionary": 1 "number of male samples with mutations mutation frequency in 40 male samples": 1 "b bp control": 1 "caloric restriction to induce weight loss in order to decrease insulin resistance of the ms exercise to aid in weight reduction by increased energy expenditure also to increase enos and eno as well as increase hdl-c with its antioxidant – anti-inflammatory effects both will result in redox stress reduction": 1 "gene or locus": 1 "functions of non-septins": 1 "2.40 2.25 879": 1 "somatic mutations in mtdna of cancers": 1 "- sunscreen with zinc oxide titanium dioxide or special protectors directed to children cause less irritation in this age group.": 1 "sirt1 low": 1 "0.44 0.38 792": 1 "24.7": 1 "24.4": 1 "ednrb": 1 "f78a/f78a": 1 "k d or k i relative to that for pdbu binding to the wt?c1b a": 1 "total females observed": 1 "ivanova et al.": 1 "slr*<1.32 and change p-value >0.999 and at least one present p detection call in control or treated array": 1 "positive edges only 428 nodes": 1 "nucant 6l n6l": 1 "cell number": 1 "primer name": 1 "13/18 72": 1 "type of alterations": 1 "outcome by kras status no of patients †": 1 " of patients n =27": 1 "4 crypts": 1 "values": 1 "mn/pgs": 1 "constructs": 1 "negative edges only 61 nodes": 1 "general": 1 "chemokine receptor 5": 1 "no of genes in our list": 1 "chemotactic factor that attracts lymphocytes and slightly neutrophils but not monocytes inhibits proliferation of myeloid progenitors in colony formation assays may be involved in formation and function of the mucosal lymphoid tissues by attracting lymphocytes and dendritic cells towards epithelial cells.": 1 "top-level prints classifications of fingerprints": 1 "type ofexperiment": 1 "ly294002 ?m": 1 "initial search query": 1 "chromosome": 1 "general gene characteristic": 1 "order of binding loss": 1 "the percent ofmajor-genotypeshift": 1 "observed functional effects of igfbp-5": 1 "number of miceanalyzed": 1 "11.1": 1 "main functions": 1 "p -value not corrected": 1 "application in the diagnostics of crc": 1 "number of cycles any grade": 1 "11.8": 1 "confirmed somatic by ss": 1 "- "protect children from lengthy sun exposure".": 1 "case 14": 1 "case 13": 1 "case 16": 1 "n7r": 1 "no of total tags": 1 "mtdna high no a": 1 "the contact pathway may activate coagulation in some clotting-based assays with low tf as initiator this pathway can be inhibited": 1 "- apply photoprotector on all areas with special care for the region around the eyes.": 1 "calm2": 1 "colo320dm cells": 1 "high cflip": 1 "encodes a proinflammatory cytokine this cytokine can induce the ifn-gamma production of t cells the combination of this cytokine and il12 has been shown to inhibit il4 dependent ige and igg1 production and enhance igg2a production of b cells il-18 binding protein il18bp can specifically interact with this cytokine and thus negatively regulate its biological activity.": 1 "igfbp-3 score": 1 "induces a mild activation of the immune system and enhances the release of growth factors.": 1 "strict": 1 "stx10": 1 "co-expression cluster": 1 "capacitance": 1 "non-septin preys in order of frequency shared preys": 1 "number of pathways involved": 1 "significant tfbs present in all promoters of a given cluster": 1 "donor age years": 1 "2.63 2.30 981": 1 "number of genes targeted that decreased pakt in screen z-score < ?1.4": 1 "case cohort": 1 "7.1": 1 "10??l": 1 "adult": 1 "7.3": 1 "7.4": 1 "enhances general metabolism by improving oxygen delivery.": 1 "organ": 1 "7.7": 1 "7.8": 1 "no feedback": 1 "certificated by the japan society for transplantation": 1 "procures a surprising wellness in most patients probably via the stimulation of the neuroendocrine system.": 1 "type i eec": 1 "library name": 1 "presents pentavalently the pseudo-tripeptide lys? ch2n-pro-arg coupled to the template h2n lys -lys- lys -gly-pro- lys -glu- lys -ahxconh2.": 1 "composition": 1 "- "this product does not offer any protection against sunstroke".": 1 "braf": 1 "number of crc without ndrg2 methylation ": 1 "number of foci/well": 1 "activated kinases at 5 min in system 2": 1 "peptides in dlkloxcreneg": 1 "endpoints": 1 "high frequency": 1 "3??l": 1 "without dtc n?=?101": 1 "encodes a member of the interleukin 1 cytokine family this cytokine is produced by activated macrophages as a proprotein which is proteolytically processed to its active form by caspase 1 casp1/ice this cytokine is an important mediator of the inflammatory response and is involved in a variety of cellular activities including cell proliferation differentiation and apoptosis.": 1 "advantages": 1 "fgf1 100 ng/ml + heparin 5 ?g/ml": 1 "number of core proteins": 1 "number of conditions per sirna": 1 "biological consequence of the interaction with mdm2 or p53": 1 "number of transcriptional profiles": 1 "filter 3": 1 "cluster number": 1 "number of dyrks": 1 "recommendations": 1 "peptide no.": 1 "case 4b": 1 "no of tumor- normal pairs": 1 "no of genes examined": 1 "main species": 1 "position in the promoter sequences human": 1 "variable across initial state": 1 "score post-decitabine": 1 "colonospheres-derived cells": 1 "data availability": 1 "itpr3": 1 "weak or negative": 1 "itpr2": 1 "present in other diseases": 1 "- keep out of direct irradiation.": 1 "81 16.3": 1 "no of gene in cluster": 1 "size kb": 1 "pathways": 1 "nº of genes in the database": 1 "number of far metastasis samples with mutations mutation frequency in 39 samples": 1 "cancer type case number": 1 "semantic agent – event": 1 "forked": 1 "contributing proteins moving into of drmds upon exposure to vtrm1": 1 "number percent of genes targeted that showed no change in pakt with different sirna": 1 "incidence of maspin-positive cells": 1 "2010": 1 "sequence of drug administration": 1 "contributing proteins moving out of drmds upon exposure to vtrm1": 1 "up-regulated in pii": 1 "2009": 1 "brain region": 1 "95 ci": 1 "main effects of polymorphisms": 1 "negative in both lepidic and invasive": 1 "2005": 1 "s10r": 1 "number of sequences containing more than one ssr": 1 "ast a iu/l": 1 "methylated": 1 "pattern change": 1 "expression pattern": 1 "percentage of cells within t cell subset": 1 "up ": 1 "skin extremely sensitive to sunburn": 1 "clus": 1 "case 7b": 1 "1 crypt": 1 "deletion of r3/g4 affects but does not abrogate pathogenicity": 1 "codon": 1 "intestinal": 1 "type of problem": 1 "type c – insertion/ deletion of a 'partial' fingerprint": 1 "fellow of the japanese board of cancer therapy": 1 "p-values": 1 "no of targets": 1 "in- degree": 1 "selectin p antigen cd62": 1 "2.49 2.15 997": 1 "?-sma number of vessels/mm2": 1 "substrate group 1—metabolic overall effect is anti-diabetic": 1 "detect method": 1 "lack of response to dna methylation inhibitor 5-aza-2-deoxycytidine as a single agent in advanced or recurrent cervical cancer*": 1 "method of analyses": 1 "alleles": 1 "30??l": 1 "max of activated kinase at 5 min in system 2": 1 "number of singletons": 1 "a aspirin": 1 "increase or decrease": 1 "mutations identified": 1 "snp type": 1 "predictor of treatment response?": 1 "1.60 1.23 1000": 1 "???—plasma ykl-40 is elevated many years before a gastrointestinal cancer is diagnosed more studies are needed.": 1 "- take care that they are not overheated and offer a great amount of liquids": 1 "pdb-code": 1 "other potential response in the macrophage": 1 "locus tag in a fumigatus genome": 1 "3.6": 1 "parental/vector transfected": 1 "average plating efficiency": 1 "erbb-2/neut colony number in ": 1 "3.57 3.71 386": 1 "total number in myrbase": 1 "all samples": 1 "vesicle transport through interaction with t-snares homolog 1a": 1 "vesicle transport through interaction with t-snares homolog 1b": 1 "predicted proteins similar a to those in": 1 "cohort i": 1 "number of clusters": 1 "rs1205": 1 "gene copy no.": 1 "not tested": 1 "count of unique domain lengths @": 1 "trigger": 1 "mean c": 1 "common in both": 1 "summary of the study": 1 "presents pentavalently the pseudo-tripeptide lys? ch2n-pro-arg coupled to the polypeptide template containing aib 2-aminoisobutyric acid ac-lys-aib-gly-lys-aib-gly-lys-aib-gly-lys-aib-gly-lys-aib-gly-conh2.": 1 "c cholesterol first target ldl second target non-hdl third target hdl fourth target crp": 1 "diversity of bacteria libraries": 1 "ctmnme·gppcp a": 1 "ncam1": 1 "negative feedback": 1 "number and patients": 1 "training data": 1 " coverage": 1 "skin very sensitive to sunburn": 1 "d diabetes prevention/diet": 1 "oocyte and blastocyst": 1 "article title or study goal": 1 "scaffolds only 714 nodes": 1 "+ a": 1 "mtdna low no a": 1 "percent of cases": 1 "fsh-nfpa": 1 "3/29": 1 "overlap with 742 cancer genes": 1 "• use of fits leads to higher participation rates than use of gfobts": 1 "no of mn- dm+": 1 "325": 1 "neural cell adhesion molecule 1": 1 "model lssa simulation": 1 "4.19 3.72 990": 1 "position": 1 "present": 1 "no .": 1 "number of entries": 1 "encodes a member of the rho family of small gtpases which cycle between inactive gdp-bound and active gtp-bound states and function as molecular switches in signal transduction cascades rho proteins promote reorganization of the actin cytoskeleton and regulate cell shape attachment and motility": 1 "plpc-pak4": 1 "- in case of irritation try other brands or use sunscreen with a titanium dioxide or zinc oxide base.": 1 "15 - 29.9": 1 "omim query": 1 "low 0.18 {32}": 1 "p corgi": 1 "c-myc <5": 1 "0.43 0.47 369": 1 "?case no.": 1 "mgmt expression": 1 "• submucosal deep abnormalities may not be detected even when the area is biopsied": 1 "number of occurrences in 3?utrs as a whole": 1 "negative and weak v moderate and strong": 1 "number of low differentiation samples with mutations mutation frequency in 33 samples": 1 "10/13 77": 1 "number of crc with ndrg2 methylation ": 1 " a lgg": 1 "2.59 2.14 932": 1 "specific manifestations": 1 "n in lepidic and n+c in invasive": 1 "1.22 1.33 338": 1 "number of matings/transformants": 1 "negative weak and moderate v strong": 1 "number of methylation positivepatients": 1 "phospholipase c delta 1": 1 "no arg0 or arg1": 1 "encodes a protein important for leukocyte-endothelial cell adhesion and mediates the interaction of activated endothelial cells or platelets with leukocytes": 1 "water resistant and that offers sun protection factor spf higher than or equal to 30.": 1 "genes in descending order of beta-values p <0.001": 1 "type b – truncation of a 'complete' to 'partial' fingerprint": 1 "encodes a mhc class ii protein that is an important modulator in the antigen presentation pathway by interaction with the hla-dm molecule in b cells": 1 "time course": 1 " of mutations in the d-loop region": 1 "accession no": 1 "time to progression months": 1 "ctmnme·gdp a": 1 "type of leukemia": 1 "no of samples with mutations": 1 "• in contrast to gfobts fits can be automated": 1 "all edges 194 nodes": 1 "aeg-1 expression in the cytoplasm": 1 "14": 1 "annotation findings": 1 "16": 1 "17": 1 "plcd1": 1 "2 the spf will be determined by in vivo tests according to fda or colipa methodology the number indicating the spf on the package is mandatory.": 1 "nlprot detected both names": 1 "370 nm": 1 "il-7": 1 "pretreatment hgf level": 1 "il-6": 1 "genes with decreased regional number of detections": 1 "encodes a cell adhesion protein that is a member of the immunoglobulin superfamily that is involved in cell-to-cell interactions as well as cell-matrix interactions during development and differentiation this protein has been shown to also be involved in development of the nervous system and for cells involved in the expansion of t cells and dendritic cells which play an important role in immune surveillance receptors": 1 "number of samples of heavy smokers with mutations mutation frequency in 17 samples": 1 "24": 1 "controls no a": 1 "25": 1 "mc1r": 1 "description of the approach": 1 "board certified hepatologist of the japan society of hepatology": 1 "cv-smse 0.05 0.50.95 quantile": 1 "vti1b": 1 "negative edges only 71 nodes": 1 "vti1a": 1 "bioactions in vitro": 1 "no of genomic alterations": 1 "hpiv3-c": 1 "gene list": 1 "probands": 1 "benign": 1 "2ros 9958 gene set linked": 1 "total number of identified ssrs": 1 "relationship": 1 "low n?=?132": 1 "1 a sun protector is defined as any cosmetic designed to be in contact with the skin and lips with the exclusive or main purpose of protecting against uva and uvb radiation absorbing dispersing or reflecting radiation.": 1 "3.90 4.07 342": 1 "33": 1 "34": 1 "35": 1 "36": 1 "plcb4": 1 "cx3cl1": 1 "prognosis": 1 "intensive lifestyle modification is the most important therapy weight reduction of 5–10 of preintervention weight over a period of four to six months sodium intake of <65–100?mmol/day with a goal of 90–120?mmol of potassium per day mediterranean diet high consumption of fruits vegetables legumes and grains moderate alcohol intake a moderate-to-low consumption of dairy products and meats/meat products and a high monounsaturated- to-saturated fat ratio dash diet rich in fruits vegetables and low-fat dairy products and low in saturated and total fat intake consider low glycemic index food complex unrefined carbohydrates viscous soluble fibres protein intake of 10–35 of total calorie intake and 25 to 35 of calories as total fat metformin is second line in delaying the onset of t2dm thiazolidinediones pioglitazones and alpha-glucosidase inhibitors acarbose have shown benefit in smaller studies and are therefore third line.": 1 "weak/moderate 1+": 1 "cases genotyped for the snp": 1 "bioie both": 1 "source database version": 1 "time point": 1 "fellowship award from the foundation for promotion of cancer research": 1 "number of uniquely mapping bases": 1 "writing of cancers generally…there are multiple” dynamic interrelationship s between intratumoral cell subpopulations… that have clear clinical significance” 305 ..": 1 "consequence of interaction on p53/mdm2": 1 "40": 1 "specific force a": 1 "42": 1 "6 - 14.9": 1 "agent": 1 "upregulates cellular antioxidant enzymes and induction of ho-1 and hsp70.": 1 "synaptic cleft width": 1 "x 2": 1 "pathway name": 1 "compd": 1 "1/13 8": 1 "number of variants": 1 "whole cohort size": 1 "56": 1 " females with one blistered wing": 1 "59": 1 "cases with complete follow-up": 1 "cut-off point": 1 "tnf independent nf-?b activity in the epithelium": 1 "epithelial ovarian tumors 90 mostly diagnosed after the age of 50 .": 1 "finding": 1 "chrysotile": 1 "zr75-1": 1 "type of cancers* tissues": 1 "regulator": 1 "positive no ": 1 "phospholipase c beta 4": 1 "64": 1 "rhoc": 1 "16.1": 1 "major histocompatibility complex class ii do beta": 1 "common genes": 1 "hepatic sc 282": 1 "high penetrance": 1 "ube2c fold induction mc/non-mc": 1 "plasmid": 1 "il6r to pi3k?": 1 "+++": 1 "number of researched samples": 1 " of perinuclear aggregates": 1 "5 the amplitude of uv protection should be evaluated by the critical wave length whose smaller value will be 370 nm.": 1 "type of drug": 1 "medical doctor": 1 "no—plasma ykl-40 is also elevated in patients with diseases characterized by acute or chronic inflammation tissue remodeling and fibrosis i.e co-morbidity shall always be considered in cancer patients with high plasma ykl-40.": 1 "conseuence": 1 "petkov et al.": 1 "71": 1 "?9-fold no ": 1 "number of rbhs": 1 "no n = 26": 1 "clusters": 1 "adjusted p-value a": 1 "1.49 1.34 903": 1 "76": 1 "77": 1 "risk of specific cancer": 1 "number of selected clones selection/primary screening/secondary screening": 1 "syntaxin 6": 1 "gene sets": 1 "encodes a member of the protein tyrosine phosphatase ptp family ptps are known to be signaling molecules that regulate a variety of cellular processes including cell growth differentiation mitotic cycle and oncogenic transformation and is an essential regulator of t- and b-cell antigen receptor signaling": 1 "t-cell neoplasms *": 1 "preconditioning specific": 1 "ccl20": 1 "9 sunscreen should not have the following statements on the labels 100 uv protection antisun effect possible to not reapply the product in any situation or other statements that imply total protection or solar radiation blocking.": 1 "ccl24": 1 "cd4?cd8?": 1 "large rgcs 400–1000 pixels": 1 "cells": 1 "vegf expression?": 1 "detection of siah2": 1 "depth m": 1 "encodes a protein that induces a chemotactic response in activated t-cells and is the dominant ligand for cxc receptor-3 ifn-gamma is a potent inducer of transcription of this gene chemotactic for interleukin-activated t-cells but not unstimulated t-cells neutrophils or monocytes induces calcium release in activated t-cells.": 1 "comment": 1 "tumbar et al.": 1 "codon change": 1 "esr1": 1 "pegfr": 1 "variation in lengths of the domain among isoforms": 1 "uacc-1598dm cells": 1 "relation": 1 "negative feedback removed": 1 "cd4?cd8+": 1 "useful for screening?": 1 "biological replicates": 1 "number of clones in rat adrenal gland": 1 "3 water resistance determination should follow fda or colipa methodology the manufacturer may indicate on the product label if it is "water resistant" "very water resistant" "water and sweat resistant" or "water/perspiration resistant" whenever this has been ascertained.": 1 "classification of asthma based on the level of severity": 1 "total n?=?134": 1 "e exercise": 1 "population studied and type of study": 1 "genes enriched in the most cohorts": 1 "presents hexavalently the pseudo-tripeptide lys? ch2n-pro-arg all bonds in l position coupled to a polypeptide template as in n6.": 1 "mir-200b high n?=?56": 1 "<2-fold no ": 1 "p53-mirs that commonly target components of the mirna processing complex": 1 "a the total number of the five motif types identified for cancer networks and stns": 1 "predominant septin prey group": 1 "microarray a": 1 "4.72 4.05 1000": 1 "3 crypts": 1 "a established motifs and extensions": 1 "sequence of event": 1 "most downregulated": 1 "pili/cell a": 1 "peptide sequence": 1 "gender": 1 "p -value a": 1 "+/+": 1 "number magea4 only": 1 "iq less than 50": 1 "number of up-regulated genes": 1 "small rgcs 100–400 pixels": 1 "encodes major glycoproteins of thymocytes and t lymphocytes and plays a role in the physicochemical properties of the t-cell surface and in lectin binding and in some b lymphocytes where it appears to be important for immune function and may be part of a physiologic ligand-receptor complex involved in t-cell activation": 1 "25.7": 1 "event": 1 "igfbp-3 ihc score": 1 "no of data points": 1 "genes with significant positive correlation with sppr c08": 1 "cavs animal tag no.": 1 "genes whose expression is up-regulated": 1 "number of litters analyzed": 1 "writing of head/neck squamous cell carcinoma “intratumor heterogeneity showed that a single biopsy may not represent the entire mutational landscape” 303 ..": 1 "avoidance and or moderation especially beer with the increased purines from hops and barley also improve the liver antioxidant potential redox stress reduction": 1 "targets of rnai": 1 "negative no ": 1 "recist criteria": 1 "process/pathway": 1 "truncation event-": 1 "study type": 1 "no misclassified/total no misclassified": 1 "msi": 1 "genes of interest": 1 "il-6 expression": 1 "80 41": 1 "interleukin 7": 1 "c-myc low": 1 "concentration vectors": 1 "maspin localization": 1 "2500": 1 "snare involved in vesicular transport from the late endosomes to the trans-golgi network": 1 "n7r/p11r": 1 " n?=?61417 with homology ": 1 "grade 1b papules or pustules <5 or 1 area of erythema or edema <1?cm in size and pain or pruritis": 1 "r in": 1 "frtl5 pcdna": 1 "d-value": 1 "mutations combination including missense point mutations/deletion/insertion": 1 "present in i3?": 1 "number of middle differentiation samples with mutations mutation frequency in 27 samples": 1 "12.2": 1 "patients studied": 1 "genes affected": 1 "all edges 1096 nodes": 1 "chemokine c-x-c motif ligand 9": 1 "interleukin 6 interferon beta 2": 1 "present at plexus": 1 "rs3093077": 1 "concurrent bmp3b and bmp6 meth": 1 "type of resistance circumvented": 1 "number of clinical trials": 1 "involved in intracellular vesicle trafficking": 1 "metastatic sites": 1 "iq between 50 and 70": 1 "20 98 99 100": 1 "common name/description": 1 "p11r": 1 "test s": 1 "certificated by the japanese society of internal medicine licensed": 1 "0.1??l": 1 "gene–environment interaction": 1 "negative edges only 242 nodes": 1 "total number of peaks identified": 1 "read-pair coverage": 1 "immunohistochemistry": 1 "additional biomarkers": 1 "percentage with high cdk5 expression": 1 "genes with significant negative correlation with sppr -c08": 1 "talin 1": 1 "clonorchis sinensis sequences": 1 "34.4": 1 "present in i5?": 1 "a densitometric analysis of western blots of gtpases - ras rac1 and rhoa and actin in normal and cml pmnl": 1 "number of genes mapped to microarray": 1 "genes with increased regional number of detections": 1 "integrin a": 1 "locus": 1 "weights in the 2nd component": 1 "4.29 4.06 984": 1 "8.3": 1 "nucant 3 n3": 1 "reviewing plasticity and csc “non-cscs can reacquire a csc phenotype” 304 ..": 1 "alt a iu/l": 1 "parental/?-catenin sirna transfected": 1 "no of atoms": 1 "il-17rb": 1 "fl-hcc cohort": 1 "v vinifera": 1 "bfgf": 1 "out- degree": 1 "gonado-stromal tumors 6 no particular pattern with age": 1 "no of singleton": 1 "expression in escs": 1 "absent": 1 "no of sediment samples": 1 "no of differentially expressed operons by valine": 1 "target sites for": 1 "1.45 1.31 801": 1 "type of tgf-?": 1 "p16 expression": 1 "ras": 1 "some of the constituent motifs of the fingerprint$": 1 "presents hexavalently the pseudo-tripeptide lys? ch2n-pro-arg a mixture in l and d configuration coupled to the polypeptide template containing aib ac-lys-aib-gly-lys-aib-gly-lys-aib-gly-lys-aib-gly-lys-aib-gly-lys-aib-gly-conh2.": 1 "1.65 1.24 999": 1 "the protein encoded by calm2 mediates the control of a large number of enzymes and other proteins by ca++ and is involved in a genetic pathway that regulates the centrosome cycle and progression through cytokinesis": 1 "no of unique tags": 1 "version": 1 "itgam": 1 "number of genes containing at least one jund peak": 1 "low state in sample": 1 "number of genotypes": 1 "- "reapplication of the product required to maintain its effectiveness".": 1 "hyper/hypo": 1 "total number of data points assayed to validate primary screen": 1 "fusion-deficient viruses can propagate at wild type levels": 1 "grade 3a papules or pustules >20 or more than 5 areas of erythema or edema <1?cm in size": 1 "number with no change in score": 1 "grade 2b papules or pustules 6–20 or 2–5 areas of erythema or edema <1?cm in size and pain pruritus or effect on emotions or functioning": 1 "kegg code": 1 "- if the baby rubs the photoprotector into the eyes clean its eyes and hands with a soft cloth.": 1 "encodes the alpha chain of the interleukin-4 receptor a type i transmembrane protein that can bind interleukin 4 and interleukin 13 to regulate ige production.": 1 "cluster size b": 1 " confirmed as somatic": 1 "• fits have better analytical sensitivity and specificity than gfobts 1": 1 "scaffolds only 141 nodes": 1 "onset": 1 "number of absolutely bistable models under different network topologies": 1 "ube2c fold induction mc/non-mc a": 1 "low 0.16 {60}": 1 "- sunscreen should be broad spectrum water resistant and with minimum 15 and maximum 50 spf avoiding those that contain oxybenzone for the more sensitive areas physical filters are preferred.": 1 "p-lpa in nmols/gr": 1 "insertion/deletion event-": 1 "t-value in bt549": 1 "no of genes that encode the domain in different lengths among the protein isoforms & as percentage fraction of genes encoding the domain in the protein isoforms$": 1 "?2-fold no ": 1 "notes": 1 "number of unknown samples with mutations mutation frequency in 1 samples": 1 "few studies simultaneously compare more than one assay": 1 "enriched msigdb gene set": 1 "different phosphoenrichment combinations": 1 "mirna processing components": 1 "number of annotated unigenes": 1 "weights in the 1st component": 1 " n?=?50769 with homology ": 1 "ev animal tag no.": 1 "clonorchis sinensis predicted proteins 50769 similar a to those in": 1 "expected no of gene hits": 1 "babies younger than 6 months of age": 1 "#genes that are also essential": 1 "chondroitin sulfate proteoglycan 2": 1 "fold-change of up- or downregulation": 1 "p b": 1 "experiment source scenario": 1 "no of unique samples": 1 "clinical factors": 1 "mscf": 1 "what is the target molecule?": 1 "tumor specific?": 1 "relative levels of mir-206 mean?±?sem": 1 "c-myc mode-rate": 1 "nras": 1 "genename": 1 "encodes an immunoregulatory cytokine produced primarily by activated th2 cells this cytokine is involved in several stages of b-cell maturation and differentiation inhibits inflammatory cytokine production synergizes with il2 in regulating interferon-gamma synthesis may be critical in regulating inflammatory and immune responses.": 1 "rab31 expression": 1 "minimum uva protection factor pf-uva": 1 "number of down-regulated genes": 1 "type of tyrosine kinase": 1 "ca19-9 false negative ": 1 "number of dinucleotide repeats": 1 "stx8": 1 "certificated by the japanese society of gastroenterology": 1 "enriched go biological process": 1 "v-snare that mediates vesicle transport pathways through interactions with t-snares on the target membrane these interactions are proposed to mediate aspects of the specificity of vesicle trafficking and to promote fusion of the lipid bilayers involved in vesicular transport from the late endosomes to the trans-golgi network": 1 "mlh1 expression": 1 "model name": 1 "additional non mandatory information on the package": 1 "maximal length": 1 "ubiquitination by mdm2": 1 "contributing proteins moving into of drmds upon exposure to 16m": 1 "stx6": 1 "same as above.": 1 "no—plasma ykl-40 is only elevated in a subgroup of cancer patients.": 1 "septin bait": 1 "number of linear paths": 1 "pak2 expression": 1 "- sunscreen should be applied from the age of 6 months onward and only on exposed areas not covered by clothes": 1 "encodes a cytokine important for b and t cell development this cytokine and the hepatocyte growth factor hgf form a heterodimer that functions as a pre-pro-b cell growth-stimulating factor this cytokine is found to be a cofactor for v dj rearrangement of the t cell receptor beta tcrb during early t cell development this cytokine can be produced locally by intestinal epithelial and epithelial goblet cells and may serve as a regulatory factor for intestinal mucosal lymphocytes.": 1 "p valuea": 1 "no of other aberrations": 1 "4.4": 1 "family": 1 "relative risk 95 ci": 1 "4.8": 1 "encodes g-protein-coupled receptor family it is a receptor for the cc chemokine - mip-1 rantes tarc and mcp-1.": 1 "no of mirnas": 1 "aug 2013": 1 "bmp3b meth": 1 "odds ratio": 1 "4 determination of uva protection factor should folow the in vivo methodology of the european committee ppd or the in vitro methodology of colipa fpa-uv or critical wave length.": 1 "total number of genes": 1 "subjects with aah": 1 "no of nodules formed no of animals": 1 "blast options": 1 "targeted by no of mirnas": 1 "number of mice": 1 "0.011": 1 "protein in a fumigatus": 1 "inositol 145-trisphosphate receptor type 3": 1 "ductal epithelia": 1 "tumors formed with": 1 "inositol 145-trisphosphate receptor type 2": 1 "system": 1 "n7r/s10r/p11r": 1 "igf-1r expression": 1 "wild type": 1 "number of unique descriptions": 1 "authors": 1 "unable to sequence": 1 "distribution of ssrs": 1 "number of gene probes that are in common with at least one other profile": 1 "number of pooled sirna targeting each gene": 1 "<9-fold no ": 1 "412": 1 "fellow of the japanese society of gastroenterology": 1 "singed": 1 "b-raf": 1 "p vq58": 1 "with dtc n?=?12": 1 "encodes a member of the immunoglobulin superfamily proteins and is an anchored neuronal membrane protein which functions as a cell adhesion molecule": 1 "type of injury": 1 " of common dmrs of all cpg islands": 1 "lxa4 lxa4-analogs and aspirin-triggered lipoxins atls": 1 "n in both lepidic and invasive": 1 "no of genes that encode the domain in how many of these genes the domain undergoes change": 1 "scaffolding only 144 nodes": 1 "negative v weak/moderate/strong": 1 "uacc-1598 cells": 1 "genome": 1 "swiss-prot no.": 1 "encodes a member of the interleukin 1 cytokine family this cytokine is a pleiotropic cytokine involved in various immune responses inflammatory processes and hematopoiesis this cytokine is produced by monocytes and macrophages as a proprotein which is proteolytically processed and released in response to cell injury and thus induces apoptosis.": 1 "tumour biomarkers": 1 "425": 1 "pdpk1": 1 "esc 1787": 1 "prognosis in mm": 1 "literature data": 1 "number of patients any grade": 1 "score pre-decitabine": 1 "cxcl11": 1 "skin little sensitive to sunburn": 1 "downregulated": 1 "higher than 50 and lower than 100": 1 "high xiap": 1 "• variations in diagnostic criteria for barrett's oesophagus and dysplasia": 1 "1500 unless otherwise noted 44 45": 1 "patients no.": 1 "chemokine c-x3-c motif ligand 1": 1 "ppi3k change": 1 "carg-like": 1 "• use of fits require fewer stool samples than gfobts": 1 "no of patients with increased gcn/total no of patients cutoff† methodology": 1 "insertion/deletion gene-": 1 "#cohorts": 1 "average r": 1 "the gene is a member of the syntaxin family the encoded protein is involved in protein trafficking from early to late endosomes via vesicle fusion and exocytosis.": 1 "number of ad genes": 1 "no of parameters": 1 "average no per gene": 1 "2.61 2.16 999": 1 "2.23 2.16 836": 1 "number of species": 1 "high n?=?5": 1 "associates with": 1 "#genes that are also in the ppi network": 1 "ski expression": 1 "lesion/tumor": 1 "early phase down-regulated mechanistic genes": 1 "11 sunscreen should not have label statements that imply the following characteristics": 1 "rs3091244": 1 "upregulated": 1 "genes whose expression is down-regulated": 1 "all edges 620 nodes": 1 "present in psd": 1 "• imaging protocols do not achieve subcellular resolution and biopsies are still required": 1 "to pep": 1 "up-regulated": 1 "risk factor": 1 "460": 1 "p53/p63-res present in the promoters of the microrna-processing components": 1 "- babies younger than 6 months of age should avoid sunlight exposure.": 1 "0.5": 1 "no of affected persons in family a": 1 "0.7": 1 "cases no a": 1 "hypothesis": 1 "no gold standard assay – the mp tf activity assay is the best available assay": 1 "reflect poor prognosis?": 1 "number of patients n =40": 1 "chemokine c-c motif receptor 4": 1 "pmek change": 1 "associated with poor outcome": 1 "tc group": 1 "rs#": 1 "20 nm 39": 1 "chemokine c-c motif receptor 8": 1 "skin sc 152": 1 "down ": 1 "number of high differentiation samples with mutations mutation frequency in 15 samples": 1 "experiment target scenario": 1 "number of stage 3a samples with mutations mutation frequency in 26 samples": 1 "number of ssr-containing sequences": 1 "feature class": 1 "percent1 ": 1 "apc": 1 "4.26 4.06 697": 1 "lh-nfpa": 1 "total size of examined sequences kb": 1 "subjects with ais": 1 "septin preys in order of frequency": 1 "vegf of positive staining cells": 1 "recommendations for cabg": 1 "encodes the protein integrin alpha-m/beta-2 and is implicated in various adhesive interactions of monocytes macrophages and granulocytes as well as in mediating the uptake of complement-coated particles": 1 "alterations in mtdna content": 1 "integrin alpha m complement component 3 receptor 3 subunit": 1 "number of patientswith p53 mutation ": 1 "genotype ": 1 "grade": 1 "l20r": 1 "k-ras": 1 "wnt related protein a and b protein a shares homology with human wnt-7b 87 while protein b shares homology with wnt-1 of the mexican axolotl ambystoma mexicanum 88 the wnt proteins are a family of secretory glycoproteins mostly associated with cell membranes and the extracellular matrix they are implicated in proliferation and differentiation of both normal and malignant cells many members of the wnt gene family including wnt-7 are up-regulated in bladder and breast carcinoma and as well as in chronic lymphocytic leukemia suggesting involvement of wnt signaling pathways in tumorigenesis 92 - 94 .": 1 "number of lymph metastasis samples with mutations mutation frequency in 11 samples": 1 "no of additional signif genes found under rht": 1 "mis below the range": 1 "no of mutations": 1 "no of new clo cases": 1 "2 crypts": 1 "number of large error predictions": 1 "ongoing phase ii trial of the combination of hydralazine and magnesium valproate added to cisplatin chemoradiation in figo stage iiib patients": 1 "akt status variation": 1 "rt-pcr only": 1 "graph type": 1 "number of sirna in screen": 1 "497": 1 "all patients": 1 "calmodulin 2": 1 "arl": 1 "attribute": 1 "detection": 1 "pi3k": 1 "pathway id": 1 "oxaloacetat.": 1 "type of biomarkers": 1 "1/3 of the spf": 1 "number of extrasynaptic nmdars": 1 "tumor": 1 "mirnas associated with negative outcome": 1 "17.6": 1 "low n?=?4": 1 "- " possibility of not reapplying the product in any circumstances."": 1 "theoretical m/z m+na+": 1 "number of stage 4 samples with mutations mutation frequency in 12 samples": 1 "4.34 4.06 999": 1 "number of transcripts": 1 "developmental stages investigated": 1 "yes n = 16": 1 "56 100": 1 "mean age ± sd years": 1 "go id": 1 "no of observed events* affecting": 1 "initiate treatment categorical hypertension bp ? 140/?90?mm?hg patients with established diabetes ?130/?80?mm?hg aceis/arbs first line agent may reduce incident diabetes mellitus beta-blockers and thiazides may have an adverse effect on impaired glucose tolerance but outweighed by the benefits of reaching bp goal and lowering the risk of cvd events.": 1 "features": 1 " with fusion a": 1 "p16": 1 "segment": 1 "nucleophosmin also referred to as b23 nucleophosmin is a 37-kda protein ubiquitously expressed chaperone that shuttles rapidly between the nucleus and cytoplasm but predominantly resides in the nucleolus 101 it is implicated in several cellular processes including ribosome biogenesis centrosome duplication cell cycle progression and apoptosis 77 somatic mutations in the exon 12 of the nucleophosmin gene npm1 are the most frequent genetic abnormality in adult acute myeloid leukemia leading to aberrant localization of nucleophosmin into the cytoplasm 77 101 which might be a critical event for leukogenesis 102 .": 1 "the function of this gene has not been specifically defined however it is thought to be involved in t cell trafficking.": 1 "grade 2": 1 "grade 3": 1 "nucant 6 n6": 1 "number of hexanucleotide repeats": 1 "v amurensis": 1 "under - or over +representation of genes": 1 "concept type": 1 "p21": 1 "0.41 0.47 266": 1 "germline by ss": 1 "sep 2002": 1 "kras mutation": 1 "- "reapply whenever you experience intense sudoresis after swimming or bathing drying yourself with a towel and during sun exposure" in case there is a time interval determined by the manufacturer for reapplication it should also be informed on the package.": 1 "parameters": 1 "mir-375 high level": 1 "summary measure": 1 "microclone density microclones per mm3": 1 "biological example": 1 "delivery system for modulation of mirnas": 1 "frequency a ": 1 "rs7553007": 1 "methylation data": 1 "rs# or amino acid change": 1 "number of wells showing colonospheres": 1 "strain background": 1 "to pyruvate": 1 "hif-1 ? expression?": 1 "no of transcripts": 1 "1.92 1.48 995": 1 "pyruvate": 1 "xenografts n out of 19 ": 1 "dystrophin a": 1 "encodes phosphoinositide-specific phospholipase c that acts as a signal transducer and has diverse biological functions including roles in inflammation cell growth signaling and death and maintenance of membrane phospholipids": 1 "a-lpa in pmols/gr": 1 "npv": 1 "0.40 0.44 365": 1 "v-snare that mediates vesicle transport pathways through interactions with t-snares on the target membrane these interactions are proposed to mediate aspects of the specificity of vesicle trafficking and to promote fusion of the lipid bilayers may be concerned with increased secretion of cytokines associated with cellular senescence.": 1 "colon": 1 "no of subjects": 1 "+/f78a": 1 "wild-type": 1 "number of uniquely mapping 50 bp reads": 1 " of mutations in coding regions": 1 "moderation in meats and seafood's especially shrimp and barbeque ribs all you can eat specials vegetables and fruits higher in purine should not be completely avoided as they provide fiber and naturally occurring antioxidants lists should be provided to demonstrate the vegetables and fruits that are higher in purines to allow patients healthier choices redox stress reduction": 1 "cspg2": 1 "interleukin 13": 1 "fraction of proteins with at least one domain ": 1 "interleukin 15": 1 "tissue": 1 "no of unique tc e": 1 "cells of origin": 1 "number of cases n": 1 "number of dilutions per sample on rppa": 1 "6-10": 1 "type of immune-mediated cell death or phenotypic alteration": 1 "mseil6": 1 "gene set": 1 "pre-analytical variables – cell-free plasma anticoagulant g-values for centrifugation discard tube in blood draw freeze thawing": 1 "6 the package should inform the protection category designation - pcd low protection if spf 6-14.9 medium protection if spf 15-29.9 high protection if spf 30-50 and very high protection if spf above 50.": 1 "nomnme·gdp a": 1 "met/del without no info": 1 "p53 wild-type n=418 ": 1 "indicated on the label": 1 "activates neuroprotective systems.": 1 "high n?=?132": 1 "collection site a year": 1 " specific killing of 10 4 cells/well by l6scfv-fasl ext ? l/well": 1 "item": 1 "bcl2 family members involved in disease": 1 "sage libraries used": 1 "evidence in data": 1 "overlap‡": 1 "fbl": 1 "number of stage 2b samples with mutations mutation frequency in 9 samples": 1 "high specificity for cancer?": 1 "number of other samples with mutations mutation frequency in 2 other samples": 1 "peptide a": 1 "critical wave length": 1 "carg": 1 "no of bb genotype pts.": 1 "detection limit of most flow cytometers above the size of small tf-positive vesicles": 1 "msh2 expression": 1 "test/procedure": 1 "methylation or ctc pos .": 1 "not present at plexus": 1 "babies": 1 "n7r/s10r/l20r": 1 "no of variables": 1 "adverse event all grade": 1 "reference number": 1 "percentage of annoted unigenes": 1 "protein tyrosine phosphatase receptor type c": 1 "initial condition of system 1": 1 "number of repeats per sirna": 1 "categories": 1 "no of gene hit": 1 "- find shade under a tree a beach umbrella or hood of a baby carriage.": 1 "observed number": 1 "8/29": 1 "the percentage of tumor with single pgcc in the stroma": 1 "systematic name": 1 "mutation rate‡": 1 "no of adjacentnon-tumors with heterozygousgenotype": 1 "writing of aggressive breast cancer…“coexistence of tumor cells with different phenotypic traits within a primary tumor” with “branched … bidirectional …evolutionary tumor growth” concluding “primary tumors are ecosystems of evolving clones with different spatial and temporal distributions” that are mutually reinforcing 5 .": 1 "proteins predicted to be similar a to those in": 1 "in ucm": 1 "fdr": 1 "gain of function": 1 "no of genes in the pathway": 1 "tf activity can be increased by post-translational modification and decreased by its inhibitor tissue factor pathway inhibitor": 1 "no tested": 1 "no of animals": 1 "proportion of patients with mutation out of number tested of patients positive": 1 "expression of abnormal hrgr": 1 "statistics": 1 "gates and and and*": 1 "total no of mice": 1 "components of mirna- processing complex": 1 "no—ykl-40 is also produced by non-malignant cells e.g inflammatory cells.": 1 "no of significantly mutated genes": 1 "to find": 1 "number of annot terms": 1 "fdns n =46": 1 "down-regulated mechanistic genes": 1 "pns n =55": 1 "up-regulated mechanistic genes": 1 "?msh": 1 "solved by ascat": 1 "pep to 2pg": 1 "cdna library name a": 1 "cyclin d dysregulation": 1 "number of gene pairs": 1 "cohort ii": 1 "ffl": 1 "postmenopausal women taking tamoxifen should be monitored closely for symptoms of endometrial hyperplasia or cancer premenopausal women treated with tamoxifen have no known increased risk of uterine cancer and as such require no additional monitoring beyond routine gynecologic care women taking tamoxifen should be informed about the risks of endometrial proliferation endometrial hyperplasia endometrial cancer and uterine sarcomas women should be encouraged to promptly report any abnormal vaginal symptoms including bloody discharge spotting staining or leukorrhea any abnormal vaginal bleeding bloody vaginal discharge staining or spotting should be investigated emerging evidence suggests the presence of high- and low-risk groups for development of atypical hyperplasias with tamoxifen treatment in postmenopausal women based on the presence or absence of benign endometrial polyps before therapy thus there may be a role for pretreatment screening of postmenopausal women with transvaginal ultrasonography and sonohysterography when needed or office hysteroscopy before initiation of tamoxifen therapy unless the patient has been identified to be at high risk for endometrial cancer routine endometrial surveillance has not been effective in increasing the early detection of endometrial cancer in women using tamoxifen such surveillance may lead to more invasive and costly diagnostic procedures and therefore is not recommended tamoxifen use should be limited to 5 years’ duration because a benefit beyond this time has not been documented if atypical endometrial hyperplasia develops appropriate gynecologic management should be instituted and the use of tamoxifen should be reassessed if tamoxifen therapy must be continued hysterectomy should be considered in women with atypical endometrial hyperplasia tamoxifen use may be reinstituted following hysterectomy for endometrial carcinoma in consultation with the physician responsible for the woman’s breast care.": 1 "marker": 1 "validation cohort": 1 "a large region between the env and r3 genes is dispensable for infectivity and viral spread": 1 "ykt6 v-snare homolog s cerevisiae": 1 "- whenever possible they should wear comfortable clothes with a tight weave and cover all the body.": 1 "~2600": 1 "all sentences": 1 "experimental question is the factor localized to mitochondria?": 1 "measured sun protection factor spf": 1 "slr*>1.32 and change p-value <0.001 and at least one present p detection call in control or treated array": 1 "appropriate range": 1 "uses of models": 1 "in the aav-mediated protocol the homologous recombination cassette is cloned within the aav inverted terminal repeats the cassette consists of two “homology arms” sequences of about 1 kb one of which contains the specific mutation a selectable marker such as the neomycin resistance gene neo is placed between the homology arms flanked by two loxp sites since cre recombinase catalyzes site-specific recombination between loxp sites this architecture allows the excision of the neo cassette from the genome of the targeted cells and the possibility of recycling the resistance marker for the sequential introduction of multiple alleles in the same cell after infection with recombinant aav raav and selection with the selective antibiotic g418 clones with locus-specific integration of the targeted alleles could be identified through a pcr screening approach positive clones are expanded and genomic dna and rna are extracted to sequence the targeted region in order to independently confirm the presence and the expression of the specific mutations.": 1 "high* 8.25* {2800}": 1 "type of testing": 1 "patient": 1 "0.47 0.35 909": 1 "encodes an mg++ independent enzyme that hydrolyzes the 4-position phosphate from the inositol ring of phosphatidylinositol 34-bisphosphate inositol 134-trisphosphate and inositol 34-bisphosphate this reaction uses calcium as a cofactor and plays an important role in the intracellular transduction of many extracellular signals similar to plcd1": 1 "reference egfr": 1 "unmethylated no.": 1 "3.61 4.07 99": 1 "a.": 1 "down-regulation of mrna": 1 "fraction number": 1 "type of protein": 1 "scaffolds only 399 nodes": 1 "number of stage 2a samples with mutations mutation frequency in 3 samples": 1 "number of positive cellsa": 1 "cell line and condition": 1 "clinical prostate tumors n out of 53 ": 1 "lh/fsh-nfpa": 1 "type of particles": 1 "hla-dob": 1 "number of peaks linked to a gene": 1 "cell type n* or t* 0r m*": 1 "nek2a upregulation": 1 "treatments": 1 "chemokine c-c motif ligand 20": 1 "scf": 1 "mainly *": 1 "fellow of the japanese society of internal medicine": 1 "investigated": 1 "case 10b": 1 "pr+sd": 1 "possible mechanisms of action": 1 "tumr type code": 1 "significant in hcc": 1 "interleukin 1 alpha": 1 "number of hits number of unique genes": 1 "number of true predictions": 1 "chemokine c-x-c motif ligand 11": 1 "all a": 1 "proxy": 1 "hmbc": 1 "high state in sample": 1 "3.57 3.70 385": 1 "weights in the 3rd component": 1 "number of antibodies in rppa": 1 "number of elements": 1 "method order": 1 "additional key words": 1 "dec.": 1 "specific diabetes type": 1 "no of motifs": 1 "taxonomic range": 1 "number of local metastasis samples with mutations mutation frequency in 8 samples": 1 "increasing ltr promoter activity decreases viral spread": 1 "virus": 1 "h3 and h4 hyperacetylation as well as inhibition of deacetylase activity in the tumors of cervical cancer patients with cervical cancer in a phase i trial of the hdac inhibitor magnesium valproate": 1 "subsets of patient-control pairs": 1 "number magea4+ other a": 1 "sem": 1 "- sensitive areas ears neck cheeks or areas not covered by clothes should receive a broad-spectrum photoprotector": 1 "type of modification": 1 "encodes a cytokine that functions in inflammation and the maturation of b cells it is a potent inducer of the acute phase response plays an essential role in the final differentiation of b-cells into ig-secreting cells involved in lymphocyte and monocyte differentiation.": 1 "protein description": 1 "socs4-elonginc-elonginb": 1 "igf1r change": 1 "sex": 1 "evidence for role in bcr–abl1-driven leukemia": 1 "number of acf with": 1 "number of acf": 1 "sample": 1 "sirt1 high": 1 "may play a role in signaling processes and phosphorylates and activates pkb/akt.": 1 "no of a-allele carriers": 1 "mlpa abnormality": 1 "with negative feedback": 1 "pten mutation": 1 "1.66 1.33 998": 1 "number of signature genes": 1 "muc1 staining": 1 "dbtf part of gene cluster 2": 1 "vhl expression no of cases": 1 "germ cell neoplasm 3 mostly diagnosed under the age of 30": 1 "what is the reactive oxygen species that is causing the oxidative injury?": 1 "and sunglasses.": 1 "cxcr4 expression?": 1 "???—high plasma ykl-40 may reflects disease progression more studies are needed.": 1 "association of kras mutation with response and survival parameters": 1 "number of samples/subtypes": 1 "brim2": 1 "brim3": 1 "1??l": 1 "arrayexpress or geo accession": 1 "1.70 1.34 905": 1 "no of litters per animal mean ± sem": 1 "adverse event": 1 "rarb": 1 "protein s": 1 "number percent of genes targeted that showed opposite change in pakt with different sirna": 1 "statin to achieve ldl-c <100?mg/dl in high-risk <130?mg/dl in intermediate-risk and <160?mg/dl in low risk patients statin intensification consider niacin and/or fibrates once statin maximized consider fibrates especially for those with combined hypertriglyceridemia/low hdl-c consider further reduction in ldl-c with statin therapy to mitigate a risk of low hdl-c consider niacin statin therapy for those with high sensitivity crp hscrp ?3?mg/dl.": 1 "real-time rt-pcr a": 1 "mutation patterns among discrepant paired samples": 1 "31.0": 1 "all molecular classes a": 1 "c -values in a perturbed tcr pathway upon maximization of concentrations of the regulators for forming zap70 lck and fyn": 1 "nucleotides": 1 "biological knowledge type": 1 "cor/loe a": 1 "mis within the range": 1 "0.44 0.47 455": 1 "origin": 1 "ontologies used": 1 "encodeds a cytokine receptor this receptor specifically binds to il17b and il17e but does not bind to il17 and il17c this receptor has been shown to mediate the activation of nf-kappab and the production of il8 induced by il17e.": 1 "• fits are more cost-effective than gfobts": 1 "4125.7": 1 "sequences with homology to unique genes": 1 "number of samples female/male": 1 "negative correlation with p27": 1 "sim": 1 "non-hyper-methylated": 1 "15/29": 1 "plpc": 1 "serum m-spike type": 1 "class": 1 "2.27 2.15 676": 1 "case 15a": 1 "q o.r.": 1 "number of deaths": 1 "number of transporters in tetrahymena percentage of total transporters": 1 "source of tissue or cell line": 1 "demethylation and reactivation of the expression of several tumor suppressor genes in the tumors of cervical cancer patients in a phase i trial of the dna methylation inhibitor hydralazine": 1 "1/29": 1 "form": 1 "500": 1 "p-value of difference of -c08 to non-correlated": 1 "rc-3095 of control a": 1 "stainings": 1 "calculate framingham risk score high risk 10-year risk ?20 moderately high risk 10-year risk 10 to 20 or lower to moderate risk 10-year risk ?10 make diagnosis of mets using the diagnostic criteria.": 1 "late phase down-regulated mechanistic genes": 1 "number of patients with p53 mutation ": 1 "evidence in cfl models": 1 "cumulative incidence of full progression at 10 years": 1 "no of unique sequences f": 1 "contig/est number": 1 "sense 5? to 3?": 1 "cntn1": 1 "frequency of telomerase activity ": 1 "mv-c": 1 "length nm a": 1 "positive feedback": 1 "p-value of true predictions": 1 "c-myc high": 1 "rc-3940-ii of control a": 1 "prediction of clinical outcome by crmp": 1 "number of cells screened per selection": 1 "pat no.": 1 "number and distribution of samples": 1 "peptides in dlkloxcrepos": 1 "hyper-methylated a": 1 "4.19 3.73 987": 1 "node color code in figures": 1 "no of ligands": 1 "kyphosis a": 1 "supported by": 1 "contributing proteins moving into or out of drmds upon exposure to 16 m": 1 "case 9": 1 "no observed": 1 "incident case recruited <2 years after diagnosis": 1 "different categories": 1 "summary table": 1 "case 4": 1 "thyroid lesions": 1 "case 6": 1 "extent of disease or surgical result": 1 "case 7": 1 "nominalization": 1 "case 1": 1 "case 2": 1 "jan 2012": 1 "association of increased egfr gcn with response and survival parameters": 1 "2.40 2.35 626": 1 "major response in a patient with cervical cancer being treated with the hdac inhibitor valproic acid followed by a single dose of epirubicin within a phase i trial": 1 "disorder/model": 1 "signaling a": 1 "library": 1 "no contigs": 1 "pakt change": 1 "tumour": 1 "binding of factor vii/viia to tf blocks access of some anti-tf antibodies": 1 "- avoid sun exposure between 1000 a.m and 400 p.m.": 1 "medium protection": 1 "40.5": 1 "effective “treatment of recurrent gbm includes combination strategies with agents that target complementary or redundant pathways” 3 .": 1 "number of yeast transformants": 1 "fold change from real-time pcr": 1 "erk1/2": 1 "mechanism of action": 1 "total no of endoscopies": 1 "sensitivity and specificity": 1 "p-value of difference of c08 to non-correlated": 1 "case n ": 1 "il6r to ras?": 1 "sirt1 <5": 1 "no of differentially expressed operons by glutamate": 1 "ube2c": 1 "stage of development": 1 "no with high-level expression for cdk5": 1 "mrna data": 1 "at least one gene methylated": 1 "interleukin 4 receptor": 1 "lo": 1 "encodes a member of the beta chemokine receptor family which is predicted to be a seven transmembrane protein similar to g protein-coupled receptors.": 1 "annotations": 1 "diffuse": 1 "number of clones after sequencing": 1 "sirt1 mode-rate": 1 "mortality rate ": 1 "number established new true predictions‡": 1 "mutations": 1 "bi-fan": 1 "number of patients participating in the study": 1 "predicted number of protein genes": 1 "- "helps to prevent sunburns".": 1 "sept.": 1 "activation status": 1 "mutational status of tumor": 1 "samplenumber": 1 "event frequency ": 1 "no of probe": 1 "high risk aspirin definitely beneficial high-intermediate risk 10–20 aspirin likely to be beneficial low-intermediate risk 6–10 “individual clinical judgment” depending on sex and risk of bleeding low risk <6 risk of haemorrhage outweighs the benefits.": 1 " in s": 1 "number of phospho and total proteins assayed in each cell line": 1 "immunogenicity": 1 "spn": 1 "p‡": 1 "list of annot terms": 1 "version/date": 1 "down-regulated": 1 "days post-injection": 1 "chemokine c-c motif ligand 8": 1 "no of litters born": 1 "no of ests": 1 "t-value in mda231": 1 "general function": 1 "number of patients with k-ras mutation ": 1 "10 sun protector labels should have the following warnings": 1 "tln1": 1 "clonorchis sinensis sequences n?=?50769": 1 "failed hypothesis": 1 "- "for children younger than 6 months of age ask a doctor' advice".": 1 "574": 1 "number percent of genes targeted that reconfirmed change in pakt with different sirna": 1 "apr 2011": 1 "fold ? by e47er": 1 "fold ? by id1": 1 "mutated": 1 "number percent of successful knockdowns in screen measured by rppa": 1 "breslow": 1 "grade 1a papules or pustules <5 or 1 area of erythema or edema <1?cm in size": 1 "specific genes regulated by dna methylation": 1 "pik3ca": 1 "recipient mice*": 1 "control": 1 "new clo as a of total endoscopies": 1 "100": 1 "without carg/carg-like* or insufficient data": 1 "pd": 1 "interleukin 18 interferon-gamma-inducing factor": 1 "number of pentanucleotide repeats": 1 "elevated values apart from crc": 1 "106": 1 "nrxn3": 1 "protein required for necroptosis": 1 "contributing proteins moving into or out of drmds upon exposure to vtrm1": 1 " in g2-m": 1 "known response in the macrophage": 1 "presence of antibody microaggregates causing false positive signals in flow cytometry studies": 1 "presents hexavalently the pseudo-tripeptide lys? ch2n-pro-arg coupled to a similar template as in hb-19 ac-lys-ala-lys-pro-gly-lys-ala-lys-pro-gly-lys-ala-lys-pro-gly-conh2.": 1 "msp and rt-pcr": 1 "emphasize the importance of fiber in the diet as fiber helps to bind excess purines in the gastrointestinal track redox stress reduction": 1 "maximum path length": 1 "nct number": 1 "?-fetoprotein a ng/ml": 1 "subjects with ad": 1 "p ds": 1 "10/15 67": 1 "c -values in an unperturbed tcr pathway upon minimization of concentrationsof the regulators for forming zap70lck and fyn": 1 "signaling molecules": 1 "113": 1 "117": 1 "ratio skov3-ip/skov3": 1 "plzf": 1 "3gei": 1 "10 101": 1 "alcohol": 1 "pdb entriesa": 1 "all edges 237 nodes": 1 "number ofpatients with apc mutation ": 1 "percentage of total sequences": 1 "loss of function": 1 "3gee": 1 "control a": 1 "number of drivers": 1 "3geh": 1 "p- or s/t-neosis": 1 "123": 1 "number of aberrant crypt": 1 "mutant": 1 "inpp4a": 1 "sequence 5?–3? for dna or n to c for pna": 1 "gleason score": 1 "rs": 1 "no of patients n =52": 1 "experiment reference": 1 "dnmts and tets": 1 "number of lcc samples with mutations mutation frequency in 2 lcc samples": 1 "edn1": 1 "high expression no ": 1 "negative 0": 1 " rejected as germline": 1 "synaptosomal-associated protein 23 kda": 1 "specificity": 1 "vector": 1 "1.98 2.16 262": 1 "immuno-positivity number ": 1 "number of common dmrs": 1 "cell line": 1 "sigma factor": 1 "no of snps with p < 0.10 1": 1 "pyruvate to": 1 "aa change": 1 "187 37.6": 1 "148": 1 "- the best photoprotection for babies is to keep them in the shade wearing long sleeves pants broad-brimmed hat": 1 "149": 1 "the protein encoded by this gene catalyzes the formation of inositol 145-trisphosphate and diacylglycerol from phosphatidylinositol 45-bisphosphate this reaction uses calcium as a cofactor and plays an important role in the intracellular transduction of many extracellular signals": 1 "number in genbank*": 1 "no of pups born": 1 "cases with consistent mutation patterns second vs first tumor sample n ": 1 "percentage in all sequenced samples": 1 "a hypermethylation alterations": 1 "shc low": 1 "interleukin 18 receptor accessory protein": 1 "genes up-regulated by the first four lipid-lowering compounds and lipid-raising dexamethasone": 1 "cd47": 1 "main effects of polymorphismsa": 1 "type of tissue protection": 1 "cd44": 1 "change a": 1 "number of tumours ": 1 "proband families": 1 "37 7.4": 1 "or ": 1 "substrate": 1 "average length of sequences bp": 1 "the whole fingerprint&": 1 "ps2c tumor vs.normal": 1 "membrane occupied": 1 "number of genes expected number": 1 "number of patients who achieved sd > 6 months/pr by mutation status": 1 "encodes a protein structurally and functionally similar to snap25 and binds tightly to multiple syntaxins and synaptobrevins/vamps it is an essential component of the high affinity receptor for the general membrane fusion machinery and is an important regulator of transport vesicle docking and fusion.": 1 "daily moderate intensity activity of minimum 30 minutes for most days of the week recommend use of pedometer with goal >10000 steps/day.": 1 "number of ests": 1 "number of female samples with mutations mutation frequency in 36 female samples": 1 "subtype/condition": 1 "hsc 2359": 1 "total number of assayed points in sirna-rppa screen": 1 "no of patients n =98": 1 "il-1b": 1 "il-1a": 1 "0.42 0.36 730": 1 "destination": 1 "previous treatment": 1 "no snps": 1 "skin moderately sensitive to sunburn": 1 "in vivo": 1 "laminin-binding a": 1 "successful": 1 "useful for monitoring?": 1 "0.3??l": 1 "johnsenscore 38": 1 "genetic point of interest": 1 "amino-acid change": 1 "no accepted international standard": 1 "number of other studies in which affected gene identified": 1 "il-18": 1 "esc 2270": 1 "fgfr3 positive primary/ post hoc ": 1 "myofiber csa a": 1 "encodes a protein that is a member of the snare recognition molecules implicated in vesicular transport between secretory compartments functions in endoplasmic reticulum to golgi transport as part of a snare complex composed of gosr1 gosr2 and stx5 functions in early/recycling endosome to tgn transport as part of a snare complex composed of bet1l gosr1 and stx5.": 1 "number of genes involved in each pathway": 1 "number of rule connections": 1 "• fits provide an adjustable cut-off point": 1 "cluster 1": 1 "encodes a member of the g-protein-coupled receptor family this protein is a receptor for interleukin 8 il8 it binds to il8 with high affinity and transduces the signal through a g-protein activated second messenger system this receptor mediates neutrophil migration to sites of inflammation the angiogenic effects of il8 in intestinal microvascular endothelial cells are found to be mediated by this receptor.": 1 "il-13": 1 "il-15": 1 "higher concentrations of factor viia can activate fx in a tf-independent manner in the presence of phospholipids": 1 "number of germline variants": 1 "genome coverage": 1 "normalized value": 1 "qpcr": 1 "98 19.7": 1 "number of cycles grade 3–4": 1 "osm": 1 "bioie-onc": 1 "none": 1 "taxonomy and species": 1 "n in lepidic but lost in invasive": 1 "ost": 1 "1.34 1.33 522": 1 "number of records": 1 "improves blood circulation and oxygen delivery in ischemic tissue owing to no co and increase levels of intra-erythrocytic 2 3-dpg.": 1 "encodes for a cytokine family of secreted proteins involved in immunoregulatory and inflammatory processes chemotactic for resting t-lymphocytes and eosinophils has lower chemotactic activity for neutrophils but none for monocytes and activated lymphocytes is a strong suppressor of colony formation by a multipotential hematopoietic progenitor cell line.": 1 "literature derived mutations and overlap with knowledgebases": 1 "total no of tumours": 1 "mutation type": 1 "contributing proteins moving out of drmds upon exposure to 16m": 1 "mutation frequency": 1 "number of predictors median": 1 "writing of a study of renal cell carcinoma…“gene-expression signatures of good and poor prognosis were detected in different regions of the same tumor…. there was extensive intratumor heterogeneity” 301 ": 1 "case 17a": 1 "data generation and filtering": 1 "stable n?=?21": 1 "mis above the range": 1 "application in the diagnosis of crc": 1 "nf-nfpa": 1 "crocidolite": 1 "intermediate and late phase only down-regulated mechanistic genes": 1 "14.4": 1 "experimental details": 1 "p-value b": 1 "shc high": 1 "difference in r 0.05and 0.95 quantile": 1 "treatments n?=?6/group": 1 "number of ctc positive patients": 1 "crude*": 1 "microrna-126": 1 "feature": 1 "mi in myrbase number in cluster": 1 "number of proteins": 1 "correlation with overall survival and outcome": 1 "number of samples of light smokers samples with mutations mutation frequency in 6 samples": 1 "median top and range months": 1 "selp": 1 "glutamate molecules per vesicle": 1 "number of tetranucleotide repeats": 1 "transformation": 1 ">p-value": 1 "percentage positive": 1 "site": 1 "documents pmid": 1 "high bcl-2 family": 1 "golgi snap receptor complex member 2": 1 "number of probe sets": 1 "number of each type of lesion obtained from a single subject": 1 "clone n°": 1 "date": 1 "data": 1 "there is “bewildering…heterogeneity” over time following the same tumor and “within individual tumor biopsies that are spatially separated” 302 .": 1 "number of unchanged genes": 1 "number of cases with a single melanoma": 1 "dec 2002": 1 "bilateria 5223 gene set linked": 1 "uniquely mapping tag pairs": 1 "tag": 1 "obesity": 1 "observed m/z m+na+": 1 "pathology type": 1 "number percent of genes that re-confirmed knockdown with different sirna": 1 "nipah-c": 1 "vesicle-associated membrane protein 2": 1 "resource": 1 "no of mirna": 1 "number of sirna targets in primary screen": 1 "oligonucleotides": 1 "method of assessment in vivo/ in vitro animal models": 1 "overall response a ": 1 "low purine diet moderation": 1 "fold change cut-off a": 1 "disease-free survival": 1 "chemokine c-c motif ligand 241": 1 "type a – insertion/ deletion of a 'complete' fingerprint": 1 "drug/molecule": 1 "total no of genes": 1 "type ii neec": 1 "no of snps with p < 0.05 1": 1 "target cells": 1 "carbachol 1 mm": 1 "number of samples of non-smoker samples with mutations mutation frequency in 52 samples": 1 "• fits are quantitative or at least semi-quantitative": 1 "- wear children-sized sunglasses with at least 99 uv protection.": 1 "number of samples with mutation combination": 1 "23.0": 1 "binding and eluting with high yield": 1 "no of tumors with allele2 homozygous genotype": 1 "number of cases ": 1 "~682500": 1 "substitutions and their score in the blosum62 matrix": 1 "c-kit": 1 "blr1": 1 "genetic alteration": 1 "o.r.": 1 "edges": 1 "0.2 µm2 s?1 unless otherwise noted 34": 1 "groups": 1 "ncbi dbest accession no.": 1 "bcat1": 1 "factors": 1 "number of pathway down-regulated": 1 "a transformation-deficient tax mutant is leukemogenic in sheep": 1 "number of cases with fold change greater than 2": 1 "e-cad": 1 "- wear hats with a full 7.5 cm brim to cover the face ears and nape.": 1 
"s": 30 "g2/m": 21 "g1": 18 "g0/g1": 12 "g2": 8 "s ": 6 "g2/m ": 6 "sub-g1": 5 " ": 4 "g0/g1 ": 4 "treatment": 4 "sample": 4 "cell line": 3 "subg1": 3 "cells": 3 "time": 3 "mda-mb-231": 2 "cell cycle distribution": 2 "group": 2 "sub-g1 ": 2 "cell cycle ": 2 "g1 ": 2 "cell line/treatment": 2 "apoptosis ": 2 "kinetochore": 2 "clone": 2 "cln3": 1 "cln4": 1 "cell cycle distributions": 1 "cln2": 1 "phase ": 1 "pre-g1": 1 "dmso": 1 "far1 cdc24 interaction": 1 "type": 1 " of cells at various phases of cell cycle": 1 "senescence": 1 "far1 ste4 interaction": 1 "mcf-7": 1 "50": 1 "mi": 1 "24 h": 1 "cell groups": 1 "untreated": 1 "strain": 1 "cell cycle distribution ± se": 1 "gene": 1 " budded": 1 "200": 1 " s-phase": 1 "20": 1 "96 h": 1 "status": 1 "gvbd": 1 "reaction cycle": 1 " g1": 1 "mii": 1 " n": 1 " s": 1 "48 h": 1 " unbudded": 1 "mitotic catastrophe": 1 "cell cycle/group": 1 "array": 1 " g2/m": 1 "c-myc chip hela": 1 "cycle length": 1 "spindle": 1 "apoptosis ratio ": 1 "zol concentration": 1 "g1/s": 1 "characteristics": 1 "g2-m": 1 "purity ": 1 "groups": 1 "gv": 1 "100": 1 "species": 1 "percentage ": 1 "coc": 1 "72 h": 1 "qpcr": 1 "gemcitabine 10 ng/ml": 1 "res ?m": 1 
"reference": 19 "cancer": 16 "1": 15 "tumor": 15 "0": 13 "elisa": 13 "marker": 13 "3": 12 "n": 11 "2": 10 "ptc": 10 "kras": 10 "breast": 10 "p-value": 9 "braf": 9 "ftc": 9 "n ": 9 "references": 8 "1.67": 8 "pten": 8 "grade": 8 "tumor type": 8 "cdkn2a": 8 "stage": 8 "bph": 8 "5": 7 "gene": 7 "adenoma": 7 "total": 7 " ": 6 "nras": 6 "pca": 6 "age": 6 "cancer type": 6 "atc": 6 "metastasis": 6 "tcga": 6 "p value": 6 "sex": 6 "sample": 6 "lung": 6 "pik3ca": 6 "tp53": 6 "benign": 6 "cell line": 6 "normal": 6 "tumour type": 6 "mtc": 6 "4": 5 "6": 5 "egfr": 5 "pancreatic": 5 "grade 1": 5 "grade 3": 5 "group": 5 "increased survival": 5 "treatment": 5 "#1": 5 "#2": 5 "titis": 5 "breast cancer": 5 "primary tumor": 5 "p -value": 5 "1+": 5 "2+": 5 "3+": 5 "genotype": 5 "characteristics": 5 "grade 3/4 ": 4 "cml": 4 "follicular": 4 "aml": 4 "ref.": 4 "colon cancer": 4 "3.33": 4 "histology": 4 "apc": 4 "genes": 4 "features": 4 "grade 2": 4 "grade 4": 4 "description": 4 "prostate": 4 "case": 4 "invasive": 4 "primary": 4 "study": 4 "tumour": 4 "no": 4 "subtype": 4 "lepidic": 4 "grade 4 ": 4 "expression": 4 "grade 3 ": 4 "microarray": 4 "geo": 4 "nsclc": 4 "biomarker": 4 "parameter": 4 "year": 3 "tumor stage": 3 "p": 3 "t": 3 "mutant type": 3 "rassf1a": 3 "cin": 3 "mutation": 3 "ned": 3 "kidney": 3 "patient population": 3 "pancreatic cancer": 3 "alcl": 3 "melanoma": 3 "5.00": 3 "rtk": 3 "tumor grade": 3 "hcc": 3 "metastases": 3 "age/gender": 3 "methods": 3 "all grades ": 3 "ovarian": 3 "thyroid cancer": 3 "stage iv": 3 "malignancy": 3 "metastatic agasaca n ": 3 "tumor location": 3 "smad4": 3 "adenocarcinoma": 3 "primary agasaca n ": 3 "escc": 3 "cytogenetics": 3 "prognosis": 3 "glioma": 3 "hras": 3 "wb": 3 "0/6 0": 3 "samples": 3 "gender": 3 "6.67": 3 "her2": 3 "8.33": 3 "sclc": 3 "": 2 "?": 2 "dysplasia": 2 "nras61": 2 "+": 2 "-": 2 "oncocytic adenomas": 2 "mean expression 1": 2 "7": 2 "9": 2 "braf mut": 2 "mirnas biomarkers": 2 "rcc": 2 "5?h": 2 "p *": 2 "exon 9 mutation": 2 "ptcl–nos": 2 "notes": 2 "controls": 2 "4/6 67": 2 "ref": 2 "metastatic colorectal cancer": 2 "phase i": 2 "ck19": 2 " n =28": 2 "4-5": 2 "primary tumors": 2 "nvp-bez235": 2 "follicular adenomas": 2 "hypermethylation": 2 "number": 2 "er+": 2 "stage i": 2 "authors": 2 "exon 20 mutation": 2 "2-3": 2 "ca19-9": 2 "pancreatic ductal adenocarcinoma": 2 "colorectal": 2 "intratumoural": 2 "whole sections": 2 "? 4": 2 "0-1": 2 "detection method": 2 "complex type": 2 "235": 2 "adenocarcinomas": 2 "stage iii": 2 "2/6 33": 2 "all cases": 2 "iris-positive": 2 "tumor size cm": 2 "pik3ca wild-type crc": 2 "source": 2 "no.": 2 "mouse": 2 "invasive local growth lymph-node and hematogenous metastases": 2 "pf-02341066 c-met alk inhibitor": 2 "3/6 50": 2 "braf wild-type ": 2 "438 85.0": 2 "parameters": 2 "classes": 2 "grade iii": 2 "grade i": 2 "target": 2 "colon": 2 "who grade": 2 "incidence": 2 "malignant": 2 "any ": 2 "effect": 2 "case number": 2 "pathology": 2 "beta-catenin score": 2 "patient": 2 "therapy": 2 "tnbc": 2 "tumor site": 2 "ac": 2 "ovarian cancer": 2 "dfs": 2 "hr 95ci": 2 "follicular carcinomas": 2 "subgroup": 2 "wbcs": 2 "characteristic": 2 "stage ii": 2 "expression in thyroid cancer": 2 "pathological stage": 2 "cp": 2 "feature n a": 2 "age years": 2 "170 32.3": 2 "aml subtype": 2 "mgmt": 2 "198 37.6": 2 "77 15.0": 2 "pancreas": 2 "inflammation": 2 "breast tumors with pik3ca mutations": 2 "leukemia": 2 "mcc": 2 "enets": 2 "tumor histology": 2 "diagnosis": 2 "mgmt methylation": 2 "pik3ca mutated crc": 2 "uicc": 2 "os": 2 "prostate cancer": 2 "pc": 2 "2/34 6": 2 "? 3": 2 "braf 599": 2 "10": 2 "11": 2 "14": 2 "relapse": 2 "120": 2 "iris-negative": 2 "breast tumors with wild-type pik3ca": 2 "association": 2 "35": 2 "p value *": 2 "baseline and tumour characteristics": 2 "non-transgenic": 2 "mlh1": 2 "50": 2 "decreased survival": 2 "10.00": 2 "gbm": 2 "location": 2 "84": 2 "none": 2 "subtypes": 2 "papillary carcinomas": 2 "msi screening status": 2 "recurrent tumors": 2 "cor mcc": 2 "stk11": 2 "astrocytoma": 2 "24?h": 2 "grade ii": 2 "159 30.2": 2 "msi": 2 "ca ": 2 "mss": 2 "drug": 2 "thyroid carcinoma n ": 2 "transgenic": 2 "msi status": 2 "muc1": 2 "response": 2 "variable": 2 "braf mutation ": 2 "vhl": 2 "category": 2 "uicc/who 2004": 1 "tumor-associated antigens": 1 "rb1": 1 "functions": 1 "sfrp1": 1 "her -": 1 "24 h oc": 1 "21304": 1 "concordant expression with 812 primary breast tumors": 1 "raf": 1 "pdac n?=?338": 1 "mcpyv": 1 "melanoma kaposi's sarcoma": 1 "diagnostic": 1 "metastatic neuroendocrine tumors": 1 "ran": 1 "treatment discontinuation ": 1 "non-cancerous": 1 "benign tumor": 1 "histologic grade ‡": 1 "rat": 1 "ny-eso-1 ssx-24 xage-1b amacr p90 ledgf + psa": 1 "12 weeks": 1 "gene name": 1 "mlh1 methylation": 1 "kras-aslnaa": 1 "target genes in lung cancer": 1 "detection techniques": 1 "sensitivity in breast cancer": 1 "8": 1 "braf mutation as prognostic factor": 1 "osteochondroma": 1 "synchronous metastasis group": 1 "0 0": 1 "lung metastasis": 1 "hpv negative tscc": 1 "kras-amp": 1 "patients tm/lm": 1 "clinical variable": 1 "90–95": 1 "primary tumor t": 1 "secondary gbms": 1 "myeloma": 1 "gleason minor": 1 "metastases her2-scores n=72": 1 "cytology a": 1 "colon head and neck": 1 "leukocytes": 1 "p -value cscc": 1 "22867": 1 "a": 1 "p -value 10 -x": 1 "tn_stromal": 1 "peritoneal seeding ": 1 "g": 1 "proximal colon": 1 "gep signature": 1 "lung pancreatic": 1 "nf2?/?": 1 "prostate1": 1 "prostate3": 1 "30/96 31": 1 "pathway": 1 "5/35 14": 1 "egfr-amp": 1 "14/27 52": 1 "tumor downregulated mirnas": 1 "iss": 1 "ca125": 1 "nct00585195": 1 "csc marker": 1 "64.9±13.3": 1 " malformed nb": 1 "tp53 ? 50–80 ? ctnnb1 ? 5–60 ? ras 20–40? braf 20–40? pik3ca 10–20? pten 5–15 akt1 ? 5–10": 1 "4/6 66": 1 "candidate rcc biomarkers – name": 1 "passage 2": 1 "igfbp1": 1 "astrocytoma grade iii": 1 "invasive cancer": 1 "kras c12/13": 1 "histotype": 1 "tumours": 1 "others": 1 "astrocytomas": 1 "neec": 1 "passage 1": 1 "75/79": 1 "seromap": 1 "adc iii": 1 "ards": 1 "case no.": 1 "alk + lung cancer": 1 "pancreatic carcinoma": 1 "materials": 1 "mirna": 1 "oncogene amplifications": 1 "pik3ca wild-type": 1 "cacna1g": 1 "primary site": 1 " tumour": 1 "patient demographics": 1 "thyroid tumor type": 1 "malignant mn525 ?m": 1 "lung metastases": 1 "msh6": 1 "c-myc-amp": 1 "65 68": 1 "histological subgroup": 1 "pcl": 1 "microrna": 1 "p-value mann-whitney": 1 "molecular": 1 "hereditary breast and ovarian cancer syndrome": 1 "dna-methylation": 1 "lung metastasis ": 1 "ovarian carcinoma subtypes": 1 "mpr? reactivity": 1 "colllagen iv": 1 "amino acid change": 1 "p-akt": 1 "48 h oc": 1 "brca 2": 1 "significance": 1 "99/42": 1 "prognostic mirnas": 1 "follicular carcinoma **": 1 "lymph node": 1 " n =15": 1 "in vitro": 1 "kras gene codon 13none/either/bothp-value": 1 "familial forms ret > 95 sporadic ret 40–50 ras 25": 1 "mng adjacent to ptc": 1 "ctc a grade 1–2": 1 "osteosarcoma": 1 "prostate cancer vs normal prostate": 1 "brain metastases ": 1 "braf mt": 1 "ongoing combination": 1 "tumor upregulated mirnas": 1 "sensitivity/specificity": 1 "primary gbms": 1 "biopsy gleason grade": 1 "+ve/+ve": 1 "liver metastases ": 1 "tma": 1 "her2 fish *": 1 "approach": 1 "mitotic activity": 1 "nad": 1 "lung cancer": 1 "pazopanib glaxosmithkline": 1 "tnm staging": 1 "core pathway mutation/dysregulation": 1 "msi statusbc": 1 "sample counts": 1 "64.6±12.3": 1 "mann–whitney u-test": 1 "anaplastic carcinoma **": 1 "imd-0354 + 48 h oc": 1 "melanosom features": 1 "sample size": 1 "tnm stage": 1 "er-": 1 "pi3kca amp adc": 1 "frequency aml ": 1 "silica-induced lung fibrosis": 1 "stage c": 1 "stage b": 1 "braf v600emutation": 1 "cimp panel 2": 1 "cimp panel 1": 1 "20/33 61": 1 "trop2 expression": 1 "kiaa1549braf fusion described": 1 "nras codon12/13": 1 "stage name": 1 "performed in ovarian cancer?": 1 "?lymphoepithelial cysts": 1 "primary tumor location": 1 "tnm": 1 "normal adjacent thyroid tissue **": 1 "nd*": 1 "70.2±24": 1 "84.1 /72.6": 1 "nbm": 1 "vmientin": 1 "additional comments": 1 "grade 3 number": 1 "lenalidomide celgene": 1 "her2 2+": 1 "panel of 29 antigens": 1 "qpcr gpx3": 1 "chloroquine": 1 "kras all": 1 "syndrome": 1 "rcc 27 ": 1 "sympathetic pgl": 1 "types of ovarian cancer": 1 "ras 40–50 pax8/ppar ? 30–35 pik3ca < 10 pten < 10": 1 "head and neck": 1 "ptcl": 1 "pha-767491 ic50 ?m": 1 "stage iiib": 1 "spec.": 1 "stage iiia": 1 " n =6": 1 "p12 days": 1 "endostatin simcere†": 1 "kras2": 1 " n?=?26": 1 "kinase substrate id": 1 "her2 1+": 1 "grade and stage distribution": 1 "12/92 13": 1 "p53 ny-eso-1 cage hu-d sox2 annexin i gbu4-5": 1 "× 10 6 ??g ?1 ml ?1": 1 "cns": 1 "stage 0": 1 "adc i": 1 "tumor incidence ": 1 "ln metastases": 1 "sex-age": 1 "ndm": 1 "stage 4": 1 "cre driver line/viral driver construct": 1 "nf2": 1 "braf wild-type meljd": 1 "ic50 mk2206 alone": 1 "ras 20–40 tp53 ? 20–30 ? braf 10–20? ctnnb1 ? 5–10 ? pik3ca 5–10? akt1 ? 5–10": 1 "nf1 marker": 1 "31 32": 1 "findings": 1 "mcfher2": 1 "expressed marker": 1 "disease stage": 1 "benign mn328 ?m": 1 "wt/wt": 1 "5.6 ±2.1": 1 "prgrammable protein clones n = 28": 1 "carcinogenesis": 1 "4 11": 1 "abcc3": 1 "rph3al": 1 "function": 1 "stage †": 1 "pik3ca exon 9/20": 1 "motif": 1 "serum p14arf": 1 "dukes": 1 "5/6 83": 1 "all": 1 "dbait": 1 "alk": 1 "expression subgroups": 1 "cervical cancer n =140": 1 "phase iii": 1 "follicular carcinoma": 1 "pyrosequencing": 1 "histologic grade mean ± se ": 1 "29.3±12.8": 1 "histological similarities": 1 "er 3": 1 "clinical": 1 "flt3": 1 "sunitinib n = 375": 1 "hrog36": 1 "kidney gist pancreatic/net*": 1 "lesion": 1 "who classification": 1 "second series": 1 "?mucinous cystic neoplasm": 1 "tnf-?": 1 "rhogef211-3b": 1 "?serous cystadenoma": 1 "70/91 77": 1 "platform for ovarian cancer": 1 "alk + or egfr + lung ca": 1 "patient no.": 1 "?/71.4": 1 "aml n?=?87": 1 "msp1": 1 "serrated adenomas": 1 "design": 1 "comprehensive stage": 1 "0-5": 1 "ku86": 1 "msp2": 1 "fvptc": 1 "no n?=?45": 1 "point mutations": 1 "comments": 1 "bt474": 1 "serum rassf1a": 1 "kras braf nras pik3ca": 1 "spot#": 1 "fhit genenone/either/bothp-value": 1 "simple mng": 1 "pnet 41 ": 1 "non tnbc": 1 "phage display clones n = 5": 1 "her2+ n?=?32": 1 "cancer site": 1 "3–5": 1 "phase ii": 1 "associated gene mutations or pathway defects *": 1 "emt-related molecules/genes": 1 "proliferation/invasion": 1 "hrog17": 1 "36/86 42": 1 "msmart": 1 "first author": 1 "hpv positive tscc": 1 "kidney pancreatic/net* brain/sega**": 1 "oligodendroglioma": 1 "pmf": 1 "lung cancer aqp +/n?=?69/408": 1 "12 34": 1 "p-egfr expression": 1 "n?=?26": 1 "n?=?24": 1 "ipi-504 hsp 90 inhibitor": 1 "26.3±21.3": 1 "hrog05": 1 " total": 1 "hrog02": 1 "hrog06": 1 "non-recurrent": 1 "apl": 1 "potential clinical value biomarker performance": 1 "6/35 17": 1 "ifn-?": 1 "liver metastasis": 1 "direction of expression in brain metastases": 1 "discordance": 1 "tumor weight g": 1 "n?=?34": 1 "grade 3 and 4 ": 1 "primary treatment": 1 "methylation ": 1 "243": 1 "advanced stage": 1 "melanoma type": 1 "all patients with metastasis": 1 " min - max": 1 "mycn**": 1 "mutation cell lines": 1 "?ve/+ve": 1 "ctnnb1": 1 "c/ebp? expression": 1 "all patients n": 1 "# of carcinomas": 1 "ctc grade": 1 "cetuximab bristol-myers squibb/imclone": 1 "advanced ovarian tumors": 1 "tumors with alk": 1 "pi3kca mut scc": 1 "tumorigenicity": 1 "all patients": 1 "anaplastic": 1 "squamous cell": 1 "verification/validation": 1 "endothelial": 1 "braf wt": 1 "bevacizumab genentech/roche": 1 "primary use": 1 "attribute": 1 "genomic aberration": 1 "hpv positive": 1 "estrogen receptor-positive status n ": 1 "tumour size mm": 1 "rcc microarray set": 1 "95–98": 1 "matched breast primary-brain metastasis pairs": 1 "m/n ": 1 "tcga tumor samples": 1 "clinicopathological parameters": 1 "?cystic degeneration of ductal adenocarcinoma": 1 " 154 ": 1 "lymph node positiveinvasive ductal carcinoma": 1 "map2k4": 1 "refs": 1 "decreased recurrence": 1 "all wild-type": 1 "authors year of publication": 1 "squamous cell carcinoma/papilloma stomach": 1 "p-erk1/2": 1 "tumor id": 1 "margins": 1 "specific mutation": 1 "normal brain": 1 "4/92 4": 1 "small-cell lung cancer": 1 "cell lines": 1 "epcam": 1 "others*": 1 "crpc": 1 "hl60": 1 "pi3kca": 1 "specificity in healthy controls": 1 "her-2": 1 "non-serrated adenomas": 1 "grade 0": 1 "recurrent and primary": 1 "anaplastic astrocytoma only": 1 "81/78": 1 "nct01449461": 1 "results": 1 "low-grade astrocytomas × high-grade astrocytomas p value": 1 "braf -sseq": 1 "probeset name": 1 "hmlh1 expression": 1 "bone metastasis": 1 "breast cancer 46 ": 1 "clinicopathologic parameters n?=?48": 1 "patients tn": 1 "cervical cancer": 1 "auc": 1 "t-all": 1 "targeted genes": 1 "metastatic melanoma": 1 "idh1 b": 1 "overall": 1 "r status": 1 "kras mutation": 1 "notch1": 1 "gastric": 1 "astler-coller": 1 "fumonths": 1 " 100?mg?ml ?1 ": 1 "poorly differentiated carcinoma": 1 "daxx/atrx": 1 "braf wild-type n": 1 "arid1a mutations by sequencing methods": 1 "other malignancies n ": 1 "cytogenetic": 1 "mice": 1 "histological subtype of ovarian cancer": 1 "ovarian cancer/pancreatic cancer": 1 "stage after meshcheriakov": 1 "rfs years±s.d.": 1 "advanced renal tumors": 1 "4.5±2.4": 1 "pr+ ": 1 "disease": 1 "vhl status": 1 "expression in endometrial cancer": 1 "nf2+/+": 1 "tumor initiating cell": 1 "13/33 39": 1 "prognostic tissue biomarkers": 1 "grade b": 1 "nr.": 1 " n?=?63": 1 "prognostic/predictive biomarkers": 1 "er+ ": 1 "specificity in benign breast diseases": 1 "hematogenous metastasis typical to bones and lungs": 1 "hpv ish": 1 "pretreated nsclc": 1 "age mos.": 1 "expression ": 1 "mrna expression": 1 "kras pyrosequencing": 1 "d1s234": 1 "preinvasive lesions": 1 "ct stage": 1 "ewing sarcoma": 1 "er?": 1 "15/31 48": 1 "tcga normal samples": 1 "criteria": 1 "potential marker": 1 "other diseases": 1 "p14arf": 1 "everolimus?+?bsc a n ?=?274": 1 "aoa n?=?26": 1 "akt2-amp": 1 "primary tumour vs tumour invasion": 1 " 171 ": 1 "p53": 1 "drugs approved and investigational": 1 "nsclc cell line": 1 "glioblastoma multiforme and anaplastic astrocytoma": 1 "pik3ca amplification": 1 "gal3 pak2 phb2 rack1 ruvbl1": 1 "hyperplasia": 1 "cytokines": 1 "merged breast cancer dataset n?=?689": 1 "furhman grade": 1 "gene symbol": 1 "ny-eso-1 xage-1 adam29 magec1": 1 "d1s488": 1 "82.7/?": 1 "d1s247": 1 "stage i/ii": 1 "p16ink4a": 1 "deregulated mirna": 1 " 172 ": 1 "76/78": 1 "fbl": 1 "?solid pseudopapillary neoplasm": 1 "liver metastases vs tumour invasion": 1 "pnets chinese": 1 "metastatic pancreatic carcinoma": 1 "ap26113 alk/egfr inhibitor": 1 "lymphocyte antigen 6 complex locus k ly6k": 1 "first series": 1 "10-year survival ": 1 "stage 9-10": 1 "loe": 1 "primary tumors her2-scores n=72": 1 "loh": 1 "?/96": 1 "pi3kca amplification": 1 "dcis with 5 year recurrence": 1 "braf v600e described": 1 "ic50 mk2206+tusc2": 1 "cdc25b phosphatase": 1 "vandetanib astrazeneca": 1 "mpnst marker": 1 "active acromegalyat diagnosis ofthyroid cancer": 1 "advanced colorectal cancer": 1 "cd 117": 1 "tumor subtype": 1 "tumor p15ink4b": 1 "primary sample": 1 "cervix": 1 "carcinoma antigens*": 1 "egfr assay method": 1 "73.9/72": 1 "gastric cancer": 1 "all non-serrated crcs": 1 "cancer genes": 1 "?cystic neuroendocrine tumor": 1 "mtc02 expression": 1 "proximal colon crc n = 9": 1 "everolimus monotherapy n ?=?204": 1 "levels": 1 "normal mucosa": 1 "braf v600e patient-3-post": 1 "phage display clones n = 45": 1 "ki-67": 1 "20/96 21": 1 "myofibroblast": 1 "11.67": 1 "d1s430": 1 "aml b": 1 "aml c": 1 "cycles": 1 "14 15": 1 "aml a": 1 "os years±s.d.": 1 "aml d": 1 "aml e": 1 "adc ii": 1 "24.1±16.6": 1 "?cystic acinar cell carcinoma": 1 "17648": 1 "ar positivity positive/tested *": 1 "adc iv": 1 "serum mgmt": 1 "sec61?": 1 "interferon alfa roche/schering": 1 "lung metastases ": 1 "stage/site": 1 "sb386023-b + 24 h oc": 1 "mirnas as biomarkers": 1 "prostate cancer n?=?87": 1 "clinical development in different tumour types": 1 "egfr expression": 1 "tumor suppressive mirnas": 1 "follicular adenoma **": 1 "26126": 1 "5.3±2.4": 1 "ffl": 1 "p16 days": 1 "zipe br": 1 "ki67 grade 0 ": 1 "91.7-93.3/90-92.7": 1 "lymph-node and hematogenous metastases": 1 "colitis-associated cancer references": 1 "squamous cell papilloma skin": 1 "who": 1 "d1s207": 1 "chronic pancreatitis": 1 "methylated gene": 1 "percent": 1 "ki67 grade 1 ": 1 "prognostic significance references": 1 "age/sex/history": 1 "ao n?=?30": 1 "grp78 afp": 1 "diet": 1 "treatment arm": 1 "number of crc": 1 "serum p15ink4b": 1 "tumor multiplicity mean ± se": 1 "benign ben-men-1 ?m": 1 "studies/methods": 1 "91/41": 1 "ki67 grade 2 ": 1 "nasopharyngeal carcinoma patients n=178 ": 1 "her2? ": 1 "23.33": 1 "patients n": 1 "nonrecurrent dcis": 1 "d1s226": 1 "immunohistochemistry/mutational analysis": 1 "detection biomarkers": 1 "inductor": 1 "p-mapk": 1 "basal triple neg ": 1 "a1at": 1 "6 100": 1 "peripheral chondrosarcoma": 1 "early detection biomarkers ovarian cancer sensitivity and specificity": 1 "scc": 1 "89.7/58.7": 1 "b-lymphoid leukemia/lymphoma": 1 "characteristics/mechanisms": 1 "nct01228435": 1 "xtc*": 1 "c cell": 1 "58/94 62": 1 "mucinous crc": 1 "hpv consensus primers": 1 "v600e braf": 1 "average fusion positive": 1 "3p abnormalities": 1 "malignancy ": 1 "g1 stage ": 1 "population": 1 "trial/acronym": 1 "non-mucinous": 1 "high-throughput method used": 1 "pancreatitis": 1 "malignant lymphoma hematopoietic system": 1 "bc": 1 "average": 1 "mda453": 1 "other raf fusion described": 1 " n?=?9": 1 "cancer subtypes": 1 " n?=?6": 1 "distal colon crc n = 21": 1 "association with mcc prognosis": 1 "type of biomarker": 1 "3.4±2.3": 1 "cdkn2b": 1 "tn/bl n?=?72": 1 "prognostic serum biomarkers": 1 "frequency mds/ mpn ": 1 "stk4/mst1 sulf1 nhsl1 srebf2 grn gtf2": 1 "1 17": 1 "loh a": 1 " ?g?ml ?1 ": 1 "intensity score": 1 "predictive": 1 "cin 2/3": 1 "metastatic ptc": 1 "6.3±1.2": 1 "tumor size mm±s.d.": 1 "nci ctcae 3.0 category/term": 1 "non astrocytoma": 1 "braf v600e mm200": 1 "aa n?=?40": 1 "bcr/tcr-based tumor type": 1 "brca": 1 "histologic subtype": 1 "anaplastic undifferentiated carcinoma": 1 "pccs ": 1 "metastases egfr-scores": 1 "gbm n?=?171": 1 "mucinous carcinoma": 1 "braf status": 1 "escc n =161": 1 "methylated and msi": 1 "p -value hpv+ hnscc": 1 "kras mutationc": 1 "s stage ": 1 "primary nb": 1 "dx": 1 "fab classification": 1 "stage iii/iv": 1 "78.7/80.6": 1 "46/86 54": 1 "tumor type a": 1 "growth factors": 1 "cancerous": 1 "hpv innolipa": 1 "gleason primary": 1 "er": 1 "serrated adenomas adjacent to cancer": 1 "et": 1 "recurrent/metastatic soft tissue sarcoma": 1 "egfr mutation status": 1 "kras c59/61": 1 "metastatic breast cancer": 1 "age †": 1 "other types": 1 "fa": 1 "fold change hpv+ hnscc": 1 "esophageal cancer": 1 "bph n?=?24": 1 "ruxolitinib n = 146": 1 "tumor number": 1 "pazopanib n = 290": 1 "stage of ovarian cancer": 1 "list of oncogenic and tumor suppressive mirnas deregulated in hepatocellular carcinoma": 1 "age *": 1 "hsp60 p53 her2-fc ny-eso-1 hsp70": 1 "brca1": 1 "advanced nsclc": 1 "tumor biomarker": 1 "rna-target": 1 "lung/liver metastasis": 1 "diameter mm": 1 "rassf1a genenone/either/bothp-value": 1 "thymic tumours ": 1 "serous": 1 "rash": 1 "pgr 3": 1 "management": 1 "u0126 + 48 h oc": 1 "samples ": 1 "fresh": 1 "postop imatinib/sunitinib treatment": 1 "subset": 1 "prevalence ": 1 "typical route of spread": 1 "n total": 1 "lymph node negativeinvasive ductal carcinoma": 1 "enchondroma": 1 "primary symptom": 1 "bilharziasis d": 1 "60/59": 1 "model": 1 "hras1": 1 "endometrioid": 1 "n?=?32": 1 "pik3ca mutation": 1 "everolimus?+?exemestane n ?=?482": 1 "pstage": 1 "men1": 1 "t stage": 1 "gefitinib": 1 "ssc vs adc": 1 "advanced head and neck cancer": 1 "glioblastoma": 1 "lung scc**": 1 "primary screen df": 1 "alteration": 1 "oligodendrogliomas": 1 "33/86 38": 1 "luminal b ": 1 "colon segment": 1 "analysis method": 1 "pca/study": 1 "skin": 1 "18.33": 1 "medullary carcinoma": 1 "targets": 1 "average braf v600e positive": 1 "sb386023-b + 48 h oc": 1 "smm": 1 "brafv 600e": 1 "bibliography": 1 "invasive carcinoma ": 1 "xenograft": 1 "clear cell carcinoma": 1 "u0126 + 24 h oc": 1 "low stage stage 1-2": 1 "gm-csf": 1 "serum biomarkers": 1 "alk + lung cancer second line": 1 "oc rare subtype": 1 "mgmt genenone/either/bothp-value": 1 "tnm*": 1 "nct00932893": 1 "p53 ny-eso-1 cage gbu4-5 sox2 hud mage a4": 1 "erlotinib genentech/roche/osi": 1 "cdk4": 1 "alcl alk+": 1 "72–100": 1 "26/32 81": 1 "yes n?=?15": 1 "malignant kt21-mg1 ?m": 1 "agents": 1 "prevalent age group": 1 "6.1±1.6": 1 "v600d braf": 1 "first author ref.": 1 "type of lesion": 1 "early stage": 1 "pancreatic adenocarcinoma": 1 "ln": 1 "endometroid carcinoma": 1 "loss of arid1a protein expression": 1 "colon lung breast brain kidney": 1 "use": 1 "er? ": 1 "braf -aslnaa": 1 "kras-sseq": 1 "mgus": 1 "alk mutation frequency": 1 "kidney liver": 1 "local lymph-node metastasis": 1 "gleason tertiary": 1 "bi-fan": 1 "1-2": 1 "sor": 1 "d1s2638": 1 "bleomycin-induced lung fibrosis": 1 "84/66": 1 "liver metastases": 1 "molecular alterations": 1 "coad": 1 "multiple myeloma": 1 "normal lung tissues": 1 "frequency mds ": 1 "pp242 ?m": 1 "luminal a ": 1 "biomarkers": 1 "author": 1 "73.33": 1 "hmsh2 expression": 1 "n status": 1 "pi3kca amp scc": 1 "10–15": 1 "g2/m stage ": 1 "ng": 1 "smoking history": 1 "fragile site gene cna": 1 "mds": 1 "characteristics/treatment options": 1 "candidate rcc biomarkers – type": 1 "bone metastasis ": 1 "mitotic count 10 hpf": 1 "tumour histology": 1 "stage 3 or 4 tumors n ": 1 "published/author": 1 "28.33": 1 "gleason secondary": 1 "kras gene codon 12none/either/bothp-value": 1 "mgmt expression": 1 "fluorescence a": 1 "prior rx": 1 "bilateral/multifocal neoplasia": 1 "colorectal cancer genes": 1 "gleason grade prostatectomy": 1 "tumor p14arf": 1 "16.67": 1 "temsirolimus wyeth": 1 "papillary carcinoma **": 1 "tumor suppressor deletions": 1 "scenario n": 1 "pr? ": 1 "tissue biomarkers": 1 "ki-67 index ": 1 "control": 1 "?95/13.2": 1 "phase i/ii": 1 "crabp1": 1 "87/60.9": 1 "sens.": 1 "regulation": 1 "84/79": 1 "clinicopathological characteristics": 1 "kras mutated/wild type b": 1 "lkb1": 1 "tumor cells/non neoplastic cells c": 1 "tumor cells/non neoplastic cells d": 1 "myleodysplastic syndrome multiple myeloma": 1 "pr": 1 "clinicopathological data n =150": 1 "pv": 1 "nkt stage": 1 "hpv positivity": 1 "prevalence of thyroid carcinomas": 1 "everolimus novartis": 1 "bat n = 73": 1 "114": 1 "mutational status": 1 "molecular alteration": 1 "copy number status": 1 "gleason sum": 1 "pt stage": 1 "genomic location": 1 "90/60.7": 1 "12": 1 "13": 1 "tissues": 1 "15": 1 "tgf-?": 1 "reference in pdac": 1 "17": 1 "23 66": 1 "18": 1 "glioblastoma multiforme only": 1 "aberrant pathways": 1 "mucinous": 1 "lung ac**": 1 "cml n?=?140": 1 "tumor rassf1a": 1 "hpv negative": 1 "adrenal cancer": 1 "uicc stage": 1 "number of cases": 1 "bmi-1": 1 "supplementary references": 1 "bloody ascites ": 1 "il-6": 1 "t2": 1 "t3": 1 "common mutations and prevalence ": 1 "grade 4 number": 1 "23": 1 "25": 1 "gleason major": 1 "mia": 1 "28": 1 "29": 1 "mmp-7": 1 "ajcc/tnm": 1 "borderline mucinous": 1 "131": 1 "g-csf": 1 "134": 1 "high stage stage 3-4": 1 "relapse event ": 1 "specificity": 1 "anaplastic large cell lymphoma": 1 "actinic keratosis basal cell carcinoma": 1 "sq": 1 "braf v600e n": 1 "34": 1 "variables": 1 "selumetinib n =34": 1 "undifferentiated": 1 "molecules/method": 1 "742 cancer genes": 1 "primary tumors egfr-scores": 1 "hematologic": 1 "any grade ": 1 "papillary carcinoma": 1 "emt marker": 1 "ldk378": 1 "44": 1 "country": 1 "cell type": 1 "kras mut": 1 "p-value *": 1 "58.33": 1 "aml sample": 1 "primary tumour status/metastasis status": 1 "395": 1 "constitutional pik3ca status": 1 "tumor mgmt": 1 "grade 3 adverse events in >1 patient and grade 4 events": 1 "kidney lymphoma": 1 "alk + lymphoma": 1 "specific alteration": 1 "nct01283516": 1 "brca1 and brca2": 1 "mpns": 1 "51": 1 "borderline uncertain malignant potential": 1 "either braf or kras": 1 "braf mutation": 1 "bcl-2": 1 "58": 1 "prognostic ?": 1 "5-15": 1 "epithelial": 1 "idc": 1 "coid": 1 "prevalence in nsclc patients": 1 "central chondrosarcoma": 1 "msi-h": 1 "?intraductal papillary mucinous neoplasm ipmn": 1 "basal": 1 "no of patients": 1 "thyroid": 1 "p-value 2": 1 "location of gists": 1 "assay output": 1 "prognostic proteins": 1 "mgmt expression a.u": 1 "fold change cscc": 1 "braf mutated/wild type b": 1 "60": 1 "62": 1 "imd-0354 + 24 h oc": 1 "65": 1 "pi3kca mut adc": 1 "kras codon 12/13": 1 "67": 1 "clinical findings": 1 "ret p": 1 "importance in malignant glioma": 1 "benign n ": 1 "cimp-h": 1 "82 85": 1 "alk alteration": 1 "60–80": 1 "p110?pi3k aberration": 1 "non melanomas": 1 "tsc2": 1 "definition": 1 " 61": 1 " 62": 1 "her2 3+ pos": 1 " 63": 1 " 64": 1 "5 83": 1 " 65": 1 "76": 1 " 66": 1 "+ve/?ve": 1 " 67": 1 " 68": 1 ">15": 1 " 69": 1 "cca references": 1 "7/86 8": 1 "31 89": 1 "e-cd": 1 "group n?=?9": 1 "her2+ ": 1 "biomarker identification biomarker candidate/panels": 1 "technology": 1 "182": 1 "treatment foracromegaly": 1 "tumor volume mm3": 1 "oncogenic alterations": 1 "melanomas": 1 "sel+tem n =35 a": 1 "idh2 b": 1 " 70": 1 " 71": 1 "comment": 1 " 72": 1 "tnm-stage": 1 " 73": 1 "?ve/?ve": 1 "85": 1 " 74": 1 "number of patients": 1 " 75": 1 "86": 1 "tumor pik3ca status*": 1 " 76": 1 "molecular type": 1 " 77": 1 " 78": 1 "sf4?±?sem": 1 " 79": 1 "0/27 0": 1 "lung ad": 1 "36/94 38": 1 "thalidomide celgene": 1 "enoa 1 2": 1 "alcl alk?": 1 "cervical carcinomas": 1 "gcm": 1 "sorafenib bayer/onyx": 1 "smad4/dpc4": 1 "tumour site": 1 "fbxw7": 1 "13/27 48": 1 "ctc grade 4": 1 " 80": 1 "ctc grade 3": 1 " 81": 1 "tumor-specific antigens": 1 "lung cancer predisposing factor": 1 " 82": 1 "94": 1 " 83": 1 "tumor #": 1 " 84": 1 "95": 1 "96": 1 " 85": 1 "89/36": 1 "matched non-serrated crcs": 1 " 86": 1 "normal ovary": 1 "nolc1 malat1 hmmr smox": 1 " 87": 1 " 88": 1 " 89": 1 "antibody": 1 "inss stage": 1 "tested for braf mutation braf mutated": 1 "method": 1 "mycn": 1 "ihc": 1 "ovarian n ": 1 "number of malignant lesions / braf+": 1 "oncomine name": 1 "normal tissue": 1 "sensitivity in breast cancer serum": 1 "total dcis": 1 "61.6/80.8": 1 "propagation method": 1 "references for ovarian cancer": 1 " 90": 1 "sensitivity": 1 "gender/age": 1 "pik3ca mutant": 1 "stage 2 ": 1 "analyzed samples": 1 "gep": 1 "braf 40–45 ras 10–20 ret/ptc 10–20 trk < 5": 1 "dose modification b": 1 "<10": 1 "sensitivity in breast cancer tissue": 1 "stage 11": 1 "hpyv7": 1 "hpyv6": 1 "size mm": 1 "arachnoid cell ac07 ?m": 1 "nucleotide substitutiona": 1 "primary tumour ": 1 "squamous cell carcinomas": 1 "lymph node metastasis+": 1 "dlbcl": 1 "histological grade": 1 "two-sample t-test": 1 "parasympathetic pgl": 1 "mortality ": 1 "lymph node metastasis ": 1 "primary tumour vs liver metastasess": 1 "astrocytoma grades i and ii": 1 "stage 3 ": 1 "<2": 1 "ema a": 1 "uip*": 1 "serrated crcs": 1 "cin 1": 1 "lymph node metastasis": 1 "sarcoma": 1 "passage": 1 "astrociticangoligodendroglial tumours who ii & iii": 1 "trial stage": 1 "cytokeratin": 1 "pdgfra": 1 "other features": 1 "inhibitor": 1 "biomarker type": 1 "60/66.7": 1 "tumour grade": 1 "th-mycn nb*": 1 "~50": 1 "preoperative psa-level": 1 "p –value": 1 "ilc": 1 "arid1a": 1 "sex years of age ": 1 "fully resected": 1 "cmml": 1 "k-ras mutation status": 1 "patients": 1 "stage 1 ": 1 "neurog1": 1 "aberration": 1 "mithramycin 0.01 µm": 1 "putative target": 1 "rassf1a methylation": 1 "metachronous metastasis group": 1 "age years±s.d.": 1 "rantes": 1 "prognostic": 1 "sunitinib pfizer": 1 "imd": 1 "eec": 1 "adz6244": 1 "grade 1/4 ": 1 "pathway/biomarker": 1 "pnets caucasian a": 1 "loh pathway": 1 "incidence of cancer": 1 "5-year survival": 1 "immunohistochemistry": 1 "serous carcinoma": 1 "potential use": 1 "c-kit": 1 "groups": 1 "rcc tma set": 1 "s100a4 labelling": 1 "lung sqc**": 1 "tp53 a": 1 "mll rearrangement partners amplified": 1 "qpcr met": 1 "primary ptc": 1 "maspin expression": 1 "ensat 2008": 1 "pi3kca mut nsclc": 1 "80–85": 1 "p53 p16 p62 survivin koc imp1": 1 "imiquimod graceway/3m": 1 "squamous cell carcinoma": 1 
"control": 63 "fold change": 41 "gene": 40 "p-value": 32 "wt": 29 "ko": 17 "mirna": 14 "protein": 14 "downregulated": 13 "upregulated": 13 "description": 13 "gene symbol": 10 "parameter": 10 "gene name": 9 "symbol": 9 "thc": 8 "accession": 8 "cbd": 8 "probe id": 7 "fold": 7 "name": 6 "vs control": 6 "p value": 6 "fc": 6 "total": 6 "microarray": 6 "fold diff.": 6 "mirna id": 5 "tel": 5 "rosi": 5 "lp-1d1b vs cl1": 5 "lp-1k vs cl1": 5 "treatment": 5 "apoptotic": 5 "effect on lps": 4 "con": 4 "fold increase": 4 "genes": 4 "time ?=?0": 4 "lps": 4 "group": 4 "cbd+lps": 4 "3h vs 0h": 4 "fold over basal": 4 "fold change versus untreated": 4 "12h vs 0h": 4 "thc+lps": 4 "down regulated": 4 "reference": 4 "‡": 3 "2": 3 "7": 3 "micro-array": 3 "post": 3 "myphd2ko+l/a": 3 "ko vs wt": 3 "tnf": 3 "time ?=?12 h": 3 "fold change *": 3 "200": 3 "up-regulated": 3 "pre": 3 "r115777": 3 "hfd": 3 "q-pcr": 3 "rt-pcr": 3 "rowspanempty": 3 "3 hpi": 3 "myphd2ko": 3 "accession no.": 3 "myphd2ko+l/a+digoxin": 3 "24 hpi": 3 "p -value": 3 "time ?=?4 h": 3 "variables": 3 "mod": 3 "raw log2 values mean k562 vs blood": 3 "48 hpi": 3 "time ?=?8 h": 3 "control+l/a": 3 "groups": 3 "7 hpi": 3 "rc-3940-ii": 2 "qrt-pcr": 2 "placebo group": 2 "qpcr fold": 2 "1": 2 "5": 2 "glucose": 2 "metformin": 2 "mm/pm fold change": 2 "surgery": 2 "mean?±?sd": 2 "tsc2 inhibited": 2 "female": 2 "chr": 2 "60?": 2 "locus link": 2 "microrna": 2 "analyte": 2 "fold stimulation": 2 "experiment": 2 "dio mice": 2 "gene name symbol": 2 "average dct": 2 "qfdr": 2 "target id": 2 "sham": 2 "species": 2 "ctr los": 2 "pio": 2 "comparison": 2 "wt n?=?6": 2 "sequence descriptionb": 2 "anti-apoptotic": 2 ">2-fold": 2 "direction": 2 "ant": 2 "control n?=?15": 2 "10 h post": 2 "ctr": 2 "249": 2 "gene expression": 2 "250": 2 "24h": 2 "avy/a mice": 2 "combined ionscore": 2 "cy3": 2 "cy5": 2 "14 days": 2 "b16 48 h ra vs control": 2 "glucose 1/2": 2 "glucose 1/4": 2 "level 4": 2 "level 5": 2 "level 1": 2 "parameters": 2 "level 2": 2 "level 3": 2 "solexa fold": 2 "vehicle vs tp": 2 "gene title": 2 "fructose": 2 "functional group": 2 "kotg vs wttg": 2 "probe set": 2 "fold change uremia vs normal": 2 "identifier": 2 " wt vs n-ras ko": 2 "tac+imd": 2 "study": 2 "brd los": 2 "pm fold change": 2 "ground control": 2 "a vs b": 2 "a vs c": 2 "a vs d": 2 "+egf": 2 " n?=?8": 2 ">5-fold": 2 "test": 2 "accession number": 2 "? cagl": 2 "0 day": 2 "id": 2 "melan-a vs b16": 2 "sensitive": 2 "n-3 fa group 1": 2 "relatively resistant": 2 "tnf +los": 2 "?3.68": 2 "300": 2 "koogd vs wtogd": 2 "cla versus control": 2 "nc": 2 "hsa-mir-494": 2 "rtq-pcr fold change": 2 ">10-fold": 2 "mag-h 2o": 2 "crabp2": 2 "100": 2 "kotm vs wttm": 2 "brd": 2 "fold change activated/dormant": 2 "mrna": 2 "20": 2 "gene ontologye": 2 "1a": 2 "excess": 2 "cell line": 2 "rc-3095": 2 "*relative growth ": 2 "pm p-value t-test": 2 "sequence namea": 2 "180?": 2 "saline": 2 "cell type": 2 "150": 2 "15?": 2 "50": 2 "refseq": 2 "4h": 2 "mm/pm p-value t-test": 2 "gene number a": 2 "cells": 2 "deficiency": 2 "untreated": 2 "microarray fold change": 2 "4 h post": 2 "ensemblid": 2 "m/z": 2 "model n?=?9": 2 "kood vs wtod": 2 "hairpin": 2 "tac": 2 "ilk": 2 "apoptotic function": 2 "sbs n?=?12": 2 "transgenic": 2 "variable": 2 "ko n?=?6": 2 "female versus male": 1 "probe_id": 1 "vorinostat": 1 "functions": 1 "qcut": 1 "vitis amurensis": 1 "6m after tam control n = 6 mutant n = 7": 1 "5-ht 2a": 1 "fig 2c": 1 "up in pds 83": 1 "?": 1 "fig 2b": 1 "fig 2e": 1 "fig 2d": 1 "fc < 1.8": 1 "fold change pdr vs pd-treated": 1 "fold-change relative to dmso fold change p value": 1 "5-ht 2c": 1 "fig 2a": 1 "wt p53-specific ctl clone 1h11": 1 "5-ht 2b": 1 "tac u/mgprot": 1 "difference between genotypes control vs mutant mice": 1 "subcellular location*": 1 "fig 2g": 1 "fig 2f": 1 "fig 2h": 1 "lncap-c4-2 vs lncap log2 fold change": 1 "map vs pbs": 1 "fold up down vs control": 1 "ter": 1 "ko vs wt tm": 1 "p53?/? versus wt p value": 1 "receptor/co-receptors": 1 "5-ht 1d": 1 "ir6": 1 "cox-1 after simulation": 1 "atorvastatin": 1 "5-ht 1b": 1 "tfa": 1 "fig 3b": 1 "5-ht 1a": 1 "fig 3a": 1 "up-regulation": 1 "3": 1 "1?25 oh2d3": 1 "4": 1 "6": 1 "8": 1 "metabolite increment fold": 1 "protein-class": 1 "mice n": 1 "high fat vs control": 1 "fold change sherk1 vs shcon": 1 "nep activity of control": 1 "flight": 1 "s5 147": 1 "protein level": 1 "activity overexpression fold": 1 "plx4720": 1 "measurement": 1 "yt/yu": 1 "treatment/control ratio": 1 "nicotine induced ?-arrestin-1 arrb1 dependent genes": 1 "fold change in cells infected with l interrogans vs uninfected": 1 "luminal markers *": 1 "fold change in hnrnp e1 binding": 1 "h": 1 "frub": 1 "os wt kras control vs egfri hazard ratio": 1 "n": 1 "p": 1 "fold of qpcr results ai/li": 1 "candidate gene": 1 "dgk?-tg stz": 1 "pathway": 1 "reference suit2": 1 "days": 1 "combined": 1 "fold change rt pcr": 1 "311.3": 1 "acc": 1 "classical analysis by genesifter": 1 "notes": 1 "left ventricle": 1 "k-ras wildtype": 1 "log phase": 1 "traf4-ko": 1 "tumor incidence": 1 "fold increase mo": 1 "serine proteases": 1 "wnt inhibitors": 1 "wt score": 1 "?-flag c": 1 "response after 9 months 1": 1 "p value1": 1 "ob/ob vs wt": 1 "intracellular renin?+?ao": 1 "96.6 28": 1 "2k1c+hpp593": 1 "response level": 1 "cluster genes": 1 "control n?=?5": 1 "progressor s n=31": 1 "1268": 1 "tnf + u0126": 1 "335.3": 1 "line-1 methylation level ": 1 "74.5 117": 1 "meljd vs mm200": 1 "gene_symbol": 1 "uhmwpe+pqq 1 mg/kg": 1 "strand": 1 "s6 195": 1 "e vs c.": 1 "gene description": 1 "gse25055 nnn vs pxn": 1 "number of shared protein pairs 2": 1 "mean vessel count": 1 "citation": 1 "cell lines n?=?33": 1 "control si nic vs control si ss": 1 "group n=8": 1 "l5/ca": 1 "microarrays": 1 "tax wt": 1 "1.04": 1 "l1 26": 1 "rnai-e": 1 "?-catenin-independent pathways activators": 1 "359.3": 1 "predicted functional significance": 1 "313.3": 1 "1.23": 1 "1.22": 1 "0.34 ±0.02": 1 "number": 1 "k-ras mutant": 1 "nep expression of control": 1 "1.14": 1 "under-repesented": 1 "cr ?g/ml": 1 "wt control": 1 "25.5 40": 1 "mig-6 ?/?": 1 "filipin": 1 "annexina1 wnt 5a 5b lamc2": 1 "morphology": 1 "epo": 1 "fold reduction": 1 "s.no": 1 "?2.71": 1 "cagl-ha": 1 "treatment line": 1 "400": 1 "ratio t/a+ vs t/a?": 1 "protein id": 1 "organism experimental condition": 1 "24 wks after ovx 12 wks after treatment": 1 "treatment groups": 1 "lat y136f vs h poly": 1 "l3/ls": 1 " n?=?12": 1 "significant dets": 1 "apc control": 1 "hy hyperthyroid": 1 "wnt ligands": 1 "mouse ensemble": 1 "1–534": 1 "number cells": 1 "boran vs n'dama": 1 "down-regulation fold": 1 "theoretical mw": 1 "wt s-220 4mgz": 1 "poko vs ppar?2ko": 1 "kinase substrate id": 1 "product": 1 "d vs b": 1 "tumor volume measurement mm3": 1 "higher-order classification": 1 "5w after tam control n = 16 mutant n = 15": 1 "up-regulation fold": 1 "comparison/contrast": 1 "1?h": 1 "arko": 1 "fold induction polysomal mrnain nmumg": 1 "sb203580": 1 "immunoreactivity": 1 "rfc fold difference": 1 "aah vs ais": 1 "2-d": 1 "akr": 1 "significantly enriched motifs": 1 "low level b": 1 "adjntl vs ad": 1 "trial": 1 "fold change rt-pcr": 1 "cells and condition": 1 "function": 1 "ala": 1 "12 wks after ovx before treatment": 1 "sah + sb386023-b after 6 hours": 1 "blood/bone marrow": 1 "mouse model": 1 "initial biomarker retrospective marker": 1 "pn day2 vs ad": 1 "condition": 1 "201": 1 "202": 1 "203": 1 "204": 1 "205": 1 "fold change total mrnain nmumg": 1 "probe-set id": 1 "hsa-mir-134": 1 "gene_id": 1 "pnday10 vs ad": 1 "days post reinfection": 1 "f c-raf vsf wt": 1 "imod": 1 "control n?=?1008": 1 "1d 1dmso": 1 "case n?=?1417": 1 "0.89 ±0.08": 1 "map mmhg": 1 "genbank acc number": 1 "gill": 1 "179–595": 1 "significant pathway": 1 "gse25065 nnn vs pxn": 1 "soggy and wif": 1 "k-ras kd": 1 "lc-ms/ms": 1 "mir serum study": 1 "e2100 nnn vs pxn": 1 "p19arf?/? versus p53?/? p value": 1 "flux control": 1 "comments": 1 "hsa-mir-149*": 1 "high level b": 1 "2 h after i/r": 1 "tax d247g": 1 "cd45r/b220 cells/mm2": 1 "225": 1 "226": 1 "arrb1 si nic vs control si ss": 1 " decrease": 1 "100 ng/kg/day": 1 "nls-trx1 tg": 1 "fold ? mb-231 cnc": 1 "intracellular renin?+?enalaprilat": 1 "?-catenin destruction complex": 1 "scrambled cd34+cd38- vs bulk": 1 "dvl 1–3 dishevelled cytoplasmic protein downstream of fzd receptors": 1 "dose gy": 1 "h-ras mutant": 1 "t -test": 1 "optimized uvb sites": 1 "fold change vs virgin": 1 "stouffer weighted z": 1 "histology": 1 "glucose 1/2 n?=?5": 1 "control vs lactone": 1 "upregulation": 1 "inducible versus non-inducible": 1 "animal model": 1 "ctr3": 1 "os mt kras control vs egfri hazard ratio": 1 "average mediaspot ": 1 "control clone 9.5": 1 "morphological type": 1 "averagemy spot ": 1 "l4 33": 1 "245": 1 "densitometry": 1 "gender female vs male": 1 "molecule": 1 "fold change in cells infected with l biflexa vs uninfected": 1 "moderately sensitive": 1 "louvain": 1 "b protein expression and mirna expression at 12h .": 1 "phospho-protein/total protein": 1 "overall response rate mt v wt kras with egfri": 1 "24d": 1 "48h": 1 "d62–90": 1 "285.2": 1 "rx vs mediadifference": 1 "poko vs wt": 1 "bt549": 1 "a 1 r-induced ip accumulation": 1 "mrna m / protein p target in networks": 1 "ir48+fa": 1 "clinicopathological features": 1 "nf- ? b reporter assay fold increase over basal": 1 "fold change microarray": 1 "repressed during sporulation b": 1 "2a n?=?37": 1 "24 hrs after infection": 1 "value to the untreated control group": 1 "?-actin fold difference": 1 "theoretical pi": 1 "2k1c": 1 "361.3": 1 "e2197 nnn vs pxn": 1 "em day18 vs ad": 1 "up-regulated mirna": 1 "hsa-mir-663": 1 "simvastatin-treated": 1 "3hvs0h fold change 3": 1 "3hvs0h fold change 2": 1 "significant": 1 "receptordrug": 1 "pd at start*": 1 "cap1": 1 "sah + sb386023-b after 0 hours": 1 "a 6 hours": 1 "5d 1dmso": 1 "controls total": 1 "transcriptome study 13": 1 "moderately resistant": 1 "ir24+fa": 1 "4 week": 1 "lps stimulation fold change1": 1 "axin 1/2": 1 "egfr degradation with kd": 1 "385.3": 1 "accessionno.": 1 "complex/protein": 1 "a66": 1 "fold change tsc2?/rapamycin versus tsc2+/vehicle": 1 "untreated cultures": 1 "cell proliferation of control": 1 "q-pcr fold change p value": 1 "bone": 1 "mean range value of cytokines mrna expression ratio ?-glu6 treated vs control": 1 "l6 38": 1 "cluster 1a no.": 1 "doubling time h": 1 "basal level of apoptosis ": 1 "?1.1": 1 "fung": 1 "time": 1 "newcastle-ottawa scale *": 1 "comparison wt vs ob/ob": 1 "no of tested animals wt ko": 1 "12/15-lo ko": 1 "d30–90": 1 "locus_tag": 1 "digitoxin treament 6h 0.1 ?g/ml": 1 "colonic crypt_fap fold change control = 1": 1 "tumour formation in nu/nu mice": 1 "cdc42t17n": 1 "rock1": 1 "cell-line": 1 "tcdd": 1 "genbank id": 1 "cytokines": 1 "response after last report 1": 1 "proinflammatory cytokines": 1 "non-progressors n=62": 1 "egfr wt": 1 "compared groups": 1 "lnk": 1 "ever-smokers versus never-smokers": 1 "kogd vs wtgd": 1 "em day16 vs ad": 1 "337.3": 1 "cd34+cd38- vs bulk": 1 "label/time point": 1 "basal expression log2": 1 "threshold level": 1 "ptso": 1 "tumor samples": 1 "ais vs ad": 1 "ir6+fa": 1 "ptsp": 1 "unstimulated thymocytes": 1 "mda nmol/mgprot": 1 "up regulated": 1 "4-week after tac": 1 "ad 2 n?=?52": 1 "down-regulatedmirna": 1 "prostate cell line mir studies": 1 "fold decrease in hd matrices after erk inhibition": 1 "digitoxin treatment 6h 1.0 ?g/ml": 1 "systematic name": 1 "1–35": 1 "down in log 11": 1 "geneid": 1 "intracellular renin": 1 "?ir3": 1 "glucose 1/4 n?=?5": 1 "used cells": 1 "1 id": 1 "u0126": 1 "cox-2 after docking": 1 "statistics": 1 "pyr": 1 "differentiating group": 1 "immunohistology": 1 "1 n?=?76": 1 "36–65": 1 "s100a8 fold increase": 1 "averagerx spot ": 1 "adjntl vs aah": 1 "irradiated": 1 "strain": 1 "uhmwpe": 1 "age/nb": 1 "secondary structural features common to the ?-gf fold1": 1 "dkk 1–4 dickkopf": 1 "fold change enz 24/48?h vs dmso": 1 "em day12 vs ad": 1 "number of genes": 1 "all n?=?223": 1 "validation cohort": 1 "339.3": 1 "pcb126": 1 "xenagraft model": 1 "crk shrna total": 1 "control ?ct1": 1 "3m after tam control n = 6 mutant n = 5": 1 "fold change 50 nm": 1 "synonym": 1 "sah": 1 "pcb153": 1 "enzyme": 1 "s2 261": 1 "283.2": 1 "fold change by keap1 knockdown keap1 knockdown/sc control": 1 "pegfr detectable": 1 "braf mutant": 1 "meljd vs patient-3-post": 1 "fold induction polysomal mrnain e1kd": 1 "gene function category": 1 "wt stz": 1 "interaction": 1 "fold decrease": 1 "stressed - 4 h": 1 "uninfected": 1 "ot/ou": 1 "target gene": 1 "hiv?+?tak vs control": 1 "anti-inflammatory cytokines": 1 "treatments": 1 "367.3": 1 "0.44 ±0.08": 1 "tiron vs h2o control 48 h exposure": 1 "ror2 receptor tyrosine kinase-like orphan receptor 2": 1 "ab": 1 "tcf1 3 and 4 lef1 t-cell factors lymphoid enhancer factor": 1 "66–95": 1 "fold in transcriptome ai/li": 1 "profile": 1 "untreated kk- a y 10": 1 "suc?+?losartan n?=?5": 1 "rx vs mydifference": 1 "1–282": 1 "after phylogenetic analysis": 1 "dose": 1 "probe set id": 1 "study a": 1 "birb 796": 1 "wt camp 4mgi": 1 "p4 52": 1 "adult": 1 "protein fold change 12h vs 0h": 1 "fold change arrays": 1 "log fold change ab": 1 "rwpe-2 vs rwfe-1 log2 fold change": 1 "65 45–81 years": 1 "fold of control": 1 "slc16a3": 1 "transcriptional co-repressors": 1 "pecdf": 1 "all genes significantly affected 1.5-fold p<0.01 by the rph1 ? knockout": 1 "real-time rt-pcr": 1 "di0": 1 "putative function": 1 "ras wt": 1 "characteristic": 1 "d3": 1 "ratio-1": 1 "ratio-2": 1 "egfr lyn cav12 msn ets1 cd445": 1 "stress response": 1 "d7": 1 "p>f": 1 "i vs s.": 1 "uspc-1": 1 "protein a nucleotide pdb entry": 1 "b a p-78-dione reduction nmol/min/mg": 1 "rt-qpcr": 1 "em day14 vs ad": 1 "chip": 1 "wt versus p53?/? p value": 1 "scrambled cd34+cd38- vs cd34+": 1 "tail": 1 "downregulation": 1 "p>t": 1 "tle transducin-like enhancer of split/groucho 1–4": 1 "co": 1 "q-rt-pcr": 1 "p = 0.009": 1 "rescue?": 1 "pfs mt kras control vs egfri hazard ratio": 1 "mirna fold change 3h vs 0h": 1 "swiss-prot id #": 1 "average acetonespot ": 1 "fold increase me-26": 1 "dm": 1 "ex lsd kd": 1 "369.3": 1 "braf wildtype": 1 "bez-235": 1 "rnase4": 1 "fold change vs.pups removed": 1 "days post primary infection": 1 "ea": 1 "log fold change huex": 1 "glucose n?=?5": 1 "?-ha b": 1 "tel + rosi": 1 "mitat vs smb": 1 "ki67": 1 "k450q camp 4mgk": 1 "fold change 12h vs 0h": 1 "fa": 1 "fold ratio qpcr/transcriptome": 1 "blank": 1 "nf?b-p65 phosphorylation of control": 1 "ais n?=?31": 1 "population doubling level": 1 "full name/brief description": 1 "10 ?m cha": 1 "nocodazole": 1 "protein pairs found significantly different of 7260": 1 "?3.19": 1 "gene expression protein classes": 1 "cluster 2b no.": 1 "ob/ob vs ppar?2ko": 1 "251–595": 1 "pdac cell lines": 1 "hf irradiated": 1 "translocation": 1 "m c-raf vsm wt": 1 "k405q d-007 4mgy": 1 " reduction": 1 "rash": 1 "cd34+cd38- vs cd34+": 1 "500": 1 "stressed - 8 h": 1 "hf": 1 "prevalence ": 1 "1/ratio-2": 1 "day 0": 1 "treatment c": 1 "metnt n?=?30": 1 "metnt vs adjntl": 1 "protein of control a b": 1 "construct": 1 "log 2 -fc t/a+ vs t/a?": 1 "p- value": 1 "cd107b cells/mm2": 1 "363.3": 1 "day 14": 1 "ir24": 1 "placebo": 1 "wtd": 1 "sch772984": 1 "index": 1 "29 vs 41": 1 "gene id": 1 "crk shrna1": 1 "fold increase due to density-induced matrix stiffness": 1 "control n?=?6": 1 "affymetric number": 1 "contrast": 1 "poko vs ob/ob": 1 "arrays": 1 "l1": 1 "wnt1 2 2b 3 3a 6 5b 7a 7b 8a 8b 9a 9b 10a 10b 16": 1 "l2": 1 "l4": 1 "untreated kk 7": 1 "3-d": 1 "succinate n?=?8": 1 "ethanol": 1 "12hvs0h fold change 3": 1 "12hvs0h fold change 2": 1 "341.3": 1 "fold induction": 1 "fold change 5 nm": 1 "778": 1 "apc+hy peptide": 1 "groups n=4": 1 "ir48": 1 "387.3": 1 "p_value": 1 "gene_name": 1 "used mouse model": 1 "change": 1 "?-catenin-dependent pathway activators": 1 "tiron vs h2o control 6 d exposure": 1 "digitoxin treatment 6h 0.2 ?g/ml": 1 "basal mek/erk dependent": 1 "day 21": 1 "genomically stable": 1 "l2 34": 1 "p-value huex": 1 "hyphal length µm b": 1 "day 28": 1 "protein levels protein classes": 1 "control n?=?34": 1 "2-week after tac": 1 "hp vs h poly": 1 "uhmwpe+pqq 10 mg/kg": 1 "transcription factors": 1 "sw1736": 1 "log fc": 1 "mi/control": 1 "24 h after i/r": 1 "boran time point vs 0 dpi": 1 "bipolar n?=?31": 1 "s1 62": 1 "basal markers +": 1 "mi": 1 "365.3": 1 "hiv vs tak fold change": 1 "author": 1 "stim cd4+ t-cells": 1 "p19arf?/? versus wt p value": 1 "mw": 1 "5-ht 3": 1 " amp": 1 "2.39": 1 "fold-change t/n mrna level": 1 "crk shrna 2": 1 "in vivo assay": 1 "designation": 1 "4 hrs after infection": 1 "overall pfs and os hazard ratio": 1 "gata3 xbp1 prlr mapt tiff1 3": 1 "n'dama time point vs 0 dpi": 1 "mirna fold change 12h vs 0h": 1 " necrotic tumor area mm2": 1 "rlk ?/? itk ?/?": 1 " of untreated control": 1 "is/rp vs control": 1 "lrp5/6 ldl receptor related protein co-receptor": 1 "?-catenin": 1 " control": 1 "serpinb3": 1 "real-time pcr fold charge": 1 "esmolol n=8": 1 "i vs ic.": 1 "ahh n?=?73": 1 "control samples": 1 "mbp+ area ": 1 "hiv vs control fold change": 1 "3.4 1": 1 "melanoma tissue": 1 "cdc42g12v": 1 "rad001": 1 "igg cells/mm2": 1 "tnbs ?ct2": 1 "regulation": 1 "pfs wt kras control vs egfri hazard ratio": 1 "lat y136f vs hp": 1 "p-value ab": 1 "fold ? mcf-7 h2d": 1 "ppar?2ko vs wt": 1 "pi": 1 "pdia3": 1 "200 ng/kg/day": 1 "regeneration": 1 "tax s240p": 1 "hours of hypoxia": 1 "landiolol n=8": 1 "ingredients wt/wt": 1 " is/rp+sala vs is/rp": 1 "cagi-flag": 1 "cholesterol": 1 "common s4 h - s8 h": 1 "l3 51": 1 "s1": 1 "spot #": 1 "s2": 1 "p-values for pair-wise comparisons of tissue types 1": 1 "s3": 1 "s4": 1 "s5": 1 "15": 1 "percent of annexin v+ dp thymocytes": 1 "10d": 1 "microarray fold charge": 1 "asthma": 1 "fold change 3h vs 0h": 1 "stimulus/simulation experiment": 1 "schizophrenia n?=?35": 1 "down in pds 61": 1 "transgenic versus knock-in": 1 "wt n?=?18": 1 "p53?/? versus p19arf?/? p value": 1 "rx vs mediat-test p": 1 "cd31": 1 "ea/mi": 1 "1h": 1 "fzd 1–10 frizzled": 1 "sfrp 1–5 secreted frizzled-related proteins": 1 "control 2": 1 "control 1": 1 "30": 1 "chromosome instability": 1 "level of apoptosis following camptothecin ": 1 "fold difference": 1 "colonic fibroblast_fap fold change control = 1": 1 "fold increase a": 1 "12h": 1 "vp16": 1 "pegfr non detectable": 1 "tumor latency": 1 "140": 1 "prognosis": 1 "141": 1 "ml1": 1 "fold change tsc2? rapamycin versus tsc2?/vehicle": 1 "necrosis": 1 "2h": 1 "mb231": 1 "mean colony number": 1 "metabric discovery nn1 vs px1": 1 "fish": 1 "fold ? mcf-7 cnc": 1 "saline n?=?5": 1 "treated kk- a y ?? 11": 1 "time point": 1 "igfbp-3": 1 "agent": 1 "fold ? mb-231 h2d": 1 "kog class": 1 "ctrl7": 1 "p-value †": 1 "ctrl.": 1 "nep level of control": 1 "ptsn/ptsn 0": 1 "scc vs ns": 1 "ic 50": 1 "3h": 1 "blasts results": 1 "hyphal branches": 1 "mdamb468 cells": 1 "309.2": 1 "160": 1 "161": 1 "control vs acid": 1 "basal": 1 "162": 1 "genotype": 1 "up in log 60": 1 "patient number with kras results": 1 "cic-l ko": 1 "carrangeen": 1 "developmental stages": 1 "genbank": 1 "dgk?-tg control": 1 "ionizing radiation": 1 "li-fu formula": 1 " difference": 1 "mirgen": 1 "170": 1 "5a": 1 "5b": 1 "p<0.05": 1 "student's t test p ": 1 "s4 30": 1 "cd3 cells/mm2": 1 "control?+?losartan n?=?3": 1 "wnt4 5a and 11": 1 "cis position chr bp": 1 "negative sirna": 1 "75": 1 "characteristics": 1 "unigene": 1 "s vs sc.": 1 "180": 1 "a protein expression and mirna expression at 3h .": 1 "181": 1 "hth7": 1 "182": 1 "183": 1 "control n=8": 1 "time ?=?8h": 1 "6h": 1 "ldh control": 1 "p1 106": 1 "location": 1 "0.7 ±0.03": 1 "metabric validation nn1 vs px1": 1 "p6 124": 1 "itk ?/?": 1 "response after 6 months 1": 1 "fold change tsc?/vehicle versus tsc2+/vehicle": 1 "fold change sherk2 vs shcon": 1 "scc vs ak": 1 "expression in recuurent vs primary": 1 "median pmrs": 1 "days after treatment": 1 "spaceflight": 1 "adjnt n?=?63": 1 "tumor dose": 1 "fructose n?=?5": 1 "apc1/2 adenomatous polyposis coli": 1 "cont": 1 "gene bank accession no.": 1 "upregulated mirna": 1 "l5 74": 1 "ck1 casein kinase 1": 1 "efficiency": 1 "salmonella ? sigd": 1 "penetrance": 1 "f/ wr vs control": 1 "wt s-280 4mh0": 1 "p3 169": 1 "samples": 1 "mrna of control a b": 1 "comb": 1 "8h": 1 "wt uvb sites": 1 "fold change differentiating group vs other groups": 1 "nymph": 1 "‘progression’": 1 "optimized score": 1 "upregulated oncogenes": 1 "transcriptional co-activators": 1 "intestine": 1 "hiv vs hiv?+?tak": 1 "ko vs wt ogd": 1 "pma/ionomycin stimulation fold change1": 1 "co control": 1 "tcga brca nnn vs pxn": 1 "ak vs ns": 1 "fold changetotal mrnain e1kd": 1 "multiple spots": 1 "egfr amp": 1 "time ?=?12h": 1 "protein name": 1 " wt vs h-ras ko": 1 "transcript": 1 "rx vs myt-test p": 1 "egfr signaling with kd": 1 "24?h": 1 "cox-1 after docking": 1 "il-6/mcp-1 gene expression relative abundance ": 1 "adj p-value": 1 "activated during sporulation a": 1 "vx-745": 1 "time ?=?4h": 1 "rlk ?/?": 1 "1000 ?g/kg/day": 1 "bht101": 1 "upper versus lower lobe": 1 "pds achieved†": 1 "adhesion and migration": 1 "common names": 1 "median age range": 1 "msg": 1 "kod": 1 "lncap vs hprar-1 log2 fold change": 1 "plasma gpx3 level n": 1 "msi": 1 "nf?b-p65-specific-transcriptional activity of control": 1 "response after 3 months 1": 1 "protein fold change3h vs 0h": 1 "drug": 1 "folds up- or down-regulation vs wt mice": 1 "lineage name": 1 "t3.70+?cd28": 1 "brainstem": 1 "327.3": 1 "hiv vs control": 1 "2d gel ph range": 1 "muscat of hamburg": 1 "2b n?=?43": 1 "fold change parental vs pd-treated": 1 "cagh-ha": 1 "ql-induced ip accumulation": 1 "sequence": 1 "c vs d": 1 "percentage of the occurrence of haustorial mother cells": 1 "c vs b": 1 "independent cultures": 1 "6 week": 1 "p2 35": 1 "line": 1 "?-cagl b": 1 "intact plc? domain": 1 "cfw ?g/ml": 1 "overexpressed enzyme activity fold": 1 "a k562 gleevec-treated group versus k562 control group": 1 "network": 1 "gsk3? glycogen synthase kinase 3 beta": 1 "array": 1 "mouse igg": 1 "mvb": 1 "encoding protein": 1 ">95": 1 "salmonella wild type": 1 "h-ras kd": 1 "age per 10 years": 1 "tfa+msg": 1 "gene kegg pathway s": 1 "wt a": 1 "wt versus p19arf?/? p value": 1 "colony efficiency in soft agar ": 1 "p5 177": 1 "s.e.": 1 "accession numbers": 1 "cox-2 after simulation": 1 "assay": 1 "s3 184": 1 "s100a9 fold increase": 1 "discovery cohort": 1 "72 h": 1 "locus": 1 "category": 1 "ebv+": 1 "1000 ng/kg/day": 1 
"references": 143 "reference": 43 "genes": 37 "function": 34 "p-value": 33 "-": 20 "mirna": 17 "target": 16 "gene": 14 "targets": 13 "score": 12 "results": 12 "name": 12 "q-value": 10 "disease": 10 "pathway": 9 "top functions": 9 "microrna": 9 "description": 9 "treatment": 9 "target genes": 9 "3": 8 "# genes": 8 "molecules": 7 "# molecules": 7 "p value": 7 "substrates": 7 "compound": 7 "ingenuity canonical pathways": 7 "drug": 7 "functions": 6 "molecules in network": 6 "features": 6 "proteins": 6 "model": 6 "mechanism of action": 6 "ratio": 6 "associated genes": 6 "": 5 "se references": 5 "1": 5 "4": 5 "5": 5 "h": 5 "n": 5 "cancer": 5 "experiment": 5 "ref.": 5 "identified gene targets": 5 "side effects": 5 "refs": 5 "tumor": 5 "dose range": 5 "cell lines or biological samples location": 5 "clinical features": 5 "assessment/modification": 5 "virus": 5 "pathways": 5 "class": 5 "author": 5 "expression": 5 "agent": 5 "cells": 5 "transgene": 5 "phase": 5 "putative targets": 4 "#": 4 "role": 4 "1173+": 4 "1173-": 4 "go term": 4 "compounds": 4 "focus molecules": 4 "1068+": 4 "1068-": 4 "micrornas": 4 "cytokines": 4 "cancer types": 4 "amino acids": 4 "id": 4 "total": 4 "p -value": 4 "mutation+": 4 "mutation-": 4 "p - value": 4 "category": 4 "gene name": 3 "detection techniques": 3 "lncrna": 3 "notes": 3 "sch9?/wt": 3 "gene description": 3 "citation": 3 "nodes genes proteins in network": 3 "function annotation": 3 "relevance": 3 "expression levels": 3 "outcome": 3 "drugs": 3 "species": 3 "human p29sn stromal cells": 3 "metabolite": 3 "comments": 3 "protein": 3 "animal model": 3 "networks": 3 "mechanism": 3 "cell lines": 3 "source": 3 "ras2?/wt": 3 "n/a": 3 "tor1?/wt": 3 "gene symbol": 3 "na16": 3 "effect": 3 "biological process": 3 "database": 3 "process": 3 "population": 3 "route": 3 "schema": 3 "average": 3 "sample": 3 "in vivo models": 3 "company": 3 ">100 b": 3 "go": 3 "mirs": 3 "nodes": 3 "mirnas": 3 "cancer cells": 3 "agents": 3 "selected ref .": 3 "z score": 3 "oh": 3 "10": 3 "11": 3 "animal": 3 "cell line": 3 "frequency": 3 "characteristics": 3 "gdp": 3 "receptors": 3 "jurkat cells": 3 "animal models": 2 "?": 2 "functional annotation": 2 "2": 2 "npp 43 organisms": 2 "primers": 2 "# non-cancer genes": 2 "ddx47 -asssociating proteins": 2 "matched fragments": 2 "p": 2 "cell/tissue/body fluid models": 2 "concentrations": 2 "selected references": 2 "entrez gene": 2 "ddx18 -associating proteins": 2 "n° of genes": 2 "tigo category down-regulated": 2 "fl-hcc comparative genomic hybridization": 2 "nop132/nol8 -associating proteins": 2 "total ": 2 "+/?": 2 "mediators symptoms pathology": 2 "inhibitors": 2 "npp 86 organisms": 2 "focus genes": 2 "mouse model": 2 "human tumors": 2 "clinical development": 2 "latency": 2 "genetics": 2 "design": 2 "ddah2": 2 "# cancer genes": 2 "leptin-treated": 2 "hippocampus": 2 "disease model": 2 "dlpfc": 2 "events": 2 "individual studies": 2 "expected": 2 "allergy": 2 "approved status": 2 "sea-treated": 2 "pathway id": 2 "p16": 2 "targets of mirnas": 2 "parameters": 2 "xenograft models": 2 "hcc": 2 "chromosomal localization": 2 "fcf": 2 "intracellular stage": 2 "bpp 86 organisms": 2 "epigenetic modification": 2 "permute p": 2 "npp 64 organisms": 2 "incidence": 2 "strain": 2 "survival": 2 "effects": 2 "differential sers*": 2 "colony": 2 "interactions": 2 "reference s": 2 "enzyme": 2 "up-regulated genes": 2 "therapy": 2 "top associated network functions": 2 "putative function": 2 "differentially expressed genes": 2 "combination agents": 2 "fl-hcc whole genome sequencing": 2 "genes ref": 2 "molecular properties": 2 "count": 2 "isoforms": 2 "regulators": 2 "chi-square": 2 "sers ": 2 "acini": 2 "rheumatism": 2 "action": 2 "associated proteins": 2 "sequences": 2 "785": 2 "protein molecules": 2 "associated network functions": 2 "biomarkers": 2 "kegg pathway": 2 "swissprot proteins coverage": 2 "control": 2 "tumors": 2 "receptor": 2 "regulation": 2 "involved genes": 2 "properties": 2 "r2": 2 "top bio functions": 2 "class target": 2 "clinical trials": 2 "# of cases": 2 "diseases": 2 "asthma": 2 "predicted target gene/possible effect": 2 "inducing agent s": 2 "combinatorial therapy": 2 "isoform": 2 "components": 2 "activators": 2 "30": 2 "normal ducts": 2 "pc vs d": 2 "tf": 2 "data source": 2 "organism": 2 "score mascot": 2 "n genes": 2 "sequence coverage ": 2 "ease score": 2 "dna methylation": 2 "microarray": 2 "role in panca": 2 "location": 2 "qpcr": 2 "dusp1": 2 "h3k27me3": 2 "npp 22 organisms": 2 "angiogenic factors": 2 "samples": 2 "islet cells": 2 "pbs-treated": 2 "gene targets": 2 "range": 2 "binding sites/associated viral proteins": 2 "h3k4me3": 2 "inhibitor": 2 "hallmark": 2 "viruses": 2 "sequence": 2 "death": 2 "tfap2a-regulated genes": 2 "network": 2 "parameter": 2 "value": 2 "tyr1068": 1 "schizophrenia subjects": 1 "mek inhibitors": 1 "target s": 1 "# down-regulated genes": 1 "target gene symbol": 1 "effects of expression manipulation": 1 "outcomes": 1 "unique genes n": 1 "redundant genes n": 1 "nk cells": 1 "human genes": 1 "oocyte 1 & 2": 1 "# protein-protein interactions": 1 "basal levels": 1 "human studies": 1 "administration route": 1 "atherosclerosis": 1 "molecular interactors": 1 "trna synthase": 1 "pool": 1 "decrease in lesion size ": 1 "+": 1 "liver cancers": 1 "analysis": 1 "modifiers of extracellular matrix": 1 "ews translocations": 1 "size": 1 "6": 1 "+/- ions": 1 "late genes": 1 "genetic markers": 1 "vdac-mediated cytotoxic": 1 "tyr1086": 1 "mediators": 1 "induced mast cell phenotype": 1 "datp pmol/106 cells ±sem": 1 " a gene ontology biological process": 1 "total genes": 1 "perturbation": 1 "drug targets": 1 "associated disease": 1 "up-reg genes": 1 "- synaptic remodeling": 1 "sarcoma types": 1 "model used": 1 "mitotic kinase": 1 "hiv-1 element": 1 "down regulated pathways": 1 "protein molecular weight": 1 "a": 1 "posttranscriptional effects": 1 "c": 1 "conh2": 1 "mode of cell death": 1 "abbreviation": 1 "selected polymorphisms": 1 "blood": 1 "therapeutic modulation": 1 "ion channels": 1 "scan time/well": 1 "component": 1 "interventions": 1 "4-ht 20 nm": 1 "reaction name": 1 "ros source/disease": 1 "braf mutation-specific promoters 125": 1 "c elegans": 1 "fold changes": 1 "rapamycin": 1 "controls": 1 "max corrected p-value": 1 "inhibitory activities on ec": 1 "dubs": 1 "mrna target": 1 "biological methods transduction": 1 "institution": 1 "mrna level noninduced cells u": 1 "ref": 1 "neuropathology": 1 "chromosome number": 1 "mir-155 targeted pathways": 1 "tumor-suppressor genes": 1 "total interactions": 1 "oral cancers": 1 "ovary cancers": 1 "up?regulation": 1 "fcf 73": 1 "primers/probes": 1 "primary transcriptional targets": 1 "blood cells": 1 " a highest ranked networks": 1 "sk-br-3 cells": 1 "animal species": 1 "brain cancers": 1 "ringgfp": 1 "eye disorders": 1 "log p": 1 "p b": 1 "renal ischemia": 1 "ssx10": 1 "effect on gc-induced apoptosis": 1 "egfr": 1 "ferritin": 1 "study designs": 1 "vaccines": 1 "down?regulation": 1 "functional category": 1 "double pulse - 2 ?×? 0.5 h 2 ?×? 4 h": 1 "cyp1b1": 1 "- activation of transcriprion factors": 1 "gscore": 1 "breast cancers": 1 "hsp90 client proteins": 1 "gastrointestinal cancers": 1 "ribosomal proteins": 1 "top networks": 1 "activation z-score": 1 "ncd etiological subtype": 1 "rh-5daysbc/100": 1 "modifications of synaptic transmission synaptic plasticity": 1 "end": 1 "resisted drugs": 1 "chemical compounds n": 1 "p values": 1 "metabolite changes in vivo/ex vivo": 1 "target disease": 1 "induced genes related": 1 "serotypes": 1 "cell lines 1": 1 "clinical significance": 1 "renal fibrotic disease": 1 "sac protein": 1 "transcriptional regulators": 1 "pathway/process": 1 "family": 1 "n 2": 1 "body aches": 1 "genes/ conditions": 1 "heart disorders": 1 "dendritic cells": 1 "- neurite extension": 1 "small molecule tki": 1 "up-regulated proteins": 1 "cell strain": 1 "p -value<10?6": 1 "extracellular environment": 1 "lf substrates": 1 "canonical pathways- day 1": 1 "immune response 23 genes": 1 "selected genes": 1 "thimax-5daysbc": 1 "sample size": 1 "total scan time": 1 "proteoglycans": 1 "sam score": 1 "high levels of expression": 1 "gstp1": 1 "mtor inhibitors": 1 "toxicities": 1 "p-hsp27b": 1 "cyp1a1": 1 "fcf 37": 1 "igf-i doses ?g/kg/day": 1 "# genes 4": 1 "average valid objects/well": 1 "mutation": 1 "system": 1 "experimental models": 1 "genes assigned n": 1 "cd4+ t cells": 1 "effect on targets": 1 "toxins": 1 "sinusitis": 1 "cancers": 1 "natural substrates": 1 "other relevant targets": 1 "p fisher test": 1 "deletions/mutations": 1 "genetic factors": 1 "chemical methods": 1 "syndrome": 1 "tumor types germline": 1 "tcm+ aea": 1 "tumors/injections nod/scid mice ?t b nk cells ?complement": 1 "blastocyst 3": 1 "hsp's": 1 "metabolic biomarker": 1 "p-value bonferroni-corrected": 1 "cns": 1 "fcf 57": 1 "mitogenicsignaling pathways": 1 "rib-p assay u/ml": 1 "pycard": 1 "cell line name": 1 "genome": 1 "names": 1 "acne": 1 "cell adhesion genes": 1 "epigenetic mechanisms in hcc": 1 "time points": 1 "putative biomarkers": 1 "epilepsy": 1 "signal protein": 1 "cnv/snv": 1 "phagocytosis 25 genes": 1 "findings": 1 "tentative identification": 1 "molecular weight kda": 1 "rassf1": 1 "identified nodes proteins": 1 "thiavr": 1 "+mesenchymal markers": 1 "members": 1 "down-reg genes": 1 "downstream consequences": 1 "receptor subtypes": 1 "markers and methods": 1 "metabolic target": 1 "animal model/ targeted gene-protein": 1 "cytokine": 1 "biological relevance": 1 "comparison": 1 "z' factor": 1 "implicated function": 1 "rnd": 1 "dosage/duration/route": 1 "major tumour sites / types": 1 "clinical": 1 "inhibiting target": 1 "possible clinical applications": 1 "organisms": 1 "pancreatic fluid": 1 "phagocytosis 18 genes": 1 "fcf 113 *": 1 "recurrent structural chromosomal changes": 1 "cntf–associated genes": 1 "kinase group": 1 "cancer type": 1 "10.1 ± 2.9": 1 "rhmax-5daysbc/100": 1 "tyr1045": 1 "input function": 1 "gene products": 1 "modified phenotype/s": 1 "early genes": 1 "48 h": 1 "innate immune response": 1 "identified proteins involved in pathway": 1 "sept2 - gppnhp": 1 "ros": 1 "patient numbers": 1 "micro rna let-7": 1 "pc-associated antigens": 1 "stimulation": 1 "opossum": 1 "average chimeric": 1 "molecular weight": 1 "mitotic kinases": 1 "kegg pathway down-regulated": 1 "description/some examples": 1 "enzymatic": 1 "i/u3": 1 "drosophila": 1 "membrane abnormality": 1 "represented biological process": 1 "strategy": 1 "colony cells": 1 "role/remarks": 1 "composition mol ": 1 "methylation frequency": 1 "features *": 1 "cytoband": 1 "endoproteolytic cleavages dibasic sites monobasic sites post poly clu/asp sites post phe-sites tri and tetrabasic sites": 1 "wounds dressing": 1 "over-represented oligo": 1 "470": 1 "centrosome proteins": 1 "effects/findings": 1 "hiv-2": 1 "hiv-1": 1 "foreign gene/promoter insertion": 1 "rescreened": 1 " total": 1 "prediction server": 1 "apc": 1 "control rats": 1 "24 h": 1 "total nodes": 1 "models": 1 "fisher p-value": 1 "fibroblast markers": 1 "genes p-value range": 1 "candidate agent": 1 "autoinmune disease": 1 "score†": 1 "ensembl id": 1 "nonhuman primates": 1 "glipr1": 1 "hybrid score": 1 "growth factor": 1 "5-fu treated mice": 1 "clinical correlates": 1 "outcomes/comments": 1 "kinase activity": 1 "transplanted cells": 1 "important regulated genesa": 1 "average expression": 1 "gtpase activity": 1 "screening parameters": 1 "a16": 1 "coupling components": 1 "- long-term potentiation ltp": 1 "strains": 1 "therapeutic agents": 1 "patient #": 1 "top canonical pathways": 1 "gastric cancers": 1 "micro rna let-7 family members": 1 "laboratory features": 1 "peptide receptors": 1 "roles in cancer stem cells": 1 "rar?af2": 1 "characteristic features": 1 "phenotype": 1 "immortalizing agent": 1 "gene-set": 1 "multiple sclerosis": 1 "serologic testing & kits": 1 "cell-based": 1 "brain region/s studied": 1 "human virus": 1 "observed genes": 1 "regulated genes": 1 "gene functions in aging": 1 "associated syndrome": 1 "sfks involved": 1 "apoptosis inducer": 1 "primer sequences 5'-3'": 1 "# up-regulated genes": 1 "gene involved": 1 "er? +": 1 "toxicity": 1 "proposed function": 1 "oxysterols": 1 "biological correlates": 1 "up-regulated genes fi?1.50 §": 1 "skin cancers": 1 "iron compounds": 1 "meme e-value": 1 "epigenetic regulation": 1 "rodents": 1 "mouse": 1 "n target genes": 1 " hypomethylated probes": 1 "decrease lesion size ": 1 "d vs n": 1 "functional alterations": 1 "subjects n": 1 "clinical trial": 1 "cellular level": 1 "nanomaterials": 1 "cerebral injury": 1 "inflammation including bowel disease and colitis": 1 "incidence ": 1 "circgfp/ ringgfp": 1 "cell lines/animal models": 1 "signals": 1 "hdac isoforms": 1 "role in cancer": 1 "antibody targeting": 1 "protein aggregation": 1 "author year": 1 "intracellular pathway": 1 "anti-proliferative targets": 1 "cell line2": 1 "bcl-2 pro-survival group": 1 "classes": 1 "multiadhesive proteins": 1 "epigenetic regulators mechanisms": 1 "system gene category – term": 1 "# tf-gene interactions": 1 "autophagic mechanisms": 1 "pi3k inhibitors": 1 "n° compounds": 1 "avt": 1 "total n": 1 "cell death 29 genes": 1 "references pudmed": 1 "pathological / psychological state": 1 "seed nodes": 1 "1.04 ± 0.16": 1 "start": 1 "gene counts": 1 "important target genes": 1 "rxr ? ligands": 1 "metabolite changes in cells": 1 "outcocmes": 1 "neurological diseases": 1 "adverse effect": 1 "activation aggressive markers": 1 "functional group": 1 "antiautophagic mechanisms": 1 "amino acid derivatizations acylations disulfide bridgings gamma carboxylation glycosylations isomerisatios phosphorylations sulfations": 1 "feces": 1 "sign probes": 1 "potential interactions with environmental factors": 1 "major distribution sites": 1 "residues": 1 "immune response 16 genes": 1 "tissue level": 1 "tyrosine phosphorylation connection": 1 "mechanistic categories": 1 "diabetic": 1 "chromatin remodeling alterations": 1 "collections": 1 "cytochrome oxidase": 1 "identified nodes deps": 1 " hypermethylated probes": 1 "nom p-val": 1 "rtks": 1 "functional annotation*": 1 "upregulate": 1 "abnormal genetic/epigenetic events involved": 1 "28°c-144 hpf": 1 "common toxicities": 1 "tnf ?": 1 "molecules in pathway": 1 "kegg category/description*": 1 " tf site containing promoters": 1 "gadd45a": 1 "# proteins": 1 "experimental model": 1 "behavioral characteristics": 1 "referencies": 1 "mast cell type/origin": 1 "k min?1": 1 "modified amino acids": 1 "dose mg/kg/day": 1 "# tfs": 1 "top 10 genes": 1 "positive expression rate": 1 "study": 1 "skin reactions": 1 "aroclor 1254-repressed genes 18 sequences": 1 "ipa ids": 1 "methods": 1 "mirna involvement": 1 "found as false positives": 1 "cancer origin": 1 "sirtuin": 1 "metastasis": 1 "dnmts": 1 "model system": 1 "categories": 1 "neurotransmitter": 1 "amenorrhoea": 1 "domain types": 1 "attractive features": 1 "esr12": 1 "organs": 1 "mitochondrial proteins": 1 "cellular proteins": 1 "pike isoforms": 1 "gc effects": 1 "fused genes": 1 "bronchitis": 1 "adverse events": 1 "reverse": 1 "aroclor 1254-induced genes 14 sequences": 1 "collagen fibers": 1 "signalling molecules": 1 "meme regular expression": 1 "potential functions": 1 "rate law": 1 "association with ctcf": 1 "diabetes": 1 "cell system": 1 "pgd2/pgj2 pathway": 1 "cancer-related genes": 1 "–log p -value": 1 "exoproteolytic trimmings carboxyamidation glutaminyl cyclation n-terminal dipeptidyl cleavage": 1 "hos/143b log2": 1 "ablation efficacy": 1 "pdac risk": 1 "enriched go terms among induced myc signature genes": 1 "major functions": 1 "- long-term depression ltd": 1 "target names": 1 "proteasome subunits": 1 "sequences probe 5?-fam- -tamra-3?": 1 "connections": 1 "group": 1 "ms/ms results": 1 "inflammation including colic inflammation": 1 "tcr?? cd4?/cd8?": 1 "ires": 1 "initial uptake rate ng/105 cells min": 1 "format": 1 "top kegg pathways": 1 "?": 1 "risk types": 1 "translocated genes": 1 "marker": 1 "known partners": 1 "stress conditions assays": 1 "platinum-based compounds": 1 "characteristics and functions": 1 "sponsor": 1 "hiv-1 rna target site": 1 "pathology": 1 "km µm": 1 "tyr845": 1 " of total": 1 "top-scoring pwms": 1 "diarrhoea": 1 "hb-19 treated mice": 1 "thiavr-5daysbc": 1 "mda-mb-231 cells": 1 "expression sites high levels of expression": 1 "integrins": 1 "pathological levels": 1 "structural": 1 "gene targeted": 1 "inflammation 15 genes": 1 "sprains": 1 "skin diseases": 1 "genetic change": 1 "oocyte 3": 1 "prp activities reported": 1 "rhmax/100": 1 "serum-free media": 1 "approaches": 1 "cell death 22 genes": 1 "chemokines": 1 "believed to date to be real interactors": 1 "associated genetic factors": 1 "infectious disease": 1 "n input genes": 1 "vegf": 1 "references showing downregulation after infection": 1 "eye infections": 1 "methodology": 1 "conhme": 1 "pretreatment h": 1 "risk gene": 1 "ganglioside": 1 "subunits": 1 "subjects and samples": 1 "h2052": 1 "il1r1": 1 "results/relevance": 1 "promoter": 1 "pancreas cancers": 1 "vegf factor": 1 "q -values<0.05": 1 "intermittent fevers": 1 "topoisomerase inhibitors": 1 "autophagy": 1 "tyr1173": 1 "cd4 + t cells": 1 "hepatic disorders": 1 "tj proteins": 1 "#genes": 1 "ar": 1 "dose": 1 "predicted biological function": 1 "chemical": 1 "intestinal worms": 1 "anti-angiogenic targets": 1 "domain": 1 "ebv gene product": 1 "internalization": 1 "limitations/strengths*": 1 "antibody-based": 1 "prostate cancers": 1 "example target genes": 1 "clinical manifestations and susceptibility genes": 1 "phospholipid homeostasis": 1 "benjamini *": 1 "er? ?": 1 "- activation/repression of different genes": 1 "protein complexes": 1 "circgfp": 1 "delivery system": 1 "associated pathways": 1 " enlarged cells controla": 1 "zn finger proteins": 1 "rms error ng/105 cells": 1 "cpg island hg19": 1 "cytokines/growth factors": 1 "alzheimer": 1 "??mit mv": 1 "ehcc": 1 "flu": 1 "e3 ligase/ dub": 1 "stage": 1 "cdkn1b": 1 "transporter": 1 "sfn": 1 "publications": 1 "therapeutic strategies": 1 "rar ?": 1 "hgf-treatment": 1 "apoptotic genes": 1 "sites": 1 "vimentin": 1 "human gene locus": 1 "recommendations": 1 "distribution patternb": 1 "down regulated genes": 1 "0.07": 1 "uniprot #": 1 "up-regulated enzyme": 1 "diseases or functions annotation": 1 "cell cycle effect": 1 "mutated n-glycosylation sites *": 1 "tumor types somatic": 1 "name of tpor variant": 1 "growth factors": 1 "z' factor calculation": 1 "alterations": 1 "protein aggregates": 1 "study design": 1 "h28": 1 "downregulate": 1 "anti-egfr antibody": 1 "cdh1": 1 "0.33": 1 "cohort": 1 "proposed molecular mechanisms": 1 "iglur alterations": 1 "rprm": 1 "mechanisms of sensitization": 1 "s6k1 ic50 ?m a": 1 "shrna dna sequences genes": 1 "duration": 1 "brain region": 1 "class of products": 1 "xeno + /axo -": 1 " contribution >10 cells": 1 "physical methods": 1 "growth factors activating tyrosine kinase receptors": 1 "cd8+ t cells": 1 "panin": 1 "0.56 ± 0.05": 1 "gb": 1 "lam/tsc cells": 1 "el4 cells": 1 "go terms and accession numbers": 1 "neuronal populations affected": 1 " refs.": 1 "viral ecs-type ubiquitin ligases": 1 "0.44": 1 "repressed genes related": 1 "oncogenes": 1 "0.45": 1 "host factors": 1 "zscore": 1 "ms results": 1 "mgmt": 1 "0.37": 1 "nuclear transcription factors": 1 "drug name": 1 "iron": 1 "urinary discharges": 1 "liver disorder": 1 "humans": 1 "blood malignancy": 1 "p-values": 1 "untreated mice": 1 "prevalence ": 1 "tumors/injections nude mice ?t cells": 1 "liver bile disorders": 1 "meme": 1 "delivery route": 1 "structural features": 1 "accession number": 1 "immunogen/adjuvant": 1 "protumorigenic effects": 1 "34°c-48 h": 1 "igf-1 action": 1 " nmol/g brain": 1 "molecular testing & kits": 1 "ssx8": 1 "h2452": 1 "compound parameters": 1 "expression levels in gc tissues": 1 "resistant to": 1 "ssx9": 1 "toxic effects": 1 "regulatory functions of cd147": 1 "burns": 1 "constipation": 1 "ligands": 1 "biological role": 1 "spleen": 1 "ssx6": 1 "mutations identified": 1 "ssx7": 1 "ssx4": 1 "ssx5": 1 "tissue/organ": 1 "cdh13": 1 "ssx2": 1 "ssx3": 1 "ssx1": 1 "gene id": 1 "sfk target events affected": 1 "clinical manifestations": 1 "remaining n-glycosylation sites *": 1 "ipmn": 1 "alteration": 1 "putative glossina -sghv protein interactions": 1 "validation method": 1 "mouse models": 1 "hypermethylated/hypomethylated": 1 "iron-loaded rats": 1 "autophagy related changes": 1 "biofunction": 1 "0.77": 1 "biliousness": 1 "affymetrix probe id": 1 "mat-5daysbc": 1 "drawbacks": 1 "occurrence": 1 "sept7 - gdp": 1 "ligand": 1 "0.71": 1 "0.72": 1 "products": 1 "circulating biomarker": 1 "literature": 1 "tetraploidy cells ": 1 "inflammation": 1 "tumour": 1 "biological outcome": 1 "modifications": 1 "mat": 1 "pathological output": 1 "forward": 1 "drug treatment and effects": 1 "gene function": 1 "steady-state mkt-077 ng/105 cells": 1 " rxr2dr1": 1 "frequency percentage": 1 "metabolic enzymes": 1 "malignancies showing promising results": 1 "up regulated pathways": 1 "rosiglitazone": 1 "screened": 1 "ccnd2": 1 "associated cancers": 1 "pediatric tumors targeted in studies": 1 "hyperactivity": 1 "transcription factors": 1 "functional class": 1 "angiogenesis inhibitor": 1 "secondary transcriptional targets": 1 "mast cells": 1 "cough": 1 "ihcc": 1 "mutated genes": 1 "ref .": 1 "host factors identified": 1 "mirna regulation validation method": 1 "rar?-rxrdr5": 1 "target niche and cells": 1 "brdu-positive cells ": 1 "tyr1148": 1 "logp": 1 "modifications of gene expression": 1 "down-modulated genes containing sp-1 binding sites": 1 "drug substrates": 1 "interactions with drug target genes": 1 "anti-metabolites": 1 "mw": 1 "biological pathways": 1 "antigen-based": 1 "go processes": 1 "dyspepsia": 1 "name/id": 1 "version/date": 1 "morph/grade": 1 "no": 1 "cell cycle dysregulation": 1 "mouse genomic changes": 1 "metabolic disease": 1 "sle features": 1 "gppnhp": 1 "microarray fc": 1 "pre-clinical": 1 "cell cycle regulators": 1 "virus family": 1 "induced cancer": 1 "trend in resistance": 1 "kcat s?1": 1 "ecologic niche": 1 "autoinmune biomarker": 1 "centromere fragments": 1 "malignancy and target screened": 1 "current status": 1 "?0.22": 1 "56h": 1 "tumor trp53 status": 1 "transplantation experiments": 1 "c - myc": 1 "recycling": 1 "ligase": 1 "targeting agents": 1 "groups of chemical compounds": 1 "lung airways disorders": 1 "structure": 1 "therapeutic approach": 1 "100": 1 "modern application": 1 "peak #": 1 "clinicopathological characteristics": 1 "corresponding genes": 1 "ecm components": 1 "rar?af2": 1 "r1": 1 "r3": 1 "r4": 1 "blood cancers": 1 "known characteristics in cd4+ t helper cells": 1 "go_id": 1 "28°c-96 hpf": 1 "mutual information values": 1 "nerve disorders": 1 "identified nodes nitroproteins": 1 "injury": 1 "protein candidate": 1 "spot #": 1 "14": 1 "incubation time": 1 "16": 1 "tumor expression": 1 "sirnas per gene": 1 "120": 1 "hut78 cells": 1 "clinical trials/mechanism": 1 "regulated regions": 1 "3?utr targeted genes": 1 "il-6": 1 "12 h": 1 "il-8": 1 "compound treatment*": 1 "parent protein": 1 "activity": 1 "ome": 1 "exemplary tools &url": 1 "treatment species": 1 "subcollections": 1 "effects on host cells": 1 "11s": 1 "fields/well": 1 "investigators references": 1 "mouse model of kidney diseases": 1 "significant interactions": 1 "mit": 1 "oligo": 1 "retinoid nuclear receptors": 1 "variables": 1 "strategies": 1 "cell cycle stage ": 1 "gilz effects": 1 "egfr tyrosine phosphorylation sites": 1 "chemical-biological characteristics": 1 "stage-specific module": 1 "uorf": 1 "delivered drugs": 1 "epigenetic effect": 1 "blastocyst 1 & 2": 1 "vmax µmol/mg/min": 1 " m+h + or m-h -": 1 "budding systematically assessed? scoring method reference": 1 "curcumin 17-bis- 4-hydroxy-3-methoxy-phenyl-hepta-16-diene-35-dione": 1 "diploidy cells ": 1 "48": 1 "cell type": 1 "control subjects": 1 "neurons": 1 "cd44": 1 "kinases": 1 "- synaptogenesis": 1 "neurogenesis": 1 "tumor suppressors": 1 "aids": 1 "coagulation factors": 1 "substrate": 1 "treatment name": 1 "p38-activationb": 1 "trp53 genotype": 1 "dgtp pmol/106 cells ±sem": 1 "modification": 1 "binding protein": 1 "fdr q-val": 1 "mrna level induced cells i": 1 "mirna function": 1 "target cancer": 1 "collagen-related proteins": 1 "cd4+": 1 "hormone receptor genes": 1 "tumor types": 1 "regulation/expression": 1 "rar?af2": 1 "rh/100": 1 "signaling cascade/effect": 1 "selected down-regulated genes": 1 "qualitative and quantitative free dna changes": 1 "phosphorylation sites": 1 "related pathology": 1 "cell surface markers": 1 "macrophages": 1 "common": 1 "types of cancer involved": 1 "definition": 1 "tumorigenesis": 1 "clusters": 1 "classification of toxins": 1 "single pulse - 0.5 h 4 h": 1 "b220+": 1 "cases": 1 "dna repair gene": 1 "clinical uses/trials": 1 "david ids": 1 "b-h p-value": 1 "* epithelial markers": 1 "drosophila model": 1 "vaccine": 1 "thyroid disorders": 1 "formula": 1 "embryos recovered": 1 "compound/drug company": 1 "clinical phase": 1 "special issues": 1 "igg": 1 "cell-cycle control genes": 1 "shared features": 1 "ocular regions": 1 "molecular interaction": 1 "mangolian gerbils": 1 "thimax": 1 "inhibitor types": 1 "tcr??": 1 "expected genes": 1 "actual or clinically tested treatments": 1 "related disorders": 1 "rxraf2": 1 "msto-211h": 1 "13-mtd µg/ml": 1 "thiol compounds": 1 "region and method": 1 " 5 year survival": 1 "total probes": 1 "antibody": 1 "swelling": 1 "pathophysiological effect": 1 " enlarged cells sb203580a": 1 "factor dependent risk levels for pc": 1 "network id": 1 "interacting proteins": 1 "30 *": 1 "cell signalling molecules": 1 "expected hits a": 1 "type/nature/class": 1 "combinations": 1 "kegg pathways": 1 "sghv proteins orfs in brackets": 1 "mammals": 1 "inhibitor/chemical": 1 "cd8+": 1 "amino acid sequences": 1 "western blotting using individual recombinant p proteins": 1 "key genes": 1 "p-value b": 1 "tumor diseases": 1 "sept3 - gdp": 1 "le c": 1 "rnd partner": 1 "causes": 1 "selected up-regulated genes": 1 "axo + /xeno -": 1 "top functions and diseases": 1 "tumor cells": 1 "p value of methylated genes": 1 "swi/snf components in mammals": 1 "integrin": 1 "hub genes": 1 "cell-based studies and xenografts": 1 "functional categories": 1 "taxanes": 1 "name space": 1 "genes in ingenuity network*": 1 "mitochondrial tigo category down-regulated": 1 "colon cancers": 1 "epigenetic marker": 1 " mkt-077 µg/ml": 1 "hits": 1 "circgfp - ringgfp": 1 "site": 1 "?siv": 1 "candidate genes": 1 "# plates": 1 "- alterations of dendritic function": 1 "sept2 - gdp": 1 "bacterial factors": 1 "responses": 1 "technique & application examples": 1 "mammary tumor": 1 "freq of mutation ": 1 "top biological functions": 1 "other molecules": 1 "insult": 1 "16671": 1 "16°c-48 h": 1 "go biological processes": 1 "no of groups": 1 "down-regulated genes fi?0.50 §": 1 "nox isoforms": 1 "rt min": 1 "ms/ms fragments": 1 "activate adcc*": 1 "inflammation 23 genes": 1 "middle genes": 1 "saos-2/lm7 log2": 1 "genes id": 1 "mechanisms": 1 "tsgs": 1 "predicted activation state": 1 "mutational hotspot": 1 "prostaglandin": 1 "avt-5daysbc": 1 "lung cancers": 1 "tyr992": 1 "biomarker": 1 "molecular target": 1 "clinicaltrials.gov identifier": 1 "techniques": 1 "category*": 1 "total cluster numbers": 1 "- activation of signaling cascades": 1 "intervention": 1 "biological functions": 1 "biological activity": 1 "challenges": 1 "corrected p": 1 "target cells": 1 "effectors": 1 "co2h": 1 "head and neck cancers": 1 "abdominal pain": 1 "expressing tumor type": 1 "potential pitfalls": 1 "profibrotic signalling pathways": 1 "validated": 1 "associated tumors": 1 "infectious biomarker": 1 "traditional application": 1 "leukoderma": 1 "tcm": 1 "clinical application": 1 "implementation": 1 "cr effects": 1 "major findings supporting pro-tumorigenic role of ampk": 1 "reprogramming effect": 1 "adaptor": 1 "groups": 1 "cardiovascular diseases": 1 "products name": 1 "glossina secretome proteins": 1 "accession numbers": 1 "analysis name": 1 "cancer correlation": 1 "- epigenetic changes": 1 "statins": 1 "variable": 1 "stages": 1 "15mer": 1 "locus": 1 "parkinson's disease": 1 "demographics": 1 "biological processes bp": 1 
"cell line": 97 "cell lines": 20 "reference": 14 "cell type": 12 "gene": 9 "p": 7 "ref.": 7 "proliferation": 7 "references": 6 "mirna": 6 "rpe": 6 "iridophore": 6 "melanocyte": 6 "pe a": 5 "embryo": 5 "origin": 5 "differentiation": 5 "apoptosis": 5 "control": 5 "rpe b": 5 "ebs scored": 4 " of beating ebs": 4 "50ci": 4 "notes": 4 "ref": 4 "sam q-value": 4 "48 h": 4 "cytoband": 4 "24 h": 4 "sictr": 4 "genbank id": 4 "hugo_symbol": 4 "sicdt2": 4 "75ci": 4 "tumor type": 4 "construct": 4 "compound": 4 "genotype": 4 "conc µm": 4 "drug": 4 "2log ratio": 4 "72 h": 3 "ic50 ?m": 3 "success": 3 "pcc": 3 "analyte": 3 "k-ras": 3 "source": 3 "target": 3 "effect": 3 "stimulus": 3 "treatment": 3 "#1": 3 "#2": 3 "stage": 3 "cell groups": 3 "37": 3 "agent": 3 "hpsc vs mrc5 relative expression": 3 "biological responses": 3 "?": 2 "ec 50 ? 48?h": 2 "targeted cell": 2 "wildtype": 2 "e12.5": 2 "apoptosis index": 2 " g1/g0": 2 "ec 50 ? 24?h": 2 "n": 2 "s": 2 "tissue origin": 2 "pri-mir-17": 2 "pri-mir-21": 2 "e14.5": 2 " apoptotic": 2 "cell functions": 2 "mutation": 2 "cell": 2 "inhibitors": 2 "cancer type": 2 "comments": 2 "p-value": 2 "histology": 2 "protein": 2 "dinr-ri": 2 "mesenchymal": 2 "phenotype": 2 "rtk": 2 "p1a": 2 "description": 2 " necrotic": 2 "cell count control": 2 "p53 status": 2 "rhox5": 2 "gpcr": 2 "cell lines 2 ": 2 "cell cycle": 2 "gal4": 2 "patient": 2 "pri-mir-10b": 2 "g2/m": 2 " s": 2 "braf": 2 "mda-mb-435": 2 "37/40": 2 "h-ras": 2 "mirnas": 2 "dinr-ca": 2 " g2m": 2 "mda-mb-231": 2 "dinr": 2 " binucleated": 2 " micronuclei a": 2 "est se": 2 "p -value": 2 "g0/g1": 2 "incubation time h": 2 "30": 2 "expression": 2 "p value 1": 2 "pri-mir-9": 2 "48": 2 "p-value *": 2 "control sirna": 2 "ic 50": 2 "50": 2 "treated": 2 "epithelial": 2 "cell size after genetic manipulations µm2": 2 " viable": 2 "emt-6": 2 "reported effects of mirna manipulation": 2 "cells": 2 "positivity": 2 "untreated": 2 "method": 2 "ed50": 2 "response of cell": 2 "ed75": 2 "cell cycle progression": 2 "cell viability": 2 "cell viability ": 2 "cytoplasm": 2 "res ?m": 2 "": 1 "ccc": 1 "human cell line": 1 "origin of cancer tissue": 1 "ccm": 1 "97 100.0": 1 "growth inhibition 2 by tgf? 1": 1 "parental virus": 1 "cell cycle distribution ± se": 1 "ano1 oe": 1 "erbb4 expression ": 1 "gene name": 1 "ovarian cell lines with increased proliferation": 1 "+": 1 "glu": 1 "2": 1 "untreated sh-sy5y": 1 "4": 1 "6": 1 "cellular": 1 "8": 1 "cell source": 1 "ic50 nemorosone ?m": 1 "p-gp 1": 1 "100 mg/kg": 1 "galangin": 1 "tyrosine kinases": 1 "?-catenin translocation": 1 "cardiomyocyte diameter": 1 "pgc1": 1 "pgc2": 1 "cell type marker": 1 "cancer stem cells": 1 "mel-ho": 1 "density": 1 "fisher’s exact test": 1 "fold change wt/ko qpcr": 1 "osteopontin": 1 "2?1": 1 "abbreviation": 1 "histological subtypes": 1 "invasion": 1 "csc source": 1 "bpr1j-097": 1 "cell wall": 1 "egc3": 1 "egc2": 1 "egc1": 1 "mcf10at": 1 "conc.": 1 "csc marker": 1 "cd44 protein": 1 "total number ommatidia": 1 "cxcr3": 1 "forward per cell": 1 "cxcr2": 1 "time-point": 1 "dose bgb324": 1 "homel-l1": 1 "cxcr4 expression": 1 "concentrations m": 1 "ag ?": 1 "observed phenotype ": 1 "melanocyte vs iridophore": 1 "cxcr4": 1 "pvl adult": 1 "egfr": 1 "blood vessel": 1 "neural": 1 "cell membrane": 1 "extracellular/blood insulin": 1 "t/n2": 1 "diabetes type": 1 "metabolic parameters": 1 "mature follicle": 1 "ic50 µm ± sem": 1 "ic50 fold increase": 1 "?runx 1/aml1 pu1 c/ebp?": 1 "multi-type": 1 "g2/m ": 1 "apoptotic fraction ": 1 "corpus luteum": 1 "mice born": 1 "nvp-bez235": 1 "cancer": 1 "intracellular insulin": 1 "sirna for": 1 "indels": 1 "mirna in rr cell lines": 1 "t/n/m stage": 1 "channel": 1 "cm3": 1 "ic50's nm": 1 "melan-a2 melanocytes": 1 "cell strain": 1 "cell line from xenograft": 1 "cancer cell line": 1 "similar": 1 "lgsh": 1 "birth": 1 "epithelial solid tumors": 1 "tumor-id": 1 "proliferation rate ": 1 "bm transplantation": 1 "dpc4/smad4": 1 "corresponding xenograft": 1 "e16.5": 1 "mda-mb-361": 1 "cell growth inhibition ratios ": 1 "expression levels": 1 "tp421 exposure h": 1 "proposed mechanism": 1 " tunel positive without tnf-?": 1 "jasmonate": 1 "kcl22": 1 "mirnas that decreased cell viability": 1 "rheb-ri": 1 "subcellular fraction": 1 "er +": 1 "primary follicle": 1 "k562": 1 "93.2 ± 5.5": 1 "pha-767491 ic50 ?m": 1 " cell sizeb": 1 "ic50 ?mol/l": 1 "hdac inhibitor": 1 "intracellular ide activity": 1 "homel-a1": 1 "multi-potency of differentiation": 1 "ecc2": 1 "ecc1": 1 "branch length": 1 "lamv unpolarized": 1 "mog epitope": 1 "ovary": 1 "esc": 1 "species": 1 "rosiglitazone + as601245": 1 "properties of the cell line": 1 "remodeling": 1 "flux per cell versus proliferation rate": 1 "csc characterization": 1 "function": 1 "cell migration of control": 1 "hormones estrogen progesterone": 1 "empty vector": 1 "alp": 1 "ips reprogramming": 1 "intracellular pathways": 1 "?mll fusions pml-rar? am?1–eto": 1 "200": 1 "ic50 ng/ml ± s.d.": 1 "characterisation": 1 "larval stages": 1 "essential oils": 1 "cell line transfectant or treatment": 1 "flux per cell versus protein synthesis rate": 1 "pkc": 1 "vav plasma membrane localization": 1 "chip assay": 1 "cardiomyocyte loss": 1 "melanoma cell line": 1 "resting cell": 1 " a increase": 1 "adult stages": 1 "concentration ? 1 ? 25 oh2d3": 1 "transfected subunit": 1 " jas conc range vehicle": 1 "flux per cell volume versus proliferation rate": 1 "34.7 ± 10.4": 1 "stem cell type": 1 "source of ros": 1 "cell sample": 1 "medulla": 1 "somatic nonsense mutations": 1 "cholera toxin": 1 "5025": 1 "donor cell type": 1 "?jak2 jak3 bcr-abl": 1 "dhaccm": 1 "tki-258": 1 "ifn-?": 1 "non-binucleated": 1 "lamv polarized": 1 "tissue of origin": 1 "mw kda": 1 "growth factor": 1 "ommatidium cell size ?m2": 1 "grade": 1 "56.5 ± 8.2": 1 "cell effect": 1 "cell line*": 1 " cell death": 1 "ssea1": 1 "igf-1r": 1 "cell group": 1 "periplasm": 1 " tunel positive 20 ng/ml tnf-?": 1 "tumor cell": 1 "stem cell system": 1 "bisulfite sequencing": 1 "cell line time point 3": 1 "tumorigenicity": 1 "fgfr3 status/expression level": 1 "endothelial": 1 "erbb2 ": 1 "tumor size cm": 1 "e14 stem cell": 1 "immortalizing agent": 1 "pluripotency marker expression": 1 "pi3k": 1 "cell death ic50 24 hours post-passage": 1 "effect proliferation": 1 "snvs": 1 "direct cell line establishment": 1 "growth upregulation a549/12.2": 1 "tumor": 1 "metalloproteases": 1 "pdgf-r?": 1 "proliferative response": 1 "methylation level": 1 "antagonist": 1 "csc culture conditions": 1 "her-3": 1 "her-2": 1 "her-4": 1 "irid vs mel": 1 "morphology and cytoskeletal organization": 1 "histological subtype": 1 "cell number cells/well": 1 " positive mfi": 1 "incidence ": 1 "pancreatic cell line": 1 "oviductal epithelium": 1 "name": 1 "mutation rate": 1 "proliferation gi 50 nm": 1 "pinch1 sirna": 1 "quercetin": 1 "allele substitution": 1 "angularity2": 1 "disease": 1 "xiap sirna": 1 "gbm-generic": 1 "11q13 amplification": 1 "doubling time h": 1 "24 hours": 1 "p16 ink4a": 1 "cell morphology": 1 "time": 1 "genomic instability": 1 "ic50 ± sd mg/ml": 1 "tissue": 1 "p53 wt": 1 "p53": 1 "electroporated": 1 "somatic snvs": 1 "mirnas that increased cell viability": 1 "120 hours": 1 "endothelial cell survival 4": 1 "dna methylation analysis": 1 "rtks": 1 "after 3 days n6/n7 - n6l": 1 "ets1": 1 "cell line #": 1 "preingression epiblast + su5402 fgfr": 1 "endothelial cell growth 3": 1 "bmp2a": 1 "bmp2b": 1 "age/gender": 1 "transfection reagent": 1 "ec50 ?m": 1 "confidence intervals ?m": 1 "pai?11": 1 "flt-3": 1 "mir296": 1 "mir298": 1 "fisetin": 1 "membrane ins.": 1 " polarized": 1 "autophagy activity factor aaf mean ± sd": 1 "kaempferol": 1 "metastasis": 1 "mlh1ihc": 1 "ve-822": 1 "curcumin concentration": 1 "egfr expression ": 1 "45.8 ± 2.5": 1 "vbs a": 1 "decreased adhesion": 1 "projected cell area": 1 "differentiated sh-sy5y ra 6 days": 1 "reverse": 1 "target gene/pathway": 1 "oct4sox2 nanog": 1 "somatic indels": 1 "average doubling time/hours ±sd": 1 "copy number markers": 1 "intramyocardial lipid": 1 "membrane": 1 "predictive effect": 1 "mutator phenotype": 1 "malignant": 1 "smad4 status 1": 1 "gi 3 ": 1 "chimeras": 1 "luteolin": 1 "ca19-9 u/ml": 1 "preingression vs lateral epiblast": 1 "combination": 1 "strain": 1 "cell line used": 1 "treated r115777": 1 "?": 1 "?": 1 "effects": 1 "methylation": 1 "normal stem cells": 1 "lsc": 1 " inhibition of cell": 1 "nonhematopoietic cafs myoepithelial cells ecs pericytes": 1 "techniques used": 1 "rosiglitazione": 1 "co sirna": 1 "rt-pcr": 1 "tp53 status": 1 "abca1 ?/?abcg1 ?/?": 1 "number of cell lines": 1 "t286 dependent? a": 1 "63.8 ± 1.5": 1 "sample source": 1 "student’s t-test p-values": 1 "cardiac mass": 1 "age/sex": 1 "tumor entities": 1 "morphological change ‡": 1 "?n-ras k-ras": 1 "ic501 ? m": 1 "percent apoptosis ": 1 " of indels in dbsnp": 1 "le2 µg": 1 "vegf-r2": 1 "treatments": 1 "piwil2": 1 "fold increase 120 h/24 h": 1 "rpkm": 1 "a ic50 µm": 1 "cell cycle and growth": 1 "mtdna": 1 "ki ?m": 1 "cell line/condition": 1 "tissue / cell lines": 1 "g0/g1 ": 1 "mcf7 her2/18": 1 "cxcr4–cxcr7 expression": 1 "chemical": 1 "rpkm counts": 1 "class i mutations induce proliferation or inhibit apoptosis": 1 "adult": 1 "sf2": 1 "cytokines and growth factors vegf igfs tnf ? cd40 il-1 il-6 il-10 il-11 il-15 il-21 hgf bfgf sdf-1 tgf ? lif osm mip-1 ? wnts": 1 "organ": 1 "mirna functions": 1 "miscellaneous": 1 "bl": 1 "ly294002": 1 "abt-869": 1 "ic 50 ? m ": 1 "3535": 1 "preingression epiblast + ly294002 pi3k": 1 "nec cell lines": 1 "ovarian carcinoma sample": 1 "dha": 1 "cytosol": 1 "ci": 1 "migration factor": 1 "23.0 ± 4.2": 1 "for example multiple myeloma": 1 "e11.5": 1 "sample": 1 "jurkat": 1 "cell ic50 ?m": 1 "mdamb231": 1 "deleted": 1 "body condition score2": 1 "a vessel count": 1 "dna repair mechanism/enzyme": 1 "receptor status": 1 "su5402": 1 "outcome measures": 1 "dmso": 1 "reaction type": 1 "mcf7": 1 " growth inhibition": 1 "rpe vs iridophore": 1 "cell line group": 1 "after 24 hours n6/n7 - n6l": 1 "ec": 1 "ic 50 ?m *": 1 "cellular morphology": 1 "ipsc3": 1 "resistant against": 1 "ipsc1": 1 "dose um": 1 "ipsc2": 1 "count": 1 "105 100.0": 1 "agonist": 1 "permissiveness": 1 "1?8": 1 "hsc": 1 "mean fluorescence intensity mfi": 1 "fa": 1 "decreased migration": 1 "differentiation induced cell death dicd": 1 "percent of brdu+ cells": 1 "cell process": 1 "c1/c2?=?2n2-n1": 1 "vemurafinib sensitive/resistance origin": 1 "proteases cathepsin b and d elastase upa plasmin mmps e.g mmp-1 -2 -3 -9": 1 "human": 1 "sk-br-3": 1 "?h2ax": 1 "5530": 1 "e13.5": 1 "cosmic genes": 1 "gprc": 1 "ic25": 1 "codon": 1 "schedule": 1 "muscle cell type": 1 "class ii mutations inhibit differentiation or induce immortalization": 1 "transfectants": 1 "increased proliferation": 1 "hepg2 transfected with hbx plasmid 2 ?g dna": 1 "lenvatinib": 1 "ic50": 1 "sorafenib": 1 "tumor location": 1 "sample id": 1 "ratio ?m": 1 "self-renewal": 1 "supplier": 1 "fibronectin laminin collagen proteoglycans thrombospondin fibrinogen elastin fibrin tenascin tetranectin": 1 "model": 1 "cell line hcc827": 1 "lower": 1 "culled cow carcass weight kg": 1 "secondary spermatocyte": 1 "kinase": 1 "elongated spermatid": 1 "growth inhibition mean ± sd": 1 "extracellular matrix ecm": 1 "tlr- expression": 1 "ic75": 1 "plate": 1 "tumor cell origin": 1 "xenograft": 1 "ic50 nm†": 1 "39.2 ± 1.8": 1 "rheb": 1 "lineage conversion": 1 "m5": 1 "rbms3": 1 "pet counts cpm": 1 "tie2 ac50 µm": 1 "300": 1 "snp": 1 "e15.5": 1 "decreased proliferation": 1 "ic90": 1 "leydig cell": 1 "functional class": 1 "nonhematopoietic fibroblasts/bmscs chondrocytes ocs obs ecs": 1 "aza induction of cd44 mrna": 1 "sub-g1": 1 "assessed parameter": 1 "spermatogonium": 1 "mutations": 1 "mc": 1 "pertussis toxin": 1 "total volume ml": 1 "patient no": 1 "o2": 1 "hematopoietic hscs bm-derived ceps hematopoietic and mesenchymal progenitor and precursor cells nk cells nkt cells macrophages t and b lymphocytes dcs monocytes platelets megakaryocytes erythrocytes": 1 "diagnosis": 1 "matrine": 1 "primary spermatocyte": 1 "spr": 1 "50 mg/kg": 1 "ssea3/4": 1 "library gene": 1 "colony-forming aefficiency ": 1 "mean met ± sd pg/µg": 1 " b decrease": 1 "total": 1 "progeny carcass fat1": 1 "subtype": 1 "signalling": 1 "mutated": 1 "kras status": 1 "100": 1 "tp53 codon 72": 1 "sitrpc1": 1 "properties": 1 "remarks": 1 "lymphoma**": 1 "fold change wt/ko": 1 "cxcl12 role": 1 "progeny carcass conformation1": 1 "hepg2 transfected with hbx plasmid 1 ?g dna": 1 "s ": 1 "adult stage": 1 "intracellular insulin-rb heterodimers": 1 "csc isolation": 1 "tissues": 1 "cell line type": 1 "lec µm": 1 "reference sequence": 1 "mrna": 1 "28.0 ± 4.2": 1 "mes ic50 ?m": 1 "p53 mutation 2": 1 "horse": 1 "tumori genicity": 1 "molm14-luc+treatment": 1 "clinicopathology": 1 "il-2": 1 "il-4": 1 "mutant p53 expression": 1 "combination analysis": 1 "array e12.5": 1 "cytokines and growth factors vegf hgf/sf bfgf pdgf ? / ? tgf ? / ? il-1 il-6 tnf ? gm-csf csf-1 igf-1/2 egf sdf-1": 1 "primary cells or cell lines": 1 "tlr2 ": 1 "12 h": 1 "20": 1 "e17.5 embryo": 1 "24": 1 "cannabinoid": 1 "enzymes": 1 "shndpk-b secretion": 1 "stem cell types": 1 "derived from": 1 "sd": 1 "as601245": 1 "number of branches": 1 "ic 50 n": 1 "benign": 1 "vector": 1 "cancer tissues": 1 "sr": 1 "35": 1 "36": 1 "childhood": 1 "38": 1 "39": 1 "adhesion": 1 "reprogramming factors/systems": 1 "teratoma formation": 1 "cell growth inhibition ratio ": 1 "40": 1 "preingression epiblast + u0126 mapk": 1 "for example breast cancer": 1 "hematopoietic tam t and b lymphocytes neutrophils nk cells mesenchymal stem cells": 1 "41": 1 "42": 1 "43": 1 "ratio": 1 "44": 1 "45": 1 " of snvs in dbsnp": 1 "46": 1 "47": 1 "transfected molecule": 1 "49": 1 "somatic frameshift indels": 1 "9545": 1 "cell cycle analysis of total cells": 1 "decreased tumoral xenograft growth": 1 "testis": 1 "cell line derived from": 1 "fak sirna": 1 "descriptions": 1 "ovarian cancer cell lines": 1 "anti-?1 integrin antibody": 1 "cell type/condition": 1 "trophoblast": 1 "51": 1 "method of vdr detection": 1 "52": 1 "par ic50 ?m": 1 "53": 1 "54": 1 "55": 1 "function/physiological role": 1 "doubling time ? h": 1 "tumour bincidence": 1 "6040": 1 "irid vs rpe": 1 "mirna in rs cell lines": 1 "round spermatid": 1 "plasmid dna *": 1 "treatment condition": 1 "nucant": 1 "higher": 1 "cell line tested": 1 "chimera formation": 1 "cancer cell lines": 1 "embryos transferred": 1 "b16f1 melanoma cells": 1 "52.5 ± 9.5": 1 "cell localization": 1 "microenvironment": 1 "nec genes": 1 "paired b-lcl": 1 "cell migration": 1 "72": 1 "wt": 1 ">g2/m": 1 "abnormal invagination l4 stage": 1 "normal": 1 "resistance factor": 1 "cxcl10-": 1 "metastatic": 1 "ccl2.": 1 " numbera": 1 "8?1": 1 "migration": 1 "tnm-stage": 1 "pupal stages": 1 "molecular type": 1 "upar1": 1 "atcc #": 1 "hela": 1 "type": 1 "nsaid": 1 "antibody": 1 "anol oe-induced": 1 "cell number ic50 72 hours post-passage": 1 "proneural": 1 "secreted": 1 "resistance": 1 "effects of hdac inhibitor": 1 "binucleated": 1 "ras status": 1 "secondary follicle": 1 "cell type/line": 1 "?flt3-itd ckit pdgfr tel-pdgfr fgfr": 1 "fibrosis": 1 "pd173074": 1 "ci mean ± s.d.": 1 "mdm2 snp309": 1 "signature": 1 "somatic non-synonymous snvs": 1 "classical": 1 "median range": 1 "apoptosis ": 1 "renilla ng": 1 "?p53 nf1": 1 "runx2a": 1 "proteasome inhibitor": 1 "nvp-bkm120": 1 "siorai1": 1 "pi3k-dn": 1 "sirna treatment": 1 "cell proliferation": 1 "ms-mlpa": 1 "nucleus": 1 "reference no.": 1 "activated cell": 1 "pten status": 1 "initial ed 50 ?m a": 1 "pseudopeptide multivalent": 1 "progeny carcass weight kg": 1 "liquid": 1 "metastatic site": 1 "gi ": 1 "mirna expression": 1 "msp": 1 "cell debris": 1 "her1": 1 "her2": 1 "sst0116cl1 ic50 ± sd ?m": 1 "vec": 1 "plating efficiency": 1 "gene/bta": 1 "hgsh": 1 "tissue type": 1 "* ic50 ?mol/l ± sd": 1 "putative target": 1 "p53 mut/null": 1 "main oncogenic events": 1 "her2 +": 1 "cancer species cell line": 1 "proteases upa plasmin mmps e.g mmp-2 -9": 1 "i? translocation": 1 "tumourigenesis in recipients": 1 "36.7 ± 6.5": 1 "hct116": 1 "pkc412": 1 "alterated oncogenic pathway": 1 "molm14-luc+ treatment": 1 "fibronectin laminin collagen proteoglycans glycosaminoglycans": 1 "5-fu ?m": 1 "cxcl12 expression": 1 "cd44 mrna": 1 "zol": 1 "melanocyte vs rpe": 1 "pathway/biological process": 1 "hematological tumors": 1 "c-kit": 1 "mitochondria": 1 "4?1": 1 "mda 231 in ": 1 "cd3": 1 "vegfr2.": 1 "observation/result": 1 "m-spike": 1 "ic50 * ?mol/l ± sd": 1 
"p value": 157 "p -value": 105 "p-value": 52 "fdr": 42 "95 ci": 39 "hazard ratio": 37 "category": 32 "gene": 26 "group": 26 "term": 26 "univariate analysis": 24 "ratio": 24 "mean": 23 "n": 22 "variable": 21 "hr": 19 "pathway": 18 "count": 18 "genotype": 18 "p": 15 "variables": 15 "strain": 14 "95 confidence interval": 12 "multivariate analysis": 12 "hr 95 ci": 11 "benjamini": 11 "fold enrichment": 11 "parameter": 11 "gene count": 10 "genes": 10 "univariate": 10 "gene symbol": 10 "rank": 10 "symbol": 10 "fold change": 10 "go term": 9 "significance": 9 "function": 9 "characteristic": 9 "": 8 "1": 8 "2": 8 "correlation": 8 "number": 8 "source": 8 "parameters": 8 "gene name": 7 "3": 7 "multivariate": 7 "log2 fc": 7 "sd": 7 "median range": 7 "p - value": 7 "odds ratio": 6 "enrichment": 6 "? 2 value": 6 "enrichment score": 6 "log2": 6 "fold-change": 6 "cases": 6 "microarray": 6 "qpcr": 6 "reference": 6 "hazard ratio 95 ci": 6 "value": 6 "score": 5 "#": 5 "sample size": 5 " mean": 5 "protein": 5 "z score standardized processing": 5 " range ": 5 "name": 5 "probeset": 5 "negative": 5 "mean ": 5 "gene id": 5 "positive": 5 "adjusted": 5 "nominal": 5 "p value fdr adjusted": 5 "z score arrayexpress": 5 "mirna id": 4 "4": 4 "size": 4 "mirna": 4 "multivariable analysis": 4 "control group": 4 "comparison": 4 "log2 fold change*": 4 "overall survival": 4 "auc": 4 "up/down expression": 4 "n?=?3": 4 "relevance score": 4 "hazard rate ratio": 4 "score 3": 4 "score 2": 4 "fc bin": 4 "distance cm": 4 "n ": 4 "2???ct": 4 "array a hsa-mir name-assay#": 4 "characteristics": 4 "median value range": 4 "median os months": 4 "fdr bh": 4 "affymetrix": 3 "5": 3 "t": 3 "30 min": 3 "log2 ratio": 3 "p-erk": 3 "unclassified": 3 "mean score": 3 "signaling pathway": 3 "factors adjusted for in multivariate analysis": 3 "sham group": 3 " m_craf/m_wt": 3 " f_craf/f_wt": 3 "nes": 3 "enrichment p -value": 3 " 95 ci": 3 "expected": 3 "strains": 3 "relevant genotype": 3 "no ": 3 "oncomorphic": 3 "no.": 3 "go id": 3 "annotation cluster 1": 3 "median": 3 "overall": 3 "s.e.m.": 3 "factor": 3 "case": 3 "grouping": 3 "3 min": 3 "erbb4-ko": 3 "source/reference": 3 "adjusted p value": 3 "1 h": 3 "5 min": 3 "proteins": 3 "ci": 3 "clinical parameter": 3 "pathways": 3 "end-point": 3 "chi-square": 3 "p-values": 3 "wtd": 3 "methylation marker": 3 "specimens": 3 "? 2 test": 3 "mi": 3 "or": 3 "std": 3 "p value f": 3 "p value a": 3 "p value m": 3 "cell line": 3 "median pfs months": 3 "bonferroni": 3 "number of patients": 3 "method": 3 "p -value a": 3 "erbb4-kod": 3 "# deg": 3 "sequence": 3 "disease-free survival": 3 "gene number": 3 "factors": 3 "response": 3 "q-value": 2 "r 2": 2 "accuracy": 2 "associated functions": 2 "ipa": 2 "rat": 2 "placebo group": 2 "achievers": 2 "0": 2 " ? r115777": 2 "normalized enrichment score": 2 "r s": 2 "molecules": 2 "gene mutation": 2 "agilent": 2 "multivariable *": 2 "pop hits/total": 2 "h.r .": 2 "p value*": 2 "functional category": 2 "test for significance p ": 2 "p 1 value *": 2 "microrna": 2 "hprd": 2 "pro/pro": 2 "treatment group": 2 "p value of ontology analysis": 2 "precision": 2 "rma": 2 "p - value adjusted": 2 "+ym155": 2 "recovery group": 2 "tt genotype": 2 "regression coefficient": 2 "<0.001": 2 "hazard ratio 95 confidence interval p -value": 2 "multivariate analysis 3 os": 2 "? m-tor group p ": 2 "median time to progression months": 2 "adjusted p-value": 2 "control group n?=?58": 2 "rna-seq e15": 2 "isozyme": 2 "probeset id": 2 "endpoint": 2 "gene ": 2 "mean maximum score": 2 "p-erk1/2": 2 "tp53 codon72 genotype": 2 "2 log? p = 3.56": 2 "end point": 2 "rr b": 2 "pathway source": 2 "description": 2 "gene title": 2 "disease": 2 "gcrma": 2 "unadjusted for covariates": 2 "p 2 value #": 2 "1b n = 2 log? p = 3.72": 2 "item": 2 "median os": 2 "statistical parameter": 2 "standard error": 2 "significant loci": 2 " + r115777": 2 "lof": 2 "low": 2 "t value": 2 "probestes": 2 "p-raf": 2 "adjusted for covariates": 2 "3 4": 2 "r value": 2 "number of genes": 2 "95 confidence iinterval": 2 "biological process": 2 "number of patients n ": 2 "david": 2 "acs group": 2 "regression equation": 2 "md group": 2 "rentgmk+/?": 2 "1 2": 2 "treatment": 2 "rate ratio": 2 "sem": 2 "rt-qpcr": 2 "1c n = 3 log? p = 4.11": 2 "subjects": 2 "covariate": 2 "stage": 2 "score 4": 2 "score 1": 2 "score 0": 2 "patient mean ± sd": 2 "mean 95 ci": 2 "95ci": 2 "arg/arg": 2 "fc": 2 "hr ci 95": 2 "exp count": 2 "origin": 2 "human": 2 "? control group p ": 2 "gq": 2 "disease onset day 13 score": 2 "main effect on function1": 2 "p- value": 2 "id": 2 "?b": 2 "m-tor group n?=?30": 2 "genebank": 2 "univariate cox regression": 2 "group n n=4": 2 "hwe": 2 "treatment effect group": 2 "number of mice with score ?3": 2 "microarray e19": 2 "maf": 2 "th2 mean ± sd": 2 "snp": 2 "score 0-1": 2 "lsb/s/f8 ? lsb/s/f8/chir": 2 "high": 2 "representative go term": 2 "vntr variant": 2 "p -value log mass adjusted": 2 "log2 ratio ca/n": 2 "total": 2 "od": 2 "+dmso": 2 "roc auc 95 ci": 2 "control": 2 "1a n = 1 log? p = 3.31": 2 "observed": 2 "mrp1": 2 "tissues": 2 "univariate analysis pfs": 2 "number of cases": 2 "count/list": 2 "rr": 2 "28": 2 "se": 2 "mir": 2 "z-score": 2 "43": 2 "pro/arg": 2 "mas5": 2 "ratio h/l": 2 "p-jnk": 2 "pathway name": 2 "collection": 2 "msigdb collection": 2 "lsb ? lsb/s/f8": 2 "gsea": 2 "dose ? m ": 2 "0.5 h": 2 "wt": 2 "10 min": 2 "wilcoxon test": 2 "univariate analysis os": 2 "weigh ratio a": 2 "p value fdr": 2 "tg/gg genotype": 2 "analysis variable": 2 "logistic regression": 2 "95": 2 "95 hazard ratio confidence limits": 2 "f-measure": 2 "ingenuity canonical pathways": 2 "p -value 1": 2 "wilcoxon fdr q-value": 2 "auc days": 2 "p-gp": 2 "recall": 2 "wilcoxon p-value": 2 "non- achievers": 2 "median expression": 2 "ipa function": 2 "drug": 2 "group eam n=6": 2 "hr 95 c.i.": 2 "model group": 2 "cam": 2 "group tel-10 n=6": 2 "nuclear grade n ": 1 "median ± se": 1 "references": 1 "? values in regression test": 1 "year": 1 "clinical factor": 1 "telomere": 1 "total gene": 1 "?": 1 "pearson’s correlation": 1 "protein ids": 1 "dysplasia": 1 "this study n=156": 1 "p-value fdr": 1 "global ? 2": 1 "global ? 1": 1 "spry4 ko": 1 "energy": 1 "hr 95": 1 "iii-astro score": 1 "cumulative survival": 1 "qrt-pcr": 1 "hazard ratio for metastasis 95 confidence interval": 1 "pool": 1 "ratio h/l p -value": 1 "in pathway": 1 "crhr2": 1 "on only": 1 "chromosome 3 gene symbols candid score": 1 "6": 1 "flanks": 1 "net ihc score": 1 "7": 1 "significantlymutated domain": 1 "ethnic group": 1 "? effect m-tor vs.control 95 ci": 1 "line-1 methylation †": 1 "57 weeks 35": 1 "enrichment score****": 1 "statistical": 1 "spearman r": 1 "chromosome 14 gene symbols candid score": 1 "multivariate analysis b": 1 "nkps group": 1 "perk1/2 positivity ": 1 "log ratio ?-gal": 1 "result": 1 "summary c": 1 "her2 genotype": 1 "univariate analysis a p -value": 1 "a61603 qpcr": 1 "membranous epex mean ± sem": 1 "number of aberrant crypts": 1 "p value wald": 1 "sets": 1 "density": 1 "id-1 expression": 1 "asymptomatic": 1 "mutant m = 16": 1 "data set": 1 "rassf10 methylation status": 1 "recurrence group": 1 "genotypes *": 1 "median progression-free survival months": 1 "m": 1 "median tumortissue": 1 "q": 1 "r": 1 "included parameters": 1 "percentage ": 1 "x": 1 "t-test adjusted p-value": 1 "syp auc": 1 "random permutation p -value": 1 "y": 1 "fold enrich.": 1 "long-term pre-bi cell growth/mouse": 1 "acc": 1 "notes": 1 "controls": 1 "pfs at 6 months": 1 "log-rank test p -values": 1 "-log10 p-value": 1 "end-res": 1 " of genes in category": 1 "nominal p -value": 1 "5-year survival rate ": 1 "real-time experiment": 1 "time-point": 1 "statistical significance p ": 1 "cells/growth condition": 1 "chr": 1 "ca/normal": 1 "ct value": 1 "cxrt n = 91": 1 "survivin score": 1 "adjusted for pc1+pc2+tgs": 1 "p63/p40 ": 1 "areg": 1 "egfr mean score": 1 "geometric mean of intensities b": 1 "statistical significance": 1 "score 5 n =12": 1 "disease onset day 11 score": 1 "r5020 fpkm": 1 "enrichment score 9.38": 1 "minimal os": 1 "total ratio": 1 "placebo n = 222": 1 "ezh2-dct_normal": 1 "t -value": 1 "rpkm 2": 1 "gene description": 1 "median rank": 1 "95 confidence interval of difference": 1 "functional groups": 1 "gobpid": 1 "minimum rank": 1 "ck5 ": 1 "proliferation index": 1 "sample1": 1 " n = 163": 1 "ratio flanks/urs": 1 "analyte": 1 "fisher's exact test": 1 "group a non-metastatic group": 1 "ttf1 ": 1 "p-akt": 1 " n = 161": 1 "rs4-11": 1 "sample2": 1 "p-met case ": 1 "mean cfu counts": 1 "caf n?=?6": 1 "cancer": 1 "combinations with": 1 "age": 1 "p-value bonferroni": 1 "localization": 1 "non-ibs": 1 "parametric p -value": 1 "pold1": 1 "mrna change not significant 2.0 > × > 0.5": 1 "? effect m-tor vs control 95ci": 1 "ratio m/l normalized": 1 "gst": 1 "fc mel60/mel30": 1 "assays": 1 "two-point lod score of family a and b ?": 1 "fwer": 1 "lung cancer": 1 "normal tissues n = 22": 1 "odds ratio or": 1 "pe qpcr": 1 "n?=?206": 1 "hw test p-value": 1 "cpg3 methylation": 1 "h1 network": 1 "univariate p": 1 "molecular features": 1 "rcc group": 1 "sam score": 1 "oncomirs": 1 "gene set size": 1 "gene set description": 1 "adjusted *": 1 "+/?": 1 "distribution responder + non-responder 2 ": 1 "fdr***": 1 "targetscan 968": 1 "protein id": 1 "pfs": 1 "genotype frequency": 1 "aggregate pct": 1 "median dfi d": 1 "degs library": 1 "1.33 0.00–204.30": 1 "patient question": 1 "signalingnetworks": 1 "poor/fair": 1 "hpv + /hpv ?": 1 "wald ? 2 p -value uk": 1 "lon staining iod ×10 4 a": 1 "group i score": 1 "manufacturer": 1 "q -value": 1 "gabra1": 1 "expression single-task weight rank": 1 "negative n = 151": 1 " standard deviation": 1 "fisher's test": 1 "median log?2": 1 "bdnf": 1 "median expected count": 1 "breast cancer cohort": 1 "fisher’s exact test pvalue": 1 "median p-value": 1 "spearman's correlation": 1 "dmrs ": 1 "positive n = 88": 1 "fdr p value": 1 "seed gene": 1 "sr n?=?6": 1 "cnv": 1 "median pfs": 1 "rac *": 1 "t stat": 1 "adjusted * ratio of proportions 95 ci": 1 "pretreatment ereg level cutoff value median": 1 "functional parameters": 1 "set 2": 1 "p-value kruskal-wallis test": 1 "p-stat3 positivity ": 1 "set 1": 1 "initial score": 1 "markers": 1 "snp ": 1 " immunostained cells": 1 "iv-mean log base 2": 1 "test model": 1 "ii-astro score": 1 "study description": 1 "c-met expression n/": 1 "sd + pd": 1 "savir": 1 "ngbr score": 1 "fdr gsea": 1 "control log2": 1 "pten": 1 "cmap name": 1 "rufy3 a": 1 "correlation with acf size/number": 1 "range 41–89": 1 "n of pathways": 1 "cytokine": 1 "control maf": 1 "aberration mean sd": 1 "sprouty2": 1 "max os": 1 " negative peak mean": 1 "condition": 1 "selection counts*": 1 "thp-1": 1 "prognostic value": 1 "high n = 30": 1 "pfs at 3 months": 1 "percentageb": 1 "biological pathway": 1 "fold by qpcr": 1 "? number ratio": 1 "a431": 1 "cluster gene count": 1 "mean ± sem": 1 "mean ? 1": 1 "cancer type": 1 "rat/human ratio": 1 "down-regulation 19": 1 "units": 1 "lkb1 genotype": 1 "ref.": 1 "mean ? 2": 1 "demon's rank": 1 "mpp group cases": 1 "correlation coefficient r": 1 "tissue/cell compartment": 1 "pdgp group": 1 "wtras n = 48 68": 1 "multifocal tumor": 1 "adjusted for pc1+pc2": 1 "e/a <1": 1 "iii-mean log base 2": 1 "mean methylation": 1 "thames cancer registry": 1 "rentgmk+/+": 1 "ratio er/lr": 1 "nom p value < 1": 1 "gene set enrichment analysis gsea": 1 "median ?ct tgf-?1 mrna": 1 "fold enrichment **": 1 "mutants m = 16 18.6": 1 "nom p value < 5": 1 "number censored": 1 "mean expression ± sd in normal tissue median value": 1 "‘jena_all’": 1 "cluster": 1 "percent of genes in group that are present": 1 "rs#": 1 " mht": 1 "correlation to ki67 proliferation index cells ki67 positive": 1 "benjamini adjusted p value": 1 "protein expression": 1 "pathway/function": 1 "24 h": 1 "events": 1 "patient distribution": 1 "gdm group n?=?30": 1 "hc n = 13": 1 "x 2 value": 1 "spearman": 1 "+ number ratio": 1 "syntenin expression": 1 "beta s.e.": 1 "primary treatment": 1 "median 71": 1 "‘total’": 1 "or p value ci 95": 1 "age 20–40": 1 "tscmko": 1 "items": 1 "cr + pr": 1 "ctrl": 1 "ranking by #ppis": 1 "median survival months": 1 "all cases": 1 "nki": 1 "top canonical pathways": 1 "patients’ cohort n = 101": 1 "pe microarrays": 1 "micrornas": 1 "smad4 status": 1 "lapatinib plus capecitabine": 1 "go category": 1 "95 or": 1 "permutation p-value": 1 "pld+b n = 318": 1 "p value space": 1 "erbb2-": 1 "mapk signaling p = 0.00006 3": 1 "erbb2+": 1 "pathway id": 1 "vitreous length mm": 1 "enriched pathway": 1 "ea group": 1 "comparison model and p value": 1 "ppv": 1 "p value ?2 test": 1 " positive peak mean": 1 "recurrence-free survival months": 1 "no of cases": 1 "dataset": 1 "gse6532 loi": 1 "single mass": 1 "cell lines": 1 "log p -value": 1 "multivariate cox regression": 1 "enrichment p value": 1 "gobpid/gomfid": 1 "mouse": 1 "t n-2": 1 "number n = 90": 1 "score 3 n =18": 1 "top term": 1 "genotype single-task weight rank": 1 "log 2 fc": 1 "fwer p-val": 1 "ref for hr?=?1": 1 "median odds-ratio": 1 "inhibition ratio ": 1 "#bkz hdfs": 1 "rodents only p -value": 1 "# of genes": 1 "# groups": 1 "multivariate analysis - model 1 a": 1 " b log2 ratio amela/mela": 1 "deg number": 1 "debniak et.al n=1210 controls": 1 "standard error se": 1 "group v n=8": 1 "amp-treated group": 1 "age comparison": 1 "4 week": 1 "pvalue*": 1 "nvp-aew541+afatinib": 1 "two-sided fisher's exact test": 1 "insulin resistance": 1 "normal mean log base 2": 1 "rir + dex n = 6–10": 1 "log rank test": 1 "univariate log-rank test p -value": 1 "krt5 auc": 1 "substance": 1 "pictar score": 1 "pooled 3": 1 "pooled 4": 1 "pooled 1": 1 "pooled 2": 1 "target": 1 "pooled 7": 1 "pooled 8": 1 "pooled 5": 1 "pooled 6": 1 "npv": 1 "pooled 9": 1 "apoptosis index a": 1 "target scan analysis": 1 "marker status # of cases": 1 "short": 1 "time": 1 "#hiv interactors": 1 "d247 mg": 1 "array experiment": 1 "relatively stable group n?=?6": 1 "score 4 n =20": 1 "fdr ": 1 "median os mo": 1 "?30": 1 "regulate": 1 "r values in correlation test": 1 "auc 95ci": 1 "p21 a =53.37 å b = 61.69 å c = 71.14å b =107.5°": 1 "++ number ratio": 1 "measures": 1 "msc presen/mscpost-sen": 1 "mv4-11": 1 "patient characteristics": 1 "1 week": 1 "probabilities": 1 "cpg2 methylation": 1 "source/ref.": 1 "dormant dor": 1 "correlation a": 1 "nri": 1 "mean expression ± sd in bc median value": 1 "ihc score": 1 "liver": 1 "overall survival months": 1 "mean combination index range effect": 1 "g test table 2×2": 1 "tf name": 1 "1–10": 1 "fold-change log2": 1 "apc methylation †": 1 "pathological t stage n ": 1 "* actual test range": 1 "study group s": 1 "mean of difference cnb-r": 1 "fold by deg": 1 "rank sum test": 1 "study": 1 "hgf": 1 "differences": 1 "genome $": 1 "?-6/?-3 ratio": 1 "enrichment score 2.43": 1 "clinical characteristics": 1 "aurora-b": 1 "transfac_subcategory": 1 "aurora-a": 1 "overall survival *": 1 "genotype *": 1 "macrophages positive ": 1 "8 week": 1 "fdr < 0.05": 1 "categories": 1 "class comparison": 1 "citogenetic localization": 1 "?=? 7": 1 "genes in go term": 1 "the phosphorylation of akt": 1 "upper 0.95": 1 "vegf/actb": 1 "favorable prognostic factors": 1 "low protein": 1 "genes in group": 1 "overall response rate ": 1 "cancer genes": 1 "mrnas": 1 "treatment setting": 1 "lab_cell line_tf_condition": 1 "geneid": 1 "molecular function": 1 "ezh2-dct_tumor": 1 "cytology": 1 "optimal score": 1 "rrm1 mean ± sem": 1 "95-ci": 1 "mtt od value": 1 "hsa-mir": 1 "mhc restriction": 1 "p value earth": 1 "gene b": 1 "elastic-net feature rank": 1 "?2 value": 1 "p-value wilcoxon test two sided": 1 "first quartile": 1 "npv ": 1 "start position": 1 "mean diff b": 1 "n?=?9": 1 "predicted category": 1 "?": 1 "pcos group n?=?12": 1 "marker": 1 "methylation": 1 "effect": 1 "log10 p": 1 "tcga": 1 "case number": 1 "reference/source": 1 "dmrs number": 1 "upper quartile": 1 "collection$": 1 "drivergenes": 1 "distribution low 2 + high": 1 "rar-? methylation †": 1 "methylated n = 54 60.7": 1 "low proliferating": 1 "ratio h/l normalized": 1 "database": 1 "‘leipzig’": 1 "virvs ctr fdr": 1 "fdr < 25": 1 "count down": 1 "eol-1": 1 "q value": 1 "95 ci for hazard ratio": 1 "mean difference b": 1 "wald ? 2 p -value japan": 1 "enriched sets": 1 "#ppis": 1 "permuted p-value": 1 "crstartend": 1 "tumor size median range": 1 "study and year": 1 "degree-based permutation p -value": 1 "max lod score ?": 1 "cold log2": 1 "test range": 1 "miranda 3733": 1 "transcription factor": 1 "protein*": 1 "bortezomib n = 318": 1 "deg": 1 "worst factor": 1 "up-regulated klb expression × > 2.0": 1 "paired t test": 1 "+++ number ratio": 1 "#proteins": 1 "concordance index": 1 "enrichment cluster 1 score 7.09": 1 "95 confidence interval of hazard ratio": 1 "false discovery rate fdr ": 1 "c-met case ": 1 "mean annual proportion": 1 "c2": 1 "population": 1 "dfs": 1 "fold": 1 "score 2 n =15": 1 "‘berlin’": 1 "test compound": 1 "interpretation": 1 "tag sequence": 1 "hr 95ci": 1 "time h": 1 "2???ct": 1 "ipss score": 1 " a": 1 "ethnicity": 1 "gene set name": 1 "treatment1": 1 "count *": 1 "cdkn2a": 1 "third quartile": 1 "mean ?ct tgf-?1 mrna": 1 "ratio control/crf 24 h": 1 "chimpanzee": 1 "correlation coefficient": 1 "ppv ": 1 "no gene": 1 "mir and a analysis": 1 "fc nevus30/mel30": 1 "refraction d": 1 "validation’s cohort n = 66": 1 "0.00": 1 "published study unadjusted p-value ‡": 1 "0.01": 1 "variables *": 1 "bdlvs ctr fdr": 1 "fisher's p value": 1 "pearson": 1 "nos2/pakt ser473": 1 "maximum": 1 "pictar analysis": 1 "pgsk-3? -": 1 "hmgs": 1 "pgsk-3? +": 1 "gene names": 1 "adjp": 1 "+/hsgal4": 1 "fc nevus60/mel60": 1 "25.19 6.89–37.10": 1 "hrpt2": 1 "0.10": 1 "rassf1a methylation †": 1 "univariate analysis hr 95 ci": 1 "median overall survival months": 1 "response after n": 1 "ratio c2/gst": 1 "brcax-a": 1 "brcax-b": 1 "0.05": 1 "protein names": 1 "antibodies": 1 "p-value unadjusted log-rank": 1 "canonical pathways": 1 "downregulated1": 1 "goterm _cc": 1 "median survival number of patients": 1 "p-akt positivity ": 1 "grouping month": 1 "log bayes factor": 1 "size kb": 1 "adverse event": 1 "official gene symbol": 1 "0.20": 1 "group ii score": 1 "brcax-c": 1 "study design": 1 "brcax-d": 1 "group b metastatic group": 1 "cd4 and cd8": 1 "prognostic factor for svl": 1 "e2f-1 case ": 1 "p-value of wilcoxon rank sum test double sided hypothesis": 1 "wild n = 70": 1 "5 year survival": 1 "basal/non-basal comparison": 1 "standard deviation": 1 "fe": 1 "gene no.": 1 "anti-egfr antibody": 1 "spearman correlation coefficient": 1 "pum2 p -value": 1 "responders ": 1 "rodents only p -value log mass adjusted": 1 "max ?ct tgf-?1 mrna": 1 "age group": 1 "category 1": 1 "cohort": 1 "pathways/ biological functions degs involved in hiv infection/ disease progression": 1 "pooled 10": 1 "genetic position cm": 1 "0.30": 1 "progressive group n?=?6": 1 "lower quartile": 1 "spot no.": 1 "m/z value": 1 "> 7": 1 "category 3": 1 "category 2": 1 "context score": 1 "ps3c_normal": 1 "0.40": 1 "parametric p-value": 1 "activated act": 1 "control n = 32": 1 "allele": 1 "enrichment score correlation coefficient": 1 "fold change act/dor": 1 "p -value **": 1 "subset": 1 "ii-mean log base 2": 1 "space group and cell parameters": 1 "cxrt n = 91 grade": 1 "accession number": 1 "95  confidence interval": 1 "accession no.": 1 "ercc1 positivity ": 1 "univariate cox regression analysis": 1 "cox multivariable analysis p -value": 1 "lower": 1 "normal group n = 15": 1 "men1": 1 "urinary arsenic": 1 "1657.50 1020.00–4855.00": 1 "age weeks": 1 "relative risk": 1 " down": 1 "dge library": 1 "unfavorable prognostic factors": 1 "group n n=6": 1 "rosuvastatin group": 1 "cxrt+r115777 n = 94": 1 "mean severity": 1 "status": 1 "pictar 746": 1 "early apoptosis index": 1 "relative risk cl": 1 "multivariate p": 1 "68 weeks 19": 1 "p-value log rank test": 1 "sequences": 1 "control group n = 35": 1 "case maf": 1 "specificity ": 1 " c log2 ratio amela/lines": 1 "< 7": 1 "t180' genes": 1 "> 10": 1 "cdk6": 1 "chromosomal location": 1 "proliferation": 1 "female n = 33": 1 "treatment group n = 33": 1 "k-ras/gadph": 1 "mutation status": 1 "upregulated1": 1 "1025.72 592.08–4029.94": 1 "criteria no of patients": 1 "urs": 1 "d/c": 1 "risk-matched control group n = 33": 1 "40–60": 1 "bonferroni - corrected p - value": 1 "rawp": 1 "nvp-aew541+gem": 1 "constant": 1 "log2 fold-change": 1 "5-year multivariable cox regression 3": 1 "level of expression of tgf-?1": 1 "anova": 1 "p value unadjusted": 1 "tp63 auc": 1 "relative ratio b": 1 "hr value": 1 "lesion origin": 1 "20–40": 1 "ratio pm/x": 1 "author": 1 "biomarkers": 1 "genes/input": 1 "pearson correlation mir-21/krit1": 1 "t60' genes": 1 "fc #": 1 "predictive value": 1 "ratio mutant/control": 1 "most overrepresented ontologies": 1 "position": 1 "kendall": 1 "nkx2–1/ttf1 auc": 1 "> 60": 1 "no": 1 "code": 1 "chga auc": 1 "kegg pathway": 1 "univariate cox analysis": 1 "mean median edges": 1 "?/?": 1 "enrichment ratio": 1 "wilcoxon signed rank test": 1 "median normalbreast": 1 "group iii score": 1 "dna/mrna correlation": 1 "t120' genes": 1 "os": 1 "study group": 1 "progression-free survival": 1 "adipose": 1 "pemetrexed n = 441": 1 "compound": 1 "lna-195 group": 1 "disease free survival **": 1 "tumors": 1 "genotype comparison": 1 "tnm groups": 1 "maximum rank": 1 "enrich-ment score": 1 "dose/duration": 1 "deg pathway members": 1 "median ttp mo": 1 "ratio m/l p -value": 1 "go-id": 1 "r2": 1 "epha7 expression": 1 "keggid": 1 "fold changespace": 1 "biopsy only": 1 "empirical": 1 "ncbimm": 1 "go_id": 1 "combination index mean ci 95": 1 "character": 1 "treated group": 1 "meaning": 1 "parameter n": 1 "molecular marker": 1 "host genotype": 1 "virvs bdl fdr": 1 "gleason sum": 1 "lr loci": 1 "day of maximal score": 1 "fold changeearth": 1 "lmgs": 1 "fold-change qrt-pcr": 1 "process annotation": 1 "hypertrophic group n = 15": 1 "10-year multivariable cox regression 3": 1 "anova p -value": 1 "mean number": 1 "percentage of cells ": 1 "pre-sen msc/tmc": 1 "map3k1": 1 "normal-score": 1 "t40' genes": 1 "rtog 98-12 n = 105": 1 "log2 fold_change": 1 "jak-stat signaling p = 0.06": 1 "mir-195 group": 1 "mirbase analysis": 1 "disease onset day 10 score": 1 "isoform": 1 "12 h": 1 "etoh fpkm": 1 "components": 1 "activity": 1 "mean rank": 1 "seed": 1 "lmg network": 1 "p -value**": 1 "adjusted p -value <0.05": 1 "patient number": 1 "?-actin": 1 "deficiency/mutant": 1 "fibrosis area ": 1 "long": 1 "r - value": 1 "a total patients": 1 "ezh2-fold change": 1 "initial condition unit": 1 "fadd": 1 "specificity": 1 "dependent variables": 1 "up-/down-regulated at chemo-radiation-resistant group": 1 "number of replicates": 1 "unmethylated n = 35 39.3": 1 "expression": 1 "mean ± sd": 1 "p value †": 1 "initial value": 1 "aeg-1 expression level": 1 "h0 network": 1 "genes in term": 1 "permutation test p-value": 1 "differentiation of groups": 1 "p value *": 1 "counta": 1 "tf": 1 "mammary": 1 "as-observed": 1 "baseline and tumour characteristics": 1 "fold-change microarray": 1 "ibs": 1 "mowse score": 1 "group b": 1 "group a": 1 "# replicates": 1 "country": 1 "multivariate analysis - model 2 b": 1 "in group and term": 1 "nuclear ep-icd mean ± sem": 1 "sf50 nm": 1 "student t test p 2-value < 0.005 # genes differentially expressed": 1 " cd99": 1 "fisher test statistical significance a": 1 "good/excellent": 1 "up-regulation 7": 1 "count up": 1 "‘jena’": 1 "capecitabine alone": 1 "group olm-10 n=8": 1 "organism": 1 "se n = 3": 1 "multivariate cox regression analysis": 1 "qrt-pcr 1": 1 "iv-astro score": 1 "pre-sen/post-sen msc": 1 "nominal mass": 1 "mss/msi": 1 "limma test adjusted p-value": 1 "total n = 86": 1 "sham n = 7–10": 1 "se n = 2": 1 "gene set name a": 1 "genbank": 1 " up": 1 "higher": 1 "changed": 1 "multi-task common weight rank": 1 "ps3c_cancer": 1 "unadjusted": 1 "univariable": 1 "geom mean of intensities in class 1": 1 "egfr genotype": 1 "pearson's correlation": 1 "high proliferating": 1 "lower 0.95": 1 "fc nevus60/nevus30": 1 "common": 1 "e/a ?1": 1 "rrm2 mean ± sem": 1 "mrp group cases": 1 "geom mean of intensities in class 2": 1 "missing": 1 "ischemic stroke group n = 33": 1 "definition": 1 "independent factors": 1 "adjusted hazard ratio a": 1 "bonferroni correction": 1 "normal": 1 "mean ratio a s.e.": 1 "relative telomere length ratio mean±s.d.": 1 "resection": 1 "p16 ink4a methylation †": 1 "cluster 2": 1 "cells": 1 "copd n = 48": 1 "cluster 1": 1 "healthy": 1 "comparison group": 1 "log?2 fold change": 1 "comment": 1 "svir": 1 "pretreatment hgf level cutoff value median": 1 "mean median nodes": 1 "multivariate analysis p -value": 1 "6 h": 1 "cpg1 methylation": 1 "transgene": 1 "reported category": 1 "tested": 1 "normalized median values": 1 "p -value *": 1 "test details": 1 "unadjusted p value": 1 "p value student t test": 1 "expression of pik3r2 protein": 1 "description/genotype": 1 "cytokine-cytokine receptor interaction p = 0.006": 1 "allele test p-value adjusted † ": 1 "example s": 1 "mir-126 levels a": 1 "40 weeks 68": 1 "line-1 methylation level mean ": 1 "exiqon": 1 "antibody": 1 "cfs n = 11": 1 "peptide rank": 1 "rank of rdss": 1 "ratio a": 1 "p-value ?2 test": 1 "samples": 1 "male n = 68": 1 "table 1": 1 "bowel preparation": 1 "multivariate cox analysis": 1 "phospho-kinase": 1 "cases/controls": 1 "p value model": 1 "sensitivity": 1 "esli mean ± sem": 1 "ratio control/crf 6 h": 1 "enrichment score 3.15": 1 "normal group": 1 "gender": 1 "p -value b": 1 "signature": 1 "+/+": 1 "genbank accession id": 1 "fdr 1": 1 "trial and regimen": 1 "cxrt+r115777 n = 94 grade": 1 "karnofsky score > 70": 1 "control group n?=?60": 1 "illumina": 1 "protein name": 1 "mutras n = 23 32": 1 "transcript": 1 "cytoplasmic ep-icd mean ± sem": 1 "identity": 1 "number of proteins": 1 "median count": 1 "total number": 1 " gsea": 1 "adj p-value": 1 "res-end": 1 "pum1 p -value": 1 "diagnostic test": 1 "cga ": 1 "low n = 31": 1 "95 c.i.": 1 "age > 60": 1 "nsclc": 1 "test name": 1 "fdr a": 1 "at position": 1 "cox regression": 1 "minimum": 1 "survival at sacrifice day 27": 1 "karnofsky score < 70": 1 "value ? l": 1 "in category from cluster": 1 "univariate logistic regression pvalue": 1 "absorbance a": 1 "str marker": 1 "chr8 location": 1 "no recurrence group": 1 "<30": 1 "fpkm": 1 "spearman's rho": 1 "t test p-value": 1 "t90' genes": 1 "vegfr/actb": 1 "prima's rank": 1 "tau": 1 "log mean": 1 "e2f-1 expression n/": 1 "virtual microarray data sets": 1 "first 10 genes": 1 "rir n = 8–11": 1 "index rank": 1 "p value urs vs flanks": 1 "jab1": 1 "count*": 1 "hbm-msc": 1 "sensitivity ": 1 "axl ihc score n ": 1 "cpg_odn_4h": 1 "p value <0.05": 1 "uascorto/hsgal4": 1 "kit wt/k641e": 1 "c/ebp? protein expression": 1 "l0 min": 1 "min ?ct tgf-?1 mrna": 1 "hazard ratio 95ci": 1 "go term for enriched process": 1 "reactome pathway": 1 "mean median survival month": 1 "mvd": 1 "cpgisl": 1 "?log p value": 1 "amd-associated": 1 "multivariable": 1 "test significance level": 1 "er loci": 1 "cfs – associated proteome all 24 samples": 1 "median 1st 3rd quartile": 1 "cd4": 1 "ratio *": 1 "down-regulated klb expression × < 0.5-fold": 1 "mean os": 1 "cd8": 1 "donor genotype": 1 "2 h": 1 "list total": 1 "her2 c": 1 "hazard ratio hr for lrr 95 ci p -value": 1 "cpg_odn_2h": 1 
"phase": 51 "no of patients": 39 "reference": 36 "name": 35 "institution": 31 "treatment": 20 "results": 19 "number of patients": 19 "study": 18 "year": 16 "diagnosis": 16 "p value": 15 "patients": 15 "regimen": 15 "comments": 14 "outcome": 14 "author": 14 "agent": 13 "": 12 "stage": 12 "references": 12 "3": 11 "no.": 11 "target": 11 "n": 10 "hr 95 ci": 10 "age": 10 "p-value": 10 "1": 9 "pfs": 9 "status": 9 "cancer type": 9 "protocol": 9 "patient number": 9 "patient population": 8 "therapy": 8 "characteristic": 8 "malignancy": 8 "number enrolled": 8 "intervention": 8 "trial": 8 "os": 8 "response": 8 "trial author": 7 "type of cancer": 7 "histology": 7 "all patients": 7 "sex": 7 "outcomes": 6 "2": 6 "4": 6 "5": 6 "7": 6 "disease": 6 "response rate": 6 "?no": 6 "ref.": 6 "toxicity": 6 "tumor type": 6 "nr": 6 "?yes": 6 "none": 6 "method": 6 "6": 5 "p": 5 "indication": 5 "age years": 5 "compound": 5 "11": 5 "variables": 5 "biomarker": 5 "variable": 5 "case": 5 "sponsor": 5 "kras": 5 "phase of trial": 5 "total": 5 "drug": 5 "8": 4 "recurrence": 4 "first author": 4 "professor and director division of diagnostic imaging and intervention pisa university school of medicine": 4 "1986": 4 "igfbp3 mrna level": 4 "2012": 4 "company": 4 "overall response": 4 "chemotherapy": 4 "patient id": 4 "16": 4 "7/02": 4 "gender": 4 "setting": 4 "7/87–12/93": 4 "overall survival": 4 "end point": 4 "7/77–10/80": 4 "gene": 4 "patient": 4 " n = 69": 4 "riccardo lencioni md fsir ebir": 4 "?unknown": 4 "orr ": 4 "treatment regimen": 4 "efficacy": 4 "target s": 3 "9": 3 "nf1 patients": 3 "median overall survival": 3 "comparison": 3 "condition": 3 "response /survival months": 3 "author year": 3 "trial number": 3 "clinical trial number": 3 "1998": 3 "patients n ": 3 "type of cancer patient in trial": 3 " 6": 3 "dose": 3 "publications": 3 "ttp/pfs months": 3 "10": 3 "15": 3 "18": 3 "44": 3 "number of patients/agent": 3 "osamu matsui": 3 "clinical trial phase": 3 "controls": 3 "ref": 3 " alive 95 ci": 3 "number at risk": 3 "number": 3 "department of advanced medical imaging kanazawa university graduate school of medical sciences": 3 "grade": 3 "official trial name": 3 "description": 3 "tissue": 3 "phase of study": 3 "refs.": 3 "effect": 3 "status of trial": 3 "no of oc patients": 3 "sample": 3 "class": 3 "no of prim endpoint": 3 "mechanism of action": 3 "progression-free survival": 3 "activity": 3 "cumulative deaths": 3 "specificity": 3 "orr or pcr rate": 3 "country": 3 "or ": 3 " 61": 3 "clinical stage": 3 "location": 3 "os months": 3 "data": 3 "clinical trial #": 3 "1998–1999": 3 "?": 2 "500 mg twice daily": 2 "analysis": 2 "median time to progression": 2 "cut-off": 2 "mos mos": 2 "12/93–6/02": 2 "american board of surgery certified in general surgery id# 32710": 2 "dosage mg/m 2 per day": 2 "mirna": 2 "follow-up month": 2 "trial status": 2 "date of surgery": 2 "remission rates": 2 "better": 2 "in vitro": 2 "cancer": 2 "date of first injection": 2 "clinical activity": 2 "time to death from disease recurrence": 2 "estimated enrollment": 2 "2006–": 2 "director of liver surgery recanati miller transplantation institute": 2 "1997–1998": 2 "arthur aufses sr prize in surgery": 2 "additional target": 2 "findings": 2 "tumor tissue": 2 "technique": 2 "trial name": 2 "director surgical oncology associate director liver transplantation": 2 "?": 2 "animal model": 2 "total nodes": 2 "1/78–10/80": 2 "without cirrhosis": 2 "pr ": 2 "authors year of publication": 2 "source": 2 "1990–1994": 2 "clinical trial": 2 "associate professor of surgery mount sinai school of medicine new york n.y.": 2 "study reference": 2 "associate attending mount sinai hospital new york n.y.": 2 "12/93": 2 "1975": 2 "alpha omega alpha medical honor society": 2 "identifier": 2 "overall survival months": 2 "cancer types": 2 "positivity ": 2 "prr ": 2 "1993–1994": 2 "tumour size cm": 2 "who grade": 2 "type of arb": 2 "specimen": 2 "clinical classification": 2 "1999–2004": 2 "1999–2001": 2 "1999–2000": 2 "physician of the year award transplant recipients’ international organization": 2 "karyotype": 2 "population": 2 "hr 95ci": 2 "ethnicity": 2 "no cart": 2 "ln fold change": 2 "outcome measures": 2 "# pts": 2 "1500 mg once daily": 2 "study design": 2 "title": 2 "duration": 2 "95 ci": 2 "molecular markers": 2 "chief radiation oncologist ibaraki prefectural hospital & cancer center": 2 "dna": 2 "affected codon": 2 "classification": 2 "relative risk": 2 "adverse effects": 2 "section chief bronx veterans admin hospital bronx n.y.": 2 "clinical condition n patients": 2 "no of patients with high met": 2 "2014–": 2 "primary endpoint": 2 "relapse rate ": 2 "administration regimen": 2 "cirrhosis": 2 "age year": 2 "time to progression months": 2 "1+": 2 "12": 2 "2+": 2 "22": 2 "24": 2 "down in a549": 2 "28": 2 "sm-ahd mpn-nos+eosinophilia": 2 "3+": 2 "31": 2 "32": 2 "33": 2 "39": 2 "54": 2 "finding": 2 "7/04": 2 "2008–": 2 "dosing regimen": 2 "7/12": 2 "characteristics": 2 "comment": 2 "p -value a": 2 "clinical trials identifier": 2 "study type": 2 "median os months": 2 "parameter": 2 "cart/no tfv": 2 "department of hepato-biliary-pancreatic surgery tokyo medical and dental university": 2 "p14m": 2 "last follow up": 2 "p16m": 2 "trials": 2 "cart/tfv": 2 "age in years": 2 "up in a549": 2 " n = 138": 2 "1/91–12/98": 2 "msi ": 2 "response ": 2 "amino acid change": 2 "median time of follow-up months": 2 "assistant professor lecturer dept of surgery institute of gastroenterology tokyo women's medical univ.": 2 "no of patients male/female": 2 "authors": 2 "phase i advanced solid tumors": 2 "adjacent tissue": 2 "q-value corrected": 2 "95 confidential interval": 2 "7/87–6/89": 2 " 100": 2 "anatomic site": 2 "assistant professor of surgery mount sinai school of medicine new york n.y.": 2 "side effects": 2 "1/99–6/02": 2 "10/87": 2 "10/88": 2 "last vs last tm vs tm in tm-jm model2": 2 "associate director division of liver transplantation": 2 "phase ii mbc": 2 "instructor in surgery mount sinai school of medicine new york n.y.": 2 "worse": 2 "crr ": 2 "7/85–6/87": 2 "pierce k.h chow mbbs m.med surg frcse fams phd": 2 "type of trial": 2 "19 38.8": 2 "median±sd": 2 "primary end point": 2 "last vs last model1 tm vs tm in tm-jm": 2 "type of study": 2 "marker": 2 "survival analysis/hr": 2 "treatment arm": 2 "study and year": 2 "american board of surgery certified in general vascular surgery id# 100100": 2 "patients n": 2 "tfv/nnrti": 2 "tfv/pi": 2 "trial first author": 2 "cr": 2 "mpfs mos": 2 "hr": 2 "inclusion period": 2 "id": 2 "ct no.": 2 "deputy director liver transplantation chief hepatobiliary surgical services": 2 "medical examiner augusta county va": 2 "first author ref.": 2 "nb of patients": 2 "publication": 2 "author reference year": 2 "mutationa": 2 "professor of surgery mount sinai school of medicine new york n.y.": 2 "no": 2 "patients with tissue samples no ": 2 "subtype": 2 "p -value": 2 "risk of 2nd cancers ": 2 "pr": 2 "nct number": 2 "objective": 2 "follow up months": 2 "selection criteria": 2 "director adult liver transplantation and hepatobiliary surgery": 2 "metastatic nodes": 2 " 28": 2 " 33": 2 "assistant attending mount sinai hospital new york n.y.": 2 "director craigsville medical center craigsville va": 2 "pik3ca mutations": 2 " 44": 2 "selected toxicities": 2 "professor department of radiation oncology yonsei university college of medicine": 2 "type of treatment": 2 "attending physician kings’ daughters’ hospital staunton va": 2 "number of cysts scored": 2 "orr": 2 "senior consultant surgeon department of general surgery singapore general hospital visiting consultant national cancer centre professor duke-nus graduate medical school": 2 "type": 2 "jinsil seong md phd": 2 "1-year survival rates": 2 "antibody": 2 "samples": 2 "stage of the disease": 2 "5 yr ": 2 "responses": 2 "healthy subjects": 2 "follow-up": 2 "1988–1989": 2 "president of hamamatsu rosai hospital japan labour health and welfare organization": 2 "purpose": 2 "doctorate degree honoris causae favolaro university buenos aires argentina": 2 "author reference": 2 "studies": 2 "sm-ahd mds/mpn-nos+eosinophilia": 2 "factors": 2 "functions": 1 "patients without tissue samples no *": 1 "study organ": 1 "type of c-kitr pattern": 1 "medical staff in surgery": 1 "approved": 1 "first author year of publication": 1 "number of prior systemic therapies": 1 "?m category ajcc": 1 "lux-lung study": 1 " ": 1 "30 50.0": 1 "inhibitor/antibody": 1 "main side effects": 1 "department of surgery otsu municipal hospital": 1 "tumor stage": 1 "hisotology": 1 "asm+eosinophilia": 1 "0": 1 "target site": 1 "size": 1 "correlation": 1 "time sample acquired": 1 "clinical outcome": 1 "staff department of radiology university of yamanashi": 1 "tumors analyzed": 1 "cohort 2 individual samples": 1 "2004–2005": 1 "2004–2006": 1 "2004–2009": 1 "ihc staining": 1 " change": 1 "result": 1 "acute gvhd": 1 "diarrhea rash nausea vomiting stomatitis anorexia 24": 1 "primary 3 -": 1 "2013–2014": 1 "preoperative psa ng/ml": 1 "2004–2013": 1 "a": 1 "69.2-2.4": 1 "f": 1 "g": 1 "patients with egfr-amplification n": 1 "100–10000": 1 "blood": 1 "m": 1 "hiv-1 status": 1 "component": 1 "t": 1 "no of patients n = 52": 1 "full response 75-100 improvement": 1 "hiroshima university graduate school of biomedical and health sciences": 1 "patients analyzed": 1 "6.1": 1 "study year": 1 "research fellow royal free hospital school of medicine university of london": 1 "-32.4": 1 "year of publication": 1 "no polyp": 1 "no of patients n = 36": 1 "igfbp1": 1 "dose and duration of treatment": 1 "biopsy origin": 1 "lecturer department of gastroenterology kinki university school of medicine": 1 "lewy body": 1 "1997–2004": 1 "p-aml": 1 "junior resident department of surgery ii osaka university hospital": 1 "600": 1 "?liver": 1 "?d": 1 "staining intensity number of patients ": 1 "?i": 1 "9.7 2.7": 1 "assistant professor dept of therapeutic radiology kyoto university": 1 "?lung": 1 "mk-2206 dose mg": 1 "stem cells source": 1 "yasuharu imai md phd": 1 "masayuki kurosaki": 1 "hb control": 1 "adverse event*": 1 "main targets": 1 "2007 nov–2008 nov": 1 "research fellow department of surgery university of minnesota": 1 "project professor department of minimum invasive and telesurgery tokushima university hospital tokushima japan": 1 "assessment of severity": 1 "hs-crp baseline mg/l": 1 "diagnosis subtype": 1 "department of surgery ii kyushu university hospital": 1 "goiter n=32": 1 "previous adjuvant treatment": 1 "total dose": 1 "design of trial": 1 "fish6": 1 "pituitary microadenoma/macroadenoma": 1 "experiment": 1 "1995–1999": 1 "1995–1997": 1 "dept of general visceral and cancer surgery university of cologne germany": 1 "target accrual": 1 "t-aml **": 1 "therapeutic indication": 1 "clinical results": 1 "clinical trial gov number": 1 "mutation": 1 "treatment groups": 1 "mcc trial phase": 1 "?descending": 1 "cell/tissue": 1 "related marker": 1 "patients in subgroup placebo n = 8901": 1 "cxrt": 1 "research associate department of gastroenterology kinki university school of medicine": 1 "-344.3": 1 "benefit in anti-vegf therapy": 1 "n-ras status in tissue biopsy": 1 " author": 1 "method of administration/timing/dosing": 1 "shinji tanaka": 1 "clinical trials with single treatment": 1 "2005–": 1 "toxicity profile grade ?2": 1 "2.1": 1 "2.3": 1 "cardiac remodeling": 1 "mutations patients positive ": 1 "best response": 1 "markers": 1 "survival after biopsy months": 1 "etiology of acromegaly n ": 1 "20 year progression risk accounting for death as competing factor ": 1 "clinical setting": 1 "classification/score": 1 "31 31": 1 "irreversible": 1 "first author/s year ref.": 1 "disease stage": 1 "partial response 50-75 improvement": 1 "cr ": 1 "phase ii mbc either her2-positive or -negative": 1 "stage of nsclc": 1 "disease control": 1 "????r-factor last shell": 1 "24-h oesophageal ph monitoring": 1 "follow-up periods months range": 1 "diagnostic accuracy": 1 "????subunits in asymmetric unit": 1 "sr no": 1 "clinical effect of dual treatment": 1 "study ref#": 1 "previous therapies": 1 "clinical": 1 "medical staff dept of surgery institute of gastroenterology tokyo women's medical univ.": 1 "tt8": 1 "study cohort on tissue microarray n?=?11152": 1 "molecule/pathway": 1 "kras genotype": 1 "2001–present": 1 "disease subtype": 1 "histology grade": 1 "expression in hcc": 1 "immunotoxin": 1 "histopathological diagnosis": 1 "trial phase patient number": 1 "professor div of radiation oncology hiroshima university hospital": 1 "type of primary": 1 "estimated rate of relapse according to gist location": 1 "yasuhiko sugawara": 1 "colon cancer": 1 "relative gene expression in tumors": 1 "interventional scenario": 1 "1–100": 1 "response to prednisolone corticosteroid-responsiveness": 1 "224": 1 "other agents": 1 "clinical use in therapy": 1 "renal function": 1 "za/hormonal intervention": 1 "frequency of alteration in adult patients": 1 "nf1 patients with plexiform neurofibroma": 1 "mode of action": 1 "mutations expected consequence": 1 "radiology": 1 "oral leukoplakia": 1 "resident in medicine in associated hospital of tokyo medical and dental university": 1 "aeca cell surv ?80": 1 "malignancy n ": 1 "primary resistance unpaired": 1 "number of patients treated with imatinib": 1 "trainee doctor kinki university hospital": 1 "additional agents": 1 "treatment outcome": 1 "line of treatment": 1 "recipient age": 1 "phase trial": 1 "surgery + medical treatment + radiotherapy": 1 "nf1 patients without plexiform neurofibroma": 1 "department of gastroenterology ikeda municipal hospital": 1 "18 30.0": 1 "year of approval company": 1 "hyperplastic polyp": 1 "factors for clinical efficacy of treatment ": 1 "median survival months": 1 "country loa acquired": 1 "localization of primary": 1 "0 pr in 18 patients 23": 1 "duration of oa year": 1 "tumor stages": 1 "inclusion criteria": 1 "time months between diagnosis and relapse": 1 "symptom score chart and use of ?2-agonist reliever therapy": 1 "bronchodilator response to ?2-adrenergic agonists": 1 "? t2": 1 "patients country nodal status a": 1 "tumor id": 1 "disease status at hsct": 1 "cell lines": 1 "response or endpoints observed in melanoma patient s": 1 "1986–1987": 1 "all cr n?=?39": 1 "1990–1993": 1 "1990–1992": 1 "high-resolution computed tomography of sinuses": 1 "ref year": 1 "disease or syndrome": 1 "snp-array analyzed": 1 "2002–2012": 1 "?gastric cancer": 1 "major bleeding": 1 "?pretreatment in stage iva": 1 "nct#": 1 "indication of biopsy": 1 "28.1": 1 "tumor grade": 1 "t-aml": 1 "biopsy id": 1 "age at 1st nih visit": 1 "therapy matching target": 1 "surgery only": 1 "internship chiba university hospital": 1 "2002–2005": 1 "??m1a": 1 "# of patients in aml trial s": 1 "median": 1 "??m1c": 1 "??m1b": 1 "overall": 1 " frequency in ssc": 1 "research fellow cancer center": 1 "1986–1990": 1 "????sigma cutoff f /? f ": 1 "pfs/ttp med months": 1 "response rate confirmed cr and pr": 1 "enrollment patients n": 1 "rassf1a m/u b": 1 "????root mean square deviation from ideal geometry bonds å/angles °": 1 "assistant professor department of radiology university of yamanashi": 1 "stage of disease": 1 "mir-146a 2??cq±sd": 1 "expected date of completion": 1 "evaluations": 1 "life-threatening": 1 "pathway inhibited": 1 "trial phase and/or population feature": 1 "37.5mm largest = 60mm": 1 "agent administered": 1 "mucositis": 1 "fda approval date": 1 "sle patients": 1 "patients a age": 1 "????number of water molecules": 1 "partial response?+?complete response": 1 "clinical diagnosis": 1 "effect of za": 1 "????resolution range last shell å": 1 "therapeutic indication mode of action": 1 "# of patients enrolled *": 1 "1973": 1 "line1 cpg site": 1 "at2r alleles": 1 "chief dpt of gastroenterology ikeda municipal hospital": 1 "1978": 1 "1 requiring surgery": 1 "1990": 1 "?adrenals": 1 "number of patients 1": 1 "age/gender": 1 "experimental model": 1 "1982": 1 "author and reference": 1 "drug brand name company": 1 "1988": 1 "agents under investigation in combination with hdi": 1 "0.995 0.77": 1 "14 38": 1 "1993–1995": 1 "clinical characteristics": 1 "*comparison has been made with diabetic patients with nephropathy ** comparison has been made with healthy subjects.": 1 "16 33.3": 1 "73.7 years": 1 "1994": 1 "c max nm a": 1 "vice president of musashino red-cross hospital": 1 "1993": 1 "e-sel": 1 "7/53 11.7/88.3": 1 "gw572016": 1 "post genetic negative testing in blood mosaic inferred": 1 "phases": 1 "graduate school of medicine kyushu university": 1 "type of alteration": 1 "drug dose": 1 "total of fnas": 1 "rearrangements": 1 "combination agent": 1 "1st-line or treated": 1 "trial identifier": 1 "mean polyp size": 1 "type of adjunctive therapy": 1 "study no of patients hypertension": 1 "neurotoxicity": 1 "tumor localization": 1 "median duration of response months": 1 "w/o pnf w/o mpnst": 1 "agent phase": 1 "combination": 1 "????free r last shell": 1 "virologic response": 1 "animal a": 1 "mean age of patients": 1 "10000–10000000": 1 "adjusted or 95ci *": 1 "diagnosis standard": 1 "additional mutations": 1 "hh-based clinical trial": 1 "massachusetts general hospital and harvard medical school": 1 "reference b": 1 "rash diarrhea nausea vomiting elevated transaminases 0.3–2 risk for interstitial lung disease 18": 1 "mutation/alterations": 1 "high 11": 1 "surgical staff department of surgery ii osaka university hospital": 1 " ?2=0.1 df=1p=0.74**": 1 "dcr": 1 "reference s": 1 "capg -": 1 "phase iii trials": 1 "capg +": 1 "frequency in adenocarcinoma": 1 "1999–2002": 1 "cd 34 dose/kg": 1 "trials in other cancers": 1 "targeted therapy": 1 "no longer under clinical development": 1 "medical staff department of surgery takamatsu municipal hospital takamatsu japan": 1 "69.2–2.4 2.5–2.4": 1 "generic name": 1 "-23.8": 1 "concentration": 1 "idiopathic hypereosinophilia": 1 "smo-inhibitors": 1 "stem cell marker": 1 "stage/grade": 1 "target antigen": 1 "hf in population": 1 "biological intervention": 1 "median pfs p/ttp t months": 1 "grade of rash": 1 "minimal response 25-50 improvement": 1 "diabetic patients without nephropathy n=40": 1 "clinical characteristic": 1 "activated status number of patients ": 1 "case no sex/age": 1 "yasushi nagata": 1 "48 34.3": 1 "major observation": 1 "dfs": 1 "33.3": 1 "nk cell functions": 1 "outcome b": 1 "number n?=?80": 1 "pathology subtype": 1 "methods of mvd identification": 1 "??ldh": 1 "american joint committee on cancer ajcc grouping system": 1 "duration of response weeks": 1 "response rate patients number n ": 1 "low 9": 1 "atc n=9": 1 "mr months": 1 "no pts.": 1 "graduated from osaka university school of medicine": 1 "mib-1": 1 "nausea vomiting asthenia diarrhea rash mucositis hypersensitivity thrombocytopenia": 1 "??other visceral": 1 "research fellow department of surgery brigham and women's hospital harvard medical school": 1 "primary resistance median range": 1 "dfs hazard ratio": 1 "chip": 1 "trial identification": 1 "phase ii clinical trials": 1 "with mpnst": 1 "subjects": 1 "toxicity grade 3/4": 1 "type of diabetes": 1 "radical operation": 1 "department of radiology university of yamanashi": 1 "assistant professor department of virology faculty of medicine kyushu university": 1 "complete pathological response": 1 "??female": 1 "14 29.2": 1 "effect on anti-her2 therapy response": 1 "resident in radiology university hospital of tsukuba": 1 "clinical parameter": 1 "family history of neoplasia": 1 "combined regimen": 1 "?sigmoid": 1 "shuntaro obi md phd": 1 "agent brand name": 1 "sweat test and genetic assessment of cftr ** mutations if indicated": 1 "graduated from kyushu university japan": 1 "test": 1 "department of hbp surgery and transplantation kyoto university": 1 "?performance status ecog": 1 "2000": 1 "residency dept of surgery institute of gastroenterology tokyo women's medical univ.": 1 "patients in subgroup rosuvastatin n = 8901": 1 "infiltrated tissues on mri and/or ct": 1 "type of analysis": 1 "validated in vitro": 1 "general classification schemes used in review of clinical efficacy and safety ": 1 "evaluable for axlno ": 1 "level of evidence": 1 "additional": 1 "cohort": 1 "kras wt": 1 "agent name": 1 "??liver": 1 "pre testing transmission risk": 1 "clinical effects": 1 "?female": 1 "overall response or complete response cr + partial response pr": 1 "schedule": 1 "drug name": 1 "28mm largest = 40mm": 1 "no of all gynecologic cancer patients": 1 "sfks targeted ic50": 1 "predictive finding": 1 "trial and reference": 1 "diagnosis n?=?30": 1 "pmi h": 1 "novel agents": 1 "??male": 1 "treatment/population": 1 "aml in older patients *": 1 "number of polypectomies": 1 "koichiro yamakado md": 1 "pp populationb": 1 "pax6 mrna level tumor/adjacent tissue": 1 "place of study": 1 "examination of nasopharyngeal airways": 1 "????wilson b-factor å2": 1 "gender/ age": 1 "3.2": 1 "-6.4": 1 "scchn clinical trial phase": 1 "effect on sv": 1 "surveillance recommendations": 1 "clinical issue": 1 "toxin used": 1 "screening and surveillance": 1 "rectal": 1 "phase/ programme": 1 "targets": 1 "first name study": 1 "specificity ": 1 "professor and chairman dept of radiation oncology": 1 "other autopsy diagnosis": 1 "adverse events aes were assessed at each cycle using the common toxicity criteria ctc.": 1 "the cardiac review and evaluation committee crec evaluates cardiac dysfunction.": 1 "ut ": 1 "yes n?=?11": 1 "gene function": 1 "positive": 1 "medical staff department of surgery shikoku chuo hospital shikoku chuo japan": 1 "approval status": 1 "drugs to overcome resistance": 1 "treatment regimen to be tested to “disease-progression” or death whichever event occurs first.": 1 "initial vs last in same model2 anticlock": 1 "phase i clinical trials": 1 "5 10.4": 1 "clinical and histopathological features": 1 "guideline organization": 1 "vice president ikeda municipal hospital": 1 "????completeness last shell ": 1 "functional outcome": 1 "adverse affects": 1 "state of trials": 1 "2009-present": 1 "weekly cetiri 250 mg/m 2": 1 "stage/ grade": 1 "conditioning regimen": 1 "5–10": 1 "mitoses in 10 fields 40×": 1 "1 mr 3 sd in 31 patients 21": 1 "intervention group": 1 "determination of pharmacological responsiveness": 1 "sample no": 1 "tumour type and setting": 1 "54.2 range 38.9–72.0": 1 "initial surgery": 1 "most common grade 3-4 adverse events": 1 "specialist": 1 "?range": 1 "result of immunostaining no of patients ": 1 "assistant professor department of surgery": 1 "full remission 75-100 improvement sustained for 4 weeks": 1 "clinical benefit rate cr pr and sd": 1 "daily dose mg": 1 "patient phenotype": 1 "comments/observations": 1 "gender/age y": 1 "current status": 1 "????cell parameters å": 1 "60.1": 1 "2013–": 1 "enrolled patients": 1 "2000–2008": 1 "2000–2002": 1 "2000–2001": 1 "?abdomen": 1 "all specimens": 1 "phase i her2-positive mbc": 1 "professor department of surgery and transplantation medicine osaka university hosipital": 1 "prostate cancer": 1 "biopsy": 1 "fellow assistant professor of 2nd dpt of internal medicine osaka university graduate school of medicine": 1 "pro-treatment arthroscopy": 1 "gene type": 1 "ekb-569": 1 "gastrointestinal perforation risk": 1 "time to progression": 1 "142.1 64.6 116.0 ? = 103.1°": 1 "department of surgery and science kyushu university": 1 "methods of c-kit/c-kitr evaluation": 1 "department of surgery and transplantation medicine osaka university hospital": 1 "phd doctor of medical science": 1 "blinding of met evaluation": 1 "vitamin d compound": 1 "tnm classification": 1 "clinical trials": 1 "karnofsky index ": 1 "fab5": 1 "13": 1 "23 62": 1 "rmi > 200 criterion": 1 "diurnal variation in peak expiratory flow": 1 "19": 1 "locoregional invasiveness status of prostatectomy specimen": 1 "inrg": 1 "95 ci of hr": 1 "2006–present": 1 "drugs compared": 1 "confirmed in patient biopsies?": 1 " 100.0": 1 "1994–1997": 1 "number of methylation positive patients": 1 "1994–1996": 1 "5 µm": 1 "resistance type": 1 "il-6": 1 "isoform": 1 "20": 1 "-2.3": 1 "artificial organ & transplantation surgery university of tokyo tokyo japan instructor": 1 "patient code": 1 "type of treatment strategy": 1 "artificial organ & transplantation surgery university of tokyo tokyo japan associate professor": 1 "combined regimen comparative arm": 1 "motor deficits": 1 "neurocognition/neuropathology": 1 "??chemotherapy": 1 "sample type": 1 "date of biopsy days": 1 "high-grade": 1 "2 pr 3 sd in 19 patients 20": 1 "target population": 1 "outcomes in hf subgroup": 1 "152 67.9": 1 "prognosis": 1 "associate professor division of hepatobiliary pancreatic surgery and transplantation department of surgery gradurate school of medicine kyoto university": 1 "fellow department of surgery tokushima university hospital tokushima japan": 1 "40": 1 "2010 dec–present": 1 "41": 1 "43": 1 "46": 1 "47": 1 "48": 1 "number of subjects": 1 "patient characteristics at the time of etnk1 testing": 1 "responders n?=?16": 1 "tubular adenoma": 1 "* k.l.image criterion": 1 "associate professor of 1st department of surgery kyoto university school of medicine": 1 "controls n=220 ": 1 "copy number variations": 1 "53": 1 "1992 apr–2000 mar": 1 "ongoing phase iii trial": 1 "56": 1 "histological types ": 1 "prognostic ?": 1 "??2 therapy regimens": 1 "dose and schedule": 1 "phase status": 1 "crc patients n=220 ": 1 "0–1": 1 "anemia": 1 "survival weeks from resection": 1 "number of methylated cpg sites": 1 "evaluable pts #": 1 "61": 1 "associate professor department of surgery graduate school of medicine osaka university": 1 "64": 1 "surgical + radiotherapy": 1 "16.1": 1 "65": 1 "????< i >/<? i > last shell": 1 "67": 1 "69": 1 "ability to take systemic treatment": 1 "aminoacid change": 1 "proteinuria": 1 "internal control": 1 "clinical relevance": 1 "adverse cardiac remodelling": 1 "other tests": 1 "clinical model": 1 "definition": 1 "71": 1 "? t1": 1 "clinical diagnosis martini and melamed criteria": 1 "72": 1 "74": 1 "hdacs inhibited": 1 "75": 1 "nb of deaths": 1 "summary": 1 "mna": 1 "4 pr in trastuzumab-refractory disease 25": 1 "metastatic": 1 "alternative names": 1 "mechanisms of action": 1 "????ramachandran plot favored/outliers ": 1 "director dep of radiation oncology ibaraki prefectural hospital & cancer center": 1 "13 27.1": 1 "akt inhibitors": 1 "diabetic patients with nephropathy n=100": 1 "sample number": 1 "2001 apr–2007 oct": 1 "professor and chairman of department of hepato-biliary-pancreatic surgery tokyo medical and dental university": 1 "codon 61": 1 "codon change": 1 "clinical phase": 1 "transgene": 1 "?c1": 1 "?c2": 1 "growth hormone + other pituitary hormone": 1 "?sex": 1 "at each contact a nurse's or physician's assessment of core symptom severity overall functional impairment side-effect severity and other symptoms": 1 "treatment at relapse": 1 "osamu nakashima md phd": 1 "median dor months": 1 "clinical characteristics and pathologic outcomes": 1 "96": 1 "type 1 diabetic patients n = 20": 1 "92 65.7": 1 "99": 1 "?b1": 1 "?b2": 1 "second line therapy": 1 "??>unl": 1 "1978 march graduated from department of medicine tokyo medical and dental university": 1 "gender/age": 1 "weekly for the first 4 weeks of each stage then every 2 weeks until 75 improvement is maintained for 4 weeks": 1 "annexin-v-/pi- ": 1 "virus type name": 1 "iii": 1 "trial and regimen": 1 "network eligible": 1 "non-metastatic": 1 "pfs at 6 months ": 1 "aee-788": 1 "uncontrolled acromegaly n ": 1 "study primary results": 1 "computed tomography of sinuses": 1 "jejuno ileal": 1 "mt ": 1 "svcam-1": 1 "treatment success rate ": 1 "lycopene formulation and source": 1 "anovap value": 1 "patients enrolled": 1 "phase/s": 1 "united states preventive services task force 33 ": 1 "clinical benefit cb complete response cr + partial response pr + stable disease sd ? 6 months": 1 "allog.9": 1 "size mb": 1 "1 pr 2 sd in 63 patients 19": 1 "gbm antigen": 1 "bsw colonoscopist n=1": 1 "rabla +": 1 "shinji uemoto": 1 "trials n .": 1 "censor": 1 "assessment of compliance to therapy and inhaler technique": 1 "progression to ap / bc ": 1 "satoru imura": 1 "?pelvis": 1 "drug and study design": 1 "cytogenetic location": 1 "ptc n=178": 1 "human trials": 1 "mtp": 1 "funded by": 1 "clinicaltrials.gov identifier": 1 ">3": 1 "mechanism of carcinogenesis": 1 "main criteria": 1 "sensitivity ": 1 "quality of life assessment": 1 " cr + pr ": 1 "b-raf status in tissue biopsy": 1 "organization/institute": 1 "age at diagnosis years range": 1 "??skin/lymph nodes": 1 "cell type/tissue": 1 "target marker": 1 "median overall survival os": 1 "tak-165": 1 "study drug": 1 "raf inhibitor": 1 "????space group": 1 "n-ras status in cell line": 1 "clinico-pathologic parameters": 1 "country of origin": 1 "ptnm a m/u b": 1 "eyeworms": 1 "recipient gender": 1 "grade 1–2": 1 "2010–present": 1 "duration of acute treatment": 1 "????resolution used for refinement å": 1 "pathological response": 1 "1994–": 1 "?metastatic sitesa": 1 "administrative route": 1 "indeterminate or suspicious lesions / ptc number": 1 "5 year os ": 1 "?serologic relapse": 1 "medical staff department of surgery anan kyoei hospital anan japan": 1 "1980–1986": 1 "response observed in melanoma patient s": 1 "1996–1999": 1 "?ii": 1 "administration route": 1 "1980–1993": 1 "tslc1": 1 "ipm": 1 "ref no": 1 "nonresponse <25 improvement": 1 "protocol id": 1 "2nd line treatment": 1 "min-max": 1 "disease-specific survival": 1 "survival after surgery months": 1 "hepatocarcinoma": 1 "president ikeda municipal hospital": 1 "dfs less than 1 year n?=?24": 1 "ad-hies": 1 "0.009/1.21": 1 "??bone": 1 "data set": 1 "overall survival in all patients": 1 "higher in slow-forming pct tepc il6pc kipc": 1 "healthy subjects n=224": 1 "primary outcome measure": 1 "division of hepato-biliary-pancreatic and transplant surgery graduate school of medicine kyoto university": 1 "tumour id": 1 "no n?=?16": 1 "adjuvant treatment": 1 "?ascending": 1 "surgery + medical treatment": 1 "mttp mos": 1 "phase of the study": 1 "cancer therapy": 1 "level of prevention": 1 "american college of gastroenterology 34 ": 1 "support therapy": 1 "medical staff yokohama general hospital yokohama japan": 1 "nct identifier": 1 "female": 1 "median progression-free survival": 1 "clinical or biomarker response": 1 "risk groups based on colonoscopy findings": 1 "patient and control": 1 "-43.9": 1 "previous treatment protocols": 1 "outcome no treatment": 1 "failure to respond to imatinib": 1 "in an intent-to-treat itt population in order to evaluate the overall response rate of the individual “patient-drug interaction.”": 1 "primary site": 1 "patients at increased risk for hcc": 1 "clinical trial no.": 1 "dose-schedules": 1 "braf mt ": 1 "adjusted founders": 1 "professor department of radiology college of medicine seoul national university hospital": 1 "additional comment": 1 "purpose and brief comments": 1 "doctor course": 1 "33 55.0": 1 "senior assistant professor of 1st department of surgery kyoto university school of medicine": 1 "k-ras mutation": 1 "erlotinib": 1 "itt population": 1 "assistant professor department of surgery graduate school of medicine osaka university": 1 "tumour type/size of study": 1 "94/1.5": 1 "patients' numbers": 1 "-7.1": 1 "2012–2013": 1 "disease-free survival in n0 m0 patients at nephroureterectomy": 1 "associate professor department of radiology university of yamanashi": 1 "patients * n=20": 1 "study id": 1 "control group": 1 "medical treatment only": 1 "property": 1 "goal of therapy 64": 1 "rabla ?": 1 "assistant professor department of surgery tokushima university tokushima japan": 1 "?transverse": 1 "site of transplantation": 1 "sicam-1": 1 "testing": 1 "1991–2008": 1 "chemical class": 1 "problems reported in glioma trials": 1 "low-grade": 1 "initial therapy": 1 "2005–2006": 1 "2005–2009": 1 "1986 sep–1986 nov": 1 "daily mtd mg": 1 "indeterminate or suspicious lesions / braf+": 1 "skin prick test to common aeroallergens": 1 "# events/# patients*": 1 "manufacturer": 1 "cetuximab line": 1 "patients without sub-telomeric aberrations 428 patients n ": 1 "fd 1": 1 "study phase": 1 "no of patients ": 1 "infiltrated tissues pathological examination": 1 "liver surgery": 1 "cancer3 -": 1 "median progression -free survival pfs": 1 "department of surgery division of hepato-biliary-pancreatic surgery kobe university graduate school of medicine": 1 "possible genes": 1 "ihc pattern": 1 "1987–1990": 1 "biweekly cetiri 500 mg/m 2": 1 "1986 dec–1988 june": 1 "therapeutic combination": 1 "sex/age": 1 "?cecum": 1 "136588": 1 "metastatic spread": 1 "histological types": 1 "observations and inferences": 1 "2008.1–": 1 "17 42.5": 1 "1989–1990": 1 "dfs 1 year or greater n?=?15": 1 "number of melanoma patients evaluable for response n": 1 "braf-directed therapy": 1 "?median age years": 1 "aml": 1 "tnf-?": 1 "????number of observations": 1 "patients without tissue samples no ": 1 "patient no.": 1 "protein target": 1 "research associate institute for frontier medical sciences kyoto university": 1 "method of egfr evaluation": 1 "intensity of c-kit/c-kitr expression": 1 "current use": 1 "hiroaki nagano md phd": 1 "rr ": 1 "recist ": 1 "fip1l1-pdgfra": 1 "transport": 1 "up-regulated": 1 "professor and chairman department of radiation oncology hiroshima university graduate school of biomedical and health sciences": 1 "trainee doctor kitano hospital": 1 "number of deg": 1 "official title": 1 "objective response and tumor response were evaluated by the who criteria 24 .": 1 "median os 95ci ‡": 1 "phase ii": 1 "0.0": 1 "clinical trials for evaluating early detection biomarkers in ovarian cancer usa": 1 "function eligible": 1 "survival weeks from diagnosis": 1 "s100p": 1 "patients n = 107": 1 "strategy": 1 "c-kit aberration": 1 "flt3-itd": 1 "potency": 1 "?colon cancer": 1 "status of clinical trial": 1 "visiting professor of gastroenterology osaka university school of medicne": 1 "clinical parameters": 1 "toxicity grade 3 or 4": 1 "bcr- abl": 1 "dids ar-hies": 1 "department of clinical laboratory medicine kurume university hospital": 1 "name trade name structure": 1 "fellow in gastroenterology general hospital national health insurance asahi central hospital chiba japan": 1 "clinical data": 1 "schedule a": 1 "protein": 1 "formulation": 1 "history of calabar swellings": 1 "??1 therapy regimen": 1 "additional information": 1 "codons 12 and 13": 1 "age at diagnosis": 1 "5fu-based treatment": 1 "frequency in squamous cell cancer": 1 "molecular change": 1 "date of transplantation": 1 "concurrent illness": 1 "maximal tumor diameter": 1 "department of interventional radiology mie university": 1 "?3": 1 "director department of gastroenterology and hepatology musashino red cross hospital adjunct professor tokyo medical and dental university assistant professor yamanashi university": 1 "patient 2": 1 "endpoint": 1 "patient 1": 1 "psychological assessment": 1 "loss of th positive neurons": 1 "unadjusted or 95ci": 1 "new category*": 1 "cohort 1 pooled samples": 1 "responses to cytokines": 1 "patient 4": 1 "mechanism": 1 "patient 3": 1 "patient 5": 1 "????average b-factor of the model a2": 1 "-25.7": 1 "1988 july–1992 mar": 1 "similarities": 1 "target patient number": 1 "refs": 1 "clinicopathological features": 1 "cell line established from biopsy": 1 "no ": 1 "reviewed in reference": 1 "clinical trial phase for scchn": 1 "?ptc with other cancer ¶": 1 "2 3.3": 1 "number of patents": 1 "mcp-1": 1 "results for cetuximab group": 1 "clinical goal": 1 "ris1": 1 "visiting associate professor department of radiology brigham & women's hospital harvard medical school": 1 "cardiac failure/cardiac toxicity was graded based on the nyha classification system.": 1 "array id": 1 "rash diarrhea nausea fatigue headache elevated transaminases": 1 "?breast cancer": 1 "reduction in relative risk of recurrence": 1 "gastric": 1 "no of kras wild-type patients": 1 "experimental setting": 1 "phase i advanced cancer completed": 1 "-16.9": 1 "conclusion": 1 "negative": 1 "instructor dept of therapeutic radiology kyoto university": 1 "maintenance treatment": 1 "biochemical relapse among categories n?=?1824": 1 "genotypes": 1 "?iii": 1 "duration years": 1 "clinical professor tokyo medical and dental university": 1 "effects of the mir-34/chemo combination": 1 "adverse effect": 1 "number of enrollment": 1 "duration of anti-androgen therapy months": 1 "?nodes": 1 "tomoaki ichikawa": 1 "resident department of surgery the center for cancer and cardiovascular diseases of osaka": 1 "median os mo": 1 "fab": 1 "criteria": 1 "eligibility": 1 "ongoing trials": 1 "cancer grade": 1 "os mo": 1 "associate professor": 1 "?median": 1 "survival wk": 1 "pts1": 1 "no of relapses": 1 "study treatment protocols": 1 "no of patients cancer type": 1 "wild type patients positive ": 1 "co-founders": 1 "???unl": 1 "no of patients with 50 psa decline": 1 "no of patients mean value of igfbp-3 in ng/ml": 1 "time-to-disease-progression ttp the time from randomization randomized initiation of drug/therapy.": 1 "ecog performance status": 1 "1 pr 3 sd 12 weeks 16 weeks and > 28 weeks in 47 patients 22": 1 "age at biopsy years": 1 "adjuvant systemic treatment c": 1 "2009 oct-": 1 "hormonal status": 1 "compound 2": 1 "compound 1": 1 "cause of death": 1 "akt isoform": 1 "cellularity ": 1 "patients awaiting surveillance ?endoscopy for more than 3 months": 1 "number of patients n=100": 1 "fibreoptic bronchoscopy with bronchial biopsy and bronchoalveolar lavage": 1 "survival b median": 1 "categories": 1 "median survival time months": 1 "assistant professor": 1 "distant metastasis": 1 "vice professor department of surgery and science kyushu university": 1 "ken shirabe": 1 "disease setting": 1 "organ and injury": 1 "use of biomarker": 1 "therapeutic agent": 1 "clinical benefit ": 1 "disorder": 1 "disease phase": 1 "mtc n=9": 1 "gene/gene cohort": 1 "evaluation at time of diagnosis": 1 "entire cohort": 1 "pathologic diagnosis": 1 "etsuro hatano md phd": 1 "assistant professor first department of surgery kyoto university": 1 "resident in radiation oncology university hospital of tsukuba": 1 "effect on pfs": 1 "1 1.7": 1 "all malignancy": 1 "combination with": 1 "pfs mo": 1 "percentage": 1 "first line therapy": 1 "suitability for testing disease modifying therapy": 1 "strain": 1 "pathological": 1 "solid cancers in phase ii or iii clinical study?": 1 "bevacizumab dose": 1 "visiting assistant professor radiation biology section dept of therapeutic radiology university of minnesota": 1 "ab type": 1 "??0": 1 "??1": 1 "serum igg iga igm and igg subclasses *": 1 "??2": 1 "23 57.5": 1 "inhibitor/agent": 1 "tdf+ftc+efv": 1 "professor graduate institute of clinical medicine national taiwan university and hospital": 1 "type of angina": 1 "case number": 1 "pathology": 1 "phase of clinical development": 1 "phase of cml at sample procurement": 1 "tdf+ftc+ral": 1 "organ-specific response rate": 1 "donor": 1 "invited professor of gastroenterology and hepatology kinki university": 1 "number of treated patients": 1 "p16 methylation": 1 "thrombopenia": 1 "complete response": 1 "sd ": 1 "other major complications": 1 "age/sex": 1 "additional criteria": 1 "mf/ml": 1 "tumour model": 1 "antiandrogen agent s": 1 "anything less than 75 improvement or full response may require a medication change": 1 "department of surgery university of tokyo": 1 "classification of esophageal cancer": 1 "follow-up period": 1 "1 7": 1 "stable disease": 1 "hb g/dl—wbc 002f?l—plt ×103/?l": 1 "commercial name": 1 "promoter": 1 "risk category": 1 "shigeki arii md phd": 1 "12 month": 1 "?only papillary thyroid cancer": 1 "no objective responses reported to date in phase i trials but 1 sd 16": 1 "observations in tretinoin group": 1 "number and type of tumor": 1 "egfr ihc": 1 "c2": 1 "mitotic count/50 hpf a": 1 "phase of clinical study": 1 "0.29 0.33": 1 "acromegaly": 1 "response rate ": 1 "n=180 n ": 1 "assistant professor of 1st department of surgery kyoto university school of medicine": 1 "initial vs last model1 lh/parallel": 1 "targets notes": 1 "thyroid cancer": 1 "associate professor department of hepato-biliary-pancreatic surgery tokyo medical and dental university": 1 "??immunotherapy": 1 "all events a": 1 "purpose of the study": 1 "fabp7 nu": 1 "liver resections 2": 1 "clinical response": 1 "melanoma patients evaluable for response n": 1 "author and year of the study": 1 "medical institute of bioregulation kyushu university": 1 "99.4 98.8": 1 "2008 dec–2010 nov": 1 "alteration pattern": 1 "dmso": 1 "t 1/2 h c": 1 "fab classification": 1 "metabolic syndrome characteristic": 1 "current clinical applications": 1 "testing stage a": 1 "trial design": 1 "antibody for ip usedin intervention 1": 1 "clinical application rct or other": 1 "advanced others solid tumors": 1 "-8.4": 1 "yonson ku": 1 "toshimi kaido md phd": 1 "surgical staff department of gastroenterological surgery national kyushu cancer center": 1 "surgical removal": 1 "radiation dose cgy": 1 "associate professor proton medical research center university of tsukuba": 1 "parameter no.of patients ": 1 "er/pr+": 1 "control arm": 1 "thyroid function tests": 1 "model of action": 1 "nausea vomiting diarrhea fatigue myalgia rash elevation of transaminases 26": 1 "tnm staging system": 1 "s no": 1 "er/pr-": 1 "therapy arms": 1 "previous history of cancer": 1 "tipifarnib a dose-schedule": 1 "tumour site/type": 1 "end-point": 1 "recurrence of polyps": 1 "graduated from kyoto university school of medicine": 1 "trial reference number": 1 "tests of ciliary function": 1 "prior treatments": 1 "fellow in the second department of internal medicine tokyo medical and dental university": 1 "director chief of gastroenterology and hepatology musashino red-cross hospital": 1 "dose schedule": 1 "differentially-expressed gene analysis": 1 "treatment of acromegaly n ": 1 "patients with egfr-overexpression n": 1 "pei-jer chen": 1 "drug combo": 1 "auc 0-48h nm•h a": 1 "association to poor outcome": 1 "approximate occurrence ": 1 " n = 105*": 1 "recurrence time after diagnosis in months": 1 "associate professor vice-chairman dept of therapeutic radiology kyoto university": 1 "duration of aawr months": 1 "department of surgery institute of gastroenterology tokyo women's medical university": 1 "author/study/ref.": 1 "trial or author": 1 "cimp ": 1 "2007–2009": 1 "case id": 1 "???3 therapy regimens": 1 "model": 1 "suboptimal response": 1 "kstar classification our method": 1 "erlotinib dose/day": 1 "shunichi ariizumi md": 1 "colonoscopy n?=?48 n ": 1 "clinicaltrials gov identifier": 1 "american cancer society- multi-society task force- american college of radiology 32 ": 1 "experimental therapy target": 1 "sex of patients": 1 "gefitinib": 1 "incomplete pathological response": 1 "iv": 1 "ftc n=16": 1 "drug in clinical use": 1 "10 µm": 1 "author and reference number": 1 "estimated study completion date": 1 "4/1993–3/1998": 1 "mouse models": 1 "overall survival month": 1 "assistant medical staff dept of surgery institute of gastroenterology tokyo women's medical univ.": 1 "proportion": 1 "barium swallow": 1 "pre testing mosaic inferred": 1 "45.3±14.4 16–74": 1 "case #": 1 "visiting doctor in head & neck surgery national cancer center": 1 "jeong min lee md phd": 1 "71.5 years": 1 "22 36.7": 1 "non-bsw colonoscopists n=4": 1 "1983 apr–1986 aug": 1 "sex n ": 1 "effects on hypertension": 1 "initial vs last same model2 rh": 1 "9 15.0": 1 "geo no": 1 "passed the examination of national board": 1 "2009.4–": 1 "alternative therapeutic options": 1 "clinical associations": 1 "blood tests": 1 "84.8±75.4 0–341": 1 "specific ige to selected allergens": 1 "growth hormone only": 1 "mutations": 1 "in vitro/in vivo": 1 "risk roup": 1 "combination therapy": 1 "mmp7 staining extent": 1 "objective response rate orr ": 1 "serum total ige": 1 "http//clinicaltrials.gov/ 65 identifier": 1 "year of approval": 1 "tdf+ftc+rpv": 1 "3 caecal = 2 rectal = 1": 1 "1st line versus 2nd line versus adjuvant": 1 "selection of patients": 1 "assistant professor division of hepato-biliary-pancreatic and transplant surgery kyoto university": 1 "trial id *": 1 "resident department of surgery tokushima university hospital tokushima japan": 1 "ms-pcr result": 1 "1.9": 1 "year of the study": 1 "mk-2206 dosing schedule": 1 "karyotype at diagnosis of t-aml": 1 "?bones": 1 "director kyoundo hospital tokyo japan division chief department of gastroenterology and hepatology kyoundo hospital tokyo japan": 1 "1993–2005": 1 "response according to recist": 1 "29–76": 1 "samples analyzed": 1 "research fellow department of radiology university of pittsburgh medical center": 1 "1992–1998": 1 "at least 75 for 4 weeks then move to continuation phase": 1 "stable disease?+?progressive disease": 1 "monoclonal ab": 1 "department of surgery the university of tokushima": 1 "or": 1 "control": 1 "medication": 1 "gene alteration": 1 "percentage of c-kit/c-kitr expression": 1 "post genetic negative testing in blood transmission risk": 1 "surgical specimen staining pattern": 1 "duodenal": 1 "histological diagnosis": 1 "fda-approval": 1 "clinical finding": 1 "pts n ": 1 "# of clinical trials": 1 "antibody for ip used in intervention 2": 1 "metastatic sites of disease": 1 "remarks": 1 "specialty": 1 "discipline": 1 "age at follow up": 1 "cytogenetics": 1 "tissue being analysed": 1 "17q-gain": 1 "immunosupression treatment at biopsy": 1 "??lung": 1 "allele frequency": 1 "at each contact": 1 "initial vs last in model1 clock": 1 "????cc1/2 last shell": 1 "b-raf status in cell line": 1 "72 32.1": 1 "relapse": 1 "p value a": 1 "mapk phosphorylation": 1 "treatment animals": 1 "target aptamer + adjuvant": 1 "1982–1983": 1 "assistant professor in proton medical research center university of tsukuba": 1 "conditions": 1 "1p-del": 1 "gleason score": 1 " 12": 1 "spirometric measurement of lung volumes and gas transfer": 1 "dosage": 1 " 17": 1 "survival>": 1 "screening of patients": 1 "other parasites identified": 1 "criteria for medication change": 1 "????number of unique reflections": 1 "aeca cell surv >80": 1 "time to disease recurrence": 1 "69 69": 1 "cr/ncr ": 1 "outcomes/most common side effects": 1 "clinical professor of tsukuba university hospital": 1 "participants": 1 "cxrt+r115777": 1 "peroration": 1 "graduate school of medical sciences kyushu university": 1 "mplc": 1 "?other": 1 "clinical development phase mpn": 1 "phase of testing": 1 "liver transplantation surgery department of hepatobiliary pancreatic surgery national cancer center tokyo japan chief resident": 1 "no of patients n =51": 1 "full blood count including eosinophil count": 1 "graduate faculty of medicine university of tokyo tokyo japan cum laude md": 1 "hiroshima red cross hospital & atomic-bomb survivors hospital": 1 " 39": 1 "21 35.0": 1 "kras mut": 1 "type of tumour": 1 "responders": 1 "glioblastomas": 1 "prior treament": 1 "2006-date": 1 "unfavorable/favorable characteristics": 1 "organism": 1 "pc tt4": 1 "target mirnas": 1 "type7": 1 "neutropenia": 1 "first author/study": 1 "bronchial responsiveness to methacholine/histamine": 1 "mcr localization by acgh": 1 "all diabetic patients n=140": 1 " 50": 1 "relapse n?=?30": 1 "method of assessment": 1 "extent methylation †": 1 "evaluable": 1 "tipifarnib a": 1 "3 pr 5 sd 12–36+ weeks in 44 patients with trastuzumab-refractory disease 27": 1 "pancreatic secretion": 1 "previous treatment": 1 "median pfs months": 1 "biomarkers of inflammation exhaled nitric oxide eosinophils in induced sputum": 1 "th expression": 1 "evaluation period": 1 "molecular agent": 1 "jak kinase inhibitor": 1 "in vivo": 1 "number of patients ": 1 "phase of development in breast cancer": 1 "local control": 1 "key findings": 1 "main tissue localization": 1 "tyk2 ar-hies": 1 "frequency of alteration in pediatric patients": 1 "rnai/target": 1 "drosophila model": 1 "vaccine": 1 "secondary resistance paired": 1 "graduate student department of gastroenterology kinki university school of medicine": 1 "trial/type of study": 1 "histological type": 1 " 72": 1 "age2/": 1 "professor emeritus of tokyo medical and dental university": 1 "type of transplantation": 1 "7 30": 1 "ci-1033": 1 "age at diagnosis years": 1 " ?2=1.89 df=1 p=0.16*": 1 "trastuzumab arm": 1 "assistant professor department of surgery and science": 1 "clinical activity in breast cancer": 1 "patients n =77": 1 "ost": 1 "associated director of medicine musashino red-cross hospital": 1 "mutation besides ph": 1 "primary endpoint/objective": 1 "secondary resistance median range": 1 "pki-166": 1 "clone vender": 1 "1978–1980": 1 " 88": 1 "t max h b": 1 "tumour type": 1 "markers used": 1 "consequences of conventional curative treatments radical prostatectomy or radiation therapy": 1 "graduate school of medicine university of tokyo tokyo japan phd": 1 "status or result": 1 "examples": 1 "diarrhea nausea fatigue rash headache elevation of transaminases": 1 "sensitivity": 1 " n?=?72": 1 "drug target": 1 "with pnf w/o mpnst": 1 "m/f": 1 "cell type/intervention 1": 1 "maintenance therapy": 1 "median range": 1 "# probes": 1 "treatment after initial diagnosis": 1 "course week": 1 "non-responders": 1 "junior resident of radiology kyoto university hospital": 1 " cd34": 1 "feature": 1 "trial identifier no": 1 "pts enrolled": 1 "rtog 98-12": 1 "patients pre-treatment": 1 "patients at increased risk of hcc": 1 "place": 1 "?rectum": 1 "38471": 1 "patient characteristics n?=?48": 1 "-44.9": 1 "mutation analysis methods": 1 "grade m/u b": 1 "patients evaluable n": 1 "11q-del": 1 "patients no of patients": 1 "36.0": 1 "prescription": 1 "cell type/intervention 2": 1 " n?=?57": 1 "professional experience": 1 "number of factors": 1 "grade 3–4": 1 "stage at biopsy ajcc": 1 "proportion of patients showing maximal pcwg2 psa response": 1 "no of patient": 1 "clinical endopoint / orr": 1 "2001–2004": 1 "median pfs mo": 1 "2001–2007": 1 "growth hormone + prolactin": 1 " year researchers": 1 "clinical use in diagnosis": 1 "11 22.4": 1 "1988–1990": 1 "natural agent": 1 "nf1 patients with cancer": 1 "associate professor division of hepato-biliary-pancreatic and transplant surgery kyoto university": 1 "immunostaining results no patients ": 1 "tissue type": 1 "hazard ratio 95 ci": 1 "patient with subtelomeric imbalance confirmed by mlpa and array 23 patients n ": 1 "biopsy specimen staining pattern": 1 "trade/code name": 1 "egfr mutation": 1 "inflammatory disorder": 1 "age at initial exposure": 1 "therapeutic context": 1 "secreting type n?=?49 * n ": 1 "method of ctc detection": 1 "non-responders n?=?16": 1 "observations": 1 "general surgery": 1 "chemotherapy a": 1 "class of antioxidants": 1 "healthy controls": 1 "?male": 1 "20 year progression risk ": 1 "rnai platform target": 1 "clinical application": 1 "patient response": 1 "assessment frequency": 1 "pmid": 1 "contact frequency": 1 "???? no of patients ": 1 "egfr positive": 1 "md cum laude faculty of medicine kyushu university resident": 1 "locations": 1 "dc-based vaccines": 1 "0.21 0.24": 1 "chest radiograph": 1 
"gene": 112 "this study": 58 "forward primer": 50 "reverse primer": 49 "primer": 43 "primer sequence": 32 "amp": 29 "pet15b": 29 "2u": 27 "gene name": 26 "primer name": 24 "product size bp": 22 "sequence": 22 "amplicon size bp": 17 "a": 14 "forward primer 5?-3?": 14 "reverse primer 5?-3?": 14 "ura": 14 "psk1": 13 "his3": 13 "exon": 12 "genes": 12 "size bp": 12 "prs426": 11 "leu2": 11 "description": 11 "ev": 11 "accession number": 10 "primer sequences": 10 "tm °c": 10 "amplicon": 9 "primers": 9 "?-gal": 9 "trp1": 9 "0.32": 9 "by4741": 9 "length bp": 9 "gal4ad": 8 "leu": 8 "name": 8 "annealing temperature °c": 8 "gene symbol": 8 "plasmid": 8 "yep-gad": 8 "reverse": 7 "james et al 1996": 7 "cbf1": 7 "construct": 7 "forward": 7 "reference": 7 "lacz": 6 "trp": 6 "0.08": 6 "0.16": 6 "product size": 5 "target": 5 "0.10": 5 "0.09": 5 "0.05": 5 "0.20": 5 "bait": 5 "yep-gbd": 5 "reverse primer 5??3?": 4 "forward primer 5??3?": 4 "lacz his3": 4 "direction": 4 "pcr product size bp": 4 "fragment size bp": 4 "primer sequence 5?-3?": 4 "target gene": 4 "0.07": 4 "0.15": 4 "0.34": 4 "0.30": 4 "0.28": 4 "0.24": 4 "0.25": 4 "0.35": 4 "0.48": 4 "product length bp": 4 "o.ex .": 4 "sequence 5??3?": 4 "mut .": 4 "oligonucleotides": 4 "amplicon size": 4 "prs416": 3 "pcr": 3 "1.16": 3 "1.32": 3 "1.31": 3 "low high": 3 "primer direction": 3 "3.03": 3 "ref.": 3 "adh1 truncated": 3 "probe": 3 "prey": 3 "lexa": 3 "clontech": 3 "gal4db": 3 "forward primer 5?–3?": 3 "gal4 3 x uasg 17-mer gal4 gal1 = 4 x uasg 17-mer ": 3 "cycles": 3 "?": 3 "reverse primer 5'-3'": 3 "source/reference": 3 "deleted ": 3 "bp": 3 "genbank accession no.": 3 "0.23": 3 "0.18": 3 "0.14": 3 "0.33": 3 "0.29": 3 "0.45": 3 "0.42": 3 "0.43": 3 "0.56": 3 "0.49": 3 "0.67": 3 "sequences": 3 "primer sequence 5?–3?": 3 "forward primer 5'-3'": 3 "library": 3 "product bp": 3 "0.83": 3 "amplicon bp": 3 "sequence 5?-3?": 3 "reverse primer 5? to 3?": 3 "amplicon length bp": 3 "reverse primer 5?–3?": 3 "mrna": 3 "forward primer 5? to 3?": 3 "tm": 3 "genotype": 3 "wt": 3 "amplified ": 3 "-": 2 "size": 2 "1485": 2 "primer sequence 5? to 3?": 2 "5? primer": 2 "distinct tag": 2 "1.00": 2 "t °c": 2 "1.11": 2 "reference or source": 2 "1.05": 2 "1.06": 2 "clone": 2 "sequence 5?–3?": 2 "1.21": 2 "sense primer": 2 "left primer": 2 "gene name symbol": 2 "1.29": 2 "1.25": 2 "1.44": 2 "1.41": 2 "1.40": 2 "larvae": 2 "3.00": 2 "1.70": 2 "gal4db+ha": 2 "total tag": 2 "kiaa1918 protein": 2 "1.98": 2 "ampliconsize bp": 2 "sequence 5?->3?": 2 "11.27": 2 "effluent": 2 "exon 5": 2 "forward primer sequence": 2 "3.70": 2 "primer nucleotide sequences": 2 "cd1a+": 2 "embryo": 2 "source": 2 "others ": 2 "gal4 gal1 = 4 x uasg 17-mer ": 2 "african americans n?=?30": 2 "sequencing primer": 2 "usage": 2 "genbank id": 2 "adh1 full length": 2 "sequence 5'-3'": 2 "kegg": 2 "his": 2 "5?-3? sequence": 2 "chromosome": 2 "homology accession number": 2 "plasmid name": 2 "e-value": 2 "qdo+x-?-gal+aureobasidin a": 2 "sample": 2 "reverse primer 5? – 3?": 2 "0.11": 2 "0.12": 2 "0.04": 2 "0.22": 2 "0.21": 2 "restriction site": 2 "0.19": 2 "0.17": 2 "primer sequence 5'-3'": 2 "clone numbers": 2 "primer sequences 5?-3?": 2 "0.27": 2 "0.44": 2 "5?-cccccgtccctccct-3?": 2 "codon": 2 "0.37": 2 "- -": 2 "right primer": 2 "0.46": 2 "0.47": 2 "his3 lacz": 2 "3? primer": 2 "bait vector": 2 "0.64": 2 "0.65": 2 "0.61": 2 "gene id": 2 "0.58": 2 "forward primer 5? – 3?": 2 "0.80": 2 "0.86": 2 "primer sense": 2 "mutation status": 2 "high": 2 "w303": 2 "nd": 2 "position": 2 "nucleotide change": 2 "mutated": 2 "2.67": 2 "receptor": 2 "cdna": 2 "array-fold": 2 "hs.13485": 2 "vector": 2 "clone id": 2 "primer pairs": 2 "winzeler et al 1999": 2 "symbol": 2 "4.55": 2 "antisense primer": 2 "gc ": 2 "clone group": 2 "unigene": 2 "tested": 2 "pbp1": 2 "primer sequence 5??3?": 2 "refseq mrna": 2 "transcript": 2 "gdna": 2 "prey vector": 2 "restriction enzyme": 2 "fold change": 2 "purpose": 2 "reverse primer sequence": 2 "y187": 2 "pcr product size": 2 "accession numbers": 2 "": 1 "year": 1 "r40161": 1 "exon examined": 1 "hxk2 into pet15b pjg1009": 1 "screened clones": 1 "a gene": 1 "leu2-3112 ura3-52 rme1 trp1 his4 gal+ hmla": 1 "pten exon": 1 "h sapiens mrna full length insert cdna clone euroimage 29222": 1 "restriction pattern length bp": 1 "unique/repetitive": 1 "reverse primer sequence 5?-3?": 1 "?yd06g01": 1 "cbf1 pev": 1 "gal1 full length inducible promoter = pjg4-5": 1 "bl21": 1 "plasmid constructs": 1 "adh1 full length cyh2": 1 "analysis": 1 "hs272814": 1 "?yf80c08": 1 "pjg1112": 1 "pjg1113": 1 "1": 1 "k5 + gip": 1 "2": 1 "pjg1111": 1 "3": 1 "selection": 1 "4": 1 "cys12": 1 "5": 1 "hs.286013": 1 "6": 1 "7": 1 "n2 clone": 1 "expected pcr product size bp": 1 "8": 1 "adh1 full length = peg202": 1 "nb cell line": 1 "9": 1 "jg2894": 1 "ssh libraries *": 1 "jg2895": 1 "reverse primer 5 ? ?>?3 ?": 1 "kiaa1100 protein": 1 "michael hall university of basel": 1 "jg3523": 1 "temp.": 1 "2572": 1 "8.72": 1 "psk1psk2cbf1": 1 "hap2": 1 "number total": 1 "mytarray 1.0 id": 1 "yrg-2": 1 "cen": 1 "result": 1 "ncbi accession cdna clone": 1 "-his": 1 "lnx1 npay-pdz4": 1 "ggcgcatgcttagtgattgattaatttttgttcaccgttc": 1 "fragment generated size": 1 "f13218 t75433": 1 "pjg232": 1 "hs.226396": 1 "pgal1-10- psk1 -flag": 1 "?c-2ba02": 1 "acession no.": 1 "abbreviation": 1 "human dna sequence from clone rp5-881l22 on chromosome 20": 1 "bl21de3": 1 "product sizes bp": 1 "as-normal": 1 "r44721": 1 "jg3522": 1 "reverse primer sequence 5? to 3?": 1 "amplicon bases and gc content": 1 "gc-2spd ts": 1 "ade2-1 can1-100 his3-1115 leu2-3112 trp1-1 ura3-1": 1 "functional domain": 1 "r11699 r17677": 1 "oligonucleotide sequence 5' – 3'": 1 "1018": 1 "ref": 1 "1257": 1 "r36936": 1 "primer pair name": 1 "pcr primers 5'-3' f forward primer r reverse primer": 1 "c.mutant": 1 "xenograft response tomab against igf-1r": 1 "reverse antisense primer": 1 "r12017 r39856": 1 "- very low": 1 "novagen": 1 "forward primer 5?– 3?": 1 "k- ras exon 4a": 1 "jgy1265": 1 "jgy1264": 1 "hs.140833": 1 "pjg725 ev into jgy1227": 1 "jgy1263": 1 "pi3k exon 20": 1 "?yg36f12": 1 "jgy1262": 1 "jgy1261": 1 "r11887": 1 "201091": 1 "db vector selection marker": 1 "6715": 1 "clone 4.3 n?=?10": 1 "hs.15921": 1 "egfr": 1 "pbtm116": 1 "hs.7888": 1 "r15181 r41632": 1 "?yg97d02": 1 "?yf49g10": 1 "hs.6311": 1 "4310": 1 "r35431 r49229": 1 "pi3k exon 9": 1 "1.02": 1 "pbp1 into pet15b pjg1009": 1 "forward primer 5’ ? 3’": 1 "pjg1123": 1 "r13137 r40616": 1 "?yg15g12": 1 "pjg1122": 1 "jgy1227": 1 "frequency ": 1 "cdna dkfzp564o0122 from clone dkfzp564o0122": 1 "probe sequence": 1 "hs.12896": 1 "pgad424": 1 "y2h gold": 1 "sfy526": 1 "jgy1": 1 "yeast origin": 1 "?yc94b11": 1 "1.12": 1 "utr1": 1 "forward primer 5' to 3'": 1 "1.13": 1 "jgy4": 1 "1.10": 1 "?yl76d07": 1 "forward primer 5?->3?": 1 "jgy1242": 1 "jgy8": 1 "jgy1241": 1 "1.09": 1 "gtcttcactcccgtgcttgtccgaggagggagggagggacgggggctgtgctggggcagc cggaacaacgcaggtcgccgggccggctgggcgagttggccgggcggggctgaggggtcggcgggggaggctgaggcgcgggggccggtgcgcggccgtgagggggtgtgagaggtggctgacggcgccgaggagcccctcagaacctgcaggtggggggagctcccatatcttacgggtgtttcggg": 1 "1.07": 1 "8918": 1 "1.08": 1 "cctccctggaggggaatggcgtctgcaccaatggaatctac": 1 "hs.40094": 1 "1.03": 1 "in vitro": 1 "5' primer": 1 "hs.41185": 1 "1.04": 1 "pjg858 into jgy43": 1 "4312": 1 "anneal temperature °c": 1 "exon typology": 1 "expected product size bp": 1 "resulting fragment bp": 1 "cdna dkfzp547k204 from clone dkfzp547k204": 1 "osh7 into pet15b pjg1009": 1 "1.23": 1 "hs.5008 hs.21515": 1 "1.20": 1 "h sapiens cdna flj12150 fis clone mamma1000422": 1 "number": 1 "ura3gal1-gal1-lacz mel1 ura3-52 his3-200 ade2-101 trp1-901 leu2-3 112 gal4del gal80del met-": 1 "aatttcagtcagtcaagatctctgcaggtcgacatcgatggatcccccggggaattcca": 1 "2388": 1 "atp2": 1 "636": 1 "hs.179946": 1 "jg3357": 1 "jg3356": 1 "david stillman university of utah": 1 "t°a": 1 "1.35": 1 "pjg858": 1 "mutated codon with amino acid": 1 "hs.180948": 1 "pjg859": 1 "primers f forward r reverse": 1 "tm °c   ": 1 "sequence 5? ? 3?": 1 "cg-1945": 1 "clone 2 n?=?10": 1 "r18075 r42970": 1 "mutation": 1 "884": 1 "y2h gold jgy1031": 1 "1.28": 1 "1067": 1 "adh1 truncated ac u07646": 1 "codon location *": 1 "kiaa0620 protein": 1 "erbb2ip pdz": 1 "hypothetical protein flj10759": 1 "kiaa0625 protein": 1 "1.45": 1 "1.46": 1 "1.43": 1 "?yg65h10": 1 "1.38": 1 "ggaacatcatacgggtatccgtgatgatgatggtggtgggatcctcgaggcatgaattcgggttttttctccttgacgttaaagtatagaggtatattaa": 1 "1.39": 1 "c int.": 1 "4345": 1 "llc-pk1": 1 "jg3376": 1 "hs.264636": 1 "hs.322844": 1 "primer design": 1 "as-hcc": 1 "gene/isoform": 1 "gactccttcatttgatggggctatggctctttcccc": 1 "jg3375": 1 "vp16ad": 1 "5690": 1 "pgad1318": 1 "hs.165570": 1 "1.56": 1 "position bp": 1 "cpg islanda": 1 "1.55": 1 "transcript bp": 1 "novel human gene mapping to chromosome 1": 1 "kiaa1036 protein": 1 "mda-mb-435-hyg": 1 "sequence 5??3? restriction sites underlined": 1 "p cbf1- t154a/s156a": 1 "425": 1 "f12859 t75226": 1 "5446": 1 "primer positions": 1 "ras mutated 3": 1 "1.60": 1 "pjg421": 1 "pjg422": 1 "psk2 nat-mx4 psk1 hph-mx4 cbf1 kan-mx4 his3-1 leu2 met15 ura3": 1 "osh7": 1 "kiaa0194 protein": 1 "1.67": 1 "pjg427": 1 "pjg428": 1 "kiaa0729 protein": 1 "pjg429": 1 "pjg423": 1 "glk1 into pet15b pjg1009": 1 "genomic coordinates": 1 "1.64": 1 "pjg425": 1 "2192": 1 "amplification conditions": 1 "hypothetical protein flj20783": 1 "neo": 1 "pten": 1 "hypothetical protein flj20300": 1 "hs.12239": 1 "cpg": 1 "empty vector": 1 "cytokine": 1 "pjg410": 1 "clones": 1 "prb1": 1 "plasmid reporter gene": 1 "3.14": 1 "5?-ctggctccgtgtcttcact-3?": 1 "3.13": 1 "3.12": 1 "genebank accession nm_": 1 "h sapiens cdna flj21691 fis clone col09555": 1 "api5-like 1": 1 "3.10": 1 "3.08": 1 "kiaa0574 protein": 1 "5469": 1 "kiaa1464 protein": 1 "yeast marker": 1 "cg-87 protein": 1 "number percentage": 1 "resulting amino acid mutations": 1 "jared rutter university of utah": 1 "pjg441": 1 "cancer type": 1 "amplified exons": 1 "1.89": 1 "3.24": 1 "23982": 1 "m13sv1-egfp-neo": 1 "5? gene information": 1 "3.23": 1 "1.85": 1 "zds1 into pet15b pjg1009": 1 "4391": 1 "forward sense primer": 1 "gtagattccattggtggcagacgccattccctccagggagg": 1 "forwardprimer 5?–3?": 1 "3.18": 1 "3.16": 1 "row": 1 "z44563": 1 "antisense primer sense primer": 1 "pas2-1": 1 "jg2229": 1 "gene/exon": 1 "1.93": 1 "?yf69g12": 1 "grose et al 2007": 1 "number of clones": 1 "cdna dkfzp564o1262 from clone dkfzp564o1262": 1 "antisense primer 5'-3'": 1 "h sapiens cdna flj21314 fis clone col02248": 1 "jg2228": 1 "hs.26409": 1 "3.36": 1 "sequence accession number": 1 "3.34": 1 "1.97": 1 "?yg51f11": 1 "3.30": 1 "3072": 1 "pgbd-c2 empty y2h bait vector": 1 "cd14?": 1 "5?-gtcttcactcccgtgcttgt-3?": 1 "products pcr bp": 1 "223": 1 "application": 1 "h sapiens cdna flj22696 fis clone hsi11696": 1 "pab1": 1 "3.29": 1 "hypothetical protein mgc13090": 1 "?yf79e07": 1 "229": 1 "primer forward 5'-->3'": 1 "anneling temprature x": 1 "reverse primer 5’ ? 3’": 1 "h7fc": 1 "f10758 f13156": 1 "cbf1 into pet15b pjg1009": 1 "forward primer sequence 5?-3? fp": 1 "hs.119004": 1 "ipp1 into pet15b pjg1009": 1 "ncbi accession for mrna record": 1 "?yf64f10": 1 "pri-mir-149 forward primer": 1 "3.48": 1 "p cbf1- t211a/t212a": 1 "padh-myc- cbf1- t154a/s156a": 1 "hif1?": 1 "phyblex/zeo": 1 "cdna dkfzp564h1916 from clone dkfzp564h1916": 1 "foreign gene/promoter insertion": 1 "apc": 1 "protein": 1 "reporter genes": 1 "exon 8 ": 1 "forward primer 5 ? ?>?3 ?": 1 "?yf53g09": 1 "prey bait": 1 "reverse primer 5' to 3'": 1 "1909": 1 "mytibase id": 1 "3.55": 1 "reverse primer sequence 5????3?": 1 "3.52": 1 "r51740": 1 "erg9": 1 "amplification": 1 "reverse primer sequence 5?–3?": 1 "control pcr": 1 "3.49": 1 "cdna dkfzp564c1216 from clone dkfzp564c1216": 1 "lexa systems": 1 "hypothetical protein cl25022": 1 "sap30 into pet15b pjg1009": 1 "r20455 r44158": 1 "exon 7 ": 1 "exon 6": 1 "insert gene": 1 "exon 7": 1 "annealing temp °c": 1 "3.60": 1 "exon 8": 1 "exon 9": 1 "mrna cdna dkfzp586c1723 from clone dkfzp586c1723": 1 "?n355pbp1 from library pjg427": 1 "r56083 r56195": 1 "3.68": 1 "r15369 r42110": 1 "pri-mir-149 reverse primer": 1 "exon 1": 1 "exon 2": 1 "exon 3": 1 "exon 4": 1 "3.63": 1 "exon 6 ": 1 "rsq": 1 "255": 1 "gal4-based": 1 "methylation t melt °c": 1 "51540": 1 "zeocin": 1 "1917": 1 "backbone": 1 "forward / reverse primer 5?-3?": 1 "forward primer concentration nm": 1 "ccr ": 1 "3.71": 1 "chromosome map": 1 "efficiencies": 1 "rtk": 1 "- low": 1 "3.76": 1 "gene*": 1 "?yg32e10": 1 "exon 5 ": 1 "his3d1 leu2d0 met15d0 ura3d0": 1 "?n931psk1 in pjg425": 1 "gene added": 1 "fragment position": 1 "fragment length bp": 1 "5.09": 1 "sequences 5? ? 3?": 1 "sequence of primer": 1 "list of primers": 1 "ref seq number": 1 "r14304 r40254": 1 "5.27": 1 "promoter ac": 1 "no.": 1 "3.87": 1 "?yf65e06": 1 "concentration nm": 1 "200671": 1 "forward primer sequence 5?–3?": 1 "interacting cdna clones": 1 "size bp*": 1 "3.95": 1 "3.94": 1 "3.91": 1 "exon 20": 1 "sense primer sequence 5?–3?": 1 "pgadt7 empty y2h prey vector": 1 "ad vector selection marker": 1 "padh-myc": 1 "mdpp9_i20.r": 1 "?yc89d09": 1 "reverse transcription primer 5'-3'": 1 "5.31": 1 "uninduced": 1 "?yg67h02": 1 "primer sequence 5? ? 3?": 1 "t anneal °c": 1 "hs.318401": 1 "primer concentration": 1 "sequence 5’-3’": 1 "r35733 r49366": 1 "position mrna": 1 "hs.6343 hs.306400": 1 "pjg960": 1 "tp53 sequencing": 1 "sanger sequencing": 1 "accession no./ref.": 1 "pjg725": 1 "cbf1 -t154a/s156a in pet15b": 1 "sense 5 ?- 3 ? ": 1 "adh1 full length cyh2 ac u30496": 1 "ctttaacgtcaaggagaaaaaacccgaattcatgccctacatcggtgcttccaacctctcagaacattcatttgttaatttgaaggaaaaacatgcgat": 1 "11000": 1 "hs.216958": 1 "h sapiens cdna flj31803 fis clone nt2ri2009101": 1 "derived": 1 "?yc91e03": 1 "kiaa1610 protein": 1 "primer length bp": 1 "reverse primer sequences 5?–3?": 1 "start": 1 "5093": 1 "viral vectors": 1 "zds1": 1 "car2": 1 "original vector 12 kb": 1 "?yg42e05": 1 "gtcgtggaagaaaacctgctgctttggccacaacagacg": 1 "prod length": 1 "yap6": 1 "forward 5?-3?": 1 "hs.16443": 1 "hypothetical protein flj20113": 1 "?yf75c06": 1 "clone 4.6 n?=?10": 1 "h sapiens cdna flj20859 fis clone adka01617": 1 "hs.20977": 1 "human dna sequence from clone 167a19 on chromosome 1p32.1-33": 1 "vhl sequencing": 1 "hs.108504": 1 "pgad10": 1 "cyc.": 1 "reverse primer 5?– 3?": 1 "pcr ": 1 "deletion": 1 "pjg1063": 1 "genx": 1 "erg9 into pet15b pjg1009": 1 "jk9": 1 "2829": 1 "mth1 into pet15b pjg1009": 1 "pcr primer pairs": 1 "adh1 truncated acu13188": 1 "liver": 1 "hs 325825": 1 "neuronal protein np25": 1 "clone 4 n?=?10": 1 "clone 6 n?=?10": 1 "pjg1079": 1 "psk1 his3 psk2 kan-mx4 leu2 lys2 met15 trp1 ura3": 1 "pjg1078": 1 "primer sequence 5?>3?": 1 "primer sequences forward/reverse": 1 "pjg1074": 1 "ypagal library": 1 "7.09": 1 "2836": 1 "h sapiens mrna cdna dkfzp547j125 from clone dkfzp547j125": 1 "hypothetical protein dkfzp564a176": 1 "kiaa0141": 1 "hs.333389": 1 "gnd1": 1 "?yf72d11": 1 "concomittant exon 2 codon 12 mutation": 1 "fwd primer 5' – 3'": 1 "reverse primer 5' ? 3'": 1 "exon size bp": 1 "hs.288368": 1 "mot3": 1 "pjg1041": 1 "pab1 into pet15b pjg1009": 1 "?yc91c07": 1 "?n692psk1-his/ha in pjg858": 1 "pgadt7 mate and plate mid-log ypagal library in jgy1073": 1 "forward primer 5'...3'": 1 "5.99": 1 "?yf51g08": 1 "7.39": 1 "primer antisense": 1 " efficiency": 1 "r25011 r45019": 1 "pjg1059": 1 "primer location relative to tss bp": 1 "pjg1057": 1 "pcr conditions": 1 "exon boundary fusion": 1 "pse1107": 1 "rt-pcr primer sequences a 5? to 3?": 1 "pjg1054": 1 "hs.222746": 1 "13.38": 1 "?yf94d09": 1 "downstream primer sequence": 1 "r38361 t77413": 1 "size of product bp": 1 "gal4 gal1 = 4 x uasg 17-mer gal4 gal1 = 4 x uasg 17-mer ": 1 "pjg859 into jgy43": 1 "nup": 1 "jgy1099": 1 "stat3-driven luciferase fold stimulation": 1 "jgy1098": 1 "lnx2": 1 "?yg57f04": 1 "primer sequences for pcr forward/reverse": 1 "sybr green primers": 1 "cbf1 -t138a in pet15b": 1 "gene a": 1 "amplification of pri-mir-149 and pre-mir-149 for assaying expression": 1 "?yg42a11": 1 "s int.": 1 "strain": 1 "temp °c": 1 "wild type braf/ras 1": 1 "hs.118983": 1 "mot3 into pet15b pjg1009": 1 "sequence 5?- 3?": 1 "cdna dkfzp564a2164 from clone dkfzp564a2164": 1 "sequence 5?- 3?": 1 "biological properties of vector": 1 "primer sequences 5’-3’": 1 "4 x lexa op 8 x lexa op": 1 "hs.288361": 1 "pgilda": 1 "hs.323396": 1 "rt primer": 1 "?yg89f11": 1 "marker": 1 "hypothetical protein dkfzp761g0313": 1 "hs.326416": 1 "cttacttgtcatcgtcatccttgtaatcacc": 1 "not amplified": 1 "pebvsirna plasmid": 1 "adh1 full length cyh2 acu30497": 1 "reference/source": 1 "unigene bp": 1 "pathology": 1 "pjg598 ?n692psk1 in jgy1031 y2h gold": 1 "atp2 into pet15b pjg1009": 1 "upl probe no.": 1 "p cbf1": 1 "hot-spot ": 1 "q-pcr": 1 "jgy1074": 1 "braf mutated 2": 1 "target/reference mrna": 1 "induced": 1 "f13362 t77404": 1 "?c-2lb03": 1 "pjg1081": 1 "kras exon 2": 1 "sens primer": 1 "reverse primer concentration nm": 1 "temp": 1 "pas2": 1 "?yf61c10": 1 "primer probe n m ": 1 "reverse primer sequence 5?-3? rp": 1 "l40": 1 "prey plasmid": 1 "hs.125034": 1 "primer location exon": 1 "?yg91g03": 1 "anti-sense primer": 1 "qiagen cat #": 1 "pas1": 1 "tpv recombinant": 1 "r23681": 1 "904": 1 "f13386 r39459": 1 "?n692psk1 in pjg425": 1 "hypothetical protein flj10813": 1 "pb42ad ": 1 "hs.5324": 1 "ahp1": 1 "pact2": 1 "at † °c": 1 "patient#": 1 "g ene": 1 "pact1": 1 "hs.7750": 1 "nob1 into pet15b pjg1009": 1 "psk1 oe": 1 "?yc95f04": 1 "car2 into pet15b pjg1009": 1 "aa": 1 "hs.7734": 1 "?c-2aa11": 1 "hs.154919": 1 "?primer": 1 "cdna library characteristics": 1 "population": 1 "1343": 1 "encompassing read pairs": 1 "promoter construct": 1 "9.46": 1 "virus": 1 "reverse primer 5?->3?": 1 "h sapiens clone 23736 mrna sequence": 1 "cgi-10 protein loc51004": 1 "jgy43": 1 "pgal1-10-myc": 1 "sense primer 5'-3'": 1 "9.58": 1 "pjg598": 1 "primer sequence 5?- 3?": 1 "p53 sites screened": 1 "?yg37d06": 1 "pjg1217": 1 "length of product bp": 1 "pjg1218": 1 "cctcgatccagcctgcccgaggctcccaggccttcgcccgccttgcgtccagcctgccgggggctcccaggccggcgcccgagctctggctccgtgtcttcactcccgtgcttgtccgaggagggagggagggacgggggctgtgctggggcagc cggaacaacgcaggtcgccgggccggctgggcgagttggccgggcggggctgaggggtcggcgggggaggctgaggcgcgggggccggtgcgcggccgtgagggggtgtgagaggtggct": 1 "hs.288776": 1 "2455": 1 "m13mda-435-3": 1 "2696": 1 "antisense 5 ?- 3 ? ": 1 "m13mda-435-1": 1 "hs.11637": 1 "copy # dot-blot": 1 "r13300 r40783": 1 "r11708": 1 "h sapiens cdna flj20848 fis clone adka01732": 1 "mth1": 1 "?yf50h09": 1 "pjg1026": 1 "f13018 t77597": 1 "bacterial marker": 1 "nos1 pdz": 1 "pjg1024": 1 "gcd14 into pet15b pjg1009": 1 "pjg1025": 1 "0.06": 1 "pjg1022": 1 "nf?b-driven luciferase fold stimulation": 1 "pjg1023": 1 "1136": 1 "pjg1021": 1 "0.02": 1 "713": 1 "name of the target gene": 1 "r20224": 1 "pet15b with james y2h mcs": 1 "lexa ": 1 "hs.6449": 1 "r13839 r36985": 1 "reverse primer 5'...3'": 1 "exon location *": 1 "h sapiens cdna flj21380 fis clone col03329": 1 "asp13": 1 "?yc85f03": 1 "pjg1035": 1 "?yf56a05": 1 "pjg1033": 1 "2479": 1 "cgi-87 protein loc51112": 1 "pjg1031": 1 "pjg1032": 1 "r34427 r48960": 1 "pjg1030": 1 "typical false positive": 1 "pgad2f": 1 "h05960 h06010": 1 "?yc94c08": 1 "frame": 1 "r17284": 1 "annealing temperatures °c": 1 "hs.90424": 1 "forward primer sequences 5????3?": 1 "deletions": 1 "111134": 1 "caagcgcgcaattaaccctcactaaagggaacaaaagctggagctccaccgcggtggcggccgctctagaactacaattcgacaggttatcagcaac": 1 "?n692psk1": 1 "hs.101375": 1 "hs.106825": 1 "r59194 r59252": 1 "pjg1009": 1 "pjg1006": 1 "plexa": 1 "ncbi accession number": 1 "pjg1005": 1 "duration": 1 "2008": 1 "pjg1000": 1 "pjg1001": 1 "mupp1 pdz 10-13": 1 "mdpp9_e20.f": 1 "anneal °c": 1 "gc": 1 "?c-24b10": 1 "sequencing primers": 1 "3? primer sequence": 1 "kiaa1034 protein": 1 "fusion strand": 1 "pgadt7": 1 "kiaa0665 gene product": 1 "0.40": 1 "pjg1017": 1 "0.41": 1 "?yc86g12": 1 "pjg1015": 1 "pjg1013": 1 "pjg1014": 1 "0.39": 1 "hs.19150": 1 "pjg1012": 1 "0.38": 1 "copy # pcr": 1 "0.36": 1 "glk1": 1 "0.55": 1 "hs.155182": 1 "?ym11b06": 1 "0.53": 1 "gene/cdna detected": 1 "psd-10": 1 "0.54": 1 "gene ablated": 1 "0.52": 1 "r13997 r39120": 1 "target protein": 1 "0.50": 1 "fusion gene directional": 1 "accession no.": 1 "hs.351029": 1 "forward primer sequence 5? to 3?": 1 "supplier": 1 "r55970 r55969": 1 "ipp1": 1 "r35543 r51112": 1 "r16328 r41404": 1 "pgal1-10- psk1 -d1230a-his/ha": 1 "pyestrp": 1 "rattus norvegicus gene": 1 "0.66": 1 "2.02": 1 "k5": 1 "s sd": 1 "hs.22109": 1 "0.63": 1 "pgad-c1 genomic library": 1 "foci/ng dna": 1 "base pairs": 1 "0.57": 1 "pgad-gh": 1 "cpg dinucleotide": 1 "cys3": 1 "prb1 into pet15b pjg1009 ": 1 "hs.288959": 1 "pgad-gl": 1 "gal4 systems": 1 "amplification of pre-mir-149 for genotyping": 1 "0.70": 1 "primer set 5?–3? forward reverse": 1 "?yf65b02": 1 "2.13": 1 "0.75": 1 "at °c": 1 "0.73": 1 "products": 1 "codon 13": 1 "codon 12": 1 "772": 1 "hs.22370": 1 "532": 1 "unmethylation t melt °c": 1 "2.06": 1 "0.68": 1 "h sapiens cdna flj21721 fis clone colf0381": 1 "4469": 1 "?n477psk1 in pjg425": 1 "copy # fish": 1 "5559": 1 "pgal1-10-flag": 1 "r45416 r25077": 1 "ggggaaagagccatagccccatcaaatgaaggagtc": 1 "genbank accession number": 1 "lexa-based": 1 "?yg73c09": 1 "utr1 into pet15b pjg1009": 1 "0.85": 1 "2.20": 1 "2.19": 1 "snp": 1 "rev primer 5' – 3'": 1 "no of amplification cycles": 1 "r20203 r44989": 1 "6657": 1 "?n694psk1 in pjg425": 1 "target transcript": 1 "0.92": 1 "a/?": 1 "0.90": 1 "probe † sequence 5' => 3'": 1 "forward primer sequence 5?-3?": 1 "5?-acctctcacaccccctcac-3?": 1 "2.36": 1 "pjg549": 1 "whole blood": 1 "0.97": 1 "r19640": 1 "0.93": 1 "pgad-c2 empty y2h prey vector": 1 "r14269 r40562": 1 "?yf78c09": 1 "mutation detated n ": 1 "genbank #": 1 "r11919": 1 "2081": 1 "tatggaattccccgggggatccatcgatgt": 1 "e7 clone": 1 "pgad-c1 empty y2h prey vector": 1 "reverse 5?-3?": 1 "nob1": 1 "r21710": 1 "author": 1 "6203": 1 "2.47": 1 "assay id": 1 "2086": 1 "2.43": 1 "2.41": 1 "y187 jgy1073": 1 "°c": 1 "h sapiens cdna flj10733 fis clone nt2rp3001392": 1 "total splitreads": 1 "cdna dkfzp434h205 from clone dkfzp434h205": 1 "2.38": 1 "background": 1 "pma424": 1 "codon mutated": 1 "jg3423": 1 "jg3422": 1 "blood gdna": 1 "no": 1 "probe 6fam5?-3?mgb": 1 "2.55": 1 "pjg568": 1 "mrm1 into pet15b pjg1009": 1 "r11837 r36955": 1 "total": 1 "entrez gene id": 1 "?yf79f12": 1 "?yc90h10": 1 "5599": 1 "hs.7132": 1 "?yg64h02": 1 "size aa": 1 "fragment bp": 1 "?yg26c11": 1 "?yg07h12": 1 "4.04": 1 "ref seq acc #": 1 "accession number genbank": 1 "control": 1 "2.65": 1 "f? ompt hsds b rb?mb? gal dcm de3": 1 "5?-cccgaaacacccgtaagata-3?": 1 "?yf76a11": 1 "forward primer 5?-3? reverse primer 5?-3?": 1 "mrm1": 1 "?yf90d07": 1 "c-terminal his/ha-tagged psk1": 1 "5140": 1 "5?-3?": 1 "?yg30b04": 1 "cbf1 -t211a/t212a in pet15b": 1 "uas regulated by + origin of uas": 1 "pt": 1 "accession no a": 1 "hxk2": 1 "taacattctcatccttgatagctctgtgaacaataccctgg": 1 "gc-1spg": 1 "2.77": 1 "2.76": 1 "2.75": 1 "lnx1 ring-pdz2": 1 "2.73": 1 "pcr product": 1 "gene categories a": 1 "selection- marker": 1 "author ref": 1 "host genotype": 1 "kiaa0945 protein": 1 "sequence accession no .": 1 "10": 1 "2.83": 1 "11": 1 "amplification product bp": 1 "13": 1 "4.22": 1 "sequence 5?to 3?": 1 "4.25": 1 "hs.59236": 1 "?yg33g08": 1 "4.27": 1 "2.89": 1 "2.87": 1 "2.86": 1 "putative gene symbols": 1 "cbf1 kan-mx4 his3-1 leu2-0 met15-0 ura3-0": 1 "h sapiens cdna flj20920 fis clone adse00877": 1 "plasmid construct": 1 "4.19": 1 "normalized cdna library": 1 "plasmid designation": 1 "cdna dkfzp434d115 from clone dkfzp434d115": 1 "adh1 truncated medium expression acu29899": 1 "2.94": 1 "shared": 1 "4.34": 1 "pgad-c2 genomic library": 1 "3' primer": 1 "short coiled-coil protein": 1 "high high": 1 "std1": 1 "primer 5?-3?": 1 "positive clones": 1 "cell line": 1 "hypothetical protein dkfzp434l0718": 1 "32": 1 "4.42": 1 "positive control": 1 "expression": 1 "10.44": 1 "hap2 into pet15b pjg1009": 1 "homo sapiens cdna flj23285 fis clone hep09071": 1 "19.98": 1 "primer type": 1 "exon/region": 1 "r51917 r54309": 1 "pgal1-10 his/ha": 1 "hs.227913": 1 "pgal1-10 psk1 -his/ha": 1 "ratio": 1 " prr": 1 "r36317 r49249": 1 "r19006 r44076": 1 "pgad-c3 empty y2h prey vector": 1 "4.57": 1 "11140": 1 "hs.80285": 1 "10.11": 1 "tcgaggtgattacaaggatgacgatgacaagtaagcatg": 1 "regulated exon": 1 "pgbt9": 1 "ccagggtattgttcacagagctatcaaggatgagaatgtta": 1 "pre-mir-149 forward primer": 1 "r16295 r40219": 1 "?yf53d08": 1 "original vector 13 kb": 1 "4.66": 1 "incidence of arthritis": 1 "hs.141003": 1 "no of patients": 1 "4.61": 1 "162": 1 "initial temp °c": 1 " none": 1 "?yg18e11": 1 "jg3380": 1 "f03885 f07635": 1 "v5 epitope + sv40 nls + b42": 1 "pjg1122 cbf1 -t211a/t212a into jgy1227": 1 "jg3381": 1 "ttaatatacctctatactttaacgtcaaggagaaaaaacccgaattcatgcctcgaggatcccaccaccatcatcatcacggatacccgtatgatgttcc": 1 "gene/cell clone": 1 "sense 5?->3?": 1 "primer efficiency": 1 "genbank": 1 "probe 5?-3?": 1 "b42+ sv40 nls + ha": 1 "r24764 r45496": 1 "?yg78h08": 1 "annealing": 1 "mmp": 1 "jg3173": 1 "gal1 full length inducible promoter": 1 "5?-gccttgcgtccagcct - 3?": 1 "similarity": 1 "pre-mir-149 reverse primer": 1 "r14349 r40677": 1 "in vivo": 1 "final temp °c": 1 "hs.169330": 1 "jg3174": 1 "antisense primer sequence 5?–3?": 1 "pgadt7 mate and plate stationary phase ypad library in jgy1073": 1 "200578": 1 "4.80": 1 "r13618 r38474": 1 "pjg1123 cbf1 -t154a/s156a into jgy1227": 1 "r12046": 1 "mp1": 1 "affy.": 1 "gcd14": 1 "intron": 1 "f12760 t74722": 1 "bait construct": 1 "oligonucleotide sequence": 1 "dna-binding excluding hotspot ": 1 "prey construct": 1 "comment": 1 "1849": 1 "?yf86c11": 1 "3? gene information": 1 "pgal1-10- psk1 -myc": 1 "gal1 full length inducible promoter centromeric vector": 1 "codon 61": 1 "sample code": 1 "6.34": 1 "codon change": 1 "cgtctgttgtggccaaagcagcaggttttcttccacgac": 1 "c ycle y": 1 "c sd": 1 "?yf93b11": 1 "transgene": 1 "6.38": 1 "f13194 t75317": 1 "gnd1 into pet15b pjg1009": 1 "r13420 r40930": 1 "type": 1 "9583": 1 "hs.106210": 1 "ggcctcgaggtggtggaggaggtgaacaaaagctaatctccgaggaagac": 1 "pjg1183": 1 "hs.301685": 1 "pjg1181": 1 "?yg69e11": 1 "dlg2": 1 "lys2gal1uas-gal1tata-his3 gal2uas-gal2tata-ade2 ura3mel1uas-mel1tata aur1-cmel1 ura3-52 his3-200 ade2-101 trp1-901 leu2-3 112 gal4del gal80del met-": 1 "primer sequence 5' => 3'": 1 "efficiency": 1 "mycn": 1 "method": 1 "6.48": 1 "?yf49e01": 1 "z41723 z44845": 1 "downregulated clones": 1 "psk1 -d1230a in pjg232": 1 "samples": 1 "1624": 1 "z45263": 1 "10701": 1 "size of pcr products bp": 1 "14.27": 1 "hspc039 protein loc51124": 1 "r12419": 1 "sap30": 1 "psk1psk2": 1 "upregulated clones": 1 "r13865 r37007": 1 "extension": 1 "genbank/embl/ddbj accession no.": 1 "full-length psk1 in pjg425": 1 "gene expression fold ? compared to gapdh": 1 "hs.337629": 1 "6.52": 1 "intron size bp": 1 "cluster id": 1 "?c-2cg09": 1 "5'splice donor": 1 "chromosomal reporter gene s": 1 "kiaa0781 protein": 1 "hs.246885": 1 "14.04": 1 "size of pcr product": 1 "bait plasmid": 1 "r22668": 1 "hypothetical protein rp1-317e23 loc56181": 1 "lassmann": 1 "hs.21710": 1 "6.61": 1 "6.60": 1 "?n931psk1-his/ha in pjg858": 1 "hs.92418 hs.63510": 1 "pjg1125 cbf1 transformed into jgy1227": 1 "pjg1170": 1 "ura3": 1 "forward primer 5' ? 3'": 1 "position of ptb- cis -acting elements": 1 "h sapiens clone 25052 mrna sequence": 1 "hs.7822": 1 "yap6 into pet15b pjg1009": 1 "5? primer sequence": 1 "braf exon 15": 1 "amplicon length nt": 1 "r38891 t81283": 1 "granuloma": 1 "cys3 into pet15b pjg1009": 1 "ca9": 1 "tag": 1 "ahp1 into pet15b pjg1009": 1 "?yf49c08": 1 "?yg33e09": 1 "??????sequence 5’-3’": 1 "p.mutant 1": 1 "6.80": 1 "h11788": 1 "p.mutant 3": 1 "annealing celsius": 1 "gene primer sequence 5?–3? ": 1 "relevant characteristicsa/genotype": 1 "glut1": 1 "1664": 1 "kiaa0483 protein": 1 "ypad library": 1 "jhg504": 1 "10.71": 1 "chromosome 20 open reading frame 67": 1 "gal4ad+ha": 1 "pcr cycles": 1 "8.39": 1 "cd14+": 1 "hypothetical protein flj11126": 1 "std1 into pet15b pjg1009": 1 "position nt": 1 "reporter s": 1 "upstream primer sequence": 1 "pcr product length bp": 1 "array": 1 "h sapiens cdna flj21304 fis clone col02111": 1 "insert and cloning description": 1 "y190": 1 "3851": 1 "hs.64691": 1 "immunohistochemistry": 1 "replication origin": 1 "primer sequence 5'-3' a": 1 "jg2901": 1 "jg2902": 1 "orientation": 1 "r14217 r40635": 1 "clone 5 n?=?10": 1 "3'splice acceptor": 1 "?yg11e11": 1 "k25": 1 "adh1 truncated acu07647": 1 "1689": 1 "antisense 5?->3?": 1 "fragment": 1 "prey iporin ?n847": 1 "rar?2 region": 1 "?yf60a03": 1 "padh-myc -cbf1 -t211a/t212a": 1 "pgad-c3 genomic library": 1 "primer reverse 5'-->3'": 1 "variable": 1 "37588": 1 "housekeeping genes": 1 "category": 1 "z40609 z44824": 1 
"n": 104 "n ": 60 "": 42 " ": 30 "p": 22 "p-value": 15 "na": 15 " + 1": 12 "neg": 12 "characteristic": 12 " – 1": 12 "pos": 11 "+": 9 "total": 9 "variables": 9 "1": 8 "grade ": 8 "3/4": 8 "1/2": 8 "??ct": 7 "1.0": 7 "rq": 7 "antibody": 7 "controls": 6 "?": 6 "++": 6 " n ": 6 "p -value": 6 "sd": 6 "+++": 6 "+ve": 5 "2": 5 "5": 5 "or 95ci": 5 "fpg a.u.": 5 "?ve": 5 "standard a.u.": 5 "variable": 5 "4": 4 "p a": 4 "? 2": 4 "cytoplasmic": 4 "membrane": 4 "site n treatment": 4 "n?=?total": 4 "nuclear": 4 "nuclear &": 4 "status": 4 "control": 4 "compound": 4 "100": 4 "112": 4 "p > 0.05": 4 "124": 4 "138": 4 "characteristics": 4 "3": 3 "_": 3 "i": 3 "females": 3 "4.5": 3 "males": 3 "pec50": 3 "hmgb1": 3 "negative": 3 "factor": 3 "abw n  = 12": 3 "gene": 3 "prox duct n ": 3 "200 125": 3 "cscore": 3 "dist duct n ": 3 "all n": 3 "7.5": 3 "adverse event": 3 "400?mg b.i.d n =10": 3 "dist acinar n ": 3 "combiscore": 3 "gefitinib": 3 "sh-sy-5y": 3 "ki": 3 " 95ci": 3 "dscore": 3 "s248a": 3 "or": 3 "300?mg b.i.d n =5": 3 "400 250": 3 "03": 3 "10": 3 "13": 3 "mrna mne": 3 "100?mg b.i.d n =4": 3 "50": 3 "genotype": 3 "lbw n  = 7": 3 "cases": 3 "emax": 3 ">20": 3 "donor contribution": 3 "800?mg b.i.d n =3": 3 "200?mg b.i.d n =3": 3 "mean sd": 3 ">15 >15 >15": 3 "prox acinar n ": 3 "parameter": 3 "0.2–6.4?mg n =21": 2 "gfp-lactc2 frap n": 2 "pirs1?pakt?pirs1": 2 "0": 2 "total n =44": 2 "v": 2 "rapamycin": 2 "ref": 2 "median age": 2 "neg.": 2 "p value ?": 2 "12–20?mg n =30": 2 "transient b": 2 "100 75": 2 "6–50": 2 "diff.": 2 "rassf1": 2 "ref.": 2 "total n =82": 2 "nct 24°c": 2 "51–100": 2 "starting dose of bay 43-9006": 2 "ic 50 mean ± sd ?g/ml": 2 "adjusted p -value": 2 "v amurensis": 2 "0 / 9 0": 2 "32?mg n =7": 2 "yes": 2 "unmethylated": 2 "gene symbol": 2 "pakt": 2 " n / n d": 2 "low expression": 2 "absent n ": 2 "600?mg b.i.d n =12": 2 "mean": 2 "patients n": 2 "expression n ": 2 "pearson’s p-value": 2 "sex": 2 "sample": 2 "cpg1 ": 2 "hage-negative n =769": 2 "24°c nct": 2 "g1": 2 "g2": 2 "g3": 2 "5.2": 2 "0.5 +/- 0.1": 2 "cpg3 ": 2 "total patients": 2 "test p ": 2 "4°c ct": 2 "methylated": 2 "cpg2 ": 2 "hage-positive n =69": 2 "placebo": 2 "ii": 2 "classification": 2 "iv": 2 "u/l": 2 "m0": 2 "m1": 2 "max": 2 "n analyz.": 2 "positive": 2 "n0": 2 "n1": 2 "high": 2 "7 / 9 77.7": 2 "nd": 2 "no": 2 "108": 2 "115": 2 "118": 2 "1+": 2 "17": 2 "2+": 2 "t1": 2 "t2": 2 "t3": 2 "132": 2 "min": 2 "3+": 2 "high expression": 2 "0.6 +/- 0.1": 2 "39": 2 "42": 2 "150": 2 "0–5": 2 "non-responding a": 2 "6 / 14 43": 2 "25?mg n =24": 2 "75": 2 "sk-n-be-2c": 2 "95": 2 "97": 2 "9 / 0": 2 "mg/dl": 2 "s.e.m": 2 "p -value b": 2 "iii": 2 "oscillation c": 2 "1+ n = 28": 1 "ora 95ci": 1 "?": 1 "s2-m": 1 "stent sems / ps": 1 "total n =27": 1 " n =45": 1 "panobinostat 30?mg n =23": 1 "bv-173": 1 "doxorubicin": 1 "n = 40": 1 "total aberrations": 1 "percentile": 1 "7": 1 "9": 1 "unused": 1 "men n ": 1 "mir-126-5p": 1 "26 20 – 40": 1 "total n =41": 1 "iqr": 1 "69 +/- 4": 1 "characters": 1 "gca n=24": 1 "2 / 9 22": 1 "strong pos score 2+": 1 "ss-lactc2-gfp-kdel fcs n": 1 ">7 n = 50": 1 "em-2": 1 "ht29": 1 "c": 1 "1+ n = 17": 1 "pmtor": 1 "all grades": 1 "pos.": 1 "fra-1 staining score* n ": 1 "pval 117?114": 1 "6.2": 1 "controls n": 1 "p *": 1 "inv ?c+pd n=16": 1 "80 +/- 1": 1 "got": 1 "follicular carcinom n =5": 1 "<40 n =4": 1 "unmethylated n": 1 "erlotinib ic 50": 1 "tumours n ": 1 "gene indices": 1 "1 conversion eus-ag": 1 "time-point": 1 " cells in g1": 1 "gpt": 1 "3 n =0": 1 "lgsc n": 1 "p-akt expression n ": 1 " a-s + a-c cpm": 1 "lnl m8a": 1 "p value*": 1 "phase i": 1 "slcs": 1 "g/g": 1 "h4-h5": 1 "egfr": 1 "32rh": 1 "gi>50 ?m ± sd": 1 "?1-aab": 1 "medium": 1 "end": 1 "cmyc": 1 "c/t+t/t": 1 "erlotinib": 1 "n #": 1 "?t1/2 wtdfna5-control": 1 "2 n =1": 1 "pval 116?114": 1 "escc n=143": 1 "4.7": 1 "4.9": 1 "32rmut": 1 "methylation of primary tumor tissue": 1 "2 / 14 14": 1 "?g kcal m?1": 1 "10 7 n= 3 ": 1 "papillary carcinoma n =31": 1 "cholesterol ": 1 "?444": 1 ">15 13 >15": 1 "gstp1": 1 "n a": 1 "non-recurrence n=20": 1 "?0.55": 1 "e/a": 1 "10 7 n= 4 ": 1 "erk2 t185e–pea-15 fl": 1 "ss-gfp-kdel fcs n": 1 "gca n=92": 1 "characteristics n =41": 1 "cads": 1 "igfbp3-c n ": 1 "ef ?50": 1 "1 conversion eus-hg": 1 "10 / 3": 1 "fold-change t/n protein-level": 1 ">4 n = 96": 1 " n =8": 1 "ic 50 897/898 clone 1": 1 "ic 50 897/898 clone 2": 1 "ic 50 897/898 clone 3": 1 "50–59 n =17": 1 "?660": 1 "r3616": 1 "crea": 1 "carcinomas n ": 1 "pval 115?114": 1 "** p-value": 1 "data set 1 coefficients sd": 1 "weak pos score 1+": 1 "pakt n =166": 1 "cacf": 1 "healthy controls n=39": 1 "ret_ptc1/normal": 1 "species": 1 "1p68": 1 "bougie": 1 "avg apical intensity": 1 "2.5": 1 "?13arf6": 1 "2.7": 1 "2.8": 1 "h2-h3": 1 "h2-h4": 1 "ps6 n =107": 1 "60 +/- 5": 1 "any threevariations * n ": 1 "trial": 1 "cr ": 1 "bevacizumab dose mg/kg iv q2w": 1 "63 +/- 4": 1 "function": 1 "pten": 1 "directedness ?cos?/n": 1 "? n": 1 "clones": 1 "snps": 1 "n = 102": 1 "c/c": 1 "absent 0 n =231": 1 "duolink er?/src": 1 "32yh": 1 "average d": 1 " n =71": 1 "accession": 1 "5?-gggagggagggaaggagggagggaggga": 1 "pancreatic cancer": 1 "<1.5 ng/ml": 1 "?468": 1 "categorization": 1 "total n=39": 1 "2 ? l m1a–m2a": 1 "bmi-1 expression": 1 "del females": 1 "9 / 9 100": 1 "hy females": 1 "panobinostat 10?mg n =4": 1 "acc.no.": 1 "apc": 1 "protein": 1 "?601": 1 "exp": 1 "high n ": 1 "genes": 1 "nalm-1": 1 "correlations": 1 "st362 1 ppm=2.0 ?m": 1 "no?ang ii?ros?no": 1 "0.3 +/- 0.1": 1 "prostate pc3 du145 lncap": 1 "novariation * n ": 1 "4 n =1": 1 "tki-sensitive": 1 "staining intensity": 1 "s-824": 1 "topfluor-ps frap n": 1 "recurrence n=19": 1 "all patients": 1 "all patients n ": 1 "50th": 1 "pr ": 1 "sd e": 1 "unmethylated n ": 1 "yan": 1 "a-s cpm": 1 "1–2": 1 "0–7 n = 125": 1 "11 / 13 84": 1 "mmtv-wnt1/p53 -/-": 1 "1 n =2": 1 "cilnidipine": 1 "median rq": 1 "hsef protein": 1 "rabbit ?1-ab": 1 "p16": 1 "t/n *": 1 "nontumoral tissue n =42": 1 "prl": 1 "5.0 8.5 11.4": 1 "38 30 – 90": 1 "cyld ihc": 1 "median": 1 "1flx": 1 "name": 1 "controls n n =892": 1 "#a/b -c tsc": 1 "600?mg b.i.d b n =12": 1 "lung a549": 1 "20 counts": 1 "tmeff2": 1 "controls n ": 1 "grade of adverse event": 1 "-114": 1 "-113": 1 "68 +/- 1": 1 "perk": 1 "-116": 1 "2 1 – conversion ptbd 1 failure": 1 "caveolin-1 n =165": 1 "score=2 n ": 1 "amplif males": 1 "n =72 100": 1 "shs + gw5074 n ?=?8": 1 "rate equation": 1 "15.5": 1 "n/c": 1 "tissue": 1 "median procedure time – min range": 1 "gstp1 n ": 1 "?/+": 1 "ef v/m": 1 ">1.5 ng/ml": 1 "28rm": 1 "dm n = 25": 1 "follow-up n ": 1 "case": 1 "?ct": 1 "?60 n=44": 1 "diathermy 6fr cystotome": 1 "-150": 1 "5?-uggggu": 1 "5?-tggggagggtggggagggtggggaagg": 1 "all tissue samples n =219": 1 "control n=29": 1 "?17arf1": 1 "eg9c 1ppm=3.2 ?m": 1 "weak/moderate 1+ 2+ n =157": 1 "cases*": 1 "er positive n ": 1 "hi ": 1 "univariate analysis": 1 "study": 1 "hgsc n": 1 "1f0m": 1 "pr >|t|": 1 "-160": 1 "p73": 1 "valuables": 1 "-156": 1 "sup-b15": 1 "1 year": 1 "low": 1 "81 +/- 2": 1 "kappa": 1 "0 n = 59": 1 "-159": 1 "lnl m1a": 1 "t value": 1 "nucleotide": 1 "numbers of samples n ": 1 "prevalence of chromosomal alteration reported in literature": 1 "6 / 7 85.7": 1 "cd151 positive n ": 1 "speed µm/hr": 1 "-166": 1 "-163": 1 "1 / 9 11": 1 "5 control": 1 "-165": 1 "-164": 1 "homa index": 1 "lnl m2a": 1 "snail1 ihc": 1 "p53 positive n ": 1 "?75 yrs n=35": 1 "l/r": 1 "?75 yrs n=38": 1 "-174": 1 "p15 n ": 1 "83 +/- 2": 1 "rcc patients n=46": 1 "strain": 1 "p4e-bp1 n =146": 1 "never-smokers n = 30": 1 "s2-cp9": 1 "ever-smokers n = 121": 1 "eus-hg n = 9 ": 1 "p-mtor+": 1 "p value": 1 "9.5": 1 "5?-cctccccctcttccctcttcccacaccgccct": 1 "cases n": 1 "ka m?1": 1 "chronic pancreatitis": 1 "del males": 1 "pakt staining": 1 "28ym": 1 "clinicopathologic characteristics": 1 "0 n = 19": 1 "methylated n ": 1 "ref 21 n =10": 1 "ss-lactc2 aaa-gfp-kdel fcs n": 1 "sas": 1 "track dilatation": 1 "hsa 102 × dpm": 1 "nsc number": 1 "shs n ?=?9": 1 "mmtv-wnt1/p53 +/-": 1 "mmtv-wnt1/mmtv-neu": 1 "ref 20 n =17": 1 "kcat/km 105 m?1s?1": 1 "saha ic 50": 1 "balloon 4mm": 1 "controls n = 1636": 1 "cygb": 1 "solute s": 1 "ref 18 n =30": 1 "std coeff.": 1 "13 / 14 92.9": 1 "identity>90": 1 "#proteins": 1 "epha4": 1 " 3h-thymidine si": 1 "negative n =19": 1 "b-s cpm": 1 "all fourvariations * n ": 1 "h5-h1": 1 "scm": 1 "g/a+a/a": 1 "colon ht-29 hct116 sw480": 1 "r7020": 1 "ephb2": 1 "comaf class*": 1 "5?-agcgcggtgtgcgaagagcgaagagcgggagg": 1 "6 n =0": 1 "pmtor n =97": 1 "2???ct": 1 "pakt?no?angii?ros?onoo?pakt": 1 "treatment": 1 "7.9": 1 "any onevariation * n ": 1 "pstat3": 1 "l/h *": 1 "jurl-mk2": 1 "lt/iris n?=?9": 1 "1b0x": 1 "avg basal/apical intensity": 1 "eg5 1ppm= 2.3 ?m": 1 "osteosarcoma u20s": 1 "all patients n =232": 1 "5?-agggcggtgtgggaagagggaagagggggagg": 1 "n =202 100": 1 "± sd": 1 "gdr mg/kg/min": 1 "grades 3–4 n ": 1 "1sv4": 1 "follicular adenoma n =10": 1 "h mlh1 methylation": 1 "5?-tccctccctccctccttccctccctccc": 1 "rar ?": 1 "1svo": 1 "50?mg comb n =7": 1 ">15 >15 11.5": 1 "0.55–1": 1 "panobinostat 40?mg n =5": 1 "postive": 1 "1dxs": 1 "46-74 yrs n=155": 1 "#a-s tsc": 1 "ef": 1 "kcl-22": 1 "test": 1 "n gruberi": 1 "er?": 1 "66 +/- 1": 1 "age years": 1 "er?": 1 "7.3 5.2 2.9": 1 "strong 3+ n =60": 1 "?t1/2 mutdfna5-wtdfna5": 1 "eus-cd n = 13 ": 1 "lnl m8": 1 "lnl m7": 1 "felix": 1 "5.1": 1 "5.6": 1 "5.7": 1 "e028 ic 50": 1 "p-mtor -": 1 "t1/2 wtdfna5": 1 "95 ci": 1 "intensity ": 1 "6 / 9 67": 1 "sham n= 6 ": 1 "h3-h4": 1 "nct 4°c": 1 "t1/2 mutdfna5": 1 "other 0 1+ 2+ n =301": 1 "15–2 years": 1 "????trop-2 protein expression": 1 "wt1": 1 "117?114": 1 "nd n = 35": 1 "n fowleri": 1 "116?114": 1 "biomarkers and mutations": 1 "tumor cell lines": 1 "peripheral n =45": 1 "amplif.": 1 "egfr intensity n =361": 1 "igfbp3-b n ": 1 "or *": 1 "7 n =3": 1 "50?mg comb n=7": 1 "diagnosis n": 1 "5?-gggagcgagcgaaggagggagcgagcga": 1 "htert": 1 "ste50": 1 "p-value*": 1 "fra-1 localization**": 1 "chromosomal alteration": 1 "2 ? l m8a–m8": 1 "25th centile": 1 "10 counts": 1 "3.9": 1 "scc n ": 1 "?2": 1 "mae": 1 "characteristic n": 1 "35 25 – 60": 1 "positive n =8": 1 "b-c cpm": 1 "v vinifera cv muscat of hamburg": 1 "m+": 1 "8.2 10.4 9.7": 1 "patients n = 266": 1 "all grades n ": 1 "freq.": 1 "1ow5": 1 "peptides 95": 1 "technical success#": 1 "0.4 +/- 0": 1 "lt/rasv12 n?=?8": 1 "panobinostat 20?mg n =7": 1 "score?1 n ": 1 "controls n?=?1056": 1 "115?114": 1 "phospho-egfr intensity n =388": 1 "mtor-": 1 "women n ": 1 "mtor+": 1 "cetuximab dose mg/m2 iv weekly *": 1 "h1-h2": 1 "del.": 1 "hnscc n ?=?273": 1 "adca n ": 1 "mgmt methylation": 1 "pakt?no?onoo?pakt": 1 "+ n": 1 "inv ?c n=29": 1 "cases n?=?664": 1 "cases n n =952": 1 "75th": 1 "40–49 n =14": 1 "log-nt-probnp": 1 "ste11": 1 " b-s + b-c cpm": 1 "8 n =34": 1 "dose level": 1 "erlotinib dose mg po daily": 1 "ef <50": 1 "q1": 1 "identity >80": 1 "q2": 1 "t1/2 control": 1 "carcinogen": 1 "pik3ca": 1 "61 +/- 2": 1 "clinical success": 1 "ic50 ppm at 72 h": 1 "101": 1 "102": 1 "pe": 1 "5 n =0": 1 "a148t + n ": 1 "ph": 1 "109": 1 "28rmut": 1 "scc-ag": 1 "00": 1 "r2": 1 "ttllong": 1 "01": 1 "02": 1 "phospho-erk2–pea-15 1–96": 1 "iarc ": 1 "pr": 1 "50 counts": 1 "04": 1 "2jmt": 1 "09": 1 "helix pair c": 1 "sss": 1 "117": 1 "estimate": 1 "pr positive n ": 1 "patients n?=?1056": 1 "12": 1 "10 3 n= 5 ": 1 "tissues": 1 "16": 1 "methylated n": 1 "?h kcal m?1": 1 "18": 1 "5 counts": 1 "cov 95": 1 "rb": 1 "121": 1 "ref 17 n =47": 1 "2 ? l m7–m8": 1 "data set 2 coefficients sd": 1 "127": 1 "129": 1 "pathological grade": 1 "conditions": 1 "cases n ": 1 "21": 1 "23": 1 "24": 1 "25": 1 "oncocytic adenoma n =14": 1 "eus-ag n = 10 ": 1 "avg basal intensity": 1 "tki-resistant": 1 "135": 1 "cell line": 1 "33": 1 "1kw4": 1 "35": 1 "ref 19 n =10": 1 "mean ± sd": 1 "her-2 positive n ": 1 "141": 1 "t+ n+": 1 "145": 1 "escc n=27": 1 "147": 1 "149": 1 "4+": 1 "n =10": 1 "41": 1 "a-c cpm": 1 "t+ n-": 1 "score=3 n ": 1 "histologic diagnosis n ": 1 "5w after tam controls n = 16 8 females 8 males mutants n = 15 5 females 10 males": 1 "47": 1 "p-value †": 1 "5?-guuuuuggggcuuuuc": 1 "10 5 n= 4 ": 1 "151": 1 "amlodipine": 1 " n?=?125": 1 "153": 1 "154": 1 "155": 1 "156": 1 "?528": 1 "158": 1 "1z1v": 1 "?524": 1 "total n ": 1 "dlc2": 1 "acf/mdf n ": 1 "73 +/- 1": 1 "?522": 1 "57": 1 "8 weeks": 1 "e/ea": 1 "10 5 n= 3 ": 1 "161": 1 "162": 1 " n?=?113": 1 "control n ?=?122": 1 "8.8 10.8 2.99": 1 "t- n-": 1 "t- n+": 1 "0–4 n = 79": 1 "scas": 1 "tumor types": 1 "66": 1 "67": 1 "46-74 yrs n=57": 1 "10 3 n= 4 ": 1 "egfr mutation n ": 1 "177": 1 "duolink er?/pi3k": 1 "interest": 1 "non-tumor cells bj fibroblasts": 1 "st357 1 ppm=2.5 ?m": 1 "std error": 1 "76": 1 "79": 1 "exposure ?g/m3": 1 "abi1 score": 1 "normalized p18 rna*": 1 "#b-s tsc": 1 "igfbp3-a n ": 1 "nuclear p53 mqs": 1 "histological type": 1 "ic 50 d54/54e trial #1": 1 "ic 50 d54/54e trial #3": 1 "87": 1 "ic 50 d54/54e trial #2": 1 "# pc": 1 "percentage of positive cells": 1 "foxp3": 1 "pegfr": 1 "central n =92": 1 "adenomas n ": 1 "tgf- ? 1": 1 "fresh air n ?=?10": 1 "92": 1 "96": 1 "amplif females": 1 "low n ": 1 "n =130 100": 1 "v vinifera cv.": 1 "74 +/- 2": 1 "ref 16 n =20": 1 "myrarf6": 1 "data set 1 pr >i t i": 1 "mice n.": 1 "control n= 7 ": 1 "myrarf1": 1 "<45 yrs n=44": 1 "ttlshort": 1 "controls n = 266": 1 "erk2–pea-15 1–96": 1 "meb55 1 ppm = 3.1 ?m": 1 "test set n =838": 1 "m?": 1 "p-value a": 1 "#ratios >1.5": 1 "clusterin n ": 1 "10.3 7.5 2.5": 1 "discovery set n =838 n ": 1 "isel": 1 "pirs1?pakt?no?ang ii ?pirs1": 1 "k-ras mutation n ": 1 "50?mg comb a n =7": 1 "genotype/allele": 1 "ref 15 n =51": 1 "her2": 1 "b – a cpm": 1 "2+ n = 13": 1 "76 +/- 2": 1 "?t1/2 mutdfna5-control": 1 "constants": 1 "muscat of hamburg": 1 "patients": 1 "9 / 10 90": 1 "total n =44 a": 1 "biomarker": 1 "methylation of metastatic lesion": 1 ">2": 1 "failure / conversion": 1 "sw480": 1 "75th centile": 1 "urea": 1 "1pk3": 1 "ct 4°c": 1 "nuclear p14 arf mqs": 1 "data set 2 pr >i t i": 1 "25th": 1 "pdb b": 1 "groups": 1 "interquartile range iqr": 1 "-87": 1 "2+ n = 42": 1 "any twovariations * n ": 1 "cases n = 583": 1 "coefficients": 1 "?s cal m?1k?1": 1 "controls n?=?702": 1 
"2": 62 "4": 29 "h": 24 "cases": 23 "snp": 22 "gene": 15 "l": 12 "chr": 12 "p-value": 12 "p": 10 "rr": 9 "maf": 8 "ceu": 7 "controls": 7 "yri": 7 "3": 6 "gene symbol": 6 "author": 6 "position": 6 "snps": 5 "genes": 5 "description": 5 "chromosome": 5 "trait": 5 "bta": 5 "locus": 5 "gene name": 4 "t": 4 "agre": 4 "t/t": 4 "cytoband": 4 "ctrl": 4 "phenotype": 4 "results": 4 "? 2": 4 "tumour characteristics": 4 "risk allele": 4 "effect": 4 "p value": 4 "aa": 4 "alleles": 4 "p -value": 4 "number of cases": 4 "variant": 4 "location": 4 "quartiles": 4 "cytokines studied": 4 "patients studied": 4 "": 3 "additive 3": 3 "n": 3 "v": 3 "mirna": 3 "9p24.1": 3 "detected ": 3 "0 mj/cm2": 3 "function": 3 "ldh": 3 "non-hf": 3 "beta ng/ml": 3 "genotypes": 3 "cases ": 3 "100 mj/cm2": 3 "s.e of effect": 3 "hip": 3 "group": 3 "50 mj/cm2": 3 "major allele": 3 "patient": 3 "nr of variants": 3 "ag": 3 "sample": 3 "rare": 3 "allele": 3 "hf": 3 "hr": 3 "chr.": 3 "hwe": 3 "polymorphism": 3 "dominance 3": 3 "symbol": 3 "genotype": 3 "power 3": 3 "gender": 3 "size mb": 3 "gain/loss": 3 "cas": 3 "references": 2 "year": 2 "physical locus bp": 2 "score": 2 "raf": 2 "?ppsa an0129": 2 "position mb": 2 "analysis": 2 "n major": 2 "?ptce an5722": 2 "start mb": 2 "end mb": 2 "haploview": 2 "or 95ci": 2 "chromosomal locus": 2 "g/g": 2 "g/t": 2 "whole genome": 2 "end": 2 "mdm2 snp309 genotype": 2 "n rare+hz": 2 "mutated cases": 2 "number": 2 "sample size": 2 "top ten": 2 "associations inclinical trials": 2 "not benign": 2 "?psra an10077": 2 "c/c": 2 "c/t": 2 "ref.": 2 "ld r?2": 2 "physical position mb": 2 "p/a": 2 "weight": 2 "surrogate": 2 "start": 2 "waist": 2 "x exome": 2 "allele 1": 2 "allele 2": 2 "whr": 2 "haplotype": 2 "?sdpa an10138": 2 "population": 2 "braf": 2 "nplall": 2 "subjects": 2 "potential causal snp": 2 "?ptcd an0914": 2 "chi-square": 2 "gg": 2 "whole exome": 2 "bmi": 2 "fungal strain": 2 "total": 2 "?msga an4544": 2 "or": 2 "pik3ca": 2 "allele frequency": 2 "height": 2 "effect allele frequency": 2 "haplotype pattern mining": 2 " +/?sd": 2 "frequency": 2 "qtl": 2 "p-value 4": 2 "region": 2 "associations inprediction": 2 "wt": 2 "coverage": 2 "index snp": 2 "characteristics": 2 "genome-wide p-value": 2 "normal tissue": 2 "6p21.32": 2 "6p21.33": 2 "?ptpb an4896": 2 "tumor 1": 2 "tumor 2": 2 "candidate genes": 2 "reference": 2 "nearest gene": 2 "patients": 2 "configuration 0": 2 "cytogenetic locus": 2 "eo01": 1 "functions": 1 "r 2": 1 "hnscc susceptibility and pre-mir-149 polymorphism": 1 "chr b": 1 "heterozygotes ": 1 "p-value <0.001": 1 "amplifications": 1 "snp id1": 1 "rs1799969": 1 "cases n=125": 1 "7q31.31": 1 "micro- cephaly": 1 "7q31.32": 1 "ras": 1 "18q23": 1 "7q31.33": 1 "+": 1 "1": 1 "percent variant": 1 "correlation": 1 "size": 1 "5": 1 "6": 1 "chr 6 allelic state centromeric region": 1 "7": 1 "cd274 pd-l1": 1 "core haplotype frequencies": 1 "replication analysis": 1 "nucleotide position of snp": 1 "cases n ‡ controls n ‡ ": 1 "13q12.11": 1 "index snp conditioning on causal snp": 1 "control ": 1 "annotation": 1 "position kb": 1 "oar22_19020858": 1 "alleles ep-ar and ep-ar tmprss2/erg": 1 "tag snp": 1 "gene groups": 1 "snp name": 1 "shared variants": 1 "lcgp": 1 "ref": 1 "p-s6": 1 "group 1 a": 1 "1p36.11": 1 "1p36.12": 1 "1p36.13": 1 "rs11575074": 1 "5613": 1 "female": 1 "5614": 1 "10p15.1": 1 "adg": 1 "queries matched": 1 "p-s1": 1 "other 36 tpm*": 1 "p-s5": 1 "p-s4": 1 "p-s3": 1 "p-s2": 1 "jak2": 1 "maximum range": 1 "egfr": 1 "sc / mb": 1 "5q14.3": 1 "controls n=200": 1 "11p15.4": 1 "8p11.23": 1 "1p36.31": 1 "no of adults": 1 "microrna": 1 "functional groups": 1 "9p24.2": 1 "chr 2": 1 "intra / mb": 1 "genotypingmethod": 1 "tir2 -f12b": 1 "1p33": 1 "allelic combination §": 1 "haplotype associated risks c": 1 "snp* risk variant alleles": 1 "discovery analysis": 1 "p §": 1 "peak marker": 1 "age": 1 "rs907577 99654938": 1 "p-value <0.01": 1 "incubation medium additions": 1 "control group": 1 "gains": 1 "multivariate analysis": 1 "frequency allele 1 p 3": 1 "1p34 1q 2p24 2q23 3p14 3q29 5p15.33 6p21 7p21 7q11.23–22.1 7q34 7q35 8q11.2 9p24.3–qter 9q22 9qter 10q25.2–26.3 11q13–q23 12p 12q13.13–13 3 13q21.1 14q11.2 14q32.2 15q21.3 16p11.2 16p13.3 16pter 17q21 18 19p13.1–13.3 20p12 xp21.2 and xq26.3": 1 "line2-t500": 1 "length kb": 1 "max nplall": 1 "pfc": 1 "alleles match": 1 "rs1801714": 1 "mutation": 1 "ch 10 map position": 1 "g allele": 1 "genotype frequency": 1 "individual iii-5": 1 "eg5 chromosomes": 1 "familial cases": 1 "dysmorphism or other congenital abnormalities": 1 "twist2": 1 "17p13.3": 1 "product": 1 " n?=?22": 1 "dominant": 1 "haplotype frequencies a": 1 "position bp": 1 "coordinate b": 1 "cnv": 1 "type of aberration": 1 "homozygotes ": 1 "possible genes": 1 "chr 7 allelic state centromeric region": 1 "20q11.1": 1 "ethiopians": 1 "ormeta": 1 "vol.": 1 "link id": 1 "wt/wt": 1 "gene_asn": 1 "trial": 1 "or 95 cl": 1 "or 95 ci": 1 "absence of methylated alleles": 1 "hla-a1 supertype": 1 "mwu adjusted p value amplification": 1 "most sensitive": 1 "characteristics patients": 1 "primers for genotyping": 1 "gbdescription": 1 "percent/total cases": 1 "individual iv-1": 1 "number variant": 1 "odds ratio 95 ci": 1 "pamr1": 1 "pdcd1lg2 pd-l2": 1 "accession": 1 "22q12.3": 1 "patient no.": 1 "human hdl mirnas": 1 "qtl effect days": 1 "erbb2 her2": 1 "row": 1 "lct": 1 "related publication": 1 "growth traits b": 1 "reference allele": 1 "maf §§": 1 "5p15.33": 1 "strategy": 1 "candidate snps": 1 "exon": 1 "alleles major/minor": 1 "eg01": 1 "mirna/gene": 1 "?": 1 "tir3b -f6": 1 "age at diagnosis": 1 "discordance": 1 "indel num": 1 "maf in cases": 1 "non-variant wt kras allele": 1 "13q21.1": 1 "13q21.2": 1 "6q15": 1 "6q12": 1 "6q13": 1 "tir3c -f12": 1 " n?=?97": 1 "candidate somatic structural variant": 1 "6q16.3": 1 "rsq": 1 "fjx1": 1 "1p31.3": 1 "1p31.1": 1 "6q21": 1 "7p11.2": 1 "effect log-sicam-1": 1 "p ?": 1 "refs": 1 "variant kras allele": 1 "clinicopathological features": 1 "dataset": 1 "asn": 1 "ihs_yri": 1 "snp gene position": 1 "unselected cases": 1 "primary/metastatic tumour": 1 "tir3a -f6": 1 "t-aml": 1 " debv 3": 1 "p meta": 1 "statistic": 1 "gene polymorphism": 1 "377 drugs and 80 diseases": 1 "r2 §": 1 "6q25.1": 1 "11p13": 1 "name": 1 "chr 6 fish copy number": 1 "mb location": 1 "alleles 1/22": 1 "rs281437": 1 "minor allele in wghs": 1 "rs1867277 99655735": 1 "core haplotype": 1 "associated allele": 1 "s.e.m.": 1 "6q14.1": 1 "6q14.3": 1 "6q14.2": 1 "pgap3": 1 "normalized abundance": 1 "# controls": 1 "homozygousdeletions": 1 "ehh b": 1 "tcap": 1 "family history": 1 "positive cases": 1 "tir1": 1 "positive rates ": 1 "size of cohort cases/controls": 1 "str locus": 1 "standard error": 1 "mut/mut": 1 "bonferroni p-value": 1 "trol allele": 1 "6q23.3": 1 "6q23.2": 1 "a allele": 1 "19q13.11": 1 "1p22.3": 1 "1p22.2": 1 "19q13.12": 1 "univariate analysis": 1 "study": 1 "pot deleterious": 1 "6q23.1": 1 "cnv a": 1 "13q14.3": 1 "13q14.2": 1 "1p35.3": 1 "1p35.2": 1 "1p35.1": 1 "phases": 1 "8q22.3": 1 "position mb version 1.0": 1 "candidate genes a": 1 "included in stepwise regression §§§": 1 "15q26.1": 1 "rehh b p value": 1 "hif-1?": 1 "putative role": 1 "cnlohs": 1 "genotyped samples controls/cases": 1 "overall frequency msi only": 1 "closest gene": 1 "p73 allele": 1 "1p13.3": 1 "oar22_18924267": 1 "8q24.3": 1 "corr.": 1 "tir3c -f6": 1 "variable studied": 1 "number of genes": 1 "l15/d": 1 "effects": 1 "marker": 1 "functional prediction by polyphen-2": 1 "haplotype id": 1 "sss patients": 1 "germinal cnvs": 1 "13q12.3": 1 "13q12.2": 1 "effect of polymorphism": 1 "tir2 -f6": 1 "18q22.1": 1 "18q22.3": 1 "df 3r tl-x": 1 "enzyme": 1 "huestpm": 1 "snp ref.": 1 "21q22.3": 1 "gene_ceu": 1 "mean": 1 "recessive": 1 "p-value one sided": 1 "cnv1": 1 " +": 1 "wt/mut": 1 "pnmt": 1 "tir3a -f12": 1 "splice / mb": 1 "genes 4 in?±?250kb": 1 "ab": 1 "slc1a2": 1 "tibetans 1": 1 "amino acid substitution damaging effect d ": 1 "#genes regulated": 1 "peak snp f st": 1 " 87 kb": 1 "growth delay": 1 "bb": 1 "insl6": 1 "ethnicity": 1 "17q22": 1 "cnv variant type": 1 "insl4": 1 "qtl reference": 1 "characteristic": 1 "oar22_18929579": 1 "tnb score*": 1 "qtl position cm": 1 "chr 7 fish copy number": 1 "duplications": 1 "gene content": 1 "ld with rs2001945": 1 "fat-related qtl 5": 1 "maximum": 1 "snp_density bp/num": 1 "dietary factors": 1 "maf in controls": 1 "dna index #": 1 "plgrkt c9orf46": 1 "final model snps": 1 "22q13.31": 1 "l95": 1 "l120/d": 1 "hla-b2 allele group": 1 "ihs_asn": 1 "ma 4": 1 "13q21.31": 1 "chrom.": 1 "17q12": 1 "major allele frequency": 1 "amhara": 1 "mut/wt": 1 "physicallocus bp": 1 "mutant alleles tested": 1 "marker s": 1 "standard deviation": 1 " ?5 kb": 1 "origin": 1 "shared heterozygosity": 1 "–log10 p-value": 1 "hla-b1 allele group": 1 "2p23.2": 1 "# of genotypes": 1 "position mb version 3.1": 1 "hla-b2 supertype": 1 "heterozygous variants": 1 "oncogenes": 1 "meta-analysis": 1 "hla-a1 allele group": 1 "l240/d": 1 "mirnas": 1 "mean difference": 1 "low birth weight": 1 "chromosome 8 location": 1 "deviation from hwe": 1 "intron / mb": 1 "dmi": 1 "2p12": 1 "rln1": 1 "#genes cytoband *": 1 "rln2": 1 "genotypes and alleles": 1 "or $": 1 "start-end mb": 1 "loci": 1 "rnas of tss snps": 1 "validation": 1 "gene/expressed allele": 1 "oct": 1 "exons": 1 "variant allele": 1 "snp type": 1 "heterozygosity": 1 "t2dm-related traits": 1 "patient id": 1 "p-value*": 1 "dbsnp 1": 1 "genetic locus cm": 1 "rs3758249 99653961": 1 "population studied": 1 "snp feature": 1 "function/ prediction": 1 "sequences": 1 "cancertype": 1 "2p25.1": 1 "group 2 a": 1 "2p25.3": 1 "or c": 1 "line3-t200": 1 "up/down regulated": 1 "chromo-some band": 1 "++": 1 "hemizygous deletions": 1 "95 ci cm": 1 "core snp alleles distance to the peak snp": 1 "regions lost in ? five cases": 1 "cohort 2": 1 "cohort 1": 1 "cohort 3": 1 "5326": 1 " 95ci": 1 "ts allele": 1 "allelic p value": 1 "inheritance": 1 "snp rs#": 1 "ocgp": 1 "exome variant server d": 1 "presence of methylated alleles": 1 "or a 95 ci": 1 "change associated with variant": 1 "7q36.1": 1 "p-value <0.0001": 1 "allele change": 1 "p*": 1 "rehh b": 1 "additive effect variant allele": 1 "mlpa probe": 1 "rs number": 1 "indel_density bp/num": 1 "permutation r 2 2": 1 "snp id": 1 " debv variance 1": 1 "19q12": 1 "genomic position build hg 19 chr 2": 1 "h-w p-value": 1 "hla-a2 supertype": 1 " ?": 1 "amplified loci": 1 "gene position": 1 "alleles -/+  d": 1 "cdna": 1 "r2": 1 "counts": 1 "bac id": 1 "estimate": 1 "case/control": 1 "832 drugs and 239 diseases": 1 "target loci": 1 " pathfinding": 1 "normal function": 1 "rmse 2": 1 "plcd1": 1 "length bp": 1 "str": 1 "male": 1 "nsc / mb": 1 "mcr unic cases": 1 "rs": 1 "cases classic ptc": 1 "seizure": 1 "6253": 1 "minor allele": 1 "allele or rnai": 1 "1a": 1 "u95": 1 "1b": 1 "combined cohort": 1 "cell line": 1 "variables": 1 "total variants": 1 "primer pairs": 1 "snp a reference #": 1 "snv location": 1 "f-value": 1 "lod score": 1 "country": 1 "validation tcga": 1 "no of genes": 1 "heterozygote individuals": 1 "6q22.31": 1 "6q22.32": 1 "6q22.33": 1 "cd44": 1 " n?=?125": 1 "associated cancer genes": 1 "gene with variant": 1 "familial hypercholesterolemia": 1 "huvec": 1 "1p32.3": 1 "1p32.2": 1 "1p32.1": 1 "assembled contig s with a novel breakpoint sequence": 1 "coordinate": 1 "idc": 1 "f4l locus 2": 1 " n?=?113": 1 "ihs_ceu": 1 "# cases": 1 "l60/d": 1 "14q32.13": 1 "rs874004 99661939": 1 " 0 kb": 1 "clinical findings": 1 "e006aa-ht": 1 "homozygous variants": 1 "mass": 1 "+++": 1 "strain 1": 1 "amino acid position c": 1 "plce1": 1 "common": 1 "chromosome umd 3.1": 1 "10p13": 1 "codominant": 1 "control patients": 1 "7q33": 1 "7q34": 1 "normal": 1 "ct+tt ": 1 "chrom locus": 1 "7q35": 1 "combined p-value": 1 "source ofcontrols": 1 "fc log": 1 "vaccine": 1 "risk variant": 1 "rvsmc": 1 "predicted transcripts": 1 "11q11": 1 "1p21.3": 1 "alleles lhsr and lhsr tmprss2/erg": 1 "1p21.1": 1 "snp a": 1 "hela": 1 "snp num": 1 "13q14.12": 1 "6q22.1": 1 "13q14.13": 1 "disease/term": 1 "type": 1 "snp location": 1 "13q13.2": 1 "13q13.1": 1 "rs10119760 99664423": 1 "1p34.3": 1 "tumour type": 1 "rs3021526 99656842": 1 "snp id chromosomal coordinate b": 1 " truncation": 1 "marker a": 1 "distance to snp kb": 1 "hla-b1 supertype": 1 "signature": 1 "marker c": 1 "rs5498": 1 "replication cohort": 1 "effect allele": 1 "validated position of breakpoint 1": 1 "j2r locus 2": 1 "validated position of breakpoint 2": 1 "hla-a2 allele group": 1 "percent/mutated cases": 1 "6q24.2": 1 "6q24.1": 1 "parameters/rat groups": 1 "top snps": 1 "minimum": 1 "ssc proband/ parent id a": 1 "mb between markers total area on chr": 1 "least sensitive": 1 "variant type": 1 "some cnv genes": 1 "gene_yri": 1 "6p22.1": 1 "configuration 2": 1 "dusp12 1q23.3 mycn 2p24 dnase1l3 3q25.2 htert 5p15.33 notch4 6p21.32 egfr 7p11.2 arhgef5 7q34 edg3 9q22 shc3 9q22 tnc 9q33.1 notch1 9q34.3 stk32c 10q26.3 mdk 11p11.2 tyr 11p13 yap1 11q22 birc2 11q22 birc3 11q22 hoxc4 12q13.13 mta1 14q32.33 slc6a10 16p11.2 prm1 16q12.2 cdc6 17p13.3 vav1 19p13.3 and jag1 20p12.2": 1 "mutational hotspot": 1 "g2361a egfr polymorphism": 1 "risk 95 ci": 1 "autistic feature": 1 "i4l locus 2": 1 "cc ": 1 "discovery umu": 1 "affymetrix human snp 6.0 array": 1 "egl-17pcfp assay": 1 "oromo": 1 "mlpa": 1 "groups": 1 "e006aa-par": 1 "3q26.1": 1 "subrange": 1 "rs894673 99652091": 1 "variable": 1 "nr of non-aligning sequence reads per locus": 1 "discovery cohort": 1 "category": 1 "tir3b -f12": 1 "ptc cases": 1 
"drug": 29 "?": 26 "target": 17 "agent": 15 "reference": 11 "dose": 8 "phase": 8 "drug name": 7 "drug class": 5 "ref.": 5 "patients": 5 "efficacy": 5 "tmax h": 4 "everolimus": 4 "losartan": 3 "3": 3 "placebo": 3 "leptin": 3 "manufacturer": 3 "sham": 3 "pec50": 3 "leptin plus losartan": 3 "rosuvastatin": 3 "tumor type": 2 "outcomes": 2 "atorvastatin": 2 "cmax ng/ml": 2 "bond2": 2 "bond1": 2 "ref": 2 "adverse event": 2 "statin": 2 "duration": 2 "pharmacologic agent": 2 "company": 2 "class": 2 "biological effects against seb": 2 "gefitinib 1126": 2 "model": 2 "adverse effects": 2 "authors": 2 "status": 2 "possible mechanism involving treg": 2 "proliferation": 2 "dose mg": 2 "half-life": 2 "comb_effect": 2 "total": 2 "dose level": 2 "pravastatin": 2 "cell line": 2 "telmisartan": 2 "placebo 562": 2 "tumor": 2 "cilnidipine": 2 "drug id": 2 "amlodipine": 2 "drug 1": 2 "drug 2": 2 "disease": 2 "drug combination": 2 "half-life h": 2 "nsaid": 2 "lovastatin": 2 "vehicle": 2 "fluvastatin": 2 "simvastatin": 2 "drug dose": 2 "mtd": 2 "combination": 2 "effect": 2 "p value": 2 "parameter": 2 "regimen": 2 "response": 2 "?regimen": 1 "motesanib 50 ": 1 "references": 1 "class of agent": 1 "major targets": 1 "target s": 1 "15–20 74 ": 1 "40?mg": 1 "cetuximab alone": 1 "mean standard deviation": 1 "elimination feces/urine": 1 "trial identifiers": 1 "erlotinib+gemcitabine combination index effect": 1 "hepatocyte-protective agents": 1 "gene name": 1 "subjects and approach": 1 "afatinib": 1 "2": 1 "pioglitazone": 1 "route": 1 "4": 1 "6": 1 "8": 1 "clinical development stage": 1 "?npc1l1 inhibitors ezetimibe": 1 "response rate ": 1 "treatment": 1 "tmax": 1 "1000": 1 "drug targets": 1 "dose mg/d": 1 "virus": 1 "characteristic": 1 "no pts.": 1 "budesonide": 1 "modal therapeutic dose mg/day": 1 "other aes": 1 "dabrafenib": 1 "dosage range": 1 "anti-tnf- experienced": 1 "?angiotensin-converting enzyme inhibitors": 1 "all grades": 1 "abbreviation": 1 "e2": 1 "lenvatinib 58 ": 1 "n": 1 "p": 1 "stage": 1 "gemcitabine": 1 "aucinf_obs h*ng/ml": 1 "phase 2 dose": 1 "troglitazone": 1 "dose range mg": 1 "nefazodone": 1 "sunitinib 37 39 ": 1 "change in cmax": 1 "cetuximab and bevacizumab": 1 "trial design": 1 "sunitinib": 1 "ssri": 1 "agent or drug dosage": 1 "hdacs targeted": 1 " rescue": 1 "axitinib ic50 nm 35": 1 "chr": 1 "plc activation": 1 "other names for the drug": 1 "peak hours": 1 "volume of distribution l": 1 "30?mg": 1 "motesanib ic50 nm 33": 1 "efficacy versus placebo": 1 "maintenance dose": 1 "inhibition effect": 1 "?disease": 1 "sorafenib 41 – 45 ": 1 "agent name": 1 "tki": 1 "?pfs": 1 "response ": 1 "?ursodeoxycholic acid": 1 "t1/2": 1 "30–40 minutes 74 3–4 h enteric coated aspirin 72 ": 1 "tkr": 1 "number of drugs": 1 " reduction in ldl": 1 "bottom-20 drug combinations": 1 "?vitamin c": 1 "cetuximab irinotecan and bevacizumab": 1 "cox-17.9 4.4–14?m 65 cox-2 >5000?m 65 ": 1 "oral bioavailability veber": 1 "vandetanib 300 mg 20": 1 "?vitamin e": 1 "citation": 1 "erlotinib": 1 "vemurafenib": 1 "trough hours": 1 "isel trial 28": 1 "dlt": 1 "acts on t315i": 1 "bioavailability ": 1 "significance": 1 "schedule": 1 "?n-3 polyunsaturated fatty acids epa and dha": 1 "important comments": 1 "drug target*": 1 "500": 1 "pazopanib 55 ": 1 "drug classes": 1 "oral bioavailability ": 1 "sorafenib": 1 "lenvatinib": 1 "vz_f_obs ml/kg": 1 "hr": 1 "ic50 nmol/l": 1 "panitumumab": 1 "change in auc b": 1 "approach": 1 "hb donors": 1 "treatment duration": 1 "1750 b.i.d.": 1 "cssmin µg/ml": 1 "afatinib+gemcitabine combination index effect": 1 "rodent": 1 "cscs enriched": 1 "vandetanib 22": 1 "formulation compound": 1 "vegf-r": 1 "cetuximab": 1 "classification": 1 "?thiazolidines pioglitazone rosiglitazone": 1 "cmax µg/ml": 1 "drug type class": 1 "indication": 1 "pk parameter": 1 "active in cells bearing bcr/abl t315i": 1 "proposed mechanism": 1 "top-20 drug combinations": 1 "axitinib 53 ": 1 "targets": 1 "80–90 74 78 ": 1 "valsartan": 1 "combination with other drugs": 1 "dlts all grade 3": 1 "trazodone": 1 "mechanism of action": 1 "onset of action": 1 "peak level": 1 "acetylsalicylic acid": 1 "biologicals": 1 "n ": 1 "coadministered drug": 1 "change in cmax b": 1 "?fibrates": 1 "49.2 40 mg single dose 68 48.2 325 mg single dose 68 50.7 325 mg for 7 days 68 approx 30 enteric coated aspirin 72 73 ": 1 "rosiglitazone": 1 "stage of development": 1 "chemical structure": 1 "ada n=150": 1 "selectivity": 1 "drug manufacturer": 1 "cdk 4/6": 1 "?dpp-4 inhibitors sitagliptin and vildagliptin": 1 "cetuximab and irinotecan": 1 "maximal plasma concentration ? m mean±sd": 1 "breast cancer selection criteria": 1 "ada n=248": 1 "method of delivery": 1 "arbs*": 1 "anti-tnf- naive": 1 "adjusted": 1 "mw": 1 "authors refs.": 1 "antiobesity drugs": 1 "buparlisib gdc-0032": 1 "rrr for stroke": 1 "vandetanib 47 – 49 ": 1 "patient population": 1 "dosage ng/ml": 1 "pki": 1 "mechanism/ drug": 1 "sirolimus": 1 "design": 1 "bound in plasma ": 1 "duration of action": 1 "vandetanib ic50 nm 32": 1 "current use": 1 "target receptor s of drug": 1 "all patients - itt": 1 "cabozantinib ic50 nm 21": 1 "clusterin": 1 "glucocorticoid": 1 "p-value": 1 "pik3ca": 1 "medication": 1 "fgfr inhibitors": 1 "structure": 1 "primary target": 1 "ixabepilone alone": 1 "day 2 cmin µg/ml": 1 "brand name": 1 "tpsa": 1 "egfr inhibitor": 1 "placebo 22": 1 "indications": 1 "irbesartan": 1 "dosing schedule": 1 "mode of action": 1 "incretin-related agents": 1 "agent class": 1 "formulation": 1 "side effects": 1 "diseases": 1 "trials reference": 1 "750 b.i.d.": 1 "pharmacokinetic parameter": 1 "ramucirumab motesanib": 1 "grade": 1 "time to maximal plasma concentration": 1 "?polyphenols resveratrol etc.": 1 "dosage": 1 "antidyslipidemia": 1 "29": 1 "dose ppm": 1 "oral daily dose": 1 "day 8 cmin µg/ml": 1 "drug description": 1 "vandetanib 100 mg 21": 1 "classification of drug": 1 "?sibutramine": 1 "250 b.i.d.": 1 "?glp-1 agonists/analogs exenatide and liraglutide": 1 "no cell lines screened": 1 "maoi": 1 "pbo n=101": 1 "axitinib": 1 "day of life": 1 "inclusion criteria": 1 "rosuvastatin dosage regimen": 1 "dose mg a": 1 "study population": 1 "dose time to peak action after oral intake h": 1 "trastuzumab": 1 "expected effect": 1 "drug clinical trial sponsor": 1 "oral bioavailability egan": 1 "antagonism": 1 "auclast h*ng/ml": 1 "administration": 1 "veliparib": 1 "?renin inhibitor aliskiren": 1 "ada n=98": 1 "frequency": 1 "mg/kg/dose": 1 "results": 1 "clinical trial": 1 "suggested phase ii dose": 1 "dose and schedule": 1 "insulin sensitizers": 1 "nci reference": 1 "genotype": 1 "1500 b.i.d.": 1 "drug target s": 1 "patient selection": 1 "overall": 1 "auc ng/ml · h 0–?": 1 "drug a": 1 "antioxidants": 1 "tki generation": 1 "?metformin biguanide": 1 "usual dose": 1 "half-life minutes": 1 "ic 50 human whole blood assays in vitro mean 95 confidence interval ci": 1 "dose of sorafenib": 1 "nondiabetes": 1 "log?? p": 1 "toxicity all grades": 1 "agent description": 1 "bisphosphonate": 1 "pertuzumab": 1 "day 3 cmin µg/ml": 1 "75": 1 "dose milligrams": 1 "relative potency": 1 "characteristics": 1 "effective dose msv": 1 "pazopanib": 1 "clinical stage": 1 "pts": 1 "?-arrestin2 recruitment": 1 "target-genes": 1 "bay 43-9006 dose b.i.d mg": 1 "oral 200 mg caps": 1 "steroids": 1 "hl_lambda_z h": 1 "auc0–8h µg*h/ml": 1 "number of patients": 1 "panobinostat dose": 1 "mechanism/ligand": 1 "combination or monotherapy": 1 "lapatinib": 1 "binding": 1 "lumbar spine bmd increase": 1 "tissue": 1 "initial dose mg/day": 1 "type": 1 "ed25": 1 "acetylsalicylic acid antiplatelet dose 75 – 100mg/day 0.52±0.12 ?m controlled release 5 7.3±2?m solution 5 analgesic dose 325 600 mg 25±12 6880±20?m 75 antiinflammatory dose 1.2g 144±22 ?m 75 salicylic acid antiplatelet dose 75 – 100mg/day 4.9±2.5 ?m controlled release 5 14.4±5 ?m solution 5 analgesic dose 600mg/day 297±96 ?m 75 anti-inflammatory dose 1.2 g/day 585±164 ?m 75 5.85–6.2 g/day1800–2300?m 76 77 ": 1 "originally termed": 1 "90": 1 "doses and dosage form": 1 "myeloma patients": 1 "pharmacokinetic parameters a": 1 "21.2 40 mg single dose 68 18.4 325 mg single dose 68 19.2 325 mg daily for 7 days 68 ": 1 "95": 1 "ic 50 value": 1 "1250 b.i.d.": 1 "sunitinib ic50 nm 34": 1 "method": 1 "primary metabolite": 1 "adverse reactions": 1 "effective dose ? ic 50 a": 1 "cancer types": 1 "20?mg": 1 "cabozantinib": 1 "experimental model": 1 "day 15 cmin µg/ml": 1 "trough level": 1 "study": 1 "regions": 1 "immunosuppressants": 1 "range": 1 "mtor inhibitor": 1 "vd l": 1 "trial description": 1 "ed50": 1 "elimination half-life h": 1 "route and formulation": 1 "phase s trial": 1 "agent as monotherapy": 1 "vandetanib": 1 "geneid": 1 "clinical trial identifier e": 1 "grade 3–4": 1 "study and indication": 1 "combination agent": 1 "diabetes": 1 "palbociclib": 1 "notes/company": 1 "pitavastatin": 1 "ras blockers": 1 "trial identifier": 1 "2-oh-e2": 1 "combination with": 1 "follow-up": 1 "ed75": 1 "examination time": 1 "protocol_ids*": 1 "mixed nsri": 1 "afatinib necitumumab": 1 "?antialdosterone spironolactone and eplerenone": 1 "?statins": 1 "custirsen": 1 "pbo n=246": 1 "10?mg": 1 "rotatable bonds": 1 "?mazindol": 1 "cl_f_obs ml/h/kg": 1 "tzds†": 1 "clinicaltrials.gov identifier": 1 "motesanib": 1 "therapeutic efficacy": 1 "drug activity": 1 "?angiotensin ii receptor blockers": 1 "development stage": 1 "bupropion": 1 "sponsor": 1 "dose escalation schedule": 1 "weight kg": 1 "t 1/2 h": 1 "maximum dosage mg/day": 1 "common side effects": 1 "special cancer types and efficacy": 1 "alone": 1 "4-oh-e2": 1 "tca": 1 "coadministered drug and dosing regimen": 1 "patient": 1 "5-asa": 1 "ed90": 1 "change in auc": 1 "parp": 1 "pbo n=145": 1 "cediranib nintedanib pazopanib ponatinib azd4547 bgj398 fp-1039": 1 "macrolide": 1 "name and dose": 1 "galactogogue drug": 1 "combination therapies": 1 "?orlistat": 1 "hb acceptors": 1 "ci values mean±s.e.": 1 "?-arrestin1 recruitment": 1 "day 29 c µg/ml": 1 "statins": 1 "known target s": 1 "category": 1 
"reference": 66 "name": 61 "gene name": 56 "p-value": 35 "description": 34 "gene symbol": 23 "unigene id": 21 "go id": 20 "go term": 19 "symbol": 18 "gene": 17 "p value": 17 "fold change": 17 "id": 15 "annotation": 14 "function": 14 "term": 11 "gene id": 11 "genotype": 11 "genes": 10 "sd": 10 "protein name": 10 "protein": 9 "uniprot id": 9 "database": 9 "geo": 9 "species": 8 "full name": 7 "source": 7 "strain": 7 "sequences": 7 "entrez gene id": 7 "pathway name": 7 "qvalue": 6 "website": 6 "kegg": 6 "gene names": 6 "p -value": 6 "o.ex .": 6 "no of genes": 6 "go name": 6 "mut .": 6 "2log ratio": 6 "category": 6 "score": 5 "affymetrix": 5 "transcript id": 5 "n": 5 "p": 5 "affy id": 5 "sample ids": 5 "probe set id": 5 "count": 5 "fc": 5 "entrez gene name": 5 "url": 5 "value": 5 "references": 4 "primers": 4 "abbreviation": 4 "affymetrix id": 4 "gene description": 4 "kegg id": 4 "entrez id": 4 "common name": 4 "sample name": 4 "geneid": 4 "fdr": 4 "accession number": 4 "#seq": 4 "sam score d": 4 "kegg pathway": 4 "total": 4 "fold-change": 4 "location": 4 "type": 4 "parameter": 4 "accession #": 3 "david gene name": 3 "l": 3 "t": 3 "percentage ": 3 "chr": 3 "alignment": 3 "ncbi gene id": 3 "pep": 3 "go term description": 3 "protein id": 3 "names": 3 "larvae": 3 "direction": 3 "cytoband": 3 "adjusted p-value": 3 "gene count": 3 "ensembl id": 3 "# genes": 3 "protein ssp a": 3 "embryo": 3 "peps": 3 "entrez symbol": 3 "qpcr taqman": 3 "disease": 3 "measured": 3 "identifier": 3 "gene name a": 3 "probe id": 3 "effect": 3 "rank": 3 "in go": 3 "e-value": 3 "protein names": 3 "strain name": 3 " gc": 3 "model": 3 "l3": 3 " present": 3 "z score": 3 "primer sequences": 3 "fold change mamb *": 3 "dv2/mock": 3 " changed": 3 "refseq": 3 "genbank": 3 "changed": 3 "cluster c": 3 "matched organism": 3 "unigene": 3 "source or reference": 3 "p adj b": 3 "reads": 3 "pc346flu2": 2 "pc346flu1": 2 "go term mf": 2 "differential exon": 2 "correlation": 2 "size": 2 "scc/normal 2": 2 "log2fc": 2 "aligned ": 2 "foldchange": 2 "yeast best hit": 2 "c": 2 "f": 2 "abl": 2 "r": 2 "fold changes": 2 "unique ": 2 "go term id": 2 "ihsmonotlr draft p": 2 "female": 2 "stdev": 2 "p-value 8‡": 2 "ncbi blast gene name": 2 "pc346dcc": 2 "5? partner": 2 "biclique": 2 "mapk signaling pathway": 2 "ensembl protein id": 2 "total reads": 2 "coverage ": 2 "no sequences": 2 "motif": 2 "tool": 2 "cremag 2": 2 "cremag 1": 2 "hiv protein": 2 "ref.": 2 "blast e-value": 2 "48 h": 2 "zv8 identifier": 2 "p-value 5?": 2 "hugo symbol": 2 "provenance of": 2 "mirna name release 17†": 2 "enrichment": 2 "24 h": 2 "avg length": 2 "taqman id": 2 "ctrl": 2 "human protein": 2 "aspgd": 2 "ko/wt ratio": 2 " sequences": 2 "no.": 2 "log2fc8": 2 "log2fc4": 2 "avg quality": 2 "pathway names": 2 "clinicaltrial.gov identifier": 2 "sequences 5? to 3?": 2 "3? partner": 2 "database term": 2 "target": 2 "a nidulans gene name": 2 "connectivity": 2 "bioie-p450": 2 "peptide sequences": 2 "categories": 2 "prob": 2 "acronym": 2 "cancer genes": 2 "response activity": 2 "go type": 2 "statistics": 2 "num": 2 "p.value": 2 "telis 2": 2 "trap 1": 2 "number of genes": 2 "3 h": 2 "ratio control vs treatment": 2 "go term bp": 2 "synonym": 2 "reference s": 2 "alias": 2 "go term cc": 2 "avg mapping quality": 2 "contextual gene sets": 2 "gene ontology go term": 2 "benjamini adjusted p-value": 2 "avg coverage depth": 2 "treatment": 2 "bh": 2 "ensembl gene id": 2 "bcr": 2 "d4": 2 "d8": 2 "sample": 2 "tfbs detection tools": 2 "stage": 2 "count a": 2 "mirna name release 20†": 2 "e-value 2": 2 "content": 2 "fdr 8‡": 2 "gi": 2 "transcript*": 2 "percentage b": 2 "accession no.": 2 "classification": 2 "affymetrix probe id": 2 "targets": 2 "relative change in expression**": 2 "p.value adjusted for multiple testing": 2 "tfm-explorer 2": 2 "tfm-explorer 1": 2 "rank a": 2 "go process network": 2 "official full name": 2 "fc 1": 2 "size bp": 2 "genia": 2 "uniprotid": 2 "code": 2 "nr": 2 "examples of predicted targets": 2 "website url": 2 "go code": 2 "coded protein gene name ": 2 "mod pos.": 2 "in motifs b": 2 "term in query": 2 "male": 2 "genes included in go term": 2 "gene assignment": 2 "expression": 2 "rkgf 1": 2 "bioie both": 2 "z-score": 2 "kegg id.": 2 "v4": 2 "agent": 2 "v8": 2 "domain function": 2 "organism": 2 "hhform": 2 "uniprot": 2 "annotation blastx against nr": 2 "go categories": 2 "kegg pathway name": 2 "interpro domain": 2 "6 h": 2 "bioie-onc": 2 "bh adj .": 2 "reduced strain": 2 "cluster id": 2 "approved name": 2 "probe name": 2 "term in genome": 2 "site": 2 "ebi identifier": 2 "ncbi refseq": 2 "official symbol": 2 "sequence": 2 "accession number 1": 2 "major go category ies": 2 "p - value": 2 "average log2": 2 "initial amount": 2 "reads number": 1 "does not interact with": 1 "q-value": 1 "treefam id": 1 "inflammatory source": 1 "functions": 1 "year": 1 "clean reads 2": 1 "explanation": 1 "raw p-value": 1 "z-ratio": 1 "egp": 1 "gene product": 1 "pubmed": 1 "sample genotype": 1 "ter": 1 "#": 1 "stitch id": 1 "qrt-pcr": 1 "resource content": 1 "hugo/mgi symbol": 1 "synonyms human": 1 "illustrative examples": 1 "average length": 1 "analysis": 1 "go category level": 1 "version": 1 "functional annotation": 1 "0": 1 "david p-value": 1 "pathogenicity": 1 "1": 1 "gene name other names": 1 "tfm": 1 "phidias": 1 "in silico datasets": 1 "primer": 1 "phi-base": 1 " unique aligned genome": 1 "biologicalnetworks/hostpathogendb": 1 "gen description": 1 "aspect": 1 "mdm-mir160ae": 1 "ipi id": 1 "ti3": 1 "locuslink": 1 "phos3d": 1 "a": 1 "b": 1 "clinical bcs": 1 "d": 1 "g": 1 "data set": 1 "number transcript matches": 1 "2 h/1 h": 1 "m": 1 "loading ": 1 "raw reads 1": 1 "p †": 1 "turbot 3 database annotation": 1 "type of ip": 1 "reaction name": 1 "pathway": 1 "notes": 1 "controls": 1 "acg": 1 "cosmic samples c": 1 "iupac name": 1 "in silico": 1 "contig number": 1 "ref": 1 "biocarta": 1 "pro-angiogenic effect": 1 "reads with at least one reported alignment": 1 "log2 ratio": 1 "expression 402-91/et vs 402-91": 1 "ratio cy3cy5": 1 "bl31 changes": 1 "gene.name": 1 "sequences 5??3?": 1 "list": 1 "description of domain family": 1 "blastn wgs an gambiae ": 1 "g4 id": 1 "probesets/clones": 1 "specific primers sequences 5? ->3?": 1 "parameter name": 1 "log odds 2": 1 "98072": 1 "annotation c": 1 "pathway s": 1 "nucleotidechange": 1 "m-cci": 1 "overlapping significant pathways": 1 "disease/model": 1 "reactome pathways": 1 "entrez gene": 1 "tma samples": 1 "strand": 1 "hypomethylated": 1 "sra accession": 1 "end": 1 "first author date": 1 "bm_orthologs": 1 "molecular functions": 1 "# inserts total": 1 "ihsmonotlr_lps": 1 "query current study": 1 "number of duplication nodes": 1 "c**": 1 "name human": 1 "# tumors hit > 1": 1 "mechanism of up-regulation": 1 "mytibase": 1 "correctly mapped": 1 "amino acid change": 1 "tumor types observed": 1 "un-adjusted probability": 1 "gene/protein abbreviation": 1 "web link": 1 "translation": 1 "120 min": 1 "cancer": 1 "betweenness": 1 "localization": 1 "percent mapped cgis/total cgis": 1 "agi": 1 "cdna change": 1 "function/process/component go 1": 1 "sequencing strategy": 1 "dna code": 1 "approach": 1 "fisher": 1 "number": 1 "genebank accession #": 1 "mcf-7": 1 "reads raw data/after cleaning": 1 "v5-mek2cr": 1 "order": 1 "homology with l pneumophil a": 1 "networkin": 1 "pathogenic": 1 "chemical class": 1 "predicted effect on mirna binding": 1 "aig": 1 "entrez": 1 "parent kegg pathway": 1 "tof": 1 "peptide name": 1 "human homologue": 1 "go terms relevant only to tissue-centric": 1 "gc content 7 ": 1 "last name": 1 "nci": 1 "syndrome": 1 "mirbase annotation": 1 "polymirts": 1 "qfdr": 1 "ave ko/wt": 1 "complex name": 1 "largest fold change log2a": 1 "unigenes id": 1 "ratio‡": 1 "uspstf": 1 "adj.p.val": 1 "literature or database aliases/synonyms": 1 "hmsc_invasive": 1 "m-value": 1 "litters": 1 "genome": 1 "site class": 1 "probe sets": 1 "protein identification information": 1 "go name*": 1 "predicted localization psortb+": 1 "chrposition": 1 "protein length": 1 "turbot database": 1 "agrigo id": 1 "pig": 1 "downregulated": 1 "go categories of 1000 most correlated genes": 1 "affymetrix probe": 1 "generic name brand name if applicable": 1 "cytokine-cytokine receptor interactions": 1 "cliques": 1 "mouse model": 1 "primer sequences 5??3?": 1 "reads mapped to garlic transcriptome catalog c": 1 "alt": 1 "alignment length 3": 1 "dock score": 1 "interpro": 1 "web service api": 1 "pfam homologs with synonyms": 1 "metabolism": 1 "probe-set id": 1 "2.1 molecular function": 1 "type s": 1 "cancer type": 1 "go annotation": 1 "synonyms rat": 1 "subfamily": 1 "extension to": 1 "scop id": 1 "technique": 1 "function go": 1 "units": 1 "accession": 1 "immune gene": 1 "trial name": 1 "contig 1": 1 "muscle": 1 "pfam domain": 1 "predicted subcellular location": 1 "expt": 1 "upregulated": 1 "virus/ires name": 1 "stage of flower development": 1 "accession# 3": 1 "localisation": 1 "molecular weight": 1 "toucan 2": 1 "total number of fragments": 1 "ihstlrv2": 1 "lf1": 1 "g ||": 1 "mean lengh bp": 1 "membership value": 1 "cluster": 1 "identity ": 1 "total contextscore": 1 "disphos 1.3": 1 "ko identifier": 1 "gopred annotationsprobability": 1 "ctd": 1 "pita": 1 "cleavage": 1 "ires name": 1 "contigs": 1 "tamoxifen": 1 "fold increase": 1 "t-statistics b": 1 "path id": 1 "sampling": 1 "expected": 1 "fdr adjusted p-value": 1 "gc a": 1 "rt1": 1 "gene ontology name": 1 "snps3d": 1 "mw kda": 1 "abundance ratio gstp1/p2?/?/wt": 1 "interacts with": 1 "assigned peptide sequences": 1 "description gene name synonym function": 1 "refseq #": 1 "base no raw data/after cleaning": 1 "sequence mb": 1 "low quality ": 1 "backbone": 1 "go category": 1 "ivdb": 1 "primary use": 1 "institution #2": 1 "percentage of annotated consensus sequences": 1 "referance a": 1 "go term accession": 1 "pathway id": 1 "1956–1976": 1 "r-cci": 1 " of unamb .": 1 "geneacc": 1 "proteins a": 1 "p53 binding motifs b": 1 "relevant genotype": 1 "expected # tumors hit > 1": 1 "google scholar": 1 "run": 1 "pfam entry id": 1 "features": 1 "subcorpus name": 1 "3bko vs wtbac": 1 "scoring pairs": 1 "multiple linear regression": 1 "mirbase accession name": 1 "top scop hit": 1 "genotype description": 1 "signalp": 1 "go description": 1 "match status": 1 "partocles": 1 "probeset": 1 "# of genes": 1 "conserved residues": 1 "string": 1 "qtl b": 1 "read number": 1 "pfam accession id": 1 "kegg pathway maps": 1 "negative": 1 "ncbi cdd hits": 1 " reads aligned transcript": 1 "number gene matches": 1 "domain name": 1 "entrezid": 1 "r-fpim": 1 "factor": 1 "r-fpis": 1 "ptc": 1 "clade/species §": 1 "seq window": 1 "3.1 molecular function": 1 "start": 1 "data resource": 1 "mutationfrequency": 1 "wat": 1 "taqman assay id": 1 "antibody format": 1 "sdev": 1 "wbc": 1 "test fragments ": 1 "panther pathway categories": 1 "time": 1 "1967": 1 "applications": 1 "oligo name": 1 "previous hgnc gene symbols": 1 "number of predicted targets/transcripts": 1 "residues": 1 "tf * name": 1 "agilent id": 1 "hla-binding capability a": 1 "nanoparticles": 1 "tfbs id †": 1 "flybase": 1 "genbank id": 1 "adj.fisher": 1 "webpage": 1 "non-scoring pairs": 1 "size kda human": 1 "1a-116 analog": 1 "blastx nr": 1 "uniprot accession number**": 1 "gene discription": 1 "position umd 3.1": 1 "liver": 1 "ensembl identifier": 1 "evalue": 1 "kegg aml": 1 "standard error": 1 "size/genes": 1 "dbsnp id": 1 "final ihsmonotlr": 1 "taxa number 2": 1 " reads aligned genome": 1 "5?-sequence-3?": 1 "acession": 1 "score bits": 1 "target genes in degs": 1 "clusters lhr-lhr+1h4h8h 20h": 1 "loc": 1 "mating pairs": 1 "fda approval": 1 "mapped cgis": 1 "genome #": 1 "s cerevisiae homolog": 1 "no of sequences reads": 1 "blastn dbest": 1 "averages/ run": 1 "o viverrini sequences ": 1 "predicted activity": 1 "inhibits": 1 "number of predicted transcripts": 1 "1999": 1 "reads processed": 1 "model representation": 1 "# tumors hit total": 1 "no unique sequences": 1 "miranda": 1 "reverse": 1 "proposed name*": 1 "lps": 1 "netmhc 3.2 ann ic50 nm": 1 "query sequence": 1 "rate law": 1 "patric coding sequences a": 1 "contigs/singlets": 1 "mak-2 phosphorylation 2": 1 "cpg_odn 2h": 1 "rosiglitazone+as601245": 1 "location chrstart-endstrand": 1 "trial identifier": 1 "primer & probe sequences 5' to 3'": 1 "coding gene name": 1 "major functions": 1 "trade name": 1 "diff a": 1 "refs.": 1 "group": 1 "goterm david-level3": 1 "path name": 1 "genedescription": 1 "reactome identifier": 1 "format": 1 "biopax": 1 "gerp": 1 "discrete peptides": 1 "primer name": 1 "gene protein name / function": 1 "22q11.2 del": 1 "read mapping": 1 "marker": 1 "biological process": 1 "hypermethylated": 1 "radio/ chemoresistance": 1 " unique aligned transcript": 1 "sponsor": 1 " of total": 1 "reference c": 1 "proteins uniprot": 1 "interacting proteins intact string biogrid hprd": 1 "chipchip p": 1 "polyclonality ": 1 "mapp name": 1 "dictybase id": 1 "amino acid sequence": 1 "complex size": 1 "bayes net toolbox": 1 "grantham score": 1 " of annotated": 1 "chromosome": 1 "generic name": 1 "go categories of 1000 most expressed genes": 1 "kiaa#": 1 "position hg19": 1 "b .": 1 "official gene name*": 1 "fold decrease": 1 "predictome": 1 "standard exchange formats for download": 1 "number of targets": 1 "sd1": 1 "centre name": 1 "protein*": 1 "gotcha est likelyhood 38": 1 "top pdb hit pdb id": 1 "target gene": 1 "sgd description": 1 " *": 1 "mimi": 1 "final library reads": 1 "pcr products": 1 "product size bp": 1 "sbml": 1 "inc.": 1 "reactome": 1 "reactome pathways downloaded": 1 "1 h/30 min": 1 "pdb codes sequence range": 1 "amino acidchange": 1 "gene-trapped": 1 "domain": 1 "virulence determinant": 1 "nucleotide sequences 5?-3?": 1 "gap ": 1 "kegg categories represented": 1 "organ": 1 "benj hoch fdr": 1 "bj": 1 "cosmiccancer genecensus": 1 "parsylated": 1 "putative function": 1 "chr no.": 1 "* p-value": 1 "bp": 1 "number of reads": 1 "approved symbol": 1 "litter/pair": 1 "centre description": 1 "protein description": 1 "kegg category": 1 "hugo gene name": 1 "gene16844-v1.0-hybrid": 1 "primer pair sequences": 1 "njcms1a": 1 "ppsp": 1 "njcms1b": 1 "go sub-ontology": 1 "no of unigenes": 1 "toucan": 1 "ros-dependent effect": 1 "enrichment score": 1 "gene family msigdb": 1 "hmgs": 1 "name #1": 1 "median b": 1 "name #3": 1 "contig id": 1 "name #2": 1 "cpg site": 1 "name #4": 1 "protein function": 1 "fiasma": 1 "best hits with mirnas in mirbase": 1 "gene/protein full name if available": 1 "go definitions": 1 "auxin response factor 16": 1 "reference sample s": 1 "signal": 1 " of reads mapping to globin clusters": 1 "ncbi refseq#": 1 "test": 1 "no hit *": 1 "systematic id": 1 "y2h": 1 "gene hgnc code": 1 "3amutb vs wt": 1 "normal contralateral": 1 "gene ids and names": 1 "cross-links": 1 "gene no.": 1 "david id": 1 "position in rank list": 1 "hss": 1 "cohort": 1 "all sequences": 1 "spliced fragments": 1 "corum id": 1 "ppred": 1 "2008": 1 "brain region": 1 "enrichment ": 1 "p -value logratio": 1 "go terms": 1 "bar type": 1 "alpha": 1 "protein name*": 1 "human": 1 "ncbi gene symbol": 1 "cleanbases 3": 1 "go": 1 "length": 1 "seq description": 1 "breed": 1 "gene bank": 1 "depth genome ?120mb": 1 "intepretation": 1 "unigene id a": 1 "drug name": 1 "locus id": 1 "anti-cd40": 1 "upregulated genes": 1 "2log foldchange": 1 "known genes": 1 "select": 1 "predicted mass": 1 "pfam id": 1 "amplicon length": 1 "sirna": 1 "variants": 1 "drugbank id": 1 "self-renewal": 1 "cancer census genes": 1 "atcc39462": 1 "output": 1 "t-value": 1 "# overlap genes": 1 "pups/litter": 1 "mean read length": 1 "pancreas": 1 "locuslink id": 1 "mda-mb-231": 1 "gef/gap": 1 "software name": 1 "# mirnas": 1 "antigen": 1 "chain length": 1 "patient id": 1 "contents": 1 "effects in host cell": 1 "60 min": 1 "ic50 ?mol/l *": 1 "nominalization": 1 "status": 1 "frequency of occurrence in virus proteome": 1 "spot no": 1 "fss": 1 "other names": 1 "synonyms mouse": 1 "maf": 1 "known": 1 "xenograft": 1 "top kegg pathway term b": 1 "hbx3?-30": 1 "biological processes": 1 "map": 1 "p_value": 1 "genes title": 1 "dr.": 1 "dr1": 1 "non-redundant sequences": 1 "predicted function": 1 "forward": 1 "change": 1 "ratio cy5/cy3": 1 "gene function": 1 "viral protein": 1 "positive": 1 "interpro name": 1 "snp": 1 "observed mass": 1 "hbx3?-40": 1 "rosiglitazone": 1 "effect of dehp": 1 "position b": 1 "usable reads ": 1 "ds1": 1 "inheritance": 1 "go s enriched": 1 "breeding pairs": 1 "hugo genename": 1 "alternative symbol": 1 "no gene sets": 1 "host": 1 "id rng": 1 " coverage": 1 "sense/antisense sequences": 1 "gerp score": 1 "clones b": 1 "assay id": 1 "license": 1 "unannotated": 1 "mutation coordinates hg19": 1 "average read length": 1 "protein clusters": 1 "fold regulation in microarray": 1 "query #": 1 "role in hiv-1 replication?": 1 "subtype": 1 "percent in total reads": 1 "snp id": 1 "phosphosite": 1 "v5-mek1cr": 1 "proteins gene name": 1 "beta": 1 "other fungi blastx taxid 4511": 1 "current status": 1 "uniprotkb": 1 "tpm eb": 1 "go term p-value": 1 "fold change mamb": 1 " regulated genes/go": 1 "control": 1 "kegg subcategory": 1 " of reads uniquely mapping < 3 mismatches": 1 "compound": 1 "rnagenes": 1 "hugo acronym": 1 "polyphen2 prediction": 1 "structure": 1 "2log fold change": 1 "st1": 1 "tumors": 1 "receptor": 1 "tpm es": 1 "number of sequences": 1 "involved genes": 1 "reads failing alignment": 1 "geo id series": 1 "msigdb annotation source": 1 "neurotrophin": 1 "submission identifier": 1 "annotated genes": 1 "kegg cell cycle": 1 "emea approval": 1 "new consensus gene symbols": 1 "tfbm": 1 "strain fgsc # or reference": 1 "observed": 1 "tca brand name": 1 "acs-mstf": 1 "4.62e-03": 1 "meaning": 1 "compound id": 1 "ipi code": 1 "estimate": 1 "entry name": 1 "unigene_id": 1 "band": 1 "genebank accession / swissprot accession": 1 "lmgs": 1 "se b": 1 "alibaba": 1 "14": 1 "group ¶": 1 "adhesion-migration": 1 "reference sequence": 1 "pfp probabality 37": 1 "error rate 4 ": 1 "tm °c": 1 "search option": 1 " of ex-pressed": 1 "senquences": 1 "msigdb accession no.": 1 "as id": 1 "access": 1 "signatures/pathways/gene sets a": 1 "activity": 1 "human cell line/tissues": 1 "kegg apoptosis": 1 "freq": 1 "name in paper †": 1 "mapped genes": 1 "significant hit *": 1 "edges in longest predicted path": 1 "sum": 1 "logratio": 1 "bases": 1 "as601245": 1 "ests num.": 1 "regulates/target": 1 "sp": 1 "key": 1 "netphosk 1.0": 1 "length aa": 1 "decision": 1 "model id": 1 "functional annotation by david": 1 "te": 1 "name comments": 1 "support vector machine": 1 "accession nr": 1 "q20 5 ": 1 "assay reference": 1 "tm": 1 "ratio": 1 "country": 1 "reads discarded after cleaning a": 1 "chembl comp id.": 1 "cell type": 1 "frequency": 1 "predicted mature mirna *": 1 "references 4": 1 "g.o.c -myeloid related": 1 " hits": 1 "kinases": 1 "enzymes a": 1 "um": 1 "reads in cgis": 1 "data set name *": 1 "swissprot id": 1 "hmsc non- invasive": 1 "tss id": 1 "go terms relevant only to cancer-generic": 1 "go term identification": 1 "query": 1 "finding": 1 "superfamily": 1 "id a": 1 "identified peptides": 1 "pfam homologs without synonyms": 1 "go group": 1 "# pregnancies a": 1 "c-4e7": 1 "tblastx expect": 1 "number§": 1 "coip": 1 "e values": 1 "sequence coverage ": 1 "average read quality": 1 "psi-blast hits in the pdb database": 1 "refseq id": 1 "q30 6 ": 1 "hgnc": 1 "primer sequences 5'--3'": 1 "pearson's correlation": 1 "institution #1 add zipcode": 1 "ncapg-specific network §": 1 "nanosystem": 1 "cytoscape": 1 "ka/ks": 1 "common": 1 "ic50 nm": 1 "affymetrix probe set id": 1 "gps 2.1": 1 "author initials": 1 "refseq coding sequences b": 1 "number of hits": 1 "bonferroni correction": 1 "database milan et al contigs": 1 "genebank id": 1 "alternative names": 1 "5-3?": 1 "# pairs": 1 "microarray": 1 "genscan": 1 "intron": 1 "url or ref.": 1 "formula": 1 "gene symbol*": 1 "comment": 1 "prl1-overex signal": 1 "pescador": 1 "corum complex name": 1 "molecular type": 1 "software": 1 "ncapg-specific sub-network mcode derived §": 1 "predicted gene models": 1 "fdr p": 1 "# of corr genes": 1 "v5- lac z": 1 "refseq rna": 1 "library fragment length": 1 "preparation": 1 "pubmed id.": 1 " contigs + singletons": 1 "bta †": 1 "first name": 1 "primer sequence 5??3?": 1 "est id": 1 "zinc69391 parental": 1 "catalog #": 1 "avg a": 1 "method": 1 "gene sym symbol": 1 "synonyms": 1 "genes identified in go terms": 1 "broad institute locus name": 1 "genes up-regulated in parous samples": 1 "alias ‡": 1 "proteins pfam": 1 "samples": 1 "table 1": 1 "total alignments": 1 "examples": 1 "accession number length": 1 "p -value 1": 1 "confunc go c-value 36": 1 "kinasephos": 1 " total genes/go": 1 "u133 probeset id": 1 "range": 1 "description genedb annotation": 1 "p-site": 1 "literature report": 1 "distribution": 1 "go term annotation": 1 "appearances": 1 "illumina": 1 "gen": 1 "feature": 1 "adj p-value": 1 "virus family /genus": 1 "nucleus": 1 "size mb": 1 "brain": 1 "hits": 1 "duod.": 1 "ihop": 1 "selection count": 1 "clean reads in millions b": 1 "sequence coverage": 1 "approved indication": 1 "conceptgen": 1 "bimas score": 1 "gi*": 1 "drug": 1 "mir_name": 1 "30 min/10 min": 1 "rna-seq": 1 "pathways enriched": 1 "accession id": 1 "development": 1 "individual": 1 "resource": 1 "mascot score": 1 "c sinensis sequences a": 1 "finished": 1 "source tissue": 1 "top pfam hit": 1 "chemical comp.": 1 "reads in millions": 1 "rep_norm": 1 "nsc27366 reference": 1 "geneset name": 1 "files": 1 "fdr ‡": 1 "uniqid": 1 "yinoyang 1.2": 1 "empty vector signal": 1 "angiogenesis inducer": 1 "human gene location": 1 "known limitations": 1 "10 min/0 h": 1 "mut": 1 "uniquely counted mapped reads with?<?3 mismatches": 1 "platform": 1 "nucleotide id": 1 "ncbi influenza db": 1 "heart disease": 1 "netphos 2.0": 1 "ref seq": 1 "avg read quality": 1 "number of annotated consensus sequences": 1 "transcript clusters": 1 "homologene datasets": 1 "pmid": 1 "cell communication 1 2": 1 "ht p-value": 1 "blastn nr": 1 "npm1 mu t-aml gene array": 1 "assay": 1 "pb01 blastx": 1 "functional linage network": 1 "variable": 1 "motifs ": 1 "phosphositeplus kinase": 1 "target/action": 1 "netsurfp 1.1": 1 "pathway/ppi database": 1 
"egfr": 9 "p-value": 8 "?": 7 "2": 6 "0": 5 "1": 5 "egf": 4 " 17": 4 " 0": 3 " 8": 3 "?+": 3 "ret": 3 "vegf pg/ml": 3 "?++": 3 "vegfr3": 3 "periostin mrna": 3 "vegfr2": 3 "vegfr1": 3 "?+++": 3 "met": 3 "periostin protein": 3 "??": 3 "notch3": 3 "erbb-4": 3 "erbb-3": 3 "erbb-2": 3 "group": 3 "bfgf": 2 "egfr -e746_a750del v ins": 2 "3": 2 "7": 2 " n?=?6": 2 "collagen i": 2 "mmp-9 ng/ml": 2 "braf": 2 "igf-1 and l.obtusiloba extract": 2 "sample": 2 "kit-y553_q556del": 2 "egfr -l747_s752del q ins": 2 "+tniiia2": 2 "vegfb": 2 "vegfc": 2 "vegfa": 2 "jagged1": 2 "egfr -d770_n771insg": 2 "?-sma": 2 "egfr -e746_a750del": 2 "other": 2 "+mg2+": 2 "ang2": 2 "ang1": 2 "collagen iii": 2 "egfr -d770_n771>agg/v769_d770insasv/v769_d770insasv": 2 "total": 2 "erbb2-p780_y781insgsp": 2 "pdgfb1": 2 "mrna": 2 "cav-1 rc": 2 "egfr -l747_e749del a750p": 2 "pdgfr": 2 " 58": 2 "kit-p551_v555del": 2 "wt": 2 "transfections": 2 "tnf ?": 2 "igf-1": 2 "l.obtusiloba extract": 2 "drug": 2 "cav-1 ko": 2 "egfr -l747_t751del": 2 "epor": 2 "plgf": 2 "sfrp5": 1 "pik3ca -h701p": 1 "sfrp1": 1 "references": 1 "sfrp2": 1 "neuregulin": 1 "met -y1230c": 1 "ret-c634r": 1 "epha3": 1 "hrg stimulation": 1 "rkkrrqrrr igehyvhvnatyvnvkcva": 1 "total vegf pg?ml ?1": 1 "collagen *": 1 "dclk3": 1 "tissue specimen": 1 "kit-y568d": 1 "nras -g12c/g12r/g12s": 1 "pik3ca -e542k": 1 "prenatal hgf tg": 1 "http//www.clinicaltrials.gov/": 1 "erbb2-a775_g776insyvma": 1 "kit-p585p": 1 "egfr -l858r": 1 "psoriasin/ranbpm": 1 "braf -d594v| g": 1 "interleukin-3 il-3": 1 "kit-k558_e562del": 1 "ephb2": 1 "4": 1 "5": 1 "ac50 µm": 1 "6": 1 "fgfr1/3": 1 "8": 1 "kit-w557r/w557r/w557g": 1 "kras -q61e/k/l/r/p/h": 1 "nras -g13c/g13r/g13s": 1 "wnt 3a": 1 "pik3ca -r38h": 1 "pdgfra-d842_h845del": 1 "erbb2 active": 1 " n?=?9": 1 "collagen vi": 1 "variables a": 1 "fgfr1-s125l": 1 "angiopoietin-1": 1 "bmp-9": 1 "n": 1 "akt1 -rs11555436": 1 "p": 1 "akt1 -rs11555435": 1 "pik3ca -h1047y": 1 "bmp-2": 1 "akt1 -rs11555433": 1 "ran bpm": 1 "akt1 -rs11555432": 1 "bmp-4": 1 "akt1 -rs11555431": 1 "bmp-6": 1 "bmp-7": 1 "fgfr3-y373c": 1 "ras-gdp": 1 "?nd": 1 "tie2 expression": 1 "braf -t599i": 1 "coreceptors": 1 "drugs in combination": 1 "hrg": 1 "fgfr3-k650t/m": 1 "pik3ca -e545k": 1 "pdgfra-f808l": 1 "kit-v825a": 1 "shc": 1 "fgfr3-s249c": 1 "afgf bfgf": 1 "insulin igf": 1 "fgfr1-p252t": 1 "akt2-s302g": 1 "pdgfr ?/?": 1 "cis": 1 "egf hb - egf pdgf low doses ": 1 "<0.84": 1 "egfr -e746_t751del i ins": 1 "?subcutaneous met": 1 "egfr -e746_t751del v ins": 1 "pdgfra-d846y": 1 "citation": 1 "egfr -t263p": 1 "met -y1235d": 1 "pdgfra-n870s": 1 "pik3ca -m1043i/m1043i": 1 "kit-v559_v560del": 1 "braf -k601n/e": 1 "drug name": 1 "cancer": 1 "hras -g13c/r/s": 1 "factor vegf/vpf": 1 "kit-d52n": 1 "kit-e839k": 1 "kit-v560del": 1 "?pdgf-r ?": 1 "?pdgf-r ?": 1 "erbb4 inactive": 1 "erbb2-g776s/g776lc": 1 "ret-c634w/y": 1 "key targets": 1 "fgf4": 1 "20 wk": 1 "ligands": 1 "fgfr3-k650q/e": 1 "fgf2": 1 "egfr -n771_p772>svdnr": 1 "fgf1": 1 "egfr -r108k": 1 "egfr -t790 m": 1 "leptin": 1 "egfr detectable": 1 "braf -v600e/k/r/l": 1 "fgf-2 pg/ml": 1 "kit-v559del": 1 "psoriasin": 1 "fgf9": 1 "fgf8": 1 "fgf6": 1 "egfr non-detectable": 1 "platelet-derived endothelial-cell growth factor pd-ecgf": 1 "nrg3": 1 " n?=?11": 1 "ligand": 1 "hras -q61h/l/r/p/k": 1 "egfr -g719s/g719c": 1 "platelet-derived growth factor pdgf": 1 "mag": 1 "bdnf": 1 "flt3-i836del": 1 "mating yeast strain": 1 "abl1 -h396r": 1 "b-raf": 1 "fgfr3-a391e": 1 "placental growth factor plgf": 1 "kit-k550_k558del": 1 "nrg2": 1 "nrg1": 1 "ptpn11 d61y": 1 "pdgfra-d842v": 1 "jak2-v617f": 1 "fgf18": 1 "fgfr": 1 "fgf17": 1 " n?=?20": 1 "cav1 +/+": 1 "response pfs": 1 "mmp-9 pg/ml": 1 "pik3ca -n345k": 1 "angiogenin": 1 "braf -g469s/e/a/v/r": 1 "braf -l597s/r/q/v": 1 "egf stimulation": 1 "abl1 -q252h": 1 "egfr -g598v": 1 "intermedin": 1 "sema3a": 1 "feature combination": 1 "met -m1250t": 1 "growth onsd/-leu-trp/aba medium": 1 "pleiotrophin": 1 "pik3ca -c901f": 1 "tie2": 1 "vegfrs": 1 "sos": 1 "pten": 1 "abl1 -t315i": 1 "?0.84": 1 "kit-y570_l576del": 1 "egfr -m766_a767insai": 1 "alp": 1 "status identifier phase": 1 "transforming growth factor- ? tgf ? ": 1 "rqikiwfqnrrmkwkk ivavncgvhyehtnvkvya": 1 "flt3": 1 "claudin-4": 1 "prediction": 1 "claudin-3": 1 "100 ng/ml fgf2": 1 "kit-v559d/v559a/v559g": 1 "claudin-2": 1 "claudin-1": 1 "claudin-7": 1 "braf -f468c": 1 "egfr -v769_d770inscv": 1 "antiangiogenic factors": 1 "sfrp c": 1 "pik3c3": 1 "vascular endothelial growth factor/vascular permeability": 1 "apoptosis": 1 "egfr -l747_t750del p ins/e746_a750del t751a": 1 "fibroblast growth factor-2 basic fgf fgf2": 1 "fibronectin *": 1 "ngf": 1 "syndecan-4": 1 "tie1 expression": 1 "lck": 1 "nras -q61e/q61k": 1 "erbb2-l755p": 1 "abl1 -g250e": 1 " 100": 1 "flt3-d835h/d835y": 1 "erbb2": 1 "vla-5": 1 "vla-4": 1 "erbb4": 1 "kit-k558_v560del": 1 "keratinocyte growth factor fgf-7": 1 "erbb2-g776vc/g776vc": 1 "control": 1 "kit-k642e": 1 "egfr -s752_i759del": 1 "pik3ca -q546k": 1 "pdgfra-d1071n": 1 "ang-2 production": 1 "claudin-11": 1 "egfr -v774_c775inshv": 1 "erbb2-m774_a775insyvma": 1 "wnt 10": 1 "interleukin-8 il-8": 1 "silent hgf": 1 "pdgfra-t674i": 1 "ret-a664d": 1 "egfr -s768i": 1 "nras -g13v/g13a/g13d": 1 "kit-v559i": 1 "antp-met": 1 "antp-scrambled": 1 "grb2": 1 "cdk-r24c/h": 1 "toxcast chemical name": 1 "egfr -h773_v774insnph/h773_v774insph/h773_v774insh": 1 "proliferin": 1 "?cd117/c-kit": 1 "egfr -h773>npy": 1 "12": 1 "kras -g13c/s/v/d": 1 "nras -a18t": 1 "erbb3 inactive": 1 "abl1 -e355g": 1 "abl1 -y253h": 1 "abl1 -y253f": 1 "kit-d816h/d816y": 1 "grade": 1 "egfr -l747_s752del p753s": 1 "tumor necrosis factor- ? tnf ? ": 1 "kit-e561k": 1 "osteogenic protein-1": 1 "progranulin": 1 "cell line": 1 "fibroblast growth factor-1 acidic fgf fgf1": 1 "abl1 -d276g": 1 "?lymph node met": 1 "pik3ca -h1047r/h1047l": 1 "pi3ka": 1 "adhesion": 1 "kras -g12v/a/d/c/s/r/f": 1 "tumor": 1 "hif-1? expression": 1 "laminin": 1 "kit-m552l": 1 "timp-1 rna": 1 " 34": 1 "abl1 -f317l": 1 "abl1 -e255v": 1 "kit-d579del": 1 "plexins/neuropilins": 1 "kit-f584s": 1 "braf -g464r": 1 "?-mhc-tta": 1 "abl1 -e255k": 1 "met -t992i": 1 "vegf expression": 1 " 42": 1 "egfr -e746_t751del s752d/snp c2255t": 1 "egfr -l747_t750del p ins": 1 "nrp2": 1 "pdgfra-i843_d846del": 1 "nrp1": 1 "braf -g596r": 1 " 50": 1 "notch4": 1 "10 wk": 1 "hgf tg": 1 "bcr/abl": 1 "erbb2 inactive": 1 "kit-d816v": 1 "transforming growth factor- ? tgf ? ": 1 "kit-l576p": 1 "timp3": 1 "ptpn11d61y": 1 "egf pg/ml": 1 "kit-v560d/v560g": 1 "ic50 nm": 1 "fgfr3-g370c": 1 "kit": 1 "gap": 1 "wdnm1": 1 "kras -a59t": 1 "70": 1 "71": 1 "73": 1 "75": 1 "braf -g466r": 1 " 66": 1 "characteristics": 1 "adrenomedullin": 1 "tat-met": 1 "wif1": 1 "erbb2-s779_p780insvgs": 1 "nras -g12v/g12a/g12d": 1 "braf -f595l": 1 "?origin of specimen": 1 "cells": 1 "wild-type": 1 "expression ": 1 "ang-1 production": 1 "kit-y503_f504insay": 1 "nras -q61l/q61r/q61p": 1 "grkkrrqrrrpp igehyvhvnatyvnvkcva": 1 "half-life h": 1 "hras -q61h": 1 "growth onsd/-leu-trp-his/aba medium": 1 "?liver met": 1 "angiogenic factors": 1 "pik3ca -c420r": 1 "egfr -e709a/e709g/e709v": 1 "pdgfra-v561d": 1 "pik3ca -p539r": 1 "akt1 -rs34409589": 1 "nt3": 1 "tgm3": 1 "egfr active": 1 "egfr -a289v": 1 "abl1 -m351t": 1 "midkine": 1 "egfr -l861q": 1 "granulocyte-colony-stimulating factor g-csf": 1 "vbs": 1 "pik3ca -g1049r": 1 "egfr -g719a": 1 "ic50 ret ? m*": 1 "fgf 8": 1 "mmp2": 1 "braf -g466v/g466g/g466e": 1 "fgf 4": 1 "fgf 3": 1 "egfr inactive": 1 "vegfr-2": 1 "del-1": 1 "fgfr3-r248c": 1 "tat s-met": 1 "hras -g13v/d": 1 "pdgfra-i843_s847>t": 1 "rqikiwfqnrrmkwkk igehyvhvnatyvnvkcva": 1 "egfr -e746_t751del i ins/s752_i759del": 1 "pik3ca -r88q": 1 "ret-e632_l633del": 1 "vhl exp.": 1 "transfection": 1 "hras -g12v/d": 1 "wnt 1": 1 "wnt 3": 1 "ret-m918t": 1 "10 ng/ml fgf2": 1 "akt2-r371h": 1 "semaphorins": 1 "growth onsd/-leu-trp-his-ade/aba medium": 1 "pdgf high doses ": 1 "erbb2-g776vc": 1 "pdgfra-s566_e571>k": 1 "ckit": 1 "wnt b": 1 "dkk1": 1 "cases n": 1 "met -r970c": 1 "line": 1 "abl1 -f311l": 1 "flt3_3": 1 "flt3_2": 1 "integrins": 1 "akt1 -rs12881616": 1 "abl1 -f359v": 1 "parameter": 1 "vegf 165b pg?ml ?1": 1 "egfr -e709k/e709h": 1 "vhl mutation": 1 "cav1 ?/?": 1 "c-kit": 1 "stimulus": 1 "follistatin": 1 "egfr -v769_d770insasv": 1 "igehyvhvnatyvnvkcva": 1 "erbb4 active": 1 "nras -q61h": 1 "hepatocyte growth factor/scatter factor hgf/sf": 1 "fibronectin": 1 "egfr -p772_h773insv": 1 "vegf": 1 "gelatin": 1 "braf -g464v/g464e": 1 "dll4": 1 
"n": 169 "ns": 81 "n ": 69 "p -value": 64 "p value": 59 "p": 56 "p-value": 50 "y": 48 "n.d.": 48 "0": 37 "***": 35 "genotype": 33 "mean": 29 "variable": 28 "": 27 "variables": 27 "vip": 25 "cadmium": 24 "++++": 24 "ext": 23 "no": 23 "pre": 23 "95 ci": 23 "post": 23 "nd": 22 "+": 21 "group": 21 "gene": 21 "2": 20 "phenanthrene": 20 "+++": 20 "abs": 19 "total": 19 "1": 18 "hts qrt-pcr": 18 "++": 18 "qrt-pcr": 18 "authors": 18 "p- value": 18 "confirm": 18 "characteristics": 17 "expt": 17 "arg0": 16 "median": 16 "ref": 16 "n0": 15 " ": 14 "hr": 13 "or 95 ci": 13 "negative": 13 "a": 12 "**": 12 "wt": 12 "m bc": 12 "t": 11 "m0": 11 "muv ": 11 "positive": 11 "year": 10 "effect": 10 "pr": 10 "sd": 10 "method": 10 "characteristic": 10 "std": 10 "-": 9 "3": 9 "4": 9 "< 10": 9 "p-value†": 9 "p -value a": 9 "parameter": 9 "pvalue": 9 "*": 8 "patients n a": 8 "?": 8 "biomarker": 8 "survival biomarker +ve vs ?ve patients": 8 "primary surgical treatment n ": 8 "fdr": 8 "b2-a2": 8 "or": 8 "pd": 8 "radio±chemotherapy n ": 8 "groups": 8 "mean median follow-up period in months": 8 "no of patients ": 8 "biomarker +ve patients b": 8 "correlation with prognosis": 8 "sem": 8 "g": 7 "x": 7 "1+": 7 "2+": 7 "b3-a2": 7 "3+": 7 "vul ": 7 "p *": 7 "cd": 7 "?2": 7 "snp": 7 "feature": 7 "category": 7 "—": 6 "d": 6 "i": 6 "p8.p": 6 "concentration": 6 "vpcs induced ": 6 "< 1": 6 "<5": 6 "pfs months": 6 "p3.p": 6 "drug": 6 "avg # of vpcs induced": 6 "gbm2": 6 "gbm5": 6 "yes": 6 "p4.p": 6 "percent": 6 "u373": 6 "p5.p": 6 "mean sd": 6 "vpcs n": 6 "p6.p": 6 "description": 6 "genotypes": 6 "sample": 6 "p7.p": 6 "cell line": 6 "frequency": 6 "response": 6 "?": 5 "–": 5 "5": 5 "6": 5 "50": 5 ">5": 5 "p ‡": 5 "study": 5 "cr": 5 "na": 5 "cases": 5 "conc": 5 "gene symbol": 5 " fdr": 5 "reference": 5 "gene name": 5 "t/n": 5 "protein": 5 "rpl19": 5 "sex": 5 "100": 5 "total n ": 5 "rps27a": 4 "b": 4 "c": 4 "e": 4 "mutation": 4 "200": 4 "pred": 4 "stability value": 4 "controls n ": 4 "mean*": 4 "cells/mm 2": 4 "heterogeneity": 4 "t cells": 4 "stage": 4 "age years": 4 "hspcb": 4 "10": 4 "12": 4 " 168 ": 4 "mut": 4 "exp": 4 "d vs n": 4 "survival months": 4 "factor": 4 "hazard ratio": 4 "probe set id": 4 "ci": 4 "ct": 4 "ras1": 4 "ras3": 4 "ras2": 4 "i2": 4 "ii": 4 "iv": 4 "n1": 4 "r2": 4 "annotation target": 4 "nono": 4 "rps18": 4 "input": 4 "hr 95 ci": 4 "abs.": 4 "pc vs d": 4 "iii": 4 "gapdh": 4 "pgk1": 4 "univariate": 4 "alg9": 4 "actb": 4 "rpl32": 4 "name": 4 "rpl11": 4 "ldha": 4 "thyroid cancer": 4 "rpl13a": 4 "arhgdia": 4 "p-value a": 4 "responses": 4 "patients": 4 "#": 3 "or 95ci a": 3 "7": 3 "9": 3 "m": 3 "r": 3 "positive ": 3 "technique": 3 "genes": 3 "strains": 3 "control n =": 3 "log 2 fc": 3 "corpses ± s.d.": 3 "total n": 3 "multivariate": 3 "e350g/442c": 3 "dcr": 3 "specimen": 3 "treatment": 3 "average": 3 "e350g": 3 "nk n ": 3 "upp": 3 "n c ": 3 "e1-a2": 3 "ck n ": 3 " n ": 3 "16": 3 "20": 3 "25": 3 "34": 3 "39": 3 "40": 3 "80": 3 "fold enrichment smoothed": 3 " corrected": 3 " genes": 3 "pathway": 3 "16 50": 3 "na1": 3 "k n ": 3 "pten": 3 "pce/pce+nce": 3 "std error of mean": 3 "translational repression": 3 "aor a 95ci b ": 3 "n vs crc": 3 "inhibition of apoptosis": 3 "ihc score": 3 "cases n": 3 "patients n": 3 "af": 3 "unknown function": 3 "cv": 3 "ep": 3 "no significant hit": 3 "n*": 3 " 95ci": 3 "mf": 3 "cases n?=?664": 3 "r1": 3 "n°": 3 "cases n ": 3 "rq": 3 "t3": 3 "t4": 3 "se": 3 "vector": 3 "mean ± sd": 3 "country": 3 "genetic model": 3 "orr": 3 "location": 3 "corr": 3 "oncogenesis": 3 "specimen n =": 3 "go term": 3 "global p value": 3 "units": 3 "t73 trx2?": 3 "aor 95 ci": 3 "pos": 3 "pr ": 3 "-102": 3 "pts": 3 "cases ": 3 " muv": 3 "no rnai": 3 "stage iv": 3 "stage ii": 3 "hua": 3 "hum": 3 " vul": 3 "s03": 3 "s06": 3 "compound": 3 "primary tumors egfr-scores": 3 "predominant localization": 3 "0–1": 3 "e-g350/g145": 3 "bonferroni": 3 "controls": 3 "af2": 3 "af1": 3 "age": 3 "fc?ri-?": 3 "ams": 3 "ref.": 3 "rot": 3 "0.1": 3 "k-ras": 3 "t73": 3 "rtk": 3 "parameters": 3 "rnai": 3 "ras1rr2": 3 "ppv ": 3 "hoxb5 1010a/g genotype": 3 "global analysis p value": 3 "control": 3 "sto": 3 "2–6": 3 "specificity": 3 "ras1rf2": 3 "positive rate ": 3 "effect se": 3 "sensitivity": 3 "mnpces": 3 "def 5": 3 "adjusted or 95 ci †": 3 "s.e.": 3 "2 ???ct": 3 "controls n?=?702": 3 "negative n/": 2 "p- value a": 2 "95 confidence interval": 2 "1000": 2 "igfbp-rp1 expression": 2 "f": 2 "premolar cx cp": 2 "aldoa": 2 " 73 ": 2 "chr": 2 "n = 13": 2 "n *": 2 "cancer": 2 "t1t2": 2 "ndrg2": 2 "mmugdna.16774.1.s1_s_at": 2 "t-ag negative n ": 2 "261": 2 "n m/f": 2 "pve by pc1 a": 2 "mmugdna.2575.1.s1_at": 2 "overall": 2 "primary": 2 "unknown": 2 "los": 2 "low": 2 "clinical features": 2 "3 +++": 2 "3 4": 2 "c max ng?ml ?1": 2 "primary trait": 2 "q-pcr ratio": 2 "term": 2 "median and range": 2 "positive ?10": 2 "n treatment groups": 2 "mirnas": 2 "rs11788747": 2 "positive n/": 2 "subgroup n": 2 "specificity ": 2 "cyclin d1 expression n ": 2 "max": 2 "t1/2 rapid phase minutes": 2 "200801_x_at": 2 "200737_at": 2 "35 38": 2 "max lifespan": 2 "350": 2 "11": 2 "13": 2 "14": 2 "rs16932912": 2 "200674_s_at": 2 "male": 2 "22": 2 "23": 2 "1st": 2 "min": 2 "max .": 2 "35": 2 "expression": 2 "38": 2 " sd": 2 "41": 2 "44": 2 "2t": 2 "2u": 2 "+ to +++": 2 "fold enrichment": 2 "62": 2 "spec ct": 2 "4t": 2 "4u": 2 "isopenicillin n synthetase": 2 "76": 2 "experimental group": 2 "<25": 2 "sensitivity ": 2 "her2/neu": 2 "p- value **": 2 "myc": 2 "n vs lpl": 2 "sfrp1 methylated": 2 "cut-off values": 2 "rs10814325": 2 "14 days post-injury n": 2 "stdev": 2 "p a": 2 "p b": 2 "sig animal b": 2 "females": 2 "p– value": 2 "control group": 2 "0.025": 2 "pten expression status": 2 "2nd": 2 "genome": 2 "neg": 2 "cancer type": 2 "mttfa in": 2 "statistical test": 2 "or ci 95": 2 "24?hr": 2 "gg n?=?64": 2 "12?hr": 2 "r max ": 2 "pec50": 2 "number of cases n": 2 "hba1c ": 2 "?/+": 2 "wwox +": 2 "rkip n ": 2 "negative <10": 2 "variables n": 2 "sham-treated controls": 2 "fcc01609": 2 "variance": 2 "kd nm": 2 "aa": 2 "ai": 2 "posterior": 2 "as": 2 "intermediate": 2 "p***": 2 "d0": 2 "anterior": 2 "btg3 expression": 2 "dq": 2 "200029_at": 2 "er": 2 "ev": 2 "fc": 2 "adj pvalue": 2 "fn": 2 "fp": 2 "ga": 2 "incisive-canine cx cp": 2 "translational repression/mrna cleavage": 2 "0.140": 2 "ir": 2 "leptin": 2 "treatment 1": 2 "m+": 2 "m1": 2 "epiya": 2 "m2": 2 "pet counts cpm": 2 "epiyt": 2 " cov": 2 "n.": 2 "tt n?=?76": 2 "pro224ala471 cc n?=?3": 2 "200017_at": 2 "wwox ?": 2 "ne": 2 "0.112": 2 "pb": 2 "pc": 2 "ps": 2 "log2ratio ca/n": 2 "rank/544": 2 "0.099": 2 "0.090": 2 "t1": 2 "rr": 2 "200966_x_at": 2 "tn": 2 "tp": 2 "diagnosis yrs": 2 "methylation status": 2 "no of patients": 2 "x2": 2 "0.082": 2 "fins mu/l": 2 "-05": 2 "n vs spl": 2 "number of patients": 2 "-12": 2 "-15": 2 "aij2": 2 "phase": 2 "low n ": 2 "-21": 2 "n1/any n": 2 "-38": 2 "total number": 2 "mitotic rate per 50?hpf": 2 "sfrp2 unmethylated": 2 ">75": 2 "log ec50": 2 "228817_at": 2 "assay": 2 "mmugdna.17381.1.s1_at": 2 " range": 2 "ag+gg n?=?52": 2 "ca+aa n ": 2 "18 38.3": 2 "> 10000": 2 "component": 2 "controls n": 2 "c elegans": 2 "200716_x_at": 2 "mean?±?sd": 2 "b bc": 2 "pearson's coefficient": 2 "ga+aa n?=?71": 2 "mirna": 2 "nf-l–cre stat3flox/ko": 2 "global analysi s n": 2 "insulin secreted": 2 "pts n": 2 "mmugdna.43260.1.s1_at": 2 "n positive ": 2 "any rate": 2 "stage iiib": 2 "stage iiia": 2 "nf-l–cre stat3flox/wt": 2 "reporter system": 2 "n?=?6310": 2 "affx-mmu-actin-3_s_at": 2 "obese n = 9": 2 "p -value ? 2-test": 2 "? 2": 2 "++/+++": 2 "t1/2 slow phase minutes": 2 "mmugdna.25831.1.s1_s_at": 2 "7 8": 2 "rs10972727": 2 "sham n = 15": 2 "t-all": 2 "mmugdna.43194.1.s1_at": 2 "disease": 2 "tt n?=?21": 2 "time": 2 "212581_x_at": 2 "slope": 2 "-145": 2 " p value": 2 "manders' coefficients": 2 "npv ": 2 "patients n ": 2 "crude or 95 ci": 2 "-186": 2 "mmugdna.30425.1.s1_at": 2 "saline control": 2 "population": 2 "h sapiens": 2 "mmugdna.25770.1.s1_at": 2 "max ic50 × 10-7m": 2 "auroc": 2 "stage ia": 2 "2000": 2 "pathways": 2 "emax of k+": 2 " rnai cdt-2": 2 " persistent exp .": 2 "fbg mmol/l": 2 "200064_at": 2 "28 days post-injury n": 2 "n?=?35": 2 "median of relative over- expression lower and upper quartile values": 2 "cohort i": 2 "n?=?56": 2 "n?=?53": 2 "ic95": 2 "combinations of variables": 2 "position": 2 "apoptosis": 2 "ki nm": 2 "n?=?11": 2 "regulation": 2 "ng/mg tissue si": 2 " kcal mol?1": 2 "hbl-1": 2 "pathological grade": 2 "-207": 2 "-216": 2 "any t": 2 "mrna levels": 2 "25°c": 2 "ihc": 2 "-269": 2 "-272": 2 "cox-proportional hazard model for prediction of patient’s survival #": 2 "m0/m1": 2 "tc+cc n?=?144": 2 "mmugdna.25225.1.s1_at": 2 "cannot be assessed": 2 "references": 2 "ora 95ci": 2 "nsaid-treated": 2 "200057_s_at": 2 "wnt unmethylated": 2 "2 ++": 2 "fu months": 2 "clinical variable": 2 "aa n?=?83": 2 "percentage ": 2 "ach": 2 "cc n ": 2 "ddfs univariable": 2 "p values": 2 "haloacid dehalogenase like hydrolase": 2 " n =17": 2 "number": 2 "rank/1444": 2 "wild type": 2 "aij": 2 "frequency n ": 2 "molar cx cp": 2 "cell length µm": 2 "t-ag positive n ": 2 "pathologic variables": 2 "accession": 2 "subgroups n ": 2 "mean lifespan days +/-sd": 2 "?t1": 2 "?t2": 2 "?t3": 2 "?t4": 2 "high n ": 2 "0 ?": 2 "males": 2 "001": 2 "005": 2 "6?hr": 2 "n?=?12": 2 "term size": 2 "sfrp2 methylated": 2 "tumor": 2 "200650_s_at": 2 "recurrent": 2 "number of risk alleles‡": 2 "target": 2 "positive cases": 2 "-378": 2 "200010_at": 2 "sfrp1 unmethylated": 2 "accuracy ": 2 "affx-mmu-gapdh-3_x_at": 2 "sfrp unmethylated": 2 "ca+aa vs cc": 2 "auc 0? ? ng?h?ml ?1": 2 "pro224val471 ct n?=?4": 2 "ch+7kc nmol/mg": 2 "t 1/2 h": 2 "min .": 2 "cd?+?los": 2 "1 +": 2 "jmjd2a": 2 "tumor type": 2 "induction±se": 2 "mtt -index ± sd **": 2 "sf2": 2 "proteins": 2 "angii n = 15": 2 "correlation coefficient": 2 "ser": 2 "pre b": 2 "nominal p-values of enrichment scores †": 2 "sig drug c": 2 "time secs": 2 "aupr": 2 "201168_x_at": 2 "cases n = 86": 2 "constant": 2 "high": 2 "odds ratio log": 2 "adjusted b or 95 ci": 2 "2 13.3": 2 "seq ct": 2 "pik3ca": 2 "118": 2 "7kc ": 2 "functions annotation": 2 "genotype n ": 2 "conditions": 2 "201049_s_at": 2 "symbol": 2 "authors and references": 2 "genotypic frequencies": 2 "ta+aa n?=?59": 2 "r mean": 2 "normal": 2 "182": 2 "p-value b": 2 "range": 2 "before igf1r": 2 "age range": 2 "57 66": 2 "n = 32": 1 "geo accession": 1 "q-value": 1 "0?gy": 1 "esiya": 1 "protein ids": 1 "os february n?=?4": 1 "cycle study cycle phase": 1 "esiyt": 1 "variable 2": 1 "p value nilotinib arms versus imatinib": 1 "centromeric regions": 1 "inversely regulated mirnamrna sets a ": 1 "stadium iv": 1 "accession #": 1 "n = 48": 1 "ins 35p2 binding curve fit": 1 "p #1 dsrct": 1 "n =153": 1 "mouse embryo < day 7": 1 "mhh-tall-1": 1 "stadium ii": 1 "size": 1 "expression of rhob ": 1 "pretreatment ereg level": 1 "ptc n?=?70": 1 "8": 1 "mean age days at vo mean +/? sd": 1 "n =158": 1 "ac alone n = 138": 1 "n =159": 1 "msi-h tumors n = 75": 1 "wcc x109/l": 1 "freq effect allele": 1 "aat genetic modifiers study n = 378": 1 "variable n": 1 "n =166": 1 "iterative-dendrix": 1 "n =161": 1 "insulin + l-name": 1 "gt counts controls": 1 "polypoid adenomas": 1 " n = 364": 1 "metformin": 1 "lewis y antigen": 1 "bone marrow": 1 "9 9.8": 1 "o": 1 "q": 1 "bi-fan-bi-fan": 1 "n =178": 1 "presence call ± sd": 1 "72 h": 1 "??3?-methyl-4-dimethylaminoazobenzene": 1 "???no of patients in test group ": 1 "dfi days": 1 "fcc00021": 1 "ddfs multivariable b": 1 "ddfs multivariable a": 1 "pharynx": 1 "selected functional event": 1 "tratuzumab + ac n = 143": 1 "mrna target": 1 "good": 1 "?ii ": 1 "cimmunomodulatory index ex vivo": 1 "n =101": 1 "trastuzumab + paclitaxel n = 92": 1 "mir-196": 1 "survival rate": 1 "0.701-0.959": 1 "n =108": 1 "n =102": 1 "copy number": 1 "n =103": 1 "fcc00015": 1 "e2f-5": 1 "ebvagc n = 30": 1 "sam68 localization": 1 "o 6-pobg": 1 "er? n = 45": 1 "normal karyotype n = 44": 1 "total ion score c.i ": 1 "50 ic20": 1 "-1013": 1 "n = 10": 1 "n = 12": 1 "fcc00002": 1 "primer conc.annealing temp": 1 " 74 ": 1 "n = 14": 1 "n = 15": 1 "wbm_unigene": 1 "moxd1 protein": 1 "487 ± 101": 1 "braf m n = 11 ": 1 "fcc00008": 1 "ffl-bi-fan": 1 "ras2rr1": 1 "ic50 cellular ps935 nm": 1 "n = 21": 1 "cd4+cd8+": 1 "braf m n = 12 ": 1 "ct ala471val": 1 "2-year": 1 "controls n = 561": 1 "severe chronic": 1 "5?-gcaacaagtgcgacctacagtcg-3?": 1 "n =": 1 "stat-{gfp}": 1 "d1/d2 *": 1 "iapbs/mm-pbsa results": 1 "mir-155": 1 "total ": 1 "mrna study": 1 "fcc00058": 1 "roc_auc": 1 "n a": 1 "pic50 cellular ps935": 1 "effector ic40*": 1 "uk national registry for aatd n = 458": 1 "tnm": 1 "gos3": 1 "inhibition of hiv-1 replication": 1 "cml": 1 "raf*?=?0 mek?=?360000 mek*?=?0 erk?=?750000 erk*?=?0": 1 " ng/ml": 1 "lama-84": 1 "k+ mn": 1 "?d p/d tmax mmhg/s": 1 "h72q-r": 1 "mmugdna.32274.1.s1_at": 1 "comparator": 1 "2.5": 1 "v-set i": 1 "5 33.3": 1 "mirna-regulated mrnas fc > 1.25": 1 "markers": 1 "lobular carcinomas n = 29": 1 "mqs 6–8 2+": 1 "?-type subunits": 1 "cr ": 1 "hazard ratio for survival": 1 "age range y": 1 "mqs 3–5 1+": 1 "ct ratio cystatin c/actin": 1 " 55 patients": 1 "cx3cl1 / gilz": 1 "t1 analysis mimics standard chi-square": 1 "condition": 1 "mir-124": 1 "mir-122": 1 "204": 1 "assay *": 1 "fcc00086": 1 "tumor tissue": 1 "fev1 pred": 1 "25 ic20": 1 "aml n?=?87": 1 "215": 1 "muscle": 1 "216": 1 "217": 1 "apc promoter status": 1 "lin-4": 1 "??ph ch2 n -ncs where n = 0 1 2 3 4 5 6 8 10": 1 "mi n?=?28": 1 "comments": 1 "overall n = 1098": 1 "fcc00074": 1 "g?11 knockout diabetes": 1 "probe": 1 "mir-149": 1 "mrna ptm/fc > 1.25 n": 1 "clinical- pathological characteristic": 1 "moderate chronic": 1 "cl/f l?h ?1": 1 "total *": 1 "cv ": 1 "microsatellite markers": 1 "fcc03172": 1 "231": 1 "233": 1 "ctc": 1 "236": 1 "n nodes in q": 1 "237": 1 "injury agent": 1 "-538": 1 "?fat mass†": 1 "n nodes in r": 1 "oxaliplatin treated n =24 ": 1 "ifn-?": 1 "hnpc iqr": 1 "facilitation of hcv replication": 1 "# genes std": 1 "small intestine": 1 "igf-1r": 1 "q1/q3 transition": 1 "cn/pi+/tunel?": 1 "severe chronic asthma n ": 1 "topfluor-ps frap n": 1 "sle n+ n ": 1 "253": 1 "mmugdna.770.1.s1_at": 1 ">6 cm": 1 "256": 1 "esli positivity n": 1 "5?-ggaattccatatgcgcgagtacaaaatagttg-3?": 1 "mirnas up-regulated in anaplastic": 1 "cdk4 - n ": 1 "ras1ir": 1 "pik3ca mutation n = 6": 1 "unmethylated n ": 1 "sd n": 1 "260": 1 "predictive for survival": 1 "262": 1 "-563": 1 "untreated n =6": 1 "z max": 1 "no of cases": 1 "ras1if": 1 "her2+/? primary tissue logfc": 1 "cell lines": 1 "source": 1 "14 days": 1 "strain alone": 1 "all cases n = 34": 1 "mirna-143 expression": 1 "cell line hnpcc n =8": 1 "kras n = 67": 1 "oxaliplatin free n =21 ": 1 "281": 1 "two-cell stage": 1 "braf wt n = 19 ": 1 "-584": 1 "heat shock protein hsp70g hsp68": 1 "count cimp?": 1 "sle n ": 1 "et-1": 1 "pathway source": 1 "total a": 1 "294": 1 "daf-12": 1 "n-o": 1 "7-pobg": 1 "model 1+ response after 9 months": 1 "genotype models": 1 "motif_consensus": 1 "endotoxin value eu/ml": 1 "hsp70 hsp68": 1 "libraries": 1 "control n ": 1 " 150 ": 1 "unmethylated": 1 "fcc03183": 1 "crpc iqr": 1 "protein score": 1 "5?-gctgcctaacacaactattt -3?": 1 "residues": 1 "validation set": 1 "m1 n = 8": 1 "ras1f": 1 "n/p": 1 "phase1": 1 "capicua": 1 "kcl mm": 1 "ms/ms match": 1 "hr brca1 brca2 rad51 rpa": 1 "p14 arf t/n": 1 "model 1+ vegfr3 vessel staining": 1 "cyclin d1 - n ": 1 "non-serrated adenomas n = 9": 1 "muscle-specific gene expression": 1 "lgp *": 1 "patients’ age": 1 "mode of regulation": 1 "??rat liver lung mammary gland bladder small intestine/colon oesophagus": 1 "membrane-associated": 1 "cephalosporin hydroxylase": 1 "6 35.3": 1 "characteristicsa": 1 "sup-b15": 1 "ras2rf1": 1 "lbf p-value": 1 "fcc00966": 1 "ns june n?=?5": 1 "loq ? g/l": 1 "maxilla": 1 "e6-a2": 1 "control of the developmental program": 1 "600 mg bid × 14d cycles =4": 1 "?variable 1": 1 "ras1qf": 1 "ras1qr": 1 "p200 cux1 n ?=?129 this study": 1 "sd-1": 1 "lymph ": 1 "technical replicate 2": 1 "p -parameter *": 1 "n =184": 1 "location n.a.": 1 "residue change": 1 "n = 70": 1 "n = 87": 1 "0~1": 1 "mutants m n = 19 ": 1 "?": 1 "ratio gsh/gssg": 1 "ras3r": 1 "5?-cgcacccacaaccaccaatt -3?": 1 "?": 1 "rate constants molecules?1 cell min?1": 1 "molm-6": 1 "ras3f": 1 "p- value vs gcn": 1 "ins 345p3 scatchard": 1 "serrated adenocarcinomas n = 42": 1 "ras2r": 1 "t4 analysis collapses low-count categories into the next lowest category": 1 "dietary factor": 1 "therapy": 1 " cal mol?1 k?1": 1 "e/w- a": 1 "adjusted or 95 ci * 2–6 versus 0–1": 1 "ras2f": 1 "mel-1 ?-gal in sd broth**": 1 "p/m1 n = 22": 1 "ras1r": 1 "5?-ggaattccatatgaccgagtacaaattggtgg-3?": 1 "n = 112 †": 1 "ln metastasis n=30": 1 "nuccyld?": 1 "mir-93 high n=25": 1 "diameter sd": 1 "diameter se": 1 "tt vs cc/ct": 1 "p- value of motif enrichment": 1 "scanned": 1 "tissues #": 1 "1.111": 1 "unique id": 1 "germline": 1 "dfi": 1 "??sulphoraphane ch3s o ch24-ncs": 1 "benign n =18": 1 "dose": 1 "control n = 12": 1 "sd minimal medium": 1 "control n = 13": 1 " a": 1 " b": 1 " c": 1 "outdoor 38 n ": 1 " d": 1 " e": 1 "left colon": 1 " n": 1 "distal colonic/rectal n = 32 †": 1 "cancer stages": 1 "fcc03839": 1 "hp + gc n=28": 1 "mean intensities of chordoma": 1 "p16 - n ": 1 "20°c": 1 "cn/pi+/tunel+": 1 "tumor/liver cells": 1 "0.00": 1 "freq cimp+": 1 "intensity score": 1 "0.01": 1 "ex {lacz} 1 / merexdiap qpcr 2": 1 "retinol dehydrogenase 11": 1 "benign n =37": 1 "short-chain dehydrogenase/reductase 9": 1 "1129": 1 "rpn2": 1 " n = 478": 1 "jurkat 8.2": 1 "mac ": 1 "gene names": 1 "y998f": 1 "n=6": 1 "cd117 expression pattern": 1 "ods n ": 1 "0.10": 1 "th+ neurons b": 1 "recommendations": 1 "0.05": 1 "tumor >10?cm": 1 "+d p/d tmax mmhg/s": 1 "treatment cell line": 1 "pathology tumor staging": 1 "test": 1 "igf-1 µg/l uln": 1 "0.20": 1 "?? n -2-flourenylacetamide acetylaminofluorence": 1 "spleen g": 1 "v ss l/kg": 1 "standard deviation": 1 "percentage of phospholipids": 1 " ?2=0.96 df=2 p=0.61**": 1 "association and highlights": 1 "0.96 hr cv": 1 "cafe assays": 1 "0.30": 1 "brain region": 1 "squamous": 1 "hematopoietic cell differentiation": 1 "nuclear": 1 "microarray samples": 1 "methylated": 1 "length": 1 "c-kit immunostaining": 1 "0.40": 1 "egcg avg signal": 1 "res mg/kg": 1 "dmd": 1 "5?-cggctgactttatctttgcgtatctc-3?": 1 "chemotherapy": 1 "relapse free survival analysis logrank p ": 1 "nuccyld+": 1 "or *": 1 "loci": 1 "alleles": 1 "kras n = 21": 1 "total n = 42 ": 1 "dp1": 1 "dp2": 1 "0.64": 1 "bancr": 1 "number ": 1 "tc mmol/l": 1 "correlation ##": 1 "p-value3": 1 "wt k-ras n=69": 1 "status": 1 "vehicle in vivo ": 1 "ld50 µm": 1 "curve": 1 "1.171": 1 "probeid": 1 "go term location": 1 "g2–g3": 1 "map": 1 "all scored taken as 100 n": 1 "dpp": 1 "forward": 1 "other cg transition": 1 "20 45": 1 "tu location": 1 "n sur": 1 "hematopoietic cells": 1 "m-s /o-l": 1 "fcc04344": 1 "scoring method": 1 "0.96": 1 " 159 ": 1 "kras mutated n ": 1 "escc": 1 "ref #": 1 "-3": 1 "n = 172 †": 1 "standard error of mean": 1 "-6": 1 "z-pot mv ± sd": 1 "kon m?1 s?1": 1 "wtd *": 1 "coating thickness mm": 1 "pool sfc / m": 1 "d5s346": 1 "-626": 1 " mf": 1 "japan controls": 1 "det +hgf": 1 "control 55": 1 "differentiation": 1 "histoscore units": 1 "peripheral blood": 1 "mef": 1 "pic50 in vitro lrrktide": 1 "dtc": 1 "333": 1 "code b": 1 "particle size d .nm ± sd": 1 " 157 ": 1 "overexpression in brain tumor glioblastoma": 1 "1 vs 2p value": 1 "338": 1 "cadmium³": 1 "controls n ?=?1056": 1 "fcc04316": 1 "fold-change": 1 "median survival months 95 c.i.": 1 "pten low n = 39": 1 " 158 ": 1 "347": 1 "349": 1 "normal n ?=?18": 1 "01": 1 "fd n = 65": 1 "fold change and p-value student’s t -test b": 1 "05": 1 "352": 1 "induction ±se": 1 " 167 ": 1 "dukes' stage c/d n = 23 †": 1 "358": 1 "age after birth": 1 "ras2ir": 1 "15": 1 "17": 1 "18": 1 "19": 1 "p vs wt vo": 1 "cml n?=?140": 1 "mrna": 1 "alleles effect/ other": 1 "hub degree": 1 "ccn amplified n = 50": 1 "361": 1 "363": 1 "caucasian population": 1 "animal": 1 "pretreatment hgf level": 1 "12300 ± 1690": 1 "21": 1 "ras2if": 1 "high n = 30 30.6": 1 "24": 1 "26": 1 "27": 1 "28": 1 "5?- ggggacttcttgttgatctgtctcac-3": 1 "29": 1 " 165 ": 1 "risk group": 1 "median of o/e p- value": 1 "sample type": 1 "30": 1 "31": 1 "all tumors n = 463": 1 "32": 1 "33": 1 "positive expression of pstat3 protein n": 1 "??site/app": 1 "36": 1 "37": 1 "validation expt/pred": 1 "1w": 1 "radiation sensitive n =18": 1 "381": 1 "382": 1 "383": 1 "aln + foh": 1 "-684": 1 "group n": 1 "freq cimp?": 1 "389": 1 " 166 ": 1 "controls n?=?501": 1 "42": 1 "43": 1 "45": 1 "46": 1 "agent": 1 "primary crc": 1 "east asian": 1 " 163 ": 1 "50th percentilea": 1 "t2dm n = 193": 1 "11 64.7": 1 "protein identified": 1 "newly formed": 1 "jk-1": 1 "adjusted a or 95 ci": 1 "tobacco": 1 "cyto st vs nuc st": 1 "56": 1 "5? noncoding region of the hcv genome": 1 "57": 1 "3w": 1 "5-15": 1 "msi-h wild-type kras and wild-type braf": 1 "#chromosomes 4": 1 " 164 ": 1 "p -values": 1 "on-rate m-1s-1": 1 "61": 1 "mapk": 1 "adjusted or 95 ci": 1 "63": 1 "5?-race": 1 "p **": 1 "lynchsyndrome": 1 "b16f1 melanoma cells": 1 "response kras wt ": 1 "tnm classification for gastric gist including primary solitary omental gists": 1 "protein expression n": 1 "fcc03067": 1 "polymorphisms": 1 "bcr-abl1 mu/wt": 1 "cd4?cd8?": 1 "nuclear ep-icd ": 1 "cells": 1 "phosphoserine aminotransferase": 1 "pts™ recovery test ": 1 "2 ???ct *": 1 "87": 1 "max/mand ratio cx cp": 1 "6w": 1 "monoisotopic mass": 1 "transgene": 1 "ras/braf": 1 "pegfr": 1 "pcdh20 downregulation in tumour tissues": 1 "low n = 16": 1 "erk-2 wb": 1 "max ": 1 "age—yr": 1 "ach + insulin": 1 "gem/cis+tipifarnib s.d n =29": 1 "average age y": 1 "rac1lox/lox": 1 "n ?=?122": 1 "n ?=?123": 1 "latency months": 1 " 160 ": 1 "tg mmol/l": 1 "off-rate s-1": 1 "panitumumab arm n = 232": 1 "1120 ± 66": 1 "ras2qf": 1 "induction±s.e.": 1 "ras2qr": 1 "low n = 68 69.4": 1 "scored 1.9?<?fis???3.5 medium impact n ": 1 "p?<?0.05 §": 1 "+/-": 1 "ftc n?=?12": 1 "??mean": 1 "model 1+ last report": 1 "k d by a µm": 1 "overexpression in b-cells lymphomas and lung cancer cell lines": 1 "mature mirna id": 1 "gem/cis+tipifarnib s.d n =30": 1 "two sets combined": 1 "mirna expression rpkm": 1 "initial conditions molecules cell?1": 1 "?3 cm": 1 "1~3": 1 "facebook": 1 "mono-isotopic mass m/z": 1 "12 different small rnas": 1 "lt50 h": 1 "erk-i wb": 1 "hoechst 33342 staining": 1 "tert promoter non-mutated n = 126 41": 1 "mmr-d status": 1 "axis": 1 "pt #4 ewing’s sarcoma": 1 "dukes' stage a/b n = 29 †": 1 "?ffm†": 1 "2 sle n?": 1 "cc vs ct/tt": 1 "xmrk / kras / myc": 1 "bcr-abl construct": 1 "group 5": 1 "group 2": 1 "resistant n = 39": 1 "group 1": 1 "group 4": 1 "group 3": 1 "sequence": 1 "left sided": 1 "eea": 1 "t allele frequency ": 1 "a52v s54n k66e": 1 "laminina": 1 "number of total": 1 "muv": 1 "test case": 1 "link to oncogenesis": 1 "males n ": 1 "pt no.": 1 "distances": 1 "??methylazoxymethanol acetate": 1 "lvi n ": 1 "locus": 1 "iterative-rme": 1 "constituents": 1 "n copies": 1 "ins 345p3 binding curve fit": 1 "vif": 1 "sites/cell matched": 1 "2 awcoff": 1 "1212": 1 "endometrioid adenocarcinomas": 1 "mean nd": 1 "clinicopathological factors n = 56": 1 "variable n a": 1 "gfp-lactc2 frap n": 1 "q1 °c a": 1 "mqs 0–2 0": 1 "multifocality n ": 1 "genotype allele": 1 "3-year": 1 "go term function": 1 "cxrt+r115777 n = 78 grade": 1 "age at 1st op yr": 1 "overall patients n?=?884": 1 "d62–d90 tp in vivo ": 1 "p53/p21 ihc": 1 "notch": 1 " 75 149 152 – 156 ": 1 "stage at diagnosis": 1 "median survival days": 1 "mirna-30c": 1 "u87mg": 1 "frameshift/nonsense n total mut": 1 "mir-1": 1 "protective isothiocyanates": 1 "ic50 dasatinib nm": 1 "lvedp mmhg": 1 " cutoff value 1412.65?pg?ml ?1": 1 "annotation": 1 "braf m n = 9 ": 1 "em-2": 1 "normalized relative expression a": 1 "ms mo": 1 "utr-snps var n = 20304": 1 "ku-812": 1 "gpr91 ?/? ? +?suc n =3": 1 "?-aminoadipyl-cysteinyl-valine synthetase": 1 "candidate mirnas n ": 1 "adjustedor 95 ci c": 1 "histology—number ": 1 "selectivity index si b ": 1 "line-1 methylation": 1 "relative activation": 1 "lin-14": 1 "female": 1 "lbf fdr q-value": 1 "treated n =6": 1 "17 73.9": 1 "?total body weight†": 1 "1271": 1 "decreased mir": 1 "mir-15a mir-16-1": 1 "tumor >5?cm to 10?cm": 1 "tumour grade*": 1 "high p110 ? expression": 1 "cancer var n = 358": 1 "fcc01574": 1 "mutated protein": 1 "kras wt n ": 1 "p value ?": 1 "tumors without membrane src n = 110": 1 "gfp-lactc2 fcs fast d slow d percent slow n": 1 "ras3ndeif": 1 "emax ": 1 "best supportive care n = 231": 1 "k-ras mutation": 1 "braf m n = 5 ": 1 "env": 1 "tr3-ko": 1 "duct & acinar n ": 1 "melan-a2 melanocytes a": 1 "rnd3 peptide": 1 "significance": 1 "vpr": 1 "monoclonal antibodies": 1 "localization": 1 "ii 7": 1 "fcc04660": 1 "m2 n = 18": 1 "cn/pi?/tunel?": 1 "mating": 1 "melan-a2 melanocytes": 1 "smokers ns n?=?25": 1 "smad4 n = 16": 1 " n = 7954": 1 "logfc": 1 "gfp-lactc2 aaa fcs fast d slow d percent slow n": 1 "rbsp3/ rassf1a": 1 "ctr n = 92": 1 "serrated adenomas n = 26 *": 1 " ?2=8.81 df=2 p=0.012*": 1 "adeno ca n = 17": 1 "cyp9/6": 1 "ratio h/l p value": 1 "ma bafi": 1 "tt val471val": 1 "402": 1 "nbm": 1 "msi-": 1 "property 5 pr ? 0.9 f 600 cyclind > 900": 1 "msi+": 1 "lin-28": 1 "equ": 1 "cc ala471ala": 1 "0.045": 1 "disease progression": 1 "0.048": 1 "0.049": 1 "her4 n = 48": 1 "score of sox2 expression": 1 "all patients n = 61": 1 "411": 1 "mir-129-5p expression a t/n ratio": 1 "all patients n = 65": 1 "b-raf": 1 "oropharynx n = 559": 1 "clinorotation": 1 "0.039": 1 "k obs min-1a": 1 "m/f ": 1 "treatment group": 1 "species": 1 "5?-cgcggatccggcgttcgttacaggatggtg-3?": 1 "10000": 1 "cd4/cd8": 1 "400 mg bid × 21d cycles =21": 1 "lin-41": 1 "utr-snps ref n = 20304": 1 "22 46.8": 1 "vul": 1 "nef": 1 "trial": 1 "mmugdna.8511.1.s1_at": 1 "tumors with membrane src n = 149": 1 "japan cancer": 1 "?1 ": 1 "434": 1 "436": 1 "average area mm2": 1 "437": 1 " n = 7207 ": 1 "-735": 1 "ratio auc 0? ? day 22/day 1": 1 "n ?=?83": 1 "hsp90 high n = 55": 1 "maintenance of heterochromatin": 1 "ic 50 µm a": 1 "braf wt n = 192 ": 1 "polymer/drug mg/mg": 1 "asthma act <20 n ": 1 "mean ldh release": 1 "sequence type": 1 "moderate expression": 1 "deleted gene": 1 "n-regional lymph node": 1 "mean±sem 2": 1 "?2 ": 1 "mean ad": 1 "shrna": 1 "fold change †": 1 "2?gy": 1 "mmugdna.34686.1.s1_at": 1 "patient no.": 1 "gill": 1 "b lymph": 1 "454": 1 "456": 1 "lesion/tumor": 1 "cell death": 1 "one-cell stage": 1 "463": 1 "464": 1 "localization score slomo": 1 "set-3 n=150": 1 "mirna-16": 1 "tumor ?2?cm": 1 "mucosa": 1 "high n = 16": 1 "1800 ± 478": 1 "pt #2 wilms’tumor": 1 "fraction of samples mutated mna | crc b ": 1 "b-raf v600e mutation": 1 "?t2 n?=?54": 1 "gc d": 1 " asym pattern": 1 "478": 1 "formulation": 1 "cesd": 1 "treated with 50 nm tpa compared with control": 1 "control of the virus assembly": 1 "peptide": 1 "duct only n ": 1 "indoor n ": 1 "missense n total mut": 1 "expected": 1 "female fetuses": 1 "pcgs": 1 "diameter mean": 1 "disease control rate cr pr and sd": 1 " univalents n 3": 1 "patients n = 12": 1 "c t / u.t ? 1": 1 "max ic50 × 10-10m": 1 "imatinib 400 mg qd of patients n = 283": 1 "b-tpm sequence type": 1 "mir-93 low n=22": 1 "tumour target organs": 1 "p-f": 1 "therapeutic agents": 1 "her1 n = 48": 1 "concen mg/g": 1 "cyp6n3v2": 1 "492": 1 "rat iv dose 3.4?mg?kg ?1": 1 "pituitary adenoma": 1 "allele or genotype": 1 "supplemental": 1 "genetic": 1 "n ?=?17": 1 "??mouse lung forestomach": 1 "?ct in qrt-pcr mean ±sd": 1 "ap n = 928": 1 "tr3-wt": 1 "std dev": 1 "n ?=?14": 1 "test set n a = 112": 1 "mmugdna.18264.1.s1_at": 1 "stages iii + iv": 1 "m-h pooled or †": 1 "good responders": 1 "protein domain": 1 "features": 1 "white": 1 "compound a": 1 "glucose mmol/g cdw h": 1 "overall survival": 1 "severity of asthma": 1 "type of mutation": 1 "2020 ± 483": 1 "hazard radio 95 ci": 1 "spasm latency min": 1 "rab7": 1 "adj p": 1 "t 821 n = 13": 1 "? max gdp": 1 "100 gene network": 1 "1 awcoff/1 awcon": 1 "basal n = 81": 1 "prevalence of dtc n ptc/n ftc": 1 "ab ratio": 1 "potential marker n ?=? responders + non-responders": 1 "14 43.8": 1 "inhibitory rate ": 1 "allelic combination": 1 "? g ° kcal mol?1": 1 "bwt g": 1 "rate constants min?1": 1 "no ln metastasis n=30": 1 "mss/msi-l n ": 1 "fcc05124": 1 "gene counts": 1 "uk cancer": 1 "kcal ": 1 "kras/braf n ": 1 "lym x106/l": 1 "colon": 1 "egfr protein expression mean ± sd": 1 "pr n = 46": 1 "domain families": 1 "p53": 1 "wnt b methylated": 1 "modified peptide s": 1 "p-h3ser10 labeling index mean±sd": 1 "yes n = 51": 1 " suppression in her2-expressing cells": 1 "let-7": 1 "liver": 1 "??ch3 ch23ch ch3-ncs": 1 "nuclear ep-icd positive n": 1 "rate constants molecules cell?1": 1 "hazard ratio 95 c.i.": 1 "crc primaries": 1 "eif4e expression": 1 "fcc05181": 1 "mm 77": 1 "n = 60 †": 1 "distant metastasis": 1 "??2-acetylnorbornyl-ncs 3 isomers": 1 "integrin ?v?6 expression": 1 "plaque number/cm 2 /fly mean ± sd": 1 "acronym": 1 "positiverate ": 1 "non-oropharynx n = 539": 1 "c-tpm number ": 1 "n sex age": 1 "after igf1r+mtor": 1 "7sl +-rn a": 1 "probestes": 1 "pik3ca wild type n = 51": 1 "et3sn": 1 "24–88": 1 "risk allele": 1 " a total dna levels ngml ?1": 1 "et3pb": 1 "cell line sporadic n =22": 1 "pfs mo": 1 "rassf1a/ nprl2/g21": 1 "ras proteins": 1 "strain": 1 "surgical margins": 1 "non-nec 24 n with samples": 1 "marker": 1 "receptor type": 1 "effect of hsp90 inhibitors c": 1 "1 g": 1 "n=15": 1 "o -glcnac": 1 "wbc x106/l": 1 "n=17": 1 "ductal carcinomas n = 80": 1 "fev1/fvc": 1 "yin yang": 1 "hrt treatment": 1 "enzyme": 1 "ssh origin": 1 "lymph node involvement": 1 "gi50 values for 2.5 × 103 mda-mb-468 ?mol/l": 1 "mst mo": 1 "auc 0–24 ng?ml ?1 × h": 1 "p interaction b": 1 "fcc00101": 1 "range of rq values": 1 "hds n ": 1 "tumor site": 1 "n=32": 1 "deaths": 1 "n=23": 1 "laminin beta 2 laminin s": 1 "parametr": 1 "differential regulation in crcs †": 1 "al": 1 "studies n": 1 "ap": 1 "1346": 1 "5?-tggcaaggaacagggacaaaatc-3?": 1 " frequency": 1 "n=20": 1 "fcc01428": 1 "glioma classification": 1 "n reference*": 1 "??4-dimethylaminoazobenzene": 1 "control of the last developmental stage l4": 1 "?? n -nitrosodiethylamine": 1 "hr 95 ci †": 1 "haloacid dehalogenase-like hydrolase": 1 "+?+++": 1 "low n = 33 29.0": 1 "indel/null": 1 "b p value": 1 "hsp90 low n = 23": 1 "novel mutations n ": 1 "n=52": 1 "protein description": 1 "std rsk2 mutants": 1 "n=47": 1 "cc": 1 "scoring": 1 "charge": 1 "alu +-rn a": 1 "cl": 1 "cn": 1 "cp": 1 "fisher's p value": 1 "13 86.7": 1 "cs": 1 "correlation with detection method": 1 "cu": 1 "sirt1+ n ": 1 "dc": 1 "n censored d": 1 "df": 1 "mirna-20b": 1 "hp - gc n=8": 1 "? max": 1 "f1": 1 "hax1 ii expression": 1 "24.96": 1 "count cimp+": 1 "antibodies": 1 "fcc05839": 1 "aneuploid 2 n < 40": 1 "coating efficiency": 1 "???/+ *": 1 "> 1000": 1 "g1": 1 "16s ribosomal rna gene no sign hits": 1 "leptin n = 8": 1 "distance cm": 1 "fb": 1 "strain name": 1 "total patients": 1 "ipma": 1 "ipmc": 1 " relative to control±sem": 1 "plaque diameter mm 2 mean ± sd": 1 "n=92": 1 "esli positive n": 1 "gg": 1 "positive selected sites beb posterior pvalue": 1 "500": 1 "muscle-invasive": 1 "uk controls": 1 "obr": 1 "hg": 1 "class i loe": 1 "0.141": 1 "hs": 1 "inflammatory response protein 6 viperin": 1 "putative jass group": 1 "phospho-her2 n = 43": 1 " ?2=2.86 df=1 p=0.091*": 1 "fibrillarin 3": 1 "pat no.": 1 "pdac": 1 "in": 1 "3 15": 1 "fcc03202": 1 "cells expressing p str-2 rfp": 1 "peaks": 1 "indoor 30 n ": 1 "fcc00170": 1 "0.135": 1 "braf wt n = 31 ": 1 "gene id": 1 "liver g": 1 "att +hgf": 1 "cat26": 1 "nilotinib 400 mg bid of patients n = 281": 1 "mcm2": 1 "c2?=?7.7?10?4 c6?=?8.3 c8?=?4?105 c10?=?15 c12?=?4?10?6": 1 "0.169": 1 "hnpcc n =7": 1 "n of studies/cases": 1 "ligand": 1 "0.168": 1 "pathological variables": 1 "0.161": 1 "0.160": 1 "535": 1 "all diabetic patients n=70": 1 "radiation resistant n =9": 1 "n nodes overlapping": 1 "bcl9": 1 "r values": 1 "adenocarcinoma": 1 "bcl2": 1 "0.152": 1 "0.159": 1 "bbd n = 96": 1 "541": 1 "0.151": 1 "ld": 1 "ras3bamhir": 1 "clo segment length": 1 "leukemia": 1 "cdt-2 rnai": 1 "0.105": 1 " n = 1090": 1 "property 4 pr ? 0.9 f 600 cycline > 900": 1 "0.109": 1 "n vs crc and v-set ii": 1 "b16f1 melanoma cells b": 1 "0.104": 1 "fcc04580": 1 "0.102": 1 "ratio fertile/infertile": 1 "e/ea >15": 1 "0.715-1.726": 1 "low 0 1+ 2+": 1 "haplotype frequencies": 1 "haplotype a": 1 "mh": 1 "geminin/ki67": 1 "author": 1 "crudeor 95 ci": 1 "diagnosis": 1 "o/e in chip-seq": 1 "mz": 1 "pls²": 1 "40 +/-3 30 +/-6 30 +/- 2 65 +/- 4": 1 "pstat3 positive expression n ": 1 "568": 1 "p*": 1 "pik3ca amplification mip copy number": 1 " dtc defect n": 1 "nn": 1 "p1": 1 "pve a": 1 "p2": 1 "breast cancer n = 142": 1 "p3": 1 "shprh protein": 1 "taqman mirna assay": 1 "total n = 32": 1 "training group n =79": 1 "high † n = 30": 1 "571": 1 "responses n ": 1 "cyto st vs cyto pm 1": 1 "hippo/warts": 1 "flat adenomas": 1 "os": 1 "p value §": 1 "abc transporter moat-d": 1 "normal adjacent liver tissues n = 46": 1 "non-serrated adenocarcinomas n = 59": 1 "patients n = 70": 1 "pa": 1 "mirna-143 low n =41": 1 "pe": 1 "n = 438": 1 "patients n = 78": 1 "pi": 1 "pl": 1 "> 65": 1 "pn": 1 "ic50 imatinib nm": 1 "jcam2 cells": 1 "pt": 1 "mss/msi-l and braf v600e mutation": 1 " a total dna levels": 1 "m5 n = 17": 1 "ras1bamhir": 1 "normalization procedure based on": 1 "3~15": 1 "mandible": 1 "estimate": 1 "grade—number ": 1 "5?-gcaggcgacagaccgaatcaag-3?": 1 "?-type subunits": 1 "biacore kinetic rate parameters": 1 "nonendometroioid carcinomas": 1 "0.091": 1 "bcs1": 1 "a downregulated er target genes": 1 "tpm type": 1 "0.095": 1 "tumor loc": 1 "i 4": 1 "mutant": 1 "t0": 1 "t2": 1 "tumor components": 1 "initial tone g": 1 "rt": 1 "homa-ir": 1 "0 vs 1+/2+/3+": 1 "heat shock experiment": 1 "ddb id": 1 "fpas": 1 "mono- nucleotides": 1 "sa": 1 "50th percentile a": 1 "african american": 1 "snp_id": 1 "sm": 1 "p value #": 1 "negative a": 1 "linearity": 1 "log  p ? a": 1 "search key": 1 "p value +": 1 "mean tocopherol concentration pmole/well n": 1 "p value *": 1 "400 mg bid × 14d cycles =6": 1 "zeigler bros phyto reduced i": 1 "c t / u.t >1": 1 "eu n = 1113": 1 "total n = 115": 1 "neut ": 1 "total n = 64": 1 "topfluor-ps spt n n tracks": 1 "tt": 1 "right sided": 1 "zap-70 pos *": 1 "ga ": 1 "0.066": 1 "tipifarnib s.d n =20": 1 "0.068": 1 "uc": 1 "0.069": 1 "literature values": 1 "scc vs ns": 1 "mitochondria location": 1 "0.060": 1 "total n = 96": 1 "moderate chronic asthma n ": 1 "or ": 1 "mdm-2 immunopositivity": 1 "8 53.3": 1 "liver-specific expression": 1 "5?-gtaggcgttggaaaatctgc-3?": 1 "0.056": 1 "stadium iii": 1 "0.053": 1 "0.054": 1 "gene symbols": 1 "magnitude of expression change": 1 "5?-cgcggatcctcagcttaaaaaagggtgcaatc-3?": 1 "h2ax": 1 "0.051": 1 "jak/stat": 1 "total n = 85": 1 "total n = 86": 1 "loss of membraneepex ": 1 "high expression n ": 1 "percent of pool": 1 "braf mutation n": 1 "0.089": 1 "-/+": 1 "0.086": 1 "biological coefficients": 1 "ka/ks": 1 "t-stage ajcc": 1 "orb": 1 "ora": 1 "tere1": 1 ">15": 1 "both n = 11": 1 "gene isoforms": 1 "0.078": 1 "allelic combinations": 1 "clinical stage": 1 "n = 13 †": 1 "0.079": 1 "cc pro224pro": 1 "-02": 1 "control of the developmental stages l1-l3": 1 "il-10": 1 "-002": 1 "-04": 1 "-004": 1 "smokers with copd cs n?=?18": 1 "-06": 1 "0.073": 1 "0.074": 1 "volume instilled": 1 "mutantsa n = 11 12.79": 1 "-008": 1 "1 sle n+": 1 "hela": 1 "rpkm level": 1 "gca": 1 "clinical pathologic": 1 "scc vs ak": 1 "2hglu": 1 "-13": 1 "lda accuracy std": 1 "-015": 1 "-014": 1 "normal skin n  = 10": 1 "advanced-stage disease n = 68": 1 "28 ± 17": 1 "-011": 1 "positivity": 1 "p -value fisher's exact test": 1 "patients n = 203 n ": 1 "keloid n  = 10": 1 "median 75 16–92": 1 "h3 k9 dna methylation": 1 "sd n ": 1 "healthy individuals n=112": 1 "-20": 1 "ots": 1 "-24": 1 " ?2=0.006 df=1 p=0.93**": 1 "zn": 1 "leaky b": 1 "breakage": 1 "crc patients n=220": 1 "os months": 1 "grade at diagnosis": 1 "overall series n = 305": 1 "ak vs ns": 1 "?i ": 1 "-036": 1 "m-distant metastasis": 1 "lod score at ?": 1 "msi-l/mss tumors n = 1098": 1 "abc-type multidrug transport system": 1 "?3 copies": 1 "mir-2 mir-6 mir-11 mir-13 mir-308": 1 "mean ± s.d n = 5 fmol/mg dna": 1 "pmef": 1 "-41": 1 "brain": 1 "statin users": 1 "asthmatics": 1 "-48": 1 "sen ": 1 "bw g": 1 "5?-arrctrcayttrttnccnac-3?": 1 "iii 16": 1 ">60": 1 "ic50 µm": 1 "msi-h and kras mutation": 1 " 18 patients": 1 "healthy subjects": 1 "-57": 1 "wt *": 1 "25 29": 1 "nr of reference reads nr of variant reads ref var ": 1 "ipi acc no.": 1 "aeca-mediated cell survival ?80 *": 1 "trastuzumab + chemotherapy n = 235": 1 "scribbled": 1 "12200 ± 1600": 1 "rd n = 19": 1 "adduct levels fmol/mg dna mean ± s.d.": 1 "mean expression non-responders": 1 "cholesterol ?g/mg protein": 1 "low k +": 1 "cytoplasm": 1 "-078": 1 "?l consumed/fly/hr mean ± sd": 1 "right colon": 1 "-075": 1 "egf/ras": 1 "-077": 1 "inv 16 n = 14": 1 "2 vs 3p value": 1 "cd 12": 1 "c2/c3 n = 16": 1 "-093": 1 "reporter assay": 1 "-092": 1 "-85": 1 "enrichment in her2+": 1 "factors": 1 "egfr group": 1 "34 75.5": 1 "geminin": 1 "-087": 1 "msi-h and braf v600e mutation": 1 "i-f": 1 "mrna profile": 1 "mmugdna.40348.1.s1_at": 1 "18 21": 1 "differential regulation": 1 "wildtype": 1 "m ? {lacz} 1 / m ? eyg qpcr 2": 1 "ex 8": 1 "immunotype": 1 "ex 7": 1 "ex 6": 1 "mascotscore": 1 "ex 5": 1 "v3/v2 *": 1 "analysis": 1 "- dna": 1 "c max nm": 1 "metalloproteinase nephrosin astacin 4": 1 " phenotype of eggshell": 1 "heg n=21 ": 1 "5?-ttkatctgyckgaccargtcrtaraa-3?": 1 "tt leu224leu": 1 "0.201": 1 "or molecular feature": 1 "phenylephrine": 1 "differentially expressed mirnas": 1 "cytokines concentration +/- sd": 1 "controls n?=?194": 1 "geographical area": 1 "es_line": 1 "hp+ ": 1 "immature n  = 10": 1 "lod ? g/l": 1 "emission spectra": 1 "120 h": 1 "sagittal/frontal plane": 1 "intra-group inhibitory rate": 1 "pval": 1 "egfr fish": 1 "controls a": 1 "diffreq": 1 "maf controls": 1 "controls n?=?471": 1 "ucn2": 1 "ucn3": 1 "cxrt n = 80 grade": 1 "induction of apoptosis": 1 "axial plane": 1 "total reference counts n": 1 "hmsh2": 1 "k-562": 1 "pin1 expression n ": 1 " of control": 1 "607": 1 "japan n = 508": 1 "gg+ga": 1 "pd2": 1 "media vegf protein": 1 "unclassified": 1 "control n = 9": 1 "statistics c log-rank": 1 "fcc04834": 1 "diagnosis*": 1 "log-rank p": 1 "2-sided p value": 1 "pdi": 1 "cy5 controls": 1 "in vitro": 1 "wildtype diabetes": 1 "pt #3 ewing’s sarcoma": 1 "628": 1 "b-tpm": 1 "amplified n ": 1 "overall n = 3202": 1 "mutants": 1 "p493-6 c-myc": 1 "downregulation in cll": 1 "mirna-145": 1 "mirna-143": 1 "0.262": 1 "percentage of chd5 immunopositive neuroblastic cells": 1 "q2 °c a": 1 "validation set n a = 138": 1 "a p value": 1 "636": 1 "sham n = 6": 1 "probucol +snpp-ix n = 6": 1 "stage i": 1 "aln + ggoh": 1 "expr values": 1 "patients n ?=?1056": 1 "ns n?=?10": 1 "homo sapiens": 1 "fcc01821-2": 1 "fcc01821-1": 1 "u n = 14c": 1 "volume ml": 1 "2 6.2": 1 " n = 1190": 1 "tumor refractory to": 1 "d17s250": 1 "no distant metastasis": 1 "a sterol composition": 1 "er pr her2 and grade": 1 " n =4": 1 " n =3": 1 "table 2a ": 1 "???-naphthyl-ncs ?-naphthyl-ncs": 1 "bcr-abl1 mrna expression level": 1 "max deg": 1 "apc codon 1492 status": 1 "10 ?m pheromone": 1 "668": 1 "percentage in females": 1 "0.220": 1 "alkaloid": 1 "vol.": 1 "i2 estimate p value": 1 "chemotherapy line": 1 "log2 values": 1 "disease control": 1 "motif": 1 "c-terminal p-smad2/3": 1 "healthy individuals n = 102": 1 "expression rate": 1 "0.218": 1 "fcc02275": 1 "non-smokers with copd cn n?=?10": 1 "0.211": 1 "positive b": 1 "characteristic n=15": 1 "cos-5.44 91.1??g/ml log2ratio": 1 "cell line hroc.": 1 "5000": 1 "seminal vesicle invasion": 1 "0.240": 1 "egfr biallelic n =12 40": 1 "1 n = 1035": 1 "5?-gtaggcgtgggaaagtccgc-3?": 1 "body weight g at vo mean +/? sd": 1 "18 40": 1 "ffl-ffl": 1 "wild-type n ?=?88 57": 1 "model 1": 1 "multi-dendrix": 1 "??benzo apyrene": 1 "avg stain intensity": 1 "tissue sample": 1 "0.231": 1 "pedf status": 1 "0.235": 1 "total n?=?145": 1 "251 ± 26": 1 "first author": 1 "no patients ": 1 "hp - cont n=24": 1 "cx - cpods": 1 "s991a": 1 "genotypings*": 1 "upregulation": 1 "events": 1 "low n =56": 1 "tumorigenesis method": 1 "nalm-1": 1 "peptides = 1": 1 "mw kda": 1 "a/c": 1 "pik3ca mutation status": 1 "low n =48": 1 "mutant n ": 1 "a/n": 1 "median survival months": 1 "met level": 1 "ahr score": 1 "nondimen values in simulations": 1 "phb copies n ": 1 " n = 170 46.7": 1 "hp + cont n=24": 1 "mpfs months": 1 "wild-type n ?=?40 this study": 1 "or 95 ci b": 1 "5?-ggaattccatatgtctcgagcaggcgacag-3?": 1 "5?-ctatgcctccgtcttcgaggttcaagaa-3?": 1 "50 +/- 4": 1 "age yr": 1 "gi50 values for 2.5 × 103 skbr-3 ?mol/l": 1 "4?gy": 1 "auco-inf nm·h": 1 "aa n = 74": 1 " n?=?30": 1 "pyrogen limit value eu/ml": 1 "nuc st vs nuc pm": 1 "relative intensity gtp?s / gdp": 1 "abc transporter abcc1": 1 "0.182": 1 "xmrk / kras": 1 "catalase": 1 "number of total a": 1 "5?-tatgttcaaggaggcgactggggtgctt-3?": 1 "grade 3–4 ae": 1 "functional group fg": 1 " irregular sperm n 2": 1 "sporadic crc a n =417 ": 1 "phosphosite s": 1 "0.178": 1 "6 26.1": 1 "5?-tccgtgtggcgtgtcgagttctattcta-3?": 1 "nec 20 n with samples": 1 "mutations/genes": 1 "-108": 1 "author year": 1 "mir-324-5p": 1 "positive n = 112": 1 "mirnas n": 1 "metaphases counted": 1 "ci n ": 1 "canonical pathway": 1 "-113": 1 "he4": 1 "low n = 65 ": 1 "insulin resistance": 1 "-118": 1 "genotype ¶": 1 "sw1783": 1 "5?-caccctcatgctggttgtgacagtgtta-3?": 1 "-125": 1 "22 26": 1 "p-smad": 1 "-121": 1 "regional local lymph node metastases egfr-scores n=28": 1 "sle n? n ": 1 "?2 p value": 1 "high 3+": 1 "5?-cgratytcrcgcacyarcgtgtagaasgc-3?": 1 "gfp-lactc2 spt n n tracks": 1 "high n =47": 1 "50 +/- 6 40 +/-2.5 0 0 0": 1 "-135": 1 "het": 1 "at2r alleles": 1 "statistical parameter": 1 "high n =55": 1 "r1-fg- ch23- ch2n- ch24-ch ohr2": 1 "5?-gacctagggcacactgttggctccatca-3?": 1 "-144": 1 "dataset no of samples": 1 "ras2ndeif": 1 "egcg vs cn fold-change": 1 "+/+ -/-": 1 "model 1+ response after 6 months": 1 "p/m1 vs c2/c3": 1 "k obs ratiob": 1 "t2 t3 t4": 1 "5?-catgccactgtcatcgaagccagttagt-3?": 1 "-152": 1 "-153": 1 "wisdom of the crowds wotc": 1 "bm_cds": 1 "-159": 1 "5?-ctgtacccgctatccgagcactggtcta-3?": 1 "spasm frequency n": 1 "met phosphorylation": 1 "who grade": 1 "m4 n = 24": 1 "reverse": 1 "-166": 1 "fbl-ffl": 1 "-164": 1 "dbc1+ n ": 1 "papillary carcinoma 81.2 n = 82": 1 "hid": 1 "no n ?=?188": 1 "putative deoxynucleoside kinase": 1 "controls n = 561 n ": 1 "agnors mean counts": 1 "-177": 1 "-176": 1 "amino acid alteration": 1 "maf cases": 1 "-leu/ -trp": 1 "sorafenib concentration per unit area mg/cm2": 1 "animal b": 1 "gcn n ?=?20": 1 "rbsp3 /nprl2/g21": 1 "amp size": 1 "cellular ps935 @ 5 ?m": 1 "-185": 1 "t ng/dl n.s.": 1 "n=217": 1 "wild-type n ": 1 "-198": 1 "hp - gc n=24": 1 "xmrk": 1 "methylated n ": 1 "hnt-34": 1 "sample population": 1 "haplotype": 1 "??4- methylnitrosamino-1- 3-pyridyl-1-butanone nnk": 1 "fbl-fbl": 1 "gate type": 1 "mmr deficiency": 1 "o 2-pobdt": 1 "cln lo n = 8": 1 "k d by b µm": 1 "methanol mmol/g cdw h": 1 "11 24.5": 1 "mel-l ?-gal in sd plates": 1 "fcc00344": 1 "fcc00343": 1 "no lymph node involvement": 1 "pcr to ct": 1 "0.302": 1 "age at dx yrs": 1 "840 ± 169": 1 "clinico-pathological variables": 1 "bladder cancer": 1 "msi-h n ": 1 "ttp mos.": 1 "brca1 groups": 1 "3550 ± 1600": 1 " ?2=5.81 df=1 p=0.016*": 1 "ypd": 1 "resistant2 n = 31 ": 1 "fsh ng/ml n.s *": 1 "restriction of pfv-1 accumulation": 1 "corrected p-value": 1 "0.329": 1 "n network observed §": 1 "putative function": 1 "egfr monoallelic n =18 60": 1 "gem/cis s.d n =24": 1 "gem/cis s.d n =23": 1 "tumor vs mucosa p value": 1 "cancer var permutation pool n = 92": 1 "15253/0.2392": 1 "chip": 1 "estimates by ekf": 1 "gene ontology term bp_fat or kegg pathway": 1 "p?<?0.001 §": 1 "asthma act ?20 n ": 1 "hrt brain region": 1 "advantages": 1 "series": 1 "mon x106/l": 1 "molecular formula": 1 "cyto pm vs nuc pm": 1 "crf2?": 1 "2 copies": 1 "100 ic20": 1 "genes examined": 1 "bat25": 1 "count n": 1 "bat26": 1 "whole group n =52": 1 "-ade/-his/ -leu/-trp": 1 "lkb1 scores": 1 "hp infected without atrophy n = 442": 1 "trait": 1 "mt k-ras n=39": 1 "kcl-22": 1 "stage ib": 1 "upstream": 1 "mehg": 1 "ki67-geminin": 1 "24.96 hr cv": 1 "strain number": 1 "cn detection p-value": 1 "ki67": 1 "n vs crc and v-set i": 1 "phenanthrene³": 1 "max ic50 × 10-8m": 1 "10 gene network": 1 "max ec50 × 10-6m": 1 "hsp": 1 "her3 n = 47": 1 "ikaros ik6": 1 "32–85": 1 "corrected p $": 1 "gir mg·kg?1·min?1": 1 "h pylori +": 1 "branching points": 1 "ic50 nilotinib nm": 1 "max ec50 × 10-7m": 1 "chemotherapy alone n = 234": 1 "stage—number ": 1 "18200": 1 "0.24 hr": 1 "type of response": 1 "demographic data": 1 "?2": 1 "parametric p-value": 1 "pio-treated group": 1 "incidence matrix": 1 "no/low expression": 1 "overall n ?=?305": 1 "ccn wild-type n = 342": 1 "day 1": 1 "acr mg/mmol": 1 "n ind.": 1 "5?-atgctgacgaggcctagagtaggctata-3?": 1 "accession no.": 1 "egcg detection p-value": 1 "48 52.2": 1 "tumour no ": 1 "pack-years": 1 "irs-1 g972r n ": 1 "endo-1314-beta-d-glucanase precursor": 1 "mir-143 mir-145": 1 "cases n = 1068": 1 "okt3": 1 "htert": 1 "prevalence of goiter ": 1 "growth inhibition mean ± sd": 1 "n =438": 1 "140 ± 25": 1 "all samples": 1 "stage i-iv p value": 1 "losartan n = 6": 1 "succinate n?=?3": 1 "rbsp3/nprl2/g21 /rassf1a": 1 "fpkm_msg": 1 "3 controls n": 1 "7 days": 1 "fcc00390": 1 "agents": 1 "fisher's exact": 1 "ex 15": 1 "day 22": 1 "negative n = 60": 1 "t1 t2": 1 "ras3rr1": 1 "? s ° cal·deg?1 mol?1": 1 "untreated n": 1 "bad tot": 1 "p/m1 vs c1": 1 "vrk2 cytoplasmic staining": 1 "3?-race": 1 "p-erkl/2 ihc": 1 "adult life span days mean ± se": 1 "expression of prl-3": 1 "koff s?1": 1 "ptc n =20": 1 "codeb": 1 "wild-type n=102 82.9": 1 "s/n/a/c": 1 "18.2 *": 1 "scansite": 1 "hoxb8": 1 "kegg pathway": 1 "s/n": 1 "-2071": 1 "15~60": 1 "bcr-abl1 breakpoint": 1 "grindr": 1 "nonresponders": 1 "clinicopathological factors": 1 "sd+pd": 1 "m n = 3a": 1 "leptin plus losartan n = 6": 1 "ptc n =42": 1 "5 11": 1 "after igf1r": 1 "median ttp mo": 1 "n -nitrosamine †": 1 "mncp": 1 "motif_name": 1 "total patients n = 392": 1 "larynx n = 15": 1 "sp cd4+": 1 "1-year": 1 "egcg diffscore": 1 "mild chronic": 1 "mirna-22": 1 "peptide =1": 1 "mutational status": 1 "distant metastases and none-lymph node metastases egfr-scores n=44": 1 "cyp2p3 fish": 1 "det ?hgf": 1 "methylatedb n = 47 54.65": 1 "gi50 values for 2.5 × 103 mda-mb-231 ?mol/l": 1 "whey acidic protein": 1 "h pylori + ": 1 "stage†": 1 "downregulation in numerous cancer cultured cells": 1 "dose level mg": 1 "peptide >1": 1 "il-2": 1 "il-4": 1 "5?-gtaggagttggaaaaagtgc-3?": 1 "tm/lm": 1 "insulin": 1 "iaa": 1 "8 9": 1 "positive n": 1 "excess": 1 "increase in survival 2 ": 1 "p?<?0.01 §": 1 "up-regulated n = 10": 1 "zap-70 neg *": 1 "cyt cytosol pn perinucleus nuc nucleus mt mitochondrion": 1 "n =19": 1 "low id1 n": 1 "adenosquamous": 1 "-206": 1 "cumulative spectral counts": 1 "bladder cancer tissue specimen n = 48": 1 "poor responders": 1 "set-2 n=48": 1 "hp + gc n=8": 1 "sp cd8+": 1 "pathway name": 1 "mcm2-ki67": 1 "v-set ii": 1 "cell line total n =30": 1 "ak n?=?13": 1 "-219": 1 "-215": 1 "catalase activity u/mg prot": 1 "-217": 1 "7800 ± 1680": 1 "s6c": 1 "n =38": 1 "gbvi/wsa dg score": 1 "pyrodetect recovery test ": 1 "mutation n=21 17.1": 1 "0.293": 1 "0.294": 1 "radiotherapy": 1 "mi+laser n?=?30": 1 "mrna cleavage": 1 "7 14.9": 1 "outdoor n ": 1 "tumor weight/mg": 1 " multivulva ± s.d n a": 1 "gonadal development": 1 "follicular carcinoma 18.8 n = 19": 1 "estimates by cho et al 2003": 1 "-235": 1 "race n": 1 "n =47": 1 "pre b-all": 1 "adjusted or b 95 ci": 1 "definition": 1 "gc n ?=?20 b / c": 1 "high id1 n": 1 "mean expression responders": 1 "???no of patients in training group ": 1 "asym": 1 "-244": 1 "mean wt": 1 "15mer sfc / m": 1 "deficiency": 1 "?? n -butyl- n - 4-hydroxybutylnitrosamine": 1 "percent p 1–4.p differentiation": 1 "high n = 81 71.1": 1 "-247": 1 "-249": 1 "5?-cgcggatcccagcactcttacagaataatac-3?": 1 "harlan-teklad 8604": 1 "disadvantages": 1 "-252": 1 "proximal colonic n = 24 †": 1 "patient # and diagnosis *": 1 "controls n = 10": 1 "ccctc-binding factor-like protein": 1 "oropharynx n = 8": 1 "cn/pi?/tunel+": 1 "-271": 1 "lnl null model": 1 "dfs hr": 1 "n?=?123": 1 "*compared to nephropathy patients ** compared to healthy individuals": 1 "evaluable patients": 1 "lkw g": 1 "church": 1 "substrates/products": 1 "spe ": 1 "-278": 1 "std dev.*": 1 "n =85": 1 "n =82": 1 "5?-gccgcccaccacaactaact-3?": 1 "ptk6 expression": 1 "downstream": 1 "15 17": 1 "histological grade": 1 "no n = 56": 1 "hela 293t": 1 "mir-29a mir-29b": 1 "p-ampk expression": 1 "mean size mm": 1 "clinico-pathological parameter": 1 "sequence coverage": 1 "40 +/- 5": 1 "mean rq": 1 "kras / myc": 1 "1652": 1 "compounds *": 1 " 12 a": 1 "47.1": 1 "tumor >2?cm to 5?cm": 1 "5?-garaartaygayccvacsatmgarga-3?": 1 "ma geni": 1 "human trials": 1 "fitness score avg 2": 1 "treatment 20 °c": 1 "d2s123": 1 "total score": 1 "braf n = 64": 1 " 3 4 75 151 ": 1 "intervention": 1 "imb": 1 "death": 1 "fold change": 1 "loss of membrane epex n": 1 "0/1+ vs 2+/3+": 1 "cycle study brain region": 1 "value": 1 "at mutation": 1 "cy3 le2ko": 1 "dtc follow-up months": 1 "overall or 95 ci a": 1 "ns february n?=?4": 1 " cut-off value 1393.55?pg?ml ?1 ": 1 "peptides > 1": 1 "ras3rf1": 1 "stages": 1 "hax1 i expression": 1 "hr beat/min": 1 "aneuploid 2 n > 40": 1 "gpr91 ?/? n?=?4": 1 "t98g": 1 "tipifarnib+gem/cis s.d n =23": 1 "setting": 1 "paclitaxel alone n = 96": 1 " n = 1337": 1 "inpp4b expression": 1 "poor": 1 "bv-173": 1 "not amplified n ": 1 "phosphorylation": 1 "-his/ -leu/-trp": 1 "5?-cagcatacttccggtcgacggctaatct-3?": 1 "ras": 1 "pool": 1 "0.410": 1 "disease-specific survival": 1 "800": 1 "sfrp c methylated": 1 "allele frequencies": 1 "0 0": 1 "tert promoter mutated n = 179 59": 1 "non-muscle invasive": 1 " n = 113": 1 "ungraded": 1 "iqr": 1 "mir-48 mir-84 mir-241": 1 "controls ": 1 "msm online": 1 "aa no.": 1 "ao/eb staining": 1 "825": 1 "t2dm without nephropathy n=21": 1 "treatment vs control group": 1 "censored n": 1 "bax tot": 1 "qpcr validation experiment": 1 "hcc tumours n = 46": 1 "p-erk2 wb": 1 "plce1 haplotypes a": 1 "endotoxin limit value eu/ml": 1 "egfr met n =30 58": 1 "43.5 *": 1 "fusion": 1 "p-akt expression n ": 1 "842": 1 "p=0.4190": 1 "?n0": 1 "?n1": 1 "at2r genotypes": 1 "egfr": 1 "p-stat3 positive ": 1 "mir-124 expression high n low n": 1 "nras": 1 "30°c": 1 "retention time min": 1 " elm animals b": 1 "gilz / ki-67": 1 "spns": 1 "functional groups": 1 "la n = 90": 1 "?m0": 1 "5?-gtrgtyatwgatggsgaracgtgyygt-3?": 1 "?m1": 1 "model 1+ hif-1? score": 1 "p valueb": 1 "p valuec": 1 "??45800": 1 "clone": 1 "us n = 563": 1 "length/th+ neuron c": 1 "fcc03748": 1 "?t0": 1 "n = 153": 1 "t120": 1 " variability": 1 "function annotation": 1 "progastrin staining in hp epithelial cells": 1 "rin": 1 "algorithm": 1 "p16 ink4 t": 1 "fcc02471": 1 "p16 ink4 n": 1 "cyt°cyld+": 1 "2 awcon": 1 "other": 1 "xmrk / myc": 1 "sig drug c effect": 1 "k d mean n = 3": 1 "our mmol/g cdw h": 1 "i 2 ": 1 "?nx": 1 "c-f": 1 "precision": 1 "cml-t1": 1 "2nd op.": 1 "follicular": 1 "vs controls": 1 " ?2=0.79 df=1 p=0.37**": 1 "bcl-x l tot": 1 "t15": 1 "buffer": 1 "total n=60": 1 "transcript abundance relative units mean ± sd": 1 "all": 1 "aln": 1 "ma si prr": 1 "pain threshold kg": 1 "unit": 1 "genotype age/mo": 1 "?tx": 1 "fcc01177": 1 "c allele frequency ": 1 "n?=?40": 1 "c/n": 1 "strong positive rate ": 1 "sensitive1 n = 29 ": 1 "neoplastic": 1 "att ?hgf": 1 "apoptotic indices mean ± sem": 1 "mature n  = 10": 1 "t30": 1 "mir-378": 1 "48 h": 1 "0-5": 1 "row": 1 "categorization": 1 "pr n": 1 "females n ": 1 "ic50 in vitro lrrktide nm": 1 "ras3ir": 1 "ag+gg n = 49": 1 "fold change tamr/ctrl": 1 "bantam": 1 "t45": 1 "avg stain": 1 "0.5": 1 "ras3if": 1 "ki67 labelling index": 1 "patients n = 107": 1 "0.9": 1 "n.d.b": 1 "no evidence of primary tumor": 1 "p16 m a": 1 "braf wt n = 145 ": 1 "tumor histology n ": 1 "number of risk genotypes carried": 1 "nilotinib 300 mg bid of patients n = 282": 1 "histology": 1 "apc": 1 "3 n = 33": 1 "no additions b": 1 "shmoo": 1 "liver metastasis": 1 "n?=?38": 1 "mutation counts": 1 "total samples": 1 "mgus 71": 1 "tet21 n mycn": 1 "cancer ref permutation pool n = 92": 1 "n?=?33": 1 "t60": 1 "iv 6": 1 "frr a": 1 "crc n = 30 ": 1 "grade": 1 "008": 1 "n network expected #": 1 "rs3741378": 1 "gene expression": 1 "phb expression mean ± sd": 1 "stage iii": 1 "ebvngc n = 38": 1 "ras1ndeif": 1 "egfr unmet n =22 42": 1 "+ dnac": 1 "all patients": 1 "egfr mrna amplification fold mean ± sd": 1 "-318": 1 "-317": 1 "?? n -nitrosobenzylmethylamine nbma": 1 "percentage in males": 1 "biomass mcmol/g cdw h": 1 "fcc04239": 1 "pathologic stage n ": 1 "n?=?17": 1 "obese + probucol n = 9": 1 "stable n =27": 1 "n?=?13": 1 "ag+gg n = 80": 1 "male/female": 1 "n?=?18": 1 "down-regulated n = 2": 1 "clinicopathological features": 1 "n ?=?93 ": 1 "ratio cy3/cy5": 1 "glycine receptor alpha 1": 1 "probucol ?snpp-ix n = 6": 1 "fcc06002": 1 "t90": 1 "control of viral particle production": 1 "-332": 1 "lvsp mmhg": 1 "??phch phch2-ncs phch2ch ph-ncs": 1 "control of the cell cycle arrest in g2": 1 "cytoplasmic": 1 "os hr": 1 "grade 1": 1 "grade 2": 1 " no oocytes n 1": 1 "grade 3": 1 "grade 4": 1 "-338": 1 "mixed lineage kinase 3 mlk3": 1 "statistic": 1 " n?=?238": 1 "041": 1 "scored fis???0.8 neutral impactb n ": 1 "045": 1 "e/ea ?15": 1 "last follow-up months": 1 "orf2 in the 3?ntr of all remaining pfv-1 mrnas": 1 "483 ± 36": 1 "d+l pooled or ‡": 1 "m/u n = 24b": 1 "sam68 levels": 1 "iccc": 1 "053": 1 "-353": 1 "057": 1 "059": 1 "mirnas down-regulated in anaplastic": 1 "1 vs 3p value": 1 "ras3qr": 1 "averaged icat ratio* h/l": 1 "substance": 1 "061": 1 "063": 1 "egfr cutoff": 1 "ms-status assessment": 1 "ras3qf": 1 "067": 1 "-362": 1 "p-erkl wb": 1 "diploid 2 n = 40": 1 "bonferroni corrected p-value": 1 "s-mkrn1-abs": 1 "h4k16ac+ n ": 1 "tissue": 1 "072": 1 "os mo": 1 "health services/testing": 1 "cn.avg signal": 1 "-374": 1 "t max h": 1 "ps detection method": 1 "leg n=57 ": 1 "monocytes": 1 "median os": 1 "c1 n = 32": 1 "# aas": 1 "085": 1 "tf name": 1 "overlap‡": 1 "087": 1 "biological replicate 2": 1 "-388": 1 "scored fis?>?3.5 high impact n ": 1 "std wt": 1 "regimen s": 1 "early-stage disease n = 28": 1 "aa n = 123": 1 "non-statin users": 1 "51700": 1 "cl ml?min ?1 per kg": 1 "p14 arf n": 1 "o 2-pobc": 1 "ssc n?=?15": 1 "p14 arf t": 1 "n articles found": 1 " n = 2617": 1 "ki-67": 1 "a fd ": 1 "subtypes included": 1 "probe id": 1 "l/r": 1 "interaction³": 1 "fcc06085": 1 "extended n?=?218": 1 "fdns n =46": 1 "pns n =57": 1 "non-smokers nc n?=?25": 1 "percentage": 1 "m0 n = 4": 1 "cdk4 + n ": 1 "collembase id¹": 1 "1788": 1 "biological process": 1 "36 42": 1 "progressive n =46": 1 "type i pip kinase": 1 "mss/msi-l and kras mutation": 1 "sensitive n = 31": 1 "asian population": 1 "sgd_description": 1 "ratio h/l normalized": 1 "sm?rac1?ko": 1 "mean age in years": 1 "di-nucleotides": 1 "biopsy timeline": 1 "kras": 1 "adca": 1 "sd ": 1 "cyclin d1 + n ": 1 "sbj": 1 " n = 1322": 1 "fcc00583": 1 "0.546": 1 "ratio h/l count": 1 "mss/msi-l wild-type kras and wild-type braf": 1 "treatments": 1 "6 100": 1 "matched bladder cancer and normal adjacent tissues n = 16": 1 "scc": 1 "gt counts cases": 1 "aif expression level": 1 "topfluor-ps fcs fast d slow d percent slow na": 1 "all n": 1 " n = 96": 1 "933 ± 89": 1 "low † n = 31": 1 "kyo-1": 1 "cx3cl1 / ki-67": 1 "acromegaly": 1 "ras1rr1": 1 " n = 194 53.3": 1 "strong": 1 "subtype n ": 1 "elevated mir": 1 "mean rsk2 mutants": 1 "cg transversion": 1 "drosophila melanogaster": 1 "jurl-mk2": 1 "treatment1": 1 "jurl-mk1": 1 "crude or": 1 "bimmunomodulatory index in vitro": 1 "50-75": 1 "control of the l2 to l3 transition": 1 " n = 60": 1 "angii n = 12": 1 "tf gene": 1 "ras2bamhir": 1 "934": 1 "wildtype control": 1 "downregulation": 1 "controls n = 2134": 1 "25-75": 1 "5?-gtgccctgacaatagatccgttcgatca-3?": 1 "sfrp methylated c": 1 "t1 n?=?36": 1 " 161 162 ": 1 "dmso": 1 "compound class": 1 "mus musculus": 1 "values in the model": 1 "p16 + n ": 1 "mda-mb-435": 1 "transcripts": 1 "median intensity unnormalized ± sd": 1 "gastric cancer n = 583": 1 "gene methylated": 1 "0.24 hr cv": 1 "western": 1 "timepoint b": 1 "25-50": 1 "-2lnl pvalue": 1 "authors and reference": 1 "# tumor cells std": 1 "fcc00343-2": 1 "fcc00343-1": 1 "lean n = 9": 1 "ta n?=?54": 1 "5?-ctgcggtcagaccagggctaggtatgca-3?": 1 "cancer ref n = 358": 1 "tom-1": 1 "5?-gaggtttccgtcaccggccttcttgtta-3?": 1 "average runtime seconds": 1 "breed": 1 "pfs kras wt months": 1 "smoking/non-smoking nsclc patients n": 1 "t-test p- values": 1 "omega class glutathione s-transferase": 1 "meg-01": 1 "nnk dose mmol/kga": 1 "global analysis n": 1 "ct pro224leu": 1 "deletion pool source 3": 1 "surface": 1 "control n?=?3": 1 "lung": 1 "aberrant methylation + n = 26 figure 7b ": 1 "msi cancers": 1 "angii + cur n = 12": 1 "tnm classification for small intestinal gist including esophagus colon rectum mesentery and other less common sites": 1 "upstream sensor mre11a": 1 "cr+pr": 1 "pten high n = 39": 1 "fcc01017": 1 "target/effect": 1 "n ?=?106 ": 1 "pten expression negative colorectal adenocarcinomas": 1 "methylation/deletion frequency ": 1 "line-1 methylation tertiles": 1 "cimp-": 1 "overexpression in bl patient": 1 "cimp+": 1 "v600e": 1 "n =213": 1 "scored 0.8?<?fis???1.9 low impact n ": 1 "lnl alter model": 1 "anova": 1 "mdr mo": 1 "treatment combination": 1 " 135 ": 1 "lmbr1 domain containing 2": 1 "p53 immunopositivity": 1 "stadium i": 1 "patients n = 203": 1 "g3 n?=?77": 1 "low p110 ? expression": 1 "mild chronic asthma n ": 1 "1.1": 1 "2 n = 254": 1 "1.6": 1 "lipid peroxidation pmol/mg prot": 1 "95.0 ci": 1 "1.7": 1 "observedmass": 1 "g/100 g": 1 "fbl-bi-fan": 1 "moo 4": 1 "braf kras wt n": 1 "uniprotkb": 1 "statisticsc log-rank": 1 "mir-142 mir-181 mir-223": 1 "negative n =52": 1 "pts n ": 1 "lh ng/ml n.s.": 1 "wnt methylated b": 1 "-408": 1 "clinicopathological characteristics": 1 "p16 ink4 t/n": 1 "17 85": 1 "os mos.": 1 "alcohol dehydrogenase acceptor": 1 "2930 ± 521": 1 "110": 1 "sss": 1 "brc": 1 "117": 1 "? h ° kcal mol?1": 1 "alcohol": 1 "icam-1": 1 "benign n?=?14": 1 "n mna mutated": 1 "t2dm with nephropathy n=49": 1 "schizosaccharomyces pombe": 1 "123": 1 "-421": 1 "125": 1 "5?-tgtccaagatgtccaatttggcg-3?": 1 "71.4": 1 "0/1+/2+ vs 3+": 1 "ce?7": 1 "-426": 1 "gleason score": 1 "dosage": 1 " 13": 1 "extra capsular extensions": 1 "location/relevance": 1 "low expression n ": 1 "mr/d": 1 "max intensity": 1 "5?-tacaarytngtngtngtngg-3?": 1 "cases n?=?193": 1 "high expression": 1 "? 65": 1 "p27kip1 n = 48": 1 " 23": 1 "rnai a": 1 "??712-dimethylbenz aanthracene dmba": 1 "??ch3 ch n -ncs where n =5 11": 1 "g?11 knockout control": 1 "cd13": 1 "143": 1 "147": 1 "p vs control log-rank": 1 "total n=78": 1 "c1?=?69 c3?=?14 c4?=?50 c5?=?0.78": 1 "fpkm_psg": 1 "ma plzf h k": 1 "acinar only n ": 1 "cytoplasmic timp-1 score": 1 "e2 pg/ml": 1 "p-value †": 1 "ratio h/l": 1 "150": 1 "responders": 1 "positive n =27": 1 " n?=?125": 1 "154": 1 "m/f with dtc": 1 "kinases": 1 "protein c.i.": 1 "shcgs?=?20000 rasgdp?=?20000 rasgtp?=?0 raf?=?10000": 1 "set-1 n=34": 1 "t-primary tumor": 1 "fcc01910": 1 "idax": 1 "mild n=24": 1 "lum a n = 235": 1 "ras1rf1": 1 "161": 1 "162": 1 " n?=?113": 1 "164": 1 "calibrator": 1 "expression of cav-1 n a": 1 "pyrogen value eu/ml": 1 "p-value 1": 1 "control n?=?14": 1 "qrt-pcr #": 1 "60 mm kcl": 1 "sym": 1 "immunoglobulin-like sid-1-like protein 2": 1 "mir-32": 1 "cyt°cyld?": 1 "fi bmi- adjusted": 1 "-475": 1 "-474": 1 "treatment agents": 1 "kit": 1 "-478": 1 "controls n?=?468 n ": 1 "no cells": 1 "crossveinless-2 bmper protein": 1 "me3pb": 1 "heat shock": 1 "ischemic stroke patients n = 110": 1 "mir-21": 1 "184": 1 "187": 1 "-488": 1 "microarray": 1 "vaccine": 1 "mirna microarray": 1 "hmlh1": 1 "all n?=?101": 1 "mutation negative n ": 1 "adpph radical scavenging ic50 mg/ml": 1 "mutation s": 1 "protein levels": 1 "adjusted or 95 ci a": 1 "m-f": 1 "controls n=220": 1 "v 8": 1 "-499": 1 "mean intensities of blood": 1 "me3sn": 1 "process regulated": 1 "kras mutation n": 1 "penetrance": 1 "her2 n = 58": 1 "caenorhabditis elegans": 1 "oral cavity n = 40": 1 "15mer peptide": 1 "c7?=?9?104 c9?=?6?105 c11?=?1.53?103": 1 "intestine": 1 "all metastases egfr-scores n=72": 1 "mirna-143 high n =36": 1 "m/f": 1 "median range": 1 "63800": 1 "treatments n?=?6/group": 1 "cer mmol/g cdw h": 1 "weak": 1 "protein name": 1 "n censoredd": 1 "stages i + ii": 1 "recall": 1 "thyroid tissue": 1 "t bc": 1 "carcinogens": 1 "os june n?=?2": 1 "adj p-value": 1 "kw/bwt ratio ": 1 "yes n ?=?117": 1 "patients n?=?135": 1 "*plasmids": 1 "negative ": 1 "nhej ku70 xrcc4 artemis dna pkcs lig 4": 1 "her2+/?primary tissue logfc": 1 "study populations": 1 "aberrant methylation ? n = 8 figure 7b ": 1 "staining": 1 "moderate to severe n=11": 1 "experimental groups": 1 "? max gtp?s": 1 "age group years": 1 "3530 ± 725": 1 "anchor cell": 1 "obesity": 1 "brain-specific gene expression": 1 "tissue type": 1 "braf v600e": 1 "prognostic": 1 "lum b n = 133": 1 "products/substrates": 1 "2 4": 1 " multivulva n a": 1 "gra x106/l": 1 "ct values‡": 1 "kras / braf mutation": 1 "high n = 113 ": 1 "mefs’ genotype": 1 "k ×105?m?1": 1 ">3 ? 6 cm": 1 "clinical status a": 1 "29 61.7": 1 "mir-17-92 cluster": 1 "efficacy": 1 "200–75000": 1 "v1 *": 1 "genes n": 1 "g1/g2 n?=?68": 1 "cpg transition": 1 "57 62": 1 
"?": 12 "mirna": 8 "downregulated mirnas": 4 "upregulated mirnas": 4 "up-regulated mirnas": 4 "down-regulated mirnas": 3 "downregulated": 3 "reference": 3 "?": 3 "microrna": 3 "upregulated": 3 "mirnas": 3 "references": 2 "function": 2 "study specifications": 2 "mir-126": 2 "fi": 2 "p-value": 2 "downregulated mirna": 2 "mir-31 ?": 1 "target gene": 1 "tumor type": 1 "?": 1 "comparison gy": 1 "mir-34 5’ 70 ?": 1 "mir-43 5’ ?": 1 "mir-74 5’ ?": 1 "mir-196a-2 78 ": 1 "si162": 1 "hallmarks": 1 "upregulated †": 1 "tumour subtype": 1 "mir-155 ?": 1 "tr-ntrk3": 1 "mir-146a 77 78 ": 1 "id": 1 "45p2": 1 "upregulated mirna": 1 "mir-125/lin4": 1 "qrt-pcr": 1 "let-7": 1 "gene": 1 "mir-2 5’ ?": 1 "s.no": 1 "fl-ntrk3": 1 "result of microrna manipulation": 1 "35 µl": 1 "5 µl": 1 "mir-73 5’ ?": 1 "total differentially expressed mirnas": 1 "downregulated *": 1 "mir-268 5’ ?": 1 "dysregulated mirnas": 1 "seed": 1 "mir-231 5’ ?": 1 "mir-1 5’ 70 ?": 1 "mir-1": 1 "targets": 1 "mir-200a/b/c 77 ": 1 "345p3": 1 "mir-214": 1 "micrornas": 1 "mir": 1 "logfc shfhcvsshrna": 1 "citogenetic localization": 1 "mir-63 5’ ?": 1 "microrna according to mirna viewer and pictar": 1 "mir-57 5’ 70 ?": 1 "mir-56 5’ ?": 1 "mir-228 5’ 70 ?": 1 "mir-50 5’ 70 ?": 1 "mir-183* 77 ": 1 "mir-65 5’ ?": 1 "mir-251 5’ ?": 1 "up/down": 1 "down": 1 "mir-10b 78 ": 1 "up-regulated mirna": 1 "mir-82 5’ ?": 1 "mir-195": 1 "up": 1 "3p": 1 "mir-296-5p 77 ": 1 "count": 1 "mir-125b": 1 "functional annotation of dysregulated mirna": 1 "utn": 1 "mir-51 5’ 70 ?": 1 "down-regulated mirna": 1 "1 µl": 1 "sequence": 1 "mirna function": 1 "mir-124": 1 "mir-81 5’ ?": 1 "lin-4 5’ 70": 1 "si135": 1 "name": 1 "let-7 5’ 70": 1 "35p2": 1 "4p": 1 "functions of mirnas": 1 "microrna delivery": 1 "mir-229 5’ ?": 1 "mir-221 79 ": 1 "references/methods": 1 "mir-34": 1 "fold change": 1 "mir-54 5’ ?": 1 "mir-196b 77 78 ": 1 "mir-217 78 79 ": 1 "ref.": 1 "mir regulator": 1 "mir-148a 80 ": 1 "mir-155 32 76 77 ": 1 "5p": 1 "mir-241 5’ ?": 1 "mir-24": 1 "mir-58 5’ ?": 1 "let-7a 79 ": 1 "mir-222 77 79 ": 1 "mir-182 77 ": 1 "mir-64 5’ ?": 1 "mir-21 76 – 79 ": 1 "rpn": 1 "mirna microarray": 1 "34p2": 1 "mir-45 5’ ?": 1 "mir-273 5’ ?": 1 "pi": 1 "mir-564 ?": 1 
"patients": 20 "trial": 19 "phase": 15 "n": 13 "treatment": 12 "target": 11 "drug": 11 "year": 9 "primary endpoint": 9 "results": 9 "reference": 9 "patients n ": 9 "pfs": 8 "outcome": 8 "regimen": 8 "setting": 7 "clinical trial": 7 "p-value": 6 "patient 2": 6 "patient 1": 6 "agent": 6 "intervention": 6 "patients n": 6 "references": 5 "p": 5 "trial design": 5 "ref.": 5 "median survival months": 5 "patient 3": 5 "5-year survival ": 5 "study": 5 "efficacy": 5 "1": 4 "2": 4 "3": 4 "4": 4 "5": 4 "6": 4 "patients ": 4 "clinical setting": 4 "author": 4 "clinical trials": 4 "disease": 4 "clinical trial phase": 3 "7": 3 "8": 3 "9": 3 "n patients": 3 "endpoints": 3 "controls": 3 "notes": 3 "control arm": 3 "51 patients 59.3": 3 "class": 3 "35 patients 40.7": 3 "status": 3 "esc->eb": 3 "patient population": 3 "design": 3 "comments": 3 "os": 3 "safety outcomes a": 3 "trial type": 3 "efficacy outcome": 3 "characteristics": 3 "eb->esc": 3 "orr ": 3 "follow-up": 3 "combination": 3 "therapy": 3 "": 2 "tumor type": 2 "target s": 2 "treatments": 2 "outcomes": 2 " ": 2 "clinical outcome": 2 "181a cohort": 2 "no pts.": 2 "target kinase": 2 "b": 2 "stage": 2 "pfs months": 2 "clinical trial id*": 2 "ref": 2 "study design": 2 "?negative": 2 "total patients": 2 "95 ci": 2 "response ": 2 "company": 2 "cancer": 2 "primary end-point": 2 "trial phase": 2 "90a cohort": 2 "recurrence": 2 "indication": 2 "non- h arm": 2 "drugs": 2 "pfs rate": 2 "publication": 2 "diagnosis": 2 "non-responder": 2 "?positive": 2 "enrollment": 2 "patient cohort": 2 "10": 2 "disease type": 2 "11": 2 "12": 2 "13": 2 "grade": 2 "dosage": 2 "mechanism": 2 "inclusion criteria": 2 "variables": 2 "91a cohort": 2 "clinicopathological features": 2 "trial group": 2 "feature type": 2 "description": 2 "median pfs months": 2 "number of patients": 2 "type": 2 "responder": 2 "lycopene formulation and source": 2 "patients enrolled": 2 "acronym": 2 "h arm": 2 "clinicaltrials.gov identifier": 2 "patient": 2 "active arm": 2 "73 patients 84.8": 1 "?": 1 "??t3b": 1 "nsaid-treated": 1 "??t3a": 1 "os hr 95?ci p value": 1 "karyotype": 1 "metgastric": 1 "population-based cohort": 1 "radiological": 1 "score criteria": 1 "design/phase": 1 "gleason grade": 1 "??t2a": 1 "agent + chemotherapy and/or radiotherapy nct identifier clinical trial phase": 1 "??t2b": 1 "population": 1 "0": 1 "advanced bc": 1 "treatment/number of patients": 1 "p-smad2": 1 "correlation": 1 "81 patients 94.1": 1 "pt popul": 1 "stool consistency": 1 "rilomet-1": 1 "dose mg/d": 1 "biomarker-selected os": 1 "biochemical relapse": 1 "preselected biomarker": 1 "mean follow-up time": 1 "treatment success": 1 "trials": 1 "series": 1 "pi3k inhibitor": 1 "pathway": 1 "triple-gene intervention": 1 "safety grade 3/4 toxicities": 1 "66 years range 45–79 years": 1 "surgery": 1 "study/author year": 1 "outcome measures": 1 "clinical trial number adult": 1 "idf 2005 9 ": 1 "phase of the study": 1 "neoadjuvant bc": 1 "rassf1a": 1 "clinical benefit": 1 "survival rate": 1 "duke’s staging": 1 "wide resection margins": 1 "os t 414 patients mo": 1 "pn uicc in enrolled patient": 1 "rr during maintenance": 1 "22 patients 25.6": 1 "rectal bleeding": 1 "treatment schema": 1 "chr": 1 "zeal": 1 "case no.": 1 "labs": 1 "month": 1 "57 months range 12.6–100 months": 1 "??7": 1 "follow-up months": 1 "title": 1 "design of the clinical trials": 1 "p value nonstratified": 1 "13 patients 15.1": 1 "13 patients 15.2": 1 "other options": 1 "biomarker-selected pfs": 1 "frequency ": 1 "microrna": 1 "ga": 1 "standardized": 1 "??10?ng?ml?1": 1 "??6": 1 "citation": 1 "?<10?ng?ml?1": 1 "remission rates": 1 "schedule": 1 "14 patients 16.3": 1 "peptide adjuvant": 1 "signs/symptoms": 1 "control group": 1 "?organ confined t2at2b": 1 "tnm staging": 1 "crt levels*": 1 "estimated enrollment": 1 "id": 1 "rit": 1 "sample size": 1 "?present": 1 "clinical results": 1 "unstandardized": 1 "response rate": 1 "dfs hr 95?ci p value": 1 "cdh13": 1 "who 1998 5 ": 1 "classification": 1 "clinical benefit references": 1 "minor criteria": 1 "control n?=?50": 1 "treatment line": 1 "er + in enrolled patients": 1 "?-sma": 1 "clinical trial number pediatric": 1 "patient id": 1 "low-risk": 1 "organ confined disease radical prostatectomy surgical": 1 "norccap criteria": 1 "authors": 1 "normal human pancreas": 1 "follow-up yr": 1 "nct code/trial name": 1 "pfs t 414 patients mo": 1 "evaluation criteria": 1 "targets": 1 "products": 1 "total material": 1 "?advanced t3at3b": 1 "study phase": 1 "trial outcome": 1 "phase/setting": 1 "species": 1 "diagnosis criteria": 1 "inhibitors": 1 "median follow-up years": 1 "pathognomic criteria": 1 "patients num.": 1 "clinical trial identifier number": 1 "chemotherapy alone": 1 "dose ¥": 1 " b independent validation patient cohort n ?=?31": 1 "eligible patient": 1 "54 patients 62.7": 1 "primary endpoint s": 1 "hg in enrolled patients": 1 "level": 1 "5 patients 5.9": 1 "clinical measures": 1 "clinical": 1 "age at diagnosis yr": 1 "tgf-?3": 1 "uk criteria": 1 "mutation criteria": 1 "tumor evolution": 1 "pretreated n": 1 "mk-2206 dosing schedule": 1 "no": 1 "cancer type": 1 "drug administration": 1 "administration regimen": 1 "mirna name": 1 "seminal vesicle invasion": 1 "?absent": 1 "patient no.": 1 "total": 1 "case-control cohort": 1 "pfs all patients mo": 1 "clinical benefit rate cr pr and sd": 1 "trial clinicaltrials.gov identifier": 1 "colonoscopy": 1 "trastuzumab plus chemotherapy": 1 "cirrhosis": 1 "pfs/ttp months": 1 "rr ": 1 "t 414 n total patients": 1 "37 patients 43.0": 1 "compound": 1 "structure": 1 "100": 1 "radiation": 1 "casp8": 1 "properties": 1 " a original discovery patient cohort ?=?44": 1 "pr": 1 "indications": 1 "sel+tem arm": 1 "allowed prior therapy": 1 "drugs/regimen": 1 "clinical data": 1 "start date": 1 "histology": 1 "selumetinib arm": 1 "single-gene intervention": 1 "clinical trial identifier number accessed on january 22 2013": 1 "grade description": 1 "14": 1 "15": 1 "16": 1 "17": 1 "18": 1 "19": 1 "diseases": 1 "trials reference": 1 "survival ": 1 "eye": 1 "109 100.0": 1 "estimated completion date": 1 "primary outcome": 1 "20": 1 "21": 1 "22": 1 "rr": 1 "23": 1 "patient 2 female": 1 "24": 1 "25": 1 "26": 1 "27": 1 "patient number": 1 "sd": 1 "endpoint": 1 "se": 1 "nct protocol #": 1 "last verified": 1 "clinical endpoints": 1 "patient 4": 1 "arm": 1 "marker expression": 1 "patient 5": 1 "median pfs m": 1 "double-gene intervention": 1 "expression": 1 "grading": 1 "ccyr ": 1 "zodiac": 1 "positive patients ": 1 "aflibercept schedule": 1 "e-cadherin ihc": 1 "patients n =156": 1 "prognosis": 1 "phase of testing": 1 "fit ?100ng/ml": 1 "refs": 1 "prostate cancer related deaths": 1 "patient 3 male": 1 "success after stent loss": 1 "planned enrolment": 1 "biological correlates": 1 "pts included randomized": 1 "no.": 1 "major criteria": 1 "3 patients 3.5": 1 "overall survival": 1 "loss of stent": 1 "pathologic cr 95 ci ": 1 "crr ": 1 "clinical presentation": 1 "patient selection": 1 "author year": 1 "mrd neg.": 1 "psa": 1 "egir 1999 6 ": 1 "primary therapy": 1 "drug s": 1 "response criteria": 1 "dosing regimen": 1 "near-homozygous phenotype": 1 "trial name clinicaltrials.gov id ": 1 "os all patients mo": 1 "6 patients 6.9": 1 "treatment number patients": 1 "atpiii 2001 7 ": 1 "principal investigator ref": 1 "lymph node status": 1 "qol fact-l": 1 "orr": 1 "er/pr assessment": 1 "wgs metrics": 1 "zest": 1 "monotherapy nct identifier clinical trial phase": 1 "p16 ink4a": 1 "comment": 1 "time": 1 "clinical diagnosis": 1 "clinical phase": 1 "who-eortc": 1 "stratification": 1 "criteria": 1 "chemical nature": 1 "secondary endpoint": 1 "ongoing trials": 1 "confirmatory diagnosis": 1 "key eligibility criteria": 1 "recruitment": 1 "aace 2003 8 ": 1 "safety": 1 "cancer examined": 1 "nra": 1 "10.92?ng?ml?1 range 0.61–34?ng?ml?1": 1 "biological endpoints": 1 "identifier": 1 "weiss score": 1 "efficiency": 1 "method": 1 "gene": 1 "conclusions": 1 "clinical trial number": 1 "age/gender": 1 "dose regimen": 1 "negative patients ": 1 "stricture recurrence": 1 "patients in brafi arm": 1 "etoposide": 1 "evaluable patients": 1 "published clinical trials": 1 "nonwide resection margins": 1 "gender": 1 "prr ": 1 "os months": 1 "trial and regimen": 1 "primary endopoint": 1 "inhibitor company commercial name": 1 "clinical outcomes": 1 "metastasis": 1 "first-line": 1 "clinical value": 1 "masking": 1 "expected accrual": 1 "dfs 95 ci ": 1 "diagnostic test": 1 "treatment setting": 1 "therapeutic agent": 1 "trial name/sponsor": 1 "dosage mg/m 2": 1 "mean age": 1 "rr in brafi arm ": 1 "10-year": 1 "phase patients enrolled status": 1 "trial identifier": 1 "healthy volunteer": 1 "inhibitor": 1 "pfs mo": 1 "trade name": 1 "administration time": 1 "trial year": 1 "positive responders": 1 "group": 1 "therapies": 1 "median os months": 1 "1-year survival": 1 "human trials": 1 "weight loss": 1 "patient 1 male": 1 "molecular target": 1 " c combined chemorefractory patient cohort n ?=?54": 1 "surgical margins": 1 "mmr ": 1 "who": 1 "sponsor": 1 "inducer": 1 "patients n?=?100": 1 "participating regions": 1 "study/identifier * /title": 1 "fold change": 1 "trial title": 1 "32 patients 37.3": 1 "dose-limiting toxicities": 1 "who diagnosis": 1 "histology number of enrolled patients": 1 "sensitivity/biomarker efficiency": 1 "5-year survival": 1 "predictor": 1 "immunohistochemistry": 1 "treatment arm": 1 "h2o2": 1 "median os m": 1 " ?±?sd": 1 "diagnostic criteria": 1 "clinical trials a": 1 "regimens": 1 "high-risk": 1 "33 patients 38.3": 1 "mean psa level": 1 "5-year": 1 "statins": 1 "variable": 1 "pathological tumor size in enrolled patients": 1 "category": 1 
"description": 38 "parameter": 20 "p-value": 14 "variable": 13 "term": 12 "range": 11 "feature": 9 "reference": 7 "classifier": 6 "model": 6 "precision": 6 "expected": 6 "loocv": 6 "recall": 6 "network": 6 "value": 6 "references": 5 "10-cv": 5 "go term": 5 "rule-based classifier": 5 "classification": 5 "#selected genes": 5 "n ": 5 "species": 5 "p -value": 5 "node": 5 "#correctly classified samples accuracy": 5 "auc": 5 "method": 5 "test set": 4 "n": 4 "count": 4 "class": 4 "rule rank": 4 "simulation": 4 "genes": 4 "simulated 95 range": 4 "source": 4 "actual": 4 "methods feature selection + classification": 4 "name": 4 "data": 4 "accuracy": 3 "‘berlin’": 3 "size": 3 "pt86": 3 "result": 3 "lemma": 3 "random": 3 "number": 3 "odds ratio log": 3 "norm.": 3 "total": 3 "fold-change": 3 "hazard ratio 95 confidence interval": 3 "reaction": 3 "term size": 3 "ratio": 3 "symbol": 3 "cell type": 3 "‘jena’": 3 "definition": 3 "step": 3 "gene": 3 "‘leipzig’": 3 "set no ": 3 "tumor experimental model": 2 "": 2 "year": 2 "?": 2 "descriptor": 2 "score": 2 "ca": 2 "dimensional value": 2 "fold-change direction": 2 "p": 2 "r": 2 "param’s": 2 "mx/av a": 2 "construction dataset n=891": 2 "ref": 2 "validation dataset n=323": 2 "theoretical m/z": 2 "adj pvalue": 2 "95 ci": 2 "gene description": 2 "false": 2 "age": 2 "mean ± standard deviation": 2 "selection order": 2 "experiment": 2 "id": 2 "term index": 2 "parameter valuesb": 2 "prcc value": 2 "frequency n ": 2 "mass error a ppm": 2 "edge": 2 "nes": 2 "annotation term": 2 "true": 2 "prediction": 2 "f1-score": 2 "f<50 b ": 2 "sse": 2 "protein": 2 "animal model": 2 "class ratio a": 2 "module": 2 "kinetic law": 2 "found": 2 "node 1 node 2 combined score": 2 "initial value": 2 "tfbs": 2 "metric": 2 "testis": 2 "mutation rate per cell division": 2 "coverage": 2 "characteristics": 2 "cases": 2 "mse ratio": 2 "terms": 2 "gene symbol": 2 "clustering coefficient": 2 "description of the best hit/unigene id": 2 "f-measure": 2 "measured m/z": 2 "reac no.a": 2 "disorder": 2 "fdr": 2 "threshold": 2 "total n=1214": 2 "p value": 2 "clone_id": 2 "genbank_accn.": 2 "homolog definition": 2 "bic 104": 1 "limited step": 1 "type 2": 1 "q-value": 1 "type 1": 1 "pten pathway ranking": 1 "r 2": 1 "optimum relative humidity ": 1 "expression level": 1 "den": 1 "ie network": 1 "modeling approach &methodology": 1 "ph range": 1 "path": 1 "disease training": 1 "pubmed": 1 "network density": 1 "network property": 1 "molecular feature": 1 "compartment": 1 "michaelis constants dimensionless": 1 "rank": 1 "mk2_3m2w fastafile": 1 "estimated range": 1 "maximum length bp": 1 "optimum water activity": 1 "training performance": 1 "std error#": 1 "oxidant": 1 "s score": 1 "studied reaction": 1 "#genes": 1 "break-mb 70": 1 "mk2_2oza fastafile": 1 "correlation": 1 "nlgn1 pathway ranking": 1 "intermediate": 1 "fold rq-pcr": 1 "# par.": 1 "average": 1 "2nd key node": 1 "dataset 1 original": 1 "dout": 1 "affymetrix probe set": 1 "gene set name": 1 "training dataset n?=?273": 1 "characteristic": 1 "proteins": 1 "pathway count": 1 "specificity in colon cancer": 1 "network centralization": 1 "fold-change mescs": 1 "biological model": 1 "biological data": 1 "d": 1 "cilia length ?m median": 1 "ode const.": 1 "procedure": 1 "cds length mode": 1 "m": 1 "sample": 1 "reference files": 1 "july 2007": 1 "maximum": 1 "information": 1 "z": 1 "dia": 1 "ks?=?0.2 kd?=?0.008": 1 "-ing": 1 "controls": 1 "degree diameter": 1 "din": 1 "corpus": 1 "cilia length ?m average standard deviation": 1 "edge #": 1 "parameter value": 1 "fab classification": 1 "union network": 1 "hierarchical": 1 "wos": 1 "mk5 model": 1 "experimentaldata": 1 "area": 1 "macro-parameter definition": 1 "minimum input quantity a": 1 "clinico-pathological feature": 1 "official gene symbol": 1 "es": 1 "fusion": 1 "pilot set": 1 "n?=?289": 1 "defined cancer types at node": 1 "simulation set": 1 "gene protein nodes": 1 "standardized coefficient ?": 1 "single gene model": 1 "standard deviation": 1 "training set": 1 "sources": 1 "training": 1 "representation": 1 "calculated activation energy kcal?mol?1": 1 "age 5": 1 "reagent": 1 "nod-ripn": 1 "gobpid": 1 "reference range for women": 1 "cell type/organ": 1 "prediction#": 1 "# test samples": 1 "module size number of cpgs": 1 "forward stepwise": 1 "simulated barabasi albert model scale free": 1 "training set from study group": 1 "y = ?x a": 1 "dependent variable": 1 "fitted parameter q1 ml o2/ 105 cells min": 1 "static network": 1 "mecp2 pathway ranking": 1 "ps1292": 1 "couldn't tell": 1 "cancer": 1 "betweenness": 1 "node attribute name": 1 "no of interactions": 1 "accession number": 1 "directionality": 1 "odds ratio": 1 "approach": 1 " test data": 1 "output": 1 "?": 1 "rin": 1 "ingenuty name": 1 "sample size": 1 "string ppi network": 1 "mustard lung network": 1 "max node degree": 1 "period": 1 "ggcrn": 1 "ps935": 1 "t?=?240": 1 "all other": 1 "t?=?480": 1 "optimum ph": 1 "lower bound": 1 "gene set size": 1 "exp coefficient": 1 "t?=?120": 1 "simulated erdos-renyi model": 1 "90 ci": 1 "p-value*": 1 "alteration": 1 "benjamini": 1 "reproductive phase": 1 "coverage ": 1 "intrans.": 1 "rms error mm hg": 1 "targets": 1 "specificity ": 1 "validation set b n?=?90": 1 "model function": 1 "connectedcomp.": 1 "decomposition method": 1 "area sq ?m": 1 "inmf step 1": 1 "phase 1": 1 "snp": 1 "# of copies length ns": 1 "?bic": 1 "avg node degree": 1 "logic": 1 "entity": 1 "nlgn3 pathway ranking": 1 "3'utr length median": 1 "-ed": 1 "feature combination": 1 "associated network functions": 1 "nei": 1 "o#": 1 "morphological description": 1 "weaknesses": 1 "log2 hy_rpkm/wt_rpkm": 1 "initial conditions dimensionless": 1 "performance rank": 1 "cpl": 1 "circumstances": 1 "months": 1 "rout": 1 "upper bound": 1 "grabcas-model": 1 " median": 1 "energy emin–emax": 1 "synth": 1 "dataset 2 validation 1": 1 "unit": 1 "control validation": 1 "condition": 1 "strengths": 1 "cross validation": 1 "ng": 1 "validation set ger": 1 "biological entity": 1 "gene_id": 1 "recessive model": 1 "who classification": 1 "technique": 1 "units": 1 "beb positively selected sites": 1 "subtype": 1 "ngr": 1 "model 2": 1 "model 1": 1 "model 4": 1 "model 3": 1 "minimum length bp": 1 "direction": 1 "model 5": 1 "dataset 2": 1 "dataset 3": 1 "average ranking": 1 "dataset 1": 1 "numerical value": 1 "full length cds sequences": 1 "-s": 1 "pik3ca": 1 "two-panels model": 1 " a lgg": 1 "module number": 1 "hr a 95 ci b ": 1 "log2-fold change": 1 "naïve bayes": 1 "clinical/pathological variable": 1 "remarks": 1 "r2": 1 "cluster": 1 "p linear slope": 1 "enrichment": 1 "notation": 1 "meaning": 1 "physical entity": 1 "estimate": 1 "chi-square value": 1 "positive selection": 1 "particles": 1 "feature selection": 1 "consensus dataset 38 genes": 1 "disease validation": 1 "net path length ?m": 1 "candidate agent": 1 "control training": 1 "break-1 54": 1 "‘total’": 1 "quality": 1 "input": 1 "blank pathway ranking": 1 "molecule": 1 "items": 1 "total edges": 1 "<cc>": 1 "jawee?=?0.90 jiwee?=?0.21 ja25?=?0.19 ji25?=?0.93": 1 "25": 1 "post gemcitabine-platinum therapy n ": 1 "co-expressed ppis": 1 "kawee?=?0.61 kiwee?=?0.71 ka25?=?0.80 ki25?=?0.35": 1 "micrornas used at node": 1 "nominal": 1 "temperature": 1 " train data": 1 "phenotype": 1 "variables": 1 "parameter estimates": 1 "decision": 1 "real #": 1 "svm": 1 "speed ?m/min": 1 "<k>": 1 "single": 1 "perpcc": 1 "bt549": 1 "refs": 1 "mb231": 1 "number of sequence": 1 "z-score": 1 "average cilia length ?ma": 1 "vl network": 1 "dataset": 1 "mk3_3fhr fastafile": 1 "principle": 1 "hr 95 ci": 1 "data source": 1 "ml network": 1 "dbest_id": 1 "mean±s.e.": 1 "probe set name": 1 "details": 1 "fmr1 pathway ranking": 1 "50": 1 "bare": 1 "pathway/aim ofthe model": 1 "results": 1 "adj p value": 1 "organism": 1 "object name": 1 "degree": 1 "dataset 3 validation 2": 1 "“high-resolution”": 1 "median": 1 "classification results in the test set": 1 "coefficient": 1 "forward reaction": 1 "eq descriptions": 1 "casvm-model": 1 "hyp*": 1 "author year": 1 "gene symbole": 1 "training set n =26": 1 "shank3 pathway ranking": 1 "nod": 1 "definition a": 1 "minimal water activity": 1 "1st key node": 1 "rule": 1 "hprd ppi": 1 "conclusion": 1 "histological description": 1 "r3k1": 1 "genomics": 1 "r3k2": 1 "75": 1 "edge width": 1 "trans.": 1 "3rd key node": 1 "4th key node": 1 "expected count": 1 "classification results in loocv": 1 "dominant model": 1 "average length bp": 1 "target": 1 "rate equation": 1 "number of fits with q<0": 1 "p-score": 1 "parameter description": 1 "asymptotic sig ?": 1 "location": 1 "time": 1 "model description": 1 "oriented network": 1 "minimum relative humidity ": 1 "av path length": 1 "methods feature selection + classification a": 1 "? 2 ^": 1 "kmeans": 1 "validation set": 1 "program": 1 "type": 1 "fold-change hescs": 1 "mef2d pathway ranking": 1 "s.e coef": 1 "igs": 1 "gene set": 1 "connectivity": 1 "parameters 1": 1 "network connectivity": 1 "nom p-val": 1 "logistic regression": 1 "ppis": 1 "comp": 1 "ppi subnetwork": 1 "var": 1 "quartiles": 1 "totalnodes": 1 "validation set 1 n =80": 1 "lnl": 1 "actual class?=?0": 1 "total path length ?m": 1 "mef2a pathway ranking": 1 "data type": 1 "cds length median": 1 "network id": 1 "model parameters": 1 "examples": 1 "validation set a n?=?40": 1 "validation set 2 n =35": 1 "* actual test range": 1 "cases ": 1 " fdr": 1 "model-based": 1 "selection parameter": 1 "independent variable": 1 "approximate frequency": 1 "distribution": 1 "variability": 1 "k?25?=?0.008 k?25?=?0.89 k?wee?=?0.03 k?wee?=?0.18": 1 "cluster id": 1 "backward stepwise": 1 "amplitude": 1 "linear slope 1": 1 "ppv 1": 1 "5'utr length median": 1 "adj p-value": 1 "accuracy ": 1 "?-state": 1 "# training samples": 1 "excised base": 1 "testing set": 1 "model parameter": 1 "break-3 3": 1 "e p": 1 "minimum": 1 "mse": 1 "node #": 1 "probe id": 1 "parameter unit": 1 "base pair substrate": 1 "h460 cells": 1 "double mutation frequencies": 1 "strain": 1 "age 20": 1 "t?=?30": 1 "matched peptides": 1 "disease definition": 1 "break-2 69": 1 "resolution range": 1 "sequence": 1 "?": 1 "november 2008": 1 "d p": 1 "t?=?720": 1 "reverse reaction": 1 "sensitivity ": 1 "# original genes": 1 "age 11": 1 "week 5": 1 "values": 1 "model behaviour": 1 "5th key node": 1 "zsummary *": 1 "optimum temp °c": 1 "actual class?=?1": 1 "temp range °c": 1 "clusteringcoefficient": 1 "dimension": 1 "asymptotic 95 confidence interval": 1 "amount": 1 "additive model": 1 "cycb?=?0.01 mpf?=?0.01 wee1?=?1.0 cdc25?=?0.01": 1 "p cox": 1 "validation set fra": 1 "stimulus": 1 "scoring criteria": 1 "kras": 1 "parameter class": 1 "fdr q-value": 1 "me network": 1 "set n ": 1 "consensus dataset 30 genes": 1 "reduction": 1 "t?=?60": 1 "test range": 1 
"pp32 nuclear": 1 "nuclear bca2": 1 "lipid rafts": 1 "gapdh": 1 "ushbz": 1 "cytoplasmic hhr23a": 1 "accession no.b": 1 "bait usps": 1 "smb": 1 "ref.": 1 "reference": 1 "methylatedc": 1 "?nt 141–592": 1 "bi-fan": 1 "sim": 1 "shbz": 1 "arl": 1 "psmd14": 1 "10 µm sim+mev": 1 "prey brap": 1 "usp17": 1 "prpf8": 1 "ubl5": 1 "itaf": 1 "cc 393–592": 1 "0.01 µm sim": 1 "mcl1": 1 "control": 1 "cytoplasmic bca2": 1 "ffl": 1 "full-length": 1 "alg9": 1 "nuclear hhr23a": 1 "fbl": 1 "sham": 1 "rpl13a": 1 "10 µm sim": 1 "structure/function": 1 "proteina": 1 " a abt-737 ic50 nm": 1 "cancer": 1 "uchl3": 1 "caveolae": 1 
"multi-task": 6 "concatenated": 6 "single-task": 6 "": 3 "p-val": 3 "class": 3 "cluster 2": 3 "cluster 3": 3 "cluster 1": 3 "identity ": 2 "organism": 2 "sequence": 2 "eo01 contigs": 2 "chromosome": 2 "class 1": 2 "eg01 contigs": 2 "species": 2 "lineage": 1 "symbol": 1 "bacteria": 1 "oxidoreductases": 1 "transferases": 1 "type": 1 "class ii": 1 "metazoan-chordates": 1 "deletion/amplification": 1 "mus musculus": 1 "livermet": 1 "viridiplantae": 1 "group": 1 "zucp5": 1 "sqnon-met": 1 "class i": 1 "zucp4": 1 "zucp1": 1 "zucp2": 1 "sfk member": 1 "zucp2l": 1 "superfamily": 1 "vertebrates": 1 "bac contigs": 1 "homo sapiens": 1 "primer designation": 1 "metazoan-invertebrates": 1 "isomerases": 1 "drosophila melanogaster": 1 "vegetable": 1 "ligases": 1 "genome encoded homologue": 1 "archaea": 1 "lyases": 1 "genbank accession": 1 "rattus norvegicus": 1 "comments": 1 "gene sequence": 1 "hydrolases": 1 "class 3": 1 "class 2": 1 "class 5": 1 "class 4": 1 "protozoa": 1 "class 6": 1 "cluster 4": 1 "genus species sub species": 1 "fungi": 1 "class iii": 1 "genbank accession no.": 1 "individual domain": 1 "member mirna": 1 "dataset": 1 
"+": 143 "-": 57 "total": 31 "o": 20 "symbol": 19 " ? ? ?": 17 " +? ?": 16 "": 12 "?": 12 "genes": 12 " +? +": 12 "fold": 11 "genotype": 11 "p": 8 "p-value": 8 "left hemisphere": 6 "right hemisphere": 6 "control": 6 "?": 5 "number": 5 "percentage": 5 "#": 4 "sham": 4 "deoxytetracycline": 4 "counts": 4 "0": 3 "1": 3 "2": 3 "3": 3 "left": 3 "oxidoreductase activity": 3 "percent tubular network": 3 "description": 3 "s.e.m.": 3 "percent": 3 "mean": 3 "relative": 3 "right": 3 "down": 3 "percent apoptotic cells ‡": 3 "diagram color": 3 "percent collapsed": 3 "?": 3 "?": 3 "up": 3 "dpp9 wt/wt": 3 "gender": 3 "total number": 3 "dpp9 wt/s729a": 3 "a800": 2 "+ let-7b": 2 "total genes": 2 "percentage of total": 2 "annotation": 2 "n": 2 "tco89": 2 "pathway": 2 "mcao + ex": 2 "p value*": 2 "percent mutant": 2 "other ": 2 "atpase activity": 2 "ptyr1068": 2 "nuclei per islet": 2 "sample size": 2 "a400": 2 "kog1": 2 "era": 2 "histodifferentiation grading": 2 "treatment group": 2 "tor1": 2 "downregulated": 2 "a200": 2 "mock": 2 "counted islets per animal": 2 "upregulated": 2 "probe": 2 "total pmole/gm n?=?10": 2 "pc-p ip": 2 "no.": 2 "pc-p total": 2 "parameters": 2 "negative": 2 "+ scramble": 2 "gene symbol": 2 "loh": 2 "gain": 2 "dpp9 s729a/s729a": 2 "p value": 2 "?mg-132": 2 "6p amplified": 2 "average": 2 "characteristic": 2 " ++? ?": 2 "ci": 2 "mcao": 2 "no reperfusion": 2 "chi-square": 2 "sham + ex": 2 "hbsag + ": 2 "a800 + p": 2 "ptyr1173": 2 "treatment effect group": 2 "total tumor/total injection": 2 "torc1": 2 "++": 2 "positive": 2 "+ +": 2 "percentage of total cell population ": 2 "--": 2 "anti-hcv + ": 2 "p -value": 2 "+mg-132": 2 "a800 + a779": 2 "compound": 2 "percent ": 2 "a800 + pd123319": 2 "tumor weight mg": 2 "lst8": 2 "ratio": 2 "plasmid": 2 "pdgf+cre vs pdgflog2 change": 2 "characteristics": 2 "cases": 2 "cells": 2 "50 µm": 2 "loss": 2 "0.998 ± 0.0005": 2 "hbsag/anti hcv + ": 2 "25 µm": 2 "counted nuclei per animal": 2 "+ + + a": 2 "total score": 2 "egfr mutation": 2 "fold change": 2 "parameter": 2 "author reference": 2 "value": 2 "category": 2 "rb1": 1 "references": 1 "functions": 1 "iban + tam": 1 " ++? ++": 1 "explanation": 1 "tissue distribution": 1 "325 white and 1 asian": 1 "go0015276": 1 "dysplasia": 1 "average percentage of volume ± sem": 1 ">5 lateral pseudopods per 10 min": 1 "average ac": 1 "normalized intensity": 1 "go0019400": 1 "blt1": 1 "~ 31800": 1 "analysis": 1 "row total": 1 "top molecules": 1 "total up-regulated est clusters": 1 "go0007635": 1 "number of differentiated cell types per gssc clone": 1 "go0006547": 1 "go0006548": 1 "1536-well": 1 "model 1 + ca9 membrane staining": 1 "cav-1-/- + telmi n=6": 1 "threonine-type endopeptidase activity": 1 "go0006776": 1 "rho_tumor": 1 "primary active transmembrane transporter activity": 1 "ovx + val": 1 "patients ": 1 "metabolism of alditol polyol glycerol aldehyde process": 1 "go0006775": 1 "lower left": 1 "~ 3.3 106": 1 "total amino acids g/100?ml whole milk": 1 "go0022834": 1 "go0017000": 1 "acyl carrier activity": 1 "abbreviation": 1 "r": 1 "age days ± sem": 1 "targeted exon bases": 1 "3–5 lateral pseudopods per 10 min": 1 "hypocellularity/ alcian blue": 1 "fo + co 1??1 + dmh": 1 "go0015075": 1 "hctr": 1 "cxodscpods ratio": 1 "sek1+/+": 1 "empty": 1 "go0015082": 1 "representative strategies/protein/drugs": 1 "mf ratio cxods cpods": 1 "positive/total": 1 "female": 1 "foci in 0.5 cs": 1 "total ests after clustering": 1 "syntenin ?": 1 "# sp -": 1 "erythroidter119+": 1 "no total bm × 10?6": 1 "egfr": 1 "p-erk": 1 "kinome genetic aberations": 1 "*sp +": 1 "water 15? ? l/g": 1 "bj + aom 4.1? ? l/g + 10?mg/kg": 1 "# his +": 1 "total down-regulated est clusters": 1 "spp.": 1 "go0006721": 1 "clone": 1 ""m1" +": 1 ""r9" -": 1 "go0044437": 1 "assays": 1 "bj + aom 1.6? ? l/g + 10?mg/kg": 1 "cell strain": 1 "total pa": 1 "large acf / per rat ‡ mean ± sem": 1 "hek293 cells + car": 1 "epo": 1 "clp": 1 "26601": 1 "total rna ensembl": 1 "percent cells showing membrane ruffling": 1 "tissue remodeling": 1 "total reads": 1 "authors": 1 "hpv ": 1 "fhit": 1 "prs_p53": 1 ""r10" -": 1 "maspin staining intensity": 1 "basidiomycota": 1 "nucleoside binding": 1 "exons screened": 1 "percentage relative mrna expression tbx2 ": 1 "pgr": 1 "status/description": 1 "peripheral nervous system development": 1 "asian": 1 "ets +": 1 "asic2": 1 "vacuolar membrane": 1 "go0005839": 1 "asian 83 ": 1 "model 1 + ca9 intensity": 1 "go0004500": 1 "ets -": 1 "species": 1 "go0004745": 1 " hatched": 1 "cpod average age range": 1 "total nuclei": 1 "focus genes": 1 "?": 1 "go0006914": 1 "?": 1 "cox-2": 1 "ovx + ena": 1 "leucine content mg/g total amino acids": 1 " di terpenoid metabolic process": 1 "wt + vehicle n=6": 1 "unit": 1 "rag2?/?": 1 "go0005811": 1 "cellular aerobic respiration": 1 "go0020037": 1 "cellular compartment": 1 "go0042048": 1 "squamous differentiation": 1 "go0008081": 1 "reference/justification": 1 "95.3 ± 2.5": 1 "go0005801": 1 "sigmoidal curve": 1 "unique transcripts": 1 "sah + sb386023-b after 12 h": 1 "model 1": 1 "endopeptidase -inhibitor activity": 1 "lane": 1 "stimulation": 1 "go0043168": 1 "prs_p21": 1 "pmyr": 1 "spin-labeled quencher": 1 "mdr3": 1 "go0031177": 1 "low homa": 1 "go0002526": 1 "227": 1 "lrp2": 1 "cd4 + cell": 1 "go0045333": 1 "f/f0 ± sem": 1 "emax ± s.e.m": 1 "rhoa–gdp + dh": 1 "choanoflagellatea": 1 "24 h stored fruit": 1 "response to alkaloid": 1 "megakaryocytecd41+": 1 "473": 1 "go0047661": 1 "apc": 1 "go0004812": 1 "nis": 1 "mitochondrial inner membrane": 1 "transition metal ion transmembrane transporter activity": 1 "average sn": 1 "ptgs2": 1 "proportion of tunel-positive nuclei per islet ": 1 "percentage linked to care": 1 "tnf-? production §": 1 "difference": 1 "percentage retained in care": 1 "go0016705": 1 "hltf": 1 "strains": 1 "top canonical pathways": 1 "go0048771": 1 "aminoacyl-trna ligase activity": 1 " ++? +": 1 "go0001523": 1 "phosphopantetheine binding": 1 "go0016709": 1 "average sp": 1 "go0016712": 1 "average score a": 1 "average score b": 1 "go0016715": 1 "percentage relative mrna expression e-cadherin ": 1 "black": 1 "?tnf-?": 1 "bcr-abl-gfp*": 1 "ascomycota": 1 "total clusters": 1 "go0070003": 1 "mouse": 1 "features": 1 "grade +": 1 "go0048311": 1 "late": 1 "white": 1 "p16": 1 "go0001503": 1 "p15": 1 "binding tetrapyrrole heme vitamin oxygen": 1 "go0015405": 1 "model 1 + response after 6 months": 1 "cell line m14": 1 "0.913 ± 0.118": 1 "tnf-? production *": 1 "measure": 1 "name": 1 "go0048308": 1 "cell line sk-mel-5": 1 "kras mutation": 1 "b cellsb220+": 1 "lkb": 1 "average pv -": 1 "average pv +": 1 "syntenin +": 1 "events missed": 1 "go0070469": 1 "total cell": 1 "go0015893": 1 "percent b220+": 1 "91.5 ± 15.0": 1 "factor": 1 "early": 1 "shp1": 1 "apaf-1": 1 "go0016999": 1 "gfp vector*": 1 "go0015662": 1 "green tea or se in diet": 1 "category name accession": 1 "total probe-sets": 1 "rar-?": 1 "obr +": 1 "obr -": 1 "temperature oc": 1 "cell cycle stage": 1 "go0007005": 1 "rhoa + dh–ph": 1 "gene": 1 "go0018958": 1 "statistical parameter": 1 "go0048102": 1 "go0008324": 1 "phosphoric diester hydrolase activity": 1 "middle 90 range": 1 "p73": 1 "mean frequency of lateral pseudopods per cell per 10 min": 1 "n33": 1 "genotype *": 1 "k+ mean ± s.e.m": 1 "proteasome core complex": 1 "total cells": 1 "apical plasma membrane": 1 "go0008553": 1 "96-well": 1 "go0019825": 1 "rat parathyroid": 1 "cellular fraction": 1 "molecular function": 1 "aqp5 immunostaining score": 1 "go0016324": 1 "cis-golgi network": 1 "experimental diets": 1 "percent vulvaless 0": 1 "98.5 ± 1.3": 1 "lipid particle": 1 "sah + sb386023-b after 6 h": 1 "# his + and ?-gal +": 1 "go0004177": 1 "group": 1 "vesicular fraction": 1 "50 µm/non": 1 "high coverage bases a": 1 "cellular amino acid catabolic process activation": 1 "go0019842": 1 "e2f_db": 1 "lower right": 1 "vectors": 1 "binding amine chloride ion": 1 "marker": 1 "total rna": 1 "methylation": 1 "biological process": 1 "go0006584": 1 "total est clusters absent in tumors": 1 "ca7a": 1 "hydrolase activity acting on acid anhydrides catalyzing transmembrane movement of substances": 1 "phenanthrene*": 1 "pretreatment *": 1 "bcr-abl-gfp + n17 h-ras*": 1 "percentage infected with hiv": 1 "go0016101": 1 "go0008514": 1 "go0030414": 1 "go0007422": 1 "go0006575": 1 "microsome": 1 "go0006576": 1 "sah": 1 "go0042625": 1 "amounts per day per animal": 1 "categorical cut points": 1 "go0019866": 1 "protein /epitope": 1 "go0042626": 1 "chromosome": 1 "percent b220+ igm+cd22hi": 1 "pc-p te": 1 "calculation pair": 1 "go0007411": 1 "model 1 + ca9 score": 1 "go0005230": 1 "ifn-? + cell": 1 "differentially expressed cdnas fdr?=?0.05": 1 "38 african american": 1 "percent p7.p defects biv.": 1 "epha3": 1 "microsporidia": 1 "go0015399": 1 "junb": 1 "go0019751": 1 "fat-soluble vitamin metabolic process": 1 "histone acetyltransferase activity": 1 "pik3cg": 1 "go0031404": 1 "no.mice": 1 "go0004497": 1 "18972520": 1 "mitoses": 1 ""r6" +": 1 "autophagy": 1 "unique id": 1 "wky": 1 "spot id": 1 "ca8b": 1 "fo + co + 2.5??1 + edta": 1 " + ? ?": 1 "go0014074": 1 "histidine meta- and catabolism": 1 "ar": 1 "1.000 ± 0.000": 1 "sgrp78 positive number": 1 "lc å ± sem": 1 "ldhb": 1 "treatment": 1 "bd": 1 "colony volume*": 1 "go0046915": 1 "aom 10?mg/kg": 1 "fo + co 1??1 + edta": 1 "go0032993": 1 "unmethylation": 1 "go0006418": 1 "percent number": 1 "htr1b": 1 "term": 1 "sem": 1 "go0046906": 1 "sex": 1 "mmp-2 score": 1 "co": 1 "sample": 1 "go0031418": 1 "cation transmembrane transporter activity": 1 "e7": 1 "proportion of ki-67–positive nuclei per islet ": 1 "percent of unigenes ": 1 "protein coexpression": 1 "rho_normal": 1 "go0005792": 1 "h19": 1 "129/j": 1 "total conserved mirna targets": 1 "mice per cohort": 1 "fo + co 2.5??1 + dmh": 1 "bone development ossification": 1 "model 1 + pdgfr? score": 1 "go0017144": 1 "count": 1 "parameter no.of patients ": 1 "pc-p rro": 1 "go0005774": 1 "shr": 1 "tumour number ± sem": 1 "n ?=?": 1 "tumour area mm 2 ± sem": 1 "0.990 ± 0.014": 1 "brca1": 1 "ga": 1 "ligand-gated ion channel activity": 1 "go0042598": 1 "total events": 1 "monocarboxylic acid transport": 1 "chytridiomycota": 1 "autophagic cell death": 1 "top 5 ?": 1 "top 5 ?": 1 "model 1 + response after 9 months": 1 "mgmt": 1 "cav-1-/- +vehicle n=6": 1 "response to purine caffeine": 1 "wt1": 1 "percent b220+ cd43+cd22lo/?": 1 "total poorly conserved mirna targets": 1 "representative proteins for each group": 1 "upregulated genes": 1 "mitochondrion distribution inheritance organization": 1 "drug associationa": 1 "no of hatched + dead": 1 "hs": 1 "calca": 1 "go0031000": 1 "go0005746": 1 "l-ascorbic acid binding": 1 "hy": 1 "go0005506": 1 "go0000299": 1 "go0005507": 1 "go0005743": 1 "acute inflammatory response": 1 "id": 1 "retinol dehydrogenase activity": 1 "total est clusters specific to tumors": 1 "sek1?/?": 1 "ras component": 1 "total od average age range": 1 "cdh13": 1 "black 149 ": 1 "oligonucleotide": 1 "zygomycota": 1 "go0004402": 1 "go0006826": 1 "percent globular and large grapes": 1 "technical terms": 1 "filasterea": 1 "dmh treated": 1 "87.5 ± 8.2": 1 "mage": 1 "rhoa–gdp + dh–ph": 1 "amino-acid racemase activity": 1 "percentages ± sem of positive cells per total cells": 1 "percent underinduced <3": 1 "go0000036": 1 "library": 1 "a549": 1 "cadmium*": 1 "foci size‡": 1 "percentage with undetectable viral load": 1 "total female cxods cpods": 1 "small acf / per rat † mean ± sem": 1 "total n of ods for gender/age": 1 "0–2 lateral pseudopods per 10 min": 1 "ic50 of paclitaxel": 1 "total rna ng/µl": 1 "mir361-3p": 1 "go0004867": 1 "go0004866": 1 "308": 1 "average induced vpcs": 1 "m-braf": 1 "go0009075": 1 "go0009077": 1 "heparanase": 1 "p 34.p fate": 1 "mb": 1 "go0004857": 1 "mc": 1 "upper left": 1 "go0009063": 1 "25 µm/non": 1 "go0009060": 1 "il-4 + cell": 1 "monooxygenase activity": 1 "stained nuclei": 1 "go0000001": 1 "go0043492": 1 "nd": 1 "immunoblot band intensity arbitrary units": 1 "groups ski-ii ?mol/l + ddp mg/l": 1 "spu": 1 "0 h stored fruit": 1 "symbols": 1 "dose i": 1 "total dag": 1 "myeloidgr-1/mac-1+": 1 "percent total cells": 1 "dose ii": 1 "iron ion binding": 1 "colony color": 1 "8?hr reperfusion": 1 "intensity": 1 "go0005911": 1 "pb": 1 "# transformants": 1 "soft agar": 1 "+tnf-?": 1 " 8 hr reperfusion": 1 "go0043039": 1 "go0043038": 1 "go0043279": 1 "po": 1 "p-p-bond-hydrolysis-driven transmembrane transporter activity": 1 "cell-cell junction": 1 "s100a2": 1 "iron ion transport": 1 "cftr": 1 "rhoa + dh": 1 "mrp1": 1 "go0044270": 1 "go0015718": 1 "band": 1 "mthfr": 1 "go0015721": 1 "go0015722": 1 "synthetic diet content ": 1 "percent b220+ cd43intcd22int": 1 "consensus length bp": 1 "vhh19": 1 "mir625*": 1 "number of cells": 1 "unique": 1 "fluorescent lipid": 1 "total male cxods cpods": 1 "trna aminoacylation for protein translation": 1 "go0043176": 1 "average rank": 1 "ro": 1 "percent propidium iodide–positive cells": 1 "male": 1 "il-8": 1 "go0016820": 1 "experiments": 1 "copper ion binding": 1 "clp + sp600125": 1 "21677780": 1 "tff1": 1 "cell subset": 1 "edn1": 1 "sb": 1 "sc": 1 "eggs hatched/total": 1 "go0001882": 1 "percent fragmented": 1 "total of unigenes": 1 "n- 5-amino-5-carboxypentanoyl-l-cysteinyl-d-valine synthase activity": 1 "go0006097": 1 "sp": 1 "cell line": 1 "sr": 1 "middle": 1 "non-coding rnas": 1 "go ids": 1 "wt + telmi n=6": 1 "necrosis": 1 " embryonic lethal": 1 "stimulation *": 1 "country": 1 "48": 1 "non-focus genes": 1 "go0006081": 1 "p-jnk": 1 "gem1? strain containing prs416 plus": 1 "cell type": 1 "average range": 1 "percent overinduced >3": 1 "go0006071": 1 "go0016854": 1 " positive nuclei": 1 "go0016855": 1 "treated": 1 "percent b220+ cd43? igm?cd22lo": 1 "# cells": 1 "bj 15? ? l/g": 1 "vitamin a metabolic process": 1 "tls3": 1 "percent control": 1 "cytoplasmic survivin": 1 "average no ioc": 1 "glyoxylate cycle": 1 "go0046487": 1 "normalized cpm": 1 "wt-braf": 1 "384-well": 1 "173": 1 "srbc": 1 " total n?=?120 ": 1 "biphasic curve": 1 " canalicular bile acid and bile salt transport": 1 "wt": 1 "percent of categories ": 1 "84.8 ± 10.5": 1 "sah + sb386023-b at 0 h": 1 "57217312": 1 "location": 1 "go0045177": 1 "go0009310": 1 "total degs": 1 "hmlh1": 1 "esr1": 1 "timp-2 score": 1 "type": 1 "ic50 of gemcitabine": 1 "go0050564": 1 "dapk": 1 "upper right": 1 "iban + ici": 1 "sp +": 1 "sp -": 1 "method": 1 "samples": 1 "lmp1": 1 "metabolic processess phenol amino acids": 1 "pec50 ± s.e.m": 1 "comt": 1 "terms with the highest log2 odds ratios >2 goeast analysis or large difference in occurrence ratio between the two ssh libraries > 2 categorizer analysis are included in the table * trend of expression higher + lower - or equal o based on term countings hu et al 2008 in the cadmium phenanthrene and normalized library.": 1 "cxod average age range": 1 "non-treat": 1 "overall total mirna targets": 1 ""r3" +": 1 "percent of total genes": 1 "protein name": 1 "p-gp": 1 "axo + /xeno -": 1 "go0060348": 1 "0.958 ± 0.032": 1 "axo + /xeno +": 1 "percent wt 3": 1 "drug metabolic process": 1 "nucleus": 1 "ovx": 1 "extracellular ligand-gated ion channel activity": 1 "ebr": 1 "total 427 ": 1 "top biological functions": 1 "average coverage per pool": 1 "olfactory chemosensory behavior": 1 "percentage diagnosed": 1 "drug transport": 1 ""r5" -": 1 "rna class": 1 "antibiotic metabolism and biosynthesis": 1 "total genetic aberrations": 1 "racemase and epimerase activity": 1 "go0004298": 1 "elisa µg/ml": 1 " +++? +++": 1 "mitochondrial respiratory chain": 1 "hbsag -": 1 "variables no.of patients ": 1 "89.0 ± 19.4": 1 "protein-dna complex": 1 "hbsag +": 1 "bj + aom 15? ? l/g + 10?mg/kg": 1 "12.2": 1 "high hom": 1 "model 1 + vegfr3 vessel staining": 1 "aca2": 1 "week": 1 "cytoplasm": 1 "average coverage per parent b": 1 "vpr2a": 1 "total acf / per rat # mean ± sem": 1 "average coverage per proband b": 1 "cxods - cpods n.": 1 "rna category": 1 "white 195": 1 "integral to membrane of membrane fraction": 1 "muc2": 1 "laminin5": 1 "groups": 1 "variable": 1 "vpr1a": 1 "vhl": 1 
"references": 52 "characteristics": 12 "-": 11 "functions": 9 "pathways": 9 "genes": 9 "reference": 9 "targets": 7 "drugs": 7 "p-value": 7 "necrotic regions": 6 "hypoxic regions": 6 "results": 6 "hif-1?+/pimo?": 6 "normoxic regions": 6 "mechanisms": 6 "pimo+/hif-1??": 6 "molecules": 5 "inhibitors": 5 "67.5": 4 "proteins": 4 "products": 4 "approach/model": 4 "functional impacts": 4 "mirna": 3 "t?=?240": 3 "t?=?480": 3 "t?=?120": 3 "markers": 3 "84.8": 3 "actions": 3 "90.0": 3 "t?=?30": 3 "factors": 3 "t?=?60": 3 "": 2 "animal models": 2 "–": 2 "stimuli": 2 "sse42sp50": 2 "1": 2 "2": 2 "tnf?": 2 "virus": 2 "journal": 2 "67.7": 2 "subjects": 2 "reactants": 2 "pathway": 2 "target genes": 2 "77.0": 2 "stimulators": 2 "regulators": 2 "microrna": 2 "actions and molecular mechanisms": 2 "65.5": 2 "cells and phenotypes": 2 "76.7": 2 "olaef1a1": 2 "64.2": 2 "87.4": 2 "agents dosage/day": 2 "63.9": 2 "63.6": 2 "truef1a1": 2 "design/fu": 2 "ref.": 2 "components and mechanisms": 2 "84.4": 2 "84.6": 2 "processes": 2 "up-regulated": 2 "activated pathways": 2 "protein": 2 "82.0": 2 "71.6": 2 "hsaef1a2": 2 "hsaef1a1": 2 "activated pathways con't": 2 "features": 2 "81.6": 2 "cellular models": 2 "parameters": 2 "suppressed pathways": 2 "types": 2 "rxn": 2 "sseef1a1": 2 "sseef1a4": 2 "sseef1a3": 2 "sseef1a2": 2 "ingenuity canonical pathways": 2 "mammals": 2 "cellular processes": 2 "author/study": 2 "consequences": 2 "tru42sp50": 2 "receptors": 2 "ola42sp50": 2 "effectors": 2 "69.8": 2 "substrates": 2 "value": 2 "stimulus": 2 "intracellular factors": 1 "adhesion receptors": 1 "ck7+/insulin+ ": 1 "68.7": 1 "68.3": 1 "68.2": 1 " ": 1 "#": 1 "topoisomerase inhibitors": 1 "qrt-pcr": 1 "multi-domain pro-apoptotic": 1 "inhibitory receptors": 1 "medical subject headings": 1 "common functional partners": 1 "0": 1 "79.7": 1 "3": 1 "4": 1 "5": 1 "clinical/biological aspects": 1 "treatment": 1 "mediators": 1 "drug targets": 1 "target molecules": 1 "modified sites": 1 "csc markers": 1 "67.4": 1 "67.3": 1 "selected characteristics": 1 "reduction ": 1 "advantages": 1 "78.7": 1 "non-patients n?=?10": 1 "transporter": 1 "78.4": 1 "sialidase": 1 "potential markers": 1 "chemotatic receptors": 1 "cell types": 1 "66.7": 1 "population?": 1 "89.8": 1 "validated targets": 1 "insulin+/c-kit+ ": 1 "numbers ": 1 "89.0": 1 "66.2": 1 "associated condition": 1 "89.2": 1 "latent genes": 1 "study characteristics": 1 "count": 1 "molecular targets": 1 "77.7": 1 "siha pmol/10e 6 cells": 1 "types of ptms": 1 "compounds": 1 "antioxidizing systems": 1 "77.5": 1 "histone mark": 1 "changes in hmga2trunc cells": 1 "roles": 1 "extracellular factors": 1 "88.6": 1 "minor features": 1 "65.9": 1 "random pathways": 1 "88.1": 1 "65.4": 1 "88.5": 1 "cells treated": 1 "88.3": 1 "translocation": 1 "disease targets": 1 "citation": 1 "cosmic genes": 1 "zscore": 1 "76.9": 1 "mirnas": 1 "76.4": 1 "family": 1 "articles": 1 "upregulated genes": 1 "ubiquitin ligase": 1 "target genes ref": 1 "hela pmol/10e 6 cells": 1 "64.9": 1 "87.7": 1 "clinical applications": 1 "64.1": 1 "87.2": 1 "action": 1 "related proteins": 1 "64.4": 1 "64.6": 1 "63.0": 1 "ahr": 1 "yeast": 1 "75.8": 1 "metabolic pathway": 1 "75.2": 1 "known or proposed functions": 1 "mouse models": 1 "pdx-1+/insulin+ ": 1 "cancer cells": 1 "zt/g9": 1 "roles and properties": 1 "86.8": 1 "86.0": 1 "86.1": 1 "metaboltes": 1 "63.8": 1 "genes down-regulated": 1 "topics": 1 "zl55": 1 "zt/f2": 1 "core and clock-related genes": 1 "agents": 1 "signaling pathways": 1 "imaging techniques": 1 "pdx-1/c-kit+ ": 1 "redox systems": 1 "clinical studies": 1 "transcription factors": 1 "human cells": 1 "virokine erbb-binding proteins": 1 "zt/#1": 1 "points": 1 "85.9": 1 "reviews": 1 "function": 1 "62.2": 1 "62.5": 1 "62.7": 1 "62.6": 1 "85.5": 1 "62.9": 1 "anti-metabolites": 1 "mouse cells": 1 "cul5-type ubiquitin ligases": 1 "pce/pce+nce": 1 "gls2-unmethylated": 1 "sdm104": 1 "dnmts mrna /promoters": 1 "61.8": 1 "83.0": 1 "60.2": 1 "disease example/association": 1 "latent phase proteins": 1 "tumors": 1 "functions and roles": 1 "drosophila": 1 "enhanced markers": 1 "95.4": 1 "properties": 1 "remarks": 1 "association with human diseases": 1 "cluster": 1 "n°": 1 "71.1": 1 "cell types expressed": 1 "83.5": 1 "60.9": 1 "models": 1 "tissues": 1 "diseases/animal models": 1 "diseases and disorders": 1 "genes up-regulated": 1 "molecule": 1 "71.9": 1 "items": 1 "70.0": 1 "trade mark/company": 1 "activity": 1 "module function": 1 "70.1": 1 "enzymes": 1 "82.6": 1 "oxidizing systems": 1 "82.4": 1 "n=82 ": 1 "82.9": 1 "phenotype": 1 "strategies": 1 "81.1": 1 "clinicopathological parameters": 1 "normal tissues 2 -?ct ": 1 "anti-apoptotic proteins": 1 "drug devlopment stage": 1 "proto-oncogenes": 1 "mechanisms of foxp3-induction": 1 "cells days": 1 "control cells": 1 "92.0": 1 "f2-sc": 1 "92.4": 1 "population*": 1 "up-regulated genes fi?1.50 §": 1 "cell type": 1 "drugs inhibitors or activators": 1 "histoanatomic variant": 1 "81.7": 1 "81.8": 1 "validation subjects": 1 "80.0": 1 "organism": 1 "proinflammatory mediators": 1 "cancer pathways": 1 "cytokine receptors": 1 "transcriptome-sequencing": 1 "occurrence ": 1 "structural proteins": 1 "activating receptors": 1 "mechanisms/representative strategies or drugs": 1 "91.0": 1 "antioxidants": 1 "91.3": 1 "phks pmol/10e 6 cells": 1 "activated molecules": 1 "80.7": 1 "ptm": 1 "nci study": 1 "polymorphisms": 1 "mechanisms of action": 1 "target": 1 "cells": 1 "hacat pmol/10e 6 cells": 1 "location": 1 "91.6": 1 "cancer tissues 2 -?ct ": 1 "90.2": 1 "non-cancer genes": 1 "mlck/mlcp balance": 1 "patients n?=?10": 1 "preparation": 1 "disadvantages": 1 "observations/lesions": 1 "exome-sequencing": 1 "method": 1 "selected studies": 1 "gene": 1 "cancer types": 1 "f1-vitd-": 1 "sources cells or tissue": 1 "changes in hmga2 wt cells": 1 "kegg pathways": 1 "omim genes": 1 "pharmacological effects": 1 "mnpces": 1 "bh3 only pro-apoptotic proteins": 1 "p-value c": 1 "treatments n?=?6/group": 1 "alterations described": 1 "gls2-methylated": 1 "modified enzymes": 1 "clinical use": 1 "ros sources": 1 "biochemical functions": 1 "f1-sc": 1 "taxanes": 1 "meansd": 1 "patients n?=?21": 1 "cancer genes": 1 "discoveries": 1 "folds 2 -??ct ": 1 "attenuated markers": 1 "major features": 1 "f2-vitd-": 1 "cancer-related genes": 1 "related functions": 1 "down-regulated genes": 1 "down-regulated genes fi?0.50 §": 1 "whole-genome sequencing": 1 "sequence": 1 "effects": 1 "methylation-profiling subjects": 1 "platinum-based compounds": 1 "biological functions": 1 "possible mechanisms of anti-hcc": 1 "target cells": 1 "interactions": 1 "69.3": 1 "69.6": 1 "69.5": 1 "69.9": 1 "studies": 1 "n/total": 1 "69.0": 1 "types of mediators": 1 "pharmacological approach": 1 "normal cells": 1 "up-regulated genes": 1 "microarray tumors": 1 "downregulated genes": 1 "microarray cells": 1 "phenotypes": 1 "wt-ras cells": 1 
"age": 18 "95 ci": 14 "sex": 12 "p-value": 12 "p": 8 "group": 8 "gender": 7 "": 5 "age years": 5 "weight g": 5 "?std": 4 "location": 4 "patient": 4 "?": 3 "treatment": 3 "#tumors ": 3 "odds ratio": 3 "classification": 3 "status": 3 "smoking": 3 "insulin": 3 "parameters": 3 "psa": 3 "risk ratio": 3 "body weight": 3 "reference": 3 "vil": 2 "tnf-? pg/ml": 2 "ethnicity": 2 "leptin ng/ml": 2 " n": 2 "ct": 2 "hrt brain region": 2 "bmi value": 2 "age in years": 2 "paod subjects": 2 "bun mg/dl": 2 "0.41": 2 "1.08": 2 "1.05": 2 "crp ng/ml": 2 "12 weeks": 2 "period": 2 "tnm": 2 "age yrs": 2 "0.82": 2 "n ": 2 "bmi": 2 "phz": 2 "mcp-1 pg/ml": 2 "or 95 ci": 2 "diagnosis": 2 "odds ratio 95 ci": 2 "p -value": 2 "baby wt kg": 2 "adiponectin ?g/dl": 2 "control": 2 "risk factor": 2 "bmi kg/m2": 2 "gestation wks": 2 "tg mg/dl": 2 "se": 2 "variables": 2 "hr 95 ci": 2 "no.": 2 "methylation status": 2 "16 weeks": 2 "il-6 pg/ml": 2 "disease": 2 "hba1c ": 2 "val": 2 "gene": 2 "body weight g": 2 "vilval": 2 "?": 2 "p value": 2 "grave": 2 "factors": 2 "variable": 2 "sbp mmhg": 1 "7.2?±?0.5 0.07": 1 "180.7±25.9": 1 "age d": 1 "23.5?±?0.7 0.31": 1 "karyotype": 1 "gc risk": 1 "risk category": 1 "11.1?±?1.1": 1 "brca1 groups": 1 "?-h2ax µm": 1 " ": 1 "serum txb2 pg/ml": 1 "hb g/dl": 1 "upper 95 ci": 1 "pool": 1 "control mice": 1 "tfa": 1 "4–10": 1 "cortisol": 1 "well/moderately/poorly": 1 "pasi": 1 "1 d": 1 "8.0±5.1 p=0.73": 1 "intermediate": 1 "average": 1 "8.7?±?0.5* 0.032": 1 "event-free survival": 1 "63/69": 1 "plts tsd/µl": 1 "sasae": 1 "plasma triglycerides mg/dl": 1 "characteristic": 1 "ca mg?dl ?1": 1 "involvement": 1 "average ci": 1 "44.6±22.5 p=0.59": 1 "15.0?±?0.09 0.09": 1 "age week-old": 1 "serum tg mg/dl": 1 "healthy donors": 1 "15.3?±?1.0 0.32": 1 "hfd mice": 1 "number of animals": 1 "41/27/64": 1 "sample": 1 "n": 1 "dm2 with hba1c > 6.5": 1 "disease status": 1 "59/54/19": 1 "9.8?±?0.5* 0.031": 1 "67.8?±?4.5 0.64": 1 "dietary factors": 1 "alt iu?l ?1": 1 "physical inactivity": 1 "ast iu/l": 1 "notes": 1 "braf status": 1 "model p-value": 1 "serum fgf21 levels": 1 "aml patients": 1 "recommendations": 1 "rassf1a": 1 "mean 95 ci": 1 "db/db mice": 1 "ingredients g/100g dietary weight": 1 "95.0 ci for relative risk": 1 "alp unit/l": 1 "fasting blood glucose mmol/l": 1 "diabetes mellitus/hyperglycemia": 1 "sd g/kg diet": 1 "hsa.mir.103 adjusted for psa": 1 "27.5±4.2 p=0.68": 1 "qp?log?hergf": 1 "wbc count": 1 "0.20": 1 "0.21": 1 "wbc tsd/µl": 1 "76.4?±?7.3": 1 "0.19": 1 "target/mechanism": 1 "1a/1b/2a/2b/3a/3b/4": 1 "sledai": 1 "vegf pg/ml": 1 "ldl-c goals": 1 "1.02": 1 "0.32": 1 "17.1?±?0.9": 1 "title": 1 "8-ohdg µm": 1 "80.3±10.3": 1 "46.4?±?3.9* 0.012": 1 "disease**": 1 "diastolic blood pressure mmhg": 1 "ci ed50": 1 "46.1?±?4.0 0.18": 1 "shp-or 95 ci": 1 "men and women": 1 "bun mg?dl ?1": 1 "lbw insulin stimulated": 1 "1.12": 1 "cmi subjects": 1 "1.10": 1 "homa": 1 "demographic data": 1 "b-fgf pg/ml": 1 "gleason grade sum": 1 "1.06": 1 "primary tumors": 1 "7.7?±?0.5* 0.0015": 1 "hsa.mir.222": 1 "23.2?±?1.4": 1 "hsa.mir.103": 1 "13.2?±?0.8* 0.045": 1 "igf-i ng/ml": 1 "poor sleep and relaxation": 1 "u87-mk": 1 "59.4?±?5.0* 0.033": 1 "cre mg?dl ?1": 1 "27.0±4.3": 1 "hr": 1 "1.22": 1 "microalbuminuric patients n=28": 1 "immunological risk factors": 1 "number": 1 "population attributable risk": 1 "1.17": 1 "8.1 ±2.1 p=0.54": 1 "plasma leptin ng/ml": 1 "hscrp": 1 "model": 1 "effects of insulin": 1 "ci ed75": 1 "hb donorc": 1 "obesity abdominal": 1 "0.018": 1 "165.4±38.9 p=0.14": 1 "percent hiv- women 95 ci": 1 "relative risk": 1 "1.29": 1 "univariate 95 ci": 1 "tissue weight mg": 1 "treatment 1": 1 "current/ex/never": 1 "number ": 1 "118.7?±?8.6": 1 "alt iu/l": 1 "plasma insulin ng/ml": 1 "iii trimester n?=?21": 1 "women": 1 "frommds": 1 "15.6?±?1.1": 1 "sensitivity 95 ci": 1 "n-factor": 1 " n?=?12": 1 "89.3±24.1 p=0.096": 1 "15.6?±?1.6 0.24": 1 "ldl mg/dl": 1 "weight 2 mg/10 flies": 1 "subject 1": 1 "subject 3": 1 "15.0?±?0.9 0.53": 1 "subject 2": 1 "ci ed90": 1 "82/34/7/9": 1 "estimate 95 ci": 1 "patientid": 1 "maternal obesity": 1 "0.84": 1 "gestational diabetes mellitus n?=?25": 1 "exposures": 1 "68.2?±?5.6** 0.003": 1 "7.15?±?0.5* 0.0043": 1 "0.79": 1 "age-adjusted ratio of proportions 95 ci": 1 "87.3±7.2 p=0.014": 1 "esr": 1 "subject": 1 "0.99": 1 "inheritance": 1 "0.97": 1 "129.5±20.7 p=0.77": 1 "0.93": 1 "trial": 1 "alt unit/l": 1 "high": 1 "n0/n1/n2/n3": 1 "53.9±9.3 p=0.79": 1 "intensive": 1 "175±36 p=0.55": 1 "44.0?±?4.9* 0.043": 1 "blood glucose at 2 hours in ogtt mmol/l": 1 "elevated ldl – cholesterol": 1 "1.78": 1 "1.79": 1 "normal glucose tolerance n?=?25": 1 "hsa.mir.125b adjusted for psa": 1 "flt3": 1 "type of cancer": 1 "tnf? mean ± se": 1 "lbw": 1 "0.008": 1 "0.009": 1 "differentiation": 1 "1.80": 1 "8.0 ±1.76 p=0.58": 1 "psoriasis type": 1 "0.001": 1 "technique": 1 "fasting plasma insulin mu/l": 1 "pool*": 1 "hyperglycemia": 1 "plasma tissue factor activity pm": 1 "men": 1 "histopathological diagnosis": 1 "45.7?±?3.6** † 0.003": 1 "100.9±28.8 p=0.98": 1 "56.4?±?3.1** 0.0005": 1 "control insulin stimulated": 1 "current status": 1 "2.60": 1 "triglycerides mg/dl": 1 "7.7 ±1.3": 1 "73.5?±?5.6 0.21": 1 "51.6?±?6.1": 1 "receptor": 1 "s+g 2/m": 1 "? 4": 1 "normoalbuminric patients n=20": 1 "hbv dna copies/ml": 1 "hr beats/min": 1 "excessive alcohol consumption": 1 "n°": 1 "hsa.mir.125b": 1 "medical history of cvd or diabetes": 1 "hsa.mir.222 adjusted for psa": 1 "8.6±6.2": 1 "cre mg/dl": 1 "rs17849071g/t n/n ": 1 "g0/g1": 1 "apc status": 1 "histology": 1 "apc": 1 "diabetes duration years": 1 "medications": 1 "mutational status": 1 "diabetes mellitus type 2": 1 "?mutation status": 1 "moderate": 1 "age at diagnosis": 1 "aor 95 ci": 1 "2.80": 1 "psychosocial stress": 1 "52.4±6.5 p=0.76": 1 "genes": 1 "31–83 mean 66": 1 "cml treatment": 1 "10.8±6.0 p=0.24": 1 "tp g?dl ?1": 1 "nonimmunological risk factors": 1 "ldl-c mg/dl": 1 "u87": 1 "i trimester n?=?16": 1 "animal": 1 "molecule": 1 "weight added": 1 "il-6": 1 "rr": 1 "hfd g/kg diet": 1 "2.91": 1 "38.5?±?3.6** 0.007": 1 "patient number": 1 "association": 1 "146.2±46.1 p=0.87": 1 "2.95": 1 "39.7?±?3.4* 0.027": 1 "sd": 1 "11.9?±?0.8* 0.039": 1 "all patients": 1 "insulin signaling": 1 "ast iu?l ?1": 1 "patients n?=?135 n ": 1 "adverse fetal growth pattern": 1 "ingredients": 1 "lower 95 ci": 1 "30": 1 "12.9?±?1.6": 1 "shp+or 95 ci": 1 "il-6 mean ± se": 1 "no of factors": 1 "23.1?±?0.7 0.85": 1 "141": 1 "type 2 diabetes": 1 "tg": 1 "refs": 1 "tumor": 1 "15.1?±?0.5 0.074": 1 "elevated triglycerides": 1 "z-score": 1 "zdf": 1 "ratio": 1 "baseline factors": 1 "agent": 1 " n?=?38": 1 "thyroid hormone": 1 " n?=?33": 1 "cell lines": 1 "e2 pg/ml": 1 "source": 1 " n?=?123": 1 "motility ?m/min": 1 "# cellsa": 1 "70.1?±?4.1": 1 "p16": 1 "odds ratio 95 ci a ": 1 "controls n?=?501 n ": 1 "npm1": 1 "nct#": 1 "ldh iu?l ?1": 1 "overall survival": 1 "50": 1 "insulin ng/ml": 1 "35.9?±?2.2** 0.0042": 1 "systolic blood pressure mmhg": 1 "histological subtype": 1 "il-1? mean ± se": 1 " n?=?40": 1 "41.7±9": 1 "105.6?±?7.3 0.43": 1 "dm2 with hba1c ? 6.5": 1 "auc": 1 "genotype": 1 "or 95? ci": 1 "ibd-related drugs": 1 "53.3?±?4.9* 0.024": 1 "156.3±65.5 p=0.7": 1 "ast unit/l": 1 "name": 1 "alb g/dl": 1 "transporter/channel": 1 "low hdl – cholesterol": 1 "braf v600eihc": 1 "adjusted or 95? ci": 1 "137.5±20.3 p=0.11": 1 "nonmodifiable risk factors": 1 "53.1±10.1": 1 "10.8?±?1.0 0.13": 1 "6.10": 1 "176": 1 "family history of cvd or diabetes": 1 "71": 1 "t-factor": 1 ">10": 1 "10.8?±?0.5** 0.004": 1 "12.7?±?1.5 0.53": 1 "characteristics": 1 "duration of disease years": 1 "10.1?±?0.5** 0.0042": 1 " ratio": 1 "age chronological": 1 "thrombogenic factors": 1 "8.4?±?0.7 0.28": 1 "hdl": 1 " human oral absorptioni": 1 "45.8±16.2 p=0.31": 1 "sampleno.": 1 "specificity 95 ci": 1 "serum 6-keto-pgf-1? pg/ml": 1 "titlea": 1 "igf-ii": 1 "fab": 1 "tissue": 1 "18.6?±?1.0": 1 "50 ci": 1 "67/22/5/6/21/7/4": 1 "fbg mg/dl": 1 "serum fgf19": 1 "p53": 1 "qp?log?po/wh": 1 "igf-i": 1 "22.1?±?1.1 0.26": 1 "serum fgf21": 1 "t1am": 1 "age years old": 1 "tumor weight": 1 "98": 1 "5.76": 1 "phase": 1 "plasma free fatty acids mg/dl": 1 "percent hiv+ women 95 ci": 1 "tnf ?": 1 "samples": 1 "148.7±62.6": 1 "tp g/dl": 1 "101±22.2": 1 "adjusted odds ratio 95 ci a ": 1 "kgf pg/ml": 1 "m/f": 1 "plasma glucose mg/dl": 1 "circulating mirna": 1 "mir-155 target": 1 "prot": 1 "nlrp3 mean ± se": 1 "lean": 1 "low": 1 "73.5?±?3.9** 0.0002": 1 "ast u/l": 1 "22.6?±?1.1 0.18": 1 "8.8?±?0.6 0.09": 1 "dyslipidemia/hyperlipidemia": 1 "modifiable risk factors": 1 "6.1?±?0.6": 1 "*comparison has been made with normoalbuminuric patients.": 1 "p-stage": 1 "14.3?±?0.8 0.11": 1 "81.1±10.9 p=0.78": 1 "site": 1 "glu g/dl": 1 "30 d": 1 "high blood pressure": 1 "t1/t2/t3/t4": 1 "msg": 1 "0.0006": 1 "9.0?±?0.6* 0.011": 1 "0.0004": 1 "0.0002": 1 "127.8±19": 1 "hb acceptord": 1 "multivariate 95 ci": 1 "9.8?±?0.6 0.09": 1 "offspring age years": 1 "primary/recurrent": 1 "dsdna": 1 "obesity": 1 "combination": 1 "macroalbuminuric patients n=22": 1 "strain": 1 "alt u/l": 1 "hdl-c mg/dl": 1 "liver weight": 1 "patients": 1 "mice id": 1 "age at injection initiation ?18 n=352 61": 1 "insulin resistance index": 1 "panca- related diabetes": 1 "26.9±4.1 p=0.95": 1 "effect": 1 "case number": 1 "old g/kg diet": 1 "week": 1 "cholesterol mg/dl": 1 "u87-wt": 1 "bil ul/dl": 1 "10.8?±?0.5 0.07": 1 "donor": 1 "10.2?±?0.5** 0.0002": 1 "protein expression/phosphorylation": 1 "or 95 ci p value": 1 "10.9?±?0.7* 0.023": 1 "qp?log?sg": 1 "age at injection initiation <18 n=229 39": 1 "10.0?±?0.6* 0.029": 1 "tfa+msg": 1 "groups": 1 "11.8?±?0.7** 0.002": 1 "12.1?±?0.8* 0.043": 1 "egfr group": 1 "55.1?±?2.3* 0.039": 1 "tc mg/dl": 1 "75 ci": 1 "8.7?±?0.9": 1 "sig p value": 1 "mwb": 1 "coefficients": 1 "c3/c4": 1 "94/15/22/1": 1 "blasts ": 1 "6.9?±?0.4 0.078": 1 
"protein": 69 "protein name": 32 "reference": 28 "protein of unknown function": 27 "conserved protein of unknown function": 23 "pi": 21 "function": 20 "gene": 19 "hypothetical protein": 17 "mw kda": 16 "protein description": 15 "sequence coverage ": 14 "fold change": 13 "peptide sequence": 12 "name": 12 "protein id": 11 "hypothetical membrane protein": 10 "100": 10 "symbol": 10 "a": 9 "conserved hypothetical protein": 9 "spot no.": 9 "location": 8 "accession no.": 7 "24": 7 "mascot score": 7 "description": 7 "conserved hypothetical membrane protein": 7 "accession number": 6 "membrane protein of unknown function": 6 "locus": 6 "localization": 6 ".01": 5 "protein score": 5 "gene symbol": 5 "sequence": 5 "score": 5 "accession": 5 "peptide": 5 "peptides": 5 "protein function": 5 "gi": 5 "r": 4 "mutation": 4 "disease association": 4 "disease": 4 "major facilitator superfamily mfs transport protein": 4 "identified protein": 4 "normal function": 4 "immunostaining": 4 "29": 4 "50": 4 "references": 4 "phosphorylation": 4 "gene name": 4 "human protein": 4 "fold": 4 "spot no": 4 "total protein": 4 "?coverage": 4 "protein class": 4 "+": 3 "function fig 1 ": 3 "proton-dependent oligopeptide transporter pot family protein di- or tripeptide h+ symporter": 3 "protein level": 3 "z": 3 "extracellular": 3 "aspartate carbamoyltransferase": 3 "?": 3 "protein expression": 3 "c-domain sace": 3 "protein type": 3 "count": 3 "nuclear": 3 "entrez gene name": 3 "fold-change": 3 "protein score c": 3 "mrna": 3 "21": 3 "22": 3 "23": 3 "26": 3 "27": 3 "ratio": 3 "sequence coverage": 3 "swiss prot acc no .": 3 "annotation": 3 "swissprot accession number": 3 "spot": 3 "serine permease": 3 "species": 3 "spot number": 3 "conserved hypothetical lipoprotein": 3 "p-value": 3 "identification": 3 "fusion protein": 3 "spot no a": 3 "subcellular localization": 3 "n-domain sace": 3 "percentage": 3 "subcellular location": 3 "virus": 3 "charge": 3 "protein symbol": 3 "protein names": 3 "503": 3 "id": 3 "mr kda": 3 "no": 3 "control": 3 "mowse score": 3 "swissprot id": 3 "matched peptide": 3 "protein name abbreviation": 3 "accession number b": 3 "protein ids": 2 "francisella effector of virulence regulation": 2 "mascotscore": 2 "8": 2 "ftl_1542": 2 "theor.pi/mw kda": 2 "-9.4": 2 "ribonuclease ii family protein": 2 "swiss-prot id": 2 "nadph-quinone reductase modulator of drug activity b": 2 "v": 2 "peptidic species count": 2 "ms/ms": 2 "others": 2 "acid phosphatase": 2 "ftn_0710": 2 "alanine racemase": 2 "pilo": 2 "pilq": 2 "ftn_0297": 2 "ftn_1137": 2 "ftn_1139": 2 "cls": 2 "ftl_1914": 2 "ftn_1154": 2 "ftn_1145": 2 "coverage ": 2 "pdb id": 2 "ftn_1175": 2 "670": 2 "200": 2 "ms-fit mowsescore": 2 "221": 2 "quea": 2 "228": 2 "prfc": 2 "ftn_1655": 2 "uniprot id": 2 "ftn_1686": 2 "competence lipoprotein coml": 2 "284": 2 "ftn_1231": 2 "ftn_1222": 2 "threonine synthase": 2 "ftn_1241": 2 "ftn_1234": 2 "intracellular growth locus subunit c": 2 "arabidopsis protein name": 2 "excinuclease abc subunit c": 2 "swiss nr": 2 "ca1a": 2 "n/a": 2 "ftn_0727": 2 "ca1h": 2 "ftn_0728": 2 "prma": 2 "unique peptides seq/mod/labels": 2 "unknown": 2 ".003": 2 "ftn_0746": 2 "tryptophan-rich sensory protein": 2 "low protein": 2 "dna/rna endonuclease g": 2 "ftn_1612": 2 "ftn_1611": 2 "ftn_0768": 2 "group": 2 "ftn_1621": 2 "migr": 2 "ftn_1624": 2 "aspartate semialdehyde dehydrogenase": 2 "p value": 2 "protein name/ function": 2 "ftn_0792": 2 "ftn_0788": 2 "no of peptides": 2 "fpi proteins": 2 "putative function": 2 "term": 2 "vgrg": 2 "bira": 2 "nudh": 2 "locus tag": 2 "human": 2 "no of unique peptides": 2 "ftn_1034": 2 "ftn_1027": 2 "-6.4": 2 "gloa": 2 "ribosomal large subunit pseudouridine synthase c": 2 "nfscs": 2 "bifunctional nmn adenylyltransferase/nudix hydrolase": 2 "ftn_1061": 2 "inheritance": 2 "transposase": 2 "ftn_1073": 2 "position": 2 "ftn_1098": 2 "intracellular growth locus a": 2 "class of protein": 2 "type i restriction–modification system subunit s": 2 "ftn_0692": 2 "theoretical/estimated pi": 2 "kpsf": 2 "ftn_1553": 2 "30": 2 "lactoylglutathione lyase": 2 "rluc": 2 "agent": 2 "kog class": 2 "septum formation inhibitor-activating atpase": 2 "wbto": 2 "cover percent ": 2 "mass": 2 "ftn_1597": 2 "ftn_0286": 2 "number of matched peptides": 2 "99": 2 "polypeptide molecular weight kda": 2 "iron–sulfur cluster-binding protein": 2 "multiple spots": 2 "ftn_0624": 2 "unique peptide sequences": 2 "lys-ac sites": 2 "fevr": 2 "ftn_0646": 2 "proteins of unknown function": 2 "gene id/gi number": 2 "holliday junction endodeoxyribonuclease": 2 "ftn_1518": 2 "quinolinate synthetase a": 2 "intracellular growth locus protein b": 2 "ftn_0680": 2 "ruvc": 2 "ftl_0439": 2 "major facilitator super family mfs transport protein": 2 "target protein s": 2 "rat": 2 "treatment/control ratio": 2 "acee": 2 "metabolic proteins": 2 "pathway": 2 "ftn_0915": 2 "controls": 2 "glycosyl transferase group 2": 2 "tspo": 2 "ref": 2 "ratio h/l significance": 2 "sm5 versus wta": 2 "shikimate 5-dehydrogenase": 2 "ftn_0925": 2 "839": 2 "uvrc": 2 "14-3-3 protein zeta/delta protein kinase c inhibitor protein 1 kcip-1": 2 "ftn_0930": 2 "ftn_0933": 2 "adenylosuccinate synthetase": 2 "gdp pyrophosphokinase/gtp pyrophosphokinase": 2 "acka": 2 "frequency ": 2 "ftn_0954": 2 "dgtp pyrophosphohydrolase": 2 "0.028": 2 "peptide chain release factor 3": 2 "theoretical/estimated mw kda": 2 "ftn_1395": 2 "ftn_0063": 2 "0.013": 2 "kdpc": 2 "nada": 2 "predicted nad/fad-dependent oxidoreductase": 2 "era": 2 "yield": 2 "418": 2 "predicted co/zn/cd cation transporter": 2 "biological function": 2 "ftn_0090": 2 "protein spot no.": 2 "alr": 2 "protein definition": 2 "t1k": 2 "trna-dihydrouridine synthase": 2 "propionate kinase 2/acetate kinase a": 2 "467": 2 "-3.5": 2 "ftn_0567": 2 "accession n °": 2 "ftn_1428": 2 "ftn_0109": 2 "ripa": 2 "ftn_0598": 2 "asd": 2 "mouse": 2 "ftn_0125": 2 "cytoplasmic": 2 "trna synthetase class ii d k and n": 2 "tyrosine permease": 2 "ftn_0133": 2 "ftn_0149": 2 "rela": 2 "rok family protein": 2 "ftn_1494": 2 "tissue": 2 "type iv pili glycosylation protein": 2 "tkta": 2 "ftn_0965": 2 "carb": 2 "igla": 2 "iglc": 2 "iglb": 2 "probability": 2 "igli": 2 "ftn_0977": 2 "nsc": 2 "ftn_0983": 2 "ftn_0504": 2 "ftn_0988": 2 "50s ribosomal protein l11 methyltransferase": 2 "branched-chain amino acid aminotransferase protein class iv": 2 "functional module": 2 "ftn_0511": 2 "ftn_0997": 2 "histidine acid phosphatase": 2 "ftn_0524": 2 "ftn_0527": 2 "effect": 2 "rnfb": 2 "p -aminobenzoate synthase component i": 2 "ftn_0545": 2 "lysine decarboxylase": 2 "ftn_1406": 2 "rank": 2 "spot id": 2 "type iv pili secretin component": 2 "acid phosphatase had superfamily protein": 2 "1.15 down": 2 "macrophage growth locus protein a": 2 "atp-binding cassette abc superfamily protein": 2 "g4": 2 "ftn_0811": 2 "5.0": 2 "mgla": 2 "carbamoyl-phosphate synthase large chain": 2 "ftn_0822": 2 "gtp-binding protein": 2 "csck": 2 "transketolase i": 2 "phosphosugar isomerase": 2 "ftn_1263": 2 "ftn_1256": 2 "transcription/translation": 2 "metallopeptidases carboxypeptidases proteases": 2 "type iv pilin": 2 "ftn_1290": 2 "viral protein": 2 "potassium-transporting atpase c chain": 2 "mr": 2 "cardiolipin synthetase": 2 "total": 2 "subtype": 2 "ncbi no.": 2 "ftn_0444": 2 "transporter proteins": 2 "spot #": 2 "amino acid–polyamine–organocation family protein": 2 "ftn_1309": 2 "glycerol kinase": 2 "ftn_1313": 2 "ftn_1317": 2 "hypothetical proteins": 2 "ftn_0480": 2 "ftn_0483": 2 "ftn_1322": 2 "ftn_1324": 2 "ftn_1323": 2 "ftn_1325": 2 "ratio h/l": 2 "ftn_1333": 2 "macrophage intracellular growth regulator": 2 "ftt1103": 2 "ftn_1344": 2 "ftn_1343": 2 "ftn_1349": 2 "pura": 2 "ftn_0030": 2 "pdpa": 2 "ftn_0027": 2 "type i restriction-modification system subunit r restriction": 2 "pdpd": 2 "coverage": 2 "transferase": 2 "ftn_0038": 2 "type": 2 "ftn_0840": 2 "ftn_0847": 2 "expectedvalue": 2 "ilve": 2 "coml": 2 "ftn_0855": 2 "required for intracellular proliferation factor a": 2 "matching peptides": 2 "pyruvate dehydrogenase complex e1 component pyruvate dehydrogenase": 2 "ftn_1711": 2 "ftn_1716": 2 "fraction": 2 "site": 2 "protein source": 2 "ftn_0877": 2 "thrc": 2 "ftn_0403": 2 "tyrp": 2 "protein interaction": 2 "metal-dependent exopeptidase": 2 "deda family protein": 2 "mdab": 2 "bifunctional protein glutaredoxin 3/ribonucleotide reductase beta subunit": 2 "groups": 2 "ftn_1764": 2 "no matched peptides": 2 "# of peptides used sequence coverage": 2 "ak020693": 1 "ret finger protein": 1 "cci": 1 "21304": 1 "swsn24_human p51532 possible global transcription activator": 1 "mw 2 kda": 1 "prot param": 1 "ratio hmyc-dok1/luntransfected": 1 "ter": 1 " ": 1 "control/toxoplasma encephalitis fold change": 1 "submaxillary gland androgen regulated protein": 1 "kog4582 runcharacterized conserved protein contains zz-type zn-finger 9": 1 "csn1s2a": 1 "nm_009973": 1 "protein size": 1 "frames": 1 "accession #": 1 "amy1": 1 "1471": 1 "1": 1 "2": 1 "size": 1 "4": 1 "5": 1 "7": 1 " of all rnas significantly bound": 1 "csn1s2b": 1 "10.9": 1 "cerebellum": 1 "# psm phos": 1 "t spiralis": 1 "arf4": 1 "protein pi": 1 "cog0386 oglutathione peroxidase 2": 1 "expressional fold change": 1 "bf119305": 1 "casein alpha s2-like a": 1 "glycine cleavage system p protein subunit 1": 1 "casein alpha s2-like b": 1 "swdri_drome q24573 dead ringer protein": 1 "av246759": 1 "av334599": 1 "i": 1 "55593": 1 "pi/mw? kda": 1 "p": 1 "t": 1 "cellulose g glucan": 1 "1485": 1 "6.1": 1 "so3na?": 1 "information": 1 "6.7": 1 "up/down": 1 "mda-mb435 protein ": 1 "swfyb_human o15117 fyn-binding protein": 1 " ethanol 3": 1 "ftt1720c": 1 "ahnak2 abcc5 cd59": 1 "tig": 1 "chloride channel calcium activated 1": 1 "total ion scored": 1 "nuclear import": 1 "ftt1721c": 1 "601": 1 "# psm non-phos": 1 "rbsk": 1 "mes peptide": 1 "p-erk": 1 "bb524685": 1 "endo phago": 1 "membrane permeability": 1 "tg-ang ii n?=?6": 1 "saicar synthetase/phosphoribosylamine-glycine ligase": 1 "kog4018 suncharacterized conserved protein contains rwd domain 2": 1 "pcdhb9": 1 "tooth 5": 1 "theoretical molar mass kda/pi": 1 "glutamine amidotransferase/asparagine synthase": 1 "1.11 down": 1 "suspected mw kda": 1 "submaxillary gland androgen regulated protein 2": 1 "total crude protein": 1 "pcp": 1 "ftn_0709": 1 "phosphoribosylformylglycinamidine synthase": 1 "tcte1l": 1 "aldolase/adducin class ii family protein": 1 "human polycomb protein": 1 "226.6": 1 "3h-dnp-sg": 1 "protein interactors": 1 "n ‡": 1 "pdb": 1 "?anti-freeze protein": 1 "emre": 1 "cancer": 1 "ang ii 12 h + dexamethasone": 1 "elisa a/ a0": 1 "rlip76 protein": 1 "non-endo": 1 "ftn_0290": 1 "janus kinase 1": 1 "ftn_1135": 1 "bc082081": 1 "ftn_0287": 1 "experiment": 1 "ak007630": 1 "35 days": 1 "choloylglycine hydrolase family protein": 1 "lepa": 1 "pila": 1 "measureda m/z ": 1 "order": 1 "dsbb": 1 "angioscore": 1 "sbp decrease mm hg": 1 "38.1513": 1 "angiogenesis": 1 "total peptide": 1 "chromosomal rearrangement": 1 "abc-type oligopeptide transport system periplasmic component": 1 "accessionnumber gi": 1 "gi|6756041": 1 "ftn_0299": 1 "heme o synthase": 1 "transcriptional response regulator": 1 "myristoylation motif": 1 "uniprot accessiona": 1 "conserved": 1 "kog4096 suncharacterized conserved protein 2": 1 "demilune cell and parotid protein": 1 "swdrpl_human p54259 atrophin-1": 1 "udp-glucose-4-epimerase wbtc o-antigen polysaccharide biosynthesis": 1 "mutt/nudix family protein": 1 "1083": 1 "ftn_1156": 1 "na+/h+ antiporter regulation of ph": 1 "-5.6": 1 "dtdp-glucose 46-dehydratase wbta o-antigen polysaccharide biosynthesis": 1 "-5.9": 1 "ftn_1170": 1 "proteins identified": 1 "ftl_0606": 1 "ftn_1172": 1 "experiment no.": 1 "ftn_1176": 1 "fe2 transport system protein a": 1 "lignin peroxidase manganese peroxidase": 1 "transcription factor ap-2 beta": 1 "bola family protein": 1 "phosphorylated peptide 1": 1 "100 um": 1 "kog0300 swd40 repeat-containing protein 2": 1 "hypothetical outer membrane protein": 1 "protein length": 1 "pia": 1 "infected lymph***": 1 "polyphen consequence": 1 "molecular weight kda": 1 "cyclin-dependent kinase inhibitor 2b p15": 1 "ace2 -/y control": 1 "674": 1 "pip": 1 "number of unique identified peptidesc d": 1 "ht/lcl": 1 "sirna screen": 1 "ncb inr id no.": 1 "ftn_1197": 1 "half-life": 1 "ace2 -/y irbesartan": 1 "688": 1 "uterine expression": 1 "gyk": 1 "coverage score": 1 "nm_013605": 1 "nm_220798": 1 " covb": 1 "47.6345": 1 "parotid secretory protein": 1 "3.9 ?": 1 "nm_011422": 1 "693": 1 "lch": 1 "210": 1 "lcl": 1 "whole cell": 1 "eg mip major intrinsic protein aquaporin-9?10": 1 "dna/rna endonuclease family": 1 "kog1717 vdual specificity phosphatase 2": 1 "swssb3_chick q98948 single-stranded dna-binding": 1 "cog4973 lsite-specific recombinase xerc 2": 1 "erbb2": 1 "gamma-glutamyl transpeptidase amino acid arachidonic acid and glutathione": 1 "alkoli insoluble": 1 "crx": 1 "arob": 1 "kog1873 oubiquitin-specific protease 2": 1 "aroa": 1 "detection method": 1 "organ- ism": 1 "kog0559 cdihydrolipoamide succinyltransferase 2-oxoglutarate dehydrogenase e2 subunit 2": 1 "identity ": 1 "change of core components g/l before/after": 1 "s991a": 1 "ftn_0330": 1 "q9nwf5 cdna flj10059 fis clone hemba 1001": 1 "kog3994 suncharacterized conserved protein 2": 1 "cancer cell": 1 "mutl": 1 "47.4533": 1 "ftn_1656": 1 "imps": 1 "238": 1 "1.07 up": 1 "lee's": 1 "molecular mass kdab": 1 "extracellular activity of key enzymes u/l or u/mg protein": 1 "amylase 1 salivary": 1 "ctu": 1 " mg/108 cells": 1 "hypothetical protein possible capsule-related protein": 1 "ftt1665": 1 "240": 1 "ftn_0331": 1 "index of evaluation": 1 "kog1716 vdual specificity phosphatase 2": 1 "ftn_0336": 1 "kinase activity": 1 "ftn_0338": 1 "molecule": 1 "ubiquitin specific peptidase 32": 1 "er protein": 1 "1902": 1 "a/j": 1 "restriction endonuclease": 1 "best hit overall": 1 "number of peptidesb": 1 "gi|3065925": 1 "go signal transduction": 1 "ftn_0343": 1 "cog1997 jribosomal protein l37ae/l43a 2": 1 "258": 1 "dihydroorotate oxidase": 1 "baz2b": 1 "kog3150 suncharacterized conserved protein 2": 1 "swk10_drome p13468 dna-binding protein k10": 1 "tissue ang ii": 1 "phenotype": 1 "kog0698 tserine/threonine protein phosphatase 2": 1 "matched peptide sequences": 1 "phosphosite 5": 1 "c-domain sace specific rxpa380 inhibitor 17": 1 "263": 1 "ftn_0358": 1 "pmef protein ": 1 "wnt3a-60": 1 "wnt3a-240": 1 "secretome": 1 "eg helicase_c dead atp-dependent rna helicase spliceosome rna helicase bat1 peroxiredoxin-5 redoxin": 1 "heat shock proteins": 1 "go regulation of gene expression": 1 "glutamate decarboxylase": 1 "3.4 ?": 1 "source": 1 "ftt1236": 1 "normal level": 1 "ftt1234": 1 "ftn_1696": 1 "trigger factor tf protein": 1 "276": 1 "ftn_1215": 1 "ftn_1217": 1 "two-component regulator sensor histidine kinase": 1 "4.2 ?": 1 "pra": 1 "dimerization/oligomerization domain": 1 "identification & functional category": 1 "domain combinations": 1 "phosphosite s": 1 "ftn_0384": 1 ".02": 1 "288": 1 "# unique peptides phos + non-phos": 1 "monosaccharide composition mol": 1 "gi|51452": 1 "ftt1244c": 1 "2.6 ?": 1 "cellular localisation": 1 "5085": 1 "kog2166 dcullins 2": 1 "rho gtpase activating protein 12": 1 "excinuclease abc subunit b": 1 "290": 1 "psp": 1 "ftn_1240": 1 "# psm phos + non-phos": 1 "protein kinase": 1 "ftn_1233": 1 "intracellular growth locus subunit i": 1 "bb795585": 1 "dj-1/pfpi family protein": 1 "ms/ms fragment": 1 "peptide sequences*": 1 "intracellular growth locus subunit d": 1 "kog2572 ajribosome biogenesis protein—nop58p/nop5p 2": 1 "sequence length aa": 1 "pak1": 1 "kog4093 suncharacterized conserved protein 2": 1 "alk ihc staining": 1 "peptide encoding transcripts": 1 "protein k d nm": 1 "?-glucan µg": 1 "bbb formation": 1 "ventricles": 1 "eyes absent 1 homolog drosophila": 1 "cellular localization": 1 "predicted pathway": 1 "crude protein": 1 "theoretical value": 1 "best hit non trichoderma": 1 "inheritance pattern": 1 "suppressed modules/subnetwork †": 1 "kog4095 runcharacterized conserved protein tumor-specific protein bcl7 in humans 2": 1 "phenotype associated with mutation": 1 "dna repair protein rad51 dnaj family": 1 "eg heat shock protein 90 hsp 70 hsp 20 hsp 30": 1 "protein mw da": 1 "ribonuclease hii": 1 "kog0691 omolecular chaperone dnaj superfamily 7": 1 "ftn_0739": 1 "adam23 cpm lgmn": 1 "swcbp_human q92793 creb-binding protein": 1 "olfactory marker protein": 1 "? h3k9me2": 1 "swpclo_rat q9jks6 piccolo protein": 1 "best ion scored": 1 "ncbinr accession number": 1 "gmp synthase glutamine-hydrolyzing": 1 "pi/ mw kda": 1 "cogs 7": 1 "fluorescence intensity of f-actin in gencs": 1 "experimental assay": 1 "ncu #": 1 ".008": 1 "bmp4": 1 "cell cycle": 1 "miranda": 1 "cog0152 fphosphoribosylaminoimidazolesuccinocarboxamide saicar synthase 5": 1 "kog3164 runcharacterized proteins of pilt n-term./vapc superfamily 2": 1 "manganese superoxide dismutase catalase p450-oxidoreductase glutathione 3": 1 "riken cdna 5330408n05 gene": 1 "adamts8 mmel1 timp3 tll1 usp46": 1 "blast result": 1 "swbrm_drome p25439 homeotic gene regulator": 1 "kog3377 suncharacterized conserved protein 2": 1 "participants or cells/treatment": 1 "kog0102 omolecular chaperones mortalin/pbp74/grp75 hsp70 superfamily 7": 1 "full-length cdnas": 1 "yeast gene s a": 1 "ftn_0759": 1 "identified peptide sequence": 1 "kog3277 suncharacterized conserved protein 2": 1 "180 days": 1 "guanine nucleotide-binding protein g i/g s/g t subunit beta-1": 1 "g2 switch i": 1 "mucin type": 1 "nm_001013228": 1 "translocation protein 1": 1 "shown": 1 "geranylgeranyltransferase ii ggt2 or rabggt": 1 "ftn_1619": 1 "site in human": 1 "sub-cellular localization": 1 "kog2443 suncharacterized conserved protein 4": 1 "cold shock-like protein cspc": 1 "effect on signaling": 1 "superoxide dismutase cu–zn precusor": 1 "ftn_1620": 1 "ncbi gi": 1 "kog0699 tserine/threonine protein phosphatase 2": 1 "ftl_1583": 1 "gap specificity": 1 "gossypol-treated": 1 "10 serum": 1 "nm_001013200": 1 "aa 1 coverage ": 1 "alias": 1 "constructc": 1 "hslv": 1 "igfbp protease": 1 "ptpip51": 1 "lyase": 1 "sodc": 1 "kog0389 bsnf2 family dna-dependent atpase 2": 1 "cytosolic": 1 "cyclin-dependent kinase inhibitor 1a p21": 1 "ftn_0799": 1 "p21 cdkn1a-activated kinase 1": 1 "ftn_0319": 1 "receptor protein": 1 "pfc522": 1 "kog2055 rwd40 repeat protein 2": 1 "chia": 1 "27.9248": 1 "access no": 1 "t-box 15": 1 "cardiac ang ii pg/mgprot": 1 "4.8 ?": 1 "bclaf": 1 "activated modules *": 1 "kog1042 dgerm-line stem cell division protein hiwi/piwi negative developmental regulator 4": 1 "ftl_0789": 1 "ftl_0304": 1 "animal protein g/y": 1 "galactose-proton symporter major facilitator superfamily mfs transport protein": 1 "pept total": 1 "clpb": 1 "7.1": 1 "7.2": 1 "treatment": 1 "phosphomannomutase": 1 "spectra": 1 "plasma ang i": 1 "maldi-tof": 1 "22739": 1 "cytochrome bd-ii terminal oxidase subunit i": 1 "chitinase acidic": 1 "kog0715 omolecular chaperone dnaj superfamily 8": 1 "swnco6_human q14686 nuclear receptor coactivator": 1 "?-glucan µg": 1 "h sapiens": 1 "ras-gtpase activating protein": 1 "glycerol-3-phosphate transporter": 1 "2449": 1 "negative control": 1 "fragment m/z": 1 "stress response": 1 "hypothetical membrane protein lps biosynthesis": 1 "cdkn2b": 1 "2442": 1 "ftl_1670": 1 "tmcg/dipy/2pcpab": 1 "alkali soluble": 1 "mind": 1 "dtdp-glucose 46-dehydratase wbtm o-antigen polysaccharide biosynthesis": 1 "minc": 1 "dotu": 1 "protein full name": 1 "ang ii peptide": 1 "sspa": 1 "bc010288": 1 "bc011134": 1 "ste-20 related kinase": 1 "3-dehydroquinate synthetase": 1 "cdkn1a": 1 "y998f": 1 "gene names": 1 "kog3992 suncharacterized conserved protein 2": 1 "similarity over aa": 1 "ftl_1606": 1 "peptide no.": 1 "6 epm2a interracting protein": 1 "710": 1 "subnetwork §": 1 "totalinstances": 1 "kog1768 j40 s ribosomal protein s26 3": 1 "bg064038": 1 "swhrs_drome q960x8 hepatocyte growth factor regulator": 1 "protein family/domain": 1 "glgb": 1 "acidic nuclear phosphoprotein 32 family member e": 1 "kog0472 sleucine-rich repeat protein 5": 1 "pryb": 1 "pfc942": 1 "cog0074 csuccinyl-coa synthetase alpha subunit 2": 1 "trpg": 1 "carbohydrate metabolism": 1 "region on protein": 1 "spectral counts": 1 "gi|33440467": 1 "c-domain ace-bppb peptide complex": 1 "name/cat #": 1 "ros 1 mmol/l": 1 "alpha": 1 "homo": 1 "brca1": 1 "nm_011709": 1 "company": 1 "fermentable sugar g/l": 1 "drug or therapy": 1 "number of unique identified peptidesc": 1 "42.7": 1 "cyoe": 1 "kog0655 dg1/s-specific cyclin e 2": 1 "source protein": 1 "ftl_0766": 1 "codon": 1 "figa": 1 "742": 1 "phospholipase b1": 1 "f11": 1 "1185": 1 "drug class": 1 "target protein": 1 "alpha-enolase 2-phospho-d-glycerate hydro-lyase non-neural enolase": 1 "ftn_0169": 1 "ftn_1018": 1 "ftn_1017": 1 "ncbi gi number": 1 "nm_008109": 1 "arsb arsenite/antimonite exporter": 1 "ligands": 1 "ftl_0706": 1 "sugar porter sp family protein": 1 "calcium/calmodulin-dependent protein kinase ii b": 1 "ftn_0182": 1 "classification": 1 "ftn_1031": 1 "cys ": 1 "tgfb2": 1 "ftn_0178": 1 "760": 1 "modules §": 1 "50 um": 1 "silact24t/t24ratio": 1 "-6.0": 1 "status": 1 "s pombe": 1 "113114": 1 "silac ratio": 1 "2056": 1 "774": 1 "777": 1 "stringent starvation protein a/regulator of transcription": 1 "man": 1 "swcbpa_dicdi p35085 calcium-binding protein": 1 "2067": 1 "cysd": 1 "kog1685 suncharacterized conserved protein 4": 1 "positive": 1 "2063": 1 "peptides 95": 1 "25.7242": 1 "ftn_0199": 1 "ftn_1046": 1 "783": 1 "kog2514 suncharacterized conserved protein 2": 1 "hydrolase": 1 "xm_229225": 1 "dimt1": 1 "class of inhibitor": 1 "kog1714 j60 s ribosomal protein l18 3": 1 "kog3214 suncharacterized zn ribbon-containing protein 2": 1 "nm_022863": 1 "kog2442 runcharacterized conserved protein contains pa domain 2": 1 "residency": 1 "score/e-value": 1 "theor mw kda": 1 "mda nmol/mg protein": 1 "bc099207": 1 "beta-lactamase class a": 1 "ftn_1064": 1 "glpk": 1 "ftn_1058": 1 "311": 1 "solution": 1 "spicule": 1 "phoh family protein putative atpase": 1 "glpt": 1 "rgs protein": 1 " coverage": 1 "cog0092 jribosomal protein s3 3": 1 "sub-cellular location": 1 "peptide sequence obtained by tandem mass spectrometry": 1 "no of peptides matched": 1 "a549/ 3kt": 1 "glpd": 1 "swca14_caeel p17139 collagen alpha 1 iv chain p": 1 "324": 1 "kog1002 lnucleotide excision repair protein rad16 2": 1 "ang ii 12 h": 1 "30?min": 1 "guaa": 1 "guab": 1 "swglt5_wheat p10388 glutenin high molecular weight": 1 "galp1": 1 "sequence covered ": 1 "relative volume of in-treated ": 1 "c57bl/6": 1 "putative protein kinase": 1 "beta": 1 "angiogenesis and blood brain barrier bbb formation": 1 "peptide antisera": 1 "putative membrane transporter of cations and cationic drugs multidrug resistance protein": 1 "protein identity b": 1 "nm_053134": 1 "fusion protein or mutated protein": 1 "bromodomain adjacent zinc finger domain 2b": 1 "ftt0435": 1 "compound": 1 "ral a-binding protein": 1 "mh+": 1 "no a": 1 "tbc1d15": 1 "totalindependentspectra": 1 "bc021770": 1 "mwa da": 1 "2007/08": 1 "content ** ": 1 "350": 1 "observed": 1 "209.7": 1 "viral life cycle": 1 "mrp1": 1 "ftn_0687": 1 "matrix protein coated": 1 "bc021401": 1 "gdf5": 1 "11": 1 "metn": 1 "12": 1 "13": 1 "whey acidic protein": 1 "17": 1 "cell division": 1 "19": 1 "pseudogene nicotinamide ribonucleoside nr uptake permease pnuc family protein": 1 "non-rgs domains": 1 "major facilitator superfamily transporter": 1 "ftn_1542": 1 "ftn_0211": 1 "ftn_0695": 1 "364": 1 "ftn_0696": 1 "368": 1 "peptidase": 1 "369": 1 "sua5/ycio/yrdc family protein": 1 "unique": 1 "ftn_0218": 1 "12 h": 1 "priming": 1 "mass kda": 1 "gi number": 1 "25": 1 "insulin": 1 "28": 1 "kpsc": 1 "experiments": 1 "wbth": 1 "maldi-tof-ms": 1 "mucin 1 transmembrane": 1 "wbtc": 1 "wbta": 1 "protein function www.uniprot.org ": 1 "116113": 1 "ftn_1557": 1 "10 tms drug/metabolite exporter protein": 1 "ratio 8 g /control": 1 "1h": 1 "116114": 1 "hypothetical protein polyphosphate kinase": 1 "heat shock protein hsp 90-beta": 1 "total length aa": 1 "32": 1 "glyoxal oxidase aryl-alcohol oxidase ferroxidase 2": 1 "34": 1 "protein added": 1 "su/lcl": 1 "kog0557 cdihydrolipoamide acetyltransferase 2": 1 "tm domains 4": 1 "bg862223": 1 "small conductance mechanosensitive ion channel mscs family protein": 1 "2h": 1 "allelic loss": 1 "protein identification": 1 "manc": 1 "manb": 1 "bone morphogenetic protein 4": 1 "kog4071 suncharacterized conserved protein 2": 1 "q9nud8 dj50o24.6 b120 c1orf4": 1 "ftn_1581": 1 "ftn_1584": 1 "ich": 1 "endo count": 1 "dcpp": 1 "type iv pili pilus assembly protein": 1 "399": 1 "protein tyrosine phosphatase interracting protein": 1 "57": 1 "# amino acids": 1 "ftn_1593": 1 "tg-ctrl n?=?6": 1 "modification": 1 "ftn_1585": 1 "wbtm": 1 "4h": 1 "ls/wt log2": 1 "g3 switch ii": 1 "-81.2": 1 "4.77": 1 "hgnc": 1 "farnesyltransferase ft": 1 "36420": 1 "# of peptides": 1 "carbamoyl-phosphate synthase small chain": 1 "ftn_0275": 1 "4.73": 1 "ftn_1121": 1 "xasa": 1 "cog0355 cf0f1-type atp synthase epsilon subunit mitochondrial delta subunit 2": 1 "transm em brane receptor": 1 "nm_011271": 1 "go cell ion homeostasis": 1 "1.2 up": 1 "asymmetric division protein": 1 "claudin 10": 1 "functional association": 1 "e2f1 status": 1 "78": 1 "ratio rp/ control": 1 "anp32e": 1 "asparaginase": 1 "kog4838 suncharacterized conserved protein 2": 1 "ppargc1a": 1 "ms/ms analysis": 1 "swssxt_mouse q62280 ssxt protein syt protein": 1 "ftn_1131": 1 "38.3": 1 "14c-dox": 1 "comment": 1 "plant viridiplantae limited": 1 "feoa": 1 "4.97": 1 "rbbp4": 1 "cldn10": 1 "molecularweight kda": 1 "stim.": 1 "arabidopsis protein": 1 "kog4681 suncharacterized conserved protein 2": 1 "protein effect": 1 "ang ii+dal": 1 "peroxidase/catalase": 1 "transport activity": 1 "125i-renin binding ": 1 "kog2167 dcullins 2": 1 "nm_024151": 1 "amino acid antiporter": 1 "experimental molar mass kda/pi": 1 "magnaporthe": 1 "8h": 1 "representative homologous protein s": 1 "? -amyloid peptide": 1 "ftn_0619": 1 "c-domain ace-ang ii peptide complex": 1 "amygdala": 1 "-33.6": 1 "type of peptide evidence": 1 "iii": 1 "25 um": 1 "cell division protein ftsq": 1 "ftt1762c": 1 "gravyf": 1 "1638": 1 "hp_aag": 1 "cog1278 kcold shock proteins 2": 1 "subunit": 1 "change direction": 1 "macrophage growth locus subunit b": 1 "spak": 1 "1644": 1 "ftn_0633": 1 "possible function": 1 "ftl_1262": 1 "ftn_0636": 1 "1647": 1 "kog3961 suncharacterized conserved protein 2": 1 "24?hrs": 1 "test 4": 1 "soluble lytic murein transglycosylase": 1 "cortex": 1 "kog4808 suncharacterized conserved protein 2": 1 "kog0558 cdihydrolipoamide transacylase alpha-keto acid dehydrogenase e2 subunit 2": 1 "oppa": 1 "kog4069 suncharacterized conserved protein 2": 1 "protein description ncbi protein": 1 "accession number*": 1 "gtp-binding protein lepa": 1 "phosphopeptide sequence": 1 "cellular interacting protein": 1 "dihydropteridine reductase": 1 "gene alias": 1 "signaling": 1 "kog3618 radenylyl cyclase 4": 1 "ang ii+los": 1 "provenance": 1 "gi no.": 1 "bifunctional purine biosynthesis protein": 1 "ftl_0380": 1 "bb745167": 1 "sr no.": 1 "dll1": 1 "18.8547": 1 "chorismate family binding protein aromatic amino acid and folate biosynthesis": 1 "gene accession #": 1 "target scan": 1 "ftn_0672": 1 "muscle specificity": 1 "capsule biosynthesis protein capb": 1 "capsule biosynthesis protein capc": 1 "phospho site a": 1 "ftn_1523": 1 "stages": 1 "enzymatic activity": 1 "variable": 1 "relative molar abundance fmolr": 1 "8.5": 1 "ratio kinase ±": 1 "8.8": 1 "functional interactors": 1 "ion": 1 "ego": 1 "preprotein translocase subunit a atpase rna helicase": 1 "sod u/mg protein": 1 "aa #": 1 "subcellular location*": 1 "kog0656 dg1/s-specific cyclin d 2": 1 "luminal er+": 1 "kog1868 oubiquitin c-terminal hydrolase 2": 1 "# identifiedpeptides ": 1 "ran": 1 "transcription/rna processing": 1 "qvalue": 1 "descrip": 1 "nm_007554": 1 "protein expression in vitro": 1 "go apoptosis": 1 "protein s targeted": 1 "tcfap2b": 1 "peptide isoforms": 1 "naïve serum *": 1 "ratio h/l variability ": 1 "av of vol ratioa": 1 "transcript isoforms": 1 "21.7": 1 "hiv-1 protein": 1 "fusion protein kda": 1 "nicotinamide ribonucleoside nr uptake permease pnuc family protein": 1 "unique peptides": 1 "kog0666 kcyclin c-dependent kinase cdk8 10": 1 "ftt0918": 1 "endo factor": 1 "redox protection superoxid dismutase and peroxidase": 1 "829": 1 "amino acids 1 schu s4 lvs/u112": 1 "notes": 1 "evidence": 1 "signaling pathways affected": 1 "potg": 1 "exodeoxyribonuclease iii": 1 "ribh": 1 "ribc": 1 "ftl_0878": 1 "uniprot_kb entry #": 1 "ireb2": 1 "controlb": 1 "swca1c_mouse q60847 collagen alpha 1 xii chain": 1 "chitin µg": 1 "kog3381 suncharacterized conserved protein 6": 1 "expression ratio tor1 /wt": 1 "involves ps727": 1 "log2 ratio": 1 "ftn_0928": 1 "cytoplasmic fraction": 1 "add": 1 "leucine": 1 "nm_012922": 1 "uvrb": 1 "mislocalization": 1 "jak1": 1 "clinical phenotype of proband": 1 "cluster coefficient": 1 "fusion": 1 "matrix protein coating concentration": 1 "sulfate adenylyltransferase subunit 2": 1 "egfr": 1 "protein feature": 1 "succinyl-coa synthetase alpha subunit": 1 "kog3228 suncharacterized conserved protein 2": 1 "retention time min": 1 "selection of biological processes": 1 "disulfide bond formation protein dsbb": 1 "sequences of variable regions": 1 "ftl_0886": 1 "anthranilate synthase component ii": 1 "group n=4": 1 "peptide sequence a": 1 "identification of protein": 1 "clinical significance": 1 "residue": 1 "nm_021855": 1 "xm_345825": 1 "p valueb": 1 "clone": 1 "-7.2": 1 "ftn_0957": 1 "pathway/process": 1 "betweenness": 1 "yield * ": 1 "family": 1 "313.4": 1 "protein expression in patient's tumor": 1 "0.029": 1 "nm_009323": 1 "sh3-domain-binding protein": 1 "trna-methylthiotransferase miab protein": 1 "transforming growth factor beta 2": 1 "ftl_0838": 1 "0.023": 1 "ftl_0837": 1 "swprpl_human p10162 salivary proline-rich protein": 1 "naïve lymph**": 1 "dna modifying": 1 "variation": 1 "carbohydrate": 1 "af099990": 1 " variability": 1 "number": 1 "ftn_1376": 1 "872": 1 "875": 1 "kog2573 ajribosome biogenesis protein—nop56p/sik1p 2": 1 "protein accession": 1 "60.8849": 1 "bacterial localization": 1 "cog0045 csuccinyl-coa synthetase beta subunit 2": 1 "inosine-5-monophosphate dehydrogenase": 1 "tmprss11a": 1 "242.1": 1 "dna mismatch repair enzyme with atpase activity": 1 "99.999": 1 "407": 1 "swfp1_myted q25460 adhesive plaque matrix protein": 1 "vasodilatory mechanism": 1 "mucin 10 submandibular gland salivary mucin": 1 "peptide name": 1 "ncbi blast": 1 "alpha-enolase 2-phospho-d-glycerate hydro-lyase": 1 "nsp adjusted probability": 1 "412": 1 "swcbp1_caeel p34545 protein cbp-1": 1 "relative protein level in iso": 1 "0.038": 1 "peptide class 1": 1 "s-adenosylmethionine trna ribosyltransferase- isomerase": 1 "424": 1 "q9uli5 kiaa1235 protein": 1 "krt6b": 1 "protein mass da": 1 "cxcl12": 1 "proline na+ symporter": 1 "organismd": 1 "ftn_0096": 1 "acpp": 1 "432": 1 "433": 1 "435": 1 "437": 1 "domainb": 1 "major reported functions": 1 "saline serum": 1 "ratioa": 1 "buffers": 1 "arhgap12": 1 "domains": 1 "capsule polysaccharide export protein kpsc": 1 "ratioc": 1 "441": 1 "445": 1 "h1299/ 3kt": 1 "447": 1 "449": 1 "acpa": 1 "secretion signal 3": 1 "activity control": 1 "p91018 human bat2 protein": 1 "basic cellular mechanism": 1 "best ion score": 1 "dna repair": 1 "kog3061 oproteasome maturation factor 2": 1 "molecular mass kda": 1 "0.003": 1 "genesymbol": 1 "glcnac": 1 "454": 1 "kog1681 ienoyl-coa isomerase 2": 1 "activity on ires *": 1 "protein target": 1 "usp32": 1 "predicted effect": 1 "recr": 1 "mol·wt·kda": 1 "atp-dependent exodnase_subunit": 1 "459": 1 "37912": 1 "-3.9": 1 "hippocampus": 1 "recb": 1 "molecular weight": 1 "transport": 1 "463": 1 "465": 1 "466": 1 "casp3": 1 "mascot ms/ms score": 1 "9604": 1 "mol wt kda": 1 "claudin protein or mrna expression": 1 "sdac": 1 "swsm41_hempu q26264 41 kd spicule matrix protein": 1 "xm_23000": 1 "ftt0588": 1 "470": 1 "siderophore biosynthesis": 1 "ribonuclease rnase a family 1 pancreatic": 1 "location number": 1 "ftn_1412": 1 "ftn_1415": 1 "ftn_1418": 1 "ftn_1417": 1 "kog4043 suncharacterized conserved protein 2": 1 "4.0 ?": 1 "exp": 1 "dna-directed rna polymerase subunit": 1 "caspase-3": 1 "recfor complex recr component": 1 "kog1864 oubiquitin-specific protease 2": 1 "glycoprotein µg": 1 "metiq": 1 "small rna processes ref": 1 "kog2103 suncharacterized conserved protein 2": 1 "ftn_1421": 1 "sww146_human q9c0j8 wd-repeat protein wdc146": 1 "ferric iron binding protein ferritin-like": 1 "riken cdna 1500031m22": 1 "ftn_0577": 1 "af059567": 1 "d -methionine transport protein abc transporter metn": 1 "gi|6754936": 1 "crisp1": 1 "9 h": 1 "clpb protein": 1 "gene arrayt24t/t24ratio": 1 "11280": 1 "bf011461": 1 "ribokinase pfkb family": 1 "cysteine-rich secretory protein 1": 1 "ftt0129": 1 "3-phosphoshikimate 1-carboxyvinyl transferase": 1 "gi|123681": 1 "490": 1 "appb": 1 "ftn_1441": 1 "gi|6680045": 1 "ftn_0593": 1 "appc": 1 "# phospho-sites mascot + sequest": 1 "3ktr/ 3kt": 1 "ftn_0588": 1 "interaction partner": 1 "ftn_0107": 1 "mechanism": 1 "neu1": 1 "dna methylated genes": 1 "neu4": 1 "dna protection rna helicase": 1 "neu3": 1 "neu2": 1 "28.1829": 1 "ftn_0111": 1 "ftn_0113": 1 "sucd": 1 "refs": 1 "sl no.": 1 "1.29 up": 1 "17.2": 1 "c.i.": 1 "total solid dry wt basis": 1 "kog1766 renhancer of rudimentary 2": 1 "neuronal phenotype after k.o./k.d animal model": 1 "strength": 1 "ftn_0132": 1 "ftn_1453": 1 "ftn_1457": 1 "plant process": 1 "pubmed id": 1 "homolog to tbc1 domain family mb 15": 1 "spot no §": 1 "hypothetical lipoprotein abc transporter and potential disulfide bond formation": 1 "atp": 1 "r culicivorax": 1 "aspc2": 1 "5.38": 1 "short chain dehydrogenase": 1 "af108501": 1 "ftn_0141": 1 "manufacture/code": 1 "hyp ": 1 "39.5": 1 "average spectral hits": 1 "glycerol-3-phosphate dehydrogenase": 1 "wt-ang ii n?=?6": 1 " sugar 2": 1 "1.1 up": 1 "rnase 1": 1 "?m ppm": 1 "mascot score *": 1 "dose mg/kg bw": 1 "nature of abnormality": 1 "0 7047": 1 "negative": 1 "t-complex associated testis expressed 1 like": 1 "c/t fold change": 1 "agent s": 1 "cytoskeletal protein binding": 1 "11249": 1 "m etabolism": 1 "kog4523 suncharacterized conserved protein 2": 1 "5.57": 1 "kog0714 omolecular chaperone dnaj superfamily 8": 1 "wap": 1 "kog2285 oe3 ubiquitin ligase cullin 1 component 2": 1 "ftn_0162": 1 "geranylgeranyltransferase i ggt1": 1 "ftn_1487": 1 "ftn_0155": 1 "ftn_1002": 1 "ftl_0094": 1 "capb": 1 "capc": 1 "experimental value": 1 "normal control": 1 "# unique peptides non-phos": 1 "os after 10?years ": 1 "1734": 1 "gpa2 -q355l": 1 "riboflavin synthase beta-chain": 1 "kog0119 asplicing factor 1/branch point binding protein rrm superfamily 2": 1 "ppar gamma coactivator 1 alpha": 1 "ftl_0028": 1 "cara": 1 "liver": 1 "igle": 1 "igld": 1 "iglg": 1 "cog1156 carchaeal/vacuolar-type h+-atpase subunit b 2": 1 "iglf": 1 "iglh": 1 "q9veg7 osa protein": 1 "iglj": 1 "francisella iron regulated gene a": 1 "deoxyadenosine deaminase/adenosine deaminase": 1 "clca1": 1 "ftl_0029": 1 "glutamate–aminobutyric acid antiporter xasa amino acid transport": 1 "2.0 ?": 1 "biotin—acetyl-coa-carboxylase ligase": 1 "ftl_0030": 1 "kog0712 omolecular chaperone dnaj superfamily 8": 1 "plb1": 1 "study": 1 "13066": 1 "kog1680 ienoyl-coa hydratase 2": 1 "peptide shift": 1 "8394": 1 "swssxt_human q15532 ssxt protein": 1 "swfp1_mytco q25434 adhesive plaque matrix protein": 1 "target prediction": 1 "ftn_0985": 1 "reference number": 1 "cone-rod homeobox protein": 1 "ftn_0507": 1 "1758": 1 "kog0653 dcyclin b and related kinase-activating proteins 2": 1 "ftt0203c": 1 "cog1758 kdna-directed rna polymerase subunit k/omega 2": 1 "s cerevisiae": 1 "41519": 1 "ftn_0995": 1 "13.8": 1 "pyrrolidone carboxylate peptidase": 1 "statistics": 1 "gcvp1": 1 "protein chain": 1 "membrane": 1 "oxidoreductase iron/ascorbate family protein": 1 "eya1": 1 "citrulline ureidase": 1 "acetyltransferase protein": 1 "pfc1061": 1 "interaction types": 1 "xm_00106535": 1 "cog0089 jribosomal protein l23 4": 1 "ang ii 6 h": 1 "pfc1069": 1 "nm_008843": 1 "strain": 1 "s-adenosylmethionine trna ribosyltransferase-isomerase": 1 "-47.4": 1 "d -methionine transport protein abc transporter metiq": 1 "matched peptides": 1 " pmol/min/mg protein": 1 "kog2123 suncharacterized conserved protein 2": 1 "flg22": 1 "bioinformatic predictions based on protein sequence": 1 "ftn_0534": 1 "restin": 1 "pfc1070": 1 "biological process": 1 "35.4": 1 "9.7": 1 "swdri1_human q99856 dead ringer like-1 protein": 1 " of total": 1 "xm_214967": 1 "sc ": 1 "ratio h/l normalized": 1 "rt-pcr": 1 "ntrk2": 1 "egfr peptide sequence": 1 "ftt0029c": 1 "chromosome location": 1 "kog2284 oe3 ubiquitin ligase cullin 2 component 2": 1 "ftl_0483": 1 "signal intensity average": 1 "? fret activity *": 1 "a2": 1 "ftn_0556": 1 "a7": 1 "type of protein": 1 "sd1": 1 "icmf": 1 "rnhb": 1 "ftl_0552": 1 "stem cell/cancer phenotype": 1 "ratio h/l count": 1 "cover ": 1 "bppb peptide": 1 "phosphopeptides": 1 "b2": 1 "atp-dependent protease hslvu peptidase subunit": 1 "1336": 1 "b6": 1 "normalized ratio": 1 "911": 1 "log2 fold": 1 "nls type": 1 "cytogenetic or molecular abnormality": 1 "ftl_0544": 1 "ac": 1 "est'd z b": 1 "chemokine c-x-c motif ligand 12": 1 "am": 1 "plasma ang ii": 1 "c2": 1 "c5": 1 "c7": 1 "proteina": 1 "time h": 1 "swbcl9_mouse q9d219 b-cell lymphoma 9 protein": 1 "site in zebrafish": 1 "923": 1 "cold shock protein": 1 "protein localization in vitro": 1 "glycogen branching enzyme glgb polysaccharide metabolism": 1 "bj": 1 "kog1679 ienoyl-coa hydratase 2": 1 "ahnak2 col4a2 nrp1 rcan2": 1 "d1": 1 "observed mr kda/p i": 1 "bp": 1 "d2": 1 "cog1761 kdna-directed rna polymerase subunit l 2": 1 "d4": 1 "haloacid dehalogenase-like hydrolase": 1 "1357": 1 "suspected pi": 1 "d8": 1 "proteins": 1 "sequence coverage d": 1 "ftl_1414": 1 "pfc731": 1 "glycosyl hydrolase family 3": 1 "6.2 ?": 1 "e2": 1 "ftl_1416": 1 "food": 1 "ftl_1415": 1 "sm7 versus wta": 1 "sm7 versus wtb": 1 "human ortholog": 1 "partner": 1 "kog1088 suncharacterized conserved protein 2": 1 "pfc739": 1 "spider": 1 "cog4974 lsite-specific recombinase xerd 2": 1 "go protein localization": 1 "kog4615 suncharacterized conserved protein 2": 1 "g2739158 ikb epsilon": 1 "kog2465 suncharacterized conserved protein 2": 1 "f2": 1 "f5": 1 "cog0271 tstress-induced morphogen activity unknown 4": 1 "protein familye": 1 "ftn_0800": 1 "k.o embryonic lethal": 1 "ratio of protein volume after tes": 1 "ftn_0806": 1 "nm_009638": 1 "kog0272 au4/u6 small nuclear ribonucleoprotein prp4 contains wd40 repeats 2": 1 "kog0660 tmitogen-activated protein kinase 12": 1 "mglb": 1 "g5": 1 "masco t score": 1 "g7": 1 "swiss-prot accession no.": 1 "conserved hypothetical protein ylea possible trna-i 6a37 methylthiotransferase": 1 "5.2": 1 "5.4": 1 "eg superoxide dismutase cu-zn sod_cu ahpc-tsa peroxiredoxin-1?2?4?6": 1 "mef protein ": 1 "5.6": 1 "nm_007446": 1 "ratio +gh/?gh 5a/5b/15 min 6": 1 "ace2 +/y control": 1 "yfio": 1 "xtha": 1 "membrane localization": 1 "pictar": 1 "kog0473 sleucine-rich repeat protein 5": 1 "1.07 down": 1 "kog2835 fphosphoribosylamidoimidazole-succinocarboxamide synthase 6": 1 "kog3458 cnadhubiquinone oxidoreductase ndufa8/pgiv/19 kda subunit 2": 1 "34926": 1 "class": 1 "not detected": 1 "protein category": 1 "501": 1 "m? type": 1 "total set": 1 "kog0870 kdna polymerase epsilon subunit d 2": 1 "adamts8 antxr2 bai3": 1 "ftn_0838": 1 "regulatory factor bvg accessory factor family": 1 "ftl_1806": 1 "lignin": 1 "ht": 1 "protein modules ‡": 1 "3119": 1 "original peptide": 1 "ns/wt log2": 1 "neurospora": 1 "514": 1 "c21 orf66 isoform d": 1 "ii": 1 "nm_010669": 1 "surface": 1 "? -glucosidase cellobiose dehydrogenase xylanase": 1 "peptide number a": 1 "muc10": 1 "gene id": 1 "kog0607 tmap kinase-interacting kinase and related serine/threonine protein kinases 2": 1 "fragment charge": 1 "521": 1 "524": 1 "alteration": 1 "slt": 1 "527": 1 "leucine content g/100 g protein": 1 "keratin 6b": 1 "1950/51": 1 "theoretical mr kda/p i": 1 "8832": 1 "analysis method": 1 "cog0553 klsuperfamily ii dna/rna helicases snf2 family 2": 1 "proteins of interest": 1 "t thermophila": 1 " amidophosphoribosyltransferase2": 1 "sequence comparison": 1 "fusarium": 1 "database entry": 1 "nfnb": 1 "description of functional domains": 1 "number of paths": 1 "chromosomal location": 1 "genbank accession number": 1 "ftn_1291": 1 "uniprot acc#": 1 "ftn_1293": 1 "fuc": 1 "renin": 1 "ang ii 6 h + dexamethasone": 1 "aaresidues": 1 "dihydropyrimidinase-related protein-2": 1 "interacting protein reference": 1 "pfc324": 1 "115116": 1 "phosoho site": 1 "fold of llq": 1 "new peptides": 1 "mutations": 1 "556": 1 "orotidine-5-phosphate decarboxylase": 1 "iron responsive element binding protein 2": 1 "localization probability a": 1 "acv effect": 1 "prolactin induced protein": 1 "4.6 ?": 1 "fupa/b": 1 "functional clustering": 1 "db-camp": 1 "neurotrophic tyrosine kinase receptor type 2": 1 "bb760085": 1 "function *": 1 "mw": 1 "interacting protein s": 1 "cardiac expression mrna": 1 "bcl-2 associated transcription factor": 1 "cilengitide": 1 "115113": 1 "kog0391 rsnf2 family dna-dependent atpase 2": 1 "115114": 1 "prediction": 1 "-4.1": 1 "8875": 1 "blaa": 1 "thioredoxin": 1 "pyrf": 1 "ftt0204": 1 "pyrb": 1 "pyrd": 1 "gi|6679651": 1 "up regulated proteins": 1 "574": 1 "chaperone": 1 "calculate mw/ p i": 1 "phosphosite": 1 "wzb": 1 "kog0392 ksnf2 family dna-dependent atpase domain-containing protein 2": 1 "# unique peptides phos": 1 "peptides match/": 1 "efg1 -t206e": 1 "cytochrome bd-ii terminal oxidase subunit ii": 1 "nature": 1 "her2+": 1 "smr1": 1 "msu-first": 1 "smr2": 1 "tloc1": 1 "receptor": 1 "103": 1 "104": 1 "similarity with": 1 "tbx15": 1 "remarks": 1 "growth differentiation factor 5": 1 "indications": 1 "seca": 1 "bifunctional proline dehydrogenase pyrroline-5-carboxylate dehydrogenase": 1 "low molecular weight lmw phosphotyrosine protein phosphatase": 1 "kog4455 suncharacterized conserved protein 2": 1 "kinari v1.0": 1 "balb/c": 1 "593": 1 "kog3738 opredicted polypeptide n-acetylgalactosaminyltransferase 4": 1 "ftn_1777": 1 "118": 1 "ipi protein index identifier": 1 "vol ratio †": 1 "119": 1 "ftl_1096": 1 "phrb": 1 "cog2007 jribosomal protein s8e 4": 1 "adh1pr-cph1": 1 "swosa_droya q9ngb4 trithorax group protein osa": 1 "hela protein ": 1 "kog0388 lsnf2 family dna-dependent atpase 2": 1 "g1 p-loop": 1 "chromosomal abnormalities": 1 "molecular phenotype": 1 "myrbase identifier": 1 "nm_013655": 1 "total ion score": 1 "kog3252 suncharacterized conserved protein 2": 1 "pseudogene dna-3-methyladenine glycosylase": 1 "hyaluronate 0.5": 1 "proteolytic cleavage sites": 1 "theoretical mr kda/pi": 1 "kog1863 oubiquitin carboxyl-terminal hydrolase 2": 1 "peptide matches n": 1 "xcor": 1 "128": 1 "71.9": 1 "atp-binding cassette putrescine uptake system atp-binding protein": 1 "protein data bank identification number": 1 "sa": 1 "swosa_drome q8in94 trithorax group protein osa": 1 "ftn_1311": 1 "ftn_1310": 1 "ftn_1312": 1 "ftn_0465": 1 "ftn_1315": 1 "ftn_1314": 1 "ftn_1316": 1 "type i restriction–modification system subunit r restriction": 1 "ftn_1318": 1 "1974/75": 1 "s pombe protein": 1 "cell line": 1 "uniprot accession #": 1 "hemicellulose g xylan": 1 "su": 1 "kog0654 dg2/mitotic-specific cyclin a 2": 1 "plastid criteria 1": 1 "ftn_1321": 1 "te": 1 "ftn_0477": 1 "katg": 1 "p-jnk": 1 "fyn-protooncogene": 1 "ftt0056c": 1 "o61603 drosophila melanogaster eyelid protein": 1 "frequency": 1 "accesion no b": 1 "ftn_0008": 1 "methylation status": 1 "h322/ 3kt": 1 "bacterial localization 5": 1 "?pigments": 1 "abc transporter atp-binding protein": 1 "uniprot accession numbera": 1 "organism": 1 "theoreticala m/z ": 1 "tmcg/dipyb intensityc": 1 "ftn_0020": 1 "0.059": 1 "kog1235 rpredicted unusual protein kinase 2": 1 "163": 1 "delta-like 1 drosophila": 1 "theoretical mr da/pi": 1 "ftn_0496": 1 "triton x-114": 1 "ftn_0019": 1 "ftn_0018": 1 "vm": 1 "size kda 2": 1 "experimental data": 1 "coatomer protein complex": 1 "rigidfinder": 1 "protein localization in patient's tumor": 1 "neurodegenerative disease": 1 "denv-2 protein": 1 "purl": 1 "destination protein": 1 "purf": 1 "purh": 1 "ftn_1355": 1 "ftn_1357": 1 "description b sgd": 1 "abundance sks1-k39r b": 1 "klk effect": 1 "aspergillus": 1 "ftl_1071": 1 "kog0187 j40s ribosomal protein s17 5": 1 "transmembrane protease serine 11a": 1 "thalamus": 1 "commonname/abbreviation": 1 "ang ii": 1 "µg/108 cells": 1 "aminotransferase": 1 "kog0310 sconserved wd40 repeat-containing protein 2": 1 "182": 1 "183": 1 "mr da": 1 "ftn_0041": 1 "plasma protein": 1 "swsmf1_human o14497 swi/snf-related p270": 1 "ftn_0035": 1 "kog2989 suncharacterized conserved protein 4": 1 "microarray": 1 "ftn_1368": 1 "ftn_1367": 1 "ftn_0036": 1 "nek2a interaction protein": 1 "phospho motifs": 1 "6 h": 1 "acid phosphatase prostate": 1 "6.37": 1 "puta": 1 "oe/tg": 1 "pep count": 1 "none": 1 "196": 1 "u82380": 1 "ligand–protein interaction energy value": 1 " coverage b": 1 "platelet-activating factor acetylhydrolase ib subunit": 1 "deoxyribodipyrimidine photolyase": 1 "kog3249 suncharacterized conserved protein 2": 1 "ftn_0848": 1 "peptide number": 1 "cont": 1 "subcellular location *": 1 "2703": 1 "protocadherin beta 9": 1 "ftl_1478": 1 "bf683028": 1 "tumour type": 1 "bf456404": 1 "swnco6_mouse q9jl19 nuclear receptor coactivator": 1 "es/m @ imsr": 1 "emd135981": 1 "pr protein": 1 "spine 4": 1 "go protein modification": 1 "xm_236659": 1 "ftna": 1 "atria?": 1 "ftn_1701": 1 "plasma ang ii pg /ml": 1 "ras1 -g13v": 1 "2716": 1 "2715": 1 "kog4528 suncharacterized conserved protein 2": 1 "p ? .05": 1 "peptide matched": 1 "protein expression rate ": 1 "c86550": 1 "83.5712": 1 "relative volume of untreated ": 1 "p-gp": 1 "ftn_1713": 1 "c3h/hej": 1 "swdri1_mouse q62431 dead ringer like-1 protein": 1 "m/z": 1 "igf-1": 1 "heat shock protein hsp60": 1 "expressed in heart": 1 "riboflavin synthase alpha chain": 1 "brain": 1 "6.63": 1 "hits": 1 "signaling protein": 1 "expect": 1 "putp": 1 "peptide matches": 1 "glucose 1": 1 "kog1718 vdual specificity phosphatase 2": 1 "gene protein": 1 "cog2012 kdna-directed rna polymerase subunit h rpoh/rpb5 2": 1 "ftl_0594": 1 "nuclear fraction": 1 "ftn_1733": 1 "camk2b": 1 "ggt": 1 "ftn_0885": 1 "gi|70794816": 1 "ftn_0888": 1 "phast cons": 1 "bq032637": 1 "ftn_1736": 1 "av275795": 1 "n peptides": 1 "ftsq": 1 "avfc": 1 "molecules affected by klk": 1 "wt-ctrl n?=?6": 1 "competence protein": 1 "peptide aptamers": 1 "ftn_0895": 1 "knockout/knockdown": 1 "ftn_0415": 1 "ftl_0592": 1 "ms/ms score": 1 "probability b": 1 "corresponding phosphorylated positions": 1 "precursor m/z 1": 1 "adp-ribosylation factor 4": 1 "nm_007865": 1 "instances": 1 "ipi accession": 1 "kog3737 opredicted polypeptide n-acetylgalactosaminyltransferase 4": 1 "basal tn": 1 "ftn_0420": 1 "kog1435 itsterol reductase/lamin b receptor 2": 1 "related functions/pathways": 1 "2.95 up": 1 "normal localization": 1 "protein mw kda": 1 "observations": 1 "ftn_0428": 1 "swca1a_bovin p23206 collagen alpha 1 x chain protein": 1 "dna modification": 1 "phosphopeptide": 1 "function in normal cells": 1 "muc1": 1 "mitochondria": 1 "identified protein expression": 1 "epm2aip": 1 "retinoblastoma binding protein 4": 1 "aspartate aminotransferase amino acid biosynthesis": 1 "ftn_1767": 1 "category": 1 "pfc1176": 1 "biotin–acetyl-coa-carboxylase ligase": 1 
"—": 165 "s404": 7 "t212": 6 "s396": 6 "t181": 6 "r2": 5 "r3": 5 "h1047r": 5 "e545k": 5 "p110?": 5 "s262": 5 "r4": 4 "123": 4 "3": 4 "s202": 4 "s356": 4 "t205": 4 "t175": 4 "s416": 3 "s46": 3 "23": 3 "compound": 3 "r1": 3 "r6": 2 "r7": 2 "r8": 2 "r9": 2 "b1": 2 "r10": 2 "sf2": 2 "r16 r19 r22 r25": 2 "contains itk monomers": 2 "s214": 2 "r5a": 2 "r5c": 2 "t231": 2 "hnrnp a1": 2 "m1": 2 "m2": 2 "m3": 2 "m4": 2 "m5": 2 "n1": 2 "b10": 1 "cluster": 1 "t5 u/b": 1 "g100": 1 "u3 g50": 1 "sapk3": 1 "0010": 1 "related pathways": 1 "protein kinase ic50 nm": 1 "b2": 1 "b3": 1 "p-2": 1 "s35": 1 "r14 r20 r24 r26 r28": 1 "p-1": 1 "0000": 1 "0001": 1 "p-3": 1 "x lavis 520 aa": 1 "c40": 1 "binding site": 1 "s pomb e 665 aa": 1 "13": 1 "#": 1 "g5 t100": 1 "genes": 1 "t9 u/u": 1 "sustained dominant t<s": 1 "lowly-transient dominant l-t>h-t": 1 "concentration µm": 1 "c1": 1 "tm °c": 1 "c2": 1 "c3": 1 "2": 1 "case 2 l-t vs h-t": 1 "0011": 1 "intermediate": 1 "s scrofa 522 aa": 1 "p4 52": 1 "r norvegicus 522 aa": 1 "g5 d100": 1 "predictors": 1 "?ic": 1 "u3 a100": 1 "r1a": 1 "t1 u/u": 1 "p110?": 1 "bnip-h ? aa189–287": 1 "p110?": 1 "p110?": 1 "t18 u/b": 1 "cysts": 1 "s324": 1 "2nd capri edition targets": 1 "t315e": 1 "t26 u/u": 1 "r1a a": 1 "o aries 522 aa": 1 "b100": 1 "r16 r18 r19 r22 r25": 1 "sex": 1 "d melanogaster 569 aa": 1 "m": 1 "...": 1 "g5 g50": 1 "r14 r20 r23 r24 r26": 1 "t": 1 "mm tumor": 1 "t11 u/m": 1 "refs": 1 "x": 1 "phosphatase": 1 "t8 u/b": 1 "sh2": 1 "dnpp-1 m3": 1 "g12v": 1 "g2 d100": 1 "k i µm": 1 "transient dominant t>s": 1 "h18": 1 "t6 u/b": 1 "g13d": 1 "g13c": 1 "u3 g100": 1 "t2 u/b": 1 "3t3 cells": 1 "proline-rich interdomain": 1 "g1": 1 "adm": 1 "maabna": 1 "g12d": 1 "g12c": 1 "h sapiens 522 aa": 1 "erk2": 1 "g2 t100": 1 "g10": 1 "q61h": 1 "t27 u/u": 1 "resistant": 1 "p38": 1 "wt": 1 "g2 g50": 1 "f rubripes 530 aa": 1 "case 3 l-s vs h-s": 1 "t7 u/b": 1 "highly-transient dominant l-t<h-t": 1 "camkii": 1 "g gallus 522 aa": 1 "dnpp-1 wt": 1 "gt": 1 "n100": 1 "c-src": 1 "3rd capri edition targets": 1 "g5 a50": 1 "p110? h1047r": 1 "p1 106": 1 "b taurus 522 aa": 1 "no +ve feedback": 1 "t12 u/b": 1 "age": 1 "p6 124": 1 "gsk3?": 1 "lowly-sustained dominant l-s>h-s": 1 "—10.50 å—": 1 "bnip-h aa 1–287": 1 "t21 u/u": 1 "g37": 1 "t123": 1 "n10": 1 "v12": 1 "p1 l4 to d6": 1 "g5 a100": 1 "ligands": 1 "pdac": 1 "r14 r20 r24 r26": 1 "gene": 1 "p110mapk": 1 "t234": 1 "p3 169": 1 "sensitive": 1 "t28 m/m": 1 "a18d": 1 "kinase": 1 "g5 d50": 1 "t3 u/b": 1 "wild type": 1 "highly-sustained dominant l-s<h-s": 1 "status": 1 "dimers": 1 "l3": 1 "u3 t100": 1 "maabna-peg2000-adm": 1 "1st capri edition targets": 1 "contains itk dimers": 1 "g2 a50": 1 "n crassa 798 aa": 1 "p110? e545k": 1 "g5 g100": 1 "c elegans 684 aa": 1 "cdk5": 1 "cdk2": 1 "m6": 1 "m7": 1 "p85": 1 "t13 u/b": 1 "contain ip4 induced +ve feedback": 1 "t24 u/m": 1 "u3 a50": 1 "lipid kinase ic50 nm": 1 "n2": 1 "bacteria": 1 "sh3n": 1 "c-abl": 1 "0.9 salt": 1 "s199": 1 "l12": 1 "pk properties": 1 "dnpp-1 e331k": 1 "drug": 1 "sh3c": 1 " abcd": 1 "p110": 1 "g2 d50": 1 "g2 g100": 1 "t19 m/b": 1 "p2 d6 to d15": 1 "-2": 1 "jnk": 1 "g2 a100": 1 "contain itk dimers": 1 "-7": 1 "m musculus 522 aa": 1 "hnrnp b1": 1 "case 1 t vs s": 1 "t4 u/b": 1 "u3 d50": 1 "cos cells": 1 "t20 u/m": 1 "u3 d100": 1 "p2 35": 1 "nr": 1 "pkb": 1 "pka": 1 "pkc": 1 "0101": 1 "0100": 1 "k117n": 1 "s409": 1 "0.2 salt": 1 "q252h y253f e255k e255v t315a f359v v379i": 1 "t14 m/b": 1 "t10 u/u": 1 "t293": 1 "p5 177": 1 "m244v g250e f311l f317l m315t l387m h396p h396r": 1 "assay": 1 "a gambiae 548 aa": 1 "t25 u/b": 1 
"study": 14 "treatment": 9 "n": 9 "phase": 9 "os months": 7 "findings": 7 "months 95 ci": 6 "nymphs": 6 "adults": 6 "reference": 6 "patients": 6 "patients n": 6 "lyg": 5 "ttp months": 5 "comments": 5 "cost": 5 "mpfs months": 4 "agent": 4 "ref": 4 "p-value": 4 "treatments": 3 "pop": 3 "sample": 3 "acp": 3 "pfs months": 3 "response ": 3 "model": 3 "drug": 3 "median os months": 3 "cost/lyg": 3 "mos months": 3 "total": 3 "receptor": 3 "indications": 2 "cyst.": 2 "limitations": 2 "4": 2 "6": 2 "n ia": 2 "8": 2 "male": 2 "cost/ lyg": 2 "experiments": 2 " rr": 2 "mean age years": 2 "p": 2 "t ia": 2 "cilnidipine": 2 "amlodipine": 2 "t ia / n ia": 2 "0.79–1.41": 2 "female": 2 "description": 2 "median pfs months": 2 "one-year lc": 2 "company": 2 "chemotherapy": 2 "ncep": 2 ">1.41": 2 "response rate": 2 "rr n ": 2 "gefitinib": 2 "grade 3–4 toxicity ": 2 "authors": 2 "one-year os": 2 "b cell": 2 "outcome": 2 "n ": 2 "?0.79": 2 "preop.": 2 "trial": 2 "drug availability": 2 "months": 2 "mz": 2 "rap 80 levels": 2 "who": 2 "p value": 2 "case number": 2 "chemokine": 2 "line": 2 "brca1 levels": 2 "observations": 2 "parameter": 2 "rr ": 2 "kras": 2 "remarks": 2 "patients included": 1 "female versus male": 1 "": 1 "time to progression": 1 "year": 1 "over-expression associated malignancies": 1 "major findings": 1 "time to progression months": 1 "total n of spns m-f": 1 "raa": 1 "tsc-lam": 1 "biofluid": 1 "definitions": 1 "who 1998": 1 "chronic myelomonocytic leukemia": 1 "10": 1 "dorv": 1 "12": 1 "frequent abnormalities": 1 "idf 2005": 1 "population": 1 "growth factor": 1 "1": 1 "hsp90 clients": 1 "aa sequence modification conserved yes/no": 1 "2": 1 "model organism": 1 "azaa": 1 "2014 n=64": 1 "5": 1 "7": 1 "9": 1 "response rate ": 1 "a/j": 1 "n=58": 1 "rr": 1 "n=57": 1 "weeks": 1 "clinical variable": 1 "phenotypic findings": 1 "smokers": 1 "comments / findings": 1 "virus": 1 "never had tst n=866": 1 "characteristic": 1 "tga": 1 "ahr of all-cause": 1 "melanoma patients n": 1 "2003 n=381": 1 "specificity": 1 "reported": 1 "pr ": 1 "n=53": 1 "?5 years": 1 "flt3 status": 1 "acquired pd biomarker": 1 "braf inhibitor": 1 "effector": 1 "sporadic lam": 1 "pbmc / plasma": 1 "51 years": 1 "treatment duration months": 1 "3 months": 1 "advantages": 1 "stage": 1 "tumor": 1 "mortality": 1 "followup months": 1 "study year": 1 "p *": 1 "experimental findings": 1 "metabolic syndrome prevalence percentage": 1 "toxicity": 1 "controls": 1 "presenting signs or symptoms": 1 "polyps/year": 1 "study cited": 1 "aitl": 1 "95 c.i months": 1 "clinical parameter": 1 "chronic myelogenous leukemia cml": 1 "investigational indications": 1 "mds/mpn unclassifiable": 1 "62 years": 1 "fdg-pet": 1 "chronic neutrophilic leukemia": 1 "52 years": 1 "receptor homodimer/heterodimer": 1 "#embryos": 1 "results": 1 "approved indications": 1 "mast cell disease": 1 "myeloproliferative neoplasms mpn": 1 "relapse <3 months": 1 "sepsis non-survivors": 1 "genotype": 1 "statin": 1 "women ": 1 "parameters": 1 "benefits": 1 "primary myelofibrosis pmf": 1 "follow-up months": 1 "cells targeted": 1 "histopathology": 1 "median pfs/ttp months": 1 "study reference": 1 "flexible sigmoidoscopy every 5 years": 1 "position mm9": 1 "patient #18": 1 "hypereosinophilic syndrome": 1 "mabs": 1 "patient #16": 1 "treatment dose no of patients": 1 "target/s": 1 "class": 1 "juvenile myelomonocytic leukemia": 1 "disease": 1 "colonoscopy every 10 years": 1 "key findings": 1 "disease control rate ": 1 "m.p.": 1 "polycythemia vera pv": 1 "orr": 1 "target": 1 "hematologic malignancies": 1 "mpn unclassifiable": 1 "quit years per 10 years": 1 "biennial gfobt": 1 "patient #02": 1 "material": 1 "patient #05": 1 "12 months": 1 "ifx": 1 "number of patients": 1 "age": 1 "ptcl/nos": 1 "expression response": 1 "survival rates": 1 "research system": 1 "chr.": 1 "mos": 1 "number": 1 "annual gfobt": 1 "mttp months": 1 "flexible sigmoidoscopy every 5 years + annual gfobt": 1 "study/phase": 1 "remission >2 years": 1 "c57b/l6j": 1 "ligands": 1 "sirs": 1 "outocome reported": 1 "non-smokers": 1 "methylated genes": 1 "method": 1 "gene": 1 "orr ": 1 "overall survival months": 1 "chemical class": 1 "s.p.": 1 "n a": 1 "2003 n=66": 1 "41 years": 1 "study first author year reference no a": 1 "h.p.": 1 "patient id": 1 "orr cr+pr ": 1 "men ": 1 "sensitivity": 1 "cmi": 1 "status": 1 "gender": 1 "vsd": 1 "skin": 1 "copd": 1 "1 year": 1 "reference number": 1 "sepsis survivors": 1 "median survival time months": 1 "integrin": 1 "hdac inhibitor": 1 "phases": 1 "platinum sensitive ": 1 "disease setting": 1 "patient n with spns m-f": 1 "mirna classification": 1 "corrected": 1 "omani": 1 "stable disease ": 1 "disorder": 1 "upper versus lower lobe": 1 "every year": 1 "molecular function": 1 "behaviour": 1 "atypical chronic myeloid leukemia": 1 "mpfs": 1 "author/type of study": 1 "polymorphism": 1 ">5 years": 1 "study description": 1 "cr ": 1 "follow-up": 1 "ifx+aza": 1 "progression-free survival months": 1 "? myelodysplastic syndromes mds/mpn": 1 "sample age range years": 1 "day": 1 "objective response": 1 "polyps": 1 "hazard ratio 95 ci": 1 "entry": 1 "ncep atp3 2001": 1 "dose cgy": 1 "biological process": 1 "intervention": 1 "egfr mutation": 1 "recommended dose modification": 1 "embryonic stage": 1 "sponsor": 1 "cellular process": 1 "chronic eosinophilic leukemia not otherwise categorized": 1 "patient population": 1 "technique": 1 "disease and number*": 1 "hair": 1 "crc": 1 "known protein domain disrupted confirmed yes/no": 1 "2014 n=502": 1 "ever had tst n=1141": 1 "virus type": 1 "regimen": 1 "bevacizumab + chemotherapy": 1 "trial/author year": 1 "fertile adults ": 1 "age per 10 years": 1 "concurrent therapy": 1 "structure": 1 "sd ": 1 "every 3 months": 1 "pack years per 10 years": 1 "reported targets": 1 "women percentage": 1 "response": 1 "variable": 1 "essential thrombocythemia et": 1 "pfs-6": 1 "duration months": 1 
"reverse": 50 "forward": 41 "gene": 19 "atc": 12 "tag": 12 "probe": 10 "ctc": 10 "gag": 10 "tgt": 9 "aca": 9 "gta": 9 "cat": 9 "primers": 8 "a": 8 "t": 8 "agt": 8 "tca": 8 "agc": 7 "tcg": 7 "tga": 6 "c": 6 "g": 6 "cgc": 6 "act": 6 "gtc": 6 "gtg": 6 "ctg": 6 "att": 6 "gac": 6 "gcg": 6 "taa": 6 "cac": 6 "cag": 6 "ccc": 4 "gapdh": 4 "cga": 4 "reverse primers": 4 "oligonucleotide": 4 "cta": 4 "genes": 4 "ata": 4 "gat": 4 "forward 5?-3?": 4 "gct": 4 "forward primers": 4 "ggg": 4 "tat": 4 "cca": 3 "ac": 3 "gene name": 3 "tgg": 3 "acc": 3 "reverse 5?-3?": 3 "tg": 3 "ggt": 3 "sequence": 3 "cct": 2 "forward 5?–3?": 2 "size": 2 "aag": 2 "cgg": 2 "cgt": 2 "product": 2 "product bp": 2 "oligonucleotide primers": 2 "accession": 2 "ttc": 2 "annealing temp °c": 2 "atg": 2 "name": 2 "gca": 2 "gcc": 2 "gene symbol": 2 "sequence 5'-3'": 2 "gga": 2 "tac": 2 "purpose": 2 "5?-cag ggg aca gca gag gaa ga-3?": 1 "ccg": 1 "target gene": 1 "?101 hsd3b2_f": 1 "reverse 5’–3’": 1 "5?-ccc gaa gtt ctt ctg cat tc-3?": 1 "380 bp": 1 "gene product": 1 "fam- 5?-taaatagttccaatgcagaagtgctggc-3? -tamra": 1 "agtggcatcacctacgac": 1 "5?-tac ttg acg gcc acg gac at-3?": 1 "ctcggtctggtacagatgtcgatg'": 1 "?170 hsd3b2_f": 1 "5'-gcgacctgcagtttgcaata- 3'": 1 "localization 2": 1 "t gt": 1 "4_sali_rp": 1 "primers for lox": 1 "premutation 50–230 cgg repeats": 1 "ggg aaa tac gta aag ctt aag atg ggg ctt gga acc gg": 1 "t gg": 1 "caspase7": 1 "dinucleotide repeats": 1 "5?-accggcaggttacccttct-3?": 1 "forward 5'-aaaggtacccgagcccagagggtttactt-3'": 1 "fam- 5?-acttgaaattattcctgcaagcc-3? -bhq": 1 "u gt": 1 "chipzr1": 1 "tgc": 1 "chipzr2": 1 "reverse primer 5'- 3'": 1 "5?- tgt caa cgc gca gga ctt ct -3?": 1 "3' polyadenylation signal": 1 "5?-cca agt cct tcc cac tcg tgc aca ct-3?": 1 "collagen type-iii": 1 "gg t ccg ga c tgg gag ccg gag tgg cg": 1 "tgcccgcatcaa acataattc": 1 "5?- gtatgtggcaggagt tcaa tt taa taagggctgagac–3?": 1 "anneal t °c": 1 "?301 hsd3b2/nbre mutation": 1 "s 5?- atacacccgtgacctcaacc–3?": 1 "5'-ggt gaa ggt cgg agt caa cgg a-3'": 1 "data set": 1 "pgl3 -357/+769": 1 "t t g": 1 "5?-gttaatccaaggtctttaga-3?": 1 "3'-utr length nt": 1 "screening": 1 "malignancy": 1 "acg": 1 "5'-cgggagcttctccttgcc- 3'": 1 "as 5?-cttctggaagcggcagaact–3?": 1 "igfbp3": 1 "meanlife span": 1 "hmdmx fw": 1 "g ga att c at gga caa cac cga gga cg": 1 "t•z 15 mer": 1 "5'-cattgcttttgcacgtaaccaa- 3'": 1 "p21 rv": 1 "5'-gagacagaatagagtgatagg- 3'": 1 "name of duplex": 1 "ct x": 1 "target genes": 1 "5'-ctccgagtcaacagattcagg- 3'": 1 "332 bp": 1 "5?-tcggtcacattgaacag-3?": 1 "5'-gacagatgtgaaggttgg- 3'": 1 "primer sequence 5'-3'": 1 "p27 forward": 1 "forward 5?- aaaggtaccgcctgaactcctaccca-3'": 1 "fam- 5?-atgccctcccccatgccatcctgcgt-3? -tamra": 1 "c y c": 1 "forward primers 5?-3?": 1 "320 bp": 1 "gtgatggcatggactgtggt": 1 "5?-att gtg atc agg tgt cca ca- 3?": 1 "ggg cgg ccg c gt cga c cc cca gaa agg gca cca gc": 1 "hybridized templates": 1 "trinucleotides": 1 "5?-catgtaggctacgctgttcttg-3?": 1 "reverse 5? ? 3?": 1 "3? ccc caa tcc ccc aag ggg cac 5?": 1 "5?-ttggaaagagtgagtattctccaaca-3?": 1 "dna sequence of oligonucleotide substrates": 1 "forward and reverse primers 5??3?": 1 "primers for rt-pcr": 1 "molecular": 1 "t•y cxc": 1 "5?-tct ggc tgt ccg acg gat ca -3?": 1 "5'-atcccccaccttatccatcct- 3'": 1 "srpr fw": 1 "5'-gta tcc agg atg tcc aac ag-3'": 1 "tbp rv": 1 "5'-aggtgcgcaaggtgaaatgt- 3'": 1 "dsred m_sali_rp": 1 "h-ras": 1 "5'-cccccactaccgtaaatgtccat-3'": 1 "lyloxf1": 1 "forward 5?- aaaggtacctgtgcttggggtgagaaa-3'": 1 "lyloxf2": 1 "aga": 1 "5?-acggcagggaccatattctg-3?": 1 "agg": 1 "pathway overlaps": 1 "p53 fw": 1 "5?-gctccattcaccagtgtgttta-3?": 1 "5?-ccatgtttgtgatgggtgtgaacca-3?": 1 "accession number": 1 "cdk2 forward": 1 "accession no.": 1 "capns1 fw": 1 "3? cta aac a cc tta aag gg a cgt 5?": 1 "ca x": 1 "reverse 5??3?": 1 "p21 forward": 1 "ca t": 1 "ca u": 1 "gene name/id": 1 "forward 5? ? 3?": 1 "sequence 5' à 3'": 1 "pgl3?+?12/+100": 1 "sensitive": 1 "hsd3b2 nm_000198": 1 "5'-aatctgtcatgctggtctgcc- 3'": 1 "upl": 1 "x ca": 1 "8oxoa•n 15 mer": 1 "reverse 5?- aaaaagcttttagtcctgctgggcttc-3'": 1 "5?-agc tgg aga gaa tcg ccc ggc tg-3?": 1 "g t g": 1 "5?-tga cgg ggt cac cca cac tgt gcc cta cta -3?": 1 "x cg": 1 "tetranucleotides": 1 "actgaacctgaccgtacagcttcttcttcgcgattc": 1 "full mutation >200 cgg repeats": 1 "net forward": 1 "s 5?- ccg ctcgag ttctggaggaggagggagcaa –3?": 1 "forward primer 5'- 3'": 1 "oligonucleotide sequence 5'-3'": 1 "mutation sites": 1 "fam- 5?-cctcggactgcccaaaccactt-3? -bhq": 1 "t•z 28 mer": 1 "sirna oligonucleotide": 1 "as 5?-gtgtacaaggtatcaccatt–3?": 1 "5?-acatcgctcagacaccatg-3?": 1 "5'-tccaaggcctcattcagctct- 3'": 1 "5_hindiii_fp": 1 "primers 5' ? 3'": 1 "coding sequence": 1 "rps11 rv": 1 "entpd5": 1 "5?-tgattgccacaattcca-3?": 1 "3? ccc cca ccc cag gag gga aaa 5?": 1 "5?-gccgcaggagctatacgag-3?": 1 "sequence 5? –3?": 1 "puma fw": 1 "u•g 28 mer": 1 "survivin rv": 1 "reverse sequence": 1 "forward sequence": 1 "s 5?- ccg ctcgag acttggagacttctcccagttt –3?": 1 "5'-caa gag gcg aac aca caa cgt ct-3'": 1 "cxcl10": 1 "7mer sites": 1 "5'-aagcagccgaccatctttca- 3'": 1 "caspase 3": 1 "5'-ttttcttgctgccagtctggac- 3'": 1 "ggg gtc gac tca cat cac cga gca tga aga c": 1 "dsred m_bspei_rp": 1 "matrilin2": 1 "product size": 1 "c gc": 1 "ggttaacccgggtaagaatgtgca": 1 "catgtgccccattaatgtcagt": 1 "?????? forward primers": 1 "as 5?- gtccc aagctt agattgttaaaagctggacagag –3?": 1 "s 5?- ccg ctcgag ttctcttcctgttcctgg –3?": 1 "hx•c": 1 "primers for chip": 1 "sequence 3": 1 "g-34": 1 "extend primers": 1 "forward 5?- aaaggtaccgccgacgtcaagtcgag-3'": 1 " af017274": 1 "hybridization #": 1 "reverse 5?- aaaaagcttacttgacgtcggcgtgac-3'": 1 "position": 1 "actgaacctgaccgtacaaagttggggatgagctgt": 1 "primers for ?-actin": 1 "amo": 1 "primers for hsd3b2 promoter constructs m77144": 1 "gt g": 1 "sequence 5?-3?": 1 "gt n": 1 "400 bp": 1 "oligo sequence 5'-3'": 1 "total": 1 "dinucleotides": 1 "caggtccgaggttactgac": 1 "tetranucleotide repeats": 1 "cdna length nt": 1 "5'-utr length nt": 1 "5?-tcacggctctgttgaatgtct-3?": 1 "c-jun forward": 1 "accession number genbank": 1 "trinucleotide repeats": 1 "reverse 5?- aaagctagcggattgggataggacgag-3'": 1 "5?-ctgg ctctttccacctct-3?": 1 "aggtcggagtcaacggatttg": 1 "n gt": 1 "nur77": 1 "z ca": 1 "5?-cgg tgg acc acg aag agt ta -3?": 1 "n gc": 1 "exon": 1 "mouse primer": 1 "revere 5?–3?": 1 "n x n": 1 "primer pair": 1 "45s": 1 "p21 fw": 1 "cdc25a rv": 1 "gaaccgtggaataggc": 1 "1_hindiii_fp": 1 "unmethylation specific primers": 1 "fam- 5?-tctcagagcacagatacccagaacttc-3? -bhq": 1 "caspase-3": 1 "lyloxzr1": 1 "lyloxzr2": 1 "ggg gtc gac ccc tgg gag ccg gag tgg cgg g": 1 " af268311": 1 "a ac cgg t cg cca cca tgg ac": 1 "pgl3-159/+100": 1 "5?-tcacccacactgtgcccatctacgc-3?": 1 "s 5?- ccg ctcgag agtgggaactctgtgggaataa –3?": 1 "t ga attc gc cgc agt cca agt ccc gg": 1 "+53 hsd3b2_r": 1 "5?-ttgggccttcagtgcatttcttg-3?": 1 "hmdm2-p2 rv": 1 "s 5?- aagctgactgtacttgaagg–3?": 1 "gt z": 1 "methylation specific primers": 1 "5?-gtcttatcagccctgatggttc-3?": 1 "5? ggg gtt a gg ggg ttc cc c gtg 3?": 1 "c-myc": 1 "mmp-7": 1 "?-actin": 1 "5?-ggg cgg cca ggg tat gta c-3?": 1 "rat opn": 1 "8oxoa•n 28 mer": 1 "p110?": 1 "5'-gag gga tct cgc tcc tgg aag a-3'": 1 "reverse 5'-3'": 1 "p110?": 1 "p110?": 1 "5'-ctctccccagccaaagaagaa- 3'": 1 "p110?": 1 "actgaacctgaccgtacatgtctgcaccataggtatca": 1 "atgatatcgccgcgctcgtc": 1 "tbp fw": 1 "t•?a-hp53": 1 "primers forward/reverse": 1 "hmdmx rv": 1 "s 5?-gaattagagatataacct a g a at tca ctattattctgagaaaagg –3?": 1 "443 bp": 1 "pai-1": 1 "5?- cct tct cct tca gca ggt tg -3?": 1 "reverse 5?- aaagctagcgggacctgggtaggagtt-3'": 1 "srpr rv": 1 "primers for nur77 cloning bc016147": 1 "tgacagcccactttagg": 1 "sequence of forward and reverse primers": 1 "reverse 5?-aaaaagcttgggacctgggtaggagttc-3'": 1 "primers for sdm on hsd3b2 promoter constructs m77144": 1 "tm": 1 "5'-ttcaaggttttctttactgtccaa- 3'": 1 "u•g 15 mer": 1 "cdk4 forward": 1 "mir-mask": 1 "product length base pair": 1 "pgl3-159/-86": 1 "387 bp": 1 "kgf": 1 "gadd45a rv": 1 "fam- 5?-tcgtcgcacatcgagtcggc-3? -bhq": 1 "5?-ggtggttatgacttcagcttcc-3?": 1 "g cg": 1 "reverse 5?- 3?": 1 "g cc": 1 "g ca": 1 "5?-aattcaagggacgggtcatg-3?": 1 "ga t": 1 "5?-tgtcggccttgtggttatcttc-3?": 1 "forward 5?- aaaggtacctcctcgaagcccagcag -3'": 1 "5?-cta gaa gca ttt gcg gtg gac gat gga ggg": 1 "5'-ctgccatttgctagcagtgtgact-3'": 1 "sequence probe 5?-fam- -tamra-3?": 1 "p53 rv": 1 "5?-tgatctcaacacgtggacaaa-3?": 1 "s 5?- ccc aagctt agccatgccctgtatccaagcc –3?": 1 "sequence 5’-3’": 1 "p-value mean life span": 1 "5?-gac taa ggc tgc tcc aga aat c-3?": 1 "resistant": 1 "5'-atggttttggcattgacacatg- 3'": 1 "collagen type-i": 1 "5'-ccatatgctgctcctgctgat- 3'": 1 "forward 5?- 3?": 1 "t•x nxn": 1 "actgaacctgaccgtacacactttctgccagtgtgtcttc": 1 "reverse 5?–3?": 1 "a c t": 1 "?301 hsd3b2/gata mutation": 1 "5?-ccttccagagtcccataca-3?": 1 "5?-tggctgcgaacacatttgtgt-3?": 1 "5? ggg ggt g gg gtc ctc cc t ttt 3?": 1 "fam- 5?-aatgggaattcctacatctgcaaatgc-3? -bhq": 1 "28s": 1 "pcr primers": 1 "target": 1 "dusp6": 1 "fam- 5?-cagaagcccagatgtggagtgccag-3? -tamra": 1 "p16 ink4a": 1 "qpcr": 1 "5?- acg ctg cca gta ttt cat cc -3?": 1 "dusp4": 1 "3?utr shortening": 1 "chipf2": 1 "cctgtgactatggctaccac": 1 "oligo name": 1 "maxlife span": 1 "forward5?- aaaggtacctgtgcttggggtgagaaa-3'": 1 "chipf1": 1 "size pb": 1 "n t n": 1 "pgl3?+?100/+276": 1 "rheb_sali_rp": 1 "?-actin forward": 1 "kgfr": 1 "5?-agggacccaagagatgaag-3?": 1 "a x c": 1 "oligonucleotide 1": 1 "annealing temperature °c": 1 "5?-cga gtc acc atc tca gca aa-3?": 1 "?301 hsd3b2/sf1 mutation": 1 "s 5?- ctaaagccaagactct tta ag acactgtggcctt–3?": 1 "18s": 1 "rat mmp-9": 1 "primers for 3'race": 1 "5'-tccgaagctggaatctgtgag- 3'": 1 "5'-attgtcttgcatgcggcc- 3'": 1 "g•n": 1 "8_sali_rp": 1 "primer sequences forward/reverse": 1 "?1050 hsd3b2 _f": 1 "pgl3-86/+12": 1 "hmdm2-p2 fw": 1 "t g a": 1 "reverse primers 5?–3?": 1 "rheb_ecori_fp": 1 "as 5?- cgc ggatcc tcagaagggcagcgtgtcc –3?": 1 "reverse primers 5?-3?": 1 "actgaacctgaccgtacatacatggacatcttctgcac": 1 "5?-ccctacctcaaggttctc-3?": 1 "probes": 1 "reverse 3?-5?": 1 "658 bp": 1 "primers for ck-19": 1 "5?-tctcagagcacagatacccagaacttc-3?": 1 "c-fos forward": 1 "313 bp": 1 "p-value max life span": 1 "5'-cacgaaccacggcactgatt- 3'": 1 "gadd45a fw": 1 "5?-accagtggatgcaggatgatgttc-3?": 1 "ggc": 1 "cyclin d1 forward": 1 "5'-tga gga gcg atg acg gaa ta-3'": 1 "ggg gtc gac tta cca gaa agg gca cca gc": 1 "capns1 rv": 1 "cycles": 1 "cdc25a fw": 1 "5?-cagcggaaccgctcattgccaatgg-3?": 1 "5.8s": 1 "5?-aaa ttc atg gat gcc tct gc-3?": 1 "forward 5’–3’": 1 "335 bp": 1 "forward 5??3?": 1 "5'-gcttgcctgtggtgtcgc- 3'": 1 "5?-act caa cgt gca agc ctc gg-3?": 1 "5?-agg cag aga ttc gct tgt gt-3?": 1 "forward 5'-3'": 1 "t•?a-mha-ras": 1 "5?-gcttgtgcgcgtacagtttc-3?": 1 "?301 hsd3b2_f": 1 "dsred m_agei_fp": 1 "5'-aac tgt tct cgt cgt ttc cgc aa-3'": 1 "primer/probe": 1 "antisense odn": 1 "8mer sites": 1 "tacttatgaaaggcccagac": 1 " aj428366": 1 "5'-ctaattgggctccatct- 3'": 1 "reverse 5'-cccaagcttgcctcaatcttccctgcttc-3'": 1 "internal deletion": 1 "356 bp": 1 "tcc": 1 "dsred m_ecori_fp": 1 "forward primers 5?–3?": 1 "targeted isoform": 1 "gatggagagctatgatgagg": 1 "taqman probe fam-5? ? 3?": 1 "enzyme": 1 "???????? reverse primers": 1 "5?-gaa caa gct cca tct gtc ac-3?": 1 "5?-gttaaactcccgcgtcatagaaa-3?": 1 "mouse h-ras": 1 "tct": 1 "puma rv": 1 "cyclin e forward": 1 "survivin fw": 1 "5'-agcagaggaagaccatgtgga- 3'": 1 "5'-acgcacgccactttttctct- 3'": 1 "cgctcggtgaggatcttca": 1 "fam- 5?-tatcatggaaatcaggacagtggcagt?-3? -tamra": 1 "nur77 nm_002135": 1 "5'-gacctcaacgcacagta- 3'": 1 "rps11 fw": 1 "locus": 1 "number of repeats": 1 "t•g": 1 "5? gat ttg tgg aat ttc cct gca 3?": 1 "ggg aaa tac gta aag ctt tac ttg gaa ccg gac ctg c": 1 
"?": 12 "hct116": 11 "ht29": 8 "sw480": 8 "ht-29": 7 "hela": 6 "mcf-7": 6 "hek293": 6 "panc1": 6 "gene": 5 "caco-2": 4 "tert": 4 "hypoxia": 4 "normoxia": 4 "a549": 4 "ouabain": 4 "hct-116": 4 "du145": 4 "l1210": 3 "pc3": 3 "dld1": 3 "time": 3 "mda-mb-231": 3 "lovo": 3 "sw-480": 3 "parameter": 3 "cne-2": 3 "v79": 3 "ls174t": 3 "p-value": 3 "compound": 3 "skbr3": 2 "fold increase": 2 "bxpc-3": 2 "gene name": 2 "erl-r": 2 "treatment": 2 "cell line": 2 "a375": 2 "cell lines": 2 "huh7": 2 "cne-2s2": 2 "cne-2s1": 2 "c.i.95": 2 "wt": 2 "at6.3": 2 "van-r": 2 "gef-r": 2 "accession number": 2 "hep3b": 2 "hepg2": 2 "msto-211h": 2 "gene symbol": 2 "panc-1": 2 "experimental group": 2 "line 2": 2 "line 3": 2 "line 1": 2 "rko": 2 "drugs": 2 "membrane": 2 "caov3": 2 "cytoplasm": 2 "fold-change": 2 "106": 2 "silibinin": 1 "hif-1? sirna": 1 "s ": 1 "??????????ic50 mean ± sd ?m": 1 "huh-7": 1 "jurkat dnase": 1 "complex": 1 "184-a1": 1 "crl5928 t/u": 1 "fo-1": 1 "ovcar-3": 1 "ras": 1 "nci-h358": 1 "crl5800 t/u": 1 "hey negative": 1 "cyclinb1": 1 "gdc-0941/pd0325901": 1 "bmal1 luciferase activity": 1 "g0/g1 ": 1 "htb182 t/u": 1 "dld-1": 1 "10-ch3 chain a": 1 "calu-3": 1 "u87": 1 "h1650": 1 "methyl selenium molecules": 1 "l1210 c": 1 "solvents": 1 "tissue expression": 1 "phenylacetate": 1 " frequency": 1 "endogenous": 1 "hey positive": 1 "hct116 p53+/+": 1 "pdgfr?": 1 "pdgfr?": 1 "u87mg": 1 "bjab": 1 "ic 50 ? m ": 1 "hmec": 1 "vector": 1 "parental": 1 "33": 1 "34": 1 "a-704": 1 "38": 1 "hl7702": 1 "ci": 1 "bl41": 1 "pyrvinium + fts": 1 "pc-3 5 µm": 1 "22rv1 2µm": 1 "hcc2998": 1 "bound factors": 1 "ovca 433": 1 "10 fcs vs 0 fcs": 1 "skov-3": 1 "cell treatment": 1 "mdamb231": 1 "bl41b95.8": 1 "smmc-7721": 1 "h3255": 1 "beas2b t/u": 1 "symbol": 1 "v79 b": 1 "achn": 1 "cfp vs yfp": 1 "cal-54": 1 "sum159": 1 "vimentin": 1 "nci-h2052": 1 "mcf7": 1 "mhcclm3": 1 "caki-1": 1 "101102": 1 "caki-2": 1 "du145 2 µm": 1 "51": 1 "hbl-100": 1 "mmtv-rtta/teto-mic": 1 " µg/ml": 1 "h358": 1 "crl5869 t/u": 1 "pc9": 1 "h23": 1 "refseq": 1 "cne-2s#": 1 "ki67": 1 "pc-3 2 µm": 1 "cne-2s*": 1 "name": 1 "sirna1": 1 "sirna2": 1 "lncap 2 µm": 1 "cancer cells w/o as": 1 "mmtv-pyv mt/mmtv-cre recombinase": 1 "sirna3": 1 "crl5872 t/u": 1 "sirna4": 1 "15- s-hete": 1 "rpmi 8226": 1 "cancer cell lines": 1 "mcf-10a": 1 "emt": 1 "nvp-bez235/pd0325901": 1 "iso -type chain a": 1 "mhcc97l": 1 "genistein": 1 "widr": 1 "sw403": 1 "lovastatin hmg-coa reductase inhibitor": 1 "quercetin": 1 "51106": 1 "ovhs 1": 1 "76": 1 "llc": 1 "pc-9": 1 "fold repression": 1 "lncap du145": 1 "namalwa": 1 "lim1215": 1 "hct116 p53?/?": 1 "g2/m ": 1 "ramos": 1 "76.2": 1 "tg line 2": 1 "tg line 1": 1 "76.4": 1 "tg line 4": 1 "76.3": 1 "tg line 3": 1 "exogenous": 1 "colo205": 1 "localization": 1 "xla-07": 1 "ic50": 1 "mda-mb-468": 1 "bl2b95.8": 1 "crl5810 t/u": 1 "igf-ir": 1 "a549 dnase": 1 "nci-h28": 1 "u87/egfr": 1 "skmel-28": 1 "ic 50 ?g/ml ± sem": 1 "sklu-1": 1 "bxpc3": 1 "91": 1 "csc-properties": 1 "transgenic line": 1 "hpac": 1 "hey": 1 "wm1366": 1 "mean fluorescence intensity": 1 "antibody": 1 "method": 1 "hff-1": 1 "scrambled sirna": 1 "chl-1": 1 "nih3t3": 1 "bl2": 1 "antigen": 1 "pkf115-584 + fts": 1 "nci-h1975": 1 "kinase": 1 "u2os": 1 "lncap": 1 "786-o": 1 "hs294t": 1 "biochanin a": 1 "g0/g1 population ± s.d *": 1 "mia paca-2": 1 "pbmc": 1 "combination index": 1 "status": 1 "sw1990": 1 "regions": 1 "qsg7701": 1 "du145 at6.3": 1 "iec-6": 1 "ras0.5": 1 "line 6": 1 "line 7": 1 "bl-36": 1 "caspase 3 + 0 fcs": 1 "ovcar3": 1 "skov3": 1 "kaempferol": 1 "sirna experiments": 1 "peo.36": 1 "hct116 p21?/?": 1 "phenotype/total*": 1 "grape seed extract a": 1 "silymarin": 1 "pc14": 1 "proliferation": 1 "cschigh mia-paca2": 1 "zr-75-30": 1 "panc1 dnase": 1 "4t1": 1 "il-1?": 1 "vhmec": 1 "t47d": 1 "mda-231": 1 "ic50 µm": 1 "sk-hep1": 1 "du145 5 µm": 1 "capan-2": 1 "e-cadherin": 1 "caspase 3 + 10 fcs": 1 "caco2": 1 "r-mcf-7dox": 1 "a-498": 1 "nci-h2452": 1 "reference": 1 " rtta/mic +dox": 1 "refs.": 1 "raji": 1 "lncap 5 µm": 1 "molt-4": 1 "csclow bxpc-3": 1 "22rv1 5 µm": 1 "calcitonin": 1 "ratio va +/va ?": 1 "cancer cells w as": 1 "hose 80": 1 "hct116 versus": 1 "daudi": 1 "rs4 11": 1 "769-p": 1 "bcap-37": 1 "colo-205": 1 "crl5807 t/u": 1 "low-na+ high-k+": 1 "p value": 1 "fgh": 1 "hl-60": 1 "apoptosis": 1 "antigen expression mif": 1 "27103104": 1 "anteiso -type chain a": 1 "wm3248": 1 "htc116": 1 "hk-2": 1 "? scha": 1 "mncs": 1 "tcga patients": 1 "plc": 1 "u266": 1 "median fluorescence positive": 1 "control high-na+ low-k+": 1 "u87/egfrviii": 1 "normal chain a": 1 "hek293 vs transf.": 1 "100": 1 "miapaca2": 1 "rm11a cell line in vitro ": 1 "105": 1 "colo-206f": 1 "u937": 1 
"p": 123 "p value": 98 "p -value": 72 "?": 67 "gene": 46 "+": 43 "n": 32 "description": 27 "positive": 26 "fold change": 26 "negative": 26 "name": 25 "protein": 22 "c": 20 "p-value": 20 "gene name": 20 "total": 20 "gene symbol": 19 "fc": 18 "reference": 16 "symbol": 15 "normal": 14 "": 13 "m": 13 "fold": 12 "hr": 12 "pi": 12 "control": 12 "f": 11 "t": 11 "protein name": 11 "a": 10 "sos p ": 10 "variable": 10 "bf": 10 "gene id": 10 "sos 0": 10 "accession": 10 "1": 9 "2": 9 "h": 9 "s": 9 "function": 9 "accession number": 9 "k 10 k -10": 9 "k 11 k -11": 9 "k 9 k -9": 9 "category": 9 "b": 8 "reference s": 8 "human": 8 "grb 2 *": 8 "id": 8 "phase": 8 "beta 95ci": 8 "?2": 8 "0.00e+00": 8 "ratio": 8 "references": 8 "score": 8 "e value": 8 "fwer p": 7 "treatment": 7 "11": 7 "nes": 7 "mw": 7 "hazard ratio 95 confidence interval": 7 "drug": 7 "target s": 7 "nominal p": 7 "?": 6 "3": 6 "4": 6 "5": 6 "7": 6 "d": 6 "q": 6 "?": 6 "stage": 6 "parameter": 6 "p a": 6 "p i": 6 "identifier *": 6 "no.": 6 "strain": 6 "mf": 6 "qpcr": 6 "hr 95 ci": 6 "gene description": 6 "rr ": 6 "tumor": 6 "cell line": 6 "0": 5 "8": 5 "9": 5 "u": 5 "y": 5 "term": 5 "pathway": 5 "p z": 5 "mm": 5 "or": 5 "sc": 5 "organism": 5 "log2fc": 5 "accession no.": 5 "compound": 5 "t 1/2": 5 "exp data": 5 "rat": 5 "spot": 5 "c elegans homolog": 5 "mouse": 5 "cell type": 5 "positive rate ": 5 "clock function": 5 "ci*": 4 "lens": 4 "comments": 4 "wistar t1-3 42xy": 4 "corby": 4 "er 0 * *": 4 "s int.": 4 "duration": 4 "classification": 4 "l longbeachae": 4 "observed": 4 "10": 4 "30": 4 "expression": 4 "l pneumophila": 4 "unigene": 4 "c sd": 4 "reaction equation": 4 "mascot score": 4 "kf nm?1 s?1": 4 "p c": 4 "p q": 4 "species": 4 "exp": 4 "expected": 4 "factor": 4 "study": 4 "enzyme": 4 "ac": 4 "dm": 4 "spot no.": 4 "i2": 4 "s sd": 4 "kcat s?1": 4 "theo": 4 "mean ± sd": 4 "clone id": 4 "similarity": 4 "number of patients": 4 "os months": 4 "copd": 4 "groups": 4 "fruitfly": 4 "c elegans": 4 "institution": 4 "go term": 4 "rpd3 s": 4 "rpd3 l": 4 "network activity values": 4 "c int.": 4 "post r": 4 "mw kda": 4 "group": 4 "k 8 k -8": 4 "score d": 4 "?b": 4 "log fold change": 4 "sequence coverage ": 4 "pufferfish": 4 "ins": 4 "rlev f kalt": 4 "mw da": 4 "er e * *": 4 "age": 4 "kb s?1": 4 "genx": 4 "s cerevisiae": 4 "scc": 4 "pre r": 4 "95ci": 4 "fold change p value": 4 "genbank accession number": 4 "cluster 2": 4 "cluster 1": 4 "g lucidum": 4 "paris": 4 "g": 3 "r": 3 "product": 3 "spot number a": 3 "comparison": 3 "?": 3 "genes": 3 "source": 3 "heterogeneity": 3 "age years": 3 "0.50": 3 "patient id": 3 "er 2 * sos 0 * * * *": 3 "mrna": 3 "variables": 3 "exp inh": 3 "gqrk r liss": 3 "mol": 3 "th1 response": 3 "site f": 3 "annotation": 3 "primer sequence": 3 "cancer type": 3 "exp act": 3 "rel k max": 3 "column id": 3 "gene title": 3 "coverage e": 3 "fc1": 3 "smoking status d": 3 "shc *": 3 "stimulus": 3 "pdii i kalp": 3 "br": 3 "con act": 3 "df": 3 "con inh": 3 "age/sex a": 3 "lc": 3 "ns": 3 "? antibody production": 3 "country": 3 "genotype": 3 "6 h": 3 "method": 3 "comb": 3 "effects on feeding": 3 "mirna": 3 "mw da b": 3 "matching peptide/searched d": 3 "locus 1": 3 "pts": 3 "correlation r": 3 "mean": 3 "population": 3 "route": 3 "hr 95ci": 3 "h sapiens": 3 "count": 3 "identified protein": 3 "position": 3 "amino acid": 3 "? 180": 3 " change *": 3 "alternate name": 3 "exon/codon": 3 "characteristics": 3 "nucleotide exchange": 3 "publication bias": 3 "s6k1 ic50 nm a": 3 "sequence coverage": 3 "sriq t slts": 3 "pi c": 3 "ac 50/?m": 3 "i 2 ": 3 "amplified": 3 "maf c ": 3 "duke's stage c": 3 "parameters": 3 "case": 3 "e coli": 3 "biological process": 3 "spot id": 3 "proteins": 3 "sex": 3 "svql l dqip": 3 "reagent": 3 "model": 3 "ethanol": 3 "m a": 3 "snp": 3 "s mansoni": 3 "nm a": 3 "coverage": 3 "kdyp s ned": 3 "exp 2": 3 "exp 1": 3 "feature": 3 "m/z": 3 "?": 2 "aqp5 expression": 2 "95 confidence interval": 2 "medium c": 2 "er * * grb 2 0": 2 "loh b ": 2 "6": 2 "27.9–1.6": 2 "shc grb 2 0": 2 "? ": 2 "cytology e": 2 "l": 2 "species identified e": 2 "x": 2 "cn/pi?": 2 "er 2 * * sos p * * *": 2 "ir i i * *": 2 "aucroc": 2 "cyclopropyl": 2 "ras2 ?": 2 "p-erk": 2 "phila": 2 "er 2 * shc p * * * *": 2 "mutation": 2 "protein id": 2 "irs grb 2 0": 2 "fraction b ×106": 2 "hm1imss colon/hm1imss culture": 2 "2.0": 2 "inmap‡": 2 "fold-change si vs sc": 2 "condition": 2 "type g": 2 "er * * p ": 2 "t-test p": 2 "24 h": 2 "official_set_id": 2 "modulator": 2 "b220+/cd43? ×106": 2 "cn/pi+": 2 "resistant": 2 "f velutipes": 2 "no ofstudies": 2 "n/a": 2 "s no.": 2 "1976": 2 " quillé et al 2011 ": 2 "1974": 2 "pakt": 2 "or – 95ci": 2 "geneid": 2 "protocol_ids*": 2 "sch9 ?": 2 "ouabain": 2 "tunel+": 2 "?": 2 "chromosome": 2 "gro ? /cxcl-1": 2 "interaction": 2 "high 10 vs others": 2 "alcoy": 2 "der": 2 "k 17 k -17": 2 "p.v.": 2 "irs p ": 2 "low c": 2 "p-mek": 2 "affy probeset": 2 "0.33": 2 "s6k1 ic50 ?m a": 2 "length": 2 "b bassiana": 2 "entrez gene name": 2 "sorafenib": 2 "grb 2 sos 0": 2 "pik3ca mutation": 2 "0.59": 2 "3.0": 2 "wilcox p": 2 "+ ": 2 "rat group": 2 "size bp": 2 "k 13 k -13": 2 " slp-76 in clusters": 2 "mgmt gene": 2 "stat3-c data": 2 "13": 2 "14": 2 "15": 2 "fc mv": 2 "19": 2 "20": 2 "12 h": 2 "23": 2 "24": 2 "25": 2 "serial no.": 2 "ir * * sos p *": 2 "31": 2 "37": 2 " fall": 2 "shr fold change": 2 "modulation time minutes": 2 "46": 2 "tor1 ?": 2 "modification": 2 "um * n?=?33 ": 2 "aminoacid change": 2 "ir * * * sos p ": 2 "? min": 2 "70": 2 "72": 2 "p -value *": 2 "1.999": 2 "93": 2 "97": 2 "protein name organism": 2 "ir i 0 * *": 2 "change in expression 2": 2 "p -value 4": 2 "gender": 2 "p -value b": 2 "tryptic fragment coverage/matches": 2 "phase s trial": 2 "4 h": 2 "?tub1": 2 "?tub2": 2 "m * n?=?29": 2 "fraction f ×106": 2 "depth of invasion g": 2 "node status e": 2 "year": 2 "egf": 2 "b thuringiensis": 2 "j.c.": 2 "shc p ": 2 "grb 2 0": 2 "fold change c": 2 "pkn0": 2 "gene symbol//gene title ref # – functional categories": 2 "er * * sos 0": 2 "98072": 2 "p f": 2 "k 23 k -23": 2 "p -adjusted": 2 "pkn3": 2 "family": 2 "forward f and reverse r primer sequences": 2 "no ofmethylationcases": 2 "rural/urban b": 2 "|fold change|": 2 "protein mass da": 2 "protein name a": 2 "nature h": 2 "leucine mg/100 g food": 2 "ilumina probe id": 2 "? 60": 2 "locus link id": 2 "side effects": 2 "cohen’s d": 2 "genome frequency": 2 "mcp1/ccl-2": 2 "metric": 2 "er * sos p *": 2 "go id": 2 "relapse-free survival": 2 "overall survival": 2 "ir * * grb 2 0 *": 2 "0830-1000": 2 "g g t>g a t": 2 "tnfrsf11b upstream": 2 "inhibitory rate ": 2 "24h lh ratio b": 2 "spot no a": 2 "npv": 2 "p53": 2 "mount sinai school of medicine": 2 "fdr": 2 "hazard ratio": 2 "effects": 2 "pathology": 2 "fraction a ×106": 2 "no homology": 2 "nsc number": 2 "discovery phase a": 2 "transcription factor": 2 "rank": 2 "k 1 k -1": 2 "cells/femur ×107": 2 "bb": 2 "cc": 2 "cl": 2 "food": 2 "cs": 2 "dt": 2 "pfs months": 2 "eg": 2 "eo": 2 "glu>lys": 2 "origin": 2 "ir 0 0 * *": 2 "obl": 2 "hs": 2 "d melanogaster": 2 "gene_name": 2 "kcal mol?1": 2 "e -value": 2 "skap55 chimera": 2 "shc sos 0": 2 "fve": 2 "md": 2 "wky p -value": 2 "mp": 2 "author": 2 "no": 2 "50? ? m egcg": 2 "ir 0 i * *": 2 "ob": 2 "pa": 2 "ph": 2 "pl": 2 "grb 2 sos p ": 2 "pn": 2 "iitl c rtvn": 2 "pu": 2 "pw": 2 "m musculus": 2 "p value b": 2 "mutant": 2 "g-csf": 2 "sf": 2 "go bp/mf": 2 "*relative growth ": 2 "p value *": 2 "ts": 2 "tt": 2 "flybase_id": 2 "hm1imss colon/rahman colon": 2 "wt": 2 "cases": 2 "location": 2 "wky fold change": 2 "type": 2 "coxph survival analysis": 2 "accession id a": 2 "p-value si vs sc": 2 "n experiments": 2 "?male": 2 "ir * * * sos 0": 2 "s score": 2 "unique identifier d": 2 "persistence": 2 "kaplan-meier survival analysis": 2 "gi number a": 2 "m * n?=?29 ": 2 "kras gene codon 12": 2 "kras gene codon 13": 2 "sem ±": 2 "medium": 2 "pca": 2 "p v alue d": 2 "thero": 2 "b.s summa cum laude pennsylvania state university state college pa": 2 "?cy1": 2 "?cy0": 2 "r s c": 2 "m anisopliae": 2 "hnpc": 2 "pi+": 2 "authors/ refs.": 2 "cimp+ ": 2 "mfc b": 2 "er * shc p *": 2 "p model * ‡": 2 "ober": 2 "scaffold_id": 2 "histologic type d": 2 "myron eliot schwartz md": 2 "locus 2": 2 "or 95 ci d": 2 "no txt": 2 "ppv": 2 "p node †": 2 " unchanged": 2 "iqlh y khgy": 2 "hepatitis b": 2 "hepatitis c": 2 "shr p -value": 2 "median": 2 "er 2 * * 0 * * *": 2 "he4": 2 "d-4968": 2 "percent coverage b ": 2 "functional group": 2 "cdt+ir": 2 "codon number": 2 "clinical characteristics": 2 "er 2 * sos p * * * *": 2 "p.value": 2 "or per allele 95 ci": 2 "hepatic metastasis f": 2 "er * grb 2 0 *": 2 "cimp? ": 2 "lithium": 2 "target genes": 2 "shc sos p ": 2 "15/600": 2 "?female": 2 "3.0? ? m": 2 "?protein": 2 "fhit gene": 2 "s pombe": 2 "som region s": 2 "gene function": 2 "t m °c": 2 "kegg pathway": 2 "fc m": 2 "k a": 2 "4.29e-18": 2 "clusters tracked per diameter": 2 "high c": 2 "lewis y": 2 "il-6": 2 "ir * * * grb 2 0": 2 "8 h": 2 "pathway name": 2 "ir * * sos 0 *": 2 "fraction c ×106": 2 "begg’stest p": 2 "total gastric cancer cases vs controls": 2 "go *": 2 "hgnc": 2 "k 2 k -2": 2 "modulated mrna": 2 "le b": 2 "?sig": 2 "blastx results": 2 "lymph node metastasis b": 2 "? ± se": 2 "er 2 * * grb 2 0 * * *": 2 "8.7? ? m 5-aza-dc": 2 "dayton": 2 "gly>asp": 2 "?iv": 2 "max speed": 2 "?ii": 2 "?ia": 2 "?ib": 2 "factors p-value": 2 "transcript id": 2 "gene #": 2 "t statistic": 2 "?h0": 2 "?h1": 2 "er 2 * grb 2 0 * * * *": 2 "?n3": 2 "?n0": 2 "?n1": 2 "?n2": 2 "alternative name s": 2 "amino acid change": 2 "um * n?=?33": 2 "er * p *": 2 "p value§": 2 "wild type": 2 "er 2 * p * * * *": 2 "doxo 40nm": 2 "av score": 2 "nsw 150": 2 "?p0": 2 "?p1": 2 "k 4 k -4": 2 "<0.001": 2 "up-regulated": 2 "0.0": 2 "?t1": 2 "?t2": 2 "?t3": 2 "?t4": 2 "exon": 2 "aberrant methylation c ": 2 "histology": 2 "er * sos 0 *": 2 "candidate gene by lowest p -value": 2 "rs control 3": 2 "base change i": 2 "crpc": 2 "egger’stest p": 2 "cytoplasmic": 2 "tunel+/pi+": 2 "v-src data": 2 "peritoneal metastasis c": 2 "target": 2 "positive cases": 2 "tissue": 2 " rise": 2 "gene set": 2 "pld+b": 2 "os ms": 2 "gene name b": 2 "univariate analysis": 2 "extension phase b": 2 "?ads": 2 "b220+/cd43+ ×106": 2 "t test": 2 "?beta": 2 "irs sos p ": 2 "k+-free medium": 2 "mrnas": 2 "gane 30nm": 2 "correlation coefficient r s ": 2 "gene s": 2 "d n": 2 "d s": 2 "nsw150": 2 "p interaction term † ?": 2 "patient": 2 "mean value of wt/itd": 2 "?iiia": 2 "?iiib": 2 "bac": 2 "er * * sos p ": 2 "n-fold": 2 "mascot probability score/expect p ": 2 "fraction e ×106": 2 "fraction d ×106": 2 "xz16": 2 "1/12": 2 "relative lifespan l a": 2 "smsc-et": 2 "xz61": 2 "autistic": 2 "placebo": 2 "6h lh ratio b": 2 "spleen": 2 "spot no": 2 "u/d": 2 "change": 2 "?por2": 2 "?por1": 2 "1.0": 2 "uniprotid": 2 "subtype": 2 "chromosome and map position build 37": 2 "b-md-c1": 2 "medication": 2 "flybaseid": 2 "aasc ": 2 "irs sos 0": 2 "specificity": 2 "inward movement": 2 "no ofdetectedcases": 2 "cmsc-et": 2 "ir gy": 2 "c-4e7": 2 "md jefferson medical college philadelphia pa": 2 "mutation a": 2 "antibody": 2 "treated/untreated ratio ± sd f": 2 "k d moles × 10?15": 2 "range": 2 "rassf1a gene": 2 "fraction": 2 "mr kd": 2 "patients": 2 "p over†": 2 "functional categorization": 2 "2 h": 2 "pool d": 1 "abbr nme": 1 "outcomes": 1 "wild type n?=?50 ": 1 "variable *": 1 "mw exp kda": 1 " ": 1 "ywhaz": 1 "additional features a": 1 "er * * grb 2 *": 1 "-": 1 "pool c": 1 "mcf7/her2-18 treated": 1 "pool b": 1 "node-negative": 1 "pool a": 1 "goid": 1 "soft agar colonies": 1 "size": 1 "1.13e-20": 1 "3643": 1 "hearing loss": 1 "1.000": 1 "q-values": 1 "fw 5?-tccctcgctgcacaaatactc-3? rev 5?-acgacccgatggccataga-3?": 1 "change type": 1 "qpcr fold change": 1 "gradient a": 1 "differential expression": 1 "shc grb 2 *": 1 "nm_138639.1": 1 "result": 1 "pi gel": 1 "k 31 k -31": 1 "benzyl": 1 "upstream regulator s": 1 "accuracy patterns ": 1 "val>gly": 1 " n ptc/ n controls": 1 "yan 2012": 1 "e": 1 "val>glu": 1 "permutated p-value e": 1 "i": 1 "k": 1 "apoptotic index ": 1 "7.56e-02": 1 "crc cases n?=?584": 1 "z": 1 "intermediate regulators in network": 1 "log phase": 1 "positive ": 1 "swiss-plot": 1 "ir i i * 0": 1 "8.96e-07": 1 "er-positive": 1 "gene ontology": 1 "p-ser 30? treated/untreated ratio ± sd f": 1 "fw 5?-ggagagggagcctgagaaac-3? rev 5?-tcgggagtgggtaatttgc-3?": 1 "nom p- val": 1 "a403g": 1 "ir * * shc * *": 1 "rassf1a c": 1 "epac2 fl": 1 "population/subgroup": 1 "week 8 tpm": 1 "1.22e-04": 1 "fungal species": 1 "3.32e-17": 1 "completeness ": 1 "9.05e-05": 1 "1040": 1 "tki": 1 "locus link": 1 "colon hm1imss/rahman": 1 "0.083 0.565": 1 "acd/pred log p ow": 1 "no ests": 1 "sourcename": 1 "g145t": 1 "dukes a v dukes b p value": 1 "nm_004324.3": 1 "?anti-freeze protein": 1 "mcf7/her2-18 control": 1 "a log2fc": 1 "bcl2-like 1 bcl-xl": 1 "smabf ml/min.100 g": 1 "real-time fold-change": 1 "pdgf-c expression": 1 "mapkk a": 1 "mcf-7": 1 "total ": 1 "cla": 1 "0.1821": 1 "k -means cluster": 1 "nurses vs methoprene bees": 1 "nm_001127240.1": 1 "ec log2-fold": 1 "n a": 1 "n c": 1 "n b": 1 "asp>asn": 1 "irs grb 2 *": 1 "n s": 1 "#aas": 1 "egger’s test p": 1 "p fisher test": 1 "pip2": 1 "gene names of unique members of each category": 1 "low cystatin c staining under 2 n?=?315": 1 "go0005842": 1 "go0005843": 1 "k i cb1 nm": 1 "++133 33.3": 1 "mss n?=?416 85.4": 1 "redundancy": 1 "tissue sample b p c/m d": 1 "drugs": 1 "simulation length ?s": 1 "hpv 16 variants": 1 "5? tgatgtatttgtttatgtg 3?": 1 "positive therapy response ": 1 "2.5": 1 "7.0 7.3": 1 "fc pv": 1 "ortholog": 1 "cellular factors": 1 "? ± se": 1 "total transcripts": 1 "protein name of the target gene": 1 "clones": 1 "ivanova et al 26": 1 "exon 1.0 st array a": 1 "failed base calling qc": 1 "rev primer seq": 1 "immunoreactivity p value primary dukes c tumour v lymph node metastasis": 1 "pqq?": 1 "ga vs aa": 1 "? 5": 1 "type s": 1 "tsa": 1 "go0008080": 1 "ir i i * irs p ": 1 "technique": 1 "mgat5?/?": 1 "crc": 1 "214": 1 "54±15.8": 1 "1.011": 1 "down in pho23 ? 111": 1 "20a": 1 "20b": 1 "20c": 1 "20d": 1 "20e": 1 "g g t>g t t": 1 "20f": 1 "spot#": 1 "20g": 1 "methanolic extract": 1 "mc hs": 1 "er * shc 0 *": 1 "cluster": 1 "21a": 1 "21b": 1 "cytoband": 1 "21c": 1 "mode of action": 1 "21d": 1 "21e": 1 "identity ": 1 "epac1": 1 "identity f": 1 "stumvoll goldstein 2005": 1 "shdab2ip": 1 "1.56e-19": 1 "total nodes": 1 "e7 n =83": 1 "element": 1 "ctr": 1 "tvb": 1 "average volume ratio": 1 "transcripts intensity under the influenced treatment c": 1 "virus-associated cellular kinase s": 1 "nurses vs winter bee pools": 1 "g t g>g a g": 1 "fasl expression": 1 "tnfrsf11b downstream": 1 "246": 1 "raw p-value d *": 1 "????????protein/water": 1 "related neurological disease": 1 ">100000": 1 "ea ? m": 1 "3.84e-06": 1 "ref s": 1 "egi-1": 1 "rplp0": 1 "gg vs ga/aa": 1 "cdc42 expression": 1 "the matched species/taxonomy in ncbi g": 1 "sift score f": 1 "dopamine": 1 "k 3 k -3": 1 "heat shock proteins": 1 "sharp study llovet et al 2008 ": 1 "asia-pacific study cheng et al 2008 ": 1 "cell lines": 1 "c briggsae – caenorhabditis remanei comparisons": 1 "functional annotation categories/ proposed function": 1 "? 6 = k 2 z 3 - z 6 e 2 - k -2 z 6 + k 3 z 2 - z 6 e 3 - k -3 z 6     53g": 1 "fw 5?-ggtgcctctagtgaaaagaacaaga-3? rev 5?-gctggtcccacatagttgca-3?": 1 "accession number swissprot": 1 "wavelength å": 1 "norepi": 1 "k 7 k -7": 1 "idh mutation/wild type": 1 "foxj2 mutated fp": 1 "6.43e-03": 1 "tnm stage s": 1 "go0046365": 1 "c244": 1 "sanger sequencing": 1 "anti-p25": 1 "2.66e-08": 1 "3.14e-09": 1 "tgf-?1 2 -? c t range": 1 "fc b wm vs mzl": 1 "bcl2-assocciated agonist of cell death": 1 "treatment administered between p and m": 1 "lqlh y knky": 1 "seed nodes": 1 "pak1": 1 "nm_003406.2": 1 "b reported compounds": 1 "start": 1 "ln+": 1 "fw 5?-gagtgacgagtttgtggactcctt-3? rev 5?-tgtgcccgcgctcttc-3?": 1 "lifestyle": 1 "on-target primary effects": 1 "nm_000546.4": 1 "ir i 0 * p ": 1 "main effect s microarray": 1 "fung": 1 "mascot protein score e": 1 "k 18 k -18": 1 "fdr ": 1 "perturbed expression following manipulation of oct4 expression up or down": 1 "kcl mm": 1 "vrk1 nuclear staining": 1 "hyperplasia": 1 "nurses vs vg knockdowns": 1 "dkdilvgiv": 1 "f b": 1 "dates": 1 "upstream kinase": 1 "grouping": 1 "dna sequence change b": 1 "?pap": 1 "1980": 1 "routes of administration": 1 "?33 8.2": 1 " deleted/lost": 1 "positive expression rate": 1 "fda approval": 1 "total expression mg / l": 1 "mw gel": 1 "pr- over pr+": 1 "c143g": 1 " 2.2±0.5": 1 "species/animal model": 1 "low": 1 "metastasis": 1 "hp_aa": 1 "nm_021127.2": 1 "ir * * * irs *": 1 "lps": 1 "20 b - al": 1 "organism/tissue/cells": 1 "go0006365": 1 "40-2.1 2.4-2.1": 1 "tv cm 3": 1 "clinical features": 1 "transfection": 1 "s japonicum": 1 "known functions": 1 "dag": 1 "univariatea": 1 "n?=?435 mean values": 1 "large follicles flat cell": 1 "ballroom d-e plenary opening session chairs jan lötvall and kenneth w witwer": 1 "1.833": 1 "ir 0 0 * p ": 1 "methods of mc identification": 1 "sodium valproate": 1 "tsc gene": 1 "go0016570": 1 "water": 1 "3 c": 1 "v cholerae 1587 ttss2? homologue id": 1 "m2kp a": 1 "average b factors": 1 "3 h": 1 "mean age diagnosis": 1 "? 2 = k 2 z 0 - z 1 - z 2 + z 4 e 2 - k -2 z 2 - z 4 + k 3 z 1 - z 4 e 2 - k -3 z 4     54c": 1 "mutated gene": 1 "reference d": 1 "er * grb 2 * *": 1 "synonym": 1 "1.812": 1 "1.813": 1 "5? ctcctcagt c ggg a gatcaggatc 3?": 1 "abbrev.": 1 "kegg term": 1 "main effect s qrt-pcr": 1 "pool a *": 1 "mutant n?=?29 ": 1 "go0016591": 1 "target antigen": 1 "median pfs 95 ci months": 1 "1.56e-03": 1 "p value versus lps": 1 "multiple regression": 1 "ir 0 i p *": 1 "3.01e-05": 1 "chiang et al.": 1 "d p value for test data": 1 "bcl2 binding component 3 puma": 1 "inducers": 1 "sequencecoverage e": 1 "in vivo effects": 1 "christensen 2011": 1 "pi3k isoform": 1 "lvs": 1 "gene name some shortened to fit": 1 "fw 5?-ctaccactcacccgcagact-3? rev 5?-aggtccgtgcagaagtcct-3?": 1 "sequence cover g": 1 "? t and b lymphocytes proliferation": 1 "domain": 1 "aqueous extract": 1 "mgat5+/+": 1 "mw kdain gel": 1 "nuclear rrm2 hr": 1 "down in sin3 ? 122": 1 "?angles °": 1 "subgroup": 1 "af n=10": 1 "n?=?40 27.7": 1 "0.26 ± 0.15": 1 "philadelphia": 1 "viability ": 1 "++187 46.8": 1 "foci in 10 cs": 1 "lxt": 1 "effector": 1 "ode const.": 1 "rpmi": 1 "liu et al.": 1 "best homologue": 1 "ttf months": 1 "zheng et al 2010": 1 "1.61e-05": 1 "?bonds å": 1 "pharmaceutical classification": 1 "gene names": 1 "peptidylprolyl isomerase a cyclophilin a": 1 "clinical parameter": 1 "rbsp3 59 tumors": 1 "titis": 1 "cell lines in which variants occur": 1 "83.2±8.7": 1 "16048": 1 "lzr": 1 "3.81e-04": 1 "totalcells": 1 "abrev.": 1 "? 7 = k 1 z 6 - z 7 e 1 - k -1 z 7 + k 2 z 5 - z 7 e 2 - k -2 z 7 + k 3 z 4 - z 7 e 3 - k -3 z 7     53h": 1 "t/c n=10": 1 "high-expression ": 1 "r ea b": 1 "solvent": 1 "pearson correlation gls rstats 74 fitting of n = ? + ?x": 1 "s132": 1 "0.34": 1 "g132t": 1 "42.8": 1 "chi-square": 1 "kegg_subcategory": 1 "0.25": 1 "electron transport": 1 "nuclear": 1 "body wt g at sacrifice mean ± sem": 1 "bcr-abl amplification": 1 "0.45": 1 "swissprot access no.": 1 "0.42": 1 "l major": 1 "0.40": 1 "vaccine-delivery systems": 1 "fwd primer seq": 1 "0.39": 1 "0.38": 1 "array fold change": 1 "0.35": 1 "t350g": 1 "mirnas": 1 "epac2 ?280": 1 "kiaa1199 targeted": 1 "gpcr name": 1 "0.55": 1 "0.56": 1 "hr hpv-16": 1 "btk inhibitor": 1 "construct": 1 "chemotherapy": 1 "0.52": 1 "target protein": 1 "msg n?=?10": 1 "tobacco useb": 1 "off-target antitumor effects": 1 "y sac": 1 "affected codon": 1 "theta_w c": 1 "alleles": 1 "biological predictors/prognosticators": 1 "t stage": 1 "0.62": 1 "ln- over ln+": 1 "0.60": 1 "met c": 1 "p21212": 1 "0.57": 1 "0.58": 1 "tc mmol/l": 1 "interval": 1 "3.7": 1 "????average b-factor å2": 1 "9/530": 1 "1.170": 1 "psoluble c": 1 "duration of action hours": 1 "maf": 1 "c reported bioactivities": 1 "number of ms/ms peptide sequences": 1 "depth of invasion mean±s.d ?m": 1 "3-mc": 1 "chevrier et al tlr targets predicted #": 1 "lr hpv-6": 1 "gleason score gsat radical prostatectomy": 1 "# of cg beads": 1 "n° of identified peptides": 1 "ir * * * irs p ": 1 "fd b pp/gp": 1 "um * n?=?39 ": 1 "5? tgatgtatttg c tta c gtg 3?": 1 "growth rate mm/day a": 1 "sequenced exons of pik3ca": 1 "size cm": 1 "fc b wm vs cll": 1 "9/545": 1 "ir 0 0 p *": 1 "9/542": 1 "cyclin d1+?n?=?400 80.3": 1 "r sym ": 1 "ko phenotype": 1 "#snps a": 1 "no .": 1 "predicted mw kda": 1 "s sclerotiorum": 1 "flt3-itd aml": 1 "gex p value": 1 "differentiation": 1 "dss": 1 "2.32e-03": 1 "2.32e-02": 1 "mec": 1 "tgbc1-tkb": 1 "r bi b": 1 "t cell depletion d": 1 "dose g": 1 "swiss prot accession number": 1 "mitochondrial large ribosomal subunit": 1 "positive percentage ": 1 "enrichment ratio": 1 "table 1a cancer": 1 "met": 1 "cirrhosis": 1 "2.04e-05": 1 "????????bond lengths å": 1 "product mg l–1": 1 "reflections used": 1 "surgical stage": 1 "rps6kb1 u": 1 "k 12 k -12": 1 "sens.": 1 "mptp?+?ampt": 1 "x= t bu": 1 "#peptides": 1 "rs 2073498": 1 "fw 5?-ccaaaggatagtgcgatgttt-3? rev 5?-ctgtccctctccactgcaac-3?": 1 "tumor classification": 1 "case/control": 1 "mukasa 2012": 1 "band": 1 "bssp4": 1 "fc ma": 1 "12": 1 "ir * * shc p *": 1 "16": 1 "17": 1 "overlapping entities": 1 "tp53": 1 "c a t>c g t": 1 "1.922": 1 "cox-regression analysis": 1 "unique": 1 "animal": 1 "male": 1 "26": 1 "27": 1 "29": 1 "p pastoris": 1 "mir": 1 "narada": 1 "32": 1 "33": 1 "34": 1 "n?=?41 28.4": 1 "g g?1": 1 "grade 2 over grade 1": 1 "japanese phase i study furuse et al 2008 ": 1 " sl": 1 "z-score": 1 "cyclin sub- families": 1 "41": 1 "43": 1 "agent": 1 "47": 1 "expressed genes": 1 "49": 1 "x 2": 1 "antimicrobial activities a": 1 "ic 50": 1 "met+/pbads136+ ": 1 "57": 1 "mlb": 1 "59": 1 "fw 5?-ggagatgcctgggaagaag-3? rev 5?-cctgagttgagtagcacactcg-3?": 1 "odds ratio p value": 1 "1.65e-02": 1 "60": 1 "61": 1 "62": 1 "63": 1 "d h–1": 1 "66": 1 "67": 1 "bcr-abl mutation": 1 "68": 1 "h?1": 1 "in lr loci": 1 "size*": 1 "space group": 1 "common": 1 "genistein": 1 "available tissues": 1 "interest": 1 "10.0? ? m": 1 "ir 0 i * p ": 1 "c elegans rnai phenotype": 1 "74": 1 "75": 1 "nonsyn": 1 "77": 1 "or and 95ci": 1 "phila-1": 1 "cells": 1 "4.05e-03": 1 "95 confidence": 1 "82": 1 "83": 1 "84": 1 "? 350": 1 "molecularweight kda": 1 "correlated clones a": 1 "no of peptides matched g": 1 "effect on host cells": 1 "don ppm d": 1 "1.997": 1 "mouse tumor model": 1 "94": 1 "95": 1 "96": 1 "sponsor exhibition": 1 "ir i 0 * 0": 1 "day of embryonic development": 1 "systemic therapy": 1 "tg mmol/l": 1 "p -value 3": 1 "2.56e-03": 1 "registration": 1 "simunovic et al 2010": 1 "19.7 ± 2.6": 1 "ad mh": 1 "pbads136 protein expression": 1 "protein identifiedby lc- msanalysis": 1 "ao mh": 1 "p -value c": 1 "eac": 1 "? 3 = k 3 z 0 - z 3 e 3 - k -3 z 3     53d": 1 "variability": 1 "pdpk1 u": 1 "1.8 × 10?2": 1 "campbell et al.": 1 "low expression of b2m a": 1 "identity": 1 "fa vs tn": 1 "y sx": 1 "mature mirna id": 1 "19.8 d": 1 "functional categories": 1 "mw theory": 1 "elstner et al 2011": 1 "blastx results against nr description": 1 "cytoplasmic rrm2 p": 1 "fdr d": 1 "lelh y erpk": 1 "fdr b": 1 "1.981": 1 "actin organization": 1 "????resolution a å": 1 "m * n?=?23": 1 "a66 r": 1 "mirna expression": 1 "a66 s": 1 "k a ": 1 "braf exon 15": 1 "lz-8": 1 "lggn": 1 "4 ab": 1 "p linteus": 1 "ihc a": 1 "amplicon lengh": 1 "da t4-30 42xy": 1 "ad hs": 1 "sperm count a": 1 "grading g": 1 "|annot t k ? annot g b m | overlap ": 1 "ao hs": 1 "1.35e-08": 1 "x fold ind .": 1 "no insert": 1 "1.78e-07": 1 "ir i i shc 0 *": 1 "putative transcription factors e": 1 "in er loci": 1 "hr as 1.0 for wt 95 ci p -value": 1 "interaction log2 effect size": 1 "platform": 1 " metastasis": 1 "lm -strain": 1 "gds1989 xfold ind nevus set as 1 11 ": 1 "lgin": 1 "clone no.": 1 "v volvacea": 1 "1.07e-03": 1 "expression in cortical migrating interneurons": 1 "msi status": 1 "max wald c": 1 "site s": 1 "atcc 30957": 1 "folding c": 1 "1.938": 1 "matchedpeptide": 1 "accession numbers": 1 "daidzein": 1 "er 2 * 0 * * * *": 1 "locus": 1 "8.65e-04": 1 "adjusted results g": 1 "netmatch": 1 "bild_lung 118": 1 "expo dataset": 1 "chr a": 1 "dwelling b": 1 "g0/g1 phase ": 1 "bcl2l1": 1 "chr c": 1 "rassf5a": 1 "?water": 1 "qrt-pcr": 1 "confidence level": 1 "lm -expressed antigen": 1 "? antibodies": 1 "p53?+?n?=?241 48.3": 1 "2.54e-11": 1 "myc": 1 "total genes": 1 "1.59e-02": 1 "mechanism s": 1 "node-positive": 1 "mdr-related abc transporters involved": 1 "predictedmw/pi": 1 "behavior": 1 "bbc3": 1 "fold change e": 1 "mkp a": 1 "affyld": 1 "cc 1/2": 1 "antidepressant": 1 "????model contents": 1 "pool c *": 1 "nitrogen starvation b": 1 "5? ctcctcagtggggtgatcaggatc 3?": 1 " significance": 1 "t cruzi": 1 "p 1": 1 "webster et al 101 statistics* gls rstats 74 fitting of n = ?x ?": 1 "p 2": 1 "notes": 1 "pkn1": 1 "pkn2": 1 "p <": 1 "rassf1a": 1 "rheb u": 1 "gene set seed": 1 "female": 1 "nm_001101.3": 1 "? 3 = k 4 z 0 - z 1 - z 3 + z 5 e 3 - k -4 z 3 - z 5 + k 5 z 1 - z 5 e 3 - k -5 z 5     54d": 1 "non-methylated": 1 "sequences 5??3?": 1 "1215-1315": 1 "gg vs aa": 1 "in vitro effects": 1 "organism origin": 1 "outcome variable": 1 "syntenin ?": 1 "k eq": 1 "p b": 1 "p e": 1 "???? i /? i": 1 "p h": 1 "6955": 1 "dose unit": 1 "cell lines d": 1 "fold-changes": 1 "protein feature": 1 "chemical formula": 1 "genename": 1 "weighted t½ fibers l > 20 ?m d": 1 "nhx1 d": 1 "pqq?/+": 1 "immunoreactivity p value normal v primary tumour": 1 "y xs g g–1": 1 "end": 1 "enc": 1 "3.0 3.1": 1 "lines": 1 "region 2": 1 "region 1": 1 "chr location": 1 "phase ii study abou-alfa et al 2006 ": 1 "vpa": 1 "fisher's exact test": 1 "? g °": 1 "localization": 1 "factors that limit carcinogenicity williams 2008 ": 1 "pqq+/?": 1 "k 14 k -14": 1 "aa impact c": 1 "aa impact d": 1 "cbl mutation": 1 "0.011": 1 "7.03e-07": 1 "nm_002228.2": 1 "pkn1i": 1 "15/594": 1 "wild type n?=?33 ": 1 "authors": 1 "pkn1a": 1 "complexes": 1 "overexpression in ovary": 1 "g lamblia": 1 "dev delay": 1 "er * 0 *": 1 "user mass da": 1 "1/? < 1 & signi-ficant ?": 1 "human homolog gene symbol": 1 "glucose-methanol": 1 "p =0.029": 1 "sum of clones": 1 "high dose mp": 1 "10?? m": 1 "clinicopathological correlations": 1 "f-score": 1 "gender f versus m": 1 "jun-proto oncogene": 1 "eg gb|cf544577.1 gb|aaq94878.1 gb|cd449707.1": 1 "97.6±4.7": 1 "422": 1 "ennea-peptides from human proteome": 1 "ms/mps d": 1 "affyid": 1 "immunoreactivity": 1 "d cited references": 1 "k 6 k -6": 1 "possible function s": 1 "? th1-specific cytokines il-2 ifn- ? lt th2-specific": 1 "mean af": 1 "focal positive n?=?30": 1 "rassf2": 1 "protein name d": 1 "5-htt +/? fps": 1 "hypertension n": 1 "codonl33ala/ser ser s?=?a ala a?=?c": 1 "low dose mp": 1 "hw g": 1 "c335t": 1 "cell or tissue type": 1 "vvo": 1 " p ?=?0.62": 1 "or hom e 95 ci": 1 "? 44": 1 "ea 2 n?=?35": 1 "100.0": 1 "fold change †": 1 "nature g": 1 "0.008": 1 "3.06e-02": 1 "ttp months": 1 "dna repair": 1 "cd4 + cd8 + depletion e": 1 "a probes": 1 " p ?=?0.32": 1 "polyphen g": 1 "mitochondrial small ribosomal subunit": 1 "s aureus b atcc 33591": 1 "er 2 * grb 2 * * * * *": 1 "crystallization d": 1 "stimulation": 1 "????????disallowed ": 1 "venditti et al 100 and pagel et al 99 statistics**": 1 "molecular weight": 1 "data collection": 1 "eg gb|ck325833.1": 1 "t k -centric gene sets": 1 "+121 30.3": 1 "sorbitol m": 1 "casp3": 1 "????completeness ": 1 "casp9": 1 "1.01e-04": 1 "swiss-prot": 1 "case n?=?81": 1 "bild_ovarian 125": 1 "nci-60/esp5400 frequency f": 1 "primary culture expression cahoy et al 2008 ": 1 "b1/2": 1 "tm domain numbers c": 1 "peptide": 1 "correlations": 1 "t/t n=15": 1 "roundtable discussion moderator matthew herper forbes": 1 "amplification": 1 "da mimic": 1 "nes†": 1 "module 1415 ": 1 "analogue a": 1 "case number n/": 1 "paired comparison": 1 "x=h": 1 "case n?=?398": 1 "osteoarthritis": 1 "ir i i p *": 1 "morris sherman mb bch phd frcp c": 1 "k 16 k -16": 1 "human protein": 1 "?muc": 1 "go category": 1 "mechanism": 1 "rdyqpcned": 1 "expression in cancer": 1 "piekarz et al 28 n = 71": 1 "rapamycin c": 1 "cancer c": 1 "k 30 k -30": 1 "? 22": 1 "seq cov /no pept a": 1 "compound s": 1 "? b lymphocyte activation proliferation and differentiation": 1 "? murine splenic lymphocytes and activation of b cells": 1 "features": 1 "p16": 1 "pubmed id": 1 "10324 1478": 1 "nm_001229.2": 1 "median follow-up time months range": 1 "immunization against specified antigen s": 1 "rac1": 1 "wilson b factor": 1 "7.51e-05": 1 "primer eff": 1 " 18 ": 1 "rs1867277 a frequency": 1 "conserved bs per module": 1 "dqnv a sm v": 1 "syntenin +": 1 "cazymes per pcw component": 1 "? 7 = k 1 z 6 - z 7 e 1 - k -1 z 7 + k 3 z 5 - z 7 e 3 - k -3 z 7 + k 5 z 4 - z 7 - k -5 z 7     54h": 1 "????unique reflections": 1 "? ± se": 1 "clinicopathological indexes": 1 "site of metastasis": 1 "variable feature": 1 "number of samples with somatic snvs": 1 "nm_000633.2": 1 "gene counts": 1 "tkis that reverse mdr": 1 "1 glycerol": 1 "wild-type": 1 "number of pik3ca -mutant patients ": 1 "p chi 2 ": 1 "mascot score g": 1 "treatment period days": 1 " d references": 1 "ku70 expression": 1 "excluded": 1 "probe set": 1 "rock1": 1 "patient characteristics": 1 "go0007005": 1 "wci": 1 "median rfs wt vs mt p -value": 1 "met protein expression": 1 "p63": 1 "amit et al regulators predicted": 1 "2.97 ± 1.53": 1 "tgf-?2 2 -? c t range": 1 "wdi": 1 "lm -based vaccine": 1 "bmp6 methylation": 1 "atm expression": 1 "fbj murine osteosarcoma viral oncogene homolog": 1 "direct": 1 "class/domain c": 1 "1.14e-04": 1 "variant identification and effect": 1 "c albicans atcc 90028": 1 "nsw": 1 "ic87114": 1 "effects following antagomir treatement": 1 "categories": 1 "nom p val‡": 1 " b log2 ratioamela/mela": 1 "gastric cancer": 1 "go biological process": 1 "systematic name": 1 "skf 38393": 1 "real-time data": 1 "u0126": 1 "kegg": 1 "k 32 k -32": 1 "ipi number": 1 "body weight": 1 "fw 5?-gacctcaacgcacagtacga-3? rev 5?-gagattgtacaggaccctcca-3?": 1 "average fold difference spret/fvb range": 1 "interaction types": 1 "pfs ms": 1 "function in bacteria b": 1 "shibahara 2011": 1 "2629": 1 "20/1047": 1 "mean square": 1 "nt rnai": 1 "hpv16 reference": 1 "survival": 1 "mowse score d": 1 "m199": 1 "marker": 1 "effect": 1 "name of the culture": 1 "shc 0": 1 "20/1056": 1 "anova p value": 1 "case number": 1 "130b": 1 "collection$": 1 "mdamb231 control": 1 "frequency and95ci ": 1 "café au lait spots m": 1 "k m ?m": 1 "rt-pcr": 1 "s ii": 1 "kras exon 2": 1 "2.5 b + al": 1 "gly>val": 1 "gene id human": 1 "nprl2 59 tumors": 1 "eif4ebp1 d": 1 "fw 5?-atgttttctgacggcaacttc-3? rev 5?-atcagttccggcaccttg-3?": 1 "reference genes": 1 "a = 45.29 b = 82.78 c = 95.99 ? = ? = ? = 90": 1 "primary b": 1 "vegf": 1 "????????allowed ": 1 "pl-1 pl-3 pl-4": 1 "non-motile sperm a": 1 "target gene": 1 "?24.88 165.05 28.32": 1 "irs 0": 1 "irs *": 1 "control n?=?445": 1 "avkv l dqmp": 1 "mir-708 targets go-term analysis": 1 "protein-mitochondrial targeting": 1 "bpv-1": 1 "bpv-4": 1 "3.56e-17": 1 "????????generously allowed ": 1 "130b*": 1 "tumor protein p53": 1 "fvptc vs tn": 1 "gene size bp": 1 "cytokine il-4 tnf- ? and il-2r": 1 "foxj2 mutated rp": 1 "?favored ": 1 "pool b *": 1 "c.": 1 "ar": 1 "at": 1 "probe set id": 1 "av": 1 "appressoria/germ tube b ": 1 "nano and schmerk 2007 ": 1 "genus": 1 "# par.": 1 "ly171555": 1 "angiogenic process": 1 "psea analysis this study": 1 "2.31e-05": 1 "caspase 9 apoptosis-related cysteine peptidase": 1 "snp id e": 1 "8.81e-06": 1 "virus": 1 "body weight g at mnu injection mean ± sem": 1 "ad-36 negative": 1 "sn34452": 1 "ethylene production nl g?1 h?1": 1 "autophagic activity a": 1 "cd": 1 "study 1": 1 "study 2": 1 "4.51e-06": 1 "cm": 1 "4.51e-03": 1 "total ion score f": 1 "cr": 1 "clinical response": 1 "e5": 1 "cw": 1 "day 8 notch off": 1 "d purpureum dictybase id": 1 "n = 202 b": 1 "da": 1 "k 25 k -25": 1 "p53 – n?=?258 51.7": 1 "dj": 1 "go0016044": 1 "dn": 1 "sites": 1 "dp": 1 "1.27e-04": 1 "dr": 1 "sub-class": 1 "fw 5?-tctacaaccctgaagtgcttgat-3? rev 5?-caatctgcagacagacactgg-3?": 1 "iii/iv": 1 "fanmod": 1 "8.02e-05": 1 "type iii sum of squares": 1 "survivin": 1 "irs expression": 1 "em": 1 "go0006626": 1 "identified proteins": 1 "s no": 1 "fa": 1 "surface exp d å2": 1 "fe": 1 "issa 16 panel 1": 1 "fh": 1 "r norvegicus": 1 "fisher p value": 1 "fos": 1 "precursor lesions": 1 "? 0 = 0     54a": 1 "genes of interest goi": 1 "low-expression ": 1 "ir 0 0 * 0": 1 "class": 1 "?solvent": 1 "monosaccharide catabolism": 1 "b reproducibility": 1 "sequence5????3?": 1 "gs": 1 "2.94e-05": 1 "20/1115": 1 "peptides numberh": 1 "5.1 71.7": 1 "? 0 = 0     53a": 1 "hg": 1 "pi theory": 1 "hp": 1 "p flt3 mut †": 1 " 121 122 ": 1 "affymetrix_id": 1 "pealmrklp": 1 "3.11e-05": 1 "shvector": 1 "0.201/0.235": 1 "k d nm": 1 "context": 1 "ii": 1 "6.98 ± 2.07": 1 "metal": 1 "index": 1 "subsite": 1 "gene size kb": 1 "simple regression": 1 "k 21 k -21": 1 "absorbance at 450 nm a450": 1 "4.41e-12": 1 "ipmn": 1 "acropora databaseno b": 1 "jg": 1 "decreased expression d ": 1 "u112": 1 "293 morph a": 1 "ligand": 1 "yield a": 1 "yield b": 1 "tumour": 1 "fusarium": 1 "sabp mmhg": 1 "decreased expression c ": 1 "bcl2": 1 "huh28": 1 " 125icgp?binding": 1 "? 5 = k 1 e 1 z 3 - z 5 - k -1 z 5 + k 5 e 3 z 1 - z 5 - k -5 z 5     54f": 1 "?bic": 1 "lg": 1 "prdm2 mrna levels": 1 "paraneoplastic tissues": 1 "ls": 1 "subfamily b": 1 "95.4 95.2": 1 "final concentration": 1 "enzyme description name": 1 "r su b": 1 "da depletion or receptor blockage": 1 "ma": 1 "mc": 1 "upstream > downstream b": 1 "????ramachandran": 1 "me": 1 "mi": 1 "author reference year": 1 "nr_003286.2": 1 "ml": 1 "percent intratumoral tregs by vector type": 1 "mo": 1 "ms": 1 "t brucei": 1 "2.25e-02": 1 "? 2 = k 2 z 0 - z 2 e 2 - k -2 z 2     53c": 1 "eif4e u": 1 "entry": 1 "dish": 1 "ne": 1 "limited disease": 1 "5-ht": 1 "nl": 1 "mitotic phenotype": 1 "kelleher et al 12 ": 1 "p bh": 1 "sequence number": 1 "ir 0 i * 0": 1 "cll *": 1 "unadjusted results": 1 "?/?": 1 "methyl": 1 "f st a": 1 "rescue": 1 "dbsnp id e": 1 "os": 1 "phyllanthus": 1 "ov": 1 "p value §": 1 "effects tgi *": 1 "n  = 4": 1 "lm -llo-e7": 1 "pd": 1 "24 hrs": 1 "n  = 5": 1 "p fal*": 1 "avslidlvp": 1 "potency*": 1 "r1": 1 "r2": 1 "n°": 1 "pr": 1 "ps": 1 "pfam description": 1 "access number c": 1 "macrocephaly b": 1 "1.64e-12": 1 "9.01e-07": 1 "nobusawa 2009": 1 "3.8±2.3": 1 "p value c": 1 "k i at2r? ? m ": 1 "qs": 1 "chromosomal loci": 1 "p value a": 1 "secondary chromosomal change *": 1 "concurrent bmp3b and bmp6 methylation": 1 "1.64e-03": 1 "ra": 1 "length bp": 1 "rf": 1 "i 2": 1 "rn": 1 "molprobity clash score": 1 "t4": 1 "rv": 1 "ome": 1 "methylation ratio ": 1 "se": 1 "sj": 1 "chip-pet in mesc": 1 "sm": 1 "303 ± 21": 1 "????????ligands": 1 "ir i 0 p *": 1 "ss": 1 "sv": 1 "decision": 1 "t109c": 1 "p value ‡": 1 "core enrichment genes contributing to the pathway enrichment": 1 "loh@ tsc1": 1 "abnormal head morphology b": 1 "boyault et al.": 1 "i a": 1 "loh@ tsc2": 1 "tf": 1 "colon rahman/hm1imss": 1 "gene symbol 1": 1 "tm": 1 "domain?": 1 "edges to intermediate regulators": 1 "tr": 1 "phorbol-12-myristate-13-acetate-induced protein 1 noxa": 1 "tv": 1 "nm_021130.3": 1 "5? gatcctgatc t ccc g actgaggag 3?": 1 "negative n?=?125": 1 "6272": 1 "y ps mg g–1": 1 "stage ii versus iii": 1 "24 h arbitrary units": 1 "103 ± 23 b": 1 "vit e": 1 "mlh1": 1 "substrate": 1 "uv": 1 "gene symbols": 1 "the first author year": 1 "region": 1 "current study": 1 "1.32e-06": 1 "1.32e-04": 1 "1.32e-03": 1 "phosphorylation sites": 1 "wick 2009": 1 "wc": 1 "y598": 1 "wd": 1 "5-year rfs wt vs mt p -value": 1 "pmas": 1 "wr": 1 "drug conc range/vehicle": 1 "c ele": 1 "fvptc vs fa": 1 "day 8 notch on": 1 "uniprotkb/swiss -prot accession": 1 "uniprot accession": 1 "go0000502": 1 "cryptorchism": 1 "schaaf et al 13 ": 1 "hyper methylation": 1 "ci b": 1 "er 2 0 * * 0 * *": 1 "coc p -value": 1 "therapeutic": 1 "lu et al dataset": 1 "lps + hocbl": 1 "proteasome complex": 1 "? mass da": 1 "fw 5?-gcctacagcccatttctccat-3? rev 5?-gcgccctggcagcat-3?": 1 ">100000 c": 1 "???? r free using 5 of reflections": 1 "otf": 1 "orr ": 1 "microarray fold change": 1 "cells/tissues": 1 "samples": 1 "optic atrophy": 1 " 125icgp": 1 "13.2 1.8": 1 "k 27 k -27": 1 "distribution": 1 "down in rco1 ? 106": 1 "2.16e-04": 1 "gene expression shift ? log2 value range d": 1 "uniprotkb/ embl accession": 1 "actin beta": 1 "? 5 = k 1 z 3 - z 5 e 1 - k -1 z 5 + k 3 z 1 - z 5 e 3 - k -3 z 5     53f": 1 "6.20e-02": 1 "culture hm1imss/rahman": 1 "4.04e-04": 1 "st dev": 1 "rrmh t sttt": 1 "d-fraction": 1 "bw g": 1 "folds al vs controls": 1 "da t4-27 42xy": 1 "probe idilumina": 1 "fw 5?-agccacatcgctcagacac-3? rev 5?-gcccaatacgaccaaatcc-3?": 1 "9.74e-03": 1 "ydm g l–1": 1 "trap expression doyle et al 2008 ": 1 "clone n°": 1 "control n?=?360": 1 "mlh1/msh2 expression": 1 "mouse hgnc homologs with expression > 100": 1 "fwd primer": 1 "6/10 months n =57": 1 "r6/2 6 w": 1 "iitl c rtin": 1 "++273 68.2": 1 "2.29e-04": 1 "wood exposure": 1 "change fold": 1 "mw kda calculated": 1 "c p value": 1 "24 weeks": 1 "structure match": 1 "c elegans subunit": 1 "????resolution å": 1 "random ennea- peptides": 1 "1.3 × 10?3": 1 "17.4 ± 6.0": 1 "matching mass da": 1 "4.73e-09": 1 "jasmonates": 1 "14-3-3? expression correlation coefficient rs": 1 "glis proteoglycan": 1 "abc transporters linked to tki resistance": 1 "bmp3b methylation": 1 "ic50 in ? m mean ± sem": 1 "freedom grades": 1 "s cerevisiae gene": 1 "estimated gene space sampled": 1 "brugi malayi": 1 "low k +": 1 "k12- ras gene mutation/total ": 1 "folds up- or down-regulation vs ace2ko mice": 1 "63.4 b": 1 "parental go terms": 1 "her2 low": 1 "tumour volume at killing days 60 mean mm 3": 1 "constant c i": 1 "ozr": 1 "welcome & networking coffee": 1 "c285g": 1 "k 29 k -29": 1 "ngbr": 1 "kinase s": 1 "bic 104": 1 "similar regulation d": 1 "in vitro et": 1 "r 2": 1 "expression level": 1 "gene annotation": 1 "go0016125": 1 "sneb": 1 "mw theor kda": 1 "wang_breast 286": 1 "pbads136 protein": 1 "ir * * grb 2 * *": 1 "rrm1 hr": 1 "? proliferation of mouse spleen lymphocytes": 1 "netgrep": 1 "tcf/lef site": 1 "accession # h": 1 "perineural capillaries": 1 "er 2 * shc 0 * * * *": 1 "primers": 1 "target e": 1 "ang 1–8 ? ang 1–7": 1 "ir i i * irs 0": 1 "polyclonal": 1 "data collection and refinement statistics": 1 "? h kcal?mol ?1 ": 1 "a p": 1 "6 bc": 1 "32.2": 1 "pkc? rnai": 1 "32.9": 1 "er 2 e * * e * *": 1 "7.02e-04": 1 "er 2 * shc * * * * *": 1 "mgat5?/?esc": 1 "smoking status": 1 "aerobic respiration": 1 "no atoms": 1 "pas": 1 "queries matched": 1 "kras mutated b": 1 "4.83e-14": 1 "5-htt +/? fc": 1 "molecular weight da": 1 " 125iang?ii": 1 "oxidative phosphorylation": 1 "nm_004346.3": 1 "no of studies": 1 "ang 1–10 ? ang 1–9": 1 "7.49e-09": 1 "er * * 0": 1 "nurses vs foragers": 1 "go number": 1 "vpa mm": 1 "function*": 1 "hoek et al 12 ": 1 "francis s collins m.d ph.d director united states national institutes of health nurturing innovative science at nih": 1 "sequence reads": 1 "european ancestry among ea range 75 to 100 n?=?35": 1 "growth in soft agar number of colonies": 1 "log-rank p": 1 "tumour incidence": 1 "pda": 1 "percentage of patients": 1 "ratio hepg2.2.15/hepg2": 1 "hdacis": 1 "sequence match": 1 "vector s": 1 "pde": 1 "binding site bs": 1 "tumoral expression": 1 "e vs m": 1 "down in rpd3 ? 105": 1 "weisenberger et al 20 panel 2": 1 "or 95 ci d e": 1 "perturbed expression following oct4 shrna": 1 "iqlh y khsy": 1 "rkip": 1 " 123 124 ": 1 "sample size": 1 "d discoideum a": 1 "basal situation": 1 "fiber": 1 "number of invasive foci per field mean±s.d.": 1 "fdr adj.p.value": 1 "# genes 1": 1 "recurrence": 1 "metabolic pathway": 1 "1400-1500": 1 "tumor of": 1 "interaction effect size": 1 "ec50 nm": 1 "entrez": 1 "5? cacataaacaaatacatca3?": 1 "p molchar †": 1 "p f a": 1 "foxj2 fp": 1 "location b": 1 "pgl": 1 "native": 1 "her2 high": 1 "stage a": 1 "cytoplasmic rrm2 hr": 1 "n?=?63 43.7": 1 "k 15 k -15": 1 "pp mmhg": 1 "emvi": 1 "function in d discoideum c": 1 "primers f r and probe z sequences 5' ? 3'": 1 "6.2 × 10?1": 1 "disease stage": 1 "0.223": 1 "pig": 1 "theotetical molecular mass/pi c": 1 "pip": 1 "deyi a rm v": 1 "1.02e-03": 1 "description of group": 1 "motif": 1 "t325c": 1 "ratio of experimentally verified mirna/target-gene pairs ": 1 "ratio of predicted mirna/target-gene pairs ": 1 " p ?=?3×10?25": 1 "basis": 1 "t-mn": 1 "caspase 3 apoptosis-related cysteine peptidase": 1 "domain annotation pfam": 1 "d discoideum dictybase id c": 1 "a442c": 1 "clinical stage/groups": 1 "p -value p <10 ?x": 1 "trait interactions b": 1 "pka": 1 "associated jak s": 1 "all tumors": 1 "map mmhg": 1 "relativeratio folds ofbiotinylated vs totalproteins h": 1 "spearman rank correlation": 1 "sdc buffered medium": 1 "primary striatal neurons": 1 "1.24e-03": 1 "8.33e-06": 1 "h sap": 1 "role/function": 1 "coc log2-fold": 1 "ratio er/lr": 1 "psca n?=?58": 1 "smar mmhg/ml.min.100 g": 1 "? t m b": 1 "sanson 2009": 1 "whittaker et al 29 * n = 96": 1 "t790m mutation e": 1 "???? r merge b": 1 "????????residues": 1 "alteration s in patients samples": 1 "sd?<?6 months": 1 " total": 1 "? 2": 1 "mitochondrial inner membrane": 1 "????????angles °": 1 "putative function 1": 1 "kd cycb e": 1 "pearson's correlation coefficient": 1 "pmaip1": 1 "time after treatment": 1 "j b": 1 "wtfps": 1 "growth factor": 1 "41.4-2.1 2.21-2.1": 1 " hyper-methylated c": 1 "t + m vs n": 1 "????unit cell å °": 1 "gex fold change": 1 "enzyme sace": 1 "best hit overall": 1 "p tet": 1 "tgx-221": 1 "polymorphic sites": 1 "agonist activity": 1 "co-efficiency": 1 "1.72e-02": 1 "grading": 1 "?/+ 30": 1 "????????favored ": 1 "msi n?=?71 14.6": 1 "or 95 ci f": 1 "104 weeks": 1 "pearson coefficient r meta-gene vs outcome": 1 "d purpureum": 1 "13.7 3.5": 1 "cell dimensions": 1 "194 d": 1 "pdim i kllp": 1 "a nidulans *": 1 "caenorhabditis briggsae – caenorhabditis sp 9 comparisons": 1 "size of tumor t": 1 "others ": 1 "pubmed gene rif": 1 "8 weeks": 1 "adjusted p -value§": 1 "p -value range": 1 "bleeker 2010": 1 "?ligands": 1 "psp": 1 "fw 5?-ccccagccaaagaagaaac-3? rev 5?-aacatctcgaagcgctcac-3?": 1 "42.4/45.4": 1 "cardiomyopathy": 1 "herbal name": 1 "ptc": 1 "chip-chip in hesc": 1 "disease": 1 " °c 3 ? 2 at r max?": 1 "yes": 1 "ptn": 1 "rassf1a expression": 1 "professor department of gastroenterology juntendo university": 1 "ptz": 1 "g at> a at": 1 "alln?=?67": 1 "pten d": 1 "in vivo et": 1 "significant prognostic correlations": 1 "++/+++ 33": 1 "2.64e-16": 1 "n° of events": 1 "deregulationa": 1 "fold difference res/vul a": 1 "ontomine predicted bioassays": 1 "effect on emt": 1 "chl2 22 m": 1 "7.50e-03": 1 "identifier": 1 "high*": 1 "ce-sox": 1 "immunization against multiple antigens*": 1 "rhace2": 1 "simultaneous variable ratio": 1 "ittl c rtvn": 1 "tgf? related genes": 1 "5-year cs os or dfs long-rank p value": 1 "m * n?=?23 ": 1 "o viverrini sequences ": 1 "total cells": 1 "dukes b v dukes c p value": 1 "ic 50 ? m a": 1 "i820": 1 "on-target antitumor effects": 1 "?146 36.5": 1 "# tissue samples": 1 "over-expressed in melan-a v b16": 1 "p-tyr 60? treated/untreated ratio ± sd f": 1 "best blast hit": 1 "panobinostat ic 50 ? m 96?h±s.d.": 1 "e coli ubc8161": 1 "334 ± 25.1": 1 "maximum ??g kcal/mol d": 1 "??g mpf c": 1 "and production of immunoglobulins": 1 "patients n ": 1 "ethyl": 1 "multivariate 2c": 1 "da and pxa": 1 "egfr overexpression": 1 "prodrugs – dxr abbreviation": 1 "2.37e-10": 1 "vectors": 1 "functional prediction by polyphen-2": 1 "transcriptional response element": 1 "gene symbol—complete name": 1 "k 34 k -34": 1 "multivariate 1b": 1 "reports frompreviousstudies": 1 "disease index c": 1 "3.16e-04": 1 "xmrk": 1 "temperature growth range *": 1 "plexin-b1 expression": 1 "fc ?±? sd b": 1 "k 33 k -33": 1 "7 abc": 1 "grade 3 over grade 2": 1 "grade 3 over grade 1": 1 "source/reference": 1 "s f": 1 "s i": 1 "?18–86 avg 68": 1 "rac1 expression": 1 "7.83": 1 "9.28e-04": 1 "6.62e-05": 1 "waist circumference cut-off": 1 " a gene symbol": 1 "sub p": 1 "?disallowed ": 1 "y2h assay with rab2": 1 "location proximal versus distal": 1 "rev primer": 1 "5? cac g taa g caaatacatca 3?": 1 "allenb": 1 "boyer et al 11": 1 "methods of mvd identification": 1 "auratus id": 1 "organ": 1 "n?=?144": 1 "e-value": 1 "ir 0 i 0 *": 1 "ks cases": 1 "characteristic": 1 "cdkn2a": 1 "ficz": 1 "james e rothman ph.d wallace professor of the biomedical sciences at yale university principles of vesicle transport": 1 "m aterials": 1 "proteinid": 1 "n crassa *": 1 "v max pmol/min per mg": 1 "4.2±2.7": 1 "target expression": 1 "esc-rescue": 1 "soy combinationa": 1 "?64 16.0": 1 "signal range b": 1 "1245-1315": 1 "cmol cmol?1": 1 "trait": 1 "hrm": 1 "pool d *": 1 "pathways": 1 "?38?85 avg 61": 1 "r1772": 1 "poster walk by chairpersons sessions i ii iii iv v vi vii posters attended by authors": 1 "? h °": 1 "t the": 1 "percent similarity to hs": 1 "functional category c": 1 "er 2 * * grb 2 * * * *": 1 "7.23e-05": 1 "event phenotype": 1 "his>arg": 1 "95 ci": 1 "54.9±15.7": 1 "under-expressed in melan-a v b16": 1 "n stage": 1 "nhme": 1 "jwee+j25 g": 1 "codon": 1 " 118 ": 1 "ad-36 positive": 1 "allele": 1 "day 1": 1 "inoculum tciu c": 1 "med abs expr.": 1 "amplicon length": 1 "7.18e-03": 1 "cal·deg?1 mol?1": 1 "0.34 ± 0.14": 1 "atcc39462": 1 "chr.": 1 "fw 5?-cttttgtggaactctatgggaaca-3? rev 5?-cagcggttgaagcgttcct-3?": 1 "velocity µm/min": 1 "1.46e-06": 1 "action": 1 "tothill et al dataset": 1 "day 5": 1 "mda-mb-231": 1 "organism/plasmid": 1 "370-496": 1 "sensitive": 1 "k i cb2 nm": 1 "approx ras aggregation time ?s": 1 "gqrk r lvst": 1 "l edodes": 1 "products": 1 "low quality sequence": 1 "pathblast": 1 "ir 0 0 0 *": 1 "sample query": 1 "biologicalfunction": 1 "p -value t test": 1 "sc c ": 1 "u133plus2.0 b": 1 "umet": 1 "female cm": 1 "# of species": 1 "sampleid": 1 "vrk2 cytoplasmic staining": 1 "activity d": 1 "inheritance": 1 "log fc": 1 "4.29e-03": 1 "797": 1 "sample no": 1 "go0009060": 1 "ec p -value": 1 "upper bound": 1 "sotiriou_breast 189": 1 "mw kda/pi": 1 "erythropoietin receptor": 1 "srebp-1 fp": 1 "extensive disease": 1 "go processes": 1 "accession nr b": 1 "m3 pparg methylation": 1 "5.65e-03": 1 "er-negative/her2 high": 1 "ivtl c rtin": 1 "hprt1": 1 "mneb": 1 "s/n": 1 "cs os or dfs multivariate hr 95 cl* p value": 1 "? 4 = k 1 e 1 z 2 - z 4 - k -1 z 4 + k 3 e 2 z 1 - z 4 - k -3 z 4     54e": 1 "at arbitrary units": 1 "b cinerea": 1 "i /? i ": 1 "limits cr vi carcinogenicity?": 1 "simultaneous fixed ratio": 1 "poster viewing sessions i ii iii iv v vi vii posters attended by authors": 1 "unique peptindes": 1 "akt1 u": 1 "????redundancy": 1 "prostate cancer": 1 "cancer activea": 1 "regulation": 1 "akap": 1 "95.3": 1 "signi-ficant ?": 1 "hbx cooh mutation": 1 "proteinscore": 1 "gc-1spg": 1 "mammalian ortholog": 1 "2.82e-14": 1 "lycopene content mg/100 g ± sd": 1 "refinement": 1 "fw 5?-ggaagcccaagctctttttc-3? rev 5?-aagtggaggccacctcaaa-3?": 1 "g frondosa": 1 " 120 ": 1 "genotyped samples": 1 "methylated a": 1 "loc/cov": 1 "term in query": 1 "appressorium penetration d ": 1 "? 4 = k 1 z 2 - z 4 e 1 - k -1 z 4 + k 2 z 1 - z 4 e 2 - k -2 z 4     53e": 1 "????????glycerol": 1 "accession n°": 1 "3.92e-04": 1 "4+8 lo": 1 "hgin": 1 "lt vs e": 1 "authors year": 1 "98.9 97.4": 1 "mass action ratios": 1 "corrected p -value": 1 "opossum matrix jaspar core": 1 "model id": 1 "prognosis": 1 "lt vs m": 1 "ir * * * grb 2 *": 1 "fish": 1 " amplified/gained": 1 "downstream target s": 1 "1000-1200": 1 "reagents": 1 "b05.10": 1 "ramachandran statistics": 1 "dna-directed rna polymerase ii holoenzyme": 1 "erbb2- over erbb2+": 1 "ich": 1 "2908": 1 "y px mg g–1": 1 "f.c.": 1 "braf mutation": 1 "t790m-7 d": 1 "viral factors": 1 "a131g": 1 "enzastaurin": 1 "acc number": 1 "activating egfr mutation": 1 "age of mice": 1 "r6/2 12 w": 1 "genbank": 1 "thymus": 1 "nf??": 1 "mgi symbol": 1 "1.55 ± 0.92": 1 "amino acid position a": 1 "primary response a": 1 "selection criterion": 1 "amino acid position c": 1 "hs med subunit": 1 "ic50 nm": 1 "median rna copy per ? l iqr": 1 "adjusted p-value d": 1 "negative growth synergism": 1 "pathological changes": 1 "ko mice jax": 1 "sr n=10": 1 "c2221": 1 "relapse free survival analysis logrank p": 1 "cytokeratin 7 expression": 1 "kras wild type b": 1 "dukes stage": 1 "male cm": 1 "n = 90 b": 1 "srebp-1 mutated fp": 1 "a motif id": 1 "small gtpases": 1 "comment": 1 "plant viridiplantae limited": 1 "????r.m.s.d from ideal": 1 "b subtilis h344": 1 "7.85e-03": 1 "fdr adj p.value": 1 "a196": 1 "srebp-1 rp": 1 "cells and stage": 1 "rheumatoid arthritis": 1 "resistance": 1 "magnaporthe": 1 "number of unique hgnc ids": 1 "pesticide exposure": 1 "| z | score b": 1 "size of colonies": 1 "day 8 notch off versus day 5": 1 "diesel": 1 "iii": 1 "le e": 1 "maximum inhibition": 1 "le c": 1 "le d": 1 "cluster id": 1 "frequency #": 1 "ratio experiment/control": 1 "ir i i * p ": 1 "term in genome": 1 "ir * * p *": 1 "srebp-1 mutated rp": 1 "sch 23390": 1 "d rer": 1 "metastatic site": 1 "common names": 1 "liao et al.": 1 "er 2 e * * * * *": 1 "connexin isotype": 1 "nuclear rrm2 p": 1 "12°c": 1 "biopsies": 1 " 125isarile": 1 "schu s4": 1 "nacl m": 1 "k 5 k -5": 1 "frequency c": 1 "differentiation grade wd md pd": 1 "nm_003998.3": 1 "target metabolite": 1 "frequency d": 1 "c sinensis sequences a": 1 "c p value for training data": 1 "corr e": 1 "clinical isolation": 1 "flt3-wt aml": 1 "lymph node metastasis *": 1 "sycp2": 1 "study size": 1 "total score": 1 "+/+ a": 1 "clinical pathological features": 1 "t k": 1 "pik3c2a u": 1 "v cholerae am19226 ttss2? homologue id a": 1 "case n?=?479": 1 "death": 1 "6.49e-07": 1 "network": 1 "or 95 ci d f *": 1 "gi no.": 1 "paper": 1 "k cat s?1": 1 "control type": 1 "????space group": 1 "protein coverage g": 1 "zol ic 50 ? m 96?h±s.d.": 1 "inv": 1 "mir id s": 1 "rat organ mitochondria": 1 " point mutations": 1 "ir i i shc p *": 1 "oligoclonal": 1 "atcc": 1 "gapdh": 1 "????average wilson b-factor å2": 1 "resolution": 1 "20 b + al": 1 "viral substrate s": 1 "lm -e7": 1 "ras": 1 "t993": 1 "peak viral load b highest to lowest": 1 "notes e": 1 "primary indication": 1 "p-tyr 30? treated/untreated ratio ± sd f": 1 "pathological parameter": 1 "raf265 ic 50 s nm": 1 "807": 1 "predicted edges": 1 "2.013": 1 "????????total number atoms": 1 "family a": 1 "follicles cuboidal cell": 1 "n-ras mutated": 1 "soluble expression mg / l": 1 "correlation between mc count & mvd": 1 "0830-0900": 1 "2.025": 1 "variable n?=?170": 1 "gs size": 1 "country/ethnic group": 1 "2.023": 1 "14-3-3 ? expression": 1 "wtfc": 1 "352 ± 173": 1 "nm_004322.2": 1 "er * shc * *": 1 "gc-2spd ts": 1 "rmace2": 1 "short insert sequence": 1 "university of toronto": 1 "controls": 1 "isp": 1 "er-negative": 1 "papillae and small irregular follicles “palisade like” border": 1 "iupac name": 1 "anglesio et al dataset": 1 "networking lunch": 1 "ref": 1 "neurite length ? m": 1 "family 4": 1 "5? gatcctgatcaccccactgaggag 3?": 1 "family 3": 1 "family 2": 1 "family 1": 1 "conidiation ×105 spores/plate": 1 "foci in 0.5 cs": 1 "tumor differentiation g": 1 "lymph nodes n": 1 "fusion": 1 "anti-atherosclerotic effect of nitric oxide": 1 "folds al vs control": 1 "i/ii": 1 "c a g>c g g": 1 "rfs": 1 "egfr": 1 "mdamb231 treated": 1 "+149 37.2": 1 "30°c": 1 "sample patient no.": 1 "theta_pairwise d": 1 "k 19 k -19": 1 "frequency ": 1 "glyceraldehyde-3-phosphate dehydrogenase": 1 "anti-braf catalytic domain": 1 "1.651": 1 "p values": 1 "p no.": 1 "hw/bw ×10?3": 1 "functions in membrane trafficking": 1 "ratio d ir/ctrl": 1 "ac no .": 1 "human hd": 1 "18s ribosomal rna": 1 "targets 1296": 1 "um * n?=?39": 1 "fw 5?-tgaccttgatttattttgcatacc-3? rev 5?-cgagcaagacgttcagtcct-3?": 1 "agi": 1 "hypoxanthine phosphoribosyltransferase 1": 1 "growth factor family": 1 "multivariate analysis": 1 "high 25 vs others": 1 "setting up posters poster sessions i ii iii iv v vi vii": 1 "number": 1 " 127 ": 1 "5.70e-15": 1 "1.03e-03": 1 "b-md-c1 adr +/+": 1 "9.85e-03": 1 "down-regulation": 1 "klhdc7b": 1 "ir * * * p ": 1 "microarray platform a": 1 "sd???6 months": 1 "il-12p70 and ifn- ? produced by activated dcs": 1 " 128 ": 1 "35s primary transcript processing": 1 "welch two sample t-test p53": 1 "jasmonate": 1 "strains and fpi gene loci 1": 1 "air": 1 "function selected from entrez/uniprotkb/swiss-prot/tocris": 1 "lovd tsc database d": 1 "mg/l cr vi": 1 "bcl2-assocciated x protein": 1 " 125 ": 1 "1.93e-03": 1 "spec.": 1 "d µm2/min": 1 "cf ? m": 1 " ×105?m?1": 1 "position bp": 1 "n = 120": 1 "coordinate b": 1 "deyi a pm v": 1 "ras conformation": 1 " 126 ": 1 "2.5 b -al": 1 "west-african ancestry among aa range 67 to 95 n?=?32": 1 "histone modification": 1 "chrposition": 1 "2.073": 1 "effects on proliferation/survival/morphogenesis": 1 "lentinan": 1 "hygr": 1 "product size": 1 "theoretical pi/mw h": 1 "funtional classes and gene descriptions": 1 "?max": 1 "predicted substitution": 1 "all": 1 "pemetrexed": 1 "2.086": 1 "histological types": 1 "# molecules": 1 "independent validation datasets .": 1 "cyclopropyl methyl": 1 "live >3 years": 1 "g t g>g g g": 1 "kinase group": 1 "2.055": 1 "app k m µm": 1 "cs os or dfs univariate hr 95 cl* p value": 1 "ref.": 1 "observed pi/mw i": 1 "48 h": 1 "mir-135 targets go-term analysis": 1 "1000-1800": 1 "localisation": 1 "total high quality": 1 "rest of cohort n?=?27514": 1 "pik-75": 1 "sequential variable ratio": 1 "6.94e-13": 1 "cytosolic small ribosomal subunit": 1 "fold change tamr/ctrl": 1 "fraction of mobile cells": 1 "facs b mean ± sd": 1 "literature evidence": 1 "0.9": 1 "shuichiro shiina md phd": 1 " 131 ": 1 "no of residues": 1 "ir i i 0 *": 1 "il-2r expression on cd4 t cells a": 1 "enrichment": 1 "? a b c å": 1 "identification": 1 "intraneural capillaries": 1 "gln>arg": 1 "coc est fold": 1 "gene count": 1 "epac": 1 "pfam domain a": 1 "fold change doane et al 2006": 1 "gene snp": 1 "1640 ± 530": 1 "women r *": 1 "conidiation ×106/ml b": 1 "????????waters": 1 "grade": 1 "r free reflections": 1 "actb": 1 "acc no a": 1 "effects following pre-mirna administration": 1 "peptides": 1 "frequency fd a and level of mrna decrease ld av b": 1 "m fortiutum atcc 6842": 1 "predicted genes": 1 "gene names and references 2": 1 "nhx1 nhx1": 1 "dna protection rna helicase": 1 " 130 ": 1 "upstream < downstream c": 1 "1.0? ? m": 1 "deyi a sm v": 1 "sl no.": 1 "toxicity": 1 " hypo-methylated": 1 "pqq treatment group": 1 "mitochondrion organization and biogenesis": 1 "???? r p.i.m c": 1 "ctbp1 clones versus mock": 1 "results": 1 "tobacco use": 1 "er 2 e * * 0 * *": 1 "caste deg l4": 1 "probeset name": 1 "dmba": 1 "max score": 1 "vulval cell type": 1 "simulation name": 1 "ic50 rolipram ?m": 1 "types of probe": 1 "auc": 1 "3 h arbitrary units": 1 "ssh libraries": 1 "process/differentiating group s": 1 "kras mutation": 1 "7.7 × 10?1": 1 "4.93e-11": 1 "begg’s test p": 1 "observedmw/pi": 1 "direction and strength of correlation r value range c": 1 "predicted effect c": 1 "drug s": 1 "cryphonectria": 1 "single bristle": 1 "rahman colon/hm1imss colon": 1 "cytokine receptor": 1 "ser>phe": 1 "mean no.": 1 "grade e": 1 "matoba et al 27": 1 "p aeruginosa atcc 27853": 1 "uniprot name c": 1 "favorable histology": 1 "lea proteins": 1 "chip-pcr in mesc": 1 "wild typen?=?50": 1 "pi theor": 1 "t-cell subset analysed": 1 "type of study": 1 "experimental mw kd/ip i": 1 "pk group": 1 "cell transfection and/or treatment": 1 "item": 1 "inhibition mechanism": 1 "66.4 ± 5.6": 1 "ppia": 1 "matches": 1 "stromal s / vascular v expression": 1 "eg muts gb|cd449386.1": 1 "study group s": 1 "gene name d": 1 "maf b": 1 "nm_000121.2": 1 "nbc *": 1 "subcellular localization": 1 "change in expression in lymph node": 1 "basal expression log2": 1 "domain y": 1 "domain x": 1 "wild typen?=?33": 1 "e abused drug/medication": 1 "rnai": 1 "0.2131": 1 "kegg pathway number": 1 "function in epithelia": 1 "er 2 * * sos 0 * * *": 1 "n-acetyltransferase activity": 1 "smad4 exon": 1 "1.57e-04": 1 "tumour differentiation": 1 "pi exp": 1 "enhances th1 dominant response through enhancement of": 1 "avg ab s expr.": 1 "antitargets 434†": 1 "li 2012": 1 "transcription factor g ko or cts ko": 1 "go0006118": 1 "go0006119": 1 "? 1 = k 1 z 0 - z 1 e 1 - k -1 z 1     53b": 1 "trematoda": 1 "ann temp c°": 1 "2.20e-03": 1 "systemgene": 1 "gene e": 1 "llelldtlt": 1 "2.09e-03": 1 "frap1 u": 1 "germ": 1 "gg/ga vs aa": 1 "protein identification by maldi-tof ms": 1 "number of matched": 1 "shnox1 regulation 2de": 1 "omim": 1 "t295g": 1 "l1511": 1 "148 b": 1 "growth < 3rd percentile": 1 "targetid": 1 "3.17e-13": 1 "tsc2 d": 1 "receptor/signaling modulator": 1 "ra stimulation": 1 "chevrier et al regulators predicted": 1 "antitargets 1293": 1 "nuclear factor of kappa light polypeptide gene enhancer in b-cells 1": 1 "sulpiride": 1 "epor": 1 "relative amount ": 1 "nm_002046.3": 1 "or and 95 ci": 1 "mek162 ic 50 s nm": 1 "kras": 1 "adca": 1 "age/sex": 1 "5 ac": 1 "? 1 = k 1 z 0 - z 1 e 1 - k -1 z 1     54b": 1 "q- value anova f": 1 "barker et al 2009 ": 1 "scenario 1 homogeneous non-overlapping subpopulations after stimulation": 1 "mrna fd f pp/gp": 1 "timing of sampling days c": 1 "cyclin d1?–n?=?98 19.7": 1 "bad": 1 "tumor type": 1 "4.97e-10": 1 "pfs w": 1 "er 2 * * p * * *": 1 "rps6 u": 1 "exp log p ow": 1 "ref.seq": 1 "bax": 1 "cacna2d3 downregulation": 1 "specific inhibitor": 1 "scm": 1 "mutation-analysis methods": 1 "age y": 1 "nm_005252.2": 1 "beta- catenin?– n?=?194 39.0": 1 "st µm2": 1 "mirna target": 1 "partition coefficient log p ": 1 "79.5": 1 "1 a": 1 "time h": 1 "time e elapsed between p and m": 1 "targets 316†": 1 "bcf": 1 "dead": 1 "monoclonal": 1 "gene set name": 1 "56-ec": 1 "? 2 value": 1 "ncbi id no.": 1 " 16.0±8.8": 1 "identified with": 1 "resolution å": 1 "sem": 1 "b-raf mutated": 1 "t286a": 1 "???? r work": 1 "f143": 1 "ott days": 1 "age a /gender": 1 "g gallus": 1 "jun": 1 "species b": 1 "s sclerotiorum ifo 9395": 1 "several bristles": 1 "5-yr rfsd": 1 "dmso": 1 "cytogenetic band": 1 "2.117": 1 "k i µm": 1 "day 8 notch on versus notch off": 1 "ludu et al 2008 ": 1 "59.8 ± 32.4 b": 1 "functional annotation category": 1 "cell fate marker": 1 "p min": 1 "matched spectra": 1 "sterol metabolism": 1 "110 c": 1 "mapk a": 1 "treatment influenced by atnhx1 b": 1 "a uniprot accession": 1 "lesions/5 cm leaf tip c": 1 "reference no": 1 "membrane organization and biogenesis": 1 "nm_001002.3": 1 "sif": 1 "genes identified": 1 "1/13": 1 "jxg": 1 "go0005762": 1 "go0005763": 1 "x 70 g x 72 p sequence": 1 "not detected": 1 "|annot t k |": 1 "g ag> a ag": 1 "dean mcentyre 2004": 1 "dependent variable": 1 "redox protection peroxidase and superoxid dismutase": 1 "node | metric": 1 "2 months n =26": 1 "4.79e-07": 1 "aa 1 n?=?32": 1 "tfk-1": 1 "go0005743": 1 "clinical applications": 1 "neurospora": 1 "mitochondrial": 1 "variantn?=?12": 1 "conc range/vehicle": 1 "significant gene": 1 "nm_000194.2": 1 "aml de novo": 1 "fw 5?-ttggaggacttggtgtgtttc-3? rev 5?-agcttccatggctcatcct-3?": 1 "met expression/pbads136 expression": 1 "lower bound": 1 "tricladida": 1 "spot n°": 1 "number of regressor probe sets": 1 "hub gene significance *": 1 "clinicopathologic features": 1 "s cer": 1 "impact type a": 1 "entropy": 1 "t c t>t t t": 1 "acgh gain/loss": 1 "class c": 1 "k 20 k -20": 1 "high cystatin c staining 2–3 n?=?120": 1 "99.9 58.3": 1 "model and refinement": 1 "1.38e-03": 1 "stage of development": 1 "7.30e-06": 1 "negatively affected go categories": 1 "m r": 1 "m s": 1 "v parahaemolyticus th3996 ttss2? homologue id": 1 "sema3e": 1 "kegg pathways with predicted paths maximum length * ": 1 "exome variant server b": 1 "exome variant server e": 1 "positively affected go categories": 1 "p-ser 60? treated/untreated ratio ± sd f": 1 "sox": 1 "r work/ r free": 1 "s phase ": 1 "disease s": 1 "ir i 0 0 *": 1 "er 2 0 * * * * *": 1 "1.5": 1 "eg gb|ck326879.1 and eg gb|ck326506.1": 1 "scores": 1 "ec est fold": 1 "hct-116": 1 "16.51": 1 "expressionand foldchange": 1 "cheh ic50 nm": 1 "wistar t3-11 42xy": 1 "bph": 1 "control n?=?85": 1 "variantn?=?29": 1 "4047": 1 "cr vi drinking water concentration mg/l": 1 "? s °": 1 "percent identity to hs": 1 "molecular structure": 1 "101": 1 "102": 1 "cytosolic large ribosomal subunit": 1 "104": 1 "cases n = 40": 1 "cyclin group": 1 "c v i jatp": 1 "dm ?m confidence interval": 1 "rank out of 15277": 1 "epha7 expression": 1 "ssg": 1 "accession no b": 1 "wb validation": 1 "eg gb|cd449793.1": 1 "root mean square deviation from ideality": 1 "p value lpe t-test": 1 "nandi accili 2004": 1 "nurses vs reversion bees": 1 "118": 1 "entry name": 1 "yeast ortholog": 1 "6.89e-03": 1 "4.5±3.0": 1 "9.16e-03": 1 "gross appearance": 1 "diffuse positive n?=?15": 1 "52.9±16.1": 1 "age yrs/sex": 1 "121": 1 "? 6 = k 2 z 3 - z 5 - z 6 + z 7 e 2 - k -2 z 6 - z 7 + k 4 z 2 - z 4 - z 6 + z 7 e 3 - k -4 z 6 - z 7 + k 3 z 5 - z 7 e 2 + k 5 z 4 - z 7 e 3 - k -3 + k -5 z 7     54g": 1 "down in dep1 ? 121": 1 "pooled frequencyand 95ci ": 1 "k 24 k -24": 1 "arx-transfected n2a cells": 1 "cspi": 1 "iqnheared": 1 "130": 1 "domains a": 1 "patient group": 1 "nano et al 2004 ": 1 "b-md-c1 adr+/+": 1 "height of follicular cells ? m": 1 "function j": 1 "g2/m phase ": 1 "fold change hnscc hpv+ or hpv?": 1 "function s": 1 "fold change teschendorff et al 2006": 1 "running time s": 1 "high density of t-cells versus low density": 1 "av ratio b": 1 "m ethods": 1 "frequency": 1 "2.27e-08": 1 "158": 1 "no molecules": 1 "?pigments": 1 "d purpureum protein id d": 1 "a289g": 1 "kras status/affected codon": 1 "tumor size cm across n?=?60": 1 "secretion b": 1 "p -score": 1 "a nidulans genes": 1 "fold change cscc": 1 "smvkr1": 1 "loca tion": 1 "smvkr2": 1 "alternative c elegans names": 1 "15a": 1 "15b": 1 "15c": 1 "15d": 1 "15e": 1 "matching score": 1 "effect i": 1 "effect j": 1 "b a p": 1 "syn": 1 "ecp 80 mmhg": 1 "culture rahman/hm1imss": 1 "loh et al 12": 1 "accesion no .": 1 "men r *": 1 "13 weeks": 1 "176": 1 "inhibition? ?of": 1 "holding time at 17 ° c": 1 "foxj2 rp": 1 "tdf#": 1 "t790m-5 d": 1 "aspergillus": 1 "lp vs m": 1 "b regulation": 1 "or het d 95 ci": 1 "protein level of staining n ": 1 "types": 1 "lp vs e": 1 "ecp 300 mmhg": 1 "key findings": 1 "aquaporins": 1 "beta-catenin?+?n?=?304 61.0": 1 "genebank id": 1 "180": 1 "eg gb|cd449847.1": 1 "48 hrs": 1 "k 22 k -22": 1 "microarray": 1 "fc qpcr": 1 "t -test p value b": 1 "mutation s": 1 "2.01e-02": 1 "pathway frequency": 1 "change in expression in tumour": 1 "mutation h": 1 "p value fdr": 1 "tumour site": 1 "36.6 ± 7.0 b": 1 "median pucai score": 1 "rahman colon/rahman culture": 1 "pik3ca amplify": 1 "mutant n?=?12 ": 1 "wnt inhbitors": 1 "1.34e-07": 1 "18s": 1 "uniprotkb/swiss-prot? accession number": 1 " c log2 ratioamela /lines": 1 "exp 4": 1 "exp 3": 1 "sensitivity": 1 "unfavorable histology": 1 "top go term for c sinensis cs and o viverrini ov": 1 "fw 5?-gatccccaatgcttcacaag-3? rev 5?-tgcttgttgtgactgatcgac-3?": 1 "yu_gastric&npc 99 e ": 1 "protein identification by maldi-tof/tof ms/ms": 1 "rassf1a 36 tumors": 1 "unadjusted p-value c": 1 "2.59e-03": 1 "down in eaf3 ? 27": 1 "percentage with rac1p29s": 1 "pfama domaina": 1 "morpholine": 1 "k 26 k -26": 1 "1.34e-20": 1 "negative ": 1 "t gon*": 1 "asp>gly": 1 "ssc proband/ parent id a": 1 "tsc1 d": 1 "kd cdk1 f": 1 "+94 23.5": 1 "egfr-tki": 1 "fw 5?-ccaaccgcgagaagatga-3? rev 5?-ccagaggcgtacagggatag-3?": 1 "rs1893217 genotype": 1 "inhibitor": 1 "t-test p values": 1 "tag": 1 "k 28 k -28": 1 "phosphorylated targets": 1 "ribosomal protein large p0": 1 "glucose a": 1 "pqq+": 1 "test power ? = 0.05": 1 "1.722": 1 "glucose b": 1 "interaction p -value": 1 "db snp id": 1 "biological activity": 1 "??g cdk1/cycb b": 1 "tyrosine 3 – monooxygenase/tryptophan 5 –monooxygenase activation protein": 1 "tfap2a-regulated genes": 1 "wells": 1 "1?? m": 1 "b-cell cll/lymphoma 2": 1 "cestoda": 1 "stock solution": 1 "accession number b": 1 "fw 5?-atgctggacccaacacaaat-3? rev 5?-tctttcactttgccaaacacc-3?": 1 "ttp days": 1 "arx knock-out mice": 1 "role of phosphorylation": 1 "g g c>g a c": 1 "cd4": 1 "cbr": 1 "egfp-ip e": 1 "2 b": 1 "rrm1 p": 1 "cd8": 1 "response": 1 "responsive": 1 "hiv-protein": 1 "fdr q val§": 1 "tf*": 1 "growth rate mm/d a": 1 "g aa> a aa": 1 "nogo-b": 1 
"study": 39 "reference": 30 "references": 16 "results": 14 "status": 9 "phase": 9 "target": 8 "study design": 7 "design": 7 "author": 6 "treatment": 5 "nct identifier": 5 "title": 5 "outcome": 5 "compound": 5 "strategy": 5 "relevant genotype": 5 "gene": 5 "patients": 5 "year": 4 "sample size": 4 "study phase": 4 "ref.": 4 "application": 4 "phenotype": 4 "study objective": 4 "country": 4 "agent": 4 "name": 4 "description": 4 "method": 4 "samples": 4 "experimental model": 4 "examples": 4 "drug": 4 "platform": 4 "study title": 3 "tumor type": 3 "population": 3 "experimental paradigm": 3 "protocol ids": 3 "pathway s": 3 "experimental finding": 3 "accesion no.": 3 "predicted treatment strategy": 3 "significance": 3 "approach": 3 "potentially relevant therapeutics": 3 "validation": 3 "mutation": 3 "publish year country study yrs": 3 "start date": 3 "experimental design": 3 "mechanism": 3 "technology": 3 "detailed subtypes": 3 "cons": 3 "source or reference": 3 "methods": 3 "pros": 3 "study type": 3 "strain": 3 "effect": 3 "sponsor": 3 "outcomes": 2 "patent document": 2 "diabetes diagnosis": 2 "result": 2 "insulin analyzed": 2 "advantages": 2 "stage": 2 "controls": 2 "ref": 2 "trial design": 2 "dosage per day": 2 "gene alteration s": 2 "duration": 2 "company": 2 "study results": 2 "exposurec": 2 "study details": 2 "normalization": 2 "model": 2 "indication": 2 "location subjects": 2 "aim": 2 "drugs": 2 "median pfs": 2 "species": 2 "discovery": 2 "key gene /biomarker s": 2 "screening method": 2 "function": 2 "increased risk?": 2 "immune testing": 2 "diagnosis": 2 "uremia": 2 "study arms": 2 "agent used": 2 "reference study design": 2 "histology": 2 "primary aim": 2 "protein": 2 "animal": 2 "molecule": 2 "3/83": 2 "proposed karyotype": 2 "pathogenesis/definition": 2 "proposed function": 2 "source": 2 "total n ": 2 "proposed terminology": 2 "organism": 2 "completion date": 2 "genotype": 2 "5/77": 2 "disease": 2 "new york #146980": 2 "orr": 2 "promising circulating mirnas": 2 "disadvantages": 2 "lethality": 2 "identifier": 2 "goal": 2 "median os": 2 "virginia #29046": 2 "exercise details": 2 "main findingab": 2 "results/interpretations": 2 "candidate genes": 2 "methylation site": 2 "treatment arms": 2 "group": 2 "factors considered in analysis": 2 "clinicaltrials.gov no.": 2 "purpose": 2 "author reference": 2 "sponsor/collaborator": 2 "experimental conditions": 2 "diagnostic technologies": 2 "source/reference": 2 "exercise type": 2 "peptide/ source": 1 "kind of approach": 1 "cancer model": 1 "target gene": 1 "problem name": 1 "resolution": 1 "setting": 1 "number of mirnas examined": 1 "promoter": 1 "cost/screening $": 1 "caucuuacugggcagcauugga---cfa-mir-200b by similarity caucuuacugggcagcauugga---hsa-mir-200b-5p": 1 "ampa/kainate receptor subunit": 1 "limitations": 1 "compound 6c": 1 "immune measures": 1 "kog information": 1 "pathway activation": 1 "identified affected pathways and major findings": 1 "ar": 1 "imaging study": 1 "dose": 1 "targeted gfr": 1 "primary objective/s": 1 "key gene/biomarker s": 1 "utility": 1 "caucuuaccggacagugcugga---cfa-mir-200a by similarity caucuuaccggacagugcugga---hsa-mir-200a-5p": 1 "worst-case running time using straightforward implementation": 1 "aucacauugccagggauua---cfa-mir-23b experimental aucacauugccagggauuacc---hsa-mir-23b-3p": 1 "perturbants/inhibitors": 1 "knockout phenotype": 1 "positives": 1 "algorithmic approach": 1 "study series": 1 "tissue requirement for biomarker analysis": 1 "approximation ratio": 1 "primary antibodies": 1 "“double-trouble” tumors": 1 "chip": 1 "address": 1 "data set": 1 "subjects": 1 "art c": 1 "primary objective": 1 "abbreviation": 1 "sample": 1 "renal": 1 "disease status": 1 "trials": 1 "2-yr os ": 1 "increased risk or with 95 ci": 1 "uuauugcuuaagaauacgcgu---cfa-mir-137 experimental uuauugcuuaagaauacgcguag---hsa-mir-137-3p": 1 "uagcaccauuugaaaucgguua---cfa-mir-29c experimental uagcaccauuugaaaucgguua---hsa-mir-29c-3p": 1 "male/fem": 1 "aicd target gene": 1 "# pts": 1 "sample ": 1 "pfs/ttp/ttf": 1 "antibodies": 1 "runx3 expression": 1 "study phase and disease status": 1 "interaction-based": 1 "constraint-based": 1 "molecule studied": 1 "10-year cost $": 1 "mechanism-based": 1 "chr": 1 "study b a8081001": 1 "methods used for molecular analysis": 1 "descriptive statistics p53": 1 "trial identifier status": 1 "mirna": 1 "standard deviation": 1 "rare disease": 1 "this study": 1 "hcc type n hcc": 1 "cohort": 1 "berberine dosage": 1 "# dead/n": 1 "provider": 1 "applies to": 1 "microrna": 1 "preferred breakpoints on hbv genome": 1 "cell type expression*/tissue affected†": 1 "antibody or stain": 1 "sponsor/lead organisations": 1 "uagcaccauuugaaaucaguguu---cfa-mir-29b experimental uagcaccauuugaaaucaguguu---hsa-mir-29b-3p": 1 "total number of studies": 1 "label": 1 "pathogenetic relevance": 1 "suggested mechanism": 1 "effective iib-iv": 1 "allele": 1 "preferred human integrated chr.": 1 "developer": 1 "cancer": 1 "replication participants": 1 "prognostic relevance": 1 "study a profile 1005": 1 "side constraints erbb1?=?1 erbb2?=?1 erbb3?=?1": 1 "focus": 1 "tma": 1 "non-effective i-iia": 1 "mean coverage depth x": 1 "known or proposed function": 1 "target accrual": 1 "treatment regimens": 1 "significant markers": 1 "if": 1 "stimulants": 1 "cdkn2a deletion": 1 "circulating mirnas examined": 1 "nmda receptor subunit": 1 "antigen": 1 "classification": 1 "phospholipid molecular systems": 1 "relevance": 1 "results behavioral": 1 "possible baits": 1 "biological material used for fractionation": 1 "treatment outcome s": 1 "baec": 1 "study aim": 1 "study groups/methods": 1 "population studied": 1 "authors": 1 "discovery cohort size": 1 "mutational frequency": 1 "# sick/n*": 1 "mab name": 1 "literature": 1 "viral load b": 1 "descriptive statistics of indicated variables": 1 "basic principle": 1 "ncbi symbols": 1 "relevant characteristics": 1 "nct": 1 "downregulated v-fos-specific candidate genes": 1 "simulation time lipid force field": 1 "y2h method": 1 "experimental protocol": 1 "agents": 1 "genetic result region/": 1 "vst hits": 1 "total markers": 1 "detection technology": 1 "attributes": 1 "n0": 1 "method based on": 1 "discovery participants": 1 "also known as": 1 "findings": 1 "screen": 1 "primary endpoint": 1 "platforms": 1 "anticancer effects": 1 "high-instability tumors": 1 "ugagaacugaauuccauggguu---cfa-mir-146a experimental ugagaacugaauuccauggguu---hsa-mir-146a-5p": 1 "mutations": 1 "copies": 1 "cellular factors": 1 "proposed functional effect": 1 "ucccugagacccuuuaaccugu---cfa-mir-125a experimental ucccugagacccuuuaaccuguga---hsa-mir-125a-5p": 1 "combination therapy": 1 "stage of screen": 1 "known functions in vulval development": 1 "mglur receptor": 1 "publication/experimenter": 1 "behavioral assessment": 1 "study ref#": 1 "required for asfv infection": 1 "ugagguaguagguuguaugguu---cfa-let-7c experimental ugagguaguagguuguaugguu---hsa-let-7c-5p": 1 "tool": 1 "proteomic analysis": 1 "pathologic response": 1 "therapeutic strategy": 1 "designation": 1 "version/date": 1 "lesion": 1 "down-regulated": 1 "seminal vesicle invasion": 1 "cancer gene discovery approach": 1 "proteomics method": 1 "technique used": 1 "p -value": 1 "biological application": 1 "animal/cell line tested": 1 "ultimate stress n/mm2": 1 "rr ": 1 "experimental restraints used in structure calculation": 1 "sample size n ": 1 "up-regulated": 1 "required for asfv entry": 1 "probe": 1 "groups l3 vertebra": 1 "regulation": 1 "results immune": 1 "specimen type": 1 "neurotrophin": 1 "remarks": 1 "major genes": 1 "computational technology": 1 "screen compatibility #": 1 "number/100000 era 2": 1 "trial aim": 1 "short name/s": 1 "number/100000 era 1": 1 "phase protocol's id": 1 "uaauacugccggguaaugaugga---cfa-mir-200c experimental uaauacugccggguaaugaugga---hsa-mir-200c-3p": 1 "major findings": 1 "experimental method": 1 "intervention goal erk?=?1 pi3k?=?0": 1 "patient identifier": 1 "vaccine name": 1 "side effects": 1 "physiological functions": 1 "ucccugagacccuaacuuguga---cfa-mir-125b experimental ucccugagacccuaacuuguga---hsa-mir-125b-5p": 1 "animal model": 1 "experimental conditionsa": 1 "chromosomal loci": 1 "identifier no.": 1 "therapeutic goal": 1 "diseases": 1 "study types": 1 "study research question": 1 "desired effects": 1 "no of proteins identified": 1 "accepted droplets": 1 "benefit": 1 "cancer type s": 1 "prognostic/predictive": 1 "current developed phase": 1 "t/total integ -rated sites": 1 "gleason score": 1 "expressed gene": 1 "aggcaguguaguuagcugauugc---cfa-mir-34c experimental aggcaguguaguuagcugauugc---hsa-mir-34c-5p": 1 "frequency in validation cohort number of cases": 1 "patient number": 1 "strains": 1 "aucacauugccagggauuu---cfa-mir-23a experimental aucacauugccagggauuucc---hsa-mir-23a-3p": 1 "graph type": 1 "rt dose gy": 1 "conventional pcr conditions": 1 "proposed key molecule": 1 "ugagguaguaguuuguacaguu---cfa-let-7g experimental ugagguaguaguuuguacaguu---hsa-let7g-5p": 1 "aggcaguguaauuagcugauug---cfa-mir-34b by similarity uaggcagugucauuagcugauug---hsa-mir-34b-5p": 1 "study subjects": 1 "vendor": 1 "neuroimmune measures": 1 "potential application": 1 "vector": 1 "sample type": 1 "rationale and hypothetical effects": 1 "publication date": 1 "pi3k": 1 "etiology of hcc": 1 "study population": 1 "basis and advantages": 1 "refs": 1 "mdm2 amplification": 1 "reagents": 1 "symbol": 1 "age yr": 1 "official name": 1 "in vitro study": 1 "probe design": 1 "frequency": 1 "features": 1 "pt#": 1 "bcl-2 inhibitor": 1 "ugagaacugaauuccauaggcu---cfa-mir-146b experimental ugagaacugaauuccauaggcu---hsa-mir-146b-5p": 1 "genotyping": 1 "refseq": 1 "descriptive title": 1 "modification": 1 "collection of existing mutation extraction approaches": 1 "experimental approach": 1 "patient condition": 1 "clinicaltrial.gov identifier": 1 "uggacggagaacugauaagggu---cfa-mir-184 by similarity uggacggagaacugauaagggu---hsa-mir-184": 1 "name of probe": 1 "biotechnological application": 1 "‘go’ annotations": 1 "proteinuria": 1 "candidate gene/ related pathwayb": 1 "wb": 1 "cdh13 expression": 1 "mice": 1 "aacacugucugguaaagaugg---cfa-mir-141 by similarity uaacacugucugguaaagaugg---hsa-mir-141-3p": 1 "apoptosis-resistant tumors": 1 "drug s": 1 "alternative name/s": 1 "normal": 1 "main results": 1 "alternative names": 1 "sample #": 1 "pts": 1 "results neuroimmune": 1 "ugagguaguagauuguauaguu---cfa-let-7f experimental ugagguaguagauuguauaguu---hsa-let-7f-5p": 1 "location": 1 "relevant literature *": 1 "clinical phase": 1 "s no.": 1 "ugagguaguagguuguauaguu---cfa-let-7a by similarity ugagguaguagguuguauaguu---hsa-let-7a-5p": 1 "tissue": 1 "strain modification": 1 "treatment design": 1 "type": 1 "study scheme": 1 "selenium salt from and dosing regime": 1 "virus titer used reference": 1 "discovery cohort n": 1 "phase study": 1 "predictive efficacy": 1 "diagnostic or predictive biomarkers under scrutiny": 1 "meanb": 1 "subgroups": 1 "cellular compartment *": 1 "acagcaggcacagacaggcagu---cfa-mir-214 by similarity acagcaggcacagacaggcagu---hsa-mir-214-3p": 1 "date infected": 1 "ultimate load n": 1 "gene symbol": 1 "negative study": 1 "clinical study": 1 "mycn": 1 "negatives": 1 "conclusions": 1 "markers used": 1 "drug/compound/treatment": 1 "neuropsychological testing": 1 "locations/countries": 1 "ongoing triala": 1 "ugagguaguagguugugugguu---cfa-let-7b not experimental ugagguaguagguugugugguu-hsa-let-7b-5p": 1 "uacaguacugugauaacuga---cfa-mir-101 experimental uacaguacugugauaacugaa---hsa-mir-101-3p": 1 "definitions/symptoms": 1 "predictive biomarkers": 1 "end points": 1 "tumor diseases": 1 "ab name": 1 "previous study": 1 "context for research": 1 "transgenes": 1 "lot": 1 "trial description": 1 "ugugcaaaucuaugcaaaacuga---cfa-mir-19a experimental ugugcaaaucuaugcaaaacuga---hsa-mir-19a-3p": 1 "fractions used": 1 "protein/transcript": 1 "main altered proteome": 1 " inhibition": 1 "replication": 1 "successful cns drug a": 1 "descriptive statistics mdm-2": 1 "methodology used": 1 "highlights": 1 "let-23 localization": 1 "responses": 1 "clinical trials.gove identifier agent trial name": 1 "summary of reported findings": 1 "4 h": 1 "part used": 1 "cellular target": 1 "control treatment": 1 "il-6 expression": 1 "tumor entity": 1 "investigated agents": 1 "refs.": 1 "study drug target": 1 "assay principle": 1 "antitumoral activity and/or mechanism": 1 "purine nucleoside": 1 "tool name": 1 "clinical status": 1 "biomarker": 1 "sequence": 1 "uggcagugucuuagcugguugu---cfa-mir-34a experimental uggcagugucuuagcugguugu---hsa-mir-34a-5p": 1 "surgical margins": 1 "study aims/findings": 1 "3 h": 1 "p value": 1 "transporters": 1 "line": 1 "study identifier name sponsor": 1 "patent number": 1 "gene identified": 1 "candidate region/": 1 "cam": 1 "inclusion": 1 "database": 1 "normal localization": 1 "array": 1 "substrates": 1 "other results": 1 "biomarker/population selection": 1 "rest": 1 "resveratrol dose and application route": 1 "chromosome location": 1 "pregnancy required": 1 "pmid": 1 "exploration time": 1 "important points": 1 "sd ": 1 "validation cohort n": 1 "response": 1 "stages": 1 "challenge": 1 "2 h": 1 "category": 1 "#pts": 1 "discovery methodology": 1 "methodology": 1 "hugo gene symbol": 1 
"cell line": 20 "treatment": 11 "mcf-7": 9 "mcf-7/?akt-1 cadoxr": 9 "mcf-7/?akt-1 ca": 9 "ic50 2n<2t<3t<3n": 8 "gefitinib": 8 "control": 8 "compound": 8 "ic50": 7 "mk-2206": 6 "log ec50": 6 "gemcitabine": 5 "rapamycin": 5 "ic50 ?m": 5 "erlotinib": 5 "kinase": 5 "dox": 5 "etoposide": 5 "inhibitor": 5 "doxorubicin": 4 "paclitaxel": 4 "ci": 4 "#1": 4 "#2": 4 "dmso": 4 "imatinib": 4 "emax ": 4 "cell lines": 4 "cells": 4 "fluvastatin": 4 "?": 3 "4ht": 3 "dasatinib": 3 "microtubule stabilizer": 3 "doxorubicin + 5 nm 4ht": 3 "doxorubicin + 1 nm rapamycin": 3 "ic50 ? m": 3 "4ht + 1 nm rapamycin": 3 "lc50": 3 "percentage of activity remaining": 3 "ku-0063794 1 ?m": 3 "hsp90 inhibitor": 3 "ku-0063794 10 ?m": 3 "etoposide + 1 nm rapamycin": 3 "lapatinib": 3 "mtor inhibitor": 3 "no dox": 3 "reference": 3 "cell viability": 3 "histone deacetylase inhibitor": 3 "mm atc": 2 "vorinostat": 2 "egf": 2 "vincristine": 2 "resistance index": 2 "mxr": 2 "palmatine": 2 " ?m": 2 "nilotinib": 2 "cc": 2 "0.01": 2 "sample": 2 "0.73 ?m": 2 "cddp": 2 "adm ic50 ?g/ml": 2 "compounds": 2 "grade 3/4": 2 "dznep": 2 "- 2": 2 "- 3": 2 "sorafenib": 2 "xcelligence ec50": 2 "epic® ec50": 2 "48 h": 2 " cell viability ± s.e.m.": 2 "drug treatment": 2 "b-rafv600e": 2 "wm266.4": 2 "eto": 2 "doxorubicin nm": 2 "p-value": 2 "any": 2 "0.1": 2 "chemotherapeutic": 2 "properties": 2 "pt": 2 "qod": 2 "r max to kpss": 2 "bufalin": 2 "pmx": 2 "tamoxifen": 2 "nf-?b": 2 "mutant": 2 "ap-1": 2 "panobinostat": 2 "vinblastine": 2 "microtubule inhibitor": 2 "treatment recipient": 2 "7.30 ?m": 2 "compd": 2 "genotype": 2 "vinorelbine": 2 "percentage cell viability": 2 "ic50 nm": 2 "inhibition": 2 "target": 2 "digitoxin": 2 "curcumin": 2 "gene": 2 "exisulind": 2 "gi50 µ m": 2 "s sulfide": 2 "vbl": 2 "gem": 2 "vehicle": 2 "ed50": 2 "egf+gefitinib": 2 "ic50 a ci 95": 2 "simvastatin": 2 "gfp": 2 "hs1 atc": 2 "ic50 µm": 2 "7 nm 2": 2 "ed75": 2 "gsno": 2 "group": 2 "ouabain": 2 "96 h": 2 "mousegene": 2 "berberine": 2 "ed90": 2 "ic50 µ m": 2 "erk ec50": 2 "hs2 atc": 2 "60 x? 2": 2 "e1a12s": 2 "binding ic50": 2 "2.5 x? 2": 2 "72 h": 2 "concentration ?m": 1 "def": 1 "references": 1 "treatment duration days": 1 "bcr-abl inhibitor": 1 "methoprene": 1 "ic50 ?m post-conf": 1 "sd rat": 1 "inhibition rate ": 1 "tel": 1 "selumetinib tgi": 1 "navelbine vinorelbine": 1 "ras": 1 "teniposide": 1 "ic50 * nilotinib": 1 "egfr ic50 ?mol/l": 1 "4.3 x? 3": 1 "nanoparticle": 1 "ic50s": 1 "atorvastatin": 1 "nu7441 days": 1 "fold": 1 "1": 1 "ic50 * imatinib": 1 "domain": 1 "taxol paclitaxel": 1 "nucleoside analogs ie azacytidine and decitabine hydroxyurea hydroxycarbamide histone deacetylase inhibitors ie butyrate trychostatin a apicidin scriptaid hydroxyamides others including erythropoietin valproate thalidomide derivatives kit ligand": 1 "ic50 ?m ± sem": 1 "cell line/treatment": 1 "ic50 * dasatinib": 1 "g2 phase": 1 "irinotecan µm": 1 "gjic ?": 1 "mir-126-5p": 1 "rbx": 1 "pecdf": 1 "anti-tumor pdt mechanisms": 1 "ly294002": 1 "i/r": 1 "arm 1 carboplatin auc 6": 1 "viability": 1 "ic50 ± sem µg/ml": 1 "selenium": 1 "romidepsin": 1 "taxol": 1 "sem": 1 "bgt226 nmol/l": 1 "nvp auy922": 1 "ic50 value": 1 "capto": 1 "dri values mean±s.e.": 1 "group ski-ii ?mol/l + ddp mg/l": 1 "loading ": 1 "jurkat": 1 "advantages": 1 "gii melatonin": 1 "gdir + nu7441 days": 1 "pi3k inh": 1 "zeta potential mv": 1 "ly294002 um": 1 "10 nm 2": 1 "kit pdgfrb vegfr 2/3 raf flt-3 ret": 1 "ic50 ganetespib nm": 1 "6?h sl327": 1 "0.05": 1 "uva + b": 1 "e2 100 ng/ml": 1 "others": 1 "sunitinib": 1 "cetuximab ?g/ml": 1 "vp-16": 1 "tel + rosi": 1 "adm": 1 "adr": 1 "panobinostat lbh589": 1 "ed50 m": 1 "75 mg/m 2": 1 "vemurafenib 61 62": 1 "cfz ic 50 ?m": 1 "aminoglycosides": 1 "hg-u133a": 1 "finisteride": 1 "ic50 ?m sorafenib": 1 "cytotoxic tgi": 1 "egfr": 1 "staurosporine": 1 "origin": 1 "30°c": 1 "lovastatin lactone": 1 "mia.ev ic50 concentration": 1 "pf-04691502": 1 "xenograft model": 1 "taxotere": 1 "bkm120 concentration": 1 "h1047r a ec50 µm": 1 "50 ?m": 1 "paclitaxel µm": 1 "150 ?m": 1 "irinotecan": 1 "reverse-fold": 1 "injection/ lens treatment": 1 "taxotere docetaxel": 1 "zm336372": 1 "emodin": 1 "pdi": 1 "ic502 or change in ic503": 1 "ridaforolimus ap23573": 1 "ref/clinical trials": 1 "ic50 ?m pre-conf": 1 "rad001 nmol/l": 1 "change in ic502": 1 "inhibitor ic50 nm": 1 "bcnu ic50 µm": 1 "methylation alone": 1 "dasision trial": 1 "gefitinib um": 1 "+upa": 1 "nac": 1 "ponatinib ic50 nm": 1 "topotecan hycamtin": 1 "salirasib treatment": 1 "single-agent erlotinib": 1 "arm 3 erlotinib": 1 "antimetabolite": 1 "perifosine µ m": 1 "mimic": 1 "treatment regimens": 1 "cisplatin ic50 ?m": 1 "48 h treatment": 1 "hmecsu ic50 ?m *": 1 "cho cell line": 1 "1 ? 25-dihydroxyvitamin d3": 1 "antitumor activity ic50 ?m *": 1 "ir": 1 "baicalein": 1 "5.8 x? 2": 1 "??cells ?": 1 "selumetinib+temsirolimus n =35": 1 "treatment 1": 1 "8.9 x? 2": 1 "treatment 2": 1 "gemcitabine µg/ml": 1 "trametinib 105": 1 "hgf/sf + fts": 1 "ic50 for emodin ?m": 1 "hgf/sf": 1 "kit pdgfra/b abl": 1 "dabrafenib 3": 1 "bkm120 nmol/l": 1 "b11b021": 1 "18.7 x? 2": 1 "ipi-504 retaspimycin": 1 "ic50 for curcumin ?m": 1 "arm 2 docetaxel": 1 "ic50 ?mol/l": 1 "outcome": 1 "1.3 x? 2": 1 "silymarin": 1 "fts": 1 "drugs": 1 "rosi": 1 "vincristine ic50 nm": 1 "h1047r b ec50 µm": 1 "sta-9090": 1 "agents": 1 "sham": 1 "depsipeptide romidepsin": 1 "cddp ic 50 ?m": 1 "20 nm2": 1 "imatinib ic50 µm": 1 "ellagic acid": 1 "hsp90? ic50 ± sd ?m": 1 "5-fu": 1 "ic50 µm 48 h": 1 "vincristine oncovin": 1 "downregulated": 1 "ic50 3t<<3n<2n<2t": 1 "24 h treatment": 1 "u0126+insulin 50 µm+0.3 µm": 1 "sulindac": 1 "mc": 1 "her2 ic50 ?mol/l": 1 "combination tgi": 1 "imatinib ic50 nm": 1 "uc50": 1 "dasatinib ic50 nm": 1 "ang ii + nac": 1 "mutation alone": 1 "mouse model": 1 "combidt 150/2 106": 1 "diagnosis": 1 "0?h": 1 "patient no .": 1 "dace": 1 "nc": 1 "ohp": 1 "45 mg c n?=?9": 1 "cudc101": 1 "gw5074": 1 "no": 1 "ly294002 50 µm": 1 "0.001": 1 "45 mg d n?=?4": 1 "gemcitabine plus placebo n=280": 1 "genetics": 1 "staur.": 1 "cisplatin": 1 "upregulated": 1 "resveratrol": 1 "uvb": 1 "amg102 ± ir": 1 "uva": 1 "coralyne": 1 "bcnu": 1 "26s proteosome inhibitor": 1 "pathways blocked": 1 "chemotherapeutic agents": 1 "amg102": 1 "structure": 1 "u87/egfrviii": 1 "100": 1 "tumors": 1 "u0126 um": 1 "pi3k mtor inhibitor": 1 "ic50 µm 24 h": 1 "siha": 1 "cisplatin µg/ml": 1 "4-oh-e2 100 ng/ml": 1 "belinostat": 1 "zol ? m ": 1 "digitoxin ug/ml": 1 "pravastatin": 1 "ir days": 1 "ic50 2n<2t<3t<<3n": 1 "her2 ic50 ± sd ?m": 1 "ang ii + apocynin": 1 "class/mechanism of action": 1 "compound id": 1 "belinostat pxd101": 1 "wogonin": 1 "bortezomib": 1 "receptor agonist": 1 "azacitidine": 1 "er status": 1 "10": 1 "ic50 3t<<2n?=?2t?=?3n": 1 "g1 phase": 1 "qw": 1 "cytotoxic product": 1 "antimitotic": 1 "control a": 1 "rf": 1 "u87": 1 "ly294002+insulin 50 µm+0.3 µm": 1 "cytotoxic dosing schedule per cycle": 1 "her2 and egfr inhibitor": 1 "decitabine": 1 "gefitinib ic50": 1 "prodrug": 1 "celecoxib": 1 "29": 1 "90 mg n?=?5": 1 "imatinib resistance": 1 "enzastaurin um": 1 "nilotinib amn107": 1 "specificity": 1 "90 mg n?=?3": 1 "aspirin": 1 "5-florouracil um": 1 "epigallocatechin 3-gallate": 1 "30": 1 "nvpaew541": 1 "33": 1 "gefitinib n?=?28": 1 "acr concentration": 1 "icell line": 1 " inhibition atp binding *": 1 "selumetinib": 1 "t80": 1 "5-fu µg/ml": 1 "vinblastine velban": 1 "camptothecin camptosar campto": 1 "simvastatin plus methoprene": 1 "rtv": 1 "ara014418 um": 1 "bkm120 ic50 ?mol/l": 1 "imatinib sensitive": 1 "kit pdgfa/b vegfr1-3": 1 "oltipraz": 1 "41": 1 "tumor id": 1 "retinoids": 1 "toxicity": 1 "actinomycin d": 1 "agent": 1 "tumour multiplicity inhibition": 1 "48": 1 "saline": 1 "source": 1 "selumetinib alone n =34": 1 "integrated data": 1 "su11274": 1 "kinases": 1 "ic 50": 1 "100 ?m": 1 "um": 1 "ir + nu7441 days": 1 "sorafenib bay 43-9006": 1 "results": 1 "carboplatin um": 1 "inhibitor name": 1 "parental ec50 µm": 1 "?upa": 1 "qod a": 1 "ic50 nm **": 1 "vatalanib ptk787/zk222584": 1 "infarct size": 1 "torin1": 1 "may benefit from im-dose-escalation **": 1 "brassinin": 1 "2 x? 3": 1 "q3w": 1 "genistein": 1 "cc50": 1 "ici 182780": 1 "n -acetylcysteine nac": 1 "ec50 µm": 1 "*ic50": 1 "75": 1 "uvb + a": 1 "ang ii": 1 "dh rat": 1 "200 mg n?=?6": 1 "gefitinib ?m": 1 "200 mg n?=?4": 1 "insulin 0.3 µm": 1 "ic50 17-aag nm": 1 "ly294002 concentration": 1 "reversible/irreversible": 1 "bcr-abl/src inhibitor": 1 "time": 1 "control days": 1 "hela": 1 "geniposide": 1 "paclitaxel 200 mg/m 2": 1 "drug combination": 1 "ec50 mitoxantrone nm": 1 "6?h vehicle": 1 "37°c": 1 "gdnu7441 days": 1 "u87/egfr": 1 "everolimus rad001": 1 "disadvantages": 1 "90": 1 "gdir days": 1 "gemcitabine plus erlotinib n=282": 1 "patient characteristics": 1 "tcdd": 1 "lovastatin": 1 "95": 1 "rosuvastatin": 1 "bosutinib": 1 "phase": 1 "item": 1 "tmz ic50 µm": 1 "gsk-3?": 1 "gsk-3?": 1 "sanguinarine iminium form": 1 "vorinostat zolinza": 1 "trametinib nm": 1 "1.5 x? 3": 1 "emd 121463 um": 1 "10 x? 3": 1 "size nm": 1 "erlotinib n?=?31": 1 "ixabepilone": 1 "ht-29": 1 "regorafenib µ m": 1 "enestnd trial": 1 "tumour incidence inhibition": 1 "hmec-1 ic50 ?m *": 1 "140 nm 2": 1 "135 mg c n?=?6": 1 " inhibition": 1 "hlc-080": 1 "organs": 1 "max ic50 shift": 1 "bela trial": 1 "45 mg n?=?6": 1 "10.7 x? 2": 1 "45 mg n?=?5": 1 "paclitaxel nm": 1 "treatment + wortmannin": 1 "pd98059": 1 "u0126": 1 "100 mg and 150 mg": 1 "ic50 braf ?m": 1 "her4 ic50 ?mol/l": 1 "ee ": 1 "docetaxel nm": 1 "q3w b": 1 "num": 1 "no of cycles": 1 "egfr inhibitor tk domain": 1 "baicalin": 1 "mia.pp32 ic50 concentration": 1 "ic50 pperk ?m": 1 "apocynin": 1 "akt inhibitor iv": 1 "combination": 1 "format": 1 "7.5 x? 2": 1 "lovastatin acid": 1 "vemurafenib µ m": 1 "alpha-difluoromethylornithine dfmo": 1 "naringenin": 1 "135 mg d n?=?6": 1 "marker": 1 "pcb126": 1 "60 mg n?=?9": 1 "60 mg/m 2": 1 "p value": 1 "kb binding peptides": 1 "mapkk inh": 1 "gi vehicle": 1 "34°c": 1 "no tamoxifen": 1 "ec50 docetaxel nm": 1 "patient": 1 "parameter": 1 "3.1 x? 3": 1 "u0126 50 µm": 1 "5-azacitidine": 1 "6.7 x? 3": 1 "pcb153": 1 "enzyme": 1 "hdaci": 1 "7 x? 3": 1 "harmine": 1 "kras": 1 "s phase": 1 "gi50 srb ?m": 1 "effect of rapamycin treatment": 1 "sorafenib ic50 µm": 1 "2.5 x? 3": 1 "assay": 1 "ic50 2n<2t?=?3t<3n": 1 "statins": 1 "nilotinib ic50 nm": 1 "135 mg n?=?5": 1 "135 mg n?=?4": 1 "atcc": 1 "adverse event n ": 1 
"gene": 56 "sequence": 33 "species": 29 "name": 28 "accession number": 23 "reference": 18 "description": 17 "genbank accession": 16 "gene sequence": 16 "encoded protein description": 15 "kegg orthology": 15 "family": 14 "gene symbol": 14 "gene name": 12 "function": 12 "chromosomal location": 12 "description unigene cluster genbank accession no.": 11 "accession": 11 "tag frequency": 11 "pituitary gland": 11 "chromosome": 11 "e-value": 11 "hypothalamus": 11 "parietal cortex": 11 "organism": 11 "length": 10 "symbol": 9 "fold change": 9 "references": 8 "primer sequence": 8 "p-value": 8 "accession no.": 8 "function and tag sequences": 7 "class": 7 "type": 7 "accession #": 6 "genes": 6 "tax id": 6 "target": 6 "drosophila melanogaster": 6 "caenorhabditis elegans": 6 "protein name": 6 "human homolog": 5 "gene description": 5 "no ests": 5 "homo sapiens": 5 "genbank accession #": 5 "cluster": 5 "identity ": 5 "protein": 5 "clade": 5 "primer name": 5 "sequence 5? to 3?": 5 "fc": 5 "annotation of sequence": 5 "reverse sequence": 5 "forward sequence": 5 "sequence 5?-3?": 5 "homolog species": 5 "genbank accession number*": 4 "pathway": 4 "location d pulex v1.1": 4 "log2 fca": 4 "c elegans orthologs": 4 "protein id": 4 "number of sequences per contig": 4 "sl/m": 4 "isozyme": 4 "hours": 4 "oligo name": 4 "sh/m": 4 "process": 4 "virus": 4 "gaps": 4 "genbank accession no.": 4 "site s with the consensus px s/tp sequence": 4 "comparison species": 4 "genbank accession number": 4 "e -value": 4 "size bp": 4 "sm/m": 4 "total": 4 "oseltamivir/m": 4 "# amino acids": 4 "similarity": 4 "location": 4 "m/n": 4 "daphnia pulex": 4 "tag sequences": 4 "putative identification on blastx": 4 "uniprotkb/trembl entry": 3 "4": 3 "primer": 3 "c elegans": 3 "sequence name gb accession #": 3 "end": 3 "# of bands band size": 3 "primer sequence 5'?3'": 3 "est": 3 "bos taurus": 3 "primary tissue": 3 "molecular weight": 3 "e value": 3 "probe": 3 "best hit overall": 3 "nucleotide sequence": 3 "sequence 5’-3’": 3 "psp": 3 "start": 3 "family & parent": 3 "chromosome location": 3 "total unique samples": 3 "target gene": 3 "product size bp": 3 "cw": 3 "mus musculus": 3 "origin": 3 "human": 3 "neurospora": 3 "gene id": 3 "d melanogaster": 3 "fusarium": 3 "lg": 3 "fc a": 3 " mutated": 3 "rattus norvegicus": 3 "fold-change": 3 "ps": 3 "unique mutated samples": 3 "length bp": 3 "animal": 3 "clone id": 3 "swiss-prot hit": 3 "# s/tp sites": 3 "cluster id": 3 "mutation data": 3 "functions": 2 "blastx homolog organism": 2 "gene product": 2 "0": 2 "primers": 2 "annotation": 2 "unique peptides": 2 "e": 2 "abbreviation": 2 "m": 2 "genbank accession numbers": 2 "contig number": 2 "go term": 2 " identity": 2 "reference species": 2 "egfr": 2 "probe sequence": 2 "number": 2 "order": 2 "go term d": 2 "seed sequence": 2 "human homologue": 2 "dot blot analysis": 2 "??name": 2 "genome": 2 "expected size": 2 "putative gene catalogs": 2 "ref.": 2 "216": 2 "no reads": 2 "s1-pri a": 2 "a thaliana orthologue": 2 "drosophila": 2 "mature sequence": 2 "peptides": 2 "e2control ratio": 2 "pan troglodytes": 2 "mechanism": 2 "arm": 2 "gene classification/description": 2 "cluster id – blast similarity to uniprot/embl": 2 "refs": 2 "sequence 5' to 3'": 2 "clone accession no.": 2 "array id": 2 "fold change parent/? yopm-1": 2 "mirnas family": 2 "insert size bp": 2 "total of ests": 2 "disease": 2 "rate equation": 2 "average coverage per nucleotide": 2 "connectivity §": 2 "position umd 3.1": 2 "log 2 ratio b": 2 "sequence 5'-3'": 2 "consensus number": 2 "p value": 2 "database": 2 "fly gene": 2 "mirna family": 2 "official gene name*": 2 "mean": 2 "annealing temperature": 2 "ustilago maydis": 2 "putative function": 2 "ko term c": 2 "bt": 2 "chimpanzee": 2 "sem": 2 "rpmm": 2 "sample": 2 "accession in ncbi-nr": 2 "myc a": 2 "homolog protein blastx value": 2 "median ‡": 2 "company": 2 " gc": 2 "sense": 2 "homologs number in other species": 2 "homology": 2 "use": 2 "product length bp": 2 "primer sequences": 2 "chordata": 2 "magnaporthe grisea": 2 "accession number genbank": 2 "accession number gi": 2 "12": 2 "blastx fungi e-value": 2 "tm °c": 2 "isoform": 2 "rt": 2 "24": 2 "total of unigenes": 2 "species name": 2 "length aa": 2 "mammalian homolog": 2 "?symbol": 2 "144": 2 "homolog species/accession no.": 2 "sequence 5??3?": 2 "superfamily": 2 "???remark": 2 "aspergillus": 2 "72": 2 "name of the encoded protein": 2 "protein class": 2 "intron": 2 "identified in psd?": 2 "plant viridiplantae limited": 2 "ssh library": 2 "antisense": 2 "peptide sequence": 2 "distribution": 2 "transcript": 2 "length identity": 2 "ests": 2 "constants": 2 "accession id": 2 "t a": 2 "sequence identity ": 2 "mirnas name": 2 "family information": 2 "parameter": 2 "blast e-value b": 2 "category": 2 "brassica rapa": 1 "": 1 "non cluster": 1 "treefam id": 1 "epi-cardium": 1 "3880": 1 "drugs/targets": 1 "gfl-1": 1 "consensus name": 1 "1217": 1 "score": 1 "trichoderma reesei": 1 "cluster 2 no.": 1 "proviruses": 1 "16s rrna gene sequence accession no a": 1 "263511": 1 "verticillium dahliae": 1 "# unique transcripts": 1 "98038": 1 "c-met activity": 1 "rrf-1": 1 "contig no.": 1 "solo ltrs *": 1 "collection site": 1 "5": 1 "c-term": 1 "6": 1 "gene set collection": 1 "rrf-3": 1 "7": 1 "8": 1 "9": 1 "3885": 1 "erbb family member": 1 "foldchange": 1 "upstream genes*": 1 "870437": 1 "tracheophyta": 1 "cluster 1 - cog classification c energy production and conversion": 1 "870436": 1 "canis lupus familiaris": 1 "matrix": 1 "wild-type lifespan": 1 "8.75": 1 "associated disease": 1 "predicted function from blast similarity": 1 "treatment/control ratio": 1 "glomerella graminicola": 1 "enzyme/protein name": 1 "est database summary": 1 "homo sa-piens nc_000017.10": 1 "est singletons": 1 "total bases sequenced": 1 "lsppryp": 1 "a": 1 "b": 1 "caenorhabditis sp11.": 1 "d": 1 "accession a": 1 "neurospora crassa": 1 "chromosome gain": 1 "data set": 1 "g": 1 "sequencing success percentage a": 1 "te-13": 1 "genome map": 1 "candidate gene": 1 "nested gene-specific primer": 1 "sid-2": 1 "sid-1": 1 "4513": 1 "total reads sequenced": 1 "relative survival": 1 "g12v": 1 "mature mirna sequence 5' - 3'": 1 "matching alignment uniprot or est accession number": 1 "b cinerea t4": 1 "amplicon length base pair": 1 "shedding enzymes": 1 "endo-cardium": 1 "sequence sense/antisense": 1 "animal with closest homology": 1 "g13d": 1 "135651": 1 "flotillin-1 promoter": 1 "base pair identities bdnf mrna": 1 "ngf-trka p-value": 1 "accession number in transfac db": 1 "cellular function": 1 "3691": 1 "mir name type": 1 "cavia porcellus": 1 "sequences 5??3?": 1 "primer sequence 5? to 3?": 1 "chr": 1 "telomeric repeat": 1 "g12d": 1 "g12c": 1 "fungal species": 1 "materials": 1 "mesembryanthemum crystallinum": 1 "mirna": 1 "cluster no.": 1 "2762845": 1 "rnai clone": 1 "dothideomycetes": 1 "mean contig length bp": 1 "rgc": 1 "strand": 1 "frequency*": 1 "accession term": 1 "50 ?m": 1 "root": 1 "ipomoea nil": 1 "frequency ": 1 "average read length bp": 1 "phosphorylation sequence": 1 "serotypes": 1 "genome size": 1 "43988": 1 "59512": 1 "amino acid sequence identity ": 1 "clone": 1 "name of sirna": 1 "nb1": 1 "4.6": 1 "32612": 1 "nb5": 1 "nb4": 1 "chaetomium thermophilum": 1 "length composition": 1 "subfamily member": 1 "drh-1": 1 "effects in bivalves": 1 "domain alternative nomenclature": 1 "toll": 1 "variation": 1 "32046": 1 "4565": 1 "gibberella zeae": 1 "participant code": 1 "sequence change": 1 "tre consensus sequence": 1 "catalytic class": 1 "consensus sequence": 1 "unique # peptides": 1 "yeast": 1 "sequence length bp": 1 "mutation": 1 "modeled residue range": 1 "name a": 1 "pseudogene": 1 "spot": 1 "cyanothece sp.": 1 "4577": 1 "eukaryotic cell structure": 1 "expression patterns": 1 "conserved": 1 "ipr or amp": 1 "panther ontology pathway": 1 "zebrafish prey genes genbank accession number": 1 "r164q": 1 "peptide name": 1 "syndrome": 1 "zea mays": 1 "log2 oa/untreated": 1 "int family": 1 "c elegans ortholog paralogs": 1 "expected product": 1 "known mirna": 1 "genebank accession no.": 1 "integra-tion within a gene": 1 "redundancy": 1 "putative biological functions": 1 "product": 1 "genbank acc no.": 1 "brachypodium distachyon": 1 "drsh-1": 1 "eurotio-mycetes": 1 "mouse homology": 1 "plant species": 1 "ekl-1": 1 "ekl-4": 1 "ekl-6": 1 "ekl-5": 1 "gen bank accession number": 1 "drh-3": 1 "residues encoded by exon": 1 "putative target protein": 1 "nucleotide identity ": 1 "ontolemur garnettii": 1 "product size": 1 "copies": 1 "underexpressed mirnas": 1 "members": 1 "mouse genbank accession number sequence 5?–3?": 1 "motif": 1 "inside-out": 1 "vsa16 osteoblastic lineage": 1 "genbank accession no a": 1 "average contig length": 1 "yeast gene": 1 "5? gsp sequence": 1 "plenty": 1 "pcr condition": 1 "vertebrates": 1 "pks 1": 1 "#probes": 1 "shrna": 1 "catalogs": 1 "type of cancer": 1 " variation": 1 "rha-1": 1 "apis mellifera": 1 "9823": 1 "# of hits": 1 "gene expression profiling": 1 "acaryochloris marina": 1 "cycle number": 1 "scop id": 1 "mol weight": 1 "suggested function **": 1 "fugu": 1 "sfrs family": 1 "blast e-value": 1 "list size": 1 "primera": 1 "pkr": 1 "6326": 1 "matched transcripts in garlic transcriptome catalog": 1 "length of protein amino acids": 1 "direction": 1 "number of clones": 1 "role/function": 1 "shrna target sequence": 1 "populus nigra": 1 "high quality reads filtered": 1 "noncoding rna profiling": 1 "prokaryote": 1 "hos/143b": 1 "based on template": 1 "caenorhabditis briggsae": 1 "n° contigs": 1 "thielavia terrestris": 1 "35720": 1 "amino acid identities bdnf protein": 1 "sequence c": 1 "life extension ": 1 "activities": 1 "threonine": 1 "25 ?m": 1 "9606": 1 "7425": 1 "protein sequence uniprot #": 1 "monoclonal antibody": 1 "exon": 1 " est coverage ?98 identity": 1 "triticum aestivum": 1 "prey": 1 "5022": 1 "syndecan member": 1 "sequence of primers": 1 "sequence name": 1 "mature apomucin": 1 "transition/transversion ratio": 1 "s991a": 1 "list hits": 1 "140110": 1 "location chromosome": 1 "contigs": 1 "number of drug compounds": 1 "9615": 1 "galectin family": 1 "reference anti-viral function": 1 "total consensus length mb": 1 "482": 1 "b cinerea b05.10": 1 "da mimic": 1 "abbreviated name": 1 "3-day schistosomula": 1 "metallo": 1 "0.0479452": 1 "gene accession number": 1 "annealing temp °c": 1 "fusarium oxysporum": 1 "organism a": 1 "hybridization": 1 "7460": 1 "northern blot": 1 "499": 1 "5039": 1 "cognitive aging effect": 1 "ests represented": 1 "accession no jgi/ncbi": 1 "corrected p value": 1 "real-time pcr primers 5'-3'": 1 "implied": 1 "probe set accession #": 1 "type species": 1 "ascomycota": 1 "median contig length bp": 1 "fragment length bp": 1 "clan": 1 "7227": 1 "target-based class": 1 "drosophila gene name": 1 "rattus norve-gicus nc_005109.2": 1 "source": 1 "caenorhabditis japonica": 1 "theoretical pi": 1 "rt/pcr": 1 "good-quality ests used for contigging b": 1 "xpo-3": 1 "xpo-2": 1 "xpo-1": 1 "pubmed id": 1 "aspartic": 1 "gene/protein expression changes": 1 "100 ?m": 1 "results": 1 "molecular interactions": 1 "sirna antisense sequence": 1 "primer sequences 5? to 3?": 1 "mirwalk": 1 "286": 1 "to tss": 1 "mode contig length bp": 1 "target sequence": 1 "860376": 1 "shrna sequence": 1 "drosophila gene id": 1 "max identity ": 1 "classes": 1 "human gene": 1 "mice": 1 "targets gene": 1 "genome variation profiling": 1 "z-score genome": 1 "adam accession number": 1 "theoretical pi a": 1 "putative functional element": 1 "acc no": 1 "fold gf vs conv": 1 "estimated": 1 "contig bwbrc": 1 "copy number molecules/cell": 1 "taqman assay id": 1 "name of oligonucleotides": 1 "7029": 1 "cys in lel *": 1 "human genbank accession number sequence 5?–3?": 1 "percentage of the": 1 "209285": 1 "bos taurus nc_007317.4": 1 "tissue": 1 "chimp protein kinase and kinase subfamily assignment": 1 "adr-2": 1 "connectivity": 1 "adr-1": 1 "spreading proteins": 1 "pop size": 1 "podospora anserina": 1 "chrosome": 1 "percentage similarity identity to human cav-1": 1 "snp reference": 1 "nrps 2": 1 "ssr motif length": 1 "rde-2": 1 "rde-4": 1 "pcr purpose": 1 "spectral counts a": 1 "overexpressed mirnas": 1 "percentage similarity identity to human cav-2": 1 "go cluster description": 1 "talaromyces stipitatus": 1 "cid-1": 1 "microcystis sp.": 1 "886184": 1 "tf description": 1 "exon size bp": 1 "281687": 1 "?1.086": 1 "oscillatoria sp.": 1 "categories": 1 "mut-16": 1 "class b gpcr": 1 "systematic name": 1 "matches in input n": 1 "7070": 1 "reverse": 1 "melting peak °c": 1 "geneid": 1 "cnidarian encoding rab homologue": 1 "28564": 1 "domain homology": 1 "best blast hit": 1 "3702": 1 "pks–nrps 3": 1 "73501": 1 "p.p.m.": 1 "known functions": 1 "cycles": 1 "dot blot": 1 "elongation": 1 "a digitifera rab protein": 1 "disease name": 1 "affy": 1 "3711": 1 "group": 1 "sequence 5?- 3?": 1 "ests in contigs": 1 "source of nearest type strain b": 1 "gene of interest": 1 "thellungiella halophila": 1 "superkingdoms": 1 "negative class #samples": 1 "growth factor/hormone signaling": 1 "tribolium castaneum": 1 "sus scrofa": 1 "phytochemical class": 1 "biological process": 1 "identification probability": 1 "uniprot toxin accession": 1 "30611": 1 "myceliophthora thermophila": 1 "substitution": 1 "fgf": 1 "cluster ag1478": 1 "conserved mirnas †": 1 "number of contigs": 1 "flotillin-2 promoter": 1 "tf family": 1 "q-pcr": 1 "quantitative or sqrt-pcr primer sequence": 1 "ego-1": 1 "n common ": 1 "descriptors": 1 "sulpiride": 1 "te-2": 1 "enzyme": 1 "product name": 1 "mus muscu-lus nc_000083.5": 1 "haplotype": 1 "c-met genome": 1 "strain accession #": 1 "concentration": 1 "protein type": 1 "te-9": 1 "number of s/tp sites": 1 "vertebrate paralogs": 1 "phylum": 1 "forward primer sequence 5'?3'": 1 "13037": 1 "n25 contig length bp": 1 "phenotype transfer": 1 "cluster iii": 1 "methodology": 1 "3988": 1 "estimated copy number in genome": 1 "go cluster #": 1 "n-term": 1 "transcript number": 1 "31234": 1 "complex": 1 "80884": 1 "hordeum vulgare": 1 "phaseolus vulgaris": 1 "sch": 1 "stomach neoplasms *": 1 "planktothrix rubescens": 1 "signal/control": 1 "an": 1 "nectria haematococca": 1 "probe set id": 1 "brugia malayi": 1 "54126": 1 "genus": 1 "matrix similarity": 1 "template structure pdb accession code #": 1 "plant": 1 "auratus id": 1 "dipteran gene": 1 "5'-3' primer sequence": 1 "protein accession number": 1 "mut-7": 1 "bc": 1 "putative id": 1 "64178": 1 "bg": 1 "percent b": 1 "mut-2": 1 "t thermophila a": 1 "cited": 1 "h sapiens": 1 "probe no *": 1 "protein kinase subfamily": 1 "fragment length": 1 "92637": 1 "protein description": 1 "relative to orf*": 1 "5970": 1 "vsa13 chondrocytic lineage": 1 "schistodb": 1 "effector": 1 "lemna gibba": 1 "native peptide sequence": 1 "caenorhabditis remanei": 1 "o -glyc": 1 "1127": 1 "lyngbya aestuarii": 1 "stage": 1 "hmdd": 1 "3544": 1 "cug-residue": 1 "probe sequence 5'?3'": 1 "78579": 1 "f sequence": 1 "2ros": 1 "g gallus": 1 "naturally presented by ssx+ tumor cells": 1 "pash-1": 1 "length bpa": 1 "y998f": 1 "matrix family murine nrf2 vs ap-1": 1 "cysteine": 1 "caenorhabditis sp9.": 1 "exon silenced": 1 "length identity b": 1 "regulatory element": 1 "arthrospira platensis": 1 "129910": 1 "antibodies": 1 "dtc 7": 1 "reaction class": 1 "gravy b": 1 "class code": 1 "count": 1 "no of est sequences": 1 "tf matrices": 1 "pristionchus pacificus": 1 "5?-3? nucleotide sequence": 1 "radioprotective/radiosensitizing efficacy reference": 1 "number of contigs > 500 bp": 1 "glycine max": 1 "5507": 1 "amplification proteins": 1 "family name": 1 "pop hits": 1 "putative function and species": 1 "putative functions": 1 "protein identity ": 1 "primer/oligonucleotide probe sequence nts": 1 "content": 1 "caenorhabditis sp7.": 1 "1159": 1 "bar type": 1 "evolutionary interpretation": 1 "biological assembly": 1 "gc": 1 "5518": 1 "matrix family human nrf2 vs ap-1": 1 "total reads raw wells": 1 "number of exons": 1 "lm7/ saos-2": 1 "sequences of primers": 1 "chs 4": 1 "autogenous outside-in": 1 "repeat content": 1 "intron length": 1 "gz": 1 "tts length": 1 "mirnas": 1 "arthrospira maxima": 1 "variants affected": 1 "colletotrichum higginsianum": 1 "locus id": 1 "ricinus communis": 1 "748": 1 "molecular species": 1 "endosymbiotic outside-in": 1 "sequence 5?-?>?3?": 1 "specific features": 1 "function/features": 1 "downstream genes*": 1 "human similarity": 1 "1184": 1 "skf": 1 "dataset name": 1 "172108": 1 "dcr-1": 1 "21020": 1 "id": 1 "loxodonta africana": 1 "578.7": 1 "homology to akt1": 1 "number of singletons": 1 "10141": 1 "repeat unit number": 1 "name of primers": 1 "caenorhabditis brenneri": 1 "average contig coverage": 1 "a146t": 1 "base pairs": 1 "smg-6": 1 "conservation": 1 "smg-5": 1 "smg-2": 1 "total megabases mb": 1 "core similarity": 1 "sirna sense sequence": 1 "amino acid identities ntrk2 protein": 1 "4470": 1 "approximate #": 1 "monodelphis domestica": 1 "spot no": 1 "mus muscu-lus nc_000077.5": 1 "snp feature": 1 "t thermophila": 1 "fold change 6 24 72 120 h": 1 "cancertype": 1 "rsd-6": 1 "aspergillus terreus": 1 "mrna species": 1 "primer sequence 5?–3?": 1 "category & gene identity": 1 "library": 1 "341.2": 1 "est coverage region aa ?98 identity": 1 "rsd-2": 1 "rsd-3": 1 "9913": 1 "paracoccidioides brasiliensis": 1 "reads in singletons": 1 "class of nf?b inhibitor": 1 "biological processes": 1 "10116": 1 "product bp": 1 "gen bank accession no": 1 "forward": 1 "nematoda": 1 "subcellular locations*": 1 "nm no.": 1 "gene function": 1 "oryza sativa japonica": 1 "v560g c-kit p-value": 1 "fisher's exact": 1 "est no.": 1 "35883": 1 "homomer": 1 "pdfg": 1 "serine": 1 "poorly conserved sites": 1 "position in gene sequence": 1 "transcription factors": 1 "contig length": 1 "sordaria macrospora": 1 "chromosome loss": 1 "ly": 1 "culture treatment": 1 "reads in contigs": 1 "clone having homology to": 1 "zfp-1": 1 "putative genes a accession no.": 1 "da depletion or receptor blockage": 1 "fluorescence": 1 "mouse cytokines": 1 "most closely related type strain": 1 "baits": 1 "calculated": 1 "position/strand *": 1 "bursaphelenchus xylophilus": 1 "ncbi accession #": 1 "mo": 1 "5111": 1 "consensus id": 1 "average singlet length": 1 "accession no l34049": 1 "utr": 1 "13616": 1 "nc": 1 "nr/svr": 1 "background": 1 "identified protein": 1 "sequence identity between chimp sequence & human sequence": 1 "position": 1 "designation": 1 "peptides sequences lc ms/ms": 1 "eri-5": 1 "s sclerotiorum": 1 "sno/mirna id": 1 "eri-1": 1 "heteromer": 1 "eri-3": 1 "p9": 1 "panther protein class": 1 "designated as": 1 "repeat": 1 "k117n": 1 "snp id": 1 "medicago truncatula": 1 "heptapeptide": 1 "oligomer name": 1 "65472": 1 "macaca mulatta": 1 "bos taurus nc_007324.4": 1 "estimated time of integration mya": 1 "structure": 1 "regulation": 1 "average cluster length": 1 "representative transcript": 1 "beauveria bassiana": 1 "putative identification": 1 "anopheles gambiae": 1 "ph": 1 "mptp?+?ampt": 1 "arabidopsis thaliana": 1 "remarks": 1 "pn": 1 "r2": 1 "10090": 1 "5141": 1 "number of cyclins analyzed": 1 "pt": 1 "non cluster ag1478": 1 "protein band mw": 1 "5145": 1 "counts": 1 "5147": 1 "155978": 1 "secretory pathway": 1 "reverse primer sequence 5'?3'": 1 "observed": 1 "organism homology and respective genbank accession number": 1 "m musculus": 1 "ifn+u0126 response compared to single treatments": 1 "amplicon length bp": 1 "claviceps purpurea": 1 "r sequence": 1 "genomic location": 1 "10": 1 "known family member recognition": 1 "expected length bp": 1 "product manufacturer": 1 "1191866": 1 " excluding 4 and 5 repetitions": 1 "a testudineus": 1 "arthrobotrys oligospora": 1 "365": 1 "accession no .": 1 "6238": 1 "6239": 1 "acyrthosiphon pisum": 1 "6253": 1 "activity": 1 "intron size kb": 1 "accession n°": 1 "cdna sequence genbank #": 1 "number of rnai effector proteins": 1 "7-day schistosomula": 1 "specificity": 1 "accession code": 1 "regulates/target": 1 "sn": 1 "13349": 1 "ss": 1 "rattus norve-gicus nc_005119.2": 1 "proteomea": 1 "name of oligonucleotide": 1 "ta": 1 "id*": 1 "microcoleus chthonoplastes": 1 "383": 1 "# unique gene sets": 1 "tf": 1 "tm": 1 " sl": 1 "z-score": 1 "41": 1 "# unique genes": 1 "cat no/lot": 1 "9785": 1 "kog class": 1 "9544": 1 "exophiala dermatitidis": 1 "6279": 1 "n50 contig length bp": 1 "triad expression": 1 "p-value *": 1 "3? gsp sequence": 1 "ich": 1 "frequency": 1 "similar sequence from blast database": 1 "33178": 1 "adult worms": 1 "5?- 3? nucleotide sequence": 1 "danaus plexippus": 1 "conserved sites": 1 "121759": 1 "substrate": 1 "compounds/plants family": 1 "n75 contig length bp": 1 "9796": 1 "chromosome alterations": 1 "primers sequence 5'-3'": 1 "user id": 1 "overrep genome": 1 "leptosphaeria maculans": 1 "trc identifier": 1 "genotype": 1 "go group": 1 "1155739": 1 "dmats 5": 1 "ancestral bilaterian gene": 1 "human homology": 1 "tetrapoda and younger": 1 "nearest human protein kinase and kinase subfamily assignment": 1 "c -glycosidic tannins": 1 "leotiomycetes": 1 "51453": 1 "genome binding/occupancy profiling": 1 "genbank": 1 "cluster i": 1 "blast score a": 1 "39947": 1 "putative protein function": 1 "mgi symbol": 1 "q61h": 1 "prey groups": 1 "annealing": 1 "candidate binding factor for tre": 1 "all class a gpcr": 1 "taxonomic classification": 1 "mrna secondary structure distance": 1 "common": 1 "n50 read length bp": 1 "definition": 1 "origin of tumor microenvironment derived shed syndecans": 1 ">10": 1 "symbolpathway": 1 "clusters": 1 "genome methylation profiling": 1 "coverage": 1 "tts id": 1 "characteristics": 1 "gene id blast result a": 1 "leptolyngbya boryana": 1 "expression array log2 ratio": 1 "vitis vinifera": 1 "genebank id": 1 "mes-6": 1 "alternative names": 1 "mes-3": 1 "singlets": 1 "uniprot accession": 1 "mes-2": 1 "origin of shed syndecans": 1 "118322": 1 "cluster 2": 1 "118562": 1 "cluster 1": 1 "pseudogene/gene pair": 1 "number of germline variants": 1 "step": 1 "7165": 1 "target mrna": 1 "coding event": 1 "species and gene": 1 "deregulation": 1 "caenorhabditis angaria": 1 "31870": 1 "crocosphaera watsonii": 1 "cordyceps militaris": 1 "cont": 1 "exon length": 1 "maximum coverage": 1 "hypermethyaltion": 1 "method": 1 "synonyms": 1 "preys binding region frequency": 1 "pan troglo-dytes nc_006473.2": 1 "m albus": 1 "samples": 1 "cpg island": 1 "stc 6": 1 "examples": 1 "size nt": 1 "contig bwtrc": 1 "cluster iv": 1 "modeling information": 1 "gender": 1 "ascaris suum": 1 "# of matches": 1 "pan troglo-dytes nc_006484.2": 1 "b cell": 1 "clinical information": 1 "multiple spots": 1 "gbm1": 1 "29760": 1 "identity": 1 "cluster ii": 1 "cyanobacteria": 1 "15368": 1 "moorea producens": 1 "castanea sativa": 1 "l19f": 1 "base pair identities ntrk2 mrna": 1 "1~5": 1 "nasonia vitripennis": 1 "class of genes": 1 "subunit": 1 "leaf": 1 "qmean score *": 1 "candidate genes": 1 "subclass": 1 "obtained sequence 1 /medline sequence 2": 1 "ratio il-1ra/control": 1 "sequence coverage": 1 "176275": 1 "rs ncbi": 1 "conserved transcription factors": 1 "total no of ests sequenced": 1 "flotillin-2": 1 "xrn-1": 1 "xrn-2": 1 "flotillin-1": 1 "pdi homolog": 1 "accession type": 1 "category & gene identity blastx": 1 "625.9": 1 "eri-6/7": 1 "sage": 1 "percent dbsnp": 1 "class a gpcr cluster 2": 1 "class a gpcr cluster 1": 1 "positive class #samples": 1 "conserved gene in a thaliana e-scroe": 1 "sordariomycetes": 1 "cluster 1 no.": 1 "mascot score": 1 "arthropoda": 1 "27337": 1 "function species": 1 "contig brbwc": 1 "gbm2": 1 "3847": 1 "gbm3": 1 "core": 1 "gbm4": 1 "kyse170": 1 "gbm5": 1 "compound/extract": 1 "gbm6": 1 "unique sequences": 1 "expected genome": 1 "t c": 1 "equus caballus": 1 "accession number*": 1 "contig trbwc": 1 "assay id ‡": 1 "gene alias": 1 "cell type/tissue": 1 "purpose": 1 "accession no.b": 1 "pathogen species": 1 "error": 1 "enrichment factor **": 1 "gi no.": 1 "adjusted p-values": 1 "target-based class abbreviation": 1 "sequence 5'?3'": 1 "protein size amino acids": 1 "interleukin": 1 "ajellomyces dermatitidis": 1 "rt-pcr primers 5'-3'": 1 "redundancy a": 1 "metarhizium acridum": 1 "orientation": 1 "pcr product size": 1 "quantity": 1 "library description": 1 "rat megalin gen": 1 "gene accession #": 1 "groups": 1 "lin-15b": 1 "homo sa-piens ab088101": 1 "sequence 5?–3? a": 1 "gene-specific primer": 1 "synechococcus elongatus": 1 "sequence 5? – 3?": 1 
"references": 77 "reference": 27 "p-value": 22 "genes": 20 "gene": 13 "number of genes": 12 "cancer type": 11 "tumor type": 11 "cell type": 11 "p value": 10 "characteristics": 10 "mirna": 9 "disease": 9 "model": 9 "n": 8 "ref.": 8 "category": 8 "functions": 7 "p": 7 "description": 7 "phase": 7 "fold change": 7 "": 6 "drugs": 6 "other agents": 6 "refs": 6 "# of genes": 6 "clinical trails": 6 "study": 6 "treatment": 6 "term": 6 "no pts": 6 "dosage": 6 "symbol": 6 "cells": 6 "type": 6 "response": 6 "year": 5 "score": 5 " of inhibition": 5 "function": 5 "study agents": 5 "results": 5 "name": 5 "parameters": 5 "main results": 5 "cell lines— in vivo models": 5 "methods": 5 "stage": 5 "methods used—comments": 5 "?": 4 "pathway": 4 "evidence": 4 "compounds": 4 "# of proteins": 4 "other tissues affected": 4 "cancer": 4 "localization": 4 "number": 4 "flow": 4 "authors": 4 "all": 4 "comments": 4 "cluster": 4 "first author year reference": 4 "phenotype": 4 "no.": 4 "compounds and concentration/dose tested": 4 "type of alteration": 4 "effects": 4 "treatments": 4 "organ": 4 "virus": 4 "castration resistance": 4 "genes regulated and underlying mechanisms": 4 "study design": 4 "mice with tumors": 4 "percentage of genes": 4 "status": 4 "targets": 4 "avg tumors/lung": 4 "no of genes": 4 "notes": 3 "microrna": 3 "redundancy": 3 "molecules in network": 3 "upregulated": 3 "cell lines": 3 "go id": 3 "duration/onset of diabetes": 3 "highest stage of neoplasia": 3 "target": 3 "tissue": 3 "cancer types": 3 "classifications": 3 "experimental model": 3 "end points": 3 "initiation phase": 3 "post-initiation phase": 3 "enriched functions": 3 "gis1/rph1 ratio": 3 "group": 3 "no genes": 3 "substrates": 3 "chromosome": 3 "fold": 3 "interpretation": 3 "stre a nr/pval": 3 "sample": 3 "other names": 3 "or": 3 "tumors": 3 "incubation time": 3 "number of cells": 3 "expression": 3 "frequency": 3 "no of patients": 3 "ischemic protocol": 3 "model of diabetes": 3 "pds b nr/pval": 3 "number of proteins": 3 "net mfi mfi of cells treated with ab - mfi of cells only": 3 "inhibitor": 3 "examples of genes": 3 "platform": 3 "expression level": 2 "adult enriched genes from rna-seq": 2 "#": 2 "1": 2 "2": 2 "3": 2 "4": 2 "5": 2 "target sites number": 2 "data set": 2 "num of dna methylated genes": 2 "mode of cell death": 2 "overlapping protein-coding genes": 2 "mechanisms of cell death": 2 "institution": 2 "ref": 2 "involving genes b": 2 "oncogene": 2 "in vitro": 2 "ouabain-treated cells": 2 "expected no significant genes": 2 "cytoplasm percentage of cells": 2 "focus molecules": 2 "term go hierarchy level": 2 "wild type": 2 "indication": 2 "also silenced in ebv ?gastric cancers ": 2 "q -value": 2 "no genes in the go term": 2 "consequence": 2 "implications": 2 "cnv": 2 "species": 2 "inhibitors": 2 "clonorchis sinensis": 2 "downregulated": 2 "type of cancer": 2 "nucleus percentage of cells": 2 "virus species": 2 "ros": 2 "full name": 2 "scc-12 cells": 2 "treatment regime": 2 "chemicals": 2 "models": 2 "sub groups of proteins with transporter activity": 2 "e15 enriched genes from rna-seq": 2 "dna methylated genes": 2 "ccn proteins": 2 "trial number country": 2 "involving genes": 2 "observed genes": 2 "dataset": 2 "gro29/gfp cell": 2 "acute leukemia subtype": 2 "fold-change calibration to 10°c": 2 "p -value range": 2 "mir-125b targets": 2 "bonferroni corrected p-value": 2 "gene set": 2 "patient characteristics": 2 "d.med.sci keio university graduate school of medicine": 2 "1985": 2 "number of interactions": 2 "1989": 2 "insulin/igf components": 2 "mirnas number": 2 "strain": 2 "l/mch cell": 2 "# of py events": 2 "normal cells": 2 "semaphorin": 2 "abnormalities": 2 "identified affected pathways and major findings": 2 "characteristic": 2 "proteins": 2 "viral agent": 2 "apoptotic cells of total": 2 "molecular and cellular functions": 2 "transcripts affected by both stimuli": 2 "alterations": 2 "target genes": 2 "s no": 2 "cells treated with k+-free medium": 2 "class": 2 "human": 2 "expression pattern": 2 "annotation cluster": 2 "number of genes fc ?2 p?0.05": 2 "16weeks": 2 "accession number": 2 "construct": 2 "dataset name": 2 "disrupting genes c": 2 "ia": 2 "gene id": 2 "type of mechanical factor": 2 "cancer cells": 2 "candidate cancer related genes": 2 "modifications": 2 "chromosomal location": 2 "publications reference": 2 "outcome measure": 2 "p ": 2 "overlap with 742 cancer genes": 2 " mb": 2 "actual no significant genes": 2 "diseases & disorders": 2 "no": 2 "kegg pathway": 2 "total": 2 "cdna libraries": 2 "carcinogen": 2 "intensity": 2 "number of candidate genes": 2 "gene silenced in ebv+ cancers": 2 "genomic location": 2 "tissues": 2 "t ": 2 "opisthorchis viverrini": 2 "mir": 2 "cell line": 2 "location in mb": 2 "normal keratinocytes": 2 "agent": 2 " of the total genes": 2 "modulation": 2 "delivery method": 2 "cell surface markers": 2 "positive rates levels of expression": 2 "kegg pathway name": 2 "in vivo": 2 "unigene": 2 "functional classification": 2 "number of patients": 2 "tumour type": 2 "samples": 2 "mean±sd": 2 "examples": 2 "consensus mcr": 2 "conditions for expression": 2 "direction of misregulation": 2 "data": 2 "8weeks": 2 "case number & specimen": 2 "biomarker": 2 "md keio university school of medicine": 2 "enrichment source": 2 "other properties": 2 "transporters": 2 "target sites/protein": 2 "pmid": 2 "factors": 2 "animal models": 1 "3 targets": 1 "2 dpi only": 1 "sensitivity to chemotherapeutic agents": 1 "other symbol": 1 "genes encoding chemical compound": 1 "known cancer genes": 1 "strength of ventralization": 1 "independent sample set n?=?13": 1 "cancer syndrome": 1 "outcomes": 1 "herbal composite formula": 1 "potential desirable effect s in hf": 1 "documentation of bbb permeability increase": 1 " ": 1 "insufficiency or drawbacks": 1 "origin of cells": 1 "- thick cover of clouds": 1 "proposed mechanisms": 1 "recombinant proteins and so forth": 1 "gene name": 1 "mean weight of tumors mg **": 1 "number of features": 1 "ligands alternative names": 1 "human tumors or cell types": 1 "6": 1 "7": 1 "8": 1 "9": 1 "notch": 1 "th1": 1 "egfr targeting agents fda-approved for clinical use": 1 "dhacs": 1 "primers": 1 "key event": 1 "th2": 1 "sizes kda or disachharide": 1 "total genes": 1 "reversal by estrogen treatment": 1 "molecules": 1 "putative target genes": 1 "other targeted gtpases": 1 "mechanisms and effectors": 1 "modification of smad7": 1 "result": 1 "the factors derived from keratinocytes": 1 "cells in the tail vein/total injected cells": 1 "stress factor": 1 "number of": 1 "taxon": 1 "high 4~6": 1 "2 dpi & 2 dpr": 1 "candidate cancer genes": 1 "cultivated": 1 "sets": 1 "decreased": 1 "genes mildly expressed": 1 "natural treg": 1 "gpiib": 1 "results of patient studies": 1 "q-value ": 1 "ann v-/pi-": 1 "lncrna": 1 "viral proteins": 1 "rats with adenocarci-noma# ": 1 "participation in biological processes relevant to tumors and pregnancy in mammals": 1 "id50 ?m on c6 cells b": 1 "nucleotide effect on ros production*": 1 "current treatment": 1 "oncogene classification according to their functions": 1 "phase of development": 1 "percentage ": 1 "disease-relevant gene sets found": 1 "compounds environmental toxins": 1 "category sub category or function annotation": 1 "common functions": 1 "overlap ‡": 1 "fold changes": 1 "cpg sites mapping to intergenic regions": 1 "more methylated after weight loss": 1 "study participants": 1 "genes regulated underlying mechanisms": 1 " down-regulated genes": 1 "wt vs mgmt ?/? treated with respect to mam vs vehicle n?=?153": 1 "log phase": 1 "- diminished concentration of 7-dhc in skin advanced age burn victims": 1 "over-representation p -value": 1 "specific therapies for underlying etiology": 1 "tumor incidence": 1 "tumor multiplicity": 1 "initial clustering": 1 "gene ontology": 1 "cd44s of cells": 1 "levels in patient samples and/or function": 1 "referenc e": 1 "rest of mutated genes": 1 "high n?=?29": 1 "clinical studies number of patients": 1 "ires targets": 1 "id50 ?m on u373 cells": 1 "factors/processes mediated by maggot extracts and secretions": 1 "iqgb ?": 1 "go term": 1 "latent genes": 1 "tissue/cell type": 1 "endocrine drugs": 1 "up?regulation": 1 "models of experiments or tests": 1 "methods and experiments": 1 "expression with representative references": 1 "disrupted genes animal": 1 "# of genes >2-fold different": 1 "transport function": 1 "additional csc markers analyzed in combination with cxcr4": 1 "genes in geneset k": 1 "predicted targets": 1 "stimuli inducing production of ros": 1 "mgmt ?/? treated with mam vs vehicle n?=?57 anchored to o 6-mg": 1 "overlap with alternate method": 1 "regulators of mir": 1 "e2f5 excluded from 13 features": 1 "selected genomic alterations and frequency in hgsoc": 1 "additional comment": 1 "down?regulation": 1 "factors inhibiting release of et-1": 1 "producing cell": 1 "roles": 1 "conditions anecdotally linked to ir": 1 "data types analyzed": 1 "go number": 1 "lipid": 1 "selected references": 1 "pre-chemotherapy treated rb tumor": 1 "pcc": 1 "top functions": 1 "may 2007": 1 "urls": 1 "diabetes type": 1 "viable cells ": 1 "gene description": 1 "pak isoform": 1 "functions in rna metabolism": 1 "number of output vl genes based on unique vl cdr3": 1 "genes accession number": 1 "array type": 1 " a genes contributing to acetylcholine control of proteasome mediated degradation 17": 1 "algorithm 1 greedy directed graph sources targets number of edges to add": 1 "lipid species in cells treated with si-con": 1 "signal proteins inhibited": 1 "go-description": 1 "cell functions": 1 "p-akt": 1 "rats with adenoma ": 1 "expression in the immune system": 1 "etiology": 1 "targets and subjects": 1 "p valuea": 1 "clinicopathologic parameters": 1 "microarrays in 0.03 fcs": 1 "issues and facts": 1 "rats with tumors ": 1 "n° of genes": 1 "meth cpg": 1 "claudin gene": 1 "pathway *": 1 "ovariectomy": 1 "acyl acceptor": 1 "main findings": 1 "ca125 excluded from 13 features": 1 "mutants": 1 "wt vs mgmt ?/? treated with respect to mam vs vehicle n?=?60 anchored to o 6-mg": 1 "no of genes fpkm > 0.1": 1 "omim no.": 1 "gains": 1 "sample size/patient type": 1 "additional beneficial effects of drugs and surgical techniques on liver i-r injury other than modulation of autophagy": 1 "hhv-8 genes": 1 "agent -": 1 "name of phytochemicals": 1 "voucher number": 1 "experiment": 1 "common genes implicated": 1 "organ/tissue/cell type": 1 "luigi bolondi": 1 "algorithm": 1 "references no": 1 "phosphorylation reactions": 1 "sam score": 1 "all observed rare cnvs": 1 "s.no": 1 "types of portal hypertension": 1 "cellular phenotype and features of sp cells": 1 "functional interaction": 1 "yeast": 1 "major risk factors for hcc are": 1 "anti-pi3k-pathway drugs": 1 "mutation": 1 "system": 1 "hedgehog": 1 "cancers": 1 "significant genes": 1 "protein id": 1 "bioaccum in humans and env.": 1 "initial concentration nm": 1 "cells/tissue": 1 "genes in overlap k": 1 "ann v+/pi+": 1 "study/reference": 1 "immunological activities": 1 "no change": 1 "swiss prot id": 1 "ann v+/pi-": 1 "target **": 1 "monitoring autophagy by flux measurements 56 ": 1 "prevalence": 1 "total upregulated genes": 1 "total no cells in wound": 1 "references on genomic deletions or duplications": 1 "phd gastroenterology tokyo university school of medicine #16800": 1 "genes with no change in expression": 1 "no of patients ": 1 "- increased skin covering with clothing": 1 "mitochondrial changes associated with apoptosis": 1 "processes p-value": 1 "number of disease samples": 1 "relevant properties": 1 "sp expressing cancers": 1 "effect on pmirglo-let7": 1 "drug treatment": 1 "type of models studied": 1 "amount used to treat cells": 1 "names": 1 "uses negative examples": 1 "percent of g1 cells sd *": 1 "diff.": 1 "mu-4": 1 "relevant reference": 1 "mu-3": 1 "mu-2": 1 "mu-1": 1 "bioassay targets": 1 "non-synonymous snv": 1 "traplantation model": 1 "significant networks": 1 "breast cancer population": 1 "peptide 100 ?m": 1 "secondary necrotic cells ": 1 "auc of cossy using kegg": 1 "mononuclear cells": 1 "iqga ?/ b ?": 1 "number of unique vl genes and number sequenced": 1 "up-/down- regulation": 1 "top mam-associated kegg pathways in mouse brain": 1 "key references": 1 "reason for testing": 1 "members": 1 "epigenetic activity": 1 "concerned pathways in skin cancer": 1 "motif": 1 "percents in total": 1 "go classification of genes up-regulated in stat3 ?/? mice": 1 "nes": 1 "proteins or signaling pathways interact with nek2a": 1 "cytokine": 1 "with dissipation": 1 "tumors formed no of the animals ": 1 "mouse model": 1 "type of detection": 1 "number of cpg sites": 1 "specific functions": 1 "enzyme localization in cells or characteristics": 1 "molecular classification": 1 "channel id": 1 "condition": 1 "result of go termfinder & david level 3": 1 "tissue or cell models": 1 "clinical development": 1 "type of e3 ligase": 1 "l2.5": 1 "amh": 1 "standard conditions": 1 "upregulated v-fos specific candidate genes": 1 "technique": 1 "tsg": 1 "patient no.": 1 "adhesion or junctional proteins regulated by prp c": 1 "number of up-regulated angiogenic genes": 1 "t-mab in mbc": 1 "no of markers": 1 "tumors formed no of animals": 1 "main characterization compared to prp expressing cells": 1 "ddx/dhx nomenclature": 1 "microvascular changes": 1 "application": 1 "detection method": 1 "type of cancer stem cells": 1 "hypothesis": 1 "0 target": 1 "inflammation mediated by chemokine and cytokine signalling pathways": 1 "in the absence of cirrhosis or advanced fibrosis - hepatitis b virus infection - aflatoxin mostly combined with hbv - some genetic disorders such as tyrosinosis - drug induced eg anabolic steroids": 1 "cna * at locus": 1 "adjusted p-value": 1 "ko identifier": 1 "novel genes": 1 "apoptosis of cells": 1 "reported pathophysiological roles": 1 "acc.no.": 1 "department of digestive diseases and internal medicine alma mater studiorum university of bologna": 1 "over-represented cluster": 1 "protein": 1 "- seasonal reduction of days winter": 1 " 35sgtp?•rac1 cpm of control": 1 "tumours with genomic deletions number & percentile": 1 "# of genes on array": 1 "anti-braf positive ": 1 "itafs": 1 "current development": 1 "chemical compound": 1 "molecular change": 1 "tumour samples": 1 "resistance to drugs": 1 "rn a*": 1 "mechanism of interference with autophagy and/or autophagy-regulating pathways": 1 "tfbs associated with conserved pg4 motif within 100 bases": 1 "molecule": 1 "1 target": 1 "intermediate regulators 2–4 hours": 1 "product type dose vol/day study period": 1 "psychiatric observations": 1 "mir binding sites": 1 "purpose of analysis": 1 "auc of dirac": 1 "category of biomarkers": 1 "cancer site primary": 1 "mir-338-3p expression": 1 "down-regulated proteins": 1 "interacts with no of known pd genes": 1 "mitochondrial transmembrane potential ??**** of cells": 1 "general features": 1 "number of animals presented with leukemia": 1 "rank in the results of union network": 1 "mirbase no.": 1 "rank in the results of hprd": 1 "nerve pathology and functional deficits": 1 "micrornas": 1 "reliability of debv": 1 "multi-target assay": 1 "frequently detected genetic/epigenetic alterations": 1 "go category": 1 "gene or group of genes": 1 "multiplicity of infection moi": 1 "p-value relative to infected cells": 1 "less aggressive csclow cells": 1 "ppa": 1 "grading": 1 "radioprotective/radiosensitizing efficacy of extracts/fractions": 1 "egfr expression changes": 1 "collagen": 1 "ex vivo": 1 "formula herbs and components": 1 "jak/stat pathway": 1 "cytotoxicity in rack1 rnai cells": 1 "tumor": 1 "compounds and concentration/dosetested": 1 "tumor size mm n": 1 "targeted exonsb": 1 "'reverse' signaling with representative references": 1 "expression compared to normal tissues": 1 "toxicity": 1 "main category": 1 "bbb in vitro ?? model": 1 "ca 2+ channel": 1 "y279c": 1 "source": 1 "name aliases": 1 "senescence": 1 "human prostate carcinoma": 1 "induced treg": 1 "sample size scc/ctrl": 1 "up-regulated mirna": 1 "compound a": 1 "absolute range ?beta": 1 "keyword": 1 "pathological condition": 1 "mrna coding genes": 1 "dephosphorylation reactions": 1 "- increased skin pigmentation": 1 "resistance mechanisms": 1 "down-regulated mirna": 1 "effects of ros in target cells": 1 "targeted genes": 1 "neurotransmitters and receptors": 1 "normalized no of probes": 1 "mechanism for mutation increasing crc risk": 1 "percentage of genes in cluster p -value via random permutation": 1 "data points min": 1 " frequency in ssc": 1 "number of nucleotides": 1 "type of ovarian cancer": 1 "conditions potentially associated with ir": 1 "no est clones": 1 "cytogenetic": 1 "the relationship with nek2a": 1 "conclusion": 1 "negative": 1 "transition feature": 1 "qrt-pcr in 0.03 fcs": 1 "low n?=?37": 1 "pathways and gene sets enriched by up-regulated genes": 1 "genes in fi network ": 1 "the effect on autophagy": 1 "effect on pml": 1 "strain background": 1 "hypo": 1 "incident of genetic/epigenetic cell cycle alterations": 1 "hours": 1 "traits 2": 1 "as events in sample transcripts": 1 "alternate method": 1 "substance": 1 "number of vh genes used": 1 "pancreatic cancer cells number of migrated cells": 1 "expreimental observation": 1 "no of subjects subject types age years": 1 "pathways number of genes mapped": 1 "timp": 1 "number associated genes 2": 1 "databases for protein/peptide data repository": 1 "hdl": 1 "drug concentration um": 1 "cycle phase or activity": 1 "genes involved in crc": 1 "nuclear receptor": 1 "common sources": 1 "pathogenic roles in ssc": 1 "kwang-hyub han": 1 "hormone expression": 1 "pathways name": 1 "lapatinib": 1 "reported/proposed role of mir in dhd": 1 "jar **": 1 "cells of origin": 1 "tumor size mm": 1 "mediators inhibited by at1 blockade": 1 "upstream signals": 1 "deletion": 1 "type of experiment": 1 "cell-line": 1 "cytokines": 1 "rtks": 1 "gene symbol": 1 "identifier": 1 "number of human homologues": 1 "mode of actions/targets": 1 "km nm": 1 "cells expressing detectable levels of ectopic apkcs": 1 "effect on wound": 1 "clostridium difficile toxins a and b": 1 "methods order": 1 "treatments*": 1 "reported protein interactions from pepcyber": 1 "1982": 1 "initial response genes 0.5–1 hour": 1 "observed rare cnvs not shared a": 1 "conclusion *": 1 "list of genes": 1 "pathways activated": 1 "range of distances between h-bond acceptor functions å": 1 "phosphomotifs": 1 "num of novel genes & stages where these are identified": 1 "number of genes containing motif among the proliferation cluster/entire array": 1 "gain": 1 "tumor size": 1 "signaling proteins with representative references": 1 "all substrates": 1 "total content of mirna target sites": 1 "sequencing platform": 1 "low": 1 "mir targets": 1 "reference number": 1 "technique for detection": 1 "probes": 1 "role of autophagy in viral life-cycle": 1 "hf type to be treated": 1 "cellviability ": 1 " inhibition": 1 "isoforms investigated and references": 1 "skin disorders and insulin resistance ir": 1 "percent of s cells sd *": 1 "go biological process": 1 "number of viable cells sd": 1 "percentage of # genes differentially regulated b/454 *": 1 "percent of g2 cells sd *": 1 "adhesion or junctional proteins found in complexes with prp c or colocalized with prp c": 1 "adverse events": 1 "cancer genes": 1 "# of perturbed molecules": 1 "number genes downregulated 2": 1 "organelles participating in the fusion event": 1 "markers of resistance": 1 "first autoryear reference": 1 "post-chemotherapy treated rb tumors": 1 "num of interactions": 1 "auc of cossy using string": 1 "oligonucleotide synthesis method": 1 "putative genes a": 1 "expression in neurodegenerative disorders": 1 "bio functions": 1 "apoptotic bodies ": 1 "width": 1 "cut-off points ng?ml –1": 1 "membrane protein": 1 "enzymes identified": 1 "with 13 features": 1 "phosphorylation pathways": 1 "frequency in ": 1 "preventive effect ": 1 "cytotoxicity in hela control cells": 1 "# of probes detected": 1 "additional genes with unaltered expression from rna-seq": 1 "pcc metastases": 1 "main applications in virology": 1 "transcription factors and co-regulators of transcription 52": 1 "type i tumors": 1 "frequency common clinical features": 1 "transfection": 1 "intended purpose": 1 "diseases in human phenotype of gene-manipulated animal": 1 "known functions": 1 "enriched goterms": 1 "conserved py events reported in literature to date": 1 "21 pathways uniquely involved in the up-regulated genes": 1 "website/link": 1 "alterations in npc": 1 "mimicked by lysosphingolipids": 1 "hyper": 1 "2626": 1 "function/characterization": 1 "data sources": 1 "target/modality": 1 "decrease in viability mtt - index ± sd **": 1 "egfr expression": 1 "number of mibc features": 1 "proapoptotic changes in membrane***": 1 "canonical metabolic pathways": 1 "type of alterations": 1 "results and conclusions": 1 "methylation": 1 "proteins with greater synthesis in ht29 cells": 1 "clinicopathologic factors": 1 "biological process": 1 "specific functions in immune responses": 1 "sugar": 1 "possible mechanisms of anti-hcc": 1 "produced mainly by": 1 "? 7 genes": 1 "differential regulation in tumors †": 1 "herbs": 1 "primary antibodies and probes": 1 "methods used": 1 "general": 1 "integrins": 1 "- lower altitude": 1 "cellular processes affected and targets": 1 "inversion": 1 "- increased solar zenith angle": 1 "class 3 semaphorin": 1 "pathophysiology in humans": 1 "top ten up-regulated genes": 1 "reference s": 1 "genomic events": 1 "genes up-regulated by the first four lipid-lowering compounds": 1 "clinicopathologic characteristics": 1 "csrbh successful orthologs": 1 "# of genes selected": 1 "chromosome location": 1 "up-regulated genes": 1 "number of input vh genes": 1 "therapy": 1 "fragmentary": 1 "arrayexpress accession": 1 "scoring criteria": 1 "data types being compared": 1 "chemokines": 1 "gpib": 1 "source/reference": 1 "expression of the molecules + positive - negative": 1 "- less reflectivity of surrounding surfaces": 1 "other diseases/effects": 1 "main functions": 1 "interaction": 1 "avg degree": 1 "uses": 1 "neurological disease relevance": 1 "no of probes": 1 "p4 atpase": 1 "number of targets": 1 "anti-diabetic mechanism": 1 "references mentioning xenoandrogenic activity": 1 "genes found by boolean implications": 1 "factors stimulating release of et-1": 1 "type of malformation": 1 "pathways p-value": 1 "type of agents": 1 "upregulated probes positive fc": 1 " +": 1 "snpsb": 1 "microrna targets in os": 1 "viable cells of control": 1 "growth factors or cytokine levels a": 1 " 2": 1 "percents in kog": 1 "total no cells with polarized sfs": 1 "related-neurological diseases": 1 "top 10 canonical maps for 20 mapped proteins": 1 "method for measuring ros production": 1 "duration of post-transplantation experiments": 1 "genes induced by both wnt-1 and b-catenin": 1 "biological functions of the cxcl12-cxcr4 axis": 1 "markers for activated stromal fibroblasts in tumours": 1 "population": 1 "symptoms": 1 "p-mab": 1 "dose": 1 "other name": 1 "1 gene": 1 "phenotype category": 1 "drugs to add to overcome resistance": 1 "proteins that cooperate with ets1": 1 "growth factors and cytokines": 1 "identification of a set of hypermethylated genes from cytological smears": 1 "ba": 1 "late effectors 6–8 hours": 1 "regulators of cell cycle": 1 "grade 3/4 or serious adverse events": 1 "exploitable markers": 1 "differentially expressed genes with pg4–tfbs in promoters": 1 "renal phenotype": 1 "pd cultures": 1 "tumor / rat mean ± sem": 1 "class of drug": 1 "relevant characteristics a /genotype": 1 "ec50 b": 1 "fc? rs expressed": 1 "number of identified proteins affected by t3": 1 "sam score 1": 1 "rmi > 200": 1 "subjects": 1 "number of sample": 1 "effectors of mptp opening": 1 "50 inhibition concentration ic50": 1 "mean age a ": 1 "reduction ": 1 "cdk11p58": 1 "transition": 1 "cs": 1 "no of unigenes": 1 "advantages": 1 "experiment 1-5": 1 "small ring structure": 1 "- increased latitude": 1 "wnt": 1 "enrichment score": 1 "mir-1/mir- 133a-regulated in human cancers*": 1 "autophagic protein": 1 "dna in tail ": 1 "adjp": 1 "methylation array samples n?=?22": 1 "cell types": 1 "targeted region mb": 1 "embryos no.": 1 "mean fold change log2 ratio": 1 "score 1": 1 "drug induced rotation": 1 "dna methylation inhibitors and/or hdacs inhibitors alone or as chemo- or radio-sensitizers": 1 "validated targets": 1 "type of synaptic potentiation": 1 "type of cell": 1 "q506p": 1 "number of genes detected in right ventricle 1": 1 "luciferase activity": 1 "way of cgrp administration": 1 "mushroom species": 1 "antibodies": 1 "secondary genes 2 n=48": 1 "frequently detected aberrant pathway signaling": 1 "protein/peptide database": 1 "genes and locations": 1 "growth factors": 1 "arsenic-transformed cells": 1 "type ii tumors": 1 "study characteristics": 1 "pathways and regulators": 1 "binding receptors with representative references": 1 "count": 1 "pathways": 1 "effect on ires activity": 1 "# pathways by regular resampling": 1 "differentially genes at the expressed 95 confidence level": 1 "fold change fc": 1 "t-mab in neoadjuvant": 1 "proteins in essential processes associated with apoptosis": 1 "pobable effect": 1 "identified affected pathways": 1 "debv": 1 "apoptotic phenotype ": 1 "localisation and function": 1 "anti-her2 drugs": 1 "fe": 1 "number of atoms": 1 "some data on occurrence usea": 1 "hsp": 1 "studies needed": 1 "fisher p value": 1 "lipid species in cells treated with r59022": 1 "title": 1 "interacting protein": 1 "brain region": 1 "95 ci": 1 "number of cpg sites with ?beta?>?10 20": 1 "metastasis sites": 1 "genes strongly expressed": 1 "group of chemical compound": 1 "type of defect location": 1 "iqga ?": 1 "l5.5": 1 "number of genes with implications": 1 "translocation": 1 "medicinal properties": 1 "oncogenes": 1 "recombinant proteins": 1 "3 day": 1 "- increased pollution": 1 "regulators of hgf and met expression": 1 "co-factor": 1 "mirnas": 1 "drug name": 1 "genes presumably down-regulated proteins": 1 "median latent period in days range": 1 "n=82": 1 "genes tested": 1 "known genes": 1 "specific features": 1 "mechanisms of tumour suppression reported": 1 "sample id": 1 "ratio of positive links to total positive and negative links in each subgroup": 1 "other functions": 1 "752": 1 "tight junction proteins alterations": 1 "0 day": 1 "targeted by mirna": 1 "id": 1 "animals": 1 "specific activity arbitrary units": 1 "family members with corresponding numbers": 1 "vaccine type name": 1 "genes implicated in asd copy number variations": 1 "frequency in primary versus metastatic when known": 1 "site per aa ×1000": 1 "antigen": 1 "classification": 1 "kinase family": 1 "expression level in os samples": 1 "degree of resistance": 1 "cd34+ cells": 1 "kinase": 1 "ephs/ephrins": 1 "substrate surfaces": 1 "primary genes 1 n=115": 1 "number of contiguous sequences": 1 "number ": 1 " ros potent oxidants": 1 "numbers of id": 1 "small molecule inhibitors": 1 "proportion": 1 "sets of markers": 1 "clinicopathologic features": 1 "nhrs": 1 "anti-p25 positive ": 1 "- increased time distance in relation to noon morning afternoon": 1 "- increased ozone concentrations": 1 "?fb cultures": 1 "cell of origin": 1 "local names in malay": 1 "specificity ": 1 "tumors / rat mean ± sem": 1 "entropy": 1 "probes and number of signals": 1 "biological processes": 1 "fgfs": 1 "nuclear substrates": 1 "iqgc ?": 1 "cd44v6 of cells": 1 "number of primer probes": 1 "p-values 3": 1 "viral protein": 1 "positive": 1 "dosing": 1 "effects mediated by cocaine": 1 "q-value 2": 1 "2-3 genes": 1 "experimental diet": 1 "# mutgenes": 1 "signaling pathways": 1 "other regions of interestb": 1 "# genes in genome assigned a": 1 "output proteins": 1 "stage of development": 1 "newly detected as events": 1 "complete": 1 "rawp": 1 "causes of fibrosis": 1 "anti-braf positive & anti-p25 negative": 1 "main result": 1 "mass spectrometry based proteomic approaches": 1 "references mentioning antiandrogenic activity": 1 "molecular mechanisms and targets": 1 "gpcrs": 1 "number angiogenic genes": 1 "transcription factors": 1 "use": 1 "p- value of pg4–tfbs enrichment in promoters": 1 "# genes differentially regulated b": 1 "n308d": 1 "putative pathways": 1 "mutated genes": 1 "number of protein spots analyzed": 1 "high": 1 "reported data": 1 "numbers in kog": 1 "special conditions": 1 "ngf induced molecules": 1 "md teikyo university school of medicine": 1 " of sp cells": 1 "patients number ": 1 "expression level and modification of schwann cell proteins": 1 "fraction of cells containing phospho-mek on golgi membranes": 1 "no rats": 1 "author": 1 "phosphorylation in humann diseases": 1 "selection of yeast scd genes with human ortholog scd genes": 1 "the effects on melanocyte": 1 "role and implications": 1 "specific targets": 1 "indels in coding regions": 1 "alteration type": 1 "motif id": 1 "cargo proteins specific to each importin or exportin": 1 "cell dose": 1 "confirmed targets": 1 "rtk type": 1 "tissue expression of receptors": 1 "trial no.": 1 "luciferase activity relative to infected cells": 1 "associated cancer types": 1 "determination of global methylation or histone modifications in tumor or peripheral blood cells determination of hypermethylated gene promoters from serum/plasma dna": 1 "reticulon": 1 " nonfunctional tumors": 1 "literature of crc": 1 "application and recommend dosage": 1 "leukemia type": 1 "functions with representative references": 1 "fold reduction in hc11-?sap vs hc11-fl cells": 1 "extracellular and ligands": 1 "neurodegenerative diseases": 1 "total possible": 1 "p -value": 1 "?/?": 1 "sum for eight pathways": 1 "enriched go annotation": 1 "functions in transcription": 1 "details of tumors": 1 "enrichment ratio": 1 "number of animals per group": 1 "# mutgenes in kegg": 1 "swissprot proteins coverage": 1 "os": 1 "#occurrence": 1 "number focus genes": 1 "missing links": 1 "secondary targets": 1 "compound": 1 "1 day": 1 "environmental cues": 1 "ca2+-dependent effectors": 1 "receptor-type": 1 "jeg **": 1 "genetic manipulations": 1 "binding factors": 1 "nb of": 1 "relative expression a": 1 "low 0~3": 1 "properties": 1 " of all proteins": 1 "genes in cluster with promoter in promoser database": 1 "annotated genes": 1 "iqga ? /c ?": 1 "functions in os": 1 "genes of cytochrome subunits": 1 "d61g": 1 "selection number": 1 "incubatio n time": 1 "panther biological functions": 1 "putative target genes of all clusters": 1 "percentage of # genes in genome a/b": 1 "genetic and environmental factors": 1 "bewo **": 1 "early detection": 1 "percents in cog": 1 "pathways represented": 1 "scale used to assess depression and/or anxiety": 1 "10": 1 "11": 1 "molecular details of their role": 1 "reported mechanisms": 1 " 1 animal models of colorectal carcinogenesis": 1 "hamster bop-treated": 1 "oncogene or tumor suppressor": 1 "semaphorins/ receptors": 1 "snv in splicing sites": 1 "tgf-?": 1 "genes in cluster": 1 "cellular localization of kinases": 1 "professor and chairman of internal medicine yonsei university college of medicine": 1 "confirmed in patient biopsies?": 1 "receptors proposed": 1 "sites per protein": 1 "prognostic/predictive": 1 "genes absent in hmonotlr": 1 "cell elongation index": 1 "all genes": 1 "conditions": 1 "authors and ref nos.": 1 "primary outcome": 1 "prevalence of total thyroid cancers": 1 "20": 1 "# pathways by hypergeometric test": 1 "2 dpr only": 1 "rs": 1 "components": 1 "experimental observation": 1 "effect on sp1": 1 "barriers and obstacles": 1 "mapped genes": 1 "number of cells plated": 1 "different cell types": 1 "analyzed os samples": 1 "examples of specific phenolic compounds researched": 1 " up-regulated genes": 1 "common gene conditions": 1 "sg": 1 "study subjects": 1 "specificity": 1 "inhibition of molecular pathways": 1 "origins": 1 "effects on hbv transcription and replication": 1 "without dissipation": 1 "measurements": 1 "chromatin factors": 1 "number of analyzed genes": 1 "strategies": 1 "zo-1 staining": 1 "classical functions": 1 "class of phenolic compounds": 1 "velocity of the substrate nm.s ?1": 1 "eeq a": 1 "completely disappeared": 1 "a ? 2 fold up-regulated total 532 genes": 1 "prognosis": 1 "effect of viral proteins on autophagy": 1 "characterization of transcripts": 1 "major group": 1 "stage/patients": 1 "monitoring phagophore and autophagosome formation by steady state methods 56 ": 1 "number of probes": 1 "pathophysiology in mice": 1 "expression in cancers": 1 "more methylated before weight loss": 1 "x 2": 1 "number of genes affected by t3": 1 "authors and references": 1 "as events in reference transcripts": 1 "399": 1 "genes and the signal pathways": 1 "more aggressive cschigh cells": 1 "a cytokines and cytokine receptors": 1 "no of animals inoculated": 1 "classification of clustered genes": 1 "targets genes": 1 "recurrent genetic abnormality": 1 "organism": 1 "number of tumor samples": 1 "- use of sun protector": 1 "types of diseases": 1 "cd34": 1 "genotype": 1 "conserved novel py events not yet reported": 1 "fdr q-val": 1 "clique": 1 "sequence n? to c?": 1 "spz type": 1 "first author/study": 1 "gsea": 1 "p -valuea": 1 "culinary": 1 "genbank": 1 "tumor types": 1 "gene symbole": 1 "altered components": 1 "nucant": 1 "cirrhosis or advanced fibrosis mostly due to - hepatitis b virus infection - hepatitis c virus infection - alcohol - nash - congenital disorders such as hemochromatosis wilson's disease etc .": 1 "cocaine-induced behaviors": 1 "cells containing phospho-mek on golgi membranes": 1 "definition a": 1 "treatment time": 1 "markers of response": 1 "2 targets": 1 "number of sites *": 1 "other notes": 1 "genes absent": 1 "mmp": 1 "1985–1991": 1 "ic50 nm": 1 "validated targets in her2 complex": 1 "lipid species in cells treated with si-dgk-?": 1 "weight factors for debv": 1 "rich source": 1 "network diameter": 1 "types": 1 "hormonal activity": 1 "snv in non-coding regions": 1 "rescue rates of ?-t ": 1 "total simulation time": 1 "phosphorylation in animal models": 1 "acyl donor acyl-coa": 1 "tcm pharmacology": 1 "rbh successful orthologs": 1 "80": 1 "downregulated probes negative fc": 1 "location": 1 "effectors of apoptosis": 1 "site of melanocytic lesions": 1 "all n?=?101": 1 "gene functions and epigenetic changes": 1 "deregulation in tumors": 1 "clinical phase": 1 "transgene": 1 "p -value #": 1 "organ tissue": 1 " origin and location enzymatic pathways": 1 "source or references": 1 "values tested": 1 "phytochemicals": 1 "selected agents under study": 1 "materials and methods": 1 "in vitro/in vivo studies": 1 "subtypes": 1 "found in tumors with…": 1 "incidence of rtk mutations/amplification": 1 "loss": 1 "disadvantages": 1 "plants family": 1 "total number of deregulated genes": 1 "wild/": 1 "tumour showing mitotic recombination number & percentile": 1 "primary endpoint/objective": 1 "references mentioning antiestrogenic activity": 1 "efficiency": 1 "total probes": 1 "chracteristic features in vivo": 1 "functions in the nervous system": 1 "clustering coefficient": 1 "most common adverse events all grades": 1 "number genes upregulated 2": 1 "putative functions of the interaction": 1 "cytoplasmic and nuclear substrates": 1 "# pathways by weighted resampling": 1 "related disease s": 1 "sensitivity": 1 "previous ids": 1 "number tumors/number injected": 1 "limits 1": 1 "different stages of wound healing": 1 "genes of glycolysis": 1 "binding partner": 1 "expression pattern on tumors": 1 "tfbms": 1 "md university of tokyo faculty of medicine": 1 "+/+": 1 "roles in bcscs": 1 "m/m": 1 "treatments n?=?6/group": 1 "distribution": 1 "mature mir sequence": 1 "tools": 1 "4 targets": 1 "transgenes": 1 "number of up-regulated genes": 1 "function of ha": 1 "incidence of tumors *": 1 "type of solid cancer": 1 "identity": 1 "diagnostic and prognostic markers": 1 "fly specific": 1 "place": 1 "no of reports": 1 "source type": 1 "conditions strongly associated with ir": 1 "organism/tissue or cells": 1 "observation": 1 "content of mirna target sites in alu s": 1 "nucleus": 1 "high entropy": 1 "genes and alterations": 1 "array condition": 1 " products oxidized lipids and proteins": 1 "the factors that increase the length of sun exposure required for adequate production of vitamin d3 are": 1 "top diseases and functions": 1 "epigenetic changes in crc": 1 "drugs or treatment": 1 "e139d": 1 "candidate genes": 1 "components mutated/activated": 1 "mimicked by apoa-i": 1 "galectin": 1 "common names": 1 "4-6 genes": 1 "representative agents s": 1 "primary subtypes": 1 "part used": 1 "no proteins": 1 "other proinflammatory molecules": 1 "key targets and their functions": 1 "ontomine predicted compound s": 1 "colony numbers a": 1 "genes of interest": 1 "fcrs expressed": 1 " tumor incidence n b": 1 "mechanismb": 1 "reported and novel grb2 interactions": 1 " 35sgtp?•rhoa cpm of control": 1 "strain designation": 1 "anti-braf negative & anti-p25 positive": 1 "kinase inhibitors": 1 "expression in lung cancer": 1 "genes presumably up-regulated proteins": 1 "ld50 ?m": 1 "tag": 1 "numbers in cog": 1 "mechanisms": 1 "putative function/involved pathways": 1 "connexin": 1 "cytoplasmic substrates": 1 "median os months": 1 "qrt-pcr in 3 fcs": 1 "aberration": 1 "possible therapies": 1 "different stem cells": 1 "primary targets": 1 " of positive cells": 1 "number of genes *": 1 "signaling proteins involved in prp c effects or modulated by prp c engagement": 1 "clinicaltrials.gov identifier": 1 "mgmt ?/? treated with mam vs vehicle n?=?362": 1 "edible/": 1 "sequence": 1 "number of mast cells per mm2": 1 "data sources and data types": 1 "techniques": 1 "number of normal samples": 1 "insertion": 1 "cpg sites mapping to known genes unique": 1 "sensitivity ": 1 "egfr mutation": 1 "binding receptors": 1 "k/k": 1 "subtelomeric genes a": 1 "avg of 1 - 2 ±sd": 1 "selected genes 3": 1 "inflamm.": 1 "network": 1 "cytoplasm": 1 "initial number of molecules": 1 "parameter": 1 "treated cell lines": 1 "combination with dna-damaging agents": 1 "main conclusions of the authors": 1 "targeted agents": 1 "use of pharmacologic treatments": 1 "de?regulation": 1 "pt no.": 1 "top 10 go processes for 35 proteins": 1 "srbh successful orthologs": 1 "genetic alteration": 1 "human microrna": 1 "groups": 1 "data gap": 1 "t-mab in adjuvant": 1 "total no injected cells at wound edge": 1 "stagea": 1 "other affected organs": 1 "functions or phenotypes": 1 "observed lipid effect": 1 "domain involved": 1 "full names": 1 "stages": 1 "experimental condition": 1 "references mentioning xenooestrogenic activity": 1 "human tissue and cell localization": 1 
"to30.005": 6 "solv vs.? ns1619": 6 "ncc": 6 "? ns1619": 6 "ti3": 6 "nbc": 6 "to30.01": 6 "solvent": 6 "12 µm": 6 "100 µm": 6 "nd": 4 "target": 2 "hd": 2 "solv.": 1 "glua1 -/-": 1 "calcium channels": 1 "excitable medium": 1 "nitrates": 1 "voltage-gated channels": 1 "nmda": 1 "tetrodotoxin resistant": 1 "sodium channels": 1 "potassium channels": 1 "all ii": 1 "parameter": 1 "ampa/kainate": 1 "glua2 -/-": 1 "wt": 1 "velocity ?m/s": 1 "12 µm ns1619": 1 "tetrodotoxin sensitive": 1 "all i": 1 "calcium channel blockers": 1 "gaba-a": 1 "l": 1 "n": 1 "wtcd1": 1 "r": 1 "t": 1 "100 µm ns1619": 1 "variable": 1 "?-blockers": 1 
"gene": 8 "gr 1/2": 3 "myc 5 ? -sage": 3 "gr 3/4": 3 "s1-pri 5 ? -sage": 3 "nup98-hoxa9": 2 "hoxa9?n": 2 "?n ": 2 "hoxa9": 2 "p-value": 2 "nup98-hoxa9/n51s": 2 "average**": 1 "klf5": 1 "q-value": 1 "bmi-1 expression": 1 "vdr": 1 "myc/max": 1 "gata-4 expression": 1 "egr1": 1 "cebpb": 1 "yy1": 1 "score": 1 "tcf7l2": 1 "cycle ?3": 1 "e2f4": 1 "e2f1": 1 "? 2": 1 "gabp": 1 "klf4": 1 "usf1": 1 "hnf4a": 1 "bhlhe40": 1 "ets1": 1 "cna/survival": 1 "dna/mrna": 1 "tcf12": 1 "gata-6 expression": 1 "gfi1": 1 "tumor evolution": 1 "ctcf": 1 "thap1 †": 1 "elk4": 1 "rxra": 1 "zbtb7a ‡": 1 "zeb1": 1 "ebf1": 1 "tm2*": 1 "pbx3 *": 1 "creb1": 1 "tead1": 1 "cycle 2": 1 "znf281": 1 "patient": 1 "stat1": 1 "prdm1": 1 "elf1": 1 "nr2c2": 1 "cycle 1": 1 "ap2": 1 "ap1": 1 "expression": 1 "tm1*": 1 "hsf2": 1 "hsf1": 1 "mcl1": 1 "hsf4": 1 "bcl-xl": 1 "bcl2": 1 "pathway/systems": 1 "hsf3": 1 "control": 1 "cna/mutations": 1 "?high": 1 "mrna/survival": 1 "srebf1": 1 "sp1": 1 "esrra": 1 "gata": 1 "runx1": 1 "lhr expression": 1 "?low": 1 
"advantages": 7 "disadvantages": 7 "details": 4 "examples": 4 "fcl": 4 "muscle": 4 "3 hours": 3 "summed prediction": 3 "merged": 3 "model": 3 "summed enrichment score": 3 "2 hours": 2 "3": 2 "24": 2 "ingredients": 2 "time hours": 2 "48": 2 "genotype": 2 "48 hours": 2 "go terms": 2 "24 hours": 2 "isoforms studied": 2 "gains": 2 "gene": 2 "losses": 2 "patients": 2 "alpha1-subunit": 2 "revised karyotypes": 2 "6 hours": 2 "embryos examined": 2 "concentration": 2 "arg0 external": 1 "ssns n=90": 1 "cand genes": 1 "neuronal granules": 1 "mode admin.": 1 "score": 1 "des": 1 "phenotypic details": 1 "zfps": 1 "mi3": 1 "mi2": 1 "gefs": 1 "48 hours *": 1 "# validated": 1 "tales": 1 "over/under representation": 1 "12": 1 "go-inducedapoptosis/cell death ": 1 "genes": 1 " disrupted muscles a b": 1 "s.d tgd": 1 "netgrep": 1 "mean tgd": 1 "1": 1 "2": 1 "6": 1 "7": 1 "narada 45 ": 1 "domain": 1 "donors": 1 "cd33 mfi *": 1 "male": 1 "river of origin": 1 "fanmod 41 ": 1 "bn": 1 "virus": 1 "go-induced ?h2ax ": 1 "methoprene bees": 1 "mechanism": 1 "gene symbol *": 1 "data set": 1 "n?=?15": 1 "gaps": 1 "transition": 1 "functional bcr sig": 1 "hilo": 1 "lolo": 1 "pe-nmt": 1 "pathway": 1 "arg0 absent": 1 "unvalidated": 1 "brps": 1 "principle": 1 "missing muscles b": 1 "hugo": 1 "ttaggg": 1 "erbb2/her2": 1 "mean tgd a": 1 "inputs": 1 "arg0 pre-nom": 1 "cell type": 1 "frequency": 1 "saga 27 ": 1 "ref": 1 "hhv s implicated": 1 "50": 1 "female": 1 "heptad": 1 "microarray*": 1 "count": 1 "fdr <0.05": 1 "nurses": 1 "ci value ±sd": 1 "# splicing mutations": 1 "5?-utr": 1 "translocations": 1 " n=150": 1 "50 atu": 1 "name": 1 "geneids": 1 "alignment": 1 "848": 1 "180 atu": 1 "full descriptions": 1 "entrezgene": 1 "arg0 post-nom": 1 "data types analyzed": 1 "cells /conditions studied": 1 "duration": 1 "sig": 1 "chi-square": 1 "expanded": 1 "refseq_dna": 1 "netmatch 26 ": 1 "scope": 1 "70": 1 "total n=125": 1 "72": 1 "n mice": 1 "sum of identified proteins": 1 "lengthbp": 1 "student t test": 1 "normal": 1 " validated": 1 "degrees of freedom": 1 "penetrance a": 1 "sourcename": 1 "significance": 1 "110 atu": 1 "nodes": 1 "allelic frequencies ": 1 "median survival time": 1 "reversion bees": 1 "mirnas": 1 "location": 1 "cx3cl1 scored 0": 1 "drugs combinations": 1 " cells apoptotic": 1 "dbait/vector complexes": 1 "criteria": 1 "sum of down- regulated spots": 1 "vg knockdowns": 1 "significant hypotheses": 1 "type": 1 "90": 1 "dmi3": 1 "antiangiogenic mechanisms": 1 "case": 1 "ligands": 1 "significance hypergeometric distribution": 1 "clinicaltrials gov identifier": 1 "method": 1 "concordance/richness": 1 "s.no": 1 "baseline": 1 "acceptors": 1 "n?=?6": 1 "attachment defects b": 1 "status": 1 "rnai*": 1 "antisense": 1 "sis ubm": 1 "total number of hypotheses": 1 "ssns n=35": 1 "entropy": 1 "feature": 1 "physical interaction*": 1 "hypotheses in submodel": 1 "mirsvr score": 1 "nephrotic syndrome ": 1 "sub-total": 1 "influencing factor": 1 "fdr": 1 "stress granules": 1 "mgi_symbol": 1 "time days": 1 "down-regulated spots": 1 "winter bees": 1 "41a": 1 "ddis": 1 "41b": 1 "num": 1 "cytotoxicresponse": 1 "cycles": 1 "3?-utr": 1 "trial": 1 "abbreviated mechanisms": 1 "erbb3/her3": 1 "uci": 1 "ucn": 1 "up-regulated spots": 1 "uct": 1 "sig phenotype": 1 "gene deregulated": 1 "sequence": 1 "crisprs": 1 "pharmacological effect": 1 "assay 1": 1 "assay 2": 1 "pathblast 37 ": 1 "p value": 1 "tgd p -value b": 1 "stimulatingantibody": 1 "immune system-related oncogenic mechanism": 1 "number of mutations": 1 "cx3cl1 scored 2–6": 1 "technique": 1 "cause": 1 "effectors": 1 "dbait conc.": 1 "foragers": 1 "symbols": 1 "egfr/erbb1/her1": 1 "significant hypotheses in submodel": 1 "sum of up- regulated spots": 1 "general": 1 "diminished": 1 "total": 1 "validated": 1 "live pups": 1 "polymorphisms control ": 1 "specimen": 1 "library type": 1 "strains/ref .": 1 "p-value": 1 "tm-2": 1 "groups": 1 "tm-3": 1 "tm-1": 1 "erbb4/her4": 1 "theoretical distances å": 1 "genotypic frequencies ": 1 "hihi": 1 "duplicated muscles b": 1 "receptor": 1 "application": 1 "gene sub-region": 1 "lohi": 1 "category": 1 "frequencies": 1 "exon": 1 "variance explained": 1 "remarks": 1 
"gene symbol": 169 "gene name": 130 "gene": 107 "fold change": 76 "p-value": 44 "gene id": 39 "reference": 31 "p value": 30 "gene description": 29 "function": 26 "gene title": 25 "symbol": 24 "description": 22 "expression": 13 "fc": 12 "+": 10 "?": 10 "accession number": 10 "fold-change": 10 "pathway": 8 "fl": 8 "category": 8 "*": 7 "ppa": 7 "ba": 7 "gene function": 7 "gene number": 7 "n": 6 "genbank id": 6 "fold regulation": 6 "mirna": 5 "optimal gene sets": 5 "name": 5 "probe set": 5 "entrez gene name": 5 "exclusivity": 5 "total": 5 "p -value": 5 "coverage": 5 "location": 5 "sara": 4 "entrez gene": 4 "accession": 4 "direction": 4 "tissue": 4 "david gene group number": 4 "fdr": 4 "percentage": 4 "chromosome location": 4 "ref.*": 4 "count": 4 "gene families": 4 "fold induction": 4 "microarray": 4 "type": 4 "accession id": 4 "fc 2.0": 3 "references": 3 "#": 3 "qrt-pcr": 3 "2": 3 "3": 3 "5": 3 "7": 3 "tfs": 3 "differential expression": 3 "entrez gene #": 3 "p": 3 "fold change†": 3 "gene ontology": 3 "go term": 3 "?/?": 3 "mcf-7": 3 "probe set 1": 3 "mutation": 3 "mda-468": 3 "gene symbol geneid": 3 "product": 3 "species": 3 "mda-231": 3 "optimal gene combo": 3 "cancer type": 3 "6–12": 3 "egr1": 3 "probeset id": 3 "smad3 mutants": 3 "gene accession number": 3 "tumor": 3 "unigene id": 3 "optimal single gene": 3 "gene name a": 3 "group": 3 "methylation": 3 "kegg term": 3 "chromosome": 3 "transcription factor": 3 "fold": 3 "fc 1.5": 3 "fc 3.0": 3 "go": 3 "affymetrix probe id": 3 "smad4": 3 "snp": 3 "functional class": 3 "official full name": 3 "assay id": 3 "position": 3 "entrez gene id": 3 "mod pos.": 3 "a-cgh ": 3 "negative/weak ": 3 "cell line": 3 "tf": 3 "z-score": 3 "organism": 3 "gene symbols": 3 "0–4": 3 "unigene": 3 "significant tfs": 3 "nearest gene": 3 "?": 2 "q-value": 2 "?": 2 "expression level": 2 "affimetrix designation": 2 "2–56": 2 "public id": 2 "snail expression": 2 "gene ontology term": 2 "genbank accession": 2 "fold change old/young": 2 "annotation": 2 "fold change*": 2 "positive ": 2 "gene location": 2 "665–721": 2 "expression 402-91/et vs 402-91": 2 "incr/decr": 2 "functional category": 2 "microrna": 2 "ad5-hif-1alpha/ad5": 2 "tax wt": 2 "referencea": 2 "family": 2 "1.24": 2 "control group": 2 "s.no": 2 "sequence name 1": 2 "entrezgene id": 2 "1.36": 2 "adj.p.val": 2 "vvsb_cd4": 2 "vvsb_cd8": 2 "fold change ratio ? 2": 2 "increased expression": 2 "folds change": 2 "or 95 ci": 2 "ad5-sihif-1alpha/ad5": 2 "315–487": 2 "ntpdase5 expression": 2 "expression in im": 2 "cacacaca": 2 "twist1 expression": 2 "relative expression in huvec": 2 "expression in gc": 2 "1–340": 2 "full name": 2 "locus link id": 2 "cytoband": 2 "decreased expression": 2 "3.42": 2 "skiw274e": 2 "histology": 2 "protein": 2 "unigeneid": 2 "genes": 2 "estradiol regulated genes": 2 "fold change pt/np": 2 "gene expression": 2 "fold change log base 2": 2 "ko/wt ratio": 2 "gene symbol/affy id": 2 "cell lines": 2 "source": 2 "gene classification": 2 "pubmed id": 2 "p-akt expression": 2 "author year": 2 "maf 2": 2 "hx/nx": 2 "benign vs malignant": 2 "252–330": 2 "gene set": 2 "transcript expression": 2 "smurf2": 2 "study": 2 "methods": 2 "geneid": 2 "vvl_cd4": 2 "wt cxcl8 promoter": 2 "vvl_cd8": 2 "different expression co treatment vs control": 2 "non-tumor": 2 "gse25906": 2 "var.exp 3": 2 "gene name abbreviated": 2 "annotation resource": 2 "alias": 2 "gene description homo sapiens gene mrna": 2 "ssc 1": 2 "tfbs hits": 2 "age/sex": 2 "786-vhl vsv": 2 "entrez gene no.": 2 "probe set id": 2 "gse10588": 2 "e-value": 2 "tgactca": 2 "gene set name": 2 "d1": 2 "d2": 2 "d3": 2 "gene family": 2 "ap-1 mutated cxcl8 promoter": 2 "gse30186": 2 "cn": 2 "gse14722": 2 "functional group gene name": 2 "rank products": 2 "rar ?": 2 "gene names": 2 "1–50": 2 "dchip criteria": 2 "percent binding to smad3 mutants relative to the binding to wild-type smad3 100": 2 "chr no": 2 "mcf-10a": 2 "class": 2 "gene bank": 2 "3–21": 2 "accession no.": 2 "ski": 2 "knockout mouse phenotypes": 2 "gene abbreviation": 2 "rho gtpase targets": 2 "sequences": 2 "moderate/ strong ": 2 "q value ": 2 "smad3": 2 "gse24129": 2 "expression value": 2 "pairwise comparison": 2 "mean fold change": 2 "contig length": 2 "significant p-value <0.05": 2 "fc 1": 2 "cancer gene": 2 "gene onthology category": 2 "gene hits": 2 "regulation": 2 "tax s240p": 2 "ratio c3/c5": 2 "10": 2 "hues_tpm": 2 "14": 2 "fold change lm/pt": 2 "fc microarray": 2 "insulin": 2 "28": 2 "ratio": 2 "modulation": 2 "pathway name": 2 "frequency": 2 "786-vhl emcv": 2 "sip1": 2 "p-value 2": 2 "±sd": 2 "gse4707": 2 "target prediction 3": 2 "bvsl_cd4": 2 "transcription factor c": 2 "definition": 2 "parp1 gene expression per log2 expression unit": 2 "characteristics": 2 "alternative names": 2 "comment": 2 "qpcr": 2 "igf": 2 "mt-pcph expression": 2 "none": 2 "method": 2 "tumour type": 2 "samples": 2 "expression during intestinal differentiation": 2 "adj p-value": 2 "negative ": 2 "predicted target gene": 2 "ratio/fold change": 2 "expression status in crc ??": 2 "mean expression": 2 "array": 2 "functional role in im/gc": 2 "gene identifier": 2 "ref seq": 2 "nuclear crea": 2 "variable": 2 "": 1 "pc346flu2": 1 "goterm over-expressed": 1 "pc346flu1": 1 "year": 1 "kd expression": 1 "sfrp2": 1 "egf": 1 "myc chip": 1 "ezh2": 1 "gene product": 1 "egr": 1 "score": 1 "systemic id": 1 "retinoid analog": 1 "sd expression": 1 "name of gene": 1 "mdm2 p53-binding protein homolog mouse": 1 "affymetrix": 1 "t2-ct": 1 "vim": 1 "her-2 expression": 1 "fisher score b": 1 "androgen": 1 "pool": 1 "epo-r protein expression method": 1 "fold change hx/nx": 1 "p “th1 specific”": 1 "atf3": 1 "rt-pcr fold change": 1 "atf6": 1 "gene set ii ec": 1 "1": 1 "autoimmunity": 1 "stop": 1 "4": 1 "selection": 1 "correlation": 1 "6": 1 "probability **": 1 "8": 1 "9": 1 "tx gene": 1 "inhibitor of kappa light polypeptide kinase ?": 1 "over-represented p-value <0.01": 1 "inhibitor of kappa light polypeptide kinase ?": 1 "primers": 1 "p16 protein expression": 1 "role": 1 "is dist *": 1 "mapk14a": 1 "il-13r ? 2": 1 "high id1 expression b n =61": 1 "mean expression for normal lung": 1 "freq in ngs": 1 "average velocity ?m/s": 1 "ease term": 1 "transcript id": 1 "regulator gene id": 1 "fi partner": 1 "^": 1 "matrix family murine atf2 vs elk1": 1 "a": 1 "pds p-value": 1 "gene 2": 1 "b": 1 "gene 1": 1 "mrp-3": 1 "end gene": 1 " c log2 ratioamela/line": 1 "ensgalg00000019514": 1 "relative high expression": 1 "hcc-ci-2": 1 "gene expression a": 1 "l": 1 "thc": 1 "matrix family human atf2 vs elk1": 1 "?6.40": 1 "up pc-": 1 "nsclc n?=?160": 1 "abi assay": 1 "isa": 1 "expression fold-increase": 1 "nease gene enrich": 1 "r-coefficient": 1 "jun proto-oncogene": 1 "combined": 1 "fold changes": 1 "cacna1g cyp19a1 cyp1b1 prkcd rasl11a": 1 "pc-related": 1 "hopx expression": 1 "acc": 1 "specie": 1 "gene accession id": 1 "all identified interactions": 1 "fc-rb": 1 "ncbi": 1 "suppressor of ikbke": 1 "protein structure": 1 "p14arf status": 1 "ref": 1 "others": 1 "serine/threonine-protein kinase b-raf": 1 "hypoxia": 1 "cellular function": 1 "rev": 1 "other aliases": 1 " samples": 1 "hg-u133a-id": 1 "chr": 1 "qpcr confirmation": 1 "cxcr4 expression": 1 "? 1 -ar expression score": 1 "function/category": 1 "ctcf": 1 "tduc": 1 "b-all ": 1 "cancer kinds": 1 "percentage of positivity": 1 "locus link": 1 "genetic abnormality": 1 "frequency ": 1 "mlh1 expression": 1 "predominant polymorphism investigated": 1 "early growth response 1": 1 "pathway †": 1 "pc346dcc": 1 "pathway/ gene family": 1 "amino acid change": 1 "significance": 1 "# of corr genes.": 1 "786-0 emcv": 1 "sorafneib": 1 "gb_accession": 1 "pdcd4 expression": 1 "ifng1-2": 1 "p-value for rt-pcr": 1 "ykl-40": 1 "localization": 1 "egfr blockade fold change": 1 "prognostic relevance": 1 "up myc pc-": 1 "sampling size": 1 "nuclear expression": 1 "mdm2": 1 "number": 1 "clone length": 1 "ndrg4": 1 "experiment": 1 "line2-t500": 1 "ap-1 complex subunit mu-1": 1 "down-regulation": 1 "log ratio": 1 "pdpn*": 1 "infection model": 1 "cll": 1 "tissue study": 1 "ikbke": 1 "p53 gene sequence": 1 "logfc": 1 "ikbkg": 1 "1.34": 1 "pc346c": 1 "1.35": 1 "ahr": 1 "pathway total gene count": 1 "tnf": 1 "tax d24g": 1 "nbc": 1 "1.29": 1 "1.28": 1 "f344_sal": 1 "ar low": 1 "cell proliferation apoptosis migration adhesion and angiogenesis": 1 "expression patterns": 1 "retinoic acid signaling": 1 "start culture": 1 "1.45": 1 "1.46": 1 "1.42": 1 "icc profile": 1 "hypoxia /normoxia": 1 "yy1 expression": 1 "top 49 th1 specific genes": 1 "sub-network": 1 "expression in macrophages": 1 "creb": 1 "ct galectin-1 sirna-transfected sigal1": 1 "p16 gene sequence": 1 "1.53": 1 "1.50": 1 "log?fc*": 1 "comparison/contrast": 1 "1.49": 1 "mart-1": 1 "wt-1": 1 "clinical and pathologic character": 1 "gene symbol pig": 1 "promoter sequence": 1 "cndp2": 1 "dac 10nm": 1 "ccl2": 1 "normalized correlation weight": 1 "ccl3": 1 "nease pvalue diff": 1 "rassf1": 1 "affymetrix probe": 1 "gata4": 1 "e2f4": 1 "1.59": 1 "gata5": 1 "a3y id": 1 "pten": 1 "her-3 cytoplasmic expression": 1 "int 407 mean±s.e.": 1 "control maf": 1 "taqman assay-id": 1 "ouabain µm": 1 "her-3 membranous expression": 1 "sox 11": 1 "up pho-": 1 "nlgn4x*": 1 "1.69": 1 "gp100": 1 "t24": 1 "type of cancer": 1 "alternative gene names": 1 "probesetids": 1 "gene_id": 1 "probe-set id": 1 "mda-ci-10": 1 "days post reinfection": 1 "amp": 1 "top 50 th2 specific genes": 1 "30-day mean": 1 "3.23": 1 "whsc2": 1 "caco-2 mean±s.e.": 1 "ref.": 1 "tfap2a binding score": 1 "list size": 1 "stimulation": 1 "decision attributes classes": 1 "description genedb": 1 "comments": 1 "class label": 1 "up-regulated": 1 "probe location": 1 "1.94": 1 "fold reduction/induction": 1 "perk-1": 1 "type 3 gene sets": 1 "tax d247g": 1 "gtse1": 1 "genbankaccession": 1 "fold change of gene expression relative to control z": 1 "exon": 1 "expression status": 1 "7b6-o vsv": 1 "a-t": 1 "covariateb": 1 "cd34+ cb": 1 "list hits": 1 "mechanism proposed": 1 "expression upregulation after 5azadc": 1 "rhos 95 confidence interval": 1 "nis": 1 "growth promotors upregulated by sod3": 1 "published year": 1 "protein expression": 1 "acvr1b": 1 "ptgs2": 1 "fold increase": 1 "transcript size kb": 1 "cyclin d1 expression": 1 "prame": 1 "3.57": 1 "ensembl id": 1 "epithelial mouse model genotype": 1 "gene expression regulation": 1 "mda-ci-2": 1 "relative low expression": 1 "methylation ": 1 "b2-ct": 1 "sox10": 1 "decrease of gene expression": 1 "expression in pbirf5 vs pbabe": 1 "column id": 1 "reduced gene counts": 1 "epo-r gene expression method": 1 "ensgalg00000003959": 1 "pea aphid gene s": 1 "nes*": 1 "ap-1": 1 "binding affinities ed50 in nm against rars and rxrs": 1 "fold alterations": 1 "chipseq peaks": 1 "mirna gene": 1 "promoter methylation ": 1 "pos": 1 "biocarta under-expressed": 1 "type 4 gene sets": 1 "go category": 1 "mechanism": 1 "bmi1": 1 "5.15": 1 "fold log ad/n": 1 "...": 1 "stre p-value": 1 "nucleotide sequence": 1 "sp1 transcription factor": 1 "clinicopathological features": 1 "no of cases": 1 "target exons": 1 "empty vector ?ct": 1 "gene description gene down-regulated in lung ad": 1 "hr 95 ci": 1 "scaffold coordinates": 1 "?3.06": 1 "tfap2a binding sequence": 1 "methylation level": 1 "p-value_bh": 1 "microarray atf2?/?/wt": 1 "ncbi gene reference": 1 "3.85": 1 "aryl hydrocarbon receptor nuclear translocator": 1 "top 18 th0 specific genes": 1 "p16": 1 "p/s": 1 "wt ar": 1 "cytoplasmic": 1 "mba468": 1 "clip2*": 1 "results": 1 "hmga1": 1 "hmga2": 1 "3.95": 1 "biopsy id": 1 "ensgalg00000012865": 1 "relevance to human pathologies": 1 "rac1": 1 "start gene": 1 "casp ase8": 1 "285": 1 "prame mrna expression": 1 "retinoic acid": 1 "cnot6 nap1l4 nol4 nop5/nop58 snrk tcof1": 1 "mba231": 1 "gist profile": 1 "ratio flt vs grd": 1 "ctnnb 1kras /wt": 1 "fold change 2???ct": 1 "mechanism of down-regulation": 1 "expressiona": 1 "types of ovarian csc/tics": 1 "condition attributes genes": 1 "hnrpl": 1 "tmeff2": 1 "human gene": 1 "gnt-v": 1 "pvalue": 1 "genes up-regulated during hcc": 1 "targeted gene": 1 "scrambled sirna sigal1": 1 "negative": 1 "down myc pho": 1 "kegg_pathway": 1 "incubation medium": 1 "stat1": 1 "increase of gene expression": 1 "underexpression": 1 "target/s": 1 "mecp2": 1 "folds difference": 1 "ensgalg00000009474": 1 "disease": 1 "traits 1": 1 "cpg no.": 1 "foldchange * ": 1 "mean gene expression in +hc/+egf": 1 "start": 1 "primers 5? to 3?": 1 "er? mean gene expression": 1 "gistic q value": 1 "p16 transcript expression": 1 "yfc": 1 "wild-type": 1 "model/study level": 1 "gene and function": 1 "fdr ": 1 "2-day mean": 1 "gene name 1": 1 "dna binding site tfbs": 1 "mda-flu-ci": 1 "t877a ar": 1 "splicing index": 1 "p53": 1 "mean gene expression in -hc/+egf #21": 1 "dnmt1": 1 "vrk1 nuclear staining": 1 "stitch 4.0 drug inhibition": 1 "nom p-val": 1 "pop size": 1 "gene discription": 1 "chromosomal localization": 1 "rgs4": 1 "days post infection": 1 "fold change pt/np*": 1 "median fold change range": 1 "tnf ?": 1 "p63": 1 "verification method": 1 "tumor sample": 1 "gadd45a": 1 "rxrs": 1 "fold expression difference": 1 "ssx-2": 1 "cntf-treated": 1 "?1.93": 1 "nfkb2": 1 "target/function": 1 "msh2 expression": 1 "prkrip1 rpl18a": 1 "primer sequence 5?-3?": 1 "ensgalg00000002495": 1 "entrez gene#": 1 "mage-a1": 1 "ap1m1": 1 "gain": 1 "rnai": 1 "hiv_sal": 1 "crhbp nr3c2": 1 "livin": 1 "expression score": 1 "experimental factor": 1 "ctnnb1 pten / wt": 1 " b log2 ratioamela/mela": 1 "low expression": 1 "funding": 1 "target mirna": 1 "activation by": 1 "lps": 1 "mrna/protein": 1 "lm/pt": 1 "sart-2": 1 "sart-1": 1 "sart-3": 1 "histone substrates": 1 "hox gene": 1 "hif": 1 "probe id": 1 "malignant": 1 "cluster theme": 1 "probe id ilumina": 1 "chchd2": 1 "disease name": 1 "gene set i cna": 1 "p.value": 1 "786-o emcv": 1 "er? mean gene expression": 1 "intracellular bapta µm": 1 "gene title annotation": 1 "frequency in crapome": 1 "strain": 1 "ouabain": 1 "egfr expression": 1 "gene n": 1 "gene symbol gene title": 1 "transcriptional regulator": 1 "effect": 1 "biological process": 1 "change viability": 1 "chi3li*": 1 "trf1": 1 "^^": 1 "cases n": 1 "mutated gene": 1 "slc01c1*": 1 "insert": 1 "relative expression levels": 1 "rt-pcr": 1 "patient": 1 "reference s": 1 "gene nomenclature": 1 "specimen": 1 "kras pten / wt": 1 "role on gene expression": 1 "ssc 3": 1 "mbh + hpc + amd": 1 "process": 1 "camp-responsive element-binding protein 1": 1 "camp-responsive element-binding protein 5": 1 "stimulus": 1 "target score": 1 "differential expression of tf genes": 1 "hcc-flu": 1 "approved targeted therapy": 1 "wt-ras cells": 1 "fold decrease": 1 "cygb": 1 "expression **": 1 "gene bank accession": 1 "balb +": 1 "egfrviii": 1 "cpxv": 1 "cholesterol metabolism other steroids": 1 "tumor type": 1 "up myc pho-": 1 "7.83": 1 "cytoplasmic expression": 1 "bal": 1 "epha2": 1 "junb": 1 "dmog": 1 "cons per gene": 1 "actn1": 1 "fbj osteosarcoma oncogene": 1 "yfca": 1 "product size bp": 1 "ebv latency": 1 "transcript cluster id": 1 "rank": 1 "gene name or description": 1 "subnetwork *": 1 "genebank accession": 1 "aim-2": 1 "log2fold expression": 1 "elk1": 1 "chromosomal": 1 "af": 1 "sox 2": 1 "hcc-flu-ci": 1 "hs169": 1 "profile": 1 "type 1 gene sets": 1 "pb/bm controls": 1 "smad4 negative": 1 "bcan*": 1 "nease term": 1 "hdac8": 1 "?5.51": 1 "7.91": 1 "hdac1": 1 "gene symbol genbank 2": 1 "hdac2": 1 "hdac3": 1 "smad4 positive": 1 "unexpressed": 1 "gene name gene symbol": 1 "bb": 1 "subgroup": 1 "ect2 mrna expression": 1 "galt-3": 1 "gene set pathway": 1 "genomic feature": 1 "tert": 1 "tert promoter mutation": 1 "ensembl gene id": 1 "epo-r antibody": 1 "virus": 1 "trp-1": 1 "characteristic": 1 "tumor cell line": 1 "tf class": 1 "trp-2": 1 "aryl hydrocarbon receptor": 1 "citations": 1 "edge p value b": 1 "down pho-": 1 "braf": 1 "hpc + amd": 1 "myc repressed": 1 "protein description": 1 "chip": 1 "probe ilmn_": 1 "pathway/probe id": 1 "vacv": 1 "sample": 1 "jund": 1 "stage": 1 "hypoxia/normoxia": 1 "pth-rp": 1 "sike 1": 1 "t1-ct": 1 "stre per promoter": 1 "pagerank": 1 "dnrii + ras/ras-slga": 1 "rar ?": 1 "contextual gene set": 1 "jun": 1 "rar ?": 1 "tnfa": 1 "dir": 1 "moderate/strong ": 1 "mcf7": 1 "f/tf": 1 "mirna expression in hcc": 1 "endogl1 ppp4r2 sap30l": 1 "hp1?": 1 "gene name or target gene name": 1 "fosl1 fra-1": 1 "survivin": 1 "caspase-3 expression": 1 "pathways": 1 "786-o vsv": 1 "target genes": 1 "er": 1 "mean expression for ad lung": 1 "log2ratio": 1 "expression ratio a": 1 "t-all ": 1 "cdh1": 1 "t3-ct": 1 "pop hits": 1 "gene expression arbitrary units": 1 "for": 1 "epb41l2 tmepai": 1 "fos": 1 "brain region": 1 "abca1 dhrs2": 1 "largest size ssc/control": 1 "promoter motifs": 1 "genomic position": 1 "rate": 1 "95 cl": 1 "translocation": 1 "down pc-": 1 "oncogenes": 1 "h2r": 1 "regulation of gene expression x?fold vs control": 1 "nodes": 1 "wt1": 1 "go term and gene symbol *": 1 "erbb2 blockade fold change": 1 "f/c": 1 "b-cyclin": 1 "gene ontology/accession number": 1 "sample id": 1 "ar status": 1 "amplicon length": 1 "down ash1-": 1 "ppp1r15a": 1 "chr.": 1 "cyclin d1 transcript expression": 1 "cbd+lps": 1 "procadmutant": 1 "overexpression": 1 "dram": 1 "prl-1 overex ?ct": 1 "dnmt3a": 1 "melk": 1 "jun b proto-oncogene": 1 "17p allelic loss": 1 "gene predictions": 1 "cyclin d1 protein expression": 1 "rt-pcr p-value": 1 "2.00": 1 "p-value†": 1 "foxa1": 1 "fc-p53+rb": 1 "htert": 1 "ebv gene transcription *": 1 "fmr1": 1 "alteration": 1 "tissue/cell line/type": 1 "nfkb": 1 "hiv_nic": 1 "status": 1 "**": 1 "included in hg-u133 array": 1 "fold changema plzf k": 1 "microarray data": 1 "probe id agilent 44 k": 1 "probeid": 1 "targets": 1 "fabp7*": 1 "maf": 1 "inflammatory chemokines": 1 "line3-t200": 1 "sma i": 1 "map": 1 "# gene": 1 "ube2v": 1 "cdk6": 1 "maff": 1 "mafk": 1 "runx3 expression positive *": 1 "positive": 1 "tyrosinase": 1 "up myc ash1": 1 "fisher's exact": 1 "mbh": 1 "sp1": 1 "human gene id": 1 "human cns disease": 1 "hedgehog-related": 1 "rosiglitazone": 1 "ganglioside gd3": 1 "estrogen": 1 "nr2e1*": 1 "transcription factors": 1 "hbc #": 1 " of microarray de b": 1 "c-jun": 1 "chuk": 1 "? 2 -ar expression score": 1 "murine gene id": 1 "rtcgd database": 1 "stage/dna methylated genes identified as tfs": 1 "mt": 1 "pathophysiological mechanism group": 1 "up-/down regulation": 1 "kegg_id": 1 "probe-set id/direction": 1 "scramble vs pax8 adj p -value": 1 "creb5": 1 "acc #": 1 "no": 1 "homdel": 1 "log fold change": 1 "nr": 1 "nuclear a": 1 "systematic no.": 1 "c3h +": 1 "2.55": 1 "kegg pathway": 1 "creb1": 1 "corticoid-related": 1 "microarray fc": 1 "gene enrich": 1 "myc db": 1 "p_perm": 1 "s/n": 1 "1/2": 1 "mgmt expression": 1 "clinicopathological factor": 1 "z-score a": 1 "mutated": 1 "uniprotkb": 1 "description david": 1 "ifnphi3": 1 "fold change lm*/pt*": 1 "ctnnb 1 /wt": 1 "down myc pc-": 1 "fusion gene": 1 "ras cl.4/ras-slga": 1 "hif-1 ? expression": 1 "clinicopathological characteristics": 1 "remarks": 1 "r2": 1 "pathway gene": 1 "gudmap": 1 "gene ontogeny": 1 "accession no": 1 "2.76": 1 "dnrii/control": 1 "translation factors": 1 "2.75": 1 "paip1": 1 "pathway/function/disease": 1 "c1orf34 qsox6 sncg stc2 fasn": 1 "p value lpe t-test": 1 "p “th0 specific”": 1 "creb1 hmg2l1 hopx meis1 mycn neurod1 pcbp3 tox2 znf423": 1 "lightdamage": 1 "type 2 gene sets": 1 "ferret-likegene id c": 1 "sma iii": 1 "tissues": 1 "physical interaction": 1 "# edge": 1 "accession no .": 1 "cytosolic non-specific dipeptidase": 1 "primer set": 1 "chromosome locus": 1 "v$tfbs": 1 "transcription complex/signaling pathway": 1 "gleason score": 1 "t4": 1 "ny-eso-1": 1 "?2.18": 1 "snai1": 1 "?2.16": 1 "freq": 1 "map3k7": 1 "name of lncrna": 1 "experiment reference": 1 "2.98": 1 "relation to disease": 1 "sf": 1 "sequences 5?3?": 1 "mir": 1 "benign": 1 "high expression": 1 "relationship": 1 "sp": 1 "stitch 4.0 activation": 1 "fc-p53": 1 "six3 expression": 1 "p value *": 1 "associated gene": 1 "jun d proto-oncogene": 1 "control cells": 1 "il1 ?": 1 "tlob": 1 "4.53": 1 "il1b": 1 "p-value †": 1 "systematic gene notation": 1 "redundant gene counts": 1 "mef2a": 1 "aacacacat": 1 "details": 1 "gene entrez id": 1 "up": 1 "hif-1b/arnt": 1 "phloridzin-dha": 1 "degree": 1 "refseq": 1 "camta1 dip2a fosl2 ndrg4 sox6 syf2 thoc4 tbr1": 1 "wt vs pax8 adj p -value": 1 "finding": 1 "fdr q-val": 1 "p adj value": 1 "plzf cis -element": 1 "cgi region": 1 "aom fold change": 1 "genbank": 1 "k+-free": 1 "r.fold": 1 "her-4 cytoplasmic expression": 1 "gene expression changes average fc a": 1 "her-4 membranous expression": 1 "growth promotors downregulated by sod3": 1 "mouse endophenotype": 1 "art-4": 1 "art-1": 1 "af/tf**": 1 "hetloss": 1 "mcf-7-mir-155 3?utr shortening": 1 "gene set iii cna + ec": 1 "snp 2": 1 "b3-ct": 1 "affymetrix probe set id": 1 "histone deacetylase/chromatin remodeling/nucleolar organization": 1 "wt": 1 "summary": 1 "aldh1a2 anxa6 lmo2 lmo3 nbl1 ndrg4 pld1 rhob rp6-213h19.1 sacs tnr": 1 "dnmt3b": 1 "atn/recovery": 1 "drosophila gene": 1 "t-test": 1 "mef2d": 1 "dna methylation": 1 "p53 expression": 1 "hcc-ci-10": 1 "motifs": 1 "steroids": 1 "prl1-overex signal": 1 "activating transcription factor 1": 1 "thc+lps": 1 "culture/treatment conditions": 1 "ets1 shrna": 1 "# cancer gene": 1 "# of corr genes": 1 "aqp1 camk2d clmn fam5c marcks meis1 mycn pdgfra pld1 ube2d3": 1 "gene expression in -hc/-egf #1 cells non-treated": 1 "protein effect": 1 "spotted": 1 "alpha-actinin-1": 1 "sz maf": 1 "subpathway": 1 "oncomine name": 1 "ovarian carcinoma": 1 "target rho ": 1 "mek inhibition": 1 " ca2+i nm": 1 "examples": 1 "runx3 expression negative *": 1 "activating transcription factor 6": 1 "log 2 ratio fold change": 1 "activating transcription factor 3": 1 "antisense": 1 "ensemblid": 1 "aza 100nm": 1 "v-maf musculoaponeurotic oncogene homolog k": 1 "epigenetic alteration": 1 "v-maf musculoaponeurotic oncogene homolog f": 1 "frequency #": 1 "clinical value": 1 "methy * w/y": 1 "replication": 1 "post-chemotherapy/pre-chemotherapy": 1 "clinico pathological features": 1 "time of peak expression ? mrna min": 1 "gene ontology biological process": 1 "coiled-coil-helix-coiled-coil-helix domain-containing protein 2 mitochondrial": 1 "re1 site": 1 "rb1 protein expression": 1 "fc-a": 1 "ests": 1 "mirna expression": 1 " gene enrich": 1 "up ash1-": 1 "percent of the tgf-? inducibility provided by wild-type smad3": 1 "ar high": 1 "fold change linear": 1 "her2": 1 "transcription factors and regulators": 1 "diploid": 1 "brain expressiona": 1 "b1-ct": 1 "gage-1": 1 "h2r p -value": 1 "official symbol": 1 "egf?+?dmog": 1 "myc activated": 1 "affymetrix gene": 1 "relative expression mir-155/vector": 1 "pds per promoter": 1 "sequence": 1 "insertion": 1 "empty vector signal": 1 "p “th2 specific”": 1 "multipath gene promoters": 1 "predicted localisation": 1 "cxcl12 expression": 1 "f344_nic": 1 "shank3": 1 "down myc ash1-": 1 "family information": 1 "validated by": 1 "mpxv": 1 "atf1": 1 "mda-flu": 1 "example gene symbols": 1 "relative expression in co-cultures vs mono-cultures ccd mda/ccd ccd": 1 "nrcam*": 1 "parameter": 1 "cc6": 1 "p - value": 1 "log2 fold change": 1 "traf6": 1 "cbd": 1 "end gene description": 1 "genetic alteration": 1 "edges": 1 "unchanged": 1 "nlgn1": 1 "nlgn3": 1 "thymocyte population": 1 "gene expression in -hc/-egf #1 cells 1 nm e2": 1 "cd133": 1 "quiescent versus tgf- ? 1+egf": 1 "pt/np": 1 "assay": 1 "transfer culture": 1 "library location": 1 "therapeutic/silenced/upregulated gene": 1 "absent/low id1 expression a n =58": 1 "locus": 1 "start gene description": 1 
"1": 38 "apoptotic": 28 "anti-apoptotic": 26 "?": 14 "3": 12 "pten": 10 "mtorc1?": 9 "akt": 8 "pak1": 8 "pak4": 8 "2": 7 "p53": 7 "hsa-mir-145": 6 "?3.68": 6 "hsa-mir-494": 6 "nfoxo1?": 6 "mtor": 6 "2.73": 6 "?": 6 "?": 6 "reference": 6 "ras": 5 "?2.04": 5 "n": 5 "p": 5 "0.001522": 5 "0.001353": 5 "hsa-mir-663": 5 "hsa-mir-665": 5 "p21": 5 "0.004048": 5 "?3.19": 5 "2.03": 5 "total": 5 "cell line": 5 "wt": 5 "references": 4 "raf": 4 "positive ": 4 "?2.59": 4 "erk": 4 "ref.": 4 "hsa-mir-675": 4 "pten +/+": 4 "ic50 µm a": 4 "group": 4 "p value": 4 "ck2?": 4 "hsa-mir-146b-5p": 4 "mek": 4 "dyrk1b": 4 "dyrk1a": 4 "dyrk2": 4 "apoptotic/ anti-apoptotic": 4 "hsa-mir-3185": 4 "negative ": 4 "sphk": 3 "0": 3 "4": 3 "6": 3 "pval": 3 "egfr": 3 "ck2": 3 "?2.75": 3 "?2.77": 3 "fgfr3": 3 "p-value": 3 "p38": 3 "disease": 3 "nb_in_ref": 3 "gene": 3 "pakt": 3 "p73": 3 "hsa-mir-602": 3 "term": 3 "pp2a": 3 "mek1": 3 "survivin": 3 "0.002702": 3 "peg10": 3 "ic50": 3 "?3.33": 3 "construct": 3 "positive": 3 "2.18": 3 "pten +/?": 3 "viable": 3 "2.67": 3 "2.65": 3 "go_id": 3 "tp53": 3 "vector": 3 "puma": 3 "id1": 3 "bcl-2": 3 "mapk": 3 "nb_in_set": 3 "drug": 3 "": 2 "mirna id": 2 "snf1": 2 "pbx1": 2 " ": 2 "7": 2 "hmdm2": 2 "itga5": 2 "r": 2 "cytosolic sphingosine kinase activity": 2 "?2.48": 2 "4.3": 2 "age": 2 "?2.63": 2 "ncf2": 2 "msk2": 2 "msk1": 2 "cdc25a": 2 "?4.44": 2 "apoptotic or anti apoptotic function": 2 "tor1": 2 "e2f3": 2 "250 mg bid": 2 "function": 2 "hsa-mir-1231": 2 "0.009065": 2 "3.05": 2 "pka": 2 "pkc": 2 "fbxo32": 2 "hsa-mir-596": 2 "cyclin d1": 2 "skp-2": 2 "arf": 2 "mst2": 2 "hsa-mir-1972": 2 "hsa-mir-432": 2 "btk ?/? lyn ?/?": 2 "p16": 2 "p18": 2 "sirt1": 2 "name": 2 "erk2": 2 "erk1": 2 "protein kinase": 2 "hsa-mir-2861": 2 "p53 +/?": 2 "mapk pathway": 2 "1–10": 2 "gadd45a": 2 "metastasis": 2 "socs3": 2 "? 2-value": 2 "effect": 2 "hog1": 2 "cyclin e": 2 "rnf4": 2 "target gene": 2 "hmcl": 2 "hdac7": 2 "btg1": 2 "0.00304": 2 "ppsp": 2 "nfoxo3?": 2 "mek2": 2 "trail": 2 "luciferase activity": 2 "er": 2 "?3.03": 2 "hmdm2-p2": 2 "kinase activity ": 2 "hc": 2 "kinase": 2 "?3.49": 2 "topors": 2 "2.14": 2 "2.09": 2 "> 10": 2 "dr5": 2 "dr4": 2 "ikk?": 2 "2.34": 2 "2.46": 2 "spp": 2 "?-catenin": 2 "p -value": 2 "compound": 2 "structure": 2 "mst1rassf5": 2 "rd": 2 "compd": 2 "s6k": 2 "faf1": 2 "p -values": 2 "genotype": 2 "?2.9": 2 "tsc2": 2 "tsc1": 2 "hsa-mir-762": 2 "il32": 2 "tested": 2 "rsk1": 2 "rsk3": 2 "rsk2": 2 "pka1": 2 "bcl-xl": 2 "150 mg bid": 2 "btk ?/?": 2 "inhibitor": 2 "stathmin": 2 "akt2": 2 "akt1": 2 "p53 ?/?": 2 "muc1": 2 "hsa-mir-146b-3p": 2 "variable": 2 "pkcth ? ikkbeta": 1 "36 ras -> raf1": 1 "study 2 verification": 1 "hmdmx": 1 "nestin": 1 "casl 215 ": 1 "-> h pylori": 1 "target s": 1 "pidd": 1 "zap70·slp76·rlk·plcg bind ? plcg act": 1 "19 pip3 -> pdk1": 1 "score": 1 "autophagy cooperates with apoptosis": 1 "mtorc2 pathway *": 1 "rab": 1 "mapk phosphorylation sites": 1 "ns2 p23065": 1 "fyn ? tcrphos": 1 "rad": 1 "lyn ? /?": 1 "12 c-cbl -> crk/crkl": 1 "tnfrsf9": 1 "ic50 ?m 95 confidence interval": 1 "p100 317 ": 1 "ran": 1 "calcin ? nfat": 1 "tbk1": 1 "mdm 2 p": 1 "pro-apoptotic proteins": 1 "rat": 1 "mir100": 1 "0.007487": 1 "lck·cd45 ? fyn": 1 "card 11": 1 "5": 1 "p-akt p?=?0.030": 1 "hdac1 119 ": 1 "go0004361": 1 "c- myb": 1 "zap70 ? lat": 1 "oxidoreductase activity": 1 "erk ? rsk": 1 "functions regulated by dgk activity": 1 "e6ap": 1 "caspase": 1 "?2.07": 1 "aldehyde reductase activity": 1 "rac 130 ": 1 " 254 255 ": 1 "gj ? v- src": 1 "hc n = 14": 1 "p-tyr 705 stat3": 1 "noxa": 1 "psshca": 1 "n-ras": 1 "smrt 122 ": 1 "chek2": 1 "p97 289 ": 1 "no pten loss +1 +2 +3": 1 " 242 243 ": 1 "vh10": 1 "abi": 1 "brg1 130 ": 1 "33 !shp2 · gab1 -> rasgap": 1 "ubiquitin deconjugating proteins": 1 "go0004105": 1 "annexin 130 ": 1 "invasion": 1 "hc n = 27": 1 "hc n = 24": 1 "hc n = 25": 1 "?2.15": 1 "pathway": 1 "39 erk1/2 -> elk1": 1 "ras ? raf": 1 "z": 1 "baf155 130 ": 1 "p 53": 1 "lck ? rlk": 1 "nutlin-3 treatm h": 1 "bnip3? rheb?": 1 "?2.21": 1 "pdz proteins": 1 "cdk7 cyclin h": 1 "37 raf1 -> mek": 1 "acetylation": 1 "go0004337": 1 "tsc2 inhibited": 1 "?2.28": 1 "ets1 ->": 1 "s-adenosylmethionine-dependent methyltransferase activity": 1 "pc2": 1 "time-point": 1 "?2.32": 1 "pten n ": 1 "akt negative": 1 "pcc ranked if pcc?0.200": 1 "case no.": 1 "?2.39": 1 "donors nad or nadp as acceptor": 1 "phosphorylated dusp10": 1 "?2.37": 1 "intensity of phosphorylated targets": 1 "p53 mutation n=273 ": 1 "p-erk": 1 "msh2": 1 "tp130": 1 "rela nuclear positive": 1 "wnt/?-catenin": 1 "copii 289 ": 1 "ck1": 1 " 237 238 ": 1 "p21 positive active p53 a": 1 "pterbb2": 1 "m-ras": 1 "55 caga -> crk/crkl": 1 "29 jnk -> atf2": 1 "mir99a": 1 "homer1": 1 "sort1": 1 "mouse/human": 1 "iap family": 1 "egft": 1 "creb ? cre": 1 "mapk negative": 1 "pten loss 0 staining score": 1 " 239 ": 1 "?2.57": 1 "krt23": 1 "key p53 gene targets": 1 "translation": 1 "rho": 1 "src ? ": 1 "protease inhibitor activity": 1 "inhibition of phosphorylation sites": 1 "localization": 1 "ras per lattice": 1 "tax1bp1 144 ": 1 "p53 hats involved": 1 "chk2 239 ": 1 "mir31": 1 "rela 75 ": 1 "pin1": 1 "40 erk1/2 -> c-myc": 1 "clinical activity": 1 "mdm2": 1 " 236 ": 1 "630": 1 "experiment": 1 "fold downregulation": 1 "61 caga · c-met -> caga/c-met": 1 "wilcoxon-test": 1 "ras signalling": 1 "total ": 1 "46 dag · ca2+ -> pkc?": 1 "rit": 1 "pdzk1ip1": 1 "dual pi3k/mtor inhibitors": 1 "mir21": 1 "rela nuclear negative": 1 "cytoskeleton": 1 "topoisomerase 1 135 ": 1 "angiogenesis": 1 "05 hgf/c-met -> grb2": 1 "functions controlled by pten": 1 "nox4 protein": 1 "?2.74": 1 "yeast": 1 "hsp70 miniarray values": 1 "go0003677": 1 "lat ? plcgbind": 1 "usp45": 1 "go0004769": 1 "f1 mg44": 1 "mdm2 amp": 1 "cdk9 cyclin t": 1 "pip3": 1 "tpor jak2 v617f": 1 "baf57 130 ": 1 "igf2 ?/? p53 ?/?": 1 "crem 28 ": 1 "ubc13 170 ": 1 "all n?=?46": 1 " 234 ": 1 "b-raf": 1 "dag ? pkcth": 1 "trb3? akt?": 1 "pi3": 1 "bad bax puma noxa": 1 "p-4ebp1 thr70": 1 "daf-16 mg44": 1 " 228 234 ": 1 "ectosomes": 1 "?2.92": 1 "creb": 1 "pkcth ? sek": 1 "hax-1": 1 "drugs": 1 "sumo conjugation": 1 "cyclin t1 138 ": 1 "protein binding": 1 "?2.96": 1 " 259 ": 1 "go0004506": 1 "go0004505": 1 "catalytic activity": 1 " 235 ": 1 "go0004740": 1 "bmf ?/?": 1 "pten pathway": 1 "? a ij": 1 "death receptors": 1 "go0047747": 1 "41 erk1/2 -> ets": 1 "all": 1 "expression rate": 1 "k- ras pten": 1 "g?2 300 ": 1 "trk": 1 "tfiia 92 ": 1 "3.08": 1 "202": 1 "3.07": 1 "4e-bp-1?": 1 "smad2 213 ": 1 "genetic mutation or overexpression": 1 "go0042043": 1 "relative dusp10 expression §": 1 "phosphatases": 1 "10 hgf/c-met -> shc1": 1 "100 + 3 days": 1 "mtor n ": 1 "mybl1": 1 "flt3 itd?": 1 "daf-16 sites †": 1 "p53 d-value": 1 "molecular mass kda": 1 "15.85": 1 "32 !i?b? -> nf-?b": 1 "50 c-src · fyn · h pylori -> caga": 1 "ikk? 159 ": 1 "nardilysin activity": 1 "msp1": 1 "antiproliferative effect": 1 "msp2": 1 "erbb2": 1 "cell death": 1 "pten activity involved": 1 "localisation": 1 "cdk5 p35": 1 "3.36": 1 "transport": 1 "cell signaling": 1 "vecfg": 1 "0.001597": 1 "plx": 1 "tip60": 1 "cdk6 221 ": 1 "gelsolin 130 ": 1 "tpor jak2 wt": 1 "ras gtpase": 1 " 240 ": 1 "p53 mut codon": 1 "cell populations": 1 "dna topoisomerase i 135 ": 1 "steroid delta-isomerase activity": 1 "stat3 pathway": 1 "atf1 28 ": 1 "p130cas 215 ": 1 "pmn": 1 "r-ras": 1 "cyclin d3": 1 "upregulation": 1 "msx2 89 ": 1 "caspase-3": 1 "nf-?b": 1 "tcrphos·lck·!ccbl ? zap70": 1 "slpi": 1 "naip": 1 "p16 d-value": 1 "pp1": 1 "mt1222": 1 "pp5": 1 "molecule": 1 "k-ras": 1 "59 pipki?661 -> talin": 1 "go0008168": 1 "3.61": 1 "gaga q08605": 1 " pyruvate dehydrogenase lipoamide kinase activity": 1 "hsa-mir-21*": 1 "ctnnb1": 1 "rpl31a nop1 rps4a rpl7b rps7a rps8a-b rps5 rps11a-b xrn1 rps22a rps13 rps9b sro9 prp43 rpl8b cbf5": 1 "ubiquitin conjugating proteins": 1 "eif-4e": 1 "all cases": 1 "phf17": 1 "mst1": 1 "arc": 1 "dapk3": 1 "calreticulin 289 ": 1 "mrna fold change 12h vs 0h": 1 "atfx 42 ": 1 "go0009008": 1 "mechanism": 1 "cnfn": 1 "mechanisms of mtorc1 activation": 1 "mekk1 157 ": 1 "p-mtor ser2448": 1 "normoxic pmn": 1 "pi3k": 1 "phenylalanine 4-monooxygenase activity": 1 "neurexin binding": 1 "mdm 2": 1 "ige binding": 1 "anti-apoptotic proteins": 1 "!ikb ? nfkb": 1 "gemcitabine ng/ml": 1 "perk cytoplasmic li": 1 "flt3 itd? n?=?85": 1 "map2k2": 1 "25 pak1 -> mkk4": 1 "ets1 62 ": 1 "-> pten": 1 "apoptosis “executioners” caspase-2 3 6 7": 1 "3.81": 1 "cdk1 cyclin b": 1 "pi3k + raf/mek": 1 "cell lines": 1 "change in activity after tsc2 inhibition": 1 "270": 1 "senp5-7": 1 "erk5/mapk7": 1 "pser-hsp70total hsp70 ratio immunoprecipitation": 1 "273": 1 "52 caga -> csk": 1 "pi3kca": 1 "18 !pten · pi3k · pip2 -> pip3": 1 "p14": 1 "tip1 272 ": 1 "277": 1 "tax1bp2 250 ": 1 "ube3a": 1 "lin7 268 ": 1 "p53 positive mutant p53 a": 1 "atm": 1 "atp": 1 "animal group": 1 "sirt3": 1 "atr": 1 "flt3 itd? n?=?38": 1 "p85? 199 ": 1 "62 caga/c-met -> plc?1": 1 "total d-value": 1 "psd95 268 ": 1 "rb 229 ": 1 "cell-type": 1 "her2/ neu": 1 "grb2sos ? ras": 1 "nox4 mrna": 1 "p27": 1 "-> pip2": 1 "sap1 63 ": 1 "scamp2 289 ": 1 "ligase activity": 1 "0.003357": 1 "spontaneous apoptosis": 1 "activity ": 1 "erk ? fos": 1 "classes": 1 "description": 1 "tra@": 1 "18.71": 1 "go0016741": 1 "50 confluent": 1 "raf1": 1 "metastases": 1 "negative": 1 "stat3": 1 "exosomes": 1 "pi3k inhibitors": 1 "xiap": 1 "sc35 141 ": 1 "perk": 1 "low p90rsk": 1 "class i pi3k in vitro kinase ic50": 1 "bim ?/?": 1 "yes": 1 "p-ikk": 1 "23 rac1 -> pak1": 1 "rbck1": 1 "tcrbind·cd45 ? fyn": 1 "scamp1 289 ": 1 "hsa-mir-638": 1 "p27 d-value": 1 "daf-16 hx546": 1 "igf2 ?/?": 1 "cdk4 cyclin d": 1 "uba2": 1 "p14arf": 1 "tissue": 1 "cancer suppressor activity": 1 "p53 localization": 1 "rhoa 130 ": 1 "lyn ?/?": 1 "pten domain involved": 1 "fak": 1 "sek ? jnk": 1 "tg737": 1 "pten +/-": 1 "p53 wild-type n=418 ": 1 "nfat ?": 1 "unfolded protein binding": 1 "case": 1 "rtks": 1 "lat ? grb2sos": 1 "ihc score": 1 "gold density": 1 "apoptosis “initiators” caspase-2 8 9 10": 1 "carbonyl reductase nadph activity": 1 "ras/raf kinase/extracellular signal-regulated kinase erk pathway *": 1 "p63": 1 "ikk? 159 ": 1 "p65": 1 "jun·fos ? ap1": 1 "mtor in vitro kinase ic50": 1 "akt negative n?=?14": 1 "54 !csk -> fyn": 1 "02 hgf/c-met -> gab1": 1 "simulation results": 1 "p110 isoform": 1 "beta-syntrophin 268 ": 1 "rasgrp1 ? ras": 1 "go0008326": 1 "0.007515": 1 "target ic50 nm": 1 "ef-tu1 mutl dna-pol iii": 1 "study": 1 "irf1": 1 "atg5 60 ": 1 "nfkb ?": 1 "shsp": 1 "spi-1 81 ": 1 "tbp 90 ": 1 "!tcrbind ? pagcsk": 1 "mtorc1?": 1 "sirtuin": 1 "1510": 1 "hsa-mir-1909": 1 "akt positive n?=?31": 1 "p16ink4a 225 ": 1 "akt negative n?=?41": 1 "tpr1/ras interaction": 1 "specific activity min?1": 1 "whole group n?=?72": 1 "categories": 1 "pathology grade": 1 " nuclear p65/rela stain": 1 "braf + mek": 1 "ap1 ?": 1 "sumo deconjugation": 1 "0.008635": 1 "pias2/x": 1 "other enzymes": 1 "sensitivity ?": 1 "plcg act ? dag": 1 "socs1": 1 "arhgef2": 1 "p/caf 101 ": 1 "35 !rasgap · sos1 -> ras": 1 "? cd45": 1 "il-1?": 1 "?-internexin 29 ": 1 "hsp90": 1 "antiapoptotic": 1 "pkb akt": 1 " gj + v- src *": 1 "rage": 1 "mapk14": 1 "mtorc1 cellular potency ec50": 1 "nutlin-3 treatment h": 1 "mtorc1 activation": 1 "cdc42": 1 "ref/s": 1 "senp1-3": 1 "atf4 29 ": 1 "concurrent p53 phosphorylation": 1 "c-myc ->": 1 "stat3 ? ": 1 "e coli": 1 "jak2 tw": 1 "60 fak · erk1/2 -> calpain 2": 1 "c- src": 1 "mcl-1": 1 "mir125b": 1 "preclinical activity": 1 "hx546": 1 "ras ink4a/arf": 1 "klhl20": 1 "mtor 61 ": 1 "fas dr4 dr5": 1 "rnf63": 1 "necrosis 3": 1 "sod2": 1 "strain": 1 "grm5": 1 "jnk": 1 "0.007565": 1 "pml-rar": 1 "gps2 183 ": 1 "f2 mg44": 1 "48 ca2+ -> calmodulin": 1 "hsp70": 1 "p53 wild-type n=418": 1 "erk1/2 activity ": 1 "ubc9": 1 "piasy": 1 "rodent and model": 1 "go0004161": 1 "grm1": 1 "!ikkbeta ? ikb": 1 "mir493": 1 "atf3 27 ": 1 "surface levels *": 1 "hsp60": 1 "a overrepresentation of down-regulated genes": 1 "go0008757": 1 "patient": 1 "pi3k/akt dependency": 1 "go0030414": 1 "go0005007": 1 "specimen": 1 "tab2 181 ": 1 "ras mutant status ?": 1 "chfr": 1 "cyclin d3 224 ": 1 " 162 241 ": 1 "caspase-8": 1 " ref.": 1 "erk cytoplasmic expression": 1 "14 dock180 -> rac1": 1 "fyn ? pagcsk": 1 "int6 149 ": 1 "ghr? hepatic igf-1? akt?": 1 "stimulus": 1 "38 mek -> erk1/2": 1 "tax1bp1 171 ": 1 "go0019863": 1 "kras": 1 "44 plc?1 · pip2 -> dag": 1 "survival days": 1 "p50 61 ": 1 "pias3": 1 "perk nuclear li": 1 "dna damage ?h2ax ": 1 "ddr sensor p-p53 ": 1 "vegf": 1 "mbd2 123 ": 1 "cyclin a": 1 "go0004146": 1 "flt3 itd+": 1 "pias1": 1 "p21 ?/? rb +/?": 1 "cyclin b": 1 "hsulf-1": 1 "transcription factor": 1 "bad": 1 "experimental system": 1 "plc- ?": 1 "apoptosis induced by glucocorticoids": 1 "magi3 273 ": 1 "tumor suppressor": 1 "p105 163 ": 1 "tcrlig·!ccbl ? tcrbind": 1 "15 rac1 -> stat3": 1 "fzd4": 1 "pp2a 168 ": 1 "go0016491": 1 "plk2": 1 "bax": 1 "hscrib 275 ": 1 "-> hgf": 1 "id3 rb": 1 "elk1 63 ": 1 "go0019767": 1 "mir221": 1 "rasgap": 1 "go0019763": 1 "sestrin3? ampk? tsc2?": 1 "p14 arf meth": 1 "jnk ? jun": 1 "3525": 1 "deacetylation": 1 "-> c-met": 1 "time h": 1 "hdac1": 1 "hdac2": 1 "hdac3": 1 "epidermal growth factor binding": 1 "hsn3 163 ": 1 "treatment": 1 "average": 1 "atf2 30 ": 1 "zeb1": 1 "her-2/neu": 1 "pp2b": 1 "flt3 itd+ n?=?8": 1 "gjic ?": 1 "hif-1 positivity": 1 "p14 arf deln": 1 "characteristic": 1 "27 jnk -> c-jun": 1 "0.006061": 1 "cdkn2a": 1 "sec": 1 "fbx3": 1 "cdk4 221 ": 1 "braf": 1 "choline-phosphate cytidylyltransferase activity": 1 "mir205": 1 "ras subfamily": 1 "relative p38 activity ¥": 1 "mir200": 1 "cre ?": 1 "pro-il16 269 ": 1 "pp1a": 1 "ch": 1 "downregulation": 1 "dr5 mab": 1 "flt3 itd+ n?=?19": 1 "dcun1d3": 1 "08 c-cbl -> pi3k": 1 "stage": 1 "mirna fold change 3h vs 0h": 1 "16 hgf/c-met -> stat3": 1 "prmt1": 1 "0.00539": 1 "rela cytoplasmic positive": 1 "c-rel 75 ": 1 "htid1 274 ": 1 "tcrbind·lck ? tcrphos": 1 "plc?1 py1173": 1 "mek/erk dysregulation": 1 "high p90rsk": 1 "actin 130 ": 1 "mapk negative n?=?40": 1 "mrna fold change 3h vs 0h": 1 "pfs months": 1 " 228 ": 1 "v- src ‡ bound": 1 "mad1 258 ": 1 "go0004450": 1 "ccng1": 1 "cell stimulus": 1 "45 ip3 -> ca2+": 1 "catalytic activity required?": 1 "positive cells of total cells counted": 1 "n- myc trk b": 1 "mir1": 1 "cytokeratin 190 ": 1 "p52 74 ": 1 "p62 290 ": 1 "src mutant": 1 "erbb2 d-value": 1 "c- fos": 1 "go0017147": 1 "i?b? 162 ": 1 "zap70·slp76 ? itk": 1 "rasgef": 1 "cdc42 130 ": 1 "cyclin d1 224 ": 1 "p300/cbp 100 ": 1 "cytokine processors caspase-1 4 5 11 12 14": 1 "geranyltranstransferase activity": 1 "akt positive n?=?23": 1 "!pagcsk·cd8·cd45 ? lck": 1 "suv39h1 124 ": 1 "wip-1": 1 "5.6": 1 "apoptotic bodies": 1 "crm1 291 ": 1 "igfbp-1? free igf-1? akt?": 1 "rb +/?": 1 "dihydrofolate reductase activity": 1 "origin": 1 "shp-1 -": 1 "tpor w515l": 1 "compound of western diet": 1 "shp-1 +": 1 "akt2 immunostaining": 1 "e3 ligases": 1 "mapk negative n?=?17": 1 "usp7": 1 "rps6": 1 "hc9 163 ": 1 "tpm1": 1 "mst1rasff5 semet": 1 "nrf1 88 ": 1 "gads ? slp76": 1 "igf2 +/? p53 +/?": 1 "human": 1 "0.002977": 1 "mct-1 low": 1 "lat ? gads": 1 "elf-4e": 1 "nr2c2ap": 1 "iap1": 1 "ctnnal1": 1 "mnk2b": 1 "histotype 1": 1 "c-8 sterol isomerase activity": 1 "iap2": 1 "pi3k/akt activation": 1 "pi3kr1": 1 "dr4 mab": 1 "go0005515": 1 "h-ras": 1 "c- jun": 1 "04 hgf/c-met -> shp2": 1 "dna binding": 1 "3-keto-steroid reductase activity": 1 "pathologist": 1 "bid": 1 "c- myc p16ink4a": 1 "nf-yb 82 ": 1 "bik": 1 "simulation": 1 "plc?1 py992": 1 "bim": 1 "cited2": 1 "11 shc1 -> grb2": 1 "0.008064": 1 "trbp 150 ": 1 "igf2 ?/? p53 +/?": 1 "0.009396": 1 "staining score": 1 "dna-methyltransferase activity": 1 "bcl-2 pro-apoptotic family members": 1 "study 1 training": 1 "torc1 44 ": 1 "hipk2": 1 "squalene monooxygenase activity": 1 "if": 1 "plaur": 1 "akt1 a p?=?0.012": 1 "hipk1": 1 "01 hgf · c-met -> hgf/c-met": 1 "chop": 1 "2.02": 1 "2.01": 1 "fas-mediated apoptosis": 1 "classification": 1 "igf2 +m/?p": 1 "patient id": 1 "ranbp2": 1 "alteration": 1 "42 gab1 -> plc?1": 1 "pik3ca/pten": 1 "ip3 ? ca": 1 "03 gab1 -> shp2": 1 "pure pi3k inhibitors": 1 "? cd8": 1 "p85 n ": 1 "26 mkk4 -> jnk": 1 "stat5 py992": 1 "ligand": 1 "34 grb2 -> sos1": 1 "rhes": 1 " 248 - 250 ": 1 "siah-1": 1 "library": 1 " 222 ": 1 "30 pak1 -> ikk": 1 " 246 ": 1 "24 rac1 · calmodulin -> iqgap-1": 1 "perk1": 1 "igf2 +m/?p p53 +/?": 1 "cdk6": 1 "proliferation": 1 "?-catenin/?-catenin/e-cadherin ->": 1 "bcl3": 1 "cdk2": 1 "go0051082": 1 "pten copy number": 1 "erk1/2": 1 "bcl2": 1 "cdk1": 1 "pet counts cpm": 1 " 247 ": 1 "?3.4": 1 "b-rafv600e": 1 "sp1 62 ": 1 "methyltransferase activity": 1 "2.16": 1 "2.15": 1 "grade 4 ctcae ": 1 "rictor? mtorc2 assembly?": 1 "bcl-2 family": 1 "transcription factors": 1 "2.36": 1 "4 months": 1 "bak1": 1 "1-alkyl-2-acetylglycerophosphocholine esterase activity": 1 "smad4 213 ": 1 "trim27": 1 "mir1826": 1 "c-jun": 1 "caspase 8": 1 " 244 ": 1 "2.26": 1 "nfoxo1? nfoxo3? nfoxo4?": 1 "0.000379": 1 "wnt-protein binding": 1 "bhlhe41": 1 "xbp1 31 ": 1 "p-ser 727 stat3": 1 "ikk? 156 ": 1 "pakt immunostaining": 1 "p-akt ser473": 1 "17 pi3k -> ilk": 1 "43 plc?1 · pip2 -> ip3": 1 "torc2 44 ": 1 "protein function / notes": 1 "2.42": 1 "28 jnk -> elk1": 1 "utp": 1 "id1 p53": 1 "pip 2": 1 "shc py1173": 1 "mek ? erk": 1 "p53 mut": 1 "go0000247": 1 "2.38": 1 " 245 ": 1 "22 akt1 -> pak1": 1 "jmjd2a 125 ": 1 "differentiation": 1 "chk1 240 ": 1 "talin ->": 1 "a microrna gene expression with their apoptotic or anti-apoptotic target mrna gene expression at 3h sorted by target .": 1 "mirna fold change 12h vs 0h": 1 "2.58": 1 "apoptosis": 1 "b microrna gene expression with their apoptotic or anti-apoptotic target mrna gene expression at 12h sorted by target.": 1 "20 pdk1 · ilk -> akt1": 1 "pten loss": 1 "cell cycle regulators": 1 "apollon": 1 "kctd11": 1 "treatment¥": 1 "51 ! h pylori -> csk": 1 "53 !csk -> c-src": 1 "creb 26 ": 1 "drp1 phosphorylation site": 1 "p53 4": 1 "pi 3 k": 1 "immunoglobulin receptor activity": 1 "src": 1 "serpinb3": 1 "cdk inhibitor": 1 "serpinb4": 1 "hoxa5": 1 "pik3ca": 1 "cross": 1 "21 akt1 -> rac1": 1 "families": 1 "2.64": 1 "p-y15 cdk1": 1 "arf positive": 1 "caspase-3 activity control": 1 "pd": 1 "cdk6 cyclin d": 1 "ras density": 1 "trna adenine-methyltransferase activity": 1 "go0016919": 1 "effect on disease": 1 "mycn status": 1 "47 pkc? -> raf1": 1 "transcription and translation": 1 "aurora kinase a": 1 "grade 3 ctcae ": 1 "s100a2": 1 " 252 ": 1 "go0003847": 1 "2.76": 1 "trim69": 1 "rna binding": 1 "s100a9": 1 "fzd": 1 "vegfr2/3 inhibitors": 1 "4.06": 1 "0.007806": 1 "copy number status": 1 "tsc1/tsc2? rheb?": 1 "p-t14 cdk1": 1 "tafii28 91 ": 1 "10": 1 "calpain ->": 1 "0.001262": 1 "14": 1 "c-raf": 1 "8667": 1 "molecular phenotype": 1 "target ic50": 1 " 253 ": 1 "boo/diva": 1 "skp1": 1 "cyclin d2 221 ": 1 "tns4": 1 "sox4": 1 "rb": 1 "her2 overexpression assessment": 1 "re": 1 "p-s6k thr389": 1 "apoptosis caspase-3 ": 1 "il-6": 1 "substrates/targets": 1 "il-8": 1 "23": 1 "25": 1 "activity": 1 "hsa-mir-499-5p": 1 "foxo1? tsc1?": 1 "target/pathway": 1 "cfoxo1?": 1 "site-specific dna-methyltransferase cytosine-specific activity": 1 "2.95": 1 "torc3 43 ": 1 "galnt1": 1 "transferase activity transferring one-carbon groups": 1 "shc py1148": 1 "4ebp1": 1 "zap70·slp76·plcg bind·itk ? plcg act": 1 "0.004553": 1 "stat": 1 "variables": 1 "p15ink4b 228 ": 1 "mdm2 brdt hsp90aa1 sumo1": 1 "go0048408": 1 " 251 ": 1 "isocitrate dehydrogenase nadp+ activity": 1 "tagln3": 1 "hif-1a vhl": 1 "58 fak -> pipki?661": 1 "biological consequences": 1 "p53 regulation": 1 "07 hgf/c-met -> c-cbl": 1 "apoptotic/anti-apoptotic": 1 "autophagy antagonizes apoptosis & necrosis": 1 "il1b": 1 "cdc20 260 ": 1 "igf2 +m/?p p53 ?/?": 1 "mir449a": 1 "hras": 1 "mct-1 high": 1 "dcr1": 1 "sensitivity to inhibitors": 1 "dcr2": 1 "mt1159": 1 "kinases": 1 "mt1158": 1 "mpp1": 1 " nuclei foxo3a excluded *": 1 "srsf9/srp30c": 1 "plc?": 1 "organism": 1 "go0016616": 1 "go0016614": 1 "gap1m 130 ": 1 "sites of p53 acetylation": 1 "160": 1 "cell cycle and dna repair": 1 "?2.5": 1 "proapoptotic": 1 "cholate-coa ligase activity": 1 "regulator": 1 "?2.6": 1 "?2.7": 1 "oxidoreductase activity acting on ch-oh group of donors": 1 "rhoc": 1 "raf ? mek": 1 "tak1 158 ": 1 "rpl6 318 ": 1 "proteasome": 1 "0.001096": 1 "syk": 1 "ranbp2 289 ": 1 "uca1": 1 "hsa-mir-29b-1*": 1 "174": 1 "timp3": 1 "mir-1301": 1 "49 !iqgap-1 -> ?-catenin/?-catenin/e-cadherin": 1 "in vivo": 1 "lymphoma type": 1 "normal": 1 "aos1": 1 "go0016874": 1 "igf2 +/?": 1 "6.29": 1 "pkcth·dag ? rasgrp1": 1 "calmodulin p62158": 1 "pi-3k pathway": 1 "mapk positive n?=?20": 1 "cells": 1 "cdk-4": 1 "cancer promoter activity": 1 "dauers": 1 "ar? mtorc2? akt? ar? lat? regulator?": 1 "ige receptor activity": 1 "87": 1 "mel-18": 1 "pyshca": 1 "survivin p?=?0.54": 1 "pakt negative n?=?20": 1 "pegfr": 1 "c-jun ->": 1 "?-tubulin 191 ": 1 "ampk": 1 "mir195": 1 "hsp100": 1 "31 !ikk -> i?b?": 1 "il4r": 1 "mets group n?=?37": 1 "idh1": 1 "mapk positive n?=?32": 1 "conc µm": 1 "p53 mutation n=273": 1 "sapk/jnk": 1 "go0004090": 1 "caspase family": 1 "activity against yb-1 peptide compared with control ": 1 "ttp 148 ": 1 "ubquitination/chaparone": 1 "oxidoreductase activity acting on the ch-oh group of": 1 "akt2 p?=?0.006": 1 "samples": 1 "p300": 1 " 257 258 ": 1 "13 crk/crkl -> dock180": 1 "go0050576": 1 "tnfsf15": 1 "igf2 +/? p53 ?/?": 1 "ranbp1 249 ": 1 "pak overexpression in gi tumourigenesis": 1 "go0016426": 1 "c/ebp? 81 ": 1 "gender": 1 "go0016429": 1 "range": 1 "apoptosis ": 1 "ca ? calcin": 1 "56 caga -> shp2": 1 "?cop 289 ": 1 "rad51 130 ": 1 "b overrepresentation of up-regulated genes": 1 "cdk2 cyclin a": 1 "0.0073": 1 "del-1": 1 "bcl-xs": 1 "nf-?b ->": 1 "57 !shp2 -> fak": 1 "grp78": 1 "cdk2 cyclin e": 1 "stat3 ->": 1 "effect of paks on signalling cascades": 1 " prorenin receptor 34 35 ": 1 "fraction": 1 "mt1167": 1 "il6": 1 "site": 1 "mdnm2": 1 "siah1 mdm2": 1 "mt1160": 1 "pakt positive n?=?73": 1 "mt1161": 1 "hypoxic pmn": 1 "hdlg 270 ": 1 "proliferation ki-67": 1 "akt positive": 1 "bcr-abl": 1 "? tcrlig": 1 "7 months": 1 "06 gab1 -> pi3k": 1 "egr1 85 ": 1 "taqman/ihc": 1 "dimethylallyltranstransferase activity": 1 "carm1 127 ": 1 "wee1": 1 "6.73": 1 "rela cytoplasmic negative": 1 "mtorc2 cellular potency ec50": 1 "mapk positive": 1 "atf2 ->": 1 "inhibitor/antagonist": 1 "s6rp": 1 "smad3 213 ": 1 "fold stimulation of protein phosphorylation": 1 "p-rps6 ser235/236": 1 "gblp csk21 hs90a andr cdc2 raf1 ctnb1 rb a4 npm ubiq 1433z": 1 "autophagy facilitates apoptosis": 1 "baf53 130 ": 1 "caspase interacting protein": 1 "grb2 py1068": 1 "relative mtorc2 activity ˆ": 1 "mir143": 1 "all n?=?104": 1 "zap70 ? ccbl": 1 "total n=691 ": 1 "pik3r1": 1 "local infiltration 2": 1 " apoptotic cells": 1 "intervention": 1 "i?b? 161 ": 1 "elk1 ->": 1 "biological activity": 1 "akt3": 1 "met/ron": 1 "compound source": 1 "14-3-3? gadd45": 1 "igfir": 1 "erk nuclear": 1 "shank3": 1 "errf-1": 1 "cullin 1": 1 "plcg act ? ip3": 1 "cullin 3": 1 "snap23 289 ": 1 "go0004032": 1 "diagnosis/ relapse§": 1 "09 gab1 -> crk/crkl": 1 "trna adenine-n1--methyltransferase activity": 1 "rd n = 14": 1 "mir129": 1 "rd n = 15": 1 "jak2 v617f": 1 "srf 59 ": 1 "c-erbb-3": 1 "rsk ? creb": 1 "cbp": 1 "rd n = 28": 1 "p-tsc2 thr1462": 1 "response": 1 "enzymatic activity": 1 "glutaryl-coa dehydrogenase activity": 1 "fibroblast growth factor receptor activity": 1 "rd n = 24": 1 
"normal": 15 "tissue": 10 "cancer": 9 "reference": 9 "organ": 8 "references": 7 "n": 7 "gene": 7 "liver": 6 "total": 5 "frequency *": 5 "lung": 4 "kidney": 4 "level": 4 "isoform": 4 "tissue type": 4 "mean": 4 "": 3 "treatment": 3 "ear tag #": 3 "age": 3 "cornea": 3 "inter": 3 "male n?=?15": 3 "lesion": 3 "lec": 3 "macroscopic finding": 3 "genotype": 3 "female n?=?21": 3 "basal-like": 3 "luminal a": 3 "luminal b": 3 "intra": 3 "limbus": 3 "glean3_entry": 2 "epithelium": 2 " n?=?8": 2 "cysts": 2 "er stress": 2 "p": 2 "deregulated noncoding rnas": 2 "maximum": 2 "tongue cancer": 2 "female": 2 "mirna": 2 "soleus": 2 "her-2 n?=?70 ": 2 "tooth 2": 2 "frequency ": 2 "class": 2 "all cancers": 2 "sp-base name": 2 "subcutaneous": 2 "pancreas": 2 "spleen": 2 "authors": 2 "ovary": 2 "sham": 2 "epididymal": 2 "lesion type": 2 "spicule": 2 "oral cancer": 2 "normal tissue type": 2 "limb n?=?14": 2 "p -value": 2 "luminal b n?=?168 ": 2 "muscular dystrophy": 2 "histology": 2 "male": 2 "mandibular molars wt": 2 "inflamed mucosa": 2 "oxidative stress": 2 "total n?=?709 ": 2 "no of patients": 2 "median": 2 "parameters": 2 "thymus": 2 "characteristics": 2 "heat shock": 2 "normal salt": 2 "blood vessels": 2 "normal tissue": 2 "a.u.": 2 "normal central corneal epithelial cells": 2 "spine 1": 2 "brain": 2 "minimum": 2 "incidence": 2 "lymph node metastasis": 2 "basement membrane": 2 "stomach": 2 "test 1": 2 "group": 2 "tnbc n?=?174 ": 2 "edl": 2 "marker": 2 "maxillary molars wt": 2 "luminal a n?=?297 ": 2 "polyp diameter ? 7 mm": 1 "year": 1 "vessels thin walled and fragile": 1 "tumor type": 1 "?": 1 "large intestine*": 1 "observed mutations2": 1 "score": 1 "tb.ar ?": 1 "metastatic lesions": 1 "cribriform patterns": 1 "herv group": 1 "mandibular molars mutant 3m": 1 "deaths": 1 "<0.66": 1 "k-ras 1": 1 "panin1b": 1 "panin1a": 1 "wet lens/dry lens ratio": 1 "oncogene vs tumor suppressor": 1 "1": 1 "2": 1 "3": 1 "4": 1 "5": 1 "ret/ptc3": 1 " mesenchymal": 1 "infliltrated cells content": 1 "mandibular molars mutant 4m": 1 "cancerous tissue n = 56": 1 "adenomas": 1 "aae": 1 "time of treatment": 1 "lack of vascular smooth muscle": 1 "tumor rna": 1 "malformed nb": 1 "plasma or sera": 1 "aah": 1 " i": 1 " n?=?9": 1 "lymph": 1 "proteins": 1 "braf": 1 "sensitization": 1 "ca": 1 "cc": 1 "n-ras": 1 "photoirritation photosensitization": 1 "pten?/?": 1 "metastasis rate": 1 "tail": 1 "volume ? l": 1 "hpp": 1 "pleural effusion": 1 "average dry lens weight mg": 1 "sample": 1 "bone marrow": 1 "cutaneous reaction to uvr": 1 "impaction or delayed eruption": 1 "normal endometrial tissue": 1 "cin ": 1 "nail dysplasia": 1 "ucis ": 1 "ckd+ast-120": 1 "tumor versus normal tissue": 1 "tgf- ?": 1 "unique to skeletal muscle proteome": 1 "tumor versus cp tissue": 1 "lymph node m1/m2": 1 "normal tissue from unaffected women n = 9": 1 "malignancy": 1 "evidence": 1 "braf digest": 1 "egfr fish": 1 "mandibular molars mutants 4m": 1 "un-eruption of permanent teeth": 1 "urethral thissue of balb-p53neu vs balb/c": 1 "hyperplasia and solid tumour": 1 "larynx": 1 "3–4 rib": 1 "adenoma ": 1 "tumor 38 versus normal 28 fdr <0.05": 1 "signal": 1 "normal plus2": 1 "others": 1 "patient malignant tissue n?=?13": 1 "concentration /ml": 1 "normal plus3": 1 "transcripts": 1 "mandibular molars mutants 3m": 1 "apc 1": 1 "cin1–cin3": 1 "rms vs urethral tissue of balb/c": 1 "rcas vector detected": 1 "new cases": 1 "tumor 30": 1 "semen": 1 "lung metastases": 1 "temperature °c": 1 "sample labels": 1 "dermis": 1 "vol": 1 "contralateral eye injection 12.5 µl": 1 "the ratio of intima to media thickness i/m": 1 "subchronic toxicity": 1 "tipe2": 1 "peritoneal mast cells of total peritoneal cells": 1 "luminal epithelium": 1 "axillary lymph node metastases right left": 1 "pda*": 1 "sublining layer": 1 "cell type gene name": 1 "primary tumors": 1 "1.5–5": 1 "lymph node": 1 "meth cpg": 1 "oral cavity": 1 "aga": 1 "pten expression": 1 "ckd": 1 "muscle tissue": 1 "ks lesion": 1 "#tumor": 1 "skin cancer": 1 "iii-95": 1 "tumor id#": 1 "s cord": 1 "mesench/epithelial": 1 "tumor thickness": 1 "adenoma": 1 "uterus": 1 "normal-like": 1 "biological response in anastomosis site": 1 "sample size": 1 "iii-84": 1 "malformation/root resorption of permanent teeth": 1 "classification": 1 "intrapulmonary metastasis": 1 "deleted segment cytology": 1 "photomutagenicity": 1 "1–2 rib": 1 "mi+los": 1 "status": 1 " ii": 1 "other": 1 "cml": 1 "p value chi square": 1 "ais": 1 "identification characteristics": 1 "stroma 1": 1 "stroma 3": 1 "stroma 2": 1 "stroma 5": 1 "stroma 4": 1 "panin3": 1 "panin2": 1 "unique to electric organ proteome": 1 "forelimb": 1 "peritoneum": 1 "pulmonary disease": 1 "22.6 3.2": 1 "endometrium": 1 "adenocarcinoma": 1 "osteoclast number no/mm": 1 "treatment group": 1 "# mice": 1 "carcinoma": 1 "mirna level correlated with poor prognosis": 1 "tissue phenotype data": 1 "malignant breast epithelium": 1 "n.": 1 "odontoma": 1 "blot number": 1 "vascular endothelium": 1 "mutations": 1 "cancer cell lines n?=?4 3": 1 "hindlimb": 1 "hypopharynx": 1 "mi": 1 "continuously unstable corneal curvatures central cornea": 1 "cytokine": 1 "neuro blastoma": 1 "her2e": 1 "upa/upar": 1 "mouse model": 1 "association with chronic inflammation": 1 "5–20": 1 "heart": 1 "all lesions": 1 "skin phototype": 1 "clinical": 1 "200": 1 "capsule penetration": 1 "increased interstitial pressure within tumor": 1 "skin phenotype": 1 "polyp diameter < 7 mm": 1 "mock": 1 "p*": 1 "position": 1 "severe asthma gina 4?=?11 5?=?4": 1 "no": 1 "tsa": 1 "tumor tissue": 1 "cqu": 1 "normal epithelium ": 1 "peripheral blood": 1 "line total": 1 "cp versus normal tissue": 1 "mineral apposition rate ?m/day": 1 "subtype": 1 "crf": 1 "muscle": 1 "transformed": 1 "mucosa 30": 1 "met": 1 "normal skin": 1 "p-value": 1 "multiple tumors": 1 "18.5 4.6": 1 "trabecular thickness ?m": 1 "saliva": 1 "polyrib": 1 "tissue specific": 1 "cancerous tissue": 1 "bone swelling": 1 "hypothalamus": 1 "normal cell line n?=?1 2": 1 "lung n?=?1": 1 "parietal cortex": 1 "lung n?=?5": 1 "graft material": 1 "114": 1 "carcinomas": 1 "patients spns": 1 "total 2": 1 "# tumor": 1 "animal study 1": 1 "1.": 1 "fusion with a permanent tooth": 1 "tissues": 1 "genes": 1 "modifying alleles and rnai lines": 1 "panin-1*": 1 "amplification": 1 "average wet lens weight mg": 1 "lymph nodes": 1 "grade": 1 "small intestine": 1 "2.": 1 "iv-92": 1 "hyperkeratosis on palms/soles": 1 "p16/p19 ?/? xake n?=?16": 1 "normal limbal basal cells": 1 "0.66–1.5": 1 "iv-90": 1 "activity or expression vs normal tissue": 1 "malposition/ crowding of teeth": 1 "thoracic tumor": 1 "3.": 1 "pten?/?dicer+/?": 1 "cell line": 1 "b-raf 1": 1 "cancer tissues": 1 "phenotype": 1 "extrapulmonary disease": 1 "childhood": 1 "adjntl": 1 "tissue and gene": 1 "16.4 2.0": 1 "her2+/er-": 1 "myometrium": 1 "gastro intestinal": 1 "tumor": 1 "4.": 1 "oropharynx": 1 "increased vessel tortuosity": 1 "inflamed": 1 "complete data set": 1 "expression in tumor tissue": 1 "testis": 1 "cell type": 1 "heart tissue": 1 "spacing/ diastema": 1 "epidermal fragility": 1 "mouse": 1 "5.": 1 "mutation ratios": 1 "normal limbal stem cells": 1 "case1": 1 "mononuclear infiltrates": 1 "pten?/?dicer?/?": 1 "ssp/a": 1 "gene symbols": 1 "synovial-lining layer": 1 "thyroid": 1 "alopecia": 1 "cd4+": 1 "6.": 1 "downredulated mirnas in crc tissue": 1 "unaffected skin": 1 "down-regulated biomarkers": 1 "author year": 1 "fresh frozen tissue ": 1 "description": 1 "protein expression of normal": 1 "genotype of skin": 1 "paraffin-embedded tissue ": 1 "numbers of lymph glands with phenotype/ total analyzed": 1 "cox-2 expression in tumor tissue": 1 "overall lifetime risk of transformation": 1 "glutathione s -transferase": 1 "macrophages": 1 "tissue disease b": 1 "tissue disease a": 1 "7.": 1 "healthymucosa": 1 "normal luminal epithelium": 1 "concentration µm ips eye/contra eye": 1 "organ system": 1 "b220+": 1 "external stimulus": 1 "tag frequency": 1 "increased vessel permeability": 1 "percutaneous absorption": 1 "figure": 1 "patient non-malignant tissue n?=?13": 1 "ki- ras mutation#": 1 "yes": 1 "generic": 1 "#adjacent normal": 1 "8.": 1 "colon": 1 "location": 1 ">20": 1 "feces": 1 "86": 1 "sample code": 1 "maxillary molars mutants 4m": 1 "primary tissue datasets": 1 "constant remodeling": 1 "endometrial carcinoma": 1 "gamma-glutamyl transferase": 1 "ii-98": 1 "mild-moderate asthma gina 1?=?11 2?=?3 3?=?2": 1 "mesenteric lymph nodes": 1 "gene set": 1 "group number": 1 "organs or tissue": 1 "gene symbol": 1 "epidermis": 1 "untreated": 1 "comment on mapping": 1 "genotype a": 1 "13.9 1.5": 1 "original function": 1 "diarrhoea and enterocolitis": 1 "high salt": 1 "skin mast cells": 1 "ii-86": 1 "clinicopathological findings": 1 "her2 enriched": 1 "genetic lesions": 1 " iii": 1 "cd8+": 1 "disease stages": 1 "pbmc": 1 "a intrapulmonary distant and lymph node metastases": 1 "primary": 1 "biliary tract?": 1 "continuously unstable curvatures of corneas central cornea": 1 "gender": 1 "p-value b": 1 "p-value a": 1 "neonatal": 1 "combined results": 1 "protein name": 1 "sinus invasion": 1 "micrornas expression": 1 "variable flow rates": 1 "integrin": 1 "tissue wt": 1 "distant metastasis": 1 "maxillary molars mutants 3m": 1 "papillary cystic proliferative changes with spindle cells and remodelling hyperplasia": 1 "mutagenicity": 1 "upregulated mirnas in crc tissue": 1 "signalling pathway": 1 "ageing types": 1 "deficiency modifying zfrp8/+ lymph gland overgrowth": 1 "serrated lesion": 1 "susceptibility to skin carcinogenesis": 1 "primary m1/m2": 1 "hepatitis": 1 "ipsilateral eye injection 12.5 µl": 1 "disorder": 1 "lens age and genotype": 1 "c/ebp?": 1 "cancer tissue type": 1 "c/ebp?": 1 "urothelium ": 1 "normal mucosa": 1 "c/ebp?": 1 "epidermal closure mm": 1 "overexpression in cancer": 1 "weight mg": 1 "ctnnb1 1": 1 "mutant allele frequency": 1 "vessel marker immaturity": 1 "perivascular region": 1 "bfr/bs ?m/day": 1 "intestinal wall": 1 "p16/p19 ?/? xbke n?=?14": 1 "fibroblasts content": 1 "24.1 2.3": 1 "stresses": 1 "patients": 1 "granulation tissue thickness ": 1 "normal tissue from cancer patients n = 56": 1 "abundance value in thyroid gland": 1 "salivary gland": 1 "tba": 1 "subgroup n?=?50": 1 "tag sequences": 1 "maxillary molars mutant 4m": 1 "hypohidrosis": 1 "recommended margins": 1 "p16/p19 ?/? xn-tva n?=?22": 1 "effect": 1 "collagen fibres production": 1 "binocular lens treatment": 1 "p value": 1 "fold change": 1 "skin toxicity": 1 "pituitary gland": 1 "infection/pain": 1 "change in staining tumour vs normal tissue": 1 "affected skin": 1 "maxillary molars mutant 3m": 1 "acute toxicity": 1 "panin-3": 1 "panin-2": 1 "irritatio of mucous membranes or skin": 1 "min surface ?": 1 "studies": 1 "unaffected tissue": 1 "cyst with micropapillae": 1 "adenocarcinoma ": 1 "c-kit": 1 "mild change md/hyperplasia": 1 "accession numbers": 1 "herv-k hml-2 activity": 1 "uterine gland": 1 "up-regulated biomarkers": 1 "the intimal thickness ?m": 1 "normal rna": 1 "methodology": 1 
"mutation": 26 "phenotype": 20 "gene": 18 "references": 16 "reference": 13 "cell line": 8 "disease": 8 "mutations": 6 "ref.": 6 "positive samples": 6 "protein": 5 "study": 5 " phenotype": 5 "model": 4 "syndrome": 4 "mouse model": 4 "exon": 4 "mutation frequency": 4 "sporadic": 4 "gene name": 3 "predicted protein function **": 3 "p": 3 "genetic modification": 3 "id": 3 "dbsnp *": 3 "amino acid mutation": 3 "pten": 3 "all": 3 "comments": 3 "inherited": 3 "histology": 3 "lgg": 3 "source": 3 "frequency": 3 "tp53 mutation": 3 "nucleotide mutation": 3 "missense": 3 "egfr mutation": 3 "patient": 3 "year": 2 "aa mutation": 2 "gene deletion": 2 "????????forward": 2 "sseq ": 2 "aslna ": 2 "+": 2 "analysis": 2 "2": 2 "chemical": 2 "domain": 2 "renal phenotype": 2 "viability": 2 "knockout phenotype": 2 "20°c": 2 "sex": 2 "????g-a transitions": 2 "castration resistance": 2 "notes": 2 "cortical phenotype s": 2 "p-mtor": 2 "duration": 2 "mouse strain": 2 "memory phenotypes": 2 "lkb1 mutation": 2 "dnr": 2 "????????total": 2 "no dnmt3a exon 23 mutation": 2 "syndromes": 2 "ltp phenotypes": 2 "inheritance": 2 "clones": 2 "developmental phenotype": 2 "cancer type": 2 "p -value": 2 "100": 2 "?": 2 "genes": 2 "genotype1": 2 "mutant": 2 "sarcoma type": 2 "schwannoma with nf2": 2 "????????reversed": 2 "exons sequenced": 2 "????total mutations": 2 "no.": 2 "ida": 2 "description": 2 "normal": 2 "p -value*": 2 "cds mutation": 2 "type": 2 "deletion": 2 "mutation type": 2 "dnmt3a exon 23 mutation": 2 "25°c": 2 "method": 2 "vbs": 2 "????deletions": 2 "disorder": 2 "pten mutation locus": 2 "gene knockout level": 2 "effect": 2 "percent": 2 "genetic alteration": 2 "efficacy": 2 "phenotypes": 2 "functions": 1 "tumor type": 1 "?": 1 "omim numbera": 1 "treatments": 1 "acquired conditions non neoplastic blood disorders pernicious anemia sideroblastic anemia pure red cell aplasia refractory normoblastic anemia aplastic anemia paroxysmal nocturnal hemoglobinuria recovery from bone marrow transplant neoplastic blood disorders acute leukemias erythroleukemia juvenile chronic myeloid leukemia marrow neoplastic metastases hepatoma": 1 "parrot-beaked nose": 1 "mental retardation": 1 "embryo lethality": 1 "tsc-lam": 1 "wilson’s disease": 1 "splice site": 1 "eosinophilia": 1 "nude mice": 1 "viability /age at death of null mutant": 1 "plc ? l phos": 1 "vdrhigh": 1 "t-cell- phenotype": 1 "defect in lck ko? *": 1 "# of amplified samples": 1 "1": 1 "expressed druggable mutations": 1 "bbs": 1 "locus gene": 1 "indels with predicted functional impact": 1 "stop": 1 "size": 1 "clinical sign": 1 "occlusion": 1 "7": 1 "heritability ": 1 "hearing loss": 1 "autophagy process": 1 "smn2 copy number": 1 "treatment": 1 "amplification ": 1 "histology who grade": 1 "fusion gene/mutation molecular": 1 "normal mice §": 1 "hras g12v copy number increase": 1 "biopsy code": 1 "disease reference": 1 "cancer mutations": 1 "autophagosomal phenotype": 1 "nras mutation analysis": 1 "genetic product/function": 1 "novel mutations n ": 1 "braf": 1 "hras mutation analysis": 1 "braf/nras mutation": 1 "brain metastases": 1 "total mutations": 1 "sample": 1 "defect in double ko? *": 1 "n": 1 "sporadic indonesia?": 1 "zygosity": 1 "wtfrequency": 1 "patients characteristics": 1 "yfp fusion location": 1 "initiating lesion": 1 "human tor": 1 "cancer related frequency a": 1 "gene location": 1 "alk mutation": 1 "mutations induced in human ad293 cells ": 1 "ref": 1 "crowded dentation": 1 "dysmorphism": 1 "phenotype upon rnai treatment": 1 "kras mutations": 1 "7 ?m": 1 "test": 1 "hras mutation frequency": 1 "other findings": 1 "cytogenetic abnormality": 1 "actin polym": 1 "jak2": 1 "p a": 1 "mutated epitopes": 1 "mirna": 1 "il-2 prod": 1 "missense mutations n = 33": 1 "frequency of hras mutations in hnpgl": 1 "egfr": 1 "syndrome phenotype ": 1 "prior cetuximab": 1 "immunohistochemical analysis": 1 "selected references": 1 "congenital masses": 1 "expressed mutated epitopes": 1 " containing nf2 somatic mutations": 1 "biochemical defects": 1 "comments/cellular effect/reference": 1 "scope": 1 "genetic abnormality": 1 "pak isoform": 1 "gna11 mutation": 1 "class": 1 "nature of genomic instability": 1 "midfacial hypoplasia": 1 "non-synonymous mutations with predicted functional impact": 1 "phenotypes of mst1/2 deficient mice": 1 "polyphen-2 score": 1 "k-ras mutation": 1 "null phenotype organ structure or cell type affected": 1 "braf copy number": 1 "rhogefs": 1 "etiology": 1 "cardiovascular phenotype": 1 "familial or sporadic": 1 "management": 1 "allele": 1 "prevalence /100.000": 1 "family": 1 "localization": 1 "class i mutations providing cellular proliferative and/or survival advantage": 1 "triplication": 1 "mutants": 1 "sample id": 1 "cumulative domain length": 1 "recommendation": 1 "transcript levels in early fil growth": 1 "affected organs/cell types": 1 "null mutant phenotype": 1 "clinical-related phenotypes": 1 "gnaq mutation": 1 "alteration in familial melanoma": 1 "#patient": 1 "affected tissue": 1 "pik3ca mutation": 1 "morphology": 1 "not deletion n?=?23": 1 "aggressiveness": 1 "ko mouse": 1 "phenotype severity": 1 "p66shc+/+": 1 "statin-induced myopathy": 1 "animal models phenotype ": 1 "rho gtpase": 1 "kinase": 1 "affected gene": 1 "knockout mouse phenotypes": 1 "patient id": 1 "alteration": 1 "double-transgenic phenotype": 1 "indel": 1 "seizure model": 1 "initial screen mutations": 1 "authors": 1 "melanoma samples analyzed": 1 "effect of somatic mutation": 1 "no change": 1 "js": 1 "fgfr1": 1 "case #": 1 "prior panitumumab": 1 "nras mutation frequency": 1 "other phenotype": 1 "growth phenotype": 1 "chip well": 1 "defect in fyn ko?": 1 "protein domain affected": 1 "proliferation": 1 "ko": 1 "egfr sequence alterations": 1 "ofd": 1 "group-iii": 1 "nf1": 1 "acvr1b gene": 1 "group-iia": 1 "group-iib": 1 "p9.1": 1 "murine model?": 1 "hnpcc/lynch": 1 "juvenile polyposis": 1 "affected amino acids": 1 "peutz-jeghers": 1 "protein function/description": 1 "ref .": 1 "chemotherapy line": 1 "henle koch’s postulates 9 ": 1 "menkes disease": 1 "function": 1 "functional abnormality": 1 "hereditary syndrome?": 1 "vdr phenotype": 1 "activation status": 1 "exophthalmos": 1 "inflammatory masses": 1 "cytokine": 1 "best response ": 1 "medulloblastoma": 1 "akita": 1 "diagnosis": 1 "activated phenotype": 1 "hras g12v mutation": 1 "affected": 1 "unclassified mutations": 1 "expt no.": 1 "obstructive azoospermia of genetic origin": 1 "erk phos": 1 "p8.1": 1 "ng": 1 "class compound": 1 "other phenotypes": 1 "amf": 1 "pathogen clearance": 1 "class ii mutations impairing cellular differentiation": 1 "amn": 1 "pkd": 1 "accession": 1 "deregulated cdk": 1 "nonsense": 1 "?-catenin": 1 "total": 1 "treatment-related situations antileukemic chemotherapy therapy with hydroxyurea aza-deoxycytidine butyrates and erythropoietin": 1 "evc": 1 "dose level": 1 "fl+/+ itd+/+ ": 1 "jath": 1 "hypertelorism": 1 "cral_trio": 1 "sma type": 1 "p-value": 1 "group-i": 1 "disease phenotype": 1 "th2 response": 1 "pik3ca": 1 "tumors": 1 "receptor": 1 "single-transgenic phenotype": 1 "p7.1": 1 "cdna": 1 "example gene mutations": 1 "mutation subtypes": 1 "lkb1": 1 "braf mutation frequency": 1 "remarks": 1 "db/db": 1 "reisolate phenotype": 1 "prognostic implications": 1 "smn1 deletion": 1 "b-raf exon 15 mutation": 1 "gene/locus": 1 "somatic point mutation": 1 "10": 1 "hereditary diseases thalassemia syndromes homozygous beta thalassemia heterozygous beta thalassemia delta beta thalassemia homozygous and heterozygous other hemoglobinopathies hereditary persistence of hemoglobin f homozygous and heterozygous sickle cell anemia hemoglobin c hemoglobin e hemoglobin lepore syndrome some unstable hemoglobin hereditary spherocytosis hemoglobin variants with retention time similar to that of hemoglobin f": 1 "models": 1 "phenotype a": 1 "18": 1 "19": 1 "melanoma": 1 "braf mutation analysis": 1 "primary clinical manifestation": 1 "percent affected": 1 "expression of transgene": 1 "miscellaneous pregnancy hyperthyroidism chronic renal disease trisomy 13 palau syndrome": 1 "tissue expression": 1 "p6.1": 1 "slsn": 1 "vdrlow": 1 "25": 1 "ca++ flux": 1 "28": 1 "stage pre- tcr": 1 "ptpn11 mutation": 1 "genetic test": 1 "sample type": 1 "30": 1 "33": 1 "genetic": 1 "phenotype ‡": 1 "expression": 1 "mutation sites checked": 1 "sporadic lam": 1 "adhesion": 1 "prognosis": 1 "aa change": 1 "treatment duration months": 1 " a uveal melanoma cell lines": 1 "arpkd": 1 "tumor": 1 "frequency of hras mutations in paraganglioma": 1 "nphp": 1 "z-score": 1 "p5.1": 1 "serrated pathway": 1 "42": 1 "germline point mutation": 1 "44": 1 "45": 1 "sterility": 1 "sporadic mds": 1 "syndrome associated with germline mutation": 1 "genetic mutation": 1 "clinical distinctive characteristics": 1 "kras mutation frequency": 1 "mouse": 1 "activation of other mapk members": 1 "follow-up screen mutations": 1 "mks": 1 "pik3ca mutations": 1 "disease omim": 1 "gene /protein": 1 "cases reported": 1 "seizures": 1 "results": 1 "56": 1 "braf mutation": 1 "aicd": 1 "relevance to human pathologies": 1 "genotype": 1 "fusion protein": 1 "setbp1 mutant": 1 "p4.1": 1 "affected genes": 1 "name": 1 "60": 1 "kras mutation": 1 "main affected cytokines": 1 "mmf": 1 "t cell phenotype": 1 "prior bevacizumab": 1 "her2 amplification": 1 "categories of hereditary colorectal cancer": 1 "mice": 1 "tsc1": 1 "naip deletion": 1 "figure": 1 "characteristics": 1 "cowden syndrome": 1 "cases": 1 "sample name": 1 "mpc subpopulation and phenotype": 1 "deletion ?/overexpression oe phenotype": 1 "p3.1": 1 "hamartin": 1 "immunophenotype": 1 "location": 1 "literature data valuesa": 1 "microcephaly capillary malformation syndrome": 1 "activity/tcr-dependent signaling pathway": 1 "extrarenal phenotype": 1 "stws phenotype": 1 "site of mutation": 1 "bradford hill’s causative principles 10 ": 1 "tissue": 1 "druggable mutations": 1 "p53": 1 "fap": 1 "idh1": 1 "93": 1 "10 ?m": 1 "98": 1 "high-dose stz": 1 "phase": 1 "liver": 1 "additional rcc cell line mutations *": 1 "3 ?m": 1 "tumour type": 1 "mpl": 1 "heredity": 1 "sift score": 1 "developmental defects": 1 "p2.1": 1 "age at biopsy years": 1 "afap": 1 "alms": 1 "adpkd": 1 "heterozygote deletion": 1 "gender/age": 1 "two-hybrid interactions": 1 "chromosomal abnormality": 1 "hepatic toxicity": 1 "clinical characteristics": 1 "nfat activ": 1 "pten genetic manipulation": 1 "gata2 mutation": 1 "occipital horn syndrome": 1 "frequency of hras mutations in phaeochromocytoma": 1 "chromosomal region": 1 "tumor incidence *": 1 "mutation assessor": 1 "phospho-erk western": 1 "type of germline mutation": 1 "phospho-mek western": 1 "neoplastic masses": 1 "total erk western": 1 "p1.2": 1 "p1.1": 1 "mutation count": 1 "alteration in sporadic melanoma": 1 "previously reported as somatic mutation in cancer b": 1 "incidence": 1 "disease associations": 1 "wild-type setbp1": 1 "ependympoma": 1 "mutator phenotype": 1 "gene b": 1 "transgenic phenotype": 1 "pdgfra": 1 "other features": 1 "pdgfrb": 1 "tissue-specific conditional phenotypes redundant phenotypes phenotypes induced by physiological challenge": 1 "genes number of mutations": 1 "percentage": 1 "treatment arms": 1 "deletion n?=?6": 1 "gene and/or product": 1 "imatinib resp.": 1 "consequence of mutation": 1 "coding mutations listed in cosmic database": 1 "strain": 1 "stage/site": 1 "#gene": 1 "braf mutations": 1 "p66shc?/?": 1 "rash grade": 1 "omim": 1 "truncating": 1 "metabolic phenotype": 1 "insertion": 1 "cac": 1 "cell/tissue type": 1 "mutation -": 1 "mutation +": 1 "genetic biomarkers": 1 "hras q61l mutation": 1 "gene identified": 1 "all mutations n ": 1 "phospho-elk western": 1 "pt no.": 1 "cdnka": 1 "targeted therapy": 1 "craniosynostosis": 1 "low-dose stz": 1 "p-tsc2": 1 "5 ?m": 1 "mode of inheritance": 1 "fl?/?itd+/+ ": 1 "hnpcc": 1 "chromosome": 1 "confidence": 1 "dysregulation": 1 "in vivo phenotype defects": 1 "kras": 1 "kras mutation analysis": 1 "duplication": 1 "homologues a": 1 "truncating mutations n = 31": 1 "assay": 1 "variable": 1 "clinical trials or pre-clinical reference www.clinicaltrials.gov ": 1 "responders cr/pr ": 1 "homozygote deletion": 1 
"reference": 9 "domain": 8 "segment": 6 "substrate": 6 "ligand": 6 "?top strand": 5 "position": 5 "?bottom strand": 4 "compounds": 4 "residue": 4 "structure": 4 "binding site": 3 "pdb code": 3 "occupancy": 3 "binding energy kcal/mol": 3 "h-bond interaction": 3 "atom": 3 "sequence": 3 "code": 3 "protein": 2 "peptide": 2 "tiam2 native i": 2 "tiam2 native ii": 2 "molecule": 2 "h-bond residues": 2 "molecules": 2 "stemp": 2 "35": 2 "ref": 2 "description": 2 "strand": 2 "target": 2 "rearrangement": 2 "docking score kcal/mol": 2 "gene": 2 "-cdocker interaction energy?gb kcal/mol": 2 "pdb id": 2 "native": 2 "sequence 5'-3'": 2 "motif": 2 "ref.": 2 "enzymatic impact": 1 "interacting molecules": 1 "eo01": 1 "references": 1 "derivative hg2+": 1 "average rmsd/å to nomnme·gpd": 1 "?tm °c a": 1 "lpar6": 1 "data processing pdb entry code": 1 "eg01": 1 "resolution": 1 "blinddock": 1 "h-4/c-4": 1 "protein name and binding site position": 1 "annealing t °": 1 "guaugauccucgaaucucacaguau": 1 "primers sets": 1 "formula of headgroup": 1 "complex": 1 "crystal name and nucleotide content": 1 "tiam2 se-met": 1 "nsp3–p130cas semet": 1 "state": 1 "caccgcagaataaggctagacaaagcgaactttgtcagccttattctgc": 1 "ftmap": 1 "s1": 1 "s2": 1 "rok? regions bound": 1 "tiam1 native": 1 "apoptin interacting residue": 1 "sec.struct.": 1 "#": 1 "residue and ??g kcal/mol": 1 "genes": 1 "arno-gdp": 1 "stealth sirna ?": 1 "binding surface": 1 "stealth sirna ?": 1 "3? v?": 1 "aaaagcagaataaggctgacaaagttcgctttgtctagccttattctgc": 1 "associated phenotype": 1 "rgm249 mt-2 shrna": 1 "glycosyl residue": 1 "macrophage-capping protein": 1 "affected structure": 1 "k-ras": 1 "proposed binding site residue": 1 "h-6ah-6b/c-6": 1 "region and contacts": 1 "c-myc": 1 "autoligand": 1 "4c9z": 1 "kd ?m": 1 "ligand mw g/mol": 1 "sum": 1 "melting": 1 "bind site": 1 "sf": 1 "akap-lbc dh–ph domain": 1 "arf1-arno": 1 "assembly": 1 "gene/chromosome location rat": 1 "pn loop or ?3 helix": 1 "red label": 1 "rgm249 mt-1 shrna": 1 "mct1": 1 "region b active site loop": 1 "34": 1 "tiam1": 1 "mct4": 1 "mct2": 1 "hydropathy": 1 "docking site": 1 "occurrence n = 855": 1 "igf-ir??igf-ir": 1 "n": 1 "igf-ir??ir-b": 1 "tf": 1 "bcar3 native": 1 "caccgcagaataaggctagacaaagcgaactttgtctagccttatttgc": 1 "refs": 1 "within lbs §": 1 "igf-ir??ir-a": 1 "ligand conc µm ligandg4": 1 "?g kcal/mol": 1 "rok? regions bound": 1 "rigor": 1 "k d ?m": 1 "affinity nm": 1 "duplex": 1 "monoclinic crystal form": 1 "uf": 1 "5'": 1 "substitution preference ¶": 1 "loop": 1 "1yah": 1 "gene/chromosome location human": 1 "artt loop": 1 "ir-a??ir-a": 1 "aaaagcaaataaggctagacaaagttcgctttgtctagccttattctgc": 1 "ir-a??ir-b": 1 "green label": 1 "rock1rhoe complex": 1 "aaaagcagaataaggctagacaaagttcgctttgtctagccttattctgc": 1 "id/accession": 1 "mean volume": 1 "catalytic subunit": 1 "nucleotide sequence 5? ? 3?": 1 "overlap": 1 "proximity": 1 "name": 1 "domain accession": 1 "rhoa": 1 "naïve state": 1 "deletions": 1 "4ca1": 1 "sequence identity": 1 "interface": 1 "annealing": 1 "semet": 1 "ethanolamine-phosphate cytidylyltransferase": 1 "apoptin residue": 1 "libdock score": 1 "space group": 1 "auacugugagauucgaggaucauac": 1 "stat3": 1 "logscore": 1 "c-kit1": 1 "pdz-binding motif": 1 "c-kit2": 1 "bottom strand": 1 "domain name": 1 "region 2": 1 " kcal/mol": 1 "region 1": 1 "il-15—il-15r?—il-2r?—?c complex": 1 "181": 1 "peak": 1 "rnd3 peptide": 1 "? h binding": 1 "molecule name": 1 "location": 1 "?g score": 1 "h-3/c-3": 1 "pocket": 1 "binding level": 1 "codon position": 1 "position of 8-oh-g": 1 "activated pca = 4.2": 1 "xps atomic ": 1 "n-terminal domain": 1 "ft2g8": 1 "tissue": 1 "interaction classes": 1 "structure completeness": 1 "?h kcal/mol": 1 "wtmek": 1 "mol/au": 1 "property": 1 "number of mismatches": 1 "complex w/ca2+/dgtp/datp": 1 "method": 1 "location n": 1 "—14.00 å—": 1 "agf bound": 1 "cancer types": 1 "? g binding": 1 "rmsd å": 1 "domain description": 1 "motif name": 1 "mutation": 1 "stoichiometry n ": 1 "system": 1 "n region": 1 "?hº kcal/mol": 1 "glycerophospholipid": 1 "aknadicine": 1 "nsp3–p130cas native": 1 "extension": 1 "binding partner": 1 "gene/chromosome location mouse": 1 "fragments size": 1 "gcagaauaaggcuagacaaagggaa": 1 "occurrence": 1 "structure determination": 1 "introduced residue": 1 "clinical characteristics": 1 "mismatch ¥": 1 "identity": 1 "v?/j?": 1 "annealing position": 1 "16beta-hydroxy-19s-vindolinine n-oxide": 1 "interacting nherf1 pdz domain": 1 "product": 1 "whole region": 1 "5? j?": 1 "fxfg complex 4fcm": 1 "akap-lbc dh domain": 1 "bcl2": 1 "hydrogen bond distance å": 1 "binding motif": 1 "pmek4": 1 "pmek3": 1 "pmek5": 1 "h-2/c-2": 1 "pmek2": 1 "pmek1": 1 "scaffold": 1 "state group": 1 "regulatory subunits": 1 "ir-b??ir-b": 1 "bcr-abl": 1 "interacting residues": 1 "t?sº kcal/mol": 1 "distance å": 1 "helical domain": 1 "form 2": 1 "unliganded 4iia": 1 "form 1": 1 "affected residue": 1 "caveolin associated molecule": 1 "edge": 1 "caccgcagaataaggctagacaaagcgaactttgtctagccttattctgc": 1 "interaction types": 1 "unliganded 4fcj": 1 "function": 1 "triclinic crystal form": 1 "h-5/c-5": 1 "nsp3–p130cas thiomerosal": 1 "protein/receptor": 1 "dock score": 1 "dscore kcal/mol": 1 "location ": 1 "motif id": 1 "hydropathy segment": 1 "phospho-ser": 1 "beyond lbs §": 1 "drug inhibitors": 1 "chip no.": 1 "nucleotide substitution": 1 "f21t": 1 "14-3-3 binding": 1 "protein interaction": 1 "amino acid": 1 "ensemble average calculation kcal/mol": 1 "primed state": 1 "g domain": 1 "uucccuuugucuagccuuauucugc": 1 "rgm249 shrna": 1 "relaxed": 1 "total": 1 "csk binding sequence": 1 "erbb2 a": 1 "erbb2 b": 1 " mol/kcal": 1 "h-1/c-1": 1 "bcr-abl residue": 1 "gate or": 1 "orientation": 1 "comments": 1 "p-value": 1 "ple": 1 "mst4-quinazoline": 1 "diffusion constant µ m2/sec": 1 "?gº kcal/mol": 1 "t?s kcal/mol": 1 "sb-590885": 1 "nherf1 ligand": 1 "assay": 1 "tripos sybyl-x scoring functions": 1 "? ts binding": 1 "binding domain in tsp-1": 1 "headgroup": 1 "nucleotide position": 1 "cromo-some": 1 
"reference": 91 "references": 71 "target": 49 "function": 48 "other function": 47 "gene": 31 "mirna": 27 "cancer type": 27 "unknown": 25 "mechanism of action": 25 "2.67": 25 "hsa-mir-145": 24 "2.18": 24 "?2.04": 23 "2.03": 23 "hsa-mir-432": 22 "pathway": 22 "drug": 20 "p-value": 19 "name": 19 "fold change": 18 "ref.": 18 "p value": 16 "compound": 16 "1.77": 16 "anti-apoptotic": 15 "hsa-mir-134": 15 "2.39": 15 "class": 14 "target gene": 13 "count": 12 "apoptotic": 12 "effect": 12 "agent": 10 "tumor type": 10 "indication": 9 "mechanism": 9 "refs.": 9 "cancer": 8 "mode of action": 8 "3.75": 8 "disease": 8 "gene symbol": 8 "status": 8 "2.15": 8 "cell type": 8 "hsa-mir-29b-1*": 8 "type": 8 "source": 7 "mechanism of synergy": 7 "molecular function": 7 "company": 7 "compound 1 target 1": 7 "regulation": 7 "compound 2 target 2": 7 "microrna": 7 "embryona": 7 "atm +/cytoplasmic": 7 "6": 6 "7": 6 "8": 6 "?2.77": 6 "target genes": 6 "evidence": 6 "protein": 6 "phase": 6 "5": 5 "9": 5 "phase of development": 5 "suggested mechanism": 5 "phenotype": 5 "organ or action": 5 "atm -": 5 "?5.32": 5 "kegg pathway": 5 "10": 5 "expression": 5 "gene name": 5 "role in cancer": 5 "hsa-mir-1909": 5 "biological process": 5 "molecular target": 5 "q-value": 4 "1": 4 "2": 4 "3": 4 "4": 4 "cellular function": 4 "genes": 4 "micrornas": 4 "social interaction": 4 "mirnas": 4 "accession number": 4 "other phenotypes": 4 "12h vs 0h": 4 "pathway name": 4 "target gene s": 4 "genes involved in pathway": 4 "ref": 4 "alveolar": 4 "repetitive behavior": 4 "pathway id": 4 "refs": 4 "no.": 4 "mouse": 4 "results": 4 "fdr": 4 "social communication": 4 "cell signaling agent": 4 "model": 4 "id": 4 "effect of combination vs single treatments": 4 "3h vs 0h": 4 "receptor": 4 "observation": 4 "th1": 3 "th2": 3 "go term": 3 "signaling pathway": 3 "developmental stage": 3 "experiment": 3 "tumor target": 3 "1.8e-02": 3 "cqu": 3 "technique": 3 "reference s": 3 "biological effects": 3 "?1.26": 3 "delivery system": 3 "stage": 3 "malignancy": 3 "drug name": 3 "target protein": 3 "targets": 3 "host": 3 "medicinal part": 3 "current status": 3 "16": 3 "mrna": 3 "21": 3 "target s and function s": 3 "38": 3 "no of molecules": 3 "effect of combination vs single treatment": 3 "molecular pathology": 3 "genetic aberration": 3 "aae": 3 "molecular mechanisms of action": 3 "aga": 3 "family": 3 "1.17": 3 "1.34": 3 "species": 3 "biological function": 3 "type of cancer": 3 "upregulated": 3 "description": 3 "mechanism of localization": 3 "process and gene": 3 "cell morphology": 3 "botanical name": 3 "study": 3 "effects": 3 "sponsor": 3 "lhr+": 3 "molecular and cellular functions": 3 "drug/s": 3 "potential therapeutics": 3 "stage of development": 3 "2.36": 3 "author reference year": 3 "ubqln1": 3 "dilution": 3 "activity": 3 "symbol": 3 "frequency": 3 "related to tc?": 3 "protein name": 3 "natural agent": 3 "mirna id": 2 "expression level": 2 "target s": 2 "role": 2 "?2.07": 2 "component": 2 "?2.19": 2 "?2.15": 2 "novel": 2 "cellular growth and proliferation": 2 "mouse strain": 2 "effectiveness": 2 "main findings": 2 "4/m.": 2 "pdzk1ip1": 2 "atm - 1": 2 "2.9": 2 "key references": 2 "immune effector response": 2 "regulation of apoptosis": 2 "comments": 2 "full name": 2 "regulated pathway": 2 "signaling axis": 2 "lh+": 2 "molecule": 2 "3.61": 2 "treatment type": 2 "modulator": 2 "name of inhibitory agent": 2 "ptc": 2 "cellular development": 2 "cellular localization": 2 "loss of function mirsnp": 2 "7.01": 2 "37°c": 2 "incidence": 2 "7.7e-05": 2 "number of genes": 2 "sqrdl": 2 "arl5b": 2 "chromosome": 2 "1.2121e-14": 2 "?1.19": 2 "?1.13": 2 "dose": 2 "route": 2 "treatment": 2 "?1.42": 2 "physiological result": 2 "?1.65": 2 "regulation of programmed cell death": 2 "upstream regulator": 2 "accession no.": 2 "ras component": 2 "antigen": 2 "classification": 2 "affected pathway": 2 "member": 2 "gene function": 2 "cellular process": 2 "apoptosis": 2 "hoxa5": 2 "structure": 2 "sensors": 2 "357": 2 "normal function": 2 "11": 2 "12": 2 "14": 2 "15": 2 "17": 2 "pathway component": 2 "22": 2 "28": 2 "29": 2 "33": 2 "differentiation potential": 2 "increasing": 2 "40": 2 "detection parameter": 2 "finding": 2 "regulator": 2 "primary metabolic process": 2 "4.71": 2 "73": 2 "mirna fold change": 2 "95": 2 "type of regulation": 2 "no of regulated genes": 2 "event": 2 "mtc": 2 "biomarker": 2 "cell death and survival": 2 "catalog number": 2 "signaling": 2 "freq .": 2 "jhdm1d": 2 "rab": 2 "itgb8": 2 "scps": 2 "positive regulation of macromolecule biosynthetic process": 2 "12 dpa": 2 "30°c": 2 "type aberration": 2 "il-7? / ?": 2 "significance": 2 "cell type expression": 2 "number": 2 "1.19": 2 "1.16": 2 "chemical class": 2 "wild type": 2 "other": 2 "1.45": 2 "1.56": 2 "1.48": 2 "regulation of phosphate metabolic process": 2 " human": 2 "1.64": 2 "downregulated": 2 "cnr ny72-4": 2 "type ccl": 2 "protein target": 2 "up-regulated": 2 "regulation of cell death": 2 "aso route of administration in the experimental model reference": 2 "actb": 2 "atc": 2 "type of mutation": 2 "dhrs9": 2 "tissue": 2 "enrichment score 2.15": 2 "physiological system development and function": 2 "genetic aberration ": 2 "phase of clinical development": 2 "diet": 2 "enzyme": 2 "chromosome location": 2 "?1.06": 2 "type of protein": 2 "gene name chromosomal location": 2 "5 dpa": 2 "no of genes involved": 2 "chemical": 2 "virus": 2 "molecular mediator s of apoptosis": 2 "nanocarrier system": 2 "protein function": 2 "origin": 2 "nfib": 2 "peg10": 2 "ppar ?": 2 "?3.33": 2 "positive regulation of macromolecule metabolic process": 2 "iaps involved": 2 "40°c": 2 "2.09": 2 "ftc": 2 "skov3/tx600/skov3": 2 "2.33": 2 "2.46": 2 "1.5": 2 "down-regulated": 2 "p -value": 2 "apoptotic or anti-apoptotic function": 2 "2.69": 2 "decreasing": 2 "signal pathway": 2 "2.75": 2 "2.73": 2 "molecular alteration": 2 "diras1": 2 "wnt signaling": 2 "cell line": 2 "mammalian homolog": 2 "tr": 2 "gain of function mirsnp": 2 "7 dpa": 2 "cef ny72-4": 2 "regulation of cell proliferation": 2 "atm + weakly/cytoplasmic": 2 "gene protein": 2 "macc1": 2 "inhibitor": 2 "tissue type": 2 "mechanism of deregulation": 2 "studies": 2 "pmid": 2 "molecular target of aso-based therapy": 2 "0.00039839": 1 "associated with": 1 "type 2": 1 "hepatic fibrosis/hepatic stellate cell activation": 1 "nrg1+pcp 16?g/ml": 1 "?": 1 "b cell receptor signaling": 1 "3.0e-03": 1 "comment s": 1 "2.3e-03": 1 "introduced": 1 "2.3e-02": 1 "1.6e-03": 1 "cells/samples and their source": 1 "name of gene": 1 "action target of src": 1 "system development": 1 " ": 1 "target molecule": 1 "target type": 1 "interacting ecm protein": 1 "#": 1 "accession #": 1 "13/181 0.072": 1 "neocortex": 1 "cdk": 1 "regulated by fkbp5": 1 "mtor physiology": 1 "david p-value": 1 "proposed substrate": 1 "cytotoxicity mtt assay in nhm": 1 "n° of mirna target genes": 1 "main ligand": 1 "implication in cancer": 1 "pollen tubes and root hairs": 1 "transmembrane receptor protein tyrosine kinase signalling pathway": 1 "caspase": 1 "result": 1 "apoptotic role": 1 "?2.08": 1 "?2.02": 1 "cytoskeleton regulation": 1 "mirna target and its role in cancer": 1 "reference for target genes": 1 "downstream functions": 1 "drug tested": 1 "target and class": 1 "developmental comparison": 1 "a": 1 " of the target region covered": 1 "b": 1 "mxra5": 1 "differences compared to sporadic tumours": 1 "open/total": 1 "targeted pca stage": 1 "n": 1 "p": 1 "positive regulation of locomotion": 1 "classification of tf": 1 "?2.16": 1 "13/118 0.11": 1 " of other": 1 "polycythaemia vera": 1 "?2.21": 1 "7.1054e-11": 1 "?2.23": 1 "mrna target": 1 "?2.28": 1 "go term id": 1 "?2.24": 1 "oncolytic virus": 1 "inhibitory action": 1 "small gtpase regulators": 1 "toll-like receptor signaling": 1 "others": 1 "establishment and/or maintenance of chromatin architecture": 1 "?2.31": 1 "inhibitors available*": 1 "pstat3 modulators": 1 "chr": 1 "compound name": 1 "2.3163e-23": 1 "incidence a": 1 "compounds": 1 "protein context": 1 "effect of pathway inhibition": 1 "small molecule inhibitor": 1 "oncogenic mirnas": 1 "inhibitory effects on signaling and targeted signal molecules": 1 "protective pathways": 1 "flnb": 1 "?2.44": 1 "cancer kinds": 1 "amino acid and derivative metabolic process": 1 "?2.48": 1 "previous disease correlations": 1 "location of 1": 1 "pathway involved": 1 "pct": 1 "citation": 1 "10/155 0.065": 1 "development of primary sexual characteristics": 1 "multiple": 1 "regulated by i/r": 1 "pi3k subunit gene symbol": 1 "major ligands": 1 "spindle shape formation": 1 "nhej non-homologous end joining": 1 "hsa21 interactors": 1 "clinical applicability of parp inhibition": 1 "2.1e-02": 1 "involved ligand": 1 "#input genes in pathway": 1 "approach": 1 "lung cancer": 1 "key regulated genes by tf": 1 "invadopodia": 1 "probe set 1": 1 "polarity disrupted": 1 "viral agents": 1 "natural source": 1 "splicing isoform activity": 1 "clinical implications": 1 "therapeutic indication": 1 "gonad development": 1 "breast cancer cell targeted": 1 "colorectal cancer": 1 "intracellular fate": 1 "angiogenesis": 1 "sequences coverage ": 1 "cells affected": 1 "involvement in disease": 1 "human **": 1 "oncogene target": 1 "maximization ofsag expressionand minimizationof tcr stimulatorymolecules": 1 "postulated role in disease evolution": 1 "sequelae of proteosome inhibition": 1 "pdb id": 1 "abdoman": 1 "host factors implicated in mlv pic or in interactions": 1 "ovarian cancer cell line": 1 "lymphocyte signaling": 1 "fbxw7 vip": 1 "top": 1 "fas signaling cd95": 1 "syndrome": 1 "cell cycle*": 1 "micro-rna": 1 "fold change after simvastatin": 1 "leukemic disease": 1 "consequence": 1 "drugs": 1 "target id": 1 "egf signaling": 1 "number of degs with pathway annotation": 1 "2.1": 1 "2.2": 1 "2.3": 1 "2.4": 1 "regulation of expression a": 1 "signaling component": 1 "p -value£": 1 "atm +/cytopiasmic": 1 "1.8e-05": 1 "sffv-a": 1 "regulation of locomotion": 1 "neuron differentiation": 1 "bacteria": 1 "predicted cdr2 action on c-myc": 1 "sffv-p": 1 "rhombomere patterning": 1 "stem cell surrogate": 1 "cell cycle function": 1 "erbb receptor": 1 "genes involving pathway": 1 "comparison": 1 "mouse model": 1 "3.15": 1 "pathway source database": 1 "3.6592e-09": 1 "cellular and biological effects": 1 "cat number": 1 "condition": 1 "3.07": 1 "uniprot-id": 1 "subnetwork": 1 "3.05": 1 "natural tlr4 signaling inhibitor": 1 "anterior–posterior patterning": 1 "biological pathway": 1 "claudins": 1 "antiangiogenic potential": 1 "biological functions/process 1": 1 "patient population": 1 "subfamily": 1 "barrier effect": 1 "gene changes": 1 "3.23": 1 "tgf-beta signaling": 1 "-ln p-value": 1 "biological effect s associated with biomarker upregulation": 1 "potential target cancer": 1 "expression in hcc": 1 "3.19": 1 "3.08e-20 -3.87e-05": 1 "involved receptor": 1 "molecular mass da *": 1 "11/106 0.104": 1 "paraspinal": 1 "fold reduction/induction": 1 "marketed by": 1 "sense aggctcggagacaga tgaaga antisense gcggacagacagacacttacc": 1 "fbxo32": 1 "food component": 1 "expression status": 1 "ntn4": 1 "autophagy promotion": 1 "in complex with": 1 "p-val": 1 "oxidative stress via nrf2": 1 "lea": 1 "main function": 1 "connective tissue disorders developmental disorder skeletal and muscular disorders": 1 "enrichment score 4.42": 1 "4.54e-05": 1 "agent class": 1 "alternative name": 1 "cell specific expression b": 1 "6.2e-03": 1 "putative mirnas that target p53 related proteins human and mouse": 1 "shown by": 1 "target scan's context percentile/mami score in decimals/mitg score in italics ": 1 "original indication": 1 "nct numbers": 1 "pathway affected": 1 "1 dpa": 1 "4.38e-04": 1 "cancer type s": 1 "growth factor": 1 "viral proteins/mechanisms": 1 "development status": 1 "biological effects of dysregulation": 1 "lh1": 1 "249": 1 "lh4": 1 "clinical condition": 1 "lh8": 1 "element treatment/snps": 1 "e6-ap-transgenic background": 1 "digestive system development and function embryonic development organismal development": 1 "drug development goal": 1 "precursors": 1 "expression and role": 1 "potential relevance in rcc": 1 "mfsd2a": 1 "oncogene or antigen": 1 "chemotherapeutic outcome prediction": 1 "pp2a subunit or regulator": 1 "q -value *": 1 "affinity for insulin/igf family members": 1 "arsi": 1 "principal gene pathways altered in uremia": 1 "265": 1 "connective tissue disorders": 1 "ecm/integrin ligands": 1 "function in aging traits": 1 "? 4 statins": 1 "inhibitory target": 1 "enrichment score 4.09": 1 "specific mutation": 1 "cell lines": 1 "antagonist": 1 "annotation cluster 6": 1 "human mmp2": 1 "gliogenesis": 1 "mmp type and target molecule": 1 "annotation cluster 5": 1 "annotation cluster 4": 1 "annotation cluster 3": 1 "annotation cluster 2": 1 "predictive to anti-egfr therapy": 1 "annotation cluster 1": 1 "times identified": 1 "therapeutic intervention": 1 "unigene id": 1 "clinical trial": 1 "associated metabolite addiction": 1 "signalling pathway and inhibitor": 1 "c -values computed ina particular condition": 1 "proteins not involved": 1 "cgh-1 bat1 brr2 * fal1 * regulated responses": 1 "associated with egfr tumor levels": 1 "leukocyte transendothelial migration": 1 "small gtpase": 1 "annotation cluster 9": 1 "annotation cluster 8": 1 "niche component": 1 "? 1 chloroquine": 1 "annotation cluster 7": 1 "sex differentiation": 1 "viral evasion of autophagy": 1 "kinase type": 1 "site and associated cancer": 1 "author year": 1 "renal structure": 1 "a direct effects": 1 "memory": 1 "8.9e-03": 1 "regulation via": 1 "enrichment score 4.24": 1 "regulation of transferase activity": 1 "virulence of loss-of-function mutant": 1 "3d human epidermal equivalent": 1 "direction of deregulation": 1 "mrna-mirna pair": 1 "ruvb rad51 rad50 regulated responses": 1 "9.2683e-10": 1 "pathway description": 1 "link with lrrk2": 1 "mediators and mechanisms": 1 "relevant gene ontology biological or molecular designations": 1 "?1.1": 1 "?1.2": 1 "microrna dysregulation": 1 "functional group": 1 "biological function s and/or cancer-related activities": 1 "gene and function": 1 "upregulated or downregulated": 1 "residues": 1 "fold ?": 1 "experimental evidence": 1 "total targets in mouse": 1 "heat-shock response hsr pathways": 1 "identification method": 1 "nanoparticles": 1 "direct inhibition": 1 "gene s involved *": 1 "mechanism of additive/synergistic action": 1 "identifier": 1 "role of autophagy in cancer cells": 1 "lbh589/obatoclax": 1 "fold change fgf+tnf vs tnf": 1 "conclusions": 1 "cancer types": 1 "cell cycle phase arrest": 1 "0.00578571": 1 "reproductive system disease": 1 "1.4e-02": 1 "kinase target": 1 "activated oncogene": 1 "initiation phase": 1 "loh": 1 "methods": 1 "overexpression in tumora": 1 "mirna involvement": 1 "main biopax classes used": 1 "study/ reference": 1 "regulation of cell cycle": 1 "modulation by hdaci": 1 "mouse snail": 1 "target mirna s and role in cancer": 1 "model system": 1 "genes down-regulated by atf3 knockdown": 1 "disease regression factors": 1 "withaferin a wfa": 1 "signalling pathway": 1 "cell cycle": 1 "translocation effect": 1 "host-virus interactions and host antiviral defense": 1 "il-2 signaling": 1 "chromatin assembly or disassembly": 1 "details and associated functions of disc1": 1 "genetic evidence": 1 "dna/rna metabolism": 1 "socs3": 1 "type of alteration": 1 "cdr2 regulation": 1 "6.66e-14 -2.84e-05": 1 "process involved": 1 "type of resistance": 1 "demethylase": 1 "mirna dysregulation": 1 "differentiating group": 1 "tumor entity": 1 "group": 1 "sod2": 1 "ednra": 1 "cancer hallmark": 1 "autophagy role": 1 "reference/trial identifier": 1 "rab43": 1 "effect on signaling": 1 "epigenetic drugs": 1 "reduced function?": 1 "known oncogenic alterations": 1 "normal stem cells": 1 "dysregulated proteins": 1 "antagonists": 1 "human bin1": 1 "biomarker or mechanistic": 1 "sense cggactcctttggctatggcctc antisense tggtgccagttccatccgca": 1 "q-pcr": 1 "host range": 1 "hsp12 pbs2 hog1 and pka regulators of hsp12 in s cerevisiae found in tardigrades 62": 1 "role in lymphatic vessels": 1 "no of peptides": 1 "proliferaion": 1 "intracellular ic or extracellular ec role": 1 "proteins / genes": 1 "process": 1 "product name": 1 "source if available": 1 "molecular therapeutic target": 1 "mechanism of action s": 1 "concentration": 1 "phenotypes": 1 "early cns": 1 "cflar": 1 "potential drug type": 1 "case 12": 1 "number of targets": 1 "case 11": 1 "case 14": 1 "case 13": 1 "case 16": 1 "cancer model": 1 "case 15": 1 "involvement of modified initiation factors in selective translation dependent on cis-elements": 1 "case 17": 1 "ppar ? agonist + antitumor agent": 1 "target description": 1 "onset of action min": 1 "rad50 regulated response": 1 "?1.15": 1 "neurites": 1 "mets in animial": 1 "case 10": 1 "in vivo tumorigenesis": 1 "physiological role of cav-1": 1 "genes down regulated during hcc": 1 "impact": 1 "?1.22": 1 "integrin subunits": 1 "?1.27": 1 "dose administration": 1 "role of emt regulation": 1 "stage of development in nsclc": 1 "3.7e-02": 1 "?1.25": 1 "domain": 1 "association with hcc development": 1 "relative percentage of regulated transcripts ": 1 "effect on barrier": 1 " a": 1 "current targetability": 1 "positive regulation of cellular biosynthetic process": 1 "?1.32": 1 "?1.33": 1 "new indication": 1 "annotated in cho mirbase v20": 1 "mechanism of autophagy induction": 1 "?1.38": 1 "involvement in cellular process": 1 "term": 1 "epigenetic function": 1 "primary antibodies": 1 "19/m.": 1 "nuak2": 1 "effector": 1 "secretion apparatus": 1 "lncrnas": 1 "7*remarks": 1 "3.6393e-16": 1 "regulation of biological process": 1 "regulation of cell migration": 1 "regulation of protein kinase activity": 1 "molecular formula": 1 "aging": 1 "gene names": 1 "0.00061206": 1 "lh20": 1 "?1.54": 1 "sirnad": 1 "documented and postulated effect": 1 "new target": 1 "validated targets": 1 "occurrence in centenarians": 1 "?1.58": 1 "?1.59": 1 "atm signaling": 1 "mouse fbln1": 1 "6.5907e-08": 1 "sense catcaacatcgtcgtaatcgga antisense cttgtcga ttccgccaca t": 1 "marine source": 1 "epigenetically regulated mirnas": 1 "oncoproteins involved in ddr": 1 "predicted pairing of target and mirna": 1 "?1.63": 1 "golgi function": 1 "signaling components of epo/epor pathway": 1 "up regulated genes": 1 "?1.67": 1 "origination": 1 "molecular cellular and physiological functions": 1 "mir identified": 1 "nrg1+pcp 8?g/ml": 1 "1.98e-23 -3.32e-05": 1 "vegf signaling": 1 "potential mechanisms to target csc": 1 "cellular location §": 1 "regulation of phosphorylation": 1 "molecular and biological function": 1 "title": 1 "associated prepositions": 1 "target and reference": 1 "duration": 1 "potential relevant function": 1 "loss or gain of function": 1 "whbv/ctrl": 1 "role on epc biology": 1 "crosstalk between dendritic cells and natural killer cells": 1 "human": 1 "mouse tbx3": 1 "8.03e-05": 1 "tumor suppressor class and complex or pathway": 1 "expression pattern": 1 "sense gtccgcagtcttacgaggag antisense gcttgagggtctgaatcttgct": 1 "potential target s": 1 "stem cell population": 1 "integrin type": 1 "translation initiation factor": 1 "? 1 eritoran e5564": 1 "regulated mirnas": 1 "gap junction": 1 "down regulation": 1 "pertussis toxin-insensitive ccr5 signaling macrophage": 1 "p-values": 1 "6.0e-03": 1 "?1.91": 1 "ppar ? agonist": 1 "3.9e-05": 1 "number of rules": 1 "cited2": 1 "study details": 1 "effect on metastasis": 1 "supplier": 1 "action": 1 "affected pathway and final effect": 1 "loci": 1 "direct binding site s on target gene?": 1 "fold change at 3h": 1 "neurological disease": 1 "relevant targets": 1 "rhcg": 1 "number aml trials": 1 "role in cell growth": 1 "silenced": 1 "pcd trigger": 1 "molecules interfering with tlr4 and tlr4-mrna expression": 1 "banf1": 1 "p -values a": 1 "5.0e-05": 1 "ontogenetic comparison": 1 "tight junction": 1 "ovarian csc/tics targeted": 1 "regulation mechanism": 1 "component or process": 1 "dynamic behaviors": 1 "gpx3 expression level n": 1 "metabolic effect of gene change": 1 "approval status": 1 "n tumors with molecular marker": 1 "signaling pathways": 1 "in vitro or in vivo": 1 "regulation fgf+tnf vs tnf": 1 "mpped2": 1 "selectivity": 1 "pd locus": 1 "protein name spot number swissprot accession average molecular weight in daltons": 1 "genes predicted by phenotype to act in process": 1 "inheritance": 1 "associated network functions": 1 "readout": 1 "chronic inflammation": 1 "molecular alterations": 1 "molecular size a.a": 1 "sense ttctggtcaaggtcacctgtc antisense caagttccccggcga tgtc": 1 "authors' conclusion": 1 "type of attenuator": 1 "metabolic co-factors": 1 "most common grade 3-4 adverse events": 1 "role of autophagy": 1 "background": 1 "enzymes that use the co-factor": 1 "mgmt ?/? mam vs vehicle plus wt vs mgmt ?/? with respect to mam vs vehicle total molecules n?=?443": 1 "parp-1 function": 1 "biological properties": 1 "signaling branching type": 1 "incidence of mds in patients §": 1 "cell cyle": 1 "type of action": 1 "activated by": 1 "disease and mirna": 1 "12 ?m": 1 "human siah1": 1 "human siah2": 1 "? 6 lidocaine": 1 "sdcbp2": 1 "mouse slug": 1 "cellular lipid metabolic process": 1 "dub": 1 "in vivo test": 1 "involved genes": 1 "mrm1": 1 "class of protein": 1 "sense tggtcaagaaaca tttcaacgcc antisense ggtgaggatctctggttttggta": 1 "tissue or biological fluid": 1 "cell growth": 1 "s100a2": 1 "mousestrain": 1 "observed": 1 "s100a9": 1 "ras-raf-mek-mapk pathway 2": 1 "sprr2a": 1 "product name and related functional pathway": 1 "corrected ? p-value": 1 "sense tcggaagcctaactacagcga antisense agatgagcattggcagcgag": 1 "genomic location": 1 "bp from stop codon": 1 "1.12e-15 -2.69e-05": 1 "13": 1 "mouse hmbs": 1 "cell-to-cell signaling and interaction": 1 "18": 1 "module": 1 "19": 1 "no of snpsin pathway": 1 "autoimmune disease": 1 "action target on atf-2": 1 "1.5643e-08": 1 "term in query": 1 "supported by data?": 1 "disease state": 1 "20": 1 "23": 1 "site of the cell": 1 "24": 1 "25": 1 "26": 1 "27": 1 "phenotypic findings": 1 "cellular movement": 1 "function of ha in inflammation": 1 "mode of action/biological activity": 1 "bmh2 pathway": 1 "interacting partner": 1 "abnormal genes": 1 "contribution to anti-tumour effect": 1 "first approved indication": 1 "sample type": 1 "30": 1 "31": 1 "32": 1 "34": 1 "35": 1 "reaction": 1 "37": 1 "induction/activation": 1 "dysregulation in ngf signaling": 1 "form of silk": 1 "prognosis": 1 "sense aggatcttcggacctatctggc antisense ggcttcgtgcatcgctttaac": 1 "maml2": 1 "downstream target s": 1 "id1": 1 "cerebellar and midbrain induction and patterning": 1 "protein identification": 1 "major mechanism": 1 "p-value related to angiogenesis": 1 "ratio": 1 "gnrh signaling": 1 "role in t cells": 1 "hypothetical mdm2 pathway": 1 "protein identified": 1 "epithelial cell signaling h pylori infection": 1 "neurogenesis": 1 "therapeutic targets": 1 "client protein or interacting protein of hsp90": 1 "53": 1 "inhibitor name": 1 "enrichment score 1.82": 1 "most cited repositories for biological pathways": 1 "physiological function in the brain": 1 "simic": 1 "molecular alteration in the pi3k pathway": 1 "mode of dysregulation": 1 "transcription factor/signaling pathway": 1 "63": 1 "small gtpases involved": 1 "68": 1 "refseq id": 1 "69": 1 "oncomir": 1 "drugs and reference": 1 "plce1": 1 "dna helicase0": 1 "regulation of phosphorus metabolic process": 1 "common": 1 "name of compound": 1 "categories and gene names": 1 "tumorigenesis": 1 "78": 1 "name 1": 1 "sense probe 5?-3?": 1 "transient activation": 1 "? 5 vitamin d3 ?": 1 "herb extract of natural chemical": 1 "ccl20": 1 "7.0e-03": 1 "role in panca": 1 "active phytochemicals": 1 "rho-gtpase pathway": 1 "formula": 1 "comment": 1 "83": 1 "86": 1 "target mrna": 1 "mouse siah1a": 1 "effect on upr or target": 1 "mouse siah1b": 1 "chemical nature": 1 "phytochemicals": 1 "preparation": 1 "e6-ap-null background": 1 "description of cancer related or other major function": 1 "mechanism of anticancer effect": 1 "96": 1 "transcriptional function": 1 "functional consequences": 1 "serum levels": 1 "pcp 8?g/ml": 1 "enrichment score 1.42": 1 "resistance": 1 "phase/model of investigation in hnscc": 1 "annotation cluster 10": 1 "sense tacaggatcattggctacacacc antisense ggtcacatcgctccagact": 1 "annotation cluster 11": 1 "semantic agent – structure": 1 "usual dose daily unless mentioned": 1 "nb of mirnas": 1 "phase of experimentation": 1 "enrichment score 1.70": 1 "? 3 ketamine": 1 "proteasome inhibitor": 1 "modulation in aki": 1 "maize contig": 1 "hypoxia stimulates": 1 "cell morphology cellular assembly and organization carbohydrate metabolism": 1 "total counts in hippo-campus 18 ": 1 "integrin": 1 "tumors associated with virus infection": 1 "refe-rence": 1 "key in vivo findings": 1 "associated inflammatory stimuli": 1 "term in genome": 1 "c1orf74": 1 "initiation of neurogenesis": 1 "genes in subnetworks": 1 "pathway databases": 1 "down in anterior tissues 1": 1 "dna packaging": 1 "upstream regulators": 1 "msg": 1 "hdac members associated with": 1 "mouse zeb1": 1 "mouse zeb2": 1 "down regulated": 1 "cell adhesion molecules cams": 1 "pi3k component": 1 "mechanism of impaired synaptic plasticity impairment": 1 "site of tumour": 1 "mir-21 targets": 1 "page number": 1 "potency ed50 nmol/100 ?l": 1 "implicated signaling pathway": 1 "metabolic?+?others": 1 "cargos/targeted delivery": 1 "target / mode of action": 1 "t cell receptor signaling": 1 "tissue selectivity": 1 "regulation of kinase activity": 1 "salivary gland": 1 "tumor example": 1 "hsd17b2": 1 "known physiological role": 1 "6.53e-21 -3.62e-05": 1 " represented": 1 "human cetn2": 1 "sense aatcacccggagtgcttatc antisense ggaccctttcccacaattta": 1 "development stage": 1 "intervention": 1 "up regulated in pii": 1 "mrna fold change": 1 "phenolic compound": 1 "observation in pcos": 1 "keratinocyte differentiation": 1 "endocytosis pathway": 1 "proposed function in viral life cycle": 1 "alterations linked to rms": 1 " ldl pathway during atherogenesis 1": 1 "array": 1 "nucleosome assembly": 1 "experimentally defined as disease-sustaining secondary adaptations": 1 "3.43e-15 -2.37e-05": 1 "interleukin": 1 "rad23 regulated responses": 1 "? 4 opioids": 1 "15/m.": 1 "0.00474381": 1 "other toxicity": 1 "accession numbers": 1 "experimental approach by targeting ha-binding motifs": 1 "genes on hsa21": 1 "sense gatgatgaatgcgagtcagatgc antisense acagcagtgtcttgttgttgt": 1 "growth": 1 "rab function": 1 "source of resistance": 1 "granulocyte adhesion and diapedesis": 1 "mirna dysregulation associated with poor response": 1 "year": 1 "molecular characteristic": 1 "bcol st6galnac5": 1 "perturbed tcrpathway conflictingobjectives’optimization": 1 "gene product": 1 "score": 1 "oscillation": 1 "paratesticular": 1 "cell adhesion partner s": 1 "pbx1": 1 "target or mode of action": 1 "qrt-pcr": 1 "vp1 vp5 regulators in z mays a thaliana not found in tardigrades b15c peroxiredoxin rab 16 rice maize barley not found in tardigrades 56 abi3 a thaliana tf regulates aba-responsive genes not found in tardigrades": 1 "major dna repair pathways": 1 "protocol id": 1 "cellular effect": 1 "function in ad": 1 "mouse ef-1": 1 "model organism": 1 "target tissue or cell": 1 "myb": 1 "presumed mechanism of action in glioma context": 1 "drug resistance": 1 "agranulocyte adhesion and diapedesis": 1 "axon guidance": 1 "molecules": 1 "srgap1": 1 "positive regulation of biosynthetic process": 1 "hgf/c-met? receptor": 1 "proteins/ pathways involved": 1 "mechanism s": 1 "lunknown": 1 "developmental phase": 1 "irf": 1 "fold change a": 1 "lncrna": 1 "itga5": 1 "regulation of cell motion": 1 "sense ccaatgccgccagaagttaag antisense cagggaaacagaactgccga": 1 "ultrasensitivity": 1 "invasion": 1 "genes in gliomas deregulated by hypo/hypermethylation/histone modification": 1 "isc": 1 "tumor molecular marker": 1 "notes": 1 "regulated by myb": 1 "2.2e-02": 1 "attenuator": 1 "bar number": 1 "organ or system": 1 "mirna processing components": 1 "fc epsilon ri signaling": 1 "homolog": 1 "0.00393855": 1 "cytoplasmic fraction": 1 "methyltransferase": 1 "z’-score": 1 "expression localization and regulatory role": 1 "nb of genes": 1 "long-term depression": 1 "dna condenser": 1 "proportion of differentially expressed genes involved *": 1 "sense agcgcagtcttaccgaagg antisense tcgctgctttcatactgaacttt": 1 "6 ?m": 1 "physiological effects": 1 "resulting effect": 1 "5.8e-04": 1 "1.01": 1 "gene description 1": 1 "top networks": 1 "activation z-score": 1 "mir function in metabolism": 1 "frequency ": 1 "molecular": 1 "sort1": 1 "variation associated with ad": 1 "therapeutic status": 1 "focal adhesion": 1 "approval year": 1 "1.7e-03": 1 "1.7e-02": 1 "cellular response": 1 "6.5259e-11": 1 "molecular formula *": 1 "kegg pathway subcategory": 1 "hematological system development and function": 1 "docking score": 1 "potential role in longevity": 1 "clinical significance": 1 "functional data available?": 1 "manuscript section": 1 "1.06": 1 "radiosensitization": 1 "1.04": 1 "compound company": 1 "rho": 1 "pathway/process": 1 "expression levels’ change in hcc": 1 "significantin hcc": 1 "apobec3g": 1 "localization": 1 "detected in tissue/cell": 1 "mouse siah2": 1 "sensitivity/specificity": 1 "vip fbxw7 pcdhgb6": 1 "1.21": 1 "edn1 signaling": 1 "study in patient samples?": 1 "1.14": 1 "source other than dionaea muscipula": 1 "phenotype major features": 1 "splicing": 1 "log ratio": 1 "mir-21 expression in human tissues/cells": 1 "biological process and function": 1 "mtor inhibitors": 1 "pcp 16?g/ml": 1 "tumor/metastasis": 1 "affected gene": 1 "1.28": 1 "transporter targets": 1 "possible biological significance": 1 "cell differentiation": 1 "proposed mechanism": 1 "4.6296e-12": 1 "lipid metabolism": 1 "1.43": 1 "cell": 1 "absolute number of regulated transcripts": 1 "1.42": 1 "4/m": 1 "1.38": 1 "1.36": 1 "human slug": 1 "hdac inhibitor": 1 "outcome": 1 "synthetically sick or suppressor": 1 "0.00950461": 1 "ratio*": 1 "1.55": 1 "targeting mirna verified": 1 "1.47": 1 "symbol s": 1 "0.00725011": 1 "tumor category": 1 "4.9e-02": 1 "fd 3": 1 "protein names and abbreviations": 1 "sense gctggcaagacaacgtgaaag antisense gcctcaggataaatgacggc": 1 "cas number *": 1 "1.66": 1 "neuronal signaling pathway": 1 "trial": 1 "biological effect s associated with biomarker downregulation": 1 "validated target genes with a potential role in cancer": 1 "1.58": 1 "2.0e-02": 1 "mode of autophagy inhibition tested": 1 "assay method": 1 "problems reported": 1 "unperturbedtcr pathway": 1 "+ azacytidine open/total": 1 "3.1e-05": 1 "7.4208e-17": 1 "cytokine": 1 "all": 1 "therapeutic combination": 1 "1.71": 1 "knowna": 1 "mhbv/ctrl": 1 "panther molecular function": 1 "6.7366e-15": 1 "analysis/findings": 1 "nrseq€": 1 "specific hypothesis/ molecular basis": 1 "gene allele used * ": 1 "6/m.": 1 "altered in nsclc": 1 "da target": 1 "1.88": 1 "1.98e-23 -2.92e-05": 1 "1.85": 1 "role of mirna in csc properties": 1 "1.5989e-14": 1 "symbol ncbi nm_id": 1 "endocytosis type": 1 "compound commercial name": 1 "sense agagctgcgagtacagcct antisense aagacctgtccacactggtag": 1 "validation assay": 1 "function or links to disease": 1 "ratios": 1 "positive regulation of cell motion": 1 "cell types expressing and influenced by galectins in glioma context": 1 "thnsl1": 1 "cancer and cancer stem cells": 1 "molecules interfering with tlr4-related intracellular signalling pathway": 1 "embryonic development": 1 "1.96": 1 "1.95": 1 "hematopoietic cell lineage": 1 "primary target": 1 "positive scoring definition s": 1 "tissue morphology": 1 "common adverse events": 1 "cancer cell morphology organ morphology": 1 "1.73e-06": 1 "cell signaling": 1 "natural killer cell signaling": 1 "steps of metastasis": 1 "strategy": 1 "disease model": 1 "disease gene": 1 "neurodegeneration": 1 "promotion or inhibition of senescence": 1 "epigenetic or cellular effect": 1 "function related to the cell wall cw": 1 "clinical data": 1 "aptamer composition": 1 "fwer p-value": 1 "associate function": 1 "histology": 1 "herpesvirus": 1 "published year": 1 "organelle lumen": 1 "pathway target": 1 "abi3bp bcol diras1 egflam st6galnac5": 1 "? 2 ketamine": 1 "network topology": 1 "expansion of neuroepithelial progenitors": 1 "grade": 1 "structure/sequence": 1 "8.3e-02": 1 "essential thrombocythaemia": 1 "biological functions in gliomas": 1 "mouse **": 1 "effect related to ir": 1 "top canonical pathways": 1 "tk fusion": 1 "cancer or disease involved": 1 "regulated by mybl1 & l2": 1 "sense gtgttgcacgatcctgaaact antisense gttgcccatcctttatcactgta": 1 "sense cacacgctgccttgtgtct antisense ggtcagcaaaagcacggtt": 1 "molecular basis for biomarker targeting in ovarian cancer": 1 "mutants or transgenic lines": 1 "lymphoid tissue structure and development": 1 "microrna identifier": 1 "inflammatory disease": 1 "structures": 1 "expression in cancer": 1 "direction of dysregulation": 1 "saha/obatoclax": 1 "grb7": 1 "combined ionscore": 1 "known /novel epo target": 1 "nls": 1 "tumor": 1 "clinicopathological features": 1 "sense taaatggtcataggcgacga antisense gcaatgctggtgtcaaagac": 1 "vesicle size": 1 "tumour type associated with nf1": 1 "toxicity": 1 "enrichment score 2.68": 1 "enrichment score 2.67": 1 "wnt pathway 1": 1 "change folds": 1 "molecular status": 1 "type of mutations": 1 "pathological condition": 1 "signalling alteration": 1 "cellular components": 1 "cellular compromise": 1 "17aag": 1 "imaging": 1 "axon pathfinding": 1 "signaling type": 1 "method used to evaluate autophagy": 1 "il13ra2": 1 "parameters": 1 "all genes with pathway annotation 2143": 1 "6.8739e-10": 1 "expressiona": 1 "muts pcna regulated response": 1 "drugs used to suppress function": 1 "biological example": 1 "mir-125b targets": 1 "procedural incidence b": 1 "il-10 anti-inflammatory signaling": 1 "intrinsic/acquired/adaptive": 1 "intracellular transport": 1 "gene symbol name and entrez id": 1 "effect of the molecular alterations": 1 "factor": 1 "adult functions?": 1 "can the longevity pathway confer neuroprotection?": 1 "dependence on catalytic activity": 1 " of the target region covered >10x": 1 "cancer effect": 1 "anomalies": 1 "suppressor mirna": 1 "role in hedgehog pathway": 1 "tyrosinase activity": 1 "modifications of initiation factors involved in inhibition of cap-dependent translation": 1 "carcinogenic events": 1 "5.86e-20 -3.62e-05": 1 "cyclin": 1 "defect in crc": 1 "down- or unregulated": 1 "consequences of phosphorylation": 1 "endocytic pathway": 1 "a microrna expression and target mrna gene expression.": 1 "lea pathways": 1 "regulation by her2": 1 "13/191 0.068": 1 "cellular assembly and organization hematological system development and function inflammatory response": 1 "multicellular organismal development": 1 "agent or approach": 1 "protein fold change": 1 "nrm": 1 "proteins involved": 1 "6.7e-02": 1 "tf name": 1 "6.7e-03": 1 "postinitiation phase": 1 "mechanism of resistance": 1 "iccs": 1 "synaptogenesis": 1 "potential targets": 1 "# genes in pathway": 1 "human fbln1": 1 "nav3": 1 "toca-1-n-wasp expression of control": 1 "superset": 1 "go classification **": 1 "main regulator": 1 "process or component": 1 "vehicle": 1 "component gene/protein": 1 "reference number": 1 "amine metabolic process": 1 "clinical use": 1 "key component s": 1 "main function of the ras signalling pathways": 1 "mechanism of internalization": 1 "antisense probe 5?-3?": 1 "stress": 1 "sequenced bases on target": 1 "human zeb2": 1 "human zeb1": 1 "skull base": 1 "use of biomarker": 1 "0.00069981": 1 "original target": 1 "putative role in disease susceptibility": 1 "role in autophagy": 1 "positive regulation of cell migration": 1 "potential functions": 1 "catalogue number": 1 "pathway size": 1 "effect on host": 1 "n tumors assessed": 1 "not regulated by i/r": 1 "channel type": 1 "effector mirna": 1 "cellular target": 1 "involvement in biological processes/ pathways a": 1 "node +": 1 "mechanism of inhibition": 1 "in vivo model": 1 "1dpa": 1 "no plant aba responsive pathway": 1 "website/link": 1 "rhogtpase or gef": 1 "strain": 1 "net mfi of ppar ?": 1 "survival": 1 "tumor lineage": 1 "3.8636e-12": 1 "oncogenic ras perturb the intrinsic biochemical properties of cell pathways": 1 " of dr": 1 "marker": 1 "human n-cadherin": 1 "enrichment score 2.03": 1 "sigset": 1 "cell fate process affected": 1 "cell type evaluated": 1 "human physiology and disease": 1 "no genes": 1 "sense caagaggcgcaaacaagcc antisense ggttggcaataccgtcatcc": 1 "rr/mst": 1 "cooperation with": 1 "function s/defect s in immune evasion": 1 "rho proteins": 1 "claudin": 1 "p53-null background": 1 "potential use for the tumor types": 1 "?1.04": 1 "?1.09": 1 "target name": 1 "control by vitamin d receptor": 1 "transcription factor": 1 "bcam": 1 "experimental system": 1 "oc subtype": 1 "telencephalon induction and patterning": 1 "specific effects": 1 "1.2576e-18": 1 "activated signaling cascade": 1 "target process": 1 "scf": 1 "sequence 5? to 3?": 1 "age category": 1 "? 6 lansoprazole through its action on socs1": 1 "mirna target": 1 "regulation of cellular process": 1 "cellular pathway": 1 "human bgn": 1 "plant": 1 "prss22": 1 "involvement in senescence": 1 "tcp1": 1 " mouse": 1 "driver oncogenic mutation": 1 "1.4034e-14": 1 "btg1": 1 "complement and coagulation cascades": 1 "sense caggtctcctca tggctttgc antisense cttccgaaaagaaggctgtcc": 1 "il-2 receptor beta chain t cell activation": 1 "6.66e-14 -2.35e-05": 1 "selection of confirmed targets": 1 "set": 1 "no of genesin pathway": 1 "pathogenperturbedtcr pathway": 1 "degs with pathway annotation 648": 1 "6.7346e-08": 1 "sample": 1 "idiopathic myelofibrosis": 1 "non-down regulated": 1 "sense atcagatggctaaccagcaca antisense a tcctgcactccttgga ttct": 1 "anatomical structure development": 1 "modulated associated event": 1 "route of administration": 1 "targeting mechanism": 1 "gene prediction": 1 "3.8e-03": 1 "tumor type s": 1 "sense cagtggctttgaacctggag antisense cagcttggagtagcgaagca": 1 "type of biological pathway": 1 "positive regulation of nitrogen compound metabolic process": 1 "sense ggacaagctgagcaaga ttca antisense cggagaaggcgtagctgag": 1 "3/m.": 1 "p-value fdr adjustment": 1 "biological target": 1 "types of cancers tested": 1 "molecular and cancer implications": 1 "functional category and known function *": 1 "up regulation": 1 "pathway name from gsea": 1 "alteration frequency ": 1 "cfl1": 1 "tumor characteristics": 1 "evidence pmids": 1 "sig": 1 "major target site s": 1 "initiating stimulus": 1 "model system/pathology": 1 "after downregulation/inactivation/antagonism of initiating stimulus": 1 "genes involved": 1 "lrrk2 fragment": 1 "t status*": 1 "? 7 glycine": 1 "summary of key events": 1 "neural induction": 1 "comparison of the free cell period fcp vs the attachment period ap": 1 "q o.r.": 1 "gk": 1 "oncogenes": 1 "984": 1 "lipid metabolic process": 1 "targets in pathway": 1 "chromosome organization and biogenesis": 1 "key reference s": 1 "agent or drug": 1 "escs hypersensitivity to dna damage": 1 "disease maintenance after down-regulation of initiating stimulus": 1 "subset": 1 "down regulated in pii": 1 "experimental mouse model": 1 "4.36e-07": 1 "ras effector pathways": 1 "protein/gene": 1 "sema7a": 1 "other functions": 1 "context": 1 "positive regulation of developmental process": 1 "endocytosis": 1 "bcl-2 family effect": 1 "number of genes1": 1 "target rank": 1 "target molecules in dataset": 1 "biological role": 1 "rested effector": 1 "2.90e-16 -3.95e-05": 1 "7*signaling molecules": 1 "gene from biological analysis": 1 "number of involved genes": 1 "secreted proteins": 1 "2.02": 1 "mycobacterium species": 1 "indication examples": 1 "immune modulation of host": 1 "gene id": 1 "case 8": 1 "case 9": 1 "case 4": 1 "case 5": 1 "sr.no": 1 "case 6": 1 "case 7": 1 "case 1": 1 "case 2": 1 "case 3": 1 "9.7426e-17": 1 "major saes": 1 "2.14": 1 "cancer cells": 1 "impact of the aberrant expression on pc cells": 1 "reporterb": 1 "chromosomal position": 1 "2.08": 1 "inflammation": 1 "2.04": 1 "mouse twist": 1 "programmed cell death": 1 "producing cell type": 1 "ic50 value nmol/l": 1 "bmh2 key regulator sck1 key regulator lcb1 depending enzyme + lcb2 depending enzyme + fig 5 49": 1 "sense cgatcttgtttgcctcatccc antisense tgagcagtgcgtccagaattt": 1 "chromosomal location": 1 "genbank accession number": 1 "5.60e-19 -2.92e-05": 1 "mouse mmp2": 1 "side-effects/disadvantages": 1 "dosing": 1 "areal patterning": 1 "2.16": 1 "3.43e-15 -3.35e-05": 1 "sense aagtgtccacca tcccagag antisense atgtaagtttggggcgacag": 1 "?3.8": 1 "species/cell/tissue type references": 1 "functional class": 1 "anova": 1 "2.34": 1 "reproductive developmental process": 1 "regulation of cell size": 1 "2.32": 1 "helicasec rad5 * tip49 * regulated responses": 1 "inhibitor/drug": 1 "rtx/obatoclax": 1 "molecular cause": 1 "upstream pathway": 1 "2.27": 1 "nitrogen compound metabolic process": 1 "dbsnp": 1 "delivery system to modulate the mirna in vivo*": 1 "bistability": 1 "level": 1 "penetrance of the rnai phenotype ": 1 "epo modulation fold change array/rtpcr": 1 "role in tzmb resistance": 1 "diagnosis": 1 "matricellular protein": 1 "prediction by mirna database s": 1 "1.1": 1 "gene regulation": 1 "2.38": 1 "confirmed targets": 1 "1.6": 1 "evidences of oncogenesis": 1 "4.1e-05": 1 "biological process 2": 1 "working mechanism": 1 "cellular location": 1 "biological function / response": 1 "biomarker†": 1 "general function": 1 "2.55": 1 "2.53": 1 "maximum effects emax mm hg": 1 "2.52": 1 "potential senescence-associated pathway/mechanism of action": 1 "targeting antigen": 1 "preparations": 1 "investigator": 1 "nf?b component regulated by rhogtpase signalling": 1 "rna helicase": 1 "hetero": 1 "mirna hypermethylated": 1 "2.49": 1 "seed match": 1 "wnt pathway": 1 "mutated": 1 "role of taurine": 1 "control": 1 "2.66": 1 "2.65": 1 "crabp2": 1 "connectivity profile of the hub node across pathways": 1 "evidence for role in angiogenesis reference": 1 "104": 1 "milk-derived mir": 1 "2.59": 1 "niche surrogate": 1 "7.14e-16 -3.62e-05": 1 "angiv/at4? receptor subtype": 1 "model system studied": 1 "nct number": 1 "accession no a": 1 "p ds": 1 "signaling molecules": 1 "expression in pc cells": 1 "comments on dysregulation": 1 "impaired pathways/biomarker": 1 "? 3 gts21 nicotinic analogue": 1 "studies in nsclc": 1 "st *": 1 "role of sam68": 1 "2.82": 1 "functions associated with oncogenesis": 1 "biological effects of lpli": 1 "involvement of tsrs": 1 "prostate/bone marrow": 1 "124": 1 "diseases and disorders": 1 "mouse bin1": 1 "mulv subgroup": 1 "126": 1 "role in pcd": 1 "129": 1 "gata2 configuration": 1 "cblb": 1 "responding cell type": 1 "mir-21 involvement in biological process": 1 "simj": 1 "role in pca": 1 "effect on autophagy": 1 "edn1": 1 "polarity not disrupted": 1 "134": 1 "mouse n-cadherin": 1 "function a": 1 "tumor sites or cell lines": 1 "vector": 1 "expression change associated with resistance": 1 "sense aagcatttcaacgcctccaaa antisense ggatctctggttgtggtatgaca": 1 "development phase": 1 "transcriptional targets of p53/p63/p73/target mirna- processing components/comments": 1 "human twist": 1 "scf signaling": 1 "function s": 1 "oncogenic virus": 1 "ner nucleotide excision repair": 1 "141": 1 "tagln3": 1 "p53 related proteins": 1 "2.19e-20 -2.00e-05": 1 "144": 1 "tf": 1 "148": 1 "natural killer cell cytotoxicity": 1 "accompany disease maintenance": 1 "transgenic mouse models": 1 "modulation": 1 "targeted region coverage": 1 "fda first approval": 1 "involvement in cellular processes": 1 "position in 3? utr": 1 "affected in pdac": 1 "ber base excision repair": 1 "effect on differentiation": 1 "level of action": 1 "158": 1 "mpp1": 1 "variant": 1 "substrate": 1 "xrcc1 regulated response": 1 "change 1": 1 "ras-raf-mek-mapk pathway": 1 "target mirnas": 1 "calcium signaling": 1 "site of expression": 1 "refseq": 1 "p-value of overlap": 1 "sense gctacagcattatccactggc antisense aggacactcaaaaagactcgc": 1 "mmr mismatch repair": 1 "?2.3": 1 "extract": 1 "mouse e-cadherin": 1 "cell wall fraction": 1 "1.3737e-05": 1 "major reported toxicities": 1 "? 5 vitamin d3 through its action on ll37": 1 "receptor or rec family": 1 "effect on": 1 "target organ": 1 "immune cell trafficking": 1 "tumor types": 1 "regulation type": 1 "?2.7": 1 "potential role": 1 "kegg entry": 1 "generic name /code number trade name": 1 "10 kda groes/hsp10 regulated response 20–30 kda grpe/hsp27 hsp20 interaction partner of mef2 40 kda dnaj/hsp40 regulated response stimulates hsp70 70 kda dnak/hsp70 regulated response 90 kda htpg/hsp90 regulated response mef2 key regulator gapdh depending enzyme 81 hsbp1 regulator of tf hsf1": 1 "epigenetic drug": 1 "respective references": 1 "bisphosphonate": 1 "top diseases and bio functions": 1 "pdgf signaling": 1 "0.006535": 1 "6.25": 1 "3.43e-15 -1.54e-05": 1 "role of mirna": 1 "180": 1 "role in angiogenesis": 1 "186": 1 "cluster 2": 1 "microarray": 1 "dbsnp#": 1 "cluster 3": 1 "cluster 1": 1 "potential function of milk microrna": 1 "potential clinical value*": 1 "location": 1 "qpcr": 1 "6.33": 1 "mechanism of crizotinib resistance": 1 "gene chromosome": 1 "grhl1": 1 "ms platform": 1 "b microrna expression and protein target expression .": 1 "tissue specificity": 1 "associated disease-phenotype/ impact on survival outcomes": 1 "feedback": 1 "feature no.": 1 "altered in cisplatin resistant": 1 "galectins": 1 "number of samples a": 1 "effect of phosphate": 1 "metabolic pathways": 1 "neuronal localization and function": 1 "antibody": 1 "target disease | stage": 1 "method": 1 "ptb effect in facilitating translational initiation": 1 "regulation of gene expression": 1 "hrr homologous recombination": 1 "potentia l target": 1 "timing of oligodendrogenesis": 1 "action mechanism": 1 "myc regulation": 1 "non-transformed cells": 1 "long-term potentiation": 1 "sense atcgcattatgcaagactggatt antisense atgcacatccttcgataagactg": 1 "abrogating effect": 1 "signaling convergence type": 1 "potential crosstalk with g proteins": 1 "? 2 resatorvid tak242": 1 "pelvis": 1 "maxic": 1 "skeletal and muscular disorders": 1 "malignancies": 1 "phenotype investigated": 1 "aberrant expression": 1 "target and mechanism": 1 "e2f and pp factors implicated": 1 "sod enzyme prx-1?2?4?6 regulated enzyme by stre ap-1 and nrf2 redox regulated tfs for stre nrf2 was not found but its inhibitor inrf2": 1 "sense tggaacccgaagaagacgtag antisense taccccgcttgtgaaactgg": 1 "mdm2-mutant mice": 1 "biological process and molecular functions": 1 "argument": 1 "signalling component": 1 "function in cancer": 1 "effect of ros": 1 "involvement of gab2": 1 "ontogenetic stage": 1 "fbxw7 vip foxk1": 1 "development": 1 "human snail": 1 "specific biosystem": 1 "prognostic": 1 "incidence of disease": 1 "effector function": 1 "other properties": 1 "reported function s": 1 "perturbedtcr pathway maximization oftoxin expressionand of tcrstimulatorymolecules": 1 "hog signal pathway": 1 "kinase name": 1 "epilepsy type": 1 "targeting": 1 "2763": 1 "astaxanthin ax": 1 "maintenance of undifferentiated neurogenic precursors": 1 "observations": 1 "enzyme id": 1 "lineage assessed": 1 "function/putative function": 1 "in vitro tumorigenesis": 1 "reported mechanisms of action": 1 "log2 t/nt": 1 "potential use": 1 "orientation": 1 "cell development": 1 "hdaci": 1 "log2 fold change": 1 "muc1": 1 "nlrc5": 1 "gene number": 1 "o.r.": 1 "rho family": 1 "advantages/disadvantages": 1 "groups": 1 "related experimental evidences": 1 "carrier": 1 "category": 1 "expression in oscc": 1 "frequency tumor samples": 1 "type/site of cancer": 1 
"references": 7 "flavonoid": 6 "herbs": 4 "nf68": 3 "polyphenol": 3 "nf200": 3 "nf160": 3 "virus": 2 "ingredient": 2 "atp generation control": 2 "refs": 2 "metabolites": 2 "target": 2 "taxus brevifolia pacific yew": 1 "minerals": 1 "association of antioxidants": 1 "calf perinatal mortality1 ×100": 1 "? rosmarinus officinalis carnosol and ursolic acid": 1 "coffea arabica": 1 "nutrient g/kg": 1 "polyphenols flavonoids resveratrol pycnogenol": 1 "polypodium leucotomos": 1 "contains 95 proanthocyanidins": 1 "enzymatic antioxidants": 1 "? ganoderma lucidum triterpenoids": 1 "substance groups": 1 "soy flour": 1 "scutellaria baicalensis chinese skullcap": 1 "10": 1 "curcumin": 1 "11": 1 "12": 1 "13": 1 "14": 1 "?vitamin d 1? 25-d3": 1 "15": 1 "genes": 1 "latin botanical name": 1 "? hibiscus sabdariffa l protocatechuic acid": 1 "g/100?g diet": 1 "bioactive substance": 1 "peaks": 1 "1": 1 "2": 1 "contains 20 resveratrol": 1 "3": 1 "4": 1 "ellagitannin source": 1 "5": 1 "silkworm lepidoptera": 1 "6": 1 "fatty acids eicosapentaenoic acid and omega 3": 1 "plant": 1 "7": 1 "8": 1 "9": 1 "fruit fly diptera": 1 "extracts": 1 "?quercetin": 1 "? taxus brevifolia taxoids": 1 "? ocimum sanctum carnosol ursolic acid": 1 "wine": 1 "? zingiber officinale 6-gingerol": 1 "?other chinese herbs see table vi ": 1 "photo-oxidized commercial squalene": 1 "?omega-3 fatty acids eicosapentaenoic acid docosahexaenoic acid": 1 "somatic cell count1 units×100": 1 "ain": 1 "? silybum marianum silymarin": 1 "diets": 1 "contains taxol": 1 "? chrysobalanus icaco methanol extract": 1 "?soy isoflavones genistein daidzein": 1 "sc": 1 "red flour beetle coleoptera": 1 "se": 1 "plant part used": 1 "mechanism": 1 "? polypodium leucotomos difur": 1 "? ginkgo biloba ginkgolide b": 1 "silybum marianum milk thistle": 1 "? dysoxylum binectariferum flavopiridol": 1 "epigallocatechin-3 gallate/green tea": 1 "angelica sinensis dong quai": 1 "contains 90 honokiol": 1 "other substances chocolate caffeine acetyl salicylic acid": 1 "green tea": 1 "ibuprofen indomethacin antimalarials corticosteroids": 1 "artemisia annua chinese wormwood": 1 "camellia sinensis green tea": 1 "contains 95 phenols 50 epigallocatechin": 1 "? poria cocos 1–3-?- d -glucan": 1 "natural host": 1 "snp": 1 "phyllanthus ?species": 1 "viscum album european mistletoe": 1 "tumor": 1 "milk fat percentage1 ×100": 1 "green-lipped mussel": 1 "pathway": 1 " +rna viruses": 1 "monarch butterfly lepidoptera": 1 "milk thistle": 1 "animal production": 1 "phytochemical": 1 "chinese skullcap": 1 "? camellia sinensis epigallocatechin": 1 "? scutellaria baicalensis baicalin and baicalein": 1 "magnolia seed cones": 1 "aloe vera": 1 "source": 1 "? glycyrrhiza glabra isoliquiritigenin glabridin": 1 "contains 95 curcumin": 1 "reference": 1 "derivatives": 1 "vitamins vitamin c and vitamin e": 1 "? livistona chinensis aqueous extract from seed": 1 "? magnolia obovata honokiol": 1 "function": 1 "contains 80 silymarin silybin": 1 "antioxidants vitamins a c e se zn carotenoids flavonoids coenzyme q10 n -acetylcysteine lipoic acid": 1 "? aloe barbadensis aloe vera leaf and pulp extracts": 1 "gene/bta": 1 "immunomodulatory activities": 1 "? viscum album lectins": 1 "squalene isolated from photo-oxidized ssl": 1 "curcuma longa turmeric": 1 "pharmaceutical name chinese pinyin ": 1 "grape seed extract proanthocyanidins": 1 "contains 4-hydroxyderricin": 1 "? artemisia annua artemisinin": 1 "tannin": 1 "percent remaining aromatizer activity": 1 "bilberry": 1 "? angelica sinensis aqueous extracts": 1 "? matricaria chamomilla flavonoids apigenin fisetin": 1 "ginger": 1 "effect": 1 "mirna": 1 "boswellia": 1 "ic50 ± sem ? g/ml": 1 "herbs and associated phytochemicals": 1 "fish oils omega-3 fatty acids eicosapentaenoic acid docosahexaenoic acid": 1 "? tanacetum parthenium l parthenolide": 1 "vitd?": 1 "carotenoids betacarotene astaxanthin lycopene lutein": 1 "probiotics": 1 "isotype": 1 "medicinal plants extract": 1 "?shark cartilage water soluble extract ae-941": 1 "? tabebuia avellanedae ?-lapachone": 1 "subfamily": 1 "? polygonum cuspidatum resveratrol": 1 "se + green tea": 1 "milk protein yield kg": 1 "panax ginseng": 1 "polygonum cuspidatum japanese knotweed": 1 "? rabdosia rubescens hora ponicidin and oridonin": 1 "?squalus acanthias dogfish liver squalamine": 1 "liquorice": 1 "contains mistletoe lectin iii ml3a": 1 "animal-derived": 1 "?panax ginseng saponins 20 r- and 20 s-ginsenoside-rg3": 1 "milk protein percentage1 ×100": 1 "?selenium": 1 "quercetin": 1 "other chinese herbs see table vi ": 1 "resveratrol": 1 "class": 1 "?bovine cartilage": 1 "bromelain": 1 "allele substitution": 1 "antioxidant activities": 1 "garlic": 1 "contains 95 artemisinin and other related terpenes and flavonoids": 1 "? curcuma longa curcumin": 1 "?cyclo-oxygenase-2 antagonists see table iv ": 1 "control": 1 "contains 95 baicalin and flavonoids": 1 "pc-3": 1 "dietary source": 1 "black bean": 1 "?proanthocyanidin": 1 "vitis vinifera grape seed extract": 1 "honey bee hymenoptera": 1 "molecular pathways 1": 1 "family": 1 "?flos magnoliae magnosalin": 1 
